PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Men, XC; Shibata, Y; Takeshita, T; Yamashita, Y				Men, Xiaochen; Shibata, Yukie; Takeshita, Toru; Yamashita, Yoshihisa			Identification of Anion Channels Responsible for Fluoride Resistance in Oral Streptococci	PLOS ONE			English	Article							MUTANS; TRANSFORMATION	Recently, it has been reported that eriC and crcB are involved in bacterial fluoride resistance. However, the fluoride-resistance mechanism in oral streptococci remains unclear. BLAST studies showed that two types of eriCs (eriC1 and eriC2) and two types of crcBs (crcB1 and crcB2) are present across 18 oral streptococci, which were identified in >= 10% of 166 orally healthy subjects with >= 0.01% of the mean relative abundance. They were divided into three groups based on the distribution of these four genes: group I, only eriC1; group II, eriC1 and eriC2; and group III, eriC2, crcB1, and crcB2. Group I consisted of Streptococcus mutans, in which one of the two eriC1s predominantly affected fluoride resistance. Group II consisted of eight species, and eriC1 was responsible for fluoride resistance, but eriC2 was not, in Streptococcus anginosus as a representative species. Group III consisted of nine species, and both crcB1 and crcB2 were crucial for fluoride resistance, but eriC2 was not, in Streptococcus sanguinis as a representative species. Based on these results, either EriC1 or CrcBs play a role in fluoride resistance in oral streptococci. Complementation between S. mutans EriC1 and S. sanguinis CrcB1/CrcB2 was confirmed in both S. mutans and S. sanguinis. However, neither transfer of S. sanguinis CrcB1/CrcB2 into wild-type S. mutans nor S. mutans EriC1 into wild-type S. sanguinis increased the fluoride resistance of the wild-type strain. Co-existence of different F-channels (EriC and CrcB) did not cause the additive effect on fluoride resistance in oral Streptococcus species.	[Men, Xiaochen; Shibata, Yukie; Takeshita, Toru; Yamashita, Yoshihisa] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka, Japan	Kyushu University	Yamashita, Y (corresponding author), Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka, Japan.	yoshi@dent.kyushu-u.ac.jp	Takeshita, Toru/AAT-2321-2021		Ministry of Education, Culture, Sports, Science and Technology of Japan [25463251, 25293428]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in Aid for Scientific Research 25463251 (YS) and 25293428 (YY) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; S. sanguinis SK36 was kindly provided by M. Kilian, Department of Biomedicine, Aarhus University, Aarhus, Denmark and S. Kawabata, Department of Oral and Molecular Microbiology, Osaka University Graduate School of Dentistry, Osaka, Japan. S. anginosus NCTC 10707 was kindly provided by A. Yoshida, Department of Oral Microbiology, Matsumoto Dental University, Shiojiri, Japan. This study was supported in part by Grants-in Aid for Scientific Research 25463251 (YS) and 25293428 (YY) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; BROWN LR, 1983, J DENT RES, V62, P746, DOI 10.1177/00220345830620061201; BUNICK FJ, 1981, INFECT IMMUN, V34, P856, DOI 10.1128/IAI.34.3.856-863.1981; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hoelscher GL, 1996, CURR MICROBIOL, V32, P156, DOI 10.1007/s002849900028; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kawada-Matsuo M, 2009, ORAL MICROBIOL IMMUN, V24, P173, DOI 10.1111/j.1399-302X.2008.00485.x; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; Li D, 2012, APPL ENVIRON MICROB, V80, P97, DOI [10.1073/pnas.1210896109, DOI 10.1073/PNAS.1210896109]; Li SS, 2013, P NATL ACAD SCI USA, V110, P19018, DOI 10.1073/pnas.1310439110; Liao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122630; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; MALTZ M, 1982, J DENT RES, V61, P786, DOI 10.1177/00220345820610062701; Marquis RE, 2003, FEMS MICROBIOL REV, V26, P493, DOI 10.1111/j.1574-6976.2003.tb00627.x; MAYHEW RR, 1981, J DENT RES, V60, P1809, DOI 10.1177/00220345810600101301; Moritani K, 2015, ORAL DIS, V21, P748, DOI 10.1111/odi.12341; Murata T, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw101; PERRY D, 1983, INFECT IMMUN, V41, P722, DOI 10.1128/IAI.41.2.722-727.1983; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Sambrook J, 2001, MOL LAB MANUAL; Silver S, 1996, GENE, V179, P9, DOI 10.1016/S0378-1119(96)00323-X; Stockbridge RB, 2012, P NATL ACAD SCI USA, V109, P15289, DOI 10.1073/pnas.1210896109; STRECKFUSS JL, 1980, J DENT RES, V59, P151, DOI 10.1177/00220345800590021501; Takeshita T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08136; VANLOVEREN C, 1991, J DENT RES, V70, P1491, DOI 10.1177/00220345910700120401; VANLOVEREN C, 1991, ORAL MICROBIOL IMMUN, V6, P288	27	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165900	10.1371/journal.pone.0165900	http://dx.doi.org/10.1371/journal.pone.0165900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824896	gold, Green Published, Green Submitted			2022-12-27	WOS:000387615200042
J	Keesman, M; Aarts, H; Vermeent, S; Hafner, M; Papies, EK				Keesman, Mike; Aarts, Henk; Vermeent, Stefan; Haefner, Michael; Papies, Esther K.			Consumption Simulations Induce Salivation to Food Cues	PLOS ONE			English	Article							APPETITE; GHRELIN; HUNGER; EXPOSURE; BEHAVIOR; HUMANS; DEPRIVATION; PERCEPTION; REACTIVITY; RESPONSES	Salivation to food cues is typically explained in terms of mere stimulus-response links. However, food cues seem to especially increase salivation when food is attractive, suggesting a more complex psychological process. Adopting a grounded cognition perspective, we suggest that perceiving a food triggers simulations of consuming it, especially when attractive. These simulations then induce salivation, which effectively prepares the body for eating the food. In two experiments, we systematically examined the role of simulations on salivation to food cues. As stimuli, both experiments used an attractive, a neutral, and a sour food, as well as a non-food control object. In Experiment 1, participants were instructed to simulate eating every object they would be exposed to. We then exposed them to each object separately. Salivation was assessed by having participants spit their saliva into a cup after one minute of exposure. In Experiment 2, we instructed half of participants to simulate eating each object, and half to merely look at them, while measuring salivation as in Experiment 1. Afterwards, participants rated their simulations and desire to eat for each object separately. As predicted, foods increased salivation compared to the non-food control object, especially when they were attractive or sour (Exp. 1 and 2). Importantly, attractive and sour foods especially increased salivation when instructed to simulate (Exp. 2). These findings suggest that consumption simulations play an important role in inducing salivary responses to food cues. We discuss directions for future research as well as the role of simulations for other appetitive processes.	[Keesman, Mike; Aarts, Henk; Vermeent, Stefan] Univ Utrecht, Dept Psychol, Utrecht, Netherlands; [Haefner, Michael] Berlin Univ Arts, Commun Psychol, Berlin, Germany; [Papies, Esther K.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	Utrecht University; University of Glasgow	Keesman, M (corresponding author), Univ Utrecht, Dept Psychol, Utrecht, Netherlands.	m.keesman@uu.nl	Vermeent, Stefan/GRS-4234-2022	Vermeent, Stefan/0000-0002-9595-5373; Papies, Esther K./0000-0002-8460-675X				Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 2009, PHILOS T R SOC B, V364, P1281, DOI 10.1098/rstb.2008.0319; BARSALOU LW, 2002, REPRESENTATION MEMOR, P1; BERRIDGE KC, 1991, APPETITE, V16, P103, DOI 10.1016/0195-6663(91)90036-R; Chen J, CORE EATING IN PRESS; CHRISTENSEN CM, 1984, APPETITE, V5, P307, DOI 10.1016/S0195-6663(84)80003-3; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Crum AJ, 2011, HEALTH PSYCHOL, V30, P424, DOI 10.1037/a0023467; de Almeida Patricia Del Vigna, 2008, J Contemp Dent Pract, V9, P72; Finch G, 1938, AM J PHYSIOL, V123, P379, DOI 10.1152/ajplegacy.1938.123.2.379; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Hardman CA, 2014, APPETITE, V76, P153, DOI [10.1016/j.appet2014.02.005, 10.1016/j.appet.2014.02.005]; Herman C. P., 1980, OBESITY; Hesslow G, 2002, TRENDS COGN SCI, V6, P242, DOI 10.1016/S1364-6613(02)01913-7; Hofmann W, 2012, J PERS SOC PSYCHOL, V102, P1318, DOI 10.1037/a0026545; Holland RW, 2005, PSYCHOL SCI, V16, P689, DOI 10.1111/j.1467-9280.2005.01597.x; Holyoak K.J., 1994, ADV CON NEUR COMP TH, P113; Inui A, 2004, FASEB J, V18, P439, DOI 10.1096/fj.03-0641rev; Jansen A, 1998, BEHAV RES THER, V36, P257, DOI 10.1016/S0005-7967(98)00055-2; Jansen A, 2010, PSYCHOTHER PSYCHOSOM, V79, P257, DOI 10.1159/000315131; Kaplan Mitchell, 1993, Dysphagia, V8, P225, DOI 10.1007/BF01354542; KLAJNER F, 1981, PHYSIOL BEHAV, V27, P195, DOI 10.1016/0031-9384(81)90256-0; LEGOFF DB, 1988, APPETITE, V11, P15, DOI 10.1016/S0195-6663(88)80018-7; Lindquist KA, 2012, TRENDS COGN SCI, V16, P533, DOI 10.1016/j.tics.2012.09.005; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; Myrick H, 2004, NEUROPSYCHOPHARMACOL, V29, P393, DOI 10.1038/sj.npp.1300295; Naumann E, 2013, APPETITE, V65, P103, DOI 10.1016/j.appet.2013.01.021; Nederkoorn C, 2000, APPETITE, V35, P45, DOI 10.1006/appe.2000.0328; Nederkoorn C, 1999, APPETITE, V33, P361, DOI 10.1006/appe.1999.0268; Nederkoorn Chantal, 2002, Eat Behav, V3, P61, DOI 10.1016/S1471-0153(01)00045-9; Neyraud E, 2012, ARCH ORAL BIOL, V57, P556, DOI 10.1016/j.archoralbio.2011.09.016; Papies EK, 2014, INT J OBESITY, V38, P597, DOI 10.1038/ijo.2013.136; Papies E.K., 2015, PSYCHOL DESIRE; Papies EK, 2016, HLTH PSYCHOL REV, P1; Papies EK, 2015, J PERS SOC PSYCHOL, V108, P148, DOI 10.1037/a0038032; Papies EK, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00838; Buzalaf MAR, 2012, J APPL ORAL SCI, V20, P493, DOI 10.1590/S1678-77572012000500001; Rad Maryam, 2010, J Dent Res Dent Clin Dent Prospects, V4, P110, DOI 10.5681/joddd.2010.028; ROGERS PJ, 1989, ADDICT BEHAV, V14, P387, DOI 10.1016/0306-4603(89)90026-9; Sanchez-Perez L, 2015, INT J PAEDIAT DENT; Schmid DA, 2005, NEUROPSYCHOPHARMACOL, V30, P1187, DOI 10.1038/sj.npp.1300670; Seibt B, 2007, EUR J SOC PSYCHOL, V37, P359, DOI 10.1002/ejsp.365; Smith E.R., 1998, HDB SOCIAL PSYCHOL, P391; Spence C, 2011, J TEXTURE STUD, V42, P157, DOI 10.1111/j.1745-4603.2011.00299.x; Tang DW, 2012, PHYSIOL BEHAV, V106, P317, DOI 10.1016/j.physbeh.2012.03.009; Tiggemann M, 2005, APPETITE, V45, P305, DOI 10.1016/j.appet.2005.06.004; Tolkien JRR, 2001, NY TIMES; Trudgill NJ, 1998, SCAND J GASTROENTERO, V33, P568; Van Gucht D, 2008, APPETITE, V50, P19, DOI 10.1016/j.appet.2007.05.003; WATANABE S, 1988, ARCH ORAL BIOL, V33, P1, DOI 10.1016/0003-9969(88)90089-1; WHITE KD, 1978, PSYCHOPHYSIOLOGY, V15, P196, DOI 10.1111/j.1469-8986.1978.tb01363.x; WOOLEY OW, 1981, APPETITE, V2, P331, DOI 10.1016/S0195-6663(81)80019-0; WOOLEY OW, 1975, J COMP PHYSIOL PSYCH, V89, P619, DOI 10.1037/h0077455; WOOLEY SC, 1973, PSYCHOSOM MED, V35, P136, DOI 10.1097/00006842-197303000-00006; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992	55	38	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165449	10.1371/journal.pone.0165449	http://dx.doi.org/10.1371/journal.pone.0165449			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BB	27820842	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000387614800009
J	Bai, GN; Korfage, IJ; Hafkamp-de Groen, E; Jaddoe, VWV; Mautner, E; Raat, H				Bai, Guannan; Korfage, Ida J.; Hafkamp-de Groen, Esther; Jaddoe, Vincent W. V.; Mautner, Eva; Raat, Hein			Associations between Nausea, Vomiting, Fatigue and Health-Related Quality of Life of Women in Early Pregnancy: The Generation R Study	PLOS ONE			English	Article							PERCEIVED STRESS; SOCIAL SUPPORT; VALIDATION; QUESTIONNAIRE; ADAPTATION; BURDEN	The objective of this study was to evaluate the independent associations between nausea, vomiting, fatigue and health-related quality of life of women in early pregnancy in the Generation R study, which is a prospective mother and child cohort. Analyses were based on 5079 women in early pregnancy in the Rotterdam area, the Netherlands. The information on nausea, vomiting and fatigue in the previous three months was measured in the questionnaire at enrollment, as well as potential confounders (i.e., maternal/gestational age, ethnic background, educational level, parity, marital status, body mass index, tobacco and alcohol use, chronic/infectious conditions, uro-genital conditions/symptoms, sleep quality, headache, anxiety, and depression). Health-related quality of life was assessed by the 12-item Short Form Health Survey and physical and mental component summary scores were calculated. Multivariate regression models were performed to evaluate the independent associations of the presence of nausea, vomiting and fatigue with health-related quality of life, adjusting for potential confounders. 33.6% of women experienced daily presence of nausea, 9.6% for vomiting and 44.4% for fatigue. Comparing with women who never reported nausea, vomiting and fatigue, women with daily presence of at least one of these symptoms had significantly lower scores of physical component summary and mental component summary, after adjusting for potential confounders. Our study shows how common nausea, vomiting and fatigue are among women in early pregnancy and how much each of these symptoms negatively impact on health-related quality of life. We call for awareness of this issue from health care professionals, pregnant women and their families.	[Bai, Guannan; Korfage, Ida J.; Hafkamp-de Groen, Esther; Raat, Hein] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Bai, Guannan; Jaddoe, Vincent W. V.] Univ Med Ctr Rotterdam, Generat R Grp, Erasmus MC, Rotterdam, Netherlands; [Jaddoe, Vincent W. V.] Univ Med Ctr Rotterdam, Dept Epidemiol, Erasmus MC, Rotterdam, Netherlands; [Mautner, Eva] Med Univ Graz, Dept Obstet & Gynaecol, Graz, Austria	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Medical University of Graz	Raat, H (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	h.raat@erasmusmc.nl			China Scholarship Council(CSC) in Erasmus MC, Rotterdam, the Netherlands; CSC [201406010271]	China Scholarship Council(CSC) in Erasmus MC, Rotterdam, the Netherlands; CSC	GB is supported by China Scholarship Council(CSC) PhD Fellowship for her PhD study in Erasmus MC, Rotterdam, the Netherlands. The scholarship file number is 201406010271, CSC URL: [http://www.csc.edu.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFONSO DD, 1990, BIRTH-ISS PERINAT C, V17, P121, DOI 10.1111/j.1523-536X.1990.tb00716.x; [Anonymous], 2015, OBSTET GYNECOL, V126, pe12, DOI [10.1097/AOG.0000000000001048, DOI 10.1097/AOG.0000000000001048]; Attard CL, 2002, AM J OBSTET GYNECOL, V186, pS220, DOI 10.1067/mob.2002.122605; Canavarro MC, 2009, INT J BEHAV MED, V16, P116, DOI 10.1007/s12529-008-9024-2; Chou FH, 2008, INT J NURS STUD, V45, P1185, DOI 10.1016/j.ijnurstu.2007.08.004; Chou FH, 2006, J MIDWIFERY WOM HEAL, V51, P370, DOI 10.1016/j.jmwh.2006.04.009; Chou FH, 2008, KAOHSIUNG J MED SCI, V24, P306, DOI 10.1016/S1607-551X(08)70157-8; Chou FH, 2003, J NURS SCHOLARSHIP, V35, P119, DOI 10.1111/j.1547-5069.2003.00119.x; Davis M, 2004, J PERINAT NEONAT NUR, V18, P312, DOI 10.1097/00005237-200410000-00002; Fairbrother N, 2008, PSYCHOL ASSESSMENT, V20, P150, DOI 10.1037/1040-3590.20.2.150; GADSBY R, 1993, BRIT J GEN PRACT, V43, P245; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Heitmann K, 2016, SCAND J PRIM HEALTH, V34, P13, DOI 10.3109/02813432.2015.1132894; Hofman A, 2004, PAEDIATR PERINAT EP, V18, P61, DOI 10.1111/j.1365-3016.2003.00521.x; Houben-van Herten M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125083; Hueston WJ, 1998, J FAM PRACTICE, V47, P209; Isbir GG, 2013, ASIAN NURS RES, V7, P175, DOI 10.1016/j.anr.2013.09.006; Jaddoe VWV, 2006, EUR J EPIDEMIOL, V21, P475, DOI 10.1007/s10654-006-9022-0; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; Jaddoe VWV, 2008, EUR J EPIDEMIOL, V23, P801, DOI 10.1007/s10654-008-9309-4; Koren G, 2002, AM J OBSTET GYNECOL, V186, pS228, DOI 10.1067/mob.2002.123054; Kosinski M, 1995, SF 12 SCORE SF 12 PH; Kugahara Tomoko, 2006, Nurs Health Sci, V8, P179, DOI 10.1111/j.1442-2018.2006.00279.x; Lacasse A, 2008, BJOG-INT J OBSTET GY, V115, P1484, DOI 10.1111/j.1471-0528.2008.01891.x; Lacasse A, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-32; Lee NM, 2011, GASTROENTEROL CLIN N, V40, P309, DOI 10.1016/j.gtc.2011.03.009; Liu MC, 2014, BIOL RES NURS, V16, P378, DOI 10.1177/1099800413506036; Matthews A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007575.pub4; Miller F, 2002, AM J OBSTET GYNECOL, V186, pS182, DOI 10.1067/mob.2002.122594; Mols F, 2009, QUAL LIFE RES, V18, P403, DOI 10.1007/s11136-009-9455-5; Munch S, 2011, J PERINATOL, V31, P10, DOI 10.1038/jp.2010.54; Nazik E, 2014, J CLIN NURS, V23, P1736, DOI 10.1111/jocn.12323; NERI A, 1995, BRIT J OBSTET GYNAEC, V102, P671, DOI 10.1111/j.1471-0528.1995.tb11412.x; OBRIEN B, 1992, BIRTH-ISS PERINAT C, V19, P138, DOI 10.1111/j.1523-536X.1992.tb00671.x; Otchet F, 1999, OBSTET GYNECOL, V94, P935, DOI 10.1016/S0029-7844(99)00439-1; PUGH LC, 1995, APPL NURS RES, V8, P140, DOI 10.1016/S0897-1897(95)80593-1; Smith C, 2000, AUST NZ J OBSTET GYN, V40, P397, DOI 10.1111/j.1479-828X.2000.tb01167.x; Statistics Netherlands, 2004, MIGR NETH 2004; Statistics Netherlands, 2008, 2006 SOI STAT NETH; Swallow B L, 2005, J Obstet Gynaecol, V25, P544, DOI 10.1080/01443610500230783; VANLIER D, 1993, BIRTH-ISS PERINAT C, V20, P193; VELLACOTT ID, 1988, INT J GYNECOL OBSTET, V27, P57, DOI 10.1016/0020-7292(88)90088-4; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Westert GP, 2005, EUR J PUBLIC HEALTH, V15, P59, DOI 10.1093/eurpub/cki116; World Medical Association, 2009, J INDIAN MED ASSOC, V107, P403	47	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166133	10.1371/journal.pone.0166133	http://dx.doi.org/10.1371/journal.pone.0166133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8TH	27814390	Green Published, Green Submitted, gold			2022-12-27	WOS:000386911100034
J	Rojas-Hernandez, N; Veliz, D; Riveros, MP; Fuentes, JP; Pardo, LM				Rojas-Hernandez, Noemi; Veliz, David; Riveros, Marcela P.; Fuentes, Juan P.; Pardo, Luis M.			Highly Connected Populations and Temporal Stability in Allelic Frequencies of a Harvested Crab from the Southern Pacific Coast	PLOS ONE			English	Article							CHAOTIC GENETIC PATCHINESS; REPRODUCTIVE OUTPUT; LARVAL DISPERSAL; KIN AGGREGATION; EFFECTIVE SIZE; LIFE-HISTORY; N-E; RECRUITMENT; DIVERSITY; MIGRATION	For marine invertebrates with a benthic adult form and a planktonic larva phase, the connectivity among populations is mainly based on larval dispersal. While an extended larval phase will promote gene flow, other factors such as an intensive fishery and geographical barriers could lead to changes in genetic variability. In this study, the population genetic structure of the commercial crab Metacarcinus edwardsii was analyzed along 700 km of the Chilean coast. The analysis, based on eight microsatellite loci genotyped from megalopae and adult crabs, considered temporal and spatial patterns of genetic variation. The results showed no evidence of spatial patterns in genetic structure, suggesting high connectivity among the sampling sites. The temporal analysis showed no evidence of changes in allele frequencies and no evidence of a recent bottleneck. The lack of spatial structure and allele variation over time could be explained by the interaction of factors such as i) low reproductive variance due to the capability of females to store sperm in the seminal receptacle, which can be used for successive broods, ii) high larval dispersal and iii) high individual reproductive output. Using our data as priors, a genetic modelling approach coincided, predicting this temporal and spatial stability. The same analysis showed that a reduction in population size leads to the loss of genetic variability in populations, as well as of the genetic cohesiveness between populations, pointing out the importance management for species under exploitation, such as M. edwardsii.	[Rojas-Hernandez, Noemi; Veliz, David] Univ Chile, Dept Ciencias Ecol, IEB,Fac Ciencias, Nucleo Milenio Ecol & Manejo Sustentable ESMOI, Santiago, Chile; [Riveros, Marcela P.; Fuentes, Juan P.; Pardo, Luis M.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Pardo, Luis M.] Ctr Invest Dinam Ecosistemas Marinos Altas Latitu, Valdivia, Chile	Universidad de Chile; Universidad Austral de Chile	Veliz, D (corresponding author), Univ Chile, Dept Ciencias Ecol, IEB,Fac Ciencias, Nucleo Milenio Ecol & Manejo Sustentable ESMOI, Santiago, Chile.	dveliz@uchile.cl	Pardo, L M/A-3178-2008; Véliz, David/J-4205-2013	Pardo, L M/0000-0003-2005-4922; Véliz, David/0000-0002-5768-9887; Pardo, Luis Miguel/0000-0002-8179-5057	Milenio grant [P05-002, NC120030]; Conicyt Basal grant [PFB 023]; Fondecyt [1110445, 1150388]; FONDAP-IDEAL [15150003]; IEB	Milenio grant; Conicyt Basal grant; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP-IDEAL; IEB	This work was supported by: Milenio grant P05-002, NC120030, Conicyt Basal grant PFB 023 (DV). Fondecyt grant 1110445, 1150388, FONDAP-IDEAL 15150003 (LMP). IEB Master Thesis (NRH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Balloux F, 2001, J HERED, V92, P301, DOI 10.1093/jhered/92.3.301; Barcia AR, 2005, MOL ECOL, V14, P2933, DOI 10.1111/j.1365-294X.2005.02613.x; Barshis DJ, 2011, MAR ECOL PROG SER, V439, P139, DOI 10.3354/meps09339; Bartilotti C, 2014, MAR ECOL PROG SER, V507, P233, DOI 10.3354/meps10817; Beebee TJC, 2009, MOL ECOL, V18, P4790, DOI 10.1111/j.1365-294X.2009.04398.x; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Belkhir K, 2002, MOL ECOL NOTES, V2, P611, DOI 10.1046/j.1471-8286.2002.00273.x; Belkhir K., 2004, GENETIX 4 05 LOGICIE; Broquet T, 2013, EVOLUTION, V67, P1660, DOI 10.1111/j.1558-5646.2012.01826.x; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; Cardenas L, 2009, J BIOGEOGR, V36, P969, DOI 10.1111/j.1365-2699.2008.02056.x; Colson I, 2004, MOL ECOL, V13, P2223, DOI 10.1111/j.1365-294X.2004.02245.x; Cornuet JM, 1996, GENETICS, V144, P2001; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Domingues CP, 2011, HEREDITY, V106, P832, DOI 10.1038/hdy.2010.126; Duchesne P, 2012, J HERED, V103, P734, DOI 10.1093/jhered/ess038; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Farias M, 2010, SCIENCE, V329, P916, DOI 10.1126/science.1192094; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Haye PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088613; HINES AH, 1991, CAN J FISH AQUAT SCI, V48, P267, DOI 10.1139/f91-037; Iacchei M, 2013, MOL ECOL, V22, P3476, DOI 10.1111/mec.12341; JARA F, 1994, B MAR SCI, V55, P295; JOHNSON MS, 1984, EVOLUTION, V38, P1371, DOI 10.1111/j.1558-5646.1984.tb05658.x; JOHNSON MS, 1982, MAR BIOL, V70, P157, DOI 10.1007/BF00397680; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; KORDOS LM, 1993, MAR BIOL, V117, P227, DOI 10.1007/BF00345667; Kyle CJ, 2000, MAR BIOL, V137, P835, DOI 10.1007/s002270000412; Laughlin KM, 2012, ECOL EVOL, V2, P1584, DOI 10.1002/ece3.283; Lee HJE, 2009, MOL ECOL, V18, P2165, DOI 10.1111/j.1365-294X.2009.04169.x; LEFEVRE J, 1992, TRENDS ECOL EVOL, V7, P288, DOI 10.1016/0169-5347(92)90223-X; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Pardo LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115525; Pardo LM, 2012, HELGOLAND MAR RES, V66, P253, DOI 10.1007/s10152-011-0267-y; Pardo LM, 2012, LAT AM J AQUAT RES, V40, P142, DOI 10.3856/vol40-issue1-fulltext-14; Pardo LM, 2009, J MAR BIOL ASSOC UK, V89, P1627, DOI 10.1017/S0025315409000010; Pardo LM, 2009, J MAR BIOL ASSOC UK, V89, P481, DOI 10.1017/S0025315409003233; Morgan Steven G., 1995, P279; Morgan SG, 2010, MAR ECOL PROG SER, V404, P109, DOI 10.3354/meps08476; Natunewicz CC, 2001, MAR ECOL PROG SER, V212, P217, DOI 10.3354/meps212217; Nunney L, 2002, AM NAT, V160, P195, DOI 10.1086/341017; Nunziata SO, 2015, CONSERV GENET, V16, P1335, DOI 10.1007/s10592-015-0743-z; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pardo LM, 2016, BEHAV ECOL SOCIOBIOL, V70, P73, DOI 10.1007/s00265-015-2026-6; Pardo LM, 2010, J EXP MAR BIOL ECOL, V393, P100, DOI 10.1016/j.jembe.2010.07.008; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pineda J, 2009, POPUL ECOL, V51, P17, DOI 10.1007/s10144-008-0118-0; Poulsen NA, 2006, MOL ECOL, V15, P321, DOI 10.1111/j.1365-294X.2005.02777.x; Pritchard JK, 2000, GENETICS, V155, P945; Puebla O, 2008, CAN J FISH AQUAT SCI, V65, P425, DOI 10.1139/F07-163; Queiroga H, 2007, PROG OCEANOGR, V74, P174, DOI 10.1016/j.pocean.2007.04.007; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Quintana R., 1983, REP USA MAR BIOL I K, V5, P1; Rojas-Hernandez N, 2014, MAR BIOL RES, V10, P839, DOI 10.1080/17451000.2013.863350; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; Selkoe KA, 2006, ECOLOGY, V87, P3082, DOI 10.1890/0012-9658(2006)87[3082:CSAKAE]2.0.CO;2; SERNAPESCA, 2011, SERNAPESCA SER 2001; Shanks AL, 2003, ECOL APPL, V13, pS159; Shanks AL, 2009, MAR ECOL PROG SER, V385, P189, DOI 10.3354/meps08043; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; SMITH PJ, 1991, FISH RES, V10, P309, DOI 10.1016/0165-7836(91)90082-Q; St-Onge P, 2015, OECOLOGIA, V178, P733, DOI 10.1007/s00442-015-3245-2; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Teske PR, 2007, MAR BIOL, V152, P697, DOI 10.1007/s00227-007-0724-y; Therkildsen NO, 2010, CAN J FISH AQUAT SCI, V67, P1585, DOI 10.1139/F10-084; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Duong TY, 2013, MOL ECOL, V22, P1282, DOI 10.1111/mec.12167; Treml EA, 2012, INTEGR COMP BIOL, V52, P525, DOI 10.1093/icb/ics101; Ungfors A, 2009, ICES J MAR SCI, V66, P462, DOI 10.1093/icesjms/fsn223; Vadopalas B, 2012, J SHELLFISH RES, V31, P697, DOI 10.2983/035.031.0314; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veliz D, 2006, MOL ECOL, V15, P4193, DOI 10.1111/j.1365-294X.2006.03078.x; Vinuesa JH, 1999, SCI MAR, V63, P321, DOI 10.3989/scimar.1999.63s1321; Waples RS, 2014, GENETICS, V197, P769, DOI 10.1534/genetics.114.164822; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; WAPLES RS, 1990, CONSERV BIOL, V4, P144, DOI 10.1111/j.1523-1739.1990.tb00103.x; Waters JM, 2004, MOL ECOL, V13, P2797, DOI 10.1111/j.1365-294X.2004.02282.x; Yannicelli B, 2012, PROG OCEANOGR, V92-95, P206, DOI 10.1016/j.pocean.2011.07.005	86	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166029	10.1371/journal.pone.0166029	http://dx.doi.org/10.1371/journal.pone.0166029			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814382	Green Published, Green Submitted, gold			2022-12-27	WOS:000386911100026
J	Rosychuk, RJ; Graham, MM; Holroyd, BR; Rowe, BH				Rosychuk, Rhonda J.; Graham, Michelle M.; Holroyd, Brian R.; Rowe, Brian H.			Volume Matters: Improved Outcomes for Patients Presenting to High-Volume Emergency Departments with Atrial Flutter and Fibrillation	PLOS ONE			English	Article							HEART-FAILURE; GUIDELINES; MORTALITY; ICD-9-CM	Objectives Clinical familiarity plays a role in health outcomes; the relationship between emergency department (ED) volume and outcomes for atrial fibrillation and flutter (AFF) are not clear. We compared ED presentation outcomes for AFF between high (HV) and low volume (LV) EDs in Alberta, Canada. Methods 45,372 AFF presentations for patients aged >= 35 years from all 104 EDs in Alberta during 1999 to 2011 using administrative health databases formed a retrospective cohort. EDs were grouped by annual AFF volume: 11 high (>100 presentations) or 93 low (<= 100 presentations). Outcomes included hospital admission rate, return to ED for AFF within 30 and 90 days, and death within 30 and 90 days. Analyses included statistical tests and mixed effects modeling. Results Mean age at ED presentation was 69.8 years (52% male). HV ED presentations were associated with lower admissions (adjusted odds ratio [aOR] = 0.68, 95% confidence interval [CI] 0.64, 0.72; p-value [p]<0.001), ED returns at 90 (aOR = 0.81, 95% CI 0.73, 0.90; p<0.001) days, and a higher likelihood of specialist visits at 30 (aOR = 1.81, 95% CI 1.68, 1.94; p<0.001) and 90 (aOR = 1.82, 95% CI 1.76, 2.03; p<0.001) days. For admitted patients, there were fewer returns to HV EDs at 30 (aOR = 0.37, 95% CI 0.15, 0.87; p = 4 0.02) and 90 (aOR = 0.48, 95% CI 0.26, 0.89; p = 0.02) days after hospital discharge. There was no difference in death between the two groups. Conclusions AFF patients presenting to HV EDs experienced fewer admissions and AFF ED revisit and higher specialist referrals compared to LV EDs.	[Rosychuk, Rhonda J.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Rosychuk, Rhonda J.] Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Graham, Michelle M.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Holroyd, Brian R.; Rowe, Brian H.] Univ Alberta, Dept Emergency Med, Edmonton, AB, Canada; [Holroyd, Brian R.; Rowe, Brian H.] Alberta Hlth Serv, Edmonton, AB, Canada; [Rowe, Brian H.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; Alberta Health Services (AHS); University of Alberta	Rosychuk, RJ (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.; Rosychuk, RJ (corresponding author), Women & Childrens Hlth Res Inst, Edmonton, AB, Canada.	rhonda.rosychuk@ualberta.ca	Rosychuk, Rhonda J./AAG-8299-2019	Holroyd, Brian/0000-0001-8221-1327; Rosychuk, Rhonda J./0000-0001-8019-5466	Women & Children's Health Research Institute (Edmonton, Canada); Alberta Health (Edmonton, Canada); Alberta Innovates-Health Solutions (AI-HS, Edmonton, Canada); Canada Research Chair in Evidence-based Emergency Medicine from the Canadian Institutes of Health Research (CIHR, Ottawa, Canada)	Women & Children's Health Research Institute (Edmonton, Canada); Alberta Health (Edmonton, Canada); Alberta Innovates-Health Solutions (AI-HS, Edmonton, Canada); Canada Research Chair in Evidence-based Emergency Medicine from the Canadian Institutes of Health Research (CIHR, Ottawa, Canada)	This study was funded by an Innovation Grant from the Women & Children's Health Research Institute (www.wchri.org; Edmonton, Canada) and Alberta Health (www.health.alberta.ca; Edmonton, Canada). RJR was salary supported by Alberta Innovates-Health Solutions (AI-HS, http://www.aihealthsolutions.ca/; Edmonton, Canada) as a Health Scholar. BHR is supported by a Tier 1 Canada Research Chair in Evidence-based Emergency Medicine from the Canadian Institutes of Health Research (CIHR, www.cihr.ca; Ottawa, Canada). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Health and Wellness, 2004, AMB CAR ALB US AMB C; Brar S, 2013, CIRC-HEART FAIL, V6, P1147, DOI 10.1161/CIRCHEARTFAILURE.113.000415; Bullard MJ, 2008, CAN J EMERG MED, V10, P136; Canadian Institute for Health Information, 2015, NAT AMB CAR REP SYST; Canadian Institute for Health Information, 2001, CAN ENH ICD 10; Canadian Institute for Health Information, 2012, CAN CLASS HLTH INT C; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fuster V, 2011, CIRCULATION, V123, pE269, DOI 10.1161/CIR.0b013e318214876d; Gamble JM, 2011, CIRC-HEART FAIL, V4, P317, DOI 10.1161/CIRCHEARTFAILURE.110.959262; Heart and Stroke Foundation, 2016, HEART DIS ATR FIBR; Kocher KE, 2014, ANN EMERG MED, V64, P446, DOI 10.1016/j.annemergmed.2014.06.008; *PRACT MAN INF COR, 1989, INT CLASS DIS; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Ro YS, 2012, RESUSCITATION, V83, P855, DOI 10.1016/j.resuscitation.2012.02.002; Rogenstein C, 2012, ACAD EMERG MED, V19, P1255, DOI 10.1111/acem.12016; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Skanes AC, 2012, CAN J CARDIOL, V28, P125, DOI 10.1016/j.cjca.2012.01.021; Stiell IG, 2011, ANN EMERG MED, V57, P13, DOI 10.1016/j.annemergmed.2010.07.005; Tsai AC, 2006, HEALTH SERV RES, V41, P252, DOI 10.1111/j.1475-6773.2005.00461.x; van Diepen S, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001708; Wong MKY, 2015, CAN MED ASSOC J, V187, pE160, DOI 10.1503/cmaj.141294	21	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165894	10.1371/journal.pone.0165894	http://dx.doi.org/10.1371/journal.pone.0165894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814387	gold, Green Submitted, Green Published			2022-12-27	WOS:000386911100021
J	Vuillier, L; Bryce, D; Szucs, D; Whitebread, D				Vuillier, Laura; Bryce, Donna; Szucs, Denes; Whitebread, David			The Maturation of Interference Suppression and Response Inhibition: ERP Analysis of a Cued Go/Nogo Task	PLOS ONE			English	Article							LATENT-VARIABLE ANALYSIS; EVENT-RELATED POTENTIALS; COGNITIVE CONTROL; EXECUTIVE FUNCTION; STROOP TASK; PSYCHOPHYSIOLOGICAL ANALYSIS; NOGO TASK; CONFLICT; ACTIVATION; ATTENTION	Inhibitory control is a core function that allows us to resist interference from our surroundings and to stop an ongoing action. To date, it is not clear whether inhibitory control is a single process or whether it is composed of different processes. Further, whether these processes are separate or clustered in childhood is under debate. In this study, we investigated the existence and development of two hypothesized component processes of inhibitory control-interference suppression and response inhibition-using a single task and event related potential components. Twenty 8-year-old children and seventeen adults performed a spatially cued Go/Nogo task while their brain activity was recorded using electroencephalography. Mean N2 amplitudes confirmed the expected pattern for response inhibition with both the children and the adults showing more negative N2 for Nogo vs. Go trials. The interference suppression N2 effect was only present in adults and appeared as a more negative N2 in response to Go trials with a congruent cue than Go trials with an incongruent cue. Contrary to previous findings, there was no evidence that the interference suppression N2 effect was later occurring than the response inhibition N2 effect. Overall, response inhibition was present in both the children and the adults whereas interference suppression was only present in the adults. These results provide evidence of distinct maturational processes for both component processes of inhibitory control, with interference suppression probably continuing to develop into late childhood.	[Vuillier, Laura] Bournemouth Univ, Dept Psychol, Bournemouth, Dorset, England; [Bryce, Donna] Univ Tubingen, Dept Psychol, Tubingen, Germany; [Szucs, Denes] Univ Cambridge, Dept Psychol, Cambridge, England; [Whitebread, David] Univ Cambridge, Fac Educ, Cambridge, England	Bournemouth University; Eberhard Karls University of Tubingen; University of Cambridge; University of Cambridge	Vuillier, L (corresponding author), Bournemouth Univ, Dept Psychol, Bournemouth, Dorset, England.	lrenshawvuillier@bournemouth.ac.uk	Bryce, Donna/H-2031-2013	Bryce, Donna/0000-0001-8311-4457; Vuillier, Laura/0000-0002-1596-9303; Szucs, Denes/0000-0002-9477-0801	PhD scholarship from Faculty of Education at the University of Cambridge, UK	PhD scholarship from Faculty of Education at the University of Cambridge, UK	This study was supported by a PhD scholarship received by LV from the Faculty of Education at the University of Cambridge, UK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Band GPH, 2003, PSYCHOL RES-PSYCH FO, V67, P266, DOI 10.1007/s00426-002-0127-0; Bartholow BD, 2005, PSYCHOPHYSIOLOGY, V42, P33, DOI 10.1111/j.1469-8986.2005.00258.x; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Bryce D, 2011, NEUROIMAGE, V57, P671, DOI 10.1016/j.neuroimage.2010.12.006; Brydges CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069826; Brydges CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034482; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Bunge SA, 2007, CURR OPIN NEUROBIOL, V17, P243, DOI 10.1016/j.conb.2007.02.005; COLES MGH, 1989, PSYCHOPHYSIOLOGY, V26, P251, DOI 10.1111/j.1469-8986.1989.tb01916.x; CRAFT JL, 1970, J EXP PSYCHOL, V83, P415, DOI 10.1037/h0028843; DEJONG R, 1990, J EXP PSYCHOL HUMAN, V16, P164, DOI 10.1037/0096-1523.16.1.164; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; JODO E, 1992, ELECTROEN CLIN NEURO, V82, P477, DOI 10.1016/0013-4694(92)90054-L; Johnstone SJ, 2005, J PSYCHOPHYSIOL, V19, P11, DOI 10.1027/0269-8803.19.1.11; Jongen EMM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-82; Kao CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013036; Karayanidis F, 1997, ELECTROEN CLIN NEURO, V103, P282, DOI 10.1016/S0013-4694(97)96077-6; Kobor A, DEV NEUROPSYCHOL; Kopp B, 1996, ELECTROEN CLIN NEURO, V99, P19, DOI 10.1016/0921-884X(96)95617-9; Kramer UM, 2011, J COGNITIVE NEUROSCI, V23, P2481, DOI 10.1162/jocn.2010.21573; Lamm C, 2006, NEUROPSYCHOLOGIA, V44, P2139, DOI 10.1016/j.neuropsychologia.2005.10.013; Logan Gordon D., 1994, P189; Martens U, 2010, J EXP PSYCHOL HUMAN, V36, P103, DOI 10.1037/a0017167; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; Randall WM, 2011, CLIN NEUROPHYSIOL, V122, P2400, DOI 10.1016/j.clinph.2011.05.012; SCHROGER E, 1993, BIOL PSYCHOL, V36, P183, DOI 10.1016/0301-0511(93)90017-3; Smith JL, 2007, CLIN NEUROPHYSIOL, V118, P343, DOI 10.1016/j.clinph.2006.09.027; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Szucs D, 2012, FUNCTIONAL DEFINITIO, DOI [10.1186/1471-2202-13-35, DOI 10.1186/1471-2202-13-35]; Szucs D, 2008, BRAIN RES, V1190, P143, DOI 10.1016/j.brainres.2007.11.010; Szucs D, 2007, NEUROPSYCHOLOGIA, V45, P3190, DOI 10.1016/j.neuropsychologia.2007.06.013; Szucs D, 2009, J COGNITIVE NEUROSCI, V21, P2195, DOI 10.1162/jocn.2009.21220; Szucs D, 2009, NEUROIMAGE, V47, P1960, DOI 10.1016/j.neuroimage.2009.05.048; Tillman CM, 2011, PSYCHOPHYSIOLOGY, V48, P1405, DOI 10.1111/j.1469-8986.2011.01203.x; Valle-Inclan F, 1998, PSYCHOPHYSIOLOGY, V35, P366, DOI 10.1017/S0048577298960917; van Boxtel GJM, 2001, BIOL PSYCHOL, V58, P229, DOI 10.1016/S0301-0511(01)00117-X; van Mourik R, 2005, J CHILD PSYCHOL PSYC, V46, P150, DOI 10.1111/j.1469-7610.2004.00345.x; Verbruggen F, 2004, ACTA PSYCHOL, V116, P21, DOI 10.1016/j.actpsy.2003.12.011; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006	50	27	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165697	10.1371/journal.pone.0165697	http://dx.doi.org/10.1371/journal.pone.0165697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8TH	27814356	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000386911100016
J	Yew, HT; Supriyanto, E; Satria, MH; Hau, YW				Yew, Hoe Tung; Supriyanto, Eko; Satria, Muhammad Haikal; Hau, Yuan Wen			New Vertical Handover Method to Optimize Utilization of Wireless Local Area Network in High-Speed Environment	PLOS ONE			English	Article							ALGORITHM; SELECTION; AUTHENTICATION	In heterogeneous wireless networks, wireless local area network (WLAN) is highly preferred by mobile terminals (MTs) owing to its high transmission bandwidth and low access cost. However, in high-speed environment, handover from a cellular network to a WLAN cell will lead to a high number of handover failures and unnecessary handovers due to the WLAN coverage limitation and will become worse at high speed. A new vertical handover method is proposed to minimize the probability of handover failure and unnecessary handover while maximizing the usage of WLAN in high-speed environment. The simulation results show that the proposed method kept the probability of handover failure and unnecessary handover below 0.5% and 1%, respectively. Compared with previous studies, the proposed method reduced the number of handover failures and unnecessary handovers up to 80.0% and 97.7%, respectively, while the MT is highly mobile. Using the proposed prediction method, the MT can benefit high bandwidth and low network access cost from the WLAN with minimum interruption regardless of speed.	[Yew, Hoe Tung] Univ Malaysia Sabah, Fac Engn, Kota Kinabalu, Malaysia; [Supriyanto, Eko; Hau, Yuan Wen] Univ Teknol Malaysia, IJN UTM Cardiovasc Engn Ctr, Fac Biosci & Med Engn, Skudai, Malaysia; [Satria, Muhammad Haikal] Univ Teknol Malaysia, Fac Biosci & Med Engn, Skudai, Malaysia	Universiti Malaysia Sabah; Universiti Teknologi Malaysia; Universiti Teknologi Malaysia	Satria, MH (corresponding author), Univ Teknol Malaysia, Fac Biosci & Med Engn, Skudai, Malaysia.	mhaikal@utm.my	YEW, HOE TUNG/AFS-1342-2022; Hau, Yuan Wen/D-2969-2014; Supriyanto, Eko/AAZ-1135-2021	YEW, HOE TUNG/0000-0003-1579-3640; SUPRIYANTO, EKO/0000-0002-2142-8351; /0000-0002-4929-3508	Ministry of Education Malaysia; Universiti Teknologi Malaysia [Q. J130000.2745.02K17, R.J130000.7309.4B120, R. J130000.7309.4B121, R.J130000.7309.4B122, R.J130000.7309.4B123]	Ministry of Education Malaysia; Universiti Teknologi Malaysia	This research is supported by the Ministry of Education Malaysia and Universiti Teknologi Malaysia under Grant No. Q. J130000.2745.02K17, R.J130000.7309.4B120, R. J130000.7309.4B121, R.J130000.7309.4B122, and R.J130000.7309.4B123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2014, IEEE COMMUN SURV TUT, V16, P776, DOI 10.1109/SURV.2013.082713.00141; [Anonymous], 2015, ARPN J ENG APPL SCI; Bao Q, 2016, 2016 6 INT C INF SCI, DOI [10.1109/ICIST.2016.7483455, DOI 10.1109/ICIST.2016.7483455]; Barclo F, 2004, IEEE T WIREL COMMUN, V3, P900, DOI 10.1109/TWC.2004.826310; Cao J, 2012, COMPUT NETW, V56, P2119, DOI 10.1016/j.comnet.2012.02.012; Feukeu EA, 2013, AFRICON, P662; Ge MM, 2016, J NETW COMPUT APPL, V63, P24, DOI 10.1016/j.jnca.2016.01.012; Hussain R, 2013, WIRELESS PERS COMMUN, V71, P1217, DOI 10.1007/s11277-012-0870-5; Janevski T, 2012, TELECOMMUNICATIONS F, DOI [10.1109/TELFOR.2012.6419155, DOI 10.1109/TELFOR.2012.6419155]; Jung-Min M, 2015, COMM WORKSH ICCW 201, DOI [10.1109/ICCW.2015.7247521, DOI 10.1109/ICCW.2015.7247521]; Kaleem F, 2013, ADV FUZZY SYST, V2013, DOI 10.1155/2013/232198; Khan M, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/173068; Kyoung Seok L, 2014, INF COMM TECHN CONV, DOI [10.1109/ICTC.2014.6983264, DOI 10.1109/ICTC.2014.6983264]; Lai YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155064; Malathy EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134232; Mohanty S, 2005, IEEE T WIREL COMMUN, V4, P2655, DOI 10.1109/TWC.2005.858300; Nam J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116709; Nguyen-Vuong QT, 2008, COMPUT NETW, V52, P3358, DOI 10.1016/j.comnet.2008.09.002; Niyato D, 2009, IEEE J SEL AREA COMM, V27, P412, DOI 10.1109/JSAC.2009.090506; Ravi A, 2015, WIRELESS PERS COMMUN, V81, P101, DOI 10.1007/s11277-014-2119-y; Santi P., 2012, MOBILITY MODELS NEXT, P19, DOI [DOI 10.1002/9781118344774.CH2, 10.1002/9781118344774.ch2]; Singh B, 2007, WIRELESS PERS COMMUN, V43, P879, DOI 10.1007/s11277-007-9261-8; Song W., 2012, ISSUES POLICY, P1, DOI [10.1007/978-1-4614-4379-7_1, DOI 10.1007/978-1-4614-4379-7_1]; Wong KD, 2001, IEEE T VEH TECHNOL, V50, P354, DOI 10.1109/25.923048; Wu J, 2006, IEEE GLOBECOM, DOI [10.1109/GLOCOM.2006.897, DOI 10.1109/GLOCOM.2006.897]; XIAOHUAN Y, 2008, COMMUNICATIONS LETT, V12, P14, DOI DOI 10.1109/LCOMM.2008.071430; Yang Y, 2012, WIR COMM SIGN PROC W, DOI [10.1109/WCSP.2012.6542876, DOI 10.1109/WCSP.2012.6542876]; Yew HT, 2015, J TEKNOL, V77, P79; Zubair M, 2015, SECUR COMMUN NETW, V8, P845, DOI 10.1002/sec.1041	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165888	10.1371/journal.pone.0165888	http://dx.doi.org/10.1371/journal.pone.0165888			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814388	gold, Green Published, Green Submitted			2022-12-27	WOS:000386911100020
J	Ausloos, M; Cerqueti, R				Ausloos, Marcel; Cerqueti, Roy			A Universal Rank-Size Law	PLOS ONE			English	Article							ZIPFS LAW; POWER-LAW; DISTRIBUTIONS; CITIES; GROWTH	A mere hyperbolic law, like the Zipf's law power function, is often inadequate to describe rank-size relationships. An alternative theoretical distribution is proposed based on theoretical physics arguments starting from the Yule-Simon distribution. A modeling is proposed leading to a universal form. A theoretical suggestion for the "best (or optimal) distribution", is provided through an entropy argument. The ranking of areas through the number of cities in various countries and some sport competition ranking serves for the present illustrations.	[Ausloos, Marcel] Univ Leicester, Sch Business, Univ Rd, Leicester LE1 7RH, Leics, England; [Ausloos, Marcel] GRAPES Grp Researchers Applicat Phys Econ & Socio, Rue Belle Jardiniere 483, B-4031 Angleur, Belgium; [Cerqueti, Roy] Univ Macerata, Dept Econ & Law, Via Crescimbeni 20, I-62100 Macerata, Italy	University of Leicester; University of Macerata	Cerqueti, R (corresponding author), Univ Macerata, Dept Econ & Law, Via Crescimbeni 20, I-62100 Macerata, Italy.	roy.cerqueti@unimc.it	Ausloos, Marcel/AAC-8812-2020	Ausloos, Marcel/0000-0001-9973-0019; CERQUETI, ROY/0000-0002-1871-7371				Abramowitz M, 1970, HANDBOOK OF MATHEMAT; Ausloos M, 2013, SCIENTOMETRICS, V95, P895, DOI 10.1007/s11192-012-0936-x; Ausloos M, 2010, PHYSICA A, V389, P2835, DOI 10.1016/j.physa.2010.02.038; Ausloos M., 2014, J APPL QUANT METHODS, V9, P1; Ausloos M, 2014, INT J MOD PHYS C, V25, DOI 10.1142/S0129183114500600; Ausloos M, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062803; Benguigui L, 2007, COMPUT ENVIRON URBAN, V31, P648, DOI 10.1016/j.compenvurbsys.2006.11.002; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Brakman S, 1999, J REGIONAL SCI, V39, P183, DOI 10.1111/1467-9787.00129; Cerqueti R, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/07/P07002; Cerqueti R, 2015, PHYSICA A, V421, P187, DOI 10.1016/j.physa.2014.11.027; Dimitrova ZI, 2015, OPEN PHYS, V13, P218, DOI 10.1515/phys-2015-0029; Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; FAIRTHORNE RA, 1969, J DOC, V25, P319, DOI 10.1108/eb026481; Fontanelli O, 1606, ARXIV160601959V1; Fujita M., 1999, SPATIAL EC CITIES RE; Fujita M, 2000, EC CITIES THEORETICA; Gabaix X, 1999, Q J ECON, V114, P739, DOI 10.1162/003355399556133; Gabaix X, 1999, AM ECON REV, V89, P129, DOI 10.1257/aer.89.2.129; Gabaix X, 2004, HDB REGIONAL URBAN E, V4; Gadomski A., 2000, Nonlinear Phenomena in Complex Systems, V3, P321; Gradshteyn I. S., 2014, TABLE INTEGRALS SERI; Hansen A, 2014, FRONT PHYS, V2, DOI 10.3389/fphy.2014.00058; HILL BM, 1974, J AM STAT ASSOC, V69, P1017, DOI 10.2307/2286182; Jefferson M, 1939, GEOGR REV, V29, P226, DOI 10.2307/209944; Kwapien J, 2012, PHYS REP, V515, P115, DOI 10.1016/j.physrep.2012.01.007; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Lourakis M.I.A., 2011, FDN RES TECHNOL, V4, P1; Mansilla R, 2007, J INFORMETR, V1, P155, DOI 10.1016/j.joi.2007.01.001; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Martinez-Mekler G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004791; Matlaba VJ, 2010, REV URBAN REGIONAL D, V25, P129; Moyano LG, 2006, EUROPHYS LETT, V73, P813, DOI 10.1209/epl/i2005-10487-1; Naumis GG, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/8/286; Pearson K, 1968, TABLES INCOMPLETE BE; Peng GH, 2010, PHYSICA A, V389, P3804, DOI 10.1016/j.physa.2010.05.004; Peterson GJ, 2010, P NATL ACAD SCI USA, V107, P16023, DOI 10.1073/pnas.1010757107; Popescu I, 1997, ROM REP PHYS, V49, P3; Popescu I., 2003, GLOTTOMETRICS, V6, P83; Roehner BM, 2007, DRIVING FORCES IN PHYSICAL, BIOLOGICAL AND SOCIO-ECONOMIC PHENOMENA: A NETWORK SCIENCE INVESTIGATION OF SOCIAL BONDS AND INTERACTIONS, P1, DOI 10.1017/CBO9780511611148; Rose C, 2002, MATH STAT MATH, DOI [10.1007/978-1-4612-2072-5, DOI 10.1007/978-1-4612-2072-5]; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SIMON HA, 1955, BIOMETRIKA, V42, P425; Stauffer D, 2004, PHYSICA A, V336, P1, DOI 10.1016/j.physa.2004.01.004; Verhulst, 1845, NOUVEAUX MEMOIRES AC, V18, P1; Vitanov NK, 2009, COMMUN NONLINEAR SCI, V14, P2379, DOI 10.1016/j.cnsns.2008.07.015; Voloshynovska IA, 2011, J QUANT LINGUIST, V18, P274, DOI 10.1080/09296174.2011.583405; WEST BJ, 1994, PHYS REP, V246, P2; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	49	31	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166011	10.1371/journal.pone.0166011	http://dx.doi.org/10.1371/journal.pone.0166011			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812192	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000386910000092
J	Bekker, A; Schaaf, HS; Draper, HR; Kriel, M; Hesseling, AC				Bekker, Adrie; Schaaf, Hendrik S.; Draper, Heather R.; Kriel, Magdalena; Hesseling, Anneke C.			Tuberculosis Disease during Pregnancy and Treatment Outcomes in HIV-Infected and Uninfected Women at a Referral Hospital in Cape Town	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SOUTH-AFRICA; TRANSMISSION; BURDEN; COINFECTION; MORTALITY; SEVERITY; SCORE	Background Tuberculosis during pregnancy and treatment outcomes are poorly defined in high prevalence tuberculosis and HIV settings. Methods A prospective cohort study of pregnant and postpartum women identified to be routinely on antituberculosis treatment was conducted at Tygerberg Hospital, Cape Town, South Africa, from January 2011 through December 2011. Maternal tuberculosis disease spectrum and tuberculosis-exposed newborns were characterized by maternal HIV status. Maternal tuberculosis treatment outcomes were documented and a multivariable regression model identified predictors of unfavourable tuberculosis treatment outcomes. Infant outcomes were also described. Results Seventy-four women with tuberculosis, 53 (72%) HIV-infected, were consecutively enrolled; 35 (47%) were diagnosed at delivery or postpartum and 22 (30%) of women reported previous antituberculosis treatment. HIV-infected women were 5.67 times more likely to have extrapulmonary tuberculosis (95% CI 1.18-27.25, p = 0.03). All 5 maternal deaths were amongst HIV-infected women. Birth outcomes were available for 75 newborns (2 sets of twins, missing data for 1 stillbirth). Of the 75 newborns, 49 (65%) were premature and 44 (59%) were low birth weight (LBW; <2500 grams). All 6 infants who died and the 4 stillbirths were born to HIV-infected women. Unfavourable tuberculosis treatment outcomes were documented in 33/74 (45%) women. Unfavourable maternal tuberculosis outcome was associated with delivery of LBW infants (OR 3.83; 95% CI 1.40-10.53, p = 0.009). Conclusions A large number of pregnant women with tuberculosis presented at a provincial referral hospital. All maternal and infant deaths occurred in HIV-infected women and their newborns. Maternal tuberculosis treatment outcomes were poor.	[Bekker, Adrie; Schaaf, Hendrik S.; Draper, Heather R.; Hesseling, Anneke C.] Univ Stellenbosch, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Fac Med & Hlth Sci, Cape Town, South Africa; [Kriel, Magdalena] Univ Stellenbosch, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res, Fac Med & Hlth Sci,MRC,Ctr Mol & Cellular Biol, Cape Town, South Africa	Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University	Bekker, A (corresponding author), Univ Stellenbosch, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Fac Med & Hlth Sci, Cape Town, South Africa.	adrie@sun.ac.za	MIZEKA, PANU/A-3952-2017	Schaaf, Hendrik Simon/0000-0001-5755-4133	United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB) [GHN-A-00-08-00004-00]; South African Medical Research Council; Discovery Foundation	United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB)(United States Agency for International Development (USAID)); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Discovery Foundation	This work was supported by the United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB - Agreement No. GHN-A-00-08-00004-00). The content is the responsibility of the authors and does not necessarily reflect the views of USAID. The South African Medical Research Council and the Discovery Foundation provided salary support to A. Bekker, who completed this research in support of her PhD thesis. For the remaining authors no source of funding were declared.	Barron P, 2013, B WORLD HEALTH ORGAN, V91, P70, DOI 10.2471/BLT.12.106807; Bates M, 2015, LANCET INFECT DIS, V15, P544, DOI 10.1016/S1473-3099(15)70058-7; Bates M, 2015, INT J INFECT DIS, V32, P124, DOI 10.1016/j.ijid.2014.12.014; Bekker A, 2014, INT J TUBERC LUNG D, V18, P335, DOI 10.5588/ijtld.13.0506; Bekker A, 2012, INT J TUBERC LUNG D, V16, P1040, DOI 10.5588/ijtld.11.0821; DeLuca A, 2009, JAIDS-J ACQ IMM DEF, V50, P196, DOI 10.1097/QAI.0b013e3181900201; Department of Health, 2009, S AFR NAT TUB MAN GU; Department of Health, 2010, CLIN GUID PMTCT; Department of Health. National committee on confidential enquiries into maternal deaths, 2015, 7 DOH; Doveren RFC, 1998, NETH J MED, V52, P100, DOI 10.1016/S0300-2977(98)00004-7; Figueroa-Damian R, 2001, ARCH MED RES, V32, P66, DOI 10.1016/S0188-4409(00)00266-6; Gupta A, 2007, CLIN INFECT DIS, V45, P241, DOI 10.1086/518974; Gupta A, 2011, CLIN INFECT DIS, V53, DOI 10.1093/cid/cir605; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; JANA N, 1994, INT J GYNECOL OBSTET, V44, P119, DOI 10.1016/0020-7292(94)90064-7; Khan M, 2001, AIDS, V15, P1857, DOI 10.1097/00002030-200109280-00016; Kriel M, 2015, INT J TUBERC LUNG D, V19, P1354, DOI 10.5588/ijtld.15.0098; Mathad JS, 2012, CLIN INFECT DIS, V55, P1532, DOI 10.1093/cid/cis732; Pillay T, 2004, INT J TUBERC LUNG D, V8, P59; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; Western Cape Government, 2013, ANN REPORT; WHO, 2008, GLOBAL TUBERCULOSIS; WHO, 2009, TREATM TUB GUID; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; Wood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025098; World Health Organization, 2013, WHOHTMTB201322013; World Health Organization, 2015, WHOHTMTB201522; World Health Organization, 1992, INT STAT CLASS DIS R; Zenner D, 2012, AM J RESP CRIT CARE, V185, P779, DOI 10.1164/rccm.201106-1083OC	29	20	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164249	10.1371/journal.pone.0164249	http://dx.doi.org/10.1371/journal.pone.0164249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812086	gold, Green Published			2022-12-27	WOS:000386910000007
J	Vogel, JP; Moore, JE; Timmings, C; Khan, S; Khan, DN; Defar, A; Hadush, A; Terefe, MM; Teshome, L; Ba-Thike, K; Than, KK; Makuwani, A; Mbaruku, G; Mrisho, M; Mugerwa, KY; Ritchie, LMP; Rashid, S; Straus, SE; Gulmezoglu, AM				Vogel, Joshua P.; Moore, Julia E.; Timmings, Caitlyn; Khan, Sobia; Khan, Dina N.; Defar, Atkure; Hadush, Azmach; Terefe, Marta Minwyelet; Teshome, Luwam; Ba-Thike, Katherine; Than, Kyu Kyu; Makuwani, Ahmad; Mbaruku, Godfrey; Mrisho, Mwifadhi; Mugerwa, Kidza Yvonne; Ritchie, Lisa M. Puchalski; Rashid, Shusmita; Straus, Sharon E.; Gulmezoglu, A. Metin			Barriers, Facilitators and Priorities for Implementation of WHO Maternal and Perinatal Health Guidelines in Four Lower-Income Countries: A GREAT Network Research Activity	PLOS ONE			English	Article								Background Health systems often fail to use evidence in clinical practice. In maternal and perinatal health, the majority of maternal, fetal and newborn mortality is preventable through implementing effective interventions. To meet this challenge, WHO's Department of Reproductive Health and Research partnered with the Knowledge Translation Program at St. Michael's Hospital (SMH), University of Toronto, Canada to establish a collaboration on knowledge translation (KT) in maternal and perinatal health, called the GREAT Network (Guideline-driven, Research priorities, Evidence synthesis, Application of evidence, and Transfer of knowledge). We applied a systematic approach incorporating evidence and theory to identifying barriers and facilitators to implementation of WHO maternal heath recommendations in four lower-income countries and to identifying implementation strategies to address these. Methods We conducted a mixed-methods study in Myanmar, Uganda, Tanzania and Ethiopia. In each country, stakeholder surveys, focus group discussions and prioritization exercises were used, involving multiple groups of health system stakeholders (including administrators, policymakers, NGOs, professional associations, frontline healthcare providers and researchers). Results Despite differences in guideline priorities and contexts, barriers identified across countries were often similar. Health system level factors, including health workforce shortages, and need for strengthened drug and equipment procurement, distribution and management systems, were consistently highlighted as limiting the capacity of providers to deliver high-quality care. Evidence-based health policies to support implementation, and improve the knowledge and skills of healthcare providers were also identified. Stakeholders identified a range of tailored strategies to address local barriers and leverage facilitators. Conclusion This approach to identifying barriers, facilitators and potential strategies for improving implementation proved feasible in these four lower-income country settings. Further evaluation of the impact of implementing these strategies is needed.	[Vogel, Joshua P.; Khan, Dina N.; Gulmezoglu, A. Metin] WHO, Dept Reprod Hlth & Res, UNDP UNFPA UNICEF WHO World Bank Special Programm, Geneva, Switzerland; [Moore, Julia E.; Timmings, Caitlyn; Khan, Sobia; Ritchie, Lisa M. Puchalski; Rashid, Shusmita; Straus, Sharon E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Knowledge Translat Program, Toronto, ON, Canada; [Defar, Atkure] Ethiopian Publ Hlth Inst, Hlth Syst & Reprod Hlth Res Directorate, Addis Ababa, Ethiopia; [Hadush, Azmach; Teshome, Luwam] WHO Country Off, Addis Ababa, Ethiopia; [Terefe, Marta Minwyelet] Minist Hlth, Maternal & Child Hlth Directorate, Addis Ababa, Ethiopia; [Than, Kyu Kyu] Burnet Inst, Melbourne, Vic, Australia; [Than, Kyu Kyu] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Makuwani, Ahmad] Minist Hlth Community Dev Gender Elderly & Childr, Dar Es Salaam, Tanzania; [Mbaruku, Godfrey; Mrisho, Mwifadhi] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Mugerwa, Kidza Yvonne] Makerere Univ, Kampala, Uganda; [Ritchie, Lisa M. Puchalski] Univ Hlth Network, Dept Emergency Med, Toronto, ON, Canada	The World Bank; United Nations Population Fund; World Health Organization; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Burnet Institute; University of Melbourne; Ifakara Health Institute; Makerere University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Vogel, JP (corresponding author), WHO, Dept Reprod Hlth & Res, UNDP UNFPA UNICEF WHO World Bank Special Programm, Geneva, Switzerland.	vogeljo@who.int	Vogel, Joshua/K-7649-2019; Ritchie, Lisa Puchalski/AAI-3717-2021	Vogel, Joshua/0000-0002-3214-7096; Ritchie, Lisa Puchalski/0000-0002-1791-5368	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, WHO; St Michael's Hospital, Toronto, Canada; Canadian Institutes of Health Research [NC1-122929]; UN Commission on Life Saving Commodities for Women and Children (Uganda, Tanzania, Ethiopia); Alliance for Health Policy and Systems Research, World Health Organization (Myanmar); KT Canada Strategic Training Initiative in Health Research Fellowship	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, WHO; St Michael's Hospital, Toronto, Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); UN Commission on Life Saving Commodities for Women and Children (Uganda, Tanzania, Ethiopia); Alliance for Health Policy and Systems Research, World Health Organization (Myanmar); KT Canada Strategic Training Initiative in Health Research Fellowship	Financial support for these activities was provided by UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, WHO (www.who.int/reproductivehealth); St Michael's Hospital, Toronto, Canada (www.stmichaelshospital.com/); Canadian Institutes of Health Research (grant number NC1-122929) (http://www.cihr-irsc.gc.ca/); the UN Commission on Life Saving Commodities for Women and Children (for activities in Uganda, Tanzania, Ethiopia) (http//www.lifesavingcommodities.org/); and the Alliance for Health Policy and Systems Research, World Health Organization (for activities in Myanmar) (http://www.who.int/alliance-hpsr/en/). LMPR was funded by a KT Canada Strategic Training Initiative in Health Research Fellowship Award in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker R, 2014, COCHRANE DB SYST REV, V4; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; DAD, 2011, MAIL INTERNET SURVEY; Fervers B, 2006, INT J QUAL HEALTH C, V18, P167, DOI 10.1093/intqhc/mzi108; Fitch K., 2001, RAND UCLA APPROPRIAT; Graham ID, 2007, ACAD EMERG MED, V14, P936, DOI 10.1197/j.aem.2007.07.004; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Jagosh J, 2012, MILBANK Q, V90, P311, DOI 10.1111/j.1468-0009.2012.00665.x; Kennedy J, 2004, CAN MED ASSOC J, V171, P455, DOI 10.1503/cmaj.1040170; Kiesler DJ, 2006, PATIENT EDUC COUNS, V61, P319, DOI 10.1016/j.pec.2005.08.002; Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub3; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; O'Connor AM, 2007, MED DECIS MAKING, V27, P554, DOI 10.1177/0272989x07307319; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Pimlott NJG, 2003, CAN MED ASSOC J, V168, P835; Saldana J, 2021, CODING MANUAL QUALIT; Shah BR, 2003, J POPUL THER CLIN PH, V11, pe239; Straus SE, 2013, BMJ BOOKS; Straus SE, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-108; Straus SE, 2009, CAN MED ASSOC J, V181, P165, DOI 10.1503/cmaj.081229; Tricco AC, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0370-1; Tuncalp O, 2015, BJOG; UNICEF World Health Organization, 2014, COUNTD 2015 FULF HLT; United Nations, 2014, MILL DEV GOALS REP 2; United Nations Population Division, 2018, WORLD POP PROSP; Wang ZC, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0440-4; WHO, 2014, WHO REC AUGM LAB; WHO, 2011, WHO REC IND LAB; WHO UNICEF, 2013, TRENDS MAT MORT 1990; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; Wooding S, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-47; World Health Organization, 2014, WHO HDB GUID DEV, V2nd; World Health Organization, 2012, OPTIMIZEMNH WHO REC; World Health Organization, 2011, WHO REC PREV TREATM; World Health Organization WHO, 2012, RECOMMENDATIONS PREV	39	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0160020	10.1371/journal.pone.0160020	http://dx.doi.org/10.1371/journal.pone.0160020			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806041	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500004
J	Mayerhofer, H; Sautron, E; Rolland, N; Catty, P; Seigneurin-Berny, D; Pebay-Peyroula, E; Ravaud, S				Mayerhofer, Hubert; Sautron, Emeline; Rolland, Norbert; Catty, Patrice; Seigneurin-Berny, Daphne; Pebay-Peyroula, Eva; Ravaud, Stephanie			Structural Insights into the Nucleotide-Binding Domains of the P-1B-type ATPases HMA6 and HMA8 from Arabidopsis thaliana	PLOS ONE			English	Article							COPPER-TRANSPORTING ATPASE; P-TYPE ATPASE; WILSON-DISEASE PROTEIN; N-DOMAIN; CHLOROPLAST ENVELOPE; X-RAY; CRYSTALLIZATION; HOMEOSTASIS; FEATURES; H1069Q	Copper is a crucial ion in cells, but needs to be closely controlled due to its toxic potential and ability to catalyse the formation of radicals. In chloroplasts, an important step for the proper functioning of the photosynthetic electron transfer chain is the delivery of copper to plastocyanin in the thylakoid lumen. The main route for copper transport to the thylakoid lumen is driven by two P-IB-type ATPases, Heavy Metal ATPase 6 (HMA6) and HMA8, located in the inner membrane of the chloroplast envelope and in the thylakoid membrane, respectively. Here, the crystal structures of the nucleotide binding domain of HMA6 and HMA8 from Arabidopsis thaliana are reported at 1.5 angstrom and 1.75 angstrom resolution, respectively, providing the first structural information on plants Cu+- ATPases. The structures reveal a compact domain, with two short helices on both sides of a twisted beta-sheet. A double mutant, aiding in the crystallization, provides a new crystal contact, but also avoids an internal clash highlighting the benefits of construct modifications. Finally, the histidine in the HP motif of the isolated domains, unable to bind ATP, shows a side chain conformation distinct from nucleotide bound structures.	[Mayerhofer, Hubert; Pebay-Peyroula, Eva; Ravaud, Stephanie] Univ Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France; [Sautron, Emeline; Rolland, Norbert; Seigneurin-Berny, Daphne] Univ Grenoble Alpes, CEA, CNRS, LPCV,Inst Biosci & Biotechnol Grenoble BIG,INRA, Grenoble, France; [Catty, Patrice] Univ Grenoble Alpes, CEA, CNRS, LCBM,BIG,INRA, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Ravaud, S (corresponding author), Univ Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.	Stephanie.Ravaud@ibs.fr	ROLLAND, Norbert/B-4405-2012; SEIGNEURIN-BERNY, Daphne/C-8412-2017	ROLLAND, Norbert/0000-0003-1959-6636; SEIGNEURIN-BERNY, Daphne/0000-0002-7436-9885	European Community's Seventh Framework Programme FP7 [HEALTH-F4-2007-201924]; Grenoble Alliance for Integrated Structural Cell Biology GRAL [ANR-10-LABX-49-01]; Institut Universitaire de France; French Centre National de la Recherche Scientifique; University Grenoble Alpes; EDICT Consortium	European Community's Seventh Framework Programme FP7; Grenoble Alliance for Integrated Structural Cell Biology GRAL; Institut Universitaire de France; French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Grenoble Alpes; EDICT Consortium	HM was supported by two post-doc fellowships, first from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement no. HEALTH-F4-2007-201924, EDICT Consortium and then from the Grenoble Alliance for Integrated Structural Cell Biology GRAL (ANR-10-LABX-49-01). EPP was Supported by the Institut Universitaire de France. SR was supported by a chair from the French Centre National de la Recherche Scientifique and from the University Grenoble Alpes. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2009, PLANTA, V229, P767, DOI 10.1007/s00425-008-0869-z; Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Abu-Abed M, 2004, BIOCHEM J, V379, P235, DOI 10.1042/BJ20040168; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Banci L, 2010, J BIOL CHEM, V285, P2537, DOI 10.1074/jbc.M109.054262; Bramkamp M, 2004, BIOCHEMISTRY-US, V43, P12289, DOI 10.1021/bi048727d; Catty P, 2011, J BIOL CHEM, V286, P36188, DOI 10.1074/jbc.M111.241034; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dimasi N, 2007, ACTA CRYSTALLOGR F, V63, P204, DOI 10.1107/S1744309107004903; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Haupt M, 2006, J BIOL CHEM, V281, P9641, DOI 10.1074/jbc.M508290200; Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924; Jayakanthan S, 2012, BIOSCIENCE REP, V32, P443, DOI 10.1042/BSR20120048; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kieselbach T, 2000, FEBS LETT, V480, P271, DOI 10.1016/S0014-5793(00)01890-1; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Liu LL, 2009, ACTA CRYSTALLOGR F, V65, P621, DOI 10.1107/S1744309109017023; Lubben M, 2007, J MOL BIOL, V369, P368, DOI 10.1016/j.jmb.2007.03.029; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng D, 2015, BIOMOL NMR ASSIGN, V9, P129, DOI 10.1007/s12104-014-9558-y; Morgan CT, 2004, J BIOL CHEM, V279, P36363, DOI 10.1074/jbc.M404553200; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; POST RL, 1972, J BIOL CHEM, V247, P6530; Puig S, 2007, PLANT CELL ENVIRON, V30, P271, DOI 10.1111/j.1365-3040.2007.01642.x; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rodriguez-Granillo A, 2008, J MOL BIOL, V383, P1097, DOI 10.1016/j.jmb.2008.07.065; Sautron E, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150065; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; STITT M, 1982, PLANT PHYSIOL, V70, P971, DOI 10.1104/pp.70.4.971; Tapken W, 2012, J BIOL CHEM, V287, P18544, DOI 10.1074/jbc.M111.318204; Tsivkovskii R, 2003, J BIOL CHEM, V278, P13302, DOI 10.1074/jbc.M300034200; Tsuda T, 2009, EMBO J, V28, P1782, DOI 10.1038/emboj.2009.143; Walden H, 2010, ACTA CRYSTALLOGR D, V66, P352, DOI 10.1107/S0907444909038207; Wang KT, 2014, NATURE, V514, P518, DOI 10.1038/nature13618; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244	45	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165666	10.1371/journal.pone.0165666	http://dx.doi.org/10.1371/journal.pone.0165666			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802305	Green Published, Green Submitted, gold			2022-12-27	WOS:000386714200035
J	Nagai, T; Honda, Y; Sugano, Y; Nishimura, K; Nakai, M; Honda, S; Iwakami, N; Okada, A; Asaumi, Y; Aiba, T; Noguchi, T; Kusano, K; Ogawa, H; Yasuda, S; Anzai, T				Nagai, Toshiyuki; Honda, Yasuyuki; Sugano, Yasuo; Nishimura, Kunihiro; Nakai, Michikazu; Honda, Satoshi; Iwakami, Naotsugu; Okada, Atsushi; Asaumi, Yasuhide; Aiba, Takeshi; Noguchi, Teruo; Kusano, Kengo; Ogawa, Hisao; Yasuda, Satoshi; Anzai, Toshihisa		NaDEF Investigators	Circulating Omega-6, But Not Omega-3 Polyunsaturated Fatty Acids, Are Associated with Clinical Outcomes in Patients with Acute Decompensated Heart Failure	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PLACEBO-CONTROLLED TRIAL; C-REACTIVE PROTEIN; CARDIAC CACHEXIA; TASK-FORCE; DIETARY; METAANALYSIS; MORTALITY; DISEASE; CELLS	Background irculating polyunsaturated fatty acid (PUFA) levels are associated with clinical outcomes in cardiovascular diseases including coronary artery disease and chronic heart failure (HF). However, their clinical implications in acute decompensated HF (ADHF) remain unclear. The aim of this study was to investigate the clinical roles of circulating PUFAs in patients with ADHF. Methods Circulating levels of PUFAs, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid (AA) and dihomo-gamma linoleic acid (DGLA), were measured on admission in 685 consecutive ADHF patients. Adverse events were defined as all-cause death and worsening HF. Results During a median follow-up period of 560 days, 262 (38.2%) patients had adverse events. Although patients with adverse events had lower n-6 PUFA (AA + DGLA) level than those without, n-3 PUFA (EPA + DHA) level was comparable between the groups. Kaplan-Meier analyses showed that lower n-6 PUFA level on admission was significantly associated with the composite of all-cause death and worsening HF, all-cause death, cardiovascular death and worsening HF (p < 0.001, p = 0.005, p = 0.021, p = 0.019, respectively). In a multivariate Cox model, lower n-6 PUFA level was independently associated with increased risk of adverse events (HR 0.996, 95% CI: 0.993 - 0.999, p = 0.027). Conclusions Lower n-6 but not n-3 PUFA level on admission was significantly related to worse clinical outcomes in ADHF patients. Measurement of circulating n-6 PUFA levels on admission might provide information for identifying high risk ADHF patients.	[Nagai, Toshiyuki; Honda, Yasuyuki; Sugano, Yasuo; Honda, Satoshi; Iwakami, Naotsugu; Okada, Atsushi; Asaumi, Yasuhide; Aiba, Takeshi; Noguchi, Teruo; Kusano, Kengo; Ogawa, Hisao; Yasuda, Satoshi; Anzai, Toshihisa] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan; [Nishimura, Kunihiro; Nakai, Michikazu] Natl Cerebral & Cardiovasc Ctr, Prevent Med & Epidemiol Informat, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Nagai, T (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan.	nagai@ncvc.go.jp	Honda, Satoshi/GXG-5198-2022; Nakai, Michikazu/ADJ-0980-2022	Asaumi, Yasuhide/0000-0002-9009-7234; Honda, Satoshi/0000-0002-1393-4270	Japan Cardiovascular Research Foundation [24-4-2]; Japan Society for the Promotion of Science [15K19402]	Japan Cardiovascular Research Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant from the Japan Cardiovascular Research Foundation (T Anzai, 24-4-2), and a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science (T Nagai, 15K19402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker SD, 2002, INT J CARDIOL, V85, P51, DOI 10.1016/S0167-5273(02)00233-4; Anker SD, 1999, CHEST, V115, P836, DOI 10.1378/chest.115.3.836; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Arya S, 2006, NUTRITION, V22, P865, DOI 10.1016/j.nut.2006.05.002; AWAN NA, 1981, ACTA MED SCAND, P169; Aziz EF, 2011, HEART INT, V6, P3, DOI 10.4081/hi.2011.e2; Chakeabarti S, 2010, J CARD FAIL, V16, pS53, DOI 10.1016/j.cardfail.2010.04.004; Chicco AJ, 2008, HYPERTENSION, V52, P549, DOI 10.1161/HYPERTENSIONAHA.108.114264; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Colin-Ramirez E, 2014, NUTRITION, V30, P1366, DOI 10.1016/j.nut.2014.04.006; Cunnane SC, 2003, PROG LIPID RES, V42, P544, DOI 10.1016/S0163-7827(03)00038-9; DAS UN, 1992, MED HYPOTHESES, V39, P90, DOI 10.1016/0306-9877(92)90147-5; DAS UN, 1981, MED J AUSTRALIA, V2, P157, DOI 10.5694/j.1326-5377.1981.tb100866.x; DAS UN, 1983, BASIC RES CARDIOL, V78, P716, DOI 10.1007/BF01907219; Das UN, 2015, NUTRITION, V31, P283, DOI 10.1016/j.nut.2014.08.011; Das UN, 2013, CIRC J, V77, P1915, DOI 10.1253/circj.CJ-13-0135; Das UN, 2011, MED HYPOTHESES, V76, P14, DOI 10.1016/j.mehy.2010.08.019; De Lorgeril Michel, 2007, Subcell Biochem, V42, P283; Faletti A, 1999, NITRIC OXIDE-BIOL CH, V3, P340, DOI 10.1006/niox.1999.0231; Ferrucci L, 2006, J CLIN ENDOCR METAB, V91, P439, DOI 10.1210/jc.2005-1303; Ghosh S, 2007, AM J PHYSIOL-HEART C, V293, pH2919, DOI 10.1152/ajpheart.00324.2007; Hara M, 2013, CIRC J, V77, P153, DOI 10.1253/circj.CJ-12-0875; Honda Y, 2016, AM J CARDIOL, V118, P550, DOI 10.1016/j.amjcard.2016.05.045; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Jacobsson A, 2004, J ADV NURS, V46, P514, DOI 10.1111/j.1365-2648.2004.03025.x; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; Kotwal S, 2012, CIRC-CARDIOVASC QUAL, V5, P808, DOI 10.1161/CIRCOUTCOMES.112.966168; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; Massie BM, 2010, NEW ENGL J MED, V363, P1419, DOI 10.1056/NEJMoa0912613; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Mijan-de-la-Torre A, 2009, CURR OPIN CLIN NUTR, V12, P251, DOI 10.1097/MCO.0b013e32832a2171; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Mulligan CM, 2012, CARDIOVASC RES, V94, P460, DOI 10.1093/cvr/cvs118; Mulvad G, 1996, Arctic Med Res, V55 Suppl 1, P20; Nikolaou M, 2013, EUR HEART J, V34, P742, DOI 10.1093/eurheartj/ehs332; Poudel-Tandukar K, 2009, NUTR RES, V29, P363, DOI 10.1016/j.nutres.2009.05.012; Ramsden CE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8707; Rauch B, 2010, CIRCULATION, V122, P2152, DOI 10.1161/CIRCULATIONAHA.110.948562; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Sakai M, 1998, BRIT J PHARMACOL, V123, P890, DOI 10.1038/sj.bjp.0701661; SCHIFFMAN SS, 1983, NEW ENGL J MED, V308, P1275; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Wang WG, 1997, BIOCHEM BIOPH RES CO, V233, P748, DOI 10.1006/bbrc.1997.6548; Wen FQ, 2000, PROSTAG LEUKOTR ESS, V62, P369, DOI 10.1054/plef.2000.0168; Yanagisawa N, 2010, J ATHEROSCLER THROMB, V17, P285, DOI 10.5551/jat.2618; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Zapatero A, 2012, REV ESP CARDIOL, V65, P421, DOI 10.1016/j.recesp.2011.09.011	51	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165841	10.1371/journal.pone.0165841	http://dx.doi.org/10.1371/journal.pone.0165841			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824904	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200037
J	Strate, LL; Singh, P; Boylan, MR; Piawah, S; Cao, Y; Chan, AT				Strate, Lisa L.; Singh, Prashant; Boylan, Matthew R.; Piawah, Sorbarikor; Cao, Yin; Chan, Andrew T.			A Prospective Study of Alcohol Consumption and Smoking and the Risk of Major Gastrointestinal Bleeding in Men	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COLONIC DIVERTICULAR HEMORRHAGE; HELICOBACTER-PYLORI INFECTION; MALE HEALTH-PROFESSIONALS; ACUTE CORONARY SYNDROMES; HUMAN GASTRIC-MUCOSA; LONG-TERM USE; UNITED-STATES; ASPIRIN; ULCER	Background and Aims Data regarding smoking and alcohol consumption and risk of gastrointestinal bleeding (GIB) are sparse and conflicting. We assessed the risk of major GIB associated with smoking and alcohol consumption in a large, prospective cohort. Methods We prospectively studied 48,000 men in the Health Professional follow-up Study (HPFS) who were aged 40-75 years at baseline in 1986. We identified men with major GIB requiring hospitalization and/or blood transfusion via biennial questionnaires and chart review. Results We documented 305 episodes of major GIB during 26 years of follow-up. Men who consumed >30 g/day of alcohol had a multivariable relative risk (RR) of 1.43 (95% confidence interval (CI), 0.88-2.35; P for trend 0.006) for major GIB when compared with nondrinkers. Alcohol consumption appeared to be primarily related to upper GIB (multivariable RR for >30 g/day vs. nondrinkers was 1.35; 95% CI, 0.66-2.77; P for trend 0.02). Men who consumed >= 5 drinks/week vs. < 1 drink/month of liquor had a multivariable RR of 1.72 (95% CI, 1.26-2.35, P for trend <0.001). Wine and beer were not significantly associated with major GIB. The risk of GIB associated with NSAIDs/aspirin use increased with greater alcohol consumption (multivariable RR 1.37; 95% CI, 0.85-2.19 for 1-14g/day of alcohol, RR 1.75; 95% CI, 1.07-2.88 for-15g/ day compared to nondrinkers). Smoking was not significantly associated with GIB. Conclusions Alcohol consumption, but not smoking, was associated with an increased risk of major GIB. Associations were most notable for upper GIB associated with liquor intake. Alcohol appeared to potentiate the risk of NSAID-associated GIB.	[Strate, Lisa L.] Univ Washington, Sch Med, Dept Med, Div Gastroenterol, Seattle, WA 98195 USA; [Singh, Prashant] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA USA; [Boylan, Matthew R.; Cao, Yin; Chan, Andrew T.] Harvard Med Sch, Massachusetts Gen Hosp, Div Gastroenterol, Dept Med, Boston, MA 02115 USA; [Boylan, Matthew R.; Cao, Yin; Chan, Andrew T.] Harvard Med Sch, Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02115 USA; [Piawah, Sorbarikor] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Cao, Yin] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Chan, Andrew T.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Dept Med, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Chan, AT (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Div Gastroenterol, Dept Med, Boston, MA 02115 USA.; Chan, AT (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02115 USA.; Chan, AT (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Dept Med, Boston, MA 02115 USA.	achan@partners.org	Cao, Yin/ABE-2332-2021; singh, prashant/AAQ-4412-2020	Cao, Yin/0000-0001-9835-7662; 	National Institutes of Health, National Cancer Institute [UM1 CM 67552]; National Institutes of Health, National Institute for Diabetes and Digestive and Kidney Diseases [R01 DK095964, K24 DK098311]	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Institute for Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the following: National Institutes of Health, National Cancer Institute UM1 CM 67552; National Institutes of Health, National Institute for Diabetes and Digestive and Kidney Diseases R01 DK095964 ATC; and National Institutes of Health, National Institute for Diabetes and Digestive and Kidney Diseases K24 DK098311 ATC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Al-Mallah M, 2007, J THROMB THROMBOLYS, V23, P51, DOI 10.1007/s11239-006-9005-8; Andersen IB, 2000, EPIDEMIOLOGY, V11, P434; Ballard HS, 1997, ALCOHOL HEALTH RES W, V21, P42; BARTLE WR, 1986, ARCH INTERN MED, V146, P2365, DOI 10.1001/archinte.146.12.2365; BATTAGLIA G, 1993, ITAL J GASTROENTEROL, V25, P419; Bode C, 1996, GUT, V39, P348, DOI 10.1136/gut.39.3.348; Chan AT, 2004, ANN INTERN MED, V140, P157, DOI 10.7326/0003-4819-140-3-200402030-00006; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Chen SH, 2005, WORLD J GASTROENTERO, V11, P3746, DOI 10.3748/wjg.v11.i24.3746; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; Cho E, 2012, AM J CLIN NUTR, V95, P413, DOI 10.3945/ajcn.111.022145; COGGON D, 1982, GUT, V23, P340, DOI 10.1136/gut.23.4.340; DAVENPOR.HW, 1969, GASTROENTEROLOGY, V56, P439; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Fisher L, 2007, ALIMENT PHARM THER, V25, P297, DOI 10.1111/j.1365-2006.03187.x; Gallerani M, 2004, J CLIN EPIDEMIOL, V57, P103, DOI 10.1016/S0895-4356(03)00255-5; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; GOULSTON K, 1968, BRIT MED J, V4, P664, DOI 10.1136/bmj.4.5632.664; HENRY D, 1993, GASTROENTEROLOGY, V105, P1078, DOI 10.1016/0016-5085(93)90952-9; Hiraishi H, 1999, J PHARMACOL EXP THER, V289, P103; HOLVOET J, 1991, GUT, V32, P730, DOI 10.1136/gut.32.7.730; Huang ES, 2011, AM J MED, V124, P426, DOI 10.1016/j.amjmed.2010.12.022; Huang ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015721; Jansen A, 2009, WORLD J GASTROENTERO, V15, P457, DOI 10.3748/wjg.15.457; Kang JM, 2011, SCAND J GASTROENTERO, V46, P1295, DOI 10.3109/00365521.2011.605468; Kaplan RC, 2002, AGE AGEING, V31, P217, DOI 10.1093/ageing/31.3.217; Kaplan RC, 2002, PREV MED, V34, P455, DOI 10.1006/pmed.2002.1008; Kaplan RC, 2001, J AM GERIATR SOC, V49, P126, DOI 10.1046/j.1532-5415.2001.49032.x; Karkkainen JM, 2015, DIGEST DIS SCI, V60, P3707, DOI 10.1007/s10620-015-3806-6; Kaufman DW, 1999, AM J GASTROENTEROL, V94, P3189, DOI 10.1111/j.1572-0241.1999.01517.x; KELLY JP, 1995, AM J GASTROENTEROL, V90, P1058; Kudoh K, 2003, J NUTR SCI VITAMINOL, V49, P451, DOI 10.3177/jnsv.49.451; Laine L, 2012, AM J GASTROENTEROL, V107, P1190, DOI 10.1038/ajg.2012.168; Matsuhashi T, 2007, DIGEST DIS SCI, V52, P434, DOI 10.1007/s10620-006-9571-9; Nagata N, 2014, J GASTROEN HEPATOL, V29, P1786, DOI 10.1111/jgh.12595; Nikolsky E, 2009, J AM COLL CARDIOL, V54, P1293, DOI 10.1016/j.jacc.2009.07.019; OATES PJ, 1988, GASTROENTEROLOGY, V94, P10, DOI 10.1016/0016-5085(88)90604-X; Pai JK, 2012, EUR HEART J, V33, P1598, DOI 10.1093/eurheartj/ehs047; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; PESKAR BM, 1988, BRIT J PHARMACOL, V93, P937, DOI 10.1111/j.1476-5381.1988.tb11483.x; Prakash UNS, 2010, APPL PHYSIOL NUTR ME, V35, P134, DOI 10.1139/H09-133; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Roberts SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049507; SCHUBERT TT, 1993, AM J MED, V94, P413, DOI 10.1016/0002-9343(93)90153-G; SEDMAN AJ, 1976, J STUD ALCOHOL, V37, P1197, DOI 10.15288/jsa.1976.37.1197; Stack WA, 2002, ALIMENT PHARM THER, V16, P497, DOI 10.1046/j.1365-2036.2002.01197.x; TARNAWSKI A, 1987, CLIN INVEST MED, V10, P259; TARNAWSKI A, 1985, GASTROENTEROLOGY, V88, P334, DOI 10.1016/S0016-5085(85)80188-8; Tsuruoka N, 2011, J GASTROEN HEPATOL, V26, P1047, DOI 10.1111/j.1440-1746.2010.06610.x; Udd M, 2007, SCAND J GASTROENTERO, V42, P1395, DOI 10.1080/00365520701478758; Weil J, 2000, GUT, V46, P27, DOI 10.1136/gut.46.1.27; Yamada A, 2008, DIS COLON RECTUM, V51, P116, DOI 10.1007/s10350-007-9137-8; ZOUCAS E, 1982, EUR SURG RES, V14, P33, DOI 10.1159/000128220	54	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165278	10.1371/journal.pone.0165278	http://dx.doi.org/10.1371/journal.pone.0165278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824864	gold, Green Submitted, Green Published			2022-12-27	WOS:000387615200015
J	Suh, KJ; Cheong, JW; Kim, I; Kim, HJ; Shin, DY; Koh, Y; Yoon, SS; Min, YH; Ahn, JS; Kim, YK; Lee, YG; Lee, JO; Bang, SM; Mun, YC; Seong, CM; Park, Y; Kim, BS; Hong, J; Park, J; Lee, JH; Kim, SY; Lee, HG				Suh, Koung Jin; Cheong, June-Won; Kim, Inho; Kim, Hyeoung-Joon; Shin, Dong-Yeop; Koh, Youngil; Yoon, Sung -Soo; Min, Yoo Hong; Ahn, Jae-Sook; Kim, Yeo-Kyeoung; Lee, Yun-Gyoo; Lee, Jeong-Ok; Bang, Soo-Mee; Mun, Yeung-Chul; Seong, Chu-Myoung; Park, Yong; Kim, Byung-Soo; Hong, Junshik; Park, Jinny; Lee, Jae Hoon; Kim, Sung -Yong; Lee, Hong Ghi			Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome	PLOS ONE			English	Article							MONOSOMAL KARYOTYPE; SCORING SYSTEM; PHASE-III; SURVIVAL; MDS; AZACITIDINE; MUTATIONS; STRATIFICATION; OUTCOMES	Chromosomal translocations are rare in myelodysplastic syndrome (MDS) and their impact on overall survival (OS) and response to hypomethylating agents (HMA) is unknown. The prognostic impact of the revised International Prognostic Scoring System (IPSS-R) and for chromosomal translocations was assessed in 751 patients from the Korea MDS Registry. IPSS-R effectively discriminated patients according to leukaemia evolution risk and OS. We identified 40 patients (5.3%) carrying translocations, 30 (75%) of whom also fulfilled complex karyotype criteria. Translocation presence was associated with a shorter OS (median, 12.0 versus 79.7 months, P < 0.01). Multivariate analysis demonstrated that translocations (hazard ratio [HR] 1.64 [1.06-2.63]; P = 0.03) as well as age, sex, IPSS-R, and CK were independent predictors of OS. In the IPSS-R high and very high risk subgroup (n=260), translocations remained independently associated with OS (HR 1.68 [1.06-2.69], P = 0.03) whereas HMA treatment was not associated with improved survival (median OS, 20.9 versus 21.2 months, P = 0.43). However, translocation carriers exhibited enhanced survival following HMA treatment (median 2.1 versus 12.4 months, P = 0.03). Our data suggest that chromosomal translocation is an independent predictor of adverse outcome and has an additional prognostic value in discriminating patients with MDS having higher risk IPSS-R who could benefit from HMA treatment.	[Suh, Koung Jin; Kim, Inho; Shin, Dong-Yeop; Koh, Youngil; Yoon, Sung -Soo] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul Natl Univ Hosp,Dept Internal Med, Seoul, South Korea; [Cheong, June-Won; Min, Yoo Hong] Yonsei Univ, Dept Internal Med, Severance Hosp, Seoul, South Korea; [Kim, Hyeoung-Joon; Ahn, Jae-Sook; Kim, Yeo-Kyeoung] Chonnam Natl Univ, Dept Internal Med, Hwasun Hosp, Hwasun, Chonnam, South Korea; [Lee, Yun-Gyoo] Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Jeong-Ok; Bang, Soo-Mee] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Songnam, Gyeonggi, South Korea; [Mun, Yeung-Chul; Seong, Chu-Myoung] Ewha Womans Univ, Dept Internal Med, Mokdong Hosp, Seoul, South Korea; [Park, Yong; Kim, Byung-Soo] Korea Univ, Anam Hosp, Dept Internal Med, Seoul, South Korea; [Hong, Junshik; Park, Jinny; Lee, Jae Hoon] Gachon Univ, Dept Internal Med, Gil Med Ctr, Inchon, South Korea; [Kim, Sung -Yong; Lee, Hong Ghi] Konkuk Univ, Dept Internal Med, Sch Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Yonsei University Health System; Chonnam National University; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Ewha Womans University; Korea University; Korea University Medicine (KU Medicine); Gachon University; Konkuk University; Konkuk University Medical Center	Kim, I (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul Natl Univ Hosp,Dept Internal Med, Seoul, South Korea.; Kim, HJ (corresponding author), Chonnam Natl Univ, Dept Internal Med, Hwasun Hosp, Hwasun, Chonnam, South Korea.	ihkimmd@snu.ac.kr; hjoonk@chonnam.ac.kr	Yoon, Sung-Soo/J-2773-2012	Suh, Koung Jin/0000-0002-1881-8738; CHEONG, JUNE-WON/0000-0002-1744-0921; Mun, Yeung-Chul/0000-0002-1882-3983; min, yoo hong/0000-0001-8542-9583				Ai J, 2015, CL LYMPH MYELOM LEUK, V15, P489, DOI 10.1016/j.clml.2015.03.017; Bejar R, 2014, BLOOD, V124, P2793, DOI 10.1182/blood-2014-04-522136; Bejar R, 2014, BLOOD, V124, P2705, DOI 10.1182/blood-2014-06-582809; BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; Bernal T, 2015, LEUKEMIA, V29, P1875, DOI 10.1038/leu.2015.115; Chun K, 2010, LEUKEMIA RES, V34, P160, DOI 10.1016/j.leukres.2009.07.006; Cluzeau T, 2013, AM J HEMATOL, V88, P780, DOI 10.1002/ajh.23509; Costa D, 2013, GENE CHROMOSOME CANC, V52, P753, DOI 10.1002/gcc.22071; Dvorak P, 2014, HEMATOL ONCOL, V32, P82, DOI 10.1002/hon.2089; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Gangat N, 2013, AM J HEMATOL, V88, P690, DOI 10.1002/ajh.23477; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Gurion R, 2010, HAEMATOL-HEMATOL J, V95, P303, DOI 10.3324/haematol.2009.010611; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Lubbert M, 2011, J CLIN ONCOL, V30, P9245; Lubbert M, 2016, ANN HEMATOL, V95, P191, DOI 10.1007/s00277-015-2547-0; Malcovati L, 2013, BLOOD, V122, P2943, DOI 10.1182/blood-2013-03-492884; McQuilten ZK, 2015, CANCER-AM CANCER SOC, V121, P2892, DOI 10.1002/cncr.29396; Nomdedeu M, 2016, GENE CHROMOSOME CANC, V55, P322, DOI 10.1002/gcc.22333; Nomenclature ISC on HC, 2013, ISCN 2013 INT SYSTEM; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Traina F, 2014, LEUKEMIA, V28, P78, DOI 10.1038/leu.2013.269; Valcarcel D, 2013, J CLIN ONCOL, V31, P916, DOI 10.1200/JCO.2012.41.6073; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Walker A, 2013, GENE CHROMOSOME CANC, V52, P385, DOI 10.1002/gcc.22036; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Xing RX, 2014, AM J HEMATOL, V89, pE163, DOI 10.1002/ajh.23801; Yang YT, 2014, AM J HEMATOL, V89, pE142, DOI 10.1002/ajh.23765; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	31	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166245	10.1371/journal.pone.0166245	http://dx.doi.org/10.1371/journal.pone.0166245			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824923	gold, Green Submitted, Green Published			2022-12-27	WOS:000387615200076
J	Kim, SH; Vlijm, R; van der Torre, J; Dalal, Y; Dekker, C				Kim, Sung Hyun; Vlijm, Rifka; van der Torre, Jaco; Dalal, Yamini; Dekker, Cees			CENP-A and H3 Nucleosomes Display a Similar Stability to Force-Mediated Disassembly	PLOS ONE			English	Article							HISTONE CHAPERONE NAP1; CENTROMERIC NUCLEOSOME; SINGLE-MOLECULE; MAGNETIC TWEEZERS; CRYSTAL-STRUCTURE; CHROMATIN FIBERS; KINETOCHORE; DNA; DYNAMICS; CORE	Centromere-specific nucleosomes are a central feature of the kinetochore complex during mitosis, in which microtubules exert pulling and pushing forces upon the centromere. CENP-A nucleosomes have been assumed to be structurally unique, thereby providing resilience under tension relative to their H3 canonical counterparts. Here, we directly test this hypothesis by subjecting CENP-A and H3 octameric nucleosomes, assembled on random or on centromeric DNA sequences, to varying amounts of applied force by using single-molecule magnetic tweezers. We monitor individual disassembly events of CENP-A and H3 nucleosomes. Regardless of the DNA sequence, the force-mediated disassembly experiments for CENP-A and H3 nucleosomes demonstrate similar rupture forces, life time residency and disassembly steps. From these experiments, we conclude that CENP-A does not, by itself, contribute unique structural features to the nucleosome that lead to a significant resistance against force-mediated disruption. The data present insights into the mechanistic basis for how CENP-A nucleosomes might contribute to the structural foundation of the centromere in vivo.	[Kim, Sung Hyun; Vlijm, Rifka; van der Torre, Jaco; Dekker, Cees] Delft Univ Technol, Kavli Inst Nanosci Delft, Dept Bionanosci, Delft, Netherlands; [Dalal, Yamini] NCI, Chromatin Struct & Epigenet Mech Unit, Lab Receptor Biol & Gene Express, Ctr Canc Res,NHI, Bethesda, MD 20892 USA; [Vlijm, Rifka] German Canc Res Ctr, Div Opt Nanoscopy, Heidelberg, Germany	Delft University of Technology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Helmholtz Association; German Cancer Research Center (DKFZ)	Dekker, C (corresponding author), Delft Univ Technol, Kavli Inst Nanosci Delft, Dept Bionanosci, Delft, Netherlands.; Dalal, Y (corresponding author), NCI, Chromatin Struct & Epigenet Mech Unit, Lab Receptor Biol & Gene Express, Ctr Canc Res,NHI, Bethesda, MD 20892 USA.	dalaly@mail.nih.gov; C.Dekker@tudelft.nl	Vlijm, Rifka/ABB-9663-2020	Vlijm, Rifka/0000-0001-8909-9518; van der Torre, Jaco/0000-0002-5405-3824; Kim, Sung Hyun/0000-0001-9272-7036	ERC Advanced Grant SynDiv [669598]; Netherlands Organization for Scientific Research (NWO/OCW) [as part of the Frontiers of Nanoscience program]; intramural research program of the Center for Cancer Research under the auspices of the National Cancer Institute at the NIH; NATIONAL CANCER INSTITUTE [ZIABC011207] Funding Source: NIH RePORTER	ERC Advanced Grant SynDiv; Netherlands Organization for Scientific Research (NWO/OCW) [as part of the Frontiers of Nanoscience program]; intramural research program of the Center for Cancer Research under the auspices of the National Cancer Institute at the NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the ERC Advanced Grant SynDiv [grant number 669598 to C.D.]; the Netherlands Organization for Scientific Research (NWO/OCW) [as part of the Frontiers of Nanoscience program]. YD is funded by the intramural research program of the Center for Cancer Research under the auspices of the National Cancer Institute at the NIH.	Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Bancaud A, 2007, MOL CELL, V27, P135, DOI 10.1016/j.molcel.2007.05.037; Bergmann JH, 2011, EMBO J, V30, P328, DOI 10.1038/emboj.2010.329; Bintu L, 2012, CELL, V151, P738, DOI 10.1016/j.cell.2012.10.009; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Black B, 2011, CELL, V144, P471, DOI 10.1016/j.cell.2011.02.002; Bloom KS, 2014, ANNU REV GENET, V48, P457, DOI 10.1146/annurev-genet-120213-092033; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; Chien FT, 2009, CURR PHARM BIOTECHNO, V10, P474, DOI 10.2174/138920109788922128; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; De Vlaminck I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041432; Dechassa ML, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1320; EARNSHAW WC, 1980, CELL, V21, P373, DOI 10.1016/0092-8674(80)90474-2; Eeftens JM, 2015, BMC BIOPHYS, V8, DOI 10.1186/s13628-015-0023-9; Falk SJ, 2016, NAT STRUCT MOL BIOL, V23, P204, DOI 10.1038/nsmb.3175; Falk SJ, 2015, SCIENCE, V348, P699, DOI 10.1126/science.1259308; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; FUJIINAKATA T, 1992, J BIOL CHEM, V267, P20980; Fukagawa T, 2014, DEV CELL, V30, P497, DOI 10.1016/j.devcel.2014.08.016; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; Greaves IK, 2007, P NATL ACAD SCI USA, V104, P525, DOI 10.1073/pnas.0607870104; Hayden KE, 2013, MOL CELL BIOL, V33, P763, DOI 10.1128/MCB.01198-12; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Jannink G, 1996, BIOPHYS J, V71, P451, DOI 10.1016/S0006-3495(96)79247-0; Katan AJ, 2015, SMALL, V11, P976, DOI 10.1002/smll.201401318; Kato H, 2013, SCIENCE, V340, P1110, DOI 10.1126/science.1235532; Killian JL, 2012, CURR OPIN STRUC BIOL, V22, P80, DOI 10.1016/j.sbi.2011.11.003; KLEIMAN L, 1972, J MOL BIOL, V64, P1, DOI 10.1016/0022-2836(72)90317-8; Kruithof M, 2009, BIOPHYS J, V96, P3708, DOI [10.1016/j.bpj.2009.01.048, 10.1016/j.bpj.2009.01.04X]; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Lyubchenko YL, 2014, NAT STRUCT MOL BIOL, V21, P8, DOI 10.1038/nsmb.2745; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; Melters DP, 2015, GENES-BASEL, V6, P751, DOI 10.3390/genes6030751; Meng H, 2015, NUCLEIC ACIDS RES, V43, P3578, DOI 10.1093/nar/gkv215; Miell MDD, 2013, NAT STRUCT MOL BIOL, V20, P763, DOI 10.1038/nsmb.2574; Miga KH, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv671; Mihardja S, 2006, P NATL ACAD SCI USA, V103, P15871, DOI 10.1073/pnas.0607526103; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Moyle-Heyrman G, 2011, J MOL BIOL, V412, P634, DOI 10.1016/j.jmb.2011.07.032; Nag R, 2009, MUTAT RES-REV MUTAT, V682, P13, DOI 10.1016/j.mrrev.2009.01.002; Nakagawa T, 2001, J BIOL CHEM, V276, P27384, DOI 10.1074/jbc.M101331200; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; NICKLAS RB, 1983, J CELL BIOL, V97, P542, DOI 10.1083/jcb.97.2.542; Okamoto Y, 2007, EMBO J, V26, P1279, DOI 10.1038/sj.emboj.7601584; Petrovic A, 2014, MOL CELL, V53, P591, DOI 10.1016/j.molcel.2014.01.019; Przewloka MR, 2009, ANNU REV GENET, V43, P439, DOI 10.1146/annurev-genet-102108-134310; Ribeiro SA, 2010, P NATL ACAD SCI USA, V107, P10484, DOI 10.1073/pnas.1002325107; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Sheinin MY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3579; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; Stellfox ME, 2013, CELL MOL LIFE SCI, V70, P387, DOI 10.1007/s00018-012-1048-8; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Teves SS, 2014, NUCLEUS-AUSTIN, V5, P211, DOI 10.4161/nucl.29086; Teves SS, 2014, NAT STRUCT MOL BIOL, V21, P88, DOI 10.1038/nsmb.2723; van Loenhout MTJ, 2012, BIOPHYS J, V102, P2362, DOI 10.1016/j.bpj.2012.03.073; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Vlijm R, 2015, CELL REP, V10, P216, DOI 10.1016/j.celrep.2014.12.022; Vlijm R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046306; Walkiewicz MP, 2014, METHODS MOL BIOL, V1170, P589, DOI 10.1007/978-1-4939-0888-2_34; Walkiewicz MP, 2014, NAT STRUCT MOL BIOL, V21, P2, DOI 10.1038/nsmb.2742; WAYE JS, 1987, NUCLEIC ACIDS RES, V15, P7549, DOI 10.1093/nar/15.18.7549; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Winogradoff D, 2015, SCI REP-UK, V5, DOI 10.1038/srep17038; Yang C., 2020, ELIFE, DOI [10.7554/eLife.51339, DOI 10.7554/ELIFE.02482, 10.7554/eLife.02482, DOI 10.7554/ELIFE.03254]; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697	71	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165078	10.1371/journal.pone.0165078	http://dx.doi.org/10.1371/journal.pone.0165078			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820823	Green Published, Green Submitted, gold			2022-12-27	WOS:000387614800006
J	Kim, B; Hyun, CK				Kim, Bobae; Hyun, Chang-Kee			Gender-Specific Mechanisms Underlying the Amelioration of High-Fat Diet-Induced Glucose Intolerance in B-Cell-Activating Factor Deficient Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; AUTOIMMUNE-DISEASES; INSULIN-RESISTANCE; BROWN-FAT; OBESITY; WHITE; IRISIN; BAFF; AMPK; PGC-1-ALPHA	It has recently been found that B cell activating factor (BAFF) plays an important role in the regulation of energy homeostasis. We also have previously reported that BAFF deficiency reverses high-fat (HF) diet-induced glucose intolerance by potentiating adipose tissue function. In the present study, we found that BAFF deficient (BAFF(-/-)) mice exhibit gender-specific differences in protection against diet-induced glucose intolerance, and aimed to characterize the gender-dependent molecular alterations in energy metabolism. Under HF feeding conditions, serum BAFF level of female wild-type (WT) mice was considerably higher than that of male mice. Despite increased body weight gain, both male and female BAFF(-/-) mice showed significantly improved glucose tolerance compared to their WT counterparts. Expressions of genes involved in glucose transport, thermogenesis and lipid oxidation were up-regulated in brown adipose tissues of both male and female BAFF(-/-) mice. Interestingly, the expression of thermogenic genes in subcutaneous adipose tissue was significantly enhanced in female BAFF(-/-) compared to WT mice, but the difference was not observed between male BAFF(-/-) and WT mice. The enhanced thermogenic program was confirmed by higher protein levels of UCP1 and irisin in female BAFF(-/-) than in WT mice. Additionally, adiponectin production in white adipose tissues and AMPK phosphorylation in subcutaneous adipose tissue were also significantly elevated in female BAFF(-/-) compared to WT mice, but not in male BAFF(-/-) mice. Our findings define a comprehensive scenario for the enhancing effect of BAFF depletion on glucose tolerance wherein the underlying mechanism is, at least in part, gender-specific, and suggest that gender difference should be considered as an important factor in the use of BAFF blockade as a therapeutic approach for the prevention and treatment of type 2 diabetes.	[Kim, Bobae; Hyun, Chang-Kee] Handong Global Univ, Sch Life Sci, Pohang, Gyungbuk, South Korea	Handong Global University	Hyun, CK (corresponding author), Handong Global Univ, Sch Life Sci, Pohang, Gyungbuk, South Korea.	ckhyun@handong.edu			Basic Science Research Program through National Research Foundation of Korea - Ministry of Education [NRF-2015R1D1A1A01058699]	Basic Science Research Program through National Research Foundation of Korea - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2015R1D1A1A01058699). The URL of funder's website is http:/www.nrf.re.kr/nrf_eng_cms/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amur S, 2012, J AUTOIMMUN, V38, pJ254, DOI 10.1016/j.jaut.2011.12.001; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bienertova-Vasku J, 2012, CENT EUR J MED, V7, P275, DOI 10.2478/s11536-011-0153-7; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Castillo-Quan JI, 2012, DIS MODEL MECH, V5, P293, DOI 10.1242/dmm.009894; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Hamada M, 2011, OBESITY, V19, P1915, DOI 10.1038/oby.2011.165; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Her M, 2016, J ALLERGY CLIN IMMUN, V137, P19, DOI 10.1016/j.jaci.2015.10.023; Hughes GC, 2014, NAT REV RHEUMATOL, V10, P740, DOI 10.1038/nrrheum.2014.144; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Hui XY, 2015, CELL METAB, V22, P279, DOI 10.1016/j.cmet.2015.06.004; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kim B, 2015, BIOCHEM BIOPH RES CO, V464, P1171, DOI 10.1016/j.bbrc.2015.07.099; Kim E, 2011, EUR J PHARMACOL, V672, P38, DOI 10.1016/j.ejphar.2011.09.172; Kovats S, 2015, CELL IMMUNOL, V294, P63, DOI 10.1016/j.cellimm.2015.01.018; Litwak SA, 2014, ENDOCRINOLOGY, V155, P4447, DOI 10.1210/en.2014-1342; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Miyake T, 2013, HEPATOL INT, V7, P539, DOI 10.1007/s12072-012-9345-8; Ng LG, 2005, MOL IMMUNOL, V42, P763, DOI 10.1016/j.molimm.2004.06.041; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Panchanathan R, 2013, MOL IMMUNOL, V53, P15, DOI 10.1016/j.molimm.2012.06.013; Pennell LM, 2012, J AUTOIMMUN, V38, pJ282, DOI 10.1016/j.jaut.2011.11.013; Pers JO, 2005, ANN NY ACAD SCI, V1050, P34, DOI 10.1196/annals.1313.004; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Tiniakou E, 2013, CLIN IMMUNOL, V149, P182, DOI 10.1016/j.clim.2013.02.011; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Varlamov O, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00241; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wan ZX, 2014, OBESITY, V22, P730, DOI 10.1002/oby.20605; White UA, 2014, BBA-MOL BASIS DIS, V1842, P377, DOI 10.1016/j.bbadis.2013.05.006; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106; Zonca M, 2012, TISSUE ENG PT A, V18, P853, DOI [10.1089/ten.tea.2011.0316, 10.1089/ten.TEA.2011.0316]	39	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166225	10.1371/journal.pone.0166225	http://dx.doi.org/10.1371/journal.pone.0166225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814392	gold, Green Submitted, Green Published			2022-12-27	WOS:000386911100037
J	Roche, SL; Wyse-Jackson, AC; Gomez-Vicente, V; Lax, P; Ruiz-Lopez, AM; Byrne, AM; Cuenca, N; Cotter, TG				Roche, Sarah L.; Wyse-Jackson, Alice C.; Gomez-Vicente, Violeta; Lax, Pedro; Ruiz-Lopez, Ana M.; Byrne, Ashleigh M.; Cuenca, Nicolas; Cotter, Thomas G.			Progesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling	PLOS ONE			English	Article							PHOTORECEPTOR CELL-DEATH; RD10 MOUSE MODEL; 18 KDA TSPO; INFLAMMATORY RESPONSE; IN-VIVO; ACTIVATION; IDENTIFICATION; NEUROTOXICITY; MIGRATION; CLEAVAGE	Retinitis pigmentosa (RP) is a degenerative disease leading to photoreceptor cell loss. Mouse models of RP, such as the rd10 mouse (B6.CXBl-Pde6brd10/J), have enhanced our understanding of the disease, allowing for development of potential therapeutics. In 2011, our group first demonstrated that the synthetic progesterone analogue 'Norgestrel' is neuroprotective in two mouse models of retinal degeneration, including the rd10 mouse. We have since elucidated several mechanisms by which Norgestrel protects stressed photoreceptors, such as upregulating growth factors. This study consequently aimed to further characterize Norgestrel's neuroprotective effects. Specifically, we sought to investigate the role that microglia might play; for microglial-derived inflammation has been shown to potentiate neurodegeneration. Dams of post-natal day (P) 10 rd10 pups were given a Norgestrel-supplemented diet (80mg/kg). Upon weaning, pups remained on Norgestrel. Tissue was harvested from P15-P50 rd10 mice on control or Norgestrel-supplemented diet. Norgestrel-diet administration provided significant retinal protection out to P40 in rd10 mice. Alterations in microglial activity coincided with significant protection, implicating microglial changes in Norgestrel-induced neuroprotection. Utilizing primary cultures of retinal microglia and 661W photoreceptor-like cells, we show that rd10 microglia drive neuronal cell death. We reveal a novel role of Norgestrel, acting directly on microglia to reduce pro-inflammatory activation and prevent neuronal cell death. Norgestrel effectively suppresses cytokine, chemokine and danger-associated molecular pattern molecule (DAMP) expression in the rd10 retina. Remarkably, Norgestrel upregulates fractalkine-CX3CR1 signaling 1 000-fold at the RNA level, in the rd10 mouse. Fractalkine-CX3CR1 signaling has been shown to protect neurons by regulating retinal microglial activation and migration. Ultimately, these results present Norgestrel as a promising treatment for RP, with dual actions as a neuroprotective and anti-inflammatory agent in the retina.	[Roche, Sarah L.; Wyse-Jackson, Alice C.; Ruiz-Lopez, Ana M.; Byrne, Ashleigh M.; Cotter, Thomas G.] Univ Coll Cork, Cell Dev & Dis Lab, Dept Biochem, Biosci Inst, Cork, Ireland; [Gomez-Vicente, Violeta] Univ Alicante, Dept Opt Farmacol & Anat, Alicante, Spain; [Lax, Pedro; Cuenca, Nicolas] Univ Alicante, Dept Fisiol Genet & Microbiol, Alicante, Spain	University College Cork; Universitat d'Alacant; Universitat d'Alacant	Cotter, TG (corresponding author), Univ Coll Cork, Cell Dev & Dis Lab, Dept Biochem, Biosci Inst, Cork, Ireland.	t.cotter@ucc.ie	Cuenca, Nicolas/I-2007-2015; Lax, Pedro/M-9074-2014; Gómez-Vicente, Violeta/A-6089-2013	Cuenca, Nicolas/0000-0002-6767-5710; Lax, Pedro/0000-0001-6931-1008; Gómez-Vicente, Violeta/0000-0002-5696-8673; Cotter, Thomas/0000-0003-4626-5613	Science Foundation Ireland [SFI 13/IA/1783]; Fighting Blindness Ireland [FB13COT]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Fighting Blindness Ireland	This work was supported by grants from Science Foundation Ireland (SFI 13/IA/1783) and Fighting Blindness Ireland (FB13COT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Arroba AI, 2011, INVEST OPHTH VIS SCI, V52, P9124, DOI 10.1167/iovs.11-7736; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Byrne AM, 2016, MOL VIS, V22, P264; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Cardona SM, 2015, ASN NEURO, V7, DOI 10.1177/1759091415608204; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Cross AK, 1999, J NEUROSCI RES, V55, P17, DOI 10.1002/(SICI)1097-4547(19990101)55:1<17::AID-JNR3>3.0.CO;2-J; Doonan F, 2011, J NEUROCHEM, V118, P915, DOI 10.1111/j.1471-4159.2011.07354.x; DUVALL E, 1985, IMMUNOLOGY, V56, P351; Dworzak J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127730; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Garton KJ, 2001, J BIOL CHEM, V276, P37993; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Guo CR, 2012, EXP EYE RES, V104, P39, DOI 10.1016/j.exer.2012.08.013; Han JJ, 2013, MOL VIS, V19, P2579; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Huang YW, 2009, J BIOL CHEM, V284, P29644, DOI 10.1074/jbc.M109.045682; Hundhausen Christian, 2003, Blood, V102, P1186; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jackson ACW, 2016, EUR J NEUROSCI, V43, P899, DOI 10.1111/ejn.13166; Jackson ACW, 2016, J NEUROCHEM, V136, P63, DOI 10.1111/jnc.13388; Karlstetter M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-3; Karlstetter M, 2010, IMMUNOBIOLOGY, V215, P685, DOI 10.1016/j.imbio.2010.05.010; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Liu GY, 2005, J BIOL CHEM, V280, P19858, DOI 10.1074/jbc.M413073200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas M, 2006, J IMMUNOL, V177, P4047, DOI 10.4049/jimmunol.177.6.4047; Lugrin J, 2015, J IMMUNOL, V194, P499, DOI 10.4049/jimmunol.1401948; Lyons A, 2009, J NEUROCHEM, V110, P1547, DOI 10.1111/j.1471-4159.2009.06253.x; Madeira MH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/673090; de la Camara CMF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11764; Mattison HA, 2013, J NEUROIMMUNOL, V257, P110, DOI 10.1016/j.jneuroim.2013.02.008; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Peng B, 2014, J NEUROSCI, V34, P8139, DOI 10.1523/JNEUROSCI.5200-13.2014; Pennesi ME, 2012, INVEST OPHTH VIS SCI, V53, P4644, DOI 10.1167/iovs.12-9611; Roche SL, 2016, INT J DEV BIOL, V60, P127, DOI 10.1387/ijdb.150400tc; Rutar M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0224-1; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Samardzija M, 2012, EXP EYE RES, V99, P17, DOI 10.1016/j.exer.2012.04.004; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scholz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0431-4; Scholz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0422-5; Thacker MA, 2009, EUR J PAIN, V13, P263, DOI 10.1016/j.ejpain.2008.04.017; Wang AL, 2005, NEUROCHEM INT, V47, P152, DOI 10.1016/j.neuint.2005.04.018; Wang K, 2014, GLIA, V62, P1943, DOI 10.1002/glia.22715; Wang MH, 2014, J NEUROSCI, V34, P3793, DOI 10.1523/JNEUROSCI.3153-13.2014; Weigelt K, 2007, J LEUKOCYTE BIOL, V82, P1564, DOI 10.1189/jlb.0707447; Yang LP, 2007, MOL VIS, V13, P2048; Yang LP, 2007, MOL VIS, V13, P1073; Yoshida N, 2013, OPHTHALMOLOGY, V120, pE5, DOI 10.1016/j.ophtha.2012.07.008; Zabel MK, 2016, GLIA, V64, P1479, DOI 10.1002/glia.23016; Zeng H, 2014, NEUROSCIENCE, V275, P54, DOI 10.1016/j.neuroscience.2014.05.065; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118; Zhang C, 2005, MOL VIS, V11, P887; Zhang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035446; Zhao L, 2015, EMBO MOL MED, V7, P1179, DOI 10.15252/emmm.201505298; Zieger M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106562; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	71	38	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165197	10.1371/journal.pone.0165197	http://dx.doi.org/10.1371/journal.pone.0165197			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814376	Green Published, gold, Green Submitted			2022-12-27	WOS:000386911100008
J	Shi, HR; Wang, B; Yang, PJ; Li, YB; Miao, F				Shi, Huarong; Wang, Bin; Yang, Piaojuan; Li, Yibo; Miao, Fang			Differences in Sugar Accumulation and Mobilization between Sequential and Non-Sequential Senescence Wheat Cultivars under Natural and Drought Conditions	PLOS ONE			English	Article							MONOCARPIC SENESCENCE; STARCH ACCUMULATION; SUCROSE SYNTHASE; TOMATO FRUIT; WATER-STRESS; METABOLISM; PHOTOSYNTHESIS; EXPRESSION; ENZYMES; GROWTH	Wheat leaf non-sequential senescence at the late grain-filling stage involves the early senescence of younger flag leaves compared to that observed in older second leaves. On the other hand, sequential senescence involves leaf senescence that follows an age-related pattern, in which flag leaves are the latest to undergo senescence. The characteristics of sugar metabolism in two sequential senescence cultivars and two non-sequential senescence cultivars under both natural and drought conditions were studied to elucidate the underlying mechanism of drought tolerance in two different senescence modes. The results showed that compared to sequential senescence wheat cultivars, under natural and drought conditions, non-sequential senescence wheat cultivars showed a higher leaf net photosynthetic rate, higher soluble sugar levels in leaves, leaf sheaths, and internodes, higher leaf sucrose synthase (SS) and sucrose phosphate synthase (SPS) activity, and higher grain SS activity, thereby suggesting that non-sequential senescence wheat cultivars had stronger source activity. Spike weight, grain weight per spike, and 100-grain weight of non-sequential senescence cultivars at maturity were significantly higher than those of sequential senescence cultivars under both natural and drought conditions. These findings indicate that the higher rate of accumulation and the higher mobilization of soluble sugar in the leaves, leaf sheaths and internodes of non-sequential senescence cultivars improve grain weight and drought tolerance. At the late grain-filling stage, drought conditions adversely affected leaf chlorophyll content, net photosynthetic rate, soluble sugar and sucrose content, SS and SPS activity, gain SS activity, and weight. This study showed that higher rates of soluble sugar accumulation in the source was one of the reasons of triggering leaf non-sequential senescence, and higher rates of soluble sugar mobilization during leaf non-sequential senescence promoted high and stable wheat yield and drought tolerance.	[Shi, Huarong; Wang, Bin; Yang, Piaojuan; Li, Yibo; Miao, Fang] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Miao, F (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.	miaofangmf@nwsuaf.edu.cn			National Natural Science Foundation of China [31170366]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (31170366), http://www.nsfc.gov.cn/, Miao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Akbar Moayedi, 2009, Australian Journal of Basic and Applied Sciences, V3, P4408; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BISWAS AK, 1980, PLANT PHYSIOL, V65, P340, DOI 10.1104/pp.65.2.340; Calvino M, 2008, RICE, V1, P166, DOI 10.1007/s12284-008-9012-9; Champigny ML, 1995, PHOTOSYNTH RES, V46, P117, DOI 10.1007/BF00020422; Chen DQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137026; CRAFTSBRANDNER SJ, 1984, PLANT PHYSIOL, V75, P318, DOI 10.1104/pp.75.2.318; CRAFTSBRANDNER SJ, 1987, J EXP BOT, V38, P2043, DOI 10.1093/jxb/38.12.2043; Dai N, 1999, PLANT CELL, V11, P1253, DOI 10.1105/tpc.11.7.1253; Douglas CD, 1988, PLANT PHYSIOL, V86, P1013; Ehdaie B, 2006, CROP SCI, V46, P2093, DOI 10.2135/cropsci2006.01.0013; Fujiki Y, 2000, PLANT PHYSIOL, V124, P1139, DOI 10.1104/pp.124.3.1139; Gan SS, 1997, PLANT PHYSIOL, V113, P313, DOI 10.1104/pp.113.2.313; GRBIC V, 1995, PLANT J, V8, P595, DOI 10.1046/j.1365-313X.1995.8040595.x; HENSEL LL, 1993, PLANT CELL, V5, P553, DOI 10.1105/tpc.5.5.553; HoffmannThoma G, 1996, PHYSIOL PLANTARUM, V97, P277, DOI 10.1034/j.1399-3054.1996.970210.x; Ishimaru K, 2007, PLANT PHYSIOL BIOCH, V45, P799, DOI 10.1016/j.plaphy.2007.07.004; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Jiang Dong, 2003, Acta Agronomica Sinica, V29, P31; Joudi M, 2012, PHYSIOL PLANTARUM, V144, P1, DOI 10.1111/j.1399-3054.2011.01517.x; Kaur K, 2012, AGROCHIMICA, V56, P42; LEOPOLD AC, 1959, PLANT PHYSIOL, V34, P570, DOI 10.1104/pp.34.5.570; LI Y G, 2001, ACTA AGR SIN, V27, P658; Masclaux C, 2000, PLANTA, V211, P510, DOI 10.1007/s004250000310; MCKERSIE BD, 1992, CAN J BOT, V70, P2245, DOI 10.1139/b92-278; Molisch H, 1938, LONGEVITY PLANTS, P123; MONDAL WA, 1985, PHYSIOL PLANTARUM, V65, P221, DOI 10.1111/j.1399-3054.1985.tb02386.x; MONDAL WA, 1984, PHYSIOL PLANTARUM, V61, P287, DOI 10.1111/j.1399-3054.1984.tb05910.x; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Noh YS, 1999, PLANT MOL BIOL, V41, P181, DOI 10.1023/A:1006342412688; Nooden LD, 1997, PHYSIOL PLANTARUM, V101, P746, DOI 10.1111/j.1399-3054.1997.tb01059.x; OULEE TM, 1985, PLANT PHYSIOL, V79, P852, DOI 10.1104/pp.79.3.852; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Quirino BF, 2001, PLANT MOL BIOL, V46, P447, DOI 10.1023/A:1010639015959; Samarah NH, 2009, J AGRON CROP SCI, V195, P427, DOI 10.1111/j.1439-037X.2009.00387.x; Schaffer AA, 1997, PLANT PHYSIOL, V113, P739, DOI 10.1104/pp.113.3.739; Stessman D, 2002, PHOTOSYNTH RES, V72, P27, DOI 10.1023/A:1016043003839; THIMANN KV, 1977, PLANT PHYSIOL, V59, P448, DOI 10.1104/pp.59.3.448; THOMAS H, 1992, J PLANT PHYSIOL, V139, P403, DOI 10.1016/S0176-1617(11)80486-4; van Doorn WG, 2008, J EXP BOT, V59, P1963, DOI 10.1093/jxb/ern076; VONSCHAEWEN A, 1990, EMBO J, V9, P3033, DOI 10.1002/j.1460-2075.1990.tb07499.x; Wang BS, 2015, PHOTOSYNTH RES, V126, P363, DOI 10.1007/s11120-015-0126-9; WANG F, 1993, PLANT PHYSIOL, V101, P321, DOI 10.1104/pp.101.1.321; WARDLAW IF, 1994, AUST J PLANT PHYSIOL, V21, P255, DOI 10.1071/PP9940255; Wardlaw IF, 2000, NEW PHYTOL, V148, P413, DOI 10.1046/j.1469-8137.2000.00777.x; Wiedemuth K, 2005, J PLANT PHYSIOL, V162, P1226, DOI 10.1016/j.jplph.2005.01.010; Wingler A, 2006, J EXP BOT, V57, P391, DOI 10.1093/jxb/eri279; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Yang JC, 2004, PLANTA, V220, P331, DOI 10.1007/s00425-004-1338-y; Yang JC, 2002, AGRON J, V94, P102, DOI 10.2134/agronj2002.0102; Yang JianChang, 2004, Acta Agronomica Sinica, V30, P108; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; Yoshida S, 2003, CURR OPIN PLANT BIOL, V6, P79, DOI 10.1016/S1369526602000092; Zhang SongWu, 2012, Acta Agronomica Sinica, V38, P2258, DOI 10.3724/SP.J.1006.2012.02258; Zhang SongWu, 2010, Scientia Agricultura Sinica, V43, P2229; ZRENNER R, 1995, PLANT J, V7, P97, DOI 10.1046/j.1365-313X.1995.07010097.x	56	40	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166155	10.1371/journal.pone.0166155	http://dx.doi.org/10.1371/journal.pone.0166155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814393	Green Published, gold, Green Submitted			2022-12-27	WOS:000386911100035
J	Krageloh, CU; Billington, DR; Hsu, PHC; Feng, XJ; Medvedev, ON; Kersten, P; Landon, J; Siegert, RJ				Krageloh, Christian U.; Billington, D. Rex; Hsu, Patricia Hsien-Chuan; Feng, Xuan Joanna; Medvedev, Oleg N.; Kersten, Paula; Landon, Jason; Siegert, Richard J.			Ordinal-To-Interval Scale Conversion Tables and National Items for the New Zealand Version of the WHOQOL-BREF	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH; QUESTIONNAIRE; ATTITUDES	The World Health Organisation Quality of Life (WHOQOL) questionnaires are widely used around the world and can claim strong cross-cultural validity due to their development in collaboration with international field centres. To enhance conceptual equivalence of quality of life across cultures, optional national items are often developed for use alongside the core instrument. The present study outlines the development of national items for the New Zealand WHOQOL-BREF. Focus groups with members of the community as well as health experts discussed what constitutes quality of life in their opinion. Based on themes extracted of aspects not contained in the existing WHOQOL instrument, 46 candidate items were generated and subsequently rated for their importance by a random sample of 585 individuals from the general population. Applying importance criteria reduced these items to 24, which were then sent to another large random sample (n = 808) to be rated alongside the existing WHOQOL-BREF. A final set of five items met the criteria for national items. Confirmatory factor analysis identified four national items as belonging to the psychological domain of quality of life, and one item to the social domain. Rasch analysis validated these results and generated ordinal-to-interval conversion algorithms to allow use of parametric statistics for domain scores with and without national items.	[Krageloh, Christian U.; Billington, D. Rex; Hsu, Patricia Hsien-Chuan; Feng, Xuan Joanna; Medvedev, Oleg N.; Landon, Jason; Siegert, Richard J.] Auckland Univ Technol, Auckland, New Zealand; [Kersten, Paula] Univ Brighton, Brighton, E Sussex, England	Auckland University of Technology; University of Brighton	Krageloh, CU (corresponding author), Auckland Univ Technol, Auckland, New Zealand.	chris.krageloh@aut.ac.nz	Medvedev, Oleg N./AAO-8339-2020; Landon, Jason/AAD-3951-2019; Siegert, Richard J./K-2030-2019; Krägeloh, Christian/AAF-7879-2020	Medvedev, Oleg N./0000-0002-2167-5002; Krägeloh, Christian/0000-0002-7298-0736; Landon, Jason/0000-0002-3595-7430; Siegert, Richard/0000-0002-3074-0929	Faculty of Health and Environmental Sciences, Auckland University of Technology	Faculty of Health and Environmental Sciences, Auckland University of Technology	The authors acknowledge the financial support from the Faculty of Health and Environmental Sciences, Auckland University of Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M. J., 1979, INTRO MEASUREMENT TH; Andrich D, 2009, 2030 RUMM; [Anonymous], 1946, Am J Public Health Nations Health, V36, P1315; Billington DR, 2010, NEW ZEAL MED J, V123, P65; Capstick S, 2009, SOC SCI MED, V68, P1341, DOI 10.1016/j.socscimed.2009.01.002; Dittman CK, 2013, NEW ZEAL J PSYCHOL, V42, P67; Egoz S., 2000, ORAL HIST, V28, P63; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Harrington L, 2002, J CROSS CULT PSYCHOL, V33, P37, DOI 10.1177/0022022102033001003; Hill EM, 2014, NOISE HEALTH, V16, P47, DOI 10.4103/1463-1741.127855; Hofstede G., 1980, CULTURES CONSEQUENCE; Hsu Pang-Hung, 2009, THESIS; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Joreskog K.G., 1993, LISREL 8 STRUCTURAL; Krageloh CU, 2015, AUST NZ J PUBL HEAL, V39, P384, DOI 10.1111/1753-6405.12350; Krageloh CU, 2013, QUAL LIFE RES, V22, P1451, DOI 10.1007/s11136-012-0265-9; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; KUYKEN W, 1994, INT J MENT HEALTH, V23, P24, DOI 10.1080/00207411.1994.11449286; Medvedev ON, 2016, MINDFULNESS, V7, P384, DOI 10.1007/s12671-015-0454-z; MUTHEN B, 1985, BRIT J MATH STAT PSY, V38, P171, DOI 10.1111/j.2044-8317.1985.tb00832.x; Power M, 1999, HEALTH PSYCHOL, V18, P495, DOI 10.1037/0278-6133.18.5.495; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Skevington SM, 2002, QUAL LIFE RES, V11, P135, DOI 10.1023/A:1015013312456; Skevington SM, 1999, SOC SCI MED, V48, P473, DOI 10.1016/S0277-9536(98)00355-4; Stucki G, 1996, J CLIN EPIDEMIOL, V49, P711, DOI 10.1016/0895-4356(96)00016-9; WHOQOL Group, 1993, WHOQOL STUD PROT DEV; Yao G, 2007, J FORMOS MED ASSOC, V106, P592, DOI 10.1016/S0929-6646(07)60012-6; Yao G, 2009, SOC INDIC RES, V91, P79, DOI 10.1007/s11205-008-9326-4	28	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166065	10.1371/journal.pone.0166065	http://dx.doi.org/10.1371/journal.pone.0166065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812203	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000099
J	Ferrao, M; Colatreli, O; de Fraga, R; Kaefer, IL; Moravec, J; Lima, AP				Ferrao, Miqueias; Colatreli, Olavo; de Fraga, Rafael; Kaefer, Igor L.; Moravec, Jiri; Lima, Albertina P.			High Species Richness of Scinax Treefrogs (Hylidae) in a Threatened Amazonian Landscape Revealed by an Integrative Approach	PLOS ONE			English	Article							ALLOBATES ANURA AROMOBATIDAE; MOLECULAR PHYLOGENY; AMPHIBIA ANURA; RIVER-BASIN; PARA STATE; DIVERSITY; CONSERVATION; FROGS; BIODIVERSITY; TAXONOMY	Rising habitat loss is one of the main drivers of the global amphibian decline. Nevertheless, knowledge of amphibian diversity needed for effective habitat protection is still highly inadequate in remote tropical regions, the greater part of the Amazonia. In this study we integrated molecular, morphological and bioacoustic evidence to evaluate the species richness of the treefrogs genus Scinax over a 1000 km transect across rainforest of the Purus-Madeira interfluve, and along the east bank of the upper Madeira river, Brazilian Amazonia. Analysis revealed that 82% of the regional species richness of Scinax is still undescribed; two nominal species, seven confirmed candidate species, two unconfirmed candidate species, and one deep conspecific lineage were detected in the study area. DNA barcoding based analysis of the 16s rRNA gene indicates possible existence of three discrete species groups within the genus Scinax, in addition to the already-known S. rostratus species Group. Quantifying and characterizing the number of undescribed Scinax taxa on a regional scale, we provide a framework for future taxonomic study in Amazonia. These findings indicate that the level to which Amazonian anura species richness has been underestimated is far greater than expected. Consequently, special attention should be paid both to taxonomic studies and protection of the still-neglected Amazonian Scinax treefrogs.	[Ferrao, Miqueias; de Fraga, Rafael] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [Colatreli, Olavo; Lima, Albertina P.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil; [Kaefer, Igor L.] Univ Fed Amazonas, Inst Ciencias Biol, Manaus, Amazonas, Brazil; [Moravec, Jiri] Natl Museum, Dept Zool, Prague, Czech Republic	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Amazonas; National Museum	Ferrao, M (corresponding author), Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.	uranoscodon@gmail.com	Ferrão, Miquéias/L-1234-2019; Kaefer, Igor L/A-3413-2009; Kaefer, Igor/AAP-2418-2021	Ferrão, Miquéias/0000-0001-7035-8276; Kaefer, Igor L/0000-0001-6515-0278; Kaefer, Igor/0000-0001-6515-0278; Lima, Albertina Pimentel/0000-0003-4586-5633; Colatreli, Olavo/0000-0003-1935-8080	PRONEX - FAPEAM/CNPq [003/2009, 653/2009]; Ministry of Culture of the Czech Republic [00023272]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), via Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM) [573721/2008-4]; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	PRONEX - FAPEAM/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Culture of the Czech Republic; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), via Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by PRONEX - FAPEAM/CNPq (proj. 003/2009, proc. 653/2009) and its publication was funded by Ministry of Culture of the Czech Republic (DKRVO 2016/15, National Museum, 00023272). Miqueias Ferrao had a fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq proc. 573721/2008-4), via Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM). Currently, Miqueias Ferrao receives a PhD scholarship from the Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM). Rafael de Fraga had a PhD scholarship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank William Etges, Edgar Lehr and an anonymous reviewer for their suggestions on this manuscript; Santo Antonio Energia S.A. for support with the fieldwork on the upper Madeira river; Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM) for assistance with fieldwork at the northern interfluve between the Purus and Madeira rivers; Fernanda Werneck and Ariane Silva for access to the INPA-H zoological collection; Alexandre Pinheiro de Almeida for the advertisement call of Scinax sp. 3. Adrian Barnett helped with the English. While conducting this study Miqueias Ferrao had a fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) under grant CNPq-proc. 573721/2008-4, via Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM), while conducting this study. Currently, Miqueias Ferrao receives a PhD scholarship from the Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM). Rafael de Fraga had a PhD scholarship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). Work of Jiri Moravec was financially supported by Ministry of Culture of the Czech Republic (DKRVO 2016/15, National Museum, 00023272).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2014, TRACER V1 6; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bioacoustics Research Program, 2015, RAV PRO INT SOUND AN; Brusquetti F, 2014, ZOOL J LINN SOC-LOND, V171, P783, DOI 10.1111/zoj.12148; Caminer MA, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.370.6291; Campbell H.W., 1982, U S FISH AND WILDLIFE SERVICE WILDLIFE RESEARCH REPORT, V13, P193; Cintra BBL, 2013, BIOGEOSCIENCES, V10, P7759, DOI 10.5194/bg-10-7759-2013; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Carvalho TR, 2015, PHYLLOMEDUSA, V14, P139, DOI 10.11606/issn.2316-9079.v14i2p139-146; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duellman W., 1993, OCCASIONAL PAPER MUS, V153, P1; Duellman W.E., 1970, Monograph Mus nat Hist Univ Kans, V1, P1; DUELLMAN WE, 1972, COPEIA, P265; Duellman WE, 2016, ZOOTAXA, V4104, P1, DOI 10.11646/zootaxa.4104.1.1; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Faivovich J, 2002, CLADISTICS, V18, P367, DOI 10.1111/j.1096-0031.2002.tb00157.x; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2007, MOL PHYLOGENET EVOL, V43, P567, DOI 10.1016/j.ympev.2006.12.006; Fouquet A, 2014, J BIOGEOGR, V41, P855, DOI 10.1111/jbi.12250; Fouquet A, 2012, MOL PHYLOGENET EVOL, V65, P547, DOI 10.1016/j.ympev.2012.07.012; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Gehara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103958; Giam XL, 2012, P ROY SOC B-BIOL SCI, V279, P67, DOI 10.1098/rspb.2011.0433; Guarnizo CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127312; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HEYER W R, 1990, Arquivos de Zoologia (Sao Paulo), V31, P231; IBGE Instituto Brasileiro de Geografia e Estatistica, 1997, REC NAT MEIO AMB BRA; Jansen M, 2011, ZOOL SCR, V40, P567, DOI 10.1111/j.1463-6409.2011.00498.x; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Junca FA, 2015, HERPETOLOGICA, V71, P299, DOI 10.1655/HERPETOLOGICA-D-14-00032; Jungfer KH, 2013, ZOOL SCR, V42, P351, DOI 10.1111/zsc.12015; Kaefer IL, 2013, EVOL BIOL, V40, P228, DOI 10.1007/s11692-012-9205-4; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kohler J, 2005, BIOSCIENCE, V55, P693, DOI 10.1641/0006-3568(2005)055[0693:NAAGCA]2.0.CO;2; Lescure J, 2000, PATRIMOINES NATURELS, V45, P1; Lima AP, 2015, ZOOTAXA, V3980, P501, DOI 10.11646/zootaxa.3980.4.3; Lima AP, 2014, ZOOTAXA, V3889, P355, DOI 10.11646/zootaxa.3889.3.2; Magnusson W.E., 2013, BIODIVERSIDADE MONIT; Maldonado FD, 2012, RIO PURUS AGUA TERRI, P183; Ortega-Andrade HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143392; Menezes L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154626; MYERS C W, 1982, American Museum Novitates, P1; Napoli MF, 2005, HERPETOLOGICA, V61, P63, DOI 10.1655/03-41; Nogueira L, 2016, GENET MOL BIOL, V39, P49, DOI 10.1590/1678-4685-GMB-2015-0037; Nunes I, 2010, ZOOTAXA, P24; Nunes I, 2012, COPEIA, P554, DOI 10.1643/CH-11-088; Nunes I, 2011, HERPETOLOGICA, V67, P80, DOI 10.1655/HERPETOLOGICA-D-10-00026.1; Padial JM, 2009, ZOOL J LINN SOC-LOND, V155, P97, DOI 10.1111/j.1096-3642.2008.00424.x; Palumbi SR, 1991, SAMPLE TOOLS GUIDE P; Pombal-Junior Jose Perez, 1995, Naturalia (Rio Claro), V20, P213; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ron SR, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.229.3580; Rosetti DF, 2015, QUATERNARY RES, V63, P78, DOI [10.1016/j.ygres.2004.10.001, DOI 10.1016/J.YGRES.2004.10.001]; Salducci MD, 2005, CR BIOL, V328, P1009, DOI 10.1016/j.crvi.2005.07.005; Salducci MD, 2002, CR BIOL, V325, P141, DOI 10.1016/S1631-0691(02)01423-3; Savage J. M., 1967, BEITR NEOTROP FAUNA, V5, P111, DOI DOI 10.1080/01650526709360400; Simoes PI, 2010, ZOOTAXA, P1; Simoes PI, 2013, ZOOTAXA, V3746, P401, DOI 10.11646/zootaxa.3746.3.1; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Sombroek Wim, 2000, Acta Amazonica, V30, P81; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sturaro Marcelo José, 2014, Pap. Avulsos Zool. (São Paulo), V54, P9, DOI 10.1590/0031-1049.2014.54.02; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toledo LF, 2012, BIOTROPICA, V44, P785, DOI 10.1111/j.1744-7429.2012.00866.x; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Peloso PLV, 2010, ZOOLOGIA-CURITIBA, V27, P667, DOI 10.1590/S1984-46702010000500001; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Wiens JJ, 2010, MOL PHYLOGENET EVOL, V55, P871, DOI 10.1016/j.ympev.2010.03.013; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	83	34	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165679	10.1371/journal.pone.0165679	http://dx.doi.org/10.1371/journal.pone.0165679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806089	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500048
J	Gulcu, A; Akman, A; Demirkan, AF; Yorukoglu, AC; Kaleli, I; Bir, F				Gulcu, Anil; Akman, Alp; Demirkan, Ahmet Fahir; Yorukoglu, Ali Cagdas; Kaleli, Ilknur; Bir, Ferda			Fosfomycin Addition to Poly((D,L)-Lactide) Coating Does Not Affect Prophylaxis Efficacy in Rat Implant-Related Infection Model, But That of Gentamicin Does	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PSEUDOMONAS-AERUGINOSA BIOFILMS; FOREIGN-BODY INFECTION; IN-VITRO; ANTIBIOTIC-RESISTANCE; TITANIUM IMPLANTS; GROWTH-FACTORS; IGF-I; OSTEOMYELITIS; RELEASE	Gentamicin is the preferred antimicrobial agent used in implant coating for the prevention of implant-related infections (IRI). However, the present heavy local and systemic administration of gentamicin can lead to increased resistance, which has made its future use uncertain, together with related preventive technologies. Fosfomycin is an alternative antimicrobial agent that lacks the cross-resistance presented by other classes of antibiotics. We evaluated the efficacy of prophylaxis of 10% fosfomycin-containing poly((D,L)-lactide) (PDL) coated K-wires in a rat IRI model and compared it with uncoated (Control 1), PDL-coated (Control 2), and 10% gentamicin-containing PDL-coated groups with a single layer of coating. Stainless steel K-wires were implanted and methicillin-resistant Staphylococcus aureus (ATCC 43300) suspensions (10(3) CFU/10 mu l) were injected into a cavity in the left tibiae. Thereafter, K-wires were removed and cultured in tryptic soy broth and then 5% sheep blood agar mediums. Sliced sections were removed from the tibiae, stained with hematoxylin-eosin, and semi-quantitatively evaluated with X-rays. The addition of fosfomycin into PDL did not affect the X-ray and histopathological evaluation scores; however, the addition of gentamicin lowered them. The addition of gentamicin showed a protective effect after the 28(th) day of X-ray evaluations. PDL-only coating provided no protection, while adding fosfomycin to PDL offered a 20% level protection and adding gentamicin offered 80%. Furthermore, there were 10(3) CFU level growths in the gentamicin-added group, while the other groups had 10(5). Thus, the addition of fosfomycin to PDL does not affect the efficacy of prophylaxis, but the addition of gentamicin does. We therefore do not advise the use of fosfomycin as a single antimicrobial agent in coating for IRI prophylaxis.	[Gulcu, Anil; Akman, Alp; Demirkan, Ahmet Fahir; Yorukoglu, Ali Cagdas] Pamukkale Univ, Orthoped & Traumatol Dept, Fac Med, Denizli, Turkey; [Kaleli, Ilknur] Pamukkale Univ, Dept Microbiol, Fac Med, Denizli, Turkey; [Bir, Ferda] Pamukkale Univ, Dept Pathol, Fac Med, Denizli, Turkey	Pamukkale University; Pamukkale University; Akdeniz University; Pamukkale University	Akman, A (corresponding author), Pamukkale Univ, Orthoped & Traumatol Dept, Fac Med, Denizli, Turkey.	alpakman@gmail.com	Bir, Ferda/HGE-9200-2022; GULCU, Anil/AAB-2932-2021; AKMAN, Alp/AAV-6767-2021	AKMAN, Alp/0000-0001-7830-1979; Gulcu, Anil/0000-0002-9012-8053; Demirkan, Ahmet Fahir/0000-0002-1393-7068				Ahire JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123648; Allerberger F, 1999, J ANTIMICROB CHEMOTH, V43, P211, DOI 10.1093/jac/43.2.211; Alt V, 2014, ACTA BIOMATER, V10, P4518, DOI 10.1016/j.actbio.2014.06.013; Amsden GW, 1999, J ANTIMICROB CHEMOTH, V34, P853; An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4; An YHH, 1998, J INVEST SURG, V11, P139, DOI 10.3109/08941939809032193; Annunziata M, 2015, J CRANIOFAC SURG, V26, P1691, DOI 10.1097/SCS.0000000000001786; Arens S, 1996, J BONE JOINT SURG BR, V78B, P647, DOI 10.1302/0301-620X.78B4.0780647; BARRY AL, 1993, EUR J CLIN MICROBIOL, V12, P352, DOI 10.1007/BF01964433; Cai Y, 2009, J ANTIMICROB CHEMOTH, V64, P563, DOI 10.1093/jac/dkp224; Chao YK, 2015, INT J PHARMACEUT, V484, P38, DOI 10.1016/j.ijpharm.2015.02.048; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Diefenbeck M, 2006, INJURY, V37, P95, DOI 10.1016/j.injury.2006.04.015; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Fuchs T, 2011, ARCH ORTHOP TRAUM SU, V131, P1419, DOI 10.1007/s00402-011-1321-6; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Garrigos C, 2013, ANTIMICROB AGENTS CH, V57, P606, DOI 10.1128/AAC.01570-12; GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258; Hoyle B D, 1991, Prog Drug Res, V37, P91; Jennings JA, 2015, CLIN ORTHOP RELAT R, V473, P2270, DOI 10.1007/s11999-014-4130-8; Jiang J, 2015, PHARM RES-DORDR, V32, P2851, DOI 10.1007/s11095-015-1667-5; Kandziora F, 2002, SPINE, V27, P1710, DOI 10.1097/00007632-200208150-00006; Kusachi S, 2011, J INFECT CHEMOTHER, V17, P91, DOI 10.1007/s10156-010-0167-0; Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4; Lucke M, 2005, BONE, V36, P770, DOI 10.1016/j.bone.2005.01.008; Malhas AM, 2015, SURG-J R COLL SURG E, V13, P250, DOI 10.1016/j.surge.2014.04.002; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Mastouri M, 2006, PATHOL BIOL, V54, P33, DOI 10.1016/j.patbio.2004.10.009; MEISSNER A, 1989, INFECTION, V17, P146, DOI 10.1007/BF01644014; Mihailescu R, 2014, ANTIMICROB AGENTS CH, V58, P2547, DOI 10.1128/AAC.02420-12; Mikuniya Takeshi, 2007, Journal of Infection and Chemotherapy, V13, P285, DOI 10.1007/s10156-007-0534-7; Monden Koichi, 2002, Journal of Infection and Chemotherapy, V8, P218, DOI 10.1007/s10156-002-0186-6; Montanaro L, 2011, INT J ARTIF ORGANS, V34, P781, DOI 10.5301/ijao.5000052; PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015; Poeppl W, 2014, ANTIMICROB AGENTS CH, V58, P5111, DOI 10.1128/AAC.02720-13; Rodriguez-Martinez JM, 2007, INT J ANTIMICROB AG, V30, P366, DOI 10.1016/j.ijantimicag.2007.05.005; Schmidmaier G, 2001, J BIOMED MATER RES, V58, P449; Sheehan E, 2004, J ORTHOP RES, V22, P39, DOI 10.1016/S0736-0266(03)00152-9; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Strobel C, 2011, INT J ARTIF ORGANS, V34, P304, DOI 10.5301/IJAO.2011.6470; Teller M, 2007, J BIOMED MATER RES B, V81B, P23, DOI 10.1002/jbm.b.30631; Vester H, 2010, INJURY, V41, P1053, DOI 10.1016/j.injury.2010.05.010; Wildemann B, 2004, J CONTROL RELEASE, V95, P249, DOI 10.1016/j.jconrel.2003.11.014; WITTMANN DH, 1980, INFECTION, V8, P330, DOI 10.1007/BF01640931; Zhang L, 2014, INT J NANOMED, V9, P3027, DOI 10.2147/IJN.S63991; ZHANG XC, 1994, J PHARM PHARMACOL, V46, P718, DOI 10.1111/j.2042-7158.1994.tb03890.x	46	5	7	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165544	10.1371/journal.pone.0165544	http://dx.doi.org/10.1371/journal.pone.0165544			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806071	gold, Green Submitted, Green Published			2022-12-27	WOS:000386715500036
J	Tucnik, P; Bures, V				Tucnik, Petr; Bures, Vladimir			Experimental Evaluation of Suitability of Selected Multi-Criteria Decision-Making Methods for Large-Scale Agent-Based Simulations	PLOS ONE			English	Article							MCDM METHODS; VIKOR; SYSTEMS; MANAGEMENT; CRITERIA; TOPSIS	Multi-criteria decision-making (MCDM) can be formally implemented by various methods. This study compares suitability of four selected MCDM methods, namely WPM, TOPSIS, VIKOR, and PROMETHEE, for future applications in agent-based computational economic (ACE) models of larger scale (i.e., over 10 000 agents in one geographical region). These four MCDM methods were selected according to their appropriateness for computational processing in ACE applications. Tests of the selected methods were conducted on four hardware configurations. For each method, 100 tests were performed, which represented one testing iteration. With four testing iterations conducted on each hardware setting and separated testing of all configurations with the-server parameter de/activated, altogether, 12800 data points were collected and consequently analyzed. An illustrational decision-making scenario was used which allows the mutual comparison of all of the selected decision making methods. Our test results suggest that although all methods are convenient and can be used in practice, the VIKOR method accomplished the tests with the best results and thus can be recommended as the most suitable for simulations of large-scale agent-based models.	[Tucnik, Petr; Bures, Vladimir] Univ Hradec Kralove, Fac Informat & Management, Rokitanskeho 62, Hradec Kralove, Czech Republic	University of Hradec Kralove	Bures, V (corresponding author), Univ Hradec Kralove, Fac Informat & Management, Rokitanskeho 62, Hradec Kralove, Czech Republic.	vladimir.bures@uhk.cz	Tučník, Petr/AAF-9744-2019; Bureš, Vladimír/A-4353-2013	Tučník, Petr/0000-0002-6705-8974; Bureš, Vladimír/0000-0001-7788-7445	Grantova Agentura Ceske Republiky (GACR) [GA15-11724S]; internal FIM UHK Excellence project "MAS Applications in Modeling of Complex Socioeconomic Systems and Intelligent Environments"	Grantova Agentura Ceske Republiky (GACR)(Grant Agency of the Czech Republic); internal FIM UHK Excellence project "MAS Applications in Modeling of Complex Socioeconomic Systems and Intelligent Environments"	This work was supported by the Grantova Agentura Ceske Republiky (GACR) scientific project GA15-11724S DEPIESDecision Processes in Intelligent Environments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The support of the internal FIM UHK Excellence project "MAS Applications in Modeling of Complex Socioeconomic Systems and Intelligent Environments" is gratefully acknowledged. The authors would also like to thank associate professor Jaroslava Mikulecka, PhD and assistant professor Pavel Cech, PhD for their assistance with the statistical data processing, and Tomas Licek, MSc and Tomas Nachazel, MSc for data preparation.	Anojkumar L, 2014, EXPERT SYST APPL, V41, P2964, DOI 10.1016/j.eswa.2013.10.028; Behzadian M, 2012, EXPERT SYST APPL, V39, P13051, DOI 10.1016/j.eswa.2012.05.056; Ben Hmida F, 2012, ADV INTEL SOFT COMPU, V151, P205; Bridgman P. W., 1922, DIMENSIONAL ANAL; Bures V, 2014, E M EKON MANAG, V17, P152, DOI 10.15240/tul/001/2014-3-012; Celik E, 2015, KNOWL-BASED SYST, V85, P329, DOI 10.1016/j.knosys.2015.06.004; Chang CL, 2010, ENVIRON MONIT ASSESS, V168, P339, DOI 10.1007/s10661-009-1117-0; Chiu WY, 2013, KNOWL-BASED SYST, V37, P48, DOI 10.1016/j.knosys.2012.06.017; COLLIER N. T., 2012, SIMULATION; Cordasco G, 2012, LECT NOTES COMPUT SC, V7155, P460, DOI 10.1007/978-3-642-29737-3_51; Alicia HDD, 2011, PROC FOOD SCI, V1, P1560; Fierek S, 2012, PROCD SOC BEHV, V54, P567, DOI 10.1016/j.sbspro.2012.09.774; FISHBURN PC, 1967, OPER RES, V15, P537, DOI 10.1287/opre.15.3.537; Georges A., 2007, P 22 ANN ACM SIGPLAN; HOBBS BF, 1992, WATER RESOUR RES, V28, P1767, DOI 10.1029/92WR00712; Ishizaka A., 2013, MULTICRITERIA DECISI, P1; Johnson DDP, 2013, TRENDS ECOL EVOL, V28, P474, DOI 10.1016/j.tree.2013.05.014; KACKAR RN, 1985, J QUAL TECHNOL, V17, P207; Kagermann H., 2013, RECOMMENDATIONS IMPL; Kantamneni A, 2015, ENG APPL ARTIF INTEL, V45, P192, DOI 10.1016/j.engappai.2015.07.005; Kiran M, 2010, P 9 INT C AUT AG MUL, V1; Klugl Franziska, 2013, Agent-Oriented Software Engineering XIII. 13th International Workshop, AOSE 2012. Revised Selected Papers: LNCS 7852, P179, DOI 10.1007/978-3-642-39866-7_11; Kumari S, 2015, ROBOT CIM-INT MANUF, V36, P36, DOI 10.1016/j.rcim.2014.12.009; Lee WS, 2011, EXPERT SYST APPL, V38, P8037, DOI 10.1016/j.eswa.2010.12.138; Li M, 2014, APPL SOFT COMPUT, V21, P28, DOI 10.1016/j.asoc.2014.03.008; Liu CH, 2012, TOURISM MANAGE, V33, P413, DOI 10.1016/j.tourman.2011.05.002; Mateo J. R. S. C., 2012, PROMETHEE MULTICRITE, P23; Miller DW., 1969, EXECUTIVE DECISIONS; Mulliner E, OMEGA; Mulliner E, 2016, OMEGA-INT J MANAGE S, V59, P146, DOI 10.1016/j.omega.2015.05.013; Nikolai C, 2009, JASSS-J ARTIF SOC S, V12; Opricovic S, 2004, EUR J OPER RES, V156, P445, DOI 10.1016/s0377-2217(03)00020-1; Opricovic S., 1998, MULTICRITERIA OPTIMI; Pekkaya M, 2015, PROC ECON FINANC, V23, P249, DOI 10.1016/S2212-5671(15)00486-4; Peng Y, 2011, OMEGA-INT J MANAGE S, V39, P677, DOI 10.1016/j.omega.2011.01.009; Peniwati K, 2007, MATH COMPUT MODEL, V46, P935, DOI 10.1016/j.mcm.2007.03.005; Premm M, 2015, LECT NOTES ARTIF INT, V9433, P101, DOI 10.1007/978-3-319-27343-3_6; Rao RV, 2013, SPRINGER SERIES ADV, P41; Rezaei J, 2015, TRANSP RES PROC, V10, P766, DOI 10.1016/j.trpro.2015.09.030; Sabaei D, 2015, PROC CIRP, V37, P30, DOI 10.1016/j.procir.2015.08.086; Saeed K, 2014, SYST DYNAM REV, V30, P233, DOI 10.1002/sdr.1525; Sanchez-Lozano JM, 2013, RENEW SUST ENERG REV, V24, P544, DOI 10.1016/j.rser.2013.03.019; Scott JA, 2012, ENERGY, V42, P146, DOI 10.1016/j.energy.2012.03.074; Tan PS, 2012, DECIS SUPPORT SYST, V52, P779, DOI 10.1016/j.dss.2011.11.013; Tesfatsion L, 2002, ARTIF LIFE, V8, P55, DOI 10.1162/106454602753694765; Thor J., 2013, INT J ENG SCI IJES, V2, P27; Tong LI, 2007, INT J ADV MANUF TECH, V31, P1049, DOI 10.1007/s00170-005-0284-6; Triantaphyllou E., 2000, MULTICRITERIA DECISI, P5, DOI [10.1007/978-1-4757-3157-6_2, DOI 10.1007/978-1-4757-3157-6_2]; Triantaphyllou E., 2000, MULTICRITERIA DECISI, VVolume 44; Tzeng GH, 2005, ENERG POLICY, V33, P1373, DOI 10.1016/j.enpol.2003.12.014; Tzeng GwoHshiung, 2002, International Journal of Hospitality Management, V21, P171, DOI 10.1016/S0278-4319(02)00005-1; Vinh Gia Nhi Nguyen, 2012, Active Media Technology. 8th International Conference, AMT 2012. Proceedings, P134, DOI 10.1007/978-3-642-35236-2_14; Voss A, 2010, E SCI E SCI 2010 IEE; Wang S, COMPUTER NETWORKS; Wang YL, 2012, EXPERT SYST APPL, V39, P5600, DOI 10.1016/j.eswa.2011.11.057; Weinberg GM., 2001, INTRO GEN SYSTEMS TH; Yazdani M, 2015, MATER DESIGN, V65, P328, DOI 10.1016/j.matdes.2014.09.004; Yoon K., 1981, MULTIPLE ATTRIBUTE D; Yu XH, 2012, INT J APPROX REASON, V53, P502, DOI 10.1016/j.ijar.2011.12.002; Zopounidis C, 2015, EUR J OPER RES, V247, P339, DOI 10.1016/j.ejor.2015.05.032	60	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165171	10.1371/journal.pone.0165171	http://dx.doi.org/10.1371/journal.pone.0165171			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806061	Green Submitted, Green Published, gold			2022-12-27	WOS:000386715500021
J	Candeloro, L; Savini, L; Conte, A				Candeloro, Luca; Savini, Lara; Conte, Annamaria			A New Weighted Degree Centrality Measure: The Application in an Animal Disease Epidemic	PLOS ONE			English	Article							NETWORK ANALYSIS; STRENGTH	In recent years researchers have investigated a growing number of weighted heterogeneous networks, where connections are not merely binary entities, but are proportional to the intensity or capacity of the connections among the various elements. Different degree centrality measures have been proposed for this kind of networks. In this work we propose weighted degree and strength centrality measures (WDC and WSC). Using a reducing factor we correct classical centrality measures (CD) to account for tie weights distribution. The bigger the departure from equal weights distribution, the greater the reduction. These measures are applied to a real network of Italian livestock movements as an example. A simulation model has been developed to predict disease spread into Italian regions according to animal movements and animal population density. Model's results, expressed as infected regions and number of times a region gets infected, were related to weighted and classical degree centrality measures. WDC and WSC were shown to be more efficient in predicting node's risk and vulnerability. The proposed measures and their application in an animal network could be used to support surveillance and infection control strategy plans.	[Candeloro, Luca; Savini, Lara; Conte, Annamaria] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Stat & GIS Dept, Teramo, Italy	IZS Dell'abruzzo E Del Molise Giuseppe Caporale	Candeloro, L (corresponding author), Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Stat & GIS Dept, Teramo, Italy.	l.candeloro@izs.it	Conte, Annamaria/H-5869-2016; Candeloro, Luca/ABA-6009-2021; Savini, Lara LS/C-2851-2018	Conte, Annamaria/0000-0001-6975-2698; Candeloro, Luca/0000-0001-8475-3787; Savini, Lara LS/0000-0001-6175-7793				Bajardi P, 2012, J R SOC INTERFACE, V9, P2814, DOI 10.1098/rsif.2012.0289; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Buttner K, 2013, PREV VET MED, V110, P418, DOI 10.1016/j.prevetmed.2013.01.008; Campbell E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01905; Chen S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04472; Cormen Thomas H., 2009, INTRO ALGORITHMS; Freeman L., 2004, DEV SOCIAL NETWORK A; FREEMAN LC, 1991, SOC NETWORKS, V13, P141, DOI 10.1016/0378-8733(91)90017-N; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Karlberg M, 1997, SOC NETWORKS, V19, P325, DOI 10.1016/S0378-8733(97)00001-4; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Leinhardt S., 1977, SOCIAL NETWORKS DEV, pxiii; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nieminen U.J., 1973, SOC SCI RES, V2, P371, DOI [10.1016/0049-089X(73)90010-0, DOI 10.1016/0049-089X(73)90010-0]; Opsahl T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168702; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Scott J., 2000, SOCIAL STRUCTURE, V2nd; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Yang S, 2001, SOC NETWORKS, V23, P285, DOI 10.1016/S0378-8733(01)00043-0	22	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165781	10.1371/journal.pone.0165781	http://dx.doi.org/10.1371/journal.pone.0165781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802327	Green Submitted, Green Published, gold			2022-12-27	WOS:000386714200053
J	Lobel, U; Forkert, ND; Schmitt, P; Dohrmann, T; Schroeder, M; Magnus, T; Kluge, S; Weiler-Normann, C; Bi, XM; Fiehler, J; Sedlacik, J				Loebel, Ulrike; Forkert, Nils Daniel; Schmitt, Peter; Dohrmann, Torsten; Schroeder, Maria; Magnus, Tim; Kluge, Stefan; Weiler-Normann, Christina; Bi, Xiaoming; Fiehler, Jens; Sedlacik, Jan			Cerebral Hemodynamics in Patients with Hemolytic Uremic Syndrome Assessed by Susceptibility Weighted Imaging and Four-Dimensional Non-Contrast MR Angiography	PLOS ONE			English	Article							ESCHERICHIA-COLI; CARBON-DIOXIDE; BLOOD-FLOW; 4D MRA; CHILDREN; 3D; QUANTIFICATION; ENHANCEMENT; INFECTION; PROPOFOL	Background and Purpose Conventional magnetic resonance imaging (MRI) of patients with hemolytic uremic syndrome (HUS) and neurological symptoms performed during an epidemic outbreak of Escherichia coli O104:H4 in Northern Europe has previously shown pathological changes in only approximately 50% of patients. In contrast, susceptibility-weighted imaging (SWI) revealed a loss of venous contrast in a large number of patients. We hypothesized that this observation may be due to an increase in cerebral blood flow (CBF) and aimed to identify a plausible cause. Materials and Methods Baseline 1.5T MRI scans of 36 patients (female, 26; male, 10; mean age, 38.2 +/- 19.3 years) were evaluated. Venous contrast was rated on standard SWI minimum intensity projections. A prototype four-dimensional (time resolved) magnetic resonance angiography (4D MRA) assessed cerebral hemodynamics by global time-to-peak (TTP), as a surrogate marker for CBF. Clinical parameters studied were hemoglobin, hematocrit, creatinine, urea levels, blood pressure, heart rate, and end-tidal CO2. Results SWI venous contrast was abnormally low in 33 of 36 patients. TTP ranged from 3.7 to 10.2 frames (mean, 7.9 +/- 1.4). Hemoglobin at the time of MRI (n = 35) was decreased in all patients (range, 5.0 to 12.6 g/dL; mean, 8.2 +/- 1.4); hematocrit (n = 33) was abnormally low in all but a single patient (range, 14.3 to 37.2%; mean, 23.7 +/- 4.2). Creatinine was abnormally high in 30 of 36 patients (83%) (range, 0.8 to 9.7; mean, 3.7 +/- 2.2). SWI venous contrast correlated significantly with hemoglobin (r = 0.52, P = 0.0015), hematocrit (r = 0.65, P < 0.001), and TTP (r = 0.35, P = 0.036). No correlation of SWI with blood pressure, heart rate, end-tidal CO2, creatinine, and urea level was observed. Findings suggest that the loss of venous contrast is related to an increase in CBF secondary to severe anemia related to HUS. SWI contrast of patients with pathological conventional MRI findings was significantly lower compared to patients with normal MRI (mean SWI score, 1.41 and 2.05, respectively; P = 0.04). In patients with abnormal conventional MRI, mean TTP (7.45), mean hemoglobin (7.65), and mean hematocrit (22.0) were lower compared to patients with normal conventional MRI scans (mean TTP = 8.28, mean hemoglobin = 8.63, mean hematocrit = 25.23). Conclusion In contrast to conventional MRI, almost all patients showed pathological changes in cerebral hemodynamics assessed by SWI and 4D MRA. Loss of venous contrast on SWI is most likely the result of an increase in CBF and may be related to the acute onset of anemia. Future studies will be needed to assess a possible therapeutic effect of blood transfusions in patients with HUS and neurological symptoms.	[Loebel, Ulrike; Fiehler, Jens; Sedlacik, Jan] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Forkert, Nils Daniel] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Forkert, Nils Daniel] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Schmitt, Peter] Siemens Hlth Care, Erlangen, Germany; [Dohrmann, Torsten; Schroeder, Maria; Kluge, Stefan] Univ Med Ctr Hamburg Eppendorf, Dept Intens Care, Hamburg, Germany; [Magnus, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Weiler-Normann, Christina] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, Hamburg, Germany; [Weiler-Normann, Christina] Univ Med Ctr Hamburg Eppendorf, Martin Zeitz Ctr Rare Dis, Hamburg, Germany; [Bi, Xiaoming] Siemens Healthcare, Los Angeles, CA USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Calgary; University of Calgary; Siemens AG; Siemens Germany; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Siemens AG	Lobel, U (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	u.loebel@uke.de	Forkert, Nils Daniel/K-6273-2012	Forkert, Nils Daniel/0000-0003-2556-3224	Siemens Healthcare	Siemens Healthcare(Siemens AG)	For Xiaoming Bi and Peter Schmitt: The funder (Siemens Healthcare) provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barhoum S, 2015, J CEREBR BLOOD F MET, V35, P1616, DOI 10.1038/jcbfm.2015.96; Bauer A, 2014, PEDIATR NEPHROL, V29, P1607, DOI 10.1007/s00467-014-2803-x; Bi XM, 2010, MAGN RESON MED, V63, P835, DOI 10.1002/mrm.22220; Braune SA, 2013, CRIT CARE MED, V41, P1702, DOI 10.1097/CCM.0b013e31828a24a8; Dhar R, 2009, STROKE, V40, P3039, DOI 10.1161/STROKEAHA.109.556159; Fan AP, 2015, NEUROIMAGE, V104, P146, DOI 10.1016/j.neuroimage.2014.09.068; Forkert ND, 2011, METHOD INFORM MED, V50, P74, DOI 10.3414/ME10-02-0003; Forkert ND, 2013, MAGN RESON IMAGING, V31, P262, DOI 10.1016/j.mri.2012.07.008; Forkert ND, 2012, J MAGN RESON IMAGING, V36, P443, DOI 10.1002/jmri.23652; Forkert ND, 2011, MAGN RESON MED, V65, P289, DOI 10.1002/mrm.22583; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; GALLO GE, 1995, PEDIATR NEPHROL, V9, P117, DOI 10.1007/BF00858990; Ge YL, 2009, J MAGN RESON IMAGING, V29, P1190, DOI 10.1002/jmri.21758; Gunther M, 2005, MAGN RESON MED, V54, P491, DOI 10.1002/mrm.20580; Hagel C, 2015, BRAIN PATHOL, V25, P146, DOI 10.1111/bpa.12166; Harreld JH, 2013, NEURORADIOLOGY, V55, P1049, DOI 10.1007/s00234-013-1187-0; Karsli C, 2003, ANESTH ANALG, V97, P694, DOI 10.1213/01.ANE.0000074235.81165.AF; Kuroda M, 2015, NEUROCHEM INT, V85-86, P24, DOI 10.1016/j.neuint.2015.04.003; Kuwabara Y, 2002, KIDNEY INT, V61, P564, DOI 10.1046/j.1523-1755.2002.00142.x; Lobel U, 2014, CLIN NEURORADIOL, V24, P111, DOI 10.1007/s00062-013-0231-0; Loos S, 2012, CLIN INFECT DIS, V55, P753, DOI 10.1093/cid/cis531; Magnus T, 2012, BRAIN, V135, P1850, DOI 10.1093/brain/aws090; Mandler JM, 2002, BRAIN DAM B, P315, DOI 10.1016/B978-012693019-1/50015-0; Morimoto Y, 2001, J NEUROSURG ANESTH, V13, P33, DOI 10.1097/00008506-200101000-00006; Navarro-Garcia F, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0008-2013; Page AV, 2013, J INFECT DIS, V208, P929, DOI 10.1093/infdis/jit268; Sedlacik J, 2010, AM J NEURORADIOL, V31, P901, DOI 10.3174/ajnr.A1960; Shimizu M, 2017, CLIN EXP NEPHROL, V21, P76, DOI 10.1007/s10157-016-1254-z; Shimizu M, 2014, CYTOKINE, V66, P1, DOI 10.1016/j.cyto.2013.12.005; Shiraishi M, 2008, J NEUROIMMUNOL, V196, P147, DOI 10.1016/j.jneuroim.2008.02.012; Ullrich S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055278; Winchell AM, 2014, AM J NEURORADIOL, V35, P1016, DOI 10.3174/ajnr.A3794	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0164863	10.1371/journal.pone.0164863	http://dx.doi.org/10.1371/journal.pone.0164863			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802295	Green Published, Green Submitted, gold			2022-12-27	WOS:000386714200011
J	Niebuhr, CN; Poulin, R; Tompkins, DM				Niebuhr, Chris N.; Poulin, Robert; Tompkins, Daniel M.			Is Avian Malaria Playing a Role in Native Bird Declines in New Zealand? Testing Hypotheses along an Elevational Gradient	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; APAPANE HIMATIONE-SANGUINEA; PARASITES PLASMODIUM SPP.; EVOLUTIONARY RELATIONSHIPS; MOHOUA-OCHROCEPHALA; FOREST BIRDS; DIVERSITY; BLOOD; PATHOGENICITY; PREVALENCE	The mosquito-borne disease avian malaria (Plasmodium spp.) has impacted both captive populations and wild individuals of native New Zealand bird species. However, whether or not it is a cause of concern to their wild populations is still unclear. In Hawaii, the disease has been a major factor in the population declines of some native forest bird species, often limiting their elevational distribution due to an inverse relationship between force of infection and elevation. While studies have investigated latitudinal patterns of infection in New Zealand, elevational patterns are unexplored. To address this, a survey was conducted in Nelson Lakes National Park, a site experiencing native bird declines in which disease has been suggested as playing a role, to investigate whether there is a similar inverse relationship in New Zealand. Results from blood samples (n = 436) collected over three seasons across a broad elevational range (650-1400 m) support there being such a relationship. In addition, an overall higher prevalence in non-native (14.1%) versus native birds (1.7%) may indicate differential impacts on these two groups, while particularly high prevalence in non-native Turdus spp. supports previous suggestions that they are key reservoir hosts for the disease. Overall, these findings add weight to the hypothesis that avian malaria is playing a role in ongoing declines of native New Zealand birds.	[Niebuhr, Chris N.; Poulin, Robert] Univ Otago, Dept Zool, Dunedin, New Zealand; [Tompkins, Daniel M.] Landcare Res, Dunedin, New Zealand	University of Otago; Landcare Research - New Zealand	Niebuhr, CN (corresponding author), Univ Otago, Dept Zool, Dunedin, New Zealand.	chris.niebuhr@postgrad.otago.ac.nz	Poulin, Robert/C-3117-2008; Poulin, Robert/GQO-8936-2022	Poulin, Robert/0000-0003-1390-1206; Poulin, Robert/0000-0003-1390-1206; Niebuhr, Chris/0000-0002-8892-3605	University of Otago Doctoral Scholarship; University of Otago Postgraduate Publishing Bursary; New Zealand Department of Conservation	University of Otago Doctoral Scholarship; University of Otago Postgraduate Publishing Bursary; New Zealand Department of Conservation	CNN was supported by a University of Otago Doctoral Scholarship and a University of Otago Postgraduate Publishing Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to the New Zealand Department of Conservation and the staff of Nelson Lakes National Park for their support and assistance, especially Jenny Long, John Henderson, and Nik Joice. Additional thanks are necessary for Clare Cross and Kevin Drew for their assistance in the field and Isa Blasco-Costa for her guidance in the laboratory.	Ahumada JA, 2004, J MED ENTOMOL, V41, P1157, DOI 10.1603/0022-2585-41.6.1157; Alley MR, 2008, NEW ZEAL VET J, V56, P247, DOI 10.1080/00480169.2008.36842; Alley MRM, 2012, KOKAKO, V19, P11; Atkinson CT, 2010, J AVIAN BIOL, V41, P357, DOI 10.1111/j.1600-048X.2009.04915.x; Atkinson CT, 2009, J AVIAN MED SURG, V23, P53, DOI 10.1647/2008-059.1; Atkinson CT, 1995, PARASITOLOGY, V111, pS59, DOI 10.1017/S003118200007582X; Atkinson CT, 2000, J WILDLIFE DIS, V36, P197, DOI 10.7589/0090-3558-36.2.197; Atkinson CT, 2001, CONDOR, V103, P209, DOI 10.1650/0010-5422(2001)103[0209:PSRADO]2.0.CO;2; Baillie SM, 2011, PARASITOLOGY, V138, P1843, DOI 10.1017/S0031182011001491; Beadell JS, 2006, P ROY SOC B-BIOL SCI, V273, P2935, DOI 10.1098/rspb.2006.3671; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; BELKIN J N, 1968, Contributions of the American Entomological Institute, V3, P1; Bensch S, 2007, J ANIM ECOL, V76, P112, DOI 10.1111/j.1365-2656.2006.01176.x; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Castro I, 2011, J WILDLIFE DIS, V47, P860, DOI 10.7589/0090-3558-47.4.860; Crump JA, 2001, EMERG INFECT DIS, V7, P767; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; DAWSON D G, 1978, Notornis, V25, P257; Derraik JGB, 2008, J ROY SOC NEW ZEAL, V38, P237, DOI 10.1080/03014220809510558; Elliott GP, 2010, BIOL CONSERV, V143, P2119, DOI 10.1016/j.biocon.2010.05.022; Ewen JG, 2012, ECOL LETT, V15, P1112, DOI 10.1111/j.1461-0248.2012.01833.x; GREENWOOD PJ, 1976, J ANIM ECOL, V45, P887, DOI 10.2307/3587; Grimaldi WW, 2015, POLAR BIOL, V38, P591, DOI 10.1007/s00300-014-1632-5; Harper G, 2014, ROTOITI NATURE RECOV; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hellgren O, 2011, J WILDLIFE DIS, V47, P849, DOI 10.7589/0090-3558-47.4.849; HOLDAWAY RN, 1990, NEW ZEAL J ZOOL, V17, P309, DOI 10.1080/03014223.1990.10422938; Howe L, 2012, PARASITOL RES, V110, P913, DOI 10.1007/s00436-011-2577-z; Ishtiaq F, 2006, P ROY SOC B-BIOL SCI, V273, P587, DOI 10.1098/rspb.2005.3313; Jahn P, 2013, NOTORNIS, V60, P201; LaPointe DA, 2012, ANN NY ACAD SCI, V1249, P211, DOI 10.1111/j.1749-6632.2011.06431.x; Lowry R., 2004, VASSARSTATS WEBSITE; McCallum H, 2005, CONSERV BIOL, V19, P1421, DOI 10.1111/j.1523-1739.2005.00217.x; Moller AP, 2007, ECOLOGY, V88, P871, DOI 10.1890/06-0747; Niebuhr CN, 2016, PARASITOL RES, V115, P3905, DOI 10.1007/s00436-016-5157-4; Niebuhr CN, 2016, THESIS; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; Samuel MD, 2011, ECOL APPL, V21, P2960, DOI 10.1890/10-1311.1; Schoener ER, 2014, NEW ZEAL VET J, V62, P189, DOI 10.1080/00480169.2013.871195; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Sijbranda DC, 2016, N Z J ECOL, V40, P72; Sturrock HJW, 2008, NEW ZEAL J ECOL, V32, P98; Tompkins DM, 2006, ECOL STU AN, V186, P67; Tompkins DM, 2006, J ROY SOC NEW ZEAL, V36, P51, DOI 10.1080/03014223.2006.9517799; Tompkins DM, 2015, TRENDS PARASITOL, V31, P149, DOI 10.1016/j.pt.2015.01.007; Tompkins DM, 2011, BIOL CONSERV, V144, P668, DOI 10.1016/j.biocon.2010.09.027; Valkinas G., 2005, AVIAN MALARIA PARASI; Williams RB, 2005, AVIAN PATHOL, V34, P29, DOI 10.1080/03079450400025430; Yorinks N, 2000, AUK, V117, P731, DOI 10.1642/0004-8038(2000)117[0731:EOMOAB]2.0.CO;2	50	25	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165918	10.1371/journal.pone.0165918	http://dx.doi.org/10.1371/journal.pone.0165918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802326	Green Submitted, gold, Green Published			2022-12-27	WOS:000386714200068
J	Boehm-Cagen, A; Bar, R; Harats, D; Shaish, A; Levkovitz, H; Bielicki, JK; Johansson, JO; Michaelson, DM				Boehm-Cagen, Anat; Bar, Roni; Harats, Dror; Shaish, Aviv; Levkovitz, Hana; Bielicki, John K.; Johansson, Jan O.; Michaelson, Daniel M.			Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEINS; CENTRAL-NERVOUS-SYSTEM; SPORADIC ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; TRANSGENIC MICE; CARDIOVASCULAR-DISEASE; CHOLESTEROL TRANSPORT; TARGETED REPLACEMENT; MOUSE MODEL; WILD-TYPE	Apolipoprotein E4 (apoE4), the leading genetic risk factor for Alzheimer's disease (AD), is less lipidated compared to the most common and AD-benign allele, apoE3. We have recently shown that i.p. injections of the ATP-binding cassette A1 (ABCA1) agonist peptide CS-6253 to apoE mice reverse the hypolipidation of apoE4 and the associated brain pathology and behavioral deficits. While in the brain apoE is the main cholesterol transporter, in the periphery apoE and apoA-I both serve as the major cholesterol transporters. We presently investigated the extent to which apoE genotype and CS-6253 treatment to apoE3 and apoE4-targeted replacement mice affects the plasma levels and lipid particle distribution of apoE, and those of plasma and brain apoA-I and apoJ. This revealed that plasma levels of apoE4 were lower and eluted faster following FPLC than plasma apoE3. Treatment with CS-6253 increased the levels of plasma apoE4 and rendered the elution profile of apoE4 similar to that of apoE3. Similarly, the levels of plasma apoA-I were lower in the apoE4 mice compared to apoE3 mice, and this effect was partially reversed by CS-6253. Conversely, the levels of apoA-I in the brain which were higher in the apoE4 mice, were unaffected by CS-6253. The plasma levels of apoJ were higher in apoE4 mice than apoE3 mice and this effect was abolished by CS-6253. Similar but less pronounced effects were obtained in the brain. In conclusion, these results suggest that apoE4 affects the levels of apoA-I and apoJ and that the anti-apoE4 beneficial effects of CS-6253 may be related to both central and peripheral mechanisms.	[Boehm-Cagen, Anat; Bar, Roni; Michaelson, Daniel M.] Tel Aviv Univ, Sagol Sch Neurosci, George S Wise Fac Life Sci, Dept Neurobiol, IL-6997801 Tel Aviv, Israel; [Harats, Dror] Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel; [Harats, Dror; Shaish, Aviv; Levkovitz, Hana] Bert W Strassburger Lipid Ctr, Sheba Med Ctr, IL-5265601 Tel Hashomer, Israel; [Bielicki, John K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Johansson, Jan O.] Artery Therapeut Inc, San Ramon, CA USA	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Michaelson, DM (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, George S Wise Fac Life Sci, Dept Neurobiol, IL-6997801 Tel Aviv, Israel.	dmichael@post.tau.ac.il		Johansson, Jan/0000-0002-3576-2748	Legacy Heritage Bio-Medical Program of the Israel Science Foundation [1575/14]; Joseph K. and Inez Eichenbaum Foundation; Harold and Eleanore Foonberg Foundation; Teva Pharmaceutical Industries Ltd., Israeli National Network of Excellence in Neuroscience (NNE); Artery Therapeutics, Inc.	Legacy Heritage Bio-Medical Program of the Israel Science Foundation; Joseph K. and Inez Eichenbaum Foundation; Harold and Eleanore Foonberg Foundation; Teva Pharmaceutical Industries Ltd., Israeli National Network of Excellence in Neuroscience (NNE); Artery Therapeutics, Inc.	This research was supported in part by grants from the Legacy Heritage Bio-Medical Program of the Israel Science Foundation (grant No. 1575/14), from the Joseph K. and Inez Eichenbaum Foundation, from the Harold and Eleanore Foonberg Foundation, and from Teva Pharmaceutical Industries Ltd., as part of the Israeli National Network of Excellence in Neuroscience (NNE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Artery Therapeutics, Inc. provided support in the form of salaries for author JOJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this authors is articulated in the 'author contributions' section.; We thank Alex Smolar for his technical assistance. This research was supported in part by grants from the Legacy Heritage Bio-Medical Program of the Israel Science Foundation (grant No. 1575/14), from the Joseph K. and Inez Eichenbaum Foundation, from the Harold and Eleanore Foonberg Foundation, and from Teva Pharmaceutical Industries Ltd., as part of the Israeli National Network of Excellence in Neuroscience (NNE). DMM is the incumbent of the Myriam Lebach Chair in Molecular Neurodegeneration.	Belinson H, 2008, J NEUROSCI, V28, P4690, DOI 10.1523/JNEUROSCI.5633-07.2008; Belinson H, 2009, J NEURAL TRANSM, V116, P1427, DOI 10.1007/s00702-009-0218-9; Bielicki JK, 2010, J LIPID RES, V51, P1496, DOI 10.1194/jlr.M003665; Boehm-Cagan A, 2016, J ALZHEIMERS DIS, V54, P1219, DOI 10.3233/JAD-160467; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DeMattos RB, 2001, NEUROCHEM INT, V39, P415, DOI 10.1016/S0197-0186(01)00049-3; DESILVA HV, 1990, BIOCHEMISTRY-US, V29, P5380, DOI 10.1021/bi00474a025; Elliott DA, 2010, CLIN LIPIDOL, V5, P555, DOI 10.2217/CLP.10.37; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; Gelissen IC, 1998, BIOCHEM J, V331, P231, DOI 10.1042/bj3310231; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; Grosskopf I, 2012, ATHEROSCLEROSIS, V224, P75, DOI 10.1016/j.atherosclerosis.2012.04.011; Haas A, 2012, NEURODEGENER DIS, V10, P41, DOI 10.1159/000334902; Hafiane A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131997; Hanson AJ, 2013, JAMA NEUROL, V70, P972, DOI 10.1001/jamaneurol.2013.396; HEDRICK CC, 1993, J BIOL CHEM, V268, P20676; Heeren J, 2006, ARTERIOSCL THROM VAS, V26, P442, DOI 10.1161/01.ATV.0000201282.64751.47; Hirsch-Reinshagen V, 2004, J BIOL CHEM, V279, P41197, DOI 10.1074/jbc.M407962200; Hopkins PCR, 2002, J LIPID RES, V43, P1881, DOI 10.1194/jlr.M200172-JLR200; Hu J, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0001-3; Huang YD, 1995, J CLIN INVEST, V96, P2693, DOI 10.1172/JCI118336; Jansen PJ, 2009, J ALZHEIMERS DIS, V18, P319, DOI 10.3233/JAD-2009-1150; JONAS A, 1990, J BIOL CHEM, V265, P22123; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Kockx M, 2004, J BIOL CHEM, V279, P25966, DOI 10.1074/jbc.M401177200; Koldamova R, 2014, NEUROBIOL DIS, V72, P13, DOI 10.1016/j.nbd.2014.05.007; LaDu MJ, 2000, ANN NY ACAD SCI, V903, P167, DOI 10.1111/j.1749-6632.2000.tb06365.x; Levi O, 2003, NEUROBIOL DIS, V13, P273, DOI 10.1016/S0969-9961(03)00045-7; Li H, 2013, ARTERIOSCL THROM VAS, V33, P687, DOI 10.1161/ATVBAHA.112.301193; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; Liraz O, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-16; Mahley RW, 2016, ARTERIOSCL THROM VAS, V36, P1305, DOI 10.1161/ATVBAHA.116.307023; Mahley RW, 2006, J CLIN INVEST, V116, P1226, DOI 10.1172/JCI28632; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Michel D, 1997, BIOCHEM J, V328, P45, DOI 10.1042/bj3280045; Michikawa M, 2000, J NEUROCHEM, V74, P1008, DOI 10.1046/j.1471-4159.2000.0741008.x; Minagawa Hirohisa, 2009, J Neurosci Res, V87, P2498, DOI 10.1002/jnr.22073; Mulder M, 1998, HAEMOSTASIS, V28, P174; Okoro EU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044430; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Phillips MC, 2013, J LIPID RES, V54, P2034, DOI 10.1194/jlr.R034025; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; PITAS RE, 1987, J BIOL CHEM, V262, P14352; Poirier J, 2005, NEUROBIOL AGING, V26, P355, DOI 10.1016/j.neurobiolaging.2004.09.003; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; Poirier J, 2014, NEUROBIOL AGING, V35, pS3, DOI 10.1016/j.neurobiolaging.2014.03.037; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Robciuc MR, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-59; Robert J, 2016, BBA-MOL BASIS DIS, V1862, P1027, DOI 10.1016/j.bbadis.2015.10.005; Rohn TT, 2014, INT J CLIN EXP PATHO, V7, P3504; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Rye KA, 1996, J BIOL CHEM, V271, P4243; Rye K, 2006, J LIPID RES, V47, P1025, DOI 10.1194/jlr.M500525-JLR200; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Stukas S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001156; Stukas S, 2014, CELL METAB, V19, P574, DOI 10.1016/j.cmet.2014.01.003; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Tai LM, 2014, J BIOL CHEM, V289, P30538, DOI 10.1074/jbc.M114.600833; Tai LM, 2013, J BIOL CHEM, V288, P5914, DOI 10.1074/jbc.M112.442103; Tang CR, 2009, BBA-MOL CELL BIOL L, V1791, P563, DOI 10.1016/j.bbalip.2009.03.011; Ulrich JD, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-13; Vance JE, 2010, BBA-MOL CELL BIOL L, V1801, P806, DOI 10.1016/j.bbalip.2010.02.007; Vitali C, 2014, CARDIOVASC RES, V103, P405, DOI 10.1093/cvr/cvu148; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wellington CL, 2016, CURR OPIN LIPIDOL, V27, P225, DOI 10.1097/MOL.0000000000000291; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Yassine HN, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002886; Yu JT, 2012, MOL NEUROBIOL, V45, P314, DOI 10.1007/s12035-012-8237-1; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152	70	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166195	10.1371/journal.pone.0166195	http://dx.doi.org/10.1371/journal.pone.0166195			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824936	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200070
J	Fujima, N; Sakashita, T; Homma, A; Hirata, K; Shiga, T; Kudo, K; Shirato, H				Fujima, Noriyuki; Sakashita, Tomohiro; Homma, Akihiro; Hirata, Kenji; Shiga, Tohru; Kudo, Kohsuke; Shirato, Hiroki			Glucose Metabolism and Its Complicated Relationship with Tumor Growth and Perfusion in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							BLOOD-FLOW; CANCER; PET; TOMOGRAPHY; HYPOXIA; CT	Objective To determine the relationship between tumor glucose metabolism and tumor blood flow (TBF) in head and neck squamous cell carcinoma (HNSCC). Methods We retrospectively analyzed 57 HNSCC patients. Tumor glucose metabolism was assessed by maximum and mean standardized uptake values (SUVmax and SUVmean) obtained by 18 F-fluorodeoxyglucose positron-emission tomography. TBF values were obtained by arterial spin labeling with 3-tesla MRI. The correlations between both SUVs and TBF were assessed in the total series and among patients divided by T-stage (T1-T3 and T4 groups) and tumor location (pharynx/oral cavity and sinonasal cavity groups). Pearson's correlation coefficients were calculated for significant correlations. Results Significant correlations were detected: a negative correlation in the advanced T-stage group (TBF and SUV max: r, -0.61, SUVmean: r, -0.62), a positive correlation in the non-advanced T-stage pharynx/oral cavity group (TBF and SUVmax: r, 0.70, SUVmean: r, 0.73), a negative correlation in the advanced T-stage pharynx/oral cavity group (TBF and SUVmax: r, -0.62, SUVmean: r, -0.65), and a negative correlation in the advanced Tstage sinonasal cavity group (TBF and SUVmax: r, -0.61, SUVmean: r, -0.65). Conclusion Significant correlations between glucose uptake and TBF in HNSCC were revealed by the division of T-stage and tumor location.	[Fujima, Noriyuki; Kudo, Kohsuke] Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Sapporo, Hokkaido, Japan; [Sakashita, Tomohiro; Homma, Akihiro] Hokkaido Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Sapporo, Hokkaido, Japan; [Hirata, Kenji; Shiga, Tohru] Hokkaido Univ, Dept Nucl Med, Grad Sch Med, Sapporo, Hokkaido, Japan; [Shirato, Hiroki] Hokkaido Univ, Dept Radiat Med, Grad Sch Med, Sapporo, Hokkaido, Japan; [Shirato, Hiroki] Global Inst Collaborat Res & Educ, Global Stn Quantum Med Sci & Engn, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Fujima, N (corresponding author), Hokkaido Univ Hosp, Dept Diagnost & Intervent Radiol, Sapporo, Hokkaido, Japan.	Noyuki.Fujima@mb9.seikyou.ne.jp	Kudo, Kohsuke/AAK-9938-2021; Fujima, Noriyuki/AAF-7270-2020	Kudo, Kohsuke/0000-0001-5351-9242; Fujima, Noriyuki/0000-0001-9021-347X	Ministry of Education, Culture, Sports, Science and Technology - Japan [25861047]	Ministry of Education, Culture, Sports, Science and Technology - Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology - Japan (ID; 25861047)(https://kaken.nii.ac.jp/d/p/25861047.ja.html), received by NF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisdas S, 2008, AM J NEURORADIOL, V29, P1376, DOI 10.3174/ajnr.A1111; Fruehwald-Pallamar J, 2011, EUR J NUCL MED MOL I, V38, P1009, DOI 10.1007/s00259-010-1718-4; Fujima N, 2016, AM J NEURORADIOL, V37, P342, DOI 10.3174/ajnr.A4513; Fujima N, 2015, DENTOMAXILLOFAC RAD, V44, DOI 10.1259/dmfr.20150074; Fujima N, 2015, EUR J RADIOL, V84, P2187, DOI 10.1016/j.ejrad.2015.07.026; Fujima N, 2015, J MAGN RESON IMAGING, V41, P983, DOI [10.1002/jmri.24637, 10.1002/jmri.24885]; Goh V, 2012, J NUCL MED, V53, P687, DOI 10.2967/jnumed.111.098525; Hirasawa S, 2007, ACAD RADIOL, V14, P312, DOI 10.1016/j.acra.2006.12.017; Kato H, 2015, EUR RADIOL, V25, P3247, DOI 10.1007/s00330-015-3755-7; Komar G, 2014, EUR J NUCL MED MOL I, V41, P2042, DOI 10.1007/s00259-014-2818-3; Komar G, 2008, J NUCL MED, V49, P1944, DOI 10.2967/jnumed.108.053785; Lin YT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-194; Newbold K, 2009, INT J RADIAT ONCOL, V74, P29, DOI 10.1016/j.ijrobp.2008.07.039; Panin VY, 2006, IEEE T MED IMAGING, V25, P907, DOI 10.1109/TMI.2006.876171; Rischin D, 2007, INT J RADIAT ONCOL, V69, pS61, DOI 10.1016/j.ijrobp.2007.05.043; Sato J, 2014, EUR J NUCL MED MOL I, V41, P2031, DOI 10.1007/s00259-014-2810-y; Sheikhbahaei S, 2015, PET CLIN, V10, P125, DOI 10.1016/j.cpet.2014.12.001; Srinivasan A, 2012, AM J NEURORADIOL, V33, P586, DOI 10.3174/ajnr.A2535; Taghipour M, 2016, JAMA OTOLARYNGOL, V142, P79, DOI 10.1001/jamaoto.2015.2607; Veit-Haibach P, 2013, EUR RADIOL, V23, P163, DOI 10.1007/s00330-012-2564-5	20	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166236	10.1371/journal.pone.0166236	http://dx.doi.org/10.1371/journal.pone.0166236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824931	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200075
J	Shao, FJ; Zhang, Q; Liu, HW; Lu, SF; Qiu, DY				Shao, Fenjuan; Zhang, Qian; Liu, Hongwei; Lu, Shanfa; Qiu, Deyou			Genome-Wide Identification and Analysis of MicroRNAs Involved in Witches'-Broom Phytoplasma Response in Ziziphus jujuba	PLOS ONE			English	Article							CHINESE JUJUBE; PLANT; EXPRESSION; GENE; AURANTIFOLIA; GENERATION; PATHWAYS; DATABASE; DISEASE; MIR172	MicroRNAs (miRNAs) play an important role in responding to biotic and abiotic stresses in plants. Jujube witches'-broom a phytoplasma disease of Ziziphus jujuba is prevalent in China and is a serious problem to the industry. However, the molecular mechanism of the disease is poorly understood. In this study, genome-wide identification and analysis of microRNAs in response to witches'-broom was performed. A total of 85 conserved miRNA unique sequences belonging to 32 miRNA families and 24 novel miRNA unique sequences, including their complementary miRNA* strands were identified from small RNA libraries derived from a uninfected and witches'-broom infected Z. jujuba plant. Differentially expressed miRNAs associated with Jujube witches'-broom disease were investigated between the two libraries, and 12 up-regulated miRNAs and 10 down-regulated miRNAs identified with more than 2 fold changes. Additionally, 40 target genes of 85 conserved miRNAs and 49 target genes of 24 novel miRNAs were predicted and their putative functions assigned. Using the modified 5'-RACE method, we confirmed that SPL and MYB were cleaved by miR156 and miR159, respectively. Our results provide insight into the molecular mechanisms of witches'-broom disease in Z. jujuba.	[Shao, Fenjuan; Zhang, Qian; Liu, Hongwei; Qiu, Deyou] Chinese Acad Forestry, Res Inst Forestry, Key Lab Tree Breeding & Cultivat State Forestry A, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Lu, Shanfa] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China; [Lu, Shanfa] Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qiu, DY (corresponding author), Chinese Acad Forestry, Res Inst Forestry, Key Lab Tree Breeding & Cultivat State Forestry A, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.; Lu, SF (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China.; Lu, SF (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	sflu@implad.ac.cn; peterqdy@aliyun.com	Lu, Shanfa/AAF-7424-2020	Lu, Shanfa/0000-0001-6284-4389	National Key Research and Development Program of China [2016YFD0600104]; Basic Research Fund of RIF [RIF2014-01]	National Key Research and Development Program of China; Basic Research Fund of RIF	The work was supported by the National Key Research and Development Program of China (grant number 2016YFD0600104) and the Basic Research Fund of RIF (grant number RIF2014-01).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blumwald E, 1998, TRENDS PLANT SCI, V3, P342, DOI 10.1016/S1360-1385(98)01289-8; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Chen L, 2012, PLANTA, V235, P873, DOI 10.1007/s00425-011-1548-z; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Christensen NM, 2005, TRENDS PLANT SCI, V10, P526, DOI 10.1016/j.tplants.2005.09.008; Dai XB, 2011, BRIEF BIOINFORM, V12, P115, DOI 10.1093/bib/bbq065; DOI Y., 1967, Annals of the Phytopathological Society of Japan, V33, P259; Ehya F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066372; Fang SZ, 2009, INT J FOOD SCI TECH, V44, P1818, DOI 10.1111/j.1365-2621.2009.02005.x; Gai YP, 2014, SCI REP-UK, V4, DOI 10.1038/srep05378; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Inal B, 2014, PLANTA, V240, P1287, DOI 10.1007/s00425-014-2153-8; Jung HY, 2003, INT J SYST EVOL MICR, V53, P1037, DOI 10.1099/ijs.0.02393-0; Lee J. T., 1988, RES REPORTS RURAL DE, V31, P155; Levy A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-524; Li JW, 2007, FOOD CHEM, V103, P454, DOI 10.1016/j.foodchem.2006.08.016; Liu MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6315; Liu XG, 2012, PLANT CELL TISS ORG, V108, P339, DOI 10.1007/s11240-011-0031-7; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Monavarfeshani A, 2013, J PROTEOME RES, V12, P785, DOI 10.1021/pr300865t; Namba S., 2002, Journal of General Plant Pathology, V68, P257, DOI 10.1007/PL00013086; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Rubio-Somoza I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003374; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shao FJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-512; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Strauss E, 2009, SCIENCE, V325, P388, DOI 10.1126/science.325_388; Streten C, 2006, AUSTRALAS PLANT PATH, V35, P129, DOI 10.1071/AP06004; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Wei S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-169; Wei S, 2010, J AGR FOOD CHEM, V58, P9572, DOI 10.1021/jf102635f; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141; Wu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044385; Zamharir MG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-1; Zhang H, 2010, FOOD CHEM TOXICOL, V48, P1461, DOI 10.1016/j.fct.2010.03.011; Zhang LS, 2014, J INTEGR PLANT BIOL, V56, P38, DOI 10.1111/jipb.12111; Zhang WX, 2011, PLANT MOL BIOL, V75, P93, DOI 10.1007/s11103-010-9710-8; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	13	18	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166099	10.1371/journal.pone.0166099	http://dx.doi.org/10.1371/journal.pone.0166099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824938	Green Submitted, gold, Green Published			2022-12-27	WOS:000387615200062
J	Hering, T; Braubach, P; Landwehrmeyer, GB; Lindenberg, KS; Melzer, W				Hering, Tanja; Braubach, Peter; Landwehrmeyer, G. Bernhard; Lindenberg, Katrin S.; Melzer, Werner			Fast-to-Slow Transition of Skeletal Muscle Contractile Function and Corresponding Changes in Myosin Heavy and Light Chain Formation in the R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							MUTANT HUNTINGTIN; TRANSGENIC MICE; FIBER TYPES; MITOCHONDRIAL DYSFUNCTION; MOLECULAR PATHOGENESIS; WIDESPREAD EXPRESSION; GENE-EXPRESSION; ISOFORMS; RAT; MOTOR	Huntington's disease (HD) is a hereditary neurodegenerative disease resulting from an expanded polyglutamine sequence (poly-Q) in the protein huntingtin (HTT). Various studies report atrophy and metabolic pathology of skeletal muscle in HD and suggest as part of the process a fast-to-slow fiber type transition that may be caused by the pathological changes in central motor control or/and by mutant HTT in the muscle tissue itself. To investigate muscle pathology in HD, we used R6/2 mice, a common animal model for a rapidly progressing variant of the disease expressing exon 1 of the mutant human gene. We investigated alterations in the extensor digitorum longus (EDL), a typical fast-twitch muscle, and the soleus (SOL), a slow-twitch muscle. We focussed on mechanographic measurements of excised muscles using single and repetitive electrical stimulation and on the expression of the various myosin isoforms (heavy and light chains) using dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) of whole muscle and single fiber preparations. In EDL of R6/2, the functional tests showed a left shift of the force-frequency relation and decrease in specific force. Moreover, the estimated relative contribution of the fastest myosin isoform MyHC IIb decreased, whereas the contribution of the slower MyHC IIx isoform increased. An additional change occurred in the alkali MyLC forms showing a decrease in 3f and an increase in 1f level. In SOL, a shift from fast MyHC IIa to the slow isoform I was detectable in male R6/2 mice only, and there was no evidence of isoform interconversion in the MyLC pattern. These alterations point to a partial remodeling of the contractile apparatus of R6/2 mice towards a slower contractile phenotype, predominantly in fast glycolytic fibers.	[Hering, Tanja; Braubach, Peter; Melzer, Werner] Univ Ulm, Inst Appl Physiol, Ulm, Germany; [Hering, Tanja; Landwehrmeyer, G. Bernhard; Lindenberg, Katrin S.] Univ Ulm, Dept Neurol, Ulm, Germany; [Braubach, Peter] Hannover Med Sch, Inst Pathol, Hannover, Germany	Ulm University; Ulm University; Hannover Medical School	Melzer, W (corresponding author), Univ Ulm, Inst Appl Physiol, Ulm, Germany.	werner.melzer@uni-ulm.de	Landwehrmeyer, Georg Bernhard/AHB-4443-2022	Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X				Agbulut O, 2003, BIOL CELL, V95, P399, DOI 10.1016/S0248-4900(03)00087-X; Andruchov O, 2006, J PHYSIOL-LONDON, V571, P231, DOI 10.1113/jphysiol.2005.099770; Andruchov O, 2004, AM J PHYSIOL-CELL PH, V287, pC1725, DOI 10.1152/ajpcell.00255.2004; [Anonymous], 2014, R LANG ENV STAT; Asmussen G, 2003, EXP NEUROL, V184, P758, DOI 10.1016/S0014-4886(03)00294-2; Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020; BAR A, 1989, EUR J BIOCHEM, V178, P591, DOI 10.1111/j.1432-1033.1989.tb14486.x; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; BOTTINELLI R, 1994, J PHYSIOL-LONDON, V478, P341, DOI 10.1113/jphysiol.1994.sp020254; Bottinelli R, 2001, PFLUG ARCH EUR J PHY, V443, P6, DOI 10.1007/s004240100700; Braubach P, 2014, J GEN PHYSIOL, V144, P393, DOI 10.1085/jgp.201411255; Browne SE, 2008, ANN NY ACAD SCI, V1147, P358, DOI 10.1196/annals.1427.018; Busse ME, 2008, J NEUROL, V255, P1534, DOI 10.1007/s00415-008-0964-x; Cepeda C, 2007, PROG NEUROBIOL, V81, P253, DOI 10.1016/j.pneurobio.2006.11.001; Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Friedrich O, 2008, BIOPHYS J, V94, P4751, DOI 10.1529/biophysj.107.126557; Gizatullina ZZ, 2006, ANN NEUROL, V59, P407, DOI 10.1002/ana.20754; Hamilton JM, 2004, J NEUROL NEUROSUR PS, V75, P209, DOI 10.1136/jnnp.2003.017822; Hering T, 2015, EXP NEUROL, V266, P22, DOI 10.1016/j.expneurol.2015.02.004; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Jacobs RA, 2013, J GERONTOL A-BIOL, V68, P1010, DOI 10.1093/gerona/gls335; Jordan T, 2004, J CELL SCI, V117, P6175, DOI 10.1242/jcs.01543; Kosinski CM, 2007, MOVEMENT DISORD, V22, P1637, DOI 10.1002/mds.21550; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Lodi R, 2000, ANN NEUROL, V48, P72; LOWEY S, 1995, BIOPHYS J, V68, pS120; Lowey S, 2010, J BIOL CHEM, V285, P16403, DOI 10.1074/jbc.R109.025551; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mielcarek M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005021; Miller BR, 2010, FUTUR NEUROL, V5, P735, DOI 10.2217/FNL.10.41; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Orth M, 2003, J NEUROCHEM, V87, P1, DOI 10.1046/j.1471-4159.2003.02009.x; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Ribchester RR, 2004, EUR J NEUROSCI, V20, P3092, DOI 10.1111/j.1460-9568.2004.03783.x; ROBERT B, 1984, CELL, V39, P129, DOI 10.1016/0092-8674(84)90198-3; Ross CA, 2001, CLIN NEUROSCI RES, V1, P142, DOI 10.1016/S1566-2772(00)00014-1; Ross CA, 2014, MOVEMENT DISORD, V29, P1351, DOI 10.1002/mds.26012; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Sassone J, 2009, EXP NEUROL, V219, P385, DOI 10.1016/j.expneurol.2009.05.012; Sathasivam K, 1999, HUM MOL GENET, V8, P803; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Singh R, 2009, J NEUROL SCI, V285, P159, DOI 10.1016/j.jns.2009.06.030; STEPKOWSKI D, 1995, FEBS LETT, V374, P6, DOI 10.1016/0014-5793(95)01049-K; Strand AD, 2005, HUM MOL GENET, V14, P1863, DOI 10.1093/hmg/ddi192; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; Svensson C, 1997, J CELL BIOCHEM, V67, P241, DOI 10.1002/(SICI)1097-4644(19971101)67:2<241::AID-JCB9>3.0.CO;2-X; Thu DCV, 2010, BRAIN, V133, P1094, DOI 10.1093/brain/awq047; Tikunov BA, 2001, J APPL PHYSIOL, V90, P1927, DOI 10.1152/jappl.2001.90.5.1927; Timson DJ, 2003, BIOCHIMIE, V85, P639, DOI 10.1016/S0300-9084(03)00131-7; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Turner C, 2010, J BIOENERG BIOMEMBR, V42, P193, DOI 10.1007/s10863-010-9290-y; Turner C, 2007, MOVEMENT DISORD, V22, P1715, DOI 10.1002/mds.21540; Ursu D, 2001, J PHYSIOL-LONDON, V533, P367, DOI 10.1111/j.1469-7793.2001.0367a.x; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Waters CW, 2013, P NATL ACAD SCI USA, V110, P9160, DOI 10.1073/pnas.1220068110; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Zielonka D, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00380	66	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166106	10.1371/journal.pone.0166106	http://dx.doi.org/10.1371/journal.pone.0166106			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820862	Green Published, gold, Green Submitted			2022-12-27	WOS:000387614800034
J	Huang, AB; Sang, YY; Sun, W; Fu, Y; Yang, ZB				Huang, Aobo; Sang, Yuying; Sun, Wenfeng; Fu, Ying; Yang, Zhenbiao			Transcriptomic Analysis of Responses to Imbalanced Carbon: Nitrogen Availabilities in Rice Seedlings	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; ALTERNATIVE OXIDASE; GENE-EXPRESSION; JASMONIC ACID; METHYL JASMONATE; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; CHALCONE SYNTHASE; PLANT-GROWTH; PHYTOPHTHORA-INFESTANS	The internal C:N balance must be tightly controlled for the normal growth and development of plants. However, the underlying mechanisms, by which plants sense and balance the intracellular C:N status correspondingly to exogenous C:N availabilities remain elusive. In this study, we use comparative gene expression analysis to identify genes that are responsive to imbalanced C:N treatments in the aerial parts of rice seedlings. Transcripts of rice seedlings treated with four C:N availabilities (1:1, 1:60, 60:1 and 60:60) were compared and two groups of genes were classified:high C:low N responsive genes and low C:high N responsive genes. Our analysis identified several functional correlated genes including chalcone synthase (CHS), chlorophyll a-b binding protein (CAB) and other genes that are implicated in C:N balancing mechanism, such as alternative oxidase 1B (OsAOX1B), malate dehydrogenase (OsMDH) and lysine and histidine specific transporter 1 (OsLHT1). Additionally, six jasmonate synthetic genes and key regulatory genes involved in abiotic and biotic stresses, such as OsMYB4, autoinhibited calcium ATPase 3 (OsACA3) and pleiotropic drug resistance 9 (OsPDR9), were differentially expressed under high C:low N treatment. Gene ontology analysis showed that high C:low N up-regulated genes were primarily enriched in fatty acid biosynthesis and defense responses. Coexpression network analysis of these genes identified eight jasmonate ZIM domain protein (OsJAZ) genes and several defense response related regulators, suggesting that high C:low N status may act as a stress condition, which induces defense responses mediated by jasmonate signaling pathway. Our transcriptome analysis shed new light on the C:N balancing mechanisms and revealed several important regulators of C:N status in rice seedlings.	[Huang, Aobo; Fu, Ying] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing, Peoples R China; [Huang, Aobo; Sun, Wenfeng; Yang, Zhenbiao] Fujian Agr & Forestry Univ, Hort Plant Biol & Metab Ctr, Haixia Inst Sci & Technol, Fuzhou, Peoples R China; [Sang, Yuying] Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yang, Zhenbiao] Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrated Genome Biol, Riverside, CA 92521 USA; [Yang, Zhenbiao] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	China Agricultural University; Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California Riverside; University of California System; University of California Riverside	Yang, ZB (corresponding author), Fujian Agr & Forestry Univ, Hort Plant Biol & Metab Ctr, Haixia Inst Sci & Technol, Fuzhou, Peoples R China.; Yang, ZB (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrated Genome Biol, Riverside, CA 92521 USA.; Yang, ZB (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	yang@ucr.edu		Huang, Aobo/0000-0002-0774-1501	California's Agricultural Experimental Station at University of California-Riverside; Horticultural Plant Biology and Metabolomics Center, Haixia Institute of Science Technology, Fujian Agriculture and Forestry University, Fuzhou, Fujian, China; Joint NSFC-ISF Research Program; National Natural Science Foundation of China; Israel Science Foundation [31361140354]	California's Agricultural Experimental Station at University of California-Riverside; Horticultural Plant Biology and Metabolomics Center, Haixia Institute of Science Technology, Fujian Agriculture and Forestry University, Fuzhou, Fujian, China; Joint NSFC-ISF Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Israel Science Foundation(Israel Science Foundation)	This work is partly supported by funds from California's Agricultural Experimental Station at University of California-Riverside, and Horticultural Plant Biology and Metabolomics Center, Haixia Institute of Science Technology, Fujian Agriculture and Forestry University, Fuzhou, Fujian, China to ZBY, and by the Joint NSFC-ISF Research Program (jointly funded by the National Natural Science Foundation of China and the Israel Science Foundation) (31361140354) to YF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalou A, 2008, PLANT MOL BIOL, V66, P87, DOI 10.1007/s11103-007-9255-7; Agrawal GK, 2004, BIOCHEM BIOPH RES CO, V317, P1, DOI 10.1016/j.bbrc.2004.03.020; Agrawal GK, 2003, BIOCHEM BIOPH RES CO, V310, P1073, DOI 10.1016/j.bbrc.2003.09.123; Agrawal GK, 2002, PLANT PHYSIOL BIOCH, V40, P771, DOI 10.1016/S0981-9428(02)01429-8; Aoyama S, 2014, PLANT CELL PHYSIOL, V55, P293, DOI 10.1093/pcp/pcu002; Appel HM, 2012, NEW PHYTOL, V195, P419, DOI 10.1111/j.1469-8137.2012.04171.x; Arnold TM, 2012, PLANT SIGNAL BEHAV, V7, P1498, DOI 10.4161/psb.21900; Bouguyon E, 2012, SEMIN CELL DEV BIOL, V23, P648, DOI 10.1016/j.semcdb.2012.01.004; Carretero-Paulet L, 2010, PLANT PHYSIOL, V153, P1398, DOI 10.1104/pp.110.153593; Champigny ML, 1995, PHOTOSYNTH RES, V46, P117, DOI 10.1007/BF00020422; Chen DQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137026; Chen LS, 1997, PLANT PHYSIOL, V115, P1127, DOI 10.1104/pp.115.3.1127; Chen XB, 2016, CURR BIOL, V26, P640, DOI 10.1016/j.cub.2015.12.066; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; COLLINGE DB, 1993, PLANT J, V3, P31, DOI 10.1046/j.1365-313X.1993.t01-1-00999.x; CORONADO C, 1995, PLANT PHYSIOL, V108, P533, DOI 10.1104/pp.108.2.533; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; Dobrenel T, 2016, ANNU REV PLANT BIOL, V67, P261, DOI 10.1146/annurev-arplant-043014-114648; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Englbrecht CC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-39; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Feng HQ, 2013, ACTA BIOCH BIOPH SIN, V45, P985, DOI 10.1093/abbs/gmt094; Ferrieri AP, 2013, PLANT PHYSIOL, V161, P692, DOI 10.1104/pp.112.208868; Feyissa DN, 2009, PLANTA, V230, P747, DOI 10.1007/s00425-009-0978-3; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; Foyer CH, 2006, ANNU PLANT REV, V22, P325; Gaffney BJ, 1996, ANNU REV BIOPH BIOM, V25, P431, DOI 10.1146/annurev.bb.25.060196.002243; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Gandin A, 2014, J EXP BOT, V65, P3133, DOI 10.1093/jxb/eru158; Gao P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001387; Gfeller A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3109cm3; Gomez S, 2010, NEW PHYTOL, V188, P835, DOI 10.1111/j.1469-8137.2010.03414.x; GOWARD CR, 1994, PROTEIN SCI, V3, P1883, DOI 10.1002/pro.5560031027; Grechkin A, 1998, PROG LIPID RES, V37, P317, DOI 10.1016/S0163-7827(98)00014-9; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Haga K, 2004, PLANT CELL PHYSIOL, V45, P119, DOI 10.1093/pcp/pch025; Hashimoto M, 2004, PLANT CELL PHYSIOL, V45, P550, DOI 10.1093/pcp/pch063; Heckmann AB, 2006, PLANT PHYSIOL, V142, P1739, DOI 10.1104/pp.106.089508; Herbers K, 2000, MOL PLANT PATHOL, V1, P51, DOI 10.1046/j.1364-3703.2000.00007.x; Hirner A, 2006, PLANT CELL, V18, P1931, DOI 10.1105/tpc.106.041012; Hristova VA, 2002, PHOTOSYNTHETICA, V40, P567, DOI 10.1023/A:1024356120016; Huda KMK, 2013, PLANT PHYSIOL BIOCH, V65, P32, DOI 10.1016/j.plaphy.2013.01.002; Itoh H, 2005, PLANT J, V44, P669, DOI 10.1111/j.1365-313X.2005.02562.x; Jasinski M, 2003, PLANT PHYSIOL, V131, P1169, DOI 10.1104/pp.102.014720; Jiang JF, 2006, TOXICON, V47, P133, DOI 10.1016/j.toxicon.2005.10.010; Jiang P, 2007, BIOCHEMISTRY-US, V46, P12979, DOI 10.1021/bi701062t; Juszczuk IM, 2003, ACTA BIOCHIM POL, V50, P1257; Kang JM, 2003, P NATL ACAD SCI USA, V100, P6872, DOI 10.1073/pnas.1030961100; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Klein D, 2000, PLANT CELL ENVIRON, V23, P863, DOI 10.1046/j.1365-3040.2000.00593.x; Krouk G, 2011, TRENDS PLANT SCI, V16, P178, DOI 10.1016/j.tplants.2011.02.004; Laura M, 2010, PLANT PHYSIOL BIOCH, V48, P764, DOI 10.1016/j.plaphy.2010.06.003; Lee YH, 2004, PLANT J, V40, P60, DOI 10.1111/j.1365-313X.2004.02186.x; Lemmermeyer S, 2015, AM NAT, V186, P264, DOI 10.1086/682005; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Lionetti V, 2012, J PLANT PHYSIOL, V169, P1623, DOI 10.1016/j.jplph.2012.05.006; Maekawa S, 2012, PLANT MOL BIOL, V79, P217, DOI 10.1007/s11103-012-9907-0; MAKINO A, 1991, PLANT PHYSIOL, V96, P355, DOI 10.1104/pp.96.2.355; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Matyssek R, 2005, PLANT BIOLOGY, V7, P557, DOI 10.1055/s-2005-873000; Meuriot F, 2004, PHYSIOL PLANTARUM, V120, P113, DOI 10.1111/j.0031-9317.2004.0210.x; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Mittelstrass K, 2006, PLANT BIOLOGY, V8, P653, DOI 10.1055/s-2006-924085; Miyashima S, 2009, PLANT CELL PHYSIOL, V50, P626, DOI 10.1093/pcp/pcp020; Molitor A, 2011, MOL PLANT MICROBE IN, V24, P1427, DOI 10.1094/MPMI-06-11-0177; Moons A, 2003, FEBS LETT, V553, P370, DOI 10.1016/S0014-5793(03)01060-3; Nabity PD, 2013, J EXP BOT, V64, P685, DOI 10.1093/jxb/ers364; Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1; Nishii A, 2000, BIOSCI BIOTECH BIOCH, V64, P1402, DOI 10.1271/bbb.64.1402; Noguchi K, 2006, PLANT CELL ENVIRON, V29, P710, DOI 10.1111/j.1365-3040.2005.01457.x; Nunes-Nesi A, 2005, PLANT PHYSIOL, V137, P611, DOI 10.1104/pp.104.055566; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Nuruzzaman M, 2014, J INTEGR PLANT BIOL, V56, P729, DOI 10.1111/jipb.12196; Ono K, 1997, PLANT CELL PHYSIOL, V38, P1032, DOI 10.1093/oxfordjournals.pcp.a029268; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pasquali G, 2008, PLANT CELL REP, V27, P1677, DOI 10.1007/s00299-008-0587-9; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; RADIN JW, 1986, PLANT PHYSIOL, V82, P869, DOI 10.1104/pp.82.3.869; REIMOLD U, 1983, EMBO J, V2, P1801, DOI 10.1002/j.1460-2075.1983.tb01661.x; Reyes TH, 2016, PLANT PHYSIOL BIOCH, V105, P195, DOI 10.1016/j.plaphy.2016.04.030; Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200; Ros B, 2008, PHYSIOL PLANTARUM, V133, P386, DOI 10.1111/j.1399-3054.2008.01048.x; Ross CA, 2007, J INTEGR PLANT BIOL, V49, P827, DOI 10.1111/j.1744-7909.2007.00504.x; Rossato L, 2002, J EXP BOT, V53, P1131, DOI 10.1093/jexbot/53.371.1131; Saika H, 2002, GENES GENET SYST, V77, P31, DOI 10.1266/ggs.77.31; Sato T, 2009, PLANT J, V60, P852, DOI 10.1111/j.1365-313X.2009.04006.x; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1214, DOI 10.1093/nar/gks1122; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; SHEEN J, 1990, PLANT CELL, V2, P1027, DOI 10.1105/tpc.2.10.1027; Sieger SM, 2005, J EXP BOT, V56, P1499, DOI 10.1093/jxb/eri146; Singh A, 2014, FEBS J, V281, P894, DOI 10.1111/febs.12656; Soltesz A, 2012, J APPL GENET, V53, P133, DOI 10.1007/s13353-011-0081-x; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; Sun WF, 2013, J PLANT GROWTH REGUL, V32, P575, DOI 10.1007/s00344-013-9324-x; Svennerstam H, 2007, PLANT PHYSIOL, V143, P1853, DOI 10.1104/pp.106.092205; Tani T, 2008, PLANTA, V227, P517, DOI 10.1007/s00425-007-0635-7; Tegeder M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00021; Thibaud MC, 2004, PLANT PHYSIOL BIOCH, V42, P81, DOI 10.1016/j.plaphy.2003.10.012; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tian CG, 2004, PLANT MOL BIOL, V54, P519, DOI 10.1023/B:PLAN.0000038256.89809.57; Tian GW, 2006, DEV BIOL, V294, P83, DOI 10.1016/j.ydbio.2006.02.026; TSUKAYA H, 1991, PLANT PHYSIOL, V97, P1414, DOI 10.1104/pp.97.4.1414; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Umate P, 2011, PLANT SIGNAL BEHAV, V6, P335, DOI 10.4161/psb.6.3.13546; Umate P, 2010, PLANT SIGNAL BEHAV, V5, P1537, DOI 10.4161/psb.5.12.13410; Van Aken O, 2009, PHYSIOL PLANTARUM, V137, P354, DOI 10.1111/j.1399-3054.2009.01240.x; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Vanlerberghe GC, 1997, ANNU REV PLANT PHYS, V48, P703, DOI 10.1146/annurev.arplant.48.1.703; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Vannini C, 2007, PLANT SCI, V173, P231, DOI 10.1016/j.plantsci.2007.05.007; VICK BA, 1986, PLANT PHYSIOL, V80, P202, DOI 10.1104/pp.80.1.202; VINCENTZ M, 1993, PLANT J, V3, P315, DOI 10.1046/j.1365-313X.1993.t01-16-00999.x; Wang H, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1933-5; Wu H, 2015, PLANT SCI, V232, P1, DOI 10.1016/j.plantsci.2014.12.010; Xiong Y, 2013, NATURE, V496, P181, DOI 10.1038/nature12030; Yamada S, 2012, PLANT CELL PHYSIOL, V53, P2060, DOI 10.1093/pcp/pcs145; Yamanouchi U, 2002, P NATL ACAD SCI USA, V99, P7530, DOI 10.1073/pnas.112209199; Yanagisawa S, 2004, P NATL ACAD SCI USA, V101, P7833, DOI 10.1073/pnas.0402267101; Yang DH, 2000, FEBS LETT, V466, P385, DOI 10.1016/S0014-5793(00)01107-8; Yang WZ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0425-5; YATES RC, 1949, AM J BOT, V36, P390, DOI 10.2307/2437736; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Yoeun S, 2015, J PLANT RES, V128, P201, DOI 10.1007/s10265-014-0670-y; Yokotani N, 2014, MOL PLANT MICROBE IN, V27, P1027, DOI 10.1094/MPMI-03-14-0065-R; Zhang HM, 1999, P NATL ACAD SCI USA, V96, P6529, DOI 10.1073/pnas.96.11.6529; Zhang SX, 2012, PLANT MOL BIOL, V80, P571, DOI 10.1007/s11103-012-9967-1; Zhao HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049210; Zheng ZL, 2009, PLANT SIGNAL BEHAV, V4, P584, DOI 10.4161/psb.4.7.8540; Zhou B, 2013, AM J BOT, V100, P2458, DOI 10.3732/ajb.1300305	135	12	13	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165732	10.1371/journal.pone.0165732	http://dx.doi.org/10.1371/journal.pone.0165732			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820840	Green Published, Green Submitted, gold			2022-12-27	WOS:000387614800016
J	Iwai, S; Weinmaier, T; Schmidt, BL; Albertson, DG; Poloso, NJ; Dabbagh, K; DeSantis, TZ				Iwai, Shoko; Weinmaier, Thomas; Schmidt, Brian L.; Albertson, Donna G.; Poloso, Neil J.; Dabbagh, Karim; DeSantis, Todd Z.			Piphillin: Improved Prediction of Metagenomic Content by Direct Inference from Human Microbiomes	PLOS ONE			English	Article							SIMILARITY SEARCH TOOL; ALIGNMENT; RECONSTRUCTION	Functional analysis of a clinical microbiome facilitates the elucidation of mechanisms by which microbiome perturbation can cause a phenotypic change in the patient. The direct approach for the analysis of the functional capacity of the microbiome is via shotgun metagenomics. An inexpensive method to estimate the functional capacity of a microbial community is through collecting 16S rRNA gene profiles then indirectly inferring the abundance of functional genes. This inference approach has been implemented in the PICRUSt and Tax4Fun software tools. However, those tools have important limitations since they rely on outdated functional databases and uncertain phylogenetic trees and require very specific data pre-processing protocols. Here we introduce Piphillin, a straightforward algorithm independent of any proposed phylogenetic tree, leveraging contemporary functional databases and not obliged to any singular data pre-processing protocol. When all three inference tools were evaluated against actual shotgun metagenomics, Piphillin was superior in predicting gene composition in human clinical samples compared to both PICRUSt and Tax4Fun (p<0.01 and p<0.001, respectively) and Piphillin's ability to predict disease associations with specific gene orthologs exhibited a 15% increase in balanced accuracy compared to PICRUSt. From laboratory animal samples, no performance advantage was observed for any one of the tools over the others and for environmental samples all produced unsatisfactory predictions. Our results demonstrate that functional inference using the direct method implemented in Piphillin is preferable for clinical biospecimens.	[Iwai, Shoko; Weinmaier, Thomas; Dabbagh, Karim; DeSantis, Todd Z.] Second Genome Inc, Dept Informat, San Francisco, CA USA; [Schmidt, Brian L.; Albertson, Donna G.] NYU, Coll Dent, Bluestone Ctr Clin Res, New York, NY USA; [Schmidt, Brian L.; Albertson, Donna G.] NYU, Coll Dent, Dept Oral & Maxillofacial Surg, New York, NY USA; [Albertson, Donna G.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Poloso, Neil J.] Allergen PLC, Res & External Sci Innovat Dept, Irvine, CA USA	New York University; New York University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	DeSantis, TZ (corresponding author), Second Genome Inc, Dept Informat, San Francisco, CA USA.	todd@secondgenome.com	Weinmaier, Thomas/K-5780-2013	Weinmaier, Thomas/0000-0002-9552-3220	National Center for Research Resources; National Center for Advancing Translational Sciences; Office of the Director, National Institutes of Health, through University of San Francisco CTSI [UL1 RR024129]; National Cancer Institute [R01 CM 31286, R21 CA163019]; National Institute of Dental and Craniofacial Research [R01 DE019796]; US government; Second Genome Inc; Allergan PLC; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R21CA163019, R01CA131286] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019796] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Office of the Director, National Institutes of Health, through University of San Francisco CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); US government; Second Genome Inc; Allergan PLC(AbbVieAllergan); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by the National Center for Research Resources, the National Center for Advancing Translational Sciences, and the Office of the Director, National Institutes of Health, through University of San Francisco CTSI grant number UL1 RR024129, and individual investigator awards from the National Cancer Institute grant (R01 CM 31286, R21 CA163019) and the National Institute of Dental and Craniofacial Research (R01 DE019796). These US government funders provided support in the form of salaries for authors DA & BS. This work was also supported in part by Second Genome Inc and Allergan PLC. These commercial funders provided support in the form of salaries for authors NP, SI, TD, KD, & TW. All funders, including government program mangers and corporate investors had no role in study design, data collection and analysis, decision to publish, nor preparation of the manuscript. The specific funded roles of each of the seven authors are articulated in the 'author contributions' section.; This work was supported in part by the National Center for Research Resources, the National Center for Advancing Translational Sciences, and the Office of the Director, National Institutes of Health, through University of San Francisco CTSI grant number UL1 RR024129, and individual investigator awards from the National Cancer Institute grant (R01 CA131286, R21 CA163019) and the National Institute of Dental and Craniofacial Research (R01 DE019796). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. We thank Tanya Yatsunenko and Morgan Langille for helpful discussions and input on the Piphillin algorithm. We also want to thank Ali Faruqi for his help with the implementation of the Piphillin website.	Asshauer KP, 2015, TAX4FUN PREDICTING F, P2; Avdeyev P, 2016, J COMPUT BIOL, V23, P150, DOI 10.1089/cmb.2015.0160; Aviles-Jimenez F, 2015, CLIN MICROBIOL INFEC, V22, DOI [10.1016/j.cmi.2015.10, DOI 10.1016/J.CMI.2015.10]; Barton NH, 2007, EVOLUTION, P1; Brown CT, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-30; Callahan BJ, 2015, BIORXIV, P0, DOI [10.1101/024034, DOI 10.1101/024034]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cunningham CW, 1999, SYST BIOL, V48, P665, DOI 10.1080/106351599260238; Curtis MM, 2014, CELL HOST MICROBE, V16, P759, DOI 10.1016/j.chom.2014.11.005; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Glaeser SP, 2015, SYST APPL MICROBIOL, V38, P237, DOI 10.1016/j.syapm.2015.03.007; Harris JK, 2013, ISME J, V7, P50, DOI 10.1038/ismej.2012.79; Iantorno S, 2014, METHODS MOL BIOL, V1079, P59, DOI 10.1007/978-1-62703-646-7_4; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kemena C, 2009, BIOINFORMATICS, V25, P2455, DOI 10.1093/bioinformatics/btp452; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Krzywinski M, 2014, NAT METHODS, V11, P467, DOI 10.1038/nmeth.2937; Kunin Victor, 2008, Mol Syst Biol, V4, P198, DOI 10.1038/msb.2008.35; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Litsios G, 2012, SYST BIOL, V61, P533, DOI 10.1093/sysbio/syr124; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Scheinin I, 2014, GENOME RES, P1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098741; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tan G, 2015, SYST BIOL, V64, P778, DOI 10.1093/sysbio/syv033; Wortman J, 2010, DATA ANAL COORDINATI, V11, P2010, DOI [10.1186/gb-2010-11-S1-O13, DOI 10.1186/GB-2010-11-S1-O13]; Ye YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-159; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	37	207	207	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166104	10.1371/journal.pone.0166104	http://dx.doi.org/10.1371/journal.pone.0166104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820856	gold, Green Published, Green Submitted			2022-12-27	WOS:000387614800033
J	Komnig, D; Imgrund, S; Reich, A; Grunder, S; Falkenburger, BH				Komnig, Daniel; Imgrund, Silke; Reich, Arno; Gruender, Stefan; Falkenburger, Bjoern H.			ASIC1a Deficient Mice Show Unaltered Neurodegeneration in the Subacute MPTP Model of Parkinson Disease	PLOS ONE			English	Article							SENSING ION CHANNELS; TUMOR-NECROSIS-FACTOR; ACTIVATED CURRENTS; SUBSTANTIA-NIGRA; MOUSE MODEL; CALCIUM; NEUROPROTECTION; NEUROTOXICITY; INFLAMMATION; CONTRIBUTES	Inflammation contributes to the death of dopaminergic neurons in Parkinson disease and can be accompanied by acidification of extracellular pH, which may activate acid-sensing ion channels (ASIC). Accordingly, amiloride, a non-selective inhibitor of ASIC, was protective in an acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson disease. To complement these findings we determined MPTP toxicity in mice deficient for ASIC1a, the most common ASIC isoform in neurons. MPTP was applied i.p. in doses of 30 mg per kg on five consecutive days. We determined the number of dopaminergic neurons in the substantia nigra, assayed by stereological counting 14 days after the last MPTP injection, the number of Nissl positive neurons in the substantia nigra, and the concentration of catecholamines in the striatum. There was no difference between ASIC1a-deficient mice and wildtype controls. We are therefore not able to confirm that ASIC1a are involved in MPTP toxicity. The difference might relate to the subacute MPTP model we used, which more closely resembles the pathogenesis of Parkinson disease, or to further targets of amiloride.	[Komnig, Daniel; Reich, Arno; Falkenburger, Bjoern H.] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Imgrund, Silke; Gruender, Stefan] Rhein Westfal TH Aachen, Inst Physiol, Aachen, Germany; [Falkenburger, Bjoern H.] JARA BRAIN Inst II, Julich, Germany; [Falkenburger, Bjoern H.] JARA BRAIN Inst II, Aachen, Germany	RWTH Aachen University; RWTH Aachen University	Falkenburger, BH (corresponding author), Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.; Falkenburger, BH (corresponding author), JARA BRAIN Inst II, Julich, Germany.; Falkenburger, BH (corresponding author), JARA BRAIN Inst II, Aachen, Germany.	bfalkenburger@ukaachen.de	Gründer, Stefan/I-2495-2019	Gründer, Stefan/0000-0002-7635-9883; Falkenburger, Bjoern/0000-0002-2387-526X	Interdisciplinary Center for Clinical Research (IZKF) Aachen [N7-1]	Interdisciplinary Center for Clinical Research (IZKF) Aachen	This work was supported by the Interdisciplinary Center for Clinical Research (IZKF) Aachen [N7-1].	Ago Y, 2011, NEUROPHARMACOLOGY, V61, P1441, DOI 10.1016/j.neuropharm.2011.08.041; Arias RL, 2008, NEUROBIOL DIS, V31, P334, DOI 10.1016/j.nbd.2008.05.008; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Bartoi T, 2014, P NATL ACAD SCI USA, V111, P8281, DOI 10.1073/pnas.1324060111; BOKA G, 1994, NEUROSCI LETT, V172, P151, DOI 10.1016/0304-3940(94)90684-X; BOWEN BC, 1995, AM J NEURORADIOL, V16, P61; Chen HL, 2003, ARCH NEUROL-CHICAGO, V60, P1059, DOI 10.1001/archneur.60.8.1059; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Frank T, 2012, BRAIN, V135, P1914, DOI 10.1093/brain/aws054; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Grunder S, 2015, NEUROPHARMACOLOGY, V94, P9, DOI 10.1016/j.neuropharm.2014.12.016; Gu XS, 2016, NEUROCHEM RES, V41, P2923, DOI 10.1007/s11064-016-2011-0; JACKSONLEWIS V, 1995, NEURODEGENERATION, V4, P257, DOI 10.1016/1055-8330(95)90015-2; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Khananshvili D, 2014, PFLUG ARCH EUR J PHY, V466, P43, DOI 10.1007/s00424-013-1405-y; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Koga K, 2006, EUR J NEUROSCI, V23, P1077, DOI 10.1111/j.1460-9568.2006.04610.x; Komnig D, 2016, J NEUROCHEM, V139, P848, DOI 10.1111/jnc.13847; Kowsky S, 2007, P NATL ACAD SCI USA, V104, P20049, DOI 10.1073/pnas.0706177104; KUPSCH A, 1995, NEUROREPORT, V6, P621, DOI 10.1097/00001756-199503000-00009; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Meredith GE, 2011, J PARKINSON DIS, V1, P19, DOI 10.3233/JPD-2011-11023; MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3; Okajima F, 2013, CELL SIGNAL, V25, P2263, DOI 10.1016/j.cellsig.2013.07.022; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Przedborski S, 2001, J NEUROCHEM, V76, P1265, DOI 10.1046/j.1471-4159.2001.00183.x; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; Rocha NP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/628192; Sheehan JP, 1997, J NEUROCHEM, V68, P1221; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Tatton NA, 1997, NEUROSCIENCE, V77, P1037, DOI 10.1016/S0306-4522(96)00545-3; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Toulorge D, 2016, J NEUROCHEM, V139, P27, DOI 10.1111/jnc.13696; Viswanath V, 2001, J NEUROSCI, V21, P9519, DOI 10.1523/JNEUROSCI.21-24-09519.2001; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zundorf G, 2011, ANTIOXID REDOX SIGN, V14, P1275, DOI 10.1089/ars.2010.3359	39	14	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165235	10.1371/journal.pone.0165235	http://dx.doi.org/10.1371/journal.pone.0165235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820820	Green Published, Green Submitted, gold			2022-12-27	WOS:000387614800008
J	Olesen, LO; Bouzinova, EV; Severino, M; Sivasaravanaparan, M; Hasselstrom, JB; Finsen, B; Wiborg, O				Olesen, Louise Orum; Bouzinova, Elena V.; Severino, Maurizio; Sivasaravanaparan, Mithula; Hasselstrom, Jorgen Bo; Finsen, Bente; Wiborg, Ove			Behavioural Phenotyping of APP(swe)/PS1(delta E9) Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; TRANSGENIC MICE; COGNITIVE IMPAIRMENT; EXPLORATORY ACTIVITY; SOCIAL-INTERACTION; AMYLOID-BETA; ANXIETY; SYMPTOMS; DEMENTIA	Alzheimer's disease (AD) is a devastating illness characterized by a progressive loss of cognitive, social, and emotional functions, including memory impairments and more global cognitive deficits. Clinical-epidemiological evidence suggests that neuropsychiatric symptoms precede the onset of cognitive symptoms both in humans with early and late onset AD. The behavioural profile promoted by the AD pathology is believed to associate with degeneration of the serotonergic system. Using the APP(swe)/PS1(delta E9) model of AD-like pathology starting with 9 months old mice, we characterised long term non-cognitive behavioural changes measured at 9, 12, 15, and 18 months of age and applied principal component analysis on data obtained from open field, elevated plus maze, and social interaction tests. Long-term treatment with the selective serotonin reuptake inhibitor (SSRI) paroxetine was applied to assess the role of 5-HT on the behavioural profile; duration of treatment was 9 months, initiated when mice were 9 months of age. Treatment with paroxetine delays the decline in locomotion, in exploration and risk assessment behaviour, found in the APP/PS1 mice. APP/PS1 mice also exhibit low social activity and less aggressiveness, both of which are not affected by treatment with paroxetine. The APP/PS1 behavioural phenotype, demonstrated in this study, only begins to manifest itself from 12 months of age. Our results indicate that treatment with SSRI might ameliorate some of the behavioural deficits found in aged APP/PS1 mice.	[Olesen, Louise Orum; Bouzinova, Elena V.; Wiborg, Ove] Aarhus Univ, Dept Clin Med, Hlth, Risskov, Denmark; [Severino, Maurizio; Sivasaravanaparan, Mithula; Finsen, Bente] Univ Southern Denmark, Inst Mol Med, Dept Neurobiol Res, Odense C, Denmark; [Hasselstrom, Jorgen Bo] Aarhus Univ, Dept Forens Med, Hlth, Aarhus N, Denmark	Aarhus University; University of Southern Denmark; Aarhus University	Wiborg, O (corresponding author), Aarhus Univ, Dept Clin Med, Hlth, Risskov, Denmark.	ove.wiborg@clin.au.dk		Finsen, Bente/0000-0002-8323-9329	Danish Medical Research Foundation; Lundbeck Foundation	Danish Medical Research Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Danish Medical Research Foundation (BF OW) and the Lundbeck Foundation (BF OW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Alexander G, 2011, BEHAV BRAIN RES, V216, P77, DOI 10.1016/j.bbr.2010.07.016; ARAI H, 1992, PROG NEURO-PSYCHOPH, V16, P883; Babcock AA, 2015, BRAIN BEHAV IMMUN, V48, P86, DOI 10.1016/j.bbi.2015.03.006; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Chung JA, 2000, NEUROL CLIN, V18, P829, DOI 10.1016/S0733-8619(05)70228-0; Cirrito JR, 2011, P NATL ACAD SCI USA, V108, P14968, DOI 10.1073/pnas.1107411108; CROSS AJ, 1984, J NEUROCHEM, V43, P1574, DOI 10.1111/j.1471-4159.1984.tb06081.x; Egashira N, 2007, BEHAV BRAIN RES, V178, P123, DOI 10.1016/j.bbr.2006.12.009; El Mansari M, 2007, INT J NEUROPSYCHOPH, V10, P31, DOI 10.1017/S1461145705006462; Emilsson JF, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010053; Ferguson SA, 2013, BEHAV BRAIN RES, V242, P125, DOI 10.1016/j.bbr.2012.12.055; Filali M, 2015, J NEUROSCI RES, V93, P948, DOI 10.1002/jnr.23552; Filali M, 2011, PHYSIOL BEHAV, V104, P880, DOI 10.1016/j.physbeh.2011.05.023; Filali M, 2009, BRAIN RES, V1292, P93, DOI 10.1016/j.brainres.2009.07.066; FILE SE, 1978, BRIT J PHARMACOL, V62, P19, DOI 10.1111/j.1476-5381.1978.tb07001.x; Garcia MF, 2004, NEUROREPORT, V15, P73, DOI 10.1097/00001756-200401190-00015; Garcia-Alloza M, 2005, NEUROPSYCHOLOGIA, V43, P442, DOI 10.1016/j.neuropsychologia.2004.06.007; Geda YE, 2013, ALZHEIMERS DEMENT, V9, P602, DOI 10.1016/j.jalz.2012.12.001; Hasselbalch SG, 2008, NEUROBIOL AGING, V29, P1830, DOI 10.1016/j.neurobiolaging.2007.04.011; Hasselstrom J, 2011, J CHROMATOGR B, V879, P123, DOI 10.1016/j.jchromb.2010.11.024; Hendricksen M, 2004, AM J PSYCHIAT, V161, P1096, DOI 10.1176/appi.ajp.161.6.1096; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Huang H, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu116; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jimenez AJ, 1996, CELL TISSUE RES, V284, P193, DOI 10.1007/s004410050579; Rodriguez JJ, 2012, PROG NEUROBIOL, V99, P15, DOI 10.1016/j.pneurobio.2012.06.010; Kalueff AV, 2005, EUR J PHARMACOL, V508, P147, DOI 10.1016/j.ejphar.2004.11.054; KRSIAK M, 1990, PSYCHOPHARMACOLOGY, V101, P396, DOI 10.1007/BF02244060; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; Lalonde R, 2004, NEUROSCI LETT, V369, P156, DOI 10.1016/j.neulet.2004.07.069; Lanctot KL, 2007, AM J GERIAT PSYCHIAT, V15, P888, DOI 10.1097/JGP.0b013e3180488325; Liu Y, 2008, J NEUROSCI, V28, P13805, DOI 10.1523/JNEUROSCI.4218-08.2008; Lok K, 2013, J NEUROL SCI, V335, P145, DOI 10.1016/j.jns.2013.09.018; Lyness SA, 2003, NEUROBIOL AGING, V24, P1, DOI 10.1016/S0197-4580(02)00057-X; Madsen K, 2011, J ALZHEIMERS DIS, V26, P457, DOI 10.3233/JAD-2011-110056; Masters MC, 2015, NEUROLOGY, V84, P617, DOI 10.1212/WNL.0000000000001238; Nelson RL, 2007, EXP NEUROL, V205, P166, DOI 10.1016/j.expneurol.2007.01.037; Pietropaolo S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.012; Pugh PL, 2007, BEHAV BRAIN RES, V178, P18, DOI 10.1016/j.bbr.2006.11.044; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Ringman JM, 2015, BRAIN, V138, P1036, DOI 10.1093/brain/awv004; Romano A, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu020; Sheline YI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008169; Sood A, 2007, NEUROPHARMACOLOGY, V53, P588, DOI 10.1016/j.neuropharm.2007.06.028; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Trillo L, 2013, NEUROSCI BIOBEHAV R, V37, P1363, DOI 10.1016/j.neubiorev.2013.05.008; Vermeiren Y, 2014, NEUROBIOL AGING, V35, P2691, DOI 10.1016/j.neurobiolaging.2014.05.031; Webster SJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00088; Webster SJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt182	51	25	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165144	10.1371/journal.pone.0165144	http://dx.doi.org/10.1371/journal.pone.0165144			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814403	Green Published, gold, Green Submitted			2022-12-27	WOS:000386911100007
J	Kindinger, LM; Kyrgiou, M; MacIntyre, DA; Cacciatore, S; Yulia, A; Cook, J; Terzidou, V; Teoh, TG; Bennett, PR				Kindinger, Lindsay M.; Kyrgiou, Maria; MacIntyre, David A.; Cacciatore, Stefano; Yulia, Angela; Cook, Joanna; Terzidou, Vasso; Teoh, T. G.; Bennett, Phillip R.			Preterm Birth Prevention Post-Conization: A Model of Cervical Length Screening with Targeted Cerclage	PLOS ONE			English	Article							PREGNANCY OUTCOMES; INTRAEPITHELIAL NEOPLASIA; PROPHYLACTIC CERCLAGE; TRANSFORMATION ZONE; OBSTETRIC OUTCOMES; LOOP EXCISION; DELIVERY; METAANALYSIS; PREDICTION; WOMEN	Women with a history of excisional treatment (conization) for cervical intra-epithelial neoplasia (CIN) are at increased risk of preterm birth, perinatal morbidity and mortality in subsequent pregnancy. We aimed to develop a screening model to effectively differentiate pregnancies post-conization into low-and high-risk for preterm birth, and to evaluate the impact of suture material on the efficacy of ultrasound indicated cervical cerclage. We analysed longitudinal cervical length (CL) data from 725 pregnant women post-conization attending preterm surveillance clinics at three London university Hospitals over a ten year period (2004-2014). Rates of preterm birth <37 weeks after targeted cerclage for CL<25mm were compared with local and national background rates and expected rates for this cohort. Rates for cerclage using monofilament or braided suture material were also compared. Of 725 women post-conization 13.5% (98/725) received an ultrasound indicated cerclage and 9.7% (70/725) delivered prematurely, <37weeks; 24.5% (24/98) of these despite insertion of cerclage. The preterm birth rate was lower for those that had monofilament (9/60, 15%) versus braided (15/38, 40%) cerclage (RR 0.7, 95% CI 0.54 to 0.94, P = 0.008). Accuracy parameters of interval reduction in CL between longitudinal second trimester screenings were calculated to identify women at low risk of preterm birth, who could safely discontinue surveillance. A reduction of CL <10% between screening timepoints predicts term birth, >37weeks. Our triage model enables timely discharge of low risk women, eliminating 36% of unnecessary follow-up CL scans. We demonstrate that preterm birth in women post-conization may be reduced by targeted cervical cerclage. Cerclage efficacy is however suture material-dependant: monofilament is preferable to braided suture. The introduction of triage prediction models has the potential to reduce the number of unnecessary CL scan for women at low risk of preterm birth.	[Kindinger, Lindsay M.; Kyrgiou, Maria; MacIntyre, David A.; Cacciatore, Stefano; Yulia, Angela; Cook, Joanna; Terzidou, Vasso; Teoh, T. G.; Bennett, Phillip R.] Imperial Coll, Inst Reprod & Dev Biol, Dept Surg & Canc, London, England; [Kindinger, Lindsay M.; Teoh, T. G.] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Obstet & Gynaecol, London, England; [Kyrgiou, Maria; Bennett, Phillip R.] Imperial Coll Healthcare NHS Trust, Queen Charlottes & Chelsea Hammersmith Hosp, Dept Obstet & Gynaecol, London, England; [Yulia, Angela; Terzidou, Vasso] Chelsea & Westminster Hosp NHS Trust, Dept Obstet & Gynaecol, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Kyrgiou, M (corresponding author), Imperial Coll, Inst Reprod & Dev Biol, Dept Surg & Canc, London, England.; Kyrgiou, M (corresponding author), Imperial Coll Healthcare NHS Trust, Queen Charlottes & Chelsea Hammersmith Hosp, Dept Obstet & Gynaecol, London, England.	m.kyrgiou@imperial.ac.uk	MacIntyre, David A/D-9267-2012	MacIntyre, David/0000-0002-4186-5567; Bennett, Phillip/0000-0002-6253-4919; Cacciatore, Stefano/0000-0001-7052-7156	Genesis Research Trust [P51389]; British Society of Colposcopy Cervical Pathology Jordan/Singer Award [P47773]; Imperial Healthcare NHS Trust Biomedical Research Centre [P45272]; British Society of Colposcopy and Cervical Pathology; Imperial College Healthcare Charity	Genesis Research Trust; British Society of Colposcopy Cervical Pathology Jordan/Singer Award; Imperial Healthcare NHS Trust Biomedical Research Centre; British Society of Colposcopy and Cervical Pathology; Imperial College Healthcare Charity	This study was supported in part by the Genesis Research Trust (P51389), the British Society of Colposcopy Cervical Pathology Jordan/Singer Award (P47773), and by the Imperial Healthcare NHS Trust Biomedical Research Centre (Grant Ref P45272). MK received support and a research award from the British Society of Colposcopy and Cervical Pathology and the Imperial College Healthcare Charity.	Albrechtsen S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1343; Alfirevic Z, 2013, ULTRASOUND OBST GYN, V41, P146, DOI 10.1002/uog.12300; Arabin B, 2013, ULTRASOUND OBST GYN, V42, P390, DOI 10.1002/uog.12540; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Behrendt N, 2013, OBSTET GYNECOL, V121, P260, DOI 10.1097/AOG.0b013e31827d8e1b; Berghella V, 2004, AM J OBSTET GYNECOL, V191, P1393, DOI 10.1016/j.ajog.2004.06.087; Berghella V, 2007, OBSTET GYNECOL, V110, P311, DOI 10.1097/01.AOG.0000270112.05025.1d; Berghella V, 2012, J MATERN-FETAL NEO M, V25, P2287, DOI 10.3109/14767058.2012.688081; Breiman L., 1984, CLASSIFICATION REGRE; Bruinsma FJ, 2011, BJOG-INT J OBSTET GY, V118, P1031, DOI 10.1111/j.1471-0528.2011.02944.x; Chandiramani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052412; Dilek TUK, 2007, GYNECOL OBSTET INVES, V64, P175, DOI 10.1159/000106486; Fowler JR, 2013, CLIN ORTHOP RELAT R, V471, P665, DOI 10.1007/s11999-012-2593-z; Fox NS, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.004; Grimes-Dennis J, 2007, CURR OPIN OBSTET GYN, V19, P191, DOI 10.1097/GCO.0b013e3280895dd3; Henry-Stanley MJ, 2010, SURG INFECT, V11, P433, DOI 10.1089/sur.2010.006; Israfil-Bayli F, 2014, J MATERN-FETAL NEO M, V27, P1584, DOI 10.3109/14767058.2013.870551; Kindinger L, 2013, BJOG-INT J OBSTET GY, V120, P50; Kindinger LM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1026; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Kyrgiou M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5847; Kyrgiou M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3633; Kyrgiou M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6192; Mehta P, 2004, BRIT J OPHTHALMOL, V88, P361, DOI 10.1136/bjo.2002.009951; Moroz LA, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.11.017; Naim A, CHANGES CERVICAL LEN, P0002; Nam KH, 2010, J GYNECOL ONCOL, V21, P225, DOI 10.3802/jgo.2010.21.4.225; Noehr B, 2009, OBSTET GYNECOL, V114, P1232, DOI 10.1097/AOG.0b013e3181bf1ef2; Noehr B, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.004; Odibo AO, 2007, AM J PERINAT, V24, P55, DOI 10.1055/s-2006-958165; Odibo Anthony O, 2003, J Perinatol, V23, P664, DOI 10.1038/sj.jp.7211004; Oh H Y, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.02.026; ONS, 2008, GEST SPEC INF MORT E; Owen J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.08.015; Pils S, 2014, BJOG-INT J OBSTET GY, V121, P457, DOI 10.1111/1471-0528.12390; Poon LCY, 2012, BJOG-INT J OBSTET GY, V119, P692, DOI 10.1111/j.1471-0528.2011.03203.x; QUINN M, 1993, BRIT J OBSTET GYNAEC, V100, P1154, DOI 10.1111/j.1471-0528.1993.tb15198.x; Rafaeli-Yehudai T, 2014, J MATERN-FETAL NEO M, V27, P1594, DOI 10.3109/14767058.2013.871254; Romero R, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.003; Sharp AN, 2014, BJOG-INT J OBSTET GY, V121, P417, DOI 10.1111/1471-0528.12512; Shin MY, 2010, J GYNECOL ONCOL, V21, P230, DOI 10.3802/jgo.2010.21.4.230; Slack M, 2006, INT UROGYNECOL J, V17, P106, DOI 10.1007/s00192-005-1320-7; Souka AP, 2011, J ULTRAS MED, V30, P997, DOI 10.7863/jum.2011.30.7.997; VANWINKLE W, 1975, SURG GYNECOL OBSTET, V140, P7	44	26	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0163793	10.1371/journal.pone.0163793	http://dx.doi.org/10.1371/journal.pone.0163793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812088	Green Submitted, gold, Green Published			2022-12-27	WOS:000386910000004
J	Costanzo, G; Pino, S; Timperio, AM; Sponer, JE; Sponer, J; Novakova, O; Sedo, O; Zdrahal, Z; Di Mauro, E				Costanzo, Giovanna; Pino, Samanta; Timperio, Anna Maria; Sponer, Judit E.; Sponer, Jiri; Novakova, Olga; Sedo, Ondrej; Zdrahal, Zbynek; Di Mauro, Ernesto			Non-Enzymatic Oligomerization of 3 ', 5 ' Cyclic AMP	PLOS ONE			English	Article							TEMPLATE-DIRECTED SYNTHESIS; NUCLEOSIDE PHOSPHORYLATION; MONTMORILLONITE CATALYSIS; MOLECULAR-STRUCTURE; RIBOZYME ACTIVITY; RNA; OLIGONUCLEOTIDES; POLYMERIZATION; GMP; DNA	Recent studies illustrate that short oligonucleotide sequences can be easily produced from nucleotide precursors in a template-free non-enzymatic way under dehydrating conditions, i.e. using essentially dry materials. Here we report that 3',5' cyclic AMP may also serve as a substrate of the reaction, which proceeds under moderate conditions yet with a lower efficiency than the previously reported oligomerization of 3',5' cyclic GMP. Optimally the oligomerization requires (i) a temperature of 80 degrees C, (ii) a neutral to alkaline environment and (iii) a time on the order of weeks. Differences in the yield and required reaction conditions of the oligomerizations utilizing 3', 5' cGMP and cAMP are discussed in terms of the crystal structures of the compounds. Polymerization of 3',5' cyclic nucleotides, whose paramount relevance in a prebiotic chemistry context has been widely accepted for decades, supports the possibility that the origin of extant genetic materials might have followed a direct uninterrupted path since its very beginning, starting from non-elaborately pre-activated monomer compounds and simple reactions.	[Costanzo, Giovanna] CNR, Ist Biol & Patol Mol, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Pino, Samanta] Sapienza Univ Roma, Dipartimento Biol & Biotecnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Timperio, Anna Maria] La Tuscia Univ, Dept Ecol & Biol, I-01100 Viterbo, Italy; [Sponer, Judit E.; Sponer, Jiri; Novakova, Olga] Acad Sci Czech Republic, Inst Biophys, Kralovopolska 135, CZ-61265 Brno, Czech Republic; [Sponer, Judit E.; Sponer, Jiri; Sedo, Ondrej; Zdrahal, Zbynek] Masaryk Univ, CEITEC Cent European Inst Technol, Kamenice 5, CZ-62500 Brno, Czech Republic; [Di Mauro, Ernesto] Sapienza Univ Roma, Dipartimento Biol Biotecnol Charles Darwin, Fdn Cenci Bolognetti, Ist Pasteur Italia, Ple Aldo Moro 5, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Tuscia University; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno; Fondazione Cenci Bolognetti; Sapienza University Rome	Sponer, JE (corresponding author), Acad Sci Czech Republic, Inst Biophys, Kralovopolska 135, CZ-61265 Brno, Czech Republic.; Sponer, JE (corresponding author), Masaryk Univ, CEITEC Cent European Inst Technol, Kamenice 5, CZ-62500 Brno, Czech Republic.; Di Mauro, E (corresponding author), Sapienza Univ Roma, Dipartimento Biol Biotecnol Charles Darwin, Fdn Cenci Bolognetti, Ist Pasteur Italia, Ple Aldo Moro 5, I-00185 Rome, Italy.	judit@ncbr.muni.cz; ernesto.dimauro@uniroma1.it	novakova, olga/H-1938-2014; Zdrahal, Zbynek/D-9491-2012; Šedo, Ondrej/D-9868-2012; Sponer, Jiri/D-9467-2012	Novakova, Olga/0000-0001-8653-4836; Sponer, Jiri/0000-0001-6558-6186; Zdrahal, Zbynek/0000-0003-3044-5548	Italian Space Agency (ASI) project "Esobiologia e Ambienti estremi: dalla chimica delle Molecola alla Biologia degli estremofili" [2014-026-R.0 (CUP: F 92114000030005)]; Ministry of Education, Youth and Sports of the Czech Republic [CEITEC 2020 (LQ1601)]; Grant Agency of the Czech Republic [14-12010S]; Proteomics Core Facility of CEITEC under CIISB project [LM2015043]; Ministry of Education, Youth and Sports of the Czech Republic; CSF [P206/12/G151]	Italian Space Agency (ASI) project "Esobiologia e Ambienti estremi: dalla chimica delle Molecola alla Biologia degli estremofili"; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Proteomics Core Facility of CEITEC under CIISB project; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); CSF	This work is supported by the Italian Space Agency (ASI) project "Esobiologia e Ambienti estremi: dalla chimica delle Molecola alla Biologia degli estremofili" Number 2014-026-R.0 (CUP: F 92114000030005); by the Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020 (LQ1601); and by the Grant Agency of the Czech Republic, grant number 14-12010S. The MS part of work was carried out with the support of Proteomics Core Facility of CEITEC under CIISB project, ID number LM2015043, funded by the Ministry of Education, Youth and Sports of the Czech Republic. OS and ZZ thanks for support of CSF (project P206/12/G151).	Atkins J. F., 2011, RNA WORLDS LIFES ORI; Attwater J, 2013, NAT CHEM, V5, P1011, DOI [10.1038/nchem.1781, 10.1038/NCHEM.1781]; Burcar BT, 2013, ORIGINS LIFE EVOL B, V43, P247, DOI 10.1007/s11084-013-9334-5; CHWANG AK, 1974, ACTA CRYSTALLOGR B, V30, P1233, DOI 10.1107/S0567740874004602; Costanzo G, 2007, J BIOL CHEM, V282, P16729, DOI 10.1074/jbc.M611346200; Costanzo G, 2012, CHEMBIOCHEM, V13, P999, DOI 10.1002/cbic.201200068; Costanzo G, 2009, J BIOL CHEM, V284, P33206, DOI 10.1074/jbc.M109.041905; Cozens C, 2012, P NATL ACAD SCI USA, V109, P8067, DOI 10.1073/pnas.1120964109; Deck C, 2011, NAT CHEM, V3, P603, DOI [10.1038/NCHEM.1086, 10.1038/nchem.1086]; Dickson KS, 2000, J BIOL CHEM, V275, P15828, DOI 10.1074/jbc.M910044199; Egetenmeyer S, 2011, CHEM-EUR J, V17, P11813, DOI 10.1002/chem.201101828; Ferris JP, 2002, ORIGINS LIFE EVOL B, V32, P311, DOI 10.1023/A:1020543312109; Gull M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17198; Huang WH, 2006, J AM CHEM SOC, V128, P8914, DOI 10.1021/ja061782k; JARVINEN P, 1991, J ORG CHEM, V56, P5396, DOI 10.1021/jo00018a037; Kaiser A, 2012, ANGEW CHEM INT EDIT, V51, P8299, DOI 10.1002/anie.201203859; Mansy SS, 2008, NATURE, V454, P122, DOI 10.1038/nature07018; MILLS DR, 1975, P NATL ACAD SCI USA, V72, P4252, DOI 10.1073/pnas.72.11.4252; Morasch M, 2014, CHEMBIOCHEM, V15, P879, DOI 10.1002/cbic.201300773; Mutschler H, 2015, NAT CHEM, V7, P502, DOI [10.1038/NCHEM.2251, 10.1038/nchem.2251]; Orgel LE, 2004, CRIT REV BIOCHEM MOL, P39; Pinheiro VB, 2012, SCIENCE, V336, P341, DOI 10.1126/science.1217622; Pino S, 2013, ENTROPY-SWITZ, V15, P5362, DOI 10.3390/e15125362; RUDOLPH SA, 1971, J BIOL CHEM, V246, P1271; Saladino R, 2006, J BIOL CHEM, V281, P5790, DOI 10.1074/jbc.M512545200; Saladino R, 2015, P NATL ACAD SCI USA, V112, pE2746, DOI 10.1073/pnas.1422225112; SCHOFFSTALL AM, 1976, ORIGINS LIFE EVOL B, V7, P399, DOI 10.1007/BF00927935; Schrum JP, 2009, J AM CHEM SOC, V131, P14560, DOI 10.1021/ja906557v; Soukup GA, 1999, TRENDS BIOTECHNOL, V17, P469, DOI 10.1016/S0167-7799(99)01383-9; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Sponer JE, 2015, J PHYS CHEM B, V119, P2979, DOI 10.1021/acs.jpcb.5b00601; Taran O, 2010, J SYST CHEM, V1, P1; USHER DA, 1976, SCIENCE, V192, P53, DOI 10.1126/science.1257755; VARUGHESE KI, 1982, J AM CHEM SOC, V104, P3398, DOI 10.1021/ja00376a026; VERLANDER MS, 1973, J MOL EVOL, V2, P303, DOI 10.1007/BF01654098; WU T, 1992, J AM CHEM SOC, V114, P7963, DOI 10.1021/ja00047a001	36	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165723	10.1371/journal.pone.0165723	http://dx.doi.org/10.1371/journal.pone.0165723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802310	Green Published, Green Submitted, gold			2022-12-27	WOS:000386714200045
J	Rivera, AL; Estanol, B; Fossion, R; Toledo-Roy, JC; Callejas-Rojas, JA; Gien-Lopez, JA; Delgado-Garcia, GR; Frank, A				Leonor Rivera, Ana; Estanol, Bruno; Fossion, Ruben; Toledo-Roy, Juan C.; Callejas-Rojas, Jose A.; Gien-Lopez, Jose A.; Delgado-Garcia, Guillermo R.; Frank, Alejandro			Loss of Breathing Modulation of Heart Rate Variability in Patients with Recent and Long Standing Diabetes Mellitus Type II	PLOS ONE			English	Article							POWER SPECTRAL-ANALYSIS; RESPIRATORY SINUS ARRHYTHMIA; AUTONOMIC NEUROPATHY; CARDIAC CONTROL; AGE; TESTS; BEAT	Healthy subjects under rhythmic breathing have heart interbeat intervals with a respiratory band in the frequency domain that can be an index of vagal activity. Diabetes Mellitus Type II (DM) affects the autonomic nervous system of patients, thus it can be expected changes on the vagal activity. Here, the influence of DM on the breathing modulation of the heart rate is evaluated by analyzing in the frequency domain heart interbeat interval (IBI) records obtained from 30 recently diagnosed, 15 long standing DM patients, and 30 control subjects during standardized clinical tests of controlled breathing at 0.1 Hz, supine rest and standing upright. Fourier spectral analysis of IBI records quantifies heart rate variability in different regions: low-frequencies (LF, 0.04-0.15 Hz), high-frequencies (HF, 0.15-0.4 Hz), and a controlled breathing peak (RP, centered around 0.1 Hz). Two new parameters are introduced: the frequency radius r(f) (square root of the sum of LF and HF squared) and beta (power of RP divided by the sum of LF and HF). As diabetes evolves, the controlled breathing peak loses power and shifts to smaller frequencies, indicating that heart rate modulation is slower in diabetic patients than in controls. In contrast to the traditional parameters LF, HF and LF/HF, which do not show significant differences between the three populations in neither of the clinical tests, the new parameters r(f) and beta, distinguish between control and diabetic subjects in the case of controlled breathing. Sympathetic activity that is driven by the baroreceptor reflex associated with the 0.1 Hz breathing modulations is affected in DM patients. Diabetes produces not only a rigid heartbeat with less autonomic induced variability (r(f) diminishes), but also alters the coupling between breathing and heart rate (reduced beta), due to a progressive decline of vagal and sympathetic activity.	[Leonor Rivera, Ana; Fossion, Ruben; Frank, Alejandro] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City, DF, Mexico; [Leonor Rivera, Ana; Estanol, Bruno; Fossion, Ruben; Toledo-Roy, Juan C.; Frank, Alejandro] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City, DF, Mexico; [Estanol, Bruno; Callejas-Rojas, Jose A.; Gien-Lopez, Jose A.; Delgado-Garcia, Guillermo R.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Neurol & Psiquiatria, Lab Neurofisiol, Mexico City, DF, Mexico; [Delgado-Garcia, Guillermo R.] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Dept Med Interna, Monterrey, Nuevo Leon, Mexico; [Frank, Alejandro] Colegio Nacl, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon	Rivera, AL (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City, DF, Mexico.; Rivera, AL (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City, DF, Mexico.	anarivera2000@gmail.com	Rivera, Ana Leonor/L-4433-2019; Fossion, Ruben/X-1682-2019; Rivera, Ana Leonor/B-5062-2010; Delgado-García, Guillermo/R-3050-2018; Toledo-Roy, Juan Claudio/N-6666-2019; Toledo-Roy, Juan/G-6071-2019; Nucleares, Instituto/AAK-6270-2020	Rivera, Ana Leonor/0000-0002-0296-7966; Fossion, Ruben/0000-0001-8456-2075; Rivera, Ana Leonor/0000-0002-0296-7966; Delgado-García, Guillermo/0000-0002-3123-5879; Toledo-Roy, Juan Claudio/0000-0002-0267-3378; Toledo-Roy, Juan/0000-0002-0267-3378; 	Consejo Nacional de Ciencia y Tecnologia; Universidad Nacional Autonoma de Mexico [UNAM/DGAPA/PAPIIT IN106215, UNAM/DGAPA/PAPIIT IV100116, CONACYT CB-2011-01-167441]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	We thank Consejo Nacional de Ciencia y Tecnologia and Universidad Nacional Autonoma de Mexico for financial support through grants: UNAM/DGAPA/PAPIIT IN106215; UNAM/DGAPA/PAPIIT IV100116 and CONACYT CB-2011-01-167441. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 1995, DIABETES CARE S1, V18, P59, DOI [10.2337/diacare.18.1.S59, DOI 10.2337/DIACARE.18.1.S59]; APPEL ML, 1989, J AM COLL CARDIOL, V14, P1139, DOI 10.1016/0735-1097(89)90408-7; BELLAVERE F, 1992, DIABETES, V41, P633, DOI 10.2337/diabetes.41.5.633; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; BIANCHI A, 1990, MED BIOL ENG COMPUT, V28, P205, DOI 10.1007/BF02442668; BIGGER jr JT, 1995, CARDIAC ELECTROPHYSI, P1151; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; BROWN TE, 1993, J APPL PHYSIOL, V75, P2310, DOI 10.1152/jappl.1993.75.5.2310; Camm AJ, 1996, CIRCULATION, V93, P1043; Camm AJ, 1996, EUR HEART J, V17, P354; Chen J, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0070-z; ECKBERG DL, 1980, CIRC RES, V47, P208, DOI 10.1161/01.RES.47.2.208; Eckert S, 2002, BLOOD PRESS MONIT, V7, P179, DOI 10.1097/00126097-200206000-00006; EWING DJ, 1985, DIABETES CARE, V8, P491, DOI 10.2337/diacare.8.5.491; FREEMAN R, 1991, ARCH NEUROL-CHICAGO, V48, P185, DOI 10.1001/archneur.1991.00530140079020; GROSSMAN P, 1991, PSYCHOPHYSIOLOGY, V28, P201, DOI 10.1111/j.1469-8986.1991.tb00412.x; Houle MS, 1999, AM J PHYSIOL-HEART C, V276, pH215, DOI 10.1152/ajpheart.1999.276.1.H215; KAMATH MV, 1993, CRIT REV BIOMED ENG, V21, P245; KITNEY R I, 1982, Automedica (London), V4, P155; Koenig J, 2016, NEUROSCI BIOBEHAV R, V64, P288, DOI 10.1016/j.neubiorev.2016.03.007; Rivera AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148378; LEVY MN, 1971, CIRC RES, V29, P437, DOI 10.1161/01.RES.29.5.437; MACKAY JD, 1983, DIABETOLOGIA, V24, P253; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; MALPAS SC, 1990, DIABETES, V39, P1177, DOI 10.2337/diabetes.39.10.1177; Michel-Chavez A, 2015, ARQ BRAS CARDIOL, V105, P276, DOI 10.5935/abc.20150073; Moak JP, 2007, HEART RHYTHM, V4, P1523, DOI 10.1016/j.hrthm.2007.07.019; Notarius CF, 2001, EUROPACE, V3, P29, DOI 10.1053/eupc.2000.0136; OBRIEN IAD, 1986, BRIT HEART J, V55, P348; PAGANI M, 1988, J AUTONOM NERV SYST, V23, P143, DOI 10.1016/0165-1838(88)90078-1; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Parati G, 2000, J HYPERTENS, V18, P7, DOI 10.1097/00004872-200018010-00003; Schmitt DT, 2007, AM J PHYSIOL-REG I, V293, pR1923, DOI 10.1152/ajpregu.00372.2007; SMITH SA, 1982, BRIT MED J, V285, P1599, DOI 10.1136/bmj.285.6355.1599; Sucharita S, 2011, Indian J Endocrinol Metab, V15, P198, DOI 10.4103/2230-8210.83406; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Van Den Akker T. J., 1983, Automedica, V4, P201; Vaschillo EG, 2006, APPL PSYCHOPHYS BIOF, V31, P129, DOI 10.1007/s10484-006-9009-3; Voss A, 2012, PHYSIOL MEAS, V33, P1289, DOI 10.1088/0967-3334/33/8/1289	42	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165904	10.1371/journal.pone.0165904	http://dx.doi.org/10.1371/journal.pone.0165904			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802329	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200066
J	de Thoisy, B; Fayad, I; Clement, L; Barrioz, S; Poirier, E; Gond, V				de Thoisy, Benoit; Fayad, Ibrahim; Clement, Luc; Barrioz, Sebastien; Poirier, Eddy; Gond, Valery			Predators, Prey and Habitat Structure: Can Key Conservation Areas and Early Signs of Population Collapse Be Detected in Neotropical Forests?	PLOS ONE			English	Article							FRENCH-GUIANA; HEIGHT ESTIMATION; CITIZEN-SCIENCE; PROTECTED AREAS; CAMERA TRAPS; LANDSCAPE; ABUNDANCE; JAGUARS; CANOPY; MAMMALS	Tropical forests with a low human population and absence of large-scale deforestation provide unique opportunities to study successful conservation strategies, which should be based on adequate monitoring tools. This study explored the conservation status of a large predator, the jaguar, considered an indicator of the maintenance of how well ecological processes are maintained. We implemented an original integrative approach, exploring successive ecosystem status proxies, from habitats and responses to threats of predators and their prey, to canopy structure and forest biomass. Niche modeling allowed identification of more suitable habitats, significantly related to canopy height and forest biomass. Capture/recapture methods showed that jaguar density was higher in habitats identified as more suitable by the niche model. Surveys of ungulates, large rodents and birds also showed higher density where jaguars were more abundant. Although jaguar density does not allow early detection of overall vertebrate community collapse, a decrease in the abundance of large terrestrial birds was noted as good first evidence of disturbance. The most promising tool comes from easily acquired LiDAR data and radar images: a decrease in canopy roughness was closely associated with the disturbance of forests and associated decreasing vertebrate biomass. This mixed approach, focusing on an apex predator, ecological modeling and remote-sensing information, not only helps detect early population declines in large mammals, but is also useful to discuss the relevance of large predators as indicators and the efficiency of conservation measures. It can also be easily extrapolated and adapted in a timely manner, since important open-source data are increasingly available and relevant for large-scale and real-time monitoring of biodiversity.	[de Thoisy, Benoit; Clement, Luc; Barrioz, Sebastien; Poirier, Eddy] Kwata NGO, BP 972, Cayenne, French Guiana; [Fayad, Ibrahim] IRSTEA, UMR TETIS, Montpellier, France; [Gond, Valery] CIRAD, Forests & Soc unit, Montpellier, France	AgroParisTech; INRAE; CIRAD	de Thoisy, B (corresponding author), Kwata NGO, BP 972, Cayenne, French Guiana.	benoit@kwata.net		Gond, Valery/0000-0002-0080-3140; de thoisy, benoit/0000-0002-8420-5112	Wildlife Conservation Society; SPECIES project; WWF Network; European Funds (FEDER); FFEM; DGIS; French Ministry of Higher Education and Research; Diren Guyane; DEAL Guyane; ONF Guyane; Reserve Naturelle Nationale de la Trinite	Wildlife Conservation Society; SPECIES project; WWF Network; European Funds (FEDER)(European Commission); FFEM; DGIS; French Ministry of Higher Education and Research; Diren Guyane; DEAL Guyane; ONF Guyane; Reserve Naturelle Nationale de la Trinite	The camera-trapping surveys were funded by the Wildlife Conservation Society and the SPECIES project, the WWF Network, European Funds (FEDER), FFEM, the DGIS and the French Ministry of Higher Education and Research. Field surveys for prey were funded by Diren Guyane, DEAL Guyane, ONF Guyane, and the Reserve Naturelle Nationale de la Trinite.; The camera-trapping surveys were funded by the Wildlife Conservation Society and the SPECIES project, the WWF Network, European Funds (FEDER), FFEM, the DGIS and the French Ministry of Higher Education and Research. Field surveys for prey were funded by Diren Guyane, DEAL Guyane, ONF Guyane, and the Reserve Naturelle Nationale de la Trinite. We are grateful to Leo Maffei (WCS) for his advice and assistance in the field for the first camera trapping session in French Guiana. We acknowledge the Nouragues Nature Reserve, the CNRS Guyane, and the DEAL Guyane, for field support during the Nouragues trap session.	Alvarez-Berrios Nora L., 2015, Environmental Research Letters, V10, DOI 10.1088/1748-9326/10/1/014006; Barbier N, 2010, GLOBAL ECOL BIOGEOGR, V19, P72, DOI 10.1111/j.1466-8238.2009.00493.x; Beck H, 2013, BIOL CONSERV, V163, P115, DOI 10.1016/j.biocon.2013.03.012; Boron V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153973; Bourbier L, 2013, BOIS FOR TROP, V315, P3; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Briant G, 2010, BIOL CONSERV, V143, P2763, DOI 10.1016/j.biocon.2010.07.024; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Caro T, 2004, ANIM CONSERV, V7, P63, DOI 10.1017/S136794300300115X; de Azevedo FCC, 2007, BIOL CONSERV, V137, P391, DOI 10.1016/j.biocon.2007.02.022; Caso A., 2008, PANTHERA ONCA IUCN R; Chen Q, 2010, REMOTE SENS ENVIRON, V114, P1610, DOI 10.1016/j.rse.2010.02.016; Clement L, 2014, TROPICAL CONSERVATIO, V7, P193; Conde DA, 2010, BIOL CONSERV, V143, P1980, DOI 10.1016/j.biocon.2010.04.049; Couvet D, 2015, ENVIRON DEV, V13, P39, DOI 10.1016/j.envdev.2014.11.003; De Barros AE, 2014, CONSERV BIOL, V28, P580, DOI 10.1111/cobi.12202; De Sy V, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124004; de Thoisy B, 2005, ORYX, V39, P149, DOI 10.1017/S0030605305000384; de Thoisy B, 2008, BIODIVERS CONSERV, V17, P2627, DOI 10.1007/s10531-008-9337-0; de Thoisy B, 2010, BIODIVERS CONSERV, V19, P1567, DOI 10.1007/s10531-010-9787-z; de Thoisy Benoit, 2009, P389, DOI 10.1007/978-0-387-78705-3_15; DEGRANVILLE JJ, 1988, TAXON, V37, P578, DOI 10.2307/1221101; Dudik M., 2005, NIPS 05 P 18 INT C N, V18, P323; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Eva HD, 2012, REMOTE SENS-BASEL, V4, P1369, DOI 10.3390/rs4051369; Farhadinia MS, 2015, BIOL CONSERV, V191, P770, DOI 10.1016/j.biocon.2015.08.027; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fayad I, 2014, REMOTE SENS-BASEL, V6, P11883, DOI 10.3390/rs61211883; Foster RJ, 2010, J ZOOL, V280, P309, DOI 10.1111/j.1469-7998.2009.00663.x; Garmendia A, 2013, J TROP ECOL, V29, P331, DOI 10.1017/S0266467413000370; Gilpin ME., 1989, ENDANGERED SPECIES U, V6-10, P15; Gond V., 2005, BOIS FOR TS TROP, V286, P5; Gond V, 2011, INT J APPL EARTH OBS, V13, P357, DOI 10.1016/j.jag.2011.01.004; Gonzalez CAL, 2002, WEST N AM NATURALIST, V62, P218; Goodwin A., 1996, PRINCIPLES PRECAMBRI; Groenendijk J, 1998, REV DISTRIBUTION CON; Guitet S, 2016, J TROP ECOL, V32, P22, DOI 10.1017/S0266467415000620; Guitet S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138456; Guitet S, 2015, BIODIVERS CONSERV, V24, P1215, DOI 10.1007/s10531-014-0854-8; Guitet S, 2013, J MAPS, V9, P325, DOI 10.1080/17445647.2013.785371; Guitet S, 2012, FOREST ECOL MANAG, V277, P124, DOI 10.1016/j.foreco.2012.04.011; Hammond DS, 2015, ENVIRON CONSERV, V42, P256, DOI 10.1017/S0376892914000411; Hammond DS, 2007, AMBIO, V36, P661, DOI 10.1579/0044-7447(2007)36[661:CACOAT]2.0.CO;2; Hammond DS, 2005, TROPICAL FORESTS OF THE GUIANA SHIELD: ANCIENT FORESTS IN A MODERN WORLD, P1, DOI 10.1079/9780851995366.0001; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Haugaasen T, 2005, J TROP ECOL, V21, P133, DOI 10.1017/s026646740400207X; Haugaasen T, 2008, BIRD CONSERV INT, V18, P87, DOI 10.1017/S0959270908000130; Hayward Matt W., 2016, Frontiers in Ecology and Evolution, V3, P148; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hilbert C, 2012, REMOTE SENS-BASEL, V4, P2210, DOI 10.3390/rs4082210; Hudson LN, 2014, ECOL EVOL, V4, P4701, DOI 10.1002/ece3.1303; Jorge MLSP, 2013, BIOL CONSERV, V163, P49, DOI 10.1016/j.biocon.2013.04.018; Kehl TN, 2012, SUSTAINABILITY-BASEL, V4, P2566, DOI 10.3390/su4102566; Kelly MJ, 2014, ANAL 5 YEARS DATA RI; Lefsky MA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023971; Leisher C., 2013, Diversity, V5, P779; Levi T, 2013, BIOL CONSERV, V163, P99, DOI 10.1016/j.biocon.2013.03.016; Lewis SL, 2015, SCIENCE, V349, P827, DOI 10.1126/science.aaa9932; Lindeman JC, 1989, FLORISTIC INVENTORY, P375; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loos J, 2015, J NAT CONSERV, V26, P45, DOI 10.1016/j.jnc.2015.05.001; Lopes MA, 2000, CONSERV BIOL, V14, P1658, DOI 10.1111/j.1523-1739.2000.98402.x; Montoya D, 2009, GLOBAL ECOL BIOGEOGR, V18, P662, DOI 10.1111/j.1466-8238.2009.00478.x; Moreira-Arce D, 2016, FOREST ECOL MANAG, V369, P135, DOI 10.1016/j.foreco.2016.03.024; Nagendra H, 2013, ECOL INDIC, V33, P45, DOI 10.1016/j.ecolind.2012.09.014; Noss AJ, 2006, PUMAS JAGUARES SIMPA, P229; Nunez-Iturri G, 2008, BIOL CONSERV, V141, P1536, DOI 10.1016/j.biocon.2008.03.020; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2000, OECOLOGIA, V122, P175, DOI 10.1007/PL00008845; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Picard N, 2012, CAN J FOREST RES, V42, P605, DOI [10.1139/X2012-018, 10.1139/x2012-018]; Pithon S, 2013, INT J REMOTE SENS, V34, P700, DOI 10.1080/01431161.2012.706719; Pitman RT, 2015, BIODIVERS CONSERV, V24, P1975, DOI 10.1007/s10531-015-0921-9; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Rheingantz ML, 2014, TROP CONSERV SCI, V7, P224; Richard-Hansen C, 1999, J ZOOL, V247, P419, DOI 10.1017/S095283699900401X; Richard-Hansen C, 2015, J TROP ECOL, V31, P423, DOI 10.1017/S0266467415000255; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rose RA, 2015, CONSERV BIOL, V29, P350, DOI 10.1111/cobi.12397; Schipper J, 2007, RMRSP49 USDA FOR SER; Sexton JO, 2016, NAT CLIM CHANGE, V6, P192, DOI [10.1038/NCLIMATE2816, 10.1038/nclimate2816]; Silver SC, 2004, ORYX, V38, P148, DOI 10.1017/S0030605304000286; Taber A, 2008, DESTINO ARQUITECTOS; Thornton D, 2016, ECOL APPL, V26, P1112, DOI 10.1890/15-0602; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; Tobler MW, 2014, ORYX, V48, P410, DOI 10.1017/S0030605312001652; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Toogood M, 2013, GEOGR COMPASS, V7, P611, DOI 10.1111/gec3.12067; Torres NM, 2012, DIVERS DISTRIB, V18, P615, DOI 10.1111/j.1472-4642.2012.00892.x; Turner W, 2015, BIOL CONSERV, V182, P173, DOI 10.1016/j.biocon.2014.11.048; Valiente-Banuet A, 2015, FUNCT ECOL, V29, P299, DOI 10.1111/1365-2435.12356; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; White GC, 1982, LA8787NERP; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wright SJ, 2000, CONSERV BIOL, V14, P227, DOI 10.1046/j.1523-1739.2000.98333.x; ZELLER K., 2007, JAGUARS NEW MILLENNI; Zimmermann NE, 2010, ECOGRAPHY, V33, P985, DOI 10.1111/j.1600-0587.2010.06953.x	100	11	11	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165362	10.1371/journal.pone.0165362	http://dx.doi.org/10.1371/journal.pone.0165362			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828993	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300040
J	Leroy, EC; Samaran, F; Bonnel, J; Royer, JY				Leroy, Emmanuelle C.; Samaran, Flore; Bonnel, Julien; Royer, Jean-Yves			Seasonal and Diel Vocalization Patterns of Antarctic Blue Whale (Balaenoptera musculus intermedia) in the Southern Indian Ocean: A Multi-Year and Multi-Site Study	PLOS ONE			English	Article							VERTICAL MIGRATION; ACOUSTIC PRESENCE; CALLS; SOUND; SITE; HEMISPHERE; INCREASES; FREQUENCY; ISLAND	Passive acoustic monitoring is an efficient way to provide insights on the ecology of large whales. This approach allows for long-term and species-specific monitoring over large areas. In this study, we examined six years (2010 to 2015) of continuous acoustic recordings at up to seven different locations in the Central and Southern Indian Basin to assess the peak periods of presence, seasonality and migration movements of Antarctic blue whales (Balaenoptera musculus intermedia). An automated method is used to detect the Antarctic blue whale stereotyped call, known as Z-call. Detection results are analyzed in terms of distribution, seasonal presence and diel pattern of emission at each site. Z-calls are detected year-round at each site, except for one located in the equatorial Indian Ocean, and display highly seasonal distribution. This seasonality is stable across years for every site, but varies between sites. Z-calls are mainly detected during autumn and spring at the subantarctic locations, suggesting that these sites are on the Antarctic blue whale migration routes, and mostly during winter at the subtropical sites. In addition to these seasonal trends, there is a significant diel pattern in Z-call emission, with more Z-calls in daytime than in nighttime. This diel pattern may be related to the blue whale feeding ecology.	[Leroy, Emmanuelle C.; Royer, Jean-Yves] Univ Brest, F-29280 Plouzane, France; [Leroy, Emmanuelle C.; Royer, Jean-Yves] IUEM, CNRS, Lab Geosci Brest, F-29280 Plouzane, France; [Leroy, Emmanuelle C.; Samaran, Flore; Bonnel, Julien] ENSTA Bretagne, UMR CNRS Lab STICC 6285, F-29806 Brest, France	Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); ENSTA Bretagne	Royer, JY (corresponding author), Univ Brest, F-29280 Plouzane, France.; Royer, JY (corresponding author), IUEM, CNRS, Lab Geosci Brest, F-29280 Plouzane, France.	jean-yves.royer@univ-brest.fr	Leroy, Emmanuelle/Q-9995-2019; Royer, Jean-Yves/B-4312-2010	Leroy, Emmanuelle/0000-0002-6469-1758; Royer, Jean-Yves/0000-0002-7653-7715	French Polar Institute (IPEV) [MD174/175, MD185, MD189, MD193, MD197, MD200, MD201 cruises, VT109/112-MD174/175, VT115-MD185, VT119-MD189, VT128-MD193, VT135-MD197, VT141-MD200, VT146-MD201]; NOAA/PMEL; INCOIS [SK 307]; Institut National des Sciences de l'Univers of CNRS; University of Brest; Regional Council of Brittany (Conseil Regional de Bretagne); Regional Council of Brittany (CPER); INSU-CNRS	French Polar Institute (IPEV); NOAA/PMEL(National Oceanic Atmospheric Admin (NOAA) - USA); INCOIS; Institut National des Sciences de l'Univers of CNRS; University of Brest; Regional Council of Brittany (Conseil Regional de Bretagne)(Region Bretagne); Regional Council of Brittany (CPER)(Region Bretagne); INSU-CNRS(Centre National de la Recherche Scientifique (CNRS))	Deployment and recovery cruises were funded by the French Polar Institute (IPEV; MD174/175, MD185, MD189, MD193, MD197, MD200, MD201 cruises) and by NOAA/PMEL and INCOIS (SK 307). Additional support for the acoustic experiments was provided by the Institut National des Sciences de l'Univers of CNRS. E.C.L. was supported by a Ph.D. fellowship from the University of Brest and from the Regional Council of Brittany (Conseil Regional de Bretagne). Moorings and hydrophones were funded by the Regional Council of Brittany (CPER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the Captains and crews of RV Marion Dufresne for the successful deployments and recoveries of the hydrophones of the OHASISBIO experiment and of ORV Sagar Kanya for the recovery of the RAMA hydrophone. French cruises were funded by the French Polar Institute (IPEV; cruises VT109/112-MD174/175, VT115-MD185, VT119-MD189, VT128-MD193, VT135-MD197, VT141-MD200 and VT146-MD201), with additional support from INSU-CNRS. We thank NOAA/PMEL and INCOIS for the opportunity to recover the RAMA hydrophone. E.C.L. was supported by a Ph.D. fellowship from the University of Brest and from the Regional Council of Brittany (Conseil Regional de Bretagne). The contribution of Mickael Beauverger at LGO in the preparation and realization of the cruises is greatly appreciated. Comments from three anonymous reviewers greatly helped improving this manuscript.	Aroyan JL, 2000, SPR HDB AUD, V12, P409; ATKINSON A, 1992, MAR BIOL, V113, P583, DOI 10.1007/BF00349702; Attard CRM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22291; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Branch T.A., 2007, Journal of Cetacean Research and Management, V9, P253; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Branch TA, 2004, MAR MAMMAL SCI, V20, P726, DOI 10.1111/j.1748-7692.2004.tb01190.x; Brown SG, 1954, DISPERSAL BLUE FIN W; Croll DA, 2002, NATURE, V417, P809, DOI 10.1038/417809a; Duhamel G, 2000, POLAR BIOL, V23, P106, DOI 10.1007/s003000050015; Gaten E, 2008, J GENET, V87, P473, DOI 10.1007/s12041-008-0070-y; Gavrilov AN, 2012, J ACOUST SOC AM, V131, P4476, DOI 10.1121/1.4707425; Gavrilov AN, 2011, J ACOUST SOC AM, V130, P3651, DOI 10.1121/1.3651817; Gedamke J, 2007, SCI COMM INT WHAL CO; Gill PC, 2011, MAR ECOL PROG SER, V421, P243, DOI 10.3354/meps08914; Hamame M, 2010, DEEP-SEA RES PT II, V57, P642, DOI 10.1016/j.dsr2.2009.10.013; Helble TA, 2013, J ACOUST SOC AM, V134, pEL400, DOI 10.1121/1.4822319; Helble TA, 2013, J ACOUST SOC AM, V134, P2556, DOI 10.1121/1.4816581; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Ljungblad Donald K., 1998, Report of the International Whaling Commission, V48, P439; Mackintosh NA., 1966, WHALES DOLPHINS PORP, P125; Mackintosh NA, 1929, SO BLUE FIN WHALES; McDonald MA, 2006, NEW ZEAL J MAR FRESH, V40, P519, DOI 10.1080/00288330.2006.9517442; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; McDonald Mark A., 2009, Endangered Species Research, V9, P13, DOI 10.3354/esr00217; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Miksis-Olds JL, 2016, J ACOUST SOC AM, V139, P501, DOI 10.1121/1.4938237; Miksis-Olds JL, 2015, AQUAT MAMM, V41, P444, DOI 10.1578/AM.41.4.2015.444; Miksis-Olds JL, 2013, J ACOUST SOC AM, V134, P3464, DOI 10.1121/1.4821537; Miller BS, 2015, ENDANGER SPECIES RES, V26, P257, DOI 10.3354/esr00642; Miller BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107740; Nemoto T., 1970, P241; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; R Core Team, 2021, R LANGUAGE ENV STAT; Rankin Shannon, 2005, Journal of Cetacean Research and Management, V7, P13; Reilly SB, 2008, IUCN RED LIST THREAT; Royer JY, 2015, GEOPHYS J INT, V202, P748, DOI 10.1093/gji/ggv178; Samaran F., 2008, CAN ACOUST, V36, P93; Samaran F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071561; Samaran F, 2010, APPL ACOUST, V71, P1099, DOI 10.1016/j.apacoust.2010.05.014; Samaran Flore, 2010, Endangered Species Research, V12, P157, DOI 10.3354/esr00302; Samaran F, 2010, J ACOUST SOC AM, V127, P3800, DOI 10.1121/1.3409479; Sirovic A, 2004, DEEP-SEA RES PT II, V51, P2327, DOI 10.1016/j.dsr2.2004.08.005; Sirovic A, 2007, J ACOUST SOC AM, V122, P1208, DOI 10.1121/1.2749452; Sirovic A, 2015, ENDANGER SPECIES RES, V28, P61, DOI 10.3354/esr00676; Sirovic A, 2009, MAR MAMMAL SCI, V25, P125, DOI 10.1111/j.1748-7692.2008.00239.x; Socheleau FX, 2015, J ACOUST SOC AM, V138, P3105, DOI 10.1121/1.4934271; Stafford KM, 2005, ANIM BEHAV, V69, P951, DOI 10.1016/j.anbehav.2004.06.025; Stafford KM, 2004, DEEP-SEA RES PT I, V51, P1337, DOI 10.1016/j.dsr.2004.05.007; Stan Development Team, 2016, RSTANARM BAYES APPL; Thode AM, 2000, J ACOUST SOC AM, V107, P1286, DOI 10.1121/1.428417; Thomisch K, 2016, ENDANGER SPECIES RES, V30, P239, DOI 10.3354/esr00739; Tripovich JS, 2015, J MAMMAL, V96, P603, DOI 10.1093/jmammal/gyv065; Tsang-Hin-Sun E, 2016, GEOPHYS J INT, V206, P1232, DOI 10.1093/gji/ggw201; Tsang-Hin-Sun E, 2015, J ACOUST SOC AM, V138, P3439, DOI 10.1121/1.4936855; Wiggins Sean M., 2005, Aquatic Mammals, V31, P161, DOI 10.1578/AM.31.2.2005.161; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	58	33	35	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0163587	10.1371/journal.pone.0163587	http://dx.doi.org/10.1371/journal.pone.0163587			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828976	Green Published, gold			2022-12-27	WOS:000387724300008
J	Pendleton, L; Comte, A; Langdon, C; Ekstrom, JA; Cooley, SR; Suatoni, L; Beck, MW; Brander, LM; Burke, L; Cinner, JE; Doherty, C; Edwards, PET; Gledhill, D; Jiang, LQ; van Hooidonk, RJ; Teh, L; Waldbusser, GG; Ritter, J				Pendleton, Linwood; Comte, Adrien; Langdon, Chris; Ekstrom, Julia A.; Cooley, Sarah R.; Suatoni, Lisa; Beck, Michael W.; Brander, Luke M.; Burke, Lauretta; Cinner, Josh E.; Doherty, Carolyn; Edwards, Peter E. T.; Gledhill, Dwight; Jiang, Li-Qing; van Hooidonk, Ruben J.; Teh, Louise; Waldbusser, George G.; Ritter, Jessica			Coral Reefs and People in a High-CO2 World: Where Can Science Make a Difference to People?	PLOS ONE			English	Article							GREAT-BARRIER-REEF; OCEAN ACIDIFICATION; CLIMATE-CHANGE; VULNERABILITY; CALCIFICATION; ADAPTATION; SUSTAINABILITY; DISTURBANCES; TEMPERATURE; RESILIENCE	Reefs and People at Risk Increasing levels of carbon dioxide in the atmosphere put shallow, warm-water coral reef ecosystems, and the people who depend upon them at risk from two key global environmental stresses: 1) elevated sea surface temperature (that can cause coral bleaching and related mortality), and 2) ocean acidification. These global stressors: cannot be avoided by local management, compound local stressors, and hasten the loss of ecosystem services. Impacts to people will be most grave where a) human dependence on coral reef ecosystems is high, b) sea surface temperature reaches critical levels soonest, and c) ocean acidification levels are most severe. Where these elements align, swift action will be needed to protect people's lives and livelihoods, but such action must be informed by data and science. An Indicator Approach Designing policies to offset potential harm to coral reef ecosystems and people requires a better understanding of where CO2-related global environmental stresses could cause the most severe impacts. Mapping indicators has been proposed as a way of combining natural and social science data to identify policy actions even when the needed science is relatively nascent. To identify where people are at risk and where more science is needed, we map indicators of biological, physical and social science factors to understand how human dependence on coral reef ecosystems will be affected by globally-driven threats to corals expected in a high-CO2 world. Western Mexico, Micronesia, Indonesia and parts of Australia have high human dependence and will likely face severe combined threats. As a region, Southeast Asia is particularly at risk. Many of the countries most dependent upon coral reef ecosystems are places for which we have the least robust data on ocean acidification. These areas require new data and interdisciplinary scientific research to help coral reef-dependent human communities better prepare for a high CO2 world.	[Pendleton, Linwood; Comte, Adrien] Univ Bretagne Occidentale, AMURE UMR6308, IUEM, Plouzane, France; [Doherty, Carolyn] Duke Univ, Durham, NC USA; [Langdon, Chris] Univ Miami, RSMAS MBE, Miami, FL USA; [Ekstrom, Julia A.] Univ Calif Davis, Policy Inst Energy Environm & Econ, Davis, CA 95616 USA; [Cooley, Sarah R.] Ocean Conservancy, Washington, DC USA; [Suatoni, Lisa] Nat Resources Def Council, New York, NY USA; [Beck, Michael W.] Nature Conservancy, Santa Cruz, CA USA; [Beck, Michael W.] Univ Calif Santa Cruz, Ocean Sci, Santa Cruz, CA 95064 USA; [Brander, Luke M.] Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands; [Burke, Lauretta] World Resources Inst, Washington, DC 20006 USA; [Cinner, Josh E.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Edwards, Peter E. T.] NOAA, Coral Reef Conservat Program, Silver Spring, MD USA; [Gledhill, Dwight] NOAA, Ocean Acidificat Program, Silver Spring, MD USA; [Jiang, Li-Qing] Univ Maryland, Cooperat Inst Climate & Satellites, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [van Hooidonk, Ruben J.] NOAA, Atlantic Oceanog & Meteorol Lab, Ocean Chem & Ecosyst Div, Miami, FL 33149 USA; [van Hooidonk, Ruben J.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Cooperat Inst Marine & Atmospher Studies, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Teh, Louise] Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada; [Waldbusser, George G.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Ritter, Jessica] Natl Wildlife Fdn, Washington, DC USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Duke University; University of Miami; University of California System; University of California Davis; Nature Conservancy; University of California System; University of California Santa Cruz; Vrije Universiteit Amsterdam; James Cook University; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University System of Maryland; University of Maryland College Park; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of Miami; University of British Columbia; Oregon State University	Pendleton, L (corresponding author), Univ Bretagne Occidentale, AMURE UMR6308, IUEM, Plouzane, France.	linwood.pendleton@duke.edu	Cooley, Sarah R/K-7373-2012; Cinner, Joshua e/E-8966-2011; Jiang, Li-Qing/G-5228-2014; Cinner, Joshua/AAA-6823-2021; Langdon, Chris/A-1543-2016; Beck, Michael W./AAB-2844-2019; BITOUN, RACHEL Elisabeth/AAC-9538-2021; van Hooidonk, Ruben J/F-7395-2010	Cooley, Sarah R/0000-0002-1034-0653; Cinner, Joshua e/0000-0003-2675-9317; Jiang, Li-Qing/0000-0003-3311-1658; Langdon, Chris/0000-0002-3043-3806; Beck, Michael W./0000-0002-5107-9973; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; van Hooidonk, Ruben J/0000-0002-3804-1233; Brander, Luke/0000-0002-5862-4030; Ekstrom, Julia/0000-0003-1060-5276; Edwards, Peter E T/0000-0002-8628-4694; Waldbusser, George/0000-0002-8334-580X; Comte, Adrien/0000-0001-9895-0669	National Socio-Environmental Synthesis Center (SESYNC) - National Science Foundation [DBI-1052875]; Prince Albert II Foundation; "Laboratoire d'Excellence" LabexMER - French government under the program "Investissements 'Avenir" [ANR-10-LABX-19]; Region of Brittany; Direct For Biological Sciences [1639145] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1052875] Funding Source: National Science Foundation	National Socio-Environmental Synthesis Center (SESYNC) - National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Prince Albert II Foundation; "Laboratoire d'Excellence" LabexMER - French government under the program "Investissements 'Avenir"; Region of Brittany(Region Bretagne); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Socio-Environmental Synthesis Center (SESYNC) under funding received from the National Science Foundation DBI-1052875, a grant from the Prince Albert II Foundation, and research effort for LP and AC was supported by the "Laboratoire d'Excellence" LabexMER (ANR-10-LABX-19), co-funded by a grant from the French government under the program "Investissements 'Avenir" and the Region of Brittany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2016, SCIENCE, V352, P338, DOI 10.1126/science.aac7125; Albright R, 2016, NATURE, V531, P362, DOI 10.1038/nature17155; Albright R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056468; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Anthony KRN, 2015, GLOBAL CHANGE BIOL, V21, P48, DOI 10.1111/gcb.12700; Barnett J, 2010, GLOBAL ENVIRON CHANG, V20, P211, DOI 10.1016/j.gloenvcha.2009.11.004; Beck MW, 2014, COASTS RISK ASSESSME, V85; Brander LM, 2012, CLIM CHANG ECON, V3, DOI 10.1142/S2010007812500029; Breshears DD, 2011, AMBIO, V40, P256, DOI 10.1007/s13280-010-0106-4; Bryant D, 1998, NATL GEOGRAPHIC; Burke L., 2011, REEFS RISK REVISITED; Center for International Earth Science Information Network (CIESIN)/ Columbia University, 2013, LOW EL COAST ZON URB, P1; Chan NCS, 2013, GLOBAL CHANGE BIOL, V19, P282, DOI 10.1111/gcb.12011; Cinner JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074321; Cinner JE, 2016, REG ENVIRON CHANGE, V16, P1133, DOI 10.1007/s10113-015-0832-z; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Ekstrom JA, 2015, NAT CLIM CHANGE, V5, P207, DOI 10.1038/NCLIMATE2508; Evans L, 2011, LIMITS CLIMATE CHANG, P1, DOI [10.1371/journal.pone.0150575, DOI 10.1371/JOURNAL.PONE.0150575]; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; Fernando H., 2005, EOS T AM GEOPHYS UN, V86, P301, DOI [10.1029/2005EO330002, DOI 10.1029/2005EO330002]; Ferrario F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4794; Gattuso JP, 2015, SCIENCE, V349, DOI 10.1126/science.aac4722; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2014, OCEAN 5 ASSESSMENT R; Howes EL, 2015, STUDIES, V2, P52, DOI [10.3389/fmars.2015.00036, DOI 10.3389/FMARS.2015.00036]; Hughes S, 2012, ENVIRON SCI POLICY, V23, P95, DOI 10.1016/j.envsci.2012.07.012; IPCC, 2013, CLIM CHANG 2013 PHYS, V33; Jiang LQ, 2015, GLOBAL BIOGEOCHEM CY, V29, P1656, DOI 10.1002/2015GB005198; Juwana I, 2012, SCI TOTAL ENVIRON, V438, P357, DOI 10.1016/j.scitotenv.2012.08.093; Kwiatkowski L, 2015, NAT CLIM CHANGE, V5, P777, DOI [10.1038/NCLIMATE2655, 10.1038/nclimate2655]; Lurig M, 2015, J SEA RES, V99, P26, DOI 10.1016/j.seares.2015.01.005; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; Manzello DP, 2014, GEOPHYS RES LETT, V41, P9001, DOI 10.1002/2014GL062501; Maynard J, 2015, NAT CLIM CHANGE, V5, P688, DOI 10.1038/nclimate2625; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McClanahan TR, 2015, CLIMATIC CHANGE, V131, P607, DOI 10.1007/s10584-015-1399-x; McLeod E, 2012, COAST MANAGE, V40, P651, DOI 10.1080/08920753.2012.728123; Mongin M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10732; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Muehllehner N, 2016, GLOB BIOCH CYCLES; Newton J.A., 2015, GLOBAL OCEAN ACIDIFI; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Obura D, 2009, CORAL REEFS; Pendleton LH, 2016, MULTIPLE STRESSORS E, V3, P1, DOI [10.3389/fmars.2016.00036, DOI 10.3389/FMARS.2016.00036]; Pramova E, 2011, CLIM POLICY, P37; Rau GH, 2012, NAT CLIM CHANGE, V2, P720, DOI 10.1038/NCLIMATE1555; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Sheppard C, 2005, ESTUAR COAST SHELF S, V64, P223, DOI 10.1016/j.ecss.2005.02.016; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Teh LSL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065397; Unsworth RKF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024026; van Hooidonk R, 2014, GLOBAL CHANGE BIOL, V20, P103, DOI 10.1111/gcb.12394; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wolff NH, 2015, GLOBAL CHANGE BIOL, V21, P3982, DOI 10.1111/gcb.13015; Yang Y., 2015, EARTH SYST SCI DATA, V8, P889, DOI [10.5194/essdd-8-889-2015, DOI 10.5194/ESSDD-8-889-2015]; Yeakel KL, 2015, P NATL ACAD SCI USA, V112, P14512, DOI 10.1073/pnas.1507021112	63	45	45	5	169	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164699	10.1371/journal.pone.0164699	http://dx.doi.org/10.1371/journal.pone.0164699			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828972	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000387724300020
J	Germeraad, EA; Hogerwerf, L; Faye-Joof, T; Goossens, B; van der Hoek, W; Jeng, M; Lamin, M; Manneh, IL; Nwakanma, D; Roest, HIJ; Secka, A; Stegeman, A; Wegmuller, R; van der Sande, MAB; Secka, O				Germeraad, Eveline A.; Hogerwerf, Lenny; Faye-Joof, Tisbeh; Goossens, Bart; van der Hoek, Wim; Jeng, Momodou; Lamin, Modou; Manneh, Ismaila L.; Nwakanma, Davis; Roest, Hendrik I. J.; Secka, Arss; Stegeman, Arjan; Wegmuller, Rita; van der Sande, Marianne A. B.; Secka, Ousman			Low Seroprevalence of Brucellosis in Humans and Small Ruminants in the Gambia	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; FEBRILE ILLNESS; EPIDEMIOLOGY; DIAGNOSIS	Background Brucellosis is a worldwide zoonosis with significant impact on rural livelihoods and a potentially underestimated contributor to febrile illnesses. The aim of this study was to estimate the seroprevalence of brucellosis in humans and small ruminants in The Gambia. Methods The study was carried out in rural and urban areas. In 12 rural villages in Kiang West district, sera were collected from humans (n = 599) and small ruminants (n = 623) from the same compounds. From lactating small ruminants, milk samples and vaginal swabs were obtained. At the urban study sites, sera were collected from small ruminants (n = 500) from slaughterhouses and livestock markets. Information on possible risk factors for seropositivity was collected through questionnaires. Sera were screened for antibodies against Brucella spp. with the Rose Bengal Test, ELISA and Micro Agglutination Test (human sera only). PCR was performed on 10 percent of the milk samples and vaginal swabs from small ruminants. Results One human and 14 sheep sera were positive by the Rose Bengal Test. The rest were negative in all serological tests used. The PCR results were all negative. Conclusions The results suggest that brucellosis is currently not a generalized problem in humans or small ruminants in The Gambia.	[Germeraad, Eveline A.; Hogerwerf, Lenny; van der Hoek, Wim; van der Sande, Marianne A. B.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Faye-Joof, Tisbeh; Manneh, Ismaila L.] Med Res Council Unit Gambia, Dept Vaccinol, Banjul, Fajara, Gambia; [Goossens, Bart] Kombo Vet Serv, Bakau, Gambia; [Jeng, Momodou; Secka, Arss] Int Trypanotolerance Ctr, Banjul, Gambia; [Lamin, Modou; Nwakanma, Davis; Secka, Ousman] MRC Unit, Dept Dis Control & Eliminat, Banjul, Fajara, Gambia; [Roest, Hendrik I. J.] Cent Vet Inst, Dept Bacteriol & Epidemiol, Lelystad, Netherlands; [Stegeman, Arjan] Univ Utrecht, Dept Farm Anim Hlth, Utrecht, Netherlands; [Wegmuller, Rita] MRC, Int Nutr Grp, MRC Unit Gambia, Keneba, Gambia; [van der Sande, Marianne A. B.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Wageningen University & Research; Utrecht University; University of London; London School of Hygiene & Tropical Medicine; Utrecht University; Utrecht University Medical Center	Hogerwerf, L (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.	lenny.hogerwerf@rivm.nl		Jeng, Momodou/0000-0001-7869-6229; Hogerwerf, Lenny/0000-0001-6329-7831; Nwakanma, Davis/0000-0002-6706-6069; van der Sande, Marianne AB/0000-0002-4778-6739; Germeraad, Evelien/0000-0001-9146-5580	Ministry of Health, Welfare and Sports, the Netherlands; Ministry of Economic Affairs, the Netherlands [W0T-01-002-006.01]	Ministry of Health, Welfare and Sports, the Netherlands; Ministry of Economic Affairs, the Netherlands(Ministry of Economic Affairs, Netherlands)	This work was supported by Ministry of Health, Welfare and Sports, the Netherlands and by the Ministry of Economic Affairs, the Netherlands (www.government.nl/ministries) via the project 'Brucellosis', grant number W0T-01-002-006.01. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan KJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003899; [Anonymous], 2014, R LANG ENV STAT COMP; Banfi G., 2002, USE ANTICOAGULANTS D; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Crump JA, 2012, CLIN INFECT DIS, V54, P1107, DOI 10.1093/cid/cis024; De Blas I, 2006, WORKING EPIDEMIOLOGY; Dean AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071501; Ducrotoy MJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003008; Fosgate GT, 2002, EMERG INFECT DIS, V8, P672, DOI 10.3201/eid0807.010351; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Godfroid J, 2010, CROAT MED J, V51, P296, DOI 10.3325/cmj.2010.51.296; Goossens B, 1998, VET REC, V142, P277, DOI 10.1136/vr.142.11.277; Klaasen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085424; Maio E, 2014, VET MICROBIOL, V173, P118, DOI 10.1016/j.vetmic.2014.07.010; McDermott JJ, 2002, VET MICROBIOL, V90, P111, DOI 10.1016/S0378-1135(02)00249-3; Medical Research Council D International Nutrition Group, KIANG W DEM SURV SYS; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Regional Project on Sustainable Management of Endemic Ruminant Livestock in West Africa (PROGEBE), 2013, ANN REPORT; Sanogo M, 2013, VET J, V195, P114, DOI 10.1016/j.tvjl.2012.06.007; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Unger F., 2003, RISK ASS BOVINE BRUC; Vanderburg S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002787; Vialle-Valentin Catherine E, 2015, J Pharm Policy Pract, V8, P1, DOI 10.1186/s40545-014-0024-0; World Health Organization, 2007, ASS TB PREV POP BAS; World Organisation for Animal Health (OIE), 2012, MANUAL DIAGNOSTIC TE, P616	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166035	10.1371/journal.pone.0166035	http://dx.doi.org/10.1371/journal.pone.0166035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824952	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200055
J	Manousek, J; Stejskal, V; Kubena, P; Jarkovsky, J; Nemec, P; Lokaj, P; Dostalova, L; Zadakova, A; Pavlusova, M; Benesova, K; Kala, P; Miklik, R; Spinar, J; Parenica, J				Manousek, Jan; Stejskal, Vera; Kubena, Petr; Jarkovsky, Jiri; Nemec, Petr; Lokaj, Petr; Dostalova, Ludmila; Zadakova, Andrea; Pavlusova, Marie; Benesova, Klara; Kala, Petr; Miklik, Roman; Spinar, Jindrich; Parenica, Jiri			Delayed-Type Hypersensitivity to Metals of Environmental Burden in Patients with Takotsubo Syndrome - Is There a Clinical Relevance?	PLOS ONE			English	Article							CARDIOMYOPATHY; ALLERGY; PROGESTERONE; ASSOCIATION; SENSITIVITY; PREGNANCY; MERCURY; STRESS	Objective Takotsubo syndrome (TS) is a heart condition characterised by a sudden transient left ventricular dysfunction; its pathophysiology is probably associated with elevated levels of catecholamines but the exact mechanism is not known as yet. Literature and clinical experience suggest that TS affects persons with various comorbidities. This pilot work aims to evaluate the frequency of comorbidities with potential pathological immune reactivity, and to evaluate the potential association between TS and hypersensitivity to metals assessed by LTT-MELISA (R). Methodology, Results A total of 24 patients (23 women, 1 man) with a history of TS attack and 27 healthy controls were evaluated. Hypersensitivity was evaluated by a lymphocyte transformation test (LTT-MELISA (R)); a questionnaire of environmental burden was used to select evaluated metals. A total of 19 patients (79%) had at least one condition that might potentially be associated with pathological immune reactivity (autoimmune thyroid disease, drug allergy, bronchial asthma, cancer, contact dermatitis, rheumatoid arthritis). Hypersensitivity to metals was identified significantly more frequently in TS patients than in healthy controls (positive reaction to at least one metal was identified in 95.8% of TS patients and in 59.3% of controls; p = 0.003); the difference was statistically significant for mercury (45.8% and 14.8%, respectively; p = 0.029). Conclusion Our work shows that conditions with pathological immune reactivity occur frequently in TS patients, and our data suggest a possible association between TS and hypersensitivity tometals (mercury in particular) evaluated by LTT-MELISA (R). We also suggest that apart from the triggering stress factor, potential existence of other serious conditions should be considered when taking medical history of TS patients.	[Manousek, Jan; Kubena, Petr; Lokaj, Petr; Dostalova, Ludmila; Zadakova, Andrea; Pavlusova, Marie; Kala, Petr; Miklik, Roman; Spinar, Jindrich; Parenica, Jiri] Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic; [Stejskal, Vera] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Stejskal, Vera] Masaryk Univ, Fac Sci, Res Ctr Tox Cpds Environm RECETOX, Brno, Czech Republic; [Jarkovsky, Jiri; Benesova, Klara] Masaryk Univ, Fac Med, Inst Biostat & Anal, Brno, Czech Republic; [Nemec, Petr] Ctr Cardiovasc Surg & Transplantat, Brno, Czech Republic; [Nemec, Petr; Lokaj, Petr; Pavlusova, Marie; Kala, Petr; Spinar, Jindrich; Parenica, Jiri] Masaryk Univ, Fac Med, Brno, Czech Republic	University Hospital Brno; Stockholm University; Masaryk University Brno; Institute of Biostatistics & Analyses; Masaryk University Brno; Masaryk University Brno	Parenica, J (corresponding author), Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic.; Parenica, J (corresponding author), Masaryk Univ, Fac Med, Brno, Czech Republic.	jiri.parenica@atlas.cz	Lokaj, Petr/AAG-4405-2020; Jarkovsky, Jiri/G-5494-2017		Ministry of Health of the Czech Republic-conceptual development of research organisation (FNBr) [65269705]; Masaryk University (Brno, CzechRepublic) [MUNI/A/1362/2015]; Czech Society of Cardiology	Ministry of Health of the Czech Republic-conceptual development of research organisation (FNBr); Masaryk University (Brno, CzechRepublic)(Czech Republic Government); Czech Society of Cardiology	This work was supported by Ministry of Health of the Czech Republic-conceptual development of research organisation (FNBr, 65269705), project MUNI/A/1362/2015 of the Masaryk University (Brno, Czech Republic) and by a grant of the Czech Society of Cardiology.	Akashi YJ, 2015, NAT REV CARDIOL, V12, P387, DOI 10.1038/nrcardio.2015.39; Akashi YJ, 2008, CIRCULATION, V118, P2754, DOI 10.1161/CIRCULATIONAHA.108.767012; Amariles P, 2011, CURR CLIN PHARMACOL, V6, P1, DOI 10.2174/157488411794941340; Ando Giuseppe, 2010, Acute Card Care, V12, P70, DOI 10.3109/17482941003732758; Basselin C, 2011, PHARMACOTHERAPY, V31, P226, DOI 10.1592/phco.31.2.226; Bernards J, 2014, INT J CARDIOL, V177, pE53, DOI 10.1016/j.ijcard.2014.09.130; Bernhard D, 2005, IUBMB LIFE, V57, P805, DOI 10.1080/15216540500459667; Bybee KA, 2004, ANN INTERN MED, V141, P858, DOI 10.7326/0003-4819-141-11-200412070-00010; Caforio ALP, 2009, EUR J HEART FAIL, V11, P428, DOI 10.1093/eurjhf/hfp008; Coli S, 2015, J CARDIOVASC MED, V16, P646, DOI 10.2459/JCM.0000000000000204; Eitel I, 2010, EUR RADIOL, V20, P422, DOI 10.1007/s00330-009-1549-5; Han LJ, 2014, INT J CARDIOL, V177, pE145, DOI 10.1016/j.ijcard.2014.09.049; Hwang S. A, 2001, HYPERSENSITIVITY T L; Hybenova M, 2010, NEUROENDOCRINOL LETT, V31, P283; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Kamada T, 2015, INTERNAL MED, V54, P31, DOI 10.2169/internalmedicine.54.3239; Kneale BJ, 2000, J AM COLL CARDIOL, V36, P1233, DOI 10.1016/S0735-1097(00)00849-4; Knott K, 2014, INT J CARDIOL, V177, pE65, DOI 10.1016/j.ijcard.2014.09.154; Koci F, 2014, TEX HEART I J, V41, P638, DOI 10.14503/THIJ-13-3500; Krejci J, 2016, HEART VESSELS, V31, P416, DOI 10.1007/s00380-014-0618-0; Lushchak Volodymyr I, 2012, J Amino Acids, V2012, P736837, DOI 10.1155/2012/736837; Lyon AR, 2016, EUR J HEART FAIL, V18, P8, DOI 10.1002/ejhf.424; Mutter J, 2011, J OCCUP MED TOXICOL, V6, DOI 10.1186/1745-6673-6-2; Pelliccia F, 2015, AM J MED, V128, DOI 10.1016/j.amjmed.2015.01.016; Postema PG, 2014, NETH HEART J, V22, P456, DOI 10.1007/s12471-012-0320-8; Prochazkova J, 2004, NEUROENDOCRINOL LETT, V25, P211; Prochazkova J, 2000, DIS MARKERS, V16, P135, DOI 10.1155/2000/205757; Saint-Mezard P, 2004, EUR J DERMATOL, V14, P131; Sato H, CLIN ASPECT MYOCARDI, P56; SIITERI PK, 1977, ANN NY ACAD SCI, V286, P384, DOI 10.1111/j.1749-6632.1977.tb29431.x; Smith-Sivertsen T, 1999, J AM ACAD DERMATOL, V40, P726, DOI 10.1016/S0190-9622(99)70154-4; Stejskal Jenny, 1999, Neuro Endocrinol Lett, V20, P351; STEJSKAL VDM, 1994, TOXICOL IN VITRO, V8, P991, DOI 10.1016/0887-2333(94)90233-X; Stejskal VDM, 1996, J CLIN IMMUNOL, V16, P31, DOI 10.1007/BF01540970; Stejskal V, 2015, J TRACE ELEM MED BIO, V31, P230, DOI 10.1016/j.jtemb.2015.01.001; SZEKERESBARTHO J, 1985, J REPROD IMMUNOL, V7, P121, DOI 10.1016/0165-0378(85)90066-X; Templin C, 2015, NEW ENGL J MED, V373, P929, DOI 10.1056/NEJMoa1406761; Thyssen JP, 2010, CHEM RES TOXICOL, V23, P309, DOI 10.1021/tx9002726; Trio O, 2015, VNITRNI LEKARSTVI, V61, P619; Trio Olimpia, 2010, Ther Adv Cardiovasc Dis, V4, P105, DOI 10.1177/1753944709356013; Yaqob A, 2006, NEUROENDOCRINOL LETT, V27, P189	41	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164786	10.1371/journal.pone.0164786	http://dx.doi.org/10.1371/journal.pone.0164786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824862	gold, Green Published, Green Submitted			2022-12-27	WOS:000387615200008
J	Huang, YH; Wu, Y				Huang, Yunhui; Wu, Yin			Ownership Effect Can Be a Result of Other-Derogation: Evidence from Behavioral and Electrophysiological Studies	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; PANCULTURAL SELF-ENHANCEMENT; MERE OWNERSHIP; SOCIAL COGNITION; ENDOWMENT; OBJECTS; PERCEPTION; ATTITUDES; RESPONSES; IMAGERY	Growing evidence suggests that people overvalue their own objects compared to those owned by others, even when the two objects are virtually identical (i.e., ownership effect). Most researchers seem to consider self-enhancement as the underlying mechanism while neglecting the possible process of other-derogation. Here, we attempted to compare these two perspectives, adopting both implicit and neurocognitive methodologies to overcome social desirability confounds. In Study 1, we found that the ownership effect (measured by Implicit Association Test), was correlated with other-derogation but not with self-enhancement (both measured by the Go/No-Go Association Task). In Study 2, by using the eventrelated potentials (ERPs) technique, we showed that positive-framed other-owned objects elicited significant evaluative incongruity (i.e. indexed by late positive potentials) compared to negative-framed other-owned objects. In contrast, negative-framed self-owned objects did not evoke significant evaluative incongruity relative to positive-framed self-owned objects. Our research suggests that, in addition to the self-enhancement that has been widely demonstrated, it is also important to keep other-derogation in mind when examining the ownership effect.	[Huang, Yunhui] Nanjing Univ, Dept Mkt & Elect Business, Nanjing, Jiangsu, Peoples R China; [Wu, Yin] Shenzhen Univ, Res Ctr Brain Funct & Psychol Sci, Shenzhen 518060, Peoples R China; [Wu, Yin] Peking Univ, Ctr Brain & Cognit Sci, Beijing 100871, Peoples R China; [Wu, Yin] Peking Univ, Sch Psychol & Cognit Sci, Beijing 100871, Peoples R China	Nanjing University; Shenzhen University; Peking University; Peking University	Wu, Y (corresponding author), Shenzhen Univ, Res Ctr Brain Funct & Psychol Sci, Shenzhen 518060, Peoples R China.; Wu, Y (corresponding author), Peking Univ, Ctr Brain & Cognit Sci, Beijing 100871, Peoples R China.; Wu, Y (corresponding author), Peking Univ, Sch Psychol & Cognit Sci, Beijing 100871, Peoples R China.	yinwu0407@gmail.com		Wu, Yin/0000-0002-6364-4597	National Natural Science Foundation of China [71102037, 71472084, 31600923]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Natural Science Foundation of China (71102037 and 71472084 to YH and 31600923 to YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholow BD, 2003, J PERS SOC PSYCHOL, V85, P627, DOI 10.1037/0022-3514.85.4.627; Bartholow BD, 2001, PSYCHOL SCI, V12, P197, DOI 10.1111/1467-9280.00336; Baumeister R. F., 1998, THE SELF; BEGGAN JK, 1992, J PERS SOC PSYCHOL, V62, P229, DOI 10.1037/0022-3514.62.2.229; BELK RW, 1988, J CONSUM RES, V15, P139, DOI 10.1086/209154; Brunel FF, 2004, J CONSUM PSYCHOL, V14, P385, DOI 10.1207/s15327663jcp1404_8; CACIOPPO JT, 1994, J PERS SOC PSYCHOL, V67, P115, DOI 10.1037/0022-3514.67.1.115; Dai XC, 2013, J MARKETING RES, V50, P207, DOI 10.1509/jmr.11.0189; De Dreu CKW, 2005, J PERS SOC PSYCHOL, V89, P345, DOI 10.1037/0022-3514.89.3.345; De Houwer J, 2007, J EXP SOC PSYCHOL, V43, P972, DOI 10.1016/j.jesp.2006.10.007; Dieguez S, 2009, CURR BIOL, V19, pR1108, DOI 10.1016/j.cub.2009.10.055; Dommer SL, 2013, J CONSUM RES, V39, P1034, DOI 10.1086/666737; Evans N, 2013, NEUROIMAGE, V64, P216, DOI 10.1016/j.neuroimage.2012.09.027; Fazio RH, 1986, J PERS SOC PSYCHOL, V50, P1062; Fein S, 1997, J PERS SOC PSYCHOL, V73, P31, DOI 10.1037/0022-3514.73.1.31; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Gregg AP, 2006, J PERS SOC PSYCHOL, V90, P1, DOI 10.1037/0022-3514.90.1.1; Herring DR, 2011, EMOTION, V11, P794, DOI 10.1037/a0022804; Hoorens V, 1999, J ECON PSYCHOL, V20, P383, DOI 10.1016/S0167-4870(99)00014-8; Huang YH, 2009, PERS SOC PSYCHOL B, V35, P713, DOI 10.1177/0146167209333046; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Kitayama S, 1997, J PERS SOC PSYCHOL, V72, P1245, DOI 10.1037/0022-3514.72.6.1245; Morewedge CK, 2015, TRENDS COGN SCI, V19, P339, DOI 10.1016/j.tics.2015.04.004; Morewedge CK, 2009, J EXP SOC PSYCHOL, V45, P947, DOI 10.1016/j.jesp.2009.05.014; Nesselroade KP, 1999, PSYCHOL MARKET, V16, P21; Nosek B.A., 2007, AUTOMATIC PROCESSES, P265, DOI DOI 10.1037/0022-3514.89.3.277; Nosek BA, 2001, SOC COGNITION, V19, P625, DOI 10.1521/soco.19.6.625.20886; Peck J, 2013, J CONSUM PSYCHOL, V23, P189, DOI 10.1016/j.jcps.2012.09.001; Press C, 2008, J COGNITIVE NEUROSCI, V20, P312, DOI 10.1162/jocn.2008.20022; Rothermund K, 2004, J EXP PSYCHOL GEN, V133, P139, DOI 10.1037/0096-3445.133.2.139; Sedikides C, 2005, J PERS SOC PSYCHOL, V89, P539, DOI 10.1037/0022-3514.89.4.539; Sedikides C, 2003, J PERS SOC PSYCHOL, V84, P60, DOI 10.1037/0022-3514.84.1.60; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Van Duynslaeger M, 2007, SOC COGN AFFECT NEUR, V2, P174, DOI 10.1093/scan/nsm016; Vignemont FD, 2011, CONSCIOUS COGN, V20, P82; WILLS TA, 1981, PSYCHOL BULL, V90, P245, DOI 10.1037/0033-2909.90.2.245; Wu Y, 2013, BIOL PSYCHOL, V92, P179, DOI 10.1016/j.biopsycho.2012.11.011; Wyer RS, 2010, CHINESE CONSUMER BEH	42	0	1	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166054	10.1371/journal.pone.0166054	http://dx.doi.org/10.1371/journal.pone.0166054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8TH	27814395	Green Submitted, gold, Green Published			2022-12-27	WOS:000386911100027
J	Kremer, IEH; Evers, SMAA; Jongen, PJ; van der Weijden, T; van de Kolk, I; Hiligsmann, M				Kremer, Ingrid E. H.; Evers, Silvia M. A. A.; Jongen, Peter J.; van der Weijden, Trudy; van de Kolk, Ilona; Hiligsmann, Mickael			Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling	PLOS ONE			English	Article							CHOICE EXPERIMENTS; CONJOINT-ANALYSIS; PREGNANCY; PREFERENCES; MANAGEMENT; THERAPIES; CHECKLIST; ADHERENCE; WOMEN; MODEL	Objectives Understanding the preferences of patients with multiple sclerosis (MS) for disease-modifying drugs and involving these patients in clinical decision making can improve the concordance between medical decisions and patient values and may, subsequently, improve adherence to disease-modifying drugs. This study aims first to identify which characteristics-or attributes-of disease-modifying drugs influence patients A decisions about these treatments and second to quantify the attributes' relative importance among patients. Methods First, three focus groups of relapsing-remitting MS patients were formed to compile a preliminary list of attributes using a nominal group technique. Based on this qualitative research, a survey with several choice tasks (best-worst scaling) was developed to prioritize attributes, asking a larger patient group to choose the most and least important attributes. The attributes' mean relative importance scores (RIS) were calculated. Results Nineteen patients reported 34 attributes during the focus groups and 185 patients evaluated the importance of the attributes in the survey. The effect on disease progression received the highest RIS (RIS = 9.64, 95% confidence interval: [9.48-9.81]), followed by quality of life (RIS = 9.21 [9.00-9.42]), relapse rate (RIS = 7.76 [7.39-8.13]), severity of side effects (RIS = 7.63 [7.33-7.94]) and relapse severity (RIS = 7.39 [7.06-7.73]). Subgroup analyses showed heterogeneity in preference of patients. For example, side effectrelated attributes were statistically more important for patients who had no experience in using disease-modifying drugs compared to experienced patients (p<.001). Conclusions This study shows that, on average, patients valued effectiveness and unwanted effects as most important. Clinicians should be aware of the average preferences but also that attributes of disease-modifying drugs are valued differently by different patients. Person-centred clinical decision making would be needed and requires eliciting individual preferences.	[Kremer, Ingrid E. H.; Evers, Silvia M. A. A.; Hiligsmann, Mickael] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Hlth Serv Res, Maastricht, Netherlands; [Evers, Silvia M. A. A.] Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Publ Mental Hlth, Utrecht, Netherlands; [Jongen, Peter J.] MS4 Res Inst, Nijmegen, Netherlands; [Jongen, Peter J.] Univ Groningen, Univ Med Ctr Groningen, Dept Community & Occupat Med, Groningen, Netherlands; [van der Weijden, Trudy] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, Maastricht, Netherlands; [van de Kolk, Ilona] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Dept Hlth Promot, Maastricht, Netherlands	Maastricht University; Trimbos Institute; University of Groningen; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Kremer, IEH (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Hlth Serv Res, Maastricht, Netherlands.	i.kremer@maastrichtuniversity.nl	Evers, Silvia MAA/K-9720-2015; Evers, Silvia/ABG-2128-2020; van de Kolk, Ilona/L-7707-2019	Evers, Silvia MAA/0000-0003-1026-570X; Evers, Silvia/0000-0003-1026-570X; van de Kolk, Ilona/0000-0003-1565-5707; van der weijden, trudy/0000-0002-7469-3781	Maastricht University in the Netherlands	Maastricht University in the Netherlands	We thank the neurologists and nurses for providing their opinions during the exploratory phase of the study. We thank the patients with MS for participating in our study and the National MS Foundation The Netherlands, MS Vereniging Nederland and MS-Anders for their cooperation in informing patients about the study. The Master's thesis based on this study has been awarded the Catharina Pijls Encouragement Award 2015 for an excellent Master's thesis in the health sciences, an initiative of Maastricht University in the Netherlands.	[Anonymous], 2000, SAWTOOTH SOFTWARE RE; Bove R, 2014, OBSTET GYNECOL, V124, P1157, DOI 10.1097/AOG.0000000000000541; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Centraal Bureau voor de Statistiek, 2013, BER BEH OND NAAR PER; Clark JP, 2003, PEER REV HLTH SCI, P219; Coyle PK, 2016, THER ADV NEUROL DISO, V9, P198, DOI 10.1177/1756285616631897; DELBECQ AL, 1971, J APPL BEHAV SCI, V7, P466, DOI 10.1177/002188637100700404; Delbecq AL, 1975, J HUMAN SCI; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Elwyn G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5146; English C, 2015, CLIN THER, V37, P691, DOI 10.1016/j.clinthera.2015.03.001; European Medicines Agency, EUR PUBL ASS REP NAT; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Flynn TN, 2007, J HEALTH ECON, V26, P171, DOI 10.1016/j.jhealeco.2006.04.002; Gommer AM, 2010, ACHTERGRONDCIJFERS B; Hanson KA, 2013, PATIENT PREFER ADHER, V7, DOI 10.2147/PPA.S41992; Heesen C, 2004, MULT SCLER J, V10, P643, DOI 10.1191/1352458504ms1112oa; Herbstritt S, 2016, MULT SCLER J, V22, P810, DOI 10.1177/1352458515623366; Hiligsmann M, 2013, PATIENT PREFER ADHER, V7, P133, DOI 10.2147/PPA.S38408; Johnson FR, 2009, J NEUROL, V256, P554, DOI 10.1007/s00415-009-0084-2; Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073; Lu E, 2013, EXPERT REV NEUROTHER, V13, P251, DOI [10.1586/ERN.13.12, 10.1586/ern.13.12]; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Menzin J, 2013, J MANAGE CARE PHARM, V19, pS24, DOI 10.18553/jmcp.2013.19.s1.S24; Michel Laure, 2015, Presse Med, V44, pe137, DOI 10.1016/j.lpm.2015.02.008; O'Connor Annette M, 2004, Health Aff (Millwood), VSuppl Variation, pVAR63; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Poulos C, 2016, THER ADV NEUROL DISO, V9, P95, DOI 10.1177/1756285615622736; Poulos C, 2016, PATIENT, V9, P171, DOI 10.1007/s40271-015-0136-x; Sawtooth Software Inc, 2014, SSI WEB V8 3 SOFTW W; Tan H, 2011, ADV THER, V28, P51, DOI 10.1007/s12325-010-0093-7; Thiel S, 2016, MULT SCLER J, V22, P801, DOI 10.1177/1352458516634872; Utz KS, 2014, THER ADV NEUROL DISO, V7, P263, DOI 10.1177/1756285614555335; Visser LH, 2011, EUR J NEUROL, V18, P1343, DOI 10.1111/j.1468-1331.2011.03411.x; Wicks P, 2015, INTERACT J MED RES, V4, P3, DOI 10.2196/ijmr.3776; Wilson L, 2014, J NEUROL SCI, V344, P80, DOI 10.1016/j.jns.2014.06.030; Wilson Leslie S, 2015, Int J MS Care, V17, P74, DOI 10.7224/1537-2073.2013-053	37	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164862	10.1371/journal.pone.0164862	http://dx.doi.org/10.1371/journal.pone.0164862			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812117	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000014
J	Panwar, B; Judd, SE; Howard, VJ; Jenny, NS; Wadley, VG; Gutierrez, OM				Panwar, Bhupesh; Judd, Suzanne E.; Howard, Virginia J.; Jenny, Nancy S.; Wadley, Virginia G.; Gutierrez, Orlando M.			Vitamin D, Fibroblast Growth Factor 23 and Incident Cognitive Impairment: Findings from the REGARDS Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; SERUM 25-HYDROXYVITAMIN D; RACIAL-DIFFERENCES; PARATHYROID-HORMONE; D SUPPLEMENTATION; NATIONAL-HEALTH; DECLINE; RISK; WOMEN; RATS	Vitamin D protects against cognitive decline in animals but evidence in humans has been inconsistent. Fibroblast growth factor 23 (FGF23) is a hormone that inhibits vitamin D activation yet few studies examined whether FGF23 is associated with cognitive impairment. The objective of this study was to examine associations of 25(OH) D and FGF23 with incident cognitive impairment in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, a cohort of black and white adults >= 45 years old. FGF23 and 25(OH) D were measured in 474 incident impairment cases and 561 controls. In multivariable-adjusted models, there were no significant associations of FGF23 with incident cognitive impairment. In analyses using clinically-relevant categories of 25(OH) D (<20 ng/ml, 20-29.9 ng/ml, >= 30 ng/ml), there was no statistically significant association of lower 25(OH) D concentrations with odds of incident cognitive impairment in models adjusted for demographic, clinical, and laboratory variables and season of blood draw (tertile 1 [>= 30 ng/ml] reference; tertile 2 [20-29.9 ng/ml], odds ratio [OR] 0.96, 95% CI 0.67, 1.38; tertile 3 [<20 ng/ml] OR 1.26, 95% CI 0.83, 1.91). When 25(OH) D was modeled as race-specific tertiles, there were no significant associations of 25(OH) D with incident cognitive impairment in whites, whereas lower 25(OH) D was associated with higher odds in blacks (tertile 1 [>23 ng/ml] reference; tertile 2 [15-23 ng/ml], OR 2.96, 95% CI 1.48,5.94; tertile 3 [<15 ng/ml] OR 2.40, 95% CI 1.07,5.40) in the fully adjusted model. In this cohort of older adults, lower race-specific tertiles of 25(OH) D were associated with higher incidence of cognitive impairment in black individuals but not white individuals. These data suggest that treating low 25(OH) D may be a novel strategy for addressing racial disparities in neurocognitive outcomes.	[Panwar, Bhupesh; Wadley, Virginia G.; Gutierrez, Orlando M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Judd, Suzanne E.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Howard, Virginia J.; Gutierrez, Orlando M.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35233 USA; [Jenny, Nancy S.] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Vermont	Gutierrez, OM (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.; Gutierrez, OM (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35233 USA.	ogutierrez@uabmc.edu		Gutierrez, Orlando/0000-0001-6593-3571	National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA [R01NS080850];  [U01 NS041588]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by a cooperative agreement U01 NS041588 and by R01NS080850 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health or the American Heart Association. Representatives of the funding agency have been involved in the review of the manuscript but not directly involved in the collection, management, analysis or interpretation of the data.	Alrefaie Z, 2015, BEHAV BRAIN RES, V287, P156, DOI 10.1016/j.bbr.2015.03.050; Annweiler C, 2012, J AM GERIATR SOC, V60, P793, DOI 10.1111/j.1532-5415.2011.03877.x; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Brewer LD, 2006, CELL CALCIUM, V40, P277, DOI 10.1016/j.ceca.2006.04.001; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; Cluse ZN, 2012, ANN CLIN BIOCHEM, V49, P159, DOI 10.1258/acb.2011.011018; Cushman M, 2014, STROKE, V45, P1646, DOI 10.1161/STROKEAHA.114.004712; Dubal DB, 2014, CELL REP, V7, P1065, DOI 10.1016/j.celrep.2014.03.076; Erbas O, 2014, LIFE SCI, V103, P68, DOI 10.1016/j.lfs.2014.03.035; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Gezen-Ak D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017553; Gillett SR, 2015, CLIN NEUROPSYCHOL, V29, P466, DOI 10.1080/13854046.2015.1042524; Granic A, 2015, EUR J NEUROL, V22, P106, DOI 10.1111/ene.12539; Gutierrez OM, 2011, OSTEOPOROSIS INT, V22, P1745, DOI 10.1007/s00198-010-1383-2; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Jovanovich AJ, 2014, CLIN NEPHROL, V82, pS1, DOI 10.5414/CN108365; Kim Joong-Seok, 2006, J Clin Neurol, V2, P252, DOI 10.3988/jcn.2006.2.4.252; Landfield PW, 1998, NEUROBIOL AGING, V19, P469, DOI 10.1016/S0197-4580(98)00079-7; Langub MC, 2001, NEUROSCIENCE, V104, P49, DOI 10.1016/S0306-4522(01)00049-5; Latimer CS, 2014, P NATL ACAD SCI USA, V111, pE4359, DOI 10.1073/pnas.1404477111; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Littlejohns TJ, 2014, NEUROLOGY, V83, P920, DOI 10.1212/WNL.0000000000000755; Llewellyn DJ, 2010, ARCH INTERN MED, V170, P1135, DOI 10.1001/archinternmed.2010.173; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; MELCHIOR LA, 1993, EDUC PSYCHOL MEAS, V53, P1117, DOI 10.1177/0013164493053004024; Miller JW, 2015, JAMA NEUROL, V72, P1295, DOI 10.1001/jamaneurol.2015.2115; Moon JH, 2015, CLIN ENDOCRINOL, V83, P36, DOI 10.1111/cen.12733; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Rossom RC, 2012, J AM GERIATR SOC, V60, P2197, DOI 10.1111/jgs.12032; Slinin Y, 2010, NEUROLOGY, V74, P33, DOI 10.1212/WNL.0b013e3181c7197b; Slinin Y, 2012, J GERONTOL A-BIOL, V67, P1092, DOI 10.1093/gerona/gls075; Smith MP, 2006, NEUROCHEM RES, V31, P533, DOI 10.1007/s11064-006-9048-4; Strauss E, 2006, COMPENDIUM NEUROPSYC; Wilson VK, 2014, J AM GERIATR SOC, V62, P636, DOI 10.1111/jgs.12765; Zadshir Ashraf, 2005, Ethn Dis, V15, pS5; Zhu CW, 2013, J AM GERIATR SOC, V61, P396, DOI 10.1111/jgs.12132	38	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165671	10.1371/journal.pone.0165671	http://dx.doi.org/10.1371/journal.pone.0165671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812184	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000045
J	Tay, DJ; Chou, CI; Li, SP; Tee, SY; Cheong, SA				Tay, Darrell Jiajie; Chou, Chung-I; Li, Sai-Ping; Tee, Shang You; Cheong, Siew Ann			Bubbles Are Departures from Equilibrium Housing Markets: Evidence from Singapore and Taiwan	PLOS ONE			English	Article							REAL-ESTATE BUBBLE; WEALTH; INCOME; DISTRIBUTIONS; UK	The housing prices in many Asian cities have grown rapidly since mid-2000s, leading to many reports of bubbles. However, such reports remain controversial as there is no widely accepted definition for a housing bubble. Previous studies have focused on indices, or assumed that home prices are lognomally distributed. Recently, Ohnishi et al. showed that the tail-end of the distribution of (Japan/Tokyo) becomes fatter during years where bubbles are suspected, but stop short of using this feature as a rigorous definition of a housing bubble. In this study, we look at housing transactions for Singapore (1995 to 2014) and Taiwan (2012 to 2014), and found strong evidence that the equilibrium home price distribution is a decaying exponential crossing over to a power law, after accounting for different housing types. We found positive deviations from the equilibrium distributions in Singapore condominiums and Zhu Zhai Da Lou in the Greater Taipei Area. These positive deviations are dragon kings, which thus provide us with an unambiguous and quantitative definition of housing bubbles. Also, the spatial-temporal dynamics show that bubble in Singapore is driven by price pulses in two investment districts. This finding provides a valuable insight for policymakers on implementation and evaluation of cooling measures.	[Tay, Darrell Jiajie; Tee, Shang You; Cheong, Siew Ann] Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, 21 Nanyang Link, Singapore 637371, Singapore; [Tay, Darrell Jiajie; Cheong, Siew Ann] Nanyang Technol Univ, Complex Inst, Innovat Ctr, Block 2,Level 2 Unit 245,18 Nanyang Dr, Singapore 637723, Singapore; [Chou, Chung-I] Chinese Cultural Univ, Dept Optoelect Phys, 55 Hwa Kang Rd, Taipei 11114, Taiwan; [Li, Sai-Ping] Acad Sinica, Inst Phys, 128 Sect 2,Acad Rd, Taipei 11529, Taiwan	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Chinese Culture University; Academia Sinica - Taiwan	Tay, DJ (corresponding author), Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, 21 Nanyang Link, Singapore 637371, Singapore.; Tay, DJ (corresponding author), Nanyang Technol Univ, Complex Inst, Innovat Ctr, Block 2,Level 2 Unit 245,18 Nanyang Dr, Singapore 637723, Singapore.	tayj0037@e.ntu.edu.sg	Cheong, Siew Ann/B-6991-2011; Li, Sai-Ping/AAP-9189-2021	Cheong, Siew Ann/0000-0002-8589-6699; Li, Sai-Ping/0000-0002-3233-2339	Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2015-T2-2-012]	Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore)	This study was supported by the Singapore Ministry of Education Academic Research Fund Tier 2 under Grant Number MOE2015-T2-2-012, awarded to SAC. The Research Fund Tier 2 website can be reached at https://www.olga.moe.gov.sg/default.aspx.	[Anonymous], 2015, FORBES; Ardila D, 2013, 1307 SWISS FIN I; Arshanapalli B., 2008, INT J BUSINESS FINAN, P35; Bouchaud JP, 2000, PHYSICA A, V282, P536, DOI 10.1016/S0378-4371(00)00205-3; Case KE, 2003, BROOKINGS PAP ECO AC, P299; Chan CH, 2012, TECTONOPHYSICS, V532, P215, DOI 10.1016/j.tecto.2012.02.004; Chatterjee A, 2007, EUR PHYS J B, V60, P135, DOI 10.1140/epjb/e2007-00343-8; Chou C., 2010, ARXIV10081376; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Colombo J., 2014, FORBES; Colombo J, 2013, FORBES; Department of Land Administration, 2016, REAL EST T FIL; Department of Statistics Singapore, 2015, CONS PRIC IND BAS YE; Dragulescu A, 2001, PHYSICA A, V299, P213, DOI 10.1016/S0378-4371(01)00298-9; Fujiwara Y, 2003, PHYSICA A, V321, P598, DOI 10.1016/S0378-4371(02)01663-1; Garino G, 2004, SOUTH ECON J, V70, P777, DOI 10.2307/4135272; Government of Singapore, 2014, RES FLAT PRIC; Hill R, 2011, OECD STAT WORKING PA, DOI 10.1787/5kghzxpt6g6f-en; Jiang L., 2014, NEW HEDONIC REGRESSI; MacKay N, 2010, ARXIV10123039; Malpezzi S, 2002, HOUSING EC PUBLIC PO; Meng H, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979215501817; Meng H, 2014, SCI REP-UK, V4, DOI 10.1038/srep03655; Mikhed V, 2009, J REAL ESTATE FINANC, V38, P366, DOI 10.1007/s11146-007-9090-2; National Statistics Republic of China, 2015, ANN CHANG CONS PRIC; Ohnishi Takaaki, 2012, International Journal of Modern Physics: Conference Series, V16, P61, DOI 10.1142/S2010194512007787; Pisarenko VF, 2012, EUR PHYS J-SPEC TOP, V205, P95, DOI 10.1140/epjst/e2012-01564-8; Ramalho E. A., 2011, HEDONIC FUNCTI UNPUB; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Smith MH, 2006, BROOKINGS PAP ECO AC, P1; Sornette D, 2009, 0936 SWISS FIN I RES; Steelcase, 2012, CULT COD LEV WORKPL; Tan JPL, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-41038-1; Urban Redevelopment Authority, 2013, REAL EST INF SYST RE; Yakovenko VM, 2005, NEW ECON WINDOWS, P15, DOI 10.1007/88-470-0389-X_2; Yip NM, 2003, J COMP ASIAN DEV, V2, P93, DOI [DOI 10.1080/15339114.2003.9678373, 10.1080/15339114.2003.9678373]; Yiu MS, 2013, J ASIAN ECON, V28, P115, DOI 10.1016/j.asieco.2013.04.005; Zhou WX, 2006, PHYSICA A, V361, P297, DOI 10.1016/j.physa.2005.06.098; Zhou WX, 2003, PHYSICA A, V329, P249, DOI 10.1016/S0378-4371(03)00600-9	39	5	5	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166004	10.1371/journal.pone.0166004	http://dx.doi.org/10.1371/journal.pone.0166004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812187	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000090
J	Tessema, GA; Gomersall, JS; Mahmood, MA; Laurence, CO				Tessema, Gizachew Assefa; Gomersall, Judith Streak; Mahmood, Mohammad Afzal; Laurence, Caroline O.			Factors Determining Quality of Care in Family Planning Services in Africa: A Systematic Review of Mixed Evidence	PLOS ONE			English	Article							CLIENT-SATISFACTION; CONTRACEPTIVE USE; PROVIDER PERSPECTIVES; DEVELOPING-COUNTRIES; WOMENS PERCEPTIONS; FACILITIES; PRIVATE; INTERVENTIONS; PROGRAMS; BARRIERS	Background Improving use of family planning services is key to improving maternal health in Africa, and provision of quality of care in family planning services is critical to support higher levels of contraceptive uptake. The objective of this systematic review was to synthesize the available evidence on factors determining the quality of care in family planning services in Africa. Methods Quantitative and qualitative studies undertaken in Africa, published in English, in grey and commercial literature, between 1990 and 2015 were considered. Methodological quality of included studies was assessed using standardized tools. Findings from the quantitative studies were summarized using narrative and tables. Client satisfaction was used to assess the quality of care in family planning services in the quantitative component of the review. Meta-aggregation was used to synthesize the qualitative study findings. Results From 4334 records, 11 studies (eight quantitative, three qualitative) met the review eligibility criteria. The review found that quality of care was influenced by client, provider and facility factors, and structural and process aspects of the facilities. Client's waiting time, provider competency, provision/prescription of injectable methods, maintaining privacy and confidentiality were the most commonly identified process factors. The quality of stock inventory was the most commonly identified structural factor. The quality of care was also positively associated with privately-owned facilities. The qualitative synthesis revealed additional factors including access related factors such as 'pre-requisites to be fulfilled by the clients and cost of services, provider workload, and providers' behaviour. Conclusion There is limited evidence on factors determining quality of care in family planning services in Africa that shows quality of care is influenced by multiple factors. The evidence suggests that lowering access barriers and avoiding unnecessary pre-requisites for taking contraceptive methods are important to improve the quality of care in family planning services. Strategies to improve provider behavior and competency are important. Moreover, strategies that minimize client waiting time and ensure client confidentiality should be implemented to ensure quality of care in family planning services. However, no strong evidence based conclusions and recommendations may be drawn from the evidence. Future studies are needed to identify the most important factors associated with quality of care in family planning services in a wider range of African countries.	[Tessema, Gizachew Assefa; Gomersall, Judith Streak; Mahmood, Mohammad Afzal; Laurence, Caroline O.] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia; [Tessema, Gizachew Assefa] Univ Gondar, Inst Publ Hlth, Dept Reprod Hlth, Gondar, Ethiopia	University of Adelaide; University of Gondar	Tessema, GA (corresponding author), Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia.; Tessema, GA (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Reprod Hlth, Gondar, Ethiopia.	gizachew.tessema@adelaide.edu.au	Laurence, Caroline O/C-9015-2011; Laurence, Caroline/AAE-1473-2019; Tessema, Gizachew A/J-9235-2018	Laurence, Caroline O/0000-0002-8506-5238; Laurence, Caroline/0000-0002-8506-5238; Tessema, Gizachew A/0000-0002-4784-8151; Gomersall, Judith/0000-0002-9148-7162				Abdel-Tawab N, 2002, SOC SCI MED, V54, P1357, DOI 10.1016/S0277-9536(01)00101-0; Agha S, 2009, INT J QUAL HEALTH C, V21, P87, DOI 10.1093/intqhc/mzp002; Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; [Anonymous], 2015, INT J NURS PRACT, DOI DOI 10.5897/IJNM2015.0163; Arends-Kuenning M, 2007, J BIOSOC SCI, V39, P1, DOI 10.1017/S0021932005001045; ASKEW I, 1994, STUD FAMILY PLANN, V25, P268, DOI 10.2307/2138058; Assaf S, 2015, DHS ANAL STUDIES, V55; Becker D, 2007, PERSPECT SEX REPRO H, V39, P206, DOI 10.1363/3920607; Bertrand J, 1994, QA Brief, V3, P6; Bessinger RE, 2001, INT FAM PLAN PERSPEC, V27, P63, DOI 10.2307/2673816; Blanc AK, 2002, STUD FAMILY PLANN, V33, P127, DOI 10.1111/j.1728-4465.2002.00127.x; Brown W, 2014, STUD FAMILY PLANN, V45, P73, DOI 10.1111/j.1728-4465.2014.00377.x; BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Cohen SA, 1994, FAM PLANN PERSPECT, V20, P150; Conry MC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-275; Coyle YM, 1999, INT J QUAL HEALTH C, V11, P5, DOI 10.1093/intqhc/11.1.5; Creel L, 2002, NEW PERSPECT QUAL CA, V1, P1; Creel LC, 1996, NEW PERSPECTIVES QUA, V2; Darroch JE, 2013, LANCET, V381, P1756, DOI 10.1016/S0140-6736(13)60597-8; Diaz J, 1993, Adv Contracept, V9, P117; Dixon-Woods Mary, 2005, J Health Serv Res Policy, V10, P45, DOI 10.1258/1355819052801804; Donabedian A., 1980, EXPLORATIONS QUALITY; Donabedian A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI [10.1001/JAMA.1988.03410120089033, DOI 10.1001/JAMA.1988.03410120089033]; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Gavin L, 2014, MMWR RECOMM REP, V63, P1; Gubhaju B, 2009, BIODEMOGR SOC BIOL, V55, P52, DOI 10.1080/19485560903054671; Hameed Waqas, 2015, Int J Reprod Med, V2015, P941708, DOI 10.1155/2015/941708; Hutchinson PL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-203; JAIN AK, 1989, STUD FAMILY PLANN, V20, P1, DOI 10.2307/1966656; Kamhawi S, 2013, GLOB HEALTH-SCI PRAC, V1, P180, DOI 10.9745/GHSP-D-12-00051; Keesara SR, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0997-7; Koenig MA, 1997, STUD FAMILY PLANN, V28, P278, DOI 10.2307/2137859; Lewis N, 1995, QUALITY CARE FAMILY; Mays Nicholas, 2005, J Health Serv Res Policy, V10 Suppl 1, P6, DOI 10.1258/1355819054308576; Mensch B, 1996, STUD FAMILY PLANN, V27, P59, DOI 10.2307/2138134; Mohammad-Alizadeh S, 2009, REPROD HEALTH MATTER, V17, P171, DOI 10.1016/S0968-8080(09)33441-2; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mugisha JF, 2008, J FAM PLAN REPROD H, V34, P37, DOI 10.1783/147118908783332230; Nakhaee N, 2005, EUR J CONTRACEP REPR, V10, P192, DOI 10.1080/13625180500329642; Nasr E, 2016, J NURS ED PRACT, V6, P85; RamaRao S, 2003, STUD FAMILY PLANN, V34, P227, DOI 10.1111/j.1728-4465.2003.00227.x; RamaRao S, 2003, INT FAM PLAN PERSPEC, V29, P76, DOI 10.2307/3181061; Shahidzadeh-Mahani A, 2008, INT J QUAL HEALTH C, V20, P284, DOI 10.1093/intqhc/mzn016; Speidel JJ, 2014, SOLUTIONS, V4, P54; Strobino DM, 2000, APPROACHES INDICATOR; Tafese F, 2013, ETHIOP J HEALTH SCI, V23, P245, DOI 10.4314/ejhs.v23i3.7; Tessema Gizachew Assefa, 2016, JBI Database System Rev Implement Rep, V14, P103, DOI 10.11124/JBISRIR-2016-003056; The Joanna Briggs Institute, 2014, J BRIGGS I SYST REV; Tumlinson K, 2015, INT PERSPECT SEX R H, V41, P69, DOI 10.1363/4106915; UNFPA, 1994, PROGR ACT AD INT C P; UNFPA, 2014, ADD IT IT COSTS BEN; United Nations Department of Economic and Social Affairs Population Division, 2015, TRENDS CONTR US WORL; USAID/Health Policy Initiative, 2009, FAM PLANN MDGS SAV L; Wang W, 2014, ASSESSING QUALITY CA; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Williams JR, 2015, AM J PREV MED, V49, pS93, DOI 10.1016/j.amepre.2015.03.017; Williams T, 2000, INT FAM PLAN PERSPEC, V26, P63, DOI 10.2307/2648269; World Health Organization (WHO), 2008, FAM PLANN; Zineldin M, 2006, INT J HEALTH CARE Q, V19, P60, DOI 10.1108/09526860610642609	60	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165627	10.1371/journal.pone.0165627	http://dx.doi.org/10.1371/journal.pone.0165627			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812124	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000040
J	Yu, XQ; Wang, YH; Lin, J; Hu, Y; Kawai, T; Taubman, MA; Han, XZ				Yu, Xiaoqian; Wang, Yuhua; Lin, Jiang; Hu, Yang; Kawai, Toshihisa; Taubman, Martin A.; Han, Xiaozhe			Lipopolysaccharides-Induced Suppression of Innate-Like B Cell Apoptosis Is Enhanced by CpG Oligodeoxynucleotide and Requires Toll-Like Receptors 2 and 4	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS LIPOPOLYSACCHARIDE; NF-KAPPA-B; PERIODONTAL-DISEASE; IMMUNE-RESPONSES; ACTIVATION; MICE; LPS; DYSBIOSIS; SUBSETS; CYCLE	Innate-like B lymphocytes play an important role in innate immunity in periodontal disease through Toll-like receptor (TLR) signaling. However, it is unknown how innate-like B cell apoptosis is affected by the periodontal infection-associated innate signals. This study is to determine the effects of two major TLR ligands, lipopolysaccharide (LPS) and CpG-oligodeoxynucleotides (CpG-ODN), on innate-like B cell apoptosis. Spleen B cells were isolated from wild type (WT), TLR2 knockout (KO) and TLR4 KO mice and cultured with E. coli LPS alone, P. gingivalis LPS alone, or combined with CpG-ODN for 2 days. B cell apoptosis and expressions of specific apoptosis-related genes were analyzed by flow cytometry and real-time PCR respectively. P. gingivalis LPS, but not E. coli LPS, reduced the percentage of AnnexinV(+)/7-AAD(-) cells within IgM(high)CD23(low)CD43(-)CD93(-) marginal zone (MZ) B cell sub-population and IgM(high)CD23(low)CD43(+)CD93(+) innate response activator (IRA) B cell subpopulation in WT but not TLR2KO or TLR4KO mice. CpG-ODN combined with P. gingivalis LPS further reduced the percentage of AnnexinV(+)/7-AAD(-) cells within MZ B cells and IRA B cells in WT but not TLR2 KO or TLR4 KO mice. Pro-apoptotic CASP4, CASP9 and Dapk1 were significantly down-regulated in P. gingivalis LPS- and CpG-ODN-treated B cells from WT but not TLR2 KO or TLR4 KO mice. Anti-apoptotic IL-10 was significantly up-regulated in P. gingivalis LPS-and CpG-ODN-treated B cells from WT and TLR2 KO but not TLR4 KO mice. These results suggested that both TLR2 and TLR4 signaling are required for P. gingivalis LPS-induced, CpG-ODN-enhanced suppression of innate-like B cell apoptosis.	[Yu, Xiaoqian; Wang, Yuhua; Lin, Jiang; Hu, Yang; Kawai, Toshihisa; Taubman, Martin A.; Han, Xiaozhe] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA; [Yu, Xiaoqian] Peking Univ, Sch & Hosp Stomatol, Dept Periodontol, Beijing, Peoples R China; [Wang, Yuhua] Shanghai Jiao Tong Univ, Sch Med, Dept Prosthodont, Peoples Hosp 9,Coll Stomatol,Shanghai Key Lab, Shanghai, Peoples R China; [Lin, Jiang] Harbin Med Univ, Dept Stomatol, Hosp 4, Harbin, Peoples R China	Harvard University; Forsyth Institute; Peking University; Shanghai Jiao Tong University; Harbin Medical University	Han, XZ (corresponding author), Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA.	Xhan@forsyth.org	Han, Xiaozhe/I-7532-2019; lin, jiang/AAC-4001-2020	Han, Xiaozhe/0000-0001-8357-1471; 	National Natural Science Foundation of China [81470740]; National Institute of Dental and Craniofacial Research [R21DE021837, R56DE023807]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE021837, R56DE023807, R01DE025255] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	National Natural Science Foundation of China 81470740 to X Yu; National Institute of Dental and Craniofacial Research R21DE021837 and R56DE023807 to X Han.	Alenzi FQB, 2004, BRIT J BIOMED SCI, V61, P99, DOI 10.1080/09674845.2004.11732652; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Andrukhov O, 2014, ACTA ODONTOL SCAND, V72, P337, DOI 10.3109/00016357.2013.834535; Bainbridge BW, 2001, ACTA ODONTOL SCAND, V59, P131, DOI 10.1080/000163501750266710; Baker PJ, 2000, MICROBES INFECT, V2, P1181, DOI 10.1016/S1286-4579(00)01272-7; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bi W, 2014, MOL MED REP, V10, P1793, DOI 10.3892/mmr.2014.2480; Boffey J, 2004, J NEUROIMMUNOL, V152, P98, DOI 10.1016/j.jneuroim.2004.04.002; Bohnhorst J, 2006, LEUKEMIA, V20, P1138, DOI 10.1038/sj.leu.2404225; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Cognasse F, 2008, IMMUNOLOGY, V125, P430, DOI 10.1111/j.1365-2567.2008.02844.x; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; de Andres B, 2012, J IMMUNOL, V189, P2300, DOI 10.4049/jimmunol.1200224; Fanzo JC, 2003, J EXP MED, V197, P303, DOI 10.1084/jem.20020717; Fujita Y, 2011, HUM REPROD, V26, P2799, DOI 10.1093/humrep/der234; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kearney JF, 2005, SPRINGER SEMIN IMMUN, V26, P377, DOI 10.1007/s00281-004-0184-0; Kinch LN, 2011, PROTEINS, V79, P21, DOI 10.1002/prot.23190; KOURY MJ, 1992, EXP HEMATOL, V20, P391; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Lopez-Hoyos M, 1998, INT J MOL MED, V1, P475; Lorencini M, 2009, TISSUE CELL, V41, P43, DOI 10.1016/j.tice.2008.07.001; Maddi A, 2013, AM J DENT, V26, P249; Maekawa T, 2014, CELL HOST MICROBE, V15, P768, DOI 10.1016/j.chom.2014.05.012; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Moore-Connors JM, 2015, MUCOSAL IMMUNOL, V8, P94, DOI 10.1038/mi.2014.45; Nebel D, 2013, ACTA ODONTOL SCAND, V71, P892, DOI 10.3109/00016357.2012.734415; O'Flaherty E, 2000, IMMUNOLOGY, V100, P289, DOI 10.1046/j.1365-2567.2000.00048.x; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Reid S, 1999, BLOOD, V93, P1524, DOI 10.1182/blood.V93.5.1524.405k07_1524_1533; Rosado MM, 2014, METHODS MOL BIOL, V1190, P3, DOI 10.1007/978-1-4939-1161-5_1; Rubtsov AV, 2008, J IMMUNOL, V180, P3882, DOI 10.4049/jimmunol.180.6.3882; Schmid-Burgk JL, 2015, EUR J IMMUNOL, V45, P2911, DOI 10.1002/eji.201545523; Tedder TF, 2015, J IMMUNOL, V194, P1395, DOI 10.4049/jimmunol.1401329; Traver D, 1998, IMMUNITY, V9, P47, DOI 10.1016/S1074-7613(00)80587-7; Vermeulen K, 2003, CELL PROLIFERAT, V36, P165, DOI 10.1046/j.1365-2184.2003.00267.x; Wang ZH, 1997, CELL IMMUNOL, V180, P162, DOI 10.1006/cimm.1997.1156; Xie H, 2012, J PERIODONTAL RES, V47, P578, DOI 10.1111/j.1600-0765.2012.01469.x; Yi AK, 1999, INT IMMUNOL, V11, P2015, DOI 10.1093/intimm/11.12.2015; Yi AK, 1998, J IMMUNOL, V160, P5898; Yoo HJ, 2012, CELL SIGNAL, V24, P1471, DOI 10.1016/j.cellsig.2012.03.010; Zenobia C, 2015, VIRULENCE, V6, P236, DOI 10.1080/21505594.2014.999567; Zhang D, 2008, INNATE IMMUN-LONDON, V14, P99, DOI 10.1177/1753425907088244; Zhang Y, 2013, CANCER IMMUNOL IMMUN, V62, P87, DOI 10.1007/s00262-012-1313-6; Zouali M, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00063	52	9	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165862	10.1371/journal.pone.0165862	http://dx.doi.org/10.1371/journal.pone.0165862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812176	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000073
J	Zheng, HJ; Liang, H; Wang, YZ; Miao, MH; Shi, T; Yang, F; Liu, EN; Yuan, W; Ji, ZS; Li, DK				Zheng, Huajun; Liang, Hong; Wang, Yuezhu; Miao, Maohua; Shi, Tao; Yang, Fen; Liu, Enuo; Yuan, Wei; Ji, Zai-Si; Li, De-Kun			Altered Gut Microbiota Composition Associated with Eczema in Infants	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; FECAL MICROBIOTA; IMMUNE-SYSTEM; ATOPIC-DERMATITIS; AT-RISK; DISEASE; CHILDHOOD; CHILDREN; ASTHMA; COHORT	Eczema is frequently the first manifestation of an atopic diathesis and alteration in the diversity of gut microbiota has been reported in infants with eczema. To identify specific bacterial communities associated with eczema, we conducted a case-control study of 50 infants with eczema (cases) and 51 healthy infants (controls). We performed high-throughput sequencing for V3-V4 hypervariable regions of the 16S rRNA genes from the gut fecal material. A total of 12,386 OTUs (operational taxonomic units) at a 97% similarity level were obtained from the two groups, and we observed a difference in taxa abundance, but not the taxonomic composition, of gut microbiota between the two groups. We identified four genera enriched in healthy infants: Bifidobacterium, Megasphaera, Haemophilus and Streptococcus; and five genera enriched in infants with eczema: Escherichia/Shigella, Veillonella, Faecalibacterium, Lachnospiraceae incertae sedis and Clostridium XlVa. Several species, such as Faecalibacterium prausnitzii and Ruminococcus gnavus, that are known to be associated with atopy or inflammation, were found to be significantly enriched in infants with eczema. Higher abundance of Akkermansia muciniphila in eczematous infants might reduce the integrity of intestinal barrier function and therefore increase the risk of developing eczema. On the other hand, Bacteroides fragilis and Streptococcus salivarius, which are known for their anti-inflammatory properties, were less abundant in infants with eczema. The observed differences in genera and species between cases and controls in this study may provide insight into the link between the microbiome and eczema risk.	[Zheng, Huajun; Liang, Hong; Miao, Maohua; Shi, Tao; Yang, Fen; Liu, Enuo; Yuan, Wei; Ji, Zai-Si] Fudan Univ, Key Lab Reprod Regulat NPFPC, SIPPR, IRD, Shanghai 200032, Peoples R China; [Wang, Yuezhu] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 201203, Peoples R China; [Li, De-Kun] Kaiser Fdn, Res Inst, Div Res, 2000 Broadway, Oakland, CA 94612 USA	Fudan University	Yuan, W; Ji, ZS (corresponding author), Fudan Univ, Key Lab Reprod Regulat NPFPC, SIPPR, IRD, Shanghai 200032, Peoples R China.	yuanwei11@yahoo.com; zai-si_ji@kta.biglobe.ne.jp	Zheng, Huajun/AAN-4973-2020		Foundation of Shanghai Health and Family Planning Commission [20154Y0031]; Shanghai Natural Science Foundation [15ZR1435100]	Foundation of Shanghai Health and Family Planning Commission; Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This work was supported by the Foundation of Shanghai Health and Family Planning Commission [20154Y0031] and Shanghai Natural Science Foundation [15ZR1435100]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillon S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111519; Beaud D, 2005, MICROBIOL-SGM, V151, P2323, DOI 10.1099/mic.0.27712-0; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Candela M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-95; Chiu CM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/906168; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Eichenfield LF, 2003, PEDIATRICS, V111, P608, DOI 10.1542/peds.111.3.608; Fiocchi A, 2012, WORLD ALLERGY ORGAN, V5, P148, DOI 10.1097/WOX.0b013e3182784ee0; Forno Erick, 2008, Clin Mol Allergy, V6, P11, DOI 10.1186/1476-7961-6-11; Gronlund MM, 2000, ARCH DIS CHILD-FETAL, V83, pF186, DOI 10.1136/fn.83.3.F186; Hong PY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009964; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kim JY, 2010, PEDIAT ALLERG IMM-UK, V21, pE386, DOI 10.1111/j.1399-3038.2009.00958.x; LILLY DM, 1965, SCIENCE, V147, P747, DOI 10.1126/science.147.3659.747; Ling ZX, 2014, APPL ENVIRON MICROB, V80, P2546, DOI 10.1128/AEM.00003-14; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Myers JMB, 2010, J PEDIATR-US, V157, P704, DOI 10.1016/j.jpeds.2010.07.009; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Nylund L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-12; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rautava S, 2012, J ALLERGY CLIN IMMUN, V130, P1355, DOI 10.1016/j.jaci.2012.09.003; Rousseau C, 2011, J CLIN MICROBIOL, V49, P858, DOI 10.1128/JCM.01507-10; Saunes M, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-168; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P518, DOI 10.1111/j.1365-2222.2008.03156.x; Sonoyama K, 2010, BRIT J NUTR, V103, P218, DOI 10.1017/S0007114509991589; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Toh ZQ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00171; Troy EB, 2010, FRONT BIOSCI-LANDMRK, V15, P25, DOI 10.2741/3603; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Vael C, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-8; von Kobyletzki LB, 2012, BMC DERMATOL, V12, DOI 10.1186/1471-5945-12-11; Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yap Gaik Chin, 2014, BMC Res Notes, V7, P166, DOI 10.1186/1756-0500-7-166	43	89	90	6	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166026	10.1371/journal.pone.0166026	http://dx.doi.org/10.1371/journal.pone.0166026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812181	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000096
J	Gilchrist, S; Gomes, AL; Kinchesh, P; Kersemans, V; Allen, PD; Smart, SC				Gilchrist, Stuart; Gomes, Ana L.; Kinchesh, Paul; Kersemans, Veerle; Allen, Philip D.; Smart, Sean C.			An MRI-Compatible High Frequency AC Resistive Heating System for Homeothermic Maintenance in Small Animals	PLOS ONE			English	Article							BODY-TEMPERATURE; ANESTHESIA; RATS; HYPOTHERMIA; MICE	Purpose To develop an MRI-compatible resistive heater, using high frequency alternating current (AC), for temperature maintenance of anaesthetised animals. Materials and Methods An MRI-compatible resistive electrical heater was formed from narrow gauge wire connected to a high frequency (10-100 kHz) AC power source. Multiple gradient echo images covering a range of echo times, and pulse-acquire spectra were acquired with the wire heater powered using high frequency AC or DC power sources and without any current flowing in order to assess the sensitivity of the MRI acquisitions to the presence of current flow through the heater wire. The efficacy of temperature maintenance using the AC heater was assessed by measuring rectal temperature immediately following induction of general anaesthesia for a period of 30 minutes in three different mice. Results Images and spectra acquired in the presence and absence of 50-100 kHz AC through the wire heater were indistinguishable, whereas DC power created field shifts and lineshape distortions. Temperature lost during induction of anaesthesia was recovered within approximately 20 minutes and a stable temperature was reached as the mouse's temperature approached the set target. Conclusion The AC-powered wire heater maintains adequate heat input to the animal to maintain body temperature, and does not compromise image quality.	[Gilchrist, Stuart] Canc Res UK, Oxford, England; Univ Oxford, MRC, Oxford Inst Radiat Oncol, Dept Oncol, Oxford, England	Cancer Research UK; University of Oxford	Gilchrist, S (corresponding author), Canc Res UK, Oxford, England.	Stuart.Gilchrist@oncology.ox.ac.uk	Kersemans, Veerle/AAG-3005-2020	Kersemans, Veerle/0000-0002-4669-236X; Allen, Danny/0000-0002-6200-0925	Cancer Research UK (CRUK grant) [C5255/A12678, C2522/A10339]; Engineering and Physical Sciences Research Council (EPSRC) [C2522/A10339]; Medical Research Council Unit Grant for the Oxford Institute for Radiation Oncology; Cancer Research UK [16466] Funding Source: researchfish	Cancer Research UK (CRUK grant); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council Unit Grant for the Oxford Institute for Radiation Oncology; Cancer Research UK(Cancer Research UK)	The work presented was supported financially by Cancer Research UK (CRUK grants C5255/A12678, C2522/A10339), http://www.cancerresearchuk.org/home-page, the Engineering and Physical Sciences Research Council (EPSRC grant C2522/A10339), https://www.epsrc.ac.uk/, and the Medical Research Council Unit Grant for the Oxford Institute for Radiation Oncology, http://www.mrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caro AC, 2013, J AM ASSOC LAB ANIM, V52, P577; Grahn DA, 1996, J APPL PHYSIOL, V81, P2547, DOI 10.1152/jappl.1996.81.6.2547; Kersemans V, 2015, MAGN RESON IMAGING, V33, P847, DOI 10.1016/j.mri.2015.03.011; McConville P, 2011, METHODS MOL BIOL, V771, P89, DOI 10.1007/978-1-61779-219-9_5; Murase K, 2013, MAGN RESON IMAGING, V31, P1744, DOI 10.1016/j.mri.2013.08.005; Rembert MS, 2004, LAB ANIM-UK, V38, P55, DOI 10.1258/00236770460734407; Reynolds RP, 2010, J AM ASSOC LAB ANIM, V49, P592; Sessler DI, 2001, ANESTHESIOLOGY, V95, P531, DOI 10.1097/00000542-200108000-00040; Taylor DK, 2007, J AM ASSOC LAB ANIM, V46, P37; Torossian A, 2004, CRIT CARE MED, V32, P1899, DOI 10.1097/01.CCM.0000139608.34486.FD; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642	11	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0164920	10.1371/journal.pone.0164920	http://dx.doi.org/10.1371/journal.pone.0164920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806062	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500017
J	O'Dwyer, L; Tanner, C; van Dongen, EV; Greven, CU; Bralten, J; Zwiers, MP; Franke, B; Heslenfeld, D; Oosterlaan, J; Hoekstra, PJ; Hartman, CA; Groen, W; Rommelse, N; Buitelaar, JK				O'Dwyer, Laurence; Tanner, Colby; van Dongen, Eelco V.; Greven, Corina U.; Bralten, Janita; Zwiers, Marcel P.; Franke, Barbara; Heslenfeld, Dirk; Oosterlaan, Jaap; Hoekstra, Pieter J.; Hartman, Catharina A.; Groen, Wouter; Rommelse, Nanda; Buitelaar, Jan K.			Decreased Left Caudate Volume Is Associated with Increased Severity of Autistic-Like Symptoms in a Cohort of ADHD Patients and Their Unaffected Siblings	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PERVASIVE DEVELOPMENTAL DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; BEHAVIOR QUESTIONNAIRE CSBQ; VOXEL-BASED MORPHOMETRY; LARGE MULTICENTER ADHD; WHOLE-BRAIN ANALYSIS; SPECTRUM DISORDER; BASAL GANGLIA; NEUROPSYCHIATRIC DISORDERS	Autism spectrum disorder (ASD) symptoms frequently occur in individuals with attention-deficit/ hyperactivity disorder (ADHD). While there is evidence that both ADHD and ASD have differential structural brain correlates, knowledge of the structural brain profile of individuals with ADHD with raised ASD symptoms is limited. The presence of ASD-like symptoms was measured by the Children's Social Behavior Questionnaire (CSBQ) in a sample of typically developing controls (n = 154), participants with ADHD (n = 239), and their unaffected siblings (n = 144) between the ages of 8 and 29. Structural magnetic resonance imaging (MRI) correlates of ASD ratings were analysed by studying the relationship between ASD ratings and grey matter volumes using mixed effects models which controlled for ADHD symptom count and total brain volume. ASD ratings were significantly elevated in participants with ADHD relative to controls and unaffected siblings. For the entire group (participants with ADHD, unaffected siblings and TD controls), mixed effect models revealed that the left caudate nucleus volume was negatively correlated with ASD ratings (t = 2.83; P = 0.005). The current findings are consistent with the role of the caudate nucleus in executive function, including the selection of goals based on the evaluation of action outcomes and the use of social reward to update reward representations. There is a specific volumetric profile associated with subclinical ASD-like symptoms in participants with ADHD, unaffected siblings and controls with the caudate nucleus and globus pallidus being of critical importance in predicting the level of ASD-like symptoms in all three groups.	[O'Dwyer, Laurence; van Dongen, Eelco V.; Greven, Corina U.; Bralten, Janita; Zwiers, Marcel P.; Buitelaar, Jan K.] Radboud UMC, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands; [Tanner, Colby] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Greven, Corina U.] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat, London, England; [Bralten, Janita; Franke, Barbara] Radboud UMC, Dept Human Genet, Nijmegen, Netherlands; [Franke, Barbara; Groen, Wouter; Rommelse, Nanda] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, Nijmegen, Netherlands; [Heslenfeld, Dirk; Oosterlaan, Jaap] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands; [Heslenfeld, Dirk] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Hoekstra, Pieter J.; Hartman, Catharina A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Greven, Corina U.; Groen, Wouter; Rommelse, Nanda; Buitelaar, Jan K.] Karakter Child & Adolescent Psychiat Univ Ctr Nij, Nijmegen, Netherlands	Radboud University Nijmegen; University of Lausanne; University of London; King's College London; Radboud University Nijmegen; Radboud University Nijmegen; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; Radboud University Nijmegen	O'Dwyer, L (corresponding author), Radboud UMC, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands.	larodwyer@gmail.com	Rommelse, Nanda NJ/D-4872-2009; Greven, Corina/GRS-7921-2022; Greven, Corina U/F-9729-2010; Franke, Barbara/D-4836-2009; Buitelaar, J.K./AAY-7522-2020; Bralten, Janita/AAB-9566-2019; Zwiers, Marcel P/D-2968-2009	Rommelse, Nanda NJ/0000-0002-1711-0359; Greven, Corina U/0000-0002-5433-7878; Franke, Barbara/0000-0003-4375-6572; Bralten, Janita/0000-0003-1440-8675; Zwiers, Marcel P/0000-0001-5483-2935; Greven, Corina U./0000-0003-2402-3074	NIH [R01MH62873]; NWO [1750102007010]; Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; Vrije Universiteit Amsterdam; Brain & Cognition Excellence Program of the Netherlands Organization for Scientific Research (NWO) [433-09-242, 056-13-015]; European Community [278948, 602450]; Innovative Medicines Initiative Joint Undertaking under European Union [115300]; Marie Curie Fellowship under FP7; Vici grant from the Netherlands Organization for Scientific Research (NWO) [016-130-669]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NWO(Netherlands Organization for Scientific Research (NWO)); Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; Vrije Universiteit Amsterdam; Brain & Cognition Excellence Program of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission); Innovative Medicines Initiative Joint Undertaking under European Union; Marie Curie Fellowship under FP7; Vici grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The NeuroIMAGE study was supported by NIH grant R01MH62873 (to Stephen V. Faraone), NWO Large Investment Grant 1750102007010 (to Jan Buitelaar) and matching grants from Radboud University Nijmegen Medical Center, University Medical Center Groningen and Accare, and Vrije Universiteit Amsterdam. This study was supported by a grant from the Brain & Cognition Excellence Program of the Netherlands Organization for Scientific Research (NWO grant 433-09-242 and 056-13-015). The research leading to these results also received support from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 278948 (TACTICS) and 602450 (IMAGEMEND), and the Innovative Medicines Initiative Joint Undertaking under grant agreement number 115300 (EU-AIMS), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007 - 2013) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) companies' in kind contribution. CT was supported by a Marie Curie Fellowship under FP7, and BF received funding from a Vici grant from the Netherlands Organization for Scientific Research (NWO; grant number 016-130-669). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell F, 1999, NEUROREPORT, V10, P1647, DOI 10.1097/00001756-199906030-00005; Abrams DA, 2013, P NATL ACAD SCI USA, V110, P12060, DOI 10.1073/pnas.1302982110; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amer Psychiatric Pub Incorporated, 2013, DIAGN STAT MAN MENT; Ames CS, 2011, J AUTISM DEV DISORD, V41, P357, DOI 10.1007/s10803-010-1049-0; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Aylward EH, 2002, NEUROLOGY, V59, P175, DOI 10.1212/WNL.59.2.175; Barnea-Goraly N, 2014, PROG NEURO-PSYCHOPH, V48, P124, DOI 10.1016/j.pnpbp.2013.09.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Bolton PF, 1997, LANCET, V349, P392, DOI 10.1016/S0140-6736(97)80012-8; Booth R, 2010, J EXP CHILD PSYCHOL, V107, P377, DOI 10.1016/j.jecp.2010.06.003; Brambilla P, 2003, BRAIN RES BULL, V61, P557, DOI 10.1016/j.brainresbull.2003.06.001; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Conners CK, 1997, J ABNORM CHILD PSYCH, V25, P487, DOI 10.1023/A:1022637815797; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Conners CK., 1999, CONNERS ADULT ADHD R, DOI DOI 10.1038/s41588-018-0269-7; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Corbett BA, 2009, PSYCHIAT RES, V166, P210, DOI 10.1016/j.psychres.2008.02.005; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; Crawley M.J., 2007, R BOOK; Cule E., 2012, RIDGE RIDGE REGRESSI; Cule E., 2012, SEMIAUTOMATIC METHOD; DAWSON G, 1983, J AUTISM DEV DISORD, V13, P269, DOI 10.1007/BF01531566; de Bildt A, 2009, J AUTISM DEV DISORD, V39, P1350, DOI 10.1007/s10803-009-0749-9; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Estes A, 2011, AUTISM RES, V4, P212, DOI 10.1002/aur.193; FEIN D, 1984, PSYCHOL BULL, V95, P258, DOI 10.1037/0033-2909.95.2.258; Fine JG, 2008, J AUTISM DEV DISORD, V38, P1797, DOI 10.1007/s10803-008-0570-x; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; Greene W. H., 1997, ECONOMETRIC ANAL; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Happe F, 2006, BRAIN COGNITION, V61, P25, DOI 10.1016/j.bandc.2006.03.004; Hardan AY, 2006, PSYCHIAT RES-NEUROIM, V147, P145, DOI 10.1016/j.pscychresns.2005.12.009; Hartman CA, 2006, J AUTISM DEV DISORD, V36, P325, DOI 10.1007/s10803-005-0072-z; Heimer L, 2003, AM J PSYCHIAT, V160, P1726, DOI 10.1176/appi.ajp.160.10.1726; Herbert MR, 2005, BRAIN, V128, P213, DOI 10.1093/brain/awh330; Herbert MR, 2003, BRAIN, V126, P1182, DOI 10.1093/brain/awg110; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; Howlin P, 2000, J CHILD PSYCHOL PSYC, V41, P561, DOI 10.1017/S0021963099005806; Jang SH, 2014, NEUROSCI LETT, V579, P140, DOI 10.1016/j.neulet.2014.07.024; Jaspers M, 2013, J ABNORM CHILD PSYCH, V41, P71, DOI 10.1007/s10802-012-9653-4; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jou RJ, 2013, BEHAV BRAIN RES, V251, P163, DOI 10.1016/j.bbr.2013.04.021; Kanner L, 1943, NERV CHILD, V2, P217; Kleinhans NM, 2008, BRAIN RES, V1221, P115, DOI 10.1016/j.brainres.2008.04.080; Kohls G, 2013, SOC COGN AFFECT NEUR, V8, P565, DOI 10.1093/scan/nss033; KRUG DA, 1980, J CHILD PSYCHOL PSYC, V21, P221, DOI 10.1111/j.1469-7610.1980.tb01797.x; Lange N, 2015, AUTISM RES, V8, P82, DOI 10.1002/aur.1427; Langen M, 2007, BIOL PSYCHIAT, V62, P262, DOI 10.1016/j.biopsych.2006.09.040; Langen M, 2014, BIOL PSYCHIAT, V76, P405, DOI 10.1016/j.biopsych.2013.08.013; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; Leyfer OT, 2006, J AUTISM DEV DISORD, V36, P849, DOI 10.1007/s10803-006-0123-0; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lim L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063660, 10.1371/journal.pone.0084487]; Luteijn EF, 2000, EUR CHILD ADOLES PSY, V9, P168, DOI 10.1007/s007870070040; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; Milardi D, 2015, CEREB CORTEX, V25, P406, DOI 10.1093/cercor/bht231; Muller UC, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-55; Muller UC, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-54; Mulligan A, 2009, J AUTISM DEV DISORD, V39, P197, DOI 10.1007/s10803-008-0621-3; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Nickl-Jockschat T, 2012, HUM BRAIN MAPP, V33, P1470, DOI 10.1002/hbm.21299; Nijmeijer JS, 2009, J ABNORM CHILD PSYCH, V37, P443, DOI 10.1007/s10802-008-9282-0; O'Dwyer L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101130; Ozonoff S, 1996, BRAIN LANG, V52, P411, DOI 10.1006/brln.1996.0022; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pellicano E, 2012, TRENDS COGN SCI, V16, P504, DOI 10.1016/j.tics.2012.08.009; Peterson BS, 2003, ARCH GEN PSYCHIAT, V60, P415, DOI 10.1001/archpsyc.60.4.415; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Plichta MM, 2014, NEUROSCI BIOBEHAV R, V38, P125, DOI 10.1016/j.neubiorev.2013.07.012; Redcay E, 2008, NEUROSCI BIOBEHAV R, V32, P123, DOI 10.1016/j.neubiorev.2007.06.004; Reiersen AM, 2007, J CHILD PSYCHOL PSYC, V48, P464, DOI 10.1111/j.1469-7610.2006.01720.x; Riva D, 2011, AM J NEURORADIOL, V32, P1430, DOI 10.3174/ajnr.A2527; Robert R., 2013, BIOMETRY PRINCIPLES; Rojas DC, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-56; Rommelse NNJ, 2008, ARCH CLIN NEUROPSYCH, V23, P579, DOI 10.1016/j.acn.2008.06.002; Rommelse NNJ, 2011, NEUROSCI BIOBEHAV R, V35, P1363, DOI 10.1016/j.neubiorev.2011.02.015; Rommelse NNJ, 2010, EUR CHILD ADOLES PSY, V19, P281, DOI 10.1007/s00787-010-0092-x; Ronald A, 2008, J CHILD PSYCHOL PSYC, V49, P535, DOI 10.1111/j.1469-7610.2007.01857.x; Rosenberg DR, 1997, ARCH GEN PSYCHIAT, V54, P824; Rutter M, 2003, J CHILD PSYCHOL PSYC, V44, P1092, DOI 10.1111/1469-7610.00194; Saitoh O, 2001, BRAIN, V124, P1317, DOI 10.1093/brain/124.7.1317; SCARONE S, 1992, PSYCHIAT RES-NEUROIM, V45, P115, DOI 10.1016/0925-4927(92)90005-O; Sears LL, 1999, PROG NEURO-PSYCHOPH, V23, P613, DOI 10.1016/S0278-5846(99)00020-2; Seltzer MM, 2004, MENT RETARD DEV D R, V10, P234, DOI 10.1002/mrdd.20038; Silk TJ, 2006, AM J PSYCHIAT, V163, P1440, DOI 10.1176/appi.ajp.163.8.1440; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Sucksmith E, 2011, NEUROPSYCHOL REV, V21, P360, DOI 10.1007/s11065-011-9183-9; 't Hart-Kerkhoffs LA, 2009, J CLIN PSYCHIAT, V70, P266, DOI 10.4088/JCP.08m04635; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; THOMPSON RL, 1959, J COMP PHYSIOL PSYCH, V52, P650, DOI 10.1037/h0038893; Turner Katherine C, 2006, Behav Brain Funct, V2, P34, DOI 10.1186/1744-9081-2-34; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; van der Meer JMJ, 2012, J AM ACAD CHILD PSY, V51, P1160, DOI 10.1016/j.jaac.2012.08.024; van Steijn DJ, 2012, J CHILD PSYCHOL PSYC, V53, P954, DOI 10.1111/j.1469-7610.2012.02556.x; von Rhein D, 2015, EUR CHILD ADOLES PSY, V24, P265, DOI 10.1007/s00787-014-0573-4; Zeileis, DIAGNOSTIC CHECKING	107	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165620	10.1371/journal.pone.0165620	http://dx.doi.org/10.1371/journal.pone.0165620			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806078	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500044
J	Stohr, S; Martynov, A				Stohr, Sabine; Martynov, Alexander			Paedomorphosis as an Evolutionary Driving Force: Insights from Deep-Sea Brittle Stars	PLOS ONE			English	Article							POSTLARVAL DEVELOPMENT; DEVELOPMENTAL BIOLOGY; AMPHIURA-FILIFORMIS; LARVAL DEVELOPMENT; EVO-DEVO; ECHINODERMATA; HETEROCHRONY; ONTOGENY; OPHIUROIDEA; PHYLOGENY	Heterochronic development has been proposed to have played an important role in the evolution of echinoderms. In the class Ophiuroidea, paedomorphosis (retention of juvenile characters into adulthood) has been documented in the families Ophiuridae and Ophiolepididae but not been investigated on a broader taxonomic scale. Historical errors, confusing juvenile stages with paedomorphic species, show the difficulties in correctly identifying the effects of heterochrony on development and evolution. This study presents a detailed analysis of 40 species with morphologies showing various degrees of juvenile appearance in late ontogeny. They are compared to a range of early ontogenetic stages from paedomorphic and non-paedomorphic species. Both quantitative and qualitative measurements are taken and analysed. The results suggest that strongly paedomorphic species are usually larger than other species at comparable developmental stage. The findings support recent notions of polyphyletic origin of the families Ophiuridae and Ophiolepididae. The importance of paedomorphosis and its correct recognition for the practice of taxonomy and phylogeny are emphasized.	[Stohr, Sabine] Swedish Museum Nat Hist, Dept Zool, Stockholm, Sweden; [Martynov, Alexander] Moscow MV Lomonosov State Univ, Zool Museum, Moscow, Russia	Swedish Museum of Natural History; Lomonosov Moscow State University	Stohr, S (corresponding author), Swedish Museum Nat Hist, Dept Zool, Stockholm, Sweden.; Martynov, A (corresponding author), Moscow MV Lomonosov State Univ, Zool Museum, Moscow, Russia.	sabine.stohr@nrm.se; martynov@zmmu.msu.ru	Martynov, Alexander/AAE-3682-2021; Stöhr, Sabine/B-8629-2011	Stöhr, Sabine/0000-0002-2586-7239	Riksmusei vanner (Swedish Museum of Natural History); MSU Zoological Museum [A16-116021660077-3]; Russian Science Foundation [14-50-00029]	Riksmusei vanner (Swedish Museum of Natural History); MSU Zoological Museum; Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Riksmusei vanner (supporters of the Swedish Museum of Natural History; travel grant and extensive SEM), Research project of MSU Zoological Museum (AAAA-A16-116021660077-3) and by the Russian Science Foundation (grant 14-50-00029, morphological and SEM study, specimens deposition).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Bizzorini F, 2001, BOLL MUS CIV STORIA, V51, P187; Bonett RM, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-27; Breton G, 1997, LETHAIA, V30, P135; BROADHEAD TW, 1987, PALEOBIOLOGY, V13, P177; Clark HL, 1914, PAP DEP MAR BIOL CAR, V5, P91; De Beer G. R., 1930, EMBRYOLOGY AND EVOLU; Dylus DV, 2016, EVODEVO, V7, DOI 10.1186/s13227-015-0039-x; Garstang W., 1922, Journal of the Linnean Society Zoology, V35, P81; Gilbert SF, 1996, DEV BIOL, V173, P357, DOI 10.1006/dbio.1996.0032; Gould SJ, 1977, ONTOGENY AND PHYLOGE; Haeckel E., 1866, ALLGEMEINE GRUNDZUGE; Hall BK, 1999, EVOLUTIONARY DEVELOP; HENDLER G, 1979, Proceedings of the Biological Society of Washington, V92, P783; HENDLER G, 1988, BIOL BULL, V174, P20, DOI 10.2307/1541755; HESS HANS, 1960, ECLOGAE GEOL HELVETIAE, V53, P335; HOTCHKISS FHC, 1980, J NAT HIST, V14, P91, DOI 10.1080/00222938000770101; Hotchkiss FHC, 2012, ZOOSYMPOSIA, V7, P121, DOI 10.11646/zoosymposia.7.1.12; Jeffery JE, 2002, SYST BIOL, V51, P478, DOI 10.1080/10635150290069904; Kjaer CR, 1999, PALEOBIOLOGY, V25, P29; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; Koehler R., 1897, Annales des Sciences Naturelles, V(8), P277; Litvinova Nina M., 1998, Zoosystema, V20, P439; Love AC, 2003, EVOL DEV, V5, P327, DOI 10.1046/j.1525-142X.2003.03040.x; Ludwig H., 1899, SB Ak Berlin, P210; Ludwig H, 1881, ZUR ENTWICKLUNGSGESC, P91; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Marshall N.B., 1984, P91; Martynov AV, 2012, PALEONTOL J+, V46, P833, DOI 10.1134/S0031030112080072; Martynov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139463; Martynov A, 2010, ZOOTAXA, P1; Martynov A, 2011, J MOLLUS STUD, V77, P129, DOI 10.1093/mollus/eyq047; Martynov AV, 2008, MAR BIOL RES, V4, P76, DOI 10.1080/17451000701840066; Matsumoto, 1917, J COLL SCI IMP U TOK, V38, P1; MCKINNEY ML, 1986, PALEOBIOLOGY, V12, P282, DOI 10.1017/S0094837300013786; MCNAMARA KJ, 1986, J PALEONTOL, V60, P4, DOI 10.1017/S0022336000021454; Mehnert E., 1897, MORPHOL ARBEIT, V7, P1, DOI [10.1159/000393310, DOI 10.1159/000393310]; MESSING CG, 1984, MAR BIOL, V80, P83, DOI 10.1007/BF00393131; Minelli A, 2015, EVOLUTIONARY DEV BIO, V1, P1, DOI DOI 10.1007/978-3-7091-1862-7_1; MOOI R, 1990, PALEOBIOLOGY, V16, P25, DOI 10.1017/S0094837300009714; O'Hara TD, 2014, CURR BIOL, V24, P1874, DOI 10.1016/j.cub.2014.06.060; Olsson L, 2010, NATURWISSENSCHAFTEN, V97, P951, DOI 10.1007/s00114-010-0720-9; Parsley R, 2009, PALEONTOL J+, V43, P1406, DOI 10.1134/S0031030109110057; Raff RA, 2000, NAT REV GENET, V1, P74, DOI 10.1038/35049594; Rozhnov SV, 2007, PALAEOGEOGR PALAEOCL, V245, P306, DOI 10.1016/j.palaeo.2006.02.026; SCHOENER A, 1967, DEEP-SEA RES, V14, P645, DOI 10.1016/S0011-7471(67)80003-2; SCHOENER A, 1969, DEEP-SEA RES, V16, P127, DOI 10.1016/0011-7471(69)90069-2; Sedgwick A., 1909, THE INFLUENCE OF DAR; Severtsov A.N, 1912, ESSAYS THEORY EVOLUT; Simms MJ, 1988, SIXTH INTERNATIONAL, P97; SMITH AB, 1995, ZOOL J LINN SOC-LOND, V114, P213, DOI 10.1006/zjls.1995.0024; Spencer W.K., 1966, TREATISE INVERTEBRAT, V3, pU4; Spencer WK., 1922, PALAEONTOGRAPHICAL S, V76, P237; Stohr S, 2005, ZOOL J LINN SOC-LOND, V143, P543, DOI 10.1111/j.1096-3642.2005.00155.x; Stohr S., 2015, WORLD OPHIUROIDEA DA; Stohr S, 2013, EUR J TAXON, V68, P1, DOI 10.5852/ejt.2013.68; Stohr S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031940; Sumida PYG, 1998, ZOOL J LINN SOC-LOND, V124, P267, DOI 10.1111/j.1096-3642.1998.tb00577.x; Thuy B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156140; Turner R. L., 1988, ECHINODERM BIOL, P493; VADON C, 1990, J NAT HIST, V24, P165, DOI 10.1080/00222939000770111; VADON C, 1991, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V151, P335; Vadon C., 1988, ECHINODERM BIOL, P323; WEBB CM, 1985, MAR BIOL, V89, P281, DOI 10.1007/BF00393662; Webster M, 2005, PALEOBIOLOGY, V31, P354, DOI 10.1666/0094-8373(2005)031[0354:EMOOHA]2.0.CO;2; Wiens JJ, 2005, SYST BIOL, V54, P91, DOI 10.1080/10635150590906037; Wolfe JM, 2014, CLADISTICS, V30, P366, DOI 10.1111/cla.12051	68	26	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0164562	10.1371/journal.pone.0164562	http://dx.doi.org/10.1371/journal.pone.0164562			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806039	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500011
J	Arena, SL; Davis, JL; Grant, JW; Madigan, ML				Arena, Sara L.; Davis, Julian L.; Grant, J. Wallace; Madigan, Michael L.			Tripping Elicits Earlier and Larger Deviations in Linear Head Acceleration Compared to Slipping	PLOS ONE			English	Article							LOCOMOTOR TASKS; HUMAN WALKING; OLDER-ADULTS; RECOVERY; BODY; STABILITY; PATTERNS; BALANCE; PELVIS; SLIPS	Slipping and tripping contribute to a large number of falls and fall-related injuries. While the vestibular system is known to contribute to balance and fall prevention, it is unclear whether it contributes to detecting slip or trip onset. Therefore, the purpose of this study was to investigate the effects of slipping and tripping on head acceleration during walking. This information would help determine whether individuals with vestibular dysfunction are likely to be at a greater risk of falls due to slipping or tripping, and would inform the potential development of assistive devices providing augmented sensory feedback for vestibular dysfunction. Twelve young men were exposed to an unexpected slip or trip. Head acceleration was measured and transformed to an approximate location of the vestibular system. Peak linear acceleration in anterior, posterior, rightward, leftward, superior, and inferior directions were compared between slipping, tripping, and walking. Compared to walking, peak accelerations were up to 4.68 m/s(2) higher after slipping, and up to 10.64 m/s(2) higher after tripping. Head acceleration first deviated from walking 100-150 ms after slip onset and 0-50ms after trip onset. The temporal characteristics of head acceleration support a possible contribution of the vestibular system to detecting trip onset, but not slip onset. Head acceleration after slipping and tripping also appeared to be sufficiently large to contribute to the balance recovery response.	[Arena, Sara L.] High Point Univ, Dept Exercise Sci, High Point, NC 27268 USA; [Davis, Julian L.] Univ Southern Indiana, Dept Engn, Evansville, IN USA; [Grant, J. Wallace] Virginia Polytech Inst & State Univ, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA; [Madigan, Michael L.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA	Virginia Polytechnic Institute & State University; Texas A&M University System; Texas A&M University College Station	Arena, SL (corresponding author), High Point Univ, Dept Exercise Sci, High Point, NC 27268 USA.	sarena@highpoint.edu		Davis, Julian/0000-0003-4109-3904; Madigan, Michael/0000-0002-4299-3851	National Institute for Occupational Safety and Health [R01OH009880]	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This work was funded from a National Institute for Occupational Safety and Health grant (R01OH009880) awarded to Michael Madigan.	Agrawal Y, 2009, ARCH INTERN MED, V169, P938, DOI 10.1001/archinternmed.2009.66; Amandus H, 2012, HUM FACTORS, V54, P387, DOI 10.1177/0018720811403140; Beeman SM, 2011, ANN BIOMED ENG, V39, P2998, DOI 10.1007/s10439-011-0379-1; Bell J, 2010, SLIP TRIP FALL PREVE; BENSON AJ, 1986, AVIAT SPACE ENVIR MD, V57, P1088; Bent LR, 2005, EXERC SPORT SCI REV, V33, P107, DOI 10.1097/00003677-200507000-00002; Bent LR, 2004, WHEN IS VESTIBULAR I, P1269; Beringer DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096525; Beschorner K. E., 2013, IIE T OCCUPATIONAL E, V1, P31, DOI [10.1080/21577323.2012.660904, DOI 10.1080/21577323.2012.660904]; BRANDT T, 1988, INT CONGR SER, V812, P127; Centers for Disease Control and Prevention, 2021, 10 LEAD CAUS DEATH U; Cham R, 2002, GAIT POSTURE, V15, P159, DOI 10.1016/S0966-6362(01)00150-3; Cham R, 2001, J BIOMECH, V34, P1439, DOI 10.1016/S0021-9290(01)00116-6; Chambers AJ, 2007, GAIT POSTURE, V25, P565, DOI 10.1016/j.gaitpost.2006.06.007; Chandler RF., 1975, INVESTIGATION INERTI; Choi S, 2015, ANN REHABIL MED-ARM, V39, P897, DOI 10.5535/arm.2015.39.6.897; Courtney TK, 2001, ERGONOMICS, V44, P1118, DOI 10.1080/00140130110085538; Day BL, 2005, CURR BIOL, V15, pR583, DOI 10.1016/j.cub.2005.07.053; DeVita P, 2000, J APPL PHYSIOL, V88, P1804, DOI 10.1152/jappl.2000.88.5.1804; ENG JJ, 1994, EXP BRAIN RES, V102, P339; Herdman SJ, 2000, AM J OTOL, V21, P847; HLAVACKA F, 1995, NEUROSCI LETT, V189, P9, DOI 10.1016/0304-3940(95)11436-Z; HORAK FB, 1994, EXP BRAIN RES, V100, P93; Hughes GB, 2007, CLIN OTOLOGY, Vxvi; Kavanagh JJ, 2004, GAIT POSTURE, V20, P291, DOI 10.1016/j.gaitpost.2003.10.004; Latt MD, 2008, EXP BRAIN RES, V184, P201, DOI 10.1007/s00221-007-1094-x; Leavy B, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0036-x; Lipscomb HJ, 2006, APPL ERGON, V37, P267, DOI 10.1016/j.apergo.2005.07.008; Marigold DS, 2003, J NEUROPHYSIOL, V89, P1727, DOI 10.1152/jn.00683.2002; Marigold DS, 2002, J NEUROPHYSIOL, V88, P339, DOI 10.1152/jn.00691.2001; Menz HB, 2003, GAIT POSTURE, V18, P35, DOI 10.1016/S0966-6362(02)00159-5; Menz HB, 2003, J GERONTOL A-BIOL, V58, P446, DOI 10.1093/gerona/58.5.M446; Menz HB, 2003, AGE AGEING, V32, P137, DOI 10.1093/ageing/32.2.137; Meriam JL, 2002, ENG MECH DYNAMICS; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pijnappels M, 2005, J BIOMECH, V38, P627, DOI 10.1016/j.jbiomech.2004.03.029; POZZO T, 1990, EXP BRAIN RES, V82, P97; POZZO T, 1995, EXP BRAIN RES, V106, P327; Rivera ARV, 2012, J EXP ZOOL PART A, V317A, P467, DOI 10.1002/jez.1739; Safety LMRIf, 2014, LIB MUT WORKPL SAF I; Tang PF, 1998, EXP BRAIN RES, V119, P141, DOI 10.1007/s002210050327; Troy KL, 2006, GAIT POSTURE, V24, P441, DOI 10.1016/j.gaitpost.2005.09.009; Wright RL, 2015, GAIT POSTURE, V41, P164, DOI 10.1016/j.gaitpost.2014.09.025	44	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165670	10.1371/journal.pone.0165670	http://dx.doi.org/10.1371/journal.pone.0165670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802298	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200037
J	Riley, E; Okabe, H; Germine, L; Wilmer, J; Esterman, M; DeGutis, J				Riley, Elizabeth; Okabe, Hidefusa; Germine, Laura; Wilmer, Jeremy; Esterman, Michael; DeGutis, Joseph			Gender Differences in Sustained Attentional Control Relate to Gender Inequality across Countries	PLOS ONE			English	Article							CONTINUOUS PERFORMANCE-TEST; CHILD-DEVELOPMENT; INHIBITORY CONTROL; YOUNG-CHILDREN; TASK; SIMILARITIES; ABILITY; SAMPLE; FACE; AGE	Sustained attentional control is critical for everyday tasks and success in school and employment. Understanding gender differences in sustained attentional control, and their potential sources, is an important goal of psychology and neuroscience and of great relevance to society. We used a large web-based sample (n = 21,484, from testmybrain.org) to examine gender differences in sustained attentional control. Our sample included participants from 41 countries, allowing us to examine how gender differences in each country relate to national indices of gender equality. We found significant gender differences in certain aspects of sustained attentional control. Using indices of gender equality, we found that overall sustained attentional control performance was lower in countries with less equality and that there were greater gender differences in performance in countries with less equality. These findings suggest that creating sociocultural conditions which value women and men equally can improve a component of sustained attention and reduce gender disparities in cognition.	[Riley, Elizabeth; Okabe, Hidefusa; Esterman, Michael; DeGutis, Joseph] VA Boston Healthcare Syst, GRECC, Boston, MA USA; [Riley, Elizabeth; DeGutis, Joseph] Harvard Med Sch, Cambridge, MA USA; [Germine, Laura] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Wilmer, Jeremy] Wellesley Coll, Dept Psychol, Wellesley, MA 02181 USA; [Esterman, Michael] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Massachusetts General Hospital; Wellesley College; Boston University	Riley, E (corresponding author), VA Boston Healthcare Syst, GRECC, Boston, MA USA.; Riley, E (corresponding author), Harvard Med Sch, Cambridge, MA USA.	lissariley@gmail.com		Germine, Laura/0000-0001-8690-8412	US Department of Veterans Affairs grant: VA Advanced Geriatric Fellowship; US Department of Veterans Affairs grant: VA Rehabilitation R&D Center of Excellence Award [B6796-C]; US Department of Veterans Affairs grant: VA Clinical Science R&D Career Development Award [1IK2CX000706-01A2]; VA Advanced Geriatric Fellowship; VA Rehabilitation R&D Center of Excellence Award [B6796-C]; VA Clinical Science R&D Career Development Award [1IK2CX000706-01A2]; Veterans Affairs [IK2CX000706] Funding Source: NIH RePORTER	US Department of Veterans Affairs grant: VA Advanced Geriatric Fellowship; US Department of Veterans Affairs grant: VA Rehabilitation R&D Center of Excellence Award; US Department of Veterans Affairs grant: VA Clinical Science R&D Career Development Award; VA Advanced Geriatric Fellowship; VA Rehabilitation R&D Center of Excellence Award; VA Clinical Science R&D Career Development Award; Veterans Affairs(US Department of Veterans Affairs)	This research was supported by 3 US Department of Veterans Affairs grants: VA Advanced Geriatric Fellowship (ER), VA Rehabilitation R&D Center of Excellence Award (JD, B6796-C), and VA Clinical Science R&D Career Development Award (ME, 1IK2CX000706-01A2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research supported by VA Advanced Geriatric Fellowship (E.R.), VA Rehabilitation R&D Center of Excellence Award (J.D., B6796-C), and VA Clinical Science R&D Career Development Award (M.E., 1IK2CX000706-01A2).	Amick MM, 2013, J INT NEUROPSYCH SOC, V19, P792, DOI 10.1017/S1355617713000544; Banz Barbara C., 2016, Yale Journal of Biology and Medicine, V89, P143; Bates D, 2014, FITTING LINEAR MIXED; Blatter K, 2006, BEHAV BRAIN RES, V168, P312, DOI 10.1016/j.bbr.2005.11.018; Boo FL, 2014, ECON LETT, V124, P55, DOI 10.1016/j.econlet.2014.04.021; Burton L, 2010, J CLIN EXP NEUROPSYC, V32, P66, DOI 10.1080/13803390902806568; Chan RCK, 2001, BRAIN INJURY, V15, P819, DOI 10.1080/02699050119721; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; Conners CK, 2003, J ABNORM CHILD PSYCH, V31, P555, DOI 10.1023/A:1025457300409; Cross CP, 2011, PSYCHOL BULL, V137, P97, DOI 10.1037/a0021591; DeGutis J, 2013, COGNITION, V126, P87, DOI 10.1016/j.cognition.2012.09.004; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Esterman M, 2013, CEREB CORTEX, V23, P2712, DOI 10.1093/cercor/bhs261; Fan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-14; Fortenbaugh FC, 2015, PSYCHOL SCI, V26, P1497, DOI 10.1177/0956797615594896; Germine L, 2012, PSYCHON B REV, V19, P847, DOI 10.3758/s13423-012-0296-9; Halperin JM., 1991, PSYCHOL ASSESS J CON, V3, P603, DOI [10.1037/1040-3590.3.4.603, DOI 10.1037/1040, DOI 10.1037/1040-3590.3.4.603]; Hyde JS, 2008, SCIENCE, V321, P494, DOI 10.1126/science.1160364; Hyde JS, 2009, P NATL ACAD SCI USA, V106, P8801, DOI 10.1073/pnas.0901265106; Hyde JS, 2014, ANNU REV PSYCHOL, V65, P373, DOI 10.1146/annurev-psych-010213-115057; Kerns KA, 1999, DEV NEUROPSYCHOL, V16, P273, DOI 10.1207/S15326942DN1602_9; Kim P, 2013, P NATL ACAD SCI USA, V110, P18442, DOI 10.1073/pnas.1308240110; Kuznetsova A., 2016, LMERTEST TESTS LINEA; Reilly D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039904; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schmidt EA, 2009, ACCIDENT ANAL PREV, V41, P1087, DOI 10.1016/j.aap.2009.06.007; Steinmayr R, 2010, LEARN INDIVID DIFFER, V20, P14, DOI 10.1016/j.lindif.2009.10.009; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Weber D, 2014, P NATL ACAD SCI USA, V111, P11673, DOI 10.1073/pnas.1319538111; Yuan JJ, 2008, PSYCHOPHYSIOLOGY, V45, P986, DOI 10.1111/j.1469-8986.2008.00693.x	32	27	27	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165100	10.1371/journal.pone.0165100	http://dx.doi.org/10.1371/journal.pone.0165100			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6CX	27802294	Green Published, gold			2022-12-27	WOS:000386714200018
J	Su, X; He, CY; Ma, JJ; Tang, T; Zhang, X; Ye, ZL; Long, YK; Shao, Q; Shao, JY; Yang, AK				Su, Xuan; He, Caiyun; Ma, Jiangjun; Tang, Tao; Zhang, Xiao; Ye, Zulu; Long, Yakang; Shao, Qiong; Shao, Jianyong; Yang, Ankui			RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease	PLOS ONE			English	Article							CARCINOMA; NODULES	RET/PTC rearrangements, resulting in aberrant activity of the RET protein tyrosine kinase receptor, occur exclusively in papillary thyroid cancer (PTC). In this study, we examined the association between RET/PTC rearrangements and thyroid hormone homeostasis, and explored whether concomitant diseases such as nodular goiter and Hashimoto's thyroiditis influenced this association. A total of 114 patients diagnosed with PTC were enrolled in this study. Thyroid hormone levels, clinicopathological parameters and lifestyle were obtained through medical records and surgical pathology reports. RET/PTC rearrangements were detected using TaqMan RT-PCR and validated by direct sequencing. No RET/PTC rearrangements were detected in benign thyroid tissues. RET/PTC rearrangements were detected in 23.68% (27/114) of PTC tissues. No association between thyroid function, clinicopathological parameters and lifestyle was observed either in total thyroid cancer patients or the subgroup of patients with concomitant disease. In the subgroup of PTC patients without concomitant disease, RET/PTC rearrangement was associated with multifocal cancer (P = 0.018). RET/PTC rearrangement was also correlated with higher TSH levels at one month post-surgery (P = 0.037). Based on likelihood-ratio regression analysis, the RET/PTC-positive PTC cases showed an increased risk of multifocal cancers in the thyroid gland (OR = 5.57, 95% CI, 1.39-22.33). Our findings suggest that concomitant diseases such as nodular goiter and Hashimoto's thyroiditis in PTC may be a confounding factor when examining the effects of RET/PTC rearrangements. Excluding the potential effect of this confounding factor showed that RET/PTC may confer an increased risk for the development of multifocal cancers in the thyroid gland. Aberrantly increased post-operative levels of TSH were also associated with RET/PTC rearrangement. Together, our data provides useful information for the treatment of papillary thyroid cancer.	[Su, Xuan; Yang, Ankui] Sun Yat Sen Univ, Canc Ctr, Dept Head & Neck, Guangzhou, Guangdong, Peoples R China; [Su, Xuan; Yang, Ankui] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Su, Xuan; He, Caiyun; Ma, Jiangjun; Tang, Tao; Zhang, Xiao; Ye, Zulu; Long, Yakang; Shao, Qiong; Shao, Jianyong; Yang, Ankui] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [He, Caiyun; Ma, Jiangjun; Tang, Tao; Zhang, Xiao; Ye, Zulu; Long, Yakang; Shao, Qiong; Shao, Jianyong] Sun Yat Sen Univ, Ctr Canc, Dept Mol Diagnost, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; State Key Lab Oncology South China; Sun Yat Sen University	Yang, AK (corresponding author), Sun Yat Sen Univ, Canc Ctr, Dept Head & Neck, Guangzhou, Guangdong, Peoples R China.; Yang, AK (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.; Shao, JY; Yang, AK (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.; Shao, JY (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Mol Diagnost, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	shaojy@sysucc.org.cn; yangak@sysucc.org.cn			National Natural Science Foundation of China [81272955, 81602426]; Medical Science and Technology Research Fund Project of Guangdong Province [A2015003]; Natural Science Foundation of Guangdong Province [2016A030310198]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science and Technology Research Fund Project of Guangdong Province; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work is supported by grants from the National Natural Science Foundation of China [grant numbers 81272955 and 81602426]; the Medical Science and Technology Research Fund Project of Guangdong Province [grant number A2015003]; and Natural Science Foundation of Guangdong Province [grant number 2016A030310198]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal M, 2013, AM J SURG PATHOL, V37, P1586, DOI 10.1097/PAS.0b013e318292b780; Boelaert K, 2006, J CLIN ENDOCR METAB, V91, P4295, DOI 10.1210/jc.2006-0527; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Lu ZM, 2016, J PATHOL, V239, P72, DOI 10.1002/path.4696; Machens A, 2007, WORLD J SURG, V31, P1960, DOI 10.1007/s00268-007-9185-1; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; Rhoden KJ, 2006, J CLIN ENDOCR METAB, V91, P2414, DOI 10.1210/jc.2006-0240; Shattuck TM, 2005, NEW ENGL J MED, V352, P2406, DOI 10.1056/NEJMoa044190; Sugg SL, 1998, J CLIN ENDOCR METAB, V83, P4116, DOI 10.1210/jc.83.11.4116	9	10	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165596	10.1371/journal.pone.0165596	http://dx.doi.org/10.1371/journal.pone.0165596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802347	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200031
J	Tiveron, AP; Rosalen, PL; Franchin, M; Lacerda, RCC; Bueno-Silva, B; Benso, B; Denny, C; Ikegaki, M; de Alencar, SM				Tiveron, Ana Paula; Rosalen, Pedro Luiz; Franchin, Marcelo; Coelho Lacerda, Risia Cristina; Bueno-Silva, Bruno; Benso, Bruna; Denny, Carina; Ikegaki, Masaharu; de Alencar, Severino Matias			Chemical Characterization and Antioxidant, Antimicrobial, and Anti-Inflammatory Activities of South Brazilian Organic Propolis	PLOS ONE			English	Article							PHENOLIC COMPOSITION; RED PROPOLIS; IN-VITRO; CYTOKINE PRODUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN; ESSENTIAL OILS; ANTIBACTERIAL; ACCUMULATION; GEOPROPOLIS	South Brazilian organic propolis (OP), which has never been studied before, was assessed and its chemical composition, scavenging potential of reactive oxygen species, antimicrobial and anti-inflammatory activities are herein presented. Based on the chemical profile obtained using HPLC, OP was grouped into seven variants (OP1-OP7) and all of them exhibited high scavenging activity, mainly against superoxide and hypochlorous acid species. OP1, OP2, and OP3 had the smallest minimal inhibitory concentration (MIC) against Gram-positive bacteria Streptococcus mutans, Streptococcus oralis, and Streptococcus aureus (12.5-100 mu g/mL). OP1, OP2, OP3, and OP4 were more effective against Pseudomonas aeruginosa (Gram-negative), with MIC values ranging from 100 to 200 mu g/mL. OP6 showed anti-inflammatory activity by decreasing NF-kappa B activation and TNF-alpha release in RAW 264.7 macrophages, and expressing the NF-kappa B-luciferase reporter stable gene. Therefore, south Brazilian OP can be considered an excellent source of bioactive compounds with great potential of application in the pharmaceutical and food industry.	[Tiveron, Ana Paula; Coelho Lacerda, Risia Cristina; de Alencar, Severino Matias] Univ Sao Paulo, Dept Agri Food Ind Food & Nutr, Luiz de Queiroz Coll Agr, Ave Padua Dias 11, BR-13418900 Piracicaba, SP, Brazil; [Rosalen, Pedro Luiz; Franchin, Marcelo; Bueno-Silva, Bruno; Benso, Bruna; Denny, Carina] Univ Campinas UNICAMP, Dept Physiol Sci, Piracicaba Dent Sch, Ave Limeira 901,CP 52, BR-13414903 Piracicaba, SP, Brazil; [Ikegaki, Masaharu] Univ Fed Alfenas, Sch Pharmaceut Sci, Rua Gabriel Monteiro da Silva 714, BR-37130000 Alfenas, MG, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Alfenas	de Alencar, SM (corresponding author), Univ Sao Paulo, Dept Agri Food Ind Food & Nutr, Luiz de Queiroz Coll Agr, Ave Padua Dias 11, BR-13418900 Piracicaba, SP, Brazil.	smalencar@usp.br	Ikegaki, Masaharu/R-2540-2019; Bueno-Silva, Bruno/J-3097-2012; Alencar, Severino Matias/B-7743-2012; Benso, Bruna/L-1010-2015; Franchin, Marcelo/M-7636-2017; Rosalen, Pedro Luiz/I-3718-2012	Bueno-Silva, Bruno/0000-0003-3275-5910; Alencar, Severino Matias/0000-0002-6637-7973; Benso, Bruna/0000-0002-4425-5174; Franchin, Marcelo/0000-0001-5613-2756; Rosalen, Pedro Luiz/0000-0003-0812-4027; Ikegaki, Masaharu/0000-0003-0688-1518; Lacerda, Risia/0000-0002-3410-0443	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo [2010/52679-9, 2011/50651-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [472848/2011-9]	Fundacao do Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Grant #2010/52679-9 - Fundacao do Amparo a Pesquisa do Estado de Sao Paulo - http://www.bv.fapesp.br/pt/bolsas/130453/caracterizacao-e-identificaco-de-compostos-com-atividade-antioxidante-de-propolis-orgenica-brasileir/ - APT. Grant # 2011/50651-2 Fundacao do Amparo a Pesquisa do Estado de Sao Paulo - http://bvs.fapesp.br/pt/auxilios/45149/composicao-quimica-e-atividade-antioxidante-de-um-novo-tipo-de-propolis-brasileira-produzida-por-abe/ - SMA. Grant # 472848/2011-9 Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - http://www.cnpq.br - SMA.	Abreu P, 2006, LIFE SCI, V78, P1578, DOI 10.1016/j.lfs.2005.07.037; Al-Duais M, 2009, EUR FOOD RES TECHNOL, V228, P813, DOI 10.1007/s00217-008-0994-8; Alencar SM, 2007, J ETHNOPHARMACOL, V113, P278, DOI 10.1016/j.jep.2007.06.005; [Anonymous], 1991, J Antimicrob Chemother, V27 Suppl D, P1; Aziz M, 2018, CRIT REV FOOD SCI, V58, P486, DOI 10.1080/10408398.2016.1194256; Bankova V, 1999, FITOTERAPIA, V70, P190, DOI [10.1016/S0367-326X(98)00045-8, 10.1016/S0367-326X(98)00044-6]; Banskota AH, 2001, PHYTOTHER RES, V15, P561, DOI 10.1002/ptr.1029; Becker EM, 2004, EUR FOOD RES TECHNOL, V219, P561, DOI 10.1007/s00217-004-1012-4; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Brown L, 2015, NAT REV MICROBIOL, V13, P620, DOI 10.1038/nrmicro3480; Bueno-Silva B, 2013, BIOFOULING, V29, P1233, DOI 10.1080/08927014.2013.834050; Bueno-Silva B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144954; Bueno-Silva B, 2013, J AGR FOOD CHEM, V61, P4546, DOI 10.1021/jf305468f; Bufalo MC, 2013, J ETHNOPHARMACOL, V149, P84, DOI 10.1016/j.jep.2013.06.004; Oldoni TLC, 2015, J BRAZIL CHEM SOC, V26, P2054, DOI 10.5935/0103-5053.20150186; Duarte MCT, 2007, J ETHNOPHARMACOL, V111, P197, DOI 10.1016/j.jep.2006.11.034; Galvao LCD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/751435; Demiirkol G., 2013, Scientific Works. Series C. Veterinary Medicine, V59, P14; Duarte S, 2006, ARCH ORAL BIOL, V51, P15, DOI 10.1016/j.archoralbio.2005.06.002; Erdem M, 2016, ARCH INSECT BIOCHEM, V93, P202, DOI 10.1002/arch.21352; Franchin M, 2016, J NAT PROD, V79, P1828, DOI 10.1021/acs.jnatprod.6b00263; Franchin M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/907041; Franchin M, 2012, J ETHNOPHARMACOL, V143, P709, DOI 10.1016/j.jep.2012.07.040; Freires IA, 2016, EUR J MED CHEM, V110, P267, DOI 10.1016/j.ejmech.2016.01.033; Furletti VF, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/985832; Gomes A, 2007, BIOORGAN MED CHEM, V15, P6027, DOI 10.1016/j.bmc.2007.06.046; Gulcin I, 2012, ARCH TOXICOL, V86, P345, DOI 10.1007/s00204-011-0774-2; Hayacibara MF, 2005, J ETHNOPHARMACOL, V101, P110, DOI 10.1016/j.jep.2005.04.001; Jananie R. K., 2011, Journal of Chemical and Pharmaceutical Research, V3, P647; Kiwa BCS OKO-Garantie GmbH, ORG CERT; Koleva II, 2001, ANAL CHEM, V73, P3373, DOI 10.1021/ac0013610; Koo H, 2000, CURR MICROBIOL, V41, P192, DOI 10.1007/s0028400101170; Koo H, 2003, J ANTIMICROB CHEMOTH, V52, P782, DOI 10.1093/jac/dkg449; Kotsinas A, 2012, CANCER LETT, V327, P97, DOI 10.1016/j.canlet.2011.12.009; Kumazawa S, 2004, FOOD CHEM, V84, P329, DOI 10.1016/S0308-8146(03)00216-4; Liu XB, 2016, FREE RADICAL BIO MED, V91, P25, DOI 10.1016/j.freeradbiomed.2015.12.001; Magalhaes LM, 2008, ANAL CHIM ACTA, V613, P1, DOI 10.1016/j.aca.2008.02.047; Marcucci MC, 2001, J ETHNOPHARMACOL, V74, P105, DOI 10.1016/S0378-8741(00)00326-3; Mattos-Graner RO, 2001, INFECT IMMUN, V69, P6931, DOI 10.1128/IAI.69.11.6931-6941.2001; Melo PS, 2015, FOOD CHEM, V181, P160, DOI 10.1016/j.foodchem.2015.02.087; Moraes-De-Souza RA, 2008, CIENC TECNOL ALIMENT, V6, P41, DOI 10.1080/11358120809487626; Oldoni TLC, 2011, SEP PURIF TECHNOL, V77, P208, DOI 10.1016/j.seppur.2010.12.007; Park YK, 2002, J AGR FOOD CHEM, V50, P2502, DOI 10.1021/jf011432b; Park YongKun, 2000, Honeybee Science, V21, P85; Paulino N, 2006, PLANTA MED, V72, P899, DOI 10.1055/s-2006-947185; Cabral ISR, 2009, QUIM NOVA, V32, P1523, DOI 10.1590/S0100-40422009000600031; Ribeiro DR, 2015, BASIC CLIN PHARMACOL, V117, P85, DOI 10.1111/bcpt.12374; Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032; Silva RL, 2015, J NAT PROD, V78, P241, DOI 10.1021/np500796f; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Szliszka E, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/735176; Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w	52	71	72	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165588	10.1371/journal.pone.0165588	http://dx.doi.org/10.1371/journal.pone.0165588			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802316	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200029
J	Hein, L; Bagstad, K; Edens, B; Obst, C; de Jong, R; Lesschen, JP				Hein, Lars; Bagstad, Ken; Edens, Bram; Obst, Carl; de Jong, Rixt; Lesschen, Jan Peter			Defining Ecosystem Assets for Natural Capital Accounting	PLOS ONE			English	Article							CONCEPTUAL-FRAMEWORK; SERVICE FLOWS; LAND-USE; CAPACITY; SCIENCE	In natural capital accounting, ecosystems are assets that provide ecosystem services to people. Assets can be measured using both physical and monetary units. In the international System of Environmental-Economic Accounting, ecosystem assets are generally valued on the basis of the net present value of the expected flow of ecosystem services. In this paper we argue that several additional conceptualisations of ecosystem assets are needed to understand ecosystems as assets, in support of ecosystem assessments, ecosystem accounting and ecosystem management. In particular, we define ecosystems' capacity and capability to supply ecosystem services, as well as the potential supply of ecosystem services. Capacity relates to sustainable use levels of multiple ecosystem services, capability involves prioritising the use of one ecosystem service over a basket of services, and potential supply considers the ability of ecosystems to generate services regardless of demand for these services. We ground our definitions in the ecosystem services and accounting literature, and illustrate and compare the concepts of flow, capacity, capability, and potential supply with a range of conceptual and real-world examples drawn from case studies in Europe and North America. Our paper contributes to the development of measurement frameworks for natural capital to support environmental accounting and other assessment frameworks.	[Hein, Lars] Wageningen Univ, Wageningen, Netherlands; [Bagstad, Ken] World Bank, Wealth Accounting & Valuat Ecosyst Serv WAVES Pro, 1818 H St NW, Washington, DC 20433 USA; [Bagstad, Ken] US Geol Survey, Geosci & Environm Change Sci Ctr, Box 25046, Denver, CO 80225 USA; [Edens, Bram; de Jong, Rixt] Stat Netherlands, The Hague, Netherlands; [Obst, Carl] Univ Melbourne, Melbourne Sustainable Soc Inst, Parkville, Vic, Australia; [Lesschen, Jan Peter] Wageningen UR, Alterra, Wageningen, Netherlands	Wageningen University & Research; The World Bank; United States Department of the Interior; United States Geological Survey; University of Melbourne; Wageningen University & Research	Hein, L (corresponding author), Wageningen Univ, Wageningen, Netherlands.	lars.hein@wur.nl		Bagstad, Kenneth/0000-0001-8857-5615; Lesschen, Jan Peter/0000-0003-1535-8294				[Anonymous], 2010, EC ECOSYSTEMS EFFICI; Bagstad KJ, 2014, ECOL SOC, V19, DOI 10.5751/ES-06523-190264; Bagstad KJ, 2013, ECOSYST SERV, V4, P117, DOI 10.1016/j.ecoser.2012.07.012; Bastian O, 2012, ECOL INDIC, V21, P7, DOI 10.1016/j.ecolind.2011.03.014; Bourassa SC, 2004, ENVIRON PLANN A, V36, P1427, DOI 10.1068/a36103; Boyd J, 2007, ECOL ECON, V63, P616, DOI 10.1016/j.ecolecon.2007.01.002; Brookhuis BJ, 2016, FOREST POLICY ECON, V62, P118, DOI 10.1016/j.forpol.2015.10.002; Burkhard B, 2014, LANDSCAPE ONLINE, V34, P1, DOI [DOI 10.3097/LO.201434, 10.3097/lo.201434, 10.3097/LO.201434]; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Coleman K, 1999, ROTHC 26 3 MODEL TUR, V11; Convertino M, 2014, ENVIRON MODELL SOFTW, V51, P296, DOI 10.1016/j.envsoft.2013.10.001; Convertino M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065056; Costanza R, 2002, ECOL MONOGR, V72, P203, DOI 10.1890/0012-9615(2002)072[0203:IEEMOT]2.0.CO;2; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Daly E, 2010, ECOLOGICAL EC PRINCI; de Groot R. S., 1992, FUNCTIONS NATURE EVA; Diaz S, 2015, CURR OPIN ENV SUST, V14, P1, DOI 10.1016/j.cosust.2014.11.002; Edens B, 2010, IARIW 2010 C; Edens B, 2013, ECOL ECON, V90, P41, DOI 10.1016/j.ecolecon.2013.03.003; Edens B, 2013, ENVIRON RESOUR ECON, V54, P419, DOI 10.1007/s10640-012-9601-3; Eggleston HS, 2006, IPCC 2006 GUIDELINES; European Commission, 2011, OUR LIF INS OUR NAT; Finke PA, 2001, 389 ALT; Granhus A, 2012, STAT SKOGTORHOLDOG S; Guerry AD, 2015, P NATL ACAD SCI USA, V112, P7348, DOI 10.1073/pnas.1503751112; Haines-Young R., 2010, ECOSYSTEM ECOLOGY NE, DOI DOI 10.1017/CBO9780511750458.007; Harrison Ann., 1993, IMPROVED ACCOUNTING; Hein L, 2015, CURR OPIN ENV SUST, V14, P86, DOI 10.1016/j.cosust.2015.04.002; Holling CS, 2002, PANARCHY UNDERSTANDI, P63; Jackson RB, 2005, SCIENCE, V310, P1944, DOI 10.1126/science.1119282; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Lesschen JP, 2012, 2396 ALT; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lilly GR, 2008, LOW WAKE FI, V24, P67, DOI 10.4027/rgsfcc.2008.04; Maes J, TRENDS ECOSYSTEMS EC; Manning R. E., 2010, STUDIES OUTDOOR RECR; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Obst C, 2016, ENVIRON RESOUR ECON, V64, P1, DOI 10.1007/s10640-015-9921-1; Obst C, 2014, OXFORD REV ECON POL, V30, P126, DOI 10.1093/oxrep/gru003; [OMB] Office of Management and Budget, 2015, M1601 OMB EX OFF PRE; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Remme RP, 2014, ECOSYST SERV, V10, P6, DOI 10.1016/j.ecoser.2014.07.006; Remme RP, 2015, ECOL ECON, V112, P116, DOI 10.1016/j.ecolecon.2015.02.015; Remme RP, 2015, ECOSYSTEM ACCOUNTI 2; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Schroter M, 2015, ECOSYST SERV, V13, P64, DOI 10.1016/j.ecoser.2014.07.003; Schroter M, 2014, ECOL INDIC, V36, P539, DOI 10.1016/j.ecolind.2013.09.018; SSB, 2012, STAT YB 2012; Statistics Netherlands and Wageningen University, 2015, EC ACC LIMB PROV N 1; Sumarga E, 2014, ENVIRON MANAGE, V54, P84, DOI 10.1007/s00267-014-0282-2; TEEB, 2010, EC EC BIOD MAINSTR E; Turner RK, 2000, ECOL ECON, V35, P7, DOI 10.1016/S0921-8009(00)00164-6; UN, 2014, SYST ENV EC ACC EXP; United Nations, 2016, SEEA EXP EC ACC TECH; United Nations, 2009, SYST NAT ACC; VANOLI A, 1995, REV INCOME WEALTH, P113; Villa F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091001; Villamagna AM, 2013, ECOL COMPLEX, V15, P114, DOI 10.1016/j.ecocom.2013.07.004; Walker B., 2002, PANARCHY UNDERSTANDI, P293; Weber J.-L., 2014, TECHNICAL SERIES, V77, P248; Weber JL, 2007, ECOL ECON, V61, P695, DOI 10.1016/j.ecolecon.2006.05.023; Zank B, 2016, LANDSCAPE URBAN PLAN, V149, P31, DOI 10.1016/j.landurbplan.2016.01.004	63	55	58	14	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e164460	10.1371/journal.pone.0164460	http://dx.doi.org/10.1371/journal.pone.0164460			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27828969	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300017
J	Lamp, B; Url, A; Seitz, K; Eichhorn, J; Riedel, C; Sinn, LJ; Indik, S; Koglberger, H; Rumenapf, T				Lamp, Benjamin; Url, Angelika; Seitz, Kerstin; Eichhorn, Juergen; Riedel, Christiane; Sinn, Leonie Janina; Indik, Stanislav; Koeglberger, Hemma; Ruemenapf, Till			Construction and Rescue of a Molecular Clone of Deformed Wing Virus (DWV)	PLOS ONE			English	Article							PICORNA-LIKE VIRUS; DESTRUCTOR ACARI VARROIDAE; HONEY-BEE COLONIES; APIS-MELLIFERA; INFECTIOUS TRANSCRIPTS; PHYLOGENETIC ANALYSIS; TRANSMISSION; VARROA-DESTRUCTOR-VIRUS-1; IDENTIFICATION; REPLICATION	European honey bees are highly important in crop pollination, increasing the value of global agricultural production by billions of dollars. Current knowledge about virulence and pathogenicity of Deformed wing virus (DWV), a major factor in honey bee colony mortality, is limited. With this study, we close the gap between field research and laboratory investigations by establishing a complete in vitro model for DWV pathogenesis. Infectious DWV was rescued from a molecular clone of a DWV-A genome that induces DWV symptoms such as crippled wings and discoloration. The expression of DWV proteins, production of infectious virus progeny, and DWV host cell tropism could be confirmed using newly generated anti-DWV monoclonal antibodies. The recombinant RNA fulfills Koch's postulates circumventing the need of virus isolation and propagation of pure virus cultures. In conclusion, we describe the development and application of a reverse genetics system for the study of DWV pathogenesis.	[Lamp, Benjamin; Seitz, Kerstin; Eichhorn, Juergen; Riedel, Christiane; Sinn, Leonie Janina; Indik, Stanislav; Ruemenapf, Till] Univ Vet Med, Inst Virol, Dept Pathobiol, Vienna, Austria; [Url, Angelika] Univ Vet Med, Inst Pathol & Forens Vet Med, Dept Pathobiol, Vienna, Austria; [Koeglberger, Hemma] Austrian Agcy Hlth & Food Safety, Agr Inspect Serv, Inst Apiculture, Vienna, Austria; [Koeglberger, Hemma] Austrian Agcy Hlth & Food Safety, Res Ctr Vienna, Vienna, Austria; [Koeglberger, Hemma] Fed Off Food Safety, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Lamp, B (corresponding author), Univ Vet Med, Inst Virol, Dept Pathobiol, Vienna, Austria.	Benjamin.Lamp@vetmeduni.ac.at	Ruemenapf, Till/D-4143-2017; Lamp, Benjamin/A-8053-2015; Riedel, Christiane/W-6679-2019	Ruemenapf, Till/0000-0002-2951-7471; Lamp, Benjamin/0000-0002-9668-1896; Seitz, Kerstin/0000-0003-2852-5047; Riedel, Christiane/0000-0002-4349-996X; Indik, Stanislav/0000-0001-8255-6544	BIOS Science Austria [2012_vetmediuni_2]; University of veterinary medicine [PP23014275]	BIOS Science Austria; University of veterinary medicine	This study was funded by "BIOS Science Austria" (http://bios-science.at/index.php/en/; grant: 2012_vetmediuni_2) and the "University of veterinary medicine" (http://www.vetmeduni.ac.at/en/; grant: PP23014275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Bakonyi T, 2002, APPL ENVIRON MICROB, V68, P6446, DOI 10.1128/AEM.68.12.6446-6450.2002; Benjeddou M, 2002, J GEN VIROL, V83, P3139, DOI 10.1099/0022-1317-83-12-3139; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; BOYER JC, 1994, VIROLOGY, V198, P415, DOI 10.1006/viro.1994.1053; CIB, 2009, CTR PROM IMP DEV COU; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2013, J INVERTEBR PATHOL, V112, P278, DOI 10.1016/j.jip.2012.12.009; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Devillers J, 2014, IN SILICO BEES, P179; EVANS AS, 1976, YALE J BIOL MED, V49, P175; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Fujiyuki T, 2004, J VIROL, V78, P1093, DOI 10.1128/JVI.78.3.1093-1100.2004; Fujiyuki T, 2009, J VIROL, V83, P11560, DOI 10.1128/JVI.00519-09; Fyg W., 1956, J SWISS ENTOMOLOGICA, V29, P404; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Grabensteiner E, 2001, CLIN DIAGN LAB IMMUN, V8, P93, DOI 10.1128/CDLI.8.1.93-104.2001; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Iwasaki JM, 2015, AMBIO, V44, P694, DOI 10.1007/s13280-015-0679-z; Kanbar G, 2005, GENET MOL RES, V4, P465; Kielmanowicz MG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004816; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Lamp B, 2011, J VIROL, V85, P3607, DOI 10.1128/JVI.02206-10; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Locke B, 2012, APPL ENVIRON MICROB, V78, P227, DOI 10.1128/AEM.06094-11; Loeffler F., 1884, MITTHEILUNGEN KAISER, V2, P421; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Moore J, 2011, J GEN VIROL, V92, P156, DOI 10.1099/vir.0.025965-0; Mordecai GJ, 2016, ISME J, V10, P1182, DOI 10.1038/ismej.2015.186; Mordecai GJ, 2016, ISME J, V10, P1264, DOI 10.1038/ismej.2015.178; Murakami R, 2014, ARCH VIROL, V159, P585, DOI 10.1007/s00705-013-1850-0; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Ongus JR, 2006, J GEN VIROL, V87, P3397, DOI 10.1099/vir.0.82122-0; Pekosz A, 1999, P NATL ACAD SCI USA, V96, P8804, DOI 10.1073/pnas.96.16.8804; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; Stokstad E, 2007, SCIENCE, V316, P970, DOI 10.1126/science.316.5827.970; Thompson CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105164; Vandervalk LP, 2014, J ECON ENTOMOL, V107, P2030, DOI 10.1603/EC14048; Wantuch HA, 2009, J ECON ENTOMOL, V102, P2033, DOI 10.1603/029.102.0603; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Winfree R, 2011, ECOL ECON, V71, P80, DOI 10.1016/j.ecolecon.2011.08.001; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0; Zhang QS, 2007, J INVERTEBR PATHOL, V96, P97, DOI 10.1016/j.jip.2007.03.019; Zioni N, 2011, VIROLOGY, V417, P106, DOI 10.1016/j.virol.2011.05.009	52	39	43	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164639	10.1371/journal.pone.0164639	http://dx.doi.org/10.1371/journal.pone.0164639			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828961	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300019
J	Skrunes, R; Svarstad, E; Reisaeter, AV; Marti, HP; Vikse, BE				Skrunes, Rannveig; Svarstad, Einar; Reisaeter, Anna Varberg; Marti, Hans-Peter; Vikse, Bjorn Egil			End Stage Renal Disease Predicts Increased Risk of Death in First Degree Relatives in the Norwegian Population	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; NEPHROTIC SYNDROME; ASSOCIATION; MORTALITY; MELLITUS; EUROPE; FSGS; MEN; ERA	Background Increased risk of end stage renal disease (ESRD) and death in Norwegian living kidney donors has been reported, most of the donors were related to the recipient. The present study investigates risk of death in first degree relatives of ESRD patients. Methods The Norwegian Population Registry, The Norwegian Cause of Death Registry and the Norwegian Renal Registry were linked. All citizens born in Norway, alive in 1960 and with at least one registered first degree relative were included; individuals who died during the first year of life were excluded. A cohort-design was used, ESRD in a first degree relative was the main exposure variable and death and causes of death were the main outcome variables. Cox regression statistics were used to investigate mortality risks. Results 5 130 600 individuals were included, 27 508 had at least one first degree relative with ESRD. 828 022 died during follow-up, of whom 4105 had a first degree relative with ESRD. Adjusted hazard ratio (aHR) for death was 1.13 (1.09-1.16) in individuals with a relative with ESRD compared to those without a relative with ESRD. Excluding known hereditary renal disease, aHR decreased to 1.12 (1.09-1.15). Cardiovascular death aHR was 1.15 (1.10-1.21), of which cerebrovascular death 1.34 (1.22-1.50). aHR for death due to non-hereditary renal/ureteric disease was 2.29 (1.81-2.91) with renal failure 1.80 (1.26-2.56) and glomerular disease 5.69 (3.88-8.34) as main contributors. Diabetes mellitus death aHR was 1.68 (1.35-2.10). Absolute mortality risks increased most for the oldest cohorts with excess mortality of 148 per 100.000 person years for the cohort born 1920-39 and 218 for the cohort born 1900-1919. Conclusions ESRD in first degree relatives was associated with increased hazard ratio for death. Death due to cardiovascular disease, renal disease and diabetes mellitus increased the most.	[Skrunes, Rannveig; Svarstad, Einar; Marti, Hans-Peter] Haukeland Hosp, Dept Med, Bergen, Norway; [Skrunes, Rannveig; Svarstad, Einar; Marti, Hans-Peter; Vikse, Bjorn Egil] Univ Bergen, Dept Clin Med, Bergen, Norway; [Reisaeter, Anna Varberg] Oslo Univ Hosp, Dept Transplantat Med, Rikshosp, Oslo, Norway; [Vikse, Bjorn Egil] Haugesund Hosp, Dept Med, Haugesund, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; National Hospital Norway	Skrunes, R (corresponding author), Haukeland Hosp, Dept Med, Bergen, Norway.; Skrunes, R (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	rannvsk@online.no			Helse-Vest	Helse-Vest	Funded by PhD grant from Helse-Vest http://www.helse-vest.no/en/Sider/default.aspx awarded to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Brancati FL, 1997, JAMA-J AM MED ASSOC, V278, P2069, DOI 10.1001/jama.278.23.2069; Brown EJ, 2014, KIDNEY INT, V85, P1030, DOI 10.1038/ki.2014.48; Finne P, 2005, JAMA-J AM MED ASSOC, V294, P1782, DOI 10.1001/jama.294.14.1782; Florez JC, 2003, ANNU REV GENOM HUM G, V4, P257, DOI 10.1146/annurev.genom.4.070802.110436; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goldfarb-Rumyantzev AS, 2006, AM J NEPHROL, V26, P142, DOI 10.1159/000092280; Koene RJ, 2016, CIRCULATION, V133, P1104, DOI 10.1161/CIRCULATIONAHA.115.020406; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Mjoen G, 2014, KIDNEY INT, V86, P162, DOI 10.1038/ki.2013.460; Naiman N, 2009, AM J NEPHROL, V29, P237, DOI 10.1159/000156721; Pollak MR, 2002, J AM SOC NEPHROL, V13, P3016, DOI 10.1097/01.ASN.0000039569.34360.5E; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Sesso HD, 2001, CIRCULATION, V104, P393, DOI 10.1161/hc2901.093115; Skrunes R, 2014, CLIN J AM SOC NEPHRO, V9, P1692, DOI 10.2215/CJN.01680214; Stewart JH, 2003, J AM SOC NEPHROL, V14, P197, DOI 10.1097/01.ASN.0000039608.81046.81; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; van Dijk PCW, 2001, NEPHROL DIAL TRANSPL, V16, P1120, DOI 10.1093/ndt/16.6.1120; Wong G, 2009, J AM SOC NEPHROL, V20, P1341, DOI 10.1681/ASN.2008090998	20	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165026	10.1371/journal.pone.0165026	http://dx.doi.org/10.1371/journal.pone.0165026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828975	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300025
J	Notohamiprodjo, M; Kalnins, A; Andrassy, M; Kolb, M; Ehle, B; Mueller, S; Thomas, MN; Werner, J; Guba, M; Nikolaou, K; Andrassy, J				Notohamiprodjo, Mike; Kalnins, Aivars; Andrassy, Martin; Kolb, Manuel; Ehle, Benjamin; Mueller, Susanna; Thomas, Michael N.; Werner, Jens; Guba, Markus; Nikolaou, Konstantin; Andrassy, Joachim			Multiparametric Functional MRI: A Tool to Uncover Subtle Changes following Allogeneic Renal Transplantation	PLOS ONE			English	Article							SPIN-LABELING MRI; LONG-TERM; ALLOGRAFT SURVIVAL; UNITED-STATES; IN-VIVO; DIFFUSION; PERFUSION; KIDNEY; MICE; PARAMETERS	Purpose To investigate multiparametric functional MRI to characterize acute rejection in a murine allogeneic renal transplant model and evaluate the effect of novel therapeutics. Material and Methods We performed allogeneic and syngeneic orthotopic transplantations (Balb/c to C57Bl/6 and C57Bl/6 to C57Bl/6). Allogeneic Groups (n = 5) were either treated with the anti-CCL2-Spiegelmer (mNOX-E36) in monotherapy or in combination with low doses of Ciclosporin-A (10mg/kgBW/d) for 10 days. Controls received equivalent doses of a non-functional spiegelmer (revmNOX-E36) or low dose Ciclosporin-A. Diffusion-weighted (DWI) and Dynamic-contrast-enhanced (DCE-) MRI-scans were performed using a clinical 3T-scanner. DWI analysis (b-values from 0-800 s/mm(2)) was performed mono-and biexponentially, while DCE-MRI was assessed with deconvolution analysis. Therapy effects were assessed ex vivo with histopathology, immunohistochemistry and RT-PCR. Statistical analysis was performed with unpaired t-tests and Spearman As correlation coefficient. Results DWI showed a significant diffusion restriction in allogeneic compared to syngeneic transplants (ADC: 0.63 +/- 0.08 vs. 1.29 +/- 0.12 mm(2)/s*10(3)) with decreasing diffusion restriction under therapy. DCE-MRI showed restored organ perfusion under Ciclosporin A alone and combination therapy (Plasma Flow: 43.43 +/- 12.49; 38.75 +/- 7.53ml/100ml/min) compared to syngeneic controls (51.03 +/- 12.49ml/100ml/min). Ex vivo analysis showed reduced monocytic infiltrates, attenuated levels of inflammatory cytokines under mNOX-E36 monotherapy with an additive effect of low dose Ciclosporin A. There was a significant (p<0.05) negative correlation between ADC and interstitial inflammation (r = -0.73) or macrophage infiltration (r = -0.81) and between organ perfusion and intimal arteritis (r = -0.63). Conclusion Multiparametric functional MRI is suited to detect renal allograft rejection in an experimental murine model and allows to characterize effects of immunosuppressive therapy alleviating acute rejection processes in allogeneic transplantation.	[Notohamiprodjo, Mike; Kolb, Manuel; Nikolaou, Konstantin] Univ Hosp Tuebingen, Dept Radiol, Tubingen, Germany; [Notohamiprodjo, Mike; Kolb, Manuel] Univ Hosp Munich, Dept Clin Radiol, Munich, Germany; [Kalnins, Aivars; Ehle, Benjamin; Thomas, Michael N.; Werner, Jens; Guba, Markus; Andrassy, Joachim] Univ Hosp Munich, Dept Surg, Munich, Germany; [Andrassy, Martin] Rupprecht Karls Univ, Dept Med, Heidelberg, Germany; [Mueller, Susanna] Ludwig Maximilians Univ Munchen, Dept Pathol, Munich, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; University of Munich; Ruprecht Karls University Heidelberg; University of Munich	Notohamiprodjo, M (corresponding author), Univ Hosp Tuebingen, Dept Radiol, Tubingen, Germany.; Notohamiprodjo, M (corresponding author), Univ Hosp Munich, Dept Clin Radiol, Munich, Germany.	Mike.Notohamiprodjo@med.uni-tuebingen.de	Guba, Markus/M-4309-2019		Else-Kroner-Fresenius Stiftung [A 80/09]; Fbrderprogramm fur Forschung und Lehre of the Ludwig-Maximilians-University Munich [762]	Else-Kroner-Fresenius Stiftung; Fbrderprogramm fur Forschung und Lehre of the Ludwig-Maximilians-University Munich	This work was supported by the Else-Kroner-Fresenius Stiftung (J.A. A 80/09) and by the Fbrderprogramm fur Forschung and Lehre (Antr. 762) of the Ludwig-Maximilians-University Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2004, J IMMUNOL, V172, P767, DOI 10.4049/jimmunol.172.2.767; Belperio JA, 2001, J CLIN INVEST, V108, P547, DOI 10.1172/JCI200112214; Braunagel M, 2016, INVEST RADIOL, V51, P316, DOI 10.1097/RLI.0000000000000245; Broecker V, 2015, TRANSPL INT, V28, P136, DOI 10.1111/tri.12446; Callot V, 2003, MAGN RESON MED, V50, P531, DOI 10.1002/mrm.10568; Chandarana H, 2011, INVEST RADIOL, V46, P285, DOI 10.1097/RLI.0b013e3181ffc485; Darisipudi MN, 2011, AM J PATHOL, V179, P116, DOI 10.1016/j.ajpath.2011.03.004; Eisenberger U, 2010, EUR RADIOL, V20, P1374, DOI 10.1007/s00330-009-1679-9; Franke M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114737; Furness PN, 2003, AM J SURG PATHOL, V27, P805, DOI 10.1097/00000478-200306000-00012; Gondos A, 2012, KIDNEY GRAFT SURVIVA; Hancock WW, 2003, IMMUNOL REV, V196, P37, DOI 10.1046/j.1600-065X.2003.00084.x; Heusch P, 2014, J MAGN RESON IMAGING, V40, P84, DOI 10.1002/jmri.24336; Heusch P, 2013, ACTA RADIOL, V54, P1210, DOI 10.1177/0284185113491090; Heusch P, 2013, INVEST RADIOL, V48, P140, DOI 10.1097/RLI.0b013e318277bfe3; Hoffmann S., 2011, CURR PROTOC NUCL ACI, V4, P41; Hueper K, 2016, INVEST RADIOL, V51, P58, DOI 10.1097/RLI.0000000000000205; Hueper K, 2014, RADIOLOGY, V270, P117, DOI 10.1148/radiol.13130367; Hueper K, 2012, INVEST RADIOL, V47, P430, DOI 10.1097/RLI.0b013e31824f272d; Hueper K, 2011, EUR RADIOL, V21, P2427, DOI 10.1007/s00330-011-2189-0; Johnston DR, 2002, FRONT BIOSCI-LANDMRK, V7, pE116, DOI 10.2741/johnston; Kalnins A, 2015, SCAND J IMMUNOL; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; Kulkarni O, 2009, J PHARMACOL EXP THER, V328, P371, DOI 10.1124/jpet.108.142711; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Lanzman RS, 2013, RADIOLOGY, V266, P218, DOI 10.1148/radiol.12112522; Lanzman RS, 2010, EUR RADIOL, V20, P1485, DOI 10.1007/s00330-009-1675-0; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lee YR, 2005, BLOOD, V105, P3951, DOI 10.1182/blood-2004-10-3927; Lodhi SA, 2011, AM J TRANSPLANT, V11, P1226, DOI 10.1111/j.1600-6143.2011.03539.x; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Ninichuk V, 2008, AM J PATHOL, V172, P628, DOI 10.2353/ajpath.2008.070601; Notohamiprodjo M, 2014, MAGNETIC RESONANCE M; Notohamiprodjo M, 2008, INVEST RADIOL, V43, P677, DOI 10.1097/RLI.0b013e31817d14e6; Notohamiprodjo M, 2010, EUR J RADIOL, V76, P337, DOI 10.1016/j.ejrad.2010.05.033; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; RUSSELL PS, 1978, J EXP MED, V147, P1449, DOI 10.1084/jem.147.5.1449; Wirestam R, 2001, ACTA RADIOL, V42, P123, DOI 10.1080/028418501127346459; Yang DW, 2004, RADIOLOGY, V231, P702, DOI 10.1148/radiol.2313021587	39	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165532	10.1371/journal.pone.0165532	http://dx.doi.org/10.1371/journal.pone.0165532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820833	Green Submitted, Green Published, gold			2022-12-27	WOS:000387614800012
J	Huang, P; Huang, HH; Luo, QL; Mo, L				Huang, Ping; Huang, Hanhua; Luo, Qiuling; Mo, Lei			The Difference between Aesthetic Appreciation of Artistic and Popular Music: Evidence from an fMRI Study	PLOS ONE			English	Article							BRAIN; EMOTION; SYSTEMS; ATTENTION; REWARDS; EMPATHY	To test the hypothesis that pleasure from artistic music is intellectual while that from popular music is physiological, this study investigated the different functional mechanisms between aesthetic appreciation of artistic and popular music using fMRI. 18 male non-musicians were scanned while they performed an aesthetic rating task for excerpts of artistic music, popular music and musical notes playing and singing (control). The rating scores of artistic and popular music excerpts were both significantly higher than that of control materials while the scores of them were not different. The fMRI results showed both artistic and popular conditions activated the VS and vmPFC, compared with control condition. When contrasted popular and artistic condition directly, we found popular music activated right putamen, while artistic music activated right mPFC. By parametric analysis, we found the activation of right putamen tracked the aesthetic ratings of popular music, whereas the BOLD signal in right mPFC tracked the aesthetic ratings of artistic music. These results indicate the reward induced by popular music is closer to a primary reward while that induced by artistic music is closer to a secondary reward. We also found artistic music activated ToM areas, including PCC/PC, arMFC and TPJ, when compared with popular music. And these areas also tracked aesthetic ratings of artistic music but not those of popular music. These results imply that the pleasure from former comes from cognitive empathy. In conclusion, this study gives clear neuronal evidences supporting the view that artistic music is of intelligence and social cognition involved while the popular music is of physiology.	[Huang, Ping; Luo, Qiuling; Mo, Lei] South China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Huang, Hanhua] South China Normal Univ, Sch Mus, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University	Mo, L (corresponding author), South China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	molei@scnu.edu.cn			National Natural Science Foundation of China (NSFC) [31170997]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The work is supported by National Natural Science Foundation of China (NSFC, No. 31170997). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno Theodor, 2002, ESSAYS MUSIC; Berenson Bernard, 1964, SELECTED LETT B BERE; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bray S, 2007, J NEUROPHYSIOL, V97, P3036, DOI 10.1152/jn.01211.2006; Brown S, 2004, NEUROREPORT, V15, P2033, DOI 10.1097/00001756-200409150-00008; Brown S, 2011, NEUROIMAGE, V58, P250, DOI 10.1016/j.neuroimage.2011.06.012; Cabeza R., 2010, SOCIAL COGNITIVE AFF, V6, P138; Cinzia D, 2009, CURR OPIN NEUROBIOL, V19, P682, DOI 10.1016/j.conb.2009.09.001; Cupchik GC, 2002, CULT PSYCHOL, V8, P155, DOI 10.1177/1354067X02008002437; Di Dio C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001201; Engelmann JB, 2009, BRAIN RES, V1290, P28, DOI 10.1016/j.brainres.2009.06.078; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; Geday J, 2009, BRAIN COGNITION, V69, P344, DOI 10.1016/j.bandc.2008.08.009; Gracyk T., 2007, LISTENING POPULAR MU; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Ishizu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021852; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kirk U, 2009, BRAIN COGNITION, V69, P306, DOI 10.1016/j.bandc.2008.08.004; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Mende-Siedlecki P, 2012, SOCIAL COGNITIVE AFF; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Mohanty A, 2007, PSYCHOPHYSIOLOGY, V44, P343, DOI 10.1111/j.1469-8986.2007.00515.x; Nummenmaa L, 2008, NEUROIMAGE, V43, P571, DOI 10.1016/j.neuroimage.2008.08.014; O'Doherty J, 2003, J NEUROSCI, V23, P7931; Sescousse G, 2013, NEUROSCI BIOBEHAV R, V37, P681, DOI 10.1016/j.neubiorev.2013.02.002; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Trost W, 2012, CEREB CORTEX, V22, P2769, DOI 10.1093/cercor/bhr353; Vartanian O, 2004, NEUROREPORT, V15, P893, DOI 10.1097/00001756-200404090-00032; Vessel EA, 2012, FRONT HUM NEUROSCI, V6; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wang T, 2014, SOCIAL COGNITIVE AFF; Warburg Aby, 1999, RENEWAL PAGAN ANTIQU; Winston JS, 2007, NEUROPSYCHOLOGIA, V45, P195, DOI 10.1016/j.neuropsychologia.2006.05.009; Yu HC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066447, 10.1371/journal.pone.0055705, 10.1371/journal.pone.0057111]	38	6	6	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165377	10.1371/journal.pone.0165377	http://dx.doi.org/10.1371/journal.pone.0165377			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814379	Green Published, gold, Green Submitted			2022-12-27	WOS:000386911100009
J	Wagland, R; Brindle, L; Ewings, S; James, E; Moore, M; Rivas, C; Esqueda, AI; Corner, J				Wagland, Richard; Brindle, Lucy; Ewings, Sean; James, Elizabeth; Moore, Mike; Rivas, Carol; Esqueda, Ana Ibanez; Corner, Jessica			Promoting Help-Seeking in Response to Symptoms amongst Primary Care Patients at High Risk of Lung Cancer: A Mixed Method Study	PLOS ONE			English	Article							DIAGNOSIS; DELAY; GP; EXPERIENCES; AWARENESS; SURVIVAL; IMPACT; UK	Background Lung cancer symptoms are vague and difficult to detect. Interventions are needed to promote early diagnosis, however health services are already pressurised. This study explored symptomology and help-seeking behaviours of primary care patients at 'high-risk' of lung cancer (>= 50 years old, recent smoking history), to inform targeted interventions. Methods Mixed method study with patients at eight general practitioner (GP) practices across south England. Study incorporated: postal symptom questionnaire; clinical records review of participant consultation behaviour 12 months pre-and post-questionnaire; qualitative participant interviews (n = 38) with a purposive sample. Results A small, clinically relevant group (n = 61/908, 6.7%) of primary care patients was identified who, despite reporting potential symptoms of lung cancer in questionnaires, had not consulted a GP >= 12 months. Of nine symptoms associated with lung cancer, 53.4% (629/1172) of total respondents reported >= 1, and 35% (411/1172) reported >= 2. Most participants (77.3%, n = 686/908) had comorbid conditions; 47.8%, (n = 414/908) associated with chest and respiratory symptoms. Participant consulting behaviour significantly increased in the 3-month period following questionnaire completion compared with the previous 3month period (p = .002), indicating questionnaires impacted upon consulting behaviour. Symptomatic non-consulters were predominantly younger, employed, with higher multiple deprivation scores than their GP practice mean. Of symptomatic non-consulters, 30% (18/61) consulted <= 1 month post-questionnaire, with comorbidities subsequently diagnosed for five participants. Interviews ( n = 39) indicated three overarching differences between the views of consulting and non-consulting participants: concern over wasting their own as well as GP time; high tolerance threshold for symptoms; a greater tendency to self-manage symptoms. Conclusions This first study to examine symptoms and consulting behaviour amongst a primary care population at 'high-risk' of lung cancer, found symptomatic patients who rarely consult GPs, might respond to a targeted symptom elicitation intervention. Such GP-based interventions may promote early diagnosis of lung cancer or other comorbidities, without burdening already pressurised services.	[Wagland, Richard; Brindle, Lucy; James, Elizabeth; Rivas, Carol; Esqueda, Ana Ibanez] Univ Southampton, Fac Hlth Sci, Southampton SO17 1BJ, Hants, England; [Ewings, Sean] Univ Southampton, Southampton Stat Sci Res Inst, Fac Social Human & Math Sci, Southampton, Hants, England; [Moore, Mike] Univ Southampton, Fac Med, Southampton SO17 1BJ, Hants, England; [Corner, Jessica] Univ Nottingham, Execut Off, Univ Pk, Nottingham NG7 2RD, England	University of Southampton; University of Southampton; University of Southampton; University of Nottingham	Wagland, R (corresponding author), Univ Southampton, Fac Hlth Sci, Southampton SO17 1BJ, Hants, England.	R.Wagland@soton.ac.uk	rivas, carol/Q-1196-2015; Moore, Michael/C-3447-2011	rivas, carol/0000-0002-0316-8090; Moore, Michael/0000-0002-5127-4509; Wagland, Richard/0000-0003-1825-7587; Corner, Jessica/0000-0002-2240-8133; Ewings, Sean/0000-0001-7214-4917	National Awareness and Early Diagnosis Initiative (NAEDI) [C3801/A14137]; National Institute for Health Research [14/156/15] Funding Source: researchfish	National Awareness and Early Diagnosis Initiative (NAEDI); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the National Awareness and Early Diagnosis Initiative (NAEDI), grant number C3801/A14137.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athey VL, 2012, THORAX, V67, P412, DOI 10.1136/thoraxjnl-2011-200714; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Birt L, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000067; Biswas M, 2015, BRIT J CANCER, V112, P271, DOI 10.1038/bjc.2014.597; Bowen EF, 2002, LUNG CANCER-J IASLC, V37, P227, DOI 10.1016/S0169-5002(02)00143-5; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brindle LA, 2014, EUR J CANCER CARE, V23, P3; Brindle LA, 2015, BEHALF IPCARD FEASIB; Brindle L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001977; Cancer Research UK, 2014, BE CLEAR CANC EV SUM; Chambers SK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-184; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Corner J, 2005, THORAX, V60, P314, DOI 10.1136/thx.2004.029264; Corner J, 2006, THORAX, V60, P1382; Corner J, 2011, J EPIDEMIOL COMMUN H, V65, P477, DOI 10.1136/jech.2008.084285; Cromme SK, 2016, BRIT J GEN PRACT, V66, pE474, DOI 10.3399/bjgp16X685621; Department of Health, 2014, IMPR OUTC STRAT CANC; Hamilton W, 2005, THORAX, V60, P1059, DOI 10.1136/thx.2005.045880; Hamilton W, 2004, FAM PRACT, V21, P605, DOI 10.1093/fampra/cmh605; Hamilton W, 2009, BRIT J CANCER, V101, pS80, DOI 10.1038/sj.bjc.6605396; Hippisley-Cox J, 2013, BR J GEN PRACT; Hippisley-Cox J, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606627; Ironmonger L, 2015, BRIT J CANCER, V112, P207, DOI 10.1038/bjc.2014.596; Lyratzopoulos G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7400; Moffat J, 2015, BRIT J CANCER, V112, pS14, DOI 10.1038/bjc.2015.31; Molassiotis A, 2010, EUR J CANCER CARE, V19, P98, DOI 10.1111/j.1365-2354.2008.01020.x; Murray SR, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008046; Newcombe RG, 1998, STAT MED, V17, P2635, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2635::AID-SIM954>3.0.CO;2-C; O'Dowd EL, 2015, THORAX, V70, P161, DOI 10.1136/thoraxjnl-2014-205692; PULSE, 2014, 3 WEEK COUGH LUNG CA; Richards MA, 2009, BRIT J CANCER, V101, pS125, DOI 10.1038/sj.bjc.6605402; Rose PW, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007212; Rubin G, 2006, BRIT J GEN PRACT, V56, P743; Scott SE, 2013, BRIT J HEALTH PSYCH, V18, P45, DOI 10.1111/j.2044-8287.2012.02077.x; Simon AE, 2010, CANCER EPIDEM BIOMAR, V19, P2272, DOI 10.1158/1055-9965.EPI-10-0219; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Smith SM, 2009, THORAX, V64, P523, DOI 10.1136/thx.2008.096560; Smith S, 2013, BRIT J GEN PRACT, V63, DOI 10.3399/bjgp13X660779; Walter FM, 2015, BRIT J CANCER, V112, pS6, DOI 10.1038/bjc.2015.30; Walton L, 2013, FAM PRACT; Weller D, 2012, BRIT J CANCER, V106, P1262, DOI 10.1038/bjc.2012.68; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208	42	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165677	10.1371/journal.pone.0165677	http://dx.doi.org/10.1371/journal.pone.0165677			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814375	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000386911100013
J	Wang, T; Meng, J; Li, L; Zhang, GF				Wang, Ting; Meng, Jie; Li, Li; Zhang, Guofan			Characterization of CgHIF alpha-Like, a Novel bHLH-PAS Transcription Factor Family Member, and Its Role under Hypoxia Stress in the Pacific Oyster Crassostrea gigas	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; PROLYL HYDROXYLASES PHD1; GENE-EXPRESSION; LITTORINA-LITTOREA; ENERGY-METABOLISM; PROLONGED ANOXIA; SEASONAL-CHANGE; MESSENGER-RNA; T-LYMPHOCYTES; FACTOR-LOT	Hypoxia-inducible factor (HIF), a critical member of the basic-helix-loop-helix (bHLH)-containing Per-Arnt-Sim (PAS) protein family, is a master transcription factor involved in maintaining oxygen homeostasis. In the present study, we isolated and characterized a novel bHLH-PAS family member, CgHIF alpha-like gene, from the Pacific oyster Crassostrea gigas, and determined its importance during hypoxia stress. The 3020-bp CgHIF alpha-like cDNA encoded a protein of 888 amino acids. The predicted CgHIF alpha-like amino acid sequence was conserved in the N-terminal bHLH, PAS, and PAC domains (but not in the C-terminal domain) and was most closely related to the HIF family in the bHLH-PAS protein phylogenic tree. Similar to the mammalian HIF-1a, CgHIF alpha-like could be expressed as four mRNA iso-forms containing alternative 50-untranslated regions and different translation initiation codons. At the mRNA level, these isoforms were expressed in a tissue-specific manner and showed increased transcription to varying degrees under hypoxic conditions. Additionally, the western blot analysis demonstrated that CgHIF alpha-like was induced by hypoxia. Electrophoretic mobility shift assay indicated that CgHIF alpha-like could bind to the hypoxia responsive element (HRE), whereas dual-luciferase reporter analysis demonstrated that CgHIF alpha-like could transactivate the reporter gene containing the HREs. In addition to CgHIF alpha-like, we identified CgARNT from the C. gigas, analyzed its expression pattern, and confirmed its interaction with CgHIF alpha-like using a yeast two-hybrid assay. In conclusion, this is the first report on the cloning and characterization of a novel hypoxia transcription factor in mollusks, which could accumulate under hypoxia and regulate hypoxia related gene expression by binding to HRE and dimerizing with CgARNT. As only one member of HIF has been identified in invertebrates to date, our results provide new insights into the unique mechanisms of hypoxia tolerance in mollusks.	[Wang, Ting; Meng, Jie; Li, Li; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Wang, Ting] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Ting; Zhang, Guofan] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Meng, Jie; Li, Li] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries & Aquaculture, Qingdao, Shandong, Peoples R China; [Wang, Ting; Meng, Jie; Li, Li; Zhang, Guofan] Chinese Acad Sci, Natl & Local Joint Engn Lab Ecol Mariculture, Inst Oceanol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Qingdao National Laboratory for Marine Science & Technology; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS	Li, L; Zhang, GF (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.; Zhang, GF (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Li, L (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries & Aquaculture, Qingdao, Shandong, Peoples R China.; Li, L; Zhang, GF (corresponding author), Chinese Acad Sci, Natl & Local Joint Engn Lab Ecol Mariculture, Inst Oceanol, Qingdao, Peoples R China.	lili@qdio.ac.cn; gfzhang@qdio.ac.cn	li, li/GPX-3938-2022; LI, LI/GVS-5344-2022; li, li/HII-4157-2022; Li, Li/AEM-3636-2022		National Basic Research Program of China (973 Program) [2010CB126401]; National Natural Science Foundation of China [31530079]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-48]; Taishan Scholars Climbing Program of Shandong	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for Modern Agro-industry Technology Research System; Taishan Scholars Climbing Program of Shandong	The authors would like to thank Prof. Cunming Duan (University of Michigan) for providing the p2.1 reporter gene. This research was supported by National Basic Research Program of China (973 Program, No.2010CB126401), the National Natural Science Foundation of China (31530079), the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-48), and Taishan Scholars Climbing Program of Shandong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Azevedo SV, 2011, J INSECT PHYSIOL, V57, P38, DOI 10.1016/j.jinsphys.2010.09.004; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Boutilier RG, 2001, J EXP BIOL, V204, P3171; Bracken CP, 2003, CELL MOL LIFE SCI, V60, P1376, DOI 10.1007/s00018-003-2370-y; Brahimi-Horn MC, 2007, FEBS LETT, V581, P3582, DOI 10.1016/j.febslet.2007.06.018; Cai XH, 2014, GENE, V534, P256, DOI 10.1016/j.gene.2013.10.048; Choi SH, 2013, FISH SHELLFISH IMMUN, V35, P476, DOI 10.1016/j.fsi.2013.05.001; Depping R, 2004, BIOL REPROD, V71, P331, DOI 10.1095/biolreprod.104.027797; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Du YS, 2013, FISH SHELLFISH IMMUN, V34, P939, DOI 10.1016/j.fsi.2012.12.007; EBERLEE JC, 1983, CAN J ZOOL, V61, P2682, DOI 10.1139/z83-353; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Feala JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100139; Gao S, 2014, FASEB J, V28, P1880, DOI 10.1096/fj.12-220152; Giannetto A, 2015, MAR BIOTECHNOL, V17, P768, DOI 10.1007/s10126-015-9655-7; Gorr TA, 2006, J INSECT PHYSIOL, V52, P349, DOI 10.1016/j.jinsphys.2006.01.002; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; Greenway SC, 2001, CAN J ZOOL, V79, P907, DOI 10.1139/cjz-79-5-907; Greenway SC, 2000, J COMP PHYSIOL B, V170, P285, DOI 10.1007/s003600000098; Hampton-Smith RJ, 2009, ANN NY ACAD SCI, V1177, P19, DOI 10.1111/j.1749-6632.2009.05035.x; Hardy KM, 2012, COMP BIOCHEM PHYS A, V163, P137, DOI 10.1016/j.cbpa.2012.05.195; Hoback WW, 2001, J INSECT PHYSIOL, V47, P533, DOI 10.1016/S0022-1910(00)00153-0; Hochachka PW, 2001, COMP BIOCHEM PHYS B, V130, P435, DOI 10.1016/S1096-4959(01)00408-0; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kawabe S, 2012, MAR BIOTECHNOL, V14, P106, DOI 10.1007/s10126-011-9394-3; Kawabe S, 2010, FISHERIES SCI, V76, P841, DOI 10.1007/s12562-010-0263-1; Kietzmann T, 2001, BIOCHEM J, V354, P531, DOI 10.1042/0264-6021:3540531; Larade K, 2002, MOL CELL BIOCHEM, V232, P121, DOI 10.1023/A:1014811017753; Larade K., 2002, CELL MOL RESPONSES S, P27, DOI DOI 10.1016/S1568-1254(02)80005-5; Le Moullac G, 2007, MAR BIOL RES, V3, P357, DOI 10.1080/17451000701635128; Li TD, 2007, COMP BIOCHEM PHYS B, V147, P11, DOI 10.1016/j.cbpb.2006.12.018; LINDEBRO MC, 1995, EMBO J, V14, P3528, DOI 10.1002/j.1460-2075.1995.tb07359.x; Liu CC, 2014, MAR ENVIRON RES, V99, P44, DOI 10.1016/j.marenvres.2014.05.012; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Lukashev D, 2001, J BIOL CHEM, V276, P48754, DOI 10.1074/jbc.M104782200; Lukashev D, 2008, HUM IMMUNOL, V69, P421, DOI 10.1016/j.humimm.2008.05.004; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Nambu JR, 1996, GENE, V172, P249, DOI 10.1016/0378-1119(96)00060-1; Piontkivska H, 2011, COMP BIOCHEM PHYS D, V6, P103, DOI 10.1016/j.cbd.2010.10.003; Portner HO, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002561; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Rytkonen KT, 2014, GENE, V541, P60, DOI 10.1016/j.gene.2014.03.007; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Sonanez-Organis JG, 2009, COMP BIOCHEM PHYS C, V150, P395, DOI 10.1016/j.cbpc.2009.06.005; STICKLE WB, 1989, BIOL BULL, V177, P303, DOI 10.2307/1541945; Storey KB, 2004, INT CONGR SER, V1275, P47, DOI 10.1016/j.ics.2004.08.072; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Sussarellu R, 2012, J EXP MAR BIOL ECOL, V412, P87, DOI 10.1016/j.jembe.2011.11.007; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tokishita SI, 2006, GENE, V376, P231, DOI 10.1016/j.gene.2006.03.022; WANG GC, 2014, PLOS ONE, V9; WANG GL, 1993, J BIOL CHEM, V268, P21513; WIDDOWS J, 1989, BIOL BULL, V177, P154, DOI 10.2307/1541843; Wiener CM, 1996, BIOCHEM BIOPH RES CO, V225, P485, DOI 10.1006/bbrc.1996.1199; Woods SL, 2002, J BIOL CHEM, V277, P10236, DOI 10.1074/jbc.M110752200; Wu R, 2002, MAR POLLUT BULL, V45, P1, DOI 10.1016/S0025-326X(02)00182-0; Yu AY, 1998, AM J PHYSIOL-LUNG C, V275, pL818, DOI 10.1152/ajplung.1998.275.4.L818; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhang P, 2012, AM J PHYSIOL-REG I, V303, pR1165, DOI 10.1152/ajpregu.00340.2012; Zhou D, 2013, ANNU REV GENOM HUM G, V14, P25, DOI 10.1146/annurev-genom-091212-153439	68	9	9	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166057	10.1371/journal.pone.0166057	http://dx.doi.org/10.1371/journal.pone.0166057			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814402	gold, Green Submitted, Green Published			2022-12-27	WOS:000386911100028
J	Aguirre, GK; Datta, R; Benson, NC; Prasad, S; Jacobson, SG; Cideciyan, AV; Bridge, H; Watkins, KE; Butt, OH; Dain, AS; Brandes, L; Gennatas, ED				Aguirre, Geoffrey K.; Datta, Ritobrato; Benson, Noah C.; Prasad, Sashank; Jacobson, Samuel G.; Cideciyan, Artur V.; Bridge, Holly; Watkins, Kate E.; Butt, Omar H.; Dain, Aleksandra S.; Brandes, Lauren; Gennatas, Efstathios D.			Patterns of Individual Variation in Visual Pathway Structure and Function in the Sighted and Blind	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; SURFACE-BASED ANALYSIS; CORTICAL THICKNESS; GEOMETRICALLY ACCURATE; STRIATE CORTEX; FIBER TRACTS; HUMAN BRAIN; DEPRIVATION; VOLUME; AREAS	Many structural and functional brain alterations accompany blindness, with substantial individual variation in these effects. In normally sighted people, there is correlated individual variation in some visual pathway structures. Here we examined if the changes in brain anatomy produced by blindness alter the patterns of anatomical variation found in the sighted. We derived eight measures of central visual pathway anatomy from a structural image of the brain from 59 sighted and 53 blind people. These measures showed highly significant differences in mean size between the sighted and blind cohorts. When we examined the measurements across individuals within each group we found three clusters of correlated variation, with V1 surface area and pericalcarine volume linked, and independent of the thickness of V1 cortex. These two clusters were in turn relatively independent of the volumes of the optic chiasm and lateral geniculate nucleus. This same pattern of variation in visual pathway anatomy was found in the sighted and the blind. Anatomical changes within these clusters were graded by the timing of onset of blindness, with those subjects with a post-natal onset of blindness having alterations in brain anatomy that were intermediate to those seen in the sighted and congenitally blind. Many of the blind and sighted subjects also contributed functional MRI measures of cross-modal responses within visual cortex, and a diffusion tensor imaging measure of fractional anisotropy within the optic radiations and the splenium of the corpus callosum. We again found group differences between the blind and sighted in these measures. The previously identified clusters of anatomical variation were also found to be differentially related to these additional measures: across subjects, V1 cortical thickness was related to cross-modal activation, and the volume of the optic chiasm and lateral geniculate was related to fractional anisotropy in the visual pathway. Our findings show that several of the structural and functional effects of blindness may be reduced to a smaller set of dimensions. It also seems that the changes in the brain that accompany blindness are on a continuum with normal variation found in the sighted.	[Aguirre, Geoffrey K.; Datta, Ritobrato; Benson, Noah C.; Prasad, Sashank; Butt, Omar H.; Dain, Aleksandra S.; Brandes, Lauren; Gennatas, Efstathios D.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Jacobson, Samuel G.; Cideciyan, Artur V.] Univ Penn, Perelman Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Bridge, Holly] Univ Oxford, FMRIB Ctr, Clin Neurosci, Oxford OX3 9DU, England; [Watkins, Kate E.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Oxford; University of Oxford	Aguirre, GK (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	aguirreg@mail.med.upenn.edu	Cideciyan, Artur V/A-1075-2007; Watkins, Kate E/A-6559-2012	Cideciyan, Artur V/0000-0002-2018-0905; Watkins, Kate E/0000-0002-2621-482X; Jacobson, Samuel/0000-0003-2122-169X; Benson, Noah/0000-0002-2365-8265; Gennatas, Efstathios/0000-0001-9280-3609	National Institutes of Health [R01 EY020516, P30 EY001583, P30 NS045839]; NATIONAL EYE INSTITUTE [P30EY001583, R01EY020516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants R01 EY020516 (GKA), P30 EY001583 (Core Grant for Vision Research), and P30 NS045839 (Neuroscience Neuroimaging Center Core Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 2007, PLOS MED, V4, P1117, DOI 10.1371/journal.pmed.0040230; Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Aleman TS, 2011, INVEST OPHTH VIS SCI, V52, P6898, DOI 10.1167/iovs.11-7701; Andrews TJ, 1997, J NEUROSCI, V17, P2859; Anurova I, 2015, CEREB CORTEX, V25, P2035, DOI 10.1093/cercor/bhu009; Avants B, 2004, NEUROIMAGE, V23, pS139, DOI 10.1016/j.neuroimage.2004.07.010; Bakken TE, 2012, P NATL ACAD SCI USA, V109, P3985, DOI 10.1073/pnas.1105829109; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bedny M, 2011, P NATL ACAD SCI USA, V108, P4429, DOI 10.1073/pnas.1014818108; Benson NC, 2012, CURR BIOL, V22, P2081, DOI 10.1016/j.cub.2012.09.014; Bock AS, 2013, NEUROIMAGE, V81, P325, DOI 10.1016/j.neuroimage.2013.05.038; Bogorodzki P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093682; BOURGEOIS JP, 1989, P NATL ACAD SCI USA, V86, P4297, DOI 10.1073/pnas.86.11.4297; Bridge H, 2009, BRAIN, V132, P3467, DOI 10.1093/brain/awp279; Burge WK, 2016, SCI REP-UK, V6, DOI 10.1038/srep23268; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Burgel U, 1999, NEUROIMAGE, V10, P489, DOI 10.1006/nimg.1999.0497; Butt OH, 2013, J NEUROSCI, V33, P16209, DOI 10.1523/JNEUROSCI.0363-13.2013; Cecchetti L, 2016, BRAIN STRUCT FUNCT, V221, P1465, DOI 10.1007/s00429-014-0984-5; Cideciyan AV, 2007, HUM MUTAT, V28, P1074, DOI 10.1002/humu.20565; Cohen LG, 1999, ANN NEUROL, V45, P451, DOI 10.1002/1531-8249(199904)45:4<451::AID-ANA6>3.0.CO;2-B; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Coullon GSL, 2015, J NEUROPHYSIOL, V113, P2889, DOI 10.1152/jn.01031.2014; Cunningham SI, 2015, VISION RES, V111, P197, DOI 10.1016/j.visres.2014.10.015; d'Almeida OC, 2013, NEUROIMAGE, V81, P222, DOI 10.1016/j.neuroimage.2013.05.032; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deen B, 2015, J COGNITIVE NEUROSCI, V27, P1633, DOI 10.1162/jocn_a_00807; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; DeVolder AG, 1997, BRAIN RES, V750, P235, DOI 10.1016/S0006-8993(96)01352-2; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frank SM, 2016, CEREB CORTEX, V26, P1211, DOI 10.1093/cercor/bhu309; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Hernowo AT, 2014, CORTEX, V56, P99, DOI 10.1016/j.cortex.2013.01.003; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; INNOCENTI GM, 1984, DEV BRAIN RES, V14, P143, DOI 10.1016/0165-3806(84)90019-1; Jiang JF, 2009, J NEUROSCI, V29, P2205, DOI 10.1523/JNEUROSCI.5451-08.2009; Kucera H., 1967, COMPUTATIONAL ANAL P; Lepore N, 2010, NEUROIMAGE, V49, P134, DOI 10.1016/j.neuroimage.2009.07.048; Levin N, 2010, NEURON, V65, P21, DOI 10.1016/j.neuron.2009.12.006; Li QJ, 2017, BRAIN IMAGING BEHAV, V11, P1029, DOI 10.1007/s11682-016-9576-8; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Noppeney U, 2005, CURR BIOL, V15, pR488, DOI 10.1016/j.cub.2005.06.053; Pan WJ, 2007, NEUROIMAGE, V37, P212, DOI 10.1016/j.neuroimage.2007.05.014; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Park HJ, 2009, NEUROIMAGE, V47, P98, DOI 10.1016/j.neuroimage.2009.03.076; Pearce E, 2013, ANN HUM BIOL, V40, P531, DOI 10.3109/03014460.2013.815272; Plank T, 2011, NEUROIMAGE, V56, P1556, DOI 10.1016/j.neuroimage.2011.02.055; Prins D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146684; Ptito M, 2008, EXP BRAIN RES, V187, P41, DOI 10.1007/s00221-008-1273-4; Reislev NL, 2016, BRAIN STRUCT FUNCT, V221, P2891, DOI 10.1007/s00429-015-1078-8; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shimony JS, 2006, CEREB CORTEX, V16, P1653, DOI 10.1093/cercor/bhj102; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Song C, 2015, NEURON, V85, P641, DOI 10.1016/j.neuron.2014.12.041; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Taki Y, 2013, HUM BRAIN MAPP, V34, P1842, DOI 10.1002/hbm.22027; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Tomaiuolo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107871; VERAART C, 1990, BRAIN RES, V510, P115, DOI 10.1016/0006-8993(90)90735-T; Voss P, 2015, NEUROIMAGE, V108, P194, DOI 10.1016/j.neuroimage.2014.12.063; Voss P, 2014, BRAIN, V137, P1224, DOI 10.1093/brain/awu030; Voss P, 2012, CEREB CORTEX, V22, P2455, DOI 10.1093/cercor/bhr311; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang JJ, 2002, MAGN RESON MED, V48, P242, DOI 10.1002/mrm.10211; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Yu LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073208; Zhang Y, 2012, BRAIN RES, V1458, P34, DOI 10.1016/j.brainres.2012.04.012	81	29	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164677	10.1371/journal.pone.0164677	http://dx.doi.org/10.1371/journal.pone.0164677			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812129	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000011
J	Gonzalez, CC; Mon-Williams, M; Burke, S; Burke, MR				Gonzalez, Claudia C.; Mon-Williams, Mark; Burke, Siobhan; Burke, Melanie R.			Cognitive Control of Saccadic Eye Movements in Children with Developmental Coordination Disorder	PLOS ONE			English	Article							SUPERIOR COLLICULUS; VOLUNTARY CONTROL; INTERNAL-MODEL; ATTENTION; INITIATION; FIXATION; BEHAVIOR; ABILITY; DEFICIT; FIELD	The ability to use advance information to prepare and execute a movement requires cognitive control of behaviour (e.g., anticipation and inhibition). Our aim was to explore the integrity of saccadic eye movement control in developmental coordination disorder (DCD) and typically developing (TD) children (8-12 years) and assess how these children plan and inhibit saccadic responses, the principal mechanisms within visual attention control. Eye movements and touch responses were measured (separately and concurrently) in Cued and Non-Cued conditions. We found that children with DCD had similar saccade kinematics to the TD group during saccade initiation. Advance information decreased hand movement duration in both groups during Cued trials, but decrements in accuracy were significantly worse in the DCD group. In addition, children with DCD exhibited greater inhibitory errors and inaccurate fixation during the Cued trials. Thus, children with DCD were reasonably proficient in executing saccades during reflexive (Non-Cued) conditions, but showed deficits in more complex control processes involving prediction and inhibition. These findings have implications for our understanding of motor control in children with DCD.	[Gonzalez, Claudia C.] Brunel Univ London, Coll Hlth & Life Sci, Sports Hlth & Exercise Sci, Uxbridge, Middx, England; [Mon-Williams, Mark; Burke, Melanie R.] Univ Leeds, Sch Psychol, Fac Med & Hlth, Leeds, W Yorkshire, England; [Burke, Siobhan] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England	Brunel University; University of Leeds; University of East Anglia	Gonzalez, CC (corresponding author), Brunel Univ London, Coll Hlth & Life Sci, Sports Hlth & Exercise Sci, Uxbridge, Middx, England.	Claudia.Gonzalez@brunel.ac.uk		Mon-Williams, Mark/0000-0001-7595-8545; Burke, Melanie/0000-0002-2561-053X				Adams ILJ, 2014, NEUROSCI BIOBEHAV R, V47, P225, DOI 10.1016/j.neubiorev.2014.08.011; Alahyane N, 2014, NEUROIMAGE, V98, P103, DOI 10.1016/j.neuroimage.2014.03.008; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; BAHILL AT, 1975, INVEST OPHTH VISUAL, V14, P317; Black D.W., 2014, DSM 5 GUIDEBOOK ESSE; BRONSTEIN AM, 1987, VISION RES, V27, P517, DOI 10.1016/0042-6989(87)90037-X; Burke MR, 2008, CEREB CORTEX, V18, P126, DOI 10.1093/cercor/bhm038; Chen-Harris H, 2008, J NEUROSCI, V28, P2804, DOI 10.1523/JNEUROSCI.5300-07.2008; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Gonzalez CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117783; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Izawa Y, 2009, J NEUROPHYSIOL, V102, P2410, DOI 10.1152/jn.00234.2009; Katschmarsky S, 2001, EXP BRAIN RES, V136, P73, DOI 10.1007/s002210000535; Kirby A, 2014, ARCH DIS CHILD, V99, P292, DOI 10.1136/archdischild-2012-303569; LOSSE A, 1991, DEV MED CHILD NEUROL, V33, P55, DOI 10.1111/j.1469-8749.1991.tb14785.x; Majerus S, 2016, CEREB CORTEX, V26, P166, DOI 10.1093/cercor/bhu189; Mandich A, 2002, BRAIN COGNITION, V50, P150, DOI 10.1016/S0278-2626(02)00020-9; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Munoz DP, 2003, J NEUROPHYSIOL, V90, P503, DOI 10.1152/jn.00192.2003; Quaia C, 1999, J NEUROPHYSIOL, V82, P999, DOI 10.1152/jn.1999.82.2.999; ROBINSON DA, 1973, KYBERNETIK, V14, P71, DOI 10.1007/BF00288906; Sparks D, 2000, VISION RES, V40, P2763, DOI 10.1016/S0042-6989(00)00133-4; Tsai CL, 2010, RES DEV DISABIL, V31, P642, DOI 10.1016/j.ridd.2010.01.003; Wilmut K, 2006, CHILD CARE HLTH DEV, V32, P665, DOI 10.1111/j.1365-2214.2006.00678.x; Wilmut K, 2008, EXP BRAIN RES, V191, P403, DOI 10.1007/s00221-008-1532-4; Wilmut K, 2007, DISABIL REHABIL, V29, P47, DOI 10.1080/09638280600947765; Wilson PH, 1998, J CHILD PSYCHOL PSYC, V39, P829, DOI 10.1111/1469-7610.00384; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Zwicker JG, 2012, EUR J PAEDIATR NEURO, V16, P573, DOI 10.1016/j.ejpn.2012.05.005; Zwicker JG, 2011, INT J DEV NEUROSCI, V29, P145, DOI 10.1016/j.ijdevneu.2010.12.002; Zwicker JG, 2009, J CHILD NEUROL, V24, P1273, DOI 10.1177/0883073809333537	32	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165380	10.1371/journal.pone.0165380	http://dx.doi.org/10.1371/journal.pone.0165380			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812128	Green Accepted, Green Published, gold			2022-12-27	WOS:000386910000028
J	Martel, C; Cairampoma, L; Stauffer, FW; Ayasse, M				Martel, Carlos; Cairampoma, Lianka; Stauffer, Fred W.; Ayasse, Manfred			Telipogon peruvianus (Orchidaceae) Flowers Elicit Pre-Mating Behaviour in Eudejeania (Tachinidae) Males for Pollination	PLOS ONE			English	Article							SEXUALLY DECEPTIVE ORCHID; GEOBLASTA-PENNICILLATA; CHEMICAL COMMUNICATION; OPHRYS ORCHIDACEAE; DRIVEN SPECIATION; MASS-SPECTROMETRY; FUNGUS GNATS; TRAP-FLOWERS; ODOR SIGNALS; HOUSE-FLY	Several neotropical orchid genera have been proposed as being sexually deceptive; however, this has been carefully tested in only a few cases. The genus Telipogon has long been assumed to be pollinated by male tachinid flies during pseudocopulatory events but no detailed confirmatory reports are available. Here, we have used an array of methods to elucidate the pollination mechanism in Telipogon peruvianus. The species presents flowers that have a mean floral longevity of 33 days and that are self-compatible, although spontaneous self-pollination does not occur. The flowers attract males of four tachinid species but only the males of an undescribed Eudejeania (Eudejeania aff. browni; Tachinidae) species are specific pollinators. Males visit the flowers during the first few hours of the day and the pollination success is very high (42% in one patch) compared with other sexually deceptive species. Female-seeking males are attracted to the flowers but do not attempt copulation with the flowers, as is usually described in sexually deceptive species. Nevertheless, morphological analysis and behavioural tests have shown an imperfect mimicry between flowers and females suggesting that the attractant stimulus is not based only on visual cues, as long thought. Challenging previous conclusions, our chemical analysis has confirmed that flowers of Telipogon release volatile compounds; however, the role of these volatiles in pollinator behaviour remains to be established. Pollinator behaviour and histological analyses indicate that Telipogon flowers possess scent-producing structures throughout the corolla. Our study provides the first confirmed case of (i) a sexually deceptive species in the Onciidinae, (ii) pollination by pre-copulatory behaviour and (iii) pollination by sexual deception involving tachinid flies.	[Martel, Carlos; Ayasse, Manfred] Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, Helmholtzstr 10-1, D-89081 Ulm, Germany; [Cairampoma, Lianka] Johannes Gutenberg Univ Mainz, Inst Spezielle Bot & Bot Garten, D-55099 Mainz, Germany; [Stauffer, Fred W.] Univ Geneva, Conservatoire & Jardin Bot Ville Geneve, CP 60, CH-1292 Geneva, Switzerland	Ulm University; Johannes Gutenberg University of Mainz; University of Geneva	Martel, C (corresponding author), Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, Helmholtzstr 10-1, D-89081 Ulm, Germany.	carlos.martel-gora@uni-ulm.de	Martel, Carlos/N-8162-2019	Martel, Carlos/0000-0001-9892-1999	Institute of Evolutionary Ecology and Conservation Genomics, University of Ulm; German Academic Exchange Service; New Hampshire Orchid Society; South Florida Orchid Society; San Diego County Orchid Society; National Geographic Society; German Academic Exchange Service (DAAD); New Hampshire Orchid Society (NHOS); South Florida Orchid Society (SFOS); San Diego County Orchid Society (SDCOS); National Geographic Society from Global Exploration Fund (Northern Europe)	Institute of Evolutionary Ecology and Conservation Genomics, University of Ulm; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); New Hampshire Orchid Society; South Florida Orchid Society; San Diego County Orchid Society; National Geographic Society(National Geographic Society); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); New Hampshire Orchid Society (NHOS); South Florida Orchid Society (SFOS); San Diego County Orchid Society (SDCOS); National Geographic Society from Global Exploration Fund (Northern Europe)	This work was funded by the Institute of Evolutionary Ecology and Conservation Genomics, University of Ulm; the German Academic Exchange Service; the New Hampshire Orchid Society; the South Florida Orchid Society; the San Diego County Orchid Society; and the National Geographic Society.; We are deeply grateful to Hermenegildo Martel for field assistance and William Nauray for providing information on Telipogon species from Southern Peru. Gunter Gerlach (M) and Martin Timana (PUCP) gave helpful comments on an earlier version of the manuscript. Two anonymous reviewers provided helpful comments and suggestions. The Central Facility for Electron Microscopy (Ulm University) allowed CM the use of its SEM. Monty Wood (CANA-COL) kindly helped with tachinid identification. Heiko Bellmann (dagger 2014) took the photos shown in Fig 2. CM acknowledges the German Academic Exchange Service (DAAD) for supporting his PhD studies at Ulm University and the New Hampshire Orchid Society (NHOS), the South Florida Orchid Society (SFOS) and the San Diego County Orchid Society (SDCOS) for financial support. CM and MA acknowledge the National Geographic Society for an award from its Global Exploration Fund (Northern Europe).	Agren L., 1984, Nova Acta Regiae Societatis Scientiarum Upsaliensis, V:C, V3, P15; ALCOCK J, 1995, J KANSAS ENTOMOL SOC, V68, P85; Ascensao L, 2005, AM J BOT, V92, P1059, DOI 10.3732/ajb.92.7.1059; Ayasse M, 2003, P ROY SOC B-BIOL SCI, V270, P517, DOI 10.1098/rspb.2002.2271; Ayasse M, 2000, EVOLUTION, V54, P1995, DOI 10.1111/j.0014-3820.2000.tb01243.x; Ayasse M, 2001, ANNU REV ENTOMOL, V46, P31, DOI 10.1146/annurev.ento.46.1.31; Ayasse M, 2006, BIOLOGY OF FLORAL SCENT, P219; Ayasse M, 2011, PHYTOCHEMISTRY, V72, P1667, DOI 10.1016/j.phytochem.2011.03.023; Benitez-Vieyra S, 2009, J EVOLUTION BIOL, V22, P2354, DOI 10.1111/j.1420-9101.2009.01840.x; BINO RJ, 1982, NEW PHYTOL, V90, P315, DOI 10.1111/j.1469-8137.1982.tb03263.x; Blanco MA, 2005, ANN BOT-LONDON, V95, P763, DOI 10.1093/aob/mci090; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Bohman B, 2016, CURR OPIN PLANT BIOL, V32, P37, DOI 10.1016/j.pbi.2016.06.004; Bohman B, 2014, NEW PHYTOL, V203, P939, DOI 10.1111/nph.12800; Bontonou Gwenaelle, 2014, Insects, V5, P439, DOI 10.3390/insects5020439; BORGKARLSON AK, 1990, PHYTOCHEMISTRY, V29, P1359, DOI 10.1016/0031-9422(90)80086-V; Brodmann J, 2008, CURR BIOL, V18, P740, DOI 10.1016/j.cub.2008.04.040; BUSER HR, 1983, ANAL CHEM, V55, P818, DOI 10.1021/ac00257a003; CARLSON DA, 1971, SCIENCE, V174, P76, DOI 10.1126/science.174.4004.76; Christensen DE, 1994, ORCHID BIOL REV PERS, VVI, P415; Ciotek L, 2006, FLORA, V201, P365, DOI 10.1016/j.flora.2005.07.012; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; DAFNI A, 1984, ANNU REV ECOL SYST, V15, P259, DOI 10.1146/annurev.es.15.110184.001355; DAFNI A, 1990, EVOL BIOL, V24, P193; de Jager ML, 2016, FUNCT ECOL, V30, P537, DOI 10.1111/1365-2435.12517; Dobson HEM, 2005, PRACTICAL POLLINATIO, P197; Dodson CH, 2003, SELBYANA, V24, P217; Dodson CH, 1987, ORQUIDEOLOGIA, V17, P3; Dodson CH, 1962, AM ORCHID SOC B, V31, P525; Dodson CH, 2003, LANKESTERIANA, V7, P99, DOI [10.15517/lank.v3i2.23028, DOI 10.15517/LANK.V3I2.23028]; Dressler R.L., 1981, ORCHIDS NATURAL HIST; DUNKELBLUM E, 1985, J CHEM ECOL, V11, P265, DOI 10.1007/BF01411414; Effmert U, 2006, BIOLOGY OF FLORAL SCENT, P105; Ellis AG, 2010, AM NAT, V176, pE143, DOI 10.1086/656487; Faegri K., 1979, PRINCIPLES POLLINATI; Gaskett AC, 2008, AM NAT, V171, pE206, DOI 10.1086/587532; Gaskett AC, 2011, BIOL REV, V86, P33, DOI 10.1111/j.1469-185X.2010.00134.x; Gaskett AC, 2010, NATURWISSENSCHAFTEN, V97, P97, DOI 10.1007/s00114-009-0611-0; GRANT V, 1994, P NATL ACAD SCI USA, V91, P3, DOI 10.1073/pnas.91.1.3; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Jersakova J, 2006, BIOL REV, V81, P219, DOI 10.1017/S1464793105006986; Jetter R, 2006, BIOLOGY OF FLORAL SCENT, P125; Kullenberg B., 1961, Zoologiska Bidrag fran Uppsala, V34, P1; Larson BMH, 2001, CAN ENTOMOL, V133, P439, DOI 10.4039/Ent133439-4; Mant J, 2005, J CHEM ECOL, V31, P1765, DOI 10.1007/s10886-005-5926-5; Martel C., 2015, Harvard Papers in Botany, V20, P93; Martel C, 2013, CANDOLLEA, V68, P245, DOI 10.15553/c2012v682a8; NILSSON LA, 1992, TRENDS ECOL EVOL, V7, P255, DOI 10.1016/0169-5347(92)90170-G; Oguma Y., 1992, Chemoecology, V3, P60, DOI 10.1007/BF01261458; PAULUS HF, 1990, ISRAEL J BOT, V39, P43; PEAKALL R, 1990, FUNCT ECOL, V4, P159, DOI 10.2307/2389335; PEAKALL R, 1989, PLANT SYST EVOL, V167, P137, DOI 10.1007/BF00936402; PEAKALL R, 1987, OECOLOGIA, V73, P522, DOI 10.1007/BF00379410; Peakall R, 2010, NEW PHYTOL, V188, P437, DOI 10.1111/j.1469-8137.2010.03308.x; Phillips RD, 2014, ANN BOT-LONDON, V113, P629, DOI 10.1093/aob/mct295; Phillips RD, 2013, J ECOL, V101, P826, DOI 10.1111/1365-2745.12068; Pridgeon AM, 2009, GENERA ORCHIDACEARUM, V5; REITZ SR, 1991, ANN ENTOMOL SOC AM, V84, P111, DOI 10.1093/aesa/84.1.111; Robertson C, 1928, ECOLOGY, V9, P505, DOI 10.2307/1929418; Schiestl FP, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-27; Schiestl FP, 2003, SCIENCE, V302, P437, DOI 10.1126/science.1087835; Schiestl FP, 2005, NATURWISSENSCHAFTEN, V92, P255, DOI 10.1007/s00114-005-0636-y; Schiestl FP, 1999, NATURE, V399, P421, DOI 10.1038/20829; Schiestl FP, 2004, BOT J LINN SOC, V144, P199, DOI 10.1111/j.1095-8339.2003.00249.x; Schiestl FP, 2002, PLANT SYST EVOL, V234, P111, DOI 10.1007/s00606-002-0187-z; Scopece G, 2010, AM NAT, V175, P98, DOI 10.1086/648555; Singer RB, 2004, ANN BOT-LONDON, V93, P755, DOI 10.1093/aob/mch091; Singer RB, 2002, ANN BOT-LONDON, V89, P157, DOI 10.1093/aob/mcf021; Spaethe J, 2007, PLANT SYST EVOL, V264, P31, DOI 10.1007/s00606-006-0503-0; STEINER KE, 1994, AM J BOT, V81, P185, DOI 10.2307/2445632; Stireman JO, 2006, ANNU REV ENTOMOL, V51, P525, DOI 10.1146/annurev.ento.51.110104.151133; Stireman JO, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.3901; Stokl J, 2005, PLANT SYST EVOL, V254, P105, DOI 10.1007/s00606-005-0330-8; UEBEL EC, 1977, J CHEM ECOL, V3, P269, DOI 10.1007/BF00988443; van der Cingel N. A., 2001, ATLAS ORCHID POLLINA; Van der Pijl L., 1966, ORCHID FLOWERS THEIR; Vereecken NJ, 2012, P ROY SOC B-BIOL SCI, V279, P4786, DOI 10.1098/rspb.2012.1804; Vereecken NJ, 2009, SIGNAL COMMUN PLANTS, P203, DOI 10.1007/978-3-540-89230-4_11; Vogel S, 1990, ROLE SCENT GLANDS PO; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Wicker-Thomas C, 2007, J INSECT PHYSIOL, V53, P1089, DOI 10.1016/j.jinsphys.2007.07.003; Wood DM, 1987, AGR CANADA MONOGRAPH, V2	82	18	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165896	10.1371/journal.pone.0165896	http://dx.doi.org/10.1371/journal.pone.0165896			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812201	gold, Green Published, Green Submitted			2022-12-27	WOS:000386910000075
J	Sima, M; Novotny, M; Pravda, L; Sumova, P; Rohousova, I; Volf, P				Sima, Michal; Novotny, Marian; Pravda, Lukas; Sumova, Petra; Rohousova, Iva; Volf, Petr			The Diversity of Yellow-Related Proteins in Sand Flies (Diptera: Psychodidae)	PLOS ONE			English	Article							SALIVARY-GLAND TRANSCRIPTOMES; FLY LUTZOMYIA-LONGIPALPIS; ANTIBODY-RESPONSE; VISCERAL LEISHMANIASIS; PHLEBOTOMINE SANDFLIES; IDENTIFICATION; VECTOR; EXPOSURE; PAPATASI; IMMUNITY	Yellow-related proteins (YRPs) present in sand fly saliva act as affinity binders of bioamines, and help the fly to complete a bloodmeal by scavenging the physiological signals of damaged cells. They are also the main antigens in sand fly saliva and their recombinant form is used as a marker of host exposure to sand flies. Moreover, several salivary proteins and plasmids coding these proteins induce strong immune response in hosts bitten by sand flies and are being used to design protecting vaccines against Leishmania parasites. In this study, thirty two 3D models of different yellow-related proteins from thirteen sand fly species of two genera were constructed based on the known protein structure from Lutzomyia longipalpis. We also studied evolutionary relationships among species based on protein sequences as well as sequence and structural variability of their ligand-binding site. All of these 33 sand fly YRPs shared a similar structure, including a unique tunnel that connects the ligand-binding site with the solvent by two independent paths. However, intraspecific modifications found among these proteins affects the charges of the entrances to the tunnel, the length of the tunnel and its hydrophobicity. We suggest that these structural and sequential differences influence the ligand-binding abilities of these proteins and provide sand flies with a greater number of YRP paralogs with more nuanced answers to bioamines. All these characteristics allow us to better evaluate these proteins with respect to their potential use as part of anti-Leishmania vaccines or as an antigen to measure host exposure to sand flies.	[Sima, Michal; Sumova, Petra; Rohousova, Iva; Volf, Petr] Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic; [Novotny, Marian] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic; [Pravda, Lukas] Masaryk Univ, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Pravda, Lukas] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno, Czech Republic	Charles University Prague; Charles University Prague; Masaryk University Brno; Masaryk University Brno	Sima, M (corresponding author), Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic.	michal-sima@seznam.cz	Pravda, Lukáš/I-7241-2013; Sima, Michal/F-2961-2016; Rohousova, Iva/B-4852-2011; Novotny, Marian/B-7036-2008; Volf, Petr/C-4300-2012; Sumova, Petra/C-2097-2017	Pravda, Lukáš/0000-0002-6435-4719; Sima, Michal/0000-0001-6927-8615; Rohousova, Iva/0000-0003-1830-0813; Novotny, Marian/0000-0001-8788-3202; Volf, Petr/0000-0003-1790-1123; Sumova, Petra/0000-0002-3480-7254	Charles University (GAUK) [120516/B-BIO]; UNCE [204013]; Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC [LQ1601]; Czech Science Foundation [P506 13-05292S]	Charles University (GAUK); UNCE; Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC; Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by Charles University (GAUK project no. 120516/B-BIO, http://www.cuni.cz/UKEN-1.html, PS; UNCE 204013, http://www.cuni.cz/UKEN-1.html, MS). LP was supported by Ministry of Education, Youth and Sports of the Czech Republic under the project CEITEC 2020 (LQ1601) (http://www.msmt.cz/?lang=2, LP) Czech Science Foundation (Project Number: P506 13-05292S, https://gacr.cz/en/, to MS, PS, IK, PV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abdeladhim M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004771; Abdeladhim M, 2014, INFECT GENET EVOL, V28, P691, DOI 10.1016/j.meegid.2014.07.028; Abdeladhim M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047347; Abrudan J, 2013, INSECT MOL BIOL, V22, P211, DOI 10.1111/imb.12015; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alves-Silva J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-213; Anderson JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-52; Aransay AM, 2000, INSECT MOL BIOL, V9, P157, DOI 10.1046/j.1365-2583.2000.00168.x; Atta AM, 2004, MEM I OSWALDO CRUZ, V99, P525, DOI 10.1590/S0074-02762004000500012; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Charlab R, 1999, P NATL ACAD SCI USA, V96, P15155, DOI 10.1073/pnas.96.26.15155; CID H, 1992, PROTEIN ENG, V5, P373, DOI 10.1093/protein/5.5.373; Collin N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000441; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Moura TR, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000084; de Moura TR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002242; Fiuza JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004322; Gidwani K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001296; Goldman N, 2000, MOL BIOL EVOL, V17, P975, DOI 10.1093/oxfordjournals.molbev.a026378; Gomes R, 2012, J INVEST DERMATOL, V132, P2735, DOI 10.1038/jid.2012.205; HANES J, 1992, J APICULT RES, V31, P22, DOI 10.1080/00218839.1992.11101256; Hofinger ESA, 2007, GLYCOBIOLOGY, V17, P444, DOI 10.1093/glycob/cwm003; Hostomska J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-282; Johnson JK, 2001, INSECT BIOCHEM MOLEC, V31, P1125, DOI 10.1016/S0965-1748(01)00072-8; Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050; Kato H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-226; Kato H, 2013, INFECT GENET EVOL, V13, P56, DOI 10.1016/j.meegid.2012.08.024; Kostalova T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003855; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Martin-Martin I, 2014, VET PARASITOL, V202, P207, DOI 10.1016/j.vetpar.2014.02.045; Marzouki S, 2011, AM J TROP MED HYG, V84, P653, DOI 10.4269/ajtmh.2011.10-0598; NASH WG, 1983, BIOCHEM GENET, V21, P1135, DOI 10.1007/BF00488465; Oliveira F, 2006, VACCINE, V24, P374, DOI 10.1016/j.vaccine.2005.07.085; Oliveira MCG, 2007, NEUROSCIENCE, V145, P708, DOI 10.1016/j.neuroscience.2006.12.021; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Reddy VB, 2000, J BIOL CHEM, V275, P15861, DOI 10.1074/jbc.275.21.15861; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Rohousova I, 2005, PARASITOLOGY, V130, P493, DOI 10.1017/S003118200400681X; Rohousova I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001660; Rohousova I, 2012, ACTA TROP, V122, P80, DOI 10.1016/j.actatropica.2011.12.004; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sima M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004553; Souza AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000649; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teixeira C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000638; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; Valenzuela JG, 2001, J EXP MED, V194, P331, DOI 10.1084/jem.194.3.331; Vlkova M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002709; Vlkova M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001344; Volf P, 2002, EUR J BIOCHEM, V269, P6294, DOI 10.1046/j.1432-1033.2002.03349.x; Volf P, 2000, MED VET ENTOMOL, V14, P251, DOI 10.1046/j.1365-2915.2000.00240.x; Xanthos DN, 2008, PAIN, V137, P640, DOI 10.1016/j.pain.2007.10.031; Xu XQ, 2011, J BIOL CHEM, V286, P32383, DOI 10.1074/jbc.M111.268904	59	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166191	10.1371/journal.pone.0166191	http://dx.doi.org/10.1371/journal.pone.0166191			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812196	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000106
J	Yadav, A; Radhakrishnan, A; Panda, A; Singh, A; Sinha, H; Bhanot, G				Yadav, Anupama; Radhakrishnan, Aparna; Panda, Anshuman; Singh, Amartya; Sinha, Himanshu; Bhanot, Gyan			The Modular Adaptive Ribosome	PLOS ONE			English	Article							SPECIALIZED RIBOSOMES; PROTEIN GENES; YEAST; GENOME; TRANSLATION; INTRONS; SPECIFICITY; DEPLETION; SELECTION; SUBUNITS	The ribosome is an ancient machine, performing the same function across organisms. Although functionally unitary, recent experiments suggest specialized roles for some ribosomal proteins. Our central thesis is that ribosomal proteins function in a modular fashion to decode genetic information in a context dependent manner. We show through large data analyses that although many ribosomal proteins are essential with consistent effect on growth in different conditions in yeast and similar expression across cell and tissue types in mice and humans, some ribosomal proteins are used in an environment specific manner. The latter set of variable ribosomal proteins further function in a coordinated manner forming modules, which are adapted to different environmental cues in different organisms. We show that these environment specific modules of ribosomal proteins in yeast have differential genetic interactions with other pathways and their 5'UTRs show differential signatures of selection in yeast strains, presumably to facilitate adaptation. Similarly, we show that in higher metazoans such as mice and humans, different modules of ribosomal proteins are expressed in different cell types and tissues. A clear example is nervous tissue that uses a ribosomal protein module distinct from the rest of the tissues in both mice and humans. Our results suggest a novel stratification of ribosomal proteins that could have played a role in adaptation, presumably to optimize translation for adaptation to diverse ecological niches and tissue microenvironments.	[Yadav, Anupama; Radhakrishnan, Aparna; Sinha, Himanshu] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Panda, Anshuman; Singh, Amartya; Bhanot, Gyan] Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA; [Sinha, Himanshu] Indian Inst Technol Madras, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Sinha, Himanshu] Indian Inst Technol Madras, Initiat Biol Syst Engn, Madras 600036, Tamil Nadu, India; [Bhanot, Gyan] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Bhanot, Gyan] Canc Inst New Jersey, New Brunswick, NJ 08903 USA	Tata Institute of Fundamental Research (TIFR); Rutgers State University New Brunswick; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Sinha, H (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India.; Bhanot, G (corresponding author), Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA.; Sinha, H (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Madras 600036, Tamil Nadu, India.; Sinha, H (corresponding author), Indian Inst Technol Madras, Initiat Biol Syst Engn, Madras 600036, Tamil Nadu, India.; Bhanot, G (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.; Bhanot, G (corresponding author), Canc Inst New Jersey, New Brunswick, NJ 08903 USA.	sinha@iitm.ac.in; gbhanot@rutgers.edu	Panda, Anshuman/T-5101-2018; Sinha, Himanshu/AAT-7853-2021	Panda, Anshuman/0000-0001-7917-0317; Sinha, Himanshu/0000-0001-7031-0491; Radhakrishnan, Aparna/0000-0002-8153-9037; Yadav, Anupama/0000-0001-5338-0455	National Science Foundation [PHY-1066293]; NCI/NIH [R01CA169182-01]; Rutgers Cancer Institute of New Jersey; Tata Institute of Fundamental Research [12P-0120]	National Science Foundation(National Science Foundation (NSF)); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Rutgers Cancer Institute of New Jersey; Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR))	GB thanks the Aspen Center for Physics (ACP), which was supported by the National Science Foundation grant PHY-1066293, for their hospitality while this work was initiated. GB was supported in part by an R01 Grant (NCI/NIH)-R01CA169182-01. AP was supported by the Rutgers Cancer Institute of New Jersey. HS was supported by an intra-mural grant (12P-0120) from Tata Institute of Fundamental Research. The funders had no role in study design, data collection	Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Ares M, 1999, RNA, V5, P1138, DOI 10.1017/S1355838299991379; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; de las Heras-Rubio A, 2014, CANCER METAST REV, V33, P115, DOI 10.1007/s10555-013-9460-6; Diesch J, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-43; Dinman JD, 2016, J MOL BIOL, V428, P2186, DOI 10.1016/j.jmb.2015.12.021; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Enyenihi AH, 2003, GENETICS, V163, P47; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Haarer B, 2007, GENE DEV, V21, P148, DOI 10.1101/gad.1477507; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lee ASY, 2013, P NATL ACAD SCI USA, V110, P324, DOI 10.1073/pnas.1216454109; Lee CR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004727; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; McCann KL, 2013, SCIENCE, V341, P849, DOI 10.1126/science.1244156; McCormick MA, 2015, CELL METAB, V22, P895, DOI 10.1016/j.cmet.2015.09.008; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Parenteau J, 2011, CELL, V147, P320, DOI 10.1016/j.cell.2011.08.044; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Ramakrishnan V, 2014, CELL, V159, P979, DOI 10.1016/j.cell.2014.10.052; ROTENBERG MO, 1988, GENE DEV, V2, P160, DOI 10.1101/gad.2.2.160; Sauert M, 2015, BIOCHIMIE, V114, P39, DOI 10.1016/j.biochi.2014.12.011; Shi Z, 2015, ANNU REV CELL DEV BI, V31, P31, DOI 10.1146/annurev-cellbio-100814-125346; Slavov N, 2015, CELL REP, V13, P865, DOI 10.1016/j.celrep.2015.09.056; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Steffen KK, 2012, GENETICS, V191, P107, DOI 10.1534/genetics.111.136549; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teixeira MC, 2011, CURR OPIN BIOTECH, V22, P150, DOI 10.1016/j.copbio.2010.10.011; Teng T, 2013, CURR OPIN GENET DEV, V23, P63, DOI 10.1016/j.gde.2013.02.001; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wilkening S, 2014, GENETICS, V196, P853, DOI 10.1534/genetics.113.160291; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wong QWL, 2014, RNA BIOL, V11, P33, DOI 10.4161/rna.27427; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yoshihama M, 2002, GENOME RES, V12, P379, DOI 10.1101/gr.214202	58	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166021	10.1371/journal.pone.0166021	http://dx.doi.org/10.1371/journal.pone.0166021			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812193	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000094
J	Lang, JK; Young, RF; Ashraf, H; Canty, JM				Lang, Jennifer K.; Young, Rebeccah F.; Ashraf, Hashmat; Canty, John M., Jr.			Inhibiting Extracellular Vesicle Release from Human Cardiosphere Derived Cells with Lentiviral Knockdown of nSMase2 Differentially Effects Proliferation and Apoptosis in Cardiomyocytes, Fibroblasts and Endothelial Cells In Vitro	PLOS ONE			English	Article							CARDIAC-FUNCTION; HEART-DISEASE; EXOSOMES; STEM; THERAPY; REGENERATION; MECHANISMS; EFFICACY; REPAIR; AGENTS	Numerous studies have shown a beneficial effect of cardiosphere-derived cell (CDC) therapy on regeneration of injured myocardium. Paracrine signaling by CDC secreted exo-somes may contribute to improved cardiac function. However, it has not yet been demonstrated by a genetic approach that exosome release contributes to the therapeutic effect of transplanted CDCs. By employing a lentiviral knockdown (KD) strategy against neutral spingomyelinase 2 (nSMase2), a crucial gene in exosome secretion, we have defined the role of physiologically secreted human CDC-derived exosomes on cardiac fibroblast, endothelial cell and primary cardiomyocyte proliferation, cell death, migration and angiogenesis using a series of in vitro coculture assays. We found that secretion of hCDC-derived exosomes was effectively inhibited by nSMase2 lentiviral KD and shRNAi expression was stable and constitutive. hCDC exosome release contributed to the angiogenic and pro-migratory effects of hCDCs on HUVECs, decreased proliferation of fibroblasts, and decreased apoptosis of cardiomyocytes. These in vitro reactions support a role for exosome secretion as a paracrine mechanism of stem cell-mediated cardiac repair in vivo. Importantly, we have established a novel tool to test constitutive inhibition of exosome secretion in stem cell populations in animal models of cardiac disease.	[Lang, Jennifer K.; Young, Rebeccah F.; Canty, John M., Jr.] Jacobs Sch Med & Biomed Sci, Dept Med, Div Cardiol, Buffalo, NY 14203 USA; [Ashraf, Hashmat] Kaleida Hlth, Dept Cardiothorac Surg, Buffalo, NY 14203 USA; [Canty, John M., Jr.] VA WNY Healthcare Syst, Buffalo, NY 14215 USA	Kaleida Health	Lang, JK (corresponding author), Jacobs Sch Med & Biomed Sci, Dept Med, Div Cardiol, Buffalo, NY 14203 USA.	jklang@buffalo.edu	Canty, John M/C-5349-2009		John C. Sable Memorial Heart Fund; National Heart Lung and Blood Institute [HL-55324, HL-61610]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061610, R01HL055324] Funding Source: NIH RePORTER	John C. Sable Memorial Heart Fund; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the John C. Sable Memorial Heart Fund (JKL) and the National Heart Lung and Blood Institute (HL-55324 and HL-61610) (JMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Zhenghong Yuan for supplying the lentiviral vectors for scrambled and nSMase2 shRNA. We would like to thank Dr. Jessica Reynolds for assistance with Nano particle Tracking Analysis. This work was supported by the John C. Sable Memorial Heart Fund and the National Heart Lung and Blood Institute (HL-55324 and HL-61610).	Arslan F, 2013, STEM CELL RES, V10, P301, DOI 10.1016/j.scr.2013.01.002; Barile L, 2014, CARDIOVASC RES, V103, P530, DOI 10.1093/cvr/cvu167; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Gallet R, 2017, EUR HEART J, V38, P201, DOI 10.1093/eurheartj/ehw240; Ghosh AK, 2014, MANUAL RES TECHNIQUE; Goldsmith EC, 2004, DEV DYNAM, V230, P787, DOI 10.1002/dvdy.20095; Gray WD, 2015, CIRC RES, V116, P255, DOI 10.1161/CIRCRESAHA.116.304360; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Ibrahim AGE, 2014, STEM CELL REP, V2, P606, DOI 10.1016/j.stemcr.2014.04.006; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Juric V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031303; Kanazawa H, 2015, CIRC-HEART FAIL, V8, P322, DOI 10.1161/CIRCHEARTFAILURE.114.001484; Khan M, 2015, CIRC RES, V117, P52, DOI 10.1161/CIRCRESAHA.117.305990; Kreke M, 2012, EXPERT REV CARDIOVAS, V10, P1185, DOI [10.1586/ERC.12.102, 10.1586/erc.12.102]; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; Lim HJ, 1999, CIRCULATION, V100, P2380, DOI 10.1161/01.CIR.100.23.2380; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Malliaras K, 2014, J AM COLL CARDIOL, V63, P110, DOI 10.1016/j.jacc.2013.08.724; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389; Sahoo S, 2014, CIRC RES, V114, P333, DOI 10.1161/CIRCRESAHA.114.300639; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Supinski GS, 2015, AM J PHYSIOL-LUNG C, V309, pL614, DOI 10.1152/ajplung.00141.2015; Suzuki G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113009; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Weil BR, 2015, CIRC RES, V117, P634, DOI 10.1161/CIRCRESAHA.115.306850; Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1; Yee K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113805	33	43	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165926	10.1371/journal.pone.0165926	http://dx.doi.org/10.1371/journal.pone.0165926			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806113	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500071
J	Li, WJ; Sui, XL; Kuss, P; Liu, YY; Li, AR; Guan, KY				Li, Wen-Jun; Sui, Xiao-Lin; Kuss, Patrick; Liu, Yan-Yan; Li, Ai-Rong; Guan, Kai-Yun			Long-Distance Dispersal after the Last Glacial Maximum (LGM) Led to the Disjunctive Distribution of Pedicularis kansuensis (Orobanchaceae) between the Qinghai-Tibetan Plateau and Tianshan Region	PLOS ONE			English	Article							MOLECULAR PHYLOGEOGRAPHY; CLIMATIC OSCILLATIONS; QUATERNARY CLIMATE; SEQUENCE VARIATION; NONCODING REGIONS; GENETIC DIVERSITY; ALPINE PLANTS; DNA; CHINA; EVOLUTION	Quaternary climate fluctuations have profoundly affected the current distribution patterns and genetic structures of many plant and animal species in the Qinghai-Tibetan Plateau (QTP) and adjacent mountain ranges, e.g. Tianshan (TSR), Altay, etc. In this greater area disjunct distributions are prominent but have nevertheless received little attention with respect to the historical processes involved. Here, we focus on Pedicularis kansuensis to test whether the current QTP and TSR disjunction is the result of a recent Holocene range expansion involving dispersal across arid land bridge(s) or a Pleistocene range fragmentation involving persistence in refugia. Two chloroplast DNA spacers were sequenced for 319 individuals from 34 populations covering the entire distribution range of this species in China. We found a total of 17 haplotypes of which all occurred in the QTP, and only five in the TSR. Overall genetic diversity was high (H-T = 0.882, H-S = 0.559) and higher in the QTP than in the TSR. Genetic differentiation among regions and populations was relatively low (G(ST) = 0.366) and little evidence for a phylogeographic pattern emerged. The divergence times for the four main lineages could be dated to the early Pleistocene. Surprisingly, the two ubiquitous haplotypes diverged just before or around the Last Glacial Maximum (LGM) and were found in different phylogenetic lineages. The Species Distribution Model suggested a disappearance of P. kansuensis from the TSR during the LGM in contrast to a relatively constant potential distribution in the QTP. We conclude that P. kansuensis colonized the TSR after the LGM. The improbable long-distance dispersal by wind or water across arid land seed flow may well have had birds or men as vector.	[Li, Wen-Jun; Liu, Yan-Yan; Guan, Kai-Yun] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi 830011, Peoples R China; [Li, Wen-Jun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Sui, Xiao-Lin; Li, Ai-Rong; Guan, Kai-Yun] Chinese Acad Sci, Kunming Inst Bot, Yunnan Key Lab Res & Dev Wild Plant Resources, Kunming 650201, Peoples R China; [Kuss, Patrick] Univ Zurich, Inst Systemat & Evolutionary Bot, CH-8008 Zurich, Switzerland	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; University of Zurich	Guan, KY (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi 830011, Peoples R China.; Li, AR; Guan, KY (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Yunnan Key Lab Res & Dev Wild Plant Resources, Kunming 650201, Peoples R China.	airongli@mail.kib.ac.cn; guanky@mail.kib.ac.cn	Li, Ai-Rong/M-1858-2013	Li, Ai-Rong/0000-0002-6134-9471; Kuss, Patrick/0000-0002-0302-6658	Natural Science Foundation of China [U1303201, 31600447, 31370512, 31400440]; Youth Innovation Promotion Association of CAS; Stiftung zur Forderung der Pflanzenkenntnis (Basel/CH); US National Science Foundation [DEB-1119098]; Direct For Biological Sciences [1119098] Funding Source: National Science Foundation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association of CAS; Stiftung zur Forderung der Pflanzenkenntnis (Basel/CH); US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Natural Science Foundation of China (U1303201, 31600447, 31370512, 31400440), a grant from The Youth Innovation Promotion Association of CAS (to ARL), the Stiftung zur Forderung der Pflanzenkenntnis (Basel/CH), and the US National Science Foundation (No. DEB-1119098) (to PK).	Abbott RJ, 2000, SCIENCE, V289, P1343, DOI 10.1126/science.289.5483.1343; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bendiksby M, 2014, J BIOGEOGR, V41, P2020, DOI 10.1111/jbi.12347; Cancio I, 2016, BIODIVERS CONSERV, V25, P693, DOI 10.1007/s10531-016-1085-y; Chen JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060948; Chen SY, 2008, BOT J LINN SOC, V157, P125, DOI 10.1111/j.1095-8339.2008.00785.x; Clark MK, 2005, GEOLOGY, V33, P525, DOI 10.1130/G21265.1; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; de Groot GA, 2016, CONSERV GENET, V17, P111, DOI 10.1007/s10592-015-0765-6; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Friar EA, 2000, MOL ECOL, V9, P2027, DOI 10.1046/j.1365-294X.2000.01111.x; FU YX, 1993, GENETICS, V133, P693; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gao QB, 2012, BOT J LINN SOC, V168, P204, DOI 10.1111/j.1095-8339.2011.01193.x; Gao XY, 2014, BIOCHEM SYST ECOL, V55, P93, DOI 10.1016/j.bse.2014.03.002; Gussarova G, 2015, AM J BOT, V102, P1703, DOI 10.3732/ajb.1500072; Guu YP, 2010, J SYST EVOL, V48, P153, DOI 10.1111/j.1759-6831.2010.00073.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hu R., 2004, PHYS GEOGRAPHY TIANS; Jiang XL, 2014, PLANT SYST EVOL, V300, P51, DOI 10.1007/s00606-013-0859-x; Kropf M, 2006, NEW PHYTOL, V172, P169, DOI 10.1111/j.1469-8137.2006.01795.x; Kuss P, 2015, NEPAL INTRO NATURAL; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Li GJ, 2011, GEOLOGY, V39, P199, DOI 10.1130/G31734.1; Li Kai-Hui, 2006, Acta Botanica Yunnanica, V28, P421; Li N, 2016, SCI REP-UK, V6, DOI 10.1038/srep17489; Li Y, 2010, MOL BIOL EVOL, V27, P1001, DOI 10.1093/molbev/msp301; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JQ, 2012, J SYST EVOL, V50, P267, DOI 10.1111/j.1759-6831.2012.00214.x; Liu ML, 2013, PLANT SYST EVOL, V299, P1645, DOI 10.1007/s00606-013-0821-y; [柳妍妍 LIU Yanyan], 2011, [水土保持通报, Bulletin of Soil and Water Conservation], V31, P52; [柳妍妍 Liu Yanyan], 2011, [自然资源学报, Journal of Natural Resources], V26, P48; Liu YY, 2011, B SOIL WATER CONSERV, V31, P65; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Meng HH, 2013, MOL PHYLOGENET EVOL, V68, P398, DOI 10.1016/j.ympev.2013.04.012; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Nybom Hilde, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P93, DOI 10.1078/1433-8319-00006; Pellerin M, 2016, BASIC APPL ECOL, V17, P321, DOI 10.1016/j.baae.2016.01.005; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pons O, 1996, GENETICS, V144, P1237; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prain D., 1890, ANN ROYAL BOT GARDEN, V3, P1; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; R Core Team, 2016, R LANG ENV STAT; Ram MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142597; Rambaut A., 2007, TRACER V1 4; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; REBOUD X, 1994, HEREDITY, V72, P132, DOI 10.1038/hdy.1994.19; Ree RH, 2005, INT J PLANT SCI, V166, P595, DOI 10.1086/430191; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; RUDDIMAN WF, 1991, SCI AM, V264, P66, DOI 10.1038/scientificamerican0391-66; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shi XJ, 2015, J PLANT RES, V128, P269, DOI 10.1007/s10265-014-0699-y; Shi YF, 1998, UPLIFT ENV CHANGES Q; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Sui XL, 2015, J PLANT RES, V128, P563, DOI 10.1007/s10265-015-0727-6; Sui XL, 2016, J ARID LAND, V8, P453, DOI 10.1007/s40333-016-0004-0; [隋晓琳 Sui Xiaolin], 2013, [生态环境学报, Ecology and Environmental Sciences], V22, P1099; Sun JM, 1998, EPISODES, V21, P28; Sun JM, 2004, EARTH PLANET SC LETT, V219, P239, DOI 10.1016/S0012-821X(04)00008-1; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang LY, 1996, ACTA MICROPALAEONTOL, V13, P321; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tkach N, 2014, MOL PHYLOGENET EVOL, V76, P75, DOI 10.1016/j.ympev.2014.03.004; Villaverde T, 2015, J BIOGEOGR, V42, P1820, DOI 10.1111/jbi.12559; Wang JF, 2013, J BIOGEOGR, V40, P1741, DOI 10.1111/jbi.12114; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025896; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wang WanLin, 2010, Xinjiang Agricultural Sciences, V47, P1242; Wang ZJ, 2011, J SYST EVOL, V49, P72, DOI 10.1111/j.1759-6831.2010.00108.x; Wen J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00004; Williams MA, 1993, QUATERNARY ENV; Wright S, 1943, GENETICS, V28, P114; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Xu ZQ, 2013, PRECAMBRIAN RES, V235, P150, DOI 10.1016/j.precamres.2013.06.001; Yang FMY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040196; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yang H-B, 1998, FLORA CHINA, V16, P97; Zhang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061954, 10.1371/journal.pone.0069046]; Zhang HX, 2012, PALAEOGEOGR PALAEOCL, V353, P93, DOI 10.1016/j.palaeo.2012.07.013; Zhang HX, 2012, J SYST EVOL, V50, P295, DOI 10.1111/j.1759-6831.2012.00198.x; Zhang JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112923; Zhang XM, 2013, J SYST EVOL, V51, P564, DOI 10.1111/jse.12026; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; Zhou SZ, 2006, QUATERN INT, V154, P44, DOI 10.1016/j.quaint.2006.02.002; Zou JB, 2012, J SYST EVOL, V50, P341, DOI 10.1111/j.1759-6831.2012.00207.x	101	10	10	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165700	10.1371/journal.pone.0165700	http://dx.doi.org/10.1371/journal.pone.0165700			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806090	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000386715500050
J	Li, YC; Sun, R; Wang, YC; Li, HY; Zheng, XF				Li, Yongcheng; Sun, Rong; Wang, Yuechao; Li, Hongyi; Zheng, Xiongfei			A Novel Robot System Integrating Biological and Mechanical Intelligence Based on Dissociated Neural Network-Controlled Closed-Loop Environment	PLOS ONE			English	Article							LONG-TERM POTENTIATION; STIMULATION; FABRICATION; PLASTICITY; ACTUATORS; PATTERNS; DENSITY; NEURONS; DEVICES; MOTORS	We propose the architecture of a novel robot system merging biological and artificial intelligence based on a neural controller connected to an external agent. We initially built a framework that connected the dissociated neural network to a mobile robot system to implement a realistic vehicle. The mobile robot system characterized by a camera and two-wheeled robot was designed to execute the target-searching task. We modified a software architecture and developed a home-made stimulation generator to build a bi-directional connection between the biological and the artificial components via simple binomial coding/decoding schemes. In this paper, we utilized a specific hierarchical dissociated neural network for the first time as the neural controller. Based on our work, neural cultures were successfully employed to control an artificial agent resulting in high performance. Surprisingly, under the tetanus stimulus training, the robot performed better and better with the increasement of training cycle because of the short-term plasticity of neural network (a kind of reinforced learning). Comparing to the work previously reported, we adopted an effective experimental proposal (i.e. increasing the training cycle) to make sure of the occurrence of the short-term plasticity, and preliminarily demonstrated that the improvement of the robot's performance could be caused independently by the plasticity development of dissociated neural network. This new framework may provide some possible solutions for the learning abilities of intelligent robots by the engineering application of the plasticity processing of neural networks, also for the development of theoretical inspiration for the next generation neuro-prostheses on the basis of the bi-directional exchange of information within the hierarchical neural networks.	[Li, Yongcheng; Wang, Yuechao; Li, Hongyi; Zheng, Xiongfei] Chinese Acad Sci, State Key Lab Robot, Shenyang Inst Automat, Shenyang, Liaoning, Peoples R China; [Li, Yongcheng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Sun, Rong] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Automation, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zheng, XF (corresponding author), Chinese Acad Sci, State Key Lab Robot, Shenyang Inst Automat, Shenyang, Liaoning, Peoples R China.	zhengxiongfei@sia.cn		Sun, Rong/0000-0002-0950-1480	Research Equipment Development Program of the Chinese Academy of Sciences [YZ201545]; National Natural Science Foundation of China [51305438]; National High Technology Research and Development Program of China (863 Program) [2015AA020312]; General Reserve Department of PLA [9140A26060214ZK63424]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R00AA020312, K99AA020312] Funding Source: NIH RePORTER	Research Equipment Development Program of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); General Reserve Department of PLA; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The work has been supported by the Research Equipment Development Program of the Chinese Academy of Sciences (YZ201545, http://www.kjtj.cas.cn), National Natural Science Foundation of China (51305438, https://isisn.nsfc.gov.cn/egrartweb), National High Technology Research and Development Program of China (863 Program 2015AA020312, http://program.most.gov.cn/), and General Reserve Department of PLA (9140A26060214ZK63424, http://www.mod.gov.cn/topnews/node_47615.htm). The funders had a key role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors want to thank the Prof. Guoqiang Bi and Prof. Pakming Lau in University of Science and Technology of China. We appreciate their useful instruction and support of the setup for our experiments. The work has been supported by the Research Equipment Development Program of the Chinese Academy of Sciences (YZ201545), National Natural Science Foundation of China (51305438), National High Technology Research and Development Program of China (863 Program 2015AA020312), and General Reserve Department of PLA (9140A26060214ZK63424).	Al-Fandi M, 2010, IET NANOBIOTECHNOL, V4, P61, DOI 10.1049/iet-nbt.2010.0003; Bakkum DJ, 2008, J NEURAL ENG, V5, P310, DOI 10.1088/1741-2560/5/3/004; Bi GQ, 2005, TRENDS NEUROSCI, V28, P222, DOI 10.1016/j.tins.2005.02.002; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Chan V, 2012, LAB CHIP, V12, P88, DOI 10.1039/c1lc20688e; Chen CP, 2006, BIOSYSTEMS, V85, P137, DOI 10.1016/j.biosystems.2005.12.006; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Cvetkovic C, 2014, P NATL ACAD SCI USA, V111, P10125, DOI 10.1073/pnas.1401577111; Erickson J, 2008, J NEUROSCI METH, V175, P1, DOI 10.1016/j.jneumeth.2008.07.023; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Feinerman O, 2008, NAT PHYS, V4, P967, DOI 10.1038/nphys1099; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; FRANCIS NR, 1994, J MOL BIOL, V235, P1261, DOI 10.1006/jmbi.1994.1079; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hyman JM, 2003, J NEUROSCI, V23, P11725; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; Jun SB, 2007, J NEUROSCI METH, V160, P317, DOI 10.1016/j.jneumeth.2006.09.009; Kim J, 2007, LAB CHIP, V7, P1504, DOI 10.1039/b705367c; Kim MJ, 2008, SMALL, V4, P111, DOI 10.1002/smll.200700641; Lamsa K, 2005, NAT NEUROSCI, V8, P916, DOI 10.1038/nn1486; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; le Feber J, 2007, J NEURAL ENG, V4, P54, DOI 10.1088/1741-2560/4/2/006; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Li Y, 2015, PLOS ONE, V10, DOI [10. 10338, 10.1073/pnas.0500717102, DOI 10.1073/PNAS.0500717102]; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; MAEDA E, 1995, J NEUROSCI, V15, P6834; Martel S, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P426, DOI 10.1109/IROS.2009.5353964; Martinoia S, 2004, NEUROCOMPUTING, V58, P1065, DOI 10.1016/j.neucom.2004.01.167; Nawroth JC, 2012, NAT BIOTECHNOL, V30, P792, DOI 10.1038/nbt.2269; Neal D, 2013, IEEE ENG MED BIO, P326, DOI 10.1109/EMBC.2013.6609503; Novellino A, 2007, Comput Intell Neurosci, P12725, DOI 10.1155/2007/12725; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; Pizzi RMR, 2009, BIOSYSTEMS, V95, P137, DOI 10.1016/j.biosystems.2008.09.006; Potter A, 2004, P BRAIN INSP COGN SY; Raichman N, 2006, NEUROCOMPUTING, V69, P1150, DOI 10.1016/j.neucom.2005.12.064; Rubinsky L, 2008, NEURAL NETWORKS, V21, P1232, DOI 10.1016/j.neunet.2008.06.008; Sakamoto K, 2015, NEURAL NETWORKS, V62, P67, DOI 10.1016/j.neunet.2014.06.009; Sakar MS, 2012, LAB CHIP, V12, P4976, DOI 10.1039/c2lc40338b; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Steager EB, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/3/035001; Tessadori J, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00099; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2002, J NEUROSCI METH, V120, P113, DOI 10.1016/S0165-0270(02)00149-8; Warwick K, 2008, NEUROCOMPUTING, V71, P2619, DOI 10.1016/j.neucom.2007.06.017; Warwick K, 2010, DEFENCE SCI J, V60, P5, DOI 10.14429/dsj.60.11; Xi JZ, 2005, NAT MATER, V4, P180, DOI 10.1038/nmat1308; Xu SJ, 2012, NAT NEUROSCI, V15, P449, DOI 10.1038/nn.3036; Yanagisawa T, 2012, ANN NEUROL, V71, P353, DOI 10.1002/ana.22613	53	1	1	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165600	10.1371/journal.pone.0165600	http://dx.doi.org/10.1371/journal.pone.0165600			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806074	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500041
J	Wang, J				Wang, Juan			A Survey of Methods for Constructing Rooted Phylogenetic Networks	PLOS ONE			English	Article							EFFICIENT; METRICS	Rooted phylogenetic networks are primarily used to represent conflicting evolutionary information and describe the reticulate evolutionary events in phylogeny. So far a lot of methods have been presented for constructing rooted phylogenetic networks, of which the methods based on the decomposition property of networks and by means of the incompatible graph (such as the CASS, the LNETWORK and the BIMLR) are more efficient than other available methods. The paper will discuss and compare these methods by both the practical and artificial datasets, in the aspect of the running time of the methods and the effective of constructed phylogenetic networks. The results show that the LNETWORK can construct much simper networks than the others.	[Wang, Juan] Inner Mongolia Univ, Sch Comp Sci, Hohhot, Peoples R China	Inner Mongolia University	Wang, J (corresponding author), Inner Mongolia Univ, Sch Comp Sci, Hohhot, Peoples R China.	wangjuanangle@hit.edu.cn						[Anonymous], 2011, PHYLOGENETIC NETWORK; BANDELT HJ, 1992, ADV MATH, V92, P47, DOI 10.1016/0001-8708(92)90061-O; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Buneman P., 1971, MATH ARCHAEOLOGICAL, P387; Cardona G, 2009, IEEE ACM T COMPUT BI, V6, P46, DOI 10.1109/TCBB.2008.70; Collins J, 2011, J COMPUT BIOL, V18, P1305, DOI 10.1089/cmb.2009.0166; Gusfield D, 2005, LECT NOTES COMPUT SC, V3500, P217; Gusfield D, 2005, J COMPUT SYST SCI, V70, P381, DOI 10.1016/j.jcss.2004.12.009; Gusfield D, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P363, DOI 10.1109/CSB.2003.1227337; Gusfield D, 2007, DISCRETE APPL MATH, V155, P806, DOI 10.1016/j.dam.2005.05.044; Hejnol A, 2016, CURR OPIN GENET DEV, V39, P48, DOI 10.1016/j.gde.2016.05.019; Huson DH, 2008, LECT N BIOINFORMAT, V5251, P296, DOI 10.1007/978-3-540-87361-7_25; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Huson DH, 2009, BIOINFORMATICS, V25, pI85, DOI 10.1093/bioinformatics/btp217; Huson DH, 2004, IEEE ACM T COMPUT BI, V1, P151, DOI 10.1109/TCBB.2004.44; Huson DH, 2005, BIOINFORMATICS, V21, P159, DOI 10.1093/bioinformatics/bti1126; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Linder CR, 2004, AM J BOT, V91, P1700, DOI 10.3732/ajb.91.10.1700; Linder CR, 2010, 9 PAC S BIOC PSB 201; Liu YS, 2017, IEEE ACM T COMPUT BI, V14, P905, DOI 10.1109/TCBB.2016.2550432; Semple C., 2006, HYBRIDIZATION NETWOR; Song YS, 2005, J COMPUT BIOL, V12, P147, DOI 10.1089/cmb.2005.12.147; van Iersel L, 2011, ALGORITHMICA, V60, P207, DOI 10.1007/s00453-009-9333-0; van Iersel L, 2010, BIOINFORMATICS, V26, pi124, DOI 10.1093/bioinformatics/btq202; van Iersel L, 2009, IEEE ACM T COMPUT BI, V6, P667, DOI 10.1109/TCBB.2009.22; Vellutini BC, 2016, SCI REP-UK, V6, DOI 10.1038/srep32387; Wang J, 2014, GENET MOL RES, V13, P1456, DOI 10.4238/2014.March.6.4; Wang J, 2013, BIOINFORMATICS, V29, P2269, DOI 10.1093/bioinformatics/btt378; Wang J, 2013, GENE, V527, P344, DOI 10.1016/j.gene.2013.06.036; Wu YF, 2010, BIOINFORMATICS, V26, pi140, DOI 10.1093/bioinformatics/btq198; Quan ZA, 2015, MOL INFORM, V34, P761, DOI 10.1002/minf.201500031; Zou Q, 2015, BIOINFORMATICS, V31, P2475, DOI 10.1093/bioinformatics/btv177; Zou Q, 2014, BRIEF BIOINFORM, V15, P637, DOI 10.1093/bib/bbs088	34	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165834	10.1371/journal.pone.0165834	http://dx.doi.org/10.1371/journal.pone.0165834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806124	Green Submitted, gold, Green Published			2022-12-27	WOS:000386715500060
J	Wu, P; Jiang, XX; Guo, XJ; Li, L; Chen, T				Wu, Ping; Jiang, Xiaoxu; Guo, Xijie; Li, Long; Chen, Tao			Genome-Wide Analysis of Differentially Expressed microRNA in Bombyx mori Infected with Nucleopolyhedrosis Virus	PLOS ONE			English	Article							RNA METHYLTRANSFERASE DNMT2; BACULOVIRUS INFECTION; DROSOPHILA; HOST; REPLICATION; IMMUNITY; TRANSCRIPTS; CELLS; DNA	Bombyx mori nucleopolyhedrosis virus (BmNPV) is a major pathogen that threatens the growth and sustainability of the sericulture industry. Since microRNAs (miRNAs) have been shown to play important roles in host-pathogen interactions, in this study we investigated the effects of BmNPV infection on silkworm microRNAs expression profile. To achieve this, we constructed and deep-sequenced two small RNA libraries generated from BmNPV infected and un-infected larvae. The results revealed that 38 silkworm miRNAs were differentially expressed after BmNPV infection. Based on the GO analysis, their predicted target genes were found to be involved in diverse functions such as binding, catalytic, virion and immune response to stimulus suggesting their potential roles in host-virus interactions. Using the dual-luciferase reporter assay, we confirmed that Bmo-miR-277-5p, up-regulated in BmNPV-infected larvae, targeted the B. mori DNA cytosine-5 methyltransferase (Dnmt2) gene which may play potential role in silkworm-BmNPV interaction. These results provide new insights into exploring the interaction mechanism between silkworm and BmNPV.	[Wu, Ping; Guo, Xijie; Li, Long; Chen, Tao] Jiangsu Univ Sci & Technol, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China; [Wu, Ping; Li, Long; Chen, Tao] Minist Agr, Qual Inspect Ctr Sericulture Prod, Zhenjiang, Jiangsu, Peoples R China; [Jiang, Xiaoxu] Jiangsu Univ Sci & Technol, Sch Biol, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University of Science & Technology; Ministry of Agriculture & Rural Affairs; Jiangsu University of Science & Technology	Wu, P; Chen, T (corresponding author), Jiangsu Univ Sci & Technol, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China.; Wu, P; Chen, T (corresponding author), Minist Agr, Qual Inspect Ctr Sericulture Prod, Zhenjiang, Jiangsu, Peoples R China.	wp4114@163.com; zjchentao@sina.com	Guo, Xijie/GPX-9247-2022		National Nature Science Foundation of China [31502016]; Natural Science Foundation of Jiangsu, China [BK20141286]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu, China(Natural Science Foundation of Jiangsu Province)	This research was financially supported by the National Nature Science Foundation of China (Grant No. 31502016) and the Natural Science Foundation of Jiangsu, China (No. BK20141286) to PW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financially supported by the National Nature Science Foundation of China (Grant No. 31502016) and the Natural Science Foundation of Jiangsu, China (No. BK20141286). PW was the receiver.	Bao YY, 2009, GENOMICS, V94, P138, DOI 10.1016/j.ygeno.2009.04.003; Blanco S, 2014, CURR OPIN CELL BIOL, V31, P1, DOI 10.1016/j.ceb.2014.06.006; Campbell CL, 2014, INSECT MOL BIOL, V23, P132, DOI 10.1111/imb.12070; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Courteau LA, 2012, CRYOBIOLOGY, V65, P210, DOI 10.1016/j.cryobiol.2012.06.005; Durdevic Z, 2013, CELL REP, V4, P931, DOI 10.1016/j.celrep.2013.07.046; Durdevic Z, 2013, EMBO REP, V14, P269, DOI 10.1038/embor.2013.3; Esslinger SM, 2013, RNA BIOL, V10, P1042, DOI 10.4161/rna.24810; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gu C, 2015, INT J CLIN EXP PATHO, V8, P10050; Gundersen-Rindal DE, 2010, ARCH VIROL, V155, P783, DOI 10.1007/s00705-010-0616-1; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hussain M, 2010, J VIROL, V84, P612, DOI 10.1128/JVI.01794-09; Ingle H, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3183; Jayachandran B, 2013, J INVERTEBR PATHOL, V114, P151, DOI 10.1016/j.jip.2013.07.004; Jiang L, 2014, INSECT BIOCHEM MOLEC, V48, P1, DOI 10.1016/j.ibmb.2014.02.003; Jiang L, 2013, ANTIVIR RES, V98, P171, DOI 10.1016/j.antiviral.2013.02.015; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lekha G, 2015, GENOMICS, V106, P393, DOI 10.1016/j.ygeno.2015.09.002; Li L, 2012, J INSECT PHYSIOL, V58, P1438, DOI 10.1016/j.jinsphys.2012.08.008; Lin MJ, 2005, J BIOL CHEM, V280, P861, DOI 10.1074/jbc.C400477200; Mead EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244; Mehrabadi M, 2013, J GEN VIROL, V94, P1385, DOI 10.1099/vir.0.051060-0; NAM S, 2005, GENOMICS INFORM, V3, P53; Padmanabhan C, 2009, CURR OPIN PLANT BIOL, V12, P465, DOI 10.1016/j.pbi.2009.06.005; Rahman MM, 2004, VIRUS RES, V101, P109, DOI 10.1016/j.virusres.2003.12.027; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rohrmann GF, 2013, BACULOVIRUS MOL BIOL, V3rd; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schaefer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001414; Simon-Mateo C, 2006, J VIROL, V80, P2429, DOI 10.1128/JVI.80.5.2429-2436.2006; Singh CP, 2014, INSECT BIOCHEM MOLEC, V49, P59, DOI 10.1016/j.ibmb.2014.03.008; Singh CP, 2012, J VIROL, V86, P7867, DOI 10.1128/JVI.00064-12; Singh J, 2010, VIROLOGY, V407, P120, DOI 10.1016/j.virol.2010.07.033; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tan HP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002681; Vilmos P, 2013, GENETICS, V195, P469, DOI 10.1534/genetics.113.153585; Wang L, 2015, REV MED VIROL, V25, P320, DOI 10.1002/rmv.1850; Wu P, 2016, GENE, V575, P264, DOI 10.1016/j.gene.2015.09.009; Wu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068209; Ye YXH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066482; Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110; Zhang YL, 2015, GENE, V557, P215, DOI 10.1016/j.gene.2014.12.038; Zhong L, 2015, 4TH INTERNATIONAL CONFERENCE ON MATERIALS ENGINEERING FOR ADVANCED TECHNOLOGIES (ICMEAT 2015), P5	47	18	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165865	10.1371/journal.pone.0165865	http://dx.doi.org/10.1371/journal.pone.0165865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806111	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500064
J	Zhang, LY; Niu, K; Zhu, K; Xia, C; Yan, J; Zhao, W; Wei, JR; Duan, ML; Zheng, GX				Zhang, Luyao; Niu, Kai; Zhu, Kang; Xia, Cui; Yan, Jing; Zhao, Wei; Wei, Junrong; Duan, Maoli; Zheng, Guoxi			Long-Term Prognostic Analysis after Endoscopic Endonasal Surgery for Olfactory Neuroblastoma: A Retrospective Study of 13 Cases	PLOS ONE			English	Article							ESTHESIONEUROBLASTOMA; EXPERIENCE; MANAGEMENT; RESECTION; CHEMOTHERAPY; METAANALYSIS; OUTCOMES; THERAPY; TUMORS	Objectives To summarize the characteristics and long-term outcomes of olfactory neuroblastoma through the analysis of 13 cases in single institution, with the assessment of treatment modality, prognostic factors. Method A retrospective study of thirteen cases diagnosed as olfactory neuroblastoma and underwent combined treatments during the period 2000-2010. Statistical analysis was performed to search for prognostic factors and compared different treatment modalities. Results 13 patients were enrolled in this study, including 8 male and 5 female, ranging from 15 to 69 (median 43) years old. One patient at stage A was only treated with endoscopic endonasal surgery (EES). Seven patients were treated with preoperative radiotherapy and EES, two with EES and postoperative radiotherapy, and the other three with combined radiotherapy and chemotherapy. The range of follow-up time varied from 23 to 116 months (median 65 months). The 5-year overall survival rate was 46.2% (6/13). To date, these thirteen patients have not suffered local recurrences while two patients had lymph node recurrences and one had distant metastasis in the bone marrow. In 13 patients, 61.5% were diagnosed as late T stage (T3/4), 69.2% late Kadish stage (C/D) and 53.8% were high Hyams grade (I/II), which indicated poor prognosis. Related prognostic factors were the TNM stage (T stage P = 0.028, N stage P = 0.000, M stage P = 0.007), Kadish stage (P = 0.025) and treatment modality (P = 0.015). Conclusion Late stage of TNM and Kadish staging system indicated a poor prognosis. Combined treatment modality, including endoscopic endonasal surgery, achieved a better outcome than non-surgical approach.	[Zhang, Luyao; Zhu, Kang; Xia, Cui; Yan, Jing; Wei, Junrong; Zheng, Guoxi] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Otorhinolaryngol Head & Neck Surg, Xian, Shaanxi, Peoples R China; [Niu, Kai; Duan, Maoli] Karolinska Inst, Karolinska Hosp, Dept Clin Sci Technol & Intervent, Stockholm, Sweden; [Niu, Kai] Jilin Univ, Affiliated Hosp 1, Dept Otorhinolaryngol Head & Neck Surg, Changchun, Jilin, Peoples R China; [Zhao, Wei] Shangluo Cent Hosp, Dept Otorhinolaryngol, Shangluo, Shaanxi, Peoples R China	Xi'an Jiaotong University; Karolinska Institutet; Karolinska University Hospital; Jilin University	Zheng, GX (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Otorhinolaryngol Head & Neck Surg, Xian, Shaanxi, Peoples R China.; Duan, ML (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Clin Sci Technol & Intervent, Stockholm, Sweden.	Maoli.Duan@ki.se; zhengguoxi@21cn.com			National Natural Science Foundation of China [81271057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China (No. 81271057,) (http://www.nsfc.gov.cn/publish/portall/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bachar G, 2008, HEAD NECK-J SCI SPEC, V30, P1607, DOI 10.1002/hed.20920; Bell D, 2015, HEAD NECK PATHOL, V9, P51, DOI 10.1007/s12105-014-0547-3; Bossi P, 2015, CANCER TREAT REV, V41, P836, DOI 10.1016/j.ctrv.2015.07.004; Bradley Patrick J, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P112, DOI 10.1097/00020840-200304000-00009; Castelnuovo P, 2007, HEAD NECK-J SCI SPEC, V29, P845, DOI 10.1002/hed.20610; Devaiah AK, 2009, LARYNGOSCOPE, V119, P1412, DOI 10.1002/lary.20280; Devaney K, 1996, MODERN PATHOL, V9, P658; Devi Parvathi, 2014, J Oral Maxillofac Pathol, V18, pS135, DOI 10.4103/0973-029X.141367; DULGUEROV P, 1992, LARYNGOSCOPE, V102, P843, DOI 10.1288/00005537-199208000-00001; Dulguerov P, 2001, LANCET ONCOL, V2, P683, DOI 10.1016/S1470-2045(01)00558-7; Ferlito A, 2003, LARYNGOSCOPE, V113, P1935, DOI 10.1097/00005537-200311000-00015; FOOTE RL, 1993, INT J RADIAT ONCOL, V27, P835, DOI 10.1016/0360-3016(93)90457-7; Fu TS, 2016, HEAD NECK-J SCI SPEC, V38, pE2306, DOI 10.1002/hed.24233; Guled M, 2008, MODERN PATHOL, V21, P770, DOI 10.1038/modpathol.2008.57; HIROSE T, 1995, CANCER, V76, P4, DOI 10.1002/1097-0142(19950701)76:1<4::AID-CNCR2820760103>3.0.CO;2-E; Jethanamest D, 2007, ARCH OTOLARYNGOL, V133, P276, DOI 10.1001/archotol.133.3.276; KADISH S, 1976, CANCER, V37, P1571, DOI 10.1002/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO;2-L; Kane AJ, 2010, J NEUROSURG, V113, P340, DOI 10.3171/2010.2.JNS091897; Komotar RJ, 2013, WORLD NEUROSURG, V80, P148, DOI 10.1016/j.wneu.2012.12.003; Lund VJ, 2015, RHINOLOGY, V53, P204, DOI 10.4193/Rhino14.318; Lund VJ, 1998, HEAD NECK-J SCI SPEC, V20, P97, DOI 10.1002/(SICI)1097-0347(199803)20:2<97::AID-HED1>3.0.CO;2-Y; Malouf GG, 2013, EUR J CANCER, V49, P1324, DOI 10.1016/j.ejca.2012.12.008; McElroy EA, 1998, NEUROSURGERY, V42, P1023, DOI 10.1097/00006123-199805000-00040; MORITA A, 1993, NEUROSURGERY, V32, P706, DOI 10.1227/00006123-199305000-00002; Ow TJ, 2014, HEAD NECK-J SCI SPEC, V36, P524, DOI 10.1002/hed.23327; Porter AB, 2008, J NEURO-ONCOL, V90, P201, DOI 10.1007/s11060-008-9645-y; Saade RE, 2015, CURR ONCOL REP, V17, DOI 10.1007/s11912-014-0423-z; Song CM, 2012, LARYNGOSCOPE, V122, P2389, DOI 10.1002/lary.23641; Tajudeen BA, 2015, J NEUROL SURG PART B, V76, P43, DOI 10.1055/s-0034-1390011; Thompson LDR, 2009, HEAD NECK PATHOL, V3, P252, DOI 10.1007/s12105-009-0125-2; TROJANOWSKI JQ, 1982, NEW ENGL J MED, V307, P159, DOI 10.1056/NEJM198207153070305; Unger F, 2001, MINIM INVAS NEUROSUR, V44, P79, DOI 10.1055/s-2001-16000; Vucinic N, 2015, ACTA NEUROL BELG, V115, P195, DOI 10.1007/s13760-014-0319-6; Zafereo ME, 2008, OTOLARYNG HEAD NECK, V138, P452, DOI 10.1016/j.otohns.2007.12.038	34	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0166046	10.1371/journal.pone.0166046	http://dx.doi.org/10.1371/journal.pone.0166046			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806104	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500079
J	Murakami, M; Nakatani, J; Oki, T				Murakami, Michio; Nakatani, Jun; Oki, Taikan			Evaluation of Risk Perception and Risk-Comparison Information Regarding Dietary Radionuclides after the 2011 Fukushima Nuclear Power Plant Accident	PLOS ONE			English	Article							HEALTH MANAGEMENT SURVEY; PSYCHOLOGICAL DISTRESS; COMMUNICATION; MORTALITY; JAPAN; REPRESENTATION; EARTHQUAKE; DISASTER; COHORT	In the wake of the 2011 Fukushima Daiichi Nuclear Power Station accident, to facilitate evidence-based risk communication we need to understand radiation risk perception and the effectiveness of risk-comparison information. We measured and characterized perceptions of dread risks and unknown risks regarding dietary radionuclides in residents of Fukushima, Tokyo, and Osaka to identify the primary factors among location, evacuation experience, gender, age, employment status, absence/presence of spouse, children and grandchildren, educational background, humanities/science courses, smoking habits, and various types of trustworthy information sources. We then evaluated the effects of these factors and risk-comparison information on multiple outcomes, including subjective and objective understanding, perceived magnitude of risk, perceived accuracy of information, backlash against information, and risk acceptance. We also assessed how risk-comparison information affected these multiple outcomes for people with high risk perception. Online questionnaires were completed by people (n = 9249) aged from 20 to 69 years in the three prefectures approximately 5 years after the accident. We gave each participant one of 15 combinations of numerical risk data and risk-comparison information, including information on standards, smoking-associated risk, and cancer risk, in accordance with Covello's guidelines. Dread-risk perception among Fukushima residents with no experience of evacuation was much lower than that in Osaka residents, whereas evacuees had strikingly higher dread-risk perception, irrespective of whether their evacuation had been compulsory or voluntary. We identified location (distance from the nuclear power station), evacuation experience, and trust of central government as primary factors. Location (including evacuation experience) and trust of central government were significantly associated with the multiple outcomes above. Only information on "cancer risk from radiation and smoking risk" enhanced both subjective and objective understanding without diminishing trust in all participants and in the high dread-risk perception group; use of other risk-comparison information could lead the public to overestimate risk.	[Murakami, Michio] Fukushima Med Univ, Dept Hlth Risk Commun, Sch Med, 1 Hikarigaoka, Fukushima 9601295, Japan; [Nakatani, Jun] Univ Tokyo, Dept Urban Engn, Grad Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan; [Oki, Taikan] Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan	Fukushima Medical University; University of Tokyo; University of Tokyo	Murakami, M (corresponding author), Fukushima Med Univ, Dept Hlth Risk Commun, Sch Med, 1 Hikarigaoka, Fukushima 9601295, Japan.	michio@fmu.ac.jp	Oki, Taikan/E-5778-2010; Nakatani, Jun/H-7864-2019	Oki, Taikan/0000-0003-4067-4678; Nakatani, Jun/0000-0002-8085-5089	"Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency	"Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency	This study was supported by a "Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency, http://www.jst.go.jp/kisoken/crest/en/index.html. MM, JN, and TO receive the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, SIGMA MENTAL ILLNESS; Apter AJ, 2008, J GEN INTERN MED, V23, P2117, DOI 10.1007/s11606-008-0803-x; Boholm A., 1998, J RISK RES, V1, P135, DOI [10.1080/136698798377231, DOI 10.1080/136698798377231]; Consumer Affairs Agency Government of Japan, 2016, FUH HIG NIK SHOH IS; Covello V.T., 1988, RISK COMMUNICATION R; FAO/WHO, 2011, JOINT FAO WHO PUBL W, P63; FISCHHOFF B, 1978, J EXP PSYCHOL HUMAN, V4, P330, DOI 10.1037/0096-1523.4.2.330; Harada KH, 2014, P NATL ACAD SCI USA, V111, pE914, DOI 10.1073/pnas.1315684111; Hino Y, 2016, TOHOKU J EXP MED, V239, P333, DOI 10.1620/tjem.239.333; Hommerich C, 2012, INT J JPN SOCIOL, V21, P46, DOI 10.1111/j.1475-6781.2012.01169.x; ICRP, 1959, ICRP PUBL; ICRP (International Commission on Radiological Protection), 2007, ANN ICRP, V37; Ikeda K, 2015, SINSAI KARA MIERU JO; Inoue M, 2004, PREV MED, V38, P516, DOI 10.1016/j.ypmed.2003.11.026; Johnson BB, 2003, RISK ANAL, V23, P767, DOI 10.1111/1539-6924.00354; Joint FAO WHO Expert Committee on Food Additives, 2011, FAO JECFA MON, V8; Kahan D. M., 2007, J EMPIR LEGAL STUD, V4, P465, DOI DOI 10.1111/J.1740-1461.2007.00097.X; Kahneman D., 2011, THINKING FAST SLOW; KLEINHESSELINK RR, 1991, J CROSS CULT PSYCHOL, V22, P11, DOI 10.1177/0022022191221004; Mattisson C, 2015, J AFFECT DISORDERS, V178, P98, DOI 10.1016/j.jad.2015.02.028; Murakami M, 2016, RADIAT PROT DOSIM, V171, P156, DOI 10.1093/rpd/ncw211; Murakami M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0112791, 10.1]; National Institute of Radiological Sciences, 1965, RAD SURV DAT JAP; National Research Council, 1987, IMPR RISK COMM; National Research Council Of The National Academies, 2005, ASS SCI INF RAD EXP, DOI 10.17226/11279; Nuclear Safety Research Association, 2011, SINB SEIK KANK HOUSH; Oguri T, 2012, FOOD CHEM TOXICOL, V50, P2663, DOI 10.1016/j.fct.2012.05.010; Oka T, 2014, JPN J RISK ANAL, V24, P101; Oki S, 2012, INT J DISAST RISK RE, V2, P37, DOI 10.1016/j.ijdrr.2012.07.002; Orita M, 2013, RADIAT PROT DOSIM, V156, P383, DOI 10.1093/rpd/nct082; Pratt LA, 2009, ANN EPIDEMIOL, V19, P202, DOI 10.1016/j.annepidem.2008.12.005; ROTH E, 1990, RISK ANAL, V10, P375, DOI 10.1111/j.1539-6924.1990.tb00520.x; Sato A., 2015, FUKUSHIMA GLOBAL COM; Science Council of Japan Daiichibu Fukushima Genpatsu saigai gono kagaku to shakai no arikata wotou bunkakai, 2014, KAG TO SHAK NO YOR K; Slovic P, 2000, LAW HUMAN BEHAV, V24, P271, DOI 10.1023/A:1005595519944; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; STARR C, 1969, SCIENCE, V165, P1232, DOI 10.1126/science.165.3899.1232; Steinhardt J, 2015, RISK ANAL, V35, P1423, DOI 10.1111/risa.12368; Suzuki Y, 2015, B WORLD HEALTH ORGAN, V93, P598, DOI 10.2471/BLT.14.146498; Thaler R.H., 2021, NUDGE FINAL EDITION; Tsubokura M, 2015, HEALTH PHYS, V108, P39, DOI 10.1097/HP.0000000000000167; United Nations Scientific Committee on the Effects of Atomic Radiation, 2014, SOURC EFF RISKS ION; United Nations Scientific Committee on the Effects of Atomic Radiation, 2011, UNSCEAR 2008 REP, VII; Visschers VHM, 2013, RISK ANAL, V33, P333, DOI 10.1111/j.1539-6924.2012.01861.x; Yamagishi K, 1997, APPL COGNITIVE PSYCH, V11, P495, DOI 10.1002/(SICI)1099-0720(199712)11:6<495::AID-ACP481>3.0.CO;2-J	46	34	34	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165594	10.1371/journal.pone.0165594	http://dx.doi.org/10.1371/journal.pone.0165594			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6CX	27802304	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200030
J	De Angelis, R; Melino, S; Prosposito, P; Casalboni, M; Lamastra, FR; Nanni, F; Bruno, L; Congestri, R				De Angelis, Roberta; Melino, Sonia; Prosposito, Paolo; Casalboni, Mauro; Lamastra, Francesca Romana; Nanni, Francesca; Bruno, Laura; Congestri, Roberta			The Diatom Staurosirella pinnata for Photoactive Material Production	PLOS ONE			English	Article							ACCUMULATION; INTEGRATION; GROWTH	A native isolate of the colonial benthic diatom Staurosirella pinnata was cultivated for biosilica production. The silicified cell walls (frustules) were used as a source of homogeneous and structurally predictable porous biosilica for dye trapping and random laser applications. This was coupled with the extraction of lipids from biomass showing potential to fabricate photoactive composite materials sustainably. The strain was selected for its ease of growth in culture and harvesting. Biosilica and lipids were obtained at the end of growth in indoor photobioreactors. Frustules were structurally characterized microscopically and their chemistry analyzed with Fourier Transform Infrared Spectroscopy. Frustule capacity of binding laser dyes was evaluated on a set of frustules/Rhodamine B (Rho B) solutions and with respect to silicon dioxide and diatomite by Fluorescence Spectroscopy demonstrating a high affinity for the organic dye. The effect of dye trapping property in conveying Rho B emission to frustules, with enhancement of scattering events, was analyzed on Rho B doped polyacrylamide gels filled or not with frustules. Amplified spontaneous emission was recorded at increasing pump power indicating the onset of a random laser effect in frustule filled gels at lower power threshold compared to unfilled matrices.	[De Angelis, Roberta; Prosposito, Paolo; Casalboni, Mauro] Univ Roma Tor Vergata, Dept Ind Engn, Rome, Italy; [De Angelis, Roberta; Prosposito, Paolo; Casalboni, Mauro; Lamastra, Francesca Romana; Nanni, Francesca] NSTM Consortium, Res Unit Roma Tor Vergata, Rome, Italy; [Melino, Sonia] Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy; [Nanni, Francesca] Univ Roma Tor Vergata, Dept Enterprise Engn, Rome, Italy; [Bruno, Laura; Congestri, Roberta] Univ Roma Tor Vergata, Dept Biol, Lab Biol Algae, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata	Bruno, L (corresponding author), Univ Roma Tor Vergata, Dept Biol, Lab Biol Algae, Rome, Italy.	laura.bruno@uniroma2.it	nanni, francesca/AAS-2924-2020	nanni, francesca/0000-0002-0484-8637; MELINO, SONIA/0000-0001-7694-5279; BRUNO, LAURA/0000-0003-4703-2088				Bailleul B, 2015, NATURE, V524, P366, DOI 10.1038/nature14599; Bao ZH, 2007, NATURE, V446, P172, DOI 10.1038/nature05570; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Bozarth A, 2009, APPL MICROBIOL BIOT, V82, P195, DOI 10.1007/s00253-008-1804-8; Brunner E, 2009, APPL MICROBIOL BIOT, V84, P607, DOI 10.1007/s00253-009-2140-3; Cao H, 2013, NATURE, V503, P200, DOI 10.1038/503200a; Cullis AG, 1997, J APPL PHYS, V82, P909, DOI 10.1063/1.366536; d'Ippolito G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0212-4; De Bhowmick G, 2015, RENEW SUST ENERG REV, V50, P1239, DOI 10.1016/j.rser.2015.04.131; De Stefano M, 2009, SUPERLATTICE MICROST, V46, P64, DOI 10.1016/j.spmi.2008.12.007; Di Caprio G, 2014, J BIOPHOTONICS, V7, P341, DOI 10.1002/jbio.201200198; Di Pippo F, 2013, J APPL PHYCOL, V25, P1697, DOI 10.1007/s10811-013-0028-1; Ferrara MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103750; Fresewinkel M, 2014, ENG LIFE SCI, V14, P560, DOI 10.1002/elsc.201300153; Gheorghiu S, 2004, AICHE J, V50, P812, DOI 10.1002/aic.10076; Gismondi A, 2016, INT J PHYTOREMEDIAT, V18, P869, DOI 10.1080/15226514.2016.1156640; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Guillard R.R.L., 1973, HDB PHYCOLOGICAL MET, P289; Gulturk E., 2011, J ACHIEV MAT MANUF E, V46, P196; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hildebrand M, 2012, BIOFUELS-UK, V3, P221, DOI 10.4155/bfs.11.157; Kieu K, 2014, OPT EXPRESS, V22, P15992, DOI 10.1364/OE.22.015992; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Lamastra FR, 2014, RSC ADV, V4, P61809, DOI 10.1039/c4ra12519c; Lang Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03205; Lettieri S, 2008, ADV FUNCT MATER, V18, P1257, DOI 10.1002/adfm.200701124; Levitan O, 2014, TRENDS BIOTECHNOL, V32, P117, DOI 10.1016/j.tibtech.2014.01.004; Liang HK, 2013, ADV MATER, V25, P6859, DOI 10.1002/adma.201303122; Losic D, 2009, ADV MATER, V21, P2947, DOI 10.1002/adma.200803778; Lynch F, 2015, ALGAL RES, V11, P411, DOI 10.1016/j.algal.2015.05.015; Magni P, 2005, HYDROBIOLOGIA, V550, P105, DOI 10.1007/s10750-005-4367-z; Masojidek J, 2010, DEVEL APPL PHYCOL, V4, P277, DOI 10.1007/978-90-481-9268-7_13; Mohan N., 2012, J ALGAL BIOMASS UTLN, V3, P52; Olof SN, 2012, NANO LETT, V12, P6018, DOI 10.1021/nl303585w; Qin T, 2008, ACS NANO, V2, P1296, DOI 10.1021/nn800114q; Qin T, 2008, J NANOSCI NANOTECHNO, V8, P2392, DOI 10.1166/jnn.2008.241; Renaud SM, 1999, AQUACULTURE, V170, P147, DOI 10.1016/S0044-8486(98)00399-8; Singh P, 2016, RENEW SUST ENERG REV, V55, P1, DOI 10.1016/j.rser.2015.11.001; Singho ND, 2012, INT J ELECTROCHEM SC, V7, P5604; Su Y, 2015, NANO RES, V8, P2363, DOI 10.1007/s12274-015-0746-6; Tesson B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014300; Toster J, 2013, NANOSCALE, V5, P873, DOI 10.1039/c2nr32716c; Van Eynde E, 2013, PHOTOCH PHOTOBIO SCI, V12, P690, DOI 10.1039/c2pp25229e; Wang Y, 2013, APPL MICROBIOL BIOT, V97, P453, DOI 10.1007/s00253-012-4568-0; Wu MC, 2012, PROCESS BIOCHEM, V47, P2204, DOI 10.1016/j.procbio.2012.08.015; Yang ZK, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-67	46	14	14	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165571	10.1371/journal.pone.0165571	http://dx.doi.org/10.1371/journal.pone.0165571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828985	Green Submitted, gold, Green Published			2022-12-27	WOS:000387724300051
J	Negin, J; Gregson, S; Eaton, JW; Schur, N; Takaruza, A; Mason, P; Nyamukapa, C				Negin, Joel; Gregson, Simon; Eaton, Jeffrey W.; Schur, Nadine; Takaruza, Albert; Mason, Peter; Nyamukapa, Constance			Rising Levels of HIV Infection in Older Adults in Eastern Zimbabwe	PLOS ONE			English	Article							RURAL SOUTH-AFRICA; SEXUAL-BEHAVIOR; WEST UGANDA; PREVALENCE; COHORT; POPULATION; DECLINE; COMMUNITY; EPIDEMIC; TRENDS	Background With the scale-up of antiretroviral treatment across Africa, many people are living longer with HIV. Understanding the ageing of the HIV cohort and sexual behaviour among older adults are important for appropriately responding to the changing demographics of people living with HIV. Methods We used data from a large population-based open cohort in eastern Zimbabwe to examine HIV prevalence trends and incidence among those aged 45 years and older. Five survey rounds have been completed between 1998 and 2011. Incidence was analysed using midpoint between last negative and first positive HIV test. Results Across the survey rounds, 13,071 individuals were followed for 57,676 person years. While HIV prevalence among people aged 15-44 has fallen across the five rounds, HIV prevalence among those aged 45-54 has increased since the 2006-08 survey round. In the 2009-11 round, HIV prevalence among men aged 45-54 was 23.4% compared to 11.0% among those aged 15-44. HIV positive people aged 45-54 now represent more than 20% of all those living with HIV in Manicaland. Among those aged 45 years and older, there were 85 seroconversions in 11,999 person years for an HIV incidence of 0.708 per 100 person years. Analysis of cohort data and assessment of behavioural risk factors for HIV infection among older people shows significantly lower levels of condom use among older adults and a number of seroconversions past the age of 50. Conclusions The cohort of people living with HIV is ageing in Zimbabwe and the behaviour of older adults puts them at risk of HIV infection. Older adults must be included in both HIV prevention and treatment programs.	[Negin, Joel] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Gregson, Simon; Takaruza, Albert; Mason, Peter; Nyamukapa, Constance] Biomed Res & Training Inst, Harare, Zimbabwe; [Gregson, Simon; Eaton, Jeffrey W.; Schur, Nadine; Nyamukapa, Constance] Imperial Coll, Dept Infect Dis Epidemiol, Sch Publ Hlth, London, England; [Mason, Peter] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe	University of Sydney; Biomedical Research Training Institute; Imperial College London; University of Zimbabwe	Negin, J (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia.	joel.negin@sydney.edu.au		Gregson, Simon/0000-0003-2707-0714; Eaton, Jeffrey/0000-0001-7728-728X; Nyamukapa, Constance/0000-0001-6779-4069	Wellcome Trust; Medical Research Council [MR/K010174/1B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Wellcome Trust funded the Manicaland HIV/STD Prevention project from which data was used for this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are grateful to all participants in the Manicaland HIV/STD Prevention Project.; The Wellcome Trust funded the Manicaland HIV/STD Prevention project from which data was used for this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We are grateful to all participants in the Manicaland HIV/STD Prevention Project.	Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Barnighausen T, 2009, AIDS RES HUM RETROV, V25, P405, DOI 10.1089/aid.2008.0211; Biraro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055060; Campbell C, 2013, AIDS CARE, V25, pS114, DOI 10.1080/09540121.2012.748170; Drew Olivia, 2008, Menopause Int, V14, P134, DOI 10.1258/mi.2008.008020; Eaton JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070447; Gomez-Olive FX, 2013, AIDS CARE, V25, P1122, DOI 10.1080/09540121.2012.750710; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2013, AIDS CARE, V25, pS88, DOI 10.1080/09540121.2012.748171; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Hargreaves JR, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000300534.97601.d6; Hontelez Jan A C, 2012, AIDS, V26 Suppl 1, pS19; Karim QA, 2011, INT J EPIDEMIOL, V40, P922, DOI 10.1093/ije/dyq176; Kuteesa MO, 2012, AJAR-AFR J AIDS RES, V11, P295, DOI 10.2989/16085906.2012.754829; Lekalakala-Mokgele E, 2014, SAHARA J-J SOC ASP H, V11, P67, DOI 10.1080/17290376.2014.931816; Mahy M, 2014, AIDS, V28, pS453, DOI 10.1097/QAD.0000000000000479; Mbulaiteye SM, 2002, LANCET, V360, P41, DOI 10.1016/S0140-6736(02)09331-5; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; National AIDS Control Council National AIDS and STI Control Programme, 2012, KEN AIDS EP UPD 2011; Negin J, 2016, ARCH SEX BEHAV, V45, P441, DOI 10.1007/s10508-015-0582-5; Negin Joel, 2012, AIDS, V26 Suppl 1, pS55; Negin J, 2012, AIDS BEHAV, V16, P63, DOI 10.1007/s10461-011-9994-y; Negin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026546; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Nyirenda M, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19201; Okiria AG, 2013, AIDS BEHAV; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Shafer LA, 2008, AIDS, V22, P1641, DOI 10.1097/QAD.0b013e32830a7502; UNAIDS, 2013, HIV AG SPEC SUPPL UN; UNAIDS, 2011, GET ZER FAST SMART B; UNAIDS, 2014, THE GAP REP; Wallrauch C, 2010, SAMJ S AFR MED J, V100, P812, DOI 10.7196/SAMJ.4181; Whitworth JAG, 2002, TROP MED INT HEALTH, V7, P1047, DOI 10.1046/j.1365-3156.2002.00973.x; Zaidi J, 2013, AIDS, V27, P2301, DOI 10.1097/QAD.0b013e328362e832	34	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0162967	10.1371/journal.pone.0162967	http://dx.doi.org/10.1371/journal.pone.0162967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27828979	Green Submitted, gold, Green Published			2022-12-27	WOS:000387724300005
J	Praputra, AV; Bong, IW; Ekowati, D; Hofstee, C; Maryudi, A				Praputra, Andhika Vega; Bong, Indah Waty; Ekowati, Dian; Hofstee, Carole; Maryudi, Ahmad			Getting the Data Flowing: Lessons Learned from Existing Reporting Systems in the Forestry Sector in Indonesia for REDD plus MRV	PLOS ONE			English	Article							COMMUNITY; DEFORESTATION; EMISSIONS	In the context of REDD+, Measurement, Reporting and Verification (MRV) is one way to manage forest change information. A national carbon and non-carbon database will be used in REDD+ to negotiate compensation schemes with the international community. Much of this data will be collected at the local level, thus a reporting system that can integrate these locally collected data into the national database is crucial. In this paper we compare and draw lessons from three existing local to national reporting systems that include the participation of local communities: 1) the government extension services, 2) the government owned forestry company, and 3) a private logging company in Indonesia, and provide recommendations for REDD+ reporting systems. The results suggest that the main desired conditions for effective data flow are: benefits to motivate local participation, based on contributions to reporting activities; simple data format and reporting procedures to allow local participation in the reporting process, and to support data aggregation at the national level; a facilitator to mediate data aggregation at the village level to ensure data consistency, completeness and accuracy; and a transparent and clear data flow. Under these conditions, continuous, accountable and consistent data flow from the local level will reach the national level where it can be fully utilized.	[Praputra, Andhika Vega; Bong, Indah Waty; Ekowati, Dian; Hofstee, Carole] Ctr Int Forestry Res, Bogor, Indonesia; [Maryudi, Ahmad] Gadjah Mada Univ, Fac Forestry, Bulaksumur, Yogyakarta, Indonesia	CGIAR; Center for International Forestry Research (CIFOR); Gadjah Mada University	Praputra, AV (corresponding author), Ctr Int Forestry Res, Bogor, Indonesia.	andhika.vega@gmail.com	Maryudi, Ahmad/T-8029-2019	Maryudi, Ahmad/0000-0001-5051-7217; Praputra, Andhika Vega/0000-0002-7976-9204	U.S. Agency for International Development (USAID) [MT0069018]; Norwegian Agency for Development Cooperation (NORAD) [GLO-3945, QZA 12/0882]; Republic of Germany [KI II 7-42206-6/75]; Consultative Group for International Agricultural Research (CGIAR), under Forests, Tree and Agroforestry: Livelihoods, Landscapes and Governance (FTA) [TF 069018]; USAID; Norwegian Agency for Development Cooperation (Norad); International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB); CGIAR	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Norwegian Agency for Development Cooperation (NORAD); Republic of Germany; Consultative Group for International Agricultural Research (CGIAR), under Forests, Tree and Agroforestry: Livelihoods, Landscapes and Governance (FTA); USAID(United States Agency for International Development (USAID)); Norwegian Agency for Development Cooperation (Norad); International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB); CGIAR(CGIAR)	Funded by: 1. The U.S. Agency for International Development (USAID), grant number MT0069018, http//www.usaid.gov/. 2. The Norwegian Agency for Development Cooperation (NORAD), grant number GLO-3945, QZA 12/0882, http://www.norad.no/. 3. The Republic of Germany, represented by the Federal Minister for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB), grant number KI II 7-42206-6/75, http://www.bmub.bund.de/en/. 4. The Consultative Group for International Agricultural Research (CGIAR), under Forests, Tree and Agroforestry: Livelihoods, Landscapes and Governance (FTA), grant number TF 069018, http://www.cgiar.org/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the local communities and forestry stakeholders in Wonosobo, Mamberamo Raya and Kapuas Hulu Districts for their participation in this study. We specially thank Manuel Boissiere, the PMRV project leader, for his continuous support in the research and writing process. We thank Douglas Sheil for his reviews and inputs during the writing process. We also thank the PMRV team members Mary Elizabeth Felker, Guillaume Beaudoin, Sandra Dharmadi Hawthorne, Arief Wijaya, Wahid Ullah, Serge Rafanoharana, and Gilang Aria Seta, for their continued support, inputs and numerous reviews during the long development process of this paper. They would also like to acknowledge other members of the team, Anggoro Santoso Edy Widayat, Haris Iskandar, Ermayanti, Lina Farida, Yuli Nugroho, Alice Bortzmeyer, Walker H. Depuy, Isack Yable, and Bagus Sartono for their contribution to the research. They also thank Glen Mulcahy, the anonymous reviewers, and the PLoS ONE editors for their valuable comments and editing. This research was carried out by the Center for International Forestry Research (CIFOR) and the Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD), and in collaboration with the University of Gadjah Mada (UGM). This research forms part of the CGIAR Research Program on Forests, Trees and Agroforestry and the Global Comparative Study on REDD+, with funding support from the USAID, the Norwegian Agency for Development Cooperation (Norad), the International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB), and the CGIAR.	Agrawal A, 2011, ANNU REV ENV RESOUR, V36, P373, DOI 10.1146/annurev-environ-042009-094508; [Anonymous], CAPACITY DEV NATL FO; [Anonymous], J MANAG SUSTAIN; Awang SA, 2006, YEAR 3 REPORT JAVA C; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Boissiere M, 2014, FORESTS, V5, P1855, DOI 10.3390/f5081855; Danielsen F, 2013, COMMUNITY MONITORING, P18; Danielsen F, 2011, CONSERV LETT, V4, P158, DOI 10.1111/j.1755-263X.2010.00159.x; Djamhuri TL, 2012, FOREST POLICY ECON, V25, P10, DOI 10.1016/j.forpol.2012.02.004; Fry B, 2011, ENVIRON SCI POLICY, V14, P181, DOI 10.1016/j.envsci.2010.12.004; GOFC-GOLD, 2012, GOGC GODL REP VERS; IIED, 2014, BRIEF WHAT PEOPL WAN; Indonesian REDD+Task Force, 2013, REDD NAT STRAT; Murdiyarso D, 2008, ECOHYDROLOGY INITIAL; Pemerintah Indonesia, 2006, UND UND REP IND 16 T; Pemerintah Republik Indonesia, 2015, PER PRES REP IND 16; Pratihast AK, 2011, COMMUNITY BASED MONI; Pratihast AK, 2013, CARBON MANAG, V4, P91, DOI [10.4155/cmt.12.75, 10.4155/CMT.12.75]; Romijn E, 2012, ENVIRON SCI POLICY, V19-20, P33, DOI 10.1016/j.envsci.2012.01.005; Skutsch M, 2014, FORESTS, V5, P1596, DOI 10.3390/f5071596; Tim Kerja MRV Satgas REDD+, 2013, STRAT DAN RENC IMPL, P1; UNFCCC, 2009, COST IMPLEMENTING ME; UNFCCC. Report of the conference of the parties on its fifteenth session, 2010, C PART ITS 16 SESS H, P1; United Nations Framework Convention on Climate Change (UNFCCC), 2010, C PART ITS 15 SESS H; Yokota Y, 2014, JARQ-JPN AGR RES Q, V48, P363, DOI 10.6090/jarq.48.363	25	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0156743	10.1371/journal.pone.0156743	http://dx.doi.org/10.1371/journal.pone.0156743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828959	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300001
J	McIntyre, MK; Peacock, TJ; Akers, KS; Burmeister, DM				McIntyre, Matthew K.; Peacock, Trent J.; Akers, Kevin S.; Burmeister, David M.			Initial Characterization of the Pig Skin Bacteriome and Its Effect on In Vitro Models of Wound Healing	PLOS ONE			English	Article								Elucidating the roles and composition of the human skin microbiome has revealed a delicate interplay between resident microbes and wound healing. Evolutionarily speaking, normal cutaneous flora likely has been selected for because it potentiates or, at minimum, does not impede wound healing. While pigs are the gold standard model for wound healing studies, the porcine skin microbiome has not been studied in detail. Herein, we performed 16S rDNA sequencing to characterize the pig skin bacteriome at several anatomical locations. Additionally, we used bacterial conditioned-media with in vitro techniques to examine the paracrine effects of bacterial-derived proteins on human keratinocytes (NHEK) and fibroblasts (NHDF). We found that at the phyla level, the pig skin bacteriome is similar to that of humans and largely consists of Firmicutes (55.6%), Bacteroidetes (20.8%), Actinobacteria (13.3%), and Proteobacteria (5.1%) however species-level differences between anatomical locations exist. Studies of bacterial supernatant revealed location-dependent effects on NHDF migration and NHEK apoptosis and growth factor release. These results expand the limited knowledge of the cutaneous bacteriome of healthy swine, and suggest that naturally occurring bacterial flora affects wound healing differentially depending on anatomical location. Ultimately, the pig might be considered the best surrogate for not only wound healing studies but also the cutaneous microbiome. This would not only facilitate investigations into the microbiome's role in recovery from injury, but also provide microbial targets for enhancing or accelerating wound healing.	[McIntyre, Matthew K.; Burmeister, David M.] US Army, Damage Control Resuscitat, Inst Surg Res, Ft Sam Houston, TX 78234 USA; [Peacock, Trent J.] US Army, Dent Trauma Res Detachment, Inst Surg Res, Ft Sam Houston, TX USA; [Akers, Kevin S.] US Army, Extrem Trauma & Regenerat Med, Inst Surg Res, Ft Sam Houston, TX USA		Burmeister, DM (corresponding author), US Army, Damage Control Resuscitat, Inst Surg Res, Ft Sam Houston, TX 78234 USA.	David.m.Burmeister3.civ@mail.mil		Burmeister, David/0000-0002-1256-0158	Oak Ridge Institute for Science and Education; US Army Medical Research and Materiel Command	Oak Ridge Institute for Science and Education(General Electric); US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This study was supported by the Oak Ridge Institute for Science and Education and the US Army Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi A, 2014, CELL MOL LIFE SCI, V71, P3241, DOI 10.1007/s00018-014-1612-5; Bradley CW, 2016, J INVEST DERMATOL; Canesso MCC, 2014, J IMMUNOLOGY, V193; Capone KA, 2011, J INVEST DERMATOL, V131, P2026, DOI 10.1038/jid.2011.168; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; de Hemptinne I, 2008, WOUND REPAIR REGEN, V16, P132, DOI 10.1111/j.1524-475X.2007.00340.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gallant CL, 2004, WOUND REPAIR REGEN, V12, P305, DOI 10.1111/j.1067-1927.2004.012311.x; Gallant-Behm CL, 2007, J INVEST DERMATOL, V127, P233, DOI 10.1038/sj.jid.5700482; Gallo RL, 2011, J INVESTIGATIVE DERM, V131; Grice EA, 2010, PNAS, V107; Grice EA, 2011, NAT REV MICROBIOL, V9, DOI 10.1038/nrmicro2619; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hybbinette S, 1999, EXP DERMATOL, V8, P30, DOI 10.1111/j.1600-0625.1999.tb00345.x; Jones SG, 2004, INT J LOW EXTREM WOU, V3; Kolmeder CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153294; Kong HH, 2012, GENOME RES; Laborel-Preneron E., 2015, PLOS ONE, V10; Lai Y, 2010, J INVESTIGATIVE DERM, V130; Lai Y, 2009, NATURE MED, V15; Lozupone C., 2005, APPL ENVIRON MICROB, V71, P12, DOI DOI 10.1128/AEM.71.12.82288235.2005; Magistrelli D, 2016, J AGR FOOD CHEM, V64, P2046, DOI 10.1021/acs.jafc.5b05732; Marano RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13296; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Misic AM, 2014, ADV WOUND CARE NEW R, V3; Moissenet D, 2012, J CLIN MICROBIOL, V50, P1495, DOI 10.1128/JCM.06038-11; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nakatsuji T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2441; Normand J, 1995, IN VITRO CELL DEV BI, V31; Oh J, 2012, GENOME MED, V4, DOI 10.1186/gm378; Poutahidis T, 2013, PLOS ONE, V8; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ramos M, 2008, J BURN CARE RES, V29; SanMiguel A, 2015, CELL MOL LIFE SCI, V72, P1499, DOI 10.1007/s00018-014-1812-z; Seaton M, 2015, ILAR J, V56, P127, DOI 10.1093/ilar/ilv016; Shrivastava HY, 2005, FREE RADIC BIOL MED, V38; Singer A, 2003, METHODS MOL MED, V78; Singer AJ, 2016, BURNS, V42, P184, DOI 10.1016/j.burns.2015.09.016; Singer AJ, 2008, N ENGL J MED, V359; Song H, 2016, J ALLERGY CLIN IMMUN, V137, P852, DOI 10.1016/j.jaci.2015.08.021; Stephens P, 2003, BR J DERMATOL, V148; Sullivan T, 2001, WOUND REPAIR REGENER, V9; Swe PM, 2014, PLOS NEGLECTED TROPI, V8; Takao K, 2015, P NATL ACAD SCI US, V112; Wang J, 2008, LAB INVEST, V88; Wang X-Q, 2009, BURNS, V35; Ward CL, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0412-x; Yao F, 2001, WOUND REPAIR REGEN, V9, P371, DOI 10.1046/j.1524-475x.2001.00371.x; Zeeuwen PLJM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r101; Zhang M, 2015, MICROBIAL ECOLOGY, V69	50	24	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166176	10.1371/journal.pone.0166176	http://dx.doi.org/10.1371/journal.pone.0166176			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824921	gold, Green Published			2022-12-27	WOS:000387615200066
J	Ding, YM; Cao, YK; Wang, B; Wang, L; Zhang, YM; Zhang, DL; Chen, XY; Li, MX; Wang, CH				Ding, Youming; Cao, Yingkang; Wang, Bin; Wang, Lei; Zhang, Yemin; Zhang, Deling; Chen, Xiaoyan; Li, Mingxin; Wang, Changhua			APPL1-Mediating Leptin Signaling Contributes to Proliferation and Migration of Cancer Cells	PLOS ONE			English	Article							BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; INSULIN-RESISTANCE; INDUCED APOPTOSIS; PROSTATE-CANCER; GROWTH-FACTOR; PPAR-ALPHA; OBESITY; APPL; EXPRESSION	Leptin has been implicated in tumorigenesis and tumor progression, particularly in obese patients. As a multifunctional adaptor protein, APPL1 (containing pleckstrin homology domain, phosphotyrosine binding domain, and a leucine zipper motif 1) plays a critical role in regulating adiponectin and insulin signaling pathways. Currently, high APPL1 level has been suggested to be related to metastases and progression of some types of cancer. However, the intercourse between leptin signaling pathway and APPL1 remains poorly understood. Here, we show that the protein levels and phosphorylation statues of APPL1-were highly expressed in tissues from human hepatocellular carcinoma and triple-positive breast cancer. Leptin stimulated APPL1 phosphorylation in a time-dependent manner in both human hepatocellular carcinoma HepG2 cell and breast cancer MCF-7 cell. Overexpression or suppression of APPL1 promoted or attenuated, respectively, leptin-induced phosphorylation of STAT3, ERK1/2, and Akt in the cancer cells, accompanied with enhanced or mitigated cell proliferation and migration. In addition, we identified that APPL1 directly bound to both leptin receptor and STAT3. This interaction was significantly enhanced by leptin stimulation. Our results suggested that APPL1 positively mediated leptin signaling and promoted leptin-induced proliferation and migration of cancer cells. This finding reveals a novel mechanism by which leptin promotes the motility and growth of cancer cells.	[Ding, Youming; Wang, Bin; Wang, Lei; Chen, Xiaoyan] Wuhan Univ, Dept Hepatobiliary & Laparascop Surg, Renmin Hosp, Wuhan 430060, Peoples R China; [Cao, Yingkang; Zhang, Yemin; Zhang, Deling; Li, Mingxin; Wang, Changhua] Wuhan Univ, Dept Pathol & Pathophysiol, Sch Basic Med Sci, Wuhan 430071, Peoples R China	Wuhan University; Wuhan University	Wang, CH (corresponding author), Wuhan Univ, Dept Pathol & Pathophysiol, Sch Basic Med Sci, Wuhan 430071, Peoples R China.	chwang0525@whu.edu.cn	chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022; chen, xi/GXH-3653-2022		National Natural Science Foundation of China [81170790]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 81170790) to Dr. Changhua Wang.; We thank Drs. Feng Liu and Lily Q. Dong (University of Texas Health Sciences Center at San Antonio, USA) for the kind gifts of plasmids of adenovirus carrying APPL1, APPL1/shRNA, and scrambled shRNA, respectively. This work was supported by a grant from the National Natural Science Foundation of China (No. 81170790) to Dr. Changhua Wang.	Agrawal Ganesh K., 2009, V527, P3, DOI 10.1007/978-1-60327-834-8_1; Ando S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00340; Arnold M, 2016, CANCER EPIDEMIOL, V41, P8, DOI 10.1016/j.canep.2016.01.003; Bai JX, 2006, J PHARMACOL EXP THER, V319, P1435, DOI 10.1124/jpet.106.110007; Belouzard S, 2004, J BIOL CHEM, V279, P28499, DOI 10.1074/jbc.M400508200; De Luis DA, 2009, MINERVA MED, V100, P229; Diradourian C, 2008, BBA-MOL CELL BIOL L, V1781, P239, DOI 10.1016/j.bbalip.2008.02.002; Duan XF, 2013, INT J CANCER, V133, P1776, DOI 10.1002/ijc.28105; Font-Burgada J, 2016, CELL METAB, V23, P48, DOI 10.1016/j.cmet.2015.12.015; Garcia-Robles MJ, 2013, J INTERF CYTOK RES, V33, P717, DOI 10.1089/jir.2012.0168; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Ghose A, 2015, NUTR CANCER, V67, P197, DOI 10.1080/01635581.2015.990569; Guan F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146553; Hennig J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.167; Iyengar NM, 2015, ANNU REV MED, V66, P297, DOI 10.1146/annurev-med-050913-022228; Jiang N, 2014, DRUG DES DEV THER, V8, P2295, DOI 10.2147/DDDT.S69004; Johnson IRD, 2015, ONCOTARGET, V6, P37919, DOI 10.18632/oncotarget.6114; Johnson IRD, 2014, MOL CANCER RES, V12, P1851, DOI 10.1158/1541-7786.MCR-14-0074; Kew MC, 2015, ANN HEPATOL, V14, P299, DOI 10.1016/S1665-2681(19)31267-0; Liu ML, 2012, J BIOL CHEM, V287, P26087, DOI 10.1074/jbc.M112.372292; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Newman G, 2014, MOL CELL ENDOCRINOL, V382, P570, DOI 10.1016/j.mce.2013.03.025; Russo VC, 2004, ENDOCRINOLOGY, V145, P4103, DOI 10.1210/en.2003-1767; Ryu JY, 2014, CELL REP, V7, P1227, DOI 10.1016/j.celrep.2014.04.006; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Schmidt S, 2015, OBES REV, V16, P473, DOI 10.1111/obr.12281; Schulenberg B, 2004, ELECTROPHORESIS, V25, P2526, DOI 10.1002/elps.200406007; Sepulveda VAT, 2002, ENDOCRINOLOGY, V143, P596, DOI 10.1210/en.143.2.596; Sinha A, 2013, CELL REP, V4, P649, DOI 10.1016/j.celrep.2013.07.029; Somasundar P, 2004, J SURG RES, V116, P337, DOI 10.1016/j.jss.2003.09.004; Song J, 2016, ONCOTARGET, V7, P279, DOI 10.18632/oncotarget.6346; VanSaun MN, 2013, CLIN CANCER RES, V19, P1926, DOI 10.1158/1078-0432.CCR-12-0930; Wang CH, 2009, J BIOL CHEM, V284, P31608, DOI 10.1074/jbc.M109.010355; Xu Miao, 2013, Zhonghua Yi Xue Za Zhi, V93, P1432; Zhang YM, 2015, ACTA PHARMACOL SIN, V36, P987, DOI 10.1038/aps.2015.37; Zhao Z, 2010, CANCER SCI, V101, P1454, DOI 10.1111/j.1349-7006.2010.01558.x; Zhu S, 2013, ASIAN PAC J CANCER P, V14, P5687, DOI 10.7314/APJCP.2013.14.10.5687; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	41	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166172	10.1371/journal.pone.0166172	http://dx.doi.org/10.1371/journal.pone.0166172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820851	Green Published, gold, Green Submitted			2022-12-27	WOS:000387614800039
J	Berhanu, R; Schnippel, K; Mohr, E; Hirasen, K; Evans, D; Rosen, S; Sanne, I				Berhanu, Rebecca; Schnippel, Kathryn; Mohr, Erika; Hirasen, Kamban; Evans, Denise; Rosen, Sydney; Sanne, Ian			Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study	PLOS ONE			English	Article							MDR-TB; TRANSMISSION; KHAYELITSHA; DIAGNOSIS; SETTINGS; DELAY	Objective We describe baseline characteristics, time to treatment initiation and interim patient outcomes at a decentralized, outpatient treatment site for rifampicin-resistant TB (RR-TB). Methods Prospective observational cohort study of RR-TB patients from March 2013 until December 2014. Study subjects were followed until completion of the intensive phase of treatment (6 months), transfer out, or a final outcome (loss from treatment (LFT) or death). Results 214 patients with RR-TB were enrolled in the study. Xpert MTB/RIF was the diagnostic test of rifampicin resistance for 87% (n = 186), followed by direct PCR on AFB positive specimen in 14 (7%) and indirect PCR on cultured isolate in 5 (2%). Median time between sputum testing and treatment initiation was 10 days (IQR 6-21). Interim outcomes were available in 148 patients of whom 78% (n = 115) were still on treatment, 9% (n = 13) had died, and 14% (n = 20) were LFT. Amongst 131 patients with culture positive pulmonary TB, 85 (64.9%) were culture negative at 6 months, 12 were still sputum culture positive (9.2%) and 34 had no culture documented or contaminated culture (26%). Patients who initiated as outpatients within 1 week of sputum collection for diagnosis of RR-TB had a significantly lower incidence of LFT (IRR 0.30, 95% CI: 0.09-0.98). HIV co-infection occurred in 178 patients (83%) with a median CD4 count 88 cells/ml 3 (IQR 27-218). Conclusions Access to decentralized treatment coupled with the rapid diagnosis of RR-TB has resulted in short time to treatment initiation. Despite the lack of treatment delays, early treatment outcomes remain poor with high rates of death and loss from care.	[Berhanu, Rebecca; Schnippel, Kathryn; Sanne, Ian] Right Care, Johannesburg, South Africa; [Berhanu, Rebecca; Mohr, Erika; Hirasen, Kamban; Evans, Denise; Rosen, Sydney; Sanne, Ian] Univ Witwatersrand, Sch Clin Med, Dept Internal Med, Fac Hlth Sci,Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa; [Schnippel, Kathryn; Sanne, Ian] Univ Witwatersrand, Sch Clin Med, Dept Internal Med, Fac Hlth Sci,Clin HIV Res Unit, Johannesburg, South Africa; [Mohr, Erika] Med Sans Frontieres, Cape Town, South Africa; [Rosen, Sydney] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA	University of Witwatersrand; University of Witwatersrand; Boston University	Berhanu, R (corresponding author), Right Care, Johannesburg, South Africa.; Berhanu, R (corresponding author), Univ Witwatersrand, Sch Clin Med, Dept Internal Med, Fac Hlth Sci,Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa.	rebecca.berhanu@unchealth.unc.edu	Sanne, Ian/ABH-2231-2020	Rosen, Sydney/0000-0002-6560-2964; Berhanu, Rebecca/0000-0002-9692-8748; Schnippel, Kathryn/0000-0003-0757-4325	United States Agency for International Development (Innovations Research on HIV/AIDS) [USAID-674-A-12-00029]	United States Agency for International Development (Innovations Research on HIV/AIDS)(United States Agency for International Development (USAID))	This study was funded by the United States Agency for International Development (Innovations Research on HIV/AIDS, grant number USAID-674-A-12-00029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MORT CAUS DEATH S AF; [Anonymous], 2011, MULT RES TUB POL FRA; [Anonymous], 2015, INTR NEW DRUGS REG M; [Anonymous], 2012, LEARN RED CROSS RED; [Anonymous], 2009, DIV AIDS TABL GRAD S; [Anonymous], 2011, MAN DRUG RES TUB POL; Berhanu R, 46 UN WORLD C LUNG H; Churchyard GJ, 2014, SAMJ S AFR MED J, V104, P244, DOI [10.7196/samj.7689, 10.7196/SAMJ.7689]; Cox H, 2014, INT J TUBERC LUNG D, V18, P441, DOI 10.5588/ijtld.13.0742; Cox H, 2014, 20 INT AIDS C JUL 20; Cox HS, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv014; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; Jacobson KR, 2013, CLIN INFECT DIS, V56, P503, DOI 10.1093/cid/cis920; Loveday M, 2015, INT J TUBERC LUNG D, V19, P163, DOI 10.5588/ijtld.14.0369; Loveday M, 2012, INT J TUBERC LUNG D, V16, P209, DOI 10.5588/ijtld.11.0401; Loveday M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094016; Marais E, 2014, INFECTION, V42, P405, DOI 10.1007/s15010-013-0572-2; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Mohr E, 2015, T ROY SOC TROP MED H, V109, P425, DOI 10.1093/trstmh/trv037; MSF, 2011, SCAL DIAGN TREATM DR; Narasimooloo R, 2012, SAMJ S AFR MED J, V102, P360, DOI 10.7196/SAMJ.5361; Nardell E, 2010, INT J TUBERC LUNG D, V14, P1233; Schnippel K, 2013, TROP MED INT HEALTH, V18, P109, DOI 10.1111/tmi.12018; Shisama O, 2012, AFRICAN NATL HIV P; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Umanah T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1214-3; Uys PW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000757; Wallengren K, 2011, EMERG INFECT DIS, V17, P1913, DOI 10.3201/eid1710.100952; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Xu L, 2008, T ROY SOC TROP MED H, V102, P797, DOI 10.1016/j.trstmh.2008.04.027; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	33	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164974	10.1371/journal.pone.0164974	http://dx.doi.org/10.1371/journal.pone.0164974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812140	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000019
J	Debus, F; Lefering, R; Lechler, P; Schwarting, T; Bockmann, B; Strasser, E; Mand, C; Ruchholtz, S; Frink, M				Debus, Florian; Lefering, Rolf; Lechler, Philipp; Schwarting, Tim; Bockmann, Benjamin; Strasser, Erwin; Mand, Carsten; Ruchholtz, Steffen; Frink, Michael		TraumaRegister DGU	Association of an In-House Blood Bank with Therapy and Outcome in Severely Injured Patients: An Analysis of 18,573 Patients from the TraumaRegister DGU (R)	PLOS ONE			English	Article							PROTHROMBIN COMPLEX CONCENTRATE; BLEEDING TRAUMA PATIENTS; MASSIVE TRANSFUSION; POLYTRAUMA PATIENTS; COAGULOPATHY; FIBRINOGEN; MANAGEMENT; MORTALITY; GUIDELINE; ROTEM(R)	Introduction Hemorrhagic shock remains one of the most common causes of death in severely injured patients. It is unknown to what extent the presence of a blood bank in a trauma center influences therapy and outcome in such patients. Material and Methods We retrospectively analyzed prospectively recorded data from the TraumaRegister DGU (R) and the TraumaNetzwerk DGU (R). Inclusion criteria were Injury Severity Score (ISS) >= 16, primarily treated patients, and hospital admission 2 years before or after the audit process. Results Complete data sets of 18,573 patients were analyzed. Of 457 hospitals included, 33.3% had an in-house blood bank. In trauma centers with a blood bank (HospBB), packed red blood cells (PRBCs) (21.0% vs. 17.4%, p < 0.001) and fresh frozen plasma (FFP) (13.9% vs. 10.2%, p < 0.001) were transfused significantly more often than in hospitals without a blood bank (Hosp0). However, no significant difference was found for in-hospital mortality (standard mortality ratio [ SMR, 0.907 vs. 0.945; p = 0.25). In patients with clinically apparent shock on admission, no difference of performed transfusions were present between HospBB and Hosp0 (PRBCs, 51.4% vs. 50.4%, p = 0.67; FFP, 32.7% vs. 32.7%, p = 0.99), and no difference in in-hospital mortality was observed (SMR, 0.907 vs. 1.004; p = 0.21). Discussion In HospBB transfusions were performed more frequently in severely injured patients without positively affecting the 24h mortality or in- house mortality. Easy access may explain a more liberal transfusion concept.	[Debus, Florian; Lechler, Philipp; Schwarting, Tim; Bockmann, Benjamin; Mand, Carsten; Ruchholtz, Steffen; Frink, Michael] Univ Hosp Giessen & Marburg, Dept Trauma Hand & Reconstruct Surg, Marburg, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, Cologne, Germany; [Lefering, Rolf; Ruchholtz, Steffen; Frink, Michael] German Trauma Soc, Sekt NIS, Comm Emergency Med Intens Care & Trauma Managemen, Berlin, Germany; [Strasser, Erwin] Univ Hosp Erlangen, Dept Transfus Med & Hemostaseol, Erlangen, Germany	University Hospital of Giessen & Marburg; Witten Herdecke University; University of Erlangen Nuremberg	Frink, M (corresponding author), Univ Hosp Giessen & Marburg, Dept Trauma Hand & Reconstruct Surg, Marburg, Germany.; Frink, M (corresponding author), German Trauma Soc, Sekt NIS, Comm Emergency Med Intens Care & Trauma Managemen, Berlin, Germany.	frink@med.uni-marburg.de						Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; ACS, SHOCK ADV TRAUM LIF; Bawazeer M, 2015, INJURY, V46, P21, DOI 10.1016/j.injury.2014.09.020; Bhananker Sanjay M, 2011, Int J Crit Illn Inj Sci, V1, P51, DOI 10.4103/2229-5151.79282; Cantor SB, 1998, J CLIN ONCOL, V16, P2364, DOI 10.1200/JCO.1998.16.7.2364; Davenport R, 2013, TRANSFUSION, V53, p23S, DOI 10.1111/trf.12032; Deras P, 2014, J TRAUMA ACUTE CARE, V77, P433, DOI 10.1097/TA.0000000000000314; Deutsche Gesellschaft fur Unfallchirurgie e. V. (DGU), 2012, WEISSB SCHWERV; DGU, 2013, TRAUMAREGISTER DGU J; Dunne JR, 2002, J SURG RES, V102, P237, DOI 10.1006/jsre.2001.6330; Fantus B., 1937, JAMA-J AM MED ASSOC, V251, P647; Fries D, 2013, TRANSFUSION, V53, p91S, DOI 10.1111/trf.12041; Goodwin ML, 2014, J TRAUMA ACUTE CARE, V77, P182, DOI 10.1097/TA.0000000000000162; Hess JR, 2014, VOX SANG, DOI [10.1111/vox.12130, DOI 10.1111/V0X.12130]; Huber-Wagner S, 2007, VOX SANG, V92, P69, DOI 10.1111/j.1423-0410.2006.00858.x; Judd W J, 1999, Immunohematology, V15, P41; Kahl JE, 2013, J TRAUMA ACUTE CARE, V75, P195, DOI 10.1097/TA.0b013e3182997865; Kaur Paramjit, 2011, J Emerg Trauma Shock, V4, P103, DOI 10.4103/0974-2700.76844; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Klein HG, 2010, BIOLOGICALS, V38, P100, DOI 10.1016/j.biologicals.2009.10.008; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Maegele M, 2009, VOX SANG, V97, P39, DOI 10.1111/j.1423-0410.2009.01179.x; Meyer MAS, 2011, VOX SANG, V101, P185, DOI 10.1111/j.1423-0410.2011.01478.x; Mitra B, 2013, ANZ J SURG, V83, P918, DOI 10.1111/ans.12417; Munoz M, 2007, VOX SANG, V92, P381, DOI 10.1111/j.1423-0410.2007.00894.x; Napolitano LM, 2009, CRIT CARE MED, V37, P3124, DOI 10.1097/CCM.0b013e3181b39f1b; Ogura T, 2014, J TRAUMA ACUTE CARE, V76, P1243, DOI 10.1097/TA.0000000000000200; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; SAWYER PR, 1990, VOX SANG, V58, P199, DOI 10.1111/j.1423-0410.1990.tb02090.x; Schochl H, 2010, ANAESTHESIA, V65, P199, DOI 10.1111/j.1365-2044.2009.06188.x; Tauber H, 2011, BRIT J ANAESTH, V107, P378, DOI 10.1093/bja/aer158; Teixeira PGR, 2008, AM SURGEON, V74, P953; Valeri CR, 2009, VOX SANG, V96, P180, DOI 10.1111/j.1423-0410.2008.01126.x; Valle EJ, 2014, J TRAUMA ACUTE CARE, V76, P1373, DOI 10.1097/TA.0000000000000242; van de Watering L, 2011, VOX SANG, V100, P36, DOI 10.1111/j.1423-0410.2010.01441.x; Wafaisade A, 2012, J TRAUMA ACUTE CARE, V72, P936, DOI 10.1097/TA.0b013e31823dca70; Zimmermann R, 1999, TRANSFUSION, V39, P351, DOI 10.1046/j.1537-2995.1999.39499235665.x	38	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0148736	10.1371/journal.pone.0148736	http://dx.doi.org/10.1371/journal.pone.0148736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812103	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000001
J	Fujita, H; Suzuki, K; Numao, A; Watanabe, Y; Uchiyama, T; Miyamoto, T; Miyamoto, M; Hirata, K				Fujita, Hiroaki; Suzuki, Keisuke; Numao, Ayaka; Watanabe, Yuji; Uchiyama, Tomoyuki; Miyamoto, Tomoyuki; Miyamoto, Masayuki; Hirata, Koichi			Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes	PLOS ONE			English	Article							I-123-MIBG MYOCARDIAL SCINTIGRAPHY; PROGRESSIVE SUPRANUCLEAR PALSY; ODOR IDENTIFICATION TEST; MULTIPLE SYSTEM ATROPHY; TRANSCRANIAL SONOGRAPHY; CLINICAL-DIAGNOSIS; JAPANESE PATIENTS; RESEARCH CRITERIA; ACCURACY; DYSFUNCTION	Background We aimed to evaluate the utility of the combined use of cardiac I-123-metaiodobenzylguanidine (MIBG) scintigraphy, olfactory testing, and substantia nigra (SN) hyperechogenicity on transcranial sonography (TCS) in differentiating Parkinson's disease (PD) from atypical parkinsonian syndromes (APSs), such as multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). Methods Cardiac MIBG scintigraphy, card-type odor identification testing (Open Essence (OE), Wako, Japan), and TCS were performed with 101 patients with PD and 38 patients with APSs (MSA and PSP). Receiver operating characteristic (ROC) curve analysis was used to assess the sensitivity and specificity of these batteries for diagnosing PD from APSs. The diagnostic accuracy of the three tests was also assessed among patients at the early disease stage (drug-naive patients with a disease duration of 3 years or less). Results In differentiating PD from APSs, the area under the ROC curve was 0.74 (95% CI, 0.65-0.83), 0.8 (95% CI, 0.73-0.87), and 0.75 (95% CI, 0.67-0.82) for TCS, cardiac MIBG scintigraphy, and olfactory testing, respectively. The diagnostic sensitivity and specificity were 53.1% and 91.7%, respectively, for TCS, 70.3% and 86.8%, respectively, for cardiac MIBG scintigraphy, 58.4% and 76.3%, respectively, for OE. Among early-stage patients, sensitivity and specificity were 50.0% and 93.8%, respectively, for TCS, 57.1% and 87.5%, respectively, for cardiac MIBG scintigraphy, and 54.8% and 79.2%, respectively, for OE. At least one positive result from 3 tests improved sensitivity (86.1%) but decreased specificity (63.2%). In contrast, at least 2 positive results from 3 tests had good discrimination for both early-stage patients (50.0% sensitivity and 93.8% specificity) and patients overall (57.8% sensitivity and 95.8% specificity). Positive results for all 3 tests yielded 100% specificity but low sensitivity (25%). Conclusions At least 2 positive results from among TCS, cardiac MIBG scintigraphy, and olfactory testing can support clinical diagnosis in distinguishing PD from APSs.	[Fujita, Hiroaki; Suzuki, Keisuke; Numao, Ayaka; Watanabe, Yuji; Uchiyama, Tomoyuki; Hirata, Koichi] Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi, Japan; [Uchiyama, Tomoyuki] Dokkyo Med Univ, Continence Ctr, Mibu, Tochigi, Japan; [Miyamoto, Tomoyuki] Dokkyo Med Univ, Koshigaya Hosp, Dept Neurol, Saitama, Japan; [Miyamoto, Masayuki] Dokkyo Med Univ, Sch Nursing, Dept Clin Med Nursing, Mibu, Tochigi, Japan	Dokkyo Medical University; Dokkyo Medical University; Dokkyo Medical University; Dokkyo Medical University	Suzuki, K (corresponding author), Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi, Japan.	keisuke@dokkyomed.ac.jp	Suzuki, Keisuke/I-5464-2014	Suzuki, Keisuke/0000-0003-0320-8993	Dokkyo Medical University [2015-14]	Dokkyo Medical University	This study was partly supported by a Dokkyo Medical University young investigator award (No. 2015-14 to Dr. Hiroaki Fujita). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CH, 2014, NEUROLOGY, V83, P406, DOI 10.1212/WNL.0000000000000641; Baba T, 2012, BRAIN, V135, P161, DOI 10.1093/brain/awr321; Behnke S, 2013, MOVEMENT DISORD, V28, P455, DOI 10.1002/mds.25193; Berg D, 1999, NEUROLOGY, V53, P1026, DOI 10.1212/WNL.53.5.1026; Berg D, 2008, LANCET NEUROL, V7, P1044, DOI 10.1016/S1474-4422(08)70239-4; Berg D, 2015, MOVEMENT DISORD, V30, P1600, DOI 10.1002/mds.26431; Berg D, 2013, MOVEMENT DISORD, V28, P216, DOI 10.1002/mds.25192; Berg D, 2011, MOVEMENT DISORD, V26, P979, DOI 10.1002/mds.23766; Berg D, 2011, J NEURAL TRANSM, V118, P453, DOI 10.1007/s00702-010-0469-5; Busse K, 2012, J NEUROL NEUROSUR PS, V83, P441, DOI 10.1136/jnnp-2011-301719; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; DOTY RL, 1993, NEUROLOGY, V43, P962, DOI 10.1212/WNL.43.5.962; Driver-Dunckley E, 2014, PARKINSONISM RELAT D, V20, P1260, DOI 10.1016/j.parkreldis.2014.08.006; Fujio H, 2012, ANN OTO RHINOL LARYN, V121, P413, DOI 10.1177/000348941212100609; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Iijima M, 2010, MOVEMENT DISORD, V25, P1143, DOI 10.1002/mds.23001; Izawa MO, 2012, EUR J NEUROL, V19, P411, DOI 10.1111/j.1468-1331.2011.03533.x; Kagi G, 2010, J NEUROL NEUROSUR PS, V81, P5, DOI 10.1136/jnnp.2008.157370; Kajimoto Y, 2009, PARKINSONISM RELAT D, V15, P270, DOI 10.1016/j.parkreldis.2008.06.004; Kikuchi A, 2011, PARKINSONISM RELAT D, V17, P698, DOI 10.1016/j.parkreldis.2011.07.011; Lauckaite K, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-12; Lee PH, 2006, MOVEMENT DISORD, V21, P1975, DOI 10.1002/mds.21083; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Marek K, 2009, NEUROLOGY, V72, pS21, DOI 10.1212/WNL.0b013e318198df97; Miyamoto T, 2006, NEUROLOGY, V67, P2236, DOI 10.1212/01.wnl.0000249313.25627.2e; Miyamoto T, 2008, SLEEP, V31, P717, DOI 10.1093/sleep/31.5.717; Miyamoto T, 2009, MOVEMENT DISORD, V24, P268, DOI 10.1002/mds.22361; Mizutani Y, 2014, PARKINSONISM RELAT D, V20, P520, DOI 10.1016/j.parkreldis.2014.02.010; Navarro-Otano J, 2014, PARKINSONISM RELAT D, V20, P192, DOI 10.1016/j.parkreldis.2013.10.025; Oka H, 2010, J NEUROL, V257, P969, DOI 10.1007/s00415-009-5447-1; Okawa M, 2007, INTERNAL MED, V46, P1527, DOI 10.2169/internalmedicine.46.0271; Orimo S, 2016, AGEING RES REV, V30, P122, DOI 10.1016/j.arr.2016.01.001; Orimo S, 2012, PARKINSONISM RELAT D, V18, P494, DOI 10.1016/j.parkreldis.2012.01.009; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996; Rizzo G, 2016, NEUROLOGY, V86, P566, DOI 10.1212/WNL.0000000000002350; Saito S, 2003, J JPN ASS ODOR ENV, V34, P1; Suzuki M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-157; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Tsujikawa K, 2015, J NEUROL NEUROSUR PS, V86, P945, DOI 10.1136/jnnp-2015-310327; Umemura A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061066; Vlaar AMM, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-27; Walter U, 2003, NEUROLOGY, V60, P74, DOI 10.1212/WNL.60.1.74	45	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165869	10.1371/journal.pone.0165869	http://dx.doi.org/10.1371/journal.pone.0165869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812167	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000074
J	Resnick, A				Resnick, Andrew			HIF Stabilization Weakens Primary Cilia	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; TUMOR-SUPPRESSOR PROTEIN; MECHANICAL-PROPERTIES; FLEXURAL RIGIDITY; MICROTUBULES; CALCIUM; MECHANOSENSATION; CILIOGENESIS; COMPARTMENT; PATHWAYS	Although solitary or sensory cilia are present in most cells of the body and their existence has been known since the sixties, very little is known about their functions. One suspected function is fluid flow sensing-physical bending of cilia produces an influx of Ca++, which can then result in a variety of activated signaling pathways. Defective cilia and ciliary-associated proteins have been shown to result in cystic diseases. Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a progressive disease, typically appearing in the 5th decade of life and is one of the most common monogenetic inherited human diseases, affecting approximately 600,000 people in the United States. Because the mechanical properties of cilia impact their response to applied flow, we asked how the stiffness of cilia can be controlled pharmacologically. We performed an experiment subjecting cilia to Taxol (a microtubule stabilizer) and CoCl2 (a HIF stabilizer to model hypoxia). Madin-Darby Canine Kidney (MDCK) cells were selected as our model system. After incubation with a selected pharmacological agent, cilia were optically trapped and the bending modulus measured. We found that HIF stabilization significantly weakens cilia. These results illustrate a method to alter the mechanical properties of primary cilia and potentially alter the flow sensing properties of cilia.	[Resnick, Andrew] Cleveland State Univ, Dept Phys, Cleveland, OH 44115 USA; [Resnick, Andrew] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University	Resnick, A (corresponding author), Cleveland State Univ, Dept Phys, Cleveland, OH 44115 USA.; Resnick, A (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA.	a.resnick@csuohio.edu	Resnick, Andrew H/A-6841-2018	Resnick, Andrew H/0000-0002-7526-6394				Abdul-Majeed S, 2012, CELL MOL LIFE SCI, V69, P165, DOI 10.1007/s00018-011-0744-0; Bernhardt WM, 2007, AM J PATHOL, V170, P830, DOI 10.2353/ajpath.2007.060455; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Broekhuis JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108470; Brown JM, 2003, MOL BIOL CELL, V14, P3192, DOI 10.1091/mbc.e03-03-0166; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Esteban MA, 2006, J AM SOC NEPHROL, V17, P1801, DOI 10.1681/ASN.2006020181; Felgner H, 1996, J CELL SCI, V109, P509; Garcia Galo 3rd, 2016, Cilia, V5, P17, DOI 10.1186/s13630-016-0038-0; GARDNER KD, 1991, KIDNEY INT, V39, P718, DOI 10.1038/ki.1991.87; Gill J, 2014, TRANSPLANTATION, V97, P668, DOI 10.1097/01.TP.0000438637.29214.10; Glaser J, 2014, OPT ENG, V53, DOI 10.1117/1.OE.53.7.074110; Han SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22281; Hawkins TL, 2013, BIOPHYS J, V104, P1517, DOI 10.1016/j.bpj.2013.02.026; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hu QC, 2011, CYTOSKELETON, V68, P313, DOI 10.1002/cm.20514; Huang TC, 1964, REPORT; Jin XJ, 2014, CELL MOL LIFE SCI, V71, P2165, DOI 10.1007/s00018-013-1483-1; Kikumoto M, 2006, BIOPHYS J, V90, P1687, DOI 10.1529/biophysj.104.055483; Landau L.D., 2012, THEORY ELASTICITY, V7; Lehmann H, 2015, J AM SOC NEPHROL, V26, P2778, DOI 10.1681/ASN.2014090875; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lin YC, 2013, NAT CHEM BIOL, V9, P437, DOI [10.1038/NCHEMBIO.1252, 10.1038/nchembio.1252]; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; Mofrad MRK, 2010, CELLULAR MECHANOTRAN, V465, pxii; Mohieldin AM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15982; Naranjo-Suarez S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030470; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Pei Y, 2001, TRENDS MOL MED, V7, P151, DOI 10.1016/S1471-4914(01)01953-0; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Qutub AA, 2008, MOL CELL BIOL, V28, P5106, DOI 10.1128/MCB.00060-08; Rankin HV, 2007, ULTRASTRUCT PATHOL, V31, P339, DOI 10.1080/01913120701643686; Resnick A, 2007, BIOPHYS J, V93, P1380, DOI 10.1529/biophysj.107.105007; Resnick A, 2015, BIOPHYS J, V109, P18, DOI 10.1016/j.bpj.2015.05.031; Resnick A, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3316378; ROTH KE, 1988, J CELL SCI, V89, P457; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Saigusa T, 2015, PHYSIOLOGY, V30, P195, DOI 10.1152/physiol.00032.2014; Schwartz EA, 1997, AM J PHYSIOL-RENAL, V272, pF132, DOI 10.1152/ajprenal.1997.272.1.F132; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Troilo A, 2014, EMBO REP, V15, P77, DOI 10.1002/embr.201337688; Verghese E, 2008, NEPHROL DIAL TRANSPL, V23, P834, DOI 10.1093/ndt/gfm743; Verghese E, 2011, CELL BIOL INT, V35, P909, DOI 10.1042/CBI20090154; WANG GL, 1993, BLOOD, V82, P3610; Wann Angus Kt, 2013, Cilia, V2, P17, DOI 10.1186/2046-2530-2-17; Weimbs T, 2007, AM J PHYSIOL-RENAL, V293, pF1423, DOI 10.1152/ajprenal.00275.2007; Young YN, 2012, BIOPHYS J, V103, P629, DOI 10.1016/j.bpj.2012.07.009; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200	51	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165907	10.1371/journal.pone.0165907	http://dx.doi.org/10.1371/journal.pone.0165907			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812213	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000077
J	Ryden, A; Sorstadius, E; Bergenheim, K; Romanovschi, A; Thoren, F; Witt, EA; Sternhufvud, C				Ryden, Anna; Sorstadius, Elisabeth; Bergenheim, Klas; Romanovschi, Alexandru; Thoren, Fredrik; Witt, Edward A.; Sternhufvud, Catarina			The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications	PLOS ONE			English	Article							SCORE DIFFERENCES; CHILDREN; TRENDS; RISK	Aims Diagnoses of Type 1 Diabetes Mellitus (T1DM) in Europe appear to be on the rise. Therefore it is imperative that researchers understand the potential impact that increases in prevalence could have on the affected individuals as well as on society as a whole. Accordingly this study examined the humanistic and economic burden of T1DM in patients relative to those without the condition across a number of health outcomes including health status, work productivity loss, activity impairment, and healthcare resource use. Methods Survey data from a large, representative sample of EU adults (The EU National Health and Wellness Survey) were examined. Results Results suggest that overall burden is higher for those diagnosed with T1DM than respondents without diabetes and that burden increases as complications associated with T1DM increase. Conclusions Taken together, these results suggest that treatment strategies for T1DM should balance clinical, humanistic, and economic burden and patients should be educated on the role of complications in disease outcomes.	[Ryden, Anna; Sorstadius, Elisabeth; Bergenheim, Klas; Thoren, Fredrik; Sternhufvud, Catarina] AstraZeneca, Molndal, Sweden; [Romanovschi, Alexandru] AstraZeneca, Mississauga, ON, Canada; [Witt, Edward A.] Kantar Hlth, Princeton, NJ USA	AstraZeneca; AstraZeneca	Ryden, A (corresponding author), AstraZeneca, Molndal, Sweden.	anna.ryden@astrazeneca.com			AstraZeneca	AstraZeneca(AstraZeneca)	This work was funded by AstraZeneca, a commercial company. AstraZeneca provided additional support in the form of salaries for authors AR, ES, KB, AR, FT, and CS. Kantar Health, a commercial company, provided support in the form of salary for author EW. These funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alleman CJM, 2015, DIABETES RES CLIN PR, V109, P215, DOI 10.1016/j.diabres.2015.04.031; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bjorner JB, 2007, CURR MED RES OPIN, V23, P731, DOI 10.1185/030079907X178757; Bjorner JB, 2013, VALUE HEALTH, V16, P993, DOI 10.1016/j.jval.2013.06.022; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Conway B, 2010, DIABETIC MED, V27, P398, DOI 10.1111/j.1464-5491.2010.02956.x; Eckel RH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004219; Ehehalt S, 2012, PEDIATR DIABETES, V13, P15, DOI 10.1111/j.1399-5448.2011.00799.x; Germano G, 2012, EUR HEART J, V33, P137; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; Huxley RR, 2015, LANCET DIABETES ENDO, V3, P198, DOI 10.1016/S2213-8587(14)70248-7; Leidig-Bruckner G, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-33; Livingstone SJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001321; MASER RE, 1991, ARTERIOSCLER THROMB, V11, P958, DOI 10.1161/01.ATV.11.4.958; Melendez-Ramirez LY, 2010, ENDOCRIN METAB CLIN, V39, P625, DOI 10.1016/j.ecl.2010.05.009; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nuhoho S, 2014, VALUE HEALTH, V17, pA356, DOI 10.1016/j.jval.2014.08.761; Orchard TJ, 2006, DIABETES CARE, V29, P2528, DOI 10.2337/dc06-1161; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Sinclair A, 2012, J AM MED DIR ASSOC, V13, P497, DOI 10.1016/j.jamda.2012.04.012; Thunander M, 2008, DIABETES RES CLIN PR, V82, P247, DOI 10.1016/j.diabres.2008.07.022; Tuominen JT, 1999, DIABETES CARE, V22, P1196, DOI 10.2337/diacare.22.7.1196; van Acker K, 2014, DIABETES-METAB RES, V30, P635, DOI 10.1002/dmrr.2523; Ware JE, 2007, USERS MANUAL SF 36V2	26	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164977	10.1371/journal.pone.0164977	http://dx.doi.org/10.1371/journal.pone.0164977			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812145	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000020
J	Sharpe, AE; Kamenov, GD; Gilli, A; Hodell, DA; Emery, KF; Brenner, M; Krigbaum, J				Sharpe, Ashley E.; Kamenov, George D.; Gilli, Adrian; Hodell, David A.; Emery, Kitty F.; Brenner, Mark; Krigbaum, John			Lead (Pb) Isotope Baselines for Studies of Ancient Human Migration and Trade in the Maya Region	PLOS ONE			English	Article							STRONTIUM ISOTOPES; CENTRAL-AMERICAN; OXYGEN; GUATEMALA; MOBILITY; TEETH; IMMIGRATION; VARIABILITY; SR-87/SR-86; EXPOSURE	We examined the potential use of lead (Pb) isotopes to source archaeological materials from the Maya region of Mesoamerica. The main objectives were to determine if: 1) geologic terrains throughout the Maya area exhibit distinct lead isotope ratios (Pb-206/Pb-204, Pb-207/Pb-204, and Pb-208/Pb-204), and 2) a combination of lead and strontium ratios can enhance sourcing procedures in the Mesoamerica region. We analyzed 60 rock samples for lead isotope ratios and a representative subset of samples for lead, uranium, and thorium concentrations across the Maya region, including the Northern Lowlands of the Mexican Yucatan Peninsula, the Southern Lowlands of Guatemala and Belize, the Volcanic Highlands, the Belizean Maya Mountains, and the Metamorphic Province/Motagua Valley. Although there is some overlap within certain sub-regions, particularly the geologically diverse Metamorphic Province, lead isotopes can be used to distinguish between the Northern Lowlands, the Southern Lowlands, and the Volcanic Highlands. The distinct lead isotope ratios in the sub-regions are related to the geology of the Maya area, exhibiting a general trend in the lowlands of geologically younger rocks in the north to older rocks in the south, and Cenozoic volcanic rocks in the southern highlands. Combined with other sourcing techniques such as strontium (Sr-87/Sr-86) and oxygen (delta O-18), a regional baseline for lead isotope ratios can contribute to the development of lead isoscapes in the Maya area, and may help to distinguish among geographic sub-regions at a finer scale than has been previously possible. These isotope baselines will provide archaeologists with an additional tool to track the origin and movement of ancient humans and artifacts across this important region.	[Sharpe, Ashley E.; Emery, Kitty F.; Krigbaum, John] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Sharpe, Ashley E.; Emery, Kitty F.] Univ Florida, Florida Museum Nat Hist, Environm Archaeol Program, Gainesville, FL 32611 USA; [Kamenov, George D.; Brenner, Mark] Univ Florida, Dept Geol Sci, Gainesville, FL USA; [Gilli, Adrian] ETH, Dept Earth Sci, Zurich, Switzerland; [Hodell, David A.] Univ Cambridge, Dept Earth Sci, Cambridge, England	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cambridge	Sharpe, AE; Krigbaum, J (corresponding author), Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA.; Sharpe, AE (corresponding author), Univ Florida, Florida Museum Nat Hist, Environm Archaeol Program, Gainesville, FL 32611 USA.	aesharpe6@gmail.com; krigbaum@ufl.edu	Kamenov, George/AAE-6176-2020; Gilli, Adrian/B-5238-2014; Emery, Kitty/B-5850-2011	Kamenov, George/0000-0002-6041-6687; Gilli, Adrian/0000-0003-4193-2157; Emery, Kitty/0000-0002-4031-1968; Sharpe, Ashley/0000-0003-3568-1734; Hodell, David/0000-0001-8537-1588	National Science Foundation [1433043]; Sigma Xi Scientific Research Society [G20141015712606]; Swiss National Science Foundation [PBEZ2-104322]; College of Liberal Arts and Sciences at the University of Florida; College of Liberal Arts and Sciences, University of Florida	National Science Foundation(National Science Foundation (NSF)); Sigma Xi Scientific Research Society; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); College of Liberal Arts and Sciences at the University of Florida; College of Liberal Arts and Sciences, University of Florida(University of Florida)	The majority of lab and data analysis was funded by the National Science Foundation (Doctoral Dissertation Improvement Grant #1433043 to AES and KFE); Website: http://www.nsf.gov/. Funding for the lab analysis was also supported in part by the Sigma Xi Scientific Research Society (grant #G20141015712606 to AES); Website: https://www.sigmaxi.org/programs/grants-in-aid. Sample collection and analysis of the Yucatan samples was supported by the Swiss National Science Foundation (grant # PBEZ2-104322 to AG); Website: http://www.snf.ch/en/Pages/default.aspx. Original sample collection was funded by research awards from the College of Liberal Arts and Sciences at the University of Florida to DAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This analysis was supported by the National Science Foundation (Doctoral Dissertation Improvement Grant #1433043 to Emery and Sharpe) and the Sigma Xi Scientific Research Society (to Sharpe). Original sample collection was funded by research awards from the College of Liberal Arts and Sciences, University of Florida (to Hodell). Sample collection and analysis by Gilli was supported by the Swiss National Science Foundation (PBEZ2-104322). We thank the numerous agencies and individuals in Mexico, Belize, and Guatemala who provided assistance to our project through the years, including the Mexican National Institute of Anthropology and History (Instituto Nacional de Antropologia e Historia), the Belize National Institute of Culture and History, the Universidad del Valle and Universidad San Carlos of Guatemala, the Guatemalan Ministry of Environment and Natural Resources (Ministerio de Ambiente y Recursos Naturales), the Guatemalan National Council of Protected Areas (Consejo Nacional de Areas Protegidas), the Guatemalan Institute of Anthropology and History (Instituto de Antropologia e Historia), the Guatemalan Authority for the Management and Sustainable Development of Lake Peten-Itza (Autoridad Para el Manejo y Desarrollo Sostenible de la Cuenca del Lago Peten-Itza), and the Wildlife Conservation Society. We also thank David Buck, Michael Rosenmeier, Lico Godoy, and Susan Milbrath for help with sample collection in the original Hodell et al. [17] investigation, and are grateful to Jason Curtis for providing the bedrock samples used in the Hodell et al. [17] and Gilli et al. [37] strontium studies. We thank Ben Valentine and an anonymous reviewer for their careful and insightful comments that substantially improved the manuscript.	Aberg G, 1998, SCI TOTAL ENVIRON, V224, P109, DOI 10.1016/S0048-9697(98)00347-7; BARDINTZEFF JM, 1992, B VOLCANOL, V54, P267, DOI 10.1007/BF00301482; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bentley RA, 2002, CURR ANTHROPOL, V43, P799, DOI 10.1086/344373; Bower NW, 2005, INT J OSTEOARCHAEOL, V15, P360, DOI 10.1002/oa.796; Braswell GE, 2002, SCI ARCH MI, P33; Budd P, 1998, SCI TOTAL ENVIRON, V220, P121, DOI 10.1016/S0048-9697(98)00244-7; Budd P, 2004, SCI TOTAL ENVIRON, V318, P45, DOI 10.1016/S0048-9697(03)00357-7; Carlson AK, 1996, J ARCHAEOL SCI, V23, P557, DOI 10.1006/jasc.1996.0052; CUMMING GL, 1976, EARTH PLANET SC LETT, V31, P262, DOI 10.1016/0012-821X(76)90218-1; CUMMING GL, 1981, EARTH PLANET SC LETT, V56, P199, DOI 10.1016/0012-821X(81)90127-8; Dudas FO, 2016, CHEM GEOL, V429, P21, DOI 10.1016/j.chemgeo.2016.03.003; Feigenson MD, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000621; Foias A.E., 1997, ANCIENT MESOAM, V8, P275, DOI [10.1017/s0956536100001735, DOI 10.1017/S0956536100001735]; Freidel DA, 2002, ANCIENT MAYA POLITICAL ECONOMIES, P41; Freiwald C., 2011, THESIS U WISCONSIN M; GHAZI AM, 1994, APPL GEOCHEM, V9, P627, DOI 10.1016/0883-2927(94)90023-X; Gilli A, 2009, GEOLOGY, V37, P723, DOI 10.1130/G30098A.1; Gulson B, 2008, SCI TOTAL ENVIRON, V400, P75, DOI 10.1016/j.scitotenv.2008.06.059; Habicht-Mauche JA, 2000, J ARCHAEOL SCI, V27, P709, DOI 10.1006/jasc.1999.0495; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Henderson J, 2005, J ARCHAEOL SCI, V32, P665, DOI 10.1016/j.jas.2004.05.008; Hodell DA, 2004, J ARCHAEOL SCI, V31, P585, DOI 10.1016/j.jas.2003.10.009; HONG SM, 1994, SCIENCE, V265, P1841, DOI 10.1126/science.265.5180.1841; Hosler D, 1996, SCIENCE, V273, P1819, DOI 10.1126/science.273.5283.1819; Huntley DL, 2007, J ARCHAEOL SCI, V34, P1135, DOI 10.1016/j.jas.2006.10.006; James KH, 2006, CENTRAL AM, P277; Kamenov GD, 2004, J ANAL ATOM SPECTROM, V19, P1262, DOI 10.1039/b403222e; Kamenov GD, 2014, SCI TOTAL ENVIRON, V490, P861, DOI 10.1016/j.scitotenv.2014.05.085; Lachniet MS, 2009, EARTH PLANET SC LETT, V284, P435, DOI 10.1016/j.epsl.2009.05.010; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martin Simon, 2000, CHRONICLE MAYA KINGS; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; MILTON C, 1964, J AM STAT ASSOC, V59, P925; Moholy-Nagy H, 2003, LAT AM ANTIQ, V14, P301, DOI 10.2307/3557562; MONTGOMERY J, 2002, THESIS; Montgomery J, 2010, J ROMAN ARCHAEOLOG S, p[78, 199]; Montgomery J, 2010, ANN HUM BIOL, V37, P325, DOI 10.3109/03014461003649297; Nachar N, 2008, TUTOR QUANT METHODS, V4, P13, DOI 10.20982/tqmp.04.1.p013; Price TD, 2008, LAT AM ANTIQ, V19, P167, DOI 10.2307/25478222; Price TD, 2012, CURR ANTHROPOL, V53, P396, DOI 10.1086/666492; Price TD, 2010, J ANTHROPOL ARCHAEOL, V29, P15, DOI 10.1016/j.jaa.2009.10.001; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; R Core Team, R LANG ENV STAT COMP; Reynolds J.H., 1980, B VOLCANOL, V43, P601, DOI 10.1007/bf02597696; ROSMAN KJR, 1994, GEOPHYS RES LETT, V21, P2669, DOI 10.1029/94GL02603; Scherer AK, 2015, J ARCHAEOL SCI-REP, V2, P666, DOI 10.1016/j.jasrep.2014.11.006; SEALY JC, 1991, J ARCHAEOL SCI, V18, P399, DOI 10.1016/0305-4403(91)90074-Y; Sedlock R.L., 1993, GEOL SOC AM BULL, P1, DOI DOI 10.1130/SPE278-P1; Shaw H, 2016, J ARCHAEOL SCI, V66, P57, DOI 10.1016/j.jas.2015.12.001; Singer BS, 2011, J PETROL, V52, P2335, DOI 10.1093/petrology/egr047; Slovak NM, 2011, ADV ISOTOP GEOCHEM, P743, DOI 10.1007/978-3-642-10637-8_35; Soto-Jimenez MF, 2011, ENVIRON RES, V111, P590, DOI 10.1016/j.envres.2011.01.020; STILLE P, 1997, RADIOGENIC ISOTOPE G; Stos-Gale ZA, 2009, ARCHAEOL ANTHROP SCI, V1, P195, DOI 10.1007/s12520-009-0011-6; Stuart David, 1993, LOWLAND MAYA CIVILIZ, P321; Thibodeau AM., 2012, THESIS; Thornton EK, 2011, THESIS; Thornton EK, 2011, J ARCHAEOL SCI, V38, P3254, DOI 10.1016/j.jas.2011.06.035; Turner BL, 2009, J ARCHAEOL SCI, V36, P317, DOI 10.1016/j.jas.2008.09.018; Valentine B, 2008, J ARCHAEOL SCI, V35, P1463, DOI 10.1016/j.jas.2007.10.016; Valentine B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123103; WALKER JA, 1995, CONTRIB MINERAL PETR, V120, P378, DOI 10.1007/s004100050082; Wright LE, 2005, J ARCHAEOL SCI, V32, P555, DOI 10.1016/j.jas.2004.11.011; Wright LE, 2012, J ANTHROPOL ARCHAEOL, V31, P334, DOI 10.1016/j.jaa.2012.02.001; Wright LE, 2010, J ANTHROPOL ARCHAEOL, V29, P155, DOI 10.1016/j.jaa.2010.01.002	66	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0164871	10.1371/journal.pone.0164871	http://dx.doi.org/10.1371/journal.pone.0164871			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806065	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500015
J	Dubey, A; Copeland, PR				Dubey, Aditi; Copeland, Paul R.			The Selenocysteine-Specific Elongation Factor Contains Unique Sequences That Are Required for Both Nuclear Export and Selenocysteine Incorporation	PLOS ONE			English	Article							MESSENGER-RNA; LEPTOMYCIN-B; SELENOPROTEIN EXPRESSION; FISSION YEAST; PROTEIN; BINDING; CRM1; LOCALIZATION; COMPLEXES; SECISBP2	Selenocysteine (Sec) is a critical residue in at least 25 human proteins that are essential for antioxidant defense and redox signaling in cells. Sec is inserted into proteins cotranslationally by the recoding of an in-frame UGA termination codon to a Sec codon. In eukaryotes, this recoding event requires several specialized factors, including a dedicated, Sec-specific elongation factor called eEFSec, which binds Sec-tRNA(Sec) with high specificity and delivers it to the ribosome for selenoprotein production. Unlike most translation factors, including the canonical elongation factor eEF1A, eEFSec readily localizes to the nucleus of mammalian cells and shuttles between the cytoplasmic and nuclear compartments. The functional significance of eEFSec's nuclear localization has remained unclear. In this study, we have examined the subcellular localization of eEFSec in the context of altered Sec incorporation to demonstrate that reduced selenoprotein production does not correlate with changes in the nuclear localization of eEFSec. In addition, we identify several novel sequences of the protein that are essential for localization as well as Sec insertion activity, and show that eEFSec utilizes CRM1-mediated nuclear export pathway. Our findings argue for two distinct pools of eEFSec in the cell, where the cytoplasmic pool participates in Sec incorporation and the nuclear pool may be involved in an as yet unknown function.	[Dubey, Aditi; Copeland, Paul R.] Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Dubey, Aditi] NYU, Dept Basic Sci & Craniofacial Biol, New York, NY USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; New York University	Copeland, PR (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.	paul.copeland@rutgers.edu		Copeland, Paul/0000-0003-3343-0587; Dubey, Aditi/0000-0003-0162-7334	National Institutes of Health [GM070773]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077073] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health GM070773 (PRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Cherfils J, 2011, NAT CHEM BIOL, V7, P493, DOI 10.1038/nchembio.608; Chung J, 2012, J CELL SCI, V125, P2684, DOI 10.1242/jcs.099267; Copeland PR, 1999, J BIOL CHEM, V274, P25447, DOI 10.1074/jbc.274.36.25447; de Jesus LA, 2006, MOL CELL BIOL, V26, P1795, DOI 10.1128/MCB.26.5.1795-1805.2006; Donovan J, 2008, J BIOL CHEM, V283, P35129, DOI 10.1074/jbc.M806008200; Dubey A, 2015, DIVERSITY SELENIUM F, P31; Fletcher JE, 2000, RNA, V6, P1573, DOI 10.1017/S1355838200000625; Fletcher JE, 2001, RNA, V7, P1442; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gonzalez-Flores JN, 2012, J BIOL CHEM, V287, P38936, DOI 10.1074/jbc.M112.415463; Gupta N, 2013, J MOL BIOL, V425, P2415, DOI 10.1016/j.jmb.2013.04.016; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Leibundgut M, 2005, EMBO J, V24, P11, DOI 10.1038/sj.emboj.7600505; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; NISHI K, 1994, J BIOL CHEM, V269, P6320; Papp LV, 2006, MOL CELL BIOL, V26, P4895, DOI 10.1128/MCB.02284-05; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seeher S, 2014, FREE RADICAL BIO MED, V75, pS9, DOI 10.1016/j.freeradbiomed.2014.10.849; Seeher S, 2014, ANTIOXID REDOX SIGN, V21, P835, DOI 10.1089/ars.2013.5358; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shetty SP, 2014, J BIOL CHEM, V289, P25317, DOI 10.1074/jbc.M114.590430; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; Sunde RA, 2011, ADV NUTR, V2, P138, DOI 10.3945/an.110.000240; Touat-Hamici Z, 2014, J BIOL CHEM, V289, P14750, DOI 10.1074/jbc.M114.551994; Watanabe M, 1999, GENES CELLS, V4, P291, DOI 10.1046/j.1365-2443.1999.00259.x; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Zavacki AM, 2003, MOL CELL, V11, P773, DOI 10.1016/S1097-2765(03)00064-9	34	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165642	10.1371/journal.pone.0165642	http://dx.doi.org/10.1371/journal.pone.0165642			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802322	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200032
J	Bakker, G; Caan, MWA; Vingerhoets, WAM; da Silva-Alves, F; de Koning, M; Boot, E; Nieman, DH; de Haan, L; Bloemen, OJ; Booij, J; van Amelsvoort, TAMJ				Bakker, Geor; Caan, Matthan W. A.; Vingerhoets, Wilhelmina A. M.; da Silva-Alves, Fabiana; de Koning, Mariken; Boot, Erik; Nieman, Dorien H.; de Haan, Lieuwe; Bloemen, Oswald J.; Booij, Jan; van Amelsvoort, Therese A. M. J.			Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome	PLOS ONE			English	Article							STRUCTURAL BRAIN ABNORMALITIES; SURFACE-BASED ANALYSIS; GYRIFICATION; SCHIZOPHRENIA; THICKNESS; NOGO-66; ADULTS; INHIBITION; SYMPTOMS; PATTERNS	Introduction Subjects with 22q11.2 deletion syndrome (22g11 DS) and subjects with ultra-high risk for psychosis (UHR) share a risk of approximately 30% to develop a psychotic disorder. Studying these groups helps identify biological markers of pathophysiological processes involved in the development of psychosis. Total cortical surface area (cSA), total cortical grey matter volume (cGMV), cortical thickness (CT), and local gyrification index (LGI) of the cortical structure have a distinct neurodevelopmental origin making them important target markers to study in relation to the development of psychosis. Materials and Methods Structural T1-weighted high resolution images were acquired using a 3 Tesla Intera MRI system in 18 UHR subjects, 18 22q11DS subjects, and 24 matched healthy control (HC) subjects. Total cSA, total cGMV, mean CT, and regional vertex-wise differences in CT and LGI were assessed using FreeSurfer software. The Positive and Negative Syndrome Scale was used to assess psychotic symptom severity in UHR and 22q11DS subjects at time of scanning. Results 22g11 DS subjects had lower total cSA and total cGMV compared to UHR and HC subjects. The 22q11DS subjects showed bilateral lower LGI in the i) prefrontal cortex, ii) precuneus, iii) precentral gyrus and iv) cuneus compared to UHR subjects. Additionally, lower LGI was found in the left i) fusiform gyrus and right i) pars opercularis, ii) superior, and iii) inferior temporal gyrus in 22q11DS subjects compared to HC. In comparison to 22q11DS subjects, the UHR subjects had lower CT of the insula. For both risk groups, positive symptom severity was negatively correlated to rostral middle frontal gyrus CT. Conclusion A shared negative correlation between positive symptom severity and rostral middle frontal gyrus CT in UHR and 22q11DS may be related to their increased vulnerability to develop a psychotic disorder. 22q11DS subjects were characterised by widespread lower degree of cortical gyrification linked to early and postnatal neurodevelopmental pathology. No implications for early neurodevelopmental pathology were found for the UHR subjects, although they did have distinctively lower insula CT which may have arisen from defective pruning processes during adolescence. Implications of these findings in relation to development of psychotic disorders are in need of further investigation in longitudinal studies.	[Bakker, Geor; Vingerhoets, Wilhelmina A. M.; Bloemen, Oswald J.; van Amelsvoort, Therese A. M. J.] Maastricht Univ, Dept Psychiat & Psychol, Maastricht, Netherlands; [Bakker, Geor; Vingerhoets, Wilhelmina A. M.; da Silva-Alves, Fabiana; Boot, Erik; Booij, Jan; van Amelsvoort, Therese A. M. J.] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, Amsterdam, Netherlands; [Caan, Matthan W. A.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Nieman, Dorien H.; de Haan, Lieuwe] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Bloemen, Oswald J.] GGZ Centraal, Ctr Mental Hlth Care Innova, Amersfoort, Netherlands; [de Koning, Mariken; de Haan, Lieuwe] Arkin Mental Hlth Care, Amsterdam, Netherlands; [Boot, Erik] Dalglish Family 22q Clin, Toronto, ON, Canada	Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Bakker, G (corresponding author), Maastricht Univ, Dept Psychiat & Psychol, Maastricht, Netherlands.; Bakker, G (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, Amsterdam, Netherlands.	geor.bakker@maastrichtuniversity.nl	Boot, Erik/AAV-8592-2021; Booij, Jan/AAD-7159-2019	Boot, Erik/0000-0002-0593-1539; Nieman, Dorien/0000-0002-9846-4254; Caan, Matthan W.A./0000-0002-5162-8880	European Commission in Brussels, Belgium [QLGU-CT-2001-01081, 2006 (916.76.048)]; Dutch Brain Foundation [15F07 (2).55]; Personal Grant Therese v Amelsvoort (NWO-Veni grant) [916.76.048]; Personal Grant Therese v Amelsvoort Dutch Brain Foundation [15F07 (2).55]	European Commission in Brussels, Belgium; Dutch Brain Foundation; Personal Grant Therese v Amelsvoort (NWO-Veni grant); Personal Grant Therese v Amelsvoort Dutch Brain Foundation	This work was supported by: European Commission in Brussels, Belgium (QLGU-CT-2001-01081) http://ec.europa.eu/index_en.htm; Personal Grant Therese v Amelsvoort (NWO-Veni grant 2006 (916.76.048)), http://www.zoonmw.nl/; Dutch Brain Foundation (grant number 15F07 (2).55); Personal Grant Therese v Amelsvoort Dutch Brain Foundation (grant number 15F07 (2).55). https://www.hersenstichting.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021685; Bakker G, 2016, PSYCHOL MED, V46, P2299, DOI 10.1017/S0033291716000970; Bearden CE, 2007, CEREB CORTEX, V17, P1889, DOI 10.1093/cercor/bhl097; Bearden CE, 2009, CEREB CORTEX, V19, P115, DOI 10.1093/cercor/bhn064; Bloemen OJN, 2010, PSYCHOL MED, V40, P1297, DOI 10.1017/S0033291709991711; Bloemen OJN, 2013, EUR NEUROPSYCHOPHARM, V23, P126, DOI 10.1016/j.euroneuro.2012.04.015; Byun MS, 2012, SCHIZOPHR RES, V141, P197, DOI 10.1016/j.schres.2012.08.028; Cauda F, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00104; Chow EWC, 2002, BIOL PSYCHIAT, V51, P208, DOI 10.1016/S0006-3223(01)01246-X; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Diaz-Caneja CM, 2015, NPJ SCHIZOPHR, V1, DOI 10.1038/npjschz.2014.5; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P220, DOI 10.1001/archgenpsychiatry.2011.1472; Gee Dylan G., 2011, Rev. Bras. Psiquiatr., V33, ps129, DOI 10.1590/S1516-44462011000600002; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Harris JM, 2007, BIOL PSYCHIAT, V62, P722, DOI 10.1016/j.biopsych.2006.11.027; Jalbrzikowski M, 2013, NEUROIMAGE-CLIN, V3, P405, DOI 10.1016/j.nicl.2013.09.013; Jung WH, 2011, SCHIZOPHRENIA BULL, V37, P839, DOI 10.1093/schbul/sbp151; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kunwar A, 2012, SCHIZOPHR RES, V137, P20, DOI 10.1016/j.schres.2012.01.032; Meechan DW, 2012, P NATL ACAD SCI USA, V109, P18601, DOI 10.1073/pnas.1211507109; Meechan DW, 2009, P NATL ACAD SCI USA, V106, P16434, DOI 10.1073/pnas.0905696106; Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Nanda P, 2014, BIOL PSYCHIAT, V76, P447, DOI 10.1016/j.biopsych.2013.11.018; Nenadic I, 2015, BRIT J PSYCHIAT, V206, P479, DOI 10.1192/bjp.bp.114.148510; Palaniyappan L, 2013, JAMA PSYCHIAT, V70, P1031, DOI 10.1001/jamapsychiatry.2013.203; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P399, DOI 10.1503/jpn.110119; Perlstein MD, 2014, SCHIZOPHR RES, V152, P117, DOI 10.1016/j.schres.2013.11.015; Schaer M, 2008, IEEE T MED IMAGING, V27, P161, DOI 10.1109/TMI.2007.903576; Schaer M, 2009, SCHIZOPHR RES, V115, P182, DOI 10.1016/j.schres.2009.09.016; Schaer M, 2009, DEV MED CHILD NEUROL, V51, P746, DOI 10.1111/j.1469-8749.2009.03281.x; Schmitt JE, 2015, BIOL PSYCHIAT, V78, P135, DOI 10.1016/j.biopsych.2014.10.025; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Tognin S, 2014, PSYCHOL MED, V44, P489, DOI 10.1017/S0033291713000998; Van Amelsvoort T, 2001, BRIT J PSYCHIAT, V178, P412; van Amelsvoort T, 2004, ARCH GEN PSYCHIAT, V61, P1085, DOI 10.1001/archpsyc.61.11.1085; van Donkersgoed RJM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141075; Wang RP, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00150; White T, 2011, DEV PSYCHOPATHOL, V23, P339, DOI 10.1017/S0954579410000842; White T, 2010, BRAIN COGNITION, V72, P36, DOI 10.1016/j.bandc.2009.10.009; Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105; Yung AR, 2012, CURR PHARM DESIGN, V18, P346; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x	48	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0159928	10.1371/journal.pone.0159928	http://dx.doi.org/10.1371/journal.pone.0159928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27828960	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300003
J	Laugeray, A; Launay, JM; Callebert, J; Mutlu, O; Guillemin, GJ; Belzung, C; Barone, PR				Laugeray, Anthony; Launay, Jean-Marie; Callebert, Jacques; Mutlu, Oguz; Guillemin, Gilles J.; Belzung, Catherine; Barone, Pascal R.			Chronic Treatment with the IDO1 Inhibitor 1-Methyl-D-Tryptophan Minimizes the Behavioural and Biochemical Abnormalities Induced by Unpredictable Chronic Mild Stress in Mice - Comparison with Fluoxetine	PLOS ONE			English	Article							TRYPTOPHAN-KYNURENINE PATHWAY; BACILLE CALMETTE-GUERIN; INDOLEAMINE 2,3-DIOXYGENASE; QUINOLINIC ACID; RAT-BRAIN; HIPPOCAMPAL NEUROGENESIS; DEPRESSIVE SYMPTOMS; RECEPTOR ANTAGONIST; IMMUNE ACTIVATION; OXIDATIVE STRESS	We demonstrated that confronting mice to the Unpredictable Chronic Mild Stress (UCMS) procedure-a validated model of stress-induced depression-results in behavioural alterations and biochemical changes in the kynurenine pathway (KP), suspected to modify the glutamatergic neurotransmission through the imbalance between downstream metabolites such as 3-hydroxykynurenine, quinolinic and kynurenic acids. We showed that daily treatment with the IDO1 inhibitor 1-methyl-D-tryptophan partially rescues UCMS-induced KP alterations as does the antidepressant fluoxetine. More importantly we demonstrated that 1-methyl-D-tryptophan was able to alleviate most of the behavioural changes resulting from UCMS exposure. We also showed that both fluoxetine and 1-methyl-D-tryptophan robustly reduced peripheral levels of proinflammatory cytokines in UCMS mice suggesting that their therapeutic effects might occur through anti-inflammatory processes. KP inhibition might be involved in the positive effects of fluoxetine on mice behaviour and could be a relevant strategy to counteract depressive-like symptoms.	[Laugeray, Anthony] CNRS, Mol & Expt Immunol & Neurogenet, UMR7355, 3b Rue Ferollerie, Orleans 2, France; [Launay, Jean-Marie; Callebert, Jacques] Hop Lariboisiere, AP HP, Serv Biochim, UMRS,INSERM,U942, Paris, France; [Mutlu, Oguz; Belzung, Catherine; Barone, Pascal R.] Univ Tours, CNRS ERL 3106, UMRS, INSERM,U930, Tours, France; [Mutlu, Oguz] Kocaeli Univ, Dept Pharmacol, Fac Med, TR-41380 Kocaeli, Turkey; [Guillemin, Gilles J.] Macquarie Univ, Fac Med & Hlth Sci, Neuroinflammat Grp, Sydney, NSW, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Kocaeli University; Macquarie University	Laugeray, A (corresponding author), CNRS, Mol & Expt Immunol & Neurogenet, UMR7355, 3b Rue Ferollerie, Orleans 2, France.	alaugeray@yahoo.fr	MUTLU, OGUZ/F-5952-2018; callebert, jacques/L-4569-2017; Guillemin, Gilles J/C-3878-2015; Laugeray, Anthony/AAJ-2919-2020; BARONE, Pascal/T-1194-2018; Belzung, Catherine/P-6512-2016	MUTLU, OGUZ/0000-0003-0952-0742; Guillemin, Gilles J/0000-0001-8105-4470; Barone, pascal/0000-0002-1742-8578; Belzung, Catherine/0000-0001-6095-5974				Asberg K, 2013, J PSYCHOL, V147, P469, DOI 10.1080/00223980.2012.715601; Asp L, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-25; Bano S, 1999, Pak J Pharm Sci, V12, P11; Bano Samina, 2003, J Coll Physicians Surg Pak, V13, P5; Capuron L, 2002, MOL PSYCHIATR, V7, P468, DOI 10.1038/sj.mp.4000995; Connor TJ, 2008, NEUROSCI LETT, V441, P29, DOI 10.1016/j.neulet.2008.06.007; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; Detanico BC, 2009, EUR J PHARMACOL, V607, P121, DOI 10.1016/j.ejphar.2009.02.037; Dobos N, 2011, J ALZHEIMERS DIS; Ducottet C, 2004, BEHAV BRAIN RES, V155, P291, DOI 10.1016/j.bbr.2004.04.020; Fava M, 1999, J CLIN PSYCHIAT, V60, P21; Fuertig R, 2016, BRAIN BEHAV IMMUN, V54, P59, DOI 10.1016/j.bbi.2015.12.020; Fujigaki S, 1998, ARCH BIOCHEM BIOPHYS, V358, P329, DOI 10.1006/abbi.1998.0861; Gibney SM, 2014, INT J NEUROPSYCHOPH, V17, P917, DOI 10.1017/S1461145713001673; Griebel G, 2005, BIOL PSYCHIAT, V57, P261, DOI 10.1016/j.biopsych.2004.10.032; Griebel G, 2002, P NATL ACAD SCI USA, V99, P6370, DOI 10.1073/pnas.092012099; Hashimoto K, 2009, BRAIN RES REV, V61, P105, DOI 10.1016/j.brainresrev.2009.05.005; HEYES MP, 1988, ANAL BIOCHEM, V174, P349, DOI 10.1016/0003-2697(88)90556-8; Hodes GE, 2014, P NATL ACAD SCI USA, V111, P16136, DOI 10.1073/pnas.1415191111; Ibarguen-Vargas Y, 2009, BEHAV BRAIN RES, V202, P245, DOI 10.1016/j.bbr.2009.03.040; Ibarguen-Vargas Y, 2008, PSYCHONEUROENDOCRINO, V33, P1357, DOI 10.1016/j.psyneuen.2008.07.010; Isingrini E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010404; Kalueff AV, 2004, BRAIN RES PROTOC, V13, P151, DOI 10.1016/j.brainresprot.2004.04.002; KEMA IP, 1993, CLIN CHIM ACTA, V221, P143, DOI 10.1016/0009-8981(93)90029-4; Kiank C, 2009, BRAIN BEHAV IMMUN, V22; Kocki T, 2011, J NEURAL TRANSM; Lapin IP, 1996, J PSYCHOPHARMACOL, V10, P246, DOI 10.1177/026988119601000312; Laugeray A, 2011, PHARM BIOCH BEHAV; Laugeray A, 2010, BEHAV BRAIN RES, V210, P84, DOI 10.1016/j.bbr.2010.02.014; Maes M, 2002, LIFE SCI, V71, P1837, DOI 10.1016/S0024-3205(02)01853-2; Martinez P, 2014, JAIDS-J ACQ IMM DEF, V65, P456, DOI 10.1097/QAI.0000000000000062; Mineur YS, 2003, BEHAV GENET, V33, P513, DOI 10.1023/A:1025770616068; Moreau M, 2005, J INFECT DIS, V192, P537, DOI 10.1086/431603; MORONI F, 1984, BRAIN RES, V295, P352, DOI 10.1016/0006-8993(84)90984-3; Murakami Y, 2012, CYTOKINE, V59, P245, DOI 10.1016/j.cyto.2012.04.022; Mutlu O, 2009, PHARMACOL BIOCHEM BE, V92, P82, DOI 10.1016/j.pbb.2008.10.013; Myint AM, 2012, FEBS J, V279, P1375, DOI 10.1111/j.1742-4658.2012.08551.x; O'Connor JC, 2009, J NEUROSCI, V29, P4200, DOI 10.1523/JNEUROSCI.5032-08.2009; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; OCONNOR JC, 2008, MOL PSYCHIAT; Okuda S, 1998, J NEUROCHEM, V70, P299; Paxinos G., 2001, MOUSE BRAIN STEREOTO; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Remus JL, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw028; RICE JM, 1989, J TOXICOL ENV HEALTH, V27, P153, DOI 10.1080/15287398909531285; Salazar A, 2012, HORM BEHAV, V62, P202, DOI 10.1016/j.yhbeh.2012.03.010; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Santamaria A, 2001, NEUROREPORT, V12, P871, DOI 10.1097/00001756-200103260-00049; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Sherkheli Muhammad Azhar, 2003, Pak J Pharm Sci, V16, P51; Simon NM, 2008, EUR NEUROPSYCHOPHARM, V18, P230, DOI 10.1016/j.euroneuro.2007.06.004; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; SMITH RS, 1991, MED HYPOTHESES, V35, P298, DOI 10.1016/0306-9877(91)90272-Z; Strekalova T, 2005, BEHAV PHARMACOL, V16, P171, DOI 10.1097/00008877-200505000-00006; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Surget A, 2009, NEUROPSYCHOPHARMACOL, V34, P1363, DOI 10.1038/npp.2008.76; Suzuki S, 2001, BIOCHEM J, V355, P425, DOI 10.1042/0264-6021:3550425; Taher YA, 2008, J ALLERGY CLIN IMMUN, V121, P983, DOI 10.1016/j.jaci.2007.11.021; Tan L, 2012, J NEUROL SCI, V323, P1, DOI 10.1016/j.jns.2012.08.005; Tavares RG, 2005, NEUROCHEM RES, V30, P439, DOI 10.1007/s11064-005-2678-0; Tynan RJ, 2012, BRAIN BEHAV IMMUN, V26, P469, DOI 10.1016/j.bbi.2011.12.011; Valera E, 2014, GLIA, V62, P317, DOI 10.1002/glia.22610; Weiss G, 1999, CLIN EXP IMMUNOL, V116, P435; Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600; Widner B, 2000, J NEURAL TRANSM, V107, P343, DOI 10.1007/s007020050029; Widner B, 2002, BRAIN BEHAV IMMUN, V16, P590, DOI 10.1016/S0889-1591(02)00006-5; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Willner P, 2016, NEUROBIOLOG IN PRESS, P1; Wirleitner B, 2003, EUR J CLIN INVEST, V33, P550, DOI 10.1046/j.1365-2362.2003.01186.x; Wu HQ, 2009, J MOL NEUROSCI	75	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164337	10.1371/journal.pone.0164337	http://dx.doi.org/10.1371/journal.pone.0164337			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828964	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300015
J	Stevenson, NJ; Boylan, GB; Hellstrom-Westas, L; Vanhatalo, S				Stevenson, Nathan J.; Boylan, Geraldine B.; Hellstrom-Westas, Lena; Vanhatalo, Sampsa			Treatment Trials for Neonatal Seizures: The Effect of Design on Sample Size	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; ELECTROGRAPHIC SEIZURES; HYPOTHERMIA; BURDEN; EEG; PHENOBARBITONE; LIDOCAINE; EFFICACY	Neonatal seizures are common in the neonatal intensive care unit. Clinicians treat these seizures with several anti-epileptic drugs (AEDs) to reduce seizures in a neonate. Current AEDs exhibit sub-optimal efficacy and several randomized control trials (RCT) of novel AEDs are planned. The aim of this study was to measure the influence of trial design on the required sample size of a RCT. We used seizure time courses from 41 term neonates with hypoxic ischaemic encephalopathy to build seizure treatment trial simulations. We used five outcome measures, three AED protocols, eight treatment delays from seizure onset (T-d) and four levels of trial AED efficacy to simulate different RCTs. We performed power calculations for each RCT design and analysed the resultant sample size. We also assessed the rate of false positives, or placebo effect, in typical uncontrolled studies. We found that the false positive rate ranged from 5 to 85% of patients depending on RCT design. For controlled trials, the choice of outcome measure had the largest effect on sample size with median differences of 30.7 fold (IQR: 13.7-40.0) across a range of AED protocols, Td and trial AED efficacy (p<0.001). RCTs that compared the trial AED with positive controls required sample sizes with a median fold increase of 3.2 ( IQR: 1.9-11.9; p<0.001). Delays in AED administration from seizure onset also increased the required sample size 2.1 fold (IQR: 1.7-2.9; p<0.001). Subgroup analysis showed that RCTs in neonates treated with hypothermia required a median fold increase in sample size of 2.6 (IQR: 2.4-3.0) compared to trials in normothermic neonates (p<0.001). These results show that RCT design has a profound influence on the required sample size. Trials that use a control group, appropriate outcome measure, and control for differences in Td between groups in analysis will be valid and minimise sample size.	[Stevenson, Nathan J.; Boylan, Geraldine B.] Univ Coll Cork, Irish Ctr Fetal & Neonatal Translat Res, Cork, Ireland; [Stevenson, Nathan J.; Boylan, Geraldine B.] Univ Coll Cork, Dept Paediat & Child Hlth, Cork, Ireland; [Hellstrom-Westas, Lena] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Vanhatalo, Sampsa] Univ Helsinki, Cent Hosp, Dept Clin Neurophysiol, HUS Med Imaging Ctr, Helsinki, Finland; [Stevenson, Nathan J.; Vanhatalo, Sampsa] Univ Helsinki, Dept Neurol Sci, Clinicum, Helsinki, Finland	University College Cork; University College Cork; Uppsala University; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Stevenson, NJ (corresponding author), Univ Coll Cork, Irish Ctr Fetal & Neonatal Translat Res, Cork, Ireland.; Stevenson, NJ (corresponding author), Univ Coll Cork, Dept Paediat & Child Hlth, Cork, Ireland.; Stevenson, NJ (corresponding author), Univ Helsinki, Dept Neurol Sci, Clinicum, Helsinki, Finland.	nathan.stevenson@helsinki.fi		Boylan, Geraldine/0000-0003-0920-5291; Hellstrom-Westas, Lena/0000-0003-3498-6069	EU Marie Sktodowska Curie Individual Fellowship [H2020-MCSA-IF-656131]; Science Foundation Ireland [12/RC/2272]; Academy of Finland [276523, 288220]; Sigrid Juselius Foundation; European Union [FP7-HEALTH-2009-4.2-1, 241479]; Health Research Board [RP/2008/238]; Wellcome Trust [085249]	EU Marie Sktodowska Curie Individual Fellowship; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Union(European Commission); Health Research Board; Wellcome Trust(Wellcome TrustEuropean Commission)	NJS was supported by an EU Marie Sktodowska Curie Individual Fellowship (H2020-MCSA-IF-656131), GBB was supported by Science Foundation Ireland (12/RC/2272). SV was supported by Academy of Finland (#276523 and #288220), Sigrid Juselius Foundation, and the European Union (FP7-HEALTH-2009-4.2-1, grant agreement 241479). The data used in this study was supported by Principal Investigator Awards to GBB from the Health Research Board (RP/2008/238) and the Wellcome Trust (085249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NJS was supported by an EU Marie Sklodowska Curie Individual Fellowship (H2020-MCSA-IF-656131), GBB was supported by Science Foundation Ireland (12/RC/2272). SV was supported by Academy of Finland (#276523 and #288220), Sigrid Juselius Foundation, and the European Union (FP7-HEALTH-2009-4.2-1, grant agreement 241479). The data used in this study was supported by Principal Investigator Awards to GBB from the Health Research Board (RP/2008/238) and the Wellcome Trust (085249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend NS, 2011, J CHILD NEUROL, V26, P465, DOI 10.1177/0883073810384263; Bjorkman ST, 2010, NEUROSCIENCE, V166, P157, DOI 10.1016/j.neuroscience.2009.11.067; Boylan GB, 2002, ARCH DIS CHILD-FETAL, V86, P165; Boylan GB, 2013, SEMIN FETAL NEONAT M, V18, P202, DOI 10.1016/j.siny.2013.04.004; Clancy RR, 2006, PEDIATRICS, V117, pS23, DOI 10.1542/peds.2005-0620D; Cock HR, 2011, EPILEPSIA, V52, P50, DOI 10.1111/j.1528-1167.2011.03237.x; Desu MM, 1990, SAMPLE SIZE METHODOL, P30; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Glass HC, 2014, CLIN PERINATOL, V41, P177, DOI 10.1016/j.clp.2013.10.004; Goldenholz DM, 2015, ANN NEUROL, V78, P329, DOI 10.1002/ana.24470; HELLSTROMWESTAS L, 1988, ACTA PAEDIATR SCAND, V77, P79, DOI 10.1111/j.1651-2227.1988.tb10602.x; Low E, 2016, NEONATOLOGY, V110, P40, DOI 10.1159/000443782; Low E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100973; Low E, 2012, ARCH DIS CHILD-FETAL, V97, pF267, DOI 10.1136/archdischild-2011-300716; Lynch NE, 2015, SEIZURE-EUR J EPILEP, V33, P60, DOI 10.1016/j.seizure.2015.10.007; Lynch NE, 2012, EPILEPSIA, V53, P549, DOI 10.1111/j.1528-1167.2011.03401.x; Murray DM, 2008, ARCH DIS CHILD-FETAL, V93, pF187, DOI 10.1136/adc.2005.086314; Painter MJ, 1999, NEW ENGL J MED, V341, P485, DOI 10.1056/NEJM199908123410704; Pressler RM, 2015, LANCET NEUROL, V14, P469, DOI 10.1016/S1474-4422(14)70303-5; Sanchez SM, 2013, EPILEPSIA, V54, P1419, DOI 10.1111/epi.12261; Srinivasakumar P, 2015, PEDIATRICS, V136, pE1302, DOI 10.1542/peds.2014-3777; Stevenson NJ, 2015, ANN CLIN TRANSL NEUR, V2, P1002, DOI 10.1002/acn3.249; van den Broek MPH, 2013, ARCH DIS CHILD-FETAL, V98, pF341, DOI 10.1136/archdischild-2012-302678; van Rooij LGM, 2010, PEDIATRICS, V125, pE358, DOI 10.1542/peds.2009-0136; VanDevanter DR, 2011, J CYST FIBROS, V10, P453, DOI 10.1016/j.jcf.2011.07.003; Vasudevan C, 2013, SEMIN FETAL NEONAT M, V18, P185, DOI 10.1016/j.siny.2013.05.008; Wusthoff CJ, 2011, J CHILD NEUROL, V26, P724, DOI 10.1177/0883073810390036	27	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165693	10.1371/journal.pone.0165693	http://dx.doi.org/10.1371/journal.pone.0165693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824913	Green Submitted, Green Published, gold			2022-12-27	WOS:000387615200028
J	Mmari, K; Kalamar, AM; Brahmbhatt, H; Venables, E				Mmari, Kristin; Kalamar, Amanda M.; Brahmbhatt, Heena; Venables, Emilie			The Influence of the Family on Adolescent Sexual Experience: A Comparison between Baltimore and Johannesburg	PLOS ONE			English	Article							PARENTING PRACTICES; MODERATING ROLE; RISK BEHAVIORS; HEALTH; SETTINGS; AFRICA; GENDER	The main objective of this paper is to understand the role of the family on the sexual experiences of adolescents from urban, disadvantaged settings in Baltimore and Johannesburg. Data were collected as part of the WAVE study, a global study of disadvantaged youth in five cities. Qualitative data were based on key informant interviews, a Photovoice exercise, community mapping, focus groups and in-depth interviews with adolescents. Quantitative data were gathered from an ACASI survey that was administered to approximately 450-500 adolescents per site. Results from the qualitative data revealed that while parents were viewed as important sources of information for sexual and reproductive health, they were often not present in the adolescents' lives. This lack of parental presence was perceived to result in adolescents feeling an overall lack of adult support and guidance. The impact of parental presence and support on adolescent sexual experience was further examined from the quantitative data and revealed a complex picture. In both Baltimore and Johannesburg, female adolescents who were raised by other relatives were less likely to report having had sex compared to those raised by two biological parents, which was not observed for males. In Johannesburg, female adolescents who were paternal orphans were less likely to have had sex compared to non-orphans; the opposite was true among males. Finally, in both sites, female adolescents who had been exposed to violence were more likely to have had sex compared to those who had not; for males, there was no significant relationship. The study demonstrates the powerful influence of both context and gender for understanding the influences of the family on adolescent sexual behaviors. Programs aiming to reduce adolescent sexual risk behaviors the need to understand the complex influences on risk behaviors in different settings and in particular, the role of mothers and fathers. Prevention strategies need to also understand and incorporate gender-specific messages and interventions in order to address the high risk of sexual behaviors among adolescents in these settings.	[Mmari, Kristin; Kalamar, Amanda M.; Brahmbhatt, Heena] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [Venables, Emilie] Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Cape Town, South Africa	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town	Mmari, K (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.	kmmari@jhsph.edu		Mmari, Kristin/0000-0003-3087-7105	AstraZeneca	AstraZeneca(AstraZeneca)	The original study, WAVE, was funded by AstraZeneca. However, the analysis and writing of this manuscript was unfunded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Babalola Stella, 2005, Afr J Reprod Health, V9, P49; Beegle K, 2010, WORLD DEV, V38, P1727, DOI 10.1016/j.worlddev.2010.06.015; Bersamin M, 2008, J MARRIAGE FAM, V70, P97, DOI 10.1111/j.1741-3737.2007.00464.x; Biddlecom A, 2009, INT PERSPECT SEX R H, V35, P72, DOI 10.1363/ipsrh.35.072.09; Blum RW, 2003, AM J PUBLIC HEALTH, V93, P456, DOI 10.2105/AJPH.93.3.456; Brahmbhatt H, 2014, J ADOLESCENT HEALTH, V55, pS48, DOI 10.1016/j.jadohealth.2014.07.023; Case A, 2004, DEMOGRAPHY, V41, P483, DOI 10.1353/dem.2004.0019; Decker MR, 2014, J ADOLESCENT HEALTH, V55, pS6, DOI 10.1016/j.jadohealth.2014.07.021; Defo Barthelemy Kuate, 2012, Afr J Reprod Health, V16, P147; Fomby P, 2010, J MARRIAGE FAM, V72, P234, DOI 10.1111/j.1741-3737.2010.00696.x; Hardie JH, 2010, J MARRIAGE FAM, V72, P1141, DOI 10.1111/j.1741-3737.2010.00755.x; Jaccard J, 1996, FAM PLANN PERSPECT, V28, P159, DOI 10.2307/2136192; Kapungu CT, 2006, J YOUTH ADOLESCENCE, V35, P787, DOI 10.1007/s10964-006-9102-1; Kincaid C, 2012, CLIN PSYCHOL REV, V32, P177, DOI 10.1016/j.cpr.2012.01.002; Lyerly JE, 2013, ANN EPIDEMIOL, V23, P233, DOI 10.1016/j.annepidem.2013.01.005; Miller KS, 1999, J MARRIAGE FAM, V61, P85, DOI 10.2307/353885; Mmari K, 2014, SOC SCI MED, V104, P124, DOI 10.1016/j.socscimed.2013.12.012; Mosack KE, 2010, J CHILD SEX ABUS, V19, P43, DOI 10.1080/10538710903485591; Ngom P, 2003, J ADOLESCENT HEALTH, V33, P369, DOI 10.1016/S1054-139X(03)00213-1; Roche KM, 2008, SOC SCI MED, V66, P2023, DOI 10.1016/j.socscimed.2008.01.009; Schwab-Reese L. M., 2016, Injury Epidemiology, V3; Sengendo J, 1997, Health Transit Rev, V7 Suppl, P105; Sidze EM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-616; Sieving RE, 2000, ARCH PEDIAT ADOL MED, V74, P465; Simons RL, 2001, J HLTH SOCIAL BEHAV, V47, P373; Simpson AR., 2001, RAISING TEENS SYNTHE; Volz E, 2008, J OFF STAT, V24, P79; Wu LL, 2001, J MARRIAGE FAM, V63, P682, DOI 10.1111/j.1741-3737.2001.00682.x; Zulu, 2004, J YOUTH STUD, V7, P279, DOI DOI 10.1080/1367626042000268926	29	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166032	10.1371/journal.pone.0166032	http://dx.doi.org/10.1371/journal.pone.0166032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BB	27820853	Green Published, Green Submitted, gold			2022-12-27	WOS:000387614800030
J	Gomes, E; Capinha, C; Rocha, J; Sousa, C				Gomes, Eduardo; Capinha, Cesar; Rocha, Jorge; Sousa, Carla			Mapping Risk of Malaria Transmission in Mainland Portugal Using a Mathematical Modelling Approach	PLOS ONE			English	Article							PRESENCE-ONLY DATA; ENVIRONMENTAL SUITABILITY; HABITAT SUITABILITY; ANOPHELES-GAMBIAE; AREAS	Malaria is currently one of the world's major health problems. About a half-million deaths are recorded every year. In Portugal, malaria cases were significantly high until the end of the 1950s but the disease was considered eliminated in 1973. In the past few years, endemic malaria cases have been recorded in some European countries. With the increasing human mobility from countries with endemic malaria to Portugal, there is concern about the resurgence of this disease in the country. Here, we model and map the risk of malaria transmission for mainland Portugal, considering 3 different scenarios of existing imported infections. This risk assessment resulted from entomological studies on An. atroparvus, the only known mosquito capable of transmitting malaria in the study area. We used the malariogenic potential (determined by receptivity, infectivity and vulnerability) applied over geospatial data sets to estimate spatial variation in malaria risk. The results suggest that the risk exists, and the hotspots are concentrated in the northeast region of the country and in the upper and lower Alentejo regions.	[Gomes, Eduardo; Rocha, Jorge] Univ Lisbon, Inst Geog & Ordenamento Terr, Ctr Estudos Geog, Lisbon, Portugal; [Capinha, Cesar] Univ Porto, CIBIO InBIO, Ctr Invest Biodiversidade & Recursos Genet, Catedra Infraestruturas Portugal Biodiversidade, Oporto, Portugal; [Capinha, Cesar] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Sousa, Carla] Univ Nova Lisboa, Global Hlth & Trop Med, GHTM, Inst Higiene & Med Trop, Lisbon, Portugal	Universidade de Lisboa; Universidade do Porto; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Gomes, E (corresponding author), Univ Lisbon, Inst Geog & Ordenamento Terr, Ctr Estudos Geog, Lisbon, Portugal.	eduardojonas@campus.ul.pt	Capinha, César D/K-6439-2017; Gomes, Eduardo/V-6159-2017; Sousa, Carla/G-6531-2012; Rocha, Jorge/F-3185-2017	Capinha, César D/0000-0002-0666-9755; Gomes, Eduardo/0000-0001-8703-1763; Sousa, Carla/0000-0002-2386-7577; Rocha, Jorge/0000-0002-7228-6330	EU grant [GOCE-2003-010284 EDEN]; Arbovirus dos mosquitos de Portugal [POCTI/35775/ESP/2000, GHTM UID/Multi/04413/2013]; Fundação para a Ciência e a Tecnologia [UID/Multi/04413/2013] Funding Source: FCT	EU grant(European Commission); Arbovirus dos mosquitos de Portugal; Fundação para a Ciência e a Tecnologia	This publication was partially funded by: (i) EU grant GOCE-2003-010284 EDEN (www.edenfp6project.net), (ii) Arbovirus dos mosquitos de Portugal (POCTI/35775/ESP/2000) and GHTM UID/Multi/04413/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772; Alten B, 2007, ECOL CONT VECTOR-BOR, V1, P35; [Anonymous], 2003, MOSQUITOES THEIR CON; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Benali A, 2014, REMOTE SENS ENVIRON, V145, P116, DOI 10.1016/j.rse.2014.01.014; Bueno-Mari, 2012, TROP BIOMED, V29, P39; Buttner PG, 2012, IMPLEMENTATION ACHIE; Cambournac F, 1938, T 3 INT C TROP MED M, V2, P1938; Cambournac F., 1942, EPIDEMIOLOGIA SEZONI; Cano Jorge, 2006, Malaria Journal, V5, P1; Capinha C, 2009, GEOSPATIAL HEALTH, V3, P177, DOI 10.4081/gh.2009.219; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; da Saude D-G, 2015, DOENC DECL OBR 2010; de Saude E, 2011, DOENC DECL OBR 2004; Detinova T, 1963, METHODES APPL CLASSE; Elith J, 2006, NOVEL METHODS IMPROV, V2; Elyazar IRF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037325; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; Gomes ED, 2016, CORDIS, P1; Grillet ME, 2010, SPAT SPATIO-TEMPORAL, V1, P251, DOI 10.1016/j.sste.2010.09.007; Hanafi-Bojd AA, 2012, ACTA TROP, V122, P132, DOI 10.1016/j.actatropica.2012.01.003; Hastie T, 2013, ECOGRAPHY, V36, P864, DOI 10.1111/j.1600-0587.2013.00321.x; Hijmans R. J., 2016, SPECIES DISTRIBUTION; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; INE, 2011, 15 REC GER POP HAB; Knell AJ, 1991, MALARIA; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawler JJ, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P271, DOI 10.1007/978-1-4419-7390-0_14; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Miranda P.M.A., 2006, ALTERA ES CLIM TICAS, P47; Molineaux L, 1988, EPIDEMIOLOGY MALARIA; Muller S, 2015, MOLECULES, V20, P10511, DOI 10.3390/molecules200610511; O'Hanley JR, 2009, ECOGRAPHY, V32, P89, DOI 10.1111/j.1600-0587.2008.05601.x; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Park YS, 2003, ECOL MODEL, V160, P265, DOI 10.1016/S0304-3800(02)00258-2; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pires C, 1982, DO I HIG MED TROP, V8, P79; Poncon N, 2008, QUANTITATIVE RISK AS, V7, P1; Ramos H, 1978, I HIG MED TROP LISB, V1, P79; Reisen W. K., 1989, Bulletin of the Society for Vector Ecology, V14, P39; Ribeiro H, 1992, GARCIA HORTA Z, V16, P137; Ribeiro H, 2002, GARCIA HORTA Z, V24, P2002; Ribeiro H, 1999, GARCIA HORTA Z, V23, P1999; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; Salvi C, 2016, HIST MALARIA ELIMINA; Santos LC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-96; Sousa C.A., 2008, MALARIA VECTORIAL CA; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Walther H, 1988, MALARIA PRINCIPLES P; WHO, 2015, WORLD MAL REP 2015; Zaniewski AE, 2002, ECOL MODEL, V157, P261, DOI 10.1016/S0304-3800(02)00199-0	56	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0164788	10.1371/journal.pone.0164788	http://dx.doi.org/10.1371/journal.pone.0164788			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814371	Green Published, Green Submitted, gold			2022-12-27	WOS:000386911100004
J	Zhao, MX; Brofeldt, S; Li, QH; Xu, JC; Danielsen, F; Laessoe, SBL; Poulsen, MK; Gottlieb, A; Maxwell, JF; Theilade, I				Zhao, Mingxu; Brofeldt, Soren; Li, Qiaohong; Xu, Jianchu; Danielsen, Finn; Laessoe, Simon Bjarke Laegaard; Poulsen, Michael Koie; Gottlieb, Anna; Maxwell, James Franklin; Theilade, Ida			Can Community Members Identify Tropical Tree Species for REDD plus Carbon and Biodiversity Measurements?	PLOS ONE			English	Review							TRADITIONAL ECOLOGICAL KNOWLEDGE; INDIGENOUS KNOWLEDGE; LOCAL KNOWLEDGE; GENERAL-PRINCIPLES; CONSERVATION; CLASSIFICATION; INVENTORY; MANAGEMENT; PEOPLE; FOLK	Biodiversity conservation is a required co-benefit of REDD+. Biodiversity monitoring is therefore needed, yet in most areas it will be constrained by limitations in the available human professional and financial resources. REDD+ programs that use forest plots for biomass monitoring may be able to take advantage of the same data for detecting changes in the tree diversity, using the richness and abundance of canopy trees as a proxy for biodiversity. If local community members are already assessing the above-ground biomass in a representative network of forest vegetation plots, it may require minimal further effort to collect data on the diversity of trees. We compare community members and trained scientists' data on tree diversity in permanent vegetation plots in montane forest in Yunnan, China. We show that local community members here can collect tree diversity data of comparable quality to trained botanists, at one third the cost. Without access to herbaria, identification guides or the Internet, community members could provide the ethno-taxonomical names for 95% of 1071 trees in 60 vegetation plots. Moreover, we show that the community-led survey spent 89% of the expenses at village level as opposed to 23% of funds in the monitoring by botanists. In participatory REDD+ programs in areas where community members demonstrate great knowledge of forest trees, community-based collection of tree diversity data can be a cost-effective approach for obtaining tree diversity information.	[Zhao, Mingxu; Li, Qiaohong; Xu, Jianchu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Zhao, Mingxu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhao, Mingxu; Li, Qiaohong; Xu, Jianchu] World Agroforestry Ctr, East & Cent Asia, Kunming, Yunnan, Peoples R China; [Brofeldt, Soren; Laessoe, Simon Bjarke Laegaard; Theilade, Ida] Univ Copenhagen, Dept Food & Resource Econ, Fac Sci, Copenhagen, Denmark; [Brofeldt, Soren; Danielsen, Finn; Poulsen, Michael Koie; Gottlieb, Anna] Nord Fdn Dev & Ecol NORDECO, Copenhagen, Denmark; [Maxwell, James Franklin] Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Copenhagen; Chiang Mai University	Theilade, I (corresponding author), Univ Copenhagen, Dept Food & Resource Econ, Fac Sci, Copenhagen, Denmark.	idat@ifro.ku.dk	Xu, Jianchu/Y-2890-2019; Theilade, Ida/A-6498-2010; Theilade, Ida/N-5882-2019	Theilade, Ida/0000-0003-3502-1277; Theilade, Ida/0000-0003-3502-1277; Danielsen, Finn/0000-0003-0229-2847; Poulsen, Michael Koie/0000-0002-3189-6423	European Community's Seventh Framework Research Programme; DANIDA research grant [13-08KU]	European Community's Seventh Framework Research Programme; DANIDA research grant	This study was part of the project Impacts of Reducing Emissions from Deforestation and Forest Degradation and Enhancing Carbon Stocks (I-REDD+) funded by the European Communitys Seventh Framework Research Programme (http://www.iredd.dk/) and DANIDA research grant 13-08KU (http://ifro.ku.dk/english/research/projects/projects_development/redd/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraao MB, 2008, J BIOGEOGR, V35, P2237, DOI 10.1111/j.1365-2699.2008.01975.x; [Anonymous], 1970, FLOR OF THAIL, V1-12; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Basset Y, 2000, BIOSCIENCE, V50, P899, DOI 10.1641/0006-3568(2000)050[0899:QBEWPA]2.0.CO;2; Basset Y, 2004, J APPL ECOL, V41, P163, DOI 10.1111/j.1365-2664.2004.00878.x; Beehler BM, 1994, TROPICAL BIODIVERSIT, V2, P333; BERLIN B, 1973, AM ANTHROPOL, V75, P214, DOI 10.1525/aa.1973.75.1.02a00140; BERLIN B, 1992, ETHNOBIOLOGICAL CLAS; de Lacerda AEB, 2010, FOREST ECOL MANAG, V259, P995, DOI 10.1016/j.foreco.2009.12.005; Boissiere M, 2014, FORESTS, V5, P1855, DOI 10.3390/f5081855; Brofeldt S, 2014, FORESTS, V5, P1834, DOI 10.3390/f5081834; Cardoso DBOS, 2010, J ETHNOBIOL, V30, P252, DOI 10.2993/0278-0771-30.2.252; CBD, 2011, CBD TECHN SER; Chalmers N, 2007, ECOL SOC, V12; CORLETT RT, 1994, J TROP ECOL, V10, P445, DOI 10.1017/S0266467400008129; Dalle SP, 2004, ECON BOT, V58, P38, DOI 10.1663/0013-0001(2004)058[0038:COUPAE]2.0.CO;2; Danielsen F, 2005, BIODIVERS CONSERV, V14, P2507, DOI 10.1007/s10531-005-8375-0; Danielsen F, 2005, BIODIVERS CONSERV, V9, P1671; Danielsen F, 2009, CONSERV BIOL, V23, P31, DOI 10.1111/j.1523-1739.2008.01063.x; Danielsen F, 2007, AMBIO, V36, P566, DOI 10.1579/0044-7447(2007)36[566:ICMABI]2.0.CO;2; Danielsen F, 2014, CONSERV LETT, V7, P380, DOI 10.1111/conl.12100; Danielsen F, 2014, BIOSCIENCE, V64, P236, DOI 10.1093/biosci/biu001; Danielsen F, 2013, ECOL SOC, V18, DOI 10.5751/ES-05464-180341; Danielsen F, 2011, CONSERV LETT, V4, P158, DOI 10.1111/j.1755-263X.2010.00159.x; Danielsen F, 2010, J APPL ECOL, V47, P1166, DOI 10.1111/j.1365-2664.2010.01874.x; Dickson B, 2012, CURR OPIN ENV SUST, V4, P717, DOI 10.1016/j.cosust.2012.09.017; Ellen R, 2008, ECON BOT, V62, P483, DOI 10.1007/s12231-008-9036-5; Epple C., 2011, MAKING BIODIVERSITY; Fleck David W., 2000, Journal of Ethnobiology, V20, P1; Fry B, 2011, ENVIRON SCI POLICY, V14, P181, DOI 10.1016/j.envsci.2010.12.004; Garcia NT, 2015, J ETHNOBIOL ETHNOMED, V11, P52, DOI [10.1186/s13002-015-0024-4, DOI 10.1186/S13002-015-0024-4]; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gardner TA, 2012, BIOL CONSERV, V154, P61, DOI 10.1016/j.biocon.2011.11.018; Gibson CC, 2005, WORLD DEV, V33, P273, DOI 10.1016/j.worlddev.2004.07.013; Gilmore MP, 2010, MAIJUNA PARTICIPATOR, P233; *GOFC GOLD, 2010, SOURC METH PROC MON; Gordon JE, 2006, FOREST ECOL MANAG, V237, P564, DOI 10.1016/j.foreco.2006.10.002; Halme KJ, 2007, BIODIVERS CONSERV, V16, P1785, DOI 10.1007/s10531-006-9071-4; Harrison ME, 2012, TROP CONSERV SCI, V5, P1; Hellier A, 1999, BIODIVERS CONSERV, V8, P869, DOI 10.1023/A:1008862005556; Hernandez-Stefanoni JL, 2006, ENVIRON MANAGE, V37, P686, DOI 10.1007/s00267-004-0371-8; Higgins MA, 2004, CONSERV BIOL, V18, P799, DOI 10.1111/j.1523-1739.2004.00235.x; Holman EW, 2002, J CLASSIF, V19, P131, DOI 10.1007/s00357-001-0036-8; Imai N, 2014, FOREST ECOL MANAG, V313, P169, DOI 10.1016/j.foreco.2013.10.041; Janzen DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018123; Janzen DH, 2004, J APPL ECOL, V41, P181, DOI 10.1111/j.1365-2664.2004.00879.x; Jinxiu W, 1992, CONSERV BIOL, V18, P1139; Kati V, 2004, CONSERV BIOL, V18, P667, DOI 10.1111/j.1523-1739.2004.00465.x; Larrazabal A, 2012, CURR OPIN ENV SUST, V4, P707, DOI 10.1016/j.cosust.2012.10.008; Martin G.J., 2004, ETHNOBOTANY METHODS; Martin GJ, 2002, PROJEK ETNOBOTANI KI; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naidoo R, 2006, ENVIRON MANAGE, V38, P377, DOI 10.1007/s00267-004-0338-9; Oldekop JA, 2011, BIODIVERS CONSERV, V20, P2615, DOI 10.1007/s10531-011-0094-0; Padmanaba M, 2013, ENVIRON MANAGE, V52, P348, DOI 10.1007/s00267-013-0051-7; Paoli Gary D, 2010, Carbon Balance Manag, V5, P7, DOI 10.1186/1750-0680-5-7; Pfeiffer Jeanine, 2003, Telopea, V10, P61; Phillips OL, 2003, J TROP ECOL, V19, P629, DOI 10.1017/S0266467403006035; Pitman N., 2011, SOCIAL BIODIVERSITY; Pitman NCA, 2011, J ETHNOBIOL, V31, P233, DOI 10.2993/0278-0771-31.2.233; Prance GT, 2000, ANN MO BOT GARD, V87, P67, DOI 10.2307/2666209; Pratihast AK, 2014, FORESTS, V5, P2464, DOI 10.3390/f5102464; Sheil D, 2004, TRENDS ECOL EVOL, V19, P634, DOI 10.1016/j.tree.2004.09.019; Shepard G.J, 2004, ADV EC BOT, V15, P133; Shepard Junior Glenn H., 2001, Journal of Ethnobiology, V21, P1; Skutsch M, 2011, COMMUNITY FOREST MON, P73; Su JC, 2004, CONSERV BIOL, V18, P167, DOI 10.1111/j.1523-1739.2004.00337.x; Sutherland WJ, 2014, ORYX, V48, P1, DOI 10.1017/S0030605313001543; The Climate Community & Biodiversity Alliance (CBBA), 2008, CLIM COMM BIOD PROJ; Theilade Ida, 2015, Carbon Balance Manag, V10, P17; Thompson ORR, 2013, ECOL SOC, V18, DOI 10.5751/ES-05239-180117; TORRECUADROS MA, 2003, J ETHNOBIOL, V23, P287; [UNEP] United Nations Environment Programme, 2012, 2 SESS PLEN M DET MO; UNFCCC, 2011, UNFCCCSBSTA2011L25; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Vergara-Asenjo G, 2015, CONSERV LETT, V8, P432, DOI 10.1111/conl.12161; Webb CO, 2010, BIODIVERS CONSERV, V19, P955, DOI 10.1007/s10531-010-9817-x; Webb EL, 2016, BIOTROPICA, V48, P132, DOI 10.1111/btp.12299; Wilkie P, 1999, BIODIVERS CONSERV, V8, P1457, DOI 10.1023/A:1008930012467; Zy W, FLORA CHINA, V1-25; Zy W, 1977, FLORA YUNNANICA, V1-16	83	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0152061	10.1371/journal.pone.0152061	http://dx.doi.org/10.1371/journal.pone.0152061			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814370	Green Published, Green Submitted, gold			2022-12-27	WOS:000386911100001
J	Amato, DW; Bishop, JM; Glenn, CR; Dulai, H; Smith, CM				Amato, Daniel W.; Bishop, James M.; Glenn, Craig R.; Dulai, Henrietta; Smith, Celia M.			Impact of Submarine Groundwater Discharge on Marine Water Quality and Reef Biota of Maui	PLOS ONE			English	Article							CORAL-REEFS; MACROALGAL BLOOMS; SEWAGE POLLUTION; KANEOHE BAY; NUTRIENT ENRICHMENT; PHYSICAL HABITAT; WASTE-WATER; ULVA SPP.; NITROGEN; DELTA-N-15	Generally unseen and infrequently measured, submarine groundwater discharge (SGD) can transport potentially large loads of nutrients and other land-based contaminants to coastal ecosystems. To examine this linkage we employed algal bioassays, benthic community analysis, and geochemical methods to examine water quality and community parameters of nearshore reefs adjacent to a variety of potential, land-based nutrient sources on Maui. Three common reef algae, Acanthophora spicifera, Hypnea musciformis, and Ulva spp. were collected and/or deployed at six locations with SGD. Algal tissue nitrogen (N) parameters (delta N-15, N %, and C:N) were compared with nutrient and delta N-15-nitrate values of coastal groundwater and nearshore surface water at all locations. Benthic community composition was estimated for ten 10-m transects per location. Reefs adjacent to sugarcane farms had the greatest abundance of macroalgae, low species diversity, and the highest concentrations of N in algal tissues, coastal groundwater, and marine surface waters compared to locations with low anthropogenic impact. Based on delta N-15 values of algal tissues, we estimate ca. 0.31 km(2) of Kahului Bay is impacted by effluent injected underground at the Kahului Wastewater Reclamation Facility (WRF); this region is barren of corals and almost entirely dominated by colonial zoanthids. Significant correlations among parameters of algal tissue N with adjacent surface and coastal groundwater N indicate that these bioassays provided a useful measure of nutrient source and loading. A conceptual model that uses Ulva spp. tissue delta N-15 and N% to identify potential N source(s) and relative N loading is proposed for Hawai'i. These results indicate that SGD can be a significant transport pathway for land-based nutrients with important biogeochemical and ecological implications in tropical, oceanic islands.	[Amato, Daniel W.; Smith, Celia M.] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA; [Bishop, James M.; Glenn, Craig R.; Dulai, Henrietta] Univ Hawaii Manoa, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Bishop, James M.] US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; United States Department of the Interior; United States Geological Survey	Amato, DW (corresponding author), Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA.	dwamato@hawaii.edu	Dulai, Henrietta/AAY-9632-2020	Dulai, Henrietta/0000-0001-5970-1483; Bishop, James/0000-0001-9394-4008; Amato, Daniel/0000-0003-0265-7711	National Oceanic and Atmospheric Administration [R/HE-17, R/SB-12, R/WR-2]; University of Hawaii Sea Grant College Program, SOEST from NOAA Office of Sea Grant, Department of Commerce [NA09OAR4170060, NA140AR4170071]; STAR Fellowship [FP-91727301-2]; U.S. Environmental Protection Agency; Office of Integrative Activities [1557349] Funding Source: National Science Foundation	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Hawaii Sea Grant College Program, SOEST from NOAA Office of Sea Grant, Department of Commerce; STAR Fellowship; U.S. Environmental Protection Agency(United States Environmental Protection Agency); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This paper is funded in part by a grant/ cooperative agreement from the National Oceanic and Atmospheric Administration, Project R/HE-17, R/SB-12, R/WR-2, which is sponsored by the University of Hawaii Sea Grant College Program, SOEST, under Institutional Grant No. NA09OAR4170060, NA140AR4170071 from NOAA Office of Sea Grant, Department of Commerce. The views expressed herein are those of the author(s) and do not necessarily reflect the views of NOAA or any of its subagencies; UNIHI-SEAGRANT-JC-14-42; http://seagrant.soest.hawaii.edu/research-0. Daniel W. Amato was supported by a STAR Fellowship Assistance Agreement no. FP-91727301-2, awarded by the U.S. Environmental Protection Agency. The EPA has not formally reviewed the work and does not endorse any products or commercial services mentioned in this publication; https://cfpub.epa.gov/ncer_abstracts/index.cfm/fuseaction/display.abstractDetail/abstract/9899/report/0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1978, STABLE ISOT EARTH SC; ATKINSON MJ, 1983, LIMNOL OCEANOGR, V28, P568, DOI 10.4319/lo.1983.28.3.0568; Barr NG, 2013, MAR POLLUT BULL, V67, P203, DOI 10.1016/j.marpolbul.2012.11.033; Bird CE, 2001, PHOTOGRID BETA 1 0; Bishop JM, 2017, J HYDROL-REG STUD, V11, P194, DOI 10.1016/j.ejrh.2015.10.008; Brown Eric, 2004, Pacific Science, V58, P145, DOI 10.1353/psc.2004.0013; Burnett WC, 2003, BIOGEOCHEMISTRY, V66, P3, DOI 10.1023/B:BIOG.0000006066.21240.53; Burnham WL, 1977, 77469 US GEOL SURV; Casciotti KL, 2008, DEEP-SEA RES PT II, V55, P1661, DOI 10.1016/j.dsr2.2008.04.017; Cole ML, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003269; Conklin EJ, 2005, BIOL INVASIONS, V7, P1029, DOI 10.1007/s10530-004-3125-x; Costa OS, 2008, J S AM EARTH SCI, V25, P257, DOI 10.1016/j.jsames.2007.10.002; Costanzo SD, 2005, MAR POLLUT BULL, V51, P212, DOI 10.1016/j.marpolbul.2004.10.018; Costanzo SD, 2000, J PHYCOL, V36, P680, DOI 10.1046/j.1529-8817.2000.99180.x; Cox TE, 2013, MAR POLLUT BULL, V71, P92, DOI 10.1016/j.marpolbul.2013.03.030; Dailer M, 2013, PREVENTING INTRO SPR; Dailer ML, 2012, HARMFUL ALGAE, V17, P111, DOI 10.1016/j.hal.2012.03.008; Dailer ML, 2012, MAR POLLUT BULL, V64, P207, DOI 10.1016/j.marpolbul.2011.12.004; Dailer ML, 2010, MAR POLLUT BULL, V60, P655, DOI 10.1016/j.marpolbul.2009.12.021; Derse E, 2007, ENVIRON SCI TECHNOL, V41, P5217, DOI 10.1021/es0700449; DLNR-DAR UH-CRAMP, 2013, LONG TERM BENTH COV; Dollar S., 2011, EVALUATION CAUSAL FA; Dollar S, 1997, ALGAL BLOOMS W MAUI; Dulai H, 2016, J RADIOANAL NUCL CH, V307, P1865, DOI 10.1007/s10967-015-4580-9; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fertig B, 2009, ESTUAR COAST, V32, P773, DOI 10.1007/s12237-009-9148-x; Fong P, 2004, AQUAT BOT, V78, P83, DOI 10.1016/j.aquabot.2003.09.006; Friedlander Alan, 2008, NOAA Technical Memorandum NOS NCCOS, V73, P219; Friedlander AM, 2007, ECOL APPL, V17, P715, DOI 10.1890/06-0536; Garrison GH, 2003, LIMNOL OCEANOGR, V48, P920, DOI 10.4319/lo.2003.48.2.0920; Gaw S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0572; Glenn C.R., 2013, LAHAINA GROUNDWATER; Glenn C.R., 2012, LAHAINA GROUNDWATER; Gonzalez FUT, 2008, ESTUAR COAST SHELF S, V76, P418, DOI 10.1016/j.ecss.2007.07.025; Granger J, 2006, LIMNOL OCEANOGR-METH, V4, P205, DOI 10.4319/lom.2006.4.205; HEATON THE, 1986, CHEM GEOL, V59, P87, DOI [10.1016/0168-9622(86)90059-X, 10.1016/0009-2541(86)90046-X]; Hernandez-Delgado E, 2008, 11 INT COR REEF S FO; Hunt CD, 2009, 20095253 US GEOL SUR; HUNTER CL, 1995, B MAR SCI, V57, P501; Johnson AG, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034574; Jokiel PL, 2008, CORAL REEF ASSESSMEN; Kendall C, 2007, ECOL METHOD CONCEPT, P375, DOI 10.1002/9780470691854.ch12; Kim CJS, 2014, LINKING SEWAGE POLLU; LAPOINTE BE, 1992, ESTUARIES, V15, P465, DOI 10.2307/1352391; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; Lapointe BE, 2010, MAR POLLUT BULL, V60, P334, DOI 10.1016/j.marpolbul.2009.10.020; Laroche J, 1997, GLOB CHANGE BIOL, V3, P397, DOI 10.1046/j.1365-2486.1997.00117.x; Laws EA, 2004, INT J ENVIRON POLLUT, V22, P531, DOI 10.1504/IJEP.2004.005908; Laws EA., 2000, AQUATIC POLLUTION IN, V3; Lecher AL, 2015, ENVIRON SCI TECHNOL, V49, P6665, DOI 10.1021/acs.est.5b00909; Lee YW, 2007, ESTUAR COAST SHELF S, V71, P309, DOI 10.1016/j.ecss.2006.08.004; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; Lyons DA, 2014, GLOBAL CHANGE BIOL, V20, P2712, DOI 10.1111/gcb.12644; Martinez JA, 2012, ESTUAR COAST SHELF S, V99, P42, DOI 10.1016/j.ecss.2011.12.022; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Meador JP, 2016, ENVIRON POLLUT, V213, P254, DOI 10.1016/j.envpol.2016.01.088; Moynihan MA, 2012, MAR POLLUT BULL, V64, P1348, DOI 10.1016/j.marpolbul.2012.05.001; NAIM O, 1993, MAR ECOL PROG SER, V99, P137; Nishimura N., 2000, THESIS; O'Kelly CJ, 2010, J PHYCOL, V46, P728, DOI 10.1111/j.1529-8817.2010.00860.x; OWENS NJP, 1987, ADV MAR BIOL, V24, P389; Paerl HW, 2013, MICROB ECOL, V65, P995, DOI 10.1007/s00248-012-0159-y; Paytan A, 2006, LIMNOL OCEANOGR, V51, P343, DOI 10.4319/lo.2006.51.1.0343; Prichard E, 2016, ENVIRON SCI POLLUT R, V23, P22365, DOI 10.1007/s11356-016-7282-0; Riera P, 2000, ESTUAR COAST SHELF S, V51, P365, DOI 10.1006/ecss.2000.0684; Risk MJ, 2014, CURR OPIN ENV SUST, V7, P108, DOI 10.1016/j.cosust.2014.01.003; Risk MJ, 2009, MAR POLLUT BULL, V58, P793, DOI 10.1016/j.marpolbul.2009.02.008; Rodgers KS, 2015, PAC SCI, V69, P1, DOI 10.2984/69.1.1; Savage C, 2004, ECOL APPL, V14, P517, DOI 10.1890/02-5396; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Slomp CP, 2004, J HYDROL, V295, P64, DOI 10.1016/j.jhydrol.2004.02.018; Smith JE, 2005, MAR ECOL PROG SER, V302, P77, DOI 10.3354/meps302077; Smith JE, 2003, J PHYCOL, V39, P53, DOI [10.1111/j.0022-3646.2003.03906001_152.x, DOI 10.1111/J.0022-3646.2003.03906001_153.X]; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Smith Jennifer E., 2004, Pacific Science, V58, P325, DOI 10.1353/psc.2004.0023; Smith Jennifer E., 2002, Pacific Science, V56, P299, DOI 10.1353/psc.2002.0030; SMITH SV, 1981, PAC SCI, V35, P279; Soicher A. J., 1997, Pacific Science, V51, P221; State of Hawai`i Office of Planning, 2014, HAW STAT GIS PROGR; Teichberg M, 2010, GLOBAL CHANGE BIOL, V16, P2624, DOI 10.1111/j.1365-2486.2009.02108.x; Umezawa Y, 2002, LIMNOL OCEANOGR, V47, P1405, DOI 10.4319/lo.2002.47.5.1405; van Beukering Pieter J. H., 2004, Pacific Science, V58, P243, DOI 10.1353/psc.2004.0012; Van Houtan KS, 2014, PEERJ, V2, DOI 10.7717/peerj.602; WALSH GE, 1971, ZOOL J LINN SOC-LOND, V50, P161, DOI 10.1111/j.1096-3642.1971.tb00757.x; Walsh W, 2010, LONG TERM MONITORING; Wear SL, 2015, ANN NY ACAD SCI, V1355, P15, DOI 10.1111/nyas.12785; Welti N, 2015, ESTUAR COAST SHELF S, V163, P116, DOI 10.1016/j.ecss.2015.06.006; Whittier R.B., 2014, HUMAN HLTH ENV RISK; Yoshioka RM, 2016, MAR POLLUT BULL, V104, P313, DOI 10.1016/j.marpolbul.2016.01.002; Zhang J, 2012, CURR OPIN ENV SUST, V4, P219, DOI 10.1016/j.cosust.2012.03.006	93	67	69	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165825	10.1371/journal.pone.0165825	http://dx.doi.org/10.1371/journal.pone.0165825			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812171	gold, Green Published, Green Submitted			2022-12-27	WOS:000386910000067
J	Cho, KS; Park, MK; Mun, SJ; Park, HY; Yu, HS; Roh, HJ				Cho, Kyu-Sup; Park, Mi-Kyung; Mun, Sue-Jean; Park, Hee-Young; Yu, Hak-Sun; Roh, Hwan-Jung			Indoleamine 2,3-Dioxygenase Is Not a Pivotal Regulator Responsible for Suppressing Allergic Airway Inflammation through Adipose-Derived Stem Cells	PLOS ONE			English	Article							KIDNEY ALLOGRAFT TOLERANCE; T-CELLS; DENDRITIC CELLS; MOUSE MODEL; TRYPTOPHAN DEGRADATION; IDO; ASTHMA; EXPRESSION; INDUCTION; MICE	Background Although indoleamine 2,3-dioxygenase (IDO)-mediated immune suppression of mesenchymal stem cells (MSCs) has been revealed in septic and tumor microenvironments, the role of IDO in suppressing allergic airway inflammation by MSCs is not well documented. We evaluated the effects of adipose-derived stem cells (ASCs) on allergic inflammation in IDO-knockout (KO) asthmatic mice or asthmatic mice treated with ASCs derived from IDO-KO mice. Methods and Findings ASCs were injected intravenously in wild-type (WT) and IDO-KO asthmatic mice. Furthermore, asthmatic mice were injected with ASCs derived from IDO-KO mice. We investigated the immunomodulatory effects of ASCs between WT and IDO-KO mice or IDO-KO ASCs in asthmatic mice. In asthmatic mice, ASCs significantly reduced airway hyperresponsiveness, the number of total inflammatory cells and eosinophils in bronchoalveolar lavage fluid (BALF), eosinophilic inflammation, goblet hyperplasia, and serum concentrations of total and allergen-specific IgE and IgG1. ASCs significantly inhibited Th2 cytokines, such as interleukin (IL)-4, IL-5, and IL-13, and enhanced Th1 cytokine (interferon-gamma) and regulatory cytokines (IL-10, TGF-beta) in BALF and lung draining lymph nodes (LLNs). ASCs led to significant increases in regulatory T-cells (Tregs) and IL-10(+) T cell populations in LLNs. However, the immunosuppressive effects of ASCs did not significantly differ between WT and IDO-KO mice. Moreover, ASCs derived from IDO-KO mice showed immunosuppressive effects in allergic airway inflammation. Conclusions IDO did not play a pivotal role in the suppression of allergic airway inflammation through ASCs, suggesting that it is not the major regulator responsible for suppressing allergic airway inflammation.	[Cho, Kyu-Sup; Park, Hee-Young] Pusan Natl Univ Hosp, Dept Otorhinolaryngol, Busan, South Korea; [Cho, Kyu-Sup; Park, Hee-Young] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Park, Mi-Kyung; Yu, Hak-Sun] Pusan Natl Univ, Dept Parasitol, Sch Med, Yangsan, South Korea; [Mun, Sue-Jean; Roh, Hwan-Jung] Pusan Natl Univ, Yangsan Hosp, Dept Otorhinolaryngol, Yangsan, South Korea; [Mun, Sue-Jean; Roh, Hwan-Jung] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Roh, HJ (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Otorhinolaryngol, Yangsan, South Korea.; Roh, HJ (corresponding author), Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea.	rohhj@pusan.ac.kr			Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and future Planning [NRF-2014R1A2A1A11053502]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and future Planning (NRF-2014R1A2A1A11053502. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Ball HJ, 2009, INT J BIOCHEM CELL B, V41, P467, DOI 10.1016/j.biocel.2008.01.005; Beutelspacher SC, 2006, AM J TRANSPLANT, V6, P1320, DOI 10.1111/j.1600-6143.2006.01324.x; Bonfield TL, 2010, AM J PHYSIOL-LUNG C, V299, pL760, DOI 10.1152/ajplung.00182.2009; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Castro-Manrreza ME, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/394917; Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245; Chaves ACL, 2001, EUR J IMMUNOL, V31, P333, DOI 10.1002/1521-4141(200102)31:2&lt;333::AID-IMMU333&gt;3.0.CO;2-X; Cho KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131813; Cho KS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/436476; Cho KS, 2010, CURR STEM CELL RES T, V5, P111, DOI 10.2174/157488810791268681; Cho KS, 2009, STEM CELLS, V27, P259, DOI 10.1634/stemcells.2008-0283; Ciccocioppo R, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0122-1; Croitoru-Lamoury J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014698; Cui L, 2007, TISSUE ENG, V13, P1185, DOI 10.1089/ten.2006.0315; Curti A, 2009, BLOOD, V113, P2394, DOI 10.1182/blood-2008-07-144485; Ebrahimi A, 2016, GENE, V576, P412, DOI 10.1016/j.gene.2015.10.054; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fu JJ, 2014, INFLAMM RES, V63, P357, DOI 10.1007/s00011-014-0707-7; Fu QL, 2012, ALLERGY, V67, P1215, DOI [10.1111/j.1398-9995.2012.02875.x, 10.1111/j.1398-9995.2012.02875.x.]; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; Ge XH, 2013, CELL BIOL INT, V37, P675, DOI 10.1002/cbin.10084; Goodwin M, 2011, STEM CELLS, V29, P1137, DOI 10.1002/stem.656; Hayashi T, 2004, J CLIN INVEST, V114, P270, DOI 10.1172/JCI200421275; He Y, 2015, TRANSPLANTATION, V99, P1829, DOI 10.1097/TP.0000000000000856; Jaffar Z, 2004, J IMMUNOL, V172, P3842, DOI 10.4049/jimmunol.172.6.3842; Kang JH, 2009, AM J RESP CRIT CARE, V179, P875, DOI 10.1164/rccm.200806-893OC; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lee YE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144298; Ling WF, 2014, CANCER RES, V74, P1576, DOI 10.1158/0008-5472.CAN-13-1656; Luo CF, 2014, CURR STEM CELL RES T, V9, P36; Matysiak M, 2008, J NEUROIMMUNOL, V193, P12, DOI 10.1016/j.jneuroim.2007.07.025; Mbongue JC, 2015, VACCINES-BASEL, V3, P703, DOI 10.3390/vaccines3030703; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Moingeon P, 2006, ALLERGY, V61, P151, DOI 10.1111/j.1398-9995.2006.01002.x; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Odemuyiwa SO, 2004, J IMMUNOL, V173, P5909, DOI 10.4049/jimmunol.173.10.5909; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Park HK, 2010, STEM CELLS DEV, V19, P1811, DOI 10.1089/scd.2009.0513; Pellaton-Longaretti C, 2011, INT IMMUNOL, V23, P17, DOI 10.1093/intimm/dxq453; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Shi HZ, 2005, ALLERGY, V60, P986, DOI 10.1111/j.1398-9995.2005.00844.x; Spaggiari GM, 2013, IMMUNOL CELL BIOL, V91, P27, DOI 10.1038/icb.2012.62; Sucher R, 2010, INT J TRYPTOPHAN RES, V3, P113; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Taher YA, 2008, J ALLERGY CLIN IMMUN, V121, P983, DOI 10.1016/j.jaci.2007.11.021; Tournoy KG, 2000, CLIN EXP ALLERGY, V30, P79; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; von Bubnoff D, 2012, ALLERGY, V67, P718, DOI 10.1111/j.1398-9995.2012.02830.x; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Xu H, 2008, P NATL ACAD SCI USA, V105, P6690, DOI 10.1073/pnas.0708809105	56	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165661	10.1371/journal.pone.0165661	http://dx.doi.org/10.1371/journal.pone.0165661			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812173	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000044
J	Samarasinghe, SAPL; Shao, Y; Huang, PJ; Pishko, M; Chu, KH; Kameoka, J				Samarasinghe, S. A. P. L.; Shao, Yiru; Huang, Po-Jung; Pishko, Michael; Chu, Kung-Hui; Kameoka, Jun			Fabrication of Bacteria Environment Cubes with Dry Lift-Off Fabrication Process for Enhanced Nitrification	PLOS ONE			English	Article							SECRETING HEK293 CELLS; MICROFLUIDIC CHIP; CALCIUM ALGINATE; STEM-CELLS; I COLLAGEN; MONODISPERSE; GROWTH; SHAPE; MICROENVIRONMENT; DIFFERENTIATION	We have developed a 3D dry lift-off process to localize multiple types of nitrifying bacteria in polyethylene glycol diacrylate (PEGDA) cubes for enhanced nitrification, a two-step biological process that converts ammonium to nitrite and then to nitrate. Ammonia-oxidizing bacteria (AOB) is responsible for converting ammonia into nitrite, and nitrite-oxidizing bacteria (NOB) is responsible for converting nitrite to nitrate. Successful nitrification is often challenging to accomplish, in part because AOB and NOB are slow growers and highly susceptible to many organic and inorganic chemicals in wastewater. Most importantly, the transportation of chemicals among scattered bacteria is extremely inefficient and can be problematic. For example, nitrite, produced from ammonia oxidation, is toxic to AOB and can lead to the failure of nitrification. To address these challenges, we closely localize AOB and NOB in PEGDA cubes as microenvironment modules to promote synergetic interactions. The AOB is first localized in the vicinity of the surface of the PEGDA cubes that enable AOB to efficiently uptake ammonia from a liquid medium and convert it into nitrite. The produced nitrite is then efficiently transported to the NOB localized at the center of the PEGDA particle and converted into non-toxic nitrate. Additionally, the nanoscale PEGDA fibrous structures offer a protective environment for these strains, defending them from sudden toxic chemical shocks and immobilize in cubes. This engineered microenvironment cube significantly enhances nitrification and improves the overall ammonia removal rate per single AOB cell. This approach D encapsulation of multiple strains at close range in cube in order to control their interactions D not only offers a new strategy for enhancing nitrification, but also can be adapted to improve the production of fermentation products and biofuel, because microbial processes require synergetic reactions among multiple species.	[Samarasinghe, S. A. P. L.; Kameoka, Jun] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA; [Shao, Yiru; Chu, Kung-Hui] Texas A&M Univ, Zachry Dept Civil Engn, College Stn, TX USA; [Huang, Po-Jung; Kameoka, Jun] Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA; [Pishko, Michael] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA; [Samarasinghe, S. A. P. L.] Wisenbaker Engn Bldg,3128 TAMU,188 Bizzell St, College Stn, TX 77843 USA; [Shao, Yiru] CE Off Bldg,3136 TAMU,199 Spence St, College Stn, TX 77843 USA; [Huang, Po-Jung] Reed McDonald Bldg,575 Ross St, College Stn, TX 77840 USA; [Pishko, Michael] Emerging Technol Bldg,3120 TAMU,101 Bizzell St, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Kameoka, J (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.; Kameoka, J (corresponding author), Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA.	kameoka@ece.tamu.edu	Chu, Kung-Hui/C-4162-2016; Kameoka, Jun/AAW-7910-2021; Huang, Po-Jung/R-7595-2018	Chu, Kung-Hui/0000-0002-4212-1789; Huang, Po-Jung/0000-0003-1273-3060; Kameoka, Jun/0000-0003-3479-354X	NIH-NCRR [1S10RR22532-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022532] Funding Source: NIH RePORTER	NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The imaging work was partially supported by NIH-NCRR (1S10RR22532-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya G, 2010, J CONTROL RELEASE, V141, P314, DOI 10.1016/j.jconrel.2009.09.032; Bashan Y, 1998, BIOTECHNOL ADV, V16, P729, DOI 10.1016/S0734-9750(98)00003-2; Berman T, 1999, J PLANKTON RES, V21, P1423, DOI 10.1093/plankt/21.8.1423; Brown A. B. D., 2000, PHYS REV E, V62; Chan BP, 2007, BIOMATERIALS, V28, P4652, DOI 10.1016/j.biomaterials.2007.07.041; Chan-Park MB, 2003, LANGMUIR, V19, P4371, DOI 10.1021/la026967t; Chen CH, 2009, ADV MATER, V21, P3201, DOI 10.1002/adma.200900499; Cheng HW, 2011, BIOMATERIALS, V32, P1526, DOI 10.1016/j.biomaterials.2010.10.021; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; Dendukuri D, 2006, NAT MATER, V5, P365, DOI 10.1038/nmat1617; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3; Dong YW, 2014, ECOL ENG, V73, P809, DOI 10.1016/j.ecoleng.2014.09.020; Endres H.J., 2009, TECHNISCHE BIOPOLYME, P152; Garcia J, 2006, BIORESOURCE TECHNOL, V97, P1709, DOI 10.1016/j.biortech.2005.07.019; Gauvin R, 2012, WIRES NANOMED NANOBI, V4, P235, DOI 10.1002/wnan.171; Hatakeyama H, 2010, ADV POLYM SCI, V232, P1, DOI 10.1007/12_2009_12; Heo YJ, 2011, P NATL ACAD SCI USA, V108, P13399, DOI 10.1073/pnas.1104954108; Ho Choi Jin, 2014, [Journal of the Korean Society for Precision Engineering, 한국정밀공학회지], V31, P743, DOI 10.7736/KSPE.2014.31.8.743; Hong SM, 2012, LAB CHIP, V12, P3277, DOI 10.1039/c2lc40558j; Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0; Hwang DK, 2008, LAB CHIP, V8, P1640, DOI 10.1039/b805176c; Koh WG, 2002, LANGMUIR, V18, P2459, DOI 10.1021/la0115740; Lee M, 2009, BIOMATERIALS, V30, P1214, DOI 10.1016/j.biomaterials.2008.11.017; Lee NY, 2006, LANGMUIR, V22, P9018, DOI 10.1021/la060790b; Li YY, 2014, TISSUE ENG PT A, V20, P1379, DOI [10.1089/ten.tea.2013.0498, 10.1089/ten.TEA.2013.0498]; McGuigan AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002258; Mi L, 2011, ADV FUNCT MATER, V21, P4028, DOI 10.1002/adfm.201100871; Obst M, 2004, BIOMACROMOLECULES, V5, P1166, DOI 10.1021/bm049949u; Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002; Othmer K., 2000, ENCY CHEM TECHNOLOGY, P22950; Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863; Peteu SF, 2010, POLYMERS-BASEL, V2, P229, DOI 10.3390/polym2030229; Randall C.W., 1998, DESIGN RETROFIT WAST, V5, P434; Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c; Stachowiak AN, 2008, J BIOMED MATER RES A, V85A, P815, DOI 10.1002/jbm.a.31661; Sudarno U, 2011, BIORESOURCE TECHNOL, V102, P5665, DOI 10.1016/j.biortech.2011.02.078; Tan YC, 2006, SENSOR ACTUAT B-CHEM, V114, P350, DOI 10.1016/j.snb.2005.06.008; Tarre S, 2004, APPL ENVIRON MICROB, V70, P6481, DOI 10.1128/AEM.70.11.6481-6487.2004; Wandrey C, 2010, ENCAPSULATION TECHNOLOGIES FOR ACTIVE FOOD INGREDIENTS AND FOOD PROCESSING, P31, DOI 10.1007/978-1-4419-1008-0_3; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wong HL, 2007, BIOMATERIALS, V28, P5369, DOI 10.1016/j.biomaterials.2007.08.016; Xu SQ, 2005, ANGEW CHEM INT EDIT, V44, P724, DOI 10.1002/anie.200462226; Yang L, 2008, BIOPHYS J, V94, P2204, DOI 10.1529/biophysj.107.111013; Yao L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt320; Yeh CH, 2009, SENSOR ACTUAT A-PHYS, V151, P231, DOI 10.1016/j.sna.2009.02.036; Yeung CW, 2009, TISSUE ENG PT A, V15, P3071, DOI [10.1089/ten.tea.2008.0661, 10.1089/ten.TEA.2008.0661]; Yu B, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/9/095016	48	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165839	10.1371/journal.pone.0165839	http://dx.doi.org/10.1371/journal.pone.0165839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812154	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000068
J	van de Garde, MDB; Movita, D; van der Heide, M; Herschke, F; De Jonghe, S; Gama, L; Boonstra, A; Vanwolleghem, T				van de Garde, Martijn D. B.; Movita, Dowty; van der Heide, Marieke; Herschke, Florence; De Jonghe, Sandra; Gama, Lucio; Boonstra, Andre; Vanwolleghem, Thomas			Liver Monocytes and Kupffer Cells Remain Transcriptionally Distinct during Chronic Viral Infection	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; HEPATITIS-B; GENE-EXPRESSION; T-CELLS; IN-VIVO; INFLAMMATION; PERSISTENCE; INTERFERON; GLYCOPROTEIN; SUPPRESSION	Due to the scarcity of immunocompetent animal models for chronic viral hepatitis, little is known about the role of the innate intrahepatic immune system during viral replication in the liver. These insights are however fundamental for the understanding of the inappropriate adaptive immune responses during the chronic phase of the infection. We apply the Lymphocytic Choriomenigitis Virus (LCMV) clone 13 mouse model to examine chronic virus-host interactions of Kupffer cells (KC) and infiltrating monocytes (IM) in an infected liver. LCMV infection induced overt clinical hepatitis, with rise in ALT and serum cytokines, and increased intrahepatic F4/80 expression. Despite ongoing viral replication, whole liver transcriptome showed baseline expression levels of inflammatory cytokines, interferons, and interferon induced genes during the chronic infection phase. Transcriptome analyses of sorted KC and IMs using NanoString technology revealed two unique phenotypes with only minimal overlap. At the chronic viral infection phase, KC showed no increased transcription of activation markers Cd80 and Cd86, but an increased expression of genes related to antigen presentation, whereas monocytes were more activated and expressed higher levels of Tnf transcripts. Although both KCs and intrahepatic IM share the surface markers F4/80 and CD11b, their transcriptomes point towards distinctive roles during virus-induced chronic hepatitis.	[van de Garde, Martijn D. B.; Movita, Dowty; van der Heide, Marieke; Boonstra, Andre; Vanwolleghem, Thomas] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Herschke, Florence; De Jonghe, Sandra] Janssen Pharmaceut NV, Beerse, Belgium; [Gama, Lucio] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA	Erasmus University Rotterdam; Erasmus MC; Johnson & Johnson; Janssen Pharmaceuticals; Johns Hopkins University	Vanwolleghem, T (corresponding author), Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	t.vanwolleghem@erasmusmc.nl	Vanwolleghem, Thomas/AAD-4094-2022	Vanwolleghem, Thomas/0000-0002-0572-8741; van de Garde, Martijn/0000-0003-0509-7713; Boonstra, Andre/0000-0001-8607-1616	Virgo consortium; Dutch government [FES0908]; Janssen Infectious Diseases Diagnostics BVBA project ICD [551306]; Erasmus MC Fellowship; mandate of the Belgian Foundation Against Cancer [2014-087]	Virgo consortium; Dutch government; Janssen Infectious Diseases Diagnostics BVBA project ICD; Erasmus MC Fellowship; mandate of the Belgian Foundation Against Cancer	This study was supported by the Virgo consortium, funded by the Dutch government project number FES0908, and by the research collaboration with Janssen Infectious Diseases Diagnostics BVBA project number ICD#551306. TV is supported by an Erasmus MC Fellowship 2011 and a mandate of the Belgian Foundation Against Cancer (2014-087). FH and SdJ are employees of Janssen-Pharmaceutica NV. The funder provided support in the form of salaries for authors FH and SdJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bhattacharya A, 2015, IMMUNITY, V43, P974, DOI 10.1016/j.immuni.2015.10.013; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Boltjes A, 2015, J INFECT DIS, V211, P1268, DOI 10.1093/infdis/jiu599; Boltjes A, 2014, J HEPATOL, V61, P660, DOI 10.1016/j.jhep.2014.04.026; Boltjes A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097006; Chen LM, 2010, GASTROENTEROLOGY, V138, P1123, DOI 10.1053/j.gastro.2009.10.046; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; Heymann F, 2015, HEPATOLOGY, V62, P279, DOI 10.1002/hep.27793; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; LOHLER J, 1994, LAB INVEST, V70, P263; MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993; Movita D, 2015, J VIROL, V89, P4809, DOI 10.1128/JVI.03733-14; Noel N, 2014, AIDS, V28, P467, DOI 10.1097/QAD.0000000000000174; Norris BA, 2013, IMMUNITY, V38, P309, DOI 10.1016/j.immuni.2012.10.022; Peppa D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001227; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; SALVATO M, 1991, J VIROL, V65, P1863, DOI 10.1128/JVI.65.4.1863-1869.1991; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wu JF, 2010, GASTROENTEROLOGY, V138, DOI DOI 10.1053/J.GASTRO.2009.09.018; Xia YC, 2016, GASTROENTEROLOGY, V150, P194, DOI 10.1053/j.gastro.2015.09.026; Zhou X, 2012, VIRUSES-BASEL, V4, P2650, DOI 10.3390/v4112650; ZINKERNAGEL RM, 1986, J EXP MED, V164, P1075, DOI 10.1084/jem.164.4.1075	33	8	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166094	10.1371/journal.pone.0166094	http://dx.doi.org/10.1371/journal.pone.0166094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812182	Green Submitted, gold, Green Published			2022-12-27	WOS:000386910000101
J	Barai, P; Kumar, A; Mukherjee, PP				Barai, Pallab; Kumar, Aloke; Mukherjee, Partha P.			Modeling of Mesoscale Variability in Biofilm Shear Behavior	PLOS ONE			English	Article							MICROFLUIDIC DEVICE; FINITE-ELEMENT; FRACTURE; STREAMERS; TRANSPORT; MATRIX; ELASTICITY; MECHANICS; STRENGTH; SYSTEMS	Formation of bacterial colonies as biofilm on the surface/interface of various objects has the potential to impact not only human health and disease but also energy and environmental considerations. Biofilms can be regarded as soft materials, and comprehension of their shear response to external forces is a key element to the fundamental understanding. A mesoscale model has been presented in this article based on digitization of a biofilm microstructure. Its response under externally applied shear load is analyzed. Strain stiffening type behavior is readily observed under high strain loads due to the unfolding of chains within soft polymeric substrate. Sustained shear loading of the biofilm network results in strain localization along the diagonal direction. Rupture of the soft polymeric matrix can potentially reduce the intercellular interaction between the bacterial cells. Evolution of stiffness within the biofilm network under shear reveals two regimes: a) initial increase in stiffness due to strain stiffening of polymer matrix, and b) eventual reduction in stiffness because of tear in polymeric substrate.	[Barai, Pallab; Mukherjee, Partha P.] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA; [Kumar, Aloke] Univ Alberta, Dept Mech Engn, Edmonton, AB, Canada; [Barai, Pallab] Lawrence Berkeley Natl Lab, Energy Storage & Distributed Resources Div, Berkeley, CA USA	Texas A&M University System; Texas A&M University College Station; University of Alberta; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Mukherjee, PP (corresponding author), Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA.; Kumar, A (corresponding author), Univ Alberta, Dept Mech Engn, Edmonton, AB, Canada.	aloke.kumar@ualberta.ca; pmukherjee@tamu.edu			Texas A&M University, Faculty Research Initiation Grant	Texas A&M University, Faculty Research Initiation Grant	This work was supported by Texas A&M University, Faculty Research Initiation Grant to PPM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support from Texas A&M University faculty research initiation grant is gratefully acknowledged.	Aggarwal S, 2012, LANGMUIR, V28, P2812, DOI 10.1021/la204342q; Aravas N, 2008, BIOTECHNOL BIOENG, V101, P196, DOI 10.1002/bit.21865; Arnoldi M, 2000, PHYS REV E, V62, P1034, DOI 10.1103/PhysRevE.62.1034; ARRUDA EM, 1993, J MECH PHYS SOLIDS, V41, P389, DOI 10.1016/0022-5096(93)90013-6; BISHOP PL, 1995, WATER SCI TECHNOL, V31, P143, DOI 10.1016/0273-1223(95)00162-G; Brown HR, 2007, MACROMOLECULES, V40, P3815, DOI 10.1021/ma062642y; Buehler MJ, 2007, J MECH MATER STRUCT, V2, P1019, DOI 10.2140/jomms.2007.2.1019; Buehler MJ, 2007, MATER TODAY, V10, P46, DOI 10.1016/S1369-7021(07)70208-0; Buxton GA, 2001, MODEL SIMUL MATER SC, V9, P485, DOI 10.1088/0965-0393/9/6/302; Cerf A, 2009, LANGMUIR, V25, P5731, DOI 10.1021/la9004642; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; Das S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07126; Drescher K, 2013, P NATL ACAD SCI USA, V110, P4345, DOI 10.1073/pnas.1300321110; Duddu R, 2008, INT J NUMER METH ENG, V74, P848, DOI 10.1002/nme.2200; Ehret AE, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0676; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Ghosh R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114613; HASHIN Z, 1963, J MECH PHYS SOLIDS, V11, P127, DOI 10.1016/0022-5096(63)90060-7; Hassanpourfard M, 2015, 2015150400098 ARXIV; Hohne DN, 2009, LANGMUIR, V25, P7743, DOI 10.1021/la803413x; Horn H, 2014, ADV BIOCHEM ENG BIOT, V146, P53, DOI 10.1007/10_2014_275; Houry A, 2012, P NATL ACAD SCI USA, V109, P13088, DOI 10.1073/pnas.1200791109; Karimi A, 2015, LAB CHIP, V15, P23, DOI 10.1039/c4lc01095g; Khoo X, 2011, MRS BULL, V36, P357, DOI 10.1557/mrs.2011.66; Kim JW, 2010, WATER RES, V44, P1193, DOI 10.1016/j.watres.2009.05.049; Klapper I, 2002, BIOTECHNOL BIOENG, V80, P289, DOI 10.1002/bit.10376; Korstgens V, 2001, J MICROBIOL METH, V46, P9, DOI 10.1016/S0167-7012(01)00248-2; Kumar A, 2013, MICROFLUID NANOFLUID, V14, P895, DOI 10.1007/s10404-012-1120-6; Kumar A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3600648; Laspidou CS, 2005, WATER SCI TECHNOL, V52, P161, DOI 10.2166/wst.2005.0196; Lembre P, 2012, COMPLEX WORLD OF POLYSACCHARIDES, P371, DOI 10.5772/51213; Li SF, 2000, INT J NUMER METH ENG, V48, P1285, DOI 10.1002/1097-0207(20000730)48:9<1285::AID-NME825>3.0.CO;2-H; Mohan SV, 2007, ENZYME MICROB TECH, V40, P1398, DOI 10.1016/j.enzmictec.2006.10.023; Nealson KH, 2011, MRS BULL, V36, P380, DOI 10.1557/mrs.2011.69; Nukala PKVV, 2005, BIOMATERIALS, V26, P6087, DOI 10.1016/j.biomaterials.2005.03.013; OHASHI A, 1994, WATER SCI TECHNOL, V29, P281, DOI 10.2166/wst.1994.0771; Picioreanu C, 2000, BIOTECHNOL BIOENG, V69, P504, DOI 10.1002/1097-0290(20000905)69:5<504::AID-BIT5>3.0.CO;2-S; Qi HJ, 2006, J ENG MATER-T ASME, V128, P509, DOI 10.1115/1.2345442; Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65; Rudge TJ, 2012, ACS SYNTH BIOL, V1, P345, DOI 10.1021/sb300031n; Schaudinn C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100002; Shaw T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098102; Shrout JD, 2011, MRS BULL, V36, P367, DOI 10.1557/mrs.2011.67; Simoes M, 2010, LWT-FOOD SCI TECHNOL, V43, P573, DOI 10.1016/j.lwt.2009.12.008; Stoodley P, 2002, J IND MICROBIOL BIOT, V29, P361, DOI 10.1038/sj.jim.7000282; Storck T, 2014, BIOPHYS J, V106, P2037, DOI 10.1016/j.bpj.2014.03.015; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Tanaka Y, 2005, J PHYS CHEM B, V109, P11559, DOI 10.1021/jp0500790; Valiei A, 2012, LAB CHIP, V12, P5133, DOI 10.1039/c2lc40815e; van Loosdrecht MCM, 2002, ANTON LEEUW INT J G, V81, P245, DOI 10.1023/A:1020527020464; Wilking JN, 2013, P NATL ACAD SCI USA, V110, P848, DOI 10.1073/pnas.1216376110; Wilking JN, 2011, MRS BULL, V36, P385, DOI 10.1557/mrs.2011.71; Wingender J, 1999, MICROBIAL EXTRACELLU; Wong GCL, 2011, MRS BULL, V36, P339, DOI 10.1557/mrs.2011.64; ZHANG TC, 1994, WATER RES, V28, P2267, DOI 10.1016/0043-1354(94)90042-6; ZHANG TC, 1994, WATER SCI TECHNOL, V29, P263, DOI 10.2166/wst.1994.0769; Zhao GF, 2011, INT J NUMER ANAL MET, V35, P859, DOI 10.1002/nag.930	58	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165593	10.1371/journal.pone.0165593	http://dx.doi.org/10.1371/journal.pone.0165593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806068	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500040
J	Huang, JH; Zhang, C; Zhang, DG; Li, L; Chen, X; Xu, DX				Huang, Jia-Hui; Zhang, Cheng; Zhang, Da-Gang; Li, Lu; Chen, Xi; Xu, De-Xiang			Rifampicin-Induced Hepatic Lipid Accumulation: Association with Up-Regulation of Peroxisome Proliferator-Activated Receptor gamma in Mouse Liver	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; PPAR-GAMMA; INDUCED HEPATOTOXICITY; LIPOGENIC PATHWAY; GENE-EXPRESSION; DISEASE; STEATOSIS; HEPATOCYTE; DRUG; MICE	Previous study found that rifampicin caused intrahepatic cholestasis. This study investigated the effects of rifampicin on hepatic lipid metabolism. Mice were orally administered with rifampicin (200 mg/kg) daily for different periods. Results showed that serum TG level was progressively reduced after a short elevation. By contrast, hepatic TG content was markedly increased in rifampicin-treated mice. An obvious hepatic lipid accumulation, as determined by Oil Red O staining, was observed in mice treated with rifampicin for more than one week. Moreover, mRNA levels of Fas, Acc and Scd-1, several key genes for fatty acid synthesis, were elevated in rifampicin-treated mice. In addition, the class B scavenger receptor CD36 was progressively up-regulated by rifampicin. Interestingly, hepatic SREBP-1c and LXR-a, two important transcription factors that regulate genes for hepatic fatty acid synthesis, were not activated by rifampicin. Instead, hepatic PXR was rapidly activated in rifampicin-treated mice. Hepatic PPAR., a downstream target of PXR, was transcriptionally up-regulated. Taken together, the increased hepatic lipid synthesis and uptake of fatty acids from circulation into liver jointly contribute to rifampicin-induced hepatic lipid accumulation. The increased uptake of fatty acids from circulation into liver might be partially attributed to rifampicin-induced up-regulation of PPAR. and its target genes.	[Huang, Jia-Hui; Zhang, Da-Gang; Li, Lu; Chen, Xi] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China; [Zhang, Cheng; Xu, De-Xiang] Anhui Med Univ, Dept Toxicol, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University	Chen, X (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China.; Xu, DX (corresponding author), Anhui Med Univ, Dept Toxicol, Hefei, Peoples R China.	ayfychenxi@163.com; xudex@126.com			National Natural Science Foundation of China [81001480, 81373495]; Research Fund for the Doctoral Program of Higher Education of China [20133420110005]; Natural Science Foundation of Anhui Province [1308085MH120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This project was supported by National Natural Science Foundation of China (81001480, 81373495), Research Fund for the Doctoral Program of Higher Education of China (20133420110005), Natural Science Foundation of Anhui Province (1308085MH120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher DE, 2014, SEMIN LIVER DIS, V34, P205, DOI 10.1055/s-0034-1375960; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Asrih M, 2014, CLIN NUTR, V33, P186, DOI 10.1016/j.clnu.2013.11.003; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chen X, 2011, EUR J PHARMACOL, V659, P53, DOI 10.1016/j.ejphar.2011.03.007; Chen X, 2009, TOXICOL APPL PHARM, V240, P26, DOI 10.1016/j.taap.2009.06.022; Chowdhury A, 2006, J HEPATOL, V45, P117, DOI 10.1016/j.jhep.2006.01.027; Enriquez-Cortina C, 2013, TOXICOL SCI, V135, P26, DOI 10.1093/toxsci/kft134; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Garcia-Monzon C, 2014, EUR J CLIN INVEST, V44, P65, DOI 10.1111/eci.12192; He JH, 2011, EXP BIOL MED, V236, P1116, DOI 10.1258/ebm.2011.011128; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Kazantzis M, 2012, BBA-MOL CELL BIOL L, V1821, P852, DOI 10.1016/j.bbalip.2011.09.010; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Meng Q, 2006, TOXICOL LETT, V166, P19, DOI 10.1016/j.toxlet.2006.05.008; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Moreau A, 2009, HEPATOLOGY, V49, P2068, DOI 10.1002/hep.22907; Nassir F, 2014, INT J MOL SCI, V15, P8713, DOI 10.3390/ijms15058713; Pieper-Furst U, 2013, BBA-MOL CELL BIOL L, V1831, P1191, DOI 10.1016/j.bbalip.2013.03.013; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schreurs M, 2010, OBES REV, V11, P380, DOI 10.1111/j.1467-789X.2009.00642.x; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652; Shen C, 2009, CELL BIOL TOXICOL, V25, P265, DOI 10.1007/s10565-008-9076-8; Shih TY, 2013, CURR DRUG METAB, V14, P720, DOI 10.2174/1389200211314060008; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Staudinger JL, 2013, DRUG METAB REV, V45, P48, DOI 10.3109/03602532.2012.748793; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Xu X, 2013, SEMIN LIVER DIS, V33, P301, DOI 10.1055/s-0033-1358523; Yew WW, 2006, RESPIROLOGY, V11, P699, DOI 10.1111/j.1440-1843.2006.00941.x; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067959; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200; Zhu JZ, 2015, DIGEST DIS SCI, V60, P3194, DOI 10.1007/s10620-015-3728-3	43	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165787	10.1371/journal.pone.0165787	http://dx.doi.org/10.1371/journal.pone.0165787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806127	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500055
J	Liu, DS; Huang, ZP; Zhang, YM; Guo, XJ; Su, SJ				Liu, Desheng; Huang, Zhiping; Zhang, Yimeng; Guo, Xiaojun; Su, Shaojing			Efficient Deterministic Finite Automata Minimization Based on Backward Depth Information	PLOS ONE			English	Article								Obtaining a minimal automaton is a fundamental issue in the theory and practical implementation of deterministic finite automatons (DFAs). A minimization algorithm is presented in this paper that consists of two main phases. In the first phase, the backward depth information is built, and the state set of the DFA is partitioned into many blocks. In the second phase, the state set is refined using a hash table. The minimization algorithm has a lower time complexity O(n) than a naive comparison of transitions O(n(2)). Few states need to be refined by the hash table, because most states have been partitioned by the backward depth information in the coarse partition. This method achieves greater generality than previous methods because building the backward depth information is independent of the topological complexity of the DFA. The proposed algorithm can be applied not only to the minimization of acyclic automata or simple cyclic automata, but also to automata with high topological complexity. Overall, the proposal has three advantages: lower time complexity, greater generality, and scalability. A comparison to Hopcroft's algorithm demonstrates experimentally that the algorithm runs faster than traditional algorithms.	[Liu, Desheng; Huang, Zhiping; Zhang, Yimeng; Guo, Xiaojun; Su, Shaojing] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha 410073, Hunan, Peoples R China	National University of Defense Technology - China	Liu, DS (corresponding author), Natl Univ Def Technol, Coll Mechatron & Automat, Changsha 410073, Hunan, Peoples R China.	deshengcyzw@163.com						Aho Alfred V, 1986, COMPILERS PRINCIPLES; Almeida J, 2008, INFORM PROCESS LETT, V107, P52, DOI 10.1016/j.ipl.2008.01.003; Beal MP, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS, VOLS 1-7, P1376, DOI 10.1109/ISIT.2007.4557131; Becchi M, 2008, I S WORKL CHAR PROC, P73; Berstel J, 2005, LECT NOTES COMPUT SC, V3317, P35; Biegler F, 2009, THEOR COMPUT SCI, V410, P3711, DOI 10.1016/j.tcs.2009.04.016; Brodie BC, 2006, CONF PROC INT SYMP C, P191, DOI 10.1145/1150019.1136500; Brzozowski J.A., 1963, MRI S SERIES, V12, P529; Carrasco RC, 2002, COMPUT LINGUIST, V28, P207, DOI 10.1162/089120102760173652; Castiglione G, 2008, LECT NOTES COMPUT SC, V5196, P172, DOI 10.1007/978-3-540-88282-4_17; Chomsky N., 1958, INF CONTROL, V1, P91, DOI [DOI 10.1016/S0019-9958(58)90082-2, 10.1016/S0019-9958(58)90082-2]; Clark CR, 2003, LECT NOTES COMPUT SC, V2778, P956; Daciuk J., 2002, CIAA, P255; David J, 2010, LECT NOTES COMPUT SC, V6281, P318, DOI 10.1007/978-3-642-15155-2_29; Glushkov V.M, 1961, RUSS MATH SURV+, V16, P3; Gries D., 1973, Acta Informatica, V2, P97, DOI 10.1007/BF00264025; Hopcroff JE, 2007, INTRO AUTOMATA THEOR; Hopcroft J., 1971, THEORY MACHINES COMP, P189, DOI [10.1016/b978-0-12-417750-5.50022-1, DOI 10.1016/B978-0-12-417750-5.50022-1, 10.1016/B978-0-12-417750-5.50022-1]; Kim H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126517; Knuutila T, 2001, THEOR COMPUT SCI, V250, P333, DOI 10.1016/S0304-3975(99)00150-4; Lamperti G, 2013, IEEE SYS MAN CYBERN, P2250, DOI 10.1109/SMC.2013.385; Li L, 2010, INF MAN ENG ICIME 20, P444; Moore EF, 1956, GEDANKEN EXPT SEQUEN, DOI [10.1515/9781400882618-006, DOI 10.1515/9781400882618-006]; REVUZ D, 1992, THEOR COMPUT SCI, V92, P181, DOI 10.1016/0304-3975(92)90142-3; Sakarovitch Jacques, 2009, ELEMENTS AUTOMATA TH, DOI [10.1017/CBO9781139195218, DOI 10.1017/CBO9781139195218]; Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; THOMPSON K, 1968, COMMUN ACM, V11, P419, DOI 10.1145/363347.363387; Valmari A, 2008, EFFICIENT MINIMIZATI; Watson BW, 2004, CONSTRUCTING MINIMAL; Xiong B, 2014, INT J COMMUN SYST, V27, P3158, DOI 10.1002/dac.2532	32	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165864	10.1371/journal.pone.0165864	http://dx.doi.org/10.1371/journal.pone.0165864			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806102	Green Submitted, gold, Green Published			2022-12-27	WOS:000386715500063
J	MacIsaac, HJ; De Roy, EM; Leung, B; Grgicak-Mannion, A; Ruiz, GM				MacIsaac, Hugh J.; De Roy, Emma M.; Leung, Brian; Grgicak-Mannion, Alice; Ruiz, Gregory M.			Possible Ballast Water Transfer of Lionfish to the Eastern Pacific Ocean	PLOS ONE			English	Article							PTEROIS-VOLITANS LINNAEUS; GULF-OF-MEXICO; RECENT INVASION; ATLANTIC COAST; SCORPAENIDAE; TOLERANCE; SHIPS; NORTH	The Indo-Pacific Red Lionfish was first reported off the Florida coast in 1985, following which it has spread across much of the SE USA, Gulf of Mexico, and Caribbean Sea. Lion fish negatively impact fish and invertebrate assemblages and abundances, thus further spread is cause for concern. To date, the fish has not been reported on the Pacific coast of North or Central America. Here we examine the possibility of ballast water transfer of lion fish from colonized areas in the Atlantic Ocean to USA ports on the Pacific coast. Over an eight-year period, we documented 27 commercial vessel-trips in which ballast water was loaded in colonized sites and later discharged untreated into Pacific coast ports in the USA. California had the highest number of discharges including San Francisco Bay and Los Angeles-Long Beach. A species distribution model suggests that the probability of lionfish establishment is low for the western USA, Colombia and Panama, low to medium for Costa Rica, Nicaragua, El Salvador and Guatemala, medium to high for mainland Ecuador, and very high for western Mexico, Peru and the Galapagos Islands. Given the species' intolerance of freshwater conditions, we propose that ballast water exchange be conducted in Gatun Lake, Panama for western-bound vessels carrying 'risky' ballast water to prevent invasion of the eastern Pacific Ocean.	[MacIsaac, Hugh J.; De Roy, Emma M.; Grgicak-Mannion, Alice] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON, Canada; [Leung, Brian] McGill Univ, Dept Biol, Montreal, PQ, Canada; [Ruiz, Gregory M.] Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA	University of Windsor; McGill University; Smithsonian Institution; Smithsonian Environmental Research Center	MacIsaac, HJ (corresponding author), Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON, Canada.	hughm@uwindsor.ca	macisaac, hugh/AAE-3742-2020	Ruiz, Gregory/0000-0003-2499-441X	Smithsonian Institution; NSERC Discovery grants; Canada Research Chair	Smithsonian Institution(Smithsonian Institution); NSERC Discovery grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	Financial support was provided by the Smithsonian Institution to GMR, NSERC Discovery grants to BL and HJM, and a Canada Research Chair to HJM.; We are grateful to two reviewers who helped improve the manuscript. Financial support was provided by the Smithsonian Institution to GMR, NSERC Discovery grants to BL and HJM, and a Canada Research Chair to HJM. We are grateful to the National Ballast Information Clearinghouse for database records, Dr. Pam Schofield of the United States Geological Survey for lionfish reports, Dr. Matthias Herb org for initial data compilation and GIS support and Dr. Nick Mandrak for information regarding lionfish biology.	Aguilar-Perera A, 2010, AQUAT INVASIONS, V5, pS9, DOI 10.3391/ai.2010.5.S1.003; Ahrenholz DW, 2010, ENVIRON BIOL FISH, V88, P305, DOI 10.1007/s10641-010-9647-4; Albins MA, 2013, ENVIRON BIOL FISH, V96, P1151, DOI 10.1007/s10641-011-9795-1; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Barker B., 2015, THESIS; Benkwitt CE, 2015, BIOL INVASIONS, V17, P1383, DOI 10.1007/s10530-014-0801-3; Betancur-R R, 2011, J BIOGEOGR, V38, P1281, DOI 10.1111/j.1365-2699.2011.02496.x; Cerino D, 2013, T AM FISH SOC, V142, P1522, DOI 10.1080/00028487.2013.811098; Coutts ADM, 2003, MAR POLLUT BULL, V46, P1510, DOI 10.1016/S0025-326X(03)00292-3; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Evangelista PH, 2016, AQUAT INVASIONS, V11, P313, DOI 10.3391/ai.2016.11.3.09; Ferreira CEL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123002; FIN (FishBase Information and Research Group), 2015, REV DISTR MAPS PTER; Fishelson L., 1975, Pubblicazioni Staz Zool Napoli, V39, P635; Gardner PG, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00007; Green SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032596; Hamner RM, 2007, J FISH BIOL, V71, P214, DOI 10.1111/j.1095-8649.2007.01575.x; Imamura Hisashi, 1996, Bulletin of the Faculty of Fisheries Hokkaido University, V47, P41; Johnston MW, 2014, BIOL INVASIONS, V16, P2681, DOI 10.1007/s10530-014-0696-z; Johnston MW, 2014, MAR POLLUT BULL, V88, P138, DOI 10.1016/j.marpolbul.2014.09.013; Johnston MA, 2016, BIOINVASIONS REC, V5, P115, DOI 10.3391/bir.2016.5.2.09; Jud ZR, 2015, ENVIRON BIOL FISH, V98, P135, DOI 10.1007/s10641-014-0242-y; Jud ZR, 2011, AQUAT BIOL, V13, P21, DOI 10.3354/ab00351; Kaschner K, 2013, AQUAMAPS ENV DATASET; Keith I., 2015, GALAPAGOS REPORT 201, P83; Kimball ME, 2004, MAR ECOL PROG SER, V283, P269, DOI 10.3354/meps283269; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Layman CA, 2014, MAR BIOL, V161, P2179, DOI 10.1007/s00227-014-2491-x; Meister HS, 2005, SOUTHEAST NAT, V4, P193, DOI 10.1656/1528-7092(2005)004[0193:FEFTIA]2.0.CO;2; Mito S., 1958, SCI B FAC AGR KYUSHU, V16, P381; Morris JA, 2009, THESIS N CAROLINA ST; Poursanidis D., 2015, 11 PANH S OC FISH MY, P621; R Core Team, 2016, R FDN STAT COMP; Rahel FJ, 2007, FRESHWATER BIOL, V52, P696, DOI 10.1111/j.1365-2427.2006.01708.x; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roche D, 2008, THESIS; Schloder C, 2013, AQUAT INVASIONS, V8, P443, DOI 10.3391/ai.2013.8.4.08; Schofield PJ, 2015, AQUAT INVASIONS, V10, P333, DOI 10.3391/ai.2015.10.3.08; Schofield Pamela J., 2009, Aquatic Invasions, V4, P473; Schofield PJ, 2015, PTEROIS VOLITANS MIL; Vasquez-Yeomans L, 2011, BIOL INVASIONS, V13, P2635, DOI 10.1007/s10530-011-9968-z; Watkins G., 2007, GALAPAGOS RISK SOCIO; Whitfield PE, 2002, MAR ECOL PROG SER, V235, P289, DOI 10.3354/meps235289; Williams SL, 2015, MANAG BIOL INVASION, V6, P13, DOI 10.3391/mbi.2015.6.1.02; Wonham MJ, 2000, MAR BIOL, V136, P1111, DOI 10.1007/s002270000303; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]	46	9	9	9	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165584	10.1371/journal.pone.0165584	http://dx.doi.org/10.1371/journal.pone.0165584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806076	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500038
J	Choi, SKY; Boyle, E; Cairney, J; Collins, EJ; Gardner, S; Bacon, J; Rourke, SB				Choi, Stephanie K. Y.; Boyle, Eleanor; Cairney, John; Collins, Evan J.; Gardner, Sandra; Bacon, Jean; Rourke, Sean B.			Prevalence, Recurrence, and Incidence of Current Depressive Symptoms among People Living with HIV in Ontario, Canada: Results from the Ontario HIV Treatment Network Cohort Study	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; MENTAL-HEALTH-SERVICES; QUALITY-OF-LIFE; INFECTED PATIENTS; RISK BEHAVIOR; ANTIRETROVIRAL THERAPY; PSYCHIATRIC-DISORDERS; POSITIVE INDIVIDUALS; ADULTS; CARE	Introduction Current studies of depression among people living with HIV focus on describing its point prevalence. Given the fluctuating nature of depression and its profound impacts on clinical and quality-of-life outcomes, this study aimed to examine the prevalence, recurrence and incidence of current depressive symptoms and its underlying catalysts longitudinally and systematically among these individuals. Methods We conducted a prospective cohort study between October 1, 2007 and December 31, 2012 using longitudinal linked data sources. Current depressive symptoms was identified using the Centre for Epidemiologic Studies Depression Scale or the Kessler Psychological Distress Scale, first at baseline and again during follow-up interviews. Multivariable regressions were used to characterize the three outcomes. Results Of the 3,816 HIV-positive participants, the point prevalence of depressive symptoms was estimated at 28%. Of the 957 participants who were identified with depressive symptoms at baseline and who had at least two years of follow-up, 43% had a recurrent episode. The cumulative incidence among 1,745 previously depressive symptoms free participants (at or prior to baseline) was 14%. During the five-year follow-up, our multivariable models showed that participants with greater risk of recurrent cases were more likely to feel worried about their housing situation. Participants at risk of developing incident cases were also likely to be younger, gay or bisexual, and unable to afford housing-related expenses. Conclusions Depressive symptoms are prevalent and likely to recur among people living with HIV. Our results support the direction of Ontario's HIV/AIDS Strategy to 2026, which addresses medical concerns associated with HIV (such as depression) and the social drivers of health in order to enhance the overall well-being of people living with or at risk of HIV. Our findings reinforce the importance of providing effective mental health care and demonstrate the need for long-term support and routine management of depression, particularly for individuals at high risk.	[Choi, Stephanie K. Y.] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON, Canada; [Choi, Stephanie K. Y.; Bacon, Jean; Rourke, Sean B.] Ontario HIV Treatment Network, Toronto, ON, Canada; [Boyle, Eleanor; Cairney, John; Gardner, Sandra] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Boyle, Eleanor; Collins, Evan J.] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark; [Cairney, John; Rourke, Sean B.] Univ Toronto, Dept Psychiat, Fac Med, Toronto, ON, Canada; [Cairney, John] McMaster Univ, Dept Family Med, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, Infant & Child Hlth Lab, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, CanChild Ctr Childhood Disabil Res, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, Offord Ctr Child Studies, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Cairney, John] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Cairney, John] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Cairney, John] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Collins, Evan J.] Univ Hlth Network, Toronto, ON, Canada; [Rourke, Sean B.] St Michaels Hosp, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Southern Denmark; University of Toronto; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Rourke, SB (corresponding author), Ontario HIV Treatment Network, Toronto, ON, Canada.; Rourke, SB (corresponding author), Univ Toronto, Dept Psychiat, Fac Med, Toronto, ON, Canada.; Rourke, SB (corresponding author), St Michaels Hosp, Toronto, ON, Canada.	sean.rourke@utoronto.ca	Boyle, Eleanor/G-4567-2016; Cairney, John/AAQ-9703-2020	Boyle, Eleanor/0000-0002-9012-9128; Cairney, John/0000-0003-2856-3967; Choi, Stephanie Ka Yee/0000-0003-3019-5729	Ontario HIV Treatment Network (OHTN) - Ontario Ministry of Health and Long-Term Care (MOHLTC); Institute for Clinical Evaluative Sciences - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Ontario HIV Treatment Network (OHTN) - Ontario Ministry of Health and Long-Term Care (MOHLTC); Institute for Clinical Evaluative Sciences - Ontario Ministry of Health and Long-Term Care (MOHLTC)	This study was supported by the Ontario HIV Treatment Network (OHTN) and the Institute for Clinical Evaluative Sciences, which are funded by annual grants from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Ontario HIV Treatment Network (OHTN) and the Institute for Clinical Evaluative Sciences, which are funded by annual grants from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akena D, 2013, AIDS BEHAV, V17, P2802, DOI 10.1007/s10461-012-0383-y; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anagnostopoulos A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140943; Bess KD, 2013, AIDS PATIENT CARE ST, V27, P171, DOI 10.1089/apc.2012.0406; Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721; Blashill AJ, 2012, AIDS BEHAV, V16, P2251, DOI 10.1007/s10461-011-0056-2; Bousman CA, 2009, J AFFECT DISORDERS, V119, P84, DOI 10.1016/j.jad.2009.04.006; Bradley MV, 2008, PSYCHOSOM MED, V70, P186, DOI 10.1097/PSY.0b013e3181642a1c; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Burnam MA, 2001, ARCH GEN PSYCHIAT, V58, P729, DOI 10.1001/archpsyc.58.8.729; Cairney J, 2007, CAN J PSYCHIAT, V52, P111, DOI 10.1177/070674370705200209; Chibanda D, 2014, JAIDS S1, V67, P54; Choi SKY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156652; Choi SKY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142706; Choi SKY, 2015, AIDS CARE, V27, P1183, DOI 10.1080/09540121.2015.1036725; Cook JA, 2014, AIDS BEHAV, V18, P1094, DOI 10.1007/s10461-013-0679-6; Curran GM, 2011, AIDS CARE, V23, P1626, DOI 10.1080/09540121.2011.579943; Del Guerra FB, 2013, J NEUROVIROL, V19, P314, DOI 10.1007/s13365-013-0177-7; Do AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092842; Donker T, 2010, J AFFECT DISORDERS, V122, P253, DOI 10.1016/j.jad.2009.07.013; Elenga N, 2014, INT J STD AIDS, V25, P559, DOI 10.1177/0956462413514954; Eller LS, 2014, AIDS CARE, V26, P795, DOI 10.1080/09540121.2013.841842; Fiest KM, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0289-5; Hardeveld F, 2010, ACTA PSYCHIAT SCAND, V122, P184, DOI 10.1111/j.1600-0447.2009.01519.x; Harrell FE, 2001, REGRESSION MODELING; Himelhoch S, 2009, GEN HOSP PSYCHIAT, V31, P538, DOI 10.1016/j.genhosppsych.2009.05.009; Hirshfield S, 2004, AIDS CARE, V16, P1036, DOI 10.1080/09540120412331292525; Johnson JG, 1999, COMPR PSYCHIAT, V40, P31, DOI 10.1016/S0010-440X(99)90073-1; Katz MH, 1996, AIDS CARE, V8, P433, DOI 10.1080/09540129650125623; Kim S, 2014, AIDS CARE, V26, P1027, DOI 10.1080/09540121.2014.894613; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Komiti A, 2002, DEPRESSION PEOPLE LI, V37, P70; KUPFER DJ, 1991, J CLIN PSYCHIAT, V52, P28; Lam RW, 2009, J AFFECT DISORDERS, V117, pS26, DOI 10.1016/j.jad.2009.06.041; Leaver CA, 2007, AIDS BEHAV, V11, pS85, DOI 10.1007/s10461-007-9246-3; Leserman J, 2008, PSYCHOSOM MED, V70, P539, DOI 10.1097/PSY.0b013e3181777a5f; Logie C, 2013, AIDS PATIENT CARE ST, V27, P114, DOI 10.1089/apc.2012.0296; Malee KM, 2014, JAIDS-J ACQ IMM DEF, V65, P526, DOI 10.1097/QAI.0000000000000070; Meade CS, 2008, DRUG ALCOHOL DEPEN, V92, P296, DOI 10.1016/j.drugalcdep.2007.07.013; Meade CS, 2005, CLIN PSYCHOL REV, V25, P433, DOI 10.1016/j.cpr.2005.02.001; Meader N, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X613151; Milloy MJ, 2012, CURR HIV-AIDS REP, V9, P364, DOI 10.1007/s11904-012-0137-5; Ministry of Health and Long-term Care, ONT PUBL DRUG PROGR; Mizuno Y, 2015, AIDS BEHAV, V19, P684, DOI 10.1007/s10461-014-0890-0; Nacher M, 2010, AIDS CARE, V22, P1086, DOI 10.1080/09540121003599232; Nanni MG, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0530-4; Normen L, 2005, J NUTR, V135, P820, DOI 10.1093/jn/135.4.820; O'Leary A, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000167353.02289.b9; Owe-Larsson B, 2009, AFR J PSYCHIATRY, V12, P115; Parhami I, 2013, AIDS BEHAV, V17, P2792, DOI 10.1007/s10461-012-0386-8; Protopopescu C, 2012, ANTIVIR THER, V17, P1079, DOI 10.3851/IMP2102; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramasubbu R, 2012, ANN CLIN PSYCHIATRY, V24, P82; Reif S, 2006, AIDS CARE, V18, pS10, DOI 10.1080/09540120600838738; Rourke SB, 2013, INT J EPIDEMIOL, V42, P402, DOI 10.1093/ije/dyr230; Rourke SB, 2012, AIDS BEHAV, V16, P2361, DOI 10.1007/s10461-012-0284-0; Schumacher JE, 2013, AIDS BEHAV, V17, P2781, DOI 10.1007/s10461-012-0342-7; Schuster R, 2012, BEHAV MODIF, V36, P123, DOI 10.1177/0145445511425231; Shacham E, 2009, AIDS PATIENT CARE ST, V23, P949, DOI 10.1089/apc.2009.0064; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Sikkema KJ, 2010, AIDS BEHAV, V14, P252, DOI 10.1007/s10461-009-9650-y; Smit PJ, 2012, AIDS CARE, V24, P405, DOI 10.1080/09540121.2011.613910; Soller M, 2011, AIDS CARE, V23, P1351, DOI 10.1080/09540121.2011.565024; Springer SA, 2012, AIDS BEHAV, V16, P2119, DOI 10.1007/s10461-012-0212-3; StataCorp, 2013, STAT SOFTW; Taylor SL, 2004, J BEHAV HEALTH SER R, V31, P149; Tsai AC, 2014, JAIDS-J ACQ IMM DEF, V66, P503, DOI 10.1097/QAI.0000000000000210; Uthman OA, 2014, CURR HIV-AIDS REP, V11, P291, DOI 10.1007/s11904-014-0220-1; Vitiello B, 2003, AM J PSYCHIAT, V160, P547, DOI 10.1176/appi.ajp.160.3.547; Vittinghoff E, 2012, REGRESSION METHODS B; Weaver MR, 2008, JAIDS-J ACQ IMM DEF, V47, P449, DOI 10.1097/QAI.0b013e3181642244; Whetten K, 2008, PSYCHOSOM MED, V70, P531, DOI 10.1097/PSY.0b013e31817749dc; Williams P, 2005, AIDS EDUC PREV, V17, P119, DOI 10.1521/aeap.17.3.119.62903; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; Zuniga JA, 2016, AIDS PATIENT CARE ST, V30, P34, DOI 10.1089/apc.2015.0214	75	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165816	10.1371/journal.pone.0165816	http://dx.doi.org/10.1371/journal.pone.0165816			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6CX	27802346	Green Published, Green Submitted, gold			2022-12-27	WOS:000386714200058
J	Wheat, RE; Allen, JM; Miller, SDL; Wilmers, CC; Levi, T				Wheat, Rachel E.; Allen, Jennifer M.; Miller, Sophie D. L.; Wilmers, Christopher C.; Levi, Taal			Environmental DNA from Residual Saliva for Efficient Noninvasive Genetic Monitoring of Brown Bears (Ursus arctos)	PLOS ONE			English	Article							FECAL DNA; INDIVIDUAL IDENTIFICATION; PREDATOR IDENTIFICATION; MARK-RECAPTURE; BLACK BEARS; POPULATION; SALMON; SIZE; AMPLIFICATION; CONSERVATION	Noninvasive genetic sampling is an important tool in wildlife ecology and management, typically relying on hair snaring or scat sampling techniques, but hair snaring is labor and cost intensive, and scats yield relatively low quality DNA. New approaches utilizing environmental DNA (eDNA) may provide supplementary, cost-effective tools for noninvasive genetic sampling. We tested whether eDNA from residual saliva on partially-consumed Pacific salmon (Oncorhynchus spp.) carcasses might yield suitable DNA quality for noninvasive monitoring of brown bears (Ursus arctos). We compared the efficiency of monitoring brown bear populations using both fecal DNA and salivary eDNA collected from partially-consumed salmon carcasses in Southeast Alaska. We swabbed a range of tissue types from 156 partially-consumed salmon carcasses from a midseason run of lakeshore-spawning sockeye (O. nerka) and a late season run of stream-spawning chum (O. keta) salmon in 2014. We also swabbed a total of 272 scats from the same locations. Saliva swabs collected from the braincases of salmon had the best amplification rate, followed by swabs taken from individual bite holes. Saliva collected from salmon carcasses identified unique individuals more quickly and required much less labor to locate than scat samples. Salmon carcass swabbing is a promising method to aid in efficient and affordable monitoring of bear populations, and suggests that the swabbing of food remains or consumed baits from other animals may be an additional cost-effective and valuable tool in the study of the ecology and population biology of many elusive and/or wide-ranging species.	[Wheat, Rachel E.; Wilmers, Christopher C.] Univ Calif Santa Cruz, Dept Environm Studies, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA; [Allen, Jennifer M.; Levi, Taal] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Miller, Sophie D. L.] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming, Peoples R China; [Miller, Sophie D. L.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China	University of California System; University of California Santa Cruz; Oregon State University; Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology	Wheat, RE (corresponding author), Univ Calif Santa Cruz, Dept Environm Studies, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA.	rwheat@ucsc.edu		Levi, Taal/0000-0003-1853-8311	NSF GRF; International Bear Association; Alaska Chilkoot Bear Foundation; National Geographic Society [141544]; Thomas G. Scott Publication Fund	NSF GRF(National Science Foundation (NSF)); International Bear Association; Alaska Chilkoot Bear Foundation; National Geographic Society(National Geographic Society); Thomas G. Scott Publication Fund	This work was funded by an NSF GRF to REW, and grants from the International Bear Association, the Alaska Chilkoot Bear Foundation, and the National Geographic Society (grant #141544). Publication of this paper was supported, in part, by the Thomas G. Scott Publication Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADFG, 2014, SE MAN AR FISH REP S; Beier LR, 2005, WILDLIFE SOC B, V33, P766, DOI 10.2193/0091-7648(2005)33[766:FTFASS]2.0.CO;2; Bellemain E, 2005, CONSERV BIOL, V19, P150, DOI 10.1111/j.1523-1739.2005.00549.x; Bellemain E, 2004, MOL ECOL NOTES, V4, P519, DOI 10.1111/j.1471-8286.2004.00711.x; Blejwas KM, 2006, J WILDLIFE MANAGE, V70, P1087, DOI 10.2193/0022-541X(2006)70[1087:SDECBM]2.0.CO;2; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; De Barba M, 2010, J APPL ECOL, V47, P172, DOI 10.1111/j.1365-2664.2009.01752.x; Farley S, 2014, WILDLIFE SOC B, V38, P370, DOI 10.1002/wsb.391; Galpern P, 2012, MOL ECOL RESOUR, V12, P771, DOI 10.1111/j.1755-0998.2012.03137.x; Gende SM, 2001, OECOLOGIA, V127, P372, DOI 10.1007/s004420000590; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Harms V, 2015, J MAMMAL, V96, P138, DOI 10.1093/jmammal/gyu014; Hilderbrand GV, 1999, CAN J ZOOL, V77, P132, DOI 10.1139/cjz-77-1-132; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Karamanlidis AA, 2010, EUR J WILDLIFE RES, V56, P693, DOI 10.1007/s10344-010-0363-3; Kelly MJ, 2012, TECH ECOL CONSERVAT, P47; Kendall KC, 2008, J WILDLIFE MANAGE, V72, P1693, DOI 10.2193/2008-007; Kendall Katherine C., 2008, P141; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Levi T, 2015, PEERJ, V3, DOI 10.7717/peerj.1157; Lobo D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139765; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Mumma MA, 2014, MOL ECOL RESOUR, V14, P100, DOI 10.1111/1755-0998.12153; Murphy MA, 2003, MOL ECOL, V12, P2261, DOI 10.1046/j.1365-294X.2003.01863.x; Murphy MA, 2007, CONSERV GENET, V8, P1219, DOI 10.1007/s10592-006-9264-0; Nichols RV, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1285-z; Nichols RV, 2015, OECOLOGIA, V178, P275, DOI 10.1007/s00442-014-3196-z; Nichols RV, 2012, MOL ECOL RESOUR, V12, P983, DOI 10.1111/j.1755-0998.2012.03172.x; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; Paetkau D, 1998, CONSERV BIOL, V12, P418, DOI 10.1046/j.1523-1739.1998.96457.x; Pennell MW, 2013, MOL ECOL RESOUR, V13, P154, DOI 10.1111/1755-0998.12019; Piggott MP, 2004, WILDLIFE RES, V31, P485, DOI 10.1071/WR03096; Quinn TP, 2003, CAN J FISH AQUAT SCI, V60, P553, DOI 10.1139/F03-045; Quinn TP, 2001, CAN J ZOOL, V79, P1782, DOI 10.1139/cjz-79-10-1782; Roon DA, 2005, MOL ECOL, V14, P195, DOI 10.1111/j.1365-294X.2004.02385.x; Saito M, 2008, URSUS, V19, P162, DOI 10.2192/08GR006.1; Skrbinsek T, 2010, MOL ECOL RESOUR, V10, P495, DOI 10.1111/j.1755-0998.2009.02780.x; Sundqvist AK, 2008, CONSERV GENET, V9, P1275, DOI 10.1007/s10592-007-9454-4; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; van Bleijswijk JDL, 2014, MAR ECOL PROG SER, V513, P277, DOI 10.3354/meps11004; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Williams CL, 2003, WILDLIFE SOC B, V31, P926; Woods JG, 1999, WILDLIFE SOC B, V27, P616	47	27	27	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165259	10.1371/journal.pone.0165259	http://dx.doi.org/10.1371/journal.pone.0165259			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828988	Green Submitted, gold, Green Published			2022-12-27	WOS:000387724300035
J	Liu, YL; Wu, K; Shi, L; Xiang, F; Tao, KX; Wang, GB				Liu, Yulin; Wu, Ke; Shi, Liang; Xiang, Fan; Tao, Kaixiong; Wang, Guobin			Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CANCER METABOLISM; EXPRESSION; GLYCOLYSIS; GLUCOSE-TRANSPORTER-1; CARCINOMA; GROWTH; SUPPRESSION; SURVIVAL; WARBURG	Objective Recently, numerous studies have reported that hexokinase-2 (HK2) is aberrantly expressed in cancer, indicating that HK2 plays a pivotal role in the development and progression of cancer. However, its prognostic significance in solid tumor remains unclear. Accordingly, we performed a meta-analysis to assess the prognostic value of HK2 in solid tumor. Methods Eligible studies were identified using PubMed, Embase, and Web of Science databases. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) for overall survival (OS) or progression-free survival (PFS)/disease-free survival (DFS)/relapse-free survival (RFS) were estimated with random effects or fixed effects models, respectively. Subgroup analysis was also performed according to patients' ethnicities, tumor types, detection methods, and analysis types. Results Data from 21 included studies with 2532 patients were summarized. HK2 overexpression was significantly associated with worse OS (pooled HR = 1.90, 95% CI = 1.51-2.38, p < 0.001) and PFS (pooled HR = 2.91, 95% CI = 2.02-4.22, p < 0.001) in solid tumor. As to a specific form of cancer, the negative effect of HK2 on OS was observed in hepatocellular carcinoma (pooled HR = 2.06, 95% CI = 1.67-2.54, p < 0.001), gastric cancer (pooled HR = 1.72, 95% CI = 1.09-2.71, p = 0.020), colorectal cancer (pooled HR = 2.89, 95% CI = 1.62-5.16, p < 0.001), but not in pancreatic cancer (pooled HR = 1.13, 95% CI = 0.28-4.66, p = 0.864). No publication bias was found in the included studies for OS (Begg's test, p = 0.325; Egger's test, p = 0.441). Conclusion In this meta-analysis, we identified that elevated HK2 expression was significantly associated with shorter OS and PFS in patients with solid tumor, but the association varies according to cancer type.	[Liu, Yulin; Wu, Ke; Xiang, Fan; Tao, Kaixiong; Wang, Guobin] Huazhong Univ Sci & Technol, Union Hosp, Dept Gastrointestinal Surg, Tongji Med Coll, Wuhan, Peoples R China; [Shi, Liang] Huazhong Univ Sci & Technol, Union Hosp, Dept Clin Lab, Tongji Med Coll, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, GB (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Gastrointestinal Surg, Tongji Med Coll, Wuhan, Peoples R China.	guobinwanguh@163.com			Chinese Ministry of Science and Technology (973 program) [2015CB5540007]; National Natural Science Foundation of China [81472740, 81101825]; Public Welfare in Health Industry, Health and Family Plan Committee of China [201402015]	Chinese Ministry of Science and Technology (973 program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Welfare in Health Industry, Health and Family Plan Committee of China	This study was supported by the Chinese Ministry of Science and Technology (973 program, 2015CB5540007), National Natural Science Foundation of China (81472740, 81101825) and Research Fund of Public Welfare in Health Industry, Health and Family Plan Committee of China (No. 201402015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemi F, 2015, CURR PROB SURG, V52, P362, DOI 10.1067/j.cpsurg.2015.07.003; Chen GQ, 2015, ONCOTARGET, V6, P24148, DOI 10.18632/oncotarget.4376; Domenech E, 2015, NAT CELL BIOL, V17, P1304, DOI 10.1038/ncb3231; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Feliciano P, 2013, NAT GENET, V45, P969, DOI [10.1038/ng.2751, DOI 10.1038/NG.2751]; Gaddis ML, 1998, ACAD EMERG MED, V5, P258, DOI 10.1111/j.1553-2712.1998.tb02624.x; Gong L, 2012, MED ONCOL, V29, P909, DOI 10.1007/s12032-011-9841-z; Guo WJ, 2015, HEPATOLOGY, V62, P1132, DOI 10.1002/hep.27929; Guzman G, 2015, DIGEST DIS SCI, V60, P420, DOI 10.1007/s10620-014-3364-3; Hamabe A, 2014, CANCER SCI, V105, P1100, DOI 10.1111/cas.12487; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho N, 2016, CANC TREATMENT COMMU, V6, P11, DOI [10.1016/j.ctrc.2016.02.008, DOI 10.1016/J.CTRC.2016.02.008]; Huang XQ, 2015, INT J CLIN EXP PATHO, V8, P4054; Hur H, 2013, INT J ONCOL, V42, P44, DOI 10.3892/ijo.2012.1687; Katagiri M, 2016, HISTOL HISTOPATHOL, P11799, DOI 10.14670/hh-11-799; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Kwee SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046591; Lim SO, 2016, CANCER RES, V76, P1284, DOI 10.1158/0008-5472.CAN-15-2478; Lyshchik A, 2007, CANCER INVEST, V25, P154, DOI 10.1080/07357900701208931; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Mathupala SP, 1997, J BIOENERG BIOMEMBR, V29, P339, DOI 10.1023/A:1022494613613; Maurya AK, 2015, NUTR CANCER, V67, P354, DOI 10.1080/01635581.2015.990574; Ogawa H, 2015, MOL CLIN ONCOL, V3, P563, DOI 10.3892/mco.2015.490; Ottawa Hospital Research Institute, NEWCASTLE OTTAWA SCA; Palmieri D, 2009, MOL CANCER RES, V7, P1438, DOI 10.1158/1541-7786.MCR-09-0234; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Paudyal B, 2008, INT J ONCOL, V33, P1047, DOI 10.3892/ijo_00000093; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Peng SY, 2008, ONCOL REP, V19, P1045; Qin LJ, 2016, ONCOTARGET, V7, P1395, DOI 10.18632/oncotarget.6366; Qiu MZ, 2011, TUMOR BIOL, V32, P159, DOI 10.1007/s13277-010-0109-6; Rho M, 2007, ANTICANCER RES, V27, P251; Rivenzon-Segal D, 2003, INT J CANCER, V107, P177, DOI 10.1002/ijc.11387; Sato-Tadano A, 2013, CANCER SCI, V104, P1380, DOI 10.1111/cas.12238; Suh DH, 2014, CLIN EXP MED, V14, P345, DOI 10.1007/s10238-013-0250-9; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tsukada H, 2012, ACTA HISTOCHEM CYTOC, V45, P147, DOI 10.1267/ahc.11063; Vazquez A, 2016, J CELL SCI, V129, P3367, DOI 10.1242/jcs.181016; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; World Health Organization, 2014, GLOBOCAN2012 EST CAN; Zhang MX, 2016, ONCOTARGET, V7, P21287, DOI 10.18632/oncotarget.7116; Zhang ZF, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0474-8	46	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166230	10.1371/journal.pone.0166230	http://dx.doi.org/10.1371/journal.pone.0166230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824926	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200074
J	Yang, Y; Shi, YZ; Zhang, N; Wang, S; Ungvari, GS; Ng, CH; Wang, YL; Zhao, XQ; Wang, YJ; Wang, CX; Xiang, YT				Yang, Yang; Shi, Yu-Zhi; Zhang, Ning; Wang, Shuo; Ungvari, Gabor S.; Ng, Chee H.; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue; Xiang, Yu-Tao			The Disability Rate of 5-Year Post-Stroke and Its Correlation Factors: A National Survey in China	PLOS ONE			English	Article							AUCKLAND STROKE OUTCOMES; MODIFIED-RANKIN-SCALE; LONG-TERM DISABILITY; COGNITIVE IMPAIRMENT; 1ST-EVER STROKE; FUNCTIONAL RECOVERY; RECURRENT STROKE; PROGNOSTIC VALUE; NATURAL-HISTORY; ISCHEMIC-STROKE	Few studies on long-term functional outcome have been conducted in post-stroke patients in China. The objective of this study was to conduct a nationwide survey in China to investigate the 5-year prevalence of post-stroke disability and its correlation factors. A total of 893 patients with ischemic stroke were included. Demographic, clinical and neuro-imaging information were collected with standardized instruments that assessed stroke severity, depression, cognitive impairment, stroke recurrence and physical disability. Disability was assessed with the modified Ranking Score (mRS), of which a cutoff score >= 2 indicates disability. Statistical analysis included chi-square tests, two independent samples t-tests, Mann-Whitney U test and multiple logistic regression analysis. The frequency of disability in this study population was 45%. Multivariate analyses revealed that older age, lower education level, previous history of stroke, stroke severity at admission, depression, cognitive impairment at 3 months, and stroke recurrence within 5 years follow up were all significantly associated with post-stroke disability. The disability rate in 5-year post-stroke was high in Chinese patients. Treatment of depression, secondary prevention of stroke and rehabilitation may benefit disabled patients with stroke in China.	[Yang, Yang; Shi, Yu-Zhi; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China; [Yang, Yang; Zhang, Ning; Wang, Chun-Xue] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neuropsychiat & Behav Neurol & Clin Psychol, Beijing, Peoples R China; [Yang, Yang; Shi, Yu-Zhi; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Yang, Yang; Shi, Yu-Zhi; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China; [Yang, Yang; Shi, Yu-Zhi; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Ungvari, Gabor S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia; [Ungvari, Gabor S.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA, Australia; [Ng, Chee H.] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Xiang, Yu-Tao] Univ Macau, Fac Hlth Sci, Unit Psychiat, Macau, Macao Sar, Peoples R China	Capital Medical University; Capital Medical University; University of Notre Dame Australia; University of Western Australia; University of Melbourne; University of Macau	Wang, CX (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China.; Wang, CX (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neuropsychiat & Behav Neurol & Clin Psychol, Beijing, Peoples R China.; Wang, CX (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Wang, CX (corresponding author), Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China.; Wang, CX (corresponding author), Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China.; Xiang, YT (corresponding author), Univ Macau, Fac Hlth Sci, Unit Psychiat, Macau, Macao Sar, Peoples R China.	snowsen@126.com; xyutly@gmail.com		Shi, YuZhi/0000-0002-4018-6984; Ng, Chee/0000-0002-3811-2732	Ministry of Science and Technology; Ministry of Health of the People's Republic of China; National 11th & 12th Five-year S & T Major Project [2006BAI01A11, 2011BAI08B01, 2011BAI08B02]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2013BAI09B03]; Ministry of Science and Technology of the People's Republic of China [2012ZX09303-005-001]; Beijing Institute for Brain Disorders [BIBD-PXM2013_014226_07_000084]; Beijing Biobank of Cerebral Vascular Disease [D131100005313003]; Beijing Brain Research [Z161100000216131]; Beijing Municipal Science & Technology Commission [Z151100004015127, Z151100003915117]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China; National 11th & 12th Five-year S & T Major Project; National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Beijing Institute for Brain Disorders; Beijing Biobank of Cerebral Vascular Disease; Beijing Brain Research; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This study was funded by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China. Individual grants include the National 11th & 12th Five-year S & T Major Project (2006BAI01A11, 2011BAI08B01, 2011BAI08B02), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2013BAI09B03), the Ministry of Science and Technology of the People's Republic of China (2012ZX09303-005-001), Beijing Institute for Brain Disorders (BIBD-PXM2013_014226_07_000084), Beijing Biobank of Cerebral Vascular Disease (D131100005313003), Beijing Brain Research (Z161100000216131) and Beijing Municipal Science & Technology Commission (Z151100004015127 and Z151100003915117).	Ayerbe L, 2014, J NEUROL NEUROSUR PS, V85, P514, DOI 10.1136/jnnp-2013-306448; Ayerbe L, 2013, STROKE, V44, P1105, DOI 10.1161/STROKEAHA.111.679340; Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664; Barker-Collo S, 2010, NEUROLOGY, V75, P1608, DOI 10.1212/WNL.0b013e3181fb44c8; Dhamoon MS, 2015, NEUROLOGY, V84, P1002, DOI 10.1212/WNL.0000000000001331; Dhamoon MS, 2009, STROKE, V40, P2805, DOI 10.1161/STROKEAHA.109.549576; Dong YH, 2012, J NEUROL NEUROSUR PS, V83, P580, DOI 10.1136/jnnp-2011-302070; Donnellan C, 2010, INT J GERIATR PSYCH, V25, P1288, DOI 10.1002/gps.2482; Feigin VL, 2010, NEUROLOGY, V75, P1597, DOI 10.1212/WNL.0b013e3181fb44b3; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; First MB, 1994, DIAGNOSTIC STAT MANU, V1994; FOLSTEIN MF, 1977, J NEUROL NEUROSUR PS, V40, P1018, DOI 10.1136/jnnp.40.10.1018; Ghosal MK, 2014, J STROKE CEREBROVASC, V23, P2614, DOI 10.1016/j.jstrokecerebrovasdis.2014.06.001; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hankey GJ, 2002, STROKE, V33, P1034, DOI 10.1161/01.STR.0000012515.66889.24; Hardie K, 2004, STROKE, V35, P731, DOI 10.1161/01.STR.0000116183.50167.D9; Huybrechts KF, 2008, CEREBROVASC DIS, V26, P381, DOI 10.1159/000151678; Jia Q, 2011, STROKE, V42, P2758, DOI 10.1161/STROKEAHA.111.621649; Jokinen H, 2015, EUR J NEUROL, V22, P1288, DOI 10.1111/ene.12743; Jonsson AC, 2014, STROKE, V45, P1784, DOI 10.1161/STROKEAHA.114.005164; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Knoflach M, 2012, NEUROLOGY, V78, P279, DOI 10.1212/WNL.0b013e31824367ab; KUNITZ SC, 1984, STROKE, V15, P740, DOI 10.1161/01.STR.15.4.740; Kutlubaev MA, 2014, INT J STROKE, V9, P1026, DOI 10.1111/ijs.12356; Liman TG, 2012, J NEUROL, V259, P1125, DOI 10.1007/s00415-011-6312-6; Liman TG, 2011, DEMENT GERIATR COGN, V31, P291, DOI 10.1159/000327358; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; Middleton LE, 2014, NEUROREHABILITATION, V34, P305, DOI 10.3233/NRE-131030; Moon HI, 2016, NEURORADIOLOGY, V58, P723, DOI 10.1007/s00234-016-1672-3; Narasimhalu K, 2011, STROKE, V42, P883, DOI 10.1161/STROKEAHA.110.594671; Nys GMS, 2005, NEUROLOGY, V64, P821, DOI 10.1212/01.WNL.0000152984.28420.5A; Park JH, 2016, EUR J NEUROL, V23, P361, DOI 10.1111/ene.12837; Quinn TJ, 2009, INT J STROKE, V4, P200, DOI 10.1111/j.1747-4949.2009.00271.x; Ullberg T, 2015, STROKE, V46, P389, DOI 10.1161/STROKEAHA.114.006538; Uyttenboogaart M, 2005, STROKE, V36, P1984, DOI 10.1161/01.STR.0000177872.87960.61; Wallace D, 2002, J CLIN EPIDEMIOL, V55, P922, DOI 10.1016/S0895-4356(02)00410-9; WOO J, 1992, NEUROEPIDEMIOLOGY, V11, P143, DOI 10.1159/000110924; Wu LY, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0505-z; Zhang N, 2012, CNS NEUROSCI THER, V18, P475, DOI 10.1111/j.1755-5949.2012.00312.x; ZHENG YP, 1988, BRIT J PSYCHIAT, V152, P660, DOI 10.1192/bjp.152.5.660	40	51	58	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165341	10.1371/journal.pone.0165341	http://dx.doi.org/10.1371/journal.pone.0165341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824877	gold, Green Published, Green Submitted			2022-12-27	WOS:000387615200017
J	Correa, A; Barba, A; Padilla, F				Correa, Angel; Barba, Antonio; Padilla, Francisca			Light Effects on Behavioural Performance Depend on the Individual State of Vigilance	PLOS ONE			English	Article							BRIGHT LIGHT; BLUE-LIGHT; SUSTAINED ATTENTION; TASK-PERFORMANCE; BRAIN RESPONSES; WORKING-MEMORY; HEART-RATE; ALERTNESS; SLEEP; SENSITIVITY	Research has shown that exposure to bright white light or blue-enriched light enhances alertness, but this effect is not consistently observed in tasks demanding high-level cognition (e.g., Sustained Attention to Response Task-SART, which measures inhibitory control). Individual differences in sensitivity to light effects might be mediated by variations in the basal level of arousal. We tested this hypothesis by measuring the participants' behavioural state of vigilance before light exposure, through the Psychomotor Vigilance Task. Then we compared the effects of a blue-enriched vs. dim light at nighttime on the performance of the auditory SART, by controlling for individual differences in basal arousal. The results replicated the alerting effects of blue-enriched light, as indexed by lower values of both proximal temperature and distal-proximal gradient. The main finding was that lighting effects on SART performance were highly variable across individuals and depended on their prior state of vigilance. Specifically, participants with higher levels of basal vigilance before light exposure benefited most from blue-enriched lighting, responding faster in the SART. These results highlight the importance of considering basal vigilance to define the boundary conditions of light effects on cognitive performance. Our study adds to current research delineating the complex and reciprocal interactions between lighting effects, arousal, cognitive task demands and behavioural performance.	[Correa, Angel; Barba, Antonio; Padilla, Francisca] Univ Granada, Ctr Invest Mente Cerebro & Comportamiento, Granada, Spain; [Correa, Angel; Padilla, Francisca] Univ Granada, Dept Psicol Expt, Granada, Spain	University of Granada; University of Granada	Correa, A (corresponding author), Univ Granada, Ctr Invest Mente Cerebro & Comportamiento, Granada, Spain.; Correa, A (corresponding author), Univ Granada, Dept Psicol Expt, Granada, Spain.	act@ugr.es		Correa, Angel/0000-0001-5256-4949	Spanish Ministerio de Economia y Competitividad (PLAN NACIONAL de I+D+i) [PSI2014-58041-P]; Junta de Andalucia [SEJ-3054]	Spanish Ministerio de Economia y Competitividad (PLAN NACIONAL de I+D+i); Junta de Andalucia(Junta de Andalucia)	This work was supported by the Spanish Ministerio de Economia y Competitividad (PLAN NACIONAL de I+D+i, grant number: PSI2014-58041-P. www.mineco.gob.es) to AC and by a pre-doctoral research contract to AB, and by the Junta de Andalucia (SEJ-3054, http://www.juntadeandalucia.es) to AC.	ADAN A, 1991, PERS INDIV DIFFER, V12, P241, DOI 10.1016/0191-8869(91)90110-W; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Beaven CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076707; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; Colavito V, 2015, NEUROSCI BIOBEHAV R, V54, P3, DOI 10.1016/j.neubiorev.2014.11.021; Daneault V, 2014, SLEEP, V37, P85, DOI 10.5665/sleep.3314; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Edelstein K, 2003, NEUROSCIENCE, V118, P253, DOI 10.1016/S0306-4522(02)00908-9; Gabela V, 2015, BEHAV BRAIN RES, V281, P258, DOI 10.1016/j.bbr.2014.12.043; Gaggioni G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00126; Genno H, 1997, INT J IND ERGONOM, V19, P161, DOI 10.1016/S0169-8141(96)00011-X; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Huiberts LM, 2015, BEHAV BRAIN RES, V294, P234, DOI 10.1016/j.bbr.2015.07.045; Huiberts LM, 2016, PHYSIOL BEHAV, V164, P129, DOI 10.1016/j.physbeh.2016.05.035; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; Kaida K, 2013, SLEEP BIOL RHYTHMS, V11, P125, DOI 10.1111/sbr.12013; Krauchi K, 1999, NATURE, V401, P36, DOI 10.1038/43366; Kretschmer V, 2012, LIGHTING RES TECHNOL, V44, P316, DOI 10.1177/1477153511418769; Lara T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088820; Lockley SW, 2006, SLEEP, V29, P161; Lucas RJ, 2014, TRENDS NEUROSCI, V37, P1, DOI 10.1016/j.tins.2013.10.004; Or Calvin K. L., 2007, Occupational Ergonomics, V7, P83; Phipps-Nelson J, 2009, CHRONOBIOL INT, V26, P891, DOI 10.1080/07420520903044364; Rahman SA, 2014, SLEEP, V37, P271, DOI 10.5665/sleep.3396; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Santhi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079688; Schneider W., 2002, E PRIME USERS GUIDE; Seli P, 2012, CAN J EXP PSYCHOL, V66, P44, DOI 10.1037/a0025111; Smolders KCHJ, 2012, PHYSIOL BEHAV, V107, P7, DOI 10.1016/j.physbeh.2012.04.028; Smolders KCHJ, 2014, J ENVIRON PSYCHOL, V39, P77, DOI 10.1016/j.jenvp.2013.12.010; van Diepen HC, 2014, EUR J NEUROSCI, V40, P3504, DOI 10.1111/ejn.12715; Vandewalle G, 1991, CEREB CORTEX N Y N, V17, P2788; Vandewalle G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001247; Vandewalle G, 2013, NEUROIMAGING OF SLEEP AND SLEEP DISORDERS, P171; Vandewalle G, 2011, J BIOL RHYTHM, V26, P249, DOI 10.1177/0748730411401736; Vandewalle G, 2009, TRENDS COGN SCI, V13, P429, DOI 10.1016/j.tics.2009.07.004; Wright KP, 1997, J SLEEP RES, V6, P26, DOI 10.1046/j.1365-2869.1997.00022.x; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	41	16	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0164945	10.1371/journal.pone.0164945	http://dx.doi.org/10.1371/journal.pone.0164945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BB	27820822	Green Submitted, Green Published, gold			2022-12-27	WOS:000387614800004
J	Wang, CH; Huang, CH; Chang, WT; Tsai, MS; Yu, PH; Wu, YW; Chen, WJ				Wang, Chih-Hung; Huang, Chien-Hua; Chang, Wei-Tien; Tsai, Min-Shan; Yu, Ping-Hsun; Wu, Yen-Wen; Chen, Wen-Jone			Outcomes of Adult In-Hospital Cardiac Arrest Treated with Targeted Temperature Management: A Retrospective Cohort Study	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; INTERNATIONAL LIAISON COMMITTEE; EUROPEAN RESUSCITATION COUNCIL; CARDIOPULMONARY-RESUSCITATION; THERAPEUTIC HYPOTHERMIA; CARE; GUIDELINES; WITHDRAWAL; STATEMENT; SURVIVORS	Aim Targeted temperature management (TTM) for in-hospital cardiac arrest (IHCA) is given different recommendation levels within international resuscitation guidelines. We aimed to identify whether TTM would be associated with favourable outcomes following IHCA and to determine which factors would influence the decision to implement TTM. Methods We conducted a retrospective observational study in a single medical centre. We included adult patients suffering IHCA between 2006 and 2014. We used multivariable logistic regression analysis to evaluate associations between independent variables and outcomes. Results We included a total of 678 patients in our analysis; only 22 (3.2%) patients received TTM. Most (81.1%) patients met at least one exclusion criteria for TTM. In all, 144 (21.2%) patients survived to hospital discharge; among them, 60 (8.8%) patients displayed favourable neurological status at discharge. TTM use was significantly associated with favourable neurological outcome (OR: 3.74, 95% confidence interval [CI]: 1.19-11.00; p-value = 0.02), but it was not associated with survival (OR: 1.41, 95% CI: 0.54-3.66; p-value = 0.48). Arrest in the emergency department was positively associated with TTM use (OR: 22.48, 95% CI: 8.40-67.64; p value < 0.001) and having vasopressors in place at the time of arrest was inversely associated with TTM use (OR: 0.08, 95% CI: 0.004-0.42; p-value = 0.02). Conclusion TTM might be associated with favourable neurological outcome of IHCA patients, irrespective of arrest rhythms. The prevalence of proposed exclusion criteria for TTM was high among IHCA patients, but these factors did not influence the use of TTM in clinical practice or neurological outcomes after IHCA.	[Wang, Chih-Hung; Huang, Chien-Hua; Chang, Wei-Tien; Tsai, Min-Shan; Chen, Wen-Jone] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Wang, Chih-Hung; Huang, Chien-Hua; Chang, Wei-Tien; Tsai, Min-Shan; Chen, Wen-Jone] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Wang, Chih-Hung] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Yu, Ping-Hsun] Minist Hlth & Welf, Taipei Hosp, Dept Emergency Med, New Taipei, Taiwan; [Wu, Yen-Wen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Wu, Yen-Wen] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Wu, Yen-Wen] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Dept Nucl Med, New Taipei, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Div Cardiol, Cardiovasc Med Ctr, New Taipei, Taiwan; [Wu, Yen-Wen] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Wen-Jone] Lotung Poh Ai Hosp, Dept Emergency Med, Yilan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University	Chen, WJ (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.; Chen, WJ (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Chen, WJ (corresponding author), Lotung Poh Ai Hosp, Dept Emergency Med, Yilan, Taiwan.	wjchen1955@ntu.edu.tw	TSAI, MIN-SHAN/AHE-3825-2022	TSAI, MIN-SHAN/0000-0002-2862-7572; WANG, CHIH-HUNG/0000-0003-0802-7825; CHANG, WEI-TIEN/0000-0002-1880-7932; WU, YEN-WEN/0000-0003-1520-1166; HUANG, CHIEN-HUA/0000-0003-2981-4537; CHEN, WEN-JONE/0000-0002-2098-5922				Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Albaeni A, 2014, RESUSCITATION, V85, P1455, DOI 10.1016/j.resuscitation.2014.08.030; Becker LB, 2011, CIRCULATION, V124, P2158, DOI 10.1161/CIR.0b013e3182340239; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Chen YS, 2008, LANCET, V372, P554, DOI 10.1016/S0140-6736(08)60958-7; Deb S, 2016, CAN J CARDIOL, V32, P259, DOI 10.1016/j.cjca.2015.05.015; Geurts M, 2014, CRIT CARE MED, V42, P231, DOI 10.1097/CCM.0b013e3182a276e8; Girotra S, 2012, NEW ENGL J MED, V367, P1912, DOI 10.1056/NEJMoa1109148; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hsu CH, 2014, CRIT CARE MED, V42, P2575, DOI 10.1097/CCM.0000000000000547; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Kory P, 2012, NEUROCRIT CARE, V16, P406, DOI 10.1007/s12028-011-9664-y; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Mikkelsen ME, 2013, CRIT CARE MED, V41, P1385, DOI 10.1097/CCM.0b013e318287f2c4; Morrison LJ, 2013, CIRCULATION, V127, P1538, DOI 10.1161/CIR.0b013e31828b2770; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Mulder M, 2014, CRIT CARE MED, V42, P2493, DOI 10.1097/CCM.0000000000000540; Nichol G, 2013, RESUSCITATION, V84, P620, DOI 10.1016/j.resuscitation.2012.12.009; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Perman SM, 2015, CIRCULATION, V132, P2146, DOI 10.1161/CIRCULATIONAHA.115.016317; Phua J, 2015, JAMA INTERN MED, V175, P363, DOI 10.1001/jamainternmed.2014.7386; Polderman KH, 2015, CIRCULATION, V131, P669, DOI 10.1161/CIRCULATIONAHA.114.012165; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Wang CH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002152; Zeiner A, 2001, ARCH INTERN MED, V161, P2007, DOI 10.1001/archinte.161.16.2007; 2005, CIRCULATION, V112, P84, DOI DOI 10.1161/CIRCULATIONAHA.104.527077	32	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166148	10.1371/journal.pone.0166148	http://dx.doi.org/10.1371/journal.pone.0166148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820847	Green Published, gold, Green Submitted			2022-12-27	WOS:000387614800037
J	Barbosa, RM; Cabral, CD; do Lago, TD; Pinho, AD				Barbosa, Regina Maria; Cabral, Cristiane da Silva; do Lago, Tania di Giacomo; Pinho, Adriana de Araujo			Differences in the Access to Sterilization between Women Living and Not Living with HIV: Results from the GENIH Study, Brazil	PLOS ONE			English	Article							FEMALE STERILIZATION; DECISION-MAKING; POSITIVE WOMEN; HEALTH; PREGNANCY; ABORTION; COHORT; MODE	Background In many countries, young women of reproductive age have been especially affected by the HIV epidemic, which have fostered research to better understand how HIV infection influences and shapes women As fertility and reproductive and sexual decisions. In Brazil, few studies have focused on the impact of the HIV epidemic on contraceptive choices among women living with HIV (WLHIV). Objective This study evaluates the impact HIV infection may have in the access to female sterilization in Brazil, using a time-to-event analysis. Methods A cross-sectional quantitative study (GENIH study) was conducted between February 2013 and April 2014 in the city of Sao Paulo, comparing two probabilistic samples of 975 WLHIV and 1,003 women not living with HIV (WNLHIV) aged 18 to 49. Sexual and reproductive data was collected retrospectively in order to reconstruct women's reproductive trajectories. Given the objectives of this study, the analysis was restricted to women with parity one or more and, in case of WLHIV, to those sterilized after HIV diagnosis and not infected through vertical transmission. The final sample analysis included 683 WNLHIV and 690 WLHIV. A series of multivariable-adjusted Cox models estimated the probability of being sterilized after HIV diagnosis, compared with WNLHIV. Models were adjusted for schooling, race/color, and stratified by parity at last delivery (1-2, 3+). Hazard ratios were calculated for female sterilization, and separately for interval and postpartum procedures (performed in conjunction with caesarean section or immediately after vaginal delivery). Additionally, information regarding unmet demand for female sterilization was also explored. Findings No statistical difference in the overall risk of sterilization between WLHIV and WNLHIV in the two parity-related groups is observed: HR = 0.88 (0.54-1.43) and 0.94 (0.69-1.29), respectively, among women with 1-2 children and those with three and more. However, significant differences regarding the impact of HIV infection at sterilization are observed depending on the timing and the type of sterilization procedure. The probability of obtaining an interval sterilization is significantly lower for WLHIV compared to those not living with HIV. The reverse occurs regarding postpartum sterilization. Although sterilization is mainly performed in conjunction with caesarean section in Brazil, it is evident that caesarean sections are not the sole factor increasing the risk of sterilization among WLHIV. Conclusion The results indicate barriers in the access to services offering interval sterilization for WLHIV and certain facilitation in obtaining the procedure in conjunction with caesarean section. Health policy makers at local and national levels should promote institutional changes in order to facilitate access to interval sterilization and to confront the sensitive discussion of WLHIV's eligibility for postpartum sterilization. It is also urgent to increase access to a wider range of contraceptive methods for WLHIV and promote dual method protection strategies. Moreover, since condom use may decrease in the future in the context of the preventive effect of antiretroviral therapy, promoting dual methods will expand the choices regarding the reproductive rights of women living with HIV.	[Barbosa, Regina Maria] Univ Estadual Campinas, Nucleo Estudos Populacao Elza Berquo, Campinas, SP, Brazil; [Barbosa, Regina Maria] Secretaria Estado Saude Sao Paulo, Ctr Referecia & Treinamento DST AIDS, Sao Paulo, Brazil; [Cabral, Cristiane da Silva] Univ Sao Paulo, Fac Saude Publ, Dept Saude Maternoinfantil, Sao Paulo, Brazil; [do Lago, Tania di Giacomo] Secretaria Estado Saude Sao Paulo, Inst Saude, Sao Paulo, Brazil; [Pinho, Adriana de Araujo] Fiocruz MS, Inst Oswaldo Cruz, Lab Educ Ambiente & Saude, Rio De Janeiro, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Fundacao Oswaldo Cruz	Barbosa, RM (corresponding author), Univ Estadual Campinas, Nucleo Estudos Populacao Elza Berquo, Campinas, SP, Brazil.; Barbosa, RM (corresponding author), Secretaria Estado Saude Sao Paulo, Ctr Referecia & Treinamento DST AIDS, Sao Paulo, Brazil.	rbarbosa@nepo.unicamp.br	CABRAL, CRISTIANE S/L-7472-2017; Lago, Tania D G/N-8609-2013; Barbosa, Regina M/J-7591-2012	CABRAL, CRISTIANE S/0000-0003-3025-2404; Barbosa, Regina M/0000-0002-3390-2137	Fapesp [2012/25239-3]; CNPq [471892/2011-4, 478296/2012-6]; United Nations Fund for Population Activities; Pan American Health Organization [BR/LOA/1200041.001/002]	Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); United Nations Fund for Population Activities; Pan American Health Organization	This work was supported by Fapesp (BR), 2012/25239-3, to Dr. Regina Maria Barbosa; CNPq (BR), 471892/2011-4, to Dr. Regina Maria Barbosa; CNPq (BR), 478296/2012-6, to Dr. Cristiane Da Silva Cabral; United Nations Fund for Population Activities to Dr. Adriana Araujo Pinho; and Pan American Health Organization, BR/LOA/1200041.001/002, to Dr. Regina Maria Barbosa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral EFL, 2015, DETERMINANTS FEMALE; Amorim FlaviaAlfen., 2008, POBLACION SALUD SEXU POBLACION SALUD SEXU, P101; Ávila Maria Betânia, 2003, Cad. Saúde Pública, V19, pS465, DOI 10.1590/S0102-311X2003000800027; Barbosa RM, 2009, CIENC SAUDE COLETIVA, V14, P1085, DOI 10.1590/S1413-81232009000400015; Bedimo AL, 1998, SOC SCI MED, V46, P171, DOI 10.1016/S0277-9536(97)00157-3; Caetano AJ, 2014, REV BRASILEIRA ESTUD, V31, P309; Cavenaghi S, 2014, COMPORTAMIENTO REPRO, P67; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; DeVincenzi I, 1997, AIDS, V11, P333, DOI 10.1097/00002030-199703110-00011; Elder GH, 2003, HDB LIFE COURSE, P3, DOI DOI 10.1007/978-0-306-48247-2_1; Figueroa-Damian R, 2001, SALUD PUBLICA MEXICO, V43, P97, DOI 10.1590/S0036-36342001000200003; Garcia S, 2008, PRATICAS SEXUAIS VUL; Healton C, 1999, AIDS CARE, V11, P675, DOI 10.1080/09540129947587; Hopkins K, 2005, SOC SCI MED, V61, P541, DOI 10.1016/j.socscimed.2004.12.011; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2012, CENS DEM 2010 RES GE; KLINE A, 1995, SOC SCI MED, V40, P1539, DOI 10.1016/0277-9536(94)00280-7; Knauth DR, 2003, REPROD HEALTH MATTER, V11, P113, DOI 10.1016/S0968-8080(03)22100-5; Maraux B, 2015, CONTRACEPTION, V92, P160, DOI 10.1016/j.contraception.2015.04.010; Menezes G, 2009, CAD SAUDE PUBLICA, V25, pS193, DOI 10.1590/S0102-311X2009001400002; Ministerio da Saude, 2015, DAD EP HIV AIDS, V4; Oliveira F, 2007, AIDS CARE, V19, P1258, DOI 10.1080/09540120701405411; Perpetuo IHO, 2009, PESQUISA NACL DEMOGR, P87; Potter JE, 2003, CONTRACEPTION, V67, P385, DOI 10.1016/S0010-7824(03)00039-8; Santos NJS, 2009, CAD SAUDE PUBLICA, V25, pS321, DOI 10.1590/S0102-311X2009001400014; Smits AK, 1999, AIDS PATIENT CARE ST, V13, P739, DOI 10.1089/apc.1999.13.739; Domingues RMSM, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00105113; Teixeira LB, 2013, CAD SAUDE PUBLICA, V29, P609, DOI 10.1590/S0102-311X2013000300018; Thackway SV, 1997, AIDS, V11, P663, DOI 10.1097/00002030-199705000-00014; UNAIDS, 2016, PREV GAP REP; van Benthem BHB, 2000, AIDS, V14, P2171, DOI 10.1097/00002030-200009290-00014; Vieira E., 2003, SEXO VIDA PANORAMA S, P151; Vieira EM, 2002, REV SAUDE PUBL, V36, P263, DOI 10.1590/S0034-89102002000300002; Villela Wilza Vieira, 2015, Rev. bras. epidemiol., V18, P131, DOI 10.1590/1809-4503201500050010	33	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164887	10.1371/journal.pone.0164887	http://dx.doi.org/10.1371/journal.pone.0164887			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812146	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000015
J	Lee, J; Horan, WP; Wynn, JK; Green, MF				Lee, Junghee; Horan, William P.; Wynn, Jonathan K.; Green, Michael F.			Neural Correlates of Belief and Emotion Attribution in Schizophrenia	PLOS ONE			English	Article							SOCIAL COGNITION; BRAIN IMAGES; MIND; FMRI; METAANALYSIS; EMPATHY; ROBUST; OPTIMIZATION; REGISTRATION; IMPAIRMENT	Impaired mental state attribution is a core social cognitive deficit in schizophrenia. With functional magnetic resonance imaging (fMRI), this study examined the extent to which the core neural system of mental state attribution is involved in mental state attribution, focusing on belief attribution and emotion attribution. Fifteen schizophrenia outpatients and 14 healthy controls performed two mental state attribution tasks in the scanner. In a Belief Attribution Task, after reading a short vignette, participants were asked infer either the belief of a character (a false belief condition) or a physical state of an affair (a false photograph condition). In an Emotion Attribution Task, participants were asked either to judge whether character(s) in pictures felt unpleasant, pleasant, or neutral emotion (other condition) or to look at pictures that did not have any human characters (view condition). fMRI data were analyzing focusing on a priori regions of interest (ROIs) of the core neural systems of mental state attribution: the medial prefrontal cortex (mPFC), temporoparietal junction (TPJ) and precuneus. An exploratory whole brain analysis was also performed. Both patients and controls showed greater activation in all four ROIs during the Belief Attribution Task than the Emotion Attribution Task. Patients also showed less activation in the precuneus and left TPJ compared to controls during the Belief Attribution Task. No significant group difference was found during the Emotion Attribution Task in any of ROIs. An exploratory whole brain analysis showed a similar pattern of neural activations. These findings suggest that while schizophrenia patients rely on the same neural network as controls do when attributing beliefs of others, patients did not show reduced activation in the key regions such as the TPJ. Further, this study did not find evidence for aberrant neural activation during emotion attribution or recruitment of compensatory brain regions in schizophrenia.	[Lee, Junghee; Horan, William P.; Wynn, Jonathan K.; Green, Michael F.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Lee, Junghee; Horan, William P.; Wynn, Jonathan K.; Green, Michael F.] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Lee, J (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA.; Lee, J (corresponding author), VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA.	jungheelee@ucla.edu	Wynn, Jonathan/H-3749-2014; Lee, Junghee/AAX-6124-2021; Lee, Junghee/C-5226-2014; Horan, William/V-7495-2019	Wynn, Jonathan/0000-0002-1763-8540; Lee, Junghee/0000-0001-9567-8700; Lee, Junghee/0000-0001-9567-8700; 	Department of Veterans Affairs, Desert Pacific Mental Illness Research, Education and Clinical Center (MIRECC) PALA Pilot Grant; National Institute of Mental Health [MH43292, MH065707]; Brain Mapping Medical Research Organization; Brain Mapping Support Foundation; Pierson-Lovelace Foundation; Tamkin Foundation; Jennifer Jones-Simon Foundation; Capital Group Companies Charitable Foundation; Robson Family; Northstar Fund	Department of Veterans Affairs, Desert Pacific Mental Illness Research, Education and Clinical Center (MIRECC) PALA Pilot Grant; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain Mapping Medical Research Organization; Brain Mapping Support Foundation; Pierson-Lovelace Foundation; Tamkin Foundation; Jennifer Jones-Simon Foundation; Capital Group Companies Charitable Foundation; Robson Family; Northstar Fund	This study is supported by Department of Veterans Affairs, Desert Pacific Mental Illness Research, Education and Clinical Center (MIRECC) PALA Pilot Grant (PI: JL), and National Institute of Mental Health Grants MH43292 and MH065707 (PI: MFG). For generous support, we would like to thank the Brain Mapping Medical Research Organization, the Brain Mapping Support Foundation, the Pierson-Lovelace Foundation, the Tamkin Foundation, the Jennifer Jones-Simon Foundation, the Capital Group Companies Charitable Foundation, the Robson Family and the Northstar Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Benedetti F, 2009, SCHIZOPHR RES, V114, P154, DOI 10.1016/j.schres.2009.06.021; Bora E, 2009, SCHIZOPHR RES, V109, P1, DOI 10.1016/j.schres.2008.12.020; Brune M, 2011, NEUROIMAGE, V55, P329, DOI 10.1016/j.neuroimage.2010.12.018; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Chung YS, 2011, SCHIZOPHRENIA BULL, V37, P1048, DOI 10.1093/schbul/sbq012; Das P, 2012, SCHIZOPHR RES, V134, P158, DOI 10.1016/j.schres.2011.08.019; Derntl B, 2012, SCHIZOPHR RES, V136, P70, DOI 10.1016/j.schres.2011.12.018; Derntl B, 2009, SCHIZOPHR RES, V108, P197, DOI 10.1016/j.schres.2008.11.009; First M.B., 2014, STRUCTURED CLIN INTE; First M. B., 1997, STRUCTURED CLIN INTE; Frith CD, 1992, COGNITIVE NEUROPSYCH; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Green MF, 2015, NAT REV NEUROSCI, V16, P620, DOI 10.1038/nrn4005; Greenwald M.K., 1993, INT AFFECTIVE PICTUR; Harvey PO, 2013, SCHIZOPHRENIA BULL, V39, P617, DOI 10.1093/schbul/sbs042; Herve PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054400; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kern RS, 2009, PSYCHOL MED, V39, P645, DOI 10.1017/S0033291708003966; Lee J, 2011, PSYCHOL MED, V41, P2297, DOI 10.1017/S0033291711000614; Lee J, 2011, SOC NEUROSCI-UK, V6, P569, DOI 10.1080/17470919.2011.620774; Lee SJ, 2010, PSYCHIAT RES-NEUROIM, V181, P121, DOI 10.1016/j.pscychresns.2009.08.003; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Savla GN, 2013, SCHIZOPHRENIA BULL, V39, P979, DOI 10.1093/schbul/sbs080; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sparks A, 2010, SCHIZOPHR RES, V122, P172, DOI 10.1016/j.schres.2010.06.011; van Veluw SJ, 2014, BRAIN IMAGING BEHAV, V8, P24, DOI 10.1007/s11682-013-9266-8; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Walter H, 2009, SOC COGN AFFECT NEUR, V4, P166, DOI 10.1093/scan/nsn047; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Zaitchik D, 2010, NEUROPSYCHOLOGIA, V48, P2528, DOI 10.1016/j.neuropsychologia.2010.04.031	41	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165546	10.1371/journal.pone.0165546	http://dx.doi.org/10.1371/journal.pone.0165546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812142	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000035
J	Morales, M; Sentchilo, V; Bertelli, C; Komljenovic, A; Kryuchkova-Mostacci, N; Bourdilloud, A; Linke, B; Goesmann, A; Harshman, K; Segers, F; Delapierre, F; Fiorucci, D; Seppey, M; Trofimenco, E; Berra, P; El Taher, A; Loiseau, C; Roggero, D; Sulfiotti, M; Etienne, A; Buendia, GR; Pillard, L; Escoriza, A; Moritz, R; Schneider, C; Alfonso, E; Ben Jeddou, F; Selmoni, O; Resch, G; Greub, G; Emery, O; Dubey, M; Pillonel, T; Robinson-Rechavi, M; van der Meer, JR				Morales, Marian; Sentchilo, Vladimir; Bertelli, Claire; Komljenovic, Andrea; Kryuchkova-Mostacci, Nadezda; Bourdilloud, Audrey; Linke, Burkhard; Goesmann, Alexander; Harshman, Keith; Segers, Francisca; Delapierre, Fabien; Fiorucci, Damien; Seppey, Mathieu; Trofimenco, Evgeniya; Berra, Pauline; El Taher, Athimed; Loiseau, Chloe; Roggero, Dejan; Sulfiotti, Madeleine; Etienne, Angela; Buendia, Gustavo Ruiz; Pillard, Loic; Escoriza, Angelique; Moritz, Roxane; Schneider, Cedric; Alfonso, Esteban; Ben Jeddou, Fatma; Selmoni, Oliver; Resch, Gregory; Greub, Gilbert; Emery, Olivier; Dubey, Manupriyam; Pillonel, Trestan; Robinson-Rechavi, Marc; van der Meer, Jan Roelof			The Genome of the Toluene-Degrading Pseudomonas veronii Strain 1YdBTEX2 and Its Differential Gene Expression in Contaminated Sand	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; TOXIN-ANTITOXIN LOCI; WIDE ANALYSIS; KDP-ATPASE; BACTERIA; BIODEGRADATION; BIOREMEDIATION; DIVERSITY; VISUALIZATION; METABOLISM	The natural restoration of soils polluted by aromatic hydrocarbons such as benzene, toluene, ethylbenzene and m-and p-xylene (BTEX) may be accelerated by inoculation of specific biodegraders (bioaugmentation). Bioaugmentation mainly involves introducing bacteria that deploy their metabolic properties and adaptation potential to survive and propagate in the contaminated environment by degrading the pollutant. In order to better understand the adaptive response of cells during a transition to contaminated material, we analyzed here the genome and short-term (1 h) changes in genome-wide gene expression of the BTEX-degrading bacterium Pseudomonas veronii 1YdBTEX2 in non-sterile soil and liquid medium, both in presence or absence of toluene. We obtained a gapless genome sequence of P. veronii 1YdBTEX2 covering three individual replicons with a total size of 8 Mb, two of which are largely unrelated to current known bacterial replicons. One-hour exposure to toluene, both in soil and liquid, triggered massive transcription (up to 208-fold induction) of multiple gene clusters, such as toluene degradation pathway(s), chemotaxis and toluene efflux pumps. This clearly underlines their key role in the adaptive response to toluene. In comparison to liquid medium, cells in soil drastically changed expression of genes involved in membrane functioning (e.g., lipid composition, lipid metabolism, cell fatty acid synthesis), osmotic stress response (e.g., polyamine or trehalose synthesis, uptake of potassium) and putrescine metabolism, highlighting the immediate response mechanisms of P. veronii 1YdBTEX2 for successful establishment in polluted soil.	[Morales, Marian; Sentchilo, Vladimir; Resch, Gregory; Emery, Olivier; Dubey, Manupriyam; van der Meer, Jan Roelof] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland; [Bertelli, Claire; Greub, Gilbert; Pillonel, Trestan] Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Bertelli, Claire; Greub, Gilbert; Pillonel, Trestan] Univ Lausanne, Lausanne, Switzerland; [Komljenovic, Andrea; Kryuchkova-Mostacci, Nadezda; Robinson-Rechavi, Marc] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Bourdilloud, Audrey; Segers, Francisca; Delapierre, Fabien; Fiorucci, Damien; Seppey, Mathieu; Trofimenco, Evgeniya; Berra, Pauline; El Taher, Athimed; Loiseau, Chloe; Roggero, Dejan; Sulfiotti, Madeleine; Etienne, Angela; Buendia, Gustavo Ruiz; Pillard, Loic; Escoriza, Angelique; Moritz, Roxane; Schneider, Cedric; Alfonso, Esteban; Ben Jeddou, Fatma; Selmoni, Oliver] Univ Lausanne, Mol Life Sci, Lausanne, Switzerland; [Linke, Burkhard; Goesmann, Alexander] Justus Liebig Univ, Bioinformat & Syst Biol, Giessen, Germany; [Harshman, Keith] Univ Lausanne, Ctr Integrat Genom, Lausanne Genom Technol Facil, CH-1015 Lausanne, Switzerland; [Bertelli, Claire; Komljenovic, Andrea; Kryuchkova-Mostacci, Nadezda; Robinson-Rechavi, Marc] SIB, Lausanne, Switzerland	University of Lausanne; University of Lausanne; University of Lausanne; University of Lausanne; Justus Liebig University Giessen; University of Lausanne; Swiss Institute of Bioinformatics	van der Meer, JR (corresponding author), Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.	janroelof.vandermeer@unil.ch	van der Meer, Jan Roelof/G-6610-2012; Greub, Gilbert GG/K-5804-2017; Bertelli, Claire/H-9609-2015; Robinson-Rechavi, Marc/E-9727-2011	van der Meer, Jan Roelof/0000-0003-1485-3082; Greub, Gilbert GG/0000-0001-9529-3317; Bertelli, Claire/0000-0003-0550-8981; Robinson-Rechavi, Marc/0000-0002-3437-3329; Trofimenko, Evgeniya/0000-0003-4910-5324; Selmoni, Oliver/0000-0003-0904-5486; Goesmann, Alexander/0000-0002-7086-2568; Loiseau, Chloe/0000-0003-4889-2784; Pillonel, Trestan/0000-0002-5725-7929	SystemsX.ch; Swiss Initiative in Systems Biology	SystemsX.ch; Swiss Initiative in Systems Biology	The study was funded by SystemsX.ch'http://SystemsX.ch', the Swiss Initiative in Systems Biology (http://www.systemsx.ch), to Marian Morales, Manupriyam Dubey and Jan R. van der Meer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backman A, 2004, APPL ENVIRON MICROB, V70, P2952, DOI 10.1128/AEM.70.5.2952-2958.2004; Ballal A, 2007, J BIOSCIENCES, V32, P559, DOI 10.1007/s12038-007-0055-7; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bertelli C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00101; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Coronado E, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00300; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Cunliffe M, 2006, FEMS MICROBIOL ECOL, V58, P364, DOI 10.1111/j.1574-6941.2006.00167.x; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; de Lima-Morales D, 2013, GENOME ANNOUNCEMENTS, V1, DOI [10.1128/genomeA.00258-13, DOI 10.1128/GEN0MEA.00258-13]; de Lima-Morales D, 2016, APPL ENVIRON MICROB, V82, P167, DOI 10.1128/AEM.03026-15; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Fivian-Hughes AS, 2010, J BACTERIOL, V192, P4348, DOI 10.1128/JB.00454-10; Freeman BC, 2013, J BACTERIOL, V195, P4742, DOI 10.1128/JB.00787-13; Gerhardt P, 1981, MANUAL METHODS GEN B; Gordon D, 2013, BIOINFORMATICS, V29, P2936, DOI 10.1093/bioinformatics/btt515; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Haghollahi A, 2016, J ENVIRON MANAGE, V180, P197, DOI 10.1016/j.jenvman.2016.05.038; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; He ZL, 2010, APPL ENVIRON MICROB, V76, P1574, DOI 10.1128/AEM.02141-09; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jeon CO, 2013, CURR OPIN BIOTECH, V24, P474, DOI 10.1016/j.copbio.2012.09.001; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Junca H, 2004, ENVIRON MICROBIOL, V6, P95, DOI 10.1046/j.1462-2920.2003.00541.x; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Lan DD, 2015, MAR POLLUT BULL, V96, P220, DOI 10.1016/j.marpolbul.2015.05.023; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Malli R, 1998, J BACTERIOL, V180, P5102, DOI 10.1128/JB.180.19.5102-5108.1998; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Martinez-Garcia E, 2014, ENVIRON MICROBIOL, V16, P291, DOI 10.1111/1462-2920.12309; Martinez-Garcia E, 2011, ENVIRON MICROBIOL, V13, P2702, DOI 10.1111/j.1462-2920.2011.02538.x; Megharaj M, 2011, ENVIRON INT, V37, P1362, DOI 10.1016/j.envint.2011.06.003; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Miyazaki R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002818; Moreno-Forero SK, 2016, ENV MICROBIOL REP, V8, P91, DOI 10.1111/1758-2229.12356; Moreno-Forero SK, 2015, ISME J, V9, P150, DOI 10.1038/ismej.2014.101; Mrozik A, 2010, MICROBIOL RES, V165, P363, DOI 10.1016/j.micres.2009.08.001; Mukherjee S, 2014, ISME J, V8, P2131, DOI 10.1038/ismej.2014.151; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parales RE, 2000, APPL ENVIRON MICROB, V66, P4098, DOI 10.1128/AEM.66.9.4098-4104.2000; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rojas A, 2001, J BACTERIOL, V183, P3967, DOI 10.1128/JB.183.13.3967-3973.2001; Samanta SK, 2002, TRENDS BIOTECHNOL, V20, P243, DOI 10.1016/S0167-7799(02)01943-1; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Singer AC, 2005, TRENDS BIOTECHNOL, V23, P74, DOI 10.1016/j.tibtech.2004.12.012; Witzig R, 2006, APPL ENVIRON MICROB, V72, P3504, DOI 10.1128/AEM.72.5.3504-3514.2006; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	59	9	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165850	10.1371/journal.pone.0165850	http://dx.doi.org/10.1371/journal.pone.0165850			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812150	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000071
J	Sanagavarapu, K; Weiffert, T; Ni Mhurchu, N; O'Connell, D; Linse, S				Sanagavarapu, Kalyani; Weiffert, Tanja; Ni Mhurchu, Niamh; O'Connell, David; Linse, Sara			Calcium Binding and Disulfide Bonds Regulate the Stability of Secretagogin towards Thermal and Urea Denaturation	PLOS ONE			English	Article							CA2+-BINDING PROTEIN; PARVALBUMIN; CALMODULIN; EXPRESSION; TARGET; TAU	Secretagogin is a calcium-sensor protein with six EF-hands. It is widely expressed in neurons and neuro-endocrine cells of a broad range of vertebrates including mammals, fishes and amphibia. The protein plays a role in secretion and interacts with several vesicle-associated proteins. In this work, we have studied the contribution of calcium binding and disulfide-bond formation to the stability of the secretagogin structure towards thermal and urea denaturation. SDS-PAGE analysis of secretagogin in reducing and non-reducing conditions identified a tendency of the protein to form dimers in a redox-dependent manner. The denaturation of apo and Calcium-loaded secretagogin was studied by circular dichroism and fluorescence spectroscopy under conditions favoring monomer or dimer or a 1: 1 monomer: dimer ratio. This analysis reveals significantly higher stability towards urea denaturation of Calcium-loaded secretagogin compared to the apo protein. The secondary and tertiary structure of the Calcium-loaded form is not completely denatured in the presence of 10 M urea. Reduced and Calcium-loaded secretagogin is found to refold reversibly after heating to 95 degrees C, while both oxidized and reduced apo secretagogin is irreversibly denatured at this temperature. Thus, calcium binding greatly stabilizes the structure of secretagogin towards chemical and heat denaturation.	[Sanagavarapu, Kalyani; Weiffert, Tanja; Linse, Sara] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden; [Ni Mhurchu, Niamh; O'Connell, David] Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin, Ireland	Lund University; University College Dublin	Sanagavarapu, K; Linse, S (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden.	Kalyani.Sanagavarapu@biochemistry.lu.se; Sara.Linse@biochemistry.lu.se		O'Connell, David/0000-0002-6461-7750	Swedish Research Council VR; SFI Investigators Programme [12/IP/1620]	Swedish Research Council VR(Swedish Research Council); SFI Investigators Programme(Science Foundation Ireland)	This work was funded by the Swedish Research Council VR (SL) and the SFI Investigators Programme 12/IP/1620 (DOC).	Attems J, 2006, CLIN NEUROPATHOL, V25, P265; Bauer M, 2011, METHODS MOL BIOL, V781, P47, DOI 10.1007/978-1-61779-276-2_3; Bitto E, 2009, PROTEINS, V76, P477, DOI 10.1002/prot.22362; Cedervall T, 2005, BIOCHEMISTRY-US, V44, P684, DOI 10.1021/bi049232r; Choi S, 2010, J PROTEOME RES, V9, P626, DOI 10.1021/pr900771r; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Gartner W, 2001, CEREB CORTEX, V11, P1161, DOI 10.1093/cercor/11.12.1161; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Karki R, 2013, EXPERT OPIN THER TAR, V17, P461, DOI 10.1517/14728222.2013.766170; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; LINSE S, 1993, PROTEIN SCI, V2, P985, DOI 10.1002/pro.5560020612; Maj M, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00084; Maj M, 2010, J ENDOCRINOL, V205, P25, DOI 10.1677/JOE-09-0341; Masino L, 2000, PROTEIN SCI, V9, P1519, DOI 10.1110/ps.9.8.1519; MATSUMURA M, 1991, METHOD ENZYMOL, V202, P336; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; Mulder J, 2009, P NATL ACAD SCI USA, V106, P22492, DOI 10.1073/pnas.0912484106; Pauls TL, 1996, BBA-GENE STRUCT EXPR, V1306, P39, DOI 10.1016/0167-4781(95)00221-9; PERMYAKOV EA, 1982, BIOPHYS CHEM, V15, P19, DOI 10.1016/0301-4622(82)87013-0; Permyakoy SE, 2008, PROTEINS, V72, P822, DOI 10.1002/prot.21974; Rogstam A, 2007, BIOCHEM J, V401, P353, DOI 10.1042/BJ20060918; Romanov RA, 2015, EMBO J, V34, P36, DOI 10.15252/embj.201488977; SMITH L, 1994, J BIOL CHEM, V269, P9857; TIDOR B, 1993, PROTEINS, V15, P71, DOI 10.1002/prot.340150109; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Venyaminov SY, 2004, ANAL BIOCHEM, V334, P97, DOI 10.1016/j.ab.2004.07.032; Wagner L, 2000, J BIOL CHEM, V275, P24740, DOI 10.1074/jbc.M001974200; WALTERSSON Y, 1993, BIOCHEMISTRY-US, V32, P7866, DOI 10.1021/bi00082a005; Wijeyesakere SJ, 2011, J BIOL CHEM, V286, P8771, DOI 10.1074/jbc.M110.169193; Zierhut B, 2005, BIOCHEM BIOPH RES CO, V329, P1193, DOI 10.1016/j.bbrc.2005.02.093	31	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165709	10.1371/journal.pone.0165709	http://dx.doi.org/10.1371/journal.pone.0165709			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812162	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000050
J	Yao, LL; Lu, PF; Ling, EA				Yao, Linli; Lu, Pengfei; Ling, Eng-Ang			Melatonin Suppresses Toll Like Receptor 4-Dependent Caspase-3 Signaling Activation Coupled with Reduced Production of Proinflammatory Mediators in Hypoxic Microglia	PLOS ONE			English	Article							PERIVENTRICULAR WHITE-MATTER; BRAIN-INJURY; APOPTOSIS; CELLS; CYTOKINES; PATHWAY; RATS	Microglia activation and associated inflammatory response play pivotal roles in the pathogenesis of different neurodegenerative diseases including neonatal hypoxic brain injury. Here we show that caspase3 expression was upregulated in activated microglia after hypoxic exposure, and remarkably, the cell viability remained unaffected alluding to the possibility of a non-apoptotic role of caspase3 in activated microglia. Chemical inhibition of caspase3 suppressed microglia activation as evident by an obvious reduction in expression of proinflammatory mediators and NF-kappa B signaling activation. Hypoxia induced caspase3 activation was TLR4 dependent as supported by the fact that caspase3 activation was hindered in cells with TLR4 knockdown. Interestingly, melatonin treatment significantly suppressed caspase3 activation. More importantly, melatonin also inhibited the increase in TLR4 protein and mRNA expression in hypoxic microglia. Inhibition of TLR4 expression by melatonin was also found in microglia of postnatal rats subjected to hypoxic exposure. Taken together, it is concluded that melatonin could inhibit TLR4 expression in hypoxic microglia followed by suppression of caspase3 activation leading to decrease in production of proinflammatory mediators.	[Yao, Linli; Lu, Pengfei] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Yao, Linli] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Ling, Eng-Ang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore, Singapore	ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National University of Singapore	Ling, EA (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore, Singapore.	antlea@nus.edu.sg			National University of Singapore [R-181-000-140-592]	National University of Singapore(National University of Singapore)	This study was supported by grant No. R-181-000-140-592 from the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alconada D, 2012, HISTOL HISTOPATHOL, V27, P771, DOI 10.14670/HH-27.771; Bonestroo HJC, 2015, DEV NEUROSCI-BASEL, V37, P78, DOI 10.1159/000368770; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Chen JY, 2014, J PINEAL RES, V57, P340, DOI 10.1111/jpi.12173; Deng YY, 2008, BRAIN PATHOL, V18, P387, DOI 10.1111/j.1750-3639.2008.00138.x; Gonzalez-Rodriguez PJ, 2014, NEUROBIOL DIS, V65, P172, DOI 10.1016/j.nbd.2014.01.020; da Silva DGH, 2015, J PINEAL RES, V58, P178, DOI 10.1111/jpi.12204; Kadhim H, 2002, NEUROLOGY, V58, P1125; Kang JW, 2012, J PINEAL RES, V53, P67, DOI 10.1111/j.1600-079X.2012.00972.x; Kaur C, 2010, J PINEAL RES, V48, P185, DOI 10.1111/j.1600-079X.2009.00740.x; Kaur C, 2009, PROG NEUROBIOL, V87, P264, DOI 10.1016/j.pneurobio.2009.01.003; Kaur C, 2013, J NEUROIMMUNE PHARM, V8, P66, DOI 10.1007/s11481-012-9347-2; Kim SY, 2010, IMMUNOLOGY, V129, P516, DOI 10.1111/j.1365-2567.2009.03203.x; Mesri Alamdari N, 2015, HORM METAB RES, V47, P504, DOI 10.1055/s-0034-1384587; Ozyener F, 2012, RESTOR NEUROL NEUROS, V30, P435, DOI 10.3233/RNN-2012-120217; Park SY, 2010, J PINEAL RES, V48, P178, DOI 10.1111/j.1600-079X.2009.00742.x; Pertsov S. S., 2015, Biomeditsinskaya Khimiya, V61, P394, DOI 10.18097/PBMC20156103394; Phiphatwatcharaded C, 2014, DRUG DEVELOP RES, V75, P235, DOI 10.1002/ddr.21177; Qi JH, 2015, APOPTOSIS, V20, P523, DOI 10.1007/s10495-014-1076-y; Rathnasamy G, 2011, J NEUROSCI, V31, P17982, DOI 10.1523/JNEUROSCI.2250-11.2011; Schulz JB, 1998, CELL DEATH DIFFER, V5, P847, DOI 10.1038/sj.cdd.4400420; Shan H, 2015, J TRACE ELEM MED BIO, V31, P85, DOI 10.1016/j.jtemb.2015.03.005; Suzumura Akio, 2014, Rinsho Shinkeigaku, V54, P1119, DOI 10.5692/clinicalneurol.54.1119; Venero JL, 2011, CELL DEATH DIFFER, V18, P1679, DOI 10.1038/cdd.2011.107; Wang L, 2015, PHYTOMEDICINE, V22, P1079, DOI 10.1016/j.phymed.2015.08.009; Yang JY, 2014, PHARMACOL THERAPEUT, V144, P321, DOI 10.1016/j.pharmthera.2014.07.002; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23	27	24	25	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166010	10.1371/journal.pone.0166010	http://dx.doi.org/10.1371/journal.pone.0166010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812200	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000091
J	Zhang, Y; Cao, Y; Zhang, RW; Zhang, XX; Lu, HY; Wu, CH; Huo, N; Xu, XY				Zhang, Yu; Cao, Ying; Zhang, Renwen; Zhang, Xiaxia; Lu, Haiying; Wu, Chihong; Huo, Na; Xu, Xiaoyuan			Pre-Existing HCV Variants Resistant to DAAs and Their Sensitivity to PegIFN/RBV in Chinese HCV Genotype 1b Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; VIRUS NS3/4A PROTEASE; IN-VITRO; NS5A INHIBITOR; POLYMERASE INHIBITORS; PREVALENCE; MUTATIONS; BMS-790052; PROFILE	Background The efficacy of direct-acting antiviral agents (DAAs) could be attenuated by the presence of resistance-associated variants (RAVs). The aim of this study was to investigate the natural prevalence of RAVs among Chinese HCV genotype 1b patients and analyze the efficacy of pegylated interferon (PegIFN)/ribavirin (RBV) therapy in patients with and without RAVs at baseline. Methods Direct sequencing of the HCV NS3, NS5A and NS5B regions was performed in baseline serum samples of 117 DAAs-naive subjects infected with HCV genotype 1b. The efficacy of PegIFN/RBV therapy in patients with and without RAVs at baseline was analyzed by comparing the response rates between patients with RAVs and patients with wild type virus. Results The incidence of RAVs was 8.00% (8/100) in the NS3 region (T54S, n = 1, 1.00%; R117H, n = 5, 5.00%; S122T, n = 1, 1.00%; S174F, n = 1, 1.00%), 29.91% (32/107) in the NS5A region (L28M, n = 12, 11.21%; R30Q, n = 10, 9.35%; L31M, n = 1, 0.93%; P58S, n = 4, 3.74%; Y93H, n = 8, 7.48%) and 98.15% (106/108) in the NS5B region (L159F, n = 1, 0.93%; C316N, n = 103, 95.37%; A421V, n = 6, 5.56%). The response rates to PegIFN/RBV treatment did not differ between patients with or without RAVs in the NS5A region. Conclusions Pre-existing RAVs, including key RAVs, were detected in Chinese DAAs-naive patients infected with HCV genotype 1b. IFN-based therapy could be a good option for patients with RAVs, especially key RAVs, at baseline.	[Zhang, Yu; Cao, Ying; Zhang, Renwen; Zhang, Xiaxia; Lu, Haiying; Wu, Chihong; Huo, Na; Xu, Xiaoyuan] Peking Univ, Dept Infect Dis, Hosp 1, Beijing, Peoples R China	Peking University	Xu, XY (corresponding author), Peking Univ, Dept Infect Dis, Hosp 1, Beijing, Peoples R China.	xiaoyuanxu6@163.com			12th Five-Year Plan of the National Major Project for Infectious Diseases Control [2012ZX10002003]; National Natural Science Foundation of China [81373056]; Beijing Municipal Science and Technology Commission [D141100000314002, D141100000314005]; Postdoctoral Programs Foundation of China [2014M560859]	12th Five-Year Plan of the National Major Project for Infectious Diseases Control; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Postdoctoral Programs Foundation of China	This study was supported by the 12th Five-Year Plan of the National Major Project for Infectious Diseases Control (no. 2012ZX10002003), National Natural Science Foundation of China (no. 81373056), Beijing Municipal Science and Technology Commission of major projects (no. D141100000314002 and D141100000314005) and the Postdoctoral Programs Foundation of China (no. 2014M560859). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L, 2009, CHINESE MED J-PEKING, V122, P5, DOI 10.3760/cma.j.issn.0366-6999.2009.01.002; Bartels DJ, 2013, J VIROL, V87, P1544, DOI 10.1128/JVI.02294-12; European Association for the Study of the Liver, 2014, Journal of Hepatology, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Fridell RA, 2011, HEPATOLOGY, V54, P1924, DOI 10.1002/hep.24594; Fridell RA, 2010, ANTIMICROB AGENTS CH, V54, P3641, DOI 10.1128/AAC.00556-10; Geneva WHO, 2014, GUID SCREEN CAR TREA; Itakura Jun, 2015, PLoS One, V10, pe0138060, DOI 10.1371/journal.pone.0138060; Itakura J, 2015, HEPATOL RES, V45, pE115, DOI 10.1111/hepr.12474; Ju W, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0341-1; Krishnan P, 2015, ANTIMICROB AGENTS CH, V59, P979, DOI 10.1128/AAC.04226-14; Larousse JA, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0318-0; Larousse JA, 2014, J MED VIROL, V86, P1350, DOI 10.1002/jmv.23958; Lawitz EJ, 2012, J HEPATOL, V57, P24, DOI 10.1016/j.jhep.2011.12.029; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Lontok E, 2015, HEPATOLOGY, V62, P1623, DOI 10.1002/hep.27934; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; Paolucci S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-355; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Peres-da-Silva A, 2015, J ANTIMICROB CHEMOTH, V70, P726, DOI 10.1093/jac/dku462; Peres-da-Silva A, 2010, ARCH VIROL, V155, P807, DOI 10.1007/s00705-010-0642-z; Poveda E, 2014, ANTIVIR RES, V108, P181, DOI 10.1016/j.antiviral.2014.05.015; Rao HY, 2014, J GASTROEN HEPATOL, V29, P545, DOI 10.1111/jgh.12398; Sarrazin C., 2016, IMPORTANCE RESISTANC, V2, P486, DOI [10.1016/j.jhep.2015.09.011, DOI 10.1016/J.JHEP.2015.09.011]; Summa V, 2012, ANTIMICROB AGENTS CH, V56, P4161, DOI 10.1128/AAC.00324-12; Tong X, 2014, J INFECT DIS, V209, P668, DOI 10.1093/infdis/jit562; Vicenti I, 2012, J ANTIMICROB CHEMOTH, V67, P984, DOI 10.1093/jac/dkr581; Wang L, 2011, CHINESE MED J-PEKING, V124, P4264, DOI 10.3760/cma.j.issn.0366-6999.2011.24.025; Zeminian LB, 2013, MEM I OSWALDO CRUZ, V108, P13, DOI 10.1590/S0074-02762013000100002	28	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165658	10.1371/journal.pone.0165658	http://dx.doi.org/10.1371/journal.pone.0165658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812165	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000043
J	Williams, RS; Stollings, JH; Bundy, L; Haardorfer, R; Kreuter, MW; Mullen, PD; Hovell, M; Morris, M; Kegler, MC				Williams, Rebecca S.; Stollings, Jana H.; Bundy, Lucja; Haardorfer, Regine; Kreuter, Matthew W.; Mullen, Patricia Dolan; Hovell, Mel; Morris, Marti; Kegler, Michelle C.			A Minimal Intervention to Promote Smoke-Free Homes among 2-1-1 Callers: North Carolina Randomized Effectiveness Trial	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; SECONDHAND SMOKE; YOUNG-CHILDREN; CANCER CONTROL; EXPOSURE; CESSATION; BANS; TRANSLATION; POPULATION; ADAPTATION	This study examined the extent to which delivery of the minimal Smoke-Free Homes intervention by trained 2-1-1 information and referral specialists had an effect on the adoption of home smoking bans in low-income households. A randomized controlled trial was conducted among 2-1-1 callers (n = 500) assigned to control or intervention conditions. 2-1-1 information and referral specialists collected baseline data and delivered the intervention consisting of 3 mailings and 1 coaching call; university-based data collectors conducted follow-up interviews at 3 and 6 months post-baseline. Data were collected from June 2013 through July 2014. Participants were mostly female (87.2%), African American (61.4%), and smokers (76.6%). Participants assigned to the intervention condition were more likely than controls to report a full ban on smoking in the home at both 3-(38.1% vs 19.3%, p = <.001) and 6-month follow-up (43.2% vs 33.2%, p=.02). The longitudinal intent-to-treat analysis showed a significant intervention effect over time (OR = 1.31, p=.001), i.e. OR = 1.72 at 6 months. This study replicates prior findings showing the effectiveness of the minimal intervention to promote smoke-free homes in low-income households, and extends those findings by demonstrating they can be achieved when 2-1-1 information and referral specialists deliver the intervention. Findings offer support for this intervention as a generalizable and scalable model for reducing secondhand smoke exposure in homes.	[Williams, Rebecca S.; Stollings, Jana H.] Univ N Carolina, Ctr Hlth Promot & Dis Prevent, Chapel Hill, NC 27514 USA; [Williams, Rebecca S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27514 USA; [Bundy, Lucja; Haardorfer, Regine; Kegler, Michelle C.] Emory Univ, Rollins Sch Publ Hlth, Emory Prevent Res Ctr, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA; [Kreuter, Matthew W.] Washington Univ, Hlth Commun Res Lab, St Louis, MO USA; [Mullen, Patricia Dolan] Univ Texas Sch Publ Hlth, Ctr Hlth Promot & Prevent Res, Houston, TX USA; [Hovell, Mel] San Diego State Univ, Grad Sch Publ Hlth, Ctr Behav Epidemiol & Community Hlth, San Diego, CA 92182 USA; [Morris, Marti] United Way North Carolina, NC 2-1-1, Cary, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Emory University; Rollins School Public Health; Washington University (WUSTL); University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; California State University System; San Diego State University	Williams, RS (corresponding author), Univ N Carolina, Ctr Hlth Promot & Dis Prevent, Chapel Hill, NC 27514 USA.; Williams, RS (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27514 USA.	rebeccawilliams@unc.edu			National Cancer Institute's State and Community Tobacco Control Research Initiative [U01 CA154282]; University of North Carolina; United Way; NATIONAL CANCER INSTITUTE [U01CA154282, P30CA016086] Funding Source: NIH RePORTER	National Cancer Institute's State and Community Tobacco Control Research Initiative; University of North Carolina; United Way; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute's (http://www.cancer.gov/) State and Community Tobacco Control Research Initiative (grant number U01 CA154282). This funder provided salary support for authors RSW, JHS, LB, RH, MWK, PDM, MH, MCK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Financial support was provided to the United Way of North Carolina for assistance in executing study protocol and activities, in the form of a grant subcontract from the University of North Carolina, to compensate them for call center staff time required to complete study activities. Independent of the grant subcontract, United Way provided support in the form of salary for the author MM. The specific roles of these authors are articulated in the 'author contributions' section.	Bandura A., 1986, SOCIAL FDN THOUGHT A; BIENER L, 1991, HEALTH PSYCHOL, V10, P360, DOI 10.1037/0278-6133.10.5.360; Biener L, 1999, J OCCUP ENVIRON MED, V41, P1121, DOI 10.1097/00043764-199912000-00017; Bopp M, 2013, J PRIM PREV, V34, P193, DOI 10.1007/s10935-013-0299-y; Bowen DJ, 2009, CANCER CAUSE CONTROL, V20, P473, DOI 10.1007/s10552-009-9308-0; Carvalho ML, 2013, J PUBLIC HEALTH MAN, V19, P348, DOI 10.1097/PHH.0b013e31826d80eb; Centers for Disease Control and Prevention, 2008, BEH RISK FACT SURV S; Emmons KM, 2001, PEDIATRICS, V108, P18, DOI 10.1542/peds.108.1.18; Escoffery C, 2009, HEALTH EDUC RES, V24, P76, DOI 10.1093/her/cym095; Forster JL, 2007, AM J PREV MED, V33, pS335, DOI 10.1016/j.amepre.2007.09.014; Gehrman CA, 2003, NICOTINE TOB RES, V5, P289, DOI 10.1080/1462220031000094231; Glasgow RE, 2003, AM J PUBLIC HEALTH, V93, P1261, DOI 10.2105/AJPH.93.8.1261; Glasgow RE, 2006, ANN BEHAV MED, V31, P105, DOI 10.1207/s15324796abm3102_1; Green LW, 2006, EVAL HEALTH PROF, V29, P126, DOI 10.1177/0163278705284445; Homa DM, 2015, MMWR-MORBID MORTAL W, V64, P103; Hopkins DP, 2001, AM J PREV MED, V20, P16, DOI 10.1016/S0749-3797(00)00297-X; Hovell ME, 2009, NICOTINE TOB RES, V11, P1254, DOI 10.1093/ntr/ntp133; Hovell MF, 2009, NICOTINE TOB RES, V11, P1383, DOI 10.1093/ntr/ntp148; Hovell MF, 2000, BRIT MED J, V321, P337, DOI 10.1136/bmj.321.7257.337; HOVELL MF, 1994, CHEST, V106, P440, DOI 10.1378/chest.106.2.440; Hovell MF, 2002, PEDIATRICS, V110, P946, DOI 10.1542/peds.110.5.946; Hyland A, 2009, NICOTINE TOB RES, V11, P614, DOI 10.1093/ntr/ntp022; International Agency for Research on Cancer, 2009, EM RES MAT, P9; Kaufmann R. B., 2010, Morbidity and Mortality Weekly Report, V59, P1141; Kegler M.C., 2012, J ENV PUBLIC HLTH, V2012, DOI [10.1155/2012/951426, DOI 10.1155/2012/951426]; Kegler MC, 2002, PREV MED, V35, P334, DOI 10.1006/pmed.2002.1091; Kegler MC, 2007, FAM COMMUNITY HEALTH, V30, P328, DOI 10.1097/01.FCH.0000290545.56199.c9; Kegler MC, 2015, AM J PUBLIC HEALTH, V105, P530, DOI 10.2105/AJPH.2014.302260; Kemp L, 2016, PREV SCI, V17, P429, DOI 10.1007/s11121-016-0642-7; King BA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120218; Kreuter MW, 2012, AM J PREV MED, V43, pS425, DOI 10.1016/j.amepre.2012.09.004; Kreuter MW, 2012, AM J PREV MED, V43, pS420, DOI 10.1016/j.amepre.2012.09.024; Mercer SL, 2007, AM J PREV MED, V33, P139, DOI 10.1016/j.amepre.2007.04.005; Messer K, 2008, AM J PREV MED, V35, P210, DOI 10.1016/j.amepre.2008.05.023; Mills AL, 2011, AM J PREV MED, V41, P559, DOI 10.1016/j.amepre.2011.08.016; Norman GJ, 1999, PREV MED, V29, P581, DOI 10.1006/pmed.1999.0574; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Pirkle JL, 2006, ENVIRON HEALTH PERSP, V114, P853, DOI 10.1289/ehp.8850; Pizacani BA, 2004, TOB CONTROL, V13, P23, DOI 10.1136/tc.2003.003038; Pizacani BA, 2003, PREV MED, V36, P99, DOI 10.1006/pmed.2002.1123; PROCHASKA JO, 1982, PSYCHOTHER-THEOR RES, V19, P276, DOI 10.1037/h0088437; Purnell JQ, 2012, J HEALTH CARE POOR U, V23, P752, DOI 10.1353/hpu.2012.0061; Rosen LJ, 2012, PEDIATRICS, V129, P141, DOI 10.1542/peds.2010-3209; Schober S. E., 2008, Morbidity and Mortality Weekly Report, V57, P744; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Sockrider MM, 2003, NICOTINE TOB RES, V5, P901, DOI 10.1080/14622200310001615240; Stotts AL, 2013, J PERINATOL, V33, P811, DOI 10.1038/jp.2013.43; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; Tyc VL, 2013, PSYCHO-ONCOLOGY, V22, P1104, DOI 10.1002/pon.3117; U.S. Department of Health and Human Services, 2010, REP SURG GEN TOB SMO; Valentine JC, 2011, PREV SCI, V12, P103, DOI 10.1007/s11121-011-0217-6; World Health Organization, TOB FREE IN SURV MON	52	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165086	10.1371/journal.pone.0165086	http://dx.doi.org/10.1371/journal.pone.0165086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806060	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500019
J	Eulenburg, C; Suling, A; Neuser, P; Reuss, A; Canzler, U; Fehm, T; Luyten, A; Hellriegel, M; Woelber, L; Mahner, S				Eulenburg, Christine; Suling, Anna; Neuser, Petra; Reuss, Alexander; Canzler, Ulrich; Fehm, Tanja; Luyten, Alexander; Hellriegel, Martin; Woelber, Linn; Mahner, Sven			Propensity Scoring after Multiple Imputation in a Retrospective Study on Adjuvant Radiation Therapy in Lymph-Node Positive Vulvar Cancer	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; CAUSAL INFERENCE; MISSING VALUES; BIAS REDUCTION; SURVIVAL; ADJUSTMENT; REGRESSION	Propensity scoring (PS) is an established tool to account for measured confounding in non-randomized studies. These methods are sensitive to missing values, which are a common problem in observational data. The combination of multiple imputation of missing values and different propensity scoring techniques is addressed in this work. For a sample of lymph node-positive vulvar cancer patients, we re-analyze associations between the application of radiotherapy and disease-related and non-related survival. Inverse-probability-of-treatment-weighting (IPTW) and PS stratification are applied after multiple imputation by chained equation (MICE). Methodological issues are described in detail. Interpretation of the results and methodological limitations are discussed.	[Eulenburg, Christine] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Med Stat & Decis Making, Groningen, Netherlands; [Suling, Anna] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Neuser, Petra; Reuss, Alexander] KKS Philipps Univ Marburg, Marburg, Germany; [Canzler, Ulrich] Univ Dresden, Dept Gynecol & Obstet, Dresden, Germany; [Fehm, Tanja] Univ Med Ctr Duesseldorf, Dept Gynecol, Dusseldorf, Germany; [Fehm, Tanja] Univ Hosp Tuebingen, Dept Gynecol & Obstet, Tubingen, Germany; [Luyten, Alexander] Klinikum Wolfsburg, Dept Gynecol Obstet & Gynecol Oncol, Wolfsburg, Germany; [Hellriegel, Martin] Univ Gottingen, Dept Gynecol, Gottingen, Germany; [Woelber, Linn] Univ Med Ctr Hamburg Eppendorf, Dept Gynecol & Gynecol Oncol, Hamburg, Germany; [Mahner, Sven] Univ Munich, Dept Gynecol & Obstet, Munich, Germany	University of Groningen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Philipps University Marburg; Technische Universitat Dresden; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich	Eulenburg, C (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Med Stat & Decis Making, Groningen, Netherlands.	c.h.zu.eulenburg@umcg.nl		Fehm, Tanja/0000-0002-4926-0108	Medac oncology company	Medac oncology company	The AGO-CaRE 1 study was partially supported by Medac oncology company without any influence in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of this manuscript; and decision to submit the manuscript for publication.	[Anonymous], 2015, PBALCHK CHECKING COV; [Anonymous], 2014, PSMATCH2 STATA MODUL; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Baser O, 2006, VALUE HEALTH, V9, P377, DOI 10.1111/j.1524-4733.2006.00130.x; Becker SO, 2002, STATA J, V2, P358, DOI 10.1177/1536867X0200200403; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Brookhart MA, 2013, CIRC-CARDIOVASC QUAL, V6, P604, DOI 10.1161/CIRCOUTCOMES.113.000359; Crowson C.S., 2013, BASICS PROPENSITY SC; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dehejia RH, 1999, J AM STAT ASSOC, V94, P1053, DOI 10.2307/2669919; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Greenland S, 2011, INT STAT REV, V79, P401, DOI 10.1111/j.1751-5823.2011.00158.x; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Lunt M., 2011, GUIDE IMPUTING MISSI; Mahner S, 2015, J NATL CANC I, V107; Mertens BJ, 2014, STAT METHODS MED RES; Mitra R, 2012, STAT METHODS MED RES; Qu YM, 2009, STAT MED, V28, P1402, DOI 10.1002/sim.3549; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rosenbaum P, 2014, J AM STAT ASSOC, V79, P516; ROSENBAUM PR, 1987, J AM STAT ASSOC, V82, P387, DOI 10.2307/2289440; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Royston P, 2005, STATA J, V5, P1; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; RUBIN DB, 1980, BIOMETRICS, V36, P293, DOI 10.2307/2529981; RUBIN DB, 1979, J AM STAT ASSOC, V74, P318, DOI 10.2307/2286330; Rubin DB, 2004, MULTIPLE IMPUTATION; Rubin DB, 2010, AM J OPHTHALMOL, V149, P7, DOI 10.1016/j.ajo.2009.08.024; Seaman S, 2014, COMMUN STAT-THEOR M, V43, P3499, DOI 10.1080/03610926.2012.700371; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Westreich D, 2010, J CLIN EPIDEMIOL, V63, P826, DOI 10.1016/j.jclinepi.2009.11.020; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	40	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165705	10.1371/journal.pone.0165705	http://dx.doi.org/10.1371/journal.pone.0165705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802342	Green Submitted, Green Published, gold			2022-12-27	WOS:000386714200041
J	Malecka-Massalska, T; Mlak, R; Smolen, A; Brzozowska, A; Surtel, W; Morshed, K				Malecka-Massalska, Teresa; Mlak, Radoslaw; Smolen, Agata; Brzozowska, Anna; Surtel, Wojciech; Morshed, Kamal			Capacitance of Membrane As a Prognostic Indicator of Survival in Head and Neck Cancer	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; TISSUE ELECTRICAL-PROPERTIES; HEALTHY-HUMAN SUBJECTS; QUALITY-OF-LIFE; PHASE-ANGLE; CLINICAL-PRACTICE; MALNUTRITION; PREVALENCE; TUMORS	Background Evaluation of prognostic value of capacitance of membrane (Cm), parameter measured by bioelectrical impedance (BIA) as an alternative to known clinical factors in patients with Head and Neck Cancer (HNC). Methods A cohort of 75 stage IIIB and IV HNC patients treated in Department of Otolaryngology, Head and Neck Surgery, Medical University of Lublin, Poland were prospectively evaluated. Cm measurements were performed in all patients using a bioelectrical impedance analyzer that was set on a frequency of 50 kHz. Results of Cm measurements were presented in nF. Survival differences were estimated using Kaplan-Meier method. Results Significantly higher Cm median was noted in well-nourished(n = 45) compared to malnourished (n = 30) patients (1.41 vs 1.01 respectively; p = 0.0009). Established in ROC curves analysis cut-off value (0.743) was characterized by 98% specificity and 37% sensitivity in the detection of malnutrition. Median overall survival (mOS) in the cohort was 32months. At the time of analysis deaths were recorded in 47 cases (62.7%). In patients who had Cm below the level of 0.743 risk of OS shortening was significantly higher than in other patients (12.1 and 43.4 months respectively; HR = 8.47, 95% CI: 2.91 - 24.66; chi(2) = 15.38, p = 0.0001). Conclusion Cm is a strong, independent prognostic factor in head and neck cancer.	[Malecka-Massalska, Teresa; Mlak, Radoslaw] Med Univ Lublin, Dept Human Physiol, Lublin, Poland; [Smolen, Agata; Morshed, Kamal] Med Univ Lublin, Dept Epidemiol & Methodol Clin Res, Lublin, Poland; [Brzozowska, Anna] Med Univ Lublin, Dept Oncol, Lublin, Poland; [Surtel, Wojciech] Tech Univ Lublin, Inst Elect & Informat Technol, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Lublin University of Technology	Malecka-Massalska, T (corresponding author), Med Univ Lublin, Dept Human Physiol, Lublin, Poland.	t.malecka@gmail.com	Miak, Radoslaw/I-9994-2019	Miak, Radoslaw/0000-0001-7399-8340; Malecka-Massalska, Teresa/0000-0003-3384-0324; Morshed, Kamal/0000-0003-0061-0362; Brzozowska, Anna/0000-0002-8883-5816				[Anonymous], [No title captured]; Barbosa-Silva MCG, 2003, NUTRITION, V19, P422, DOI 10.1016/S0899-9007(02)00932-2; Blad B, 1996, PHYSIOL MEAS, V17, pA105, DOI 10.1088/0967-3334/17/4A/015; Davis MP, 2009, AM J HOSP PALLIAT ME, V26, P180, DOI 10.1177/1049909108330028; De Luis DA, 2006, ANN NUTR METAB, V50, P7, DOI 10.1159/000089484; Desport JC, 2003, AM J CLIN NUTR, V77, P1179, DOI 10.1093/ajcn/77.5.1179; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; FRICKE HUGO, 1926, JOUR CANCER RES, V10, P340; Garcia-Peris P, 2007, CLIN NUTR, V26, P710, DOI 10.1016/j.clnu.2007.08.006; Grundmann O, 2015, EUROPEAN J CLIN NUTR, P1; Guo CB, 2007, BRIT J ORAL MAX SURG, V45, P467, DOI 10.1016/j.bjoms.2006.11.014; Gupta D, 2004, AM J CLIN NUTR, V80, P1634, DOI 10.1093/ajcn/80.6.1634; Health and Social Care Information Centre, 2014, NAT HEAD NECK CANC A; Hui D, 2014, CANCER-AM CANCER SOC, V120, P2207, DOI 10.1002/cncr.28624; Kumar S, 2012, IRAN J BASIC MED SCI, V15, P1180; Leandro-Merhi VA, 2014, CLINNUTR, V14, pS0261; Lee SY, 2014, KOREAN J FAM MED, V35, P251, DOI 10.4082/kjfm.2014.35.5.251; Liboff AR, 1997, BIOELECTROMAGNETICS, V18, P85, DOI 10.1002/(SICI)1521-186X(1997)18:1<85::AID-BEM13>3.0.CO;2-P; Maggiore Q, 1996, KIDNEY INT, V50, P2103, DOI 10.1038/ki.1996.535; Malecka-Massalska T, 2014, INDIAN J CANCER, V51, P209, DOI 10.4103/0019-509X.146717; Malecka-Massalska T, 2013, HEAD NECK-J SCI SPEC, V35, P1101, DOI 10.1002/hed.23091; Norman K, 2010, AM J CLIN NUTR, V92, P612, DOI 10.3945/ajcn.2010.29215; OTT M, 1995, J ACQ IMMUN DEF SYND, V9, P20; Pencharz PB, 1996, AM J CLIN NUTR, V64, P485; Santarpia L, 2009, NUTRITION, V25, P930, DOI 10.1016/j.nut.2009.01.015; Schwenk A, 2000, AM J CLIN NUTR, V72, P496; Segura A, 2005, CLIN NUTR, V24, P801, DOI 10.1016/j.clnu.2005.05.001; Selberg O, 2002, EUR J APPL PHYSIOL, V86, P509, DOI 10.1007/s00421-001-0570-4; SIMONS JPFHA, 1995, AM J CLIN NUTR, V61, P741, DOI 10.1093/ajcn/61.4.741; Stern RG, 1999, MED HYPOTHESES, V52, P367, DOI 10.1054/mehy.1997.0657; SZENTGYORGYI A, 1968, SCIENCE, V161, P988, DOI 10.1126/science.161.3845.988; ZAROWITZ BJ, 1989, DICP ANN PHARMAC, V23, P548, DOI 10.1177/1060028089023007-803	32	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165809	10.1371/journal.pone.0165809	http://dx.doi.org/10.1371/journal.pone.0165809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802349	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200056
J	Sheweita, SA; El-Hosseiny, LS; Nashashibi, MA				Sheweita, Salah A.; El-Hosseiny, Lobna S.; Nashashibi, Munther A.			Protective Effects of Essential Oils as Natural Antioxidants against Hepatotoxicity Induced by Cyclophosphamide in Mice	PLOS ONE			English	Article							DRUG-METABOLIZING-ENZYMES; OXIDATIVE STRESS; INDUCED GENOTOXICITY; GLUTATHIONE; DAMAGE; TRANSFERASE; ACTIVATION; QUERCETIN; INDUCTION; REDUCTASE	Clinical application of cyclophosphamide (CP) as an anticancer drug is often limited due to its toxicity. CP is metabolized mainly in the liver by cytochrome P450 system into acrolein which is the proximate toxic metabolite. Many different natural antioxidants were found to alleviate the toxic effects of various toxic agents via different mechanisms. Therefore, the present study aimed at investigating the role of essential oils extracted from fennel, cumin and clove as natural antioxidants in the alleviation of hepatotoxicity induced by CP through assessment of hepatotoxicity biomarkers (AST, ALT, ALP), histopathology of liver tissues as well as other biochemical parameters involved in the metabolism of CP. The data of the present study showed that treatment of male mice with cyclophosphamide (2.5 mg/Kg BW) as repeated dose for 28 consecutive days was found to induce hepatotoxicity through the elevation in the activities of AST, ALT, and ALP. Combined administration of any of these oils with CP to mice partially normalized the altered hepatic biochemical markers caused by CP, whereas administration of fennel, clove or cumin essential oils alone couldn't change liver function indices. Moreover, CP caused histological changes in livers of mice including swelling and dilation in sinusoidal space, inflammation in portal tract and hepatocytes, as well as, hyperplasia in Kuppfer cells. However, co-administration of any of the essential oils with CP alleviated to some extent the changes caused by CP but not as the normal liver. CP was also found to induce free radical levels (measured as thiobarbituric acid reactive substances) and inhibited the activities of superoxide dismutase, glutathione reductase, and catalase as well as activities and protein expressions of both (GST pi) and glutathione peroxidase. Essential oils restored changes in activities of antioxidant enzymes (SOD, CAT, GR, GST, and GPx) caused by CP to their normal levels compared to control group. In addition, treatment of mice with CP was found to induce the protein expression of CYP 3A4, 2B1/2, 2C6, 2C23. Moreover, the present study showed that essential oils reduced the expression of CYPs 2E1, 3A4 but could not restore the expression of CYP 2C6 and 2C23 compared to CP-treated mice. Interestingly, pretreatment of mice with essential oil of clove was found to restore activities of DMN-dI, AHH, and ECOD which were induced by CP to their normal control levels. It is concluded that EOs showed a marked hepatoprotective effect against hepatotoxicity induced by CP. In addition, co-administration of CP with any of these oils might be used as a new strategy for cancer treatment to alleviate the hepatotoxicity induced by CP.	[Sheweita, Salah A.; Nashashibi, Munther A.] Univ Alexandria, Inst Grad Studies & Res, Dept Biotechnol, Alexandria, Egypt; [El-Hosseiny, Lobna S.] Univ Alexandria, Inst Grad Studies & Res, Dept Environm Studies, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University	Sheweita, SA (corresponding author), Univ Alexandria, Inst Grad Studies & Res, Dept Biotechnol, Alexandria, Egypt.	ssheweita@yahoo.com	Sheweita, Salah A/AFU-1622-2022	Sheweita, Salah A/0000-0001-8113-4403; El-Hosseiny, Lobna/0000-0001-9770-7835				Aboul-Ela El, 2014, J CELL BIOL, V2, P18; Abozid MM, 2013, INT J CHEM TECH RES, V5, P1470; Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; ARIYOSHI T, 1975, XENOBIOTICA, V5, P33, DOI 10.3109/00498257509056091; AUSTIN CA, 1988, BIOCHEM PHARMACOL, V37, P2223, DOI 10.1016/0006-2952(88)90585-0; Badgujar SB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/842674; Barakat L. A. A., 2011, Journal of Applied Sciences Research, P1368; Barouki R, 2007, FEBS LETT, V581, P749, DOI [10.1016/j.febslet.2007.01.044, DOI 10.1016/J.FEBSLET.2007.01.044]; Baskaran Y, 2010, TOXICOLOGY, V268, P204, DOI 10.1016/j.tox.2009.12.018; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bhattacharya A, 2003, J AM COLL NUTR, V22, P388, DOI 10.1080/07315724.2003.10719322; Chakraborty P, 2009, CANCER CHEMOTH PHARM, V64, P971, DOI 10.1007/s00280-009-0950-8; Chang TKH, 1997, CANCER RES, V57, P1946; CHIU DTY, 1976, BIOCHIM BIOPHYS ACTA, V445, P558, DOI 10.1016/0005-2744(76)90110-8; Conklin DJ, 2009, J PHARMACOL EXP THER, V331, P456, DOI 10.1124/jpet.109.156513; Cortes-Rojas Diego Francisco, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P90, DOI 10.1016/S2221-1691(14)60215-X; David M., 1983, METHOD ENZYMAT AN, P358; De-Oliveira ACAX, 1997, TOXICOLOGY, V124, P135, DOI 10.1016/S0300-483X(97)00144-3; Dhanalakshmi GS, 2003, NUTR CANCER, V47, P171, DOI 10.1207/s15327914nc4702_10; Drury AR., 1980, CARLETONS HISTOLOGIC, V5; Emadi A, 2009, NAT REV CLIN ONCOL, V6, P638, DOI 10.1038/nrclinonc.2009.146; Gnanasekaran Sadhana, 2015, J Exp Ther Oncol, V11, P51; GOPALAN P, 1993, CARCINOGENESIS, V14, P1469, DOI 10.1093/carcin/14.7.1469; GREENLEE WF, 1978, J PHARMACOL EXP THER, V205, P596; Gupta AK, 2006, AM J PHARM TOXICOL, V1, P17, DOI [DOI 10.3844/AJPTSP.2006.17.20, 10.3844/ajptsp.2006.17.20]; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Han EH, 2007, FEBS LETT, V581, P749, DOI 10.1016/j.febslet.2007.01.044; Huang HC, 2015, INT J MOL SCI, V16, P10470, DOI 10.3390/ijms160510470; IARC, 2012, IARC MON A, V100A; Johri R K, 2011, Pharmacogn Rev, V5, P63, DOI 10.4103/0973-7847.79101; Kalmes M, 2012, J TOXICOL ENV HEAL A, V75, P478, DOI 10.1080/15287394.2012.674916; Kaurinovic B, 2010, MOLECULES, V15, P5943, DOI 10.3390/molecules15095943; Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maor Y, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/815105; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Misharina TA, 2008, APPL BIOCHEM MICRO+, V44, P438, DOI 10.1134/S0003683808040182; MISRA HP, 1972, J BIOL CHEM, V247, P3170; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185; Moignet A, 2014, LEUKEMIA, V28, P1134, DOI 10.1038/leu.2013.359; Mostafa M, 1992, RAMAZZINI NEWSLETTER, V2, P15; MURRAY GI, 1987, BRIT J CANCER, V55, P605, DOI 10.1038/bjc.1987.123; Musonda CA, 1998, CARCINOGENESIS, V19, P1583, DOI 10.1093/carcin/19.9.1583; Muzio G, 1999, FREE RADICAL BIO MED, V26, P1314, DOI 10.1016/S0891-5849(98)00329-3; Myers CR, 2009, TOXICOLOGY, V257, P95, DOI 10.1016/j.tox.2008.12.013; Nadeem M., 2012, PAK J FOOD SCI, V22, P101; Nithya N., 2012, Journal of Pharmacology and Toxicology, V7, P38, DOI 10.3923/jpt.2012.38.45; Rabeh N. M., 2014, Pakistan Journal of Nutrition, V13, P303; Rayan D., 1978, METHOD ENZYMOL, V752, P118; Rodriguez-Antona C, 2006, ONCOGENE, V25, P1679, DOI 10.1038/sj.onc.1209377; Saleh MA, 2010, ETHNIC DIS, V20, P78; Shanmugarajan TS, 2008, J PHARM TOXICOL, V3, P363, DOI DOI 10.3923/JPT.2008.363.372; Sheweita SA, 2000, CURR DRUG METAB, V1, P107, DOI 10.2174/1389200003339117; Sheweita SA, 2003, CURR DRUG METAB, V4, P45, DOI 10.2174/1389200033336919; Singh S, 2015, INDIAN J EXP BIOL, V53, P647; TAPPEL A. L., 1959, ARCH BIOCHEM AND BIOPHYS, V80, P333, DOI 10.1016/0003-9861(59)90259-0; Tripathi P, 2013, DRUG CHEM TOXICOL, V36, P396, DOI 10.3109/01480545.2012.749271; Tripathi P, 2013, DRUG CHEM TOXICOL, V36, P35, DOI 10.3109/01480545.2011.648328; Tsai-Turton M, 2007, TOXICOL SCI, V98, P216, DOI 10.1093/toxsci/kfm087; VENKATESAN N, 1968, LIFE SCI PT 1 PHYSI, V7, P1111, DOI 10.1016/0024-3205(68)90217-8; Vieira PM, 2012, J MED FOOD, V15, P563, DOI 10.1089/jmf.2011.0270; Wahlang B, 2015, Adv Pharmacol, V74, P1, DOI 10.1016/bs.apha.2015.04.004; WILLIAMS CH, 1962, J BIOL CHEM, V237, P587; Xie HJ, 2003, PHARMACOGENOMICS J, V3, P53, DOI 10.1038/sj.tpj.6500157; Zarei M, 2013, FOOD CHEM TOXICOL, V57, P179, DOI 10.1016/j.fct.2013.03.028; Zhang YLMCQ, 2005, TOXICOL SCI, V88, P545, DOI 10.1093/toxsci/kfi333; Zhou SF, 2007, CURR DRUG METAB, V8, P526; Zhu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep17536	68	48	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165667	10.1371/journal.pone.0165667	http://dx.doi.org/10.1371/journal.pone.0165667			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802299	Green Published, Green Submitted, gold			2022-12-27	WOS:000386714200036
J	Walter, RFH; Werner, R; Vollbrecht, C; Hager, T; Flom, E; Christoph, DC; Schmeller, J; Schmid, KW; Wohlschlaeger, J; Mairinger, FD				Walter, Robert Fred Henry; Werner, Robert; Vollbrecht, Claudia; Hager, Thomas; Flom, Elena; Christoph, Daniel Christian; Schmeller, Jan; Schmid, Kurt Werner; Wohlschlaeger, Jeremias; Mairinger, Fabian Dominik			ACTB, CDKN1B, GAPDH, GRB2, RHOA and SDCBP Were Identified as Reference Genes in Neuroendocrine Lung Cancer via the nCounter Technology	PLOS ONE			English	Article							EXPRESSION ANALYSIS; RNA EXPRESSION; TUMORS; TISSUE; SAMPLES; MARKER	Background Neuroendocrine lung cancer (NELC) represents 25% of all lung cancer cases and large patient collectives exist as formalin-fixed, paraffin-embedded (FFPE) tissue only. FFPE is controversially discussed as source for molecular biological analyses and reference genes for NELC are poorly establishes. Material and methods Forty-three representative FFPE-specimens were used for mRNA expression analysis using the digital nCounter technology (NanoString). Based on recent literature, a total of 91 mRNA targets were investigated as potential tumor markers or reference genes. The geNorm, NormFinder algorithms and coefficient of correlation were used to identify the most stable reference genes. Statistical analysis was performed by using the R programming environment (version 3.1.1) Results RNA integrity (RIN) ranged from 1.8 to 2.6 and concentrations from 34 to 2,109 ng/mu l. However, the nCounter technology gave evaluable results for all samples tested. ACTB, CDKN1B, GAPDH, GRB2, RHOA and SDCBP were identified as constantly expressed genes with high stability (M-) values according to geNorm, NormFinder and coefficients of correlation. Conclusion FFPE-derived mRNA is suitable for molecular biological investigations via the nCounter technology, although it is highly degraded. ACTB, CDKN1B, GAPDH, GRB2, RHOA and SDCBP are potent reference genes in neuroendocrine tumors of the lung.	[Walter, Robert Fred Henry; Flom, Elena] Univ Duisburg Essen, Univ Hosp Essen, West German Lung Ctr, Ruhrlandklin, Essen, Germany; [Walter, Robert Fred Henry; Hager, Thomas; Schmeller, Jan; Schmid, Kurt Werner; Wohlschlaeger, Jeremias; Mairinger, Fabian Dominik] Univ Duisburg Essen, Univ Hosp Essen, Inst Pathol, Essen, Germany; [Werner, Robert] Helios Klinikum Emil von Behring, Inst Pathol, Berlin, Germany; [Vollbrecht, Claudia] German Canc Consortium DKTK, Partnersite Berlin, Berlin, Germany; [Vollbrecht, Claudia] Charite, Inst Pathol, Berlin, Germany; [Vollbrecht, Claudia] German Canc Res Ctr, Heidelberg, Germany; [Christoph, Daniel Christian] Univ Duisburg Essen, Univ Hosp Essen, Dept Med Oncol, West German Canc Ctr, Essen, Germany; [Wohlschlaeger, Jeremias] Ev Luth Diakonissenkrankenhaus Flensburg, Inst Pathol, Flensburg, Germany	University of Duisburg Essen; University of Duisburg Essen; Helios Kliniken; Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen	Walter, RFH (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, West German Lung Ctr, Ruhrlandklin, Essen, Germany.; Walter, RFH (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Pathol, Essen, Germany.	robert.walter@ruhrlandklinik.uk-essen.de		Schmeller, Jan/0000-0002-2012-2350; Walter, Robert/0000-0003-3725-7064; Mairinger, Fabian/0000-0003-1067-0051; Vollbrecht, Claudia/0000-0002-0861-001X	Institute of Pathology and Ruhrlandklinik	Institute of Pathology and Ruhrlandklinik	The study was financed by the Institute of Pathology and Ruhrlandklinik.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Beaume M, 2011, J MICROBIOL METH, V84, P327, DOI 10.1016/j.mimet.2010.12.025; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dhakal B, 2016, F1000RES, V5; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Joerger M, 2010, CURR DRUG TARGETS, V11, P37, DOI 10.2174/138945010790030974; Kalmar A, 2013, METHODS, V59, pS16, DOI 10.1016/j.ymeth.2012.09.011; Lewis F, 2001, J PATHOL, V195, P66, DOI 10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F; Li RN, 2013, LIFE SCI, V92, P747, DOI 10.1016/j.lfs.2013.02.014; Mairinger FD, 2014, J CANCER, V5, P465, DOI 10.7150/jca.9235; Mairinger FD, 2014, MODERN PATHOL, V27, P1632, DOI 10.1038/modpathol.2014.74; Mairinger FD, 2014, J CANCER, V5, P646, DOI 10.7150/jca.9955; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Rekhtman N, 2010, ARCH PATHOL LAB MED, V134, P1628, DOI 10.1043/2009-0583-RAR.1; Sobin LH., 2003, INT UNION CANC UICC, V7, DOI [10.1002/0471463752, DOI 10.1002/0471463752]; Travis WD., 2004, TRAVIS WB WHO CLASSI; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vollbrecht C, 2015, BRIT J CANCER, V113, P1704, DOI 10.1038/bjc.2015.397; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Walter R. F. H., 2016, ONCOTARGET; Walter RFH, 2015, ONCOTARGET, V6, P24690, DOI 10.18632/oncotarget.3992; Walter RFH, 2015, FUTURE ONCOL, V11, P1027, DOI 10.2217/fon.15.18; Walter RFH, 2013, PATHOL RES PRACT, V209, P784, DOI 10.1016/j.prp.2013.09.007	23	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165181	10.1371/journal.pone.0165181	http://dx.doi.org/10.1371/journal.pone.0165181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802291	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200019
J	Guo, QY; Miller, D; An, HY; Wang, H; Lopez, J; Lough, D; He, L; Kumar, A				Guo, Qiongyu; Miller, Devin; An, Hongying; Wang, Howard; Lopez, Joseph; Lough, Denver; He, Ling; Kumar, Anand			Controlled Heat Stress Promotes Myofibrillogenesis during Myogenesis	PLOS ONE			English	Article							SKELETAL-MUSCLE REGENERATION; MITOCHONDRIAL BIOGENESIS; MYOBLAST FUSION; DIFFERENTIATION; GENE; HYPERTHERMIA; ACTIVATION; EXPRESSION; ATROPHY; CELLS	Hyperthermia therapy has recently emerged as a clinical modality used to finely tune heat stress inside the human body for various biomedical applications. Nevertheless, little is known regarding the optimal timing or temperature of heat stress that is needed to achieve favorable results following hyperthermia therapy for muscle regeneration purposes. The regeneration of skeletal muscle after injury is a highly complex and coordinated process that involves a multitude of cellular mechanisms. The main objective of this study was to characterize the effects of hyperthermal therapy on the overall behavior of myoblasts during myogenic differentiation. Various cellular processes, including myogenesis, myofibrillogenesis, hypertrophy/atrophy, and mitochondrial biogenesis, were studied using systematic cellular, morphological, and pathway-focused high-throughput gene expression profiling analyses. We found that C2C12 myoblasts exhibited distinctive time and temperature-dependence in biosynthesis and regulatory events during myogenic differentiation. Specifically, we for the first time observed that moderate hyperthermia at 39 degrees C favored the growth of sarcomere in myofibrils at the late stage of myogenesis, showing universal up-regulation of characteristic myofibril proteins. Characteristic myofibrillogenesis genes, including heavy polypeptide 1 myosin, heavy polypeptide 2 myosin, alpha 1 actin, nebulin and titin, were all significantly upregulated (p<0.01) after C2C12 cells differentiated at 39 degrees C over 5 days compared with the control cells cultured at 37 degrees C. Furthermore, moderate hyperthermia enhanced myogenic differentiation, with nucleus densities per myotube showing 2.2-fold, 1.9-fold and 1.6-fold increases when C2C12 cells underwent myogenic differentiation at 39 E C over 24 hours, 48 hours and 72 hours, respectively, as compared to the myotubes that were not exposed to heat stress. Yet, atrophy genes were sensitive even to moderate hyperthermia, indicating that strictly controlled heat stress is required to minimize the development of atrophy in myotubes. In addition, mitochondrial biogenesis was enhanced following thermal induction of myoblasts, suggesting a subsequent shift toward anabolic demand requirements for energy production. This study offers a new perspective to understand and utilize the time and temperature-sensitive effects of hyperthermal therapy on muscle regeneration.	[Guo, Qiongyu; Miller, Devin; Wang, Howard; Lopez, Joseph; Lough, Denver; Kumar, Anand] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD 21218 USA; [An, Hongying; He, Ling] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Metab, Baltimore, MD 21205 USA; [An, Hongying; He, Ling] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Endocrinol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kumar, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD 21218 USA.	akumar40@jhu.edu	Guo, Qiongyu/J-3118-2014; Lopez, Joseph/AAD-7424-2020	Guo, Qiongyu/0000-0002-1916-9100; Lopez, Joseph/0000-0001-8723-6347; Kumar, Anand/0000-0002-4429-0236	Johns Hopkins School of Medicine Faculty Start Up Research Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107641] Funding Source: NIH RePORTER	Johns Hopkins School of Medicine Faculty Start Up Research Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by Johns Hopkins School of Medicine Faculty Start Up Research Grant (AK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Bartoli M, 2005, INT J BIOCHEM CELL B, V37, P2115, DOI 10.1016/j.biocel.2004.12.012; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Castellani JW, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12777; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Chatterjee DK, 2011, THER DELIV, V2, P1001, DOI 10.4155/TDE.11.72; Cleveland BM, 2010, COMP BIOCHEM PHYS B, V157, P248, DOI 10.1016/j.cbpb.2010.06.010; Crawford Garland L, 2011, Biophys Rev, V3, P25, DOI 10.1007/s12551-011-0043-x; Duguez S, 2002, AM J PHYSIOL-ENDOC M, V282, pE802, DOI 10.1152/ajpendo.00343.2001; Foulstone EJ, 2003, J CELL PHYSIOL, V195, P70, DOI 10.1002/jcp.10227; Gagan J, 2012, J BIOL CHEM, V287, P40360, DOI 10.1074/jbc.M112.378414; Giombini A, 2007, BRIT MED BULL, V83, P379, DOI 10.1093/bmb/ldm020; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Hatade T, 2014, J MUSCULOSKEL NEURON, V14, P325; Hauerslev S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-43; He L, 2016, J BIOL CHEM, V291, P10562, DOI 10.1074/jbc.M116.719666; Hubbard SR, 2013, BBA-PROTEINS PROTEOM, V1834, P2166, DOI 10.1016/j.bbapap.2013.02.034; Hwang PM, 2015, NAT REV DRUG DISCOV, V14, P313, DOI 10.1038/nrd4554; Ikeda K, 2017, J TISSUE ENG REGEN M, V11, P1322, DOI 10.1002/term.2030; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Kim KI, 2006, ARTERIOSCL THROM VAS, V26, P91, DOI 10.1161/01.ATV.0000193569.12490.4b; Kislinger T, 2005, MOL CELL PROTEOMICS, V4, P887, DOI 10.1074/mcp.M400182-MCP200; Kumar CSSR, 2011, ADV DRUG DELIVER REV, V63, P789, DOI 10.1016/j.addr.2011.03.008; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Li J, 2006, BIOCHEM BIOPH RES CO, V345, P1425, DOI 10.1016/j.bbrc.2006.05.051; Lima GA, 2009, AM J PHYSIOL-ENDOC M, V296, pE132, DOI 10.1152/ajpendo.90548.2008; Liu CT, 2012, J APPL PHYSIOL, V112, P354, DOI 10.1152/japplphysiol.00989.2011; Melkani GC, 2006, J MOL BIOL, V358, P635, DOI 10.1016/j.jmb.2006.02.043; Montesano A, 2013, INT J BIOL SCI, V9, P391, DOI 10.7150/ijbs.4729; Oishi Y, 2015, MUSCLE NERVE, V52, P1047, DOI 10.1002/mus.24686; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Qazi TH, 2015, BIOMATERIALS, V53, P502, DOI 10.1016/j.biomaterials.2015.02.110; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sanger JW, 2009, CELL MOTIL CYTOSKEL, V66, P556, DOI 10.1002/cm.20365; Sanger JW, 2002, CLIN ORTHOP RELAT R, pS153, DOI 10.1097/01.blo.0000031973.69509.21; Schoneich C, 2014, APOPTOSIS, V19, P42, DOI 10.1007/s10495-013-0922-7; Takeuchi K, 2014, ACTA HISTOCHEM, V116, P327, DOI 10.1016/j.acthis.2013.08.010; Welc SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148927; Welc SS, 2013, AM J PHYSIOL-CELL PH, V305, pC406, DOI 10.1152/ajpcell.00084.2013; Yamaguchi T, 2010, AM J PHYSIOL-CELL PH, V298, pC140, DOI 10.1152/ajpcell.00050.2009; Yusuf F, 2012, HISTOCHEM CELL BIOL, V138, P187, DOI 10.1007/s00418-012-0972-x	42	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166294	10.1371/journal.pone.0166294	http://dx.doi.org/10.1371/journal.pone.0166294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824934	gold, Green Published			2022-12-27	WOS:000387615200082
J	Hornsey, RL; Hibbard, PB; Scarfe, P				Hornsey, Rebecca L.; Hibbard, Paul B.; Scarfe, Peter			Binocular Depth Judgments on Smoothly Curved Surfaces	PLOS ONE			English	Article							STEREOSCOPIC SLANT; VISUAL-PERCEPTION; LOCAL REFERENCE; DISPARITY; DISCRIMINATION; SENSITIVITY; ORIENTATION; PICTORIAL; RESPONSES; NEURONS	Binocular disparity is an important cue to depth, allowing us to make very fine discriminations of the relative depth of objects. In complex scenes, this sensitivity depends on the particular shape and layout of the objects viewed. For example, judgments of the relative depths of points on a smoothly curved surface are less accurate than those for points in empty space. It has been argued that this occurs because depth relationships are represented accurately only within a local spatial area. A consequence of this is that, when judging the relative depths of points separated by depth maxima and minima, information must be integrated across separate local representations. This integration, by adding more stages of processing, might be expected to reduce the accuracy of depth judgements. We tested this idea directly by measuring how accurately human participants could report the relative depths of two dots, presented with different binocular disparities. In the first, Two Dot condition the two dots were presented in front of a square grid. In the second, Three Dot condition, an additional dot was presented midway between the target dots, at a range of depths, both nearer and further than the target dots. In the final, Surface condition, the target dots were placed on a smooth surface defined by binocular disparity cues. In some trials, this contained a depth maximum or minimum between the target dots. In the Three Dot condition, performance was impaired when the central dot was presented with a large disparity, in line with predictions. In the Surface condition, performance was worst when the midpoint of the surface was at a similar distance to the targets, and relatively unaffected when there was a large depth maximum or minimum present. These results are not consistent with the idea that depth order is represented only within a local spatial area.	[Hornsey, Rebecca L.; Hibbard, Paul B.] Univ Essex, Dept Psychol, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Scarfe, Peter] Univ Reading, Sch Psychol & Clin Language Sci, Whiteknights Rd, Reading RG6 6AL, Berks, England	University of Essex; University of Reading	Hibbard, PB (corresponding author), Univ Essex, Dept Psychol, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	phibbard@essex.ac.uk	Hibbard, Paul/AAD-4044-2020	Hornsey, Rebecca/0000-0001-6888-8155; Hibbard, Paul/0000-0001-6133-6729	British Academy MidCareer Fellowship [MD130066]; Royal Society Research Grant [RG150529]; University of Essex Undergraduate Research Opportunities Programme	British Academy MidCareer Fellowship; Royal Society Research Grant(Royal Society of London); University of Essex Undergraduate Research Opportunities Programme	This work was funded by a British Academy MidCareer Fellowship (MD130066) to PH (http://www.britac.ac.uk), a Royal Society Research Grant to PS (RG150529) and University of Essex Undergraduate Research Opportunities Programme awards to RH and NK (http://www.essex.ac.uk/urop/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Naveed Khan and Martin Ellis for assistance with data collection. This work was funded by a British Academy MidCareer Fellowship (MD130066) to PH (http://www.britac.ac.uk), a Royal Society Research Grant to PS (RG150529) and University of Essex Undergraduate Research Opportunities Programme awards to RH and NK (http://www.essex.ac.uk/urop/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenmark F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002142; Andrews TJ, 2001, VISION RES, V41, P3051, DOI 10.1016/S0042-6989(01)00192-4; Anzai A, 2011, J NEUROSCI, V31, P10270, DOI 10.1523/JNEUROSCI.5956-10.2011; Banks MS, 2004, J NEUROSCI, V24, P2077, DOI 10.1523/JNEUROSCI.3852-02.2004; Bradshaw MF, 2002, PERCEPT PSYCHOPHYS, V64, P32, DOI 10.3758/BF03194555; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bredfeldt CE, 2009, J NEUROPHYSIOL, V101, P701, DOI 10.1152/jn.00729.2007; Bredfeldt CE, 2006, J NEUROSCI, V26, P7581, DOI 10.1523/JNEUROSCI.5308-05.2006; BURT P, 1980, SCIENCE, V208, P615, DOI 10.1126/science.7367885; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; Cumming BG, 1999, J NEUROSCI, V19, P5602; Deas LM, 2015, J VISION, V15, DOI 10.1167/15.11.11; Deas LM, 2014, J VISION, V14, DOI 10.1167/14.9.14; Elder JH, 2002, J VISION, V2, DOI 10.1167/2.4.5; FAHLE M, 1988, VISION RES, V28, P171, DOI 10.1016/0042-6989(88)90017-X; Felsen G, 2005, NAT NEUROSCI, V8, P1643, DOI 10.1038/nn1608; Filippini HR, 2009, J VISION, V9, DOI 10.1167/9.1.8; Fleet DJ, 1996, VISION RES, V36, P1839, DOI 10.1016/0042-6989(95)00313-4; Fowlkes CC, 2007, J VISION, V7, DOI 10.1167/7.8.2; GILLAM B, 1984, PERCEPT PSYCHOPHYS, V36, P559, DOI 10.3758/BF03207516; GILLAM B, 1988, J EXP PSYCHOL HUMAN, V14, P163, DOI 10.1037/0096-1523.14.2.163; Gillam B, 2007, PERCEPTION, V36, P596, DOI 10.1068/p5535; Gillam BJ, 2011, J VISION, V11, DOI 10.1167/11.6.5; Gillam BJ, 2005, VISION RES, V45, P3083, DOI 10.1016/j.visres.2005.07.003; Gillam BJ, 1998, PERCEPTION, V27, P1267, DOI 10.1068/p271267; Glennerster A, 1996, VISION RES, V36, P3441, DOI 10.1016/0042-6989(96)00090-9; Glennerster A, 2004, J VISION, V4, P378, DOI 10.1167/4.5.3; Glennerster A, 2002, CURR BIOL, V12, P825, DOI 10.1016/S0960-9822(02)00817-5; Glennerster A, 1999, VISION RES, V39, P3057, DOI 10.1016/S0042-6989(98)00324-1; Glennerster A., 2013, SHAPE PERCEPTION HUM; Goutcher R, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01014; Hibbard PB, 2016, VISION RES, V120, P108, DOI 10.1016/j.visres.2015.10.016; Hibbard PB, 2008, SPATIAL VISION, V21, P549, DOI 10.1163/156856808786451444; Hinkle DA, 2002, NAT NEUROSCI, V5, P665, DOI 10.1038/nn875; Hou F, 2006, VISION RES, V46, P2061, DOI 10.1016/j.visres.2005.12.010; Kingdom FAA, 2009, PSYCHOPHYSICS PRACTI; Kleiner M, WHATS NEW PSYCHTOOLB, V1007, P36; Koenderink J, 2015, I-PERCEPTION, V6, DOI 10.1177/2041669515615713; Koenderink JJ, 1998, PHILOS T R SOC A, V356, P1071, DOI 10.1098/rsta.1998.0211; KOENDERINK JJ, 1995, IMAGE VISION COMPUT, V13, P321, DOI 10.1016/0262-8856(95)99719-H; Lu HJ, 2006, J VISION, V6, P75, DOI 10.1167/6.1.7; MCKEE SP, 1983, VISION RES, V23, P191, DOI 10.1016/0042-6989(83)90142-6; Mitchison GJ, 1984, VISION RES, V30; Nguyenkim JD, 2003, J NEUROSCI, V23, P7117, DOI 10.1523/JNEUROSCI.23-18-07117.2003; Norman JF, 2006, VISION RES, V46, P1057, DOI 10.1016/j.visres.2005.09.034; Norman JF, 1998, PERCEPTION, V27, P257, DOI 10.1068/p270257; Norman JF, 1996, PERCEPTION, V25, P381, DOI 10.1068/p250381; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Orban GA, 2006, TRENDS NEUROSCI, V29, P466, DOI 10.1016/j.tins.2006.06.012; Parker AJ, 2007, NAT REV NEUROSCI, V8, P379, DOI 10.1038/nrn2131; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrov Y, 2004, VISION RES, V44, P367, DOI 10.1016/j.visres.2003.09.034; Petrov Y, 2006, VISION RES, V46, P4321, DOI 10.1016/j.visres.2006.07.011; Pierce BJ, 1998, PERCEPTION, V27, P87, DOI 10.1068/p270087; Prince SJD, 2002, J NEUROPHYSIOL, V87, P209, DOI 10.1152/jn.00466.2000; Roe AW, 2007, J NEUROSCI, V27, P11820, DOI 10.1523/JNEUROSCI.4164-07.2007; ROGERS B, 1989, NATURE, V339, P135, DOI 10.1038/339135a0; Rust NC, 2005, NAT NEUROSCI, V8, P1647, DOI 10.1038/nn1606; Scarfe P, 2015, J VISION, V15, DOI 10.1167/15.9.3; Tittle JS, 1997, PERCEPT PSYCHOPHYS, V59, P1167, DOI 10.3758/BF03214205; TODD JT, 1989, PSYCHOL REV, V96, P643, DOI 10.1037/0033-295X.96.4.643; TYLER CW, 1995, PERCEPTION, V24, P127, DOI 10.1068/p240127; Umeda K, 2007, J NEUROPHYSIOL, V98, P241, DOI 10.1152/jn.01336.2006; VanEe R, 1996, VISION RES, V36, P43, DOI 10.1016/0042-6989(95)00078-E; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; Wardle SG, 2016, J VISION, V16, DOI 10.1167/16.5.16; Westheimer G., 1979, PROCTOR LECT INVEST, V18; Yin C, 2000, VISION RES, V40, P1969, DOI 10.1016/S0042-6989(00)00047-X	69	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165932	10.1371/journal.pone.0165932	http://dx.doi.org/10.1371/journal.pone.0165932			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824895	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000387615200045
J	Liu, WY; Lin, SG; Zhu, GQ; Van Poucke, S; Braddock, M; Zhang, ZH; Mao, Z; Shen, FX; Zheng, MH				Liu, Wen-Yue; Lin, Shi-Gang; Zhu, Gui-Qi; Van Poucke, Sven; Braddock, Martin; Zhang, Zhongheng; Mao, Zhi; Shen, Fei-Xia; Zheng, Ming-Hua			Establishment and Validation of GV-SAPS II Scoring System for Non-Diabetic Critically Ill Patients	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; GLUCOSE VARIABILITY; GLYCEMIC CONTROL; HOSPITAL MORTALITY; ASSOCIATION; ICU	Background and Aims Recently, glucose variability (GV) has been reported as an independent risk factor for mortality in non-diabetic critically ill patients. However, GV is not incorporated in any severity scoring system for critically ill patients currently. The aim of this study was to establish and validate a modified Simplified Acute Physiology Score II scoring system (SAPS II), integrated with GV parameters and named GV-SAPS II, specifically for non-diabetic critically ill patients to predict short-term and long-term mortality. Methods Training and validation cohorts were exacted from the Multiparameter Intelligent Monitoring in Intensive Care database III version 1.3 (MIMIC-III v1.3). The GV-SAPS II score was constructed by Cox proportional hazard regression analysis and compared with the original SAPS II, Sepsis-related Organ Failure Assessment Score (SOFA) and Elixhauser scoring systems using area under the curve of the receiver operator characteristic (auROC) curve. Results 4,895 and 5,048 eligible individuals were included in the training and validation cohorts, respectively. The GV-SAPS II score was established with four independent risk factors, including hyperglycemia, hypoglycemia, standard deviation of blood glucose levels (Glu(SD)), and SAPS II score. In the validation cohort, the auROC values of the new scoring system were 0.824 (95% CI: 0.813-0.834, P<0.001) and 0.738 (95% CI: 0.725-0.750, P<0.001), respectively for 30 days and 9 months, which were significantly higher than other models used in our study (all P<0.001). Moreover, Kaplan-Meier plots demonstrated significantly worse outcomes in higher GV-SAPS II score groups both for 30-day and 9-month mortality endpoints (all P<0.001). Conclusions We established and validated a modified prognostic scoring system that integrated glucose variability for non-diabetic critically ill patients, named GV-SAPS II. It demonstrated a superior prognostic capability and may be an optimal scoring system for prognostic evaluation in this patient group.	[Liu, Wen-Yue; Shen, Fei-Xia] Wenzhou Med Univ, Dept Endocrinol, Affiliated Hosp 1, Wenzhou 325000, Peoples R China; [Lin, Shi-Gang; Zhu, Gui-Qi] Wenzhou Med Univ, Sch Clin Med Sci 1, Wenzhou 325000, Peoples R China; [Zhu, Gui-Qi; Zheng, Ming-Hua] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, Liver Res Ctr, Wenzhou 325000, Peoples R China; [Van Poucke, Sven] Ziekenhuis Oost Limburg, Dept Anesthesiol Intens Care Emergency Med & Pain, Genk, Belgium; [Braddock, Martin] AstraZeneca R&D, Global Med Dev, Loughborough, Leics, England; [Zhang, Zhongheng] Zhejiang Univ, Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Crit Care Med, Jinhua 321000, Peoples R China; [Mao, Zhi] Chinese Peoples Liberat Army Gen Hosp, Dept Crit Care Med, Beijing, Peoples R China; [Zheng, Ming-Hua] Wenzhou Med Univ, Inst Hepatol, Wenzhou 325000, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; East Limburg Hospital; AstraZeneca; Zhejiang University; Chinese People's Liberation Army General Hospital; Wenzhou Medical University	Shen, FX (corresponding author), Wenzhou Med Univ, Dept Endocrinol, Affiliated Hosp 1, Wenzhou 325000, Peoples R China.; Zheng, MH (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, Liver Res Ctr, Wenzhou 325000, Peoples R China.; Zheng, MH (corresponding author), Wenzhou Med Univ, Inst Hepatol, Wenzhou 325000, Peoples R China.	327654951@qq.com; blueman1320@163.com	Zhu, Gui-Qi/H-9265-2017; Zhang, Zhongheng/E-1282-2011; Zheng, Ming-Hua/H-5584-2019; zhang, zh/GWV-4677-2022; Van Poucke, Sven/K-5999-2016	Zhu, Gui-Qi/0000-0001-5089-6923; Zhang, Zhongheng/0000-0002-2336-5323; Zheng, Ming-Hua/0000-0003-4984-2631; Van Poucke, Sven/0000-0001-8070-8786	National Natural Science Foundation of China [81500665]; Zhejiang Provincial Natural Science Foundation [Y14H070034]; High Level Creative Talents from Department of Public Health in Zhejiang Province; Project of New Century 551 Talent Nurturing in Wenzhou; AstraZeneca RD	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); High Level Creative Talents from Department of Public Health in Zhejiang Province; Project of New Century 551 Talent Nurturing in Wenzhou; AstraZeneca RD(AstraZeneca)	This work was supported by grants from National Natural Science Foundation of China (81500665), Zhejiang Provincial Natural Science Foundation (Y14H070034), High Level Creative Talents from Department of Public Health in Zhejiang Province and Project of New Century 551 Talent Nurturing in Wenzhou. AstraZeneca R&D provided support in the form of salaries for author Martin Braddock, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha A, 2002, CHIRURG, V73, P439, DOI 10.1007/s00104-001-0374-4; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bagshaw SM, 2009, CRIT CARE MED, V37, P463, DOI 10.1097/CCM.0b013e318194b097; Deane AM, 2013, DIABETES OBES METAB, V15, P792, DOI 10.1111/dom.12078; Donati A, 2014, CRIT CARE RESUSC, V16, P13; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Eslami S, 2011, INTENS CARE MED, V37, P583, DOI 10.1007/s00134-010-2129-5; Falciglia M, 2009, CRIT CARE MED, V37, P3001, DOI 10.1097/CCM.0b013e3181b083f7; Farrokhi F, 2014, ENDOCR PRACT, V20, P41, DOI 10.4158/EP13131.OR; Farrokhi F, 2011, BEST PRACT RES CL EN, V25, P813, DOI 10.1016/j.beem.2011.05.004; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Hermanides J, 2010, CRIT CARE MED, V38, P838, DOI 10.1097/CCM.0b013e3181cc4be9; Kavanagh BP, 2010, NEW ENGL J MED, V363, P2540, DOI 10.1056/NEJMcp1001115; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lheureux O, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0571-4; Lipska KJ, 2012, CIRC-CARDIOVASC QUAL, V5, P550, DOI 10.1161/CIRCOUTCOMES.111.963298; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Meyfroidt G, 2010, CRIT CARE MED, V38, P1021, DOI 10.1097/CCM.0b013e3181cf710e; Ooi YC, 2012, NEUROSURGERY, V71, P692, DOI 10.1227/NEU.0b013e3182631eb4; Pisarchik AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046582; Risso A, 2001, AM J PHYSIOL-ENDOC M, V281, pE924, DOI 10.1152/ajpendo.2001.281.5.E924; Saeed M, 2011, CRIT CARE MED, V39, P952, DOI 10.1097/CCM.0b013e31820a92c6; SCHLICHTING P, 1983, HEPATOLOGY, V3, P889; Schuster HP, 1997, INTENS CARE MED, V23, P1056, DOI 10.1007/s001340050456; Sechterberger MK, 2013, CRIT CARE, V17, DOI 10.1186/cc12572; Sekulic AD, 2015, MED SCI MONITOR, V21, DOI 10.12659/MSM.894153; Siegelaar SE, 2011, BEST PRACT RES CL EN, V25, P825, DOI 10.1016/j.beem.2011.03.004; Todi S, 2014, INDIAN J CRIT CARE M, V18, P285, DOI [10.4103/0972-5229.132484, 10.4103/0972-5229.130574]; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216; Yan Chiu-Lan, 2013, Acta Anaesthesiol Taiwan, V51, P67, DOI 10.1016/j.aat.2013.06.004; Zimmerman JE, 2013, CRIT CARE, V17, DOI 10.1186/cc12695	34	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166085	10.1371/journal.pone.0166085	http://dx.doi.org/10.1371/journal.pone.0166085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824941	Green Submitted, Green Published, gold			2022-12-27	WOS:000387615200060
J	Zhang, C; Li, XM; Liu, Y; Qiao, S; Zhou, YJ; Shen, ZY; Chen, Y				Zhang, Chen; Li, Xiaoming; Liu, Yu; Qiao, Shan; Zhou, Yuejiao; Shen, Zhiyong; Chen, Yi			Substance Use and Psychosocial Status among People Living with HIV/AIDS Who Encountered HIV Stigma in China: Stratified Analyses by Socio-Economic Status	PLOS ONE			English	Article							MENTAL-HEALTH; ASSOCIATION; SES	This study examined whether the impact of HIV stigma on psychosocial status and substance use among people living with HIV/AIDS (PLWHA) differed by their socio-economic status (SES) in a Chinese setting. A total of 2,987 PLWHA were recruited from 12 sites with the highest number of cumulative HIV incidence in Guangxi, China. Participants were asked to provide information regarding their psychosocial status (e.g., depression, anxiety), history of substance use (e.g., tobacco, alcohol and drug) and SES (e.g., education, monthly income, residence type, and job category). By employing stratified multivariate regression analyses, we assessed stratum-specific impacts of HIV stigma on PLWHA's psychosocial status and behaviors of substance use based upon participants' SES. The impact of HIV stigma differed significantly on psychosocial status across SES gradients. Psychosocial status among people with higher education was more sensitive to HIV stigma compared with PLWHA who were less educated. The odds of substance use behaviors were higher among people with better monthly income than their low-income peers. Our study is the first paper to document the paucity of SES stratified analyses between HIV stigma and psychosocial status and substance use among PLWHA in China. We call for tailored intervention programs to target PLWHA with different backgrounds and characteristics in order to help them to better manage their seropositivity.	[Zhang, Chen; Liu, Yu] Vanderbilt Univ, Div Epidemiol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Li, Xiaoming; Qiao, Shan] Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC USA; [Zhou, Yuejiao; Shen, Zhiyong; Chen, Yi] Guangxi CDC, Dept HIV STD Prevent, Nanning, Guangxi, Peoples R China	Vanderbilt University; University of South Carolina System; University of South Carolina Columbia	Zhang, C (corresponding author), Vanderbilt Univ, Div Epidemiol, 221 Kirkland Hall, Nashville, TN 37235 USA.	chen.zhang.1@vanderbilt.edu	Li, Xiaoming/AAF-1362-2019	Li, Xiaoming/0000-0002-5555-9034; Zhang, Chen/0000-0002-8771-561X	National Institute of Child and Human Development Grant [R01HD074221]	National Institute of Child and Human Development Grant	The study was supported by the National Institute of Child and Human Development Grant (#R01HD074221) (https://www.nichd.nih.gov/Pages/index.aspx). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Child and Human Development.	Ahsan Ullah A K M, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P97, DOI 10.1177/1545109710381926; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; China Government, 2006, COMP ED ACT PEOPL RE; Dray J, 2016, CHILD ADOL PSYCH MEN, V10, DOI 10.1186/s13034-016-0120-9; Earnshaw VA, 2013, AIDS BEHAV, V17, P1785, DOI 10.1007/s10461-013-0437-9; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Foster G, 2007, AIDS CARE, V19, pS54, DOI 10.1080/09540120601114469; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Guangxi CDC, 2011, UPD HIV AIDS EP GUAN; Guangxi CDC, 2014, GUANGX HIV SURV REP; Guangxi Statistic Bureau, 2011, REP 6 POP CENS SURV; Kuria EN, 2010, PUBLIC HEALTH NUTR, V13, P475, DOI 10.1017/S1368980009990826; Lepiece Brice, 2015, Psychiatr Danub, V27 Suppl 1, pS92; Link B, 2001, ANNU REV SOCIOL, V27, P418; Milloy MJ, 2012, CURR HIV-AIDS REP, V9, P364, DOI 10.1007/s11904-012-0137-5; Oakes JM, 2003, SOC SCI MED, V56, P769, DOI 10.1016/S0277-9536(02)00073-4; Park S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2731-8; Probst C, 2016, TROP MED INT HEALTH, V21, P846, DOI 10.1111/tmi.12712; Qian HZ, 2007, AIDS CARE, V19, P1283, DOI 10.1080/09540120701402814; Qiao S, 2015, AIDS CARE, V27, P28, DOI 10.1080/09540121.2015.1034648; Qiao Shan, 2015, AIDS, V29 Suppl 1, pS25, DOI 10.1097/QAD.0000000000000670; Queen S, 2012, 2012 NAT C HLTH STAT; Reich WA, 2010, PSYCHOL HEALTH MED, V15, P135, DOI 10.1080/13548501003623930; Ritte S A, 2012, East Afr J Public Health, V9, P33; Siegfried N, 2010, INT J EPIDEMIOL, V39, P1556, DOI 10.1093/ije/dyq198; Sugiyama T, 2016, HEALTH PLACE, V38, P16, DOI 10.1016/j.healthplace.2016.01.002; Tam C L, 2011, East Asian Arch Psychiatry, V21, P73; Tsai AC, 2017, AIDS BEHAV, V21, P248, DOI 10.1007/s10461-015-1285-6; Veenstra G, 2000, SOC SCI MED, V50, P619, DOI 10.1016/S0277-9536(99)00307-X; WACC, 2014, PEER ED HIV AIDS STI; World Health Organization, 2016, GLOB HLTH OBS GHO DA; Wu LY, 2013, HEALTH PSYCHOL BEHAV, V1, P31, DOI 10.1080/21642850.2013.822798; Yi SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121461; Zhang C, 2016, PLOS ONE IN PRESS; Zhang C, 2016, AIDS CARE, V28, P124, DOI 10.1080/09540121.2016.1146206	35	7	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165624	10.1371/journal.pone.0165624	http://dx.doi.org/10.1371/journal.pone.0165624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BE	27824948	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200023
J	Tan, WS; Khetrapal, P; Tan, WP; Rodney, S; Chau, M; Kelly, JD				Tan, Wei Shen; Khetrapal, Pramit; Tan, Wei Phin; Rodney, Simon; Chau, Marisa; Kelly, John D.			Robotic Assisted Radical Cystectomy with Extracorporeal Urinary Diversion Does Not Show a Benefit over Open Radical Cystectomy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials	PLOS ONE			English	Review							QUALITY-OF-LIFE; BLADDER-CANCER; PERIOPERATIVE OUTCOMES; SURGICAL MARGINS; LEARNING-CURVE; CLINICAL-TRIAL; PROSTATECTOMY; COMPLICATIONS; NEOBLADDER; MORBIDITY	Background The number of robotic assisted radical cystectomy (RARC) procedures is increasing despite the lack of Level I evidence showing any advantages over open radical cystectomy (ORC). However, several systematic reviews with meta-analyses including non-randomised studies, suggest an overall benefit for RARC compared to ORC. We performed a systematic review with meta-analysis of randomised controlled trials (RCTs) to evaluate the perioperative morbidity and efficacy of RARC compared to ORC in patients with bladder cancer. Methods Literature searches of Medline/Pubmed, Embase, Web of Science and clinicaltrials. gov databases up to 10th March 2016 were performed. The inclusion criteria for eligible studies were RCTs which compared perioperative outcomes of ORC and RARC for bladder cancer. Primary objective was perioperative and histopathological outcomes of RARC versus ORC while the secondary objective was quality of life assessment (QoL), oncological outcomes and cost analysis. Results Four RCTs (from 5 articles) met the inclusion criteria, with a total of 239 patients all with extracorporeal urinary diversion. Patient demographics and clinical characteristics of RARC and ORC patients were evenly matched. There was no significant difference between groups in perioperative morbidity, length of stay, positive surgical margin, lymph node yield and positive lymph node status. RARC group had significantly lower estimated blood loss (p<0.001) and wound complications (p = 0.03) but required significantly longer operating time (p<0.001). QoL was not measured uniformly across trials and cost analysis was reported in one RCTs. A test for heterogeneity did highlight differences across operating time of trials suggesting that surgeon experience may influence outcomes. Conclusions This study does not provide evidence to support a benefit for RARC compared to ORC. These results may not have inference for RARC with intracorporeal urinary diversion. Well-designed trials with appropriate endpoints conducted by equally experienced ORC and RARC surgeons will be needed to address this.	[Tan, Wei Shen; Khetrapal, Pramit; Rodney, Simon; Chau, Marisa; Kelly, John D.] UCL, Div Surg & Intervent Sci, London, England; [Tan, Wei Shen; Khetrapal, Pramit; Rodney, Simon; Kelly, John D.] Univ Coll London Hosp, Dept Urol, London, England; [Tan, Wei Phin] Rush Univ, Med Ctr, Dept Urol, Chicago, IL 60612 USA	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Rush University	Tan, WS (corresponding author), UCL, Div Surg & Intervent Sci, London, England.; Tan, WS (corresponding author), Univ Coll London Hosp, Dept Urol, London, England.	wei.tan@ucl.ac.uk	Tan, Wei Shen/H-8835-2019; Tan, Wei Phin/H-4196-2019; Khetrapal, Pramit/AAC-6401-2020	Tan, Wei Shen/0000-0002-6119-4043; Tan, Wei Phin/0000-0003-2651-781X; Khetrapal, Pramit/0000-0001-8769-5797	Urology Foundation; UCLH Biomedical Research Centre grant; National Institute for Health Research [ACF-2013-18-016] Funding Source: researchfish; The Urology Foundation [RESCH15_RODNEY] Funding Source: researchfish	Urology Foundation; UCLH Biomedical Research Centre grant; National Institute for Health Research(National Institute for Health Research (NIHR)); The Urology Foundation	Support was provided by the Urology Foundation [http://dx.doi.org/10.13039/501100007568] and a UCLH Biomedical Research Centre grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochner BH, 2015, EUR UROL, V67, P1042, DOI 10.1016/j.eururo.2014.11.043; Braga M, 2005, DIS COLON RECTUM, V48, P2217, DOI 10.1007/s10350-005-0185-7; Collins JW, 2013, EUR UROL, V64, P654, DOI 10.1016/j.eururo.2013.05.020; Desai MM, 2014, J UROLOGY, V192, P1734, DOI 10.1016/j.juro.2014.06.087; Dotan ZA, 2007, J UROLOGY, V178, P2308, DOI 10.1016/j.juro.2007.08.023; Fonseka T, 2015, ARCH ITAL UROL ANDRO, V87, P41, DOI 10.4081/aiua.2015.1.41; Glance LG, 2011, ANESTHESIOLOGY, V114, P283, DOI 10.1097/ALN.0b013e3182054d06; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Harrop E, 2016, TRIALS, V17, P016; Hautmann RE, 2010, J UROLOGY, V184, P990, DOI 10.1016/j.juro.2010.05.037; Hayn MH, 2010, EUR UROL, V58, P197, DOI 10.1016/j.eururo.2010.04.024; Herr HW, 2002, J UROLOGY, V167, P1295, DOI 10.1016/S0022-5347(05)65284-6; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Khan MS, 2016, EUR UROL, V69, P613, DOI 10.1016/j.eururo.2015.07.038; Lamb BW, 2016, UROL ONCOL, V34, P16; Li KW, 2013, CANCER TREAT REV, V39, P551, DOI 10.1016/j.ctrv.2012.11.007; Martin RCG, 2002, ANN SURG, V235, P803, DOI 10.1097/00000658-200206000-00007; Messer JC, 2014, BJU INT, V114, P896, DOI 10.1111/bju.12818; Moschini M, 2016, EUR UROL FOCUS, V2, P86, DOI 10.1016/j.euf.2015.03.002; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Nix J, 2010, EUR UROL, V57, P196, DOI 10.1016/j.eururo.2009.10.024; Novara G, 2015, EUR UROL, V67, P376, DOI 10.1016/j.eururo.2014.12.007; Novara G, 2010, J UROLOGY, V183, P2165, DOI 10.1016/j.juro.2010.02.021; Ou YC, 2011, BJU INT, V108, P420, DOI 10.1111/j.1464-410X.2010.09847.x; Parekh DJ, 2013, J UROLOGY, V189, P474, DOI 10.1016/j.juro.2012.09.077; Trinh QD, 2012, EUR UROL, V61, P679, DOI 10.1016/j.eururo.2011.12.027; Shabsigh A, 2009, EUR UROL, V55, P164, DOI 10.1016/j.eururo.2008.07.031; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Tan WS, 2016, SCAND J UROL, V50, P95, DOI 10.3109/21681805.2016.1141318; Tan WS, 2016, EUR UROL FOCUS; Tan WS, 2016, UROL ONCOL, V34; Tang K, 2014, EJSO-EUR J SURG ONC, V40, P1399, DOI 10.1016/j.ejso.2014.03.008; Thompson JE, 2014, EUR UROL, V65, P521, DOI 10.1016/j.eururo.2013.10.030; Wilson TG, 2015, EUR UROL, V67, P363, DOI 10.1016/j.eururo.2014.12.009; Xia LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121032; Yaxley JW, 2016, LANCET, V388, P1057, DOI 10.1016/S0140-6736(16)30592-X	36	63	65	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166221	10.1371/journal.pone.0166221	http://dx.doi.org/10.1371/journal.pone.0166221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820855	Green Published, gold, Green Submitted			2022-12-27	WOS:000387614800042
J	Kerviel, A; Dash, S; Moncorge, O; Panthu, B; Prchal, J; Decimo, D; Ohlmann, T; Lina, B; Favard, C; Decroly, E; Ottmann, M; Roingeard, P; Muriaux, D				Kerviel, Adeline; Dash, Shantoshini; Moncorge, Olivier; Panthu, Baptiste; Prchal, Jan; Decimo, Didier; Ohlmann, Theophile; Lina, Bruno; Favard, Cyril; Decroly, Etienne; Ottmann, Michele; Roingeard, Philippe; Muriaux, Delphine			Involvement of an Arginine Triplet in M1 Matrix Protein Interaction with Membranes and in M1 Recruitment into Virus-Like Particles of the Influenza A(H1N1)pdm09 Virus	PLOS ONE			English	Article							A VIRUS; QUANTITATIVE-ANALYSIS; NS1 PROTEIN; BINDING; ASSOCIATION; GLYCOPROTEINS; DOMAINS; RNA; OLIGOMERIZATION; HEMAGGLUTININ	The influenza A(H1N1) pdm09 virus caused the first influenza pandemic of the 21st century. In this study, we wanted to decipher the role of conserved basic residues of the viral M1 matrix protein in virus assembly and release. M1 plays many roles in the influenza virus replication cycle. Specifically, it participates in viral particle assembly, can associate with the viral ribonucleoprotein complexes and can bind to the cell plasma membrane and/or the cytoplasmic tail of viral transmembrane proteins. M1 contains an N-terminal domain of 164 amino acids with two basic domains: the nuclear localization signal on helix 6 and an arginine triplet (R76/77/78) on helix 5. To investigate the role of these two M1 basic domains in influenza A(H1N1) pdm09 virus molecular assembly, we analyzed M1 attachment to membranes, virus-like particle (VLP) production and virus infectivity. In vitro, M1 binding to large unilamellar vesicles (LUVs), which contain negatively charged lipids, decreased significantly when the M1 R76/77/78 motif was mutated. In cells, M1 alone was mainly observed in the nucleus (47%) and in the cytosol (42%). Conversely, when co-expressed with the viral proteins NS1/NEP and M2, M1 was relocated to the cell membranes (55%), as shown by subcellular fractionation experiments. This minimal system allowed the production of M1 containing-VLPs. However, M1 with mutations in the arginine triplet accumulated in intracellular clusters and its incorporation in VLPs was strongly diminished. M2 over-expression was essential for M1 membrane localization and VLP production, whereas the viral transmembrane proteins HA and NA seemed dispensable. These results suggest that the M1 arginine triplet participates in M1 interaction with membranes. This R76/77/78 motif is essential for M1 incorporation in virus particles and the importance of this motif was confirmed by reverse genetic demonstrating that its mutation is lethal for the virus. These results highlight the molecular mechanism of M1-membrane interaction during the formation of influenza A(H1N1)pdm09 virus particles which is essential for infectivity.	[Kerviel, Adeline; Dash, Shantoshini; Moncorge, Olivier; Prchal, Jan; Favard, Cyril; Muriaux, Delphine] CNRS, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, Montpellier, France; [Kerviel, Adeline; Dash, Shantoshini; Moncorge, Olivier; Prchal, Jan; Favard, Cyril; Muriaux, Delphine] Univ Montpellier, Montpellier, France; [Panthu, Baptiste; Decimo, Didier; Ohlmann, Theophile] CIRI, INSERM U 1111, Lyon, France; [Panthu, Baptiste; Decimo, Didier; Ohlmann, Theophile] ENS Lyon, Lyon, France; [Lina, Bruno; Ottmann, Michele] Univ Lyon 1, Fac Med Lyon Est, Lab Virol & Pathol Humaine, EA 4610, Lyon, France; [Roingeard, Philippe] Univ Tours, INSERM U966, Tours, France; [Roingeard, Philippe] CHRU Tours, Tours, France; [Decroly, Etienne] Aix Marseille Univ, 163 Ave Luminy, F-13288 Marseille 09, France; [Decroly, Etienne] CNRS, AFMB UMR 7257, 163 Ave Luminy, F-13288 Marseille 09, France; [Prchal, Jan] Inst Chem Technol, Lab NMR Spect, Tech 5, Prague 16628, Czech Republic	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Ecole Normale Superieure de Lyon (ENS de LYON); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); University of Chemistry & Technology, Prague	Muriaux, D (corresponding author), CNRS, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, Montpellier, France.; Muriaux, D (corresponding author), Univ Montpellier, Montpellier, France.	delphine.muriaux@cpbs.cnrs.fr	Ohlmann, Theophile/H-6522-2016; lina, bruno/N-3663-2019; Prchal, Jan/H-9756-2014; Moncorge, Olivier/E-3233-2017; Favard, Cyril/P-6392-2016; Carmen, Team2/Y-7383-2019; ohlmann, Theophile/M-4463-2014	lina, bruno/0000-0002-8959-2123; Prchal, Jan/0000-0002-3398-5059; Moncorge, Olivier/0000-0003-0512-1824; Favard, Cyril/0000-0002-8304-2980; Carmen, Team2/0000-0001-9867-5724; ohlmann, Theophile/0000-0002-2001-8916; Decimo, Didier/0000-0002-0390-1205; Kerviel, Adeline/0000-0002-1315-9841; DECROLY, Etienne/0000-0002-6046-024X; ottmann, michele/0000-0002-6911-0705; Lab, Carmen/0000-0002-5935-3236	ENS Lyon; IHU Infectiopole Sud Mediterranee Fondation; French National Research Agency [ANR 13-BSV5-0006-01]; CNRS; French Ministry/ENS Lyon	ENS Lyon; IHU Infectiopole Sud Mediterranee Fondation; French National Research Agency(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry/ENS Lyon	AK received doctoral fellowship support from French Minister/ENS Lyon. SD received a fellowship from IHU Infectiopole Sud Mediterranee Fondation. DM received grant funding from the French National Research Agency (ANR 13-BSV5-0006-01) and the CNRS.; We thank Prof W. Weissenhorn (Grenoble, France) and members of his laboratory, especially Jens Radzimanowski, for scientific exchanges during this work. We thank the MRI microscopy facility (Montpellier), and Dr Olivier Coux (CRBM, CNRS Montpellier, France) for technical suggestions concerning M1 protein purification. We thank Juliette Rousseau and Fabienne Arcanger for technical assistance with EM sections. Our data were obtained with the assistance of the IBiSA Electron Microscopy Facility of Francois Rabelais University. AK had a PhD studentship from the French Ministry/ENS Lyon, and SD from the IHU Infectiopole Sud Mediterranee Fondation. We are thankful to Elisabetta Andermarcher MD, PhD (Cantab) for editing the manuscript. This work was supported by grants from the French National Research Agency (ANR 13-BSV5-0006-01) and CNRS.	Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Ali A, 2000, J VIROL, V74, P8709, DOI 10.1128/JVI.74.18.8709-8719.2000; Arzt S, 2004, VIRUS RES, V99, P115, DOI 10.1016/j.virusres.2003.10.010; Avalos RT, 1997, J VIROL, V71, P2947, DOI 10.1128/JVI.71.4.2947-2958.1997; Barman S, 2001, VIRUS RES, V77, P61, DOI 10.1016/S0168-1702(01)00266-0; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Chen BJ, 2008, J VIROL, V82, P10059, DOI 10.1128/JVI.01184-08; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Chlanda P, 2015, J VIROL, V89, P8957, DOI 10.1128/JVI.00592-15; Das SC, 2012, J VIROL, V86, P1522, DOI 10.1128/JVI.06230-11; Elster C, 1997, J GEN VIROL, V78, P1589, DOI 10.1099/0022-1317-78-7-1589; ENAMI K, 1994, J VIROL, V68, P1432, DOI 10.1128/JVI.68.3.1432-1437.1994; Enami M, 1996, J VIROL, V70, P6653, DOI 10.1128/JVI.70.10.6653-6657.1996; Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Hamard-Peron E, 2010, J VIROL, V84, P503, DOI 10.1128/JVI.01134-09; Hilsch M, 2014, BIOPHYS J, V107, P912, DOI 10.1016/j.bpj.2014.06.042; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hutchinson EC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5816; Kretzschmar E, 1996, VIROLOGY, V220, P37, DOI 10.1006/viro.1996.0283; Leser GP, 2005, VIROLOGY, V342, P215, DOI 10.1016/j.virol.2005.09.049; LU Y, 1994, GENE DEV, V8, P1817, DOI 10.1101/gad.8.15.1817; McCown MF, 2006, J VIROL, V80, P8178, DOI 10.1128/JVI.00627-06; Momose F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021123; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; Noton SL, 2007, J GEN VIROL, V88, P2280, DOI 10.1099/vir.0.82809-0; RICHARDSON JC, 1991, ARCH VIROL, V116, P69, DOI 10.1007/BF01319232; Robb NC, 2012, J GEN VIROL, V93, P113, DOI 10.1099/vir.0.035485-0; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Ruigrok RWH, 2000, VIROLOGY, V267, P289, DOI 10.1006/viro.1999.0134; Ruigrok RWH, 2000, J MOL BIOL, V300, P103, DOI 10.1006/jmbi.2000.3822; Safo MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109510; Sha BD, 1997, NAT STRUCT BIOL, V4, P239, DOI 10.1038/nsb0397-239; Shimizu T, 2011, FEBS LETT, V585, P41, DOI 10.1016/j.febslet.2010.11.017; Shtykova EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082431; Soni SP, 2013, BIOPHYS J, V104, P1940, DOI [10.1016/j.bpj.2013.03.021, 10.1016/j.bPj.2013.03.021]; Thaa B, 2009, VIROLOGY, V383, P150, DOI 10.1016/j.virol.2008.10.001; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Wang C, 2010, IEEE INFOCOM SER, DOI 10.1109/PEDG.2010.5545769; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; YE ZP, 1995, J VIROL, V69, P1964, DOI 10.1128/JVI.69.3.1964-1970.1995; Zhang J, 2000, J VIROL, V74, P4634, DOI 10.1128/JVI.74.10.4634-4644.2000; Zhang J, 1996, VIROLOGY, V225, P255, DOI 10.1006/viro.1996.0599; Zhang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037786	45	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165421	10.1371/journal.pone.0165421	http://dx.doi.org/10.1371/journal.pone.0165421			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814373	Green Published, Green Submitted, gold			2022-12-27	WOS:000386911100011
J	Arriagada, F; Correa, O; Gunther, G; Nonell, S; Mura, F; Olea-Azar, C; Morales, J				Arriagada, Francisco; Correa, Olosmira; Gunther, German; Nonell, Santi; Mura, Francisco; Olea-Azar, Claudio; Morales, Javier			Morin Flavonoid Adsorbed on Mesoporous Silica, a Novel Antioxidant Nanomaterial	PLOS ONE			English	Article							RADICAL SCAVENGING ACTIVITY; OXIDATIVE STRESS; SINGLET OXYGEN; GAMMA-AMINOPROPYLTRIETHOXYSILANE; FUNDAMENTAL PROPERTIES; AQUEOUS-SOLUTION; DRUG-DELIVERY; NANOPARTICLES; KINETICS; ADSORPTION	Morin (2' A, 3, 4' , 5,7-pentahydroxyflavone) is a flavonoid with several beneficial health effects. However, its poor water solubility and it sensitivity to several environmental factors avoid its use in applications like pharmaceutical and cosmetic. In this work, we synthetized morinmodified mesoporous silica nanoparticles (AMSNPs-MOR) as useful material to be used as potential nanoantioxidant. To achieve this, we characterized its adsorption kinetics, isotherm and the antioxidant capacity as hydroxyl radical (HO center dot) scavenger and singlet oxygen (O-1(2)) quencher. The experimental data could be well fitted with Langmuir, Freundlich and Temkin isotherm models, besides the pseudo-second order kinetics model. The total quenching rate constant obtained for singlet oxygen deactivation by AMSNPs-MOR was one order of magnitude lower than the morin rate constant reported previously in neat solvents and lipid membranes. The AMSNPs-MOR have good antioxidant properties by itself and exhibit a synergic effect with morin on the antioxidant property against hydroxyl radical. This effect, in the range of concentrations studied, was increased when the amount of morin adsorbed increased.	[Arriagada, Francisco; Correa, Olosmira; Morales, Javier] Univ Chile, Dept Ciencias & Tecnol Farmaceut, Fac Ciencias Quim & Farmaceut, Sergio Livingstone,1007,Independencia, Santiago, Chile; [Gunther, German] Univ Chile, Dept Quim Organ & Fisicoquim, Fac Ciencias Quim & Farmaceut, Sergio Livingstone,1007,Independencia, Santiago, Chile; [Nonell, Santi] Univ Ramon Llull, IQS, Via Augusta 390, Barcelona 08017, Spain; [Mura, Francisco; Olea-Azar, Claudio] Univ Chile, Dept Quim Inorgan & Analit, Fac Ciencias Quim & Farmaceut, Sergio Livingstone,1007,Independencia, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universitat Ramon Llull; Institut Quimic de Sarria; Universidad de Chile	Morales, J (corresponding author), Univ Chile, Dept Ciencias & Tecnol Farmaceut, Fac Ciencias Quim & Farmaceut, Sergio Livingstone,1007,Independencia, Santiago, Chile.	javiermv@ciq.uchile.cl	Gunther, German/I-1028-2013; OLEA AZAR, CLAUDIO/I-1605-2013	Gunther, German/0000-0002-4733-8426; OLEA AZAR, CLAUDIO/0000-0001-5805-0746; Mura Mardones, Francisco/0000-0003-0463-1814; Morales Valenzuela, Javier Eduardo/0000-0002-9880-2567	FONDECYT [1160757]; CONICYT [21160932, 21120376]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by FONDECYT (grant 1160757 to JM), CONICYT (grant 21160932 to FA) and CONICYT (grant 21120376 to FM).	Amic A, 2014, FOOD CHEM, V152, P578, DOI 10.1016/j.foodchem.2013.12.025; Anbia M, 2012, DYES PIGMENTS, V94, P1, DOI 10.1016/j.dyepig.2011.10.016; Anbia M, 2010, DESALINATION, V261, P61, DOI 10.1016/j.desal.2010.05.030; Anbia M, 2010, APPL SURF SCI, V256, P3228, DOI 10.1016/j.apsusc.2009.12.010; Azizian S, 2004, J COLLOID INTERF SCI, V276, P47, DOI 10.1016/j.jcis.2004.03.048; Beganskiene A., 2004, MAT SCI, V10, P287; Berlier G, 2013, INT J PHARMACEUT, V457, P177, DOI 10.1016/j.ijpharm.2013.09.018; Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345; Bhattacharya K, 2015, SCI REP-UK, V5, DOI 10.1038/srep17072; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; BOYD GE, 1947, J AM CHEM SOC, V69, P2836, DOI 10.1021/ja01203a066; Chandran PR, 2015, GOLD NANOPARTICLES C, P221; Chen YP, 2013, J AM CHEM SOC, V135, P1516, DOI 10.1021/ja3105208; Chen YY, 2014, CHEM ENG J, V254, P579, DOI 10.1016/j.cej.2014.05.120; DARR D, 1994, J INVEST DERMATOL, V102, P671, DOI 10.1111/1523-1747.ep12374036; Deligiannakis Y, 2012, ACS APPL MATER INTER, V4, P6609, DOI 10.1021/am301751s; Devasagayam Thomas P. A., 2002, Indian Journal of Experimental Biology, V40, P680; Doane T, 2013, ADV DRUG DELIVER REV, V65, P607, DOI 10.1016/j.addr.2012.05.012; Elliott J, 2006, MRS BULL, V31, P869, DOI 10.1557/mrs2006.205; Endo N, 2009, J CLIN BIOCHEM NUTR, V45, P193, DOI 10.3164/jcbn.08-265; Eriksson M, 1997, J APPL PHYS, V82, P3143, DOI 10.1063/1.366158; FINKELSTEIN E, 1980, J AM CHEM SOC, V102, P4994, DOI 10.1021/ja00535a029; Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013; Gao ZP, 2013, J FOOD ENG, V116, P195, DOI 10.1016/j.jfoodeng.2012.10.037; Ghaedi M, 2014, J IND ENG CHEM, V20, P17, DOI 10.1016/j.jiec.2013.04.031; Goldstein S, 2007, ENVIRON SCI TECHNOL, V41, P7486, DOI 10.1021/es071379t; Govindasamy C, 2014, J AM COLL CARDIOL, V64, pC56, DOI 10.1016/j.jacc.2014.06.271; Gunther G, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0129749, DOI 10.1371/J0URNAL.P0NE.0129749]; Guo YY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/6/065102; HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011; Ho YS, 2005, PROCESS BIOCHEM, V40, P3455, DOI 10.1016/j.procbio.2005.02.017; Ho YS, 1998, CHEM ENG J, V70, P115, DOI 10.1016/S0923-0467(98)00076-1; Hulchanskyy TY, 2007, NANO LETT, V7, P2835, DOI 10.1021/nl0714637; HUSAIN SR, 1987, PHYTOCHEMISTRY, V26, P2489, DOI 10.1016/s0031-9422(00)83860-1; Iglesias CV, 2005, TOXICON, V46, P751, DOI 10.1016/j.toxicon.2005.07.017; Kamiya H, 2000, J AM CERAM SOC, V83, P287; Kumar R, 2008, ACS NANO, V2, P449, DOI 10.1021/nn700370b; Kupetz E, 2014, J CONTROL RELEASE, V189, P54, DOI 10.1016/j.jconrel.2014.06.007; Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002; Langmuir I, 1917, J AM CHEM SOC, V39, P1848, DOI 10.1021/ja02254a006; Lee GH, 2016, COLLOIDS SURFACES B; Lee J, 2014, INT J RADIAT BIOL, V90, P20, DOI 10.3109/09553002.2013.835502; Liberman A, 2014, SURF SCI REP, V69, P132, DOI 10.1016/j.surfrep.2014.07.001; Limousin G, 2007, APPL GEOCHEM, V22, P249, DOI 10.1016/j.apgeochem.2006.09.010; Liu WY, 2008, MOL PHARMACEUT, V5, P588, DOI 10.1021/mp7001413; Liu Y, 2008, SEP PURIF TECHNOL, V61, P229, DOI 10.1016/j.seppur.2007.10.002; Markovic Z, 2012, FOOD CHEM, V135, P2070, DOI 10.1016/j.foodchem.2012.05.119; Masood F, 2016, MAT SCI ENG C-MATER, V60, P569, DOI 10.1016/j.msec.2015.11.067; Mehnert W, 2012, ADV DRUG DELIVER REV, V64, P83, DOI 10.1016/j.addr.2012.09.021; Mladenka P, 2011, J INORG BIOCHEM, V105, P693, DOI 10.1016/j.jinorgbio.2011.02.003; Morales J, 2012, PLOS ONE, P7; Morales J, 2009, AFINIDAD, V539, P56; Mortera R, 2010, CHEM ENG J, V156, P184, DOI 10.1016/j.cej.2009.10.018; Mura F, 2014, FREE RADICAL RES, V48, P1473, DOI 10.3109/10715762.2014.965702; Musialik M, 2009, J ORG CHEM, V74, P2699, DOI 10.1021/jo802716v; Nagai S, 2005, J PHYS CHEM B, V109, P4234, DOI 10.1021/jp0451389; OGILBY PR, 1992, MACROMOLECULES, V25, P3399, DOI 10.1021/ma00039a014; Parisi O.I., 2014, POLYPHENOLS HUMAN HL, P29, DOI DOI 10.1016/B978-0-12-398456-2.00004-9; Park JT, 2010, J IND ENG CHEM, V16, P517, DOI 10.1016/j.jiec.2010.03.030; Pasternack RM, 2008, LANGMUIR, V24, P12963, DOI 10.1021/la8024827; Pena-Alonso R, 2007, J MATER SCI, V42, P595, DOI 10.1007/s10853-006-1138-9; Peppas NA, 2006, MRS BULL, V31, P888, DOI 10.1557/mrs2006.208; Prahalathan P, 2012, METABOLISM, V61, P1087, DOI 10.1016/j.metabol.2011.12.012; Pu YY, 2012, CHINESE CHEM LETT, V23, P1201, DOI 10.1016/j.cclet.2012.07.010; Qiao B, 2015, APPL SURFACE SCI; Qiu H, 2009, J ZHEJIANG UNIV-SC A, V10, P716, DOI 10.1631/jzus.A0820524; Queiroz RG, 2016, INT J BIOL MACROMOL, V85, P82, DOI 10.1016/j.ijbiomac.2015.12.074; Rahman IA, 2009, CERAM INT, V35, P1883, DOI 10.1016/j.ceramint.2008.10.028; Rai M, 2015, INT J PHARMACEUT, V496, P159, DOI 10.1016/j.ijpharm.2015.10.059; Rao BVB, 2014, MAT SCI ENG C-MATER, V34, P9, DOI 10.1016/j.msec.2013.10.002; Schlipf DM, 2015, COLLOID SURFACE A, V478, P15, DOI 10.1016/j.colsurfa.2015.03.039; Shah P, 2006, MRS BULL, V31, P894, DOI 10.1557/mrs2006.209; Shetty PK, 2015, INT J NANOMED, V10, P6477, DOI 10.2147/IJN.S90964; Sivaramakrishnan V, 2010, CHEM-BIOL INTERACT, V183, P284, DOI 10.1016/j.cbi.2009.11.011; Sposito G., 2008, CHEM SOILS, V2nd; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Sun XX, 2011, J AM CHEM SOC, V133, P18554, DOI 10.1021/ja2080168; Tang L, 2013, NANO TODAY, V8, P290, DOI 10.1016/j.nantod.2013.04.007; Tien C, 2014, SEP PURIF TECHNOL, V136, P303, DOI 10.1016/j.seppur.2014.08.013; Tseng RL, 2010, J TAIWAN INST CHEM E, V41, P661, DOI 10.1016/j.jtice.2010.01.014; Uppal A, 2011, PHOTOCHEM PHOTOBIOL, V87, P1146, DOI 10.1111/j.1751-1097.2011.00967.x; Vasiliu S, 2011, CARBOHYD POLYM, V85, P376, DOI 10.1016/j.carbpol.2011.02.039; VENUGOPAL J, 2013, PHARMACOGNOSY J, V5, P123, DOI DOI 10.1016/j.phcgj.2013.04.006; Vergara-Castaneda H, 2016, J COLLOID INTERF SCI, V466, P44, DOI 10.1016/j.jcis.2015.12.011; Wang X, 2014, COMPOS SCI TECHNOL, V104, P1, DOI 10.1016/j.compscitech.2014.08.027; Wang Y, 2015, NANOMED-NANOTECHNOL, V11, P313, DOI 10.1016/j.nano.2014.09.014; WU TW, 1995, BIOCHEM PHARMACOL, V49, P537, DOI 10.1016/0006-2952(94)00446-S; Yue H, 2015, VACCINE, V33, P5927, DOI 10.1016/j.vaccine.2015.07.100; Zelenak V, 2008, CHEM ENG J, V144, P336, DOI 10.1016/j.cej.2008.07.025; Zhang B, 2008, SCI CHINA SER B, V51, P145, DOI 10.1007/s11426-007-0104-y; Zhang R, 2009, CHEM-BIOL INTERACT, V177, P21, DOI 10.1016/j.cbi.2008.08.009; Zhou H, 2013, MATER CHEM PHYS, V140, P148, DOI 10.1016/j.matchemphys.2013.03.013; Zhou QH, 2009, SPECTROCHIM ACTA A, V72, P110, DOI 10.1016/j.saa.2008.08.012	94	35	35	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164507	10.1371/journal.pone.0164507	http://dx.doi.org/10.1371/journal.pone.0164507			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812111	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000009
J	Brophy, JC; Hawkes, MT; Mwinjiwa, E; Mateyu, G; Sodhi, SK; Chan, AK				Brophy, Jason C.; Hawkes, Michael T.; Mwinjiwa, Edson; Mateyu, Gabriel; Sodhi, Sumeet K.; Chan, Adrienne K.			Survival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern Malawi	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; FOLLOW-UP; OBSERVATIONAL DATABASE; TREATMENT PROGRAMS; CLINICAL-OUTCOMES; THERAPY; MORTALITY; CARE; LOST; TUBERCULOSIS	Background Pediatric uptake and outcomes in antiretroviral treatment (ART) programmes have lagged behind adult programmes. We describe outcomes from a population-based pediatric ART cohort in rural southern Malawi. Methods Data were analyzed on children who initiated ART from October/2003-September/2011. Demographics and diagnoses were described and survival analyses conducted to assess the impact of age, presenting features at enrolment, and drug selection. Results The cohort consisted of 2203 children <15 years of age. Age at entry was <1 year for 219 (10%), 1-1.9 years for 343 (16%), 2-4.9 years for 584 (27%), and 5-15 years for 1057 (48%) patients. Initial clinical diagnoses of tuberculosis and wasting were documented for 409 (19%) and 523 (24%) patients, respectively. Median follow-up time was 1.5 years (range 0-8 years), with 3900 patient-years of follow-up. Over the period of observation, 134 patients (6%) died, 1324 (60%) remained in the cohort, 345 (16%) transferred out, and 387 (18%) defaulted. Infants <1 year of age accounted for 19% of deaths, with a 2.7-fold adjusted mortality hazard ratio relative to 5-15 year olds; median time to death was also shorter for infants (60 days) than older children (108 days). Survival analysis demonstrated younger age at ART initiation, more advanced HIV stage, and presence of tuberculosis to each be associated with shorter survival time. Among children <5 years, severe wasting (weight-for-height z-score </=-3.0) was also associated with reduced survival. Conclusions Cumulative incidence of mortality was 5.2%, 7.1% and 7.7% after 1, 3, and 5 years, respectively, with disproportionate mortality in infants <1 year of age and those presenting with tuberculosis. These findings reinforce the urgent need for early diagnosis and treatment in this population, but also demonstrate that provision of pediatric care in a rural setting can yield outcomes comparable to more resourced urban settings of poor countries.	[Brophy, Jason C.; Mateyu, Gabriel; Sodhi, Sumeet K.; Chan, Adrienne K.] Dignitas Int, Zomba, Malawi; [Brophy, Jason C.] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON, Canada; [Hawkes, Michael T.] Univ Alberta, Stollery Childrens Hosp, Dept Pediat, Edmonton, AB, Canada; [Mwinjiwa, Edson] Minist Hlth, Zomba Cent Hosp, Zomba, Malawi; [Sodhi, Sumeet K.] Univ Toronto, Univ Hlth Network, Dept Family & Community Med, Toronto, ON, Canada; [Chan, Adrienne K.] Univ Toronto, Sunnybrook Hosp, Dept Med, Toronto, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; Stollery Children's Hospital; University of Alberta; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Brophy, JC (corresponding author), Dignitas Int, Zomba, Malawi.; Brophy, JC (corresponding author), Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON, Canada.	jbrophy@cheo.on.ca	, Michael/AAP-3049-2020		Canadian Institutes for Health Research-Operating Grant-PA: HIV/AIDS Res Initiative-HIth Svs/Population HIth Stream; USAID-Malawi: APS [M/OAA/GRO/ EGAS - 09-232]	Canadian Institutes for Health Research-Operating Grant-PA: HIV/AIDS Res Initiative-HIth Svs/Population HIth Stream; USAID-Malawi: APS(United States Agency for International Development (USAID))	Support was provided by: Canadian Institutes for Health Research-Operating Grant-PA: HIV/AIDS Res Initiative-HIth Svs/Population HIth Stream. "Assessing the Impact of HIV/AIDS Service Delivery in Zomba District, Malawi: The Zomba District Observational Cohort Study [to SS]; and USAID-Malawi: APS No: M/OAA/GRO/ EGAS - 09-232 "Support for Health Systems Strengthening and HIV/AIDS Service Delivery in Malawi's South-East Zone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakeera-Kitaka S, 2011, INT J TUBERC LUNG D, V15, P1082, DOI 10.5588/ijtld.10.0538; Binagwaho A, 2013, J PUBLIC HEALTH POL, V34, P2, DOI 10.1057/jphp.2012.62; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Bong CN, 2007, INT J TUBERC LUNG D, V11, P534; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Davies MA, 2009, SAMJ S AFR MED J, V99, P730; Edmonds A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001044; Fenner L, 2010, JAIDS-J ACQ IMM DEF, V54, P524, DOI 10.1097/QAI.0b013e3181e0c4cf; Gray B., 2014, PACKAGE CMPRSK SUBDI; Hansudewechakul R, 2010, JAIDS-J ACQ IMM DEF, V55, P503, DOI 10.1097/QAI.0b013e3181f5379a; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Kabue MM, 2012, PEDIATRICS, V130, pE591, DOI 10.1542/peds.2011-1187; Malawi Ministry of Health, 2008, GUID US ANT THER MAL; Malawi Ministry of Health, 2014, MAL HIV PROGR DAT Q4; McNairy ML, 2013, JAIDS-J ACQ IMM DEF, V62, pE70, DOI 10.1097/QAI.0b013e318278bcb0; National Statistical Office, 2013, 2008 POP HOUS CENS R; Palmer D, 2006, REPROD HEALTH MATTER, V14, P27, DOI 10.1016/S0968-8080(06)27244-6; Peacock-Villada E, 2011, PEDIATRICS, V127, pE423, DOI 10.1542/peds.2009-2701; Phongsamart W, 2014, INT J INFECT DIS, V22, P19, DOI 10.1016/j.ijid.2013.12.011; Preidis GA, 2011, J PEDIATR-US, V159, P484, DOI 10.1016/j.jpeds.2011.02.033; Rasschaert F, 2011, JAIDS-J ACQ IMM DEF, V57, pS109, DOI 10.1097/QAI.0b013e31821f9b69; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Sengayi M, 2013, GLOBAL HEALTH ACTION, V6, P169, DOI 10.3402/gha.v6i0.19248; Tene G, 2013, PEDIATR INFECT DIS J, V32, pE341, DOI 10.1097/INF.0b013e31828c2744; Therneau T, 2012, PACKAGE SURVIVAL ANA; Therneau TG, 2002, MODELING SURVIVAL DA, P85; Torpey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042859; Waning B, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-74; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; Weigel R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-31; WHO, 2013, GLOB UPD HIV TREATM; World Health Organization, 2010, ANT THER HIV INF INF; World Health Organization and United Nations Children's Fund, 2009, WHO CHILD GROWTH STA; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165772	10.1371/journal.pone.0165772	http://dx.doi.org/10.1371/journal.pone.0165772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812166	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000056
J	Chan, ASH; Jonas, AB; Qiu, X; Ottoson, NR; Walsh, RM; Gorden, KB; Harrison, B; Maimonis, PJ; Leonardo, SM; Ertelt, KE; Danielson, ME; Michel, KS; Nelson, M; Graff, JR; Patchen, ML; Bose, N				Chan, Anissa S. H.; Jonas, Adria Bykowski; Qiu, Xiaohong; Ottoson, Nadine R.; Walsh, Richard M.; Gorden, Keith B.; Harrison, Ben; Maimonis, Peter J.; Leonardo, Steven M.; Ertelt, Kathleen E.; Danielson, Michael E.; Michel, Kyle S.; Nelson, Mariana; Graff, Jeremy R.; Patchen, Myra L.; Bose, Nandita			Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation	PLOS ONE			English	Article							FC-GAMMA RECEPTORS; YEAST BETA-GLUCAN; CHRONIC LYMPHOCYTIC-LEUKEMIA; DENGUE VIRUS-INFECTION; HUMAN-NEUTROPHILS; MONOCLONAL-ANTIBODY; XENOGRAFT MODELS; OXIDATIVE BURST; HUMAN MONOCYTES; IGG SUBCLASSES	Imprime PGG (Imprime), an intravenously-administered, soluble beta-glucan, has shown compelling efficacy in multiple phase 2 clinical trials with tumor targeting or anti-angiogenic antibodies. Mechanistically, Imprime acts as pathogen-associated molecular pattern (PAMP) directly activating innate immune effector cells, triggering a coordinated anti-cancer immune response. Herein, using whole blood from healthy human subjects, we show that Imprime-induced anti-cancer functionality is dependent on immune complex formation with naturally-occurring, anti-beta glucan antibodies (ABA). The formation of Imprime-ABA complexes activates complement, primarily via the classical complement pathway, and is opsonized by iC3b. Immune complex binding depends upon Complement Receptor 3 and Fcg Receptor IIa, eliciting phenotypic activation of, and enhanced chemokine production by, neutrophils and monocytes, enabling these effector cells to kill antibody-opsonized tumor cells via the generation of reactive oxygen species and antibody-dependent cellular phagocytosis. Importantly, these innate immune cell changes were not evident in subjects with low ABA levels but could be rescued with exogenous ABA supplementation. Together, these data indicate that pre-existing ABA are essential for Imprime-mediated anti-cancer immune activation and suggest that pre-treatment ABA levels may provide a plausible patient selection biomarker to delineate patients most likely to benefit from Imprime-based therapy.	[Chan, Anissa S. H.; Jonas, Adria Bykowski; Qiu, Xiaohong; Ottoson, Nadine R.; Walsh, Richard M.; Gorden, Keith B.; Harrison, Ben; Maimonis, Peter J.; Leonardo, Steven M.; Ertelt, Kathleen E.; Danielson, Michael E.; Michel, Kyle S.; Nelson, Mariana; Graff, Jeremy R.; Patchen, Myra L.; Bose, Nandita] Biothera Pharmaceut Inc, Eagan, MN 55121 USA		Bose, N (corresponding author), Biothera Pharmaceut Inc, Eagan, MN 55121 USA.	nbose@biothera.com			Biothera Pharmaceuticals Inc.	Biothera Pharmaceuticals Inc.	Biothera Pharmaceuticals Inc. provided support in the form of salaries for authors (Anissa S.H. Chan, Adria Bykowski Jonas, Xiaohong Qiu, Nadine R. Ottoson, Richard M. Walsh, Keith B. Gorden, Ben Harrison, Peter J. Maimonis, Steven Leonardo, Kathleen E. Ertelt, Michael E. Danielson, Kyle S. Michel, Mariana Nelson, Jeremy R. Graff, Myra L. Patchen and Nandita Bose), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BARRETT DJ, 1986, CLIN EXP IMMUNOL, V63, P127; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; Bose N, 2014, GLYCOBIOLOGY, V24, P379, DOI 10.1093/glycob/cwu005; Bose N, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00230; Brandsma AM, 2015, IMMUNOL REV, V268, P74, DOI 10.1111/imr.12332; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; CHESON BD, 1981, INT ARCH ALLER A IMM, V66, P48, DOI 10.1159/000232798; Chiani P, 2009, VACCINE, V27, P513, DOI 10.1016/j.vaccine.2008.11.030; DANIELS RH, 1992, IMMUNOLOGY, V75, P157; Leoratti FMD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001710; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; EMBER JA, 1994, AM J PATHOL, V144, P393; Fortunati E, 2009, CLIN EXP IMMUNOL, V155, P559, DOI 10.1111/j.1365-2249.2008.03791.x; Fukuoka Y, 2001, CURR EYE RES, V23, P320, DOI 10.1076/ceyr.23.5.320.5437; Geller MA, 2010, CANCER IMMUNOL IMMUN, V59, P1877, DOI 10.1007/s00262-010-0914-1; Ghosh TK, 2006, CELL IMMUNOL, V243, P48, DOI 10.1016/j.cellimm.2006.12.002; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Halstenson CE, 2016, INVEST NEW DRUG, V34, P202, DOI 10.1007/s10637-016-0325-z; Hao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038317; Hood JD, 2010, HUM VACCINES, V6, P322, DOI 10.4161/hv.6.4.10866; Huang ZY, 2011, J BIOL CHEM, V286, P160, DOI 10.1074/jbc.M110.163030; Hunniger K, 2015, J IMMUNOL, V194, P1199, DOI 10.4049/jimmunol.1401845; Ishibashi K, 2013, INT J MED MUSHROOMS, V15, P115, DOI 10.1615/IntJMedMushr.v15.i2.10; Li B, 2007, CANCER RES, V67, P7421, DOI 10.1158/0008-5472.CAN-07-1465; Li B, 2006, J IMMUNOL, V177, P1661, DOI 10.4049/jimmunol.177.3.1661; Masuzawa S, 2003, DRUG DEVELOP RES, V58, P179, DOI 10.1002/ddr.10158; Milton DK, 2001, APPL ENVIRON MICROB, V67, P5420, DOI 10.1128/AEM.67.12.5420-5424.2001; Mollnes TE, 2002, BLOOD, V100, P1869; PARREN PWHI, 1992, J CLIN INVEST, V90, P1537, DOI 10.1172/JCI116022; Perkins H, 2012, J CLIN IMMUNOL, V32, P1082, DOI 10.1007/s10875-012-9687-y; PETTY HR, 1993, J LEUKOCYTE BIOL, V54, P492, DOI 10.1002/jlb.54.5.492; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Ravetch JV, 2002, J CLIN INVEST, V110, P1759, DOI 10.1172/JCI200217349; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; SALMON JE, 1992, J CLIN INVEST, V89, P1274, DOI 10.1172/JCI115712; Salvador C, 2008, CLIN CANCER RES, V14, P1239, DOI 10.1158/1078-0432.CCR-07-1669; Schaeffer V, 2007, SHOCK, V27, P623, DOI 10.1097/SHK.0b013e31802fa0bd; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Schwarzer E, 1998, INFECT IMMUN, V66, P1601, DOI 10.1128/IAI.66.4.1601-1606.1998; Segal NH, 2016, J CLIN COLO IN PRESS; Shankar G, 2007, NAT BIOTECHNOL, V25, P555, DOI 10.1038/nbt1303; SIPKA S, 1985, INT J IMMUNOPHARMACO, V7, P747, DOI 10.1016/0192-0561(85)90161-4; Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367; Tsuboi N, 2011, ARTHRITIS RHEUM-US, V63, P467, DOI 10.1002/art.30141; VALIM YML, 1991, CLIN EXP IMMUNOL, V84, P1, DOI 10.1111/j.1365-2249.1991.tb08115.x; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang LY, 2010, CLIN IMMUNOL, V137, P157, DOI 10.1016/j.clim.2010.05.012; WARMERDAM PAM, 1991, J IMMUNOL, V147, P1338; Zent CS, 2008, CANCER, V113, P2110, DOI 10.1002/cncr.23824; Zent CS, 2015, LEUKEMIA LYMPHOMA, V56, P2373, DOI 10.3109/10428194.2015.1016932; Zhong WJ, 2009, J IMMUNOTHER, V32, P703, DOI 10.1097/CJI.0b013e3181ad3fcf; ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407	56	30	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165909	10.1371/journal.pone.0165909	http://dx.doi.org/10.1371/journal.pone.0165909			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812183	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000078
J	Jiang, ZB; Yang, Q				Jiang, Zi-Bin; Yang, Qiong			A Discrete Fruit Fly Optimization Algorithm for the Traveling Salesman Problem	PLOS ONE			English	Article							INVENTORY CONTROL-PROBLEM; NETWORK	The fruit fly optimization algorithm (FOA) is a newly developed bio-inspired algorithm. The continuous variant version of FOA has been proven to be a powerful evolutionary approach to determining the optima of a numerical function on a continuous definition domain. In this study, a discrete FOA (DFOA) is developed and applied to the traveling salesman problem (TSP), a common combinatorial problem. In the DFOA, the TSP tour is represented by an ordering of city indices, and the bio-inspired meta-heuristic search processes are executed with two elaborately designed main procedures: the smelling and tasting processes. In the smelling process, an effective crossover operator is used by the fruit fly group to search for the neighbors of the best-known swarm location. During the tasting process, an edge intersection elimination (EXE) operator is designed to improve the neighbors of the non-optimum food location in order to enhance the exploration performance of the DFOA. In addition, benchmark instances from the TSPLIB are classified in order to test the searching ability of the proposed algorithm. Furthermore, the effectiveness of the proposed DFOA is compared to that of other meta-heuristic algorithms. The results indicate that the proposed DFOA can be effectively used to solve TSPs, especially large-scale problems.	[Jiang, Zi-Bin; Yang, Qiong] Hunan Univ, Coll Business Adm, Changsha, Hunan, Peoples R China	Hunan University	Jiang, ZB (corresponding author), Hunan Univ, Coll Business Adm, Changsha, Hunan, Peoples R China.	jiangzibin@hnu.edu.cn			Doctoral Program Foundation of the Institutions of Higher Education of China [20100161120006]; Humanities and Social Sciences Foundation of the Ministry of Education of China [11YJC630078]; China Scholarship Council [201306135011]	Doctoral Program Foundation of the Institutions of Higher Education of China; Humanities and Social Sciences Foundation of the Ministry of Education of China(Ministry of Education, China); China Scholarship Council(China Scholarship Council)	This research was partially supported by the Doctoral Program Foundation of the Institutions of Higher Education of China (No.20100161120006), the Humanities and Social Sciences Foundation of the Ministry of Education of China (No. 11YJC630078), and the China Scholarship Council (No. 201306135011).	Baraglia R, 2001, IEEE T EVOLUT COMPUT, V5, P613, DOI 10.1109/4235.974843; Burkard RE, 1998, SIAM REV, V40, P496, DOI 10.1137/S0036144596297514; Choubey N.-S., 2014, INT J COMPUTER APPL, V107, P22, DOI [10.5120/18851-0385, DOI 10.5120/18851-0385]; CLARKE G, 1964, OPER RES, V12, P568, DOI 10.1287/opre.12.4.568; Dorigo M, 1997, BIOSYSTEMS, V43, P73, DOI 10.1016/S0303-2647(97)01708-5; Duan Yanming, 2016, Computer Engineering and Applications, V52, P144, DOI 10.3778/j.issn.1002-8331.1404-0468; Goldberg DE, 1985, INT C GENETIC ALGORI, V12, P154; Grefenstette J., 1985, PROC 1 INT C GENET A, V160, P160; Gutin G., 2007, COMBINATORIAL OPTIMI, V12, DOI [10.1007/b101971, DOI 10.1007/B101971]; Johnson D. S., 1997, LOCAL SEARCH COMBINA, P215, DOI DOI 10.1108/01445150910987763; Karthikeyan S, 2015, INT J BIO-INSPIR COM, V7, P386, DOI 10.1504/IJBIC.2015.073165; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Wu L, 2016, INT J COMPUT INT SYS, V9, P80, DOI 10.1080/18756891.2016.1144155; Lei XJ, 2016, KNOWL-BASED SYST, V105, P270, DOI 10.1016/j.knosys.2016.05.019; Li HZ, 2013, KNOWL-BASED SYST, V37, P378, DOI 10.1016/j.knosys.2012.08.015; Li HY, 2014, IEEE INT C INFORM AU, V58, P58, DOI [10.1109/ICInfA.2014.6932728, DOI 10.1109/ICINFA.2014.6932728]; LIN S, 1973, OPER RES, V21, P498, DOI 10.1287/opre.21.2.498; Lin SM, 2013, NEURAL COMPUT APPL, V22, P783, DOI 10.1007/s00521-011-0769-1; Mousavi SM, 2016, SOFT COMPUT, V20, P2281, DOI 10.1007/s00500-015-1641-5; Mousavi SM, 2015, COMPUT IND ENG, V87, P543, DOI 10.1016/j.cie.2015.05.022; Mousavi SM, 2014, INFORM SCIENCES, V276, P42, DOI 10.1016/j.ins.2014.02.046; Mousavi SM, 2014, INT J ADV MANUF TECH, V70, P1739, DOI 10.1007/s00170-013-5378-y; Nguyen HD, 2007, IEEE T SYST MAN CY B, V37, P92, DOI 10.1109/TSMCB.2006.880136; Oncan T, 2009, COMPUT OPER RES, V36, P637, DOI 10.1016/j.cor.2007.11.008; Orman AJ, 2007, ADV COMPUT MANAG SCI, V9, P91; Osaba E, 2016, ENG APPL ARTIF INTEL, V48, P59, DOI 10.1016/j.engappai.2015.10.006; Pan QK, 2014, KNOWL-BASED SYST, V62, P69, DOI 10.1016/j.knosys.2014.02.021; Pan WT, 2012, KNOWL-BASED SYST, V26, P69, DOI 10.1016/j.knosys.2011.07.001; Pasandideh SHR, 2013, INT J ADV MANUF TECH, V69, P1671, DOI 10.1007/s00170-013-5130-7; Shan D, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/108768; Shi XH, 2007, INFORM PROCESS LETT, V103, P169, DOI 10.1016/j.ipl.2007.03.010; Spanos AC, 2014, INT T OPER RES, V21, P479, DOI 10.1111/itor.12056; Wang FR, 2015, MATEC WEB CONF, V22, DOI 10.1051/matecconf/20152201040; Wang Ke-fu, 2014, Computer Engineering and Design, V35, P2789; Wang L, 2016, KNOWL-BASED SYST, V97, P158, DOI 10.1016/j.knosys.2016.01.006; Wang L, 2013, KNOWL-BASED SYST, V48, P17, DOI 10.1016/j.knosys.2013.04.003; WHITLEY D, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P133; Yin LJ, 2016, 2016 EIGHTH INTERNATIONAL CONFERENCE ON ADVANCED COMPUTATIONAL INTELLIGENCE (ICACI), P21, DOI 10.1109/ICACI.2016.7449797; Zhang P, 2014, CHIN CONTR CONF, P7466, DOI 10.1109/ChiCC.2014.6896242; Zheng XL, 2014, KNOWL-BASED SYST, V57, P95, DOI 10.1016/j.knosys.2013.12.011; Zhou YQ, 2015, NEUROCOMPUTING, V151, P1227, DOI 10.1016/j.neucom.2014.01.078	42	11	11	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165804	10.1371/journal.pone.0165804	http://dx.doi.org/10.1371/journal.pone.0165804			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812175	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000061
J	Borner, J; Baylis, K; Corbera, E; Ezzine-de-Blas, D; Ferraro, PJ; Honey-Roses, J; Lapeyre, R; Persson, UM; Wunder, S				Boerner, Jan; Baylis, Kathy; Corbera, Esteve; Ezzine-de-Blas, Driss; Ferraro, Paul J.; Honey-Roses, Jordi; Lapeyre, Renaud; Persson, U. Martin; Wunder, Sven			Emerging Evidence on the Effectiveness of Tropical Forest Conservation	PLOS ONE			English	Article							ECOSYSTEM SERVICES; ENVIRONMENTAL SERVICES; PROTECTED AREAS; LAND-USE; PAYMENTS; MANAGEMENT; POVERTY	The PLOS ONE Collection "Measuring forest conservation effectiveness" brings together a series of studies that evaluate the effectiveness of tropical forest conservation policies and programs with the goal of measuring conservation success and associated co-benefits. This overview piece describes the geographic and methodological scope of these studies, as well as the policy instruments covered in the Collection as of June 2016. Focusing on forest cover change, we systematically compare the conservation effects estimated by the studies and discuss them in the light of previous findings in the literature. Nine studies estimated that annual conservation impacts on forest cover were below one percent, with two exceptions in Mexico and Indonesia. Differences in effect sizes are not only driven by the choice of conservation measures. One key lesson from the studies is the need to move beyond the current scientific focus of estimating average effects of undifferentiated conservation programs. The specific elements of the program design and the implementation context are equally important factors for understanding the effectiveness of conservation programs. Particularly critical will be a better understanding of the causal mechanisms through which conservation programs have impacts. To achieve this understanding we need advances in both theory and methods.	[Boerner, Jan] Univ Bonn, Ctr Dev Res ZEF, Bonn, Germany; [Boerner, Jan] Ctr Int Forestry Res CIFOR, Bonn, Germany; [Baylis, Kathy] Univ Illinois, Dept Agr & Consumer Econ, Urbana, IL 61801 USA; [Corbera, Esteve] Univ Autonoma Barcelona, Inst Environm Sci & Technol ICTA, Barcelona, Spain; [Corbera, Esteve] Univ Autonoma Barcelona, Dept Econ & Econ Hist, Barcelona, Spain; [Ezzine-de-Blas, Driss] CIRAD, Montpellier, France; [Ferraro, Paul J.] Johns Hopkins Univ, Dept Geog & Environm Engn, Carey Business Sch, Baltimore, MD 21218 USA; [Ferraro, Paul J.] Johns Hopkins Univ, Dept Geog & Environm Engn, Whiting Sch Engn, Baltimore, MD 21218 USA; [Honey-Roses, Jordi] Univ British Columbia, Sch Community & Reg Planning, Vancouver, BC, Canada; [Lapeyre, Renaud] IDDRI, Paris, France; [Persson, U. Martin] Chalmers Univ Technol, Dept Energy & Environm, Gothenburg, Sweden; [Wunder, Sven] Ctr Int Forestry Res CIFOR, Lima, Peru	University of Bonn; CGIAR; Center for International Forestry Research (CIFOR); University of Illinois System; University of Illinois Urbana-Champaign; Autonomous University of Barcelona; Autonomous University of Barcelona; CIRAD; Johns Hopkins University; Johns Hopkins University; University of British Columbia; Chalmers University of Technology; CGIAR; Center for International Forestry Research (CIFOR)	Borner, J (corresponding author), Univ Bonn, Ctr Dev Res ZEF, Bonn, Germany.; Borner, J (corresponding author), Ctr Int Forestry Res CIFOR, Bonn, Germany.	jborner@uni-bonn.de	Honey-Rosés, Jordi/H-3364-2019; Corbera, Esteve/C-5368-2015; Ferraro, Paul J/B-4435-2014; Wunder, Sven/ABE-7773-2020; Börner, Jan/ABF-8775-2021	Honey-Rosés, Jordi/0000-0003-0097-1811; Corbera, Esteve/0000-0001-7970-4411; Ferraro, Paul J/0000-0002-4777-5108; Wunder, Sven/0000-0002-9422-0260; Börner, Jan/0000-0003-3034-5360; Persson, U. Martin/0000-0001-7069-6734	European Commission [DCI-ENV/2011/269520]; Robert Bosch Foundation [32.5.8043.00 12.0]; CGIAR Research Program on Forests, Trees and Agroforestry (FTA); European Association of Environmental and Resource Economists	European Commission(European CommissionEuropean Commission Joint Research Centre); Robert Bosch Foundation; CGIAR Research Program on Forests, Trees and Agroforestry (FTA)(CGIAR); European Association of Environmental and Resource Economists	This work was supported by European Commission - Grant no. DCI-ENV/2011/269520, Robert Bosch Foundation (Grant: 32.5.8043.00 12.0), the CGIAR Research Program on Forests, Trees and Agroforestry (FTA), and European Association of Environmental and Resource Economists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financially supported by the European Commission-Grant no DCI-ENV/2011/269520 and the Robert Bosch Foundation; the CGIAR Research Program on Forests, Trees and Agroforestry (FTA); and European Association of Environmental and Resource Economists. We thank the participants of the International Workshop "Evaluating Forest Conservation Initiatives: New Tools and Policy Needs", 10-12th December 2013 in Barcelona, Spain, for discussions and comments that have helped putting together this Collection.	Abadie A, 2014, AM J POLITI IN PRESS; Arriagada RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131544; Arriagada RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148094; Arriagada RA, 2012, LAND ECON, V88, P382, DOI 10.3368/le.88.2.382; Baylis K, 2016, CONSERV LETT, V9, P58, DOI 10.1111/conl.12180; Borner J, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0121544, 10.1371/journal.pone.0116846]; Borner J., 2013, GOVERNING PROVISION, P21, DOI [10.1007/978-94-007-5176-7_2, DOI 10.1007/978-94-007-5176-7]; Bowler DE, 2012, FRONT ECOL ENVIRON, V10, P29, DOI 10.1890/110040; Bringezu S, 2012, LAND USE POLICY, V29, P224, DOI 10.1016/j.landusepol.2011.06.010; CBD (Convention on Biological Diversity), 2014, GLOB BIOD OUTL 4; Cisneros E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136402; Costedoat S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119881; Deininger K, 2013, AGR ECON-BLACKWELL, V44, P115, DOI 10.1111/agec.12056; FAO, 2015, 163 FAO; Ferraro P., 2009, ENV PROGRAM POLICY E, P75, DOI [10.1002/ev.297, DOI 10.1002/EV.297]; Ferraro PJ, 2015, P NATL ACAD SCI USA, V112, P7420, DOI 10.1073/pnas.1406487112; Ferraro PJ, 2014, P NATL ACAD SCI USA, V111, P4332, DOI 10.1073/pnas.1307712111; Ferraro PJ, 2011, CONSERV BIOL, V25, P1134, DOI 10.1111/j.1523-1739.2011.01791.x; Fisher J, 2012, ORYX, V46, P45, DOI 10.1017/S0030605311001384; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; Henders S, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/125012; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Honey-Roses J, 2011, CONSERV BIOL, V25, P1032, DOI 10.1111/j.1523-1739.2011.01729.x; Le Velly G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149374; Miteva DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129675; Pagiola S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147829; Pailler S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133252; Pattanayak SK, 2010, REV ENV ECON POLICY, V4, P254, DOI 10.1093/reep/req006; Persson UM, 2013, WORLD DEV, V43, P124, DOI 10.1016/j.worlddev.2012.10.006; Pfaff A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129460; Puyravaud JP, 2003, FOREST ECOL MANAG, V177, P593, DOI 10.1016/S0378-1127(02)00335-3; Riehl B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125531; Robalino J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124910; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; Samii C., 2014, Campbell Systematic Reviews, V10; Shah P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124872; Sills EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132590; White H, 2009, J DEV EFFECT, V1, P271, DOI 10.1080/19439340903114628	38	48	49	8	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0159152	10.1371/journal.pone.0159152	http://dx.doi.org/10.1371/journal.pone.0159152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806043	Green Published, gold			2022-12-27	WOS:000386715500002
J	Daan, NMP; Koster, MPH; de Wilde, MA; Dalmeijer, GW; Evelein, AMV; Fauser, BCJM; de Jager, W				Daan, Nadine M. P.; Koster, Maria P. H.; de Wilde, Marlieke A.; Dalmeijer, Gerdien W.; Evelein, Annemieke M. V.; Fauser, Bart C. J. M.; de Jager, Wilco			Biomarker Profiles in Women with PCOS and PCOS Offspring; A Pilot Study	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; JUVENILE IDIOPATHIC ARTHRITIS; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; MULTIPLEX IMMUNOASSAY; S100 PROTEINS; ADIPONECTIN; METAANALYSIS; CHILDREN; LEPTIN	Objective To study metabolic/inflammatory biomarker risk profiles in women with PCOS and PCOS offspring. Design Cross-sectional comparison of serum biomarkers. Setting University Medical Center Utrecht. Patients Hyperandrogenic PCOS women (HA-PCOS, n = 34), normoandrogenic PCOS women (NA-PCOS, n = 34), non-PCOS reference population (n = 32), PCOS offspring (n = 14, age 6-8 years), and a paedriatic reference population (n = 30). Main Outcome Measure(s) Clustering profile of adipocytokines (IL-1b, IL-6, IL-13, IL-17, IL-18, TNF-alpha, adiponectin, adipsin, leptin, chemerin, resistin, RBP4, DPP-IV/sCD26, CCL2/MCP-1), growth factors (PIGF, VEGF, sVEGF-R1), soluble cell adhesion molecules (sICAM-1/sCD54, sVCAM-1/sCD106), and other inflammatory related proteases (MMP-9, S100A8, Cathepsin S). Differences in median biomarker concentrations between groups, and associations with the free androgen index (FAI; Testosterone/SHBG x100). Results The cluster analysis identified leptin, RBP-4, DPP-IV and adiponectin as potential discriminative markers for HA-PCOS with a specifically strong correlation in cases with increased BMI. Leptin (R-2 = 0.219) and adiponectin ((R2) = 0.182) showed the strongest correlation with the FAI. When comparing median protein concentrations adult PCOS women with or without hyperandrogenemia, the most profound differences were observed for leptin (P < 0.001), DPP-IV (P = 0.005), and adiponectin (P < 0.001). Adjusting for age, BMI and multiple testing attenuated all differences. In PCOS offspring, MMP-9 (P = 0.001) and S100A8 (P < 0.001) concentrations were significantly higher compared to a healthy matched reference population, even after correcting for age and BMI and adjustment for multiple testing. Conclusion In this preliminary investigation we observed significant differences in adipocytokines between women with or without hyperandrogenic PCOS and non-PCOS controls, mostly influenced by BMI. Leptin and adiponectin showed the strongest correlation with the FAI in adult women with PCOS. In PCOS offspring other inflammatory biomarkers (MMP-9, S100A8) were increased, suggesting that these children may exhibit increased chronic low-grade inflammation. Additional research is required to confirm results of the current exploratory investigation.	[Daan, Nadine M. P.; Koster, Maria P. H.; de Wilde, Marlieke A.; Fauser, Bart C. J. M.] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands; [Dalmeijer, Gerdien W.; Evelein, Annemieke M. V.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Jager, Wilco] Wilhelmina Childrens Hosp, Div Pediat, Lab Translat Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Daan, NMP (corresponding author), Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands.	n.m.p.daan@umcutrecht.nl		de Jager, Wilco/0000-0002-0014-0682	Dutch Heart Foundation [2013T083]; Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO) [11679]; Ministry of Economic Affairs; Actavis; COGI; Euroscreen; Ferring; Finox; Genovum; Gedeon-Richter; Merck-Serono; OvaScience; Pantharei Bioscience; PregLem; Roche; Uteron; Watson laboratories; Child Health research programme of the University Medical Center Utrecht; Netherlands Organisation for Health Research and Development [2100.0095]; Dutch Asthma Foundation; Glaxo Smith Kline; ReumaFonds [LLP-10] Funding Source: researchfish	Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; Actavis; COGI; Euroscreen; Ferring(Ferring Pharmaceuticals); Finox; Genovum; Gedeon-Richter; Merck-Serono(Merck & Company); OvaScience; Pantharei Bioscience; PregLem; Roche(Roche Holding); Uteron; Watson laboratories; Child Health research programme of the University Medical Center Utrecht; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch Asthma Foundation; Glaxo Smith Kline(GlaxoSmithKline); ReumaFonds	N.M.P. Daan has received funding from the Dutch Heart Foundation, grant number 2013T083. W. de Jager is supported by the Dutch Technology Foundation STW (project 11679), which is part of the Netherlands Organisation for Scientific Research (NWO), and which is partly funded by the Ministry of Economic Affairs. During the recent 5 year period B.C.J.M. Fauser has received fees and grant support from the following companies (in alphabetic order); Actavis, COGI, Euroscreen, Ferring, Finox, Genovum, Gedeon-Richter, Merck-Serono, OvaScience, Pantharei Bioscience, PregLem, Roche, Uteron, and Watson laboratories. This funding is unrelated to the current investigation. The Children follow-up study from women with PCOS (CHOPS) was funded in part by the Child Health research programme of the University Medical Center Utrecht. A.M.V. Evelein being part of the Wheezing Illnesses Study Leidsche Rijn (WHISTLER) Study group received funding from The Netherlands Organisation for Health Research and Development, grant number 2100.0095 (ZonMw), the Dutch Asthma Foundation and from Glaxo Smith Kline (no personal grant). None of the funders stated above of any of the authors had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIEL SA, 1991, J CLIN ENDOCR METAB, V72, P277, DOI 10.1210/jcem-72-2-277; Ardawi MSM, 2005, FERTIL STERIL, V83, P1708, DOI 10.1016/j.fertnstert.2004.11.077; Atiomo W, 2009, BJOG-INT J OBSTET GY, V116, P137, DOI 10.1111/j.1471-0528.2008.02041.x; Battaglia C, 2009, FERTIL STERIL, V92, P240, DOI 10.1016/j.fertnstert.2008.05.018; Cassar S, 2015, CLIN ENDOCRINOL, V83, P50, DOI 10.1111/cen.12619; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chen CI, 2015, GYNECOL ENDOCRINOL, V31, P264, DOI 10.3109/09513590.2014.984676; Cohen B, 1996, SCIENCE, V274, P1185, DOI 10.1126/science.274.5290.1185; Daan NM, 2014, FERTIL STERIL; de Jager W, 2005, J IMMUNOL METHODS, V300, P124, DOI 10.1016/j.jim.2005.03.009; de Jager W, 2007, ANN RHEUM DIS, V66, P589, DOI 10.1136/ard.2006.061853; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Eikendal ALM, 2014, ATHEROSCLEROSIS, V236, P270, DOI 10.1016/j.atherosclerosis.2014.07.018; Escobar-Morreale HF, 2006, HUM REPROD, V21, P2257, DOI 10.1093/humrep/del146; Escobar-Morreale HF, 2011, FERTIL STERIL, V95, P1048, DOI 10.1016/j.fertnstert.2010.11.036; Escobar-Morreale HF, 2004, J CLIN ENDOCR METAB, V89, P806, DOI 10.1210/jc.2003-031365; Fauser BCJM, 2012, FERTIL STERIL, V97, P28, DOI 10.1016/j.fertnstert.2011.09.024; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Geerts CC, 2012, ANN MED, V44, P350, DOI 10.3109/07853890.2011.558520; Glintborg D, 2009, CLIN ENDOCRINOL, V71, P652, DOI 10.1111/j.1365-2265.2009.03523.x; Goldman S, 2004, FRONT BIOSCI-LANDMRK, V9, P2474, DOI 10.2741/1409; Hart R, 2015, J CLIN ENDOCR METAB, V100, P911, DOI 10.1210/jc.2014-3886; Huet C, 1997, BIOL REPROD, V56, P1025, DOI 10.1095/biolreprod56.4.1025; Jacobs HS, 1999, HUM REPROD UPDATE, V5, P166, DOI 10.1093/humupd/5.2.166; Kent SC, 2008, J CLIN ENDOCR METAB, V93, P1662, DOI 10.1210/jc.2007-1958; Khurana R, 2005, CIRCULATION, V112, P1813, DOI 10.1161/CIRCULATIONAHA.105.535294; Kofla-Dlubacz A, 2014, ADV CLIN EXP MED, V23, P103, DOI 10.17219/acem/37031; Lewandowski KC, 2006, J CLIN ENDOCR METAB, V91, P1173, DOI 10.1210/jc.2005-0648; Lim SS, 2012, HUM REPROD UPDATE, V18, P618, DOI 10.1093/humupd/dms030; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Montaner J, 2001, STROKE, V32, P2762, DOI 10.1161/hs1201.99512; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Plati E, 2010, FERTIL STERIL, V94, P1451, DOI 10.1016/j.fertnstert.2009.04.055; Price DT, 1999, AM J MED, V107, P85, DOI 10.1016/S0002-9343(99)00153-9; Rath T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115847; Samy N, 2009, DIS MARKERS, V26, P163, DOI [10.3233/DMA-2009-0627, 10.1155/2009/465203]; Sarray S, 2015, FERTIL STERIL; Schipper HS, 2010, CLIN CHEM, V56, P1320, DOI 10.1373/clinchem.2010.146118; Spranger J, 2004, CLIN ENDOCRINOL, V61, P738, DOI 10.1111/j.1365-2265.2004.02159.x; Svendsen PF, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.056; Teng Z, 2015, J CELL PHYSIOL, V230, P2998, DOI 10.1002/jcp.25032; Toulis KA, 2009, HUM REPROD UPDATE, V15, P297, DOI 10.1093/humupd/dmp006; Toulis KA, 2011, HUM REPROD UPDATE, V17, P741, DOI 10.1093/humupd/dmr025; Turkeli A, 2015, RESP MED, V109, P680, DOI 10.1016/j.rmed.2015.04.004; van den Ham HJ, 2009, RHEUMATOLOGY, V48, P899, DOI 10.1093/rheumatology/kep125; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666	51	38	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165033	10.1371/journal.pone.0165033	http://dx.doi.org/10.1371/journal.pone.0165033			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806063	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500018
J	Frolich, AM; Buhk, JH; Fiehler, J; Kemmling, A				Froelich, Andreas M.; Buhk, Jan-Hendrik; Fiehler, Jens; Kemmling, Andre			Voxel-Based Sensitivity of Flat-Panel CT for the Detection of Intracranial Hemorrhage: Comparison to Multi-Detector CT	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; MINIMALLY INVASIVE SURGERY; INTRAVENTRICULAR HEMORRHAGE; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; ENDOVASCULAR THERAPY; THROMBECTOMY; EVACUATION; TRIAL	Objectives Flat-panel CT (FPCT) allows cross-sectional parenchymal, vascular and perfusion imaging within the angiography suite, which could greatly facilitate acute stroke management. We hypothesized that FPCT offers equal diagnostic accuracy compared to multi-detector CT (MDCT) as a primary tool to exclude intracranial hemorrhage. Methods 22 patients with intracranial hematomas who had both MDCT and FPCT performed within 24 hours were retrospectively identified. Patients with visible change in hematoma size or configuration were excluded. Two raters independently segmented hemorrhagic lesions. Data sets and corresponding binary lesion maps were co-registered to compare hematoma volume. Diagnostic accuracy of FPCT to detect hemorrhage was calculated from voxelwise analysis of lesion overlap compared to reference MDCT. Results Mean hematoma size was similar between MDCT (16.2 +/- 8.9 ml) and FPCT (16.1 +/- 8.6 ml), with near perfect correlation of hematoma sizes between modalities (rho = 0.95, p<0.001). Sensitivity and specificity of FPCT to detect hemorrhagic voxels was 61.6% and 99.8% for intraventricular hematomas and 67.7% and 99.5% for all other intracranial hematomas. Conclusions In this small sample containing predominantly cases with subarachnoid hemorrhage, FPCT based assessment of hemorrhagic volume in brain yields acceptable accuracy compared to reference MDCT, albeit with a limited sensitivity on a voxel level. Further assessment and improvement of FPCT is necessary before it can be applied as a primary imaging modality to exclude intracranial hemorrhage in acute stroke patients.	[Froelich, Andreas M.; Buhk, Jan-Hendrik; Fiehler, Jens] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Martinistr 52, D-20246 Hamburg, Germany; [Kemmling, Andre] Univ Med Ctr Schleswig Holstein, Dept Neuroradiol, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Kiel; Schleswig Holstein University Hospital	Frolich, AM (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Martinistr 52, D-20246 Hamburg, Germany.	a.froelich@gmail.com						Arakawa H, 2008, AM J NEURORADIOL, V29, P766, DOI 10.3174/ajnr.A0898; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Dey M, 2014, NEUROSURGERY, V74, pS142, DOI 10.1227/NEU.0000000000000221; Doelken M, 2008, NEURORADIOLOGY, V50, P517, DOI 10.1007/s00234-008-0372-z; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Kau T, 2014, AM J NEURORADIOL, V35, P1759, DOI 10.3174/ajnr.A4021; Khatri P, 2014, LANCET NEUROL, V13, P567, DOI 10.1016/S1474-4422(14)70066-3; Macellari F, 2014, STROKE, V45, P903, DOI 10.1161/STROKEAHA.113.003701; Menon BK, 2014, STROKE, V45, P2024, DOI 10.1161/STROKEAHA.114.005050; Mordasini P, 2012, AM J NEURORADIOL, V33, P154, DOI 10.3174/ajnr.A2715; Mould WA, 2013, STROKE, V44, P627, DOI 10.1161/STROKEAHA.111.000411; Mullins ME, 2004, AM J NEURORADIOL, V25, P533; Psychogios MN, 2010, AM J NEURORADIOL, V31, P1226, DOI 10.3174/ajnr.A2086; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Struffert T, 2011, EUR RADIOL, V21, P882, DOI 10.1007/s00330-010-1957-6; Struffert T, 2010, J NEUROSURG, V113, P901, DOI 10.3171/2010.2.JNS091054	20	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165794	10.1371/journal.pone.0165794	http://dx.doi.org/10.1371/journal.pone.0165794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806106	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500056
J	Fjeld, K; Beer, S; Johnstone, M; Zimmer, C; Mossner, J; Ruffert, C; Krehan, M; Zapf, C; Njolstad, PR; Johansson, S; Bugert, P; Miyajima, F; Liloglou, T; Brown, LJ; Winn, SA; Davies, K; Latawiec, D; Gunson, BK; Criddle, DN; Pirmohamed, M; Grutzmann, R; Michl, P; Greenhalf, W; Molven, A; Sutton, R; Rosendahl, J				Fjeld, Karianne; Beer, Sebastian; Johnstone, Marianne; Zimmer, Constantin; Moessner, Joachim; Ruffert, Claudia; Krehan, Mario; Zapf, Christian; Njolstad, Pal Rasmus; Johansson, Stefan; Bugert, Peter; Miyajima, Fabio; Liloglou, Triantafillos; Brown, Laura J.; Winn, Simon A.; Davies, Kelly; Latawiec, Diane; Gunson, Bridget K.; Criddle, David N.; Pirmohamed, Munir; Gruetzmann, Robert; Michl, Patrick; Greenhalf, William; Molven, Anders; Sutton, Robert; Rosendahl, Jonas			Length of Variable Numbers of Tandem Repeats in the Carboxyl Ester Lipase (CEL) Gene May Confer Susceptibility to Alcoholic Liver Cirrhosis but Not Alcoholic Chronic Pancreatitis	PLOS ONE			English	Article							SALT-STIMULATED LIPASE; ACID ETHYL-ESTER; HEREDITARY PANCREATITIS; VARIANTS; ASSOCIATION; MUTATIONS; RISK; POLYMORPHISM; DYSFUNCTION; INHIBITOR	Background Carboxyl-ester lipase (CEL) contributes to fatty acid ethyl ester metabolism, which is implicated in alcoholic pancreatitis. The CEL gene harbours a variable number of tandem repeats (VNTR) region in exon 11. Variation in this VNTR has been linked to monogenic pancreatic disease, while conflicting results were reported for chronic pancreatitis (CP). Here, we aimed to investigate a potential association of CEL VNTR lengths with alcoholic CP. Methods Overall, 395 alcoholic CP patients, 218 patients with alcoholic liver cirrhosis (ALC) serving as controls with a comparable amount of alcohol consumed, and 327 healthy controls from Germany and the United Kingdom (UK) were analysed by determination of fragment lengths by capillary electrophoresis. Allele frequencies and genotypes of different VNTR categories were compared between the groups. Results Twelve repeats were overrepresented in UK ACP patients (P = 0.04) compared to controls, whereas twelve repeats were enriched in German ALC compared to alcoholic CP patients (P = 0.03). Frequencies of CEL VNTR lengths of 14 and 15 repeats differed between German ALC patients and healthy controls (P = 0.03 and 0.008, respectively). However, in the genotype and pooled analysis of VNTR lengths no statistical significant association was depicted. Additionally, the 16-16 genotype as well as 16 repeats were more frequent in UK ALC than in alcoholic CP patients (P = 0.034 and 0.02, respectively). In all other calculations, including pooled German and UK data, allele frequencies and genotype distributions did not differ significantly between patients and controls or between alcoholic CP and ALC. Conclusions We did not obtain evidence that CEL VNTR lengths are associated with alcoholic CP. However, our results suggest that CEL VNTR lengths might associate with ALC, a finding that needs to be clarified in larger cohorts.	[Fjeld, Karianne; Njolstad, Pal Rasmus; Johansson, Stefan; Molven, Anders] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Diabet Res, Bergen, Norway; [Fjeld, Karianne; Johansson, Stefan] Haukeland Hosp, Ctr Med Genet & Mol Med, Bergen, Norway; [Beer, Sebastian; Zimmer, Constantin; Moessner, Joachim; Krehan, Mario; Zapf, Christian] Univ Leipzig, Div Gastroenterol & Rheumatol, Dept Internal Med Neurol & Dermatol, Leipzig, Germany; [Johnstone, Marianne; Brown, Laura J.; Winn, Simon A.; Davies, Kelly; Latawiec, Diane; Greenhalf, William; Sutton, Robert] Univ Liverpool, Royal Liverpool Univ Hosp, Inst Translat Med, NIHR Liverpool Pancreas Biomed Res Unit, Liverpool, Merseyside, England; [Ruffert, Claudia; Michl, Patrick; Rosendahl, Jonas] Univ Halle Wittenberg, Dept Internal Med 1, Halle, Germany; [Njolstad, Pal Rasmus] Haukeland Hosp, Dept Pediat, Bergen, Norway; [Bugert, Peter] Heidelberg Univ, Med Fac Mannheim, Inst Transfus Med & Immunol, German Red Cross Blood Serv Baden Wurttemberg Hes, Mannheim, Germany; [Miyajima, Fabio; Pirmohamed, Munir] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England; [Liloglou, Triantafillos] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Med, Liverpool, Merseyside, England; [Gunson, Bridget K.] Queen Elizabeth Hosp, NIHR Birmingham Liver Biomed Res Unit, Birmingham, W Midlands, England; [Gunson, Bridget K.] Univ Birmingham, Birmingham, W Midlands, England; [Criddle, David N.] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool, Merseyside, England; [Gruetzmann, Robert] Univ Erlangen Nurnberg, Dept Surg, Erlangen, Germany; [Molven, Anders] Univ Bergen, Dept Clin Med, Gade Lab Pathol, Bergen, Norway; [Molven, Anders] Haukeland Hosp, Dept Pathol, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; Leipzig University; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Martin Luther University Halle Wittenberg; University of Bergen; Haukeland University Hospital; Ruprecht Karls University Heidelberg; University of Liverpool; University of Liverpool; University of Birmingham; University of Birmingham; University of Liverpool; University of Erlangen Nuremberg; University of Bergen; University of Bergen; Haukeland University Hospital	Rosendahl, J (corresponding author), Univ Halle Wittenberg, Dept Internal Med 1, Halle, Germany.	jonas.rosendahl@uk-halle.de	Pirmohamed, Munir/H-6004-2011; Miyajima, Fabio/K-6587-2012; Johansson, Stefan/C-4394-2011; Greenhalf, William/A-2680-2013; Fjeld, Karianne/Q-7122-2018; Michl, Patrick/AAG-3987-2021; Michl, Patrick/HDN-4172-2022; Hollyman, Marianne/J-8362-2016	Pirmohamed, Munir/0000-0002-7534-7266; Miyajima, Fabio/0000-0002-1347-4825; Johansson, Stefan/0000-0002-2298-7008; Fjeld, Karianne/0000-0003-0441-1475; Hollyman, Marianne/0000-0002-5972-0454	Deutsche Forschungsgemeinschaft [RO 3929/1-1, RO 3939/2-1]; Colora Stiftung gGmbH; KG Jebsen Foundation; Regional Health Authority of Western Norway; Norwegian Research Council; Royal College of Surgeons of England; National Institute for Health Research; Cancer Research UK [16812] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10064, NF-SI-0515-10084] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Colora Stiftung gGmbH; KG Jebsen Foundation; Regional Health Authority of Western Norway; Norwegian Research Council(Research Council of NorwayEuropean Commission); Royal College of Surgeons of England; National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Deutsche Forschungsgemeinschaft RO 3929/1-1 & RO 3939/2-1, by a grant of the Colora Stiftung gGmbH (to J.R.), by grants from the KG Jebsen Foundation, Regional Health Authority of Western Norway and Norwegian Research Council (to A.M. and P.R.N), by the Royal College of Surgeons of England and Biomedical Research Unit funding scheme from the National Institute for Health Research. M.J. was supported by a Fellowship from the Royal College of Surgeons of England. Robert Sutton is an NIHR Senior Investigator. No sources of funding have influenced the study in any regard.	Aparisi L, 2008, WORLD J GASTROENTERO, V14, P6171, DOI 10.3748/wjg.14.6171; Bengtsson-Ellmark SH, 2004, EUR J HUM GENET, V12, P627, DOI 10.1038/sj.ejhg.5201204; Buch S, 2015, NAT GENET, V47, P1443, DOI 10.1038/ng.3417; Buchner AM, 2001, AM J GASTROENTEROL, V96, P2231, DOI 10.1111/j.1572-0241.2001.03941.x; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Fjeld K, 2015, NAT GENET, V47, P518, DOI 10.1038/ng.3249; Forsmark CE, 2008, CLIN GASTROENTEROL H, V6, P1291, DOI 10.1016/j.cgh.2008.08.008; Higuchi S, 2002, J HUM GENET, V47, P213, DOI 10.1007/s100380200027; Huang W, 2014, GUT, V63, P1313, DOI 10.1136/gutjnl-2012-304058; Hui DY, 2002, J LIPID RES, V43, P2017, DOI 10.1194/jlr.R200013-JLR200; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; Lombardo D, 2001, BBA-MOL CELL BIOL L, V1533, P1, DOI 10.1016/S1388-1981(01)00130-5; Miyasaka K, 2005, PANCREAS, V30, pE87, DOI 10.1097/01.mpa.0000160960.21580.mL; Nakamura Y, 2004, J GASTROENTEROL, V39, P879, DOI 10.1007/s00535-004-1405-y; Pace A, 2009, CLIN GASTROENTEROL H, V7, P1241, DOI 10.1016/j.cgh.2009.06.010; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Ragvin A, 2013, PANCREATOLOGY, V13, P29, DOI 10.1016/j.pan.2012.12.059; RENNER IG, 1984, DIGEST DIS SCI, V29, P593, DOI 10.1007/BF01347290; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; SINGER MV, 1985, GASTROENTEROLOGY, V89, P683, DOI 10.1016/0016-5085(85)90468-8; Stromqvist M, 1997, ARCH BIOCHEM BIOPHYS, V347, P30, DOI 10.1006/abbi.1997.0307; Torsvik J, 2010, HUM GENET, V127, P55, DOI 10.1007/s00439-009-0740-8; TSUJITA T, 1994, EUR J BIOCHEM, V224, P57, DOI 10.1111/j.1432-1033.1994.tb19994.x; Whitcomb DC, 2012, NAT GENET, V44, P1349, DOI 10.1038/ng.2466; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2001, JAMA-J AM MED ASSOC, V285, P2716, DOI 10.1001/jama.285.21.2716-a; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797; Witt H, 2007, GASTROENTEROLOGY, V132, P1557, DOI 10.1053/j.gastro.2007.03.001; Witt H, 2013, NAT GENET, V45, P1216, DOI 10.1038/ng.2730	33	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165567	10.1371/journal.pone.0165567	http://dx.doi.org/10.1371/journal.pone.0165567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802312	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200027
J	Libedinsky, C; So, R; Xu, ZM; Kyar, TK; Ho, DC; Lim, C; Chan, L; Chua, Y; Yao, L; Cheong, JH; Lee, JH; Vishal, KV; Guo, YX; Chen, ZN; Lim, LK; Li, P; Liu, L; Zou, XD; Ang, KK; Gao, Y; Ng, WH; Han, BS; Chng, K; Guan, C; Je, M; Yen, SC				Libedinsky, Camilo; So, Rosa; Xu, Zhiming; Kyar, Toe K.; Ho, Duncun; Lim, Clement; Chan, Louiza; Chua, Yuanwei; Yao, Lei; Cheong, Jia Hao; Lee, Jung Hyup; Vishal, Kulkarni Vinayak; Guo, Yongxin; Chen, Zhi Ning; Lim, Lay K.; Li, Peng; Liu, Lei; Zou, Xiaodan; Ang, Kai K.; Gao, Yuan; Ng, Wai Hoe; Han, Boon Siew; Chng, Keefe; Guan, Cuntai; Je, Minkyu; Yen, Shih-Cheng			Independent Mobility Achieved through a Wireless Brain-Machine Interface	PLOS ONE			English	Article							CORTICAL CONTROL; NEURAL-CONTROL; ARM; TETRAPLEGIA; WHEELCHAIR; VELOCITY; GRASP	Individuals with tetraplegia lack independent mobility, making them highly dependent on others to move from one place to another. Here, we describe how two macaques were able to use a wireless integrated system to control a robotic platform, over which they were sitting, to achieve independent mobility using the neuronal activity in their motor cortices. The activity of populations of single neurons was recorded using multiple electrode arrays implanted in the arm region of primary motor cortex, and decoded to achieve brain control of the platform. We found that free-running brain control of the platform (which was not equipped with any machine intelligence) was fast and accurate, resembling the performance achieved using joystick control. The decoding algorithms can be trained in the absence of joystick movements, as would be required for use by tetraplegic individuals, demonstrating that the non-human primate model is a good pre-clinical model for developing such a cortically-controlled movement prosthetic. Interestingly, we found that the response properties of some neurons differed greatly depending on the mode of control (joystick or brain control), suggesting different roles for these neurons in encoding movement intention and movement execution. These results demonstrate that independent mobility can be achieved without first training on prescribed motor movements, opening the door for the implementation of this technology in persons with tetraplegia.	[Libedinsky, Camilo] Natl Univ Singapore, Dept Psychol, Singapore, Singapore; [Libedinsky, Camilo; Lim, Clement; Yen, Shih-Cheng] Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore, Singapore; [Libedinsky, Camilo; Chan, Louiza; Chng, Keefe] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [So, Rosa; Xu, Zhiming; Kyar, Toe K.; Chua, Yuanwei; Lee, Jung Hyup; Vishal, Kulkarni Vinayak; Chen, Zhi Ning; Ang, Kai K.; Han, Boon Siew; Guan, Cuntai] ASTAR, Inst Infocomm Res, Singapore, Singapore; [Ho, Duncun; Ng, Wai Hoe] Natl Neurosci Inst, Singapore, Singapore; [Yao, Lei; Cheong, Jia Hao; Lim, Lay K.; Li, Peng; Liu, Lei; Zou, Xiaodan; Gao, Yuan; Je, Minkyu] ASTAR, Inst Microelect, Singapore, Singapore; [Guo, Yongxin; Chen, Zhi Ning; Yen, Shih-Cheng] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore, Singapore; [Guan, Cuntai] Nanyang Technol Univ, Sch Comp Sci & Engn, Singapore, Singapore; [Guan, Cuntai] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); National Neuroscience Institute (NNI); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Microelectronics (IME); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Yen, SC (corresponding author), Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore, Singapore.; Yen, SC (corresponding author), Natl Univ Singapore, Dept Elect & Comp Engn, Singapore, Singapore.	shihcheng@nus.edu.sg	Je, Minkyu/P-5960-2019; Chen, Zhi Ning/AAD-4349-2019; Je, Minkyu/Q-9864-2018; Guan, Cuntai/G-7835-2016; Je, Minkyu/G-3056-2016; Ang, Kai Keng/F-1626-2016; Gao, Yuan/E-4502-2011; Libedinsky, Camilo/AAZ-8543-2020; Yen, Shih-Cheng/AAU-6487-2021	Je, Minkyu/0000-0003-4580-2771; Chen, Zhi Ning/0000-0002-3617-6468; Guan, Cuntai/0000-0002-0872-3276; Ang, Kai Keng/0000-0002-3053-6311; Gao, Yuan/0000-0002-0832-2982; Libedinsky, Camilo/0000-0003-4980-4088; Yen, Shih-Cheng/0000-0001-7723-0072; Guo, Yongxin/0000-0001-8842-5609	A*STAR SERC grant [1021710167]	A*STAR SERC grant(Agency for Science Technology & Research (A*STAR))	This work was funded by A*STAR SERC grant (ID 1021710167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Cheng KW, 2012, IEEE ASIAN SOLID STA, P185; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Collinger JL, 2013, J SPINAL CORD MED, V36, P258, DOI 10.1179/2045772313Y.0000000128; Ethier C, 2012, NATURE, V485, P368, DOI 10.1038/nature10987; Gilja V, 2012, NAT NEUROSCI, V15, P1752, DOI 10.1038/nn.3265; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Ifft PJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006159; Iturrate I, 2009, IEEE T ROBOT, V25, P614, DOI 10.1109/TRO.2009.2020347; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; Millan JDR, 2009, ANN INT C IEEE; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rebsamen B, 2010, IEEE T NEUR SYS REH, V18, P590, DOI 10.1109/TNSRE.2010.2049862; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Zou X, 2013, INVENTORSA RECORDING; Zou XD, 2013, IEEE T CIRCUITS-I, V60, P2584, DOI 10.1109/TCSI.2013.2249175	20	23	23	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165773	10.1371/journal.pone.0165773	http://dx.doi.org/10.1371/journal.pone.0165773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802344	Green Submitted, Green Published, gold			2022-12-27	WOS:000386714200052
J	Heger, Z; Rodrigo, MAM; Michalek, P; Polanska, H; Masarik, M; Vit, V; Plevova, M; Pacik, D; Eckschlager, T; Stiborova, M; Adam, V				Heger, Zbynek; Rodrigo, Miguel Angel Merlos; Michalek, Petr; Polanska, Hana; Masarik, Michel; Vit, Vitezslav; Plevova, Mariana; Pacik, Dalibor; Eckschlager, Tomas; Stiborova, Marie; Adam, Vojtech			Sarcosine Up-Regulates Expression of Genes Involved in Cell Cycle Progression of Metastatic Models of Prostate Cancer	PLOS ONE			English	Article							METABOLISM-RELATED PROTEINS; ONE-CARBON METABOLISM; THYMIDYLATE SYNTHASE; PHOSPHORYLATION; RECEPTORS; GLYCINE; SERINE; URINE	The effects of sarcosine on the processes driving prostate cancer (PCa) development remain still unclear. Herein, we show that a supplementation of metastatic PCa cells (androgen independent PC-3 and androgen dependent LNCaP) with sarcosine stimulates cells proliferation in vitro. Similar stimulatory effects were observed also in PCa murine xenografts, in which sarcosine treatment induced a tumor growth and significantly reduced weight of treated mice (p < 0.05). Determination of sarcosine metabolism-related amino acids and enzymes within tumor mass revealed significantly increased glycine, serine and sarcosine concentrations after treatment accompanied with the increased amount of sarcosine dehydrogenase. In both tumor types, dimethylglycine and glycine-N-methyltransferase were affected slightly, only. To identify the effects of sarcosine treatment on the expression of genes involved in any aspect of cancer development, we further investigated expression profiles of excised tumors using cDNA electrochemical microarray followed by validation using the semi-quantitative PCR. We found 25 differentially expressed genes in PC-3, 32 in LNCaP tumors and 18 overlapping genes. Bioinformatical processing revealed strong sarcosine- related induction of genes involved particularly in a cell cycle progression. Our exploratory study demonstrates that sarcosine stimulates PCa metastatic cells irrespectively of androgen dependence. Overall, the obtained data provides valuable information towards understanding the role of sarcosine in PCa progression and adds another piece of puzzle into a picture of sarcosine oncometabolic potential.	[Heger, Zbynek; Rodrigo, Miguel Angel Merlos; Michalek, Petr; Adam, Vojtech] Mendel Univ Brno, Dept Chem & Biochem, Zemedelska 1, CZ-61300 Brno, Czech Republic; [Heger, Zbynek; Rodrigo, Miguel Angel Merlos; Michalek, Petr; Masarik, Michel; Adam, Vojtech] Brno Univ Technol, Cent European Inst Technol, Purkynova 123, CZ-61200 Brno, Czech Republic; [Polanska, Hana; Masarik, Michel] Masaryk Univ, Dept Physiol, Fac Med, Kamenice 5, CZ-62500 Brno, Czech Republic; [Vit, Vitezslav; Plevova, Mariana; Pacik, Dalibor] Univ Hosp Brno, Dept Urol, Jihlavska 20, CZ-62500 Brno, Czech Republic; [Eckschlager, Tomas] Charles Univ Prague, Fac Med 2, Dept Paediat Haematol & Oncol, CZ-15006 Prague 5, Czech Republic; [Eckschlager, Tomas] Univ Hosp Motol, Uvalu 84, CZ-15006 Prague 5, Czech Republic; [Stiborova, Marie] Charles Univ Prague, Dept Biochem, Fac Sci, Albertov 2030, CZ-12840 Prague 2, Czech Republic	Mendel University in Brno; Brno University of Technology; Masaryk University Brno; University Hospital Brno; Charles University Prague; Motol University Hospital; Charles University Prague	Adam, V (corresponding author), Mendel Univ Brno, Dept Chem & Biochem, Zemedelska 1, CZ-61300 Brno, Czech Republic.; Adam, V (corresponding author), Brno Univ Technol, Cent European Inst Technol, Purkynova 123, CZ-61200 Brno, Czech Republic.	vojtech.adam@mendelu.cz	Holcova Polanska, Hana/N-2075-2014; Merlos, Miguel/H-7196-2012; Heger, Zbyněk/D-1973-2013; Rodrigo, Miguel Angel Merlos/AAA-2451-2020; Masarik, Michal/D-9920-2012; Stiborova, Marie/A-5982-2015; Adam, Vojtech/D-7686-2012; Plevová, Mariana/ABE-1174-2020; Vít, Vítězslav/ABE-1517-2020	Holcova Polanska, Hana/0000-0003-2970-7408; Merlos, Miguel/0000-0002-1920-0948; Heger, Zbyněk/0000-0002-3915-7270; Rodrigo, Miguel Angel Merlos/0000-0002-1920-0948; Masarik, Michal/0000-0003-1172-7195; Stiborova, Marie/0000-0001-5430-4403; Adam, Vojtech/0000-0002-8527-286X; Vít, Vítězslav/0000-0002-4132-5333; Michalek, Petr/0000-0002-0121-0128	Czech Science Foundation [GA CR 16-18917S]; Central European Institute of Technology [CEITEC 2020 LQ1601]	Czech Science Foundation(Grant Agency of the Czech Republic); Central European Institute of Technology	Financial support from The Czech Science Foundation (GA CR 16-18917S) and Central European Institute of Technology (CEITEC 2020 LQ1601) is highly acknowledged.	Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Ankerst DP, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0095-5; Brody JR, 2009, CANCER RES, V69, P984, DOI 10.1158/0008-5472.CAN-08-3610; Brosnan ME, 2015, BIOCHEM J, V472, P135, DOI 10.1042/BJ20150837; Burdelski C, 2015, ONCOTARGET, V6, P8377, DOI 10.18632/oncotarget.3107; Cernei N, 2013, INT J MOL SCI, V14, P13893, DOI 10.3390/ijms140713893; Chen YM, 2002, J BIOL CHEM, V277, P49408, DOI 10.1074/jbc.M207069200; Chien CS, 2010, MOL CELL BIOCHEM, V333, P169, DOI 10.1007/s11010-009-0217-z; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Cooper CR, 2008, J CELL BIOCHEM, V104, P2298, DOI 10.1002/jcb.21785; Dahl M, 2011, MOL BIOL REP, V38, P4237, DOI 10.1007/s11033-010-0442-2; Deutsch AJA, 2012, ANTI-CANCER AGENT ME, V12, P1001; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Geschwind DH, 2003, LANCET NEUROL, V2, P275, DOI 10.1016/S1474-4422(03)00379-X; Green T, 2013, PROSTATE, V73, P1561, DOI 10.1002/pros.22706; Haney S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064946; Heger Z, 2016, PROSTATE, V76, P679, DOI 10.1002/pros.23159; Heger Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145426; Heger Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep08868; Heger Z, 2014, ONCOL REP, V31, P1846, DOI 10.3892/or.2014.3054; Heger Z, 2013, INT J MOL SCI, V14, P21629, DOI 10.3390/ijms141121629; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jentzmik F, 2010, EUR UROL, V58, P12, DOI 10.1016/j.eururo.2010.01.035; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Khan AP, 2013, NEOPLASIA, V15, P491, DOI 10.1593/neo.13314; Kim MJ, 2015, INT J CLIN EXP PATHO, V8, P7967; Kote-Jarai Z, 2011, HUM GENET, V129, P687, DOI 10.1007/s00439-011-0981-1; Kumar D, 2015, J PROTEOME RES, V14, P1455, DOI 10.1021/pr5011108; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Marchetti C, 2014, ONCOTARGETS THER, V7, P1223, DOI 10.2147/OTT.S40947; Mukai S, 2015, HUM CELL, V28, P133, DOI 10.1007/s13577-015-0114-6; Park K, 2014, HUM PATHOL, V45, P2136, DOI 10.1016/j.humpath.2014.06.008; Roth KM, 2006, ELECTROANAL, V18, P1982, DOI 10.1002/elan.200603603; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Sudhakaran PR, 2014, J CANCER RES THER, V10, P603, DOI 10.4103/0973-1482.137945; Tomlins SA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001970; Wang H, 2015, BIOSCIENCE REP, V35, P35, DOI DOI 10.1042/BSR20150003; Yoon JK, 2014, J TRANSL MED, V12, DOI [10.6109/jicce.2014.12.1.001, 10.1186/1479-5876-12-149]; Zhou XJ, 2009, INT J CANCER, V124, P483, DOI 10.1002/ijc.23964	42	38	38	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165830	10.1371/journal.pone.0165830	http://dx.doi.org/10.1371/journal.pone.0165830			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824899	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200035
J	Kovacs, SD; van Eijk, AM; Sevene, E; Dellicour, S; Weiss, NS; Emerson, S; Steketee, R; ter Kuile, FO; Stergachis, A				Kovacs, Stephanie D.; van Eijk, Anna Maria; Sevene, Esperanca; Dellicour, Stephanie; Weiss, Noel S.; Emerson, Scott; Steketee, Richard; ter Kuile, Feiko O.; Stergachis, Andy			The Safety of Artemisinin Derivatives for the Treatment of Malaria in the 2nd or 3rd Trimester of Pregnancy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PLASMODIUM-FALCIPARUM MALARIA; ARTEMETHER-LUMEFANTRINE; SULFADOXINE-PYRIMETHAMINE; DIHYDROARTEMISININ-PIPERAQUINE; ARTESUNATE; WOMEN; EPIDEMIOLOGY; QUININE	Given the high morbidity for mother and fetus associated with malaria in pregnancy, safe and efficacious drugs are needed for treatment. Artemisinin derivatives are the most effective antimalarials, but are associated with teratogenic and embryotoxic effects in animal models when used in early pregnancy. However, several organ systems are still under development later in pregnancy. We conducted a systematic review and meta-analysis of the occurrence of adverse pregnancy outcomes among women treated with artemisinins monotherapy or as artemisinin-based combination therapy during the 2nd or 3rd trimesters relative to pregnant women who received non-artemisinin antimalarials or none at all. Pooled odds ratio (POR) were calculated using Mantel-Haenszel fixed effects model with a 0.5 continuity correction for zero events. Eligible studies were identified through Medline, Embase, and the Malaria in Pregnancy Consortium Library. Twenty studies (11 cohort studies and 9 randomized controlled trials) contributed to the analysis, with 3,707 women receiving an artemisinin, 1,951 a non-artemisinin antimalarial, and 13,714 no antimalarial. The PORs (95% confidence interval (CI)) for stillbirth, fetal loss, and congenital anomalies when comparing artemisinin versus quinine were 0.49 (95% CI 0.24 +/- 0.97, I-2 = 0%, 3 studies); 0.58 (95% CI 0.31 +/- 1.16, I-2 = 0%, 6 studies); and 1.00 (95% CI 0.27 +/- 3.75, I-2 = 0%, 3 studies), respectively. The PORs comparing artemisinin users to pregnant women who received no antimalarial were 1.13 (95% CI 0.77 +/- 1.66, I-2 = 86.7%, 3 studies); 1.10 (95% CI 0.79 +/- 1.54, I-2 = 0%, 4 studies); and 0.79 (95% CI 0.37 +/- 1.67, I-2 = 0%, 3 studies) for miscarriage, stillbirth and congenital anomalies respectively. Treatment with artemisinin in 2nd and 3rd trimester was not associated with increased risks of congenital malformations or miscarriage and may be was associated with a reduced risk of stillbirths compared to quinine. This study updates the reviews conducted by the WHO in 2002 and 2006 and supports the current WHO malaria treatment guidelines malaria in pregnancy.	[Kovacs, Stephanie D.; Weiss, Noel S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [van Eijk, Anna Maria; Dellicour, Stephanie; ter Kuile, Feiko O.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Sevene, Esperanca] Eduardo Mondlane Univ, Fac Med, Manh Hlth Res Ctr, Maputo, Mozambique; [Emerson, Scott] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Steketee, Richard] PATH, Seattle, WA USA; [ter Kuile, Feiko O.] Kenya Med Res Inst KEMRI, Ctr Global Hlth, Kisumu, Kenya; [Stergachis, Andy] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Stergachis, Andy] Univ Washington, Dept Pharm, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Liverpool School of Tropical Medicine; Centro de Investigacao em Saude de Manhica; Eduardo Mondlane University; University of Washington; University of Washington Seattle; Kenya Medical Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kovacs, SD (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	Stephk08@gmail.com	Sevene, Esperança/AAI-3532-2020; Kuile, Feiko ter/ABD-6681-2020; van Eijk, Anna Maria/AAQ-9894-2021	Kuile, Feiko ter/0000-0003-3663-5617; van Eijk, Anna Maria/0000-0003-1635-1289	National Center For Advancing Translational Sciences of the National Institutes of Health [TL1TR000422]; Malariain Pregnancy Consortium; Bill & Melinda Gates Foundation; PATH	National Center For Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Malariain Pregnancy Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); PATH	This publication was supported in part by the National Center For Advancing Translational Sciences of the National Institutes of Health under Award Number TL1TR000422 to SDK. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. In addition this work was supported by the Malariain Pregnancy Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine. PATH provided support in the form of salaries for author RS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adam I, 2004, E MEDITERR HEAL J, V10; Adam I, 2006, T ROY SOC TROP MED H, V100, P632, DOI 10.1016/j.trstmh.2005.09.019; [Anonymous], 2014, WHO WORLD MALARIA RE; [Anonymous], ASS SAF ART COMP PRE; Bounyasong Suntit, 2001, Journal of the Medical Association of Thailand, V84, P1289; Burger RJ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv170; Chaabane S, 2013, CURR DRUG SAF, V8, P128, DOI 10.2174/15748863112079990011; Clark RL, 2009, REPROD TOXICOL, V28, P285, DOI 10.1016/j.reprotox.2009.05.002; Cochrane Collaboration, 2006, COCHRANE HDB SYSTEMA; Deen JL, 2001, T ROY SOC TROP MED H, V95, P424, DOI 10.1016/S0035-9203(01)90204-4; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Desai M, 2015, LANCET, V386, P2507, DOI 10.1016/S0140-6736(15)00310-4; Julian E, 2011, ASSESSING RISK BIAS, P1; Kakuru A, 2016, NEW ENGL J MED, V374, P928, DOI 10.1056/NEJMoa1509150; Kalilani L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001166; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Manyando C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-141; Manyando C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-249; McGready R, 2012, LANCET INFECT DIS, V12, P388, DOI 10.1016/S1473-3099(11)70339-5; McGready R, 2001, T ROY SOC TROP MED H, V95, P651, DOI 10.1016/S0035-9203(01)90106-3; McGready R, 1999, ANN TROP MED PARASIT, V93, pS19, DOI 10.1080/00034989957709; McGready R, 2001, CLIN INFECT DIS, V33, P2009, DOI 10.1086/324349; McGready R, 2000, T ROY SOC TROP MED H, V94, P689, DOI 10.1016/S0035-9203(00)90235-9; McGready R, 2005, J INFECT DIS; McGready R, 2008, PLOS MED, V5, P1699, DOI 10.1371/journal.pmed.0050253; Mosha D, 2014, ANTIMICROB AGENTS CH, V58, P4583, DOI 10.1128/AAC.02595-14; Mutabingwa TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005138; Nakelembe M, 2012, AM J TROP MED HYG, V87, P138; Nosten F, 2006, CURR DRUG SAF, V1, P1, DOI 10.2174/157488606775252584; Osterholm M, 2016, LANCET INFECT DIS, V16, pE1, DOI [10.1016/S1473-3099(15)00416-8, 10.1016/S1473-3099(15)00547-2]; Piola P, 2010, LANCET INFECT DIS, V10, P762, DOI 10.1016/S1473-3099(10)70202-4; Poespoprodjo JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084976; Rulisa S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-225; Samson D, 2012, METHODS GUIDE MED TE; Scheuerle A, 2002, PHARMACOEPIDEM DR S, V11, P465, DOI 10.1002/pds.726; Sowunmi A., 1998, Journal of Obstetrics and Gynaecology (Abingdon), V18, P322; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; van Eijk AM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-362; WANG T, 1989, Journal of Traditional Chinese Medicine, V9, P28; White NJ, 2008, PLOS MED, V5, P843, DOI 10.1371/journal.pmed.0050133; WHO, 2014, MALARIA J, V11, P424, DOI [10.1186/1475-2875-11-424, DOI 10.1186/1475-2875-11-424.]; World Health Organization (WHO), 2003, ASS SAF ART COMP PRE; Yoon PW, 2001, PUBLIC HLTH REP, P116	43	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164963	10.1371/journal.pone.0164963	http://dx.doi.org/10.1371/journal.pone.0164963			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824884	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000387615200009
J	Shi, HH; Zhang, JF; Zhu, RR; Hu, N; Lu, H; Yang, M; Qin, B; Shi, J; Guan, HJ				Shi, Haihong; Zhang, Junfang; Zhu, Rongrong; Hu, Nan; Lu, Hong; Yang, Mei; Qin, Bai; Shi, Jian; Guan, Huaijin			Primary Angle Closure and Sequence Variants within MicroRNA Binding Sites of Genes Involved in Eye Development	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; PROTEIN MFRP; GLAUCOMA; MECHANISM; HOMOCYSTEINE; BIOGENESIS; RECEPTOR; CHINA	Purpose The formation of primary angle closure (PAC) and primary angle closure glaucoma (PACG) is regulated by a tissue remodeling pathway that plays a critical role in eye development. MicroRNAs (miRNAs) are powerful gene expression regulators and may exert their effects on tissue remodeling genes. This study investigated the associations between gene variants (single-nucleotide polymorphism, SNP) in miRNA binding sites in the 3'-UTR region of genes involved in eye development and PAC. Methods The sample consisted of 232 PAC subjects and 306 controls obtained from a population-based cohort in the Funing District of Jiangsu, China. The markers include 9 SNPs in the COL11A1, PCMTD1, ZNRF3, MTHFR, and ALPPL2 genes respectively. SNP genotyping was performed with a TaqMan-MGB probe using an RT-PCR system. Results Of the 9 SNPs studied, the frequency of the minor A allele of COL11A1 rs1031820 was higher in the PAC group than in the control group in allele analysis (p = 0.047). The genotype analysis indicated that MTHFR rs1537514 is marginally associated with PAC (p = 0.014). The CC genotype of rs1537514 was present solely in the PAC group. However, the differences lost significance after Bonferroni correction. Conclusion Our study reveals a possible association of COL11A1 and MTHFR with PAC in the Han Chinese population. These results will contribute to an improved understanding of the genetic basis of PACG.	[Shi, Haihong; Zhang, Junfang; Zhu, Rongrong; Hu, Nan; Lu, Hong; Yang, Mei; Qin, Bai; Shi, Jian; Guan, Huaijin] Nantong Univ, Inst Eye, Affiliated Hosp, Nantong, Peoples R China	Nantong University	Guan, HJ (corresponding author), Nantong Univ, Inst Eye, Affiliated Hosp, Nantong, Peoples R China.	guanhjeye@163.com						Annunen S, 1999, AM J HUM GENET, V65, P974, DOI 10.1086/302585; Aung T, 2008, MOL VIS, V14, P1313; Aung T, 2008, J GLAUCOMA, V17, P257, DOI 10.1097/IJG.0b013e31815c3aa5; Ayub H, 2010, MOL VIS, V16, P18; Barathi VA, 2009, VISION RES, V49, P383, DOI 10.1016/j.visres.2008.11.005; Barkana Y, 2007, ARCH OPHTHALMOL-CHIC, V125, P1331, DOI 10.1001/archopht.125.10.1331; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng CY, 2013, AM J HUM GENET, V93, P264, DOI 10.1016/j.ajhg.2013.06.016; Cong YH, 2009, MOL VIS, V15, P1412; Day AC, 2013, BRIT J OPHTHALMOL, V97, P704, DOI 10.1136/bjophthalmol-2012-302969; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Foster PJ, 2000, BRIT J OPHTHALMOL, V84, P186, DOI 10.1136/bjo.84.2.186; Foster PJ, 2001, BRIT J OPHTHALMOL, V85, P1277, DOI 10.1136/bjo.85.11.1277; Fuhrmann Sabine, 2008, Organogenesis, V4, P60; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Kahler RA, 2008, MATRIX BIOL, V27, P330, DOI 10.1016/j.matbio.2008.01.002; Khor CC, 2016, NAT GENET, V48, P556, DOI 10.1038/ng.3540; Michael I, 2008, INVEST OPHTH VIS SCI, V49, P3981, DOI 10.1167/iovs.08-1674; Michael S, 2008, MOL VIS, V14, P661; Mujumdar VS, 2002, AM J PHYSIOL-CELL PH, V282, pC1009, DOI 10.1152/ajpcell.00353.2001; Nongpiur ME, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004089; Patel V, 2012, CURR OPIN NEPHROL HY, V21, P410, DOI 10.1097/MNH.0b013e328354e559; Shi HH, 2013, MOL VIS, V19, P128; Sihota R, 2000, CLIN EXP OPHTHALMOL, V28, P253, DOI 10.1046/j.1442-9071.2000.00324.x; Tyagi SC, 1998, AM J PHYSIOL-CELL PH, V274, pC396, DOI 10.1152/ajpcell.1998.274.2.C396; Vettori Serena, 2012, Open Rheumatol J, V6, P130, DOI 10.2174/1874312901206010130; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Wang IJ, 2008, MOL VIS, V14, P1673; Wang IJ, 2006, MOL VIS, V12, P1223	31	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166055	10.1371/journal.pone.0166055	http://dx.doi.org/10.1371/journal.pone.0166055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824919	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200058
J	Teshima, T; Matsumoto, H; Okusa, T; Uchiyama, R; Koyama, H				Teshima, Takahiro; Matsumoto, Hirotaka; Okusa, Tomoko; Uchiyama, Rion; Koyama, Hidekazu			Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; ADRENOCORTICOTROPIC HORMONE; DOGS; TRILOSTANE; EXPRESSION; ADENOMAS; CORTISOL	Pituitary-dependent hyperadrenocorticism (PDH) is mainly caused by pituitary corticotroph tumors in dogs. A characteristic feature of corticotroph tumors is their resistance to negative feedback by glucocorticoids. In some animal species, including dogs, the aberrant expression of 11 beta-hydroxysteroid dehydrogenase (11HSD), a cortisol metabolic enzyme, is observed in corticotroph tumors. We previously reported that carbenoxolone (CBX), an inhibitor of 11HSD, suppressed ACTH secretion from the pituitary gland, and decreased cortisol concentrations in healthy dogs. Therefore, the aim of this study was to investigate the therapeutic effects of CBX on dogs with PDH. Six dogs with PDH were treated with 60 to 80 mg/kg/day of CBX for 6 weeks, followed by trilostane, which is a commonly used agent for canine PDH. CBX treatment led to a gradual decrease in both basal and in corticotropic releasing hormone (CRH)-stimulated plasma ACTH concentrations and CRH-stimulated serum cortisol concentrations, without side effects. However, basal and stimulated ACTH and cortisol concentrations remained higher than those of healthy dogs, and clinical symptoms such as polydipsia and polyuria were not ameliorated. After a 2-week wash-out interval, trilostane was administered for 2 weeks. Although basal plasma ACTH concentrations were higher after trilostane treatment than CBX treatment, polydipsia and polyuria resolved in all six dogs. The reason for the lack of improvement in polydipsia and polyuria with CBX treatment is unclear. Other mechanisms, in addition to a partial decrease in ACTH secretion, are likely to be involved. In conclusion, this is the first study to report the in vivo effects of CBX in dogs with PDH. The findings suggest that CBX inhibits ACTH secretion from canine pituitary tumors, resulting in lower cortisol concentrations.	[Teshima, Takahiro; Matsumoto, Hirotaka; Okusa, Tomoko; Uchiyama, Rion; Koyama, Hidekazu] Nippon Vet & Life Sci Univ, Sch Vet Med, Div Therapeut Sci 1, Fac Vet Sci,Dept Vet Clin Med, 1-7-1 Kyonan Cho, Musashino, Tokyo 1808602, Japan	Nippon Veterinary & Life Science University	Teshima, T (corresponding author), Nippon Vet & Life Sci Univ, Sch Vet Med, Div Therapeut Sci 1, Fac Vet Sci,Dept Vet Clin Med, 1-7-1 Kyonan Cho, Musashino, Tokyo 1808602, Japan.	teshima63@nviu.ac.jp						Bell R, 2006, VET REC, V159, P277, DOI 10.1136/vr.159.9.277; BIEWENGA WJ, 1991, ACTA ENDOCRINOL-COP, V124, P583, DOI 10.1530/acta.0.1240583; Fracassi F, 2007, DOMEST ANIM ENDOCRIN, V32, P43, DOI 10.1016/j.domaniend.2005.12.009; KEMPPAINEN RJ, 1984, J ENDOCRINOL, V103, P219, DOI 10.1677/joe.0.1030219; Kemppainen RJ, 1997, VET CLIN N AM-SMALL, V27, P173, DOI 10.1016/S0195-5616(97)50026-X; Kooistra HS, 1997, J ENDOCRINOL, V152, P113, DOI 10.1677/joe.0.1520113; Korbonits M, 2001, J CLIN ENDOCR METAB, V86, P2728, DOI 10.1210/jc.86.6.2728; Ma X, 2011, TOXICOLOGY, V285, P83, DOI 10.1016/j.tox.2011.04.007; Nigawara T, 2006, ENDOCRINOLOGY, V147, P769, DOI 10.1210/en.2005-0544; PAPANEK PE, 1994, AM J PHYSIOL, V266, pR1744, DOI 10.1152/ajpregu.1994.266.6.R1744; Peterson ME, 1997, VET CLIN N AM-SMALL, V27, P255, DOI 10.1016/S0195-5616(97)50030-1; Pineiro MIR, 2009, J VET INTERN MED, V23, P850, DOI 10.1111/j.1939-1676.2009.0328.x; Rabbitt E, 2003, ONCOGENE, V22, P1663, DOI 10.1038/sj.onc.1206293; Ramsey IK, 2010, VET CLIN N AM-SMALL, V40, P269, DOI 10.1016/j.cvsm.2009.10.008; Teshima T, 2009, DOMEST ANIM ENDOCRIN, V36, P3, DOI 10.1016/j.domaniend.2008.08.002; Teshima T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135516; Teshima T, 2014, VET J, V200, P452, DOI 10.1016/j.tvjl.2014.03.022; Witt AL, 2004, VET REC, V154, P399, DOI 10.1136/vr.154.13.399	18	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166267	10.1371/journal.pone.0166267	http://dx.doi.org/10.1371/journal.pone.0166267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824928	gold, Green Submitted, Green Published			2022-12-27	WOS:000387615200079
J	Javor, A; Ransmayr, G; Struhal, W; Riedl, R				Javor, Andrija; Ransmayr, Gerhard; Struhal, Walter; Riedl, Rene			Parkinson Patients' Initial Trust in Avatars: Theory and Evidence	PLOS ONE			English	Article							IMMERSIVE VIRTUAL ENVIRONMENTS; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; BASAL GANGLIA; FACIAL EXPRESSIONS; CLINICAL-DIAGNOSIS; NEURAL CIRCUITRY; DECISION-MAKING; LEWY BODY; DISEASE	Parkinson's disease (PD) is a neurodegenerative disease that affects the motor system and cognitive and behavioral functions. Due to these impairments, PD patients also have problems in using the computer. However, using computers and the Internet could help these patients to overcome social isolation and enhance information search. Specifically, avatars (defined as virtual representations of humans) are increasingly used in online environments to enhance human-computer interaction by simulating face-to-face interaction. Our laboratory experiment investigated how PD patients behave in a trust game played with human and avatar counterparts, and we compared this behavior to the behavior of age, income, education and gender matched healthy controls. The results of our study show that PD patients trust avatar faces significantly more than human faces. Moreover, there was no significant difference between initial trust of PD patients and healthy controls in avatar faces, while PD patients trusted human faces significantly less than healthy controls. Our data suggests that PD patients' interaction with avatars may constitute an effective way of communication in situations in which trust is required (e.g., a physician recommends intake of medication). We discuss the implications of these results for several areas of human-computer interaction and neurological research.	[Javor, Andrija; Ransmayr, Gerhard; Struhal, Walter] Johannes Kepler Univ Linz, Kepler Univ Clin, Dept Neurol 2, Linz, Austria; [Riedl, Rene] Univ Appl Sci Upper Austria, Sch Management, Steyr, Austria; [Riedl, Rene] Johannes Kepler Univ Linz, Dept Business Informat Informat Engn, Linz, Austria	Johannes Kepler University Linz; Kepler University Hospital; Johannes Kepler University Linz	Javor, A (corresponding author), Johannes Kepler Univ Linz, Kepler Univ Clin, Dept Neurol 2, Linz, Austria.	javor@gmx.at			Internet Foundation Austria [688]	Internet Foundation Austria	This study was supported by a research grant from the Internet Foundation Austria (Call 8 - No. 688), https://www.netidee.at. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2010, BRAIN PATHOL, V20, P633, DOI 10.1111/j.1750-3639.2009.00369.x; Achey M, 2014, MOVEMENT DISORD, V29, P871, DOI 10.1002/mds.25903; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Alesina A, 2002, J PUBLIC ECON, V85, P207, DOI 10.1016/S0047-2727(01)00084-6; Arias P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030021; Arsalidou M, 2013, HUM BRAIN MAPP, V34, P3031, DOI 10.1002/hbm.22124; Bailenson JN, 2006, PRESENCE-VIRTUAL AUG, V15, P359, DOI 10.1162/pres.15.4.359; Bailenson JN, 2005, PRESENCE-VIRTUAL AUG, V14, P379, DOI 10.1162/105474605774785235; Bailenson JN, 2003, PERS SOC PSYCHOL B, V29, P819, DOI 10.1177/0146167203029007002; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Begnum MEN, 2010, LECT NOTES COMPUT SC, V6179, P292, DOI 10.1007/978-3-642-14097-6_47; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Berger CR, 1975, HUM COMMUN RES, V1, P99, DOI [10.1111/j.1468-2958.1975.tb00258.x, DOI 10.1111/J.1468-2958.1975.TB00258.X]; Bertrand JA, 2012, MOVEMENT DISORD, V27, P1781, DOI 10.1002/mds.25272; Bessiere K, 2007, CYBERPSYCHOL BEHAV, V10, P530, DOI 10.1089/cpb.2007.9994; Bhatt M, 2005, GAME ECON BEHAV, V52, P424, DOI 10.1016/j.geb.2005.03.007; Biswas P, 2008, ACCESSIBLE DESIGN DI; Bodden ME, 2010, MOVEMENT DISORD, V25, P13, DOI 10.1002/mds.22818; BRAAK H, 1994, ACTA NEUROPATHOL, V88, P493, DOI 10.1007/BF00296485; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Brand M, 2004, BEHAV NEUROL, V15, P77, DOI 10.1155/2004/578354; Bromiley P., 1995, RES NEGOTIATION ORG, V5, P219; Carrasco E, 2008, NATURAL INTERACTION, P38; Chevalier JA, 2006, J MARKETING RES, V43, P345, DOI 10.1509/jmkr.43.3.345; Coleman J., 1994, FDN SOCIAL THEORY; Cotten SR, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2306; Cunningham L M, 2009, Technol Health Care, V17, P269, DOI 10.3233/THC-2009-0547; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Donath J, 2007, SCIENCE, V317, P53, DOI 10.1126/science.1142770; Mendes FAD, 2012, PHYSIOTHERAPY, V98, P217, DOI 10.1016/j.physio.2012.06.001; DuBois T., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P418, DOI 10.1109/PASSAT/SocialCom.2011.56; Dujardin K, 2004, NEUROPSYCHOLOGIA, V42, P239, DOI 10.1016/S0028-3932(03)00154-4; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; Fabri M, 2007, LECT NOTES COMPUT SC, V4552, P275; Fahn S., 1987, RECENT DEV PARKINSON, P153; Fehr E, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P215, DOI 10.1016/B978-0-12-374176-9.00015-4; Fehr E, 2009, J EUR ECON ASSOC, V7, P235, DOI 10.1162/JEEA.2009.7.2-3.235; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fong K. N., 2010, J NEUROENG REHABIL, V30, P7; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gambetta D., 1988, TRUST MAKING BREAKIN, P213; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Goodwin VA, 2008, MOVEMENT DISORD, V23, P631, DOI 10.1002/mds.21922; Grenci RT, 2002, COMMUN ACM, V45, P64, DOI 10.1145/504729.504730; Grujic Z, 2009, CONTEL 2009: PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON TELECOMMUNICATIONS, P185; Hamm MP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002819; Harding AJ, 2002, BRAIN, V125, P2431, DOI 10.1093/brain/awf251; Hartzband P, 2010, NEW ENGL J MED, V362, P1063, DOI 10.1056/NEJMp0911938; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Holzwarth M, 2006, J MARKETING, V70, P19, DOI 10.1509/jmkg.70.4.19; Hughes AJ, 2001, NEUROLOGY, V57, P1497, DOI 10.1212/WNL.57.8.1497; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Hum NJ, 2011, COMPUT HUM BEHAV, V27, P1828, DOI 10.1016/j.chb.2011.04.003; Javor A, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0374-5; Javor A, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-13; Karlsen KH, 2000, J NEUROL NEUROSUR PS, V69, P584, DOI 10.1136/jnnp.69.5.584; Keates S, 2005, P 7 INT ACM SIGACCES, P68; KELLEY HH, 1950, J PERS, V18, P431, DOI 10.1111/j.1467-6494.1950.tb01260.x; Kim E, 2009, PROG NEURO-PSYCHOPH, V33, P1409, DOI 10.1016/j.pnpbp.2009.07.019; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Klinger E, 2006, CYBERPSYCHOL BEHAV, V9, P342, DOI 10.1089/cpb.2006.9.342; Kopton I. M., 2013, P INT C INF SYST; Koscik TR, 2011, NEUROPSYCHOLOGIA, V49, P602, DOI 10.1016/j.neuropsychologia.2010.09.023; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104; Lee M, 2013, INTERNET RES, V23, P116, DOI 10.1108/10662241311313277; Lee SJ, 2007, EDUC STUD-UK, V33, P209, DOI 10.1080/03055690601068477; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; Lowe BP, 2001, GESUNDHEITSFRAGEBOGE; Lundqvist D, 1998, DATABASE KAROLINSKA; Maasland E, 2007, ACTA NEUROL SCAND, V115, P41, DOI 10.1111/j.1600-0404.2006.00722.x; MacDorman KF, 2009, COMPUT HUM BEHAV, V25, P695, DOI 10.1016/j.chb.2008.12.026; MAES P, 1994, COMMUN ACM, V37, P31, DOI 10.1145/176789.176792; Manderson L, 2010, QUAL HEALTH RES, V20, P1418, DOI [10.1177/1049732310373105, DOI 10.1177/1049732310373105]; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; McCabe KA, 2000, P NATL ACAD SCI USA, V97, P3777, DOI 10.1073/pnas.040577397; McCabe KA, 2003, J ECON BEHAV ORGAN, V52, P267, DOI 10.1016/S0167-2681(03)00003-9; Monahan T, 2008, COMPUT EDUC, V50, P1339, DOI 10.1016/j.compedu.2006.12.008; MONTGOMERY EB, 1994, AM J MED, V97, P429, DOI 10.1016/0002-9343(94)90322-0; Moser E, 2007, J NEUROSCI METH, V161, P126, DOI 10.1016/j.jneumeth.2006.10.016; Newbold KB, 2011, MEDIA SOCIAL MEDIA P; Nombela Cristina, 2011, Front Neurol, V2, P82, DOI 10.3389/fneur.2011.00082; Noy D, 2013, MULTIMODAL END 2 END, P135; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Park IH, 2009, PSYCHIATRY, V72, P79, DOI 10.1521/psyc.2009.72.1.79; Pavlou P.A., 2007, MIS Q, V31, P1; Poletti M, 2012, J NEUROL, V259, P1029, DOI 10.1007/s00415-011-6302-8; Riedl R., 2011, P 32 INT C INF SYST, P1; Riedl R, 2014, J MANAGE INFORM SYST, V30, P83, DOI 10.2753/MIS0742-1222300404; Riedl R, 2012, J NEUROSCI PSYCHOL E, V5, P63, DOI 10.1037/a0026318; Riedl R, 2010, MIS QUART, V34, P397; Rizzo A A, 1997, Stud Health Technol Inform, V39, P22; Robert LP, 2009, J MANAGE INFORM SYST, V26, P241, DOI 10.2753/MIS0742-1222260210; Rolls ET, 2015, CORTEX, V62, P119, DOI 10.1016/j.cortex.2013.12.005; Rousseau DM, 1998, ACAD MANAGE REV, V23, P393, DOI 10.5465/AMR.1998.926617; Ruiz JG, 2012, FED PRACT, V29, P25; Rust RT, 2003, COMMUN ACM, V46, P36, DOI 10.1145/777313.777336; Saenz A, 2013, EUR J NEUROL, V20, P571, DOI 10.1111/ene.12040; Schneider David, 1979, PERSON PERCEPTION; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Sockeel P, 2006, J NEUROL NEUROSUR PS, V77, P579, DOI 10.1136/jnnp.2005.075929; Tinaz S, 2011, MOVEMENT DISORD, V26, P436, DOI 10.1002/mds.23453; van der Vegt JPM, 2013, BRAIN, V136, P1192, DOI 10.1093/brain/awt027; Vasalou A, 2008, INT J HUM-COMPUT ST, V66, P801, DOI 10.1016/j.ijhcs.2008.08.002; von der Putten AM, 2010, COMPUT HUM BEHAV, V26, P1641, DOI 10.1016/j.chb.2010.06.012; WALTHER JB, 1992, COMMUN RES, V19, P52, DOI 10.1177/009365092019001003; Weintraub D, 2009, MOVEMENT DISORD, V24, P1461, DOI 10.1002/mds.22571; Wenhui Yu, 2011, Virtual and Mixed Reality - Systems and Applications. Proceedings International Conference, Virtual and Mixed Reality 2011. Held as Part of HCI International 2011, P129, DOI 10.1007/978-3-642-22024-1_15; WILLIAMSON OE, 1993, J LAW ECON, V36, P453, DOI 10.1086/467284; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Wu T, 2012, NEUROSCI LETT, V524, P55, DOI 10.1016/j.neulet.2012.07.012; Yu RL, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-7; Zak P., 2011, ECON J, V111, P295, DOI [10.111114680297.00609, DOI 10.1111/1468-0297.00609]; Zak PJ, 2004, ANN NY ACAD SCI, V1032, P224, DOI 10.1196/annals.1314.025; Zgaljardic Dennis J, 2003, Cogn Behav Neurol, V16, P193, DOI 10.1097/00146965-200312000-00001	118	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165998	10.1371/journal.pone.0165998	http://dx.doi.org/10.1371/journal.pone.0165998			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BB	27820864	Green Submitted, gold, Green Published			2022-12-27	WOS:000387614800028
J	Kotajima-Murakami, H; Narumi, S; Yuzaki, M; Yanagihara, D				Kotajima-Murakami, Hiroko; Narumi, Sakae; Yuzaki, Michisuke; Yanagihara, Dai			Involvement of GluD2 in Fear-Conditioned Bradycardia in Mice	PLOS ONE			English	Article							ANTERIOR CEREBELLAR VERMIS; DELTA-2 GLUTAMATE-RECEPTOR; LONG-TERM DEPRESSION; MOTOR COORDINATION; SYNAPTIC CHANGES; RESPONSES; LTD; EXPRESSION; AMYGDALA; SUBUNIT	Lesions in the cerebellar vermis abolish acquisition of fear-conditioned bradycardia in animals and human patients. The delta 2 glutamate receptor (GluD2) is predominantly expressed in cerebellar Purkinje cells. The mouse mutant ho15J carries a spontaneous mutation in GluD2 and these mice show a primary deficiency in parallel fiber-Purkinje cell synapses, multiple innervations of Purkinje cells by climbing fibers, and impairment of long-term depression. In the present study, we used ho15J mice to investigate the role of the cerebellum in fear-conditioned bradycardia. We recorded changes in heart rate of ho15J mice induced by repeated pairing of an acoustic (conditioned) stimulus (CS) with an aversive (unconditioned) stimulus (US). The mice acquired conditioned bradycardia on Day 1 of the CS-US phase, similarly to wild-type mice. However, the magnitude of the conditioned bradycardia was not stable in the mutant mice, but rather was exaggerated on Days 2-5 of the CS-US phase. We examined the effects of reversibly inactivating the cerebellum by injection of an antagonist against the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor (AMPAR). The antagonist abolished expression of conditioned responses in both wild-type and ho15J mice. We conclude that the GluD2 mutation in the ho15J mice affects stable retention of the acquired conditioned bradycardia.	[Kotajima-Murakami, Hiroko; Yanagihara, Dai] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan; [Narumi, Sakae; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo, Japan; [Kotajima-Murakami, Hiroko] Sch Sci & Engn, Dept Biosci, Utsunomiya, Tochigi, Japan; [Kotajima-Murakami, Hiroko] Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Setagaya Ku, Tokyo, Japan	University of Tokyo; Keio University; Tokyo Metropolitan Institute of Medical Science	Yanagihara, D (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan.	dai-y@idaten.c.u-tokyo.ac.jp	Yuzaki, Michisuke/K-5328-2013; Murakami-Kotajima, Hiroko/AAY-6913-2020	Yuzaki, Michisuke/0000-0002-5750-3544; 	Sasakawa Scientific Research; Japan Science Society; Grants-in-Aid for Scientific Research [15K01498] Funding Source: KAKEN	Sasakawa Scientific Research; Japan Science Society; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by: Grants in Aid for Scientific Research (C), https://www.jsps.go.jp/english/e-grants/, Sasakawa Scientific Research, Grant from The Japan Science Society, www.jss.or.jp/ikusei/sasakawa/.	ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; Attwell PJE, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0003.1999; BRADLEY DJ, 1991, NEUROSCI RES, V12, P45, DOI 10.1016/0168-0102(91)90099-K; Emi K, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00180; Hills LB, 2013, NEUROLOGY, V81, P1378, DOI 10.1212/WNL.0b013e3182a841a3; Hirai H, 2003, NAT NEUROSCI, V6, P869, DOI 10.1038/nn1086; Kakegawa W, 2011, NAT NEUROSCI, V14, P603, DOI 10.1038/nn.2791; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; Kohda K, 2013, P NATL ACAD SCI USA, V110, pE948, DOI 10.1073/pnas.1218380110; Kotajima H, 2014, NEUROREPORT, V25, P556, DOI 10.1097/WNR.0000000000000135; Maier A, 2014, MUSCLE NERVE, V49, P289, DOI 10.1002/mus.24096; Maschke M, 2002, J NEUROL NEUROSUR PS, V72, P116, DOI 10.1136/jnnp.72.1.116; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; Matsuda S, 2002, EUR J NEUROSCI, V16, P1507, DOI 10.1046/j.1460-9568.2002.02219.x; Motohashi J, 2007, BRAIN RES, V1140, P153, DOI 10.1016/j.brainres.2006.03.068; Nisimaru N, 2004, JPN J PHYSIOL, V54, P431, DOI 10.2170/jjphysiol.54.431; NISIMARU N, 1984, JPN J PHYSIOL, V34, P539, DOI 10.2170/jjphysiol.34.539; Sacchetti B, 2005, NEUROSCIENTIST, V11, P217, DOI 10.1177/1073858405276428; Sacchetti B, 2004, NEURON, V42, P973, DOI 10.1016/j.neuron.2004.05.012; Sacchetti B, 2007, EUR J NEUROSCI, V25, P2875, DOI 10.1111/j.1460-9568.2007.05508.x; Schonewille M, 2010, NEURON, V67, P618, DOI 10.1016/j.neuron.2010.07.009; Schonewille M, 2011, NEURON, V70, P43, DOI 10.1016/j.neuron.2011.02.044; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; SUPPLE WF, 1993, NEUROREPORT, V4, P975, DOI 10.1097/00001756-199307000-00035; SUPPLE WF, 1993, J NEUROSCI, V13, P3705; SUPPLE WF, 1990, BRAIN RES, V509, P17, DOI 10.1016/0006-8993(90)90303-S; Takayama C, 1996, DEV BRAIN RES, V92, P147, DOI 10.1016/0165-3806(95)00212-X; Takeuchi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047553; Thompson RF, 2009, NEUROSCIENCE, V162, P732, DOI 10.1016/j.neuroscience.2009.01.041; Utine GE, 2013, J CHILD NEUROL, V28, P926, DOI 10.1177/0883073813484967; Yoshida M, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-52; Yuzaki M, 2013, NEURAL NETWORKS, V47, P36, DOI 10.1016/j.neunet.2012.07.001	34	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166144	10.1371/journal.pone.0166144	http://dx.doi.org/10.1371/journal.pone.0166144			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820843	Green Published, Green Submitted, gold			2022-12-27	WOS:000387614800035
J	LoMauro, A; Aliverti, A; Mastella, C; Arnoldi, MT; Banfi, P; Baranello, G				LoMauro, A.; Aliverti, A.; Mastella, C.; Arnoldi, M. T.; Banfi, P.; Baranello, G.			Spontaneous Breathing Pattern as Respiratory Functional Outcome in Children with Spinal Muscular Atrophy (SMA)	PLOS ONE			English	Article							LUNG-FUNCTION; PULMONARY-FUNCTION; REFERENCE VALUES; MUSCLE ATROPHY; VENTILATION; TRIAL; PLETHYSMOGRAPHY; SALBUTAMOL; SPIROMETRY; SCOLIOSIS	Introduction SMA is characterised by progressive motor and respiratory muscle weakness. We aimed to verify if in SMA children 1) each form is characterized by specific ventilatory and thoracoabdominal pattern(VTAp) during quiet breathing(QB); 2) VTAp is affected by salbutamol therapy, currently suggested as standard treatment, or by the natural history(NH) of SMA; 3) the severity of global motor impairment linearly correlates with VTAp. Materials and methods VTAp was analysed on 32 SMA type I (SMA1, the most severe form), 51 type II (SMA2, the moderate), 8 type III (SMA3, the mildest) and 20 healthy (HC) using opto-electronic plethysmography. Spirometry, cough and motor function were measured in a subgroup of patients. Results In SMA1, a normal ventilation is obtained in supine position by rapid and shallow breathing with paradoxical ribcage motion. In SMA2, ventilation is within a normal range in seated position due to an increased respiratory rate(p<0.05) with reduced tidal volume(p<0.05) secondary to a poor contribution of pulmonary ribcage(%Delta V-RC,(P), p<0.001). Salbutamol therapy had no effect on VTAp during QB(p>0.05) while tachypnea occurred in type I NH. A linear correlation(p<0.001) was found between motor function scales and VTAp. Conclusion A negative or reduced %Delta V-RC,V- P,V- indicative of ribcage muscle weakness, is a distinctive feature of SMA1 and SMA2 since infancy. Its quantitative assessment represents a non-invasive, non-volitional index that can be obtained in all children, even uncollaborative, and provides useful information on the action of ribcage muscles that are known to be affected by the disease. Low values of motor function scales indicate impairment of motor but also of respiratory function.	[LoMauro, A.; Aliverti, A.] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy; [Mastella, C.] Osped Policlin Maggiore Mangiagalli, SAPRE, Milan, Italy; [Mastella, C.] Regina Elena Fdn, Milan, Italy; [Arnoldi, M. T.; Baranello, G.] Carlo Besta Neurol Res Inst Fdn, Dev Neurol Unit, Milan, Italy; [Banfi, P.] Pulm Rehabil Fdn Don Carlo Gnocchi, Milan, Italy	Polytechnic University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	LoMauro, A (corresponding author), Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy.	antonella.lomauro@polimi.it	Arnoldi, Maria Teresa/AAJ-2217-2021; Andrea, Aliverti/A-3901-2015	Arnoldi, Maria Teresa/0000-0002-3920-5869; Andrea, Aliverti/0000-0002-2950-0231; LoMauro, Antonella/0000-0002-1408-6971	Associazione Famiglie SMA ONLUS	Associazione Famiglie SMA ONLUS	The consumables of the study (markers and ipoallergenic adhesive tapes to fix the markers to the skin) were supported by Associazione Famiglie SMA ONLUS. There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliverti A, 2001, ANN BIOMED ENG, V29, P60, DOI 10.1114/1.1332084; Bach JR, 2012, AM J PHYS MED REHAB, V91, P487, DOI 10.1097/PHM.0b013e31824fa5dd; Bach JR, 2008, PAEDIATR RESPIR REV, V9, P45, DOI 10.1016/j.prrv.2007.11.003; Bach JR, 2007, AM J PHYS MED REHAB, V86, P339, DOI 10.1097/PHM.0b013e31804a8505; Bach JR, 1996, CHEST, V110, P1566, DOI 10.1378/chest.110.6.1566; BERMAN S, 1991, ARCH DIS CHILD, V66, P81, DOI 10.1136/adc.66.1.81; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Bianchi C, 2008, AM J PHYS MED REHAB, V87, P461, DOI 10.1097/PHM.0b013e318174e4c7; Bushby K, 2004, Neuromuscul Disord, V14, P526, DOI 10.1016/j.nmd.2004.05.006; Cala SJ, 1996, J APPL PHYSIOL, V81, P2680, DOI 10.1152/jappl.1996.81.6.2680; Chng SY, 2003, J PAEDIATR CHILD H, V39, P673, DOI 10.1046/j.1440-1754.2003.00266.x; Darras BT, 2015, PEDIATR CLIN N AM, V62, P743, DOI 10.1016/j.pcl.2015.03.010; De Troyer A, 2005, PHYSIOL REV, V85, P717, DOI 10.1152/physrev.00007.2004; De Troyer A, 2012, J APPL PHYSIOL, V112, P529, DOI 10.1152/japplphysiol.01067.2011; Dellaca RL, 2010, PEDIATR RES, V67, P11, DOI 10.1203/PDR.0b013e3181c0b184; DETROYER A, 1985, J CLIN INVEST, V75, P850, DOI 10.1172/JCI111782; DUBOWITZ V, 1995, NEUROMUSCULAR DISORD, V5, P3, DOI 10.1016/0960-8966(94)00075-K; Dubowitz V, 2009, NEUROMUSCULAR DISORD, V19, P69, DOI 10.1016/j.nmd.2008.10.004; Fauroux B, 2008, CHEST, V133, P161, DOI 10.1378/chest.07-1615; Fauroux B, 2015, CHEST, V147, P552, DOI 10.1378/chest.14-0819; Finkel R, 2015, NEUROMUSCULAR DISORD, V25, P593, DOI 10.1016/j.nmd.2015.04.009; Finkel RS, 2014, PEDIATR PULM, V49, P1234, DOI 10.1002/ppul.22997; Fujak A, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-283; GAULTIER C, 1981, RESP PHYSIOL, V46, P71, DOI 10.1016/0034-5687(81)90069-4; Glanzman AM, 2010, NEUROMUSCULAR DISORD, V20, P155, DOI 10.1016/j.nmd.2009.11.014; Glanzman AM, 2011, PEDIATR PHYS THER, V23, P322, DOI 10.1097/PEP.0b013e3182351f04; Gormley MC, 2014, J NEUROSCI NURS, V46, pE33, DOI 10.1097/JNN.0000000000000080; Ioos C, 2004, CHEST, V126, P831, DOI 10.1378/chest.126.3.831; Kaufmann P, 2011, ARCH NEUROL-CHICAGO, V68, P779, DOI 10.1001/archneurol.2010.373; Khirani S, 2013, EUR J PAEDIATR NEURO, V17, P552, DOI 10.1016/j.ejpn.2013.04.004; Kinali M, 2002, NEUROLOGY, V59, P609, DOI 10.1212/WNL.59.4.609; KUZUHARA S, 1981, ANN NEUROL, V9, P506, DOI 10.1002/ana.410090515; Leduc D, 2013, J APPL PHYSIOL, V114, P941, DOI 10.1152/japplphysiol.01392.2012; Lewelt A, 2012, CURR NEUROL NEUROSCI, V12, P42, DOI 10.1007/s11910-011-0240-9; Lissoni A, 1996, AM J PHYS MED REHAB, V75, P332, DOI 10.1097/00002060-199609000-00005; LoMauro A, 2014, RESP PHYSIOL NEUROBI, V197, P1, DOI 10.1016/j.resp.2014.03.001; LUMB AB, 1991, ANESTH ANALG, V73, P422; MACKLEM PT, 1980, CHEST, V78, P753, DOI 10.1378/chest.78.5.753; Mayer OH, 2003, CHEST, V124, P1812, DOI 10.1378/chest.124.5.1812; Mazzone E, 2011, NEUROMUSCULAR DISORD, V21, P406, DOI 10.1016/j.nmd.2011.02.014; Mercuri E, 2016, NEUROMUSCULAR DISORD, V26, P126, DOI 10.1016/j.nmd.2015.10.006; Mercuri E, 2012, NEUROMUSCULAR DISORD, V22, P1105, DOI [10.1016/j.nmd.2012.11.001, 10.1016/j.nmd.2012.06.006]; Miske LJ, 2004, CHEST, V125, P1406, DOI 10.1378/chest.125.4.1406; Nicot F, 2006, AM J RESP CRIT CARE, V174, P67, DOI 10.1164/rccm.200512-1841OC; Nugent JK, 2016, PEDIAT NURS, V7, P18; Nugent JK, 2016, PEDIAT NURS, V7, P18; Numa AH, 1996, J APPL PHYSIOL, V80, P1485, DOI 10.1152/jappl.1996.80.5.1485; Ogino S, 2004, EUR J HUM GENET, V12, P1015, DOI 10.1038/sj.ejhg.5201288; Ogino S, 2002, HUM GENET, V111, P477, DOI 10.1007/s00439-002-0828-x; Pane M, 2008, NEUROMUSCULAR DISORD, V18, P536, DOI 10.1016/j.nmd.2008.05.004; Perez A, 1996, CHEST, V110, P454, DOI 10.1378/chest.110.2.454; Petrone A, 2007, AM J PHYS MED REHAB, V86, P216, DOI 10.1097/PHM.0b013e31802ef774; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Quanjer PH, 2012, EUR RESPIR J, V40, P190, DOI 10.1183/09031936.00161011; Reinaux CMA, 2016, PEDIAT PULMONOL; Romei M, 2010, RESP PHYSIOL NEUROBI, V172, P184, DOI 10.1016/j.resp.2010.05.018; RUSCONI F, 1994, PEDIATRICS, V94, P350; Sansone VA, 2015, NEUROMUSCUL DISORD; Schroth MK, 2009, PEDIATRICS, V123, pS245, DOI 10.1542/peds.2008-2952K; SIMOES EAF, 1991, ARCH DIS CHILD, V66, P1199, DOI 10.1136/adc.66.10.1199; Takazakura R, 2004, J MAGN RESON IMAGING, V19, P605, DOI 10.1002/jmri.20051; Tangsrud SE, 2001, ARCH DIS CHILD, V84, P521, DOI 10.1136/adc.84.6.521; Tiziano FD, 2010, J MED GENET, V47, P856, DOI 10.1136/jmg.2010.080366; Van Meerbeke JP, 2011, DISCOV MED, V12, P291; Vieira DSR, 2013, RESP PHYSIOL NEUROBI, V189, P473, DOI 10.1016/j.resp.2013.08.023; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788	66	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165818	10.1371/journal.pone.0165818	http://dx.doi.org/10.1371/journal.pone.0165818			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820869	Green Published, Green Submitted, gold			2022-12-27	WOS:000387614800022
J	An, HQ; Zhu, QK; Pei, W; Fan, J; Liang, Y; Cui, YH; Lv, N; Wang, WJ				An, Hongqiang; Zhu, Qiankun; Pei, Wei; Fan, Jing; Liang, Yi; Cui, Yihui; Lv, Nan; Wang, Wanjun			Whole-Transcriptome Selection and Evaluation of Internal Reference Genes for Expression Analysis in Protocorm Development of Dendrobium officinale Kimura et Migo	PLOS ONE			English	Article							TIME RT-PCR; POLYMERASE CHAIN-REACTION; MESSENGER-RNA LEVELS; BETA-ACTIN; HOUSEKEEPING GENES; QUANTITATIVE PCR; ABIOTIC STRESS; SEED MASS; NORMALIZATION; ARABIDOPSIS	Dendrobium officinale Kimu et Migo has increased many researchers' interest for its high medical and horticultural values and the molecular mechanism of its protocorm development remains unclear. In this study, 19 genes from 26 most stably expressed genes in whole transcriptome of protocorms and 5 housekeeping genes were used as candidate reference genes and screened with 4 application softwares (geNorm, NormFinder, BestKeeper and RefFinder). The results showed that a few reference genes could effectively normalize expression level of specific genes in protocorm development and the optimal top 2 reference genes were ASS and APH1L. Meanwhile, validation of GNOM, AP2 and temperature induced gene (TIL) for normalization demonstrates the usefulness of the validated candidate reference genes. The expression profiles of these genes varied under protocorms and temperature stress according to the stablest and unstablest reference genes, which proved the importance of the choice of appropriate reference genes. The first systematic evaluation of stably expressed genes will be very useful in the future analysis of specific genes expression in D. officinale.	[An, Hongqiang; Zhu, Qiankun; Pei, Wei; Fan, Jing; Liang, Yi; Cui, Yihui; Lv, Nan; Wang, Wanjun] Southwest Jiaotong Univ, Sch Life Sci & Engn, Chengdu 610031, Peoples R China	Southwest Jiaotong University	Wang, WJ (corresponding author), Southwest Jiaotong Univ, Sch Life Sci & Engn, Chengdu 610031, Peoples R China.	wanjunwang@home.swjtu.edu.cn		Zhu, Qiankun/0000-0003-4727-8969	National Natural Science Foundation of China [31371232]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Grant (NO. 31371232) from National Natural Science Foundation of China, the urls was(https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). WW achieved the funding for the study of "Molecular Mechanisms with Specific NAC Family Genes on Promeristem of Protocorm in Dendrobium candidum Wall ex Lindl." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Han X, 2012, PLOS ONE, V7; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jofuku KD, 2005, P NATL ACAD SCI USA, V102, P3117, DOI 10.1073/pnas.0409893102; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kim S, 2006, MOL BIOL EVOL, V23, P107, DOI 10.1093/molbev/msj014; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Li QF, 2010, PLANT MOL BIOL REP, V28, P49, DOI 10.1007/s11105-009-0124-1; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Ohto M, 2005, P NATL ACAD SCI USA, V102, P3123, DOI 10.1073/pnas.0409858102; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Provenzano M, 2005, EUREKAH BIOSCIENCE, V1, P510; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; RICHARDSON KA, 1992, CAN J BOT, V70, P291, DOI 10.1139/b92-040; Riechmann JL, 1998, BIOL CHEM, V379, P633; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; SHEVELL DE, 1994, CELL, V77, P1051, DOI 10.1016/0092-8674(94)90444-8; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xi GangJun, 2012, Medicinal Plant, V3, P67; Xie F., 2012, PLANT MOL BIOL; Xu Huaisheng, 2015, BMC Res Notes, V8, P58, DOI 10.1186/s13104-015-0973-7; Yan L, 2015, MOL PLANT, V8, P922, DOI 10.1016/j.molp.2014.12.011; Yan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104124; Zelmer Carla D., 1996, Mycoscience, V37, P439, DOI 10.1007/BF02461001; Zhao P, 2008, IN VITRO CELL DEV-PL, V44, P178, DOI 10.1007/s11627-007-9101-2; Zhao P, 2011, PLANT CELL TISS ORG, V107, P151, DOI 10.1007/s11240-011-9968-9	44	12	15	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0163478	10.1371/journal.pone.0163478	http://dx.doi.org/10.1371/journal.pone.0163478			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814359	Green Submitted, Green Published, gold			2022-12-27	WOS:000386911100003
J	Balzano, G; Dugnani, E; Gandolfi, A; Scavini, M; Pasquale, V; Aleotti, F; Liberati, D; Di Terlizzi, G; Petrella, G; Reni, M; Doglioni, C; Bosi, E; Falconi, M; Piemonti, L				Balzano, Gianpaolo; Dugnani, Erica; Gandolfi, Alessandra; Scavini, Marina; Pasquale, Valentina; Aleotti, Francesca; Liberati, Daniela; Di Terlizzi, Gaetano; Petrella, Giovanna; Reni, Michele; Doglioni, Claudio; Bosi, Emanuele; Falconi, Massimo; Piemonti, Lorenzo			Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study	PLOS ONE			English	Article							LONG-TERM SURVIVAL; BODY-MASS INDEX; CANCER-PATIENTS; TEMPORAL ASSOCIATION; CLINICAL-OUTCOMES; BLOOD-GLUCOSE; RISK-FACTORS; NEW-ONSET; MELLITUS; PROGNOSIS	Aim To investigate the effect of diabetes mellitus (DM) on disease-free and overall post-resection survival of patients with pancreatic ductal adenocarcinoma (PDAC) Methods Prospective observational study on patients admitted for pancreatic disease from January 2008 to October 2012. DM was classified as recent-onset (<48 months before PDAC diagnosis), longstanding (>= 48 months before PDAC) or new onset (after surgery). Results Of 296 patients, 140 had a diagnosis of DM prior to surgery (26 longstanding, 99 recent-onset, 15 with unknown duration). Median follow-up time was 5.4 +/- 0.22 years. Patients with recent onset DM had poorer postoperative survival than patients without DM: disease-free survival and overall survival were 1.14 +/- 0.13 years and 1.52 +/- 0.12 years in recent onset DM, versus 1.3 +/- 0.15 years and 1.87 +/- 0.15 years in non-diabetic patients (p = 0.013 and p = 0.025, respectively). Longstanding DM and postoperative new onset DM had no impact on prognosis. Compared to cases without DM, patients with recent onset DM were more likely to have residual disease after surgery and to develop liver metastases during follow-up. Multivariate analysis confirmed recent onset DM was independently associated with PDAC relapse (hazard ratio 1.45 [1.06-1.99]). Conclusion Preoperative recent onset DM has an impact on survival after the resection of PDAC.	[Balzano, Gianpaolo; Aleotti, Francesca; Falconi, Massimo] IRCCS San Raffaele Sci Inst, Pancreas Translat & Clin Res Ctr, Pancreat Surg Unit, Milan, Italy; [Dugnani, Erica; Gandolfi, Alessandra; Scavini, Marina; Pasquale, Valentina; Liberati, Daniela; Bosi, Emanuele; Piemonti, Lorenzo] IRCCS San Raffaele Sci Inst, San Raffaele Diabet Res Inst SR DRI, Milan, Italy; [Di Terlizzi, Gaetano; Petrella, Giovanna; Reni, Michele] IRCCS San Raffaele Sci Inst, Dept Med Oncol, Milan, Italy; [Doglioni, Claudio] IRCCS San Raffaele Sci Inst, Dept Pathol, Milan, Italy; [Doglioni, Claudio; Falconi, Massimo] Univ Vita Salute San Raffaele, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Piemonti, L (corresponding author), IRCCS San Raffaele Sci Inst, San Raffaele Diabet Res Inst SR DRI, Milan, Italy.	piemonti.lorenzo@hsr.it	Scavini, Marina/AAN-1892-2020; Reni, Michele/J-8296-2016; Dugnani, Erica/AAN-1898-2020; Balzano, Gianpaolo/ABG-9920-2020; Piemonti, Lorenzo/P-7605-2017; Falconi, Massimo/K-2194-2016	Reni, Michele/0000-0002-6463-0293; Balzano, Gianpaolo/0000-0003-4636-4566; Piemonti, Lorenzo/0000-0002-2172-2198; Falconi, Massimo/0000-0001-9654-7243; Pasquale, Valentina/0000-0002-1250-0825; Scavini, Marina/0000-0002-7983-6905; Aleotti, Francesca/0000-0001-7474-0325; DUGNANI, Erica/0000-0002-7701-7535	Associazione Italiana per la Ricerca sul Cancro (AIRC) [bando 5 x 1,000 N_12182, Progetto IGN_ 11783]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This study was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC, bando 5 x 1,000 N_12182 and Progetto IGN_ 11783, both to LP).	Andersen DK, 2013, PANCREAS, V42, P1227, DOI 10.1097/MPA.0b013e3182a9ad9d; ANDRENSANDBERG A, 1983, ANN SURG, V198, P605, DOI 10.1097/00000658-198311000-00008; Balzano G, 2014, ACTA DIABETOL, V51, P801, DOI 10.1007/s00592-014-0614-y; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; Beg MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098511; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; BOCKMAN DE, 1994, GASTROENTEROLOGY, V107, P219, DOI 10.1016/0016-5085(94)90080-9; Bosetti C, 2014, ANN ONCOL, V25, P2065, DOI 10.1093/annonc/mdu276; Cannon RM, 2012, HPB, V14, P228, DOI 10.1111/j.1477-2574.2011.00432.x; Cereda E, 2009, CURR OPIN CLIN NUTR, V12, P1, DOI 10.1097/MCO.0b013e3283186f59; Chari ST, 2008, GASTROENTEROLOGY, V134, P95, DOI 10.1053/j.gastro.2007.10.040; Cheon YK, 2014, GUT LIVER, V8, P205, DOI 10.5009/gnl.2014.8.2.205; Choi Y, 2016, CANCER RES TREAT, V48, P171, DOI 10.4143/crt.2014.292; Chu CK, 2010, ANN SURG ONCOL, V17, P502, DOI 10.1245/s10434-009-0789-6; Dandona M, 2011, PANCREAS, V40, P931, DOI 10.1097/MPA.0b013e318215a9b1; Dugnani E, 2016, PANCREATOLOGY; Dugnani E., 2016, ACTA DIABETOL; Elena JW, 2013, CANCER CAUSE CONTROL, V24, P13, DOI 10.1007/s10552-012-0078-8; Ganti AK, 2002, MED ONCOL, V19, P233, DOI 10.1385/MO:19:4:233; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Hart PA, 2014, AM J GASTROENTEROL, V109, P1484, DOI 10.1038/ajg.2014.193; Hart PA, 2013, PANCREAS, V42, P1207, DOI 10.1097/MPA.0b013e3182a7c963; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Hwang A, 2013, CANCER-AM CANCER SOC, V119, P404, DOI 10.1002/cncr.27731; Illes D, 2015, PANCREATOLOGY; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Kanda M, 2011, BRIT J SURG, V98, P268, DOI 10.1002/bjs.7305; Kang SP, 2010, J PANCREAS, V11, P334; Karlin NJ, 2012, ENDOCR PRACT, V18, P898, DOI 10.4158/EP12128.OR; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li DH, 2015, AM J CANCER RES, V5, P3260; Mao YX, 2015, SCI REP-UK, V5, DOI 10.1038/srep17102; Mao YX, 2015, J CLIN ONCOL, V33, P2120, DOI 10.1200/JCO.2014.60.2896; McWilliams RR, 2010, CANCER, V116, P203, DOI [10.1002/cncr.24697, 10.1002/cncr.25465]; Mizuno S, 2013, PANCREATOLOGY, V13, P285, DOI 10.1016/j.pan.2013.03.013; Nakai Y, 2013, PANCREAS, V42, P202, DOI 10.1097/MPA.0b013e31825de678; Ni XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111886; Olson SH, 2010, INT J CANCER, V127, P2412, DOI 10.1002/ijc.25240; Pannala R, 2009, AM J GASTROENTEROL, V104, P2318, DOI 10.1038/ajg.2009.253; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Partelli S, 2012, DIGEST LIVER DIS, V44, P945, DOI 10.1016/j.dld.2012.05.017; Pelucchi C, 2014, PANCREAS, V43, P47, DOI 10.1097/MPA.0b013e3182a7c74b; Pezzilli R, 2013, WORLD J GASTROENTERO, V19, P4861, DOI 10.3748/wjg.v19.i30.4861; Piemonti L, 2013, DIABETES, V62, P1656, DOI 10.2337/db12-1258; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Raghavan SR, 2013, PANCREAS, V42, P1210, DOI 10.1097/MPA.0b013e3182a6db8e; Ranc K, 2014, DIABETOLOGIA, V57, P927, DOI 10.1007/s00125-014-3186-z; Sah RP, 2013, NAT REV GASTRO HEPAT, V10, P423, DOI 10.1038/nrgastro.2013.49; Sahin IH, 2012, CANCER MED-US, V1, P357, DOI 10.1002/cam4.43; Song SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134321; Sperti C, 1996, BRIT J SURG, V83, P625, DOI 10.1002/bjs.1800830512; Stolzenberg-Solomon RZ, 2005, JAMA-J AM MED ASSOC, V294, P2872, DOI 10.1001/jama.294.22.2872; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Wakasugi Hideyuki, 2001, International Journal of Clinical Oncology, V6, P50, DOI 10.1007/PL00012080; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Walter U, 2014, ANN SURG ONCOL, V21, P1082, DOI 10.1245/s10434-013-3415-6; Yuan C, 2015, J CLIN ONCOL, V33, P29, DOI 10.1200/JCO.2014.57.5688	59	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166008	10.1371/journal.pone.0166008	http://dx.doi.org/10.1371/journal.pone.0166008			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814399	gold, Green Published, Green Submitted			2022-12-27	WOS:000386911100025
J	Ianniello, RG; Zotta, T; Matera, A; Genovese, F; Parente, E; Ricciardi, A				Ianniello, Rocco G.; Zotta, Teresa; Matera, Attilio; Genovese, Francesco; Parente, Eugenio; Ricciardi, Annamaria			Investigation of Factors Affecting Aerobic and Respiratory Growth in the Oxygen-Tolerant Strain Lactobacillus casei N87	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; CYTOCHROME BD OXIDASE; LACTOCOCCUS-LACTIS; OXIDATIVE STRESS; ELECTRON-TRANSPORT; PLANTARUM WCFS1; PYRUVATE OXIDASE; METABOLISM; AERATION; SURVIVAL	Aerobic and respiratory cultivations provide benefits for some lactic acid bacteria (LAB). Growth, metabolites, enzymatic activities (lactate dehydrogenase; pyruvate and NADH oxidases, NADH peroxidase; catalase), antioxidant capability and stress tolerance of Lactobacillus casei N87 were evaluated in anaerobic, aerobic and respiratory (aerobiosis with heme and menaquinone supplementation) batch cultivations with different dissolved oxygen (DO) concentrations. The expression of pox (pyruvate oxidase) and cydABCD operon (cytochrome bd oxidase complex) was quantified by quantitative Real Time polymerase chain reaction. Respiration increased biomass production compared to anaerobiosis and unsupplemented aerobiosis, and altered the central metabolism rerouting pyruvate away from lactate accumulation. All enzymatic activities, except lactate dehydrogenase, were higher in respiratory cultures, while unsupplemented aerobiosis with 60% of DO promoted H2O2 and free radical accumulation. Respiration improved the survival to oxidative and freeze-drying stresses, while significant numbers of dead, damaged and viable but not cultivable cells were found in unsupplemented aerobic cultures (60% DO). Analysis of gene expression suggested that the activation of aerobic and respiratory pathways occurred during the exponential growth phase, and that O-2 and hemin induced, respectively, the transcription of pox and cydABCD genes. Respiratory cultivation might be a natural strategy to improve functional and technological properties of L. casei.	[Ianniello, Rocco G.; Matera, Attilio; Genovese, Francesco; Ricciardi, Annamaria] Univ Basilicata, Scuola Sci Agr Forestali Alimentari & Ambientali, Potenza, Italy; [Zotta, Teresa] CNR, Ist Sci Alimentaz, Avellino, Italy; [Parente, Eugenio] Univ Basilicata, Dipartimento Sci, Potenza, Italy	University of Basilicata; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Basilicata	Zotta, T (corresponding author), CNR, Ist Sci Alimentaz, Avellino, Italy.	teresa.zotta@isa.cnr.it	GENOVESE, FRANCESCO/AAB-7694-2020; Matera, Attilio/GOK-0930-2022; Parente, Eugenio/B-3809-2014	GENOVESE, FRANCESCO/0000-0002-9326-1183; Matera, Attilio/0000-0003-4372-1564; Parente, Eugenio/0000-0002-5716-2348; Zotta, Teresa/0000-0001-8228-6804	Ministero dell'Istruzione, dell'Universita e della Ricerca, Rome, Italy, FIRB [RBFR107VML]	Ministero dell'Istruzione, dell'Universita e della Ricerca, Rome, Italy, FIRB	This work was funded by Ministero dell'Istruzione, dell'Universita e della Ricerca, Rome, Italy, FIRB n. RBFR107VML.	Arioli S, 2013, APPL ENVIRON MICROB, V79, P376, DOI 10.1128/AEM.02734-12; BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0; BARANYI J., 1996, DMFIT MANUAL VERSION; Borisov VB, 2013, FEBS LETT, V587, P2214, DOI 10.1016/j.febslet.2013.05.047; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Brooijmans RJW, 2007, J BACTERIOL, V189, P5203, DOI 10.1128/JB.00361-07; Brooijmans RJW, 2009, APPL ENVIRON MICROB, V75, P3580, DOI 10.1128/AEM.00147-09; Brooijmans R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-28; Cesselin B., 2010, JPN J LACT ACID BACT, V21, P10, DOI [10.4109/jslab.21.10, DOI 10.4109/JSLAB.21.10]; de Felipe FL, 2009, APPL MICROBIOL BIOT, V82, P1115, DOI 10.1007/s00253-009-1897-8; Duwat P, 2001, J BACTERIOL, V183, P4509, DOI 10.1128/JB.183.15.4509-4516.2001; Forte E, 2016, SCI REP-UK, V6, DOI 10.1038/srep23788; Giuffre A, 2012, FEBS LETT, V586, P622, DOI 10.1016/j.febslet.2011.07.035; Goffin P, 2006, APPL ENVIRON MICROB, V72, P7933, DOI 10.1128/AEM.00659-06; Guidone A, 2013, WORLD J MICROB BIOT, V29, P1713, DOI 10.1007/s11274-013-1334-0; Iacumin L, 2015, FOOD MICROBIOL, V46, P357, DOI 10.1016/j.fm.2014.08.007; Ianniello RG, 2015, J APPL MICROBIOL, V119, P763, DOI 10.1111/jam.12853; Ianniello RG, 2015, LWT-FOOD SCI TECHNOL, V60, P817, DOI 10.1016/j.lwt.2014.10.020; Lechardeur D, 2011, CURR OPIN BIOTECH, V22, P143, DOI 10.1016/j.copbio.2010.12.001; Lorquet F, 2004, J BACTERIOL, V186, P3749, DOI 10.1128/JB.186.12.3749-3759.2004; Pedersen MB, 2012, ANNU REV FOOD SCI T, V3, P37, DOI 10.1146/annurev-food-022811-101255; Pedersen MB, 2005, FEMS MICROBIOL REV, V29, P611, DOI 10.1016/j.femsre.2005.04.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puri-Taneja A, 2007, J BACTERIOL, V189, P3348, DOI 10.1128/JB.00050-07; Quatravaux S, 2006, J APPL MICROBIOL, V101, P903, DOI 10.1111/j.1365-2672.2006.02955.x; Rezaiki L, 2004, MOL MICROBIOL, V53, P1331, DOI 10.1111/j.1365-2958.2004.04217.x; Ricciardi A, 2015, ANN MICROBIOL, V65, P1639, DOI 10.1007/s13213-014-1003-z; Ricciardi A, 2014, ANN MICROBIOL, V64, P1861, DOI 10.1007/s13213-014-0819-x; Stevens MJA, 2008, APPL ENVIRON MICROB, V74, P4776, DOI 10.1128/AEM.00136-08; Wang AN, 2009, J APPL MICROBIOL, V107, P1140, DOI 10.1111/j.1365-2672.2009.04294.x; Watanabe M, 2012, MICROBIOL-SGM, V158, P293, DOI 10.1099/mic.0.051250-0; Zotta T, 2014, J APPL MICROBIOL, V116, P632, DOI 10.1111/jam.12398; Zotta T, 2013, J APPL MICROBIOL, V115, P848, DOI 10.1111/jam.12285; Zotta T, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00348-16; Zotta T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099189; Zotta T, 2012, INT J FOOD MICROBIOL, V155, P51, DOI 10.1016/j.ijfoodmicro.2012.01.017	36	27	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164065	10.1371/journal.pone.0164065	http://dx.doi.org/10.1371/journal.pone.0164065			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812097	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000006
J	Shrestha, RM; Miyaguchi, M; Shibanuma, A; Khanal, A; Yasuoka, J; Jimba, M				Shrestha, Rachana Manandhar; Miyaguchi, Moe; Shibanuma, Akira; Khanal, Arun; Yasuoka, Junko; Jimba, Masamine			A School Health Project Can Uplift the Health Status of School Children in Nepal	PLOS ONE			English	Article							PROMOTING SCHOOLS; EDUCATION; HYGIENE; SCHOOLCHILDREN; INTERVENTION; KNOWLEDGE; STUDENTS; BEHAVIOR; TRIAL; KENYA	Background School health is effective in helping students achieve health literacy, enhance their health-related behaviors, and thereby improve their health status. However, in resource-limited countries, evidence is limited to show the impact of school health. We determined the association of the school health and nutrition (SHN) project activities on students' a) health knowledge, b) hygiene practices, and c) health outcomes, one year after the project completion. Methods This is a cross-sectional study conducted among the schools with the SHN project and without the project in four districts of Nepal. We recruited 604 students from six schools in the project group and 648 students from other six schools in the comparison group. We used a self-administered questionnaire to collect the data, and analyzed them using regression models and a structural equation model (SEM). Results Students from the SHN project group reported the decreased odds of worm infestation (AOR = 0.50, 95% CI: 0.34 to 0.75) and diarrhea/ dysentery infection (AOR = 0.67, 95% CI: 0.47 to 0.97) compared to those in the comparison group. Furthermore, the SEM analysis also showed that the students in the project group were more likely to have better health outcomes (beta = 0.03, p< 0.05). Conclusion Students in the SHN project group were more likely to have better health outcomes compared to those in the comparison group, even after one year of the project completion. As it can bring about sustainable changes for students, it should be scaled up in other parts of the country.	[Shrestha, Rachana Manandhar; Miyaguchi, Moe; Shibanuma, Akira; Yasuoka, Junko; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Khanal, Arun] Tritunga Dev Soc, POB 8162, Kathmandu, Nepal	University of Tokyo	Jimba, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mjimba@m.u-tokyo.ac.jp	Yasuoka, Junko/GVT-8950-2022; Jimba, Masamine/AAF-5630-2020; Shibanuma, Akira/C-7652-2016	Shibanuma, Akira/0000-0003-2058-1722	National Center for Global Health and Medicine [27S1]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This study was supported by a Grant from the National Center for Global Health and Medicine (http://www.ncgm.go.jp/) (grant number: 27S1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavifar A, 2012, ENG SCI TECHNOLOGY I, V2; [Anonymous], 2011, 20672010011 GOV NEP; [Anonymous], 1983, HLTH BEH SCH AG CHIL; [Anonymous], 2010, 20662009010 GOV NEP; [Anonymous], 2011, REP ENDL SURV SCH HL; [Anonymous], 2013, 20692012013 GOV NEP; [Anonymous], 2009, CAS STUD GLOB SCH HL; Baidya P, 2010, MINIMUM PACKAGE SCH; Biswas A B, 1990, Indian J Public Health, V34, P87; Busch V, 2015, HLTH PROMOT PRACT; Denman S., 2002, HLTH PROMOTING SCH P; Deschesnes M, 2003, HEALTH PROMOT INT, V18, P387, DOI 10.1093/heapro/dag410; Dixit LP, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-20; Drake LJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004106; Gabrie JA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-354; Greene LE, 2012, AM J TROP MED HYG, V87, P385, DOI 10.4269/ajtmh.2012.11-0633; Gyorkos Theresa W, 2013, PLoS Negl Trop Dis, V7, pe2397, DOI 10.1371/journal.pntd.0002397; Hoelscher DM, 2004, PREV MED, V38, P594, DOI 10.1016/j.ypmed.2003.11.017; Honkala S, 2014, MED PRIN PRACT, V23, P24, DOI 10.1159/000354172; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ilika A L, 2002, Niger Postgrad Med J, V9, P79; Jimba Masamine, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P237; Jourdan D, 2010, SCAND J PUBLIC HEALT, V38, P86, DOI 10.1177/1403494809350518; Kunwar R, 2016, TROP MED INT HLTH; Lee A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-42; Master D, 1997, Fam Med, V29, P336; National Population and Housing Census, 2011, NAT REP; Nunkoo R, 2012, CURR ISSUES TOUR, V15, P777, DOI 10.1080/13683500.2011.641947; Pengpid S, 2011, INT J BEHAV MED, V18, P150, DOI 10.1007/s12529-010-9109-6; Pickering AJ, 2013, AM J TROP MED HYG, V89, P411, DOI 10.4269/ajtmh.13-0008; Pommier J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-43; Rai C, 2009, J FIELD REPORTS, V3; Rajbhandary J, 1999, CHILDRENS CLUBS NEPA; Sandora TJ, 2008, PEDIATRICS, V121, pE1555, DOI 10.1542/peds.2007-2597; Sherman J, 2007, J NUTR EDUC BEHAV, V39, P335, DOI 10.1016/j.jneb.2007.07.011; Shrestha RM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-244; UNICEF, 2011, WASH SCH MON PACK; World Health Organization, 1999, IMPR HLTH SCH NAT IN; Xiaohua Y, 2014, PLOS ONE, V9	39	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166001	10.1371/journal.pone.0166001	http://dx.doi.org/10.1371/journal.pone.0166001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812190	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000089
J	Kyeremeh, IA; Charles, CJ; Rout, SP; Laws, AP; Humphreys, PN				Kyeremeh, Isaac A.; Charles, Christopher J.; Rout, Simon P.; Laws, Andrew P.; Humphreys, Paul N.			Microbial Community Evolution Is Significantly Impacted by the Use of Calcium Isosaccharinic Acid as an Analogue for the Products of Alkaline Cellulose Degradation	PLOS ONE			English	Article							SP-NOV.; RNA; ACINETOBACTER; ENVIRONMENTS; BACTERIA; SLUDGE	Diasteriomeric isosaccharinic acid (ISA) is an important consideration within safety assessments for the disposal of the United Kingdoms' nuclear waste legacy, where it may potentially influence radionuclide migration. Since the intrusion of micro-organisms may occur within a disposal concept, the impact of ISA may be impacted by microbial metabolism. Within the present study we have established two polymicrobial consortia derived from a hyperalkaline soil. Here, alpha-ISA and a diatereomeric mix of ISAs' were used as a sole carbon source, reflecting two common substrates appearing within the literature. The metabolism of ISA within these two consortia was similar, where ISA degradation resulted in the acetogenesis and hydrogenotrophic methanogenesis. The chemical data obtained confirm that the diastereomeric nature of ISA is likely to have no impact on its metabolism within alkaline environments. High throughput sequencing of the original soil showed a diverse community which, in the presence of ISA allowed for the dominance the Clostridiales associated taxa with Clostridium clariflavum prevalent. Further taxonomic investigation at the genus level showed that there was in fact a significant difference (p = 0.004) between the two community profiles. Our study demonstrates that the selection of carbon substrate is likely to have a significant impact on microbial community composition estimations, which may have implications with respect to a safety assessment of an ILW-GDF.	[Kyeremeh, Isaac A.; Charles, Christopher J.; Rout, Simon P.; Laws, Andrew P.; Humphreys, Paul N.] Univ Huddersfield, Dept Biol, Sch Appl Sci, Huddersfield, W Yorkshire, England	University of Huddersfield	Humphreys, PN (corresponding author), Univ Huddersfield, Dept Biol, Sch Appl Sci, Huddersfield, W Yorkshire, England.	p.n.humphreys@hud.ac.uk		Rout, Simon/0000-0001-5778-6145; Humphreys, Paul/0000-0003-3431-7930				B.S.I, 2005, 148532005 BSIISO; Bassil NM, 2015, ISME J, V9, P310, DOI 10.1038/ismej.2014.125; BM W, 1963, METHODS CARBOHYDRATE, V2; Burke IT, 2012, GEOMICROBIOL J, V29, P769, DOI 10.1080/01490451.2011.619638; Charles CJ, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv085; Cowper M, SERCO CONTRACTORS RE; DEINEMA MH, 1985, WATER SCI TECHNOL, V17, P119, DOI 10.2166/wst.1985.0226; Doulgeris C, 2015, MINERALOGIC IN PRESS; FARROW JAE, 1995, INT J SYST BACTERIOL, V45, P436, DOI 10.1099/00207713-45-3-436; Glaus MA, 1999, ANAL CHIM ACTA, V398, P111, DOI 10.1016/S0003-2670(99)00371-2; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hattori S, 2008, MICROBES ENVIRON, V23, P118, DOI 10.1264/jsme2.23.118; Izquierdo JA, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0136-4; Jung JY, 2011, APPL ENVIRON MICROB, V77, P2264, DOI 10.1128/AEM.02157-10; Kato S, 2004, INT J SYST EVOL MICR, V54, P2043, DOI 10.1099/ijs.0.63148-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Knill CJ, 2003, CARBOHYD POLYM, V51, P281, DOI 10.1016/S0144-8617(02)00183-2; Kuippers G, 2015, MINERAL MAG, V79, P1443, DOI 10.1180/minmag.2015.079.6.19; Lawson PA, 2004, INT J SYST EVOL MICR, V54, P413, DOI 10.1099/ijs.0.02653-0; LOTTER LH, 1986, WATER SA, V12, P203; NDA, 2010, GAS STAT REP NUCL DE; NDA, 2010, NEAR FIELD EV STAT R; Oksanen J., 2007, COMMUNITY ECOL PACKA, V10; Racine JS, 2012, J APPL ECONOMET, V27, P167, DOI 10.1002/jae.1278; Randall M, 2013, ASSESSMENT EFFECTS C; Rout SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107433; Rout SP, 2015, PLOS ONE, V10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shiratori H, 2009, INT J SYST EVOL MICR, V59, P1764, DOI 10.1099/ijs.0.003483-0; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; Van Dyke MI, 2002, APPL ENVIRON MICROB, V68, P2049, DOI 10.1128/AEM.68.4.2049-2053.2002; Vercammen K, 2001, RADIOCHIM ACTA, V89, P393, DOI 10.1524/ract.2001.89.6.393; WORAKIT S, 1986, INT J SYST BACTERIOL, V36, P380, DOI 10.1099/00207713-36-3-380	34	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165832	10.1371/journal.pone.0165832	http://dx.doi.org/10.1371/journal.pone.0165832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806095	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500059
J	Natisvili, T; Yandim, C; Silva, R; Emanuelli, G; Krueger, F; Nageshwaran, S; Festenstein, R				Natisvili, Theona; Yandim, Cihangir; Silva, Raquel; Emanuelli, Giulia; Krueger, Felix; Nageshwaran, Sathiji; Festenstein, Richard			Transcriptional Activation of Pericentromeric Satellite Repeats and Disruption of Centromeric Clustering upon Proteasome Inhibition	PLOS ONE			English	Article							RNA-POLYMERASE-II; STRESS-INDUCED TRANSCRIPTION; HEAT-SHOCK RESPONSE; CELL-CYCLE; HISTONE H3; HETEROCHROMATIN FORMATION; PROTEIN-DEGRADATION; 26S PROTEASOME; HUMAN GENOME; CHROMATIN MODIFICATIONS	Heterochromatinisation of pericentromeres, which in mice consist of arrays of major satellite repeats, are important for centromere formation and maintenance of genome stability. The dysregulation of this process has been linked to genomic stress and various cancers. Here we show in mice that the proteasome binds to major satellite repeats and proteasome inhibition by MG132 results in their transcriptional de-repression; this de-repression is independent of cell-cycle perturbation. The transcriptional activation of major satellite repeats upon proteasome inhibition is accompanied by delocalisation of heterochromatin protein 1 alpha ( HP1 alpha) from chromocentres, without detectable change in the levels of histone H3K9me3, H3K4me3, H3K36me3 and H3 acetylation on the major satellite repeats. Moreover, inhibition of the proteasome was found to increase the number of chromocentres per cell, reflecting destabilisation of the chromocentre structures. Our findings suggest that the proteasome plays a role in maintaining heterochromatin integrity of pericentromeres.	[Natisvili, Theona; Yandim, Cihangir; Silva, Raquel; Emanuelli, Giulia; Nageshwaran, Sathiji; Festenstein, Richard] Imperial Coll London, Hammersmith Hosp, Gene Control Mech & Dis Grp, Dept Med,Div Brain Sci, London, England; [Natisvili, Theona; Yandim, Cihangir; Silva, Raquel; Emanuelli, Giulia; Nageshwaran, Sathiji; Festenstein, Richard] Imperial Coll London, Hammersmith Hosp, MRC Clin Sci Ctr, London, England; [Krueger, Felix] Babraham Inst, Bioinformat Grp, Cambridge, England; [Yandim, Cihangir] Inst Canc Res, 15 Cotswold Rd, London, England; [Silva, Raquel] UCL, Inst Ophthalmol, 11-43 Bath St, London, England; [Emanuelli, Giulia] Kings Coll London, James Black Ctr, Cardiovasc Div, Denmark Hill Campus, London, England	Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University College London; University of London; King's College London	Festenstein, R (corresponding author), Imperial Coll London, Hammersmith Hosp, Gene Control Mech & Dis Grp, Dept Med,Div Brain Sci, London, England.; Festenstein, R (corresponding author), Imperial Coll London, Hammersmith Hosp, MRC Clin Sci Ctr, London, England.	r.festenstein@imperial.ac.uk	Krueger, Felix/J-3340-2019; YANDIM, Cihangir/AAA-2250-2021	YANDIM, Cihangir/0000-0002-2050-6186; Silva, Raquel/0000-0002-1455-3082; Emanuelli, Giulia/0000-0001-8899-6110; Krueger, Felix/0000-0002-5513-3324	MRC (UK) Wellcome Trust Fellowship [48935]; Biotechnology and Biological Sciences Research Council [BB/M003760/1] Funding Source: researchfish; Medical Research Council [MC_U120081321, MR/J007943/1] Funding Source: researchfish; BBSRC [BB/M003760/1] Funding Source: UKRI; MRC [MC_U120081321, MR/J007943/1] Funding Source: UKRI	MRC (UK) Wellcome Trust Fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MRC (UK) Wellcome Trust Fellowship 48935. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1999, CANCER RES, V59, P2615; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Azzaz AM, 2014, J BIOL CHEM, V289, P6850, DOI 10.1074/jbc.M113.512137; Banfalvi G, 2008, NAT PROTOC, V3, P663, DOI 10.1038/nprot.2008.34; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bonvini P, 2007, LEUKEMIA, V21, P838, DOI 10.1038/sj.leu.2404528; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Bulut-Karslioglu A, 2012, NAT STRUCT MOL BIOL, V19, P1023, DOI 10.1038/nsmb.2382; Bush KT, 1997, J BIOL CHEM, V272, P9086; Catic A, 2013, CELL, V155, P1380, DOI 10.1016/j.cell.2013.11.016; Chaves S, 2010, MOL CELL BIOL, V30, P5284, DOI 10.1128/MCB.00952-10; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Enukashvily NI, 2007, CYTOGENET GENOME RES, V118, P42, DOI 10.1159/000106440; Eymery A, 2010, EXP CELL RES, V316, P1845, DOI 10.1016/j.yexcr.2010.02.002; Eymery A, 2009, NUCLEIC ACIDS RES, V37, P6340, DOI 10.1093/nar/gkp639; Fatyol K, 2008, BBA-GENE REGUL MECH, V1779, P850, DOI 10.1016/j.bbagrm.2008.08.010; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Ferri F, 2009, NUCLEIC ACIDS RES, V37, P5071, DOI 10.1093/nar/gkp529; Geng FQ, 2012, P NATL ACAD SCI USA, V109, P6060, DOI 10.1073/pnas.1200854109; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Hassan KMA, 2001, HUM GENET, V109, P452; Javerzat JP, 1999, MOL CELL BIOL, V19, P5155; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jolly C, 2004, J CELL BIOL, V164, P25, DOI 10.1083/jcb.200306104; Jung T, 2013, REDOX BIOL, V1, P178, DOI 10.1016/j.redox.2013.01.004; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kinyamu HK, 2007, MOL CELL BIOL, V27, P4891, DOI 10.1128/MCB.02162-06; Kitagawa T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4597; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Ling YH, 2003, CLIN CANCER RES, V9, P1145; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Machiels BM, 1997, CYTOMETRY, V28, P243; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mateos-Langerak J, 2007, MOL BIOL CELL, V18, P1464, DOI 10.1091/mbc.E06-01-0025; Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091; Mengual E, 1996, J NEUROSCI, V16, P6331; Metz A, 2004, J CELL SCI, V117, P4551, DOI 10.1242/jcs.01329; Millanes-Romero A, 2013, MOL CELL, V52, P746, DOI 10.1016/j.molcel.2013.10.015; MINIOU P, 1994, HUM MOL GENET, V3, P2093, DOI 10.1093/hmg/3.12.2093; Mosch K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015894; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; Narayan A, 1998, INT J CANCER, V77, P833, DOI 10.1002/(SICI)1097-0215(19980911)77:6<833::AID-IJC6>3.0.CO;2-V; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Oliva J, 2009, WORLD J GASTROENTERO, V15, P705, DOI 10.3748/wjg.15.705; PALMER A, 1994, EUR J CELL BIOL, V64, P163; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; PETERS JM, 1994, J BIOL CHEM, V269, P7709; Probst AV, 2010, DEV CELL, V19, P625, DOI 10.1016/j.devcel.2010.09.002; Qu GZ, 1999, MUTAT RES-FUND MOL M, V423, P91, DOI 10.1016/S0027-5107(98)00229-2; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280; Rizzi N, 2004, MOL BIOL CELL, V15, P543, DOI 10.1091/mbc.E03-07-0487; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Saksouk N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-3; Santenard A, 2010, NAT CELL BIOL, V12, P853, DOI 10.1038/ncb2089; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Sulahian R, 2006, NUCLEIC ACIDS RES, V34, P1351, DOI 10.1093/nar/gkl012; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Valgardsdottir R, 2008, NUCLEIC ACIDS RES, V36, P423, DOI 10.1093/nar/gkm1056; WOJCIK C, 1995, EUR J CELL BIOL, V68, P191; Yuan CM, 2004, CYTOM PART B-CLIN CY, V58B, P47, DOI 10.1002/cyto.b.20000; Zhang HS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004202; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	83	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165873	10.1371/journal.pone.0165873	http://dx.doi.org/10.1371/journal.pone.0165873			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806100	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500065
J	Pal, A; Rhoads, DB; Tavakkoli, A				Pal, Atanu; Rhoads, David B.; Tavakkoli, Ali			Effect of Portal Glucose Sensing on Systemic Glucose Levels in SD and ZDF Rats	PLOS ONE			English	Article							HEPATIC NERVES; CONSCIOUS DOG; DELIVERY; SENSOR; METABOLISM; CAPSAICIN; INFUSION; LIVER	Background The global epidemic of Type-2-Diabetes (T2D) highlights the need for novel therapeutic targets and agents. Roux-en-Y-Gastric-Bypass (RYGB) is the most effective treatment. Studies investigating the mechanisms of RYGB suggest a role for post-operative changes in portal glucose levels. We investigate the impact of stimulating portal glucose sensors on systemic glucose levels in health and T2D, and evaluated the role of sodium-glucose-cotransporter-3 (SGLT3) as the possible sensor. Methods Systemic glucose and hormone responses to portal stimulation were measured. In Sprague-Dawley (SD) rats, post-prandial state was simulated by infusing glucose into the portal vein. The SGLT3 agonist, alpha-methyl-glucopyranoside (alpha MG), was then added to further stimulate the portal sensor. To elucidate the neural pathway, vagotomy or portal denervation was followed by alpha MG+glucose co-infusion. The therapeutic potential of portal glucose sensor stimulation was investigated by alpha MG-only infusion (vs. saline) in SD and Zucker Diabetic-Fatty (ZDF) rats. Hepatic mRNA expression was also measured. Results alpha MG+glucose co-infusion reduced peak systemic glucose (vs. glucose alone), and lowered hepatic G6Pase expression. Portal denervation, but not vagotomy, abolished this effect. alpha MG-only infusion lowered systemic glucose levels. This glucose-lowering effect was more pronounced in ZDF rats, where portal alpha MG infusion increased insulin, C-peptide and GIP levels compared to saline infusions. Conclusions The portal vein is capable of sensing its glucose levels, and responds by altering hepatic glucose handling. The enhanced effect in T2D, mediated through increased GIP and insulin, highlights a therapeutic target that could be amenable to pharmacological modulation or minimally-invasive surgery.	[Pal, Atanu; Tavakkoli, Ali] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Pal, Atanu; Rhoads, David B.; Tavakkoli, Ali] Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA; [Rhoads, David B.] MassGen Hosp Children, Pediat Endocrine Unit, 55 Fruit St, Boston, MA 02114 USA; [Tavakkoli, Ali] Brigham & Womens Hosp, Ctr Weight Management & Metab Surg, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Tavakkoli, A (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.; Tavakkoli, A (corresponding author), Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA.; Tavakkoli, A (corresponding author), Brigham & Womens Hosp, Ctr Weight Management & Metab Surg, 75 Francis St, Boston, MA 02115 USA.	atavakkoli@partners.org			National Institutes of Health [1 R01 DK084064]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant 1 R01 DK084064 (AT).	ADKINS BA, 1987, J CLIN INVEST, V79, P557, DOI 10.1172/JCI112847; ADKINSMARSHALL B, 1992, AM J PHYSIOL, V262, pE679, DOI 10.1152/ajpendo.1992.262.5.E679; Baird JP, 1997, AM J PHYSIOL-REG I, V272, pR1454, DOI 10.1152/ajpregu.1997.272.5.R1454; Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; Boubaker J, 2012, J NEUROENDOCRINOL, V24, P1096, DOI 10.1111/j.1365-2826.2012.02326.x; Burcelin R, 2000, DIABETES, V49, P1635, DOI 10.2337/diabetes.49.10.1635; Burcelin R, 2000, DIABETES, V49, P1643, DOI 10.2337/diabetes.49.10.1643; Chan OW, 2014, DIABETES, V63, P2617, DOI 10.2337/db14-0755; Coate KC, 2013, DIABETES, V62, P392, DOI 10.2337/db12-0417; Delaere F, 2013, MOL METAB, V2, P47, DOI 10.1016/j.molmet.2012.11.003; DiCostanzo CA, 2007, METABOLISM, V56, P814, DOI 10.1016/j.metabol.2007.01.012; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Diez-Sampedro A, 2001, AM J PHYSIOL-RENAL, V280, pF278, DOI 10.1152/ajprenal.2001.280.2.F278; Holzer P, 1998, AM J PHYSIOL-GASTR L, V275, pG8, DOI 10.1152/ajpgi.1998.275.1.G8; IMAMURA M, 1984, TOHOKU J EXP MED, V143, P335, DOI 10.1620/tjem.143.335; Johansen SL, 2015, AUTON NEUROSCI-BASIC, V193, P51, DOI 10.1016/j.autneu.2015.07.002; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; McCrate F, 2010, CAN FAM PHYSICIAN, V56, pE13; PAGLIASSOTTI MJ, 1992, DIABETES, V41, P1247, DOI 10.2337/diabetes.41.10.1247; Pal A, 2015, DIABETES; Saeidi N, 2013, SCIENCE, V341, P406, DOI 10.1126/science.1235103; Shiota Masakazu, 2012, Methods Mol Biol, V933, P103, DOI 10.1007/978-1-62703-068-7_8; Stearns AT, 2012, DIGEST DIS SCI, V57, P1281, DOI 10.1007/s10620-011-1968-4; Stearns AT, 2008, AM J PHYSIOL-GASTR L, V294, pG1078, DOI 10.1152/ajpgi.00591.2007; Tanaka Tadashi, 2005, J Anesth, V19, P277, DOI 10.1007/s00540-005-0341-1	25	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165592	10.1371/journal.pone.0165592	http://dx.doi.org/10.1371/journal.pone.0165592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806092	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500039
J	Park, HR; Lee, JM; Kim, JW; Han, JH; Chung, HT; Han, MH; Kim, DG; Paek, SH				Park, Hye Ran; Lee, Jae Meen; Kim, Jin Wook; Han, Jung-Ho; Chung, Hyun-Tai; Han, Moon Hee; Kim, Dong Gyu; Paek, Sun Ha			Time-Staged Gamma Knife Stereotactic Radiosurgery for Large Cerebral Arteriovenous Malformations: A Preliminary Report	PLOS ONE			English	Article							NATURAL-HISTORY; GRADING SYSTEM; HEMORRHAGE; MANAGEMENT; OUTCOMES; BRAIN; RISK; COMPLICATIONS; OBLITERATION; THERAPY	Objective We retrospectively analyzed our experience with time-staged gamma knife stereotactic radiosurgery (GKS) in treating large arteriovenous malformation(AVM) s; >= 10 cm(3)). Methods Forty-five patients who underwent time-staged GKS (2-stage, n = 37; 3-stage, n = 8) between March 1998 and December 2011 were included. The mean volume treated was 20.42 +/- 6.29 cm(3) (range, 10.20-38.50 cm(3)). Obliteration rates of AVMs and the associated complications after GKS were evaluated. Results Mean AVM volume (and median marginal dose) at each GKS session in the 37 patients who underwent 2-stage GKS was 19.67 +/- 6.08 cm(3) (13 Gy) at session 1 and 6.97 +/- 6.92 cm(3) (17 Gy) at session 2. The median interval period was 39 months. After follow-up period of 37 months, the complete obliteration rate was 64.9%. The mean AVM volume (and median marginal dose) at each GKS session in the 8 patients who underwent 3-stage GKS was 23.90 +/- 6.50 cm(3) (12.25 Gy), 19.43 +/- 7.46 cm(3) (13.5 Gy), 7.48 +/- 6.86 cm(3) (15.5 Gy) at session 1, 2, and 3, respectively. The median interval duration between each GKS session was 37.5 and 38 months, respectively. After a median follow-up period of 47.5 months, 5 patients (62.5%) achieved complete obliteration. Postradiosurgical hemorrhage developed in 5 patients (11.1%) including one case of major bleeding and 4 cases of minor bleeding. No patient suffered from clinically symptomatic radiation necrosis following radiation. Conclusion Time-staged GKS could be an effective and safe treatment option in the management of large AVMs.	[Park, Hye Ran] Soonchunhyang Univ Hosp, Dept Neurosurg, Seoul, South Korea; [Lee, Jae Meen; Kim, Jin Wook; Chung, Hyun-Tai; Kim, Dong Gyu; Paek, Sun Ha] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea; [Han, Jung-Ho] Seoul Natl Univ, Bundang Hosp, Dept Neurosurg, Seoul, South Korea; [Han, Moon Hee] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea	Soonchunhyang University; Soonchunhyang University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Paek, SH (corresponding author), Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea.	paeksh@snu.ac.kr	Lee, Jeong Min/V-3429-2019	Lee, Jeong Min/0000-0003-0561-8777	Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries, Republic of Korea [311011-05-3-SB020]; Korea Healthcare Technology R&D Project - Ministry of Health & Welfare, Republic of Korea [HI11C21100200]; Technology Innovation Program (Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information) - Ministry of Trade, Industry & Energy (MI, Korea) [10050154]; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [2015M3C7A1028926]	Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries, Republic of Korea; Korea Healthcare Technology R&D Project - Ministry of Health & Welfare, Republic of Korea; Technology Innovation Program (Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information) - Ministry of Trade, Industry & Energy (MI, Korea); Bio & Medical Technology Development Program of the NRF - Korean government, MSIP	SHP received these fundings: This study was supported by the Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries, Republic of Korea (311011-05-3-SB020), by the Korea Healthcare Technology R&D Project (HI11C21100200) funded by Ministry of Health & Welfare, Republic of Korea, by the Technology Innovation Program (10050154, Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information) funded by the Ministry of Trade, Industry & Energy (MI, Korea), and by the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (2015M3C7A1028926). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CJ, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.6.FOCUS1454; COLOMBO F, 1994, NEUROSURGERY, V34, P14; Ding DL, 2014, BRIT J NEUROSURG, V28, P666, DOI 10.3109/02688697.2013.872227; Duffner F, 2000, STEREOT FUNCT NEUROS, V75, P27, DOI 10.1159/000048380; Fleetwood IG, 2002, LANCET, V359, P863, DOI 10.1016/S0140-6736(02)07946-1; Flickinger JC, 2002, RADIOTHER ONCOL, V63, P347, DOI 10.1016/S0167-8140(02)00103-2; Foote KD, 2003, J NEUROSURG, V98, P337, DOI 10.3171/jns.2003.98.2.0337; Han PP, 2003, J NEUROSURG, V98, P3, DOI 10.3171/jns.2003.98.1.0003; Hernesniemi JA, 2008, NEUROSURGERY, V63, P823, DOI 10.1227/01.NEU.0000330401.82582.5E; Izawa M, 2005, J NEUROSURG, V102, P34, DOI 10.3171/jns.2005.102.s_supplement.0034; Kano H, 2012, J NEUROSURG, V116, P54, DOI 10.3171/2011.9.JNS11177; Kjellberg R, 1979, ISOEFFECTIVE DOSE PA; KJELLBERG RN, 1983, NEW ENGL J MED, V309, P269, DOI 10.1056/NEJM198308043090503; Liscak R, 2007, NEUROSURGERY, V60, P1005, DOI 10.1227/01.NEU.0000255474.60505.4A; Maesawa S, 2000, J NEUROSURG, V92, P961, DOI 10.3171/jns.2000.92.6.0961; Maruyama K, 2005, NEW ENGL J MED, V352, P146, DOI 10.1056/NEJMoa040907; Mohr JP, 2014, LANCET, V383, P614, DOI 10.1016/S0140-6736(13)62302-8; Moosa S, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.5.FOCUS14205; Ogilvy CS, 2001, CIRCULATION, V103, P2644; Pollock BE, 2000, INT J RADIAT ONCOL, V48, P817, DOI 10.1016/S0360-3016(00)00696-9; Pollock BE, 1998, NEUROSURGERY, V42, P1239, DOI 10.1097/00006123-199806000-00020; Pollock BE, 2002, J NEUROSURG, V96, P79, DOI 10.3171/jns.2002.96.1.0079; Pollock BE, 1996, NEUROSURGERY, V38, P652, DOI 10.1227/00006123-199604000-00004; Pollock BE, 2008, NEUROSURGERY, V63, P239, DOI 10.1227/01.NEU.0000315861.24920.92; Regis J, 2002, GAMMA KNIFE SURGERY; Schneider BF, 1997, J NEUROSURG, V87, P352, DOI 10.3171/jns.1997.87.3.0352; Sirin S, 2006, NEUROSURGERY, V58, P17, DOI 10.1227/01.NEU.0000190653.42970.6B; Spetzler R F, 1978, Clin Neurosurg, V25, P651; Yamamoto M, 1999, NEUROSURG CLIN N AM, V10, P181, DOI 10.1016/S1042-3680(18)30189-X; Yang SY, 2009, ACTA NEUROCHIR, V151, P113, DOI 10.1007/s00701-008-0173-5; YU H, 2010, J NEUROSURG, V113, P2, DOI [10.3171/3171/2010.7.GKS101043, DOI 10.3171/3171/2010.7.GKS101043]	31	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165783	10.1371/journal.pone.0165783	http://dx.doi.org/10.1371/journal.pone.0165783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806123	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500054
J	Porz, N; Habegger, S; Meier, R; Verma, R; Jilch, A; Fichtner, J; Knecht, U; Radina, C; Schucht, P; Beck, J; Raabe, A; Slotboom, J; Reyes, M; Wiest, R				Porz, Nicole; Habegger, Simon; Meier, Raphael; Verma, Rajeev; Jilch, Astrid; Fichtner, Jens; Knecht, Urspeter; Radina, Christian; Schucht, Philippe; Beck, Jurgen; Raabe, Andreas; Slotboom, Johannes; Reyes, Mauricio; Wiest, Roland			Fully Automated Enhanced Tumor Compartmentalization: Man vs. Machine Reloaded	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; VOLUMETRIC-ANALYSIS; PROGNOSTIC VALUE; RESECTION; EXTENT; SURGERY; SEGMENTATION; SURVIVAL; LESIONS; MRI	Objective Comparison of a fully-automated segmentation method that uses compartmental volume information to a semi-automatic user-guided and FDA-approved segmentation technique. Methods Nineteen patients with a recently diagnosed and histologically confirmed glioblastoma (GBM) were included and MR images were acquired with a 1.5 T MR scanner. Manual segmentation for volumetric analyses was performed using the open source software 3D Slicer version 4.2.2.3 (www.slicer.org). Semi-automatic segmentation was done by four independent neurosurgeons and neuroradiologists using the computer-assisted segmentation tool SmartBrush (R) (referred to as SB), a semi-automatic user-guided and FDA-approved tumor-outlining program that uses contour expansion. Fully automatic segmentations were performed with the Brain Tumor Image Analysis (BraTumIA, referred to as BT) software. We compared manual (ground truth, referred to as GT), computer-assisted (SB) and fully-automated (BT) segmentations with regard to: (1) products of two maximum diameters for 2D measurements, (2) the Dice coefficient, (3) the positive predictive value, (4) the sensitivity and (5) the volume error. Results Segmentations by the four expert raters resulted in a mean Dice coefficient between 0.72 and 0.77 using SB. BT achieved a mean Dice coefficient of 0.68. Significant differences were found for intermodal (BT vs. SB) and for intramodal (four SB expert raters) performances. The BT and SB segmentations of the contrast-enhancing volumes achieved a high correlation with the GT. Pearson correlation was 0.8 for BT; however, there were a few discrepancies between raters (BT and SB 1 only). Additional non-enhancing tumor tissue extending the SB volumes was found with BT in 16/19 cases. The clinically motivated sum of products of diameters measure (SPD) revealed neither significant intermodal nor intramodal variations. The analysis time for the four expert raters was faster (1 minute and 47 seconds to 3 minutes and 39 seconds) than with BT (5 minutes). Conclusion BT and SB provide comparable segmentation results in a clinical setting. SB provided similar SPD measures to BT and GT, but differed in the volume analysis in one of the four clinical raters. A major strength of BT may its independence from human interactions, it can thus be employed to handle large datasets and to associate tumor volumes with clinical and/or molecular datasets ("-omics") as well as for clinical analyses of brain tumor compartment volumes as baseline outcome parameters. Due to its multi-compartment segmentation it may provide information about GBM subcompartment compositions that may be subjected to clinical studies to investigate the delineation of the target volumes for adjuvant therapies in the future.	[Porz, Nicole; Habegger, Simon; Verma, Rajeev; Knecht, Urspeter; Slotboom, Johannes; Wiest, Roland] Inselspital Bern, Univ Hosp, Support Ctr Adv Neuroimaging, Inst Diagnost & Intervent Neuroradiol, Bern, Switzerland; [Porz, Nicole; Habegger, Simon; Verma, Rajeev; Jilch, Astrid; Fichtner, Jens; Knecht, Urspeter; Radina, Christian; Schucht, Philippe; Beck, Jurgen; Raabe, Andreas; Slotboom, Johannes; Wiest, Roland] Univ Bern, Bern, Switzerland; [Porz, Nicole; Jilch, Astrid; Fichtner, Jens; Radina, Christian; Schucht, Philippe; Beck, Jurgen; Raabe, Andreas] Inselspital Bern, Univ Hosp, Dept Neurosurg, Bern, Switzerland; [Meier, Raphael; Reyes, Mauricio] Univ Bern, Inst Surg Technol & Biomech, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern	Habegger, S (corresponding author), Inselspital Bern, Univ Hosp, Support Ctr Adv Neuroimaging, Inst Diagnost & Intervent Neuroradiol, Bern, Switzerland.; Habegger, S (corresponding author), Univ Bern, Bern, Switzerland.	simon.habegger@insel.ch		Beck, Jurgen/0000-0002-7687-6098	Swiss National Science Foundation (SNF) [320030_140958]; Bernese Cancer League; Swiss Cancer League; European Unions Seventh Framework Programme for research, technological development and demonstration [600841]; Brainlab AG; Swiss National Foundation [140958]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Bernese Cancer League; Swiss Cancer League; European Unions Seventh Framework Programme for research, technological development and demonstration; Brainlab AG; Swiss National Foundation(Swiss National Science Foundation (SNSF))	This study was supported by the Swiss National Science Foundation (SNF Grant No. 320030_140958), the Bernese Cancer League, the Swiss Cancer League and the European Unions Seventh Framework Programme for research, technological development and demonstration under grant agreement No. 600841. Brainlab AG provided support in the form of salary for author CR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.r We thank the MR technicians of our department for their excellent support. The authors also wish to acknowledge funding from Swiss National Foundation Grant number 140958.	Aldave G, 2013, NEUROSURGERY, V72, P915, DOI 10.1227/NEU.0b013e31828c3974; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; [Anonymous], 2012, SEGMENTATION BRAIN T; Bauer S, 2011, LECT NOTES COMPUT SC, V6893, P354, DOI 10.1007/978-3-642-23626-6_44; Coburger J, 2015, J NEUROSURG SCI; Coburger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131872; Coburger J, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2013.11.FOCUS13463; Crum WR, 2006, IEEE T MED IMAGING, V25, P1451, DOI 10.1109/TMI.2006.880587; Davatzikos C, 2011, IEEE ENG MED BIO, P6979, DOI 10.1109/IEMBS.2011.6091764; Deeley MA, 2011, PHYS MED BIOL, V56, P4557, DOI 10.1088/0031-9155/56/14/021; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Ellingson BM, 2011, J NEURO-ONCOL, V102, P95, DOI 10.1007/s11060-010-0293-7; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Perez-Larraya JG, 2012, NEURO-ONCOLOGY, V14, P667, DOI 10.1093/neuonc/nos070; Grabowski MM, 2014, J NEUROSURG, V121, P1115, DOI 10.3171/2014.7.JNS132449; Huber T, 2015, CLIN NEURORADIOL, P1; Jiang J, 2013, COMPUT MED IMAG GRAP, V37, P512, DOI 10.1016/j.compmedimag.2013.05.007; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Mazzara GP, 2004, INT J RADIAT ONCOL, V59, P300, DOI 10.1016/j.ijrobp.2004.01.026; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Pica A, 2014, NEUROONCOLOGY S2, V16, pii3; Porz N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096873; Raabe A, 2014, J NEUROSURG, V120, P1015, DOI 10.3171/2014.1.JNS13909; Reyes, 2012, INSIGHT J; Rios VE, 2015, MED PHYS, V42, P3589; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Schucht P, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14082; Schucht P, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.10.FOCUS14524; Schucht P, 2014, ACTA NEUROCHIR, V156, P305, DOI 10.1007/s00701-013-1906-7; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Stummer W, 2009, CURR OPIN NEUROL, V22, P645, DOI 10.1097/WCO.0b013e3283320165; Van Leemput K, CAUTIONARY ANAL STAP; Velazquez ER, 2015, MED PHYS, V42, P3603, DOI 10.1118/1.4925589; Velazquez ER, 2015, SCI REP-UK, V5, DOI 10.1038/srep16822; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	37	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165302	10.1371/journal.pone.0165302	http://dx.doi.org/10.1371/journal.pone.0165302			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806121	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500025
J	Jeon, SJ; Cunha, F; Ma, XJ; Martinez, N; Vieira-Neto, A; Daetz, R; Bicalho, RC; Lima, S; Santos, JEP; Jeong, KC; Galvao, KN				Jeon, Soo Jin; Cunha, Federico; Ma, Xiaojie; Martinez, Natalia; Vieira-Neto, Achilles; Daetz, Rodolfo; Bicalho, Rodrigo C.; Lima, Svetlana; Santos, Jose E. P.; Jeong, K. Casey; Galvao, Klibs N.			]Uterine Microbiota and Immune Parameters Associated with Fever in Dairy Cows with Metritis	PLOS ONE			English	Article							POSTPARTUM UTERINE DISEASE; BACTEROIDES-PYOGENES; NEUTROPHIL FUNCTION; CEFTIOFUR HYDROCHLORIDE; STERILE SUSPENSION; TISSUE-DAMAGE; HOLSTEIN COWS; MILK-YIELD; CAT BITE; INFERTILITY	Objective This study aimed to evaluate bacterial and host factors causing a fever in cows with metritis. For that, we investigated uterine microbiota using a metagenomic sequencing of the 16S rRNA gene (Study 1), and immune response parameters (Study 2) in metritic cows with and without a fever. Principal Findings (Study1) Bacterial communities were similar between the MNoFever and MFever groups based on distance metrics of relative abundance of bacteria. Metritic cows showed a greater prevalence of Bacteroidetes, and Bacteroides and Porphyromonas were the largest contributors to that difference. A comparison of relative abundance at the species level pointed to Bacteroides pyogenes as a fever-related species which was significantly abundant in the MFever than the MNoFever and Healthy groups; however, absolute abundance of Bacteroides pyogenes determined by droplet digital PCR (ddPCR) was similar between MFever and MNoFever groups, but higher than the Healthy group. The same trend was observed in the total number of bacteria. Principal Findings (Study2) The activity of polymorphonuclear leukocyte (PMN) and the production of TNF alpha, PGE(2) metabolite, and PGE(2) were evaluated in serum, before disease onset, at 0 and 3 DPP. Cows in the MNoFever had decreased proportion of PMN undergoing phagocytosis and oxidative burst compared with the MFever. The low PMN activity in the MNoFever was coupled with the low production of TNF alpha, but similar PGE(2) metabolite and circulating PGE(2). Conclusion/Significance Our study is the first to show a similar microbiome between metritic cows with and without a fever, which indicates that the host response may be more important for fever development than the microbiome. Bacteroides pyogenes was identified as an important pathogen for the development of metritis but not fever. The decreased inflammatory response may explain the lack of a febrile response in the MNoFever group.	[Jeon, Soo Jin; Cunha, Federico; Ma, Xiaojie; Daetz, Rodolfo; Galvao, Klibs N.] Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32610 USA; [Martinez, Natalia; Vieira-Neto, Achilles; Santos, Jose E. P.; Jeong, K. Casey] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Bicalho, Rodrigo C.; Lima, Svetlana] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY USA; [Jeong, K. Casey] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Galvao, Klibs N.] Univ Florida, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Cornell University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Galvao, KN (corresponding author), Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32610 USA.; Galvao, KN (corresponding author), Univ Florida, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL USA.	galvaok@ufl.edu	Cunha, Federico/ABF-1860-2021; Martinez-Patino, Natalia/AAB-9445-2021; Santos, José Eduardo P./K-5564-2013; Neto, Achilles Vieira/AEC-4084-2022	Cunha, Federico/0000-0002-8947-7686; Santos, José Eduardo P./0000-0003-3403-1465; Neto, Achilles Vieira/0000-0001-7592-381X; Jeon, Soo Jin/0000-0001-7473-3184	USDA-NIFA-CRIS program [1002880]	USDA-NIFA-CRIS program	This project was supported by the USDA-NIFA-CRIS program (accession number: 1002880).	Alexander CJ, 1997, J CLIN MICROBIOL, V35, P406, DOI 10.1128/JCM.35.2.406-411.1997; BARTLETT PC, 1986, PREV VET MED, V4, P235, DOI 10.1016/0167-5877(86)90026-7; BENNO Y, 1983, SYST APPL MICROBIOL, V4, P396, DOI 10.1016/S0723-2020(83)80024-1; Benzaquen ME, 2007, J DAIRY SCI, V90, P2804, DOI 10.3168/jds.2006-482; Blatteis CM, 2005, PROSTAG OTH LIPID M, V76, P1, DOI 10.1016/j.prostaglandins.2005.01.001; Blatteis CM, 2004, J THERM BIOL, V29, P359, DOI 10.1016/j.jtherbio.2004.08.008; Bromfield JJ, 2015, J ANIM SCI, V93, P2021, DOI 10.2527/jas.2014-8496; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chenault JR, 2004, JAVMA-J AM VET MED A, V224, P1634, DOI 10.2460/javma.2004.224.1634; Clifford RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048558; Falentin H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00480; Galvao KN, 2012, THERIOGENOLOGY, V77, P356, DOI 10.1016/j.theriogenology.2011.08.008; Giuliodori MJ, 2013, J DAIRY SCI, V96, P3621, DOI 10.3168/jds.2012-5922; Hammon DS, 2006, VET IMMUNOL IMMUNOP, V113, P21, DOI 10.1016/j.vetimm.2006.03.022; Healy LL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07060; Herath S, 2009, ENDOCRINOLOGY, V150, P1912, DOI 10.1210/en.2008-1379; HUSSAIN AM, 1989, J VET MED B, V36, P641, DOI 10.1111/j.1439-0450.1989.tb00657.x; Jeon SJ, 2015, APPL ENVIRON MICROB, V81, P6324, DOI 10.1128/AEM.01753-15; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Lima FS, 2014, J DAIRY SCI, V97, P5401, DOI 10.3168/jds.2013-7569; Madsen IR, 2011, J CLIN MICROBIOL, V49, P3092, DOI 10.1128/JCM.00250-11; Martinez N, 2014, J DAIRY SCI, V97, P874, DOI 10.3168/jds.2013-7408; Martinez N, 2012, J DAIRY SCI, V95, P7158, DOI 10.3168/jds.2012-5812; McLaughlin CL, 2012, J DAIRY SCI, V95, P4363, DOI 10.3168/jds.2011-5111; Myers RD, 1982, PYRETICS ANTIPYRETIC, P151; Netea MG, 2000, CLIN INFECT DIS, V31, pS178, DOI 10.1086/317513; Obita T, 2003, CELL MOL LIFE SCI, V60, P176, DOI 10.1007/s000180300012; Peng Y, 2013, FOLIA MICROBIOL, V58, P593, DOI 10.1007/s12223-013-0238-6; Rajala PJ, 1998, J DAIRY SCI, V81, P3172, DOI 10.3168/jds.S0022-0302(98)75883-7; Ribeiro ES, 2013, J DAIRY SCI, V96, P5682, DOI 10.3168/jds.2012-6335; Sakamoto M, 2010, INT J SYST EVOL MICR, V60, P2984, DOI 10.1099/ijs.0.021154-0; Santos TMA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053048; Schukken YH, 2009, J DAIRY SCI, V92, P3091, DOI 10.3168/jds.2008-1557; Sheldon IM, 2009, REPROD DOMEST ANIM, V44, P1, DOI 10.1111/j.1439-0531.2009.01465.x; Sheldon IM, 2006, THERIOGENOLOGY, V65, P1516, DOI 10.1016/j.theriogenology.2005.08.021; Ster C, 2012, J DAIRY SCI, V95, P708, DOI 10.3168/jds.2011-4695; Tavares E, 2005, CLIN DIAGN LAB IMMUN, V12, P1085, DOI 10.1128/CDLI.12.9.1085-1093.2005; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zeisberger E, 1999, J THERM BIOL, V24, P287, DOI 10.1016/S0306-4565(99)00033-9	42	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165740	10.1371/journal.pone.0165740	http://dx.doi.org/10.1371/journal.pone.0165740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802303	Green Submitted, gold, Green Published			2022-12-27	WOS:000386714200048
J	Song, F; Xu, DD; Mai, KS; Zhou, HH; Xu, W; He, G				Song, Fei; Xu, Dandan; Mai, Kangsen; Zhou, Huihui; Xu, Wei; He, Gen			Comparative Study on the Cellular and Systemic Nutrient Sensing and Intermediary Metabolism after Partial Replacement of Fishmeal by Meat and Bone Meal in the Diet of Turbot (Scophthalmus maximus L.)	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; GCN2 EIF2-ALPHA KINASE; TRANSCRIPTION FACTOR 4; RAINBOW-TROUT; AMINO-ACID; GENE-EXPRESSION; MAMMALIAN TARGET; POSTPRANDIAL REGULATION; MOLECULAR-MECHANISMS; PROTEIN-SOURCE	This study was designed to examine the cellular and systemic nutrient sensing mechanisms as well as the intermediary metabolism responses in turbot (Scophthalmus maximus L.) fed with fishmeal diet (FM diet), 45% of FM replaced by meat and bone meal diet (MBM diet) or MBM diet supplemented with essential amino acids to match the amino acid profile of FM diet (MBM+AA diet). During the one month feeding trial, feed intake was not affected by the different diets. However, MBM diet caused significant reduction of specific growth rate and nutrient retentions. Compared with the FM diet, MBM diet down-regulated target of rapamycin (TOR) and insulin-like growth factor (IGFs) signaling pathways, whereas up-regulated the amino acid response (AAR) signaling pathway. Moreover, MBM diet significantly decreased glucose and lipid anabolism, while increased muscle protein degradation and lipid catabolism in liver. MBM+AA diet had no effects on improvement of MBM diet deficiencies. Compared with fasted, re-feeding markedly activated the TOR signaling pathway, IGF signaling pathway and glucose, lipid metabolism, while significantly depressed the protein degradation signaling pathway. These results thus provided a comprehensive display of molecular responses and a better explanation of deficiencies generated after fishmeal replacement by other protein sources.	[Song, Fei; Xu, Dandan; Mai, Kangsen; Zhou, Huihui; Xu, Wei; He, Gen] Ocean Univ China, Key Lab Aquaculture Nutr & Feed, Minist Agr, Qingdao 266003, Peoples R China; [Song, Fei; Xu, Dandan; Mai, Kangsen; Zhou, Huihui; He, Gen] Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao 266003, Peoples R China	Ministry of Agriculture & Rural Affairs; Ocean University of China; Ocean University of China	He, G (corresponding author), Ocean Univ China, Key Lab Aquaculture Nutr & Feed, Minist Agr, Qingdao 266003, Peoples R China.; He, G (corresponding author), Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao 266003, Peoples R China.	hegen@ouc.edu.cn			National Scientific Foundation of China [311222055, 31572627]; National Basic Research Program of China (973 Program) [2014CB138600]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was funded by National Scientific Foundation of China (grant number 311222055 to GH), National Scientific Foundation of China (grant number 31572627 to GH), and National Basic Research Program of China (973 Program) (grant number 2014CB138600 to KM).	Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Azizi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147618; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Dai W, 2013, J EXP BIOL, V216, P4483, DOI 10.1242/jeb.091157; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Du M, 2007, J ANIM SCI, V85, P919, DOI 10.2527/jas.2006-342; Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022; Duan CM, 2010, GEN COMP ENDOCR, V167, P344, DOI 10.1016/j.ygcen.2010.04.009; Fabbrini E, 2016, GASTROENTEROLOGY, V150, P79, DOI 10.1053/j.gastro.2015.09.003; Fuentes EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044256; Gallinetti J, 2013, BIOCHEM J, V449, P1, DOI 10.1042/BJ20121098; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; Hatlen B, 2015, AQUACULT NUTR, V21, P714, DOI 10.1111/anu.12194; Hevroy EM, 2007, GEN COMP ENDOCR, V152, P39, DOI 10.1016/j.ygcen.2007.02.015; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Honda T, 2004, J HEPATOL, V40, P439, DOI 10.1016/j.jhep.2003.11.003; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; KETTELHUT IC, 1988, DIABETES METAB REV, V4, P751, DOI 10.1002/dmr.5610040805; Kikuchi K, 1997, FISHERIES SCI, V63, P29, DOI 10.2331/fishsci.63.29; Kimball SR, 2007, BIOCHEM SOC T, V35, P1298, DOI 10.1042/BST0351298; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Kissinger KR, 2016, AQUACULTURE, V452, P37, DOI 10.1016/j.aquaculture.2015.10.022; Kokou F, 2015, J WORLD AQUACULT SOC, V46, P115, DOI 10.1111/jwas.12181; Koyama S, 2008, J MOL BIOL, V376, P1224, DOI 10.1016/j.jmb.2007.11.049; Lansard M, 2011, J NUTR, V141, P75, DOI 10.3945/jn.110.124511; Lansard M, 2009, BRIT J NUTR, V102, P1564, DOI 10.1017/S000711450999095X; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Liao XH, 2008, AMINO ACIDS, V35, P761, DOI 10.1007/s00726-008-0100-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; De Sousa-Coelho AL, 2012, BIOCHEM J, V443, P165, DOI 10.1042/BJ20111748; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maures TJ, 2002, ENDOCRINOLOGY, V143, P2722, DOI 10.1210/en.143.7.2722; McCarthy ID, 2011, J EXP BIOL, V214, P1821, DOI 10.1242/jeb.052753; Moriyama S, 2000, BIOSCI BIOTECH BIOCH, V64, P1553, DOI 10.1271/bbb.64.1553; Panserat S, 2001, J EXP BIOL, V204, P2351; Picha ME, 2008, J ENDOCRINOL, V199, P81, DOI 10.1677/JOE-07-0649; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Reinecke M, 2005, GEN COMP ENDOCR, V142, P20, DOI 10.1016/j.ygcen.2005.01.016; Rodland GE, 2014, CELL CYCLE, V13, P453, DOI 10.4161/cc.27270; Rossi W, 2012, AQUACULTURE, V338, P160, DOI 10.1016/j.aquaculture.2012.01.026; Safian D, 2012, J ENDOCRINOL, V214, P95, DOI 10.1530/JOE-12-0057; Sasai N, 2010, MUSCLE NERVE, V41, P100, DOI 10.1002/mus.21473; Seiliez I, 2008, AM J PHYSIOL-REG I, V295, pR329, DOI 10.1152/ajpregu.00146.2008; Seiliez I, 2013, ZEBRAFISH, V10, P237, DOI 10.1089/zeb.2012.0835; Seiliez I, 2011, AM J PHYSIOL-REG I, V300, pR733, DOI 10.1152/ajpregu.00579.2010; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shin ES, 2006, EUR J NUTR, V45, P159, DOI 10.1007/s00394-005-0576-5; Skiba-Cassy S, 2009, AM J PHYSIOL-REG I, V297, pR1421, DOI 10.1152/ajpregu.00312.2009; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Tan BP, 2005, AQUAC RES, V36, P439, DOI 10.1111/j.1365-2109.2005.01223.x; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899; Valente LMP, 2012, BRIT J NUTR, V108, P2148, DOI 10.1017/S0007114512000396; van den Borne JJGC, 2012, J NUTR, V142, P2075, DOI 10.3945/jn.112.165670; Wacyk J, 2012, AQUACULTURE, V356, P223, DOI 10.1016/j.aquaculture.2012.05.013; Wang Q, 2016, AQUACULT NUTR, V22, P752, DOI 10.1111/anu.12296; Xu DD, 2016, BRIT J NUTR, V115, P379, DOI 10.1017/S0007114515004535; Yang Y, 2004, AQUACULT NUTR, V10, P289, DOI 10.1111/j.1365-2095.2004.00301.x; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	64	31	33	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165708	10.1371/journal.pone.0165708	http://dx.doi.org/10.1371/journal.pone.0165708			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802317	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200042
J	Roik, A; Rothig, T; Roder, C; Ziegler, M; Kremb, SG; Voolstra, CR				Roik, Anna; Rothig, Till; Roder, Cornelia; Ziegler, Maren; Kremb, Stephan G.; Voolstra, Christian R.			Year-Long Monitoring of Physico-Chemical and Biological Variables Provide a Comparative Baseline of Coral Reef Functioning in the Central Red Sea	PLOS ONE			English	Article							BACTERIAL COMMUNITY COMPOSITION; WHITE PLAGUE DISEASE; MICROBIAL COMMUNITY; WATER-QUALITY; TERRESTRIAL RUNOFF; SALINITY GRADIENT; DISSOLVED-OXYGEN; CHLOROPHYLL-A; OCEAN; BIOFILMS	Coral reefs in the central Red Sea are sparsely studied and in situ data on physico-chemical and key biotic variables that provide an important comparative baseline are missing. To address this gap, we simultaneously monitored three reefs along a cross-shelf gradient for an entire year over four seasons, collecting data on currents, temperature, salinity, dissolved oxygen (DO), chlorophyll-a, turbidity, inorganic nutrients, sedimentation, bacterial communities of reef water, and bacterial and algal composition of epilithic biofilms. Summer temperature (29-33 degrees C) and salinity (39 PSU) exceeded average global maxima for coral reefs, whereas DO concentration was low (2-4 mg L-1). While temperature and salinity differences were most pronounced between seasons, DO, chlorophyll-a, turbidity, and sedimentation varied most between reefs. Similarly, biotic communities were highly dynamic between reefs and seasons. Differences in bacterial biofilms were driven by four abundant families: Rhodobacteraceae, Flavobacteriaceae, Flammeovirgaceae, and Pseudanabaenaceae. In algal biofilms, green crusts, brown crusts, and crustose coralline algae were most abundant and accounted for most of the variability of the communities. Higher bacterial diversity of biofilms coincided with increased algal cover during spring and summer. By employing multivariate matching, we identified temperature, salinity, DO, and chlorophyll-a as the main contributing physico-chemical drivers of biotic community structures. These parameters are forecast to change most with the progression of ocean warming and increased nutrient input, which suggests an effect on the recruitment of Red Sea benthic communities as a result of climate change and anthropogenic influence. In conclusion, our study provides insight into coral reef functioning in the Red Sea and a comparative baseline to support coral reef studies in the region.	[Roik, Anna; Rothig, Till; Roder, Cornelia; Ziegler, Maren; Kremb, Stephan G.; Voolstra, Christian R.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Red Sea Res Ctr, Thuwal 239556900, Saudi Arabia	King Abdullah University of Science & Technology	Voolstra, CR (corresponding author), King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Red Sea Res Ctr, Thuwal 239556900, Saudi Arabia.	christian.voolstra@kaust.edu.sa	Voolstra, Christian R/H-7158-2014	Voolstra, Christian R/0000-0003-4555-3795; Roik, Anna/0000-0002-8293-8339; Ziegler, Maren/0000-0003-2237-9261; Roder, Cornelia/0000-0003-1074-2473	King Abdullah University of Science and Technology (KAUST)	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	The research reported in this publication was supported by funding from King Abdullah University of Science and Technology (KAUST).; We thank the team from the Coastal and Marine Resources Lab (CMOR) at King Abdullah University of Science and Technology (KAUST) for logistics and operations at sea (E. Al-Jahdali, A. Al-Jandali, G. Al-Jandali, R. Al-Jandali, H. Al-Jandali, F. Mallon, P. Muller, and D. Pallett), as well as for the assistance with the deployment of oceanographic instruments (CTDs, ADCPs) (L. Smith, M.D. Pantalita, and S. Mahmoud). We would like to acknowledge additional field assistance by C. Walcher. Research reported in this publication was supported by funding to CRV from King Abdullah University of Science and Technology (KAUST).	Acker J, 2008, J MARINE SYST, V69, P191, DOI 10.1016/j.jmarsys.2005.12.006; Afeworki Y, 2013, CORAL REEFS, V32, P475, DOI 10.1007/s00338-012-1000-2; Ainsworth TD, 2010, TRENDS ECOL EVOL, V25, P233, DOI 10.1016/j.tree.2009.11.001; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Ansari MI, 2015, SCI REP-UK, V5, DOI 10.1038/srep09001; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; Ateweberhan M, 2006, CORAL REEFS, V25, P391, DOI 10.1007/s00338-006-0109-6; Badran M. I., 2001, AQU ECOSYSTEM HLTH M, V4, P139, DOI [10.1080/14634980127711., DOI 10.1080/14634980127711]; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; Bauman AG, 2013, MAR POLLUT BULL, V72, P302, DOI 10.1016/j.marpolbul.2012.10.013; Bayer T, 2013, APPL ENVIRON MICROB, V79, P4759, DOI 10.1128/AEM.00695-13; Bengtsson MM, 2010, AQUAT MICROB ECOL, V60, P71, DOI 10.3354/ame01409; Bonaldo RM, 2011, CORAL REEFS, V30, P381, DOI 10.1007/s00338-010-0704-4; Bourne D.G., 2013, PROKARYOTES PROKARYO, P163, DOI [10.1007/978-3-642-30123-0_48, DOI 10.1007/978-3-642-30123-0_48]; Bouvier TC, 2002, LIMNOL OCEANOGR, V47, P453, DOI 10.4319/lo.2002.47.2.0453; Bouwmeester J, 2015, CORAL REEFS, V34, P65, DOI 10.1007/s00338-014-1214-6; Bower AS, 2015, SPRING EARTH SYST SC, P329, DOI 10.1007/978-3-662-45201-1_19; Boyd PW, 2012, MAR ECOL PROG SER, V470, P125, DOI 10.3354/meps10121; Brodie J, 2007, MAR FRESHWATER RES, V58, P342, DOI 10.1071/MF06236; Browne NK, 2015, J EXP MAR BIOL ECOL, V466, P98, DOI 10.1016/j.jembe.2015.02.010; Campbell AM, 2015, MICROBIOLOGYOPEN, V4, P390, DOI 10.1002/mbo3.245; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; CHAO A, 1984, SCAND J STAT, V11, P265; Clarke K.R., 2006, PRIMER V6 USER MANUA; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; Davis KA, 2011, CORAL REEFS, V30, P25, DOI 10.1007/s00338-011-0740-8; Dean AJ, 2015, CORAL REEFS, V34, P581, DOI 10.1007/s00338-015-1263-5; Diaz-Pulido G, 2005, J EXP MAR BIOL ECOL, V317, P13, DOI 10.1016/j.jembe.2004.11.013; Diaz-Pulido G, 2007, VULNERABILITY OF MAC; Diez I, 1999, MAR POLLUT BULL, V38, P463, DOI 10.1016/S0025-326X(98)90161-8; Dinsdale EA, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P231, DOI 10.1007/978-94-007-0114-4_16; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edinger EN, 2000, MAR POLLUT BULL, V40, P404, DOI 10.1016/S0025-326X(99)00237-4; Eidens C, 2014, PEERJ, V2, DOI 10.7717/peerj.554; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Falter JL, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007268; Ferrari R, 2012, CORAL REEFS, V31, P683, DOI 10.1007/s00338-012-0889-9; Fong P, 1996, J EXP MAR BIOL ECOL, V206, P203, DOI 10.1016/S0022-0981(96)02630-5; Furby KA, 2013, CORAL REEFS, V32, P505, DOI 10.1007/s00338-012-0998-5; Gattuso JP, 2006, BIOGEOSCIENCES, V3, P489, DOI 10.5194/bg-3-489-2006; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Guadayol O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085213; Guan Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128831; Haas AF, 2013, PEERJ, V1, DOI 10.7717/peerj.108; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; HATCHER BG, 1983, J EXP MAR BIOL ECOL, V69, P61, DOI 10.1016/0022-0981(83)90172-7; HEALEY FP, 1979, J FISH RES BOARD CAN, V36, P1364, DOI 10.1139/f79-195; Helmuth B, 2014, CLIMATE CHANGE RESPO, V1, P6, DOI [10.1186/s40665-014-0006-0, DOI 10.1186/S40665-014-0006-0]; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hoegh-Guldberg O, 2015, REVIVING OCEAN EC CA, P60; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hume B, 2013, MAR POLLUT BULL, V72, P313, DOI 10.1016/j.marpolbul.2012.11.032; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jessen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066992; Jessen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062091; Jouffray JB, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0268; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kelly LW, 2014, P NATL ACAD SCI USA, V111, P10227, DOI 10.1073/pnas.1403319111; Khalil MT, 2013, ENVIRON BIOL FISH, V96, P1065, DOI 10.1007/s10641-012-0103-5; Klaus R, 2015, SPRING EARTH SYST SC, P409, DOI 10.1007/978-3-662-45201-1_25; Kleypas JA, 1999, AM ZOOL, V39, P146; Klindworth Anna, 2013, Nucleic Acids Res, V41, pe1, DOI 10.1093/nar/gks808; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kuerten B, 2014, J SEA RES, V85, P379, DOI 10.1016/j.seares.2013.07.008; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Lefevre CD, 2010, MAR BIOL, V157, P955, DOI 10.1007/s00227-009-1376-x; Lowe RJ, 2015, ANNU REV MAR SCI, V7, P43, DOI 10.1146/annurev-marine-010814-015834; Magalhaes CM, 2005, WATER RES, V39, P1783, DOI 10.1016/j.watres.2005.03.008; Mallela J, 2007, CORAL REEFS, V26, P775, DOI 10.1007/s00338-007-0260-8; Manaspah R, 2006, OCEANOLOGIA, V48, P237; Martins I, 1999, ACTA OECOL, V20, P259, DOI 10.1016/S1146-609X(99)00140-X; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; MCLACHLAN J, 1961, CAN J MICROBIOL, V7, P399, DOI 10.1139/m61-048; Miranda LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058269; Monismith SG, 2007, ANNU REV FLUID MECH, V39, P37, DOI 10.1146/annurev.fluid.38.050304.092125; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Moss JA, 2006, APPL ENVIRON MICROB, V72, P5679, DOI 10.1128/AEM.02773-05; MUTHIGA NA, 1987, BIOL BULL-US, V173, P539, DOI 10.2307/1541699; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; Ngugi DK, 2012, MOL ECOL, V21, P388, DOI 10.1111/j.1365-294X.2011.05378.x; Nocker A, 2007, MICROB ECOL, V54, P532, DOI 10.1007/s00248-007-9236-z; Ohde S, 1999, B MAR SCI, V65, P559; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Pineda J, 2013, LIMNOL OCEANOGR, V58, P1531, DOI 10.4319/lo.2013.58.5.1531; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raitsos DE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047984; Raitsos DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064909; Rasul NMA, 2015, SPRING EARTH SYST SC, P1, DOI 10.1007/978-3-662-45201-1_1; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Riegl B, 2013, ECOL EVOL, V3, P1050, DOI 10.1002/ece3.519; Roder C, 2015, MOL ECOL, V24, P3501, DOI 10.1111/mec.13251; Roder C, 2014, MOL ECOL, V23, P965, DOI 10.1111/mec.12638; Roder C, 2014, ISME J, V8, P31, DOI 10.1038/ismej.2013.127; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Roik A, 2015, MIDEAST CORAL REEF S, P3; Roik A, 2016, CORAL REEFS, V35, P681, DOI 10.1007/s00338-015-1383-y; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rothig T, MOL ECOLOGY; Rouze H, 2015, MAR POLLUT BULL, V92, P212, DOI 10.1016/j.marpolbul.2014.12.016; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sawall Y, 2014, J ECOSYST ECOGR S, VS4, DOI [10.4172/2157-7625.1000s4-003, DOI 10.4172/2157-7625.1000S4-003]; Sawall Y, 2015, SPRING EARTH SYST SC, P487, DOI 10.1007/978-3-662-45201-1_28; Sawall Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039951; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharp KH, 2015, BIOL BULL-US, V228, P98, DOI 10.1086/BBLv228n2p98; Shibl AA, 2014, FEMS MICROBIOL LETT, V356, P118, DOI 10.1111/1574-6968.12490; Silbiger NJ, 2014, MAR ECOL PROG SER, V515, P33, DOI 10.3354/meps10999; Silverman J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003770; Sneed JM, 2015, ISME J, V9, P2527, DOI 10.1038/ismej.2015.67; Sofianos SS, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001185; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; SPENCER CP, 1985, NETH J SEA RES, V19, P269, DOI 10.1016/0077-7579(85)90033-X; Stratil SB, 2013, MICROBIOLOGYOPEN, V2, P338, DOI 10.1002/mbo3.79; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Szmant AM, 2002, ESTUARIES, V25, P743, DOI 10.1007/BF02804903; Uthicke S, 2007, ESTUAR COAST SHELF S, V72, P188, DOI 10.1016/j.ecss.2006.10.017; van Woesik R, 1999, MAR FRESHWATER RES, V50, P427, DOI 10.1071/MF97046; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Wall M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.0650; Webster FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124162; Webster NS, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00444; Webster NS, 2006, ENVIRON MICROBIOL, V8, P1177, DOI 10.1111/j.1462-2920.2006.01007.x; Webster NS, 2011, ISME J, V5, P759, DOI 10.1038/ismej.2010.152; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Wickham H, 2015, GGPLOT2 AN IMPLEMENT; WILLIAMS PJL, 1995, MAR CHEM, V51, P17, DOI 10.1016/0304-4203(95)00046-T; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279; Witt V, 2012, APPL ENVIRON MICROB, V78, P7786, DOI 10.1128/AEM.01623-12; Witt V, 2012, AQUAT MICROB ECOL, V66, P117, DOI 10.3354/ame01562; Witt V, 2011, ENVIRON MICROBIOL, V13, P2976, DOI 10.1111/j.1462-2920.2011.02571.x; Witt V, 2011, FEMS MICROBIOL LETT, V323, P188, DOI 10.1111/j.1574-6968.2011.02374.x; Ziegler M, MAR POLLUT BULL IN R; Ziegler M, 2015, MAR ECOL PROG SER, V533, P149, DOI 10.3354/meps11365	149	46	46	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0163939	10.1371/journal.pone.0163939	http://dx.doi.org/10.1371/journal.pone.0163939			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828965	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000387724300011
J	Ward, CS; Huang, TW; Herrera, JA; Samaco, RC; Pitcher, MR; Herron, A; Skinner, SA; Kaufmann, WE; Glaze, DG; Percy, AK; Neul, JL				Ward, Christopher S.; Huang, Teng-Wei; Herrera, Jose A.; Samaco, Rodney C.; Pitcher, Meagan R.; Herron, Alan; Skinner, Steven A.; Kaufmann, Walter E.; Glaze, Daniel G.; Percy, Alan K.; Neul, Jeffrey L.			Loss of MeCP2 Causes Urological Dysfunction and Contributes to Death by Kidney Failure in Mouse Models of Rett Syndrome	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; URINARY-TRACT SYMPTOMS; RESPIRATORY PHENOTYPES; OBSTRUCTIVE UROPATHY; GENETIC BACKGROUNDS; BLADDER DYSFUNCTION; CEREBRAL-PALSY; MICE; RETENTION; MUTATIONS	Rett Syndrome (RTT) is a neurodevelopmental disorder characterized by loss of acquired skills during development, autonomic dysfunction, and an increased risk for premature lethality. Clinical experience identified a subset of individuals with RTT that present with urological dysfunction including individuals with frequent urinary tract infections, kidney stones, and urine retention requiring frequent catheterization for bladder voiding. To determine if urologic dysfunction is a feature of RTT, we queried the Rett Syndrome Natural History Study, a repository of clinical data from over 1000 individuals with RTT and found multiple instances of urological dysfunction. We then evaluated urological function in a mouse model of RTT and found an abnormal pattern of micturition. Both male and female mice possessing Mecp2 mutations show a decrease in urine output per micturition event. Furthermore, we identified signs of kidney failure secondary to urethral obstruction. Although genetic strain background significantly affects both survival and penetrance of the urethral obstruction phenotype, survival and penetrance of urethral obstruction do not directly correlate. We have identified an additional phenotype caused by loss of MeCP2, urological dysfunction. Furthermore, we urge caution in the interpretation of survival data as an endpoint in preclinical studies, especially where causes of mortality are poorly characterized.	[Ward, Christopher S.; Glaze, Daniel G.; Neul, Jeffrey L.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Ward, Christopher S.; Samaco, Rodney C.; Neul, Jeffrey L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Huang, Teng-Wei; Neul, Jeffrey L.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Huang, Teng-Wei; Neul, Jeffrey L.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Herrera, Jose A.; Samaco, Rodney C.; Pitcher, Meagan R.; Neul, Jeffrey L.] Baylor Coll Med, Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Herron, Alan] Baylor Coll Med, Ctr Comparat Med, Houston, TX 77030 USA; [Skinner, Steven A.; Kaufmann, Walter E.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Kaufmann, Walter E.] Boston Childrens Hosp, Boston, MA 02115 USA; [Percy, Alan K.] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Neul, Jeffrey L.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Neul, Jeffrey L.] Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr,M-C 0626, La Jolla, CA 92093 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Greenwood Genetic Center; Harvard University; Boston Children's Hospital; University of Alabama System; University of Alabama Birmingham; Baylor College of Medicine; University of California System; University of California San Diego	Neul, JL (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.; Neul, JL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Neul, JL (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.; Neul, JL (corresponding author), Baylor Coll Med, Program Translat Biol & Mol Med, Houston, TX 77030 USA.; Neul, JL (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.; Neul, JL (corresponding author), Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr,M-C 0626, La Jolla, CA 92093 USA.	jneul@ucsd.edu	Neul, Jeffrey/AAF-5324-2020	Samaco, Rodney/0000-0001-5636-5314; Huang, Teng-Wei/0000-0002-8604-1262; Neul, Jeffrey/0000-0002-5628-5872; Ward, Christopher/0000-0002-3445-6327	International Rett Syndrome Foundation; NIH [HD062553, DP50D009134, HD024064, HD061222, NS066601]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, R01HD062553, U54HD061222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS066601, T32NS043124] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009134] Funding Source: NIH RePORTER	International Rett Syndrome Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	International Rett Syndrome Foundation (JLN) and NIH grants HD062553 (JLN), DP50D009134 (RCS), HD024064 (BCM IDDRC), HD061222 (AKP), NS066601 (CSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the generous contributions of Yaling Sun, Diana Parra and E. Melissa Arvide for technical help and assistance in generating the animals used for this study. This work was supported by funding from the International Rett Syndrome Foundation (JLN), NIH grants HD062553 (JLN), DP50D009134 (RCS), HD024064 (BCM IDDRC), HD061222 (AKP), NS066601 (CSW). The Rett Syndrome Natural History Study (U54 HD061222) is a part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS). The Rett Syndrome Natural History Study is funded through collaboration between NCATS, and the Eunice Kennedy Shriver Child Health and Human Development Institute (NICHD). The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Development of the National Institutes of Health.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anigilaje EA, 2013, INT J NEPHROL, V2013, DOI 10.1155/2013/937268; BENDELE AM, 1986, LAB ANIM SCI, V36, P282; Bilbault Heloise, 2016, World J Nephrol, V5, P189, DOI 10.5527/wjn.v5.i2.189; Bissonnete JM, 2006, PEDIATR RES, V59, P513, DOI 10.1203/01.pdr.0000203157.31924.4a; Bissonnette JM, 2014, NEUROSCIENCE, V267, P166, DOI 10.1016/j.neuroscience.2014.02.043; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chicoine B, 2015, J AM BOARD FAM MED, V28, P115, DOI 10.3122/jabfm.2015.01.140065; Clayton-Smith J, 2009, EUR J HUM GENET, V17, P434, DOI 10.1038/ejhg.2008.192; Conway PH, 2007, JAMA-J AM MED ASSOC, V298, P179, DOI 10.1001/jama.298.2.179; Curhan GC, 1997, ANN INTERN MED, V126, P497, DOI 10.7326/0003-4819-126-7-199704010-00001; Silva JAF, 2014, J PEDIATR UROL, V10, P413, DOI 10.1016/j.jpurol.2013.07.004; FISCHER CP, 1978, J UROLOGY, V120, P328, DOI 10.1016/S0022-5347(17)57158-X; FITZGERALD PM, 1990, MOVEMENT DISORD, V5, P195, DOI 10.1002/mds.870050303; Geerdink N, 2002, NEUROPEDIATRICS, V33, P33, DOI 10.1055/s-2002-23598; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HAGBERG B, 1985, BRAIN DEV-JPN, V7, P277, DOI 10.1016/S0387-7604(85)80028-0; Hong CC, 1978, LAB ANIMALS, V12; JOTKOWITZ S, 1976, JAMA-J AM MED ASSOC, V235, P2586, DOI 10.1001/jama.1976.03260500014014; Kerr AM, 1997, EUR CHILD ADOLES PSY, V6, P71; KLARSKOV P, 1987, SCAND J UROL NEPHROL, V21, P29, DOI 10.3109/00365598709180286; KUNSTYR I, 1982, LAB ANIM, V16, P151, DOI 10.1258/002367782781110205; Leary S., 2013, AVMA GUIDELINES FOR; Lieske JC, 2006, KIDNEY INT, V69, P760, DOI 10.1038/sj.ki.5000150; Marild S, 1998, ACTA PAEDIATR, V87, P549, DOI 10.1080/08035259850158272; McCauley MD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002982; Neul JL, 2008, NEUROLOGY, V70, P1313, DOI 10.1212/01.wnl.0000291011.54508.aa; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Ninomiya H, 1999, J VET MED SCI, V61, P53, DOI 10.1292/jvms.61.53; Ogier M, 2007, J NEUROSCI, V27, P10912, DOI 10.1523/JNEUROSCI.1869-07.2007; Percy AK, 2010, ANN NEUROL, V68, P951, DOI 10.1002/ana.22154; Ransmayr GN, 2008, NEUROLOGY, V70, P299, DOI 10.1212/01.wnl.0000296826.61499.26; Rao C N, 1987, Lab Anim Sci, V37, P8; REID CJD, 1993, ARCH DIS CHILD, V68, P739, DOI 10.1136/adc.68.6.739; Roux JC, 2007, EUR J NEUROSCI, V25, P1915, DOI 10.1111/j.1460-9568.2007.05466.x; Samaco RC, 2013, HUM MOL GENET, V22, P96, DOI 10.1093/hmg/dds406; Samijn B, 2017, NEUROUROL URODYNAM, V36, P541, DOI 10.1002/nau.22982; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SOKOLOFF L, 1962, AM J PATHOL, V41, P233; Sugino Y, 2008, NEUROUROL URODYNAM, V27, P548, DOI 10.1002/nau.20552; Todorova MT, 2003, EPILEPSIA, V44, P25, DOI 10.1046/j.1528-1157.2003.11402.x; Viemari JC, 2005, J NEUROSCI, V25, P11521, DOI 10.1523/JNEUROSCI.4373-05.2005; Ward CS, 2011, J NEUROSCI, V31, P10359, DOI 10.1523/JNEUROSCI.0057-11.2011; Weese-Mayer DE, 2006, PEDIATR RES, V60, P443, DOI 10.1203/01.pdr.0000238302.84552.d0; Wells S, 2009, J AM ASSOC LAB ANIM, V48, P296; WHEELER JS, 1985, BRIT J UROL, V57, P63, DOI 10.1111/j.1464-410X.1985.tb08987.x; Yu WQ, 2014, AM J PHYSIOL-RENAL, V306, pF1296, DOI 10.1152/ajprenal.00074.2014	49	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165550	10.1371/journal.pone.0165550	http://dx.doi.org/10.1371/journal.pone.0165550			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828991	Green Published, gold			2022-12-27	WOS:000387724300050
J	Biesbroek, JM; Weaver, NA; Hilal, S; Kuijf, HJ; Ikram, MK; Xu, X; Tan, BY; Venketasubramanian, N; Postman, A; Biessels, GJ; Chen, CPLH				Biesbroek, J. Matthijs; Weaver, Nick A.; Hilal, Saima; Kuijf, Hugo J.; Ikram, Mohammad Kamran; Xu, Xin; Tan, Boon Yeow; Venketasubramanian, Narayanaswamy; Postman, Albert; Biessels, Geert Jan; Chen, Christopher P. L. H.			Impact of Strategically Located White Matter Hyperintensities on Cognition in Memory Clinic Patients with Small Vessel Disease	PLOS ONE			English	Article							PROCESSING SPEED DEFICITS; ALZHEIMERS-DISEASE; CEREBRAL MICROBLEEDS; SUNNYBROOK DEMENTIA; EXECUTIVE FUNCTION; VASCULAR DEMENTIA; LESION LOCATION; ROTTERDAM SCAN; RISK-FACTORS; IMPAIRMENT	Background and Purpose Studies on the impact of small vessel disease (SVD) on cognition generally focus on white matter hyperintensity (WMH) volume. The extent to which WMH location relates to cognitive performance has received less attention, but is likely to be functionally important. We examined the relation between WMH location and cognition in a memory clinic cohort of patients with sporadic SVD. Methods A total of 167 patients with SVD were recruited from memory clinics. Assumption-free region of interest-based analyses based on major white matter tracts and voxel-wise analyses were used to determine the association between WMH location and executive functioning, visuomotor speed and memory. Results Region of interest-based analyses showed that WMHs located particularly within the anterior thalamic radiation and forceps minor were inversely associated with both executive functioning and visuomotor speed, independent of total WMH volume. Memory was significantly associated with WMH volume in the forceps minor, independent of total WMH volume. An independent assumption-free voxel-wise analysis identified strategic voxels in these same tracts. Region of interest-based analyses showed that WMH volume within the anterior thalamic radiation explained 6.8% of variance in executive functioning, compared to 3.9% for total WMH volume; WMH volume within the forceps minor explained 4.6% of variance in visuomotor speed and 4.2% of variance in memory, compared to 1.8% and 1.3% respectively for total WMH volume. Conclusions Our findings identify the anterior thalamic radiation and forceps minor as strategic white matter tracts in which WMHs are most strongly associated with cognitive impairment in memory clinic patients with SVD. WMH volumes in individual tracts explained more variance in cognition than total WMH burden, emphasizing the importance of lesion location when addressing the functional consequences of WMHs.	[Biesbroek, J. Matthijs; Weaver, Nick A.; Ikram, Mohammad Kamran; Biessels, Geert Jan] Univ Med Ctr Utrecht, Dept Neurol, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Hilal, Saima; Ikram, Mohammad Kamran; Xu, Xin; Chen, Christopher P. L. H.] Natl Univ Hlth Syst, Memory Aging & Cognit Ctr, Singapore, Singapore; [Hilal, Saima; Xu, Xin; Chen, Christopher P. L. H.] Natl Univ Singapore, Dept Pharmacol, Singapore, Singapore; [Kuijf, Hugo J.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Ikram, Mohammad Kamran] Natl Univ Singapore, Acad Med Res Inst, Duke NUS Grad Med Sch, Singapore, Singapore; [Tan, Boon Yeow] St Lukes Hosp, Singapore, Singapore; [Venketasubramanian, Narayanaswamy] Raffles Hosp, Raffles Neurosci Ctr, Singapore, Singapore; [Postman, Albert] Univ Utrecht, Helmholtz Inst, Expt Psychol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; National University of Singapore; National University of Singapore; Utrecht University; Utrecht University Medical Center; National University of Singapore; Raffles Hospital; Utrecht University	Biessels, GJ (corresponding author), Univ Med Ctr Utrecht, Dept Neurol, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	g.j.biessels@umcutrecht.nl	Venketasubramanian, Narayanaswamy/GPP-5948-2022; Xu, Xin/S-6074-2016; Kuijf, Hugo J/G-2711-2013; Weaver, Nick A./AAA-8756-2019; Hilal, Saima/D-6028-2016; Chen, Christopher/E-7023-2013	Xu, Xin/0000-0002-4639-6480; Kuijf, Hugo J/0000-0001-6997-9059; Hilal, Saima/0000-0001-5434-5635; Chen, Christopher/0000-0002-1047-9225; Biesbroek, Matthijs/0000-0001-7017-2148; Weaver, Nick/0000-0001-8425-8436; Ikram, Mohammad Kamran/0000-0003-0173-9571	National Medical Council of Singapore Centre Grant [NMRC/CG/013/2013]; project Brainbox (Quantitative analysis of MR brain images for cerebrovascular disease management); Netherlands Organisation for Health Research and Development (ZonMw) [104002002]	National Medical Council of Singapore Centre Grant; project Brainbox (Quantitative analysis of MR brain images for cerebrovascular disease management); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	The Memory Aging and Cognition Centre is funded by a National Medical Council of Singapore Centre Grant (NMRC/CG/013/2013). Hugo J. Kuijf was financially supported by the project Brainbox (Quantitative analysis of MR brain images for cerebrovascular disease management), funded by the Netherlands Organisation for Health Research and Development (ZonMw) in the framework of the research programme IMDI (Innovative Medical Devices Initiative); project 104002002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Biesbroek JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060541; Biffi A, 2011, J CLIN NEUROL, V7, P1, DOI 10.3988/jcn.2011.7.1.1; Bolandzadeh N, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-126; Burton EJ, 2004, STROKE, V35, P1270, DOI 10.1161/01.STR.0000126041.99024.86; Carew TG, 1997, NEUROPSYCHOLOGY, V11, P400, DOI 10.1037/0894-4105.11.3.400; Chabriat H, 2016, STROKE, V47, P4, DOI 10.1161/STROKEAHA.115.010696; Charlton RA, 2006, NEUROLOGY, V66, P1523, DOI 10.1212/01.wnl.0000216270.02610.7e; Cordonnier C, 2009, STROKE, V40, P94, DOI 10.1161/STROKEAHA.108.526996; Diller L., 1974, STUDIES COGNITION RE; Dong YH, 2013, J NEUROL SCI, V333, P5, DOI 10.1016/j.jns.2013.05.011; Duering M, 2015, NEUROLOGY, V84, P1685, DOI 10.1212/WNL.0000000000001502; Duering M, 2014, NEUROLOGY, V82, P1946, DOI 10.1212/WNL.0000000000000475; Duering M, 2013, NEUROIMAGE, V66, P177, DOI 10.1016/j.neuroimage.2012.10.084; Duering M, 2011, BRAIN, V134, P2366, DOI 10.1093/brain/awr169; Elia LF, 1996, COLOR TRAILS TEST PR; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [DOI 10.1016/S1053-8119(09)70884-5, 10.1016/s1053-8119(09)70884-5]; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kloppenborg RP, 2014, NEUROLOGY, V82, P2127, DOI 10.1212/WNL.0000000000000505; Kuijf HJ, 2013, THESIS; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McNeely AA, 2015, J ALZHEIMERS DIS, V43, P785, DOI 10.3233/JAD-140588; Mega MS, 2005, NEUROIMAGE, V26, P1009, DOI 10.1016/j.neuroimage.2005.03.031; O'Brien JT, 2002, ANN NY ACAD SCI, V977, P436, DOI 10.1111/j.1749-6632.2002.tb04849.x; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Porteus SD., 1959, MAZE TEST CLIN PSYCH; Prins ND, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.10; Ramirez J, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt279; Reijmer YD, 2013, NEUROLOGY, V80, P1370, DOI 10.1212/WNL.0b013e31828c2ee5; Ritter F, 2011, IEEE PULSE, V2, P60, DOI 10.1109/MPUL.2011.942929; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Sahadevan S., 1997, Annals Academy of Medicine Singapore, V26, P271; Sepehry AA, 2016, AM J NEURORADIOL, V37, P215, DOI 10.3174/ajnr.A4525; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith EE, 2011, NEUROLOGY, V76, P1492, DOI 10.1212/WNL.0b013e318217e7c8; van Norden AGW, 2012, J ALZHEIMERS DIS, V32, P667, DOI 10.3233/JAD-2012-120784; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wiederkehr S, 2008, J NEUROPSYCH CLIN N, V20, P150, DOI 10.1176/appi.neuropsych.20.2.150	44	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166261	10.1371/journal.pone.0166261	http://dx.doi.org/10.1371/journal.pone.0166261			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824925	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200078
J	Ellmers, TJ; Cocks, AJ; Doumas, M; Williams, AM; Young, WR				Ellmers, Toby J.; Cocks, Adam J.; Doumas, Michail; Williams, A. Mark; Young, William R.			Gazing into Thin Air: The Dual-Task Costs of Movement Planning and Execution during Adaptive Gait	PLOS ONE			English	Article							WORKING-MEMORY RESOURCES; AGE-RELATED DECLINE; VISUAL RISK-FACTORS; OLDER-ADULTS; COGNITIVE PERFORMANCE; GAZE BEHAVIOR; STOPS WALKING; FALL-RISK; REINVESTMENT; ATTENTION	We examined the effect of increased cognitive load on visual search behavior and measures of gait performance during locomotion. Also, we investigated how personality traits, specifically the propensity to consciously control or monitor movements (trait movement 'reinvestment'), impacted the ability to maintain effective gaze under conditions of cognitive load. Healthy young adults traversed a novel adaptive walking path while performing a secondary serial subtraction task. Performance was assessed using correct responses to the cognitive task, gaze behavior, stepping accuracy, and time to complete the walking task. When walking while simultaneously carrying out the secondary serial subtraction task, participants visually fixated on task-irrelevant areas 'outside' the walking path more often and for longer durations of time, and fixated on task-relevant areas 'inside' the walkway for shorter durations. These changes were most pronounced in high-trait-reinvesters. We speculate that reinvestment-related processes placed an additional cognitive demand upon working memory. These increased task-irrelevant 'outside' fixations were accompanied by slower completion rates on the walking task and greater gross stepping errors. Findings suggest that attention is important for the maintenance of effective gaze behaviors, supporting previous claims that the maladaptive changes in visual search observed in high-risk older adults may be a consequence of inefficiencies in attentional processing. Identifying the underlying attentional processes that disrupt effective gaze behaviour during locomotion is an essential step in the development of rehabilitation, with this information allowing for the emergence of interventions that reduce the risk of falling.	[Ellmers, Toby J.; Cocks, Adam J.; Young, William R.] Brunel Univ London, Dept Life Sci, Uxbridge, Middx, England; [Doumas, Michail] Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland; [Williams, A. Mark] Univ Utah, Coll Heath, Salt Lake City, UT USA; [Young, William R.] Brunel Univ London, Coll Hlth & Life Sci, Ctr Cognit Neurosci, Uxbridge, Middx, England; [Young, William R.] Brunel Univ London, Inst Environm Hlth & Soc, Uxbridge, Middx, England	Brunel University; Queens University Belfast; Utah System of Higher Education; University of Utah; Brunel University; Brunel University	Ellmers, TJ (corresponding author), Brunel Univ London, Dept Life Sci, Uxbridge, Middx, England.	toby.ellmers@brunel.ac.uk	Doumas, M/A-4494-2009	Doumas, M/0000-0002-5323-6258; Young, William/0000-0002-5064-8601; Ellmers, Toby/0000-0001-9595-6360; Cocks, Adam/0000-0001-7793-3827	Royal Society [IE131576]; British Academy [SG132820]	Royal Society(Royal Society of London); British Academy	This research was partially supported by grants awarded to author WRY from The Royal Society (grant number:IE131576, URL: www.royalsociety.org) and British Academy (grant number: SG132820, URL: www.brriac.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon M, 2014, CLIN INTERV AGING, V9, P477, DOI 10.2147/CIA.S54978; Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; [Anonymous], 2013, NICE GUIDELINES FALL; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Beauchet O, 2009, EUR J NEUROL, V16, P786, DOI 10.1111/j.1468-1331.2009.02612.x; Beurskens R, 2013, HUM MOVEMENT SCI, V32, P1456, DOI 10.1016/j.humov.2013.07.013; Beurskens R, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/131608; Beurskens R, 2012, EXP BRAIN RES, V217, P117, DOI 10.1007/s00221-011-2978-3; Bialoszewski Dariusz, 2008, Ortop Traumatol Rehabil, V10, P441; Bock O, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-27; Chapman GJ, 2007, GAIT POSTURE, V26, P59, DOI 10.1016/j.gaitpost.2006.07.010; Chapman GJ, 2006, EXP BRAIN RES, V174, P613, DOI 10.1007/s00221-006-0507-6; De Rammelaere S, 1999, PSYCHOL RES-PSYCH FO, V62, P72, DOI 10.1007/s004260050041; De Rammelaere S, 2001, MEM COGNITION, V29, P267, DOI 10.3758/BF03194920; De Rammelaere S., 2001, CURRENT PSYCHOL LETT, V2, P79; Derakshan N, 2009, EUR PSYCHOL, V14, P168, DOI 10.1027/1016-9040.14.2.168; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Henry L., 2011, DEV WORKING MEMORY C; Higuchi T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00277; Hollands MA, 2001, J MOTOR BEHAV, V33, P205, DOI 10.1080/00222890109603151; HOLLANDS MA, 1995, J MOTOR BEHAV, V27, P155, DOI 10.1080/00222895.1995.9941707; Hollands MA, 1996, EXP BRAIN RES, V109, P343; Hyman Ira E Jr, 2014, Front Psychol, V5, P356, DOI 10.3389/fpsyg.2014.00356; Hyman IE, 2010, APPL COGNITIVE PSYCH, V24, P597, DOI 10.1002/acp.1638; Imbo I, 2007, EUR J COGN PSYCHOL, V19, P910, DOI 10.1080/09541440601051571; Jackson RC, 2006, J SPORT EXERCISE PSY, V28, P49, DOI 10.1123/jsep.28.1.49; Lord SR, 2001, J AM GERIATR SOC, V49, P508, DOI 10.1046/j.1532-5415.2001.49107.x; Lord SR, 2006, AGE AGEING, V35, P42, DOI 10.1093/ageing/afl085; LundinOlsson L, 1997, LANCET, V349, P617, DOI 10.1016/S0140-6736(97)24009-2; Masters R., 2008, INT REV SPORT EXER P, V1, P160, DOI [10.1080/17509840802287218, DOI 10.1080/17509840802287218]; Masters R. S. W., 2005, INT SOC SPORT PSYCHO; MCDOWD JM, 1986, J GERONTOL, V41, P764, DOI 10.1093/geronj/41.6.764; Muhaidat J, 2013, PHYSIOTHER THEOR PR, V29, P351, DOI 10.3109/09593985.2012.752056; Muir SW, 2012, AGE AGEING, V41, P299, DOI 10.1093/ageing/afs012; Muir-Hunter SW, 2016, PHYSIOTHERAPY, V102, P29, DOI 10.1016/j.physio.2015.04.011; Nagamatsu LS, 2011, PSYCHOL AGING, V26, P253, DOI 10.1037/a0022929; National Center for Injury Prevention and Control, 2013, WEB BAS INJ STAT QUE; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; Schwebel DC, 2012, ACCIDENT ANAL PREV, V45, P266, DOI 10.1016/j.aap.2011.07.011; Seitz K, 2000, EUR J COGN PSYCHOL, V12, P552, DOI 10.1080/095414400750050231; Stavrinos D, 2011, J SAFETY RES, V42, P101, DOI 10.1016/j.jsr.2011.01.004; Strayer DL, 2003, J EXP PSYCHOL-APPL, V9, P23, DOI 10.1037/1076-898X.9.1.23; Strayer DL, 2004, P HUM FACTORS ERGON, V48, P2213; Terrier P, 2013, J NEUROL SCI, V333, pe570; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Uiga L, 2015, COGN PROCESS, V16, pS421, DOI 10.1007/s10339-015-0685-x; Uiga L, 2015, AGEING RES REV, V20, P24, DOI 10.1016/j.arr.2014.12.005; Veltman JA, 1996, BIOL PSYCHOL, V42, P323, DOI 10.1016/0301-0511(95)05165-1; Wong WL, 2008, NEUROREHAB NEURAL RE, V22, P410, DOI 10.1177/1545968307313510; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Young WR, 2016, EXP BRAIN RES, V234, P161, DOI 10.1007/s00221-015-4445-z; Young WR, 2015, GAIT POSTURE, V41, P7, DOI 10.1016/j.gaitpost.2014.09.006; Young WR, 2012, GAIT POSTURE, V36, P477, DOI 10.1016/j.gaitpost.2012.04.009; Young WR, 2012, J GERONTOL B-PSYCHOL, V67, P43, DOI 10.1093/geronb/gbr074; Young WR, 2010, EXP BRAIN RES, V204, P103, DOI 10.1007/s00221-010-2300-9; Young WR, 2007, PLOS ONE, V7; Zaback M, 2015, HUM MOVEMENT SCI, V40, P393, DOI 10.1016/j.humov.2015.01.015; Zettel JL, 2007, NEUROSCI LETT, V422, P207, DOI 10.1016/j.neulet.2007.06.020; Zijlstra F. R. H., 1993, EFFICIENCY WORK BEHA	60	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166063	10.1371/journal.pone.0166063	http://dx.doi.org/10.1371/journal.pone.0166063			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BE	27824937	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200059
J	Marzi, C; Holdt, LM; Fiorito, G; Tsai, PC; Kretschmer, A; Wahl, S; Guarrera, S; Teupser, D; Spector, TD; Iacoviello, L; Sacerdote, C; Strauch, K; Lee, S; Thasler, WE; Peters, A; Thorand, B; Wolf, P; Prokisch, H; Tumino, R; Gieger, C; Krogh, V; Panico, S; Bell, JT; Matullo, G; Waldenberger, M; Grallert, H; Koenig, W				Marzi, Carola; Holdt, Lesca M.; Fiorito, Giovanni; Tsai, Pei-Chien; Kretschmer, Anja; Wahl, Simone; Guarrera, Simonetta; Teupser, Daniel; Spector, Tim D.; Iacoviello, Licia; Sacerdote, Carlotta; Strauch, Konstantin; Lee, Serene; Thasler, Wolfgang E.; Peters, Annette; Thorand, Barbara; Wolf, Petra; Prokisch, Holger; Tumino, Rosario; Gieger, Christian; Krogh, Vittorio; Panico, Salvatore; Bell, Jordana T.; Matullo, Giuseppe; Waldenberger, Melanie; Grallert, Harald; Koenig, Wolfgang			Epigenetic Signatures at AQP3 and SOCS3 Engage in Low-Grade Inflammation across Different Tissues	PLOS ONE			English	Article							C-REACTIVE PROTEIN; DNA METHYLATION PATTERNS; PROMOTES CELL-GROWTH; CARDIOVASCULAR-DISEASE; CANCER; AQUAPORIN-3; BLOOD; ATHEROSCLEROSIS; MECHANISMS; LEUKOCYTES	Background Elevated levels of C-reactive protein (CRP, determined by a high-sensitivity assay) indicate low-grade inflammation which is implicated in many age-related disorders. Epigenetic studies on CRP might discover molecular mechanisms underlying CRP regulation. We aimed to identify DNA methylation sites related to CRP concentrations in cells and tissues regulating low-grade inflammation. Results Genome-wide DNA methylation was measured in peripheral blood in 1,741 participants of the KORA F4 study using Illumina HumanMethylation450 BeadChip arrays. Four CpG sites (located at BCL3, AQP3, SOCS3, and cg19821297 intergenic at chromosome 19p13.2, P <= 1.01E-07) were significantly hypomethylated at high CRP concentrations independent of various confounders including age, sex, BMI, smoking, and white blood cell composition. Findings were not sex-specific. CRP-related top genes were enriched in JAK/STAT pathways (Benjamini-Hochberg corrected P < 0.05). Results were followed-up in three studies using DNA from peripheral blood (EPICOR, n = 503) and adipose tissue (TwinsUK, n = 368) measured as described above and from liver tissue (LMU liver cohort, n = 286) measured by MALDI-TOF mass spectrometry using EpiTYPER. CpG sites at the AQP3 locus (significant p-values in peripheral blood = 1.72E-03 and liver tissue = 1.51E-03) and the SOCS3 locus (p-values in liver < 2.82E-05) were associated with CRP in the validation panels. Conclusions Epigenetic modifications seem to engage in low-grade inflammation, possibly via JAK/STAT mediated pathways. Results suggest a shared relevance across different tissues at the AQP3 locus and highlight a role of DNA methylation for CRP regulation at the SOCS3 locus.	[Marzi, Carola; Kretschmer, Anja; Wahl, Simone; Gieger, Christian; Waldenberger, Melanie; Grallert, Harald] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Res Unit Mol Epidemiol, Neuherberg, Germany; [Marzi, Carola; Thorand, Barbara; Grallert, Harald] German Ctr Diabet Res DZD eV, Neuherberg, Germany; [Holdt, Lesca M.; Teupser, Daniel] Ludwig Maximilians Univ Munchen, Inst Lab Med, Munich, Germany; [Fiorito, Giovanni; Guarrera, Simonetta] Human Genet Fdn HuGeF Torino, Turin, Italy; [Fiorito, Giovanni; Guarrera, Simonetta] Univ Turin, Dept Med Sci, Turin, Italy; [Tsai, Pei-Chien; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Iacoviello, Licia] IRCCS Ist Neurol Mediterraneo Neuromed, Dept Epidemiol & Prevent, Pozzilli, IS, Italy; [Sacerdote, Carlotta] Univ Turin, Citta Salute Sci Hosp, Canc Epidemiol Unit, Turin, Italy; [Sacerdote, Carlotta] CPO, Turin, Italy; [Strauch, Konstantin] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Strauch, Konstantin] Ludwig Maximilians Univ Munchen, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Lee, Serene; Thasler, Wolfgang E.] Ludwig Maximilians Univ Munchen, Dept Surg, Munich, Germany; [Peters, Annette; Thorand, Barbara] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Wolf, Petra; Prokisch, Holger] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Wolf, Petra; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Tumino, Rosario] Civile MP Arezzo Hosp, ASP 7, Canc Registry, Ragusa, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, ASP 7, Histopathol Unit, Ragusa, Italy; [Krogh, Vittorio] Fdn IRCSS Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy; [Panico, Salvatore] Univ Naples Federico II, Dept Clin & Med & Surg, Naples, Italy; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, Ulm, Germany; [Koenig, Wolfgang] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Koenig, Wolfgang] Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Turin; University of London; King's College London; IRCCS Neuromed; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Civile M.P. Arezzo Hospital; Civile M.P. Arezzo Hospital; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Naples Federico II; Ulm University; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Marzi, C (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Res Unit Mol Epidemiol, Neuherberg, Germany.; Marzi, C (corresponding author), German Ctr Diabet Res DZD eV, Neuherberg, Germany.	carolamarzi@helmholtz-muenchen.de	Thorand, Barbara/B-5349-2014; Iacoviello, Licia/K-4676-2016; Guarrera, Simonetta/AAB-8482-2022; Waldenberger, Melanie/B-5355-2014; Grallert, Harald/B-3424-2013; Krogh, Vittorio/K-2628-2016; Krogh, Vittorio/AAA-9171-2019; Peters, Annette/A-6117-2011; Siani, Alfonso/B-7925-2015; Bell, Jordana/AAH-7312-2019; Iacoviello, Licia/AGX-7071-2022; MATULLO, Giuseppe/K-6383-2016; bisconti, alessandro/I-8016-2018	Thorand, Barbara/0000-0002-8416-6440; Iacoviello, Licia/0000-0003-0514-5885; Waldenberger, Melanie/0000-0003-0583-5093; Krogh, Vittorio/0000-0003-0122-8624; Krogh, Vittorio/0000-0003-0122-8624; Peters, Annette/0000-0001-6645-0985; Iacoviello, Licia/0000-0003-0514-5885; tumino, rosario/0000-0003-2666-414X; Lee, Serene/0000-0001-5231-0607; TSAI, PEI-CHIEN/0000-0003-1575-9020; MATULLO, Giuseppe/0000-0003-0674-7757; Prokisch, Holger/0000-0003-2379-6286; Sacerdote, Carlotta/0000-0002-8008-5096; Fiorito, Giovanni/0000-0002-7651-5452; Koenig, Wolfgang/0000-0002-2064-9603; Bell, Jordana/0000-0002-3858-5986; bisconti, alessandro/0000-0002-8474-5733	Helmholtz Zentrum MuEnchen - German Research Center for Environmental Health; German Federal Ministry of Education and Research (BMBF); State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ; Helmholtz Association (Helmholtz-Russia Joint Research Group 310); European Union's Seventh Framework Programme (FP7) [261433, 603288, HEALTH-F2-2013-602736]; European Union's Seventh Framework Programme [FP7-Health-F5-2012, 305280]; BMBF [01ZX1313A-2014]; German Center for Diabetes Research (DZD) - BMBF; German National Genome Research Network (NGFNplus) [01GS0834]; University of Ulm; Compagnia di San Paolo for the EPIC-Italy; EPICOR; MIUR ex60% grant; Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan) [IG2013 N.14410]; European Research Council [250157]; Economic and Social Research council [ES/N000404/1]; Twins UK; Wellcome Trust; European Community's Seventh Framework Programme (FP7); National Institute for Health Research (NIHR)- BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; ERC Advanced Principal Investigator award [ERC 250157]; Human Genetics Foundation-HuGeF; Economic and Social Research Council [ES/N000404/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10027] Funding Source: researchfish; ESRC [ES/N000404/1] Funding Source: UKRI	Helmholtz Zentrum MuEnchen - German Research Center for Environmental Health; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ; Helmholtz Association (Helmholtz-Russia Joint Research Group 310); European Union's Seventh Framework Programme (FP7); European Union's Seventh Framework Programme(European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); German Center for Diabetes Research (DZD) - BMBF(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network (NGFNplus); University of Ulm; Compagnia di San Paolo for the EPIC-Italy(Compagnia di San Paolo); EPICOR; MIUR ex60% grant(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan)(Fondazione AIRC per la ricerca sul cancro); European Research Council(European Research Council (ERC)European Commission); Economic and Social Research council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Twins UK; Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Seventh Framework Programme (FP7)(European Commission); National Institute for Health Research (NIHR)- BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; ERC Advanced Principal Investigator award(European Research Council (ERC)); Human Genetics Foundation-HuGeF; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The KORA study was initiated and financed by the Helmholtz Zentrum MuEnchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Furthermore, KORA research was supported with in the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LM Uinnovativ. The research leading to these results has received funding from the Helmholtz Association (Helmholtz-Russia Joint Research Group 310), the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreements number 261433 (BioSHaRE-EU), number 603288 (SysVasc) and HEALTH-F2-2013-602736 (PAIN-OMICS), as well as the European Union's Seventh Framework Programme (FP7-Health-F5-2012) under grant agreement number305280 (MIMOmics) and BMBF e:Med project: e:AtheroSysMedD-Systems medicine of myocardial infarction and stroke, grant number 01ZX1313A-2014. In addition, part of this work was financed by the German Center for Diabetes Research (DZD) funded by the BMBF, by the German National Genome Research Network (NGFNplus, project number 01GS0834), and through additional funds from the University of Ulm. EPICOR: This work was supported by the Compagnia di San Paolo for the EPIC-Italy and EPICOR projects (to SP, VK, RT, LI, CS, GM), the Human Genetics Foundation-HuGeF (to GM), and the MIUR ex60% grant (to GM). EPIC-Italy is further supported by grant number IG2013 N.14410 from the Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan) (to SP, CS). Twins UK: Funding support for this project was obtained from the European Research Council (project number 250157), the Economic and Social Research council (grant number ES/N000404/1), and in part by Twins UK, which is funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. Laboratory work was performed by The Wellcome Trust Sanger Institute and National Eye Institute via NIH/CIDR. TDS is the holder of an ERC Advanced Principal Investigator award (ERC 250157). LMU liver cohort: We acknowledge the support of the non-profit foundation HTCR, which holds human tissue on trust, making it broadly available for research on an ethical and legal basis.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Arnaud C, 2005, ARTERIOSCL THROM VAS, V25, P1231, DOI 10.1161/01.ATV.0000163840.63685.0c; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Burrell AM, 2011, DISCOV MED, V11, P187; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Durham A, 2010, EPIGENOMICS-UK, V2, P523, DOI 10.2217/EPI.10.27; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Gentilini D, 2013, AGE, V35, P1961, DOI 10.1007/s11357-012-9463-1; Grimaldi V, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-014-0476-3; Hara-Chikuma M, 2008, J MOL MED-JMM, V86, P221, DOI 10.1007/s00109-007-0272-4; Ho SM, 2010, J ALLERGY CLIN IMMUN, V126, P453, DOI 10.1016/j.jaci.2010.07.030; Holdt LM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003588; Horie I, 2009, BIOCHEM BIOPH RES CO, V387, P564, DOI 10.1016/j.bbrc.2009.07.077; Houseman EA, 2014, BIOINFORMATICS, V30, P1431, DOI 10.1093/bioinformatics/btu029; Isomoto H, 2007, GASTROENTEROLOGY, V132, P384, DOI 10.1053/j.gastro.2006.10.037; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Karsli-Ceppioglu S, 2014, EPIGENOMICS-UK, V6, P651, DOI [10.2217/EPI.14.59, 10.2217/epi.14.59]; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kiu H, 2012, GROWTH FACTORS, V30, P88, DOI 10.3109/08977194.2012.660936; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kucukali CI, 2014, NEUROMOLECULAR MED; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; MacGregor AJ, 2004, CLIN CHEM, V50, P130, DOI 10.1373/clinchem.2003.028258; Marchini G, 2003, PEDIATR DERMATOL, V20, P377, DOI 10.1046/j.1525-1470.2003.20501.x; Mei W. X., 2010, J CHIN INTEGR MED, V8, P111, DOI [10.3736/jcim20100203, DOI 10.3736/JCIM20100203]; Molavi O, 2013, BRIT J HAEMATOL, V161, P348, DOI 10.1111/bjh.12262; Nakahigashi K, 2011, J INVEST DERMATOL, V131, P865, DOI 10.1038/jid.2010.395; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; Pfeiffer L, 2015, CIRC-CARDIOVASC GENE, V8, P334, DOI 10.1161/CIRCGENETICS.114.000804; Pierconti F, 2011, PROSTATE, V71, P318, DOI 10.1002/pros.21245; Sarter B, 2005, HUM GENET, V117, P402, DOI 10.1007/s00439-005-1317-9; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Sun YV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073480; Tancharoen S, 2008, J CELL PHYSIOL, V217, P338, DOI 10.1002/jcp.21506; Tischoff I, 2007, GUT, V56, P1047, DOI 10.1136/gut.2006.111633; Wang J, 2014, J MOL MED, V92, P1257, DOI 10.1007/s00109-014-1184-8; Wang XL, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-87; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812	49	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166015	10.1371/journal.pone.0166015	http://dx.doi.org/10.1371/journal.pone.0166015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824951	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200053
J	Fan, X; Xiao, M; Liu, P; Chen, SR; Kong, FR; Wang, H; Zhang, L; Hou, X; Xu, YC				Fan, Xin; Xiao, Meng; Liu, Ping; Chen, Sharon; Kong, Fanrong; Wang, He; Zhang, Li; Hou, Xin; Xu, Ying-Chun			Novel Polymorphic Multilocus Microsatellite Markers to Distinguish Candida tropicalis Isolates	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; HOSPITAL STAY; FLUCONAZOLE; SURVEILLANCE; POPULATION; INFECTIONS; RESISTANCE; MORTALITY; OUTBREAK; CHINA	Candida tropicalis is an important pathogen. Here we developed and evaluated a polymorphic multilocus microsatellite scheme employing novel genetic markers for genotyping of C. tropicalis. Using 10 isolates from 10 unique (separate) patients to screen over 4000 tandem repeats from the C. tropicalis genome (strain MYA-3404), six new candidate microsatellite loci (ctm1, ctm3, ctm8, ctm18, ctm24 and ctm26) were selected according to amplification success, observed polymorphisms and stability of flanking regions by preliminary testing. Two known microsatellite loci CT14 and URA3 were also studied. The 6-locus scheme was then tested against a set of 82 different isolates from 32 patients. Microsatellite genotypes of isolates from the same patient (two to five isolates per patient) were identical. The six loci produced eight to 17 allele types and identified 11 to 24 genotypes amongst 32 patients' isolates, achieving a discriminatory power (DP) of 0.76 to 0.97 (versus 0.78 for both CT14 and URA3 loci, respectively). Testing of a combination of only three loci, ctm1, ctm3 and ctm24, also achieved maximum typing efficiency (DP = 0.99, 29 genotypes). The microsatellite typing scheme had good correlation compared with pulsed-field gel electrophoresis, although was slightly less discriminatory. The new sixlocus microsatellite typing scheme is a potentially valuable tool for genotyping and investigating microevolution of C. tropicalis.	[Fan, Xin; Xiao, Meng; Wang, He; Zhang, Li; Hou, Xin; Xu, Ying-Chun] Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Fan, Xin; Hou, Xin] Chinese Acad Med Sci, Grad Sch, Peking Union Med Coll, Beijing, Peoples R China; [Liu, Ping] Tianjin First Ctr Hosp, Dept Clin Lab, Tianjin, Peoples R China; [Chen, Sharon; Kong, Fanrong] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Darcy Rd, Westmead, NSW, Australia	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Sydney	Xu, YC (corresponding author), Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing, Peoples R China.	xycpumch@139.com	Xiao, Meng/J-6518-2017	Xiao, Meng/0000-0003-2103-7008	Research Special Fund for Public Welfare Industry of Health [201402001]	Research Special Fund for Public Welfare Industry of Health	YCX received funding from The Research Special Fund for Public Welfare Industry of Health, Grant Number 201402001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005; Amouri I, 2012, J MED MICROBIOL, V61, P1091, DOI 10.1099/jmm.0.043992-0; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Chakrabarti A, 2015, INTENS CARE MED, V41, P285, DOI 10.1007/s00134-014-3603-2; Magri MMC, 2013, J CLIN MICROBIOL, V51, P268, DOI 10.1128/JCM.02366-12; Chen KW, 2009, INFECT GENET EVOL, V9, P912, DOI 10.1016/j.meegid.2009.06.011; Chou HH, 2007, DIAGN MICR INFEC DIS, V58, P427, DOI 10.1016/j.diagmicrobio.2007.03.014; Chou HH, 2007, DIAGN MICR INFEC DIS, V57, P451, DOI 10.1016/j.diagmicrobio.2006.09.009; Chowdhary A, 2003, MYCOSES, V46, P287, DOI 10.1046/j.1439-0507.2003.00883.x; Desnos-Ollivier M, 2008, EMERG INFECT DIS, V14, P557, DOI 10.3201/eid1404.071083; DOEBBELING BN, 1991, J CLIN MICROBIOL, V29, P1268, DOI 10.1128/JCM.29.6.1268-1270.1991; Fan X, 2014, CHINESE MED J-PEKING, V127, P4226, DOI 10.3760/cma.j.issn.0366-6999.20142048; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jang SJ, 2005, JPN J INFECT DIS, V58, P263; Kothavade RJ, 2010, J MED MICROBIOL, V59, P873, DOI 10.1099/jmm.0.013227-0; Metwally L, 2008, J MED MICROBIOL, V57, P296, DOI 10.1099/jmm.0.47617-0; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Morgan J, 2005, INFECT CONT HOSP EP, V26, P540, DOI 10.1086/502581; Munoz P, 2011, CLIN MICROBIOL INFEC, V17, P1538, DOI 10.1111/j.1469-0691.2010.03338.x; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Pfaller MA, 2015, DIAGN MICR INFEC DIS, V82, P303, DOI DOI 10.1016/J.DIAGMICR0BI0.2015.04.008; Rho J, 2004, J MICROBIOL, V42, P80; Sabino R, 2010, J CLIN MICROBIOL, V48, P1677, DOI 10.1128/JCM.02151-09; Saghrouni F, 2013, J APPL MICROBIOL, V114, P1559, DOI 10.1111/jam.12132; Sheng WH, 2005, J HOSP INFECT, V59, P205, DOI 10.1016/j.jhin.2004.06.003; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5593, DOI 10.1128/JCM.43.11.5593-5600.2005; Wang H, 2012, J CLIN MICROBIOL, V50, P3952, DOI 10.1128/JCM.01130-12; Wu Y, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0245-z; Xiao M, 2015, J ANTIMICROB CHEMOTH, V70, P802, DOI 10.1093/jac/dku460; Zhang L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1086-6	30	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166156	10.1371/journal.pone.0166156	http://dx.doi.org/10.1371/journal.pone.0166156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820850	Green Published, Green Submitted, gold			2022-12-27	WOS:000387614800038
J	Liu, Z; Sun, CJ; Qu, L; Wang, KH; Yang, N				Liu, Zhuang; Sun, Congjiao; Qu, Liang; Wang, Kehua; Yang, Ning			Genome-Wide Detection of Selective Signatures in Chicken through High Density SNPs	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; REVEALS LOCI; ASSOCIATION; SCAN; SIGNALS; DIFFERENTIATION; VARIANTS; MODEL; TOOL	Chicken is recognized as an excellent model for studies of genetic mechanism of phenotypic and genomic evolution, with large effective population size and strong human-driven selection. In the present study, we performed Extended Haplotype Homozygosity (EHH) tests to identify significant core regions employing 600K SNP Chicken chip in an F2 population of 1,534 hens, which was derived from reciprocal crosses between White Leghorn and Dongxiang chicken. Results indicated that a total of 49,151 core regions with an average length of 9.79 Kb were identified, which occupied approximately 52.15% of genome across all autosomes, and 806 significant core regions attracted us mostly. Genes in candidate regions may experience positive selection and were considered to have possible influence on beneficial economic traits. A panel of genes including AASDHPPT, GDPD5, PAR3, SOX6, GPC1 and a signal pathway of AKT1 were detected with the most extreme P-values. Further enrichment analyses indicated that these genes were associated with immune function, sensory organ development and neurogenesis, and may have experienced positive selection in chicken. Moreover, some of core regions exactly overlapped with genes excavated in our previous GWAS, suggesting that these genes have undergone positive selection may affect egg production. Findings in our study could draw a comparatively integrate genome-wide map of selection signature in the chicken genome, and would be worthy for explicating the genetic mechanisms of phenotypic diversity in poultry breeding.	[Liu, Zhuang; Sun, Congjiao; Yang, Ning] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China; [Liu, Zhuang; Sun, Congjiao; Yang, Ning] China Agr Univ, MOA Key Lab Anim Genet & Breeding, Coll Anim Sci & Technol, Beijing 100193, Peoples R China; [Qu, Liang; Wang, Kehua] Jiangsu Inst Poultry Sci, Yangzhou 225125, Jiangsu, Peoples R China	China Agricultural University; China Agricultural University	Yang, N (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China.; Yang, N (corresponding author), China Agr Univ, MOA Key Lab Anim Genet & Breeding, Coll Anim Sci & Technol, Beijing 100193, Peoples R China.	nyang@cau.edu.cn		Liu, Zhuang/0000-0001-8938-0086; Yang, Ning/0000-0001-5772-3320	National High Technology Research and Development Program of China [2013AA102501]; National Natural Science Foundation of China [31320103905]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1191]; China Agriculture Research Systems [CARS-41]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); China Agriculture Research Systems	This work was funded by National High Technology Research and Development Program of China (2013AA102501), National Natural Science Foundation of China (31320103905), Program for Changjiang Scholars and Innovative Research Team in University (IRT1191), and China Agriculture Research Systems (CARS-41).	Aburto MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030790; Afonso C, 2006, J CELL SCI, V119, P4293, DOI 10.1242/jcs.03170; Antao EM, 2008, MICROB PATHOGENESIS, V45, P361, DOI 10.1016/j.micpath.2008.08.005; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Benevolo M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-132; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dorval KM, 2005, J BIOL CHEM, V280, P10100, DOI 10.1074/jbc.M412676200; Enard D, 2014, GENOME RES, V24, P885, DOI 10.1101/gr.164822.113; Feng SZ, 2011, J GEN VIROL, V92, P1688, DOI 10.1099/vir.0.030866-0; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Harris MP, 2004, DEV DYNAM, V231, P22, DOI 10.1002/dvdy.20096; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Kim Y, 2004, GENETICS, V167, P1513, DOI 10.1534/genetics.103.025387; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Lee KE, 2014, P NATL ACAD SCI USA, V111, P2794, DOI 10.1073/pnas.1308758111; LEWONTIN RC, 1973, GENETICS, V74, P175; Li DF, 2012, POULTRY SCI, V91, P1804, DOI 10.3382/ps.2012-02275; Mann ZF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4839; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Pan DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060440; Park S, 2013, SCIENCE, V339, P324, DOI 10.1126/science.1231921; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qanbari S, 2010, ANIM GENET, V41, P377, DOI 10.1111/j.1365-2052.2009.02016.x; Qanbari S, 2014, LIVEST SCI, V166, P133, DOI 10.1016/j.livsci.2014.05.003; Roux C, 2013, MOL BIOL EVOL, V30, P435, DOI 10.1093/molbev/mss246; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Shi LH, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/354094; Shiau CE, 2010, DEV BIOL, V348, P107, DOI 10.1016/j.ydbio.2010.09.017; Smith J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-49; Tako E, 2010, POULTRY SCI, V89, P514, DOI 10.3382/ps.2009-00326; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Velleman SG, 2004, POULTRY SCI, V83, P1020, DOI 10.1093/ps/83.6.1020; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walsh EC, 2006, HUM GENET, V119, P92, DOI 10.1007/s00439-005-0090-0; Wang ZH, 2005, HUM MOL GENET, V14, P2075, DOI 10.1093/hmg/ddi212; Wang Z, 2014, ANIM GENET, V45, P808, DOI 10.1111/age.12229; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yi GQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1945-y; Yuan J, 2015, PLOS ONE, V10; Yuan JW, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0161-1; Zhang C, 2006, BIOINFORMATICS, V22, P2122, DOI 10.1093/bioinformatics/btl365; Zhang H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-704	49	6	6	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166146	10.1371/journal.pone.0166146	http://dx.doi.org/10.1371/journal.pone.0166146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820849	Green Submitted, Green Published, gold			2022-12-27	WOS:000387614800036
J	Seiter, M; Schausberger, P				Seiter, Michael; Schausberger, Peter			Constitutive and Operational Variation of Learning in Foraging Predatory Mites	PLOS ONE			English	Article							AMBLYSEIUS-SWIRSKII; NATURAL VARIATION; MEMORY; FOOD; BEHAVIOR; ABILITY; COST; REPRODUCTION; DYNAMICS; THRIPS	Learning is widely documented across animal taxa but studies stringently scrutinizing the causes of constitutive or operational variation of learning among populations and individuals are scarce. The ability to learn is genetically determined and subject to constitutive variation while the performance in learning depends on the immediate circumstances and is subject to operational variation. We assessed variation in learning ability and performance of plant-inhabiting predatory mites, Amblyseius swirskii, caused by population origin, rearing diet, and type of experience. Using an early learning foraging paradigm, we determined that homogeneous single prey environments did not select for reduced learning ability, as compared to natural prey-diverse environments, whereas a multi-generational pollen diet resulted in loss of learning, as compared to a diet of live prey. Associative learning produced stronger effects than non-associative learning but both types of experience produced persistent memory. Our study represents a key example of environmentally caused variation in learning ability and performance.	[Seiter, Michael; Schausberger, Peter] Univ Nat Resources & Life Sci, Dept Crop Sci, Grp Arthropod Ecol & Behav, Vienna, Austria; [Schausberger, Peter] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Vienna	Schausberger, P (corresponding author), Univ Nat Resources & Life Sci, Dept Crop Sci, Grp Arthropod Ecol & Behav, Vienna, Austria.; Schausberger, P (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	peter.schausberger@univie.ac.at		Schausberger, Peter/0000-0002-1529-3198	Austrian Science Fund (FWF) [P 25876-B25]; Austrian Science Fund (FWF) [P 25876] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The study was supported by a grant from the Austrian Science Fund (FWF; P 25876-B25) to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar Y, 2003, J INSECT BEHAV, V16, P811, DOI 10.1023/B:JOIR.0000018322.45068.a9; Akman C, 2004, EPILEPSY BEHAV, V5, P446, DOI 10.1016/j.yebeh.2004.03.008; ALCOCK J, 2005, ANIMAL BEHAV EVOLUTI; ALLOWAY TM, 1972, ANNU REV ENTOMOL, V17, P43, DOI 10.1146/annurev.en.17.010172.000355; Barron AB, 2015, TRENDS NEUROSCI, V38, P405, DOI 10.1016/j.tins.2015.04.008; BATESON P, 1979, ANIM BEHAV, V27, P470, DOI 10.1016/0003-3472(79)90184-2; Bernays EA, 1998, AM NAT, V151, P451, DOI 10.1086/286132; Bolckmans K.J.F., 2006, WO Patent, Patent No. [WO/2006/057552, 2006057552]; Brydges NM, 2008, ANIM BEHAV, V75, P935, DOI 10.1016/j.anbehav.2007.08.005; Burger JMS, 2010, AGING CELL, V9, P327, DOI 10.1111/j.1474-9726.2010.00560.x; Christiansen IC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23571; Colombelli-Negrel D, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1154; Darmaillacq AS, 2006, BIOL LETTERS, V2, P345, DOI 10.1098/rsbl.2006.0477; De Boer JG, 2006, ANIM BIOL, V56, P143, DOI 10.1163/157075606777304221; Drukker B, 2000, EXP APPL ACAROL, V24, P881, DOI 10.1023/A:1010645720829; Nguyen DT, 2013, BIOCONTROL, V58, P369, DOI 10.1007/s10526-012-9502-y; Dudai Y., 1989, NEUROBIOLOGY MEMORY; Dukas R, 2000, BEHAV ECOL, V11, P536, DOI 10.1093/beheco/11.5.536; Ferreira F. R., 2006, Bioscience Journal, V22, P91; Fidgett M.J., 2008, WO patent, Patent No. [WO2008/015393, 2008015393]; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; Gandolfi M, 2003, J CHEM ECOL, V29, P1871, DOI 10.1023/A:1024854312528; Giurfa M, 2004, LEARN MEMORY, V11, P294, DOI 10.1101/lm.63604; Goleva I, 2013, EXP APPL ACAROL, V61, P259, DOI 10.1007/s10493-013-9700-z; GOODENOUGH J, 2001, PERSPECTIVES ANIMAL; Hebets EA, 2003, P NATL ACAD SCI USA, V100, P13390, DOI 10.1073/pnas.2333262100; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Hoedjes KM, 2011, P ROY SOC B-BIOL SCI, V278, P889, DOI 10.1098/rspb.2010.2199; IMMELMANN K, 1975, ANNU REV ECOL SYST, V6, P15, DOI 10.1146/annurev.es.06.110175.000311; Calvo FJ, 2015, EXP APPL ACAROL, V65, P419, DOI 10.1007/s10493-014-9873-0; Kaiser L, 2003, ANIM BEHAV, V66, P1077, DOI 10.1006/anbe.2003.2302; Kawecki TJ, 2010, POPUL ECOL, V52, P15, DOI 10.1007/s10144-009-0174-0; Kolss M, 2008, ECOL ENTOMOL, V33, P583, DOI 10.1111/j.1365-2311.2008.01007.x; LEVINS R, 1969, Ecology (Washington D C), V50, P910, DOI 10.2307/1933709; McMurtry JA, 1997, ANNU REV ENTOMOL, V42, P291, DOI 10.1146/annurev.ento.42.1.291; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Mery F, 2002, P NATL ACAD SCI USA, V99, P14274, DOI 10.1073/pnas.222371199; Mery F, 2003, P ROY SOC B-BIOL SCI, V270, P2465, DOI 10.1098/rspb.2003.2548; Mery F, 2004, ANIM BEHAV, V68, P589, DOI 10.1016/j.anbehav.2003.12.005; Mery F, 2007, P NATL ACAD SCI USA, V104, P13051, DOI 10.1073/pnas.0702923104; Mery F, 2013, CURR OPIN NEUROBIOL, V23, P52, DOI 10.1016/j.conb.2012.09.001; Messelink GJ, 2008, BIOL CONTROL, V44, P372, DOI 10.1016/j.biocontrol.2007.10.017; Mogensen J, 2003, PHARMACOL BIOCHEM BE, V76, P197, DOI 10.1016/S0091-3057(03)00220-X; Papaj D.R., 1993, INSECT LEARNING ECOL; Pearce J. M., 2008, ANIMAL LEARNING COGN, V3rd; Peralta Quesada PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053229; Pereira S, 2012, J NEUROSCI, V32, P9035, DOI 10.1523/JNEUROSCI.4221-11.2012; Potting RPJ, 1997, ANIM BEHAV, V53, P1211, DOI 10.1006/anbe.1996.0382; Punzo F, 2002, BEHAV PROCESS, V58, P177, DOI 10.1016/S0376-6357(02)00031-1; Rahmani H, 2009, BEHAV ECOL, V20, P946, DOI 10.1093/beheco/arp081; Rowe C, 2014, BEHAV ECOL, V25, P1287, DOI 10.1093/beheco/aru090; Sabelis M.W., 1985, P43; Schausberger P, 1997, EXP APPL ACAROL, V21, P131, DOI 10.1023/A:1018478418010; Schausberger P, 2007, BEHAV ECOL SOCIOBIOL, V62, P119, DOI 10.1007/s00265-007-0444-9; Schausberger P, 2010, BEHAVIOUR, V147, P883, DOI 10.1163/000579510X495799; Segura DF, 2007, ANIM BEHAV, V74, P131, DOI 10.1016/j.anbehav.2006.12.005; Snell-Rood EC, 2011, BEHAV ECOL, V22, P291, DOI 10.1093/beheco/arq169; Stephens D.W., 1986, pi; Stireman JO, 2002, J INSECT BEHAV, V15, P689, DOI 10.1023/A:1020752024329; Strodl MA, 2013, OIKOS, V122, P1217, DOI 10.1111/j.1600-0706.2012.20833.x; Strodl MA, 2012, NATURWISSENSCHAFTEN, V99, P303, DOI 10.1007/s00114-012-0903-7; Vangansbeke D, 2016, PEST MANAG SCI, V72, P466, DOI 10.1002/ps.4000; Walzer A, 2011, ANIM BEHAV, V81, P177, DOI 10.1016/j.anbehav.2010.09.031; Walzer A, 2009, OIKOS, V118, P934, DOI 10.1111/j.1600-0706.2008.17299.x; Xia SZ, 1997, PHYSIOL BEHAV, V62, P263, DOI 10.1016/S0031-9384(97)00113-3; Yanai S, 2004, NEUROBIOL AGING, V25, P325, DOI 10.1016/S0197-4580(03)00115-5	66	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166334	10.1371/journal.pone.0166334	http://dx.doi.org/10.1371/journal.pone.0166334			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814380	Green Published, Green Submitted, gold			2022-12-27	WOS:000386911100038
J	Wu, YY; Liu, PY; Gao, Y; Jia, KB				Wu, Yueying; Liu, Pengyu; Gao, Yuan; Jia, Kebin			Medical Ultrasound Video Coding with H.265/HEVC Based on ROI Extraction	PLOS ONE			English	Article								High-efficiency video compression technology is of primary importance to the storage and transmission of digital medical video in modern medical communication systems. To further improve the compression performance of medical ultrasound video, two innovative technologies based on diagnostic region-of-interest (ROI) extraction using the high efficiency video coding (H.265/HEVC) standard are presented in this paper. First, an effective ROI extraction algorithm based on image textural features is proposed to strengthen the applicability of ROI detection results in the H.265/HEVC quad-tree coding structure. Second, a hierarchical coding method based on transform coefficient adjustment and a quantization parameter (QP) selection process is designed to implement the otherness encoding for ROIs and non-ROIs. Experimental results demonstrate that the proposed optimization strategy significantly improves the coding performance by achieving a BD-BR reduction of 13.52% and a BD-PSNR gain of 1.16 dB on average compared to H. 265/HEVC (HM15.0). The proposed medical video coding algorithm is expected to satisfy low bit-rate compression requirements for modern medical communication systems.	[Wu, Yueying; Liu, Pengyu; Gao, Yuan; Jia, Kebin] Beijing Univ Technol, Beijing Adv Innovat Ctr Future Internet Technol, Beijing, Peoples R China; [Wu, Yueying; Liu, Pengyu; Gao, Yuan; Jia, Kebin] Beijing Lab Adv Informat Networks, Beijing, Peoples R China; [Wu, Yueying; Liu, Pengyu; Gao, Yuan; Jia, Kebin] Beijing Univ Technol, Coll Elect Informat & Control Engn, Beijing, Peoples R China; [Wu, Yueying; Liu, Pengyu; Gao, Yuan; Jia, Kebin] Beijing Univ Technol, Coll Elect Informat & Control Engn, 100 Pingleyuan, Beijing 100124, Peoples R China	Beijing University of Technology; Beijing University of Technology; Beijing University of Technology	Liu, PY; Jia, KB (corresponding author), Beijing Univ Technol, Beijing Adv Innovat Ctr Future Internet Technol, Beijing, Peoples R China.; Liu, PY; Jia, KB (corresponding author), Beijing Lab Adv Informat Networks, Beijing, Peoples R China.; Liu, PY; Jia, KB (corresponding author), Beijing Univ Technol, Coll Elect Informat & Control Engn, Beijing, Peoples R China.; Liu, PY; Jia, KB (corresponding author), Beijing Univ Technol, Coll Elect Informat & Control Engn, 100 Pingleyuan, Beijing 100124, Peoples R China.	liupengyu@bjut.edu.cn; kebinj@bjut.edu.cn			Beijing Postdoctoral Research foundation [2015ZZ-23]; Project for the Key Project of Beijing Municipal Education Commission [KZ201610005007]; China Postdoctoral Research Foundation [2015M580029, 2016T90022]; National Natural Science Foundation of China [61672064]; Computational Intelligence and Intelligent System of Beijing Key Laboratory Research Foundation [002000546615004]	Beijing Postdoctoral Research foundation(China Postdoctoral Science Foundation); Project for the Key Project of Beijing Municipal Education Commission; China Postdoctoral Research Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Computational Intelligence and Intelligent System of Beijing Key Laboratory Research Foundation	This paper is supported by the Beijing Postdoctoral Research foundation under Grant No. 2015ZZ-23, the Project for the Key Project of Beijing Municipal Education Commission under Grant No. KZ201610005007, the China Postdoctoral Research Foundation under Grant Nos. 2015M580029 and 2016T90022, the National Natural Science Foundation of China under Grant No. 61672064, and the Computational Intelligence and Intelligent System of Beijing Key Laboratory Research Foundation under Grant No. 002000546615004.	[Anonymous], 2014, JCTVCP1006; Bjontegaard G., 2001, P 13 VCEG M33 M, P2; Dasarathy B. V., 1991, NEAREST NEIGHBOR NN; Doron Y, 2014, PROC SPIE, V9035, DOI 10.1117/12.2043697; Hanhart P, 2013, AHG4 SUBJECTIVE EVAL, V16; Moorthi M, 2012, COMM COM INF SC, V270, P451; Panayides A, 2013, CONF REC ASILOMAR C, P1117, DOI 10.1109/ACSSC.2013.6810467; Panayides A, 2012, IEEE ENG MED BIO, P2170, DOI 10.1109/EMBC.2012.6346391; Panayides AS, 2013, IEEE ENG MED BIO, P7253, DOI 10.1109/EMBC.2013.6611232; Panayides AS, 2015, IEEE J BIOMED HEALTH, V19, P668, DOI 10.1109/JBHI.2014.2329572; Shenthil KKR, 2014, P 2014 INT C COMM SI, P808; SRIDHAR KV, 2008, P IEEE INT C SIGN EL, P239; Sullivan GJ, 2012, IEEE T CIRC SYST VID, V22, P1649, DOI 10.1109/TCSVT.2012.2221191; Wang Z, 2004, SIGNAL PROCESS-IMAGE, V19, P121, DOI 10.1016/S0923-5965(03)00076-6; Zhu B.Y., 2013, CHINA MED EQUIP, V10, P77; Zulpe N., 2012, INT J COMPUT SCI ISS, V9, P354	16	9	9	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165698	10.1371/journal.pone.0165698	http://dx.doi.org/10.1371/journal.pone.0165698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814367	Green Published, gold, Green Submitted			2022-12-27	WOS:000386911100017
J	Lopez-Garcia, P; Schulz, S				Lopez-Garcia, Pablo; Schulz, Stefan			Structural Patterns under X-Rays: Is SNOMED CT Growing Straight?	PLOS ONE			English	Article							TERMINOLOGIES; HIERARCHIES	Unprincipled modeling decisions in large-domain ontologies, such as SNOMED CT, are problematic and might act as a barrier for their quality assurance and successful use in electronic health records. Most previous work has focused on clustering problematic concepts, which is helpful for quality control but faces difficulties in pinpointing the origin of those modeling problems. In this study, we examined the underlying structural patterns in SNOMED CT's data model as such patterns directly reflect the modeling strategies of editors. Our results showed that 92% of all structural patterns found accumulated in the Procedure and Clinical finding sub-hierarchies, and pattern reuse was low; over 30% of patterns were only used once. A qualitative analysis of a sample of 50 such singleton patterns revealed modeling problems, including redundancy, omission, and inconsistency. The problems detected in the sample suggest that the analysis of structural patterns is a valuable technique for revealing problematic areas of SNOMED CT and modeling the styles of terminology editors. Furthermore, the patterns that describe the modeling of a large number of concepts could provide insights for template creation and refinement in SNOMED CT.	[Lopez-Garcia, Pablo; Schulz, Stefan] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria	Medical University of Graz	Lopez-Garcia, P (corresponding author), Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria.	pablo.lopez@medunigraz.at		Lopez-Garcia, Pablo/0000-0001-5419-7337				Agrawal A, 2013, STUD HEALTH TECHNOL, V192, P773, DOI 10.3233/978-1-61499-289-9-773; Andrews JE, 2007, J AM MED INFORM ASSN, V14, P497, DOI 10.1197/jamia.M2372; [Anonymous], 2015, OWL 2 WEB ONTOLOGY L; [Anonymous], 2015, SNOMED CT INT RELEAS; [Anonymous], 2014, SNOMED CT TECHNICAL; Baader F., 2003, DESCRIPTION LOGIC HD; Baader F, 2005, P 2005 INT JOINT C A, V5, P59; Bodenreider O, 2007, ARTIF INTELL MED, V39, P183, DOI 10.1016/j.artmed.2006.12.003; Campbell KE, 1998, J AM MED INFORM ASSN, P785; Cheetham E, 2015, P 2015 INT C BIOM ON; Chiang Michael F, 2006, AMIA Annu Symp Proc, P131; Dentler K, 2015, ARTIF INTELL MED, V65, P29, DOI 10.1016/j.artmed.2014.10.003; Elkin PL, 2006, MAYO CLIN PROC, V81, P741, DOI 10.4065/81.6.741; Fung KW, 2010, J AM MED INFORM ASSN, V17, P675, DOI 10.1136/jamia.2010.007047; Geller James, 2012, AMIA Annu Symp Proc, V2012, P237; Giannangelo Kathy, 2008, Perspect Health Inf Manag, V5, P7; Halper Michael, 2007, AMIA Annu Symp Proc, P314; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jiang GQ, 2009, J AM MED INFORM ASSN, V16, P89, DOI 10.1197/jamia.M2541; Kalankesh LR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-127; Mikroyannidi E, 2012, J BIOMED SEMANT, V3, DOI 10.1186/2041-1480-3-8; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Ochs C, 2015, J AM MED INFORM ASSN, V22, P507, DOI 10.1136/amiajnl-2014-003151; Ochs Christopher, 2013, AMIA Annu Symp Proc, V2013, P1071; Pacheco Edson, 2009, AMIA Annu Symp Proc, V2009, P492; Rector AL, 2011, J AM MED INFORM ASSN, V18, P432, DOI 10.1136/amiajnl-2010-000045; Schulz S, 2005, ARTIF INTELL MED, V34, P179, DOI 10.1016/j.artmed.2004.11.005; Schulz S, 2006, J BIOMED INFORM, V39, P350, DOI 10.1016/j.jbi.2005.11.003; Schurig D, 2008, PROCEEDINGS OF THE 2008 INTERNATIONAL WORKSHOP ON METAMATERIALS, P11; Spackman KA, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P712; Wang Y, 2007, J BIOMED INFORM, V40, P561, DOI 10.1016/j.jbi.2006.12.003; Wang Y, 2012, J BIOMED INFORM, V45, P15, DOI 10.1016/j.jbi.2011.08.013; Wang Y, 2012, J BIOMED INFORM, V45, P1, DOI 10.1016/j.jbi.2011.08.016; Wei D, 2010, STUD HEALTH TECHNOL, V160, P1070, DOI 10.3233/978-1-60750-588-4-1070; Wei Duo, 2009, AMIA Annu Symp Proc, V2009, P685; Zhang M, 2006, P 1 SEM MIN C SNOMED, P59	36	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165619	10.1371/journal.pone.0165619	http://dx.doi.org/10.1371/journal.pone.0165619			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812127	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000038
J	Ma, FS; Zhang, L; Wang, Y; Lu, RG; Hu, B; Lv, S; Xue, XH; Li, XT; Ling, MY; Fan, SN; Zhang, HL; Yan, XJ				Ma, Fanshu; Zhang, Lei; Wang, Yang; Lu, Rongguang; Hu, Bo; Lv, Shuang; Xue, Xianghong; Li, Xintong; Ling, Mingyu; Fan, Sining; Zhang, Hailing; Yan, Xijun			Development of a Peptide ELISA for the Diagnosis of Aleutian Mink Disease	PLOS ONE			English	Article							SEROLOGICAL RESPONSES; VIRUS; ANTIBODIES; INFECTION; ERADICATION; PROTEINS; PATHOGENICITY; VALIDATION; PREDICTION; EPITOPES	Aleutian disease (AD) is a common immunosuppressive disease in mink farms world-wide. Since the 1980s, counterimmunoelectrophoresis (CIEP) has been the main detection method for infection with the Aleutian Mink Disease Virus (AMDV). In this study, six peptides derived from the AMDV structural protein VP2 were designed, synthesized, and used as ELISA antigens to detect anti-AMDV antibodies in the sera of infected minks. Serum samples were collected from 764 minks in farms from five different provinces, and analyzed by both CIEP (a gold standard) and peptide ELISA. A peptide designated P1 (415 aa-433 aa) exhibited good antigenicity. A novel ELISA was developed using ovalbumin-linked peptide P1 to detect anti-AMDV antibodies in mink sera. The sensitivity and specificity of the peptide ELISA was 98.0% and 97.5%, respectively. Moreover, the ELISA also detected 342 early-stage infected samples (negative by CIEP and positive by PCR), of which 43.6% (149/342) were true positives. These results showed that the peptide ELISA had better sensitivity compared with CIEP, and therefore could be preferable over CIEP for detecting anti-AMDV antibodies in serological screening.	[Ma, Fanshu; Zhang, Lei; Wang, Yang; Lu, Rongguang; Hu, Bo; Lv, Shuang; Xue, Xianghong; Li, Xintong; Ling, Mingyu; Fan, Sining; Zhang, Hailing; Yan, Xijun] Chinese Acad Agr Sci, Inst Special Anim & Plant Sci, Div Infect Dis Special Anim, Changchun, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Special Animal & Plant Sciences, CAAS	Yan, XJ (corresponding author), Chinese Acad Agr Sci, Inst Special Anim & Plant Sci, Div Infect Dis Special Anim, Changchun, Peoples R China.	yanxijun@caas.cn		Ma, Fanshu/0000-0002-5258-9158	Jilin Province Science and Technology Program [20140204074NY]	Jilin Province Science and Technology Program	This study was funded by the Jilin Province Science and Technology Program (20140204074NY). The funder is Zhang Lei, who has taken part in study design, data collection and analysis, and the decision to publish.	AASTED B, 1982, ACTA PATH MICRO IM C, V90, P15; AASTED B, 1986, ACTA VET SCAND, V27, P410; ALEXANDERSEN S, 1985, ELECTROPHORESIS, V6, P535, DOI 10.1002/elps.1150061104; Amat-ur-Rasool H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119854; Andersson AM, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-86; Bloom ME, 1997, J VIROL, V71, P705, DOI 10.1128/JVI.71.1.705-714.1997; Bloom ME, 2001, J VIROL, V75, P11116, DOI 10.1128/JVI.75.22.11116-11127.2001; CHAPMAN MS, 1993, VIROLOGY, V194, P491, DOI 10.1006/viro.1993.1288; Chen X, 2015, J CLIN MICROBIOL, P02625; CHO HJ, 1978, J CLIN MICROBIOL, V7, P18; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Costello F, 1999, SCAND J IMMUNOL, V49, P347; Farid AH, 2012, PREV VET MED, V106, P332, DOI 10.1016/j.prevetmed.2012.03.010; Farid AH, 2015, J VET DIAGN INVEST, V27, P287, DOI 10.1177/1040638715580982; Gorham J R, 1976, Front Biol, V44, P135; Gray DP, 1964, THESIS; Gunnarsson E, 2001, ACTA VET SCAND, P87; HADLOW WJ, 1983, INFECT IMMUN, V41, P1016, DOI 10.1128/IAI.41.3.1016-1023.1983; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Huang QF, 2014, VIROLOGY, V452, P23, DOI 10.1016/j.virol.2014.01.005; Hussain I, 2014, VET MICROBIOL, V173, P50, DOI 10.1016/j.vetmic.2014.07.014; Jensen TH, 2011, J VIROL METHODS, V171, P81, DOI 10.1016/j.jviromet.2010.10.004; Jensen TH, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0214-7; Jensen TH, 2014, VET MICROBIOL, V168, P420, DOI 10.1016/j.vetmic.2013.11.041; Jepsen JR, 2009, EMERG INFECT DIS, V15, P2040, DOI 10.3201/eid1512.090514; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; KENYON AJ, 1978, AM J VET RES, V39, P1011; Knuuttila A, 2009, CLIN VACCINE IMMUNOL, V16, P1360, DOI 10.1128/CVI.00148-09; Lang A, 2013, J VIROL METHODS, V193, P667, DOI 10.1016/j.jviromet.2013.07.044; Menezes-Souza D, 2015, APPL MICROBIOL BIOT, V99, P1323, DOI 10.1007/s00253-014-6168-7; Oem Jae Ku, 2005, J Vet Sci, V6, P317; Oie KL, 1996, J VIROL, V70, P852, DOI 10.1128/JVI.70.2.852-861.1996; Oleksiewicz MB, 2005, J VIROL METHODS, V129, P134, DOI 10.1016/j.jviromet.2005.05.017; Pennick KE, 2007, VET PATHOL, V44, P687, DOI 10.1354/vp.44-5-687; Pennick KE, 2005, J VET DIAGN INVEST, V17, P594, DOI 10.1177/104063870501700614; Plagemann PGW, 2006, J VIROL METHODS, V134, P99, DOI 10.1016/j.jviromet.2005.12.003; PORTER DD, 1986, PROG MED VIROL, V33, P42; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Saha Sudipto, 2007, V409, P387, DOI 10.1007/978-1-60327-118-9_29; Soria-Guerra RE, 2015, J BIOMED INFORM, V53, P405, DOI 10.1016/j.jbi.2014.11.003; Soutullo A, 2001, VET MICROBIOL, V79, P111, DOI 10.1016/S0378-1135(00)00352-7; Sun P, 2013, COMPUT MATH METHOD M, V2013, P529; Uttenthal A., 1992, APPL THEORETICAL ELE, V3; Velumani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020737; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang ZJ, 2014, VIRUS RES, V184, P14, DOI 10.1016/j.virusres.2014.02.007; Zhang L, 2013, BINGDUXUEBAO, V11, P102	47	14	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165793	10.1371/journal.pone.0165793	http://dx.doi.org/10.1371/journal.pone.0165793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802320	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200055
J	Koblitz, JC; Stilz, P; Rasmussen, MH; Laidre, KL				Koblitz, Jens C.; Stilz, Peter; Rasmussen, Marianne H.; Laidre, Kristin L.			Highly Directional Sonar Beam of Narwhals (Monodon monoceros) Measured with a Vertical 16 Hydrophone Array	PLOS ONE			English	Article							DOLPHINS TURSIOPS-TRUNCATUS; HIGH-FREQUENCY CLICKS; ECHOLOCATION CLICKS; SOURCE PARAMETERS; HARBOR PORPOISES; NARROW-BAND; SIGNALS; PATTERN; BEHAVIOR; SOUND	Recordings of narwhal (Monodon monoceros) echolocation signals were made using a linear 16 hydrophone array in the pack ice of Baffin Bay, West Greenland in 2013 at eleven sites. An average-3 dB beam width of 5.0 degrees makes the narwhal click the most directional biosonar signal reported for any species to date. The beam shows a dorsal-ventral asymmetry with a narrower beam above the beam axis. This may be an evolutionary advantage for toothed whales to reduce echoes from the water surface or sea ice surface. Source level measurements show narwhal click intensities of up to 222 dB pp re 1 mu Pa, with a mean apparent source level of 215 dB pp re 1 mu Pa. During ascents and descents the narwhals perform scanning in the vertical plane with their sonar beam. This study provides valuable information for reference sonar parameters of narwhals and for the use of acoustic monitoring in the Arctic.	[Koblitz, Jens C.] Bioacoust Network, Neuss, Germany; [Stilz, Peter] Bioacoust Network, Hechingen, Germany; [Rasmussen, Marianne H.] Univ Iceland, Res Ctr Husavik, Husavik, Iceland; [Laidre, Kristin L.] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA	University of Iceland; University of Washington; University of Washington Seattle	Koblitz, JC (corresponding author), Bioacoust Network, Neuss, Germany.; Laidre, KL (corresponding author), Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA.	Jens.Koblitz@gmail.com; klaidre@uw.edu			ONR [N00014-11-1-0201]	ONR(Office of Naval Research)	ONR funded the study on a grant to K. Laidre (N00014-11-1-0201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ONR funded the study on a grant to K.L. Laidre (N00014-11-1-0201). Mikkel Villium Jensen assisted in the field, and skilled flying was conducted by our pilot Geir Akse of Air Greenland. People of the community of Niaqornat are thanked for their generosity and assistance. Greenland Institute of Natural Resource provided housing. The University of Tubingen and the German Oceanographic Museum Stralsund provided recording equipment. Support from CAE Software & Systems is highly appreciated. Two reviewers improved the manuscript.	AMSA, 2009, ARCT MAR SHIPP ASS 2; AROYAN JL, 1992, J ACOUST SOC AM, V92, P2539, DOI 10.1121/1.404424; Au WWL, 2012, J ACOUST SOC AM, V131, P569, DOI 10.1121/1.3662077; Au WWL, 2010, J ACOUST SOC AM, V128, P1426, DOI 10.1121/1.3372643; Au WWL, 2003, NATURE, V423, P861, DOI 10.1038/nature01727; Au WWL, 2003, J ACOUST SOC AM, V113, P598, DOI 10.1121/1.1518980; AU WWL, 1978, J ACOUST SOC AM, V64, P411, DOI 10.1121/1.382015; AU WWL, 1986, J ACOUST SOC AM, V80, P688, DOI 10.1121/1.394012; AU WWL, 1995, J ACOUST SOC AM, V98, P51, DOI 10.1121/1.413643; AU WWL, 1987, J ACOUST SOC AM, V82, P807, DOI 10.1121/1.395278; Baumann-Pickering S, 2013, J ACOUST SOC AM, V134, P2293, DOI 10.1121/1.4817832; Baumann-Pickering S, 2010, J ACOUST SOC AM, V128, P2212, DOI 10.1121/1.3479549; de Freitas M, 2015, J ACOUST SOC AM, V137, P3033, DOI 10.1121/1.4921277; Dietz Rune, 2007, BMC Ecology, V7, P14, DOI 10.1186/1472-6785-7-14; Finley K.J., 1990, Canadian Bulletin of Fisheries and Aquatic Sciences, V224, P97; Finneran JJ, 2014, J ACOUST SOC AM, V136, P2025, DOI 10.1121/1.4895682; FISHER FH, 1977, J ACOUST SOC AM, V62, P558, DOI 10.1121/1.381574; FORD JKB, 1978, CAN J ZOOL, V56, P552, DOI 10.1139/z78-079; Heide-Jorgensen MP, 2010, J MAMMAL, V91, P1135, DOI 10.1644/09-MAMM-A-198.1; Heide-Jorgensen MP, 2002, POLAR BIOL, V25, P331, DOI 10.1007/s00300-001-0347-6; Innes Stuart, 2002, NAMMCO Scientific Publications, V4, P169; Jensen FH, 2009, J EXP BIOL, V212, P1078, DOI 10.1242/jeb.025619; Jensen FH, 2015, J EXP BIOL, V218, P1314, DOI 10.1242/jeb.116285; Jensen FH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059284; Johnson M, 2009, MAR ECOL PROG SER, V395, P55, DOI 10.3354/meps08255; Koblitz JC, 2012, J ACOUST SOC AM, V131, P2315, DOI 10.1121/1.3683254; Kyhn LA, 2010, J EXP BIOL, V213, P1940, DOI 10.1242/jeb.042440; Kyhn LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063763; Kyhn LA, 2009, J ACOUST SOC AM, V125, P1783, DOI 10.1121/1.3075600; Ladegaard M, 2015, J EXP BIOL, V218, P3091, DOI 10.1242/jeb.120501; Laidre KL, 2004, MAR BIOL, V145, P821, DOI 10.1007/s00227-004-1371-1; Laidre KL, 2004, ICES J MAR SCI, V61, P430, DOI 10.1016/j.icesjms.2004.02.002; Laidre KL, 2003, MAR ECOL PROG SER, V261, P269, DOI 10.3354/meps261269; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Laidre KL, 2015, CONSERV BIOL, V29, P724, DOI 10.1111/cobi.12474; Lurton X., 2002, INTRO UNDERWATER ACO; Madsen PT, 2010, J EXP BIOL, V213, P3105, DOI 10.1242/jeb.044420; Madsen PT, 2004, J EXP BIOL, V207, P1811, DOI 10.1242/jeb.00966; Marcoux M, 2012, MAR MAMMAL SCI, V28, P649, DOI 10.1111/j.1748-7692.2011.00514.x; MILLER LA, 1995, MAR MAMMAL SCI, V11, P491, DOI 10.1111/j.1748-7692.1995.tb00672.x; Mohl B, 2003, J ACOUST SOC AM, V114, P1143, DOI 10.1121/1.1586258; MOHL B, 1990, NATO ADV SCI I A-LIF, V196, P295; Mohl B, 2000, J ACOUST SOC AM, V107, P638, DOI 10.1121/1.428329; Moore PW, 2008, J ACOUST SOC AM, V124, P3324, DOI 10.1121/1.2980453; NORRIS KS, 1961, BIOL BULL, V120, P163, DOI 10.2307/1539374; Overland JE, 2013, GEOPHYS RES LETT, V40, P2097, DOI 10.1002/grl.50316; Rasmussen MH, 2015, AQUAT MAMM, V41, P256, DOI 10.1578/AM.41.3.2015.256; Rasmussen MH, 2004, J ACOUST SOC AM, V116, P1826, DOI 10.1121/1.1775274; Rasmussen MH, 2002, J ACOUST SOC AM, V111, P1122, DOI 10.1121/1.1433814; Reeves RR, 2014, MAR POLICY, V44, P375, DOI 10.1016/j.marpol.2013.10.005; Richard PR, 2010, ARCTIC, V63, P85; Roch MA, 2011, J ACOUST SOC AM, V129, P467, DOI 10.1121/1.3514383; SCHEVILL WILLIAM E., 1956, BREVIORA MUS COMP ZOOL [HARVARD], V53, P1; Seibert AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060752; Shaffer JW, 2013, J ACOUST SOC AM, V133, P1770, DOI 10.1121/1.4776177; Soldevilla MS, 2008, J ACOUST SOC AM, V124, P609, DOI 10.1121/1.2932059; Stafford KM, 2012, MAR MAMMAL SCI, V28, pE197, DOI 10.1111/j.1748-7692.2011.00500.x; Surlykke A, 2009, J EXP BIOL, V212, P1011, DOI 10.1242/jeb.024620; Villadsgaard A, 2007, J EXP BIOL, V210, P56, DOI 10.1242/jeb.02618; Wahlberg M, 2001, J ACOUST SOC AM, V109, P397, DOI 10.1121/1.1329619; Wahlberg M, 2014, SPRINGER HANDB AUDIT, V51, P107, DOI 10.1007/978-1-4614-9146-0_4; Wahlberg M, 2011, J ACOUST SOC AM, V130, P2263, DOI 10.1121/1.3624822; WATKINS WA, 1971, J ACOUST SOC AM, V49, P595, DOI 10.1121/1.1912391; Wei C, 2014, J ACOUST SOC AM, V136, P423, DOI 10.1121/1.4883597; Wisniewska DM, 2015, ELIFE, V4, DOI 10.7554/eLife.05651; Wisniewska DM, 2012, J EXP BIOL, V215, P4358, DOI 10.1242/jeb.074013; Yovel Y, 2010, SCIENCE, V327, P701, DOI 10.1126/science.1183310; Zimmer WMX, 2005, J ACOUST SOC AM, V117, P3919, DOI 10.1121/1.1910225	68	14	14	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0162069	10.1371/journal.pone.0162069	http://dx.doi.org/10.1371/journal.pone.0162069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828956	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300004
J	Walther, S; Tietze, M; Czerny, CP; Konig, S; Diesterbeck, US				Walther, Stefanie; Tietze, Manfred; Czerny, Claus-Peter; Koenig, Sven; Diesterbeck, Ulrike S.			Development of a Bioinformatics Framework for the Detection of Gene Conversion and the Analysis of Combinatorial Diversity in Immunoglobulin Heavy Chains in Four Cattle Breeds	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; COMPLEMENTARITY-DETERMINING REGION-3; VARIABLE REGION; SOMATIC DIVERSIFICATION; IG; REPERTOIRE; CHICKEN; GERMLINE; FAMILY; REARRANGEMENT	We have developed a new bioinformatics framework for the analysis of rearranged bovine heavy chain immunoglobulin (Ig) variable regions by combining and refining widely used alignment algorithms. This bioinformatics framework allowed us to investigate alignments of heavy chain framework regions (FRHs) and the separate alignments of FRHs and heavy chain complementarity determining regions (CDRHs) to determine their germline origin in the four cattle breeds Aubrac, German Black Pied, German Simmental, and Holstein Friesian. Now it is also possible to specifically analyze Ig heavy chains possessing exceptionally long CDR3Hs. In order to gain more insight into breed specific differences in Ig combinatorial diversity, somatic hypermutations and putative gene conversions of IgG, we compared the dominantly transcribed variable (IGHV), diversity (IGHD), and joining (IGHJ) segments and their recombination in the four cattle breeds. The analysis revealed the use of 15 different IGHV segments, 21 IGHD segments, and two IGHJ segments with significant different transcription levels within the breeds. Furthermore, there are preferred rearrangements within the three groups of CDR3H lengths. In the sequences of group 2 (CDR3H lengths (L) of 11-47 amino acid residues (aa)) a higher number of recombination was observed than in sequences of group 1 (L <= 10 aa) and 3 (L >= 48 aa). The combinatorial diversity of germline IGHV, IGHD, and IGHJ-segments revealed 162 rearrangements that were significantly different. The few preferably rearranged gene segments within group 3 CDR3H regions may indicate specialized antibodies because this length is unique in cattle. The most important finding of this study, which was enabled by using the bioinformatics framework, is the discovery of strong evidence for gene conversion as a rare event using pseudogenes fulfilling all definitions for this particular diversification mechanism.	[Walther, Stefanie; Czerny, Claus-Peter; Diesterbeck, Ulrike S.] Georg August Univ Goettingen, Inst Vet Med, Fac Agr Sci, Dept Anim Sci,Div Microbiol & Anim Hyg, Gottingen, Germany; [Tietze, Manfred; Koenig, Sven] Univ Kassel, Dept Anim Breeding, Witzenhausen, Germany; [Diesterbeck, Ulrike S.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	University of Gottingen; Universitat Kassel; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Diesterbeck, US (corresponding author), Georg August Univ Goettingen, Inst Vet Med, Fac Agr Sci, Dept Anim Sci,Div Microbiol & Anim Hyg, Gottingen, Germany.; Diesterbeck, US (corresponding author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.	ulrike.diesterbeck@nih.gov			Georg-August University Goettingen [GAUGIVM9100010893]; German Research Foundation (DFG); Open Access Publication Funds of the Gottingen University	Georg-August University Goettingen; German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University	Stefanie Walther was supported by a scholarship provided by the Georg-August University Goettingen (GAUGIVM9100010893). We acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; BECKER RS, 1990, CELL, V63, P987, DOI 10.1016/0092-8674(90)90502-6; Berens SJ, 1997, INT IMMUNOL, V9, P189, DOI 10.1093/intimm/9.1.189; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Dufour V, 1996, J IMMUNOL, V156, P2163; EDELMAN GM, 1973, SCIENCE, V180, P830, DOI 10.1126/science.180.4088.830; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gaeta BA, 2007, BIOINFORMATICS, V23, P1580, DOI 10.1093/bioinformatics/btm147; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Hosseini A, 2004, INT IMMUNOL, V16, P843, DOI 10.1093/intimm/dxh085; KABAT EA, 2006, SEQUENCES PROTEINS I; Koti M, 2008, DEV BIOLOGICALS, V132, P307, DOI 10.1159/000317176; Koti M, 2010, MOL IMMUNOL, V47, P2119, DOI 10.1016/j.molimm.2010.02.014; Larsen PA, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-52; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Liljavirta J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099808; Lucier MR, 1998, J IMMUNOL, V161, P5438; MILLER JR, 1992, ANIM GENET, V23, P51, DOI 10.1111/j.1365-2052.1992.tb00017.x; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Niku M, 2012, DEV COMP IMMUNOL, V37, P457, DOI 10.1016/j.dci.2012.02.006; Parng CL, 1996, J IMMUNOL, V157, P5478; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1985, CELL, V40, P283, DOI 10.1016/0092-8674(85)90142-4; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; REYNAUD CA, 1994, ADV IMMUNOL, V57, P353, DOI 10.1016/S0065-2776(08)60676-8; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Saini SS, 1997, MOL IMMUNOL, V34, P641, DOI 10.1016/S0161-5890(97)00055-2; Saini SS, 2003, INT IMMUNOL, V15, P845, DOI 10.1093/intimm/dxg083; Saini SS, 1999, J IMMUNOL, V162, P5624; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scaviner D, 1999, EXP CLIN IMMUNOGENET, V16, P234, DOI 10.1159/000019115; Shojaei F, 2003, MOL IMMUNOL, V40, P61, DOI 10.1016/S0161-5890(03)00098-1; Sinclair MC, 1997, J IMMUNOL, V159, P3883; Souto-Carneiro MM, 2004, J IMMUNOL, V172, P6790, DOI 10.4049/jimmunol.172.11.6790; SUN J, 1994, J IMMUNOL, V153, P5618; Sun Y, 2010, DEV COMP IMMUNOL, V34, P1009, DOI 10.1016/j.dci.2010.05.003; Tallmadge RL, 2014, DEV COMP IMMUNOL, V46, P171, DOI 10.1016/j.dci.2014.04.001; Tallmadge RL, 2013, DEV COMP IMMUNOL, V41, P33, DOI 10.1016/j.dci.2013.03.020; THOMPSON CB, 1987, CELL, V48, P369, DOI 10.1016/0092-8674(87)90188-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Wagner SD, 1996, ANNU REV IMMUNOL, V14, P441, DOI 10.1146/annurev.immunol.14.1.441; Walther S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064234; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Wang Y, 2008, IMMUNOL CELL BIOL, V86, P111, DOI 10.1038/sj.icb.7100144; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhao YF, 2003, J BIOL CHEM, V278, P35024, DOI 10.1074/jbc.M301337200	51	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164567	10.1371/journal.pone.0164567	http://dx.doi.org/10.1371/journal.pone.0164567			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828971	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300018
J	Abraham, A; Alabdali, M; Alsulaiman, A; Breiner, A; Barnett, C; Katzberg, HD; Lovblom, LE; Perkins, BA; Bril, V				Abraham, Alon; Alabdali, Majed; Alsulaiman, Abdulla; Breiner, Ari; Barnett, Carolina; Katzberg, Hans D.; Lovblom, Leif E.; Perkins, Bruce A.; Bril, Vera			Laser Doppler Flare Imaging and Quantitative Thermal Thresholds Testing Performance in Small and Mixed Fiber Neuropathies	PLOS ONE			English	Article							SYMPTOMS; DENSITY	Introduction Small fiber neuropathy might be a part of typical mixed small and large fiber neuropathy, or a distinct entity, affecting exclusively small nerve fibers. Objectives Explore the utility of small nerve fiber testing in patients with clinical presentation suggesting small fiber neuropathy, with and without evidence for concomitant large fiber neuropathy. Methods Patients attending the neuromuscular clinic from 2012 to 2015 with a clinical presentation suggesting small nerve fiber impairment, who had Laser Doppler flare imaging (LDIFlare) and quantitative thermal testing (QTT) were evaluated for this study. Patients with clinical or electrophysiological evidence for concomitant large fiber neuropathy were not excluded. Results The sensitivities of LDIFlare, cooling and heat threshold testing were 64%, 36%, and 0% respectively for clinically highly suggestive small fiber neuropathy, 64%, 56%, and 19% respectively for mixed fiber neuropathy, and 86%, 79%, and 29% respectively for diabetic mixed fiber neuropathy. Discussion LDIFlare and cooling thresholds testing are non-invasive small nerve fiber testing modalities, with moderate performance in patients with small and mixed fiber neuropathy, and excellent performance in diabetic mixed fiber neuropathy.	[Abraham, Alon; Breiner, Ari; Barnett, Carolina; Katzberg, Hans D.; Bril, Vera] Univ Toronto, Dept Med, Div Neurol, Univ Hlth Network,Ellen & Martin Prosserman Ctr N, Toronto, ON, Canada; [Alabdali, Majed; Alsulaiman, Abdulla] Univ Dammam, King Fahad Hosp Univ, Dept Neurol, Dammam, Saudi Arabia; [Lovblom, Leif E.; Perkins, Bruce A.] Univ Toronto, Div Endocrinol & Metab, Dept Med, Mt Sinai Hosp, Toronto, ON, Canada; [Lovblom, Leif E.; Perkins, Bruce A.] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Imam Abdulrahman Bin Faisal University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bril, V (corresponding author), Univ Toronto, Dept Med, Div Neurol, Univ Hlth Network,Ellen & Martin Prosserman Ctr N, Toronto, ON, Canada.	vera.bril@utoronto.ca	Perkins, Bruce A/L-3726-2017; Abraham, Alon/H-9343-2019; Barnett, Carolina/AFM-9470-2022; BRIL, vera/ABA-6509-2020	Abraham, Alon/0000-0002-9020-2399; Lovblom, Leif Erik/0000-0002-6774-8924; Barnett, Carolina/0000-0001-5546-0221				Almurdhi MM, 2017, DIABETIC MED, V34, P356, DOI 10.1111/dme.13163; Bolton CF, 2000, CANADIAN J NEUROLOGI, P288; Breiner A, 2014, DIABETES CARE, V37, P1418, DOI 10.2337/dc13-2005; CLAUS D, 1993, MUSCLE NERVE, V16, P757, DOI 10.1002/mus.880160711; Devigili G, 2008, BRAIN, V131, P1912, DOI 10.1093/brain/awn093; Ebadi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042208; Green AQ, 2009, MUSCLE NERVE, V40, P985, DOI 10.1002/mus.21333; Hagander LG, 2000, CLIN NEUROPHYSIOL, V111, P17, DOI 10.1016/S1388-2457(99)00192-3; Holland NR, 1998, ANN NEUROL, V44, P47, DOI 10.1002/ana.410440111; Huang CS, 2012, MICROVASC RES, V84, P351, DOI 10.1016/j.mvr.2012.07.003; Lacomis D, 2002, MUSCLE NERVE, V26, P173, DOI 10.1002/mus.10181; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Lefaucheur J-P, 2015, NEUROPHYSIOL CLIN; Lysy Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106995; Nabavi Nouri M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034807, DOI 10.1371/JOURNAL.PONE.0034807]; Provitera V, 2016, EUR J NEUROL, V23, P333, DOI 10.1111/ene.12842; Vas PRJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069920; Walk D, 2007, J NEUROL SCI, V255, P23, DOI 10.1016/j.jns.2007.01.052	18	25	26	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165731	10.1371/journal.pone.0165731	http://dx.doi.org/10.1371/journal.pone.0165731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824912	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200030
J	Singh, R; Teel, C; Sabus, C; McGinnis, P; Kluding, P				Singh, Rupali; Teel, Cynthia; Sabus, Carla; McGinnis, Patricia; Kluding, Patricia			Fatigue in Type 2 Diabetes: Impact on Quality of Life and Predictors	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; GLYCEMIC CONTROL; NATIONAL SAMPLE; CANCER-PATIENTS; SLEEP QUALITY; 6-MINUTE WALK; DEPRESSION; MELLITUS; HEALTH; SYMPTOMS	Fatigue is a persistent symptom, impacting quality of life (QoL) and functional status in people with type 2 diabetes, yet the symptom of fatigue has not been fully explored. The purpose of this study was to explore the relationship between fatigue, QoL functional status and to investigate the predictors of fatigue. These possible predictors included body mass index (BMI), Hemoglobin A1C (HbA1C), sleep quality, pain, number of complications from diabetes, years since diagnosis and depression. Forty-eight individuals with type 2 diabetes (22 females, 26 males; 59.66 +/- 7.24 years of age; 10.45 +/- 7.38 years since diagnosis) participated in the study. Fatigue was assessed by using Multidimensional Fatigue Inventory (MFI-20). Other outcomes included: QoL (Audit of Diabetes Dependent QoL), and functional status (6 minute walk test), BMI, HbA1c, sleep (Pittsburg sleep quality index, PSQI), pain (Visual Analog Scale), number of complications, years since diagnosis, and depression (Beck's depression Inventory-2). The Pearson correlation analysis followed by multivariable linear regression model was used. Fatigue was negatively related to quality of life and functional status. Multivariable linear regression analysis revealed sleep, pain and BMI as the independent predictors of fatigue signaling the presence of physiological (sleep, pain, BMI) phenomenon that could undermine health outcomes.	[Singh, Rupali] Sage Coll, Dept Phys Therapy, Troy, NY 12180 USA; [Teel, Cynthia] Univ Kansas, Med Ctr, Sch Nursing, Kansas City, KS 66103 USA; [Sabus, Carla; Kluding, Patricia] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66103 USA; [McGinnis, Patricia] Stockton Univ, Dept Phys Therapy, Galloway, NJ USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Singh, R (corresponding author), Sage Coll, Dept Phys Therapy, Troy, NY 12180 USA.	singhr@sage.edu		Singh, Rupali/0000-0002-8747-3999				Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Aistars J, 1987, Oncol Nurs Forum, V14, P25; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Anderson RM, 1997, DIABETES CARE, V20, P299, DOI 10.2337/diacare.20.3.299; Benbow SJ, 1998, QJM-INT J MED, V91, P733, DOI 10.1093/qjmed/91.11.733; Bonora E, 2001, DIABETES CARE, V24, P2023, DOI 10.2337/diacare.24.12.2023; Bonora E, 2001, DIABETOLOGIA, V44, P2107, DOI 10.1007/s001250100020; Borneman Tami, 2012, Clin J Oncol Nurs, V16, pE26, DOI 10.1188/12.CJON.E26-E32; Bradley C, 2002, DIABETES-METAB RES, V18, pS64, DOI 10.1002/dmrr.279; Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100; Brown GC, 2000, J DIABETES COMPLICAT, V14, P18, DOI 10.1016/S1056-8727(00)00061-1; BRUNO RL, 1993, ARCH PHYS MED REHAB, V74, P1061, DOI 10.1016/0003-9993(93)90062-F; Bulpitt CJ, 1998, DIABETES CARE, V21, P111, DOI 10.2337/diacare.21.1.111; Buysse D J, 1989, Psychiatry Res, V28, P193; Chasens ER, 2013, DIABETES EDUCATOR, V39, P74, DOI 10.1177/0145721712467683; Coleman EA, 2011, CANCER NURS, V34, P219, DOI 10.1097/NCC.0b013e3181f9904d; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Cuellar NG, 2008, J CLIN SLEEP MED, V4, P50; du Bois RM, 2014, EUR RESPIR J, V43, P1421, DOI 10.1183/09031936.00131813; Egede LE, 2003, DIABETES CARE, V26, P104, DOI 10.2337/diacare.26.1.104; Field A, 2013, DISCOVERING STAT USI; Fritschi C, 2012, DIABETES EDUCATOR, V38, P662, DOI 10.1177/0145721712450925; Funk S, 1989, PROJECT DNR KEY ASPE, DOI [10.1111/J.1365-2702.2006.01349.X, DOI 10.1111/J.1365-2702.2006.01349.X]; Garber CE, 2003, NEUROLOGY, V60, P1119, DOI 10.1212/01.WNL.0000055868.06222.AB; GIBSON H, 1985, SPORTS MED, V2, P120, DOI 10.2165/00007256-198502020-00004; Glasgow RE, 1997, DIABETES CARE, V20, P562, DOI 10.2337/diacare.20.4.562; Goldman MD, 2008, MULT SCLER J, V14, P383, DOI 10.1177/1352458507082607; Goldney RD, 2004, DIABETES CARE, V27, P1066, DOI 10.2337/diacare.27.5.1066; Hamilton D M, 2000, J Cardiopulm Rehabil, V20, P156, DOI 10.1097/00008483-200005000-00003; HERMANN LS, 1979, DIABETES METAB, V5, P233; Huibers MJH, 2007, J PSYCHOSOM RES, V63, P137, DOI 10.1016/j.jpsychores.2007.02.014; Hume C, 2010, DIABETES EDUCATOR, V36, P495, DOI 10.1177/0145721710368326; Ingle L, 2006, J AM COLL CARDIOL, V47, P1909, DOI 10.1016/j.jacc.2006.02.005; Kanade RV, 2006, DIABETOLOGIA, V49, P1747, DOI 10.1007/s00125-006-0309-1; Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914; Khurana R, 2010, POSTGRAD MED J, V86, P371, DOI 10.1136/hrt.2009.173773; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Kong DL, 2011, DIABETES RES CLIN PR, V94, P45, DOI 10.1016/j.diabres.2011.05.026; Lasselin J, 2012, PSYCHONEUROENDOCRINO, V37, P1468, DOI 10.1016/j.psyneuen.2012.01.016; Lin Jin-Mann S, 2009, Popul Health Metr, V7, P18, DOI 10.1186/1478-7954-7-18; Magnusson K, 1999, EUR J CANCER CARE, V8, P224; Morrato EH, 2007, DIABETES CARE, V30, P203, DOI 10.2337/dc06-1128; Morsch CM, 2006, J CLIN NURS, V15, P498, DOI 10.1111/j.1365-2702.2006.01349.x; Nortvedt MW, 1999, MULT SCLER, V5, P317, DOI 10.1177/135245859900500503; Park H, 2015, J ADV NURS, V71, P1650, DOI 10.1111/jan.12632; Portenoy R K, 1999, Oncologist, V4, P1; Rayburn WF, 1997, J REPROD MED, V42, P585; Ream E, 1996, INT J NURS STUD, V33, P519, DOI 10.1016/0020-7489(96)00004-1; Redeker N S, 2000, Sch Inq Nurs Pract, V14, P275; Resnick HE, 2003, DIABETES CARE, V26, P702, DOI 10.2337/diacare.26.3.702; Resnick HE, 2006, J CLIN SLEEP MED, V2, P163; Rijken PM, 1998, DISABIL REHABIL, V20, P330, DOI 10.3109/09638289809166090; Rose L, 1998, J ADV NURS, V28, P295, DOI 10.1046/j.1365-2648.1998.00789.x; Ryerson B, 2003, DIABETES CARE, V26, P206, DOI 10.2337/diacare.26.1.206; Sachedina N, 2003, DIABETIC MED, V20, P1012, DOI 10.1046/j.1464-5491.2003.01037.x; Siegel K, 2012, J PAIN SYMPTOM MANAG, V44, P52, DOI 10.1016/j.jpainsymman.2011.07.013; Singh R, 2013, DIABETES EDUCATOR, V39, P320, DOI 10.1177/0145721713479144; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Soon SS, 2010, APPL HEALTH ECON HEA, V8, P239, DOI 10.2165/11313920-000000000-00000; St Pierre B A, 1992, Oncol Nurs Forum, V19, P419; STEWART AL, 1994, J CLIN EPIDEMIOL, V47, P719, DOI 10.1016/0895-4356(94)90169-4; Surani S, 2015, WORLD J DIABETES, V6, P868, DOI 10.4239/wjd.v6.i6.868; Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490; Thomas N, 2004, POSTGRAD MED J, V80, P287, DOI 10.1136/pgmj.2003.010553; Trendall J, 2000, J ADV NURS, V32, P1126, DOI 10.1046/j.1365-2648.2000.01583.x; van Weert E, 2006, ONCOLOGIST, V11, P184, DOI 10.1634/theoncologist.11-2-184; VanderDoes FEE, 1996, DIABETES CARE, V19, P204, DOI 10.2337/diacare.19.3.204; Vigg A, 2003, J Assoc Physicians India, V51, P479; Visser MRM, 1998, SUPPORT CARE CANCER, V6, P101, DOI 10.1007/s005200050142; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; Wandell PE, 1997, SCAND J PRIM HEALTH, V15, P97, DOI 10.3109/02813439709018495; Warren RE, 2003, DIABETES-METAB RES, V19, P408, DOI 10.1002/dmrr.396; Watkins K, 2004, PHARMACOECONOMICS, V22, P1109, DOI 10.2165/00019053-200422170-00002; Wei M, 2000, ANN INTERN MED, V132, P605, DOI 10.7326/0003-4819-132-8-200004180-00002; Weijman I, 2004, J OCCUP ENVIRON MED, V46, P828, DOI 10.1097/01.jom.0000135605.62330.ca; Weijman I, 2003, OCCUP ENVIRON MED, V60, P93; Wilmoth MC, 2004, ONCOL NURS FORUM, V31, P1069, DOI 10.1188/04.ONF.1069-1075; Winningham M L, 1994, Oncol Nurs Forum, V21, P23; Wu MS, 2010, INT J NURS STUD, V47, P49, DOI 10.1016/j.ijnurstu.2009.05.026	79	30	30	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165652	10.1371/journal.pone.0165652	http://dx.doi.org/10.1371/journal.pone.0165652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BE	27824886	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200026
J	Sugiura, Y; Tanimoto, Y; Imbe, A; Inaba, Y; Sakai, S; Shishikura, K; Tanimoto, K; Hanafusa, T				Sugiura, Yumiko; Tanimoto, Yoshimi; Imbe, Ayumi; Inaba, Yuiko; Sakai, Satoshi; Shishikura, Kanako; Tanimoto, Keiji; Hanafusa, Toshiaki			Association between Functional Capacity Decline and Nutritional Status Based on the Nutrition Screening Initiative Checklist: A 2-Year Cohort Study of Japanese Community-Dwelling Elderly	PLOS ONE			English	Article							OLDER-ADULTS; HEALTH; INDEX; NSI	Aim To assess whether nutritional status based on the Nutrition Screening Initiative Checklist is useful for predicting functional capacity decline in community-dwelling Japanese elderly. Methods This two-year observational cohort study included 536 community-dwelling Japanese (65 years and older at baseline) who were independent in both activities and instrumental activities of daily living. Demographic attributes, chronic illness, lifestyle-related habits, nutritional status, functional capacity, and anthropometric measurements were assessed, with decline in functional capacity used as the outcome measure. Results Subjects were classified into three groups as follows based on the Nutrition Screening Initiative Checklist: low (59.5%), moderate (23.7%), and high (16.8%) nutritional risk. Significant differences were found between nutritional status and the following four baseline variables: age, hypertension, cerebrovascular diseases, and current smoking. However, no significant differences were evident between nutritional status and sex, body mass index, diabetes, drinking habit, or exercise habit. Logistic regression analysis adjusted for age, sex, body mass index, hypertension, cerebrovascular diseases and smoking habit showed that the high nutritional risk group was significantly associated with a decline in both activities of daily living (odds ratio: 4.96; 95% confidence interval (CI): 1.59-15.50) and instrumental activities of daily living (OR: 2.58; 95% CI: 1.31-5.06) compared with the low nutritional risk group. Conclusions Poor nutritional status based on the Nutrition Screening Initiative Checklist was associated with a decline in functional capacity over a 2-year period in community-dwelling Japanese elderly. These results suggest that the Nutrition Screening Initiative Checklist is a suitable tool for predicting functional capacity decline in community-dwelling elderly.	[Sugiura, Yumiko] Med Corp Hatsunekai, Sugiura Clin, Kariya, Aichi, Japan; [Tanimoto, Yoshimi; Imbe, Ayumi; Inaba, Yuiko; Sakai, Satoshi; Shishikura, Kanako; Tanimoto, Keiji; Hanafusa, Toshiaki] Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka, Japan	Osaka Medical College	Tanimoto, Y (corresponding author), Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka, Japan.	hyg022@osaka-med.ac.jp			Japan Society for the Promotion of Science KAKENHI Grant [24590823]	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 24590823.	Aida J, 2012, J AM GERIATR SOC, V60, P338, DOI 10.1111/j.1532-5415.2011.03791.x; BARROCAS A, 1995, J AM DIET ASSOC, V95, P647, DOI 10.1016/S0002-8223(95)00177-8; Bartlett S, 1997, GERIATRIC NUTR HDB, P27; Cabinet Office Government of Japan, 2013, WHIT PAP AG SOC VERS; Chen CCH, 2007, J CLIN NURS, V16, P2015, DOI 10.1111/j.1365-2702.2006.01867.x; de Groot LCPGM, 1998, EUR J CLIN NUTR, V52, P877, DOI 10.1038/sj.ejcn.1600658; Fujiwara Y, 2008, GERONTOLOGY, V54, P373, DOI 10.1159/000151221; Ishizaki T, 2002, ARCH GERONTOL GERIAT, V35, P107, DOI 10.1016/S0167-4943(02)00002-X; Kamo T, 2014, GERIATR GERONTOL INT, V14, P799, DOI 10.1111/ggi.12169; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Keller HH, 2004, J GERONTOL A-BIOL, V59, P68; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Kumagai Shu, 2003, Nihon Koshu Eisei Zasshi, V50, P1117; Kusabiraki Toshiyuki, 2014, Bulletin of the Osaka Medical College, V60, P27; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Alvarenga MRM, 2010, REV ESC ENFERM USP, V44, P1041; Nutrition Screening Initiative, 1991, REP NUTR SCREEN 1 CO; Okamura T, 2008, J AM GERIATR SOC, V56, P529, DOI 10.1111/j.1532-5415.2007.01549.x; Phillips MB, 2010, ASIA PAC J CLIN NUTR, V19, P440; POSNER BM, 1993, AM J PUBLIC HEALTH, V83, P972, DOI 10.2105/AJPH.83.7.972; REUBEN DB, 1995, J AM GERIATR SOC, V43, P415, DOI 10.1111/j.1532-5415.1995.tb05818.x; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Sherina M S Jr, 2004, Malays J Nutr, V10, P149; Simsek H, 2014, GERIATR GERONTOL INT, V14, P960, DOI 10.1111/ggi.12166; Takahashi Ryutaro, 2006, Nihon Ronen Igakkai Zasshi, V43, P375; WHITE JV, 1991, J AM DIET ASSOC, V91, P783; Yap K. B., 2007, SMJ Singapore Medical Journal, V48, P911	27	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166037	10.1371/journal.pone.0166037	http://dx.doi.org/10.1371/journal.pone.0166037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BE	27824916	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200056
J	Li, CM; Lim, S; Braunewell, KH; Ames, JB				Li, Congmin; Lim, Sunghyuk; Braunewell, Karl H.; Ames, James B.			Structure and Calcium Binding Properties of a Neuronal Calcium-Myristoyl Switch Protein, Visinin-Like Protein 3	PLOS ONE			English	Article							GUANYLYL CYCLASE; SENSOR PROTEINS; SUBCELLULAR-LOCALIZATION; MOLECULAR-STRUCTURE; APO-CALMODULIN; IQ MOTIF; VILIP-1; HIPPOCALCIN; FAMILY; DREAM	Visinin-like protein 3 (VILIP-3) belongs to a family of Ca2+-myristoyl switch proteins that regulate signal transduction in the brain and retina. Here we analyze Ca2+ binding, characterize Ca2+-induced conformational changes, and determine the NMR structure of myristoylated VILIP-3. Three Ca2+ bind cooperatively to VILIP-3 at EF2, EF3 and EF4 (K-D = 0.52 mu M and Hill slope of 1.8). NMR assignments, mutagenesis and structural analysis indicate that the covalently attached myristoyl group is solvent exposed in Ca2+-bound VILIP-3, whereas Ca2+-free VILIP-3 contains a sequestered myristoyl group that interacts with protein residues (E26, Y64, V68), which are distinct from myristate contacts seen in other Ca2+-myristoyl switch proteins. The myristoyl group in VILIP-3 forms an unusual L-shaped structure that places the C-14 methyl group inside a shallow protein groove, in contrast to the much deeper myristoyl binding pockets observed for recoverin, NCS-1 and GCAP1. Thus, the myristoylated VILIP-3 protein structure determined in this study is quite different from those of other known myristoyl switch proteins (recoverin, NCS-1, and GCAP1). We propose that myristoylation serves to fine tune the three-dimensional structures of neuronal calcium sensor proteins as a means of generating functional diversity.	[Li, Congmin; Lim, Sunghyuk; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Braunewell, Karl H.] Ruhr Univ Bochum, Fac Med, Dept Neurophysiol, Bochum, Germany	University of California System; University of California Davis; Ruhr University Bochum	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	jbames@ucdavis.edu			NIH [EY012347]; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by NIH grant EY012347.	Adams PJ, 2014, CELL, V159, P608, DOI 10.1016/j.cell.2014.09.047; Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; AMES JB, 1995, J BIOL CHEM, V270, P4526, DOI 10.1074/jbc.270.9.4526; Ames JB, 1995, J BIOL CHEM, V270, P30909, DOI 10.1074/jbc.270.52.30909; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Badger J, 1999, PROTEINS, V35, P25, DOI 10.1002/(SICI)1097-0134(19990401)35:1<25::AID-PROT3>3.3.CO;2-M; BAGBY S, 1994, STRUCTURE, V2, P107, DOI 10.1016/S0969-2126(00)00013-7; Bernstein HG, 1999, J NEUROCYTOL, V28, P655, DOI 10.1023/A:1007056731551; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Chagot B, 2011, J MOL BIOL, V406, P106, DOI 10.1016/j.jmb.2010.11.046; Chen KC, 2009, J PEPT SCI, V15, P89, DOI 10.1002/psc.1097; Clore GM, 1997, NAT STRUCT BIOL, V4, P849; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Feldkamp MD, 2011, STRUCTURE, V19, P733, DOI 10.1016/j.str.2011.02.009; Gomez-Villafuertes R, 2005, J NEUROSCI, V25, P10822, DOI 10.1523/JNEUROSCI.3912-05.2005; Hoffman L, 2014, J BIOL CHEM, V289, P14644, DOI 10.1074/jbc.M114.560656; Johny MB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2727; Kim KS, 2012, BIOPHYS J, V103, P2446, DOI 10.1016/j.bpj.2012.11.002; KOBAYASHI M, 1993, J BIOL CHEM, V268, P18898; LADANT D, 1995, J BIOL CHEM, V270, P3179; Li CM, 2014, BIOMOL NMR ASSIGN, V8, P63, DOI 10.1007/s12104-012-9453-3; Li CM, 2011, J BIOL CHEM, V286, P6354, DOI 10.1074/jbc.M110.173724; Lim S, 2016, J BIOL CHEM, V291, P4429, DOI 10.1074/jbc.M115.696161; Lim S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208868; Liu ZH, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00038; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Osawa M, 2001, J BIOL CHEM, V276, P41005, DOI 10.1074/jbc.M105842200; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Paterlini M, 2000, NEUROSCIENCE, V99, P205, DOI 10.1016/S0306-4522(00)00201-3; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Scsucova S, 2005, NUCLEIC ACIDS RES, V33, P2269, DOI 10.1093/nar/gki503; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Spilker C, 2000, NEUROSCIENCE, V96, P121, DOI 10.1016/S0306-4522(99)00536-9; Spilker C, 2003, MOL CELL NEUROSCI, V24, P766, DOI 10.1016/S1044-7431(03)00242-2; Spilker C, 2002, BBA-PROTEINS PROTEOM, V1600, P118, DOI 10.1016/S1570-9639(02)00452-1; Spilker C, 2002, J NEUROSCI, V22, P7331; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Tiruppathi C, 2014, NAT IMMUNOL, V15, P239, DOI 10.1038/ni.2823; Tzingounis AV, 2007, NEURON, V53, P487, DOI 10.1016/j.neuron.2007.01.011; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	51	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165921	10.1371/journal.pone.0165921	http://dx.doi.org/10.1371/journal.pone.0165921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820860	Green Submitted, gold, Green Published			2022-12-27	WOS:000387614800026
J	Babiker, F; Al-Jarallah, A; Joseph, S				Babiker, Fawzi; Al-Jarallah, Aishah; Joseph, Shaji			The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL-INFARCTION; TYPE-1 RECEPTOR; II FORMATION; CHYMASE; HEART; STRESS; INHIBITION; MECHANISMS	Background Accumulating evidence suggests a cardioprotective role of pacing postconditioning (PPC) maneuvers in animal models and more recently in humans. The procedure however remains to be optimized and its interaction with physiological systems remains to be further explored. The renin angiotensin system (RAS) plays a dual role in ischemia/reperfusion (I/R) injury. The interaction between RAS and PPC induced cardiac protection is however not clearly understood. We have recently demonstrated that angiotensin (1-7) via Mas receptor played a significant role in PPC mediated cardiac protection against I/R injury. Objective The objective of this study was to investigate the role of angiotensin converting enzyme (ACE) D chymase D angiotensin II (Ang II) D angiotensin receptor 1 (AT1) axes of RAS in PPC mediated cardiac protection. Methods Isolated rat hearts were subjected to I/R (control) or PPC in the presence or absence of Ang II, chymostatin (inhibitor of locally produced Ang II), ACE blocker (captopril) or AT1 antagonist (irbesartan). Hemodynamics data was computed digitally and infarct size was determined histologically using TTC staining and biochemically by measuring creatine kinase (CK) and lactate dehydrogenase levels. Results Cardiac hemodynamics were significantly (P<0.001) improved and infarct size and cardiac enzymes were significantly (P<0.001) reduced in hearts subjected to PPC relative to hearts subjected to I/R injury. Exogenous administration of Ang II did not affect I/R injury or PPC mediated protection. Nonetheless inhibition of endogenously synthesized Ang II protected against I/R induced cardiac damage yet did not block or augment the protective effects of PPC. The administration of AT1 antagonist did not alleviate I/R induced damage. Interestingly it abrogated PPC induced cardiac protection in isolated rat hearts. Finally, PPC induced protection and blockade of locally produced Ang II involved enhanced activation of ERK1/2 and Akt components of the reperfusion injury salvage kinase (RISK) pathway. Conclusions This study demonstrate a novel role of endogenously produced Ang II in mediating I/R injury and highlights the significance of AT1 signaling in PPC mediated cardiac protection in isolated rodents hearts ex vivo. The interaction between Ang II-AT1 and PPC appears to involve alterations in the activation state of ERK1/2 and Akt components of the RISK pathway.	[Babiker, Fawzi; Joseph, Shaji] Kuwait Univ, Dept Physiol, Fac Med, Hlth Sci Ctr, Jabriya, Kuwait; [Al-Jarallah, Aishah] Kuwait Univ, Dept Biochem, Fac Med, Hlth Sci Ctr, Jabriya, Kuwait	Kuwait University; Kuwait University	Babiker, F (corresponding author), Kuwait Univ, Dept Physiol, Fac Med, Hlth Sci Ctr, Jabriya, Kuwait.	Fawzi.b@hsc.edu.kw			Research Administration Kuwait University grant [MY 02/ 10]	Research Administration Kuwait University grant	This work is supported by Research Administration, Kuwait University, grant #MY 02/ 10.	Abwainy A, 2016, AM J PHYSIOL-HEART C, V310, pH104, DOI 10.1152/ajpheart.00121.2015; Babiker FA, 2006, ARTERIOSCL THROM VAS, V26, P1524, DOI 10.1161/01.ATV.0000223344.11128.23; Babiker FA, 2014, J PHYSIOL BIOCHEM, V70, P151, DOI 10.1007/s13105-013-0289-9; Babiker FA, 2010, BASIC RES CARDIOL, V105, P523, DOI 10.1007/s00395-010-0095-2; Bice JS, 2015, BRIT J PHARMACOL, V172, P1933, DOI 10.1111/bph.12976; Bouhidel JO, 2014, FRONT BIOSCI-LANDMRK, V19, P566, DOI 10.2741/4227; Carey RM, 2003, ENDOCR REV, V24, P261, DOI 10.1210/er.2003-0001; Cat AND, 2012, CURR OPIN NEPHROL HY, V21, P147, DOI 10.1097/MNH.0b013e32834fb25b; Clausmeyer S, 2000, ENDOCRINOLOGY, V141, P2963, DOI 10.1210/en.141.8.2963; Daugherty A, 2004, TRENDS CARDIOVAS MED, V14, P117, DOI 10.1016/j.tcm.2004.01.002; De Mello WC, 2011, PEPTIDES, V32, P1774, DOI 10.1016/j.peptides.2011.06.018; De Mello WC, 2003, REGUL PEPTIDES, V115, P31, DOI 10.1016/S0167-0115(03)00128-9; de Oliveira UO, 2012, FUND CLIN PHARMACOL, V26, P679, DOI 10.1111/j.1472-8206.2011.00995.x; Dell'Italia LJ, 2002, CURR OPIN CARDIOL, V17, P374, DOI 10.1097/00001573-200207000-00009; DOSTAL DE, 1992, AM J PHYSIOL, V263, pC851, DOI 10.1152/ajpcell.1992.263.4.C851; Ernsberger P, 2007, CURR OPIN PHARMACOL, V7, P140, DOI 10.1016/j.coph.2006.11.008; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Ferrera R, 2009, CARDIOVASC DRUG THER, V23, P327, DOI 10.1007/s10557-009-6176-5; Fleming I, 2006, CIRC RES, V98, P887, DOI 10.1161/01.RES.0000217340.40936.53; Freixa X, 2012, EUR HEART J, V33, P103, DOI 10.1093/eurheartj/ehr297; Garcia RA, 2005, AM J PHYSIOL-HEART C, V288, pH1080, DOI 10.1152/ajpheart.00860.2004; Hahn JY, 2013, CIRCULATION, V128, P1889, DOI 10.1161/CIRCULATIONAHA.113.001690; Hausenloy DJ, 2007, PHARMACOL THERAPEUT, V116, P173, DOI 10.1016/j.pharmthera.2007.06.005; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Ihara M, 1999, HYPERTENSION, V33, P1399, DOI 10.1161/01.HYP.33.6.1399; Ihara M, 2000, CARDIOLOGY, V94, P247, DOI 10.1159/000047325; Jandeleit-Dahm K, 2006, ENDOCRIN METAB CLIN, V35, P469, DOI 10.1016/j.ecl.2006.06.007; Kumar R, 2012, AM J PHYSIOL-REG I, V302, pR510, DOI 10.1152/ajpregu.00512.2011; Kurdi M, 2005, INT J BIOCHEM CELL B, V37, P1357, DOI 10.1016/j.biocel.2005.01.012; Limalanathan S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000679; Lonborg JT, 2015, HEART, V101, P1612, DOI 10.1136/heartjnl-2015-307804; Messadi-Laribi E, 2007, J PHARMACOL EXP THER, V323, P210, DOI 10.1124/jpet.107.124859; Nishimoto M, 2001, J THORAC CARDIOV SUR, V121, P729, DOI 10.1067/mtc.2001.112467; Pagliaro P, 2005, CARDIOVASC DRUG THER, V19, P77, DOI 10.1007/s10557-005-6900-8; Penna C, 2008, J CELL MOL MED, V12, P435, DOI 10.1111/j.1582-4934.2007.00210.x; Pipicz M, 2015, BRIT J PHARMACOL, V172, P3472, DOI 10.1111/bph.13154; Prosser HCG, 2009, CARDIOVASC RES, V82, P40, DOI 10.1093/cvr/cvp003; Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65; Sharma A, 2000, PHARMACOL RES, V41, P635, DOI 10.1006/phrs.1999.0631; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Tsang A, 2004, CIRC RES, V95, P230, DOI 10.1161/01.RES.0000138303.76488.fe; Uehara Y, 2002, CARDIOVASC RES, V55, P870, DOI 10.1016/S0008-6363(02)00458-3; Urata H, 2000, J Renin Angiotensin Aldosterone Syst, V1, pS35; Vanagt WY, 2007, J AM COLL CARDIOL, V49, P1813, DOI 10.1016/j.jacc.2007.01.070; Vanagt WY, 2006, CIRCULATION, V114, pI264, DOI 10.1161/CIRCULATIONAHA.105.000893; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Waltenberger J, 2014, JACC-CARDIOVASC IMAG, V7, P620, DOI 10.1016/j.jcmg.2014.01.017; Yasuda N, 2008, EMBO REP, V9, P179, DOI 10.1038/sj.embor.7401157; Yetgin T, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0403-3; Zablocki D, 2011, CURR HYPERTENS REP, V13, P129, DOI 10.1007/s11906-011-0180-4; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	54	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165777	10.1371/journal.pone.0165777	http://dx.doi.org/10.1371/journal.pone.0165777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814397	Green Published, Green Submitted, gold			2022-12-27	WOS:000386911100018
J	Ohno, Y; Fujita, K; Toyofuku, T; Nakamaura, T				Ohno, Yoshikazu; Fujita, Kazuhiko; Toyofuku, Takashi; Nakamaura, Takashi			Cytological Observations of the Large Symbiotic Foraminifer Amphisorus kudakajimensis Using Calcein Acetoxymethyl Ester	PLOS ONE			English	Article							BENTHIC FORAMINIFERA; ALLOGROMIA-LATICOLLARIS; RETICULOPODIAL NETWORK; INTRACELLULAR PH; CELLS; CALCIFICATION; MICROTUBULES; PHYLOGENY; MOTILITY; PROTOZOA	Large benthic foraminifera are unicellular calcifying reef organisms that can form symbiotic relationships with a range of different microalgae. However, the cellular functions, such as symbiosis and calcification, and other aspects of cellular physiology in large benthic foraminifera are not fully understood. Amphisorus kudakajimensis was used as a model to determine the detailed cellular characteristics of large benthic foraminifera. We used calcein acetoxymethyl ester (calcein AM) as a fluorescent indicator for live confocal imaging. We demonstrated that calcein AM is a useful fluorescent indicator to stain the fine network of reticulopodia and the cytoplasm in living A. kudakajimensis. We showed that at least two types of reticulopodia exist in A. kudakajimensis: the straight bundle of reticulopodia that spreads from the aperture and the fine reticulopodia along the surface of the aperture and chamber walls. The cytoplasm in outer chambers was highly branched and contained a few dinoflagellates. In contrast, the inner chamberlets contained condensed cytoplasm and many dinoflagellates, suggesting that the cytoplasm of A. kudakajimensis performs different functions based on its location within the large test. Our confocal detailed image analysis provides real-time cellular morphology and cell physiology of living foraminifera.	[Ohno, Yoshikazu] Univ Ryukyus, Grad Sch Engn & Sci, Marine & Environm Sci Course, Senbaru 1, Nishihara, Okinawa 9030213, Japan; [Fujita, Kazuhiko] Univ Ryukyus, Fac Sci, Dept Phys & Earth Sci, Senbaru 1, Nishihara, Okinawa 9030213, Japan; [Fujita, Kazuhiko; Nakamaura, Takashi] Univ Ryukyus, Trop Biosphere Res Ctr, Senbaru 1, Nishihara, Okinawa 9030213, Japan; [Toyofuku, Takashi] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Marine Biodivers Res B DIVE, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan; [Nakamaura, Takashi] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Senbaru 1, Nishihara, Okinawa 9030213, Japan; [Nakamaura, Takashi] Japan Sci & Technol Agcy JST, Japan Int Cooperat Agcy JICA SATREPS, Chiyoda Ku, 8th Floor,Ks Gobancho 7, Tokyo 1020076, Japan	University of the Ryukyus; University of the Ryukyus; University of the Ryukyus; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of the Ryukyus; Japan Science & Technology Agency (JST)	Ohno, Y (corresponding author), Univ Ryukyus, Grad Sch Engn & Sci, Marine & Environm Sci Course, Senbaru 1, Nishihara, Okinawa 9030213, Japan.	yoshikazu.ohno7@gmail.com	Ohno, Yoshikazu/AAU-9366-2021; Takashi, Toyofuku/E-4441-2011	Takashi, Toyofuku/0000-0001-8095-6077; Kazuhiko, Fujita/0000-0002-9833-007X; Ohno, Yoshikazu/0000-0002-6179-0363	KAKENHI [24340131];  [15J04797]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	This work was supported by KAKENHI (24340131), Grant-in-Aid for JSPS Fellows (15J04797), URL: https//www.jsps.go.jp/english/e-grants/; and The International Research Hub Project for Climate Change, and Coral Reef/Island Dynamics Department of the University of the Ryukyus, and the University of the Ryukyus Foundation, URL: http://www.u-ryukyu.ac.jp/en.	Allen R. D., 1964, PRIMITIVE MOTILE SYS, P407; Bentov S, 2005, GEOLOGY, V33, P841, DOI 10.1130/G21800.1; Bentov S, 2009, P NATL ACAD SCI USA, V106, P21500, DOI 10.1073/pnas.0906636106; BERNHARD JM, 1992, MAR ECOL PROG SER, V83, P263, DOI 10.3354/meps083263; Bernhard JM, 2004, J FORAMIN RES, V34, P96, DOI 10.2113/0340096; Bernhard JM, 1996, J MICROPALAEONTOL, V15, P68, DOI 10.1144/jm.15.1.68; Bernhard JM, 2000, MICROPALEONTOLOGY, V46, P38; Bernhard JM, 2008, J EUKARYOT MICROBIOL, V55, P135, DOI 10.1111/j.1550-7408.2008.00318.x; Bernhard JM, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001290; BOWSER SS, 1985, TISSUE CELL, V17, P823, DOI 10.1016/0040-8166(85)90039-4; Bowser SS, 2002, J FORAMIN RES, V32, P440, DOI 10.2113/0320440; BOWSER SS, 1988, J CELL SCI, V89, P297; CALLEWAERT DM, 1991, CYTOMETRY, V12, P666, DOI 10.1002/cyto.990120711; Cavalier-Smith T, 2003, EUR J PROTISTOL, V39, P338, DOI 10.1078/0932-4739-00002; Cedhagen T, 2002, J FORAMIN RES, V32, P434, DOI 10.2113/0320434; de Nooijer LJ, 2009, BIOGEOSCIENCES, V6, P2669, DOI 10.5194/bg-6-2669-2009; de Nooijer LJ, 2008, LIMNOL OCEANOGR-METH, V6, P610, DOI 10.4319/lom.2008.6.610; de Nooijer LJ, 2009, P NATL ACAD SCI USA, V106, P15374, DOI 10.1073/pnas.0904306106; DECLERCK LS, 1994, J IMMUNOL METHODS, V172, P115, DOI 10.1016/0022-1759(94)90384-0; DENHOLM EM, 1995, CYTOKINE, V7, P436, DOI 10.1006/cyto.1995.0059; Dissard D, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002417; Fujita K, 2000, MAR MICROPALEONTOL, V38, P267, DOI 10.1016/S0377-8398(99)00042-0; GUDMUNDSSON G, 1994, MICROPALEONTOLOGY, V40, P101, DOI 10.2307/1485772; Hamann S, 2002, J FLUORESC, V12, P139, DOI 10.1023/A:1016832027325; Hemleben C., 1989, MODERN PLANKTONIC FO, DOI [DOI 10.1016/S0016-6995(89)80108-1, DOI 10.1007/978-1-4612-3544-6_2]; Knight R., 1986, Journal of Micropalaeontology, V5, P83; Kruger R, 1997, ARCH PROTISTENKD, V147, P307; Kurtarkar SR, 2015, MAR MICROPALEONTOL, V114, P36, DOI 10.1016/j.marmicro.2014.10.001; Lee JJ, 1997, J FORAMIN RES, V27, P254, DOI 10.2113/gsjfr.27.4.254; Lee JJ, 1991, BIOL FORAMINIFERA, P91; Lee JJ, 2006, SYMBIOSIS, V42, P63; LEUTENEGGER S, 1979, MAR BIOL, V54, P11, DOI 10.1007/BF00387046; LIPPS JH, 1973, ANNU REV MICROBIOL, V27, P471, DOI 10.1146/annurev.mi.27.100173.002351; Lipps JH, 1993, FOSSIL PROKARYOTES A; MULLERMERZ E, 1976, J PROTOZOOL, V23, P390, DOI 10.1111/j.1550-7408.1976.tb03793.x; Neri S, 2001, CLIN DIAGN LAB IMMUN, V8, P1131, DOI 10.1128/CDLI.8.6.1131-1135.2001; Orokos DD, 2000, CELL MOTIL CYTOSKEL, V47, P296, DOI 10.1002/1097-0169(200012)47:4<296::AID-CM4>3.0.CO;2-4; ROTTGER R, 1974, MAR BIOL, V26, P5, DOI 10.1007/BF00389081; SAVIN SM, 1975, GEOL SOC AM BULL, V86, P1499, DOI 10.1130/0016-7606(1975)86<1499:TMP>2.0.CO;2; Tawakoli PN, 2013, CLIN ORAL INVEST, V17, P841, DOI 10.1007/s00784-012-0792-3; Toyofuku T, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001772; TRAVIS JL, 1983, J CELL BIOL, V97, P1668, DOI 10.1083/jcb.97.6.1668; TRAVIS JL, 1981, J CELL BIOL, V90, P211, DOI 10.1083/jcb.90.1.211; Tyszka J, 2005, STUD GEOL POLON, V124, P143; Vogel N, 2012, J EXP MAR BIOL ECOL, V424, P15, DOI 10.1016/j.jembe.2012.05.008; West CA, 2001, J HISTOCHEM CYTOCHEM, V49, P511, DOI 10.1177/002215540104900411; Zachos JC, 1986, PALEOCEANOGRAPHY, V1, P5, DOI 10.1029/PA001i001p00005	47	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165844	10.1371/journal.pone.0165844	http://dx.doi.org/10.1371/journal.pone.0165844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812157	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000070
J	Rodriguez, N; Bollen, J; Ahn, YY				Rodriguez, Nathaniel; Bollen, Johan; Ahn, Yong-Yeol			Collective Dynamics of Belief Evolution under Cognitive Coherence and Social Conformity	PLOS ONE			English	Article							OPINION DYNAMICS; MINORITY; DISSONANCE; ATTITUDES; BALANCE; MODELS	Human history has been marked by social instability and conflict, often driven by the irreconcilability of opposing sets of beliefs, ideologies, and religious dogmas. The dynamics of belief systems has been studied mainly from two distinct perspectives, namely how cognitive biases lead to individual belief rigidity and how social influence leads to social conformity. Here we propose a unifying framework that connects cognitive and social forces together in order to study the dynamics of societal belief evolution. Each individual is endowed with a network of interacting beliefs that evolves through interaction with other individuals in a social network. The adoption of beliefs is affected by both internal coherence and social conformity. Our framework may offer explanations for how social transitions can arise in otherwise homogeneous populations, how small numbers of zealots with highly coherent beliefs can overturn societal consensus, and how belief rigidity protects fringe groups and cults against invasion from mainstream beliefs, allowing them to persist and even thrive in larger societies. Our results suggest that strong consensus may be insufficient to guarantee social stability, that the cognitive coherence of belief-systems is vital in determining their ability to spread, and that coherent belief-systems may pose a serious problem for resolving social polarization, due to their ability to prevent consensus even under high levels of social exposure. We argue that the inclusion of cognitive factors into a social model could provide a more complete picture of collective human dynamics.	[Rodriguez, Nathaniel; Bollen, Johan; Ahn, Yong-Yeol] Indiana Univ, Sch Informat & Comp, Ctr Complex Networks & Syst Res, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Ahn, YY (corresponding author), Indiana Univ, Sch Informat & Comp, Ctr Complex Networks & Syst Res, Bloomington, IN 47405 USA.	yyahn@indiana.edu	Ahn, Yong-Yeol/C-6334-2011	Ahn, Yong-Yeol/0000-0002-4352-4301	Microsoft Research and Defense Advanced Research Projects Agency NGS2 program [D17AC00005]	Microsoft Research and Defense Advanced Research Projects Agency NGS2 program(Microsoft)	Microsoft Research and Defense Advanced Research Projects Agency NGS2 program (grant #D17AC00005) contributed funding to the project, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdyan AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099557; Alvarez-Galvez J, 2016, SOC SCI COMPUT REV, V34, P567, DOI 10.1177/0894439315605607; Antal T, 2006, PHYSICA D, V224, P130, DOI 10.1016/j.physd.2006.09.028; Arendt DL, 2015, COMPUT MATH ORGAN TH, V21, P184, DOI 10.1007/s10588-015-9181-1; Asch S., 1951, ORG INFLUENCE PROCES; ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Axelrod R., 2009, J CONFLICT RESOLUT, V42, P203; Britannica E., 2014, HIST OF EUROPE; CARTWRIGHT D, 1956, PSYCHOL REV, V63, P277, DOI 10.1037/h0046049; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; CLIFFORD P, 1973, BIOMETRIKA, V60, P581, DOI 10.2307/2335008; Daniel S., 2000, INTRO THERMAL PHYS; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; Doreian P, 2002, SOC NETWORKS, V24, P93, DOI 10.1016/S0378-8733(01)00051-X; ELLIOT AJ, 1994, J PERS SOC PSYCHOL, V67, P382, DOI 10.1037/0022-3514.67.3.382; Evans EM, 2001, COGNITIVE PSYCHOL, V42, P217, DOI 10.1006/cogp.2001.0749; Festinger L., 1962, THEORY COGNITIVE DIS; Galam S, 2002, EUR PHYS J B, V25, P403, DOI 10.1140/epjb/e20020045; Galam S, 2000, PHYSICA A, V287, P644, DOI 10.1016/S0378-4371(00)00399-X; Galam S, 2008, INT J MOD PHYS C, V19, P409, DOI 10.1142/S0129183108012297; Galehouse D, 2014, P 5 INT C APPL HUM F, P2318; Goldstone RL, 2005, TRENDS COGN SCI, V9, P424, DOI 10.1016/j.tics.2005.07.009; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; Hammond RA, 2006, J CONFLICT RESOLUT, V50, P926, DOI 10.1177/0022002706293470; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Hitler McDonough F., 2012, HITLER RISE NAZI PAR; Hoffer E., 1966, TRUE BELIEVER THOUGH; Hummon NP, 2003, SOC NETWORKS, V25, P17, DOI 10.1016/S0378-8733(02)00019-9; Javarone MA, 2014, PHYSICA A, V414, P19, DOI 10.1016/j.physa.2014.07.018; Javarone MA, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/45/455102; Kashisaz H, 2014, PHYSICA A, V402, P49, DOI 10.1016/j.physa.2014.01.055; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lazer D, 2001, J MATH SOCIOL, V25, P69, DOI 10.1080/0022250X.2001.9990245; LORD CG, 1979, J PERS SOC PSYCHOL, V37, P2098, DOI 10.1037/0022-3514.37.11.2098; Marvel SA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.198701; Mason WA, 2007, PERS SOC PSYCHOL REV, V11, P279, DOI 10.1177/1088868307301032; Masuda N, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/02/L02002; Masuda N, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.010103; Matz DC, 2005, J PERS SOC PSYCHOL, V88, P22, DOI 10.1037/0022-3514.88.1.22; MCGARTY C, 1992, BRIT J SOC PSYCHOL, V31, P253, DOI 10.1111/j.2044-8309.1992.tb00971.x; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mobilia M, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/08/P08029; Mobilia M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.028701; Mobilia M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046102; Mobilia M, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012803; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Nishi R, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062123; Pechey R, 2012, J COGN CULT, V12, P81, DOI 10.1163/156853712X633947; Pechey R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048446; Quine Willard, 1970, WEB BELIEF; Rivera MT, 2010, ANNU REV SOCIOL, V36, P91, DOI 10.1146/annurev.soc.34.040507.134743; Rohkramer T., 2007, GERMAN RIGHT CONSERV; Schilling MA, 2005, CREATIVITY RES J, V17, P131, DOI 10.1207/s15326934crj1702&3_2; Sekara V, 2016, P NATL ACAD SCI USA, V113, P9977, DOI 10.1073/pnas.1602803113; Shi F, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062818; Sood V, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041121; Sowell T., 2002, CONFLICT VISIONS IDE; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Taber CS, 2006, AM J POLIT SCI, V50, P755, DOI 10.1111/j.1540-5907.2006.00214.x; Tessone CJ, 2004, EUR PHYS J B, V39, P535, DOI 10.1140/epjb/e2004-00227-5; Thagard Paul, 2000, COHERENCE THOUGHT AC; Waagen A, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.022811; Wang SW, 2014, SIMUL-T SOC MOD SIM, V90, P238, DOI 10.1177/0037549713515029; Xie J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011130	67	19	19	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165910	10.1371/journal.pone.0165910	http://dx.doi.org/10.1371/journal.pone.0165910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812210	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000079
J	Wang, JJ; Yang, YP; Sun, H; Wen, J; Deng, T; Nie, ZL; Meng, Y				Wang, Jia-Jian; Yang, Yong-Ping; Sun, Hang; Wen, Jun; Deng, Tao; Nie, Ze-Long; Meng, Ying			The Biogeographic South-North Divide of Polygonatum (Asparagaceae Tribe Polygonateae) within Eastern Asia and Its Recent Dispersals in the Northern Hemisphere	PLOS ONE			English	Article							HISTORICAL BIOGEOGRAPHY; MOLECULAR PHYLOGENETICS; DNA-SEQUENCES; EVOLUTION; TERTIARY; AMERICA; DIVERSIFICATION; DISJUNCT; ANGIOSPERMS; CHINA	Eastern Asia (EA) is a key region for the diversification of flowering plants in the Northern Hemisphere, but few studies have focused on the biogeographic history within EA in the context of the other northern continents. Polygonatum is an important medicinal genus widely distributed in the Northern Hemisphere with its highest species richness in EA, and it represents an excellent model for studying the evolution of biogeographic patterns in this region. Divergence time estimation was used to examine the biogeographic history of Polygonatum based on nuclear ITS and four plastid sequences (rbcL, matK, psbA-trnH and trnC-petN) from 30 Polygonatum species and 35 outgroup taxa. The ancestral area of Polygonatum and subsequent dispersal routes were inferred using Bayes-Lagrange. Polygonatum was estimated to have originated in southern EA during the middle Miocene (14.34-13.57 Ma) with subsequent south-to-north expansion in the late Miocene. Multiple intercontinental dispersal events were inferred between EA and Europe or North America, and all of them have occurred recently in the late Miocene to Pliocene. The separation of Polygonatum into the south and north lineages and their subsequent diversifications in the late Miocene supports the existence of a biogeographic divide between the northern and southern parts of EA that also coincides with the retreat and redevelopment of the arid zone in EA in the Neogene. Our results demonstrate the complexity of biogeographic history of Polygonatum in the Northern Hemisphere including early vicariance followed by frequent and recent dispersals in the Neogene.	[Wang, Jia-Jian; Nie, Ze-Long; Meng, Ying] Jishou Univ, Coll Biol & Environm Sci, Key Lab Plant Resources Conservat & Utilizat, Jishou 416000, Hunan, Peoples R China; [Yang, Yong-Ping; Sun, Hang; Deng, Tao] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog E Asia, Kunming 650201, Yunnan, Peoples R China; [Wen, Jun] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, MRC 166, Washington, DC 20013 USA	Jishou University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History	Nie, ZL; Meng, Y (corresponding author), Jishou Univ, Coll Biol & Environm Sci, Key Lab Plant Resources Conservat & Utilizat, Jishou 416000, Hunan, Peoples R China.	zelongnie@163.com; mengyingnie@163.com	Wang, Jiajian/I-4126-2019	Nie, Ze-Long/0000-0001-8065-3981	Natural Sciences Foundation of China [NSFC31270273, 31570211, 31590823]; Laboratory of Analytical Biology of the National Museum of Natural History; Smithsonian Institution; Small Grants Program of the National Museum of Natural History	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Laboratory of Analytical Biology of the National Museum of Natural History; Smithsonian Institution(Smithsonian Institution); Small Grants Program of the National Museum of Natural History	This study was supported by grants from Natural Sciences Foundation of China (NSFC31270273, 31570211, 31590823). This work was also partially supported by the Laboratory of Analytical Biology of the National Museum of Natural History, Smithsonian Institution, as well as the Small Grants Program of the National Museum of Natural History, the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1967, BERING LAND BRIDGE; Bai WN, 2016, NEW PHYTOL, V209, P1757, DOI 10.1111/nph.13711; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Beaulieu JM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-80; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Buerki S, 2013, ANN BOT-LONDON, V111, P361, DOI 10.1093/aob/mcs286; Buerki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039377; BUSH BENJAMIN FRANKLIN, 1927, AMER MIDLAND NAT, V10, P385, DOI 10.2307/2993208; Chen S.C., 2000, FLORA CHINA, V24, P223; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059472; Deng XY, 2009, BOT J LINN SOC, V159, P245, DOI 10.1111/j.1095-8339.2008.00944.x; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Donoghue MJ, 2004, PHILOS T R SOC B, V359, P1633, DOI 10.1098/rstb.2004.1538; Donoghue MJ, 2001, INT J PLANT SCI, V162, pS41, DOI 10.1086/323278; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Forest F, 2009, ANN BOT-LONDON, V104, P789, DOI 10.1093/aob/mcp192; Friis E. M., 2011, EARLY FLOWERS ANGIOS; Gandolfo MA, 2002, AM J BOT, V89, P1940, DOI 10.3732/ajb.89.12.1940; Guo ZT, 2008, CLIM PAST, V4, P153, DOI 10.5194/cp-4-153-2008; Hertweck KL, 2015, BOT J LINN SOC, V178, P375, DOI 10.1111/boj.12260; Huang WP, 2013, BOT J LINN SOC, V171, P395, DOI 10.1111/j.1095-8339.2012.01321.x; Iles WJD, 2015, BOT J LINN SOC, V178, P346, DOI 10.1111/boj.12233; Jang C.G., 2002, STAPFIA, V80, P333; JEFFREY C, 1982, Kew Bulletin, V37, P335, DOI 10.2307/4109978; JEFFREY C, 1980, Kew Bulletin, V34, P435, DOI 10.2307/4109822; Judd Walter S., 2003, Harvard Papers in Botany, V7, P93; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kim JH, 2010, ANN BOT-LONDON, V106, P775, DOI 10.1093/aob/mcq167; LI HUI-LIN, 1948, TAIWANIA, V1, P1; Manos PS, 2001, INT J PLANT SCI, V162, pS77, DOI 10.1086/323280; Meng Y, 2008, MOL PHYLOGENET EVOL, V49, P424, DOI 10.1016/j.ympev.2008.07.017; Meng Y, 2014, BOT J LINN SOC, V176, P435, DOI 10.1111/boj.12218; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Milne RI, 2006, ANN BOT-LONDON, V98, P465, DOI 10.1093/aob/mcl148; Nie ZL, 2006, AM J BOT, V93, P1343, DOI 10.3732/ajb.93.9.1343; Nie ZL, 2006, MOL PHYLOGENET EVOL, V40, P155, DOI 10.1016/j.ympev.2006.03.012; Nie ZL, 2016, NEW PHYTOL, V209, P1795, DOI 10.1111/nph.13740; Nie ZL, 2010, AM J BOT, V97, P1342, DOI 10.3732/ajb.1000085; Quandt D, 2010, PHYDE PHYLOGENETIC D; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Rudall PJ, 2000, BOT J LINN SOC, V134, P73, DOI 10.1006/bojl.2000.0365; SHINWARI ZK, 1994, PLANT SYST EVOL, V192, P263, DOI 10.1007/BF00986256; Suchard M.A., 2014, TRACER V1 6; Sun XJ, 2005, PALAEOGEOGR PALAEOCL, V222, P181, DOI 10.1016/j.palaeo.2005.03.005; Tamura M. N., 1997, Feddes Repertorium, V108, P159; Tang T., 1978, FLORA REIPUBLICAE PO, V15, P52; TIDWELL WD, 1990, REV PALAEOBOT PALYNO, V62, P79, DOI 10.1016/0034-6667(90)90018-E; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; Wang P X., 1997, CHANGING FACE E ASIA, P263; WANG PX, 1990, PALAEOGEOGR PALAEOCL, V77, P315, DOI 10.1016/0031-0182(90)90183-8; Wang W.-T., 1992, ACTA PHYTOTAXONOMICA, V30, P97; WANG WT, 1992, ACTA PHYTOTAXON SIN, V30, P1, DOI DOI 10.4324/9780429500190-1; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wen J., 2010, DARWINS HERITAGE TOD, P252; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wu ZY., 1998, P 1 INT S FLOR CHAR, P3; Xiang QYJ, 2004, EVOLUTION, V58, P2175, DOI 10.1111/j.0014-3820.2004.tb01596.x; Xiang QYJ, 2001, INT J PLANT SCI, V162, pS29, DOI 10.1086/323332; Xie L, 2009, MOL PHYLOGENET EVOL, V53, P995, DOI 10.1016/j.ympev.2009.09.009; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Zhu WD, 2013, BOT J LINN SOC, V171, P377, DOI 10.1111/j.1095-8339.2012.01318.x	64	13	14	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166134	10.1371/journal.pone.0166134	http://dx.doi.org/10.1371/journal.pone.0166134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812188	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000104
J	Xiao, GJ; Jiang, SW; Qian, LL; Cai, CB; Wang, QQ; Ma, DZ; Li, B; Xie, SS; Cui, WT; Li, K				Xiao, Gao-Jun; Jiang, Sheng-Wang; Qian, Li-Li; Cai, Chun-Bo; Wang, Qing-Qing; Ma, De-Zun; Li, Biao; Xie, Shan-Shan; Cui, Wen-Tao; Li, Kui			A 90-Day Feeding Study in Rats to Assess the Safety of Genetically Engineered Pork	PLOS ONE			English	Article							GENE; GUIDANCE; CATTLE	Our laboratory recently produced genetically engineered (GE) Meishan pigs containing a ZFN-edited myostatin loss-of-function mutant. These GE pigs develop and grow as normal as wild type pigs but produce pork with greater lean yield and lower fat mass. To assess any potential subchronic toxicity risks of this GE pork, a 90-day feeding study was conducted in Sprague-Dawley rats. Rats were randomly divided into five groups, and fed for 90 days with basic diet and basic diets formulated with low dose and high dose pork prepared from wild type pigs and GE pigs, respectively. Animal behaviors and clinical signs were monitored twice daily, and body weight and food consumption were measured and recorded weekly. At days 45 and 90, blood tests (lipid panel, electrolytes, parameters related to liver and kidney functions, and complete blood counts) were performed. Additionally, gross pathology and histopathological analyses were performed for major organs in each group. Data analysis shows that there were no significant differences in growth rate, food consumption, and blood test parameters between rat groups fed with GE pork and wild type pork. Although differences in some liver function parameters (such as aspartate aminotransferase, total proteins, albumin, and alkaline phosphatase) and white blood cell counts (such as lymphocyte percentage and monocyte percentage) were observed between rats fed with high dose GE pork and basic diet, all test results in rats fed with GE pork are in the normal range. Additionally, there are no apparent lesions noted in all organs isolated from rats in all five feeding groups on days 45 and 90. Overall, our results clearly indicate that food consumption of GE pork produced by ZFN-edited myostatin loss-of-function mutant pigs did not have any long-term adverse effects on the health status in rats.	[Xiao, Gao-Jun; Jiang, Sheng-Wang; Cai, Chun-Bo; Wang, Qing-Qing; Ma, De-Zun; Li, Biao; Xie, Shan-Shan; Cui, Wen-Tao; Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China; [Qian, Li-Li; Cai, Chun-Bo] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; China Agricultural University	Cui, WT (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	cuiwentao@caas.cn	钱, 钱丽丽/GWV-8162-2022; xie, shanshan/GSM-8999-2022		National Transgenic Project of China [2011ZX08006-003]; Agricultural Science and Technology Innovation Program [ASTIP-IA505]; Safety Evaluation Project of Transgenic Animals and Feeding Materials [2011-G11]	National Transgenic Project of China; Agricultural Science and Technology Innovation Program; Safety Evaluation Project of Transgenic Animals and Feeding Materials	This work was supported by the National Transgenic Project of China (2011ZX08006-003) the Agricultural Science and Technology Innovation Program (ASTIP-IA505), and Safety Evaluation Project of Transgenic Animals and Feeding Materials (2011-G11). K.L. received the above funding. The funding agents had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson HC, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2501; Antunovic B, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2438; Bai H, 2015, PLOS ONE, V10; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; CHINA SAOTPSRO, 2003, DET AM AC FOODS, p6P; CHINA SAOTPSRO, 2003, DET FAT FOODS, p4P; CHINA SAOTPSRO, 2006, FEED STUFF DET CRUD, p12P; CHINA SAOTPSRO, 2010, NAT FOOD SAF STAND D, p6P; CHINA SAOTPSRO, 2010, NAT FOOD SAF STAND D, p9P; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Ge K. Y Y, 2008, ACTA NUTRIMENTA SINI, V30, P1; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gupta RM, 2014, J CLIN INVEST, V124, P4154, DOI 10.1172/JCI72992; Hashimoto W, 1999, BIOSCI BIOTECH BIOCH, V63, P1942, DOI 10.1271/bbb.63.1942; Hatada I, 2016, ENDOCR J, V63, P105, DOI 10.1507/endocrj.EJ15-0716; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Liu S, 2013, FOOD CHEM TOXICOL, V57, P314, DOI 10.1016/j.fct.2013.04.003; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Qian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14435; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Song H, 2015, TRANSGENIC RES, V24, P295, DOI 10.1007/s11248-014-9844-6; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhu YX, 2013, FOOD CHEM TOXICOL, V51, P280, DOI 10.1016/j.fct.2012.09.008	37	5	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165843	10.1371/journal.pone.0165843	http://dx.doi.org/10.1371/journal.pone.0165843			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812153	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000069
J	Aasted, CM; Yucel, MA; Steele, SC; Peng, K; Boas, DA; Becerra, L; Borsook, D				Aasted, Christopher M.; Yucel, Meryem A.; Steele, Sarah C.; Peng, Ke; Boas, David A.; Becerra, Lino; Borsook, David			Frontal Lobe Hemodynamic Responses to Painful Stimulation: A Potential Brain Marker of Nociception	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; FUNCTIONAL CONNECTIVITY; RATING-SCALES; HUMAN CORTEX; INTENSITY; DISTRACTION; HUMANS; GYRUS	The purpose of this study was to use functional near-infrared spectroscopy (fNIRS) to examine patterns of both activation and deactivation that occur in the frontal lobe in response to noxious stimuli. The frontal lobe was selected because it has been shown to be activated by noxious stimuli in functional magnetic resonance imaging studies. The brain region is located behind the forehead which is devoid of hair, providing a relative ease of placement for fNIRS probes on this area of the head. Based on functional magnetic resonance imaging studies showing blood-oxygenation-level dependent changes in the frontal lobes, we evaluated functional near-infrared spectroscopy measures in response to two levels of electrical pain in awake, healthy human subjects (n = 10; male = 10). Each subject underwent two recording sessions separated by a 30-minute resting period. Data collected from 7 subjects were analyzed, containing a total of 38/36 low/high intensity pain stimuli for the first recording session and 27/31 pain stimuli for the second session. Our results show that there is a robust and significant deactivation in sections of the frontal cortices. Further development and definition of the specificity and sensitivity of the approach may provide an objective measure of nociceptive activity in the brain that can be easily applied in the surgical setting.	[Aasted, Christopher M.; Steele, Sarah C.; Peng, Ke; Becerra, Lino; Borsook, David] Harvard Med Sch, Ctr Pain & Brain, Boston, MA 02115 USA; [Aasted, Christopher M.; Steele, Sarah C.; Peng, Ke; Becerra, Lino; Borsook, David] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Aasted, Christopher M.; Yucel, Meryem A.; Steele, Sarah C.; Peng, Ke; Boas, David A.; Becerra, Lino; Borsook, David] Harvard Med Sch, Boston, MA 02115 USA; [Aasted, Christopher M.; Yucel, Meryem A.; Steele, Sarah C.; Peng, Ke; Boas, David A.; Becerra, Lino; Borsook, David] Massachusetts Gen Hosp, Dept Radiol, Martinos Ctr Biomed Imaging, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Borsook, D (corresponding author), Harvard Med Sch, Ctr Pain & Brain, Boston, MA 02115 USA.; Borsook, D (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA.; Borsook, D (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Borsook, D (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Martinos Ctr Biomed Imaging, Boston, MA 02114 USA.	david.borsook@childrens.harvard.edu		YUCEL, MERYEM/0000-0002-4291-2847	Mayday Foundation; Anesthesia Research Distinguished Trailblazer Award; National Institute of General Medical Science of the National Institutes of Health [R01GM104986]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104986] Funding Source: NIH RePORTER	Mayday Foundation; Anesthesia Research Distinguished Trailblazer Award; National Institute of General Medical Science of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this article was supported by the Mayday Foundation, the Anesthesia Research Distinguished Trailblazer Award, and the National Institute of General Medical Science of the National Institutes of Health under award number R01GM104986. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anticevic A, 2010, COGN AFFECT BEHAV NE, V10, P159, DOI 10.3758/CABN.10.2.159; Barati Z, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.117007; Barati Z, 2013, ANN BIOMED ENG, V41, P223, DOI 10.1007/s10439-012-0642-0; Becerra L, 2008, NEUROIMAGE, V41, P252, DOI 10.1016/j.neuroimage.2008.01.047; Becerra L, 2016, PAIN, V157, P840, DOI 10.1097/j.pain.0000000000000446; Bonhomme V, 2016, ANESTHESIOLOGY, V125, P873, DOI 10.1097/ALN.0000000000001275; Cauda F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004542; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Gohil K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22317; Gold AL, 2015, BIOL PSYCHIAT, V77, P394, DOI 10.1016/j.biopsych.2014.03.030; Hautvast RWM, 1997, EUR J NEUROSCI, V9, P1178, DOI 10.1111/j.1460-9568.1997.tb01472.x; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Kucyi A, 2014, J NEUROSCI, V34, P3969, DOI 10.1523/JNEUROSCI.5055-13.2014; Kussman BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158975; Lee CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075360; Lenz FA, 1998, J NEUROPHYSIOL, V79, P2231, DOI 10.1152/jn.1998.79.4.2231; Lobanov OV, 2013, PAIN, V154, P1758, DOI 10.1016/j.pain.2013.05.030; MANTYH PW, 1982, J COMP NEUROL, V206, P146, DOI 10.1002/cne.902060205; Minamoto T, 2015, CORTEX, V71, P277, DOI 10.1016/j.cortex.2015.07.025; Moayedi M, 2015, BRAIN STRUCT FUNCT, V220, P2603, DOI 10.1007/s00429-014-0809-6; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Porro CA, 1998, J NEUROPHYSIOL, V80, P3312, DOI 10.1152/jn.1998.80.6.3312; Pourshoghi A, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0190-9; Sakuma S, 2014, NEUROSCI LETT, V575, P74, DOI 10.1016/j.neulet.2014.05.040; Simons LE, 2014, HUM BRAIN MAPP, V35, P527, DOI 10.1002/hbm.22199; Svensson P, 1997, J NEUROPHYSIOL, V78, P450, DOI 10.1152/jn.1997.78.1.450; Symonds LL, 2006, J NEUROPHYSIOL, V95, P3823, DOI 10.1152/jn.01162.2005; Wheelock MD, 2014, NEUROIMAGE, V102, P904, DOI 10.1016/j.neuroimage.2014.08.005; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Yucel MA, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.3.035005; Yucel MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09469	32	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165226	10.1371/journal.pone.0165226	http://dx.doi.org/10.1371/journal.pone.0165226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806119	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500022
J	de Moraes, AV; Carvalho, CDS; Carneiro, CC; do Vale, CR; Lima, DCD; Carvalho, WF; Vieira, TB; Silva, DDE; Cunha, KS; Chen-Chen, L				de Moraes Filho, Aroldo Vieira; Silva Carvalho, Claudia de Jesus; Carneiro, Cristiene Costa; do Vale, Camila Regina; da Silva Lima, Debora Cristina; Carvalho, Wanessa Fernandes; Vieira, Thiago Bernardi; de Melo e Silva, Daniela; Cunha, Kenya Silva; Chen-Chen, Lee			Genotoxic and Cytotoxic Effects of Antiretroviral Combinations in Mice Bone Marrow	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; TENOFOVIR DISOPROXIL FUMARATE; HPRT LYMPHOCYTE MUTANTS; COMET ASSAY; MICRONUCLEUS ASSAY; LYMPHOBLASTOID-CELLS; GENETIC-DAMAGE; DNA-DAMAGE; ZIDOVUDINE; LAMIVUDINE	Commonly used guidelines for the management of human immunodeficiency virus (HIV) infection (highly active antiretroviral therapy, HAART) include drug combinations such as tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) and combivir [zidovudine (AZT) + 3TC] + efavirenz (EFV). These combinations may enhance the genotoxic effects induced by such drugs individually, since the therapy requires lifelong adherence and the drugs have unknown effects during treatment. Thus, the evaluation of the benefits and risks of HAART is of great importance. In order to assess the cytotoxic and genotoxic potential of three concentrations of each of the antiretroviral combinations TDF + 3TC (800 + 400, 1600 + 800, and 3200 + 1600 mg/kg body weight, BW) and combivir + EFV (200 + 100 + 400, 400 + 200 + 800, and 800 + 400 + 1600 mg/kg BW) after two exposure periods (24 h and 48 h), in the present study the in vivo comet assay (single-cell gel electrophoresis) and the mouse bone marrow micronucleus test were used. Neither TDF + 3TC nor combivir + EFV induced DNA damage at any concentrations tested after 24 h or 48 h using the comet assay. After 24 h, both combinations increased the micronucleus frequency at all concentrations tested. After 48 h, combivir + EFV increased the micronucleated polychromatic erythrocyte (MNPCE) frequency at the two highest concentrations tested. Polychromatic erythrocytes (PCE)/normochromatic erythrocytes (NCE) ratio was high for both combinations, suggesting that they can be mitogenic. Since genotoxicity may be related to carcinogenesis, it is necessary to conduct further studies to verify the long-term mutagenic effects of these drugs.	[de Moraes Filho, Aroldo Vieira; Silva Carvalho, Claudia de Jesus; Carneiro, Cristiene Costa; do Vale, Camila Regina; da Silva Lima, Debora Cristina; Carvalho, Wanessa Fernandes; de Melo e Silva, Daniela; Cunha, Kenya Silva; Chen-Chen, Lee] Univ Fed Goias, ICB, Dept Genet, Lab Radiobiol & Mutagenese, Campus Samambaia,Caixa Postal 131, BR-74001970 Goiania, Go, Brazil; [Vieira, Thiago Bernardi] Univ Estado Mato Grosso, Programa Posgrad Ecol & Conservacao, Campus Univ Nova Xavantina,BR 158,Caixa Postal 8, BR-78690000 Nova Xavantina, MT, Brazil	Universidade Federal de Goias; Universidade do Estado de Mato Grosso	de Moraes, AV (corresponding author), Univ Fed Goias, ICB, Dept Genet, Lab Radiobiol & Mutagenese, Campus Samambaia,Caixa Postal 131, BR-74001970 Goiania, Go, Brazil.	aroldodemoraes@gmail.com	Chen-Chen, Lee/Q-9797-2019; Filho, Aroldo Moraes/AAQ-5257-2021; Vieira, Thiago Bernardi/H-4520-2017; Vieira, Thiago Bernardi/P-5233-2015; Chen, Lee Chen/B-1668-2013	Chen-Chen, Lee/0000-0002-0386-247X; Vieira, Thiago Bernardi/0000-0003-1762-8294; Vieira, Thiago Bernardi/0000-0003-1762-8294; Chen, Lee Chen/0000-0002-0386-247X; Carvalho, Wanessa Fernandes/0000-0003-4297-5191	CAPES Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior	CAPES Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by CAPES Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior.	Anderson PL, 2003, AIDS, V17, P2159, DOI 10.1097/00002030-200310170-00003; Attia SM, 2014, MUTAGENESIS, V29, P55, DOI 10.1093/mutage/get063; Barditch-Crovo P, 2001, ANTIMICROB AGENTS CH, V45, P2733, DOI 10.1128/AAC.45.10.2733-2739.2001; Bayram S, 2008, ENVIRON MOL MUTAGEN, V49, P328, DOI 10.1002/em.20393; Bialkowska A, 2000, CARCINOGENESIS, V21, P1059, DOI 10.1093/carcin/21.5.1059; Bishop JB, 2004, ENVIRON MOL MUTAGEN, V43, P3, DOI 10.1002/em.10210; Bisset LR, 2002, ANTIVIR RES, V53, P35, DOI 10.1016/S0166-3542(01)00190-5; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Brambilla G, 2011, MUTAGENESIS, P1, DOI [10.1093/mutage/ger052, DOI 10.1093/MUTAGE/GER052]; Brambilla G, 2012, MUTAT RES-REV MUTAT, V750, P1, DOI 10.1016/j.mrrev.2011.09.002; Carter MM, 2007, ENVIRON MOL MUTAGEN, V48, P239, DOI 10.1002/em.20282; Cihlar T, 2002, ANTIVIR RES, V54, P37, DOI 10.1016/S0166-3542(01)00210-8; COLEGIO BRASILEIRO DE EXPERIMENTACAO ANIMAL-COBEA, 1991, PRINC ET EXP AN; Collins A, 2014, MUTAT RES-REV MUTAT, V759, P27, DOI 10.1016/j.mrrev.2013.10.001; Collins AR, 2014, BBA-GEN SUBJECTS, V1840, P794, DOI 10.1016/j.bbagen.2013.04.022; de Baar MP, 2007, ANTIVIR RES, V76, P68, DOI 10.1016/j.antiviral.2007.05.004; de Oliveira HM, 2014, ENVIRON TOXICOL PHAR, V37, P390, DOI 10.1016/j.etap.2013.12.011; Decordier I, 2002, MUTAGENESIS, V17, P337, DOI 10.1093/mutage/17.4.337; Decordier I, 2008, MUTAT RES-GEN TOX EN, V651, P30, DOI 10.1016/j.mrgentox.2007.10.016; Diaz-Delfin J, 2011, ANTIVIR RES, V91, P112, DOI 10.1016/j.antiviral.2011.04.018; Duan CY, 2001, J INFECT DIS, V184, P1336, DOI 10.1086/323995; Ehteshami M, 2008, J BIOL CHEM, V283, P29904, DOI 10.1074/jbc.M804882200; Escobar PA, 2007, ENVIRON MOL MUTAGEN, V48, P330, DOI 10.1002/em.20285; Friedrich A, 2011, REGUL TOXICOL PHARM, V60, P225, DOI 10.1016/j.yrtph.2011.04.001; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Godschalk RWL, 2013, MUTAT RES-GEN TOX EN, V757, P60, DOI 10.1016/j.mrgentox.2013.06.020; Guimaraes NN, 2013, FOOD CHEM TOXICOL, V53, P299, DOI 10.1016/j.fct.2012.12.005; Hartmann A, 2004, MUTAGENESIS, V19, P51, DOI 10.1093/mutage/geg038; HAYASHI M, 1994, MUTAT RES, V312, P293, DOI 10.1016/0165-1161(94)90039-6; Hecht M, 2013, AIDS, V27, P2031, DOI 10.1097/QAD.0b013e3283625444; HEDDLE JA, 1973, MUTAT RES, V18, P187, DOI 10.1016/0027-5107(73)90035-3; Herd O., 2014, Journal of AIDS and Clinical Research, V5, P397; Krishna G, 2000, MUTAT RES-FUND MOL M, V455, P155, DOI 10.1016/S0027-5107(00)00117-2; Lei FX, 2011, CHIN J ANTIBIOT; Lourenco ED, 2010, GENET MOL BIOL, V33, P756, DOI 10.1590/S1415-47572010005000084; MACGREGOR JT, 1987, MUTAT RES, V189, P103, DOI 10.1016/0165-1218(87)90016-4; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2016, GUIDELINES USE ANTIR; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ribaudo HJ, 2006, CLIN INFECT DIS, V42, P401, DOI 10.1086/499364; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; SCHILLING BE, 1995, CURR THER RES CLIN E, V56, P201, DOI 10.1016/0011-393X(95)85025-2; SCHLEGEL R, 1984, MUTAT RES, V127, P169, DOI 10.1016/0027-5107(84)90018-6; SHAFIK HM, 1991, ANTIVIR RES, V16, P205, DOI 10.1016/0166-3542(91)90026-N; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Tripathi DN, 2008, MUTAT RES-GEN TOX EN, V653, P134, DOI 10.1016/j.mrgentox.2008.03.004; Von Tungeln LS, 2007, ENVIRON MOL MUTAGEN, V48, P258, DOI 10.1002/em.20237; Von Tungeln LS, 2002, CARCINOGENESIS, V23, P1427, DOI 10.1093/carcin/23.9.1427; Walker DM, 2009, ENVIRON MOL MUTAGEN, V50, P460, DOI 10.1002/em.20482; Wu KM, 2012, INT J TOXICOL, V31, P211, DOI 10.1177/1091581812439585; Xiang GG, 2013, FOOD CHEM TOXICOL, V53, P352, DOI 10.1016/j.fct.2012.12.020	51	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165706	10.1371/journal.pone.0165706	http://dx.doi.org/10.1371/journal.pone.0165706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806085	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500051
J	Nagata, JM; Gippetti, J; Wager, S; Chavez, A; Wise, PH				Nagata, Jason M.; Gippetti, James; Wager, Stefan; Chavez, Alejandro; Wise, Paul H.			Prevalence and Predictors of Malnutrition among Guatemalan Children at 2 Years of Age	PLOS ONE			English	Article							TZUTUJIL MAYA; INTERVENTIONS; CHILDHOOD; SUPPLEMENTATION; PATTERNS; WATER	Objective To identify the prevalence and predictors of malnutrition among 2-year old children in the Western Highlands of Guatemala. Methods Prospective cohort of 852 Guatemalan children in San Lucas Toliman, Guatemala followed from birth to age 2 from May 2008 to December 2013. Socio-demographic, anthropometric, and health data of children was collected at 2 month intervals. Results Among the 402 males and 450 females in the cohort, mean weight-for-age Z-score (WAZ) declined from -0.67 +/- 1.01 at 1 year to -1.07 +/- 0.87 at 2 years, while mean height-for-age Z-score (HAZ) declined from -1.88 +/- 1.19 at 1 year to -2.37 +/- 0.99 at 2 years. Using multiple linear regression modeling, number of children <5 years old, vomiting in the past week, fever in the past week, and WAZ at 1 year were significant predictors of WAZ at 2 years. Significant predictors of HAZ at 2 years included household size, number of children <5 years old, diarrhea in the past week, WAZ at 1 year, and HAZ at 1 year. Vomiting in the past week and WAZ at 1 year were significant predictors of weight-for-height z-score (WHZ) at 2 years. Conclusions Number of children <5 years old, symptoms such as vomiting or diarrhea in the previous week, and prior nutritional status were the most significant predictors of malnutrition in this cohort. Future research may focus on the application of models to develop predictive algorithms for mobile device technology, as well as the identification of other predictors of malnutrition that are not well characterized such as the interaction of environmental exposures with protein consumption and epigenetics.	[Nagata, Jason M.; Wise, Paul H.] Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA; [Gippetti, James; Chavez, Alejandro; Wise, Paul H.] Stanford Univ, Ctr Hlth Policy, Palo Alto, CA 94304 USA; [Gippetti, James; Chavez, Alejandro; Wise, Paul H.] Stanford Univ, Ctr Primary Care & Outcomes Res, Palo Alto, CA 94304 USA; [Wager, Stefan] Stanford Univ, Grad Sch Business, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Stanford University	Nagata, JM (corresponding author), Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA.	jasonmnagata@gmail.com		Nagata, Jason/0000-0002-6541-0604	Mary Duke Biddle Clinical Scholars Program at Stanford University	Mary Duke Biddle Clinical Scholars Program at Stanford University	JMN was supported by the Mary Duke Biddle Clinical Scholars Program at Stanford University, http://globalhealth.stanford.edu/field-service/mary-duke.html. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrman JR, 2009, AM J CLIN NUTR, V90, P1372, DOI 10.3945/ajcn.2009.27524; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berngard SC, 2013, EARLY HUM DEV, V89, P967, DOI 10.1016/j.earlhumdev.2013.09.008; Bhaskaram P, 2002, NUTR REV, V60, pS40, DOI 10.1301/00296640260130722; Brown K, 2014, MATERN CHILD NUTR; Chanani S., 2016, FOOD NUTR B; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Frongillo EA, 1997, J NUTR, V127, P2302, DOI 10.1093/jn/127.12.2302; HABICHT JP, 1995, J NUTR, V125, pS1042; Hien Nguyen Ngoc, 2008, J Prev Med Public Health, V41, P232, DOI 10.3961/jpmph.2008.41.4.232; Islam MM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-11; Kinyoki DK, 2015, PUBLIC HEALTH NUTR, P1; Lakkam M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099632; Lundeen EA, 2014, AM J CLIN NUTR, V100, P821, DOI 10.3945/ajcn.114.084368; Maleta K, 2003, PAEDIATR PERINAT EP, V17, P384, DOI 10.1046/j.1365-3016.2003.00519.x; Nagahori C, 2015, NURS HEALTH SCI, V17, P229, DOI 10.1111/nhs.12176; Nagata JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091403; Nagata JM, 2013, DIABETES TECHNOL THE, V15, P606, DOI 10.1089/dia.2013.0058; Nagata JM, 2011, ECOL FOOD NUTR, V50, P297, DOI 10.1080/03670244.2011.568911; Nagata JM, 2011, REV PANAM SALUD PUBL, V29, P9; Nagata JM, 2009, ECON HUM BIOL, V7, P96, DOI 10.1016/j.ehb.2009.02.002; Nandy S, 2005, B WORLD HEALTH ORGAN, V83, P210; Oruamabo RS, 2015, ARCH DIS CHILD, V100, pS19, DOI 10.1136/archdischild-2013-305384; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; Schrezenmeir J, 2004, CLIN PEDIATR, V43, P239, DOI 10.1177/000992280404300305; Stein AD, 2010, AM J HUM BIOL, V22, P353, DOI 10.1002/ajhb.20998; United Nations, 2014, MILL DEV GOALS REP 2; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0164772	10.1371/journal.pone.0164772	http://dx.doi.org/10.1371/journal.pone.0164772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806066	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500012
J	Tomitaka, S; Kawasaki, Y; Ide, K; Akutagawa, M; Yamada, H; Furukawa, TA; Ono, Y				Tomitaka, Shinichiro; Kawasaki, Yohei; Ide, Kazuki; Akutagawa, Maiko; Yamada, Hiroshi; Furukawa, Toshiaki A.; Ono, Yutaka			Relationship between Item Responses of Negative Affect Items and the Distribution of the Sum of the Item Scores in the General Population	PLOS ONE			English	Article							DEPRESSION; COMMUNITY; DISORDER; SAMPLE	Background Several studies have shown that total depressive symptom scores in the general population approximate an exponential pattern, except for the lower end of the distribution. The Center for Epidemiologic Studies Depression Scale (CES-D) consists of 20 items, each of which may take on four scores: rarely, "some,'' ''occasionally,'' and ''most of the time.'' Recently, we reported that the item responses for 16 negative affect items commonly exhibit exponential patterns, except for the level of ''rarely,'' ''leading us to hypothesize that the item responses at the level of ''rarely'' may be related to the non-exponential pattern typical of the lower end of the distribution. To verify this hypothesis, we investigated how the item responses contribute to the distribution of the sum of the item scores. Methods Data collected from 21,040 subjects who had completed the CES-D questionnaire as part of a Japanese national survey were analyzed. To assess the item responses of negative affect items, we used a parameter r, which denotes the ratio of ''rarely'' to ''some'' in each item response. The distributions of the sum of negative affect items in various combinations were analyzed using log-normal scales and curve fitting. Results The sum of the item scores approximated an exponential pattern regardless of the combination of items, whereas, at the lower end of the distributions, there was a clear divergence between the actual data and the predicted exponential pattern. At the lower end of the distributions, the sum of the item scores with high values of r exhibited higher scores to those predicted from the exponential pattern, whereas the sum of the item scores with low values of r exhibited lower scores compared to those predicted.compared Conclusions The distributional pattern of the sum of the item scores could be predicted from the item responses of such items.	[Tomitaka, Shinichiro] Panason Hlth Ctr, Dept Mental Hlth, Tokyo, Japan; [Tomitaka, Shinichiro; Kawasaki, Yohei; Ide, Kazuki; Akutagawa, Maiko; Yamada, Hiroshi] Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka, Japan; [Furukawa, Toshiaki A.] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Promot & Human Behav, Kyoto, Japan; [Ono, Yutaka] Ctr Dev Cognit Behav Therapy Training, Tokyo, Japan	University of Shizuoka; Kyoto University	Tomitaka, S (corresponding author), Panason Hlth Ctr, Dept Mental Hlth, Tokyo, Japan.; Tomitaka, S (corresponding author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka, Japan.	tomitaka.shinichiro@jp.panasonic.com	Ide, Kazuki/H-3154-2018; Furukawa, Toshi A./B-9259-2011	Ide, Kazuki/0000-0001-6377-1361; Furukawa, Toshi A./0000-0003-2159-3776; Kawasaki, Yohei/0000-0002-7474-7647; Tomitaka, Shinichiro/0000-0002-7161-6967				Adult psychiatric morbidity in England, 2007, RESULTS OF A HOUSEHO; Bebbington PE, 2013, BRIT J PSYCHIAT, V202, P419, DOI 10.1192/bjp.bp.112.119032; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Brugha TS, 2004, BRIT J PSYCHIAT, V185, P378, DOI 10.1192/bjp.185.5.378; Dragulescu A, 2000, EUR PHYS J B, V17, P723, DOI 10.1007/s100510070114; Kaji T, 2010, PSYCHIAT CLIN NEUROS, V64, P426, DOI 10.1111/j.1440-1819.2010.02097.x; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Melzer D, 2002, PSYCHOL MED, V32, P1195, DOI 10.1017/S0033291702006049; Ministry of Health Labor and Welfare Statistics and Information Department, 2002, ACT SURV HLTH WELF H; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Shima S, 1985, PSYCHIATRY, V27, P717, DOI DOI 10.11477/MF.1405203967; Tomitaka S, 2016, P JAP JOINT STAT M, V56; Tomitaka S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147577; Tomitaka S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008599; Tomitaka S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114624	17	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165928	10.1371/journal.pone.0165928	http://dx.doi.org/10.1371/journal.pone.0165928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806132	gold, Green Submitted, Green Published			2022-12-27	WOS:000386715500072
J	Wang, SY; Newman, IM; Shell, DF				Wang, Shiyuan; Newman, Ian M.; Shell, Duane F.			Cultural Orientation and Its Associations with Alcohol Use by University Students in China	PLOS ONE			English	Article							BINGE DRINKING; ADOLESCENTS; ZIMBABWE	Cultural orientation is defined as an individual's cultural preferences when encountering imported culture while still living in the native culture. Data was analyzed from 1305 Chinese university students attending universities in Beijing, Kunming, and Wuhan. Cultural orientation was assessed with the Chinese Cultural Orientation Questionnaire, which assesses both Western and Traditional Chinese cultural orientations. The analysis used hierarchical logistic regression with nondrinkers as the reference group and controlling for demographic factors (age, gender, and urban/rural background). Western cultural orientation was found to significantly increase the odds of recent drinking. The results indicated that higher Western cultural orientation was, after gender, the second most important factor associated with Chinese college student drinking frequency. Traditional Chinese cultural orientation was not associated with drinking frequency. This study highlights an unexpected outcome of globalization on students who have not left their home cultures.	[Wang, Shiyuan; Newman, Ian M.; Shell, Duane F.] Univ Nebraska, Dept Educ Psychol, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Newman, IM (corresponding author), Univ Nebraska, Dept Educ Psychol, Lincoln, NE 68588 USA.	inewman1@unl.edu		Newman, Ian/0000-0002-4669-7064				Chen SX, 2008, J PERS, V76, P803, DOI 10.1111/j.1467-6494.2008.00505.x; COLON I, 1994, J ADDICT DIS, V13, P59, DOI 10.1300/J069v13n02_05; Eide AH, 1998, J CROSS CULT PSYCHOL, V29, P343, DOI 10.1177/0022022198292005; Eide AH, 1997, J ADOLESCENCE, V20, P511, DOI 10.1006/jado.1997.0106; Eide AH, 1996, ADDICTION, V91, P807; Hanson D. J., 1995, PREVENTING ALCOHOL A; Hao W, 2005, ADDICTION, V100, P737, DOI 10.1111/j.1360-0443.2005.01036.x; Hao W., 2000, J SUBST USE, V5, P71, DOI [DOI 10.3109/14659890009053065, 10.3109/14659890009053065]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kim JH, 2008, ALCOHOL ALCOHOLISM, V43, P360, DOI 10.1093/alcalc/agm181; Ma Y, 2011, ZHONGHUA YU FANG YI, V45, P323; Newman I.M., 2004, CHIN J DRUG ABUS PRE, V10, P272; Newman IM, 2009, ZHONG GUO XUE XIAO W, V30, P1139; Pan SW, 2006, APPL ECON LETT, V13, P975, DOI 10.1080/13504850500425964; Pedhazur EJ., 1997, MULTIPLE REGRESSION, V3rd ed; Qian Ling, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P235; Rehm J, 2003, EUR ADDICT RES, V9, P147, DOI 10.1159/000072221; Shell DF, 2010, ADDICTION, V105, P1608, DOI 10.1111/j.1360-0443.2010.03006.x; Tang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054796; Wang SV, 2011, THESIS; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Xing Y, 2006, J ADOLESCENT HEALTH, V39, P495, DOI 10.1016/j.jadohealth.2006.03.014; Xue J., 2002, THESIS; Xue J., 2006, THESIS; Xue J.P., 2007, ZHONGGUO WIESHENG TO, V24, P386; Yuan JM, 1997, BRIT MED J, V314, P18, DOI 10.1136/bmj.314.7073.18	26	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165858	10.1371/journal.pone.0165858	http://dx.doi.org/10.1371/journal.pone.0165858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806096	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500062
J	Hall, SE; Schubert, E; Wilson, SJ				Hall, Sarah E.; Schubert, Emery; Wilson, Sarah J.			The Role of Trait and State Absorption in the Enjoyment of Music	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; EVERYDAY LIFE; LOVED MUSIC; SAD MUSIC; RESPONSES; EXPERIENCES; PREFERENCES; EMOTIONS; OPENNESS; SCALE	Little is known about the role of state versus trait characteristics on our enjoyment of music. The aim of this study was to investigate the influence of state and trait absorption upon preference for music, particularly preference for music that evokes negative emotions. The sample consisted of 128 participants who were asked to listen to two pieces of self-selected music and rate the music on variables including preference and felt and expressed emotions. Participants completed a brief measure of state absorption after listening to each piece, and a trait absorption inventory. State absorption was strongly positively correlated with music preference, whereas trait absorption was not. Trait absorption was related to preference for negative emotions in music, with chi-square analyses demonstrating greater enjoyment of negative emotions in music among individuals with high trait absorption. This is the first study to show that state and trait absorption have separable and distinct effects on a listener's music experience, with state characteristics impacting music enjoyment in the moment, and trait characteristics influencing music preference based on its emotional content.	[Hall, Sarah E.; Wilson, Sarah J.] Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic, Australia; [Schubert, Emery] Univ New South Wales, Sch Arts & Media, Sydney, NSW, Australia	University of Melbourne; University of New South Wales Sydney	Schubert, E (corresponding author), Univ New South Wales, Sch Arts & Media, Sydney, NSW, Australia.	e.schubert@unsw.edu.au		Hall, Sarah/0000-0002-3000-5975; Schubert, Emery/0000-0002-6541-8083	Australian Research Council [FT120100053]	Australian Research Council(Australian Research Council)	This study was supported by the Australian Research Council (http://www.arc.gov.au/future-fellowships), FT120100053 held by ES.; This research was supported by the Australian Research Council (FT120100053).	Agarwal R, 2000, MIS QUART, V24, P665, DOI 10.2307/3250951; [Anonymous], 1999, C1 CTR RES PSYCH, DOI DOI 10.1002/PER.2410010304; Csikszentmihalyi M., 1991, FLOW PSYCHOL OPTIMAL; Eerola T., 2015, PSYCHOMUSICOLOGY MUS, V25, P116, DOI [DOI 10.1037/PMU0000096, 10.1037/pmu0000096]; FINNAS L, 1989, B COUN RES MUSIC ED, P1; Gabrielsson Alf, 2011, STRONG EXPERIENCES M; Garrido S, 2011, MUSIC PERCEPT, V28, P279, DOI 10.1525/MP.2011.28.3.279; GLISKY ML, 1993, INT J CLIN EXP HYP, V41, P112, DOI 10.1080/00207149308414542; Herbert R, 2012, MUSIC SCI, V16, P41, DOI 10.1177/1029864911423161; Honing H, 2008, EMPIR MUSICOL REV, V3, P4, DOI 10.18061/1811/31692; Hunter PG, 2008, COGNITION EMOTION, V22, P327, DOI 10.1080/02699930701438145; Hunter PG, 2010, SPRINGER HANDB AUDIT, V36, P129, DOI 10.1007/978-1-4419-6114-3_5; Huron D, 2011, MUSIC SCI, V15, P146, DOI 10.1177/1029864911401171; Jackson SA, 1996, J SPORT EXERCISE PSY, V18, P17, DOI 10.1123/jsep.18.1.17; Jameson E, 2011, PAIN RES MANAG, V16, P27, DOI 10.1155/2011/856014; Jamieson GA, EMPIRICAL TEST UNPUB; Jamieson GrahamA., 2005, AUST J CLIN EXP HYPN, V33, P119, DOI DOI 10.1037/T14465-000; Juslin PN, 2013, PHYS LIFE REV, V10, P235, DOI 10.1016/j.plrev.2013.05.008; Kreutz G, 2008, PSYCHOL MUSIC, V36, P101, DOI 10.1177/0305735607082623; Lowis MJ, 2002, CREATIVITY RES J, V14, P351, DOI 10.1207/S15326934CRJ1434_6; McCrae R.R., 1993, IMAGIN COGN PERS, V13, P39, DOI [10.2190/H8H6-QYKR-KEU8-GAQ0, DOI 10.2190/H8H6-QYKR-KEU8-GAQ0]; Menard S.W., 1995, APPL LOGISTIC REGRES, V2nd ed.; North AC, 2004, MUSIC PERCEPT, V22, P41, DOI 10.1525/mp.2004.22.1.41; North AC, 1996, J ENVIRON PSYCHOL, V16, P55, DOI 10.1006/jevp.1996.0005; PEKALA RJ, 1985, J PERS SOC PSYCHOL, V48, P125, DOI 10.1037/0022-3514.48.1.125; Pekala RJ, 1991, QUANTIFYING CONSCIOU; Plutchik R., 1962, EMOTIONS FACTS THEOR; Rentfrow PJ, 2003, J PERS SOC PSYCHOL, V84, P1236, DOI 10.1037/0022-3514.84.6.1236; RHODES LA, 1988, PERCEPT MOTOR SKILL, V66, P737, DOI 10.2466/pms.1988.66.3.737; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; ROCHE SM, 1990, J PERS SOC PSYCHOL, V59, P91, DOI 10.1037/0022-3514.59.1.91; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Salimpoor VN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007487; Schubert E, 2012, P 30 ISME WORLD C MU; Schubert E., 1996, PSYCHOL MUSIC, V24, P18, DOI [10.1177/0305735696241003, DOI 10.1177/0305735696241003]; Schubert E., 2007, PSYCHOL MUSIC, V35, P499, DOI [10.1177/0305735607072657, DOI 10.1177/0305735607072657]; Schubert E, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00312; Schubert E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00837; Schubert E, 2013, MUSIC SCI, V17, P11, DOI 10.1177/1029864912461321; Schubert E, 2010, PSYCHOL AESTHET CREA, V4, P36, DOI 10.1037/a0016316; Smuts A, 2007, J AESTHET EDUC, V41, P59, DOI 10.1353/jae.2007.0029; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; Vuoskoski JK, 2012, MUSIC PERCEPT, V29, P311, DOI 10.1525/MP.2012.29.3.311; WILD TC, 1995, J PERS SOC PSYCHOL, V69, P569; Yorke M, 2001, BRIT EDUC RES J, V27, P171, DOI 10.1080/01411920120037126; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	47	14	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164029	10.1371/journal.pone.0164029	http://dx.doi.org/10.1371/journal.pone.0164029			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27828970	Green Published, gold			2022-12-27	WOS:000387724300012
J	Marongiu, L; Shain, E; Drumright, L; Lillestol, R; Somasunderam, D; Curran, MD				Marongiu, Luigi; Shain, Eric; Drumright, Lydia; Lillestol, Reidun; Somasunderam, Donald; Curran, Martin D.			Analysis of TaqMan Array Cards Data by an Assumption-Free Improvement of the maxRatio Algorithm Is More Accurate than the Cycle-Threshold Method	PLOS ONE			English	Article							REAL-TIME PCR; VALIDATION; AGREEMENT	Quantitative PCR diagnostic platforms are moving towards increased sample throughput, with instruments capable of carrying out thousands of reactions at once already in use. The need for a computational tool to reliably assist in the validation of the results is therefore compelling. In the present study, 328 residual clinical samples provided by the Public Health England at Addenbrooke's Hospital (Cambridge, UK) were processed by TaqMan Array Card assay, generating 15 744 reactions from 54 targets. The amplification data were analysed by the conventional cycle-threshold (CT) method and an improvement of the maxRatio (MR) algorithm developed to filter out the reactions with irregular amplification profiles. The reactions were also independently validated by three raters and a consensus was generated from their classification. The inter-rater agreement by Fleiss' kappa was 0.885; the agreement between either CT or MR with the raters gave Fleiss' kappa 0.884 and 0.902, respectively. Based on the consensus classification, the CT and MR methods achieved an assay accuracy of 0.979 and 0.987, respectively. These results suggested that the assumption-free MR algorithm was more reliable than the CT method, with clear advantages for the diagnostic settings.	[Marongiu, Luigi; Drumright, Lydia; Lillestol, Reidun] Univ Cambridge, Dept Med, Cambridge CB2 0QQ, Cambs, England; [Shain, Eric] Grove St Technol LLC, 459 Grove St, Glencoe, IL 60022 USA; [Somasunderam, Donald; Curran, Martin D.] Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Publ Hlth England, Hills Rd, Cambridge CB2 0QW, Cambs, England; [Marongiu, Luigi] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Marongiu, Luigi] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Public Health England; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Marongiu, L (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 0QQ, Cambs, England.; Marongiu, L (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland.; Marongiu, L (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland.	luigi.marongiu@ed.ac.uk	Marongiu, Luigi/O-9964-2014	Marongiu, Luigi/0000-0003-4720-7087; Drumright, Lydia/0000-0002-3361-8080	National Institute for Health Research Cambridge Biomedical Research Centre (NIHR-BRC) [CDF-2011-04-017]; Isaac Newton / Wellcome Trust / University of Cambridge Joint Research Grant; NIHR-BRC; National Institute for Health Research [CDF-2011-04-017] Funding Source: researchfish	National Institute for Health Research Cambridge Biomedical Research Centre (NIHR-BRC); Isaac Newton / Wellcome Trust / University of Cambridge Joint Research Grant; NIHR-BRC; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the National Institute for Health Research Cambridge Biomedical Research Centre (NIHR-BRC) [CDF-2011-04-017] and Isaac Newton / Wellcome Trust / University of Cambridge Joint Research Grant. Funding for open access charge: NIHR-BRC. Grove Street Technology LLC provided support in the form of salaries for authors LM RL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Benaglia T, 2009, J STAT SOFTW, V32, P1; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Darragh TM, 2013, CANCER CYTOPATHOL, V121, P72, DOI 10.1002/cncy.21218; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Fardy John M., 2009, V473, P127, DOI 10.1007/978-1-59745-385-1_7; Gasparic MB, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-26; Gisev N, 2013, RES SOC ADMIN PHARM, V9, P330, DOI 10.1016/j.sapharm.2012.04.004; Goll R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-107; Guescini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068481; Guescini M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-326; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Juzenas S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132327; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; Krzywinski M, 2014, NAT METHODS, V11, P119, DOI 10.1038/nmeth.2813; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Leamon JH, 2003, ELECTROPHORESIS, V24, P3769, DOI 10.1002/elps.200305646; Linnet K, 2012, CLIN CHEM, V58, P1292, DOI 10.1373/clinchem.2012.182543; Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Magalang UJ, 2013, SLEEP, V36, P591, DOI 10.5665/sleep.2552; Morrison T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl639; Mucci B, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130245; Ounpraseuth Songthip, 2012, BMC Res Notes, V5, P656, DOI 10.1186/1756-0500-5-656; Pripuzova N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043246; Qi YH, 2014, VIRUSES-BASEL, V6, P1823, DOI 10.3390/v6041823; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177; Schlesinger J, 2010, METHODS, V50, pS19, DOI 10.1016/j.ymeth.2010.01.007; Shain EB, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn408; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Tichopad A, 2010, METHODS, V50, P308, DOI 10.1016/j.ymeth.2010.01.028; Wiland HO, 2013, AM J CLIN PATHOL, V139, P730, DOI 10.1309/AJCPG8AYN9MUWJXV; Wilhelm J, 2003, ANAL BIOCHEM, V317, P218, DOI 10.1016/S0003-2697(03)00167-2; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Zaas AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006280; Zhao YL, 2010, J NEMATOL, V42, P166	41	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165282	10.1371/journal.pone.0165282	http://dx.doi.org/10.1371/journal.pone.0165282			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828987	gold, Green Published, Green Submitted			2022-12-27	WOS:000387724300036
J	Ibrahim, A; Souissi, A; Leray, A; Heliot, L; Vandenbunder, B; Souissi, S				Ibrahim, Ali; Souissi, Anissa; Leray, Aymeric; Heliot, Laurent; Vandenbunder, Bernard; Souissi, Sami			Myofibril Changes in the Copepod Pseudodiaptomus marinus Exposed to Haline and Thermal Stresses	PLOS ONE			English	Article							EURYTEMORA-AFFINIS COPEPODA; SKINNED MUSCLE-FIBERS; BEHAVIORAL-RESPONSES; SWIMMING BEHAVIOR; ESTUARINE COPEPOD; SALINITY; CALANOIDA; TEMPERATURE; EXPRESSION; MICROSCOPY	Copepods are small crustaceans capable to survive in various aquatic environments. Their responses to changes in different external factors such as salinity and temperature can be observed at different integration levels from copepod genes to copepod communities. Until now, no thorough observation of the temperature or salinity effect stresses on copepods has been done by optical microscopy. In this study, we used autofluorescence to visualize these effects on the morphology of the calanoid copepod Pseudodiaptomus marinus maintained during several generations in the laboratory at favorable and stable conditions of salinity (30 psu) and temperature (18 degrees C). Four different stress experiments were conducted: at a sharp decrease in temperature (18 to 4 degrees C), a moderate decrease in salinity (from 30 to 15 psu), a major decrease in salinity (from 30 to 0 psu), and finally a combined stress with a decrease in both temperature and salinity (from 18 degrees C and 30 psu to 4 degrees C and 0 psu). After these stresses, images acquired by confocal laser scanning microscopy (CLSM) revealed changes in copepod cuticle and muscle structure. Low salinity and/or temperature stresses affected both the detection of fluorescence emitted by muscle sarcomeres and the distance between them. In the remaining paper we will use the term sarcomeres to describe the elements located within sarcomeres and emitted autofluorescence signals. Quantitative study showed an increase in the average distance between two consecutive sarcomeres from 2.06 +/- 0.11 mu m to 2.44 +/- 0.42 mu m and 2.88 +/- 0.45 mu m after the exposure to major haline stress (18 degrees C, 0 psu) and the combined stress (4 degrees C, 0 psu), respectively. These stresses also caused cuticle cracks which often occurred at the same location, suggesting the cuticle as a sensitive area for osmoregulation. Our results suggest the use of cuticular and muscle autofluorescence as new biomarkers of stress detectable in formalin-preserved P. marinus individuals. Our label-free method can be easily applied to a large number of other copepod species or invertebrates with striated musculature.	[Ibrahim, Ali; Leray, Aymeric; Heliot, Laurent; Vandenbunder, Bernard] Univ Lille, CNRS, Interdisciplinary Res Inst, USR 3078, Parc Sci Haute Borne, F-59650 Villeneuve Dascq, France; [Ibrahim, Ali; Souissi, Anissa; Souissi, Sami] Univ Littoral Cote dOpale, Univ Lille, CNRS, UMR LOG 8187,Lab Oceanol & Geosci, F-62930 Wimereux, France; [Leray, Aymeric] Univ Bourgogne France Comte, Lab Interdisciplinaire Carnot Bourgogne ICB, CNRS, UMR 6303, F-21078 Dijon, France; [Heliot, Laurent; Vandenbunder, Bernard] Univ Lille, CNRS, UMR 8523, Lab Phys Lasers Atomes & Mol, Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Bourgogne; Universite de Technologie de Belfort-Montbeliard (UTBM); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CNRS - Institute of Physics (INP); Universite de Lille - ISITE; Universite de Lille	Souissi, S (corresponding author), Univ Littoral Cote dOpale, Univ Lille, CNRS, UMR LOG 8187,Lab Oceanol & Geosci, F-62930 Wimereux, France.	Sami.Souissi@univ-lille1.fr	Souissi, Sami/C-5146-2018	Souissi, Sami/0000-0002-6720-0096; Souissi, Anissa/0000-0001-6999-0178	University of Lille 1; GIP Seine-Aval (grant ZOOGLOBAL); Nord-Pas de Calais Regional Council; CNRS; FEDER (UE); GDR2588 ("Functional microscopy for life")	University of Lille 1; GIP Seine-Aval (grant ZOOGLOBAL); Nord-Pas de Calais Regional Council(Region Hauts-de-France); CNRS(Centre National de la Recherche Scientifique (CNRS)); FEDER (UE)(European Commission); GDR2588 ("Functional microscopy for life")	University of Lille 1 provided a PhD scholarship (salary) to AI. The GIP Seine-Aval provided a research grant to SS to study the habitats and role of zooplankton in estuaries (grant ZOOGLOBAL). Nord-Pas de Calais Regional Council provided a grant (salary) to AS for the project COPEFISH. This grant to SS allowed them to maintain copepod cultures during several generations. CNRS provided a grant in 2010 called "Risk taking support" CNRS Interdisciplinary Program to LH. Nord-Pas de Calais Regional Council and FEDER (UE) supported LH through the CPER 2007-2013 project. The GDR2588 ("Functional microscopy for life") provided support to LH.	Agarkova I, 2003, J MUSCLE RES CELL M, V24, P191, DOI 10.1023/A:1026094924677; Bayly IAE, 2009, HYDROBIOLOGIA, V630, P39, DOI 10.1007/s10750-009-9797-6; Beaugrand G, 2003, FISH OCEANOGR, V12, P270, DOI 10.1046/j.1365-2419.2003.00248.x; Bhandiwad A, 2011, J EXP BIOL, V214, P709, DOI 10.1242/jeb.049296; Bollmohr S, 2009, ECOTOX ENVIRON SAFE, V72, P756, DOI 10.1016/j.ecoenv.2008.08.003; BRADLEY BP, 1988, HYDROBIOLOGIA, V167, P197, DOI 10.1007/BF00026305; Brylinski JM, 2012, AQUAT INVASIONS, V7, P577, DOI 10.3391/ai.2012.7.4.014; Buttino I, 2003, MICROSC RES TECHNIQ, V60, P458, DOI 10.1002/jemt.10284; Buttino I, 2011, CHEM ECOL, V27, P97, DOI 10.1080/02757540.2011.625944; Cailleaud K, 2007, COMP BIOCHEM PHYS A, V147, P841, DOI 10.1016/j.cbpa.2006.09.012; Cailleaud K, 2009, ENVIRON POLLUT, V157, P64, DOI 10.1016/j.envpol.2008.07.026; Devreker D, 2004, J EXP MAR BIOL ECOL, V303, P31, DOI 10.1016/j.jembe.2003.11.002; Devreker D, 2010, ESTUAR COAST SHELF S, V89, P245, DOI 10.1016/j.ecss.2010.07.010; Devreker D, 2008, J PLANKTON RES, V30, P1329, DOI 10.1093/plankt/fbn086; FLEMINGER A, 1988, MAR BIOL, V98, P535, DOI 10.1007/BF00391545; Gislason A, 2012, ICES J MAR SCI, V69, P1263, DOI 10.1093/icesjms/fss070; GODT RE, 1977, BIOPHYS J, V19, P103, DOI 10.1016/S0006-3495(77)85573-2; Hansen BW, 2012, J COMP PHYSIOL B, V182, P613, DOI 10.1007/s00360-012-0646-y; Ibrahim A, 2015, J STRUCT BIOL, V191, P224, DOI 10.1016/j.jsb.2015.06.004; Jackson KA, 2004, STEM CELLS, V22, P180, DOI 10.1634/stemcells.22-2-180; Jiang ZB, 2008, J THERM BIOL, V33, P419, DOI 10.1016/j.jtherbio.2008.06.008; Johnson KE, 2014, PHYSIOL BIOCHEM ZOOL, V87, P310, DOI 10.1086/674319; Kiernan DA, 2006, EVOL DEV, V8, P537, DOI 10.1111/j.1525-142X.2006.00126.x; Lauritano C, 2012, MAR ENVIRON RES, V76, P22, DOI 10.1016/j.marenvres.2011.09.015; Lee HW, 2003, J PLANKTON RES, V25, P261, DOI 10.1093/plankt/25.3.261; Li CL, 2009, THESCIENTIFICWORLDJO, V9, P866, DOI 10.1100/tsw.2009.96; MAUGHAN DW, 1979, BIOPHYS J, V28, P391, DOI 10.1016/S0006-3495(79)85188-7; Michalec FG, 2013, AQUAT TOXICOL, V138, P129, DOI 10.1016/j.aquatox.2013.05.007; Michalec FG, 2012, J EXP MAR BIOL ECOL, V438, P24, DOI 10.1016/j.jembe.2012.09.013; Michalec FG, 2010, J PLANKTON RES, V32, P805, DOI 10.1093/plankt/fbq006; Michels J, 2007, J MICROSC-OXFORD, V227, P1, DOI 10.1111/j.1365-2818.2007.01787.x; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Pereira VM, 2012, NEUROTOXICOLOGY, V33, P469, DOI 10.1016/j.neuro.2012.03.005; Pfeffer CP, 2011, BIOMED OPT EXPRESS, V2, P1366, DOI 10.1364/BOE.2.001366; Poulet SA, 2003, MAR BIOL, V143, P889, DOI 10.1007/s00227-003-1142-4; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; Rajakaruna H, 2012, BIOL INVASIONS, V14, P633, DOI 10.1007/s10530-011-0104-x; Recher G, 2009, OPT EXPRESS, V17, P19763, DOI 10.1364/OE.17.019763; Sabia L, 2014, ZOOL STUD, V53, DOI 10.1186/s40555-014-0049-8; Silva C, 2013, MAR ENVIRON RES, V90, P39, DOI 10.1016/j.marenvres.2013.05.010; Souissi S, 2007, J PLANKTON RES, V29, pI1, DOI 10.1093/plankt/fbm026; Souissi S, 2010, J PLANKTON RES, V32, P1227, DOI 10.1093/plankt/fbq059; Vehmaa A, 2013, ECOL EVOL, V3, P4548, DOI 10.1002/ece3.839; Wallace SJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3027970; Xu MG, 2000, APPL OPTICS, V39, P6312, DOI 10.1364/AO.39.006312; Xuereb B, 2012, CELL STRESS CHAPERON, V17, P457, DOI 10.1007/s12192-012-0323-9; Yu JG, 2005, J HISTOCHEM CYTOCHEM, V53, P839, DOI 10.1369/jhc.4A6608.2005; Zirbel MJ, 2007, LIMNOL OCEANOGR-METH, V5, P106, DOI 10.4319/lom.2007.5.106	48	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164770	10.1371/journal.pone.0164770	http://dx.doi.org/10.1371/journal.pone.0164770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824880	Green Submitted, gold, Green Published			2022-12-27	WOS:000387615200006
J	Iguchi, T; Nambara, S; Masuda, T; Komatsu, H; Ueda, M; Kidogami, S; Ogawal, Y; Hu, QJ; Sato, K; Saito, T; Hirata, H; Sakimura, S; Uchi, R; Hayashi, N; Ito, S; Eguchi, H; Sugimachi, K; Maehara, Y; Mimori, K				Iguchi, Tomohiro; Nambara, Sho; Masuda, Takaaki; Komatsu, Hisateru; Ueda, Masami; Kidogami, Shinya; Ogawal, Yushi; Hu, Qingjiang; Sato, Kuniaki; Saito, Tomoko; Hirata, Hidenari; Sakimura, Shotaro; Uchi, Ryutaro; Hayashi, Naoki; Ito, Shuhei; Eguchi, Hidetoshi; Sugimachi, Keishi; Maehara, Yoshihiko; Mimori, Koshi			miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver Metastasis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; FUNCTIONAL POLYMORPHISM; GASTRIC-CANCER; EXPRESSION; MICRORNAS; RISK; SUPPRESSION; INHIBITION; SURVIVAL; GENE	miR-146a plays important roles in cancer as it directly targets NUMB, an inhibitor of Notch signaling. miR-146a is reportedly regulated by a G>C polymorphism (SNP; rs2910164). This polymorphism affects various cancers, including colorectal cancer (CRC). However, the clinical significance of miR-146a polymorphism in CRC remains unclear. A total of 59 patients with CRC were divided into 2 groups: a CC/CG genotype (n = 32) and a GG genotype (n = 27), based on the miR-146a polymorphism. cDNA microarray analysis was performed using 59 clinical samples. Significantly enriched gene sets in each genotype were extracted using GSEA. We also investigated the association between miR-146a polymorphism and miR-146a, NUMB expression or migratory response in CRC cell lines. The CC/CG genotype was associated with significantly more synchronous liver metastasis (p = 0.007). A heat map of the two genotypes showed that the expression profiles were clearly stratified. GSEA indicated that Notch signaling and JAK/STAT3 signaling were significantly associated with the CC/CG genotype (p = 0.004 and p = 0.023, respectively). CRC cell lines with the pre-miR-146a/C revealed significantly higher miR-146a expression (p = 0.034) and higher NUMB expression and chemotactic activity. In CRC, miR-146a polymorphism is involved in liver metastasis. Identification of this polymorphism could be useful to identify patients with a high risk of liver metastasis in CRC.	[Iguchi, Tomohiro; Nambara, Sho; Masuda, Takaaki; Komatsu, Hisateru; Ueda, Masami; Kidogami, Shinya; Ogawal, Yushi; Hu, Qingjiang; Sato, Kuniaki; Saito, Tomoko; Hirata, Hidenari; Sakimura, Shotaro; Uchi, Ryutaro; Hayashi, Naoki; Ito, Shuhei; Eguchi, Hidetoshi; Sugimachi, Keishi; Mimori, Koshi] Kyushu Univ, Beppu Hosp, Dept Surg, 4546 Tsurumihara, Beppu, Oita 8740838, Japan; [Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan	Kyushu University; Kyushu University	Mimori, K (corresponding author), Kyushu Univ, Beppu Hosp, Dept Surg, 4546 Tsurumihara, Beppu, Oita 8740838, Japan.	kmimori@beppu.kyushu-u.ac.jp	Sato, Kuniaki/AAD-2565-2020	Mimori, Koshi/0000-0003-3897-9974; Hu, Qingjiang/0000-0002-8313-5861; Sato, Kuniaki/0000-0001-6014-1911	MEXT [26461980, 15H04921, 15K10168, 15K10170]; RIKEN Advanced Institute for Computational Science through the HPCI System Research project [hp140230]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Advanced Institute for Computational Science through the HPCI System Research project	This work was supported by Grants-in-Aid for Scientific Research of MEXT (26461980, 15H04921, 15K10168, 15K10170) (https://www.isps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; d This work was supported by the following grants and foundations: Grants-in-Aid for Scientific Research of MEXT (26461980, 15H04921, 15K10168, 15K10170). This research used computational resources of the K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research project (Project ID: hp140230). Computation time was also provided by the Supercomputer System, Human Genome Center, Institute of Medical Science, University of Tokyo (http://sc.hgc.jp/shirokane.html). We appreciate the technical support of Ms. Kazumi Oda, Michiko Kasagi, Sachiko Sakuma, Noriko Mishima and Tomoko Kawano.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chae YS, 2013, ANTICANCER RES, V33, P3233; Chen G, 2013, PLOS ONE, DOI [10.1371/journal.pone.0060317, DOI 10.1371/JOURNAL.PONE.0060317PMID:23555954]; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forloni M, 2014, ELIFE, V3, DOI 10.7554/eLife.01460; Gayyed MF, 2015, J GASTROINTEST ONCOL, V6, P618, DOI 10.3978/j.issn.2078-6891.2015.072; Hezova R, 2012, WORLD J GASTROENTERO, V18, P2827, DOI 10.3748/wjg.v18.i22.2827; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hung PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079926; Hwang WL, 2014, NAT CELL BIOL, V16, P268, DOI 10.1038/ncb2910; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jia H, 2016, BBA-GEN SUBJECTS, V1860, P1417, DOI 10.1016/j.bbagen.2016.04.007; Kang J, 2013, J BIOL CHEM, V288, P27343, DOI 10.1074/jbc.M113.490482; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Kuang W, 2009, BIOCHEM BIOPH RES CO, V378, P259, DOI 10.1016/j.bbrc.2008.11.041; Kumaraswamy E, 2015, ONCOGENE, V34, P4333, DOI 10.1038/onc.2014.363; Landau DA, 2011, SEMIN ONCOL, V38, P743, DOI 10.1053/j.seminoncol.2011.08.003; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Ma L, 2013, ARCH TOXICOL, V87, P825, DOI 10.1007/s00204-012-1004-2; Mimori K, 1999, P NATL ACAD SCI USA, V96, P7456, DOI 10.1073/pnas.96.13.7456; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Shinden Y, 2015, MOL CLIN ONCOL, V3, P919, DOI 10.3892/mco.2015.565; Slaby O, 2012, J CELL MOL MED, V16, P8, DOI 10.1111/j.1582-4934.2011.01359.x; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Sugimachi K, 2014, ANN SURG ONCOL, V21, pS515, DOI 10.1245/s10434-013-3468-6; Sun XX, 2015, CELL CYCLE, V14, P243, DOI 10.4161/15384101.2014.977112; Ueda M, 2015, ANN SURG ONCOL, V22, pS1490, DOI 10.1245/s10434-015-4652-7; Vinci S, 2013, METHODS, V59, P138, DOI 10.1016/j.ymeth.2012.09.002; Wang C, 2016, BRIT J CANCER, V114, P290, DOI 10.1038/bjc.2015.463; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Washington MK, 2008, ARCH PATHOL LAB MED, V132, P1600, DOI 10.1043/1543-2165(2008)132[1600:CCSIIP]2.0.CO;2; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Yao QY, 2013, CANCER LETT, V335, P219, DOI 10.1016/j.canlet.2013.02.031; Yu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079137; Yumimoto K, 2015, J CLIN INVEST, V125, P621, DOI 10.1172/JCI78782; Zeng Changqing, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P396; Zhong WM, 1997, DEVELOPMENT, V124, P1887	44	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165912	10.1371/journal.pone.0165912	http://dx.doi.org/10.1371/journal.pone.0165912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824903	gold, Green Published, Green Submitted			2022-12-27	WOS:000387615200043
J	Kniss, AR; Savage, SD; Jabbour, R				Kniss, Andrew R.; Savage, Steven D.; Jabbour, Randa			Commercial Crop Yields Reveal Strengths and Weaknesses for Organic Agriculture in the United States (vol 11, e0161673, 2016)	PLOS ONE			English	Correction																		Kniss AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161673	1	7	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165851	10.1371/journal.pone.0165851	http://dx.doi.org/10.1371/journal.pone.0165851			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824908	Green Submitted, gold, Green Published			2022-12-27	WOS:000387615200038
J	Pereira, N; Cozzubbo, T; Cheung, S; Rosenwaks, Z; Palermo, GD; Neri, QV				Pereira, Nigel; Cozzubbo, Tyler; Cheung, Stephanie; Rosenwaks, Zev; Palermo, Gianpiero D.; Neri, Queenie V.			Identifying Maternal Constraints on Fetal Growth and Subsequent Perinatal Outcomes Using a Multiple Embryo Implantation Model	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; IN-VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; INFANT DEVELOPMENT-II; LOW-BIRTH-WEIGHT; STAGES QUESTIONNAIRES; BAYLEY SCALES; FOLLOW-UP; PRETERM; AGES	Introduction Although the majority of singleton births after in vitro fertilization (IVF) are uncomplicated, studies have suggested that IVF pregnancies may be independently associated with low birth weight (LBW), preterm birth (PTB), and perinatal mortality. These outcomes complicate multiple gestations as expected, but have also been reported in singletons. A multiple embryo implantation model allows for assessment of the early in utero environment, and therefore, assessment of any maternal constraints on developing fetuses. We question whether adverse perinatal outcomes associated with assisted reproductive techniques (ART) occur as a result of maternal physiologic adaptations. Patients and Methods This is a retrospective, single center study of ART cycles, specifically intracytoplasmic sperm injection (ICSI) cycles during a 16-year period. For each positive pregnancy test 9-11 days after embryo transfer, an ultrasonogram was performed at 7 weeks of gestation to record the number of implanted fetal poles with cardiac activity. Controlled ovarian stimulation (COS), hCG trigger, oocyte retrieval and sperm injection were performed as per our standard protocols. First trimester implantation sites that resulted in live births were defined as "true" to distinguish them from those that spontaneously reduced called "virtual". Birth outcomes analyzed included birth weight and gestational age at delivery. Results A total of 17,415 cycles were analyzed. The average maternal age was 36.9 (+/- 5.0) years. An overall fertilization rate of 73.4% generated approximately 48,708 good quality cleavage-stage embryos. In most patients (92.8%), an average of 3 embryos were transferred. The clinical pregnancy rate was 39.2% (n = 6,281). The overall occurrence of multiple gestations was 38.2% (n = 2,608) consisting of 2,038 twin, 511 triplet, and 59 quadruplet pregnancies. Of these multiple gestations, 18.6% of twin, 54.2% of triplet and 76.3% of quadruplet gestations spontaneously reduced. Failure of the implanted embryo to progress was not related to maternal age. Singleton newborns resulting from multiple implantation sites had lower birth weights (P<0.01) and shorter gestational ages (P<0.01) than those from a single implanted embryo. The number of embryos transferred did not affect the gestational length of singleton newborns. Although the birth weights of singletons from multiple implantation sites (virtual singletons) were lower than true singletons, the birth weight of virtual singletons were comparable to the birth weights of true twin, triplet, and quadruplet live births. Multiple logistic regression revealed that virtual singletons were an independent risk factor for PTB (odds ratio: 4.55, 95% CI 2.23-9.29) and LBW (odds ratio: 3.61, 95% CI 1.78-7.32), even after controlling for the number of oocytes, stimulation protocol type, sperm source, total gonadotropins administered, age, embryo quality, and day of embryo transfer. Conclusions Our study highlights that embryonic implantation sites during early gestation set the growth profile of each embryo, dictating later growth patterns. Specifically, spontaneous reduction of an embryo after multiple embryo implantations can confer greater perinatal risk in the form of LBW and PTB to the surviving fetus. Our findings suggest that maternal constraints or physiologic adaptations maybe one of the mechanisms mediating adverse perinatal outcomes when multiple embryo implantation occurs.	[Pereira, Nigel; Cozzubbo, Tyler; Cheung, Stephanie; Rosenwaks, Zev; Palermo, Gianpiero D.; Neri, Queenie V.] Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA	Cornell University	Palermo, GD (corresponding author), Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA.	gdpaterm@med.cornell.edu		Palermo, Gianpiero D./0000-0001-8440-4560; Cheung, Stephanie/0000-0002-2092-7001				Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Allen WR, 2002, REPRODUCTION, V123, P445, DOI 10.1530/rep.0.1230445; [Anonymous], 2010, WHO LAB MAN EX PROC; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; BROOKS AA, 1995, EARLY HUM DEV, V42, P29, DOI 10.1016/0378-3782(95)01637-I; Buckler JMH, 2004, ANN HUM BIOL, V31, P311, DOI 10.1080/03014460410001670120; Bulletti C, 2005, CURR OPIN OBSTET GYN, V17, P265, DOI 10.1097/01.gco.0000169104.85128.0e; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Ceelen M, 2008, J CLIN ENDOCR METAB, V93, P1682, DOI 10.1210/jc.2007-2432; Chen Q, 2011, J BIOL CHEM, V286, P4349, DOI 10.1074/jbc.M110.197202; COGSWELL ME, 1995, SEMIN PERINATOL, V19, P222, DOI 10.1016/S0146-0005(05)80028-X; De Sutter P, 2006, HUM REPROD, V21, P2633, DOI 10.1093/humrep/del247; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dickey RP, 2004, HUM REPROD, V19, P783, DOI 10.1093/humrep/deh181; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Gluckman PD, 2003, J NUTR, V133, p1741S, DOI 10.1093/jn/133.5.1741S; Gluckman Peter D, 2004, Semin Fetal Neonatal Med, V9, P419, DOI 10.1016/j.siny.2004.03.001; Gosden LV, 2014, METHODS MOL BIOL, V1154, P343, DOI 10.1007/978-1-4939-0659-8_16; Hama K, 2007, BIOL REPROD, V77, P954, DOI 10.1095/biolreprod.107.060293; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Huang JYJ, 2014, METHODS MOL BIOL, V1154, P171, DOI 10.1007/978-1-4939-0659-8_8; Ishihara O, 2015, FERTIL STERIL, V103, P402, DOI 10.1016/j.fertnstert.2014.11.004; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Kwun Y, 2015, J KOREAN MED SCI, V30, P450, DOI 10.3346/jkms.2015.30.4.450; La Sala GB, 2006, FERTIL STERIL, V86, P247, DOI 10.1016/j.fertnstert.2005.11.073; Luke B, 2009, FERTIL STERIL, V91, P2578, DOI 10.1016/j.fertnstert.2008.03.068; McGovern PG, 2004, FERTIL STERIL, V82, P1514, DOI 10.1016/j.fertnstert.2004.06.038; Neri QV, 2014, METHODS MOL BIOL, V1154, P91, DOI 10.1007/978-1-4939-0659-8_5; PALERMO GD, 1995, FERTIL STERIL, V63, P1231, DOI 10.1016/S0015-0282(16)57603-1; Palermo GD, 2014, FERTIL STERIL, V102, P1508, DOI 10.1016/j.fertnstert.2014.10.008; Palermo GD, 2008, REPROD BIOMED ONLINE, V17, P820, DOI 10.1016/S1472-6483(10)60411-7; Pandey S, 2012, HUM REPROD UPDATE, V18, P485, DOI 10.1093/humupd/dms018; Petrini AC, 2016, WOMENS HEALTH, V12, P420, DOI 10.1177/1745505716658898; Saadeldin IM, 2015, STEM CELLS CLONING, V8, P103, DOI 10.2147/SCCAA.S84991; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Schieve LA, 2004, OBSTET GYNECOL, V103, P1144, DOI 10.1097/01.AOG.0000127037.12652.76; Shebl O, 2008, FERTIL STERIL, V90, P310, DOI 10.1016/j.fertnstert.2007.06.048; Shevell T, 2005, OBSTET GYNECOL, V106, P1039, DOI 10.1097/01.AOG.0000183593.24583.7c; Simard MN, 2012, PEDIATRICS, V130, pE108, DOI 10.1542/peds.2011-3532; Spong CY, 2011, OBSTET GYNECOL, V118, P323, DOI 10.1097/AOG.0b013e3182255999; Squires J, 2003, FERTIL STERIL, V79, P453, DOI 10.1016/S0015-0282(02)04685-X; Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313; Steel AJ, 2009, HUM FERTIL, V12, P21, DOI 10.1080/14647270802499201; Stojnic J, 2013, CLIN EXP OBSTET GYN, V40, P277; Sunderam S, 2015, MMWR SURVEILL SUMM, V64, P1; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Woodward BJ, 2011, J PERINATOL, V31, P641, DOI 10.1038/jp.2011.1	47	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166222	10.1371/journal.pone.0166222	http://dx.doi.org/10.1371/journal.pone.0166222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824942	gold, Green Published, Green Submitted			2022-12-27	WOS:000387615200073
J	Rush, D; Osborne, KA; Birgel, D; Kappler, A; Hirayama, H; Peckmann, J; Poulton, SW; Nickel, JC; Mangelsdorf, K; Kalyuzhnaya, M; Sidgwick, FR; Talbot, HM				Rush, Darci; Osborne, Kate A.; Birgel, Daniel; Kappler, Andreas; Hirayama, Hisako; Peckmann, Joern; Poulton, Simon W.; Nickel, Julia C.; Mangelsdorf, Kai; Kalyuzhnaya, Marina; Sidgwick, Frances R.; Talbot, Helen M.			The Bacteriohopanepolyol Inventory of Novel Aerobic Methane Oxidising Bacteria Reveals New Biomarker Signatures of Aerobic Methanotrophy in Marine Systems	PLOS ONE			English	Article							SUBMARINE HYDROTHERMAL SYSTEM; CARBON ISOTOPIC FRACTIONATION; SUSPENDED PARTICULATE MATTER; MOSBY MUD VOLCANO; LIPID BIOMARKERS; WATER COLUMN; BLACK-SEA; SEDIMENTARY BACTERIOHOPANEPOLYOLS; MICROBIAL COMMUNITIES; HYDROCARBON SEEPS	Aerobic methane oxidation (AMO) is one of the primary biologic pathways regulating the amount of methane (CH4) released into the environment. AMO acts as a sink of CH4, converting it into carbon dioxide before it reaches the atmosphere. It is of interest for (paleo) climate and carbon cycling studies to identify lipid biomarkers that can be used to trace AMO events, especially at times when the role of methane in the carbon cycle was more pronounced than today. AMO bacteria are known to synthesise bacteriohopanepolyol (BHP) lipids. Preliminary evidence pointed towards 35-aminobacteriohopane-30,31,32,33,34-pentol (aminopentol) being a characteristic biomarker for Type I methanotrophs. Here, the BHP compositions were examined for species of the recently described novel Type I methanotroph bacterial genera Methylomarinum and Methylomarinovum, as well as for a novel species of a Type I Methylomicrobium. Aminopentol was the most abundant BHP only in Methylomarinovum caldicuralii, while Methylomicrobium did not produce aminopentol at all. In addition to the expected regular aminotriol and aminotetrol BHPs, novel structures tentatively identified as methylcarbamate lipids related to C-35 amino-BHPs (MCBHPs) were found to be synthesised in significant amounts by some AMO cultures. Subsequently, sediments and authigenic carbonates from methane-influenced marine environments were analysed. Most samples also did not contain significant amounts of aminopentol, indicating that aminopentol is not a useful biomarker for marine aerobic methanotophic bacteria. However, the BHP composition of the marine samples do point toward the novel MC-BHPs components being potential new biomarkers for AMO.	[Rush, Darci; Osborne, Kate A.; Sidgwick, Frances R.; Talbot, Helen M.] Newcastle Univ, Sch Civil Engn & Geosci, Drummond Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Birgel, Daniel; Peckmann, Joern] Univ Hamburg, Inst Geol, Hamburg, Germany; [Kappler, Andreas] Univ Tubingen, Ctr Appl Geosci, Tubingen, Germany; [Kappler, Andreas] Ctr Geomicrobiol, Dept Biosci, Ny Munkegade 116, DK-8000 Aarhus C, Denmark; [Hirayama, Hisako] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Subsurface Geobiol Anal & Res, Yokosuka, Kanagawa, Japan; [Peckmann, Joern] Univ Vienna, Dept Geodynam & Sedimentol, A-1090 Vienna, Austria; [Poulton, Simon W.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Nickel, Julia C.; Mangelsdorf, Kai] GFZ German Res Ctr Geosci, D-14473 Potsdam, Germany; [Kalyuzhnaya, Marina] San Diego State Univ, Fac Biol, 5500 Campanile Dr, San Diego, CA 92182 USA	Newcastle University - UK; University of Hamburg; Eberhard Karls University of Tubingen; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Vienna; University of Leeds; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; California State University System; San Diego State University	Rush, D (corresponding author), Newcastle Univ, Sch Civil Engn & Geosci, Drummond Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	darci.rush@nioz.nl		Kappler, Andreas/0000-0002-3558-9500; Peckmann, Jorn/0000-0002-8572-0060; Poulton, Simon/0000-0001-7621-189X; Sidgwick, Frances/0000-0001-8792-1096; Rush, Darci/0000-0002-6567-4116	European Research Council [258734]; Lundin Petroleum	European Research Council(European Research Council (ERC)European Commission); Lundin Petroleum	The work was funded by a Starting Grant (No. 258734) awarded to HMT for project AMOPROX, from the European Research Council. KM and JCN thank Lundin Petroleum for financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baco AR, 2010, MAR GEOL, V272, P251, DOI 10.1016/j.margeo.2009.06.015; Banta AB, 2015, P NATL ACAD SCI USA, V112, P13478, DOI 10.1073/pnas.1511482112; Berndmeyer C, 2013, ORG GEOCHEM, V55, P103, DOI 10.1016/j.orggeochem.2012.11.010; Birgel D, 2015, GEOBIOLOGY, V13, P245, DOI 10.1111/gbi.12130; Birgel D, 2011, CHEM GEOL, V285, P82, DOI 10.1016/j.chemgeo.2011.03.004; Birgel D, 2008, ORG GEOCHEM, V39, P1659, DOI 10.1016/j.orggeochem.2008.01.023; Bischoff J, 2016, BIOGEOSCIENCES, V13, P4899, DOI 10.5194/bg-13-4899-2016; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blumenberg M, 2013, BIOGEOSCIENCES, V10, P2725, DOI 10.5194/bg-10-2725-2013; Blumenberg M, 2007, ORG GEOCHEM, V38, P84, DOI 10.1016/j.orggeochem.2006.08.011; Blumenberg M, 2006, ENVIRON MICROBIOL, V8, P1220, DOI 10.1111/j.1462-2920.2006.01014.x; Blumenberg M, 2013, ORG GEOCHEM, V55, P55, DOI 10.1016/j.orggeochem.2012.11.004; Blumenberg M, 2012, ORG GEOCHEM, V49, P1, DOI 10.1016/j.orggeochem.2012.05.003; Blumenberg M, 2010, ORG GEOCHEM, V41, P1119, DOI 10.1016/j.orggeochem.2010.06.005; Blumenberg M, 2009, GEOCHIM COSMOCHIM AC, V73, P750, DOI 10.1016/j.gca.2008.11.005; Blumenberg M, 2009, FEMS MICROBIOL LETT, V293, P73, DOI 10.1111/j.1574-6968.2009.01520.x; BOUVIER P, 1976, BIOCHEM J, V159, P267, DOI 10.1042/bj1590267; Bradley AS, 2010, ORG GEOCHEM, V41, P1075, DOI 10.1016/j.orggeochem.2010.07.003; Chand S, 2012, EARTH PLANET SC LETT, V331, P305, DOI 10.1016/j.epsl.2012.03.021; COLLISTER JW, 1992, ORG GEOCHEM, V19, P265, DOI 10.1016/0146-6380(92)90042-V; Cooke MP, 2008, ORG GEOCHEM, V39, P1347, DOI 10.1016/j.orggeochem.2008.05.003; Cooke MP, 2008, ORG GEOCHEM, V39, P965, DOI 10.1016/j.orggeochem.2008.03.009; Cooke MP, 2009, ORG GEOCHEM, V40, P1151, DOI 10.1016/j.orggeochem.2009.07.014; Cooke MP, 2011, THESIS; Coolen MJL, 2008, ENVIRON MICROBIOL, V10, P1783, DOI 10.1111/j.1462-2920.2008.01601.x; Cre Amiere A, 2016, NAT COMMUN, V7, P1; Crespo-Medina M, 2014, NAT GEOSCI, V7, P423, DOI [10.1038/ngeo2156, 10.1038/NGEO2156]; Crossman ZM, 2001, ORG GEOCHEM, V32, P359, DOI 10.1016/S0146-6380(00)00178-9; Cvejic JH, 2000, FEMS MICROBIOL LETT, V182, P361; De Jonge C, 2016, GEOCHIM COSMOCHIM AC, V174, P85, DOI 10.1016/j.gca.2015.11.008; Dedysh SN, 2009, MICROBIOLOGY+, V78, P655, DOI 10.1134/S0026261709060010; Dickens GR, 1997, GEOLOGY, V25, P259, DOI 10.1130/0091-7613(1997)025<0259:ABOGIT>2.3.CO;2; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Dunfield PF, 2007, NATURE, V450, P879, DOI 10.1038/nature06411; Elvert M, 2000, ORG GEOCHEM, V31, P1175, DOI 10.1016/S0146-6380(00)00111-X; Elvert M, 2008, ORG GEOCHEM, V39, P167, DOI 10.1016/j.orggeochem.2007.11.006; Farrimond P, 2000, GEOCHIM COSMOCHIM AC, V64, P2985, DOI 10.1016/S0016-7037(00)00404-X; Farrimond P, 2004, GEOCHIM COSMOCHIM AC, V68, P3873, DOI 10.1016/j.gca.2004.04.011; Farrimond P., 1998, ANCIENT BIOMOLECULES, V2, P147; Felden J, 2013, BIOGEOSCIENCES, V10, P3269, DOI 10.5194/bg-10-3269-2013; Felden J, 2010, LIMNOL OCEANOGR, V55, P2366, DOI 10.4319/lo.2010.55.6.2366; Fuse H, 1998, BIOSCI BIOTECH BIOCH, V62, P1925, DOI 10.1271/bbb.62.1925; Gibson RA, 2008, ORG GEOCHEM, V39, P1020, DOI 10.1016/j.orggeochem.2008.04.014; Gibson RA, 2014, ORG GEOCHEM, V69, P61, DOI 10.1016/j.orggeochem.2014.02.004; Hamersley MR, 2007, LIMNOL OCEANOGR, V52, P923, DOI 10.4319/lo.2007.52.3.0923; Handley L, 2008, EARTH PLANET SC LETT, V275, P17, DOI 10.1016/j.epsl.2008.07.030; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Himmler T, 2015, CHEM GEOL, V415, P102, DOI 10.1016/j.chemgeo.2015.09.016; Hinrichs KU, 2001, GEOCHEM GEOPHY GEOSY, V2, part. no.; Hirayama H, 2007, APPL ENVIRON MICROB, V73, P7642, DOI 10.1128/AEM.01258-07; Hirayama H, 2014, INT J SYST EVOL MICR, V64, P989, DOI 10.1099/ijs.0.058172-0; Hirayama H, 2013, INT J SYST EVOL MICR, V63, P1073, DOI 10.1099/ijs.0.040568-0; Hofle ST, 2015, ORG GEOCHEM, V88, P1, DOI 10.1016/j.orggeochem.2015.08.002; Hovland M, 2005, MAR GEOL, V218, P191, DOI 10.1016/j.margeo.2005.04.005; Inglis GN, 2015, PALAEOGEOGR PALAEOCL, V438, P245, DOI 10.1016/j.palaeo.2015.08.001; Islam T, 2008, P NATL ACAD SCI USA, V105, P300, DOI 10.1073/pnas.0704162105; Jahnke LL, 1999, GEOCHIM COSMOCHIM AC, V63, P79, DOI 10.1016/S0016-7037(98)00270-1; JAHNKE LL, 1995, APPL ENVIRON MICROB, V61, P576, DOI 10.1128/AEM.61.2.576-582.1995; Jensen S, 2008, FEMS MICROBIOL ECOL, V66, P320, DOI 10.1111/j.1574-6941.2008.00575.x; Joyeux C, 2004, FEMS MICROBIOL ECOL, V47, P371, DOI 10.1016/S0168-6496(03)00302-7; Kalyuzhnaya MG, 2008, INT J SYST EVOL MICR, V58, P591, DOI 10.1099/ijs.0.65317-0; Kellermann MY, 2012, ORG GEOCHEM, V43, P112, DOI 10.1016/j.orggeochem.2011.10.005; Kessler JD, 2011, SCIENCE, V331, P312, DOI 10.1126/science.1199697; Kharbush JJ, 2013, APPL ENVIRON MICROB, V79, P7491, DOI 10.1128/AEM.02367-13; Kim JH, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003364; Lelieveld J, 1998, TELLUS B, V50, P128, DOI 10.1034/j.1600-0889.1998.t01-1-00002.x; LIDSTROM ME, 1988, A VAN LEEUW J MICROB, V54, P189, DOI 10.1007/BF00443577; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; Mastalerz V, 2009, GEOCHIM COSMOCHIM AC, V73, P3849, DOI 10.1016/j.gca.2008.12.030; McDonald IR, 2005, FEMS MICROBIOL LETT, V250, P287, DOI 10.1016/j.femsle.2005.07.016; McInerney FA, 2011, ANNU REV EARTH PL SC, V39, P489, DOI 10.1146/annurev-earth-040610-133431; Mondamert L, 2011, BIOFOULING, V27, P21, DOI 10.1080/08927014.2010.536614; Moussard H, 2009, ENV MICROBIOL REP, V1, P424, DOI 10.1111/j.1758-2229.2009.00063.x; NEUNLIST S, 1985, BIOCHEM J, V231, P635, DOI 10.1042/bj2310635; Nickel JC, 2012, MAR GEOL, V332, P152, DOI 10.1016/j.margeo.2012.02.002; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Osborne KA, 2015, THESIS; OURISSON G, 1992, ACCOUNTS CHEM RES, V25, P398, DOI 10.1021/ar00021a003; Pancost RD, 2000, GEOLOGY, V28, P663, DOI 10.1130/0091-7613(2000)28<663:CVARDO>2.0.CO;2; Pancost RD, 2005, PALAEOGEOGR PALAEOCL, V227, P48, DOI 10.1016/j.palaeo.2005.04.035; Pancost RD, 2000, APPL ENVIRON MICROB, V66, P1126, DOI 10.1128/AEM.66.3.1126-1132.2000; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Pol A, 2007, NATURE, V450, P874, DOI 10.1038/nature06222; Redmond MC, 2010, APPL ENVIRON MICROB, V76, P6412, DOI 10.1128/AEM.00271-10; Redshaw CH, 2008, J SOIL SEDIMENT, V8, P217, DOI 10.1007/s11368-008-0024-2; Rethemeyer J, 2010, ORG GEOCHEM, V41, P1130, DOI 10.1016/j.orggeochem.2010.06.004; Ricci JN, 2014, ISME J, V8, P675, DOI 10.1038/ismej.2013.191; ROHMER M, 1984, J GEN MICROBIOL, V130, P1137; Ruff SE, 2015, P NATL ACAD SCI USA, V112, P4015, DOI 10.1073/pnas.1421865112; Ruff SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072627; Rush D, 2014, GEOCHIM COSMOCHIM AC, V140, P50, DOI 10.1016/j.gca.2014.05.014; Saenz JP, 2011, ORG GEOCHEM, V42, P1351, DOI 10.1016/j.orggeochem.2011.08.016; Saenz JP, 2011, ORG GEOCHEM, V42, P774, DOI 10.1016/j.orggeochem.2011.05.006; Sassen R, 2004, CHEM GEOL, V205, P195, DOI 10.1016/j.chemgeo.2003.12.032; Sauter LM, 2012, SYST APPL MICROBIOL, V35, P198, DOI 10.1016/j.syapm.2011.10.006; Schaeffer P, 2008, ORG GEOCHEM, V39, P1479, DOI 10.1016/j.orggeochem.2008.07.007; Selver AD, 2015, ORG GEOCHEM, V83-84, P16, DOI 10.1016/j.orggeochem.2015.01.005; Selver AD, 2012, ORG GEOCHEM, V51, P63, DOI 10.1016/j.orggeochem.2012.08.002; Sharp CE, 2014, ENVIRON MICROBIOL, V16, P1867, DOI 10.1111/1462-2920.12454; SIEBURTH JM, 1987, CURR MICROBIOL, V14, P285, DOI 10.1007/BF01568138; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Spencer-Jones CL, 2015, ORG GEOCHEM, V89-90, P1, DOI 10.1016/j.orggeochem.2015.09.003; Spencer-Jones CL, 2016, THESIS; SUMMONS RE, 1994, GEOCHIM COSMOCHIM AC, V58, P2853, DOI 10.1016/0016-7037(94)90119-8; Talbot HM, 2008, ORG GEOCHEM, V39, P232, DOI 10.1016/j.orggeochem.2007.08.006; Talbot HM, 2007, ORG GEOCHEM, V38, P1212, DOI 10.1016/j.orggeochem.2007.04.006; Talbot HM, 2007, RAPID COMMUN MASS SP, V21, P880, DOI 10.1002/rcm.2911; Talbot HM, 2016, ORG GEOCHEM, V97, P95, DOI 10.1016/j.orggeochem.2016.04.011; Talbot HM, 2016, ORG GEOCHEM, V96, P77, DOI 10.1016/j.orggeochem.2016.03.006; Talbot HM, 2014, GEOCHIM COSMOCHIM AC, V133, P387, DOI 10.1016/j.gca.2014.02.035; Talbot HM, 2003, ORG GEOCHEM, V34, P1353, DOI 10.1016/S0146-6380(03)00159-1; Talbot HM, 2001, J CHROMATOGR A, V921, P175, DOI 10.1016/S0021-9673(01)00871-8; Tavormina PL, 2008, APPL ENVIRON MICROB, V74, P3985, DOI 10.1128/AEM.00069-08; Taylor KA, 2011, ORG GEOCHEM, V42, P487, DOI 10.1016/j.orggeochem.2011.03.012; Thiel V, 2001, MAR CHEM, V73, P97, DOI 10.1016/S0304-4203(00)00099-2; van Teeseling MCF, 2014, APPL ENVIRON MICROB, V80, P6782, DOI 10.1128/AEM.01838-14; van Winden JF, 2012, ORG GEOCHEM, V53, P73, DOI 10.1016/j.orggeochem.2012.07.001; van Winden JF, 2012, GEOCHIM COSMOCHIM AC, V77, P52, DOI 10.1016/j.gca.2011.10.026; van Winden JF, 2010, ORG GEOCHEM, V41, P1040, DOI 10.1016/j.orggeochem.2010.04.015; Wagner T, 2014, ORG GEOCHEM, V67, P85, DOI 10.1016/j.orggeochem.2013.12.003; Wakeham SG, 2007, ORG GEOCHEM, V38, P2070, DOI 10.1016/j.orggeochem.2007.08.003; Wakeham SG, 2012, DEEP-SEA RES PT I, V63, P133, DOI 10.1016/j.dsr.2012.01.005; Wasmund K, 2009, FEMS MICROBIOL ECOL, V68, P142, DOI 10.1111/j.1574-6941.2009.00667.x; Watson DF, 2002, THESIS; Welander PV, 2012, P NATL ACAD SCI USA, V109, P12905, DOI 10.1073/pnas.1208255109; Wild Christian, 2015, Galaxea - Tokyo, V17, P13; Xu YP, 2009, ORG GEOCHEM, V40, P79, DOI 10.1016/j.orggeochem.2008.09.003; Yan TF, 2006, FEMS MICROBIOL ECOL, V57, P251, DOI 10.1111/j.1574-6941.2006.00122.x; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zhang CL, 2007, GEOMICROBIOL J, V24, P519, DOI 10.1080/01490450701572515; Zhu C, 2011, LIMNOL OCEANOGR, V56, P1850, DOI 10.4319/lo.2011.56.5.1850; Zhu C, 2010, ORG GEOCHEM, V41, P1056, DOI 10.1016/j.orggeochem.2010.03.015; Zink KG, 2004, ANAL BIOANAL CHEM, V380, P798, DOI 10.1007/s00216-004-2828-2; ZUNDEL M, 1985, EUR J BIOCHEM, V150, P23, DOI 10.1111/j.1432-1033.1985.tb08980.x	134	25	27	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165635	10.1371/journal.pone.0165635	http://dx.doi.org/10.1371/journal.pone.0165635			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824887	Green Published, gold			2022-12-27	WOS:000387615200024
J	Xiao, FQ; Zheng, ZW; Zhang, HY; Xin, ZQ; Chen, YG; Li, YW				Xiao, Fengqiu; Zheng, Zhiwei; Zhang, Heyi; Xin, Ziqiang; Chen, Yinghe; Li, Yiwei			Who Are You More Likely to Help? The Effects of Expected Outcomes and Regulatory Focus on Prosocial Performance	PLOS ONE			English	Article							OTHER DECISION-MAKING; LOSS-AVERSION; MOTIVATION; PROMOTION; BEHAVIOR; LOSSES; GAINS; INFORMATION; PERSPECTIVE; PREVENTION	Prosocial behavior refers to a broad category of actions that benefit other people or the society. Compared with other factors that affect prosocial performance, prosocial outcomes, consisting of prosocial gains and prosocial non-losses have received less attention up to now. In the current research, we explored the influences of different types of expected outcomes and regulatory focus on prosocial performance. Studies 1a and 1b examined the differences in prosocial performance elicited by prosocial gain (e.g., enhancing others' access to clean water) and prosocial non-loss outcomes (e.g., protecting others from suffering dirty water). We found that the expected prosocial non-loss outcomes induced greater prosocial performance compared with the expected prosocial gain outcomes. Studies 2a and 2b examined the effects of dispositional and situational regulatory focus on prosocial loss aversion. We found that differences in prosocial performance between two expected prosocial outcomes were reduced when promotion focus was primed; whereas a primed prevention focus did not significantly increase this difference. Additionally, participants displayed a greater prosocial loss aversion in the prevention focus condition than in the promotion focus condition. The reason for the non-significant interaction between regulatory focus and expected prosocial outcome was discussed.	[Xiao, Fengqiu; Chen, Yinghe; Li, Yiwei] Beijing Normal Univ, Inst Dev Psychol, Sch Psychol, Beijing, Peoples R China; [Xiao, Fengqiu] China Natl Childrens Ctr, Beijing, Peoples R China; [Zheng, Zhiwei] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing, Peoples R China; [Zhang, Heyi] Univ Cambridge, Psychol & Educ Grp, Fac Educ, Cambridge, England; [Xin, Ziqiang] Cent Univ Finance & Econ, Dept Psychol, Sch Social Dev, Beijing, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS; University of Cambridge; Central University of Finance & Economics	Chen, YG (corresponding author), Beijing Normal Univ, Inst Dev Psychol, Sch Psychol, Beijing, Peoples R China.	chenyinghe@bnu.edu.cn	Zheng, Zhiwei/AAS-9499-2020	Zheng, Zhiwei/0000-0002-8205-420X	Major Project of the National Social Science Foundation of China [14ZDB160]; major projects of Humanity and Social Science base of the Ministry of Education in China [12JJD190001]; Beijing Social Science Foundation of China [12JYA003]	Major Project of the National Social Science Foundation of China; major projects of Humanity and Social Science base of the Ministry of Education in China; Beijing Social Science Foundation of China	This study was supported by the Major Project of the National Social Science Foundation of China (14ZDB160), the major projects of Humanity and Social Science base of the Ministry of Education in China (12JJD190001), and the grant from Beijing Social Science Foundation of China (12JYA003). The funding agents had no further role in the study design, in the collection, analysis, and interpretation of the data, in the writing of the manuscript, and in the decision to submit the paper for publication.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Balconi M, 2014, SOC NEUROSCI-UK, V9, P82, DOI 10.1080/17470919.2013.861361; BATSON CD, 1988, J PERS SOC PSYCHOL, V55, P52, DOI 10.1037/0022-3514.55.1.52; Boyce CJ, 2013, PSYCHOL SCI, V24, P2557, DOI 10.1177/0956797613496436; Byrd DA, 2004, J INT NEUROPSYCH SOC, V10, P401, DOI 10.1017/S1355617704103081; Caviola L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00897; Cherry B, 2003, J BEHAV DECIS MAKING, V16, P375, DOI 10.1002/bdm.452; Crowe E, 1997, ORGAN BEHAV HUM DEC, V69, P117, DOI 10.1006/obhd.1996.2675; DELLASALA S, 1992, PSYCHOL MED, V22, P885, DOI 10.1017/S0033291700038460; Fellner B, 2007, SWISS J PSYCHOL, V66, P109, DOI 10.1024/1421-0185.66.2.109; Fransen ML, 2011, J EXP SOC PSYCHOL, V47, P202, DOI 10.1016/j.jesp.2010.09.004; Friedman RS, 2001, J PERS SOC PSYCHOL, V81, P1001, DOI 10.1037/0022-3514.81.6.1001; Gorman CA, 2012, J VOCAT BEHAV, V80, P160, DOI 10.1016/j.jvb.2011.07.005; Grant A, 2012, PSYCHOL SCI, V23, P1033, DOI 10.1177/0956797612439424; Higgins ET, 2000, AM PSYCHOL, V55, P1217, DOI 10.1037/0003-066X.55.11.1217; Higgins ET, 1997, J PERS SOC PSYCHOL, V72, P515, DOI 10.1037/0022-3514.72.3.515; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Holler M, 2008, J ECON PSYCHOL, V29, P597, DOI 10.1016/j.joep.2008.01.001; Idson LC, 2000, J EXP SOC PSYCHOL, V36, P252, DOI 10.1006/jesp.1999.1402; Idson LC, 2004, PERS SOC PSYCHOL B, V30, P926, DOI 10.1177/0146167204264334; KAHNEMAN D, 1986, PSYCHOL REV, V93, P136, DOI 10.1037/0033-295X.93.2.136; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; Li YJ, 2012, EC DECISION BIASES F, P550; Liberman N, 2005, J EXP SOC PSYCHOL, V41, P527, DOI 10.1016/j.jesp.2004.06.007; Lockwood P, 2002, J PERS SOC PSYCHOL, V83, P854, DOI 10.1037//0022-3514.83.4.854; Mathews MA, 2013, J RES PERS, V47, P191, DOI 10.1016/j.jrp.2013.01.001; Mayr M, 2012, IMPACT NUMERACY GAIN; McGraw AP, 2010, PSYCHOL SCI, V21, P1438, DOI 10.1177/0956797610381504; McMahon R, 2008, TRANSFUSION, V48, P321, DOI 10.1111/j.1537-2995.2007.01526.x; Novemsky N, 2005, J MARKETING RES, V42, P119, DOI 10.1509/jmkr.42.2.119.62292; Pabst S, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00142; Penner LA, 2005, ANNU REV PSYCHOL, V56, P365, DOI 10.1146/annurev.psych.56.091103.070141; Polman E, 2012, ORGAN BEHAV HUM DEC, V119, P141, DOI 10.1016/j.obhdp.2012.06.005; Polman E, 2012, J PERS SOC PSYCHOL, V102, P980, DOI 10.1037/a0026966; Polman E, 2010, J EXP SOC PSYCHOL, V46, P432, DOI 10.1016/j.jesp.2009.11.003; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rand DG, 2014, J BEHAV DECISION MAK; Ren XZ, 2010, PSYCHOL DEV ED, V4, P337; Robinson NG, 2008, TRANSFUSION, V48, P2559, DOI 10.1111/j.1537-2995.2008.01904.x; Suleiman R, 2014, J BEHAV DECISION MAK; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; TVERSKY A, 1994, JPN PSYCHOL RES, V36, P3, DOI 10.4992/psycholres1954.36.3; Weinstein N, 2010, J PERS SOC PSYCHOL, V98, P222, DOI 10.1037/a0016984; Williams A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00425; Xiao F, CREATIVITY RES J; Yechiam E, 2013, COGNITIVE PSYCHOL, V66, P212, DOI 10.1016/j.cogpsych.2012.12.001; Zikmund-Fisher BJ, 2006, J GEN INTERN MED, V21, P618, DOI 10.1111/j.1525-1497.2006.00410.x; Zou X, 2014, J PERS SOC PSYCHOL, V106, P183, DOI 10.1037/a0035391	48	2	2	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165717	10.1371/journal.pone.0165717	http://dx.doi.org/10.1371/journal.pone.0165717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BE	27824909	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200029
J	Rigo-Adrover, MD; Franch, A; Castell, M; Perez-Cano, FJ				del Mar Rigo-Adrover, Maria; Franch, Angels; Castell, Margarida; Jose Perez-Cano, Francisco			Preclinical Immunomodulation by the Probiotic Bifidobacterium breve M-16V in Early Life	PLOS ONE			English	Article							IMMUNE-SYSTEM; ALLERGIC SYMPTOMS; SMALL-INTESTINE; T-LYMPHOCYTES; SYNBIOTICS; ADHESION; MODEL; OLIGOSACCHARIDES; INTERVENTION; MODULATION	This study aimed to investigate the effect of supplementation with the probiotic Bifidobacterium breve M-16V on the maturation of the intestinal and circulating immune system during suckling. In order to achieve this purpose, neonatal Lewis rats were supplemented with the probiotic strain from the 6th to the 18th day of life. The animals were weighed during the study, and faecal samples were obtained and evaluated daily. On day 19, rats were euthanized and intestinal wash samples, mesenteric lymph node (MLN) cells, splenocytes and intraepithelial lymphocytes (IEL) were obtained. The probiotic supplementation in early life did not modify the growth curve and did not enhance the systemic immune maturation. However, it increased the proportion of cells bearing TLR4 in the MLN and IEL, and enhanced the percentage of the integrin alpha E beta 7+ and CD62L+ cells in the MLN and that of the integrin alpha E beta 7+ cells in the IEL, suggesting an enhancement of the homing process of naive T lymphocytes to the MLN, and the retention of activated lymphocytes in the intraepithelial compartment. Interestingly, B. breve M-16V enhanced the intestinal IgA synthesis. In conclusion, supplementation with the probiotic strain B. breve M-16V during suckling improves the development of mucosal immunity in early life.	[del Mar Rigo-Adrover, Maria; Franch, Angels; Castell, Margarida; Jose Perez-Cano, Francisco] Univ Barcelona, Dept Bioquim & Fisiol, Fac Farm & Ciencies Alimentacio, Barcelona, Spain; [del Mar Rigo-Adrover, Maria; Franch, Angels; Castell, Margarida; Jose Perez-Cano, Francisco] Inst Recerca Nutr & Seguretat Alimentaria INSA, Barcelona, Spain	University of Barcelona; University of Barcelona	Perez-Cano, FJ (corresponding author), Univ Barcelona, Dept Bioquim & Fisiol, Fac Farm & Ciencies Alimentacio, Barcelona, Spain.; Perez-Cano, FJ (corresponding author), Inst Recerca Nutr & Seguretat Alimentaria INSA, Barcelona, Spain.	franoiscoperez@ub.edu	Franch, Àngels/G-5669-2019; Castell, Margarida/G-9078-2015; Perez-Cano, Francisco J/G-6516-2019	Franch, Àngels/0000-0002-2362-1374; Castell, Margarida/0000-0001-5408-0593; Perez-Cano, Francisco J/0000-0001-6243-9164				Agace W, 2010, IMMUNOL LETT, V128, P21, DOI 10.1016/j.imlet.2009.09.012; Agace WW, 2008, TRENDS IMMUNOL, V29, P514, DOI 10.1016/j.it.2008.08.003; Amit-Romach E, 2010, MOL NUTR FOOD RES, V54, P277, DOI 10.1002/mnfr.200800591; Aureli P, 2011, PHARMACOL RES, V63, P366, DOI 10.1016/j.phrs.2011.02.006; Bermudez-Brito M, 2012, ANN NUTR METAB, V61, P160, DOI 10.1159/000342079; Bernardo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036262; Bertelsen RJ, 2016, BEST PRACT RES CL GA, V30, P39, DOI 10.1016/j.bpg.2016.01.001; Bodera P, 2009, RECENT PATENTS INFLA, V3, P58, DOI 10.2174/187221309787158461; Borruel N, 2002, GUT, V51, P659, DOI 10.1136/gut.51.5.659; Carasi P, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/361604; Carol M, 2006, J LEUKOCYTE BIOL, V79, P917, DOI 10.1189/jlb.0405188; Castillo NA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-177; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Chu ZX, 2010, DIGEST DIS SCI, V55, P2505, DOI 10.1007/s10620-009-1063-2; de Kivit S, 2012, ALLERGY, V67, P343, DOI 10.1111/j.1398-9995.2011.02771.x; de Vrese M, 2008, ADV BIOCHEM ENG BIOT, V111, P1, DOI 10.1007/10_2008_097; Delcenserie V, 2008, CURR ISSUES MOL BIOL, V10, P37; Escribano E, 2014, ARCH DIS CHILD; FAO/WHO, 2006, PROB FOOD HLTH NUTR; Frei R, 2015, CURR OPIN GASTROEN, V31, P153, DOI 10.1097/MOG.0000000000000151; Fukushima Y, 1998, INT J FOOD MICROBIOL, V42, P39, DOI 10.1016/S0168-1605(98)00056-7; Galdeano CM, 2007, CLIN VACCINE IMMUNOL, V14, P485, DOI 10.1128/CVI.00406-06; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Guarner F, 2012, J CLIN GASTROENTEROL, V46, P468, DOI 10.1097/MCG.0b013e3182549092; Gueimonde M, 2006, J PEDIATR GASTR NUTR, V42, P604, DOI 10.1097/01.mpg.0000221897.45910.d3; Hashemi A, 2016, FOOD FUNCT, V7, P1752, DOI [10.1039/C5FO01148E, 10.1039/c5fo01148e]; Hong M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117451; Hougee S, 2010, INT ARCH ALLERGY IMM, V151, P107, DOI 10.1159/000236000; Hu GZ, 2016, EXP THER MED, V11, P33, DOI 10.3892/etm.2015.2854; Ivetic A, 2013, INT J BIOCHEM CELL B, V45, P550, DOI 10.1016/j.biocel.2012.12.023; Kaplan JL, 2011, PEDIATR RES, V69, P465, DOI 10.1203/PDR.0b013e318217638a; Kick AR, 2012, J ANIM SCI, V90, P649, DOI 10.2527/jas.2010-3470; Kilshaw PJ, 1999, J CLIN PATHOL-MOL PA, V52, P203, DOI 10.1136/mp.52.4.203; Knight SC, 2016, DIGEST DIS, V34, P51, DOI 10.1159/000442926; Kotzamanidis C, 2010, INT J FOOD MICROBIOL, V140, P154, DOI 10.1016/j.ijfoodmicro.2010.04.004; Liu YY, 2012, AM J PHYSIOL-GASTR L, V302, pG608, DOI 10.1152/ajpgi.00266.2011; Macfarlane GT, 2011, J CLIN GASTROENTEROL, V45, pS120, DOI 10.1097/MCG.0b013e31822fecfe; Majamaa H, 1997, J ALLERGY CLIN IMMUN, V99, P179, DOI 10.1016/S0091-6749(97)70093-9; Mann ER, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/573576; Marin-Gallen S, 2008, DEV COMP IMMUNOL, V32, P1405, DOI 10.1016/j.dci.2008.06.011; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; Park JH, 2002, CELL IMMUNOL, V219, P22, DOI 10.1016/S0008-8749(02)00579-8; Partty A, 2015, PEDIATR RES, V77, P823, DOI 10.1038/pr.2015.51; Perez-Cano FJ, 2005, PEDIATR RES, V58, P885, DOI 10.1203/01.pdr.0000182187.88505.49; Perez-Cano FJ, 2005, PEDIATR RES, V58, P164, DOI 10.1203/01.PDR.0000156367.60769.36; Perez-Cano FJ, 2007, DEV COMP IMMUNOL, V31, P1264, DOI 10.1016/j.dci.2007.03.004; Perez-Cano FJ, 2007, BRIT J NUTR, V98, pS80, DOI 10.1017/S0007114507838074; Perez-Cano FJ, 2007, PEDIATR RES, V62, P658, DOI 10.1203/PDR.0b013e318159a273; Perez-Cano FJ, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/537310; Perez-Cano FJ, 2010, IMMUNOBIOLOGY, V215, P996, DOI 10.1016/j.imbio.2010.01.004; Ramos-Romero S, 2012, BRIT J NUTR, V107, P378, DOI 10.1017/S0007114511003035; Rigo-Adrover M, 2017, EUR J NUTR, V56, P1657, DOI 10.1007/s00394-016-1213-1; Salvatore S, 2010, BIOACTIVE FOODS IN PROMOTING HEALTH: PROBIOTICS AND PREBIOTICS, P181, DOI 10.1016/B978-0-12-374938-3.00013-X; Serazin Andrew C, 2010, Nat Immunol, V11, P769, DOI 10.1038/ni0910-769; Smelt MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068952; van de Pol MA, 2011, ALLERGY, V66, P39, DOI 10.1111/j.1398-9995.2010.02454.x; Veereman-Wauters G, 2011, J PEDIATR GASTR NUTR, V52, P763, DOI 10.1097/MPG.0b013e3182139f39; Verheijden KAT, 2016, EUR J NUTR, V55, P1141, DOI 10.1007/s00394-015-0928-8; Westerbeek EAM, 2011, ACTA PAEDIATR, V100, P1426, DOI 10.1111/j.1651-2227.2011.02295.x; Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d; Yang X, 2013, J HUAZHONG U SCI-MED, V33, P661, DOI 10.1007/s11596-013-1177-9	63	15	17	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166082	10.1371/journal.pone.0166082	http://dx.doi.org/10.1371/journal.pone.0166082			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820846	gold, Green Published, Green Submitted			2022-12-27	WOS:000387614800031
J	Moens, SJB; van Leuven, SI; Zheng, KH; Havik, SR; Versloot, MV; van Duivenvoorde, LM; Hahne, M; Stroes, ESG; Baeten, DL; Hamers, AAJ				Moens, Sophie J. Bernelot; van Leuven, Sander I.; Zheng, Kang H.; Havik, Stefan R.; Versloot, Miranda V.; van Duivenvoorde, Leonie M.; Hahne, Michael; Stroes, Erik S. G.; Baeten, Dominique L.; Hamers, Anouk A. J.			Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; NATURAL ANTIBODIES; IMMUNOGLOBULIN-M; BAFF; MICE; IGM; MACROPHAGE; FAMILY; LIGAND	Studies on the role of B lymphocytes in atherosclerosis development, have yielded contradictory results. Whereas B lymphocyte-deficiency aggravates atherosclerosis in mice; depletion of mature B lymphocytes reduces atherosclerosis. These observations led to the notion that distinct B lymphocyte subsets have different roles. B1a lymphocytes exert an atheroprotective effect, which has been attributed to secretion of IgM, which can be deposited in atherosclerotic lesions thereby reducing necrotic core formation. Tumor necrosis factor (TNF)-family member 'A Proliferation-Inducing Ligand' (APRIL, also known as TNFSF13) was previously shown to increase serum IgM levels in a murine model. In this study, we investigated the effect of APRIL overexpression on advanced lesion formation and composition, IgM production and B cell phenotype. We crossed APRIL transgenic (APRIL-Tg) mice with ApoE knockout (ApoE(-/-)) mice. After a 12-week Western Type Diet, ApoE(-/-) APRIL-Tg mice and ApoE(-/-) littermates showed similar increases in body weight and lipid levels. Histologic evaluation showed no differences in lesion size, stage or necrotic area. However, smooth muscle cell (a-actin stain) content was increased in ApoE(-/-) APRIL-Tg mice, implying more stable lesions. In addition, increases in both plaque IgM deposition and plasma IgM levels were found in ApoE(-/-) APRIL-Tg mice compared with ApoE(-/-) mice. Flow cytometry revealed a concomitant increase in peritoneal B1a lymphocytes in ApoE(-/-) APRIL-Tg mice. This study shows that ApoE(-/-) APRIL-Tg mice have increased oxLDL-specific serum IgM levels, potentially mediated via an increase in B1a lymphocytes. Although no differences in lesion size were found, transgenic ApoE(-/-) APRIL-Tg mice do show potential plaque stabilizing features in advanced atherosclerotic lesions.	[Moens, Sophie J. Bernelot; Zheng, Kang H.; Stroes, Erik S. G.] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [van Leuven, Sander I.; van Duivenvoorde, Leonie M.; Baeten, Dominique L.] Acad Med Ctr, Amsterdam Rheumatol & Immunol Ctr, Dept Clin Immunol & Rheumatol, Amsterdam, Netherlands; [Versloot, Miranda V.; Hamers, Anouk A. J.] Acad Med Ctr, Dept Expt Vasc Med, Amsterdam, Netherlands; [van Duivenvoorde, Leonie M.; Baeten, Dominique L.] Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands; [Hahne, Michael] Univ Montpellier, CNRS, Inst Genet Mol Montpellier, Montpellier, France	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Moens, SJB (corresponding author), Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands.	s.j.bernelotmoens@amc.uva.nl	/AAF-6018-2020; van Leuven, Sander I/R-7844-2017	Bernelot Moens, Sophie/0000-0001-6915-521X; Zheng, Kang He/0000-0001-8954-1337; van Leuven, Sander/0000-0003-1432-069X	Netherlands Heart Foundation (Generating the best evidence-based pharmaceutical targets for atherosclerosis (GENIUS) [CVON 2011/ B019]; ReumaFonds [LLP-2] Funding Source: researchfish	Netherlands Heart Foundation (Generating the best evidence-based pharmaceutical targets for atherosclerosis (GENIUS); ReumaFonds	This research is supported by The Netherlands Heart Foundation (CVON 2011/ B019: Generating the best evidence-based pharmaceutical targets for atherosclerosis (GENIUS).	Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Binder CJ, 2005, J LIPID RES, V46, P1353, DOI 10.1194/jlr.R500005-JLR200; Cesena FHY, 2012, ATHEROSCLEROSIS, V220, P59, DOI 10.1016/j.atherosclerosis.2011.10.002; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; DAVIES MJ, 1993, BRIT HEART J, V69, P377; de Waard Vivian, 2012, Curr Protoc Mouse Biol, V2, P317, DOI 10.1002/9780470942390.mo120069; Fernandez L, 2013, ANN RHEUM DIS, V72, P1367, DOI 10.1136/annrheumdis-2012-202382; Gower RM, 2011, ARTERIOSCL THROM VAS, V31, P160, DOI 10.1161/ATVBAHA.110.215434; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Huan TX, 2013, ARTERIOSCL THROM VAS, V33, P1427, DOI 10.1161/ATVBAHA.112.300112; Karvonen J, 2003, CIRCULATION, V108, P2107, DOI 10.1161/01.CIR.0000092891.55157.A7; Kolodgie FD, 2001, CURR OPIN CARDIOL, V16, P285, DOI 10.1097/00001573-200109000-00006; Kyaw T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029371; Kyaw T, 2011, CIRC RES, V109, P830, DOI 10.1161/CIRCRESAHA.111.248542; Kyaw T, 2010, J IMMUNOL, V185, P4410, DOI 10.4049/jimmunol.1000033; Lewis MJ, 2009, CIRCULATION, V120, P417, DOI 10.1161/CIRCULATIONAHA.109.868158; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Major AS, 2002, ARTERIOSCL THROM VAS, V22, P1892, DOI 10.1161/01.ATV.0000039169.47943.EE; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Perry HM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00373; Planelles L, 2004, CANCER CELL, V6, P399, DOI 10.1016/j.ccr.2004.08.033; Rincon-Arevalo H, 2016, ATHEROSCLEROSIS, V247, P118, DOI 10.1016/j.atherosclerosis.2015.12.022; Rong JX, 2001, CIRCULATION, V104, P2447, DOI 10.1161/hc4501.098952; Rosenfeld SM, 2015, CIRC RES, V117, pE28, DOI 10.1161/CIRCRESAHA.117.306044; Sage AP, 2012, ARTERIOSCL THROM VAS, V32, P1573, DOI 10.1161/ATVBAHA.111.244731; Sandberg WJ, 2009, THROMB HAEMOSTASIS, V102, P704, DOI 10.1160/TH08-10-0665; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; Stein JV, 2002, J CLIN INVEST, V109, P1587, DOI 10.1172/JCI200215034; Tsiantoulas D, 2014, CIRC RES, V114, P1743, DOI 10.1161/CIRCRESAHA.113.301145; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P2218, DOI 10.1016/j.jacc.2012.08.979; Turpeinen H, 2011, ATHEROSCLEROSIS, V219, P799, DOI 10.1016/j.atherosclerosis.2011.08.011	31	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0164690	10.1371/journal.pone.0164690	http://dx.doi.org/10.1371/journal.pone.0164690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820817	Green Submitted, Green Published, gold			2022-12-27	WOS:000387614800002
J	Sadeghinejad, L; Cvitkovitch, DG; Siqueira, WL; Santerre, JP; Finer, Y				Sadeghinejad, Lida; Cvitkovitch, Dennis G.; Siqueira, Walter L.; Santerre, J. Paul; Finer, Yoav			Triethylene Glycol Up-Regulates Virulence-Associated Genes and Proteins in Streptococcus mutans	PLOS ONE			English	Article							TERMINAL HALF PART; BIOFILM FORMATION; DENTAL COMPOSITE; POSTERIOR RESTORATIONS; SALIVARY ESTERASE; SIGNALING SYSTEM; EXPRESSION; AMALGAM; BIODEGRADATION; LONGEVITY	Triethylene glycol dimethacrylate (TEGDMA) is a diluent monomer used pervasively in dental composite resins. Through hydrolytic degradation of the composites in the oral cavity it yields a hydrophilic biodegradation product, triethylene glycol (TEG), which has been shown to promote the growth of Streptococcus mutans, a dominant cariogenic bacterium. Previously it was shown that TEG up-regulated gtfB, an important gene contributing to polysaccharide synthesis function in biofilms. However, molecular mechanisms related to TEG's effect on bacterial function remained poorly understood. In the present study, S. mutans UA159 was incubated with clinically relevant concentrations of TEG at pH 5.5 and 7.0. Quantitative real-time PCR, proteomics analysis, and glucosyltransferase enzyme (GTF) activity measurements were employed to identify the bacterial phenotypic response to TEG. A S. mutans vicK isogenic mutant (SM Delta vicK1) and its associated complemented strain (SM Delta vicK1C), an important regulatory gene for biofilm-associated genes, were used to determine if this signaling pathway was involved in modulation of the S. mutans virulence-associated genes. Extracted proteins from S. mutans biofilms grown in the presence and absence of TEG were subjected to mass spectrometry for protein identification, characterization and quantification. TEG up-regulated gtfB/C, gbpB, comC, comD and comE more significantly in biofilms at cariogenic pH (5.5) and defined concentrations. Differential response of the vicK knock-out (SM Delta vicK1) and complemented strains (SM Delta vicK1C) implicated this signalling pathway in TEG-modulated cellular responses. TEG resulted in increased GTF enzyme activity, responsible for synthesizing insoluble glucans involved in the formation of cariogenic biofilms. As well, TEG increased protein abundance related to biofilm formation, carbohydrate transport, acid tolerance, and stress-response. Proteomics data was consistent with gene expression findings for the selected genes. These findings demonstrate a mechanistic pathway by which TEG derived from commercial resin materials in the oral cavity promote S. mutans pathogenicity, which is typically associated with secondary caries.	[Sadeghinejad, Lida; Cvitkovitch, Dennis G.; Santerre, J. Paul; Finer, Yoav] Univ Toronto, Dent Res Inst, Fac Dent, Toronto, ON, Canada; [Sadeghinejad, Lida; Cvitkovitch, Dennis G.; Santerre, J. Paul; Finer, Yoav] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Siqueira, Walter L.] Univ Western Ontario, Schulich Dent, London, ON, Canada; [Siqueira, Walter L.] Univ Western Ontario, Dept Biochem, London, ON, Canada	University of Toronto; University of Toronto; Western University (University of Western Ontario); Western University (University of Western Ontario)	Finer, Y (corresponding author), Univ Toronto, Dent Res Inst, Fac Dent, Toronto, ON, Canada.; Finer, Y (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	yoav.finer@dentistry.utoronto.ca	Siqueira, Walter/ABE-8924-2020; Siqueira, Walter/ABE-4069-2021; Cvitkovitch, Dennis/AAF-9311-2020	Siqueira, Walter/0000-0003-1921-3658; 	National Institute of Dental & Craniofacial Research [R01DE021385]; Canadian Institute of Health Research [MOP115113, 97577]; Canada Foundation for Innovation [25116]; CIHR [97577]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021385] Funding Source: NIH RePORTER	National Institute of Dental & Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institute of Dental & Craniofacial Research R01DE021385 (YF); Canadian Institute of Health Research MOP115113 (YF); Canadian Institute of Health Research grant #97577 (WLS); and Canada Foundation for Innovation grant #25116 (WLS).; The authors thank Dr. Shida Wang, Kirsten Krastel, Yizhi Xiao and Eduardo B. Moffa, for their technical assistance. This investigation was funded by National Institute of Dental & Craniofacial Research R01DE021385; Canadian Institute of Health Research MOP115113, CIHR grant # 97577 and Canada Foundation for Innovation grant # 25116. This is an independent study free of conflict of interest.	Abranches J, 2003, APPL ENVIRON MICROB, V69, P4760, DOI 10.1128/AEM.69.8.4760-4769.2003; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; [Anonymous], 2007, ADA SURV DENT SERV R; Ballantyne B, 2007, J APPL TOXICOL, V27, P291, DOI 10.1002/jat.1220; Beazoglou T, 2007, PUBLIC HEALTH REP, V122, P657, DOI 10.1177/003335490712200513; BENDER GR, 1986, INFECT IMMUN, V53, P331, DOI 10.1128/IAI.53.2.331-338.1986; Bernardo M, 2007, J AM DENT ASSOC, V138, P775, DOI 10.14219/jada.archive.2007.0265; BIGG E, 1945, AM J PUBLIC HEALTH, V35, P788; Bourbia M, 2013, J DENT RES, V92, P989, DOI 10.1177/0022034513504436; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Brooun A, 2000, ANTIMICROB AGENTS CH, V44, P640, DOI 10.1128/AAC.44.3.640-646.2000; Casal M, 2016, ADV EXP MED BIOL, V892, P229, DOI 10.1007/978-3-319-25304-6_9; Chattoraj P, 2010, J BACTERIOL, V192, P1312, DOI 10.1128/JB.01350-09; CHIRIFE J, 1983, ANTIMICROB AGENTS CH, V24, P409, DOI 10.1128/AAC.24.3.409; Chrysanthakopoulos Nikolaos Andreas, 2011, J Dent Res Dent Clin Dent Prospects, V5, P87; Cvitkovitch DG, 2003, J CLIN INVEST, V112, P1626, DOI 10.1172/JCI200320430; Duque C, 2011, INFECT IMMUN, V79, P786, DOI 10.1128/IAI.00725-10; Englemann J, 2001, J DENT RES, V80, P869, DOI 10.1177/00220345010800030501; Erbse A, 2004, BIOCHEM SOC T, V32, P617, DOI 10.1042/BST0320617; Falsetta ML, 2012, ANTIMICROB AGENTS CH, V56, P6201, DOI 10.1128/AAC.01381-12; Ferracane JL, 2011, DENT MATER, V27, P29, DOI 10.1016/j.dental.2010.10.020; FINCHER EL, 1962, APPL MICROBIOL, V10, P542, DOI 10.1128/AEM.10.6.542-547.1962; Finer Y, 2007, J BIOMED MATER RES A, V81A, P75, DOI 10.1002/jbm.a.31004; Finer Y, 2004, J BIOMED MATER RES A, V69A, P233, DOI 10.1002/jbm.a.30000; Finer Y, 2004, J DENT RES, V83, P22, DOI 10.1177/154405910408300105; Finer Y, 2003, J BIOMAT SCI-POLYM E, V14, P837, DOI 10.1163/156856203768366558; Fozo EA, 2004, APPL ENVIRON MICROB, V70, P929, DOI 10.1128/AEM.70.2.929-936.2004; Frost Peter M, 2002, Prim Dent Care, V9, P31, DOI 10.1308/135576102322547548; Fujita K, 2011, ARCH ORAL BIOL, V56, P258, DOI 10.1016/j.archoralbio.2010.09.018; Geurtsen W, 2001, J DENT RES, V80, P2046, DOI 10.1177/00220345010800120401; Gordan VV, 2012, J AM DENT ASSOC, V143, P593, DOI 10.14219/jada.archive.2012.0238; HAMBURGER M, 1945, J INFECT DIS, V77, P177, DOI 10.1093/infdis/77.3.177; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Inagaki S, 2009, ORAL MICROBIOL IMMUN, V24, P104, DOI 10.1111/j.1399-302X.2008.00480.x; Inagaki S, 2013, SCI WORLD J, DOI 10.1155/2013/405075; Jaffer F, 2002, BIOMATERIALS, V23, P1707, DOI 10.1016/S0142-9612(01)00298-8; JAYARAMAN GC, 1995, FEMS MICROBIOL LETT, V131, P255; Ji CH, 2014, J GEN PHYSIOL, V144, P257, DOI 10.1085/jgp.201411243; Kajfasz JK, 2009, J BACTERIOL, V191, P2060, DOI 10.1128/JB.01609-08; KAWAI F, 1978, APPL ENVIRON MICROB, V35, P679, DOI 10.1128/AEM.35.4.679-684.1978; Kawai F, 2002, APPL MICROBIOL BIOT, V58, P30, DOI 10.1007/s00253-001-0850-2; Kermanshahi S, 2010, J DENT RES, V89, P996, DOI 10.1177/0022034510372885; Khalichi P, 2004, BIOMATERIALS, V25, P5467, DOI 10.1016/j.biomaterials.2003.12.056; Khalichi P, 2009, BIOMATERIALS, V30, P452, DOI 10.1016/j.biomaterials.2008.09.053; Klein MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045795; Koo H, 2006, ANTIMICROB AGENTS CH, V50, P542, DOI 10.1128/AAC.50.2.542-546.2006; Koo H, 2003, J ANTIMICROB CHEMOTH, V52, P782, DOI 10.1093/jac/dkg449; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Kopperud SE, 2012, EUR J ORAL SCI, V120, P539, DOI 10.1111/eos.12004; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95; Lemos JA, 2007, J BACTERIOL, V189, P1582, DOI 10.1128/JB.01655-06; Len ACL, 2004, MICROBIOL-SGM, V150, P1339, DOI 10.1099/mic.0.27008-0; Len ACL, 2003, PROTEOMICS, V3, P627, DOI 10.1002/pmic.200300391; Len MCL, 2004, MICROBIOL-SGM, V150, P1353, DOI 10.1099/mic.0.26888-0; LESTER W, 1949, AM J HYG, V50, P175, DOI 10.1093/oxfordjournals.aje.a119352; Li YH, 2002, J BACTERIOL, V184, P6333, DOI 10.1128/JB.184.22.6333-6342.2002; Li YH, 2001, J BACTERIOL, V183, P897, DOI 10.1128/JB.183.3.897-908.2001; Li YH, 2002, J BACTERIOL, V184, P2699, DOI 10.1128/JB.184.10.2699-2708.2002; Li YH, 2012, SENSORS-BASEL, V12, P2519, DOI 10.3390/s120302519; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Loo CY, 2003, J BACTERIOL, V185, P6241, DOI 10.1128/JB.185.21.6241-6254.2003; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mattos-Graner RO, 2006, J BACTERIOL, V188, P3813, DOI 10.1128/JB.01845-05; Moraschini V, 2015, J DENT, V43, P1043, DOI 10.1016/j.jdent.2015.06.005; MUNRO C, 1991, INFECT IMMUN, V59, P2316, DOI 10.1128/IAI.59.7.2316-2323.1991; Nedeljkovic I, 2015, DENT MATER, V31, pE247, DOI 10.1016/j.dental.2015.09.001; Opdam NJM, 2007, DENT MATER, V23, P2, DOI 10.1016/j.dental.2005.11.036; Palotie U, 2012, ACTA ODONTOL SCAND, V70, P485, DOI 10.3109/00016357.2011.640274; QUIVEY RG, 1995, FEMS MICROBIOL LETT, V126, P257, DOI 10.1016/0378-1097(95)00019-2; Rho YJ, 2013, OPER DENT, V38, P572, DOI 10.2341/12-432-C; ROBERTSON OH, 1948, J INFECT DIS, V83, P124, DOI 10.1093/infdis/83.2.124; ROBERTSON OH, 1951, AM J HYG, V53, P69, DOI 10.1093/oxfordjournals.aje.a119437; ROSEBURY T, 1947, J EXP MED, V85, P65, DOI 10.1084/jem.85.1.65; Roumanas Eleni D, 2010, J Evid Based Dent Pract, V10, P23, DOI 10.1016/j.jebdp.2009.11.009; Santerre JP, 2001, CRIT REV ORAL BIOL M, V12, P136, DOI 10.1177/10454411010120020401; SCHROEDER VA, 1989, INFECT IMMUN, V57, P3560, DOI 10.1128/IAI.57.11.3560-3569.1989; Sciotti MA, 1997, ADV EXP MED BIOL, V418, P699; Sciotti MA, 1997, FEMS MICROBIOL LETT, V153, P439, DOI 10.1016/S0378-1097(97)00287-5; Senadheera D, 2009, J BACTERIOL, V191, P6415, DOI 10.1128/JB.00793-09; Senadheera DB, 2012, J BACTERIOL, V194, P1307, DOI 10.1128/JB.06071-11; Senadheera MD, 2007, J BACTERIOL, V189, P1451, DOI 10.1128/JB.01161-06; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Shemesh M, 2007, MICROBIOL-SGM, V153, P1307, DOI 10.1099/mic.0.2006/002030-0; Shokati B, 2010, J BIOMED MATER RES B, V94B, P230, DOI 10.1002/jbm.b.31645; Simecek JW, 2009, J AM DENT ASSOC, V140, P200, DOI 10.14219/jada.archive.2009.0134; Siqueira WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042204; Smith AMV, 2007, CARIES RES, V41, P445, DOI 10.1159/000107930; Smith Daniel J, 2003, J Dent Educ, V67, P1130; Smith DJ, 1996, INFECT IMMUN, V64, P3069, DOI 10.1128/IAI.64.8.3069-3073.1996; Soncini JA, 2007, J AM DENT ASSOC, V138, P763, DOI 10.14219/jada.archive.2007.0264; Spencer P, 2014, J DENT RES, V93, P1243, DOI 10.1177/0022034514550039; Stipp RN, 2008, ORAL MICROBIOL IMMUN, V23, P466, DOI 10.1111/j.1399-302X.2008.00451.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sunnegardh-Gronberg K, 2009, J DENT, V37, P673, DOI 10.1016/j.jdent.2009.04.010; Svensater G, 2001, FEMS MICROBIOL LETT, V205, P139, DOI 10.1111/j.1574-6968.2001.tb10937.x; Tamura H, 2014, GENES GENET SYST, V89, P41, DOI 10.1266/ggs.89.41; Terao Y, 2009, ORAL MICROBIOL IMMUN, V24, P211, DOI 10.1111/j.1399-302X.2008.00497.x; Van den Bogert B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083418; Wolman A, 1947, AM J PUBLIC HEALTH N, V37, P189; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; YAMASHITA Y, 1993, INFECT IMMUN, V61, P3811, DOI 10.1128/IAI.61.9.3811-3817.1993	103	28	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165760	10.1371/journal.pone.0165760	http://dx.doi.org/10.1371/journal.pone.0165760			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820867	Green Published, Green Submitted, gold			2022-12-27	WOS:000387614800019
J	de Sousa, DCP; Soldati, GT; Monteiro, JM; Araujo, TAD; Albuquerque, UP				Pires de Sousa, Daniel Carvalho; Soldati, Gustavo Taboada; Monteiro, Julio Marcelino; de Sousa Araujo, Thiago Antonio; Albuquerque, Ulysses Paulino			Information Retrieval during Free Listing Is Biased by Memory: Evidence from Medicinal Plants	PLOS ONE			English	Article							EPISODIC MEMORY; SEMANTIC MEMORY; AGE-DIFFERENCES; KNOWLEDGE; ORGANIZATION; CONTEXT; SYSTEMS	Free listing is a methodological tool that is widely used in various scientific disciplines. A typical assumption of this approach is that individual lists reflect a subset of total knowledge and that the first items listed are the most culturally important. However, little is known about how cognitive processes influence free lists. In this study, we assess how recent memory of use, autonoetic and anoetic memory, and long-term associative memory can affect the composition and order of items in free lists and evaluate whether free lists indicate the most important items. Based on a model of local knowledge about medicinal plants and their therapeutic targets, which was collected via individual semi-structured interviews, we classify each item recorded in free lists according to the last time that the item was used by the informant (recently or long ago), the type of relevant memory (autonoetic or anoetic memory) and the existing associations between therapeutic targets (similar or random). We find that individuals have a tendency to recall information about medicinal plants used during the preceding year and that the recalled plants were also the most important plants during this period. However, we find no trend in the recall of plants from long-term associative memory, although this phenomenon is well established in studies on cognitive psychology. We suggest that such evidence should be considered in studies that use lists of medicinal plants because this temporal cognitive limit on the retrieval of knowledge affects data interpretation.	[Pires de Sousa, Daniel Carvalho; Albuquerque, Ulysses Paulino] Univ Fed Rural Pernambuco, Lab Ecol & Evolucao Sistemas Socioecol LEA, Dept Biol, Av Dom Manoel Medeiros S-N, BR-52171900 Recife, PE, Brazil; [Soldati, Gustavo Taboada] Univ Fed Juiz de Fora, Rua Jose Lourenco Kelmer S-N, BR-36036330 Juiz De Fora, MG, Brazil; [Monteiro, Julio Marcelino] Univ Fed Piaui, Campus Univ Minist Petronio Portella S-N, BR-64049550 Teresina, Piaui, Brazil; [de Sousa Araujo, Thiago Antonio] Univ Fed Pernambuco, Lab Prod Nat Lapronat, Dept Farm, Av Prof Moraes Rego 1235,Cidade Univ, BR-50670901 Recife, PE, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal de Juiz de Fora; Universidade Federal do Piaui; Universidade Federal de Pernambuco	Albuquerque, UP (corresponding author), Univ Fed Rural Pernambuco, Lab Ecol & Evolucao Sistemas Socioecol LEA, Dept Biol, Av Dom Manoel Medeiros S-N, BR-52171900 Recife, PE, Brazil.	upa677@hotmail.com	Albuquerque, Ulysses P/I-5037-2012	Albuquerque, Ulysses P/0000-0002-8131-8429; Soldati, Gustavo/0000-0002-0173-8440; Sousa, Daniel/0000-0001-8074-2570	Brazilian Federal Agency for Support and Evaluation of Graduate Education (Coordenacao de Aperfeicoamento de Pessoal Nivel Superior-CAPES); CNPq	Brazilian Federal Agency for Support and Evaluation of Graduate Education (Coordenacao de Aperfeicoamento de Pessoal Nivel Superior-CAPES); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by: The Brazilian Federal Agency for Support and Evaluation of Graduate Education (Coordenacao de Aperfeicoamento de Pessoal Nivel Superior-CAPES); and CNPq to productivity grant to UPA.	Albuquerque UP, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-72; Albuquerque UP., 2014, METHODS TECHNIQUES E, V1, DOI [10.1007/978-1-4614-8636-7, DOI 10.1007/978-1-4614-8636-7]; Alencar NL, 2014, ECON BOT, V68, P371, DOI 10.1007/s12231-014-9284-5; Alencar NL, 2014, REV BRAS FARMACOGN, V24, P506, DOI 10.1016/j.bjp.2014.09.003; Alencar NL, 2010, ECON BOT, V64, P68, DOI 10.1007/s12231-009-9104-5; Baddeley A, 2001, PHILOS T R SOC B, V356, P1345, DOI 10.1098/rstb.2001.0957; Bernard H.R., 2006, RES METHODS ANTHR, V4th; Brewer D., 2002, FIELD METHOD, V14, P108, DOI 10.1177/1525822X02014001007; Brewer GA, 2012, J MEM LANG, V66, P407, DOI 10.1016/j.jml.2011.12.009; Cartaxo SL, 2010, J ETHNOPHARMACOL, V131, P326, DOI 10.1016/j.jep.2010.07.003; Ceuterick M, 2011, J ETHNOPHARMACOL, V136, P27, DOI 10.1016/j.jep.2011.03.038; Cruz MP, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-79; da Silva K., 2015, INT J TROP BIOL, V63, P903, DOI [10.15517/RBT.V63I4.16538, DOI 10.15517/RBT.V63I4.16538]; de Albuquerque UP, 2007, J ETHNOPHARMACOL, V110, P76, DOI 10.1016/j.jep.2006.09.010; de Medeiros PM, 2015, J ETHNOPHARMACOL, V159, P43, DOI 10.1016/j.jep.2014.11.001; Abreu DBD, 2015, J ETHNOPHARMACOL, V175, P124, DOI 10.1016/j.jep.2015.09.019; de Oliveira FC, 2009, ACTA BOT BRAS, V23, P590, DOI 10.1590/S0102-33062009000200031; Siqueira CFD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/434782; Araujo TAD, 2008, J ETHNOPHARMACOL, V120, P72, DOI 10.1016/j.jep.2008.07.032; Engle RW, 2004, PSYCHOL LEARN MOTIV, V44, P145; Ferreira WS, 2013, ETHNOBIOL CONSERV, V2, DOI 10.15451/ec2013-8-2.1-1-10; Ferreira WS, 2011, J ETHNOPHARMACOL, V138, P238, DOI 10.1016/j.jep.2011.09.018; Gravlee CC, 2013, SOC SCI COMPUT REV, V31, P119, DOI 10.1177/0894439312455312; Hills TT, 2012, PSYCHOL REV, V119, P431, DOI 10.1037/a0027373; Hough G, 2010, FOOD QUAL PREFER, V21, P295, DOI 10.1016/j.foodqual.2009.04.001; Howard MW, 2002, J MEM LANG, V46, P85, DOI 10.1006/jmla.2001.2798; Kahana MJ, 1996, MEM COGNITION, V24, P103, DOI 10.3758/BF03197276; Klein SB, 2016, Q J EXP PSYCHOL, V69, P381, DOI 10.1080/17470218.2015.1007150; Ladio A, 2007, J ARID ENVIRON, V69, P695, DOI 10.1016/j.jaridenv.2006.11.008; Libertino L, 2012, FOOD QUAL PREFER, V24, P269, DOI 10.1016/j.foodqual.2011.11.003; Mickes L, 2013, J MEM LANG, V68, P333, DOI 10.1016/j.jml.2013.01.001; Miranda TM, 2007, FIELD METHOD, V19, P76, DOI 10.1177/1525822X06295987; Nadel L, 2012, NEUROSCI BIOBEHAV R, V36, P1640, DOI 10.1016/j.neubiorev.2012.03.001; Nyberg L, 1996, J GERONTOL B-PSYCHOL, V51, pP234, DOI 10.1093/geronb/51B.4.P234; Polyn SM, 2009, NEUROPSYCHOLOGIA, V47, P2158, DOI 10.1016/j.neuropsychologia.2009.02.013; Quinlan M., 2005, FIELD METHOD, V17, P219, DOI [10.1177/1525822X05277460, DOI 10.1177/1525822X05277460]; RAAIJMAKERS JGW, 1981, PSYCHOL REV, V88, P93, DOI 10.1037/0033-295X.88.2.93; Reyes-Garcia V., 2004, FIELD METHOD, V16, P135, DOI [DOI 10.1177/1525822X03262804, 10.1177/1525822X03262804]; Ribeiro NF, 2012, J TRAVEL RES, V51, P555, DOI 10.1177/0047287511431322; ROMNEY AK, 1986, AM ANTHROPOL, V88, P313, DOI 10.1525/aa.1986.88.2.02a00020; Rowland CA, 2014, PSYCHON B REV, V21, P1516, DOI 10.3758/s13423-014-0625-2; Ryan G. W., 2000, FIELD METHOD, V12, P83; Santoro FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119826; Saslis-Lagoudakis CH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2768; Schrauf RW, 2010, FIELD METHOD, V22, P70, DOI 10.1177/1525822X09359747; Schrauf RW, 2008, J GERONTOL B-PSYCHOL, V63, pS385, DOI 10.1093/geronb/63.6.S385; Silva FD, 2011, REV BRAS FARMACOGN, V21, P382, DOI 10.1590/S0102-695X2011005000054; Smith J. Jerome, 1993, CULTURAL ANTHR METHO, V5, P1, DOI DOI 10.1177/1525822X9300500301; Araujo TAS, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-11; Spillers GJ, 2011, J EXP PSYCHOL LEARN, V37, P1532, DOI 10.1037/a0024852; Squire LR, 2009, J NEUROSCI, V29, P12711, DOI 10.1523/JNEUROSCI.3575-09.2009; SQUIRE LR, 1993, ANNU REV PSYCHOL, V44, P453, DOI 10.1146/annurev.ps.44.020193.002321; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Squire LR, 1998, HIPPOCAMPUS, V8, P205, DOI 10.1002/(SICI)1098-1063(1998)8:3<205::AID-HIPO3>3.0.CO;2-I; Sutrop Urmas, 2001, FIELD METHOD, V13, P263; Thompson EC, 2006, FIELD METHOD, V18, P398, DOI 10.1177/1525822X06293128; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Tulving Endel, 1995, P839	59	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165838	10.1371/journal.pone.0165838	http://dx.doi.org/10.1371/journal.pone.0165838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8TH	27814398	Green Published, gold, Green Submitted			2022-12-27	WOS:000386911100019
J	Heng, BL; Ding, HW; Ren, HL; Shi, LP; Chen, J; Wu, X; Lai, CY; Yu, GS; Xu, Y; Su, ZX				Heng, Baoli; Ding, Hongwen; Ren, Haolin; Shi, Liping; Chen, Jie; Wu, Xun; Lai, Caiyong; Yu, Ganshen; Xu, Yin; Su, Zexuan			Diagnostic Performance of Fas Ligand mRNA Expression for Acute Rejection after Kidney Transplantation: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RENAL-ALLOGRAFT REJECTION; PERIPHERAL-BLOOD LYMPHOCYTES; GENE-EXPRESSION; GRANZYME-B; NONINVASIVE DIAGNOSIS; MOLECULAR DIAGNOSIS; LIKELIHOOD RATIOS; TEST ACCURACY; TESTS; PERFORIN	Background The value of Fas ligand (FASL) as a diagnostic immune marker for acute renal rejection is controversial; this meta-analysis aimed to clarify the role of FASL in acute renal rejection. Methods The relevant literature was included by systematic searching the MEDLINE, EMBASE, and Cochrane Library databases. Accuracy data for acute rejection (AR) and potential confounding variables (the year of publication, area, sample source, quantitative techniques, housekeeping genes, fluorescence staining, sample collection time post-renal transplantation, and clinical classification of AR) were extracted after carefully reviewing the studies. Data were analyzed by Meta-DiSc 1.4, RevMan 5.0, and the Midas module in Stata 11.0 software. Results Twelve relevant studies involving 496 subjects were included. The overall pooled sensitivity, specificity, positive likelihood ratio (LR), negative LR, and diagnostic odds ratio, together with the 95% CI were 0.64 (0.57-0.70), 0.90 (0.85-0.93), 5.66 (3.51-9.11), 0.30 (0.16-0.54), and 30.63 (14.67-63.92), respectively. The area under the summary receiver operating characteristic curve (AUC) was 0.9389. Fagan's nomogram showed that the probability of AR episodes in the kidney transplant recipient increased from 15% to 69% when FASL was positive, and was reduced to 4% when FASL was negative. No threshold effect, sensitivity analyses, meta-regression, and subgroup analyses based on the potential variables had a significant statistical change for heterogeneity. Conclusions Current evidence suggests the diagnostic potential for FASL mRNA detection as a reliable immune marker for AR in renal allograft recipients. Further large, multicenter, prospective studies are needed to validate the power of this test marker in the non-invasive diagnosis of AR after renal transplantation.	[Heng, Baoli; Ding, Hongwen; Ren, Haolin; Shi, Liping; Chen, Jie; Wu, Xun; Lai, Caiyong; Yu, Ganshen; Xu, Yin; Su, Zexuan] Jinan Univ, Affiliated Hosp 1, Dept Urol, Guangzhou, Guangdong, Peoples R China	Jinan University	Su, ZX (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Urol, Guangzhou, Guangdong, Peoples R China.	suz2008@126.com			Major Research Fund for the People's Livelihood of Guangzhou Science and Technology Plan [2011Y-00003]	Major Research Fund for the People's Livelihood of Guangzhou Science and Technology Plan	Major Research Fund for the People's Livelihood of Guangzhou Science and Technology Plan (2011Y-00003).	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Akobeng AK, 2007, ACTA PAEDIATR, V96, P487, DOI 10.1111/j.1651-2227.2006.00179.x; Akobeng AK, 2007, ACTA PAEDIATR, V96, P338, DOI 10.1111/j.1651-2227.2006.00180.x; Alachkar N, 2012, NEPHROL THER, V8, P13, DOI 10.1016/j.nephro.2011.07.409; Aquino-Dias EC, 2008, KIDNEY INT, V73, P877, DOI 10.1038/sj.ki.5002795; BECKINGHAM IJ, 1994, BRIT J UROL, V73, P13, DOI 10.1111/j.1464-410X.1994.tb07449.x; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Desvaux D, 2004, TRANSPLANTATION, V78, P647, DOI 10.1097/01.tp.0000133530.26680.dc; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Dias ECA, 2004, CLIN TRANSPLANT, V18, P281, DOI 10.1111/j.1399-0012.2004.00161.x; Dugre FJ, 2000, TRANSPLANTATION, V70, P1074, DOI 10.1097/00007890-200010150-00014; Flechner SM, 2004, AM J TRANSPLANT, V4, P1475, DOI 10.1111/j.1600-6143.2004.00526.x; Galante NZ, 2006, TRANSPL IMMUNOL, V16, P73, DOI 10.1016/j.trim.2006.03.014; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Graziotto R, 2006, TRANSPLANTATION, V81, P1125, DOI 10.1097/01.tp.0000208573.16839.67; HARDING MW, 1988, TRANSPLANTATION, V46, pS29; Hee L, 2011, ACTA OBSTET GYN SCAN, V90, P1189, DOI 10.1111/j.1600-0412.2011.01187.x; Heng BL, 2015, TRANSPLANTATION, V99, P1477, DOI 10.1097/TP.0000000000000567; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higuchi R., 1992, NAT BIOTECHNOL, V10, P413, DOI DOI 10.1038/NBT0492-413; Ho J, 2012, AM J KIDNEY DIS, V60, P629, DOI 10.1053/j.ajkd.2012.01.028; HURAIB S, 1989, AM J KIDNEY DIS, V14, P13, DOI 10.1016/S0272-6386(89)80087-3; Hutchinson JA, 2015, TRANSPLANTATION, V99, P2009, DOI 10.1097/TP.0000000000000948; Jones CM, 2005, ANN THORAC SURG, V79, P16, DOI 10.1016/j.athoracsur.2004.09.040; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Lau HT, 1996, SCIENCE, V273, P109, DOI 10.1126/science.273.5271.109; Lebranchu Y, 2014, TRANSPL INT, V27, P129, DOI 10.1111/tri.12205; Leeflang MMG, 2014, CLIN MICROBIOL INFEC, V20, P105, DOI 10.1111/1469-0691.12474; Lettau M, 2011, EUR J CELL BIOL, V90, P456, DOI 10.1016/j.ejcb.2010.10.006; Lipman ML, 1998, TRANSPLANTATION, V66, P1673, DOI 10.1097/00007890-199812270-00018; Machida J, 1996, Int J Urol, V3, P228, DOI 10.1111/j.1442-2042.1996.tb00521.x; Merhi Basma, 2015, World J Transplant, V5, P251, DOI 10.5500/wjt.v5.i4.251; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Netto MVP, 2002, TRANSPLANT P, V34, P476, DOI 10.1016/S0041-1345(02)02601-5; Olive C, 1999, TRANSPL IMMUNOL, V7, P27, DOI 10.1016/S0966-3274(99)80016-1; PAUL K, 1991, TRANSPLANT P, V23, P974; Qu X, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/728673; Seino K, 1997, TRANSPL P, V29, P1092, DOI 10.1016/S0041-1345(96)00421-6; Seino K, 1996, INT IMMUNOL, V8, P1347, DOI 10.1093/intimm/8.9.1347; Shang YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039610; Sharma VK, 1996, TRANSPLANTATION, V62, P1860, DOI 10.1097/00007890-199612270-00031; Sharma VK, 1998, TRANSPL P, V30, P2364, DOI 10.1016/S0041-1345(98)00656-3; Shin GT, 2005, NEPHRON CLIN PRACT, V100, pC63, DOI 10.1159/000085050; Skupski DW, 2002, OBSTET GYNECOL, V99, P129, DOI 10.1016/S0029-7844(01)01645-3; Strehlau J, 1997, P NATL ACAD SCI USA, V94, P695, DOI 10.1073/pnas.94.2.695; Vasconcellos LM, 1998, TRANSPLANTATION, V66, P562, DOI 10.1097/00007890-199809150-00002; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wu KY, 2014, TRANSPLANTATION, V97, P1146, DOI 10.1097/01.TP.0000441094.32217.05; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	52	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165628	10.1371/journal.pone.0165628	http://dx.doi.org/10.1371/journal.pone.0165628			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812144	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000041
J	Liu, YA; Wang, BJ; Wang, L; Vikash, V; Wang, Q; Roggendorf, M; Lu, MJ; Yang, DL; Liu, J				Liu, Yanan; Wang, Baoju; Wang, Lu; Vikash, Vikash; Wang, Qin; Roggendorf, Michael; Lu, Mengji; Yang, Dongliang; Liu, Jia			Transcriptome Analysis and Comparison of Marmota monax and Marmota himalayana	PLOS ONE			English	Article							HEPATITIS-B; THERAPEUTIC VACCINATION; RNA-SEQ; TOOL; EXPRESSION; PHYLOGENY; SCIURIDAE; RODENTIA; MARKERS; MODELS	The Eastern woodchuck (Marmota monax) is a classical animal model for studying hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC) in humans. Recently, we found that Marmota himalayana, an Asian animal species closely related to Marmota monax, is susceptible to woodchuck hepatitis virus (WHV) infection and can be used as a new mammalian model for HBV infection. However, the lack of genomic sequence information of both Marmota models strongly limited their application breadth and depth. To address this major obstacle of the Marmota models, we utilized Illumina RNA-Seq technology to sequence the cDNA libraries of liver and spleen samples of two Marmota monax and four Marmota himalayana. In total, over 13 billion nucleotide bases were sequenced and approximately 1.5 billion clean reads were obtained. Following assembly, 106,496 consensus sequences of Marmota monax and 78,483 consensus sequences of Marmota himalayana were detected. For functional annotation, in total 73,603 Unigenes of Marmota monax and 78,483 Unigenes of Marmota himalayana were identified using different databases (NR, NT, Swiss-Prot, KEGG, COG, GO). The Unigenes were aligned by blastx to protein databases to decide the coding DNA sequences (CDS) and in total 41,247 CDS of Marmota monax and 34,033 CDS of Marmota himalayana were predicted. The single nucleotide polymorphisms (SNPs) and the simple sequence repeats (SSRs) were also analyzed for all Unigenes obtained. Moreover, a large-scale transcriptome comparison was performed and revealed a high similarity in transcriptome sequences between the two marmota species. Our study provides an extensive amount of novel sequence information for Marmota monax and Marmota himalayana. This information may serve as a valuable genomics resource for further molecular, developmental and comparative evolutionary studies, as well as for the identification and characterization of functional genes that are involved in WHV infection and HCC development in the woodchuck model.	[Liu, Yanan; Wang, Baoju; Wang, Lu; Vikash, Vikash; Wang, Qin; Yang, Dongliang; Liu, Jia] Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Infect & Immunol, Dept Infect Dis,Union Hosp, Wuhan, Peoples R China; [Roggendorf, Michael; Lu, Mengji] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany	Huazhong University of Science & Technology; University of Duisburg Essen	Yang, DL; Liu, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Infect & Immunol, Dept Infect Dis,Union Hosp, Wuhan, Peoples R China.	dlyang@hust.edu.cn; jialiu77@hotmail.com	Lu, Mengji/ABF-9410-2020; VIKASH, ,/B-2293-2016	VIKASH, ,/0000-0001-6063-1558	National Nature Science Foundation of China (SG-JIRP) [81461130019]; National Key Technology RD Program [2015BA109B06]; Deutsche Forschungsgemeinschaft [TRR60]	National Nature Science Foundation of China (SG-JIRP)(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Support was provided by the National Nature Science Foundation of China (SG-JIRP, 81461130019, [http://www.nsfc.gov.cn/]), the National Key Technology R&D Program (2015BA109B06, [http://www.most.gov.cn/]), the Deutsche Forschungsgemeinschaft (TRR60, [www.dfg.de/]).; This work was supported by the National Nature Science Foundation of China (SG-JIRP, 81461130019, http://www.nsfc.gov.cn/), the National Key Technology R&D Program (2015BA109B06, http://www.most.gov.cn/) and the Deutsche Forschungsgemeinschaft (TRR60, www.dfg.de/).	Cardini A, 2003, SYST BIOL, V52, P186, DOI 10.1080/10635150390192807; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dandri M, 2005, J CLIN VIROL, V34, pS54, DOI 10.1016/S1386-6532(05)80011-3; Dembek C, 2015, MED MICROBIOL IMMUN, V204, P95, DOI 10.1007/s00430-014-0378-6; Fletcher SP, 2012, HEPATOLOGY, V56, P820, DOI 10.1002/hep.25730; Gan L, 2015, GENE, V560, P96, DOI 10.1016/j.gene.2015.01.051; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kwok Pui-Yan, 2003, Current Issues in Molecular Biology, V5, P43; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Liu J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003856; Liu Jia, 2014, Virologica Sinica, V29, P10, DOI 10.1007/s12250-014-3410-5; Lohrengel B, 1998, IMMUNOGENETICS, V47, P332, DOI 10.1007/s002510050366; Lu YP, 2008, DEV COMP IMMUNOL, V32, P445, DOI 10.1016/j.dci.2007.08.003; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Roggendorf M, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021451; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Sharma N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097497; Sim SC, 2009, GENOME, V52, P431, DOI [10.1139/G09-019, 10.1139/g09-019]; Steppan SJ, 1999, SYST BIOL, V48, P715, DOI 10.1080/106351599259988; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wang BJ, 2011, J GEN VIROL, V92, P681, DOI 10.1099/vir.0.025023-0; Wang BJ, 2005, CYTOKINE, V32, P296, DOI 10.1016/j.cyto.2005.11.007; Wang XL, 2014, GENE, V549, P252, DOI 10.1016/j.gene.2014.07.072; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhou J, 2009, J HUAZHONG U SCI-MED, V29, P313, DOI 10.1007/s11596-009-0310-2	30	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165875	10.1371/journal.pone.0165875	http://dx.doi.org/10.1371/journal.pone.0165875			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806133	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500066
J	Miller, RR; Uyaguari-Diaz, M; McCabe, MN; Montoya, V; Gardy, JL; Parker, S; Steiner, T; Hsiao, W; Nesbitt, MJ; Tang, P; Patrick, DM				Miller, Ruth R.; Uyaguari-Diaz, Miguel; McCabe, Mark N.; Montoya, Vincent; Gardy, Jennifer L.; Parker, Shoshana; Steiner, Theodore; Hsiao, William; Nesbitt, Matthew J.; Tang, Patrick; Patrick, David M.		CCD Study Grp	Metagenomic Investigation of Plasma in Individuals with ME/CFS Highlights the Importance of Technical Controls to Elucidate Contamination and Batch Effects	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; GUT MICROBIOTA; GENOME; CLASSIFICATION; INFECTION; SEQUENCES; DISEASE	Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating disease causing indefinite fatigue. ME/CFS has long been hypothesised to have an infectious cause; however, no specific infectious agent has been identified. We used metagenomics to analyse the RNA from plasma samples from 25 individuals with ME/CFS and compare their microbial content to technical controls as well as three control groups: individuals with alternatively diagnosed chronic Lyme syndrome (N = 13), systemic lupus erythematosus (N = 11), and healthy controls (N = 25). We found that the majority of sequencing reads were removed during host subtraction, thus there was very low microbial RNA content in the plasma. The effects of sample batching and contamination during sample processing proved to outweigh the effects of study group on microbial RNA content, as the few differences in bacterial or viral RNA abundance we did observe between study groups were most likely caused by contamination and batch effects. Our results highlight the importance of including negative controls in all metagenomic analyses, since there was considerable overlap between bacterial content identified in study samples and control samples. For example, Proteobacteria, Firmicutes, Actinobacteria, and Bacteriodes were found in both study samples and plasma-free negative controls. Many of the taxonomic groups we saw in our plasma-free negative control samples have previously been associated with diseases, including ME/CFS, demonstrating how incorrect conclusions may arise if controls are not used and batch effects not accounted for.	[Miller, Ruth R.; Gardy, Jennifer L.; Patrick, David M.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Uyaguari-Diaz, Miguel; McCabe, Mark N.; Montoya, Vincent; Gardy, Jennifer L.; Patrick, David M.] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Parker, Shoshana] Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Steiner, Theodore] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Hsiao, William] British Columbia Publ Hlth Microbiol & Reference, Vancouver, BC, Canada; [Hsiao, William] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Nesbitt, Matthew J.] Coastal Genom Inc, Burnaby, BC, Canada; [Tang, Patrick] Sidra Med & Res Ctr, Dept Pathol, Doha, Qatar	University of British Columbia; University of British Columbia; University of British Columbia; Sidra Medical & Research Center	Patrick, DM (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.; Patrick, DM (corresponding author), British Columbia Ctr Dis Control, Vancouver, BC, Canada.	david.patrick@ubc.ca		Steiner, Ted/0000-0002-3136-6668	British Columbia Centre for Disease Control Foundation for Population and Public Health	British Columbia Centre for Disease Control Foundation for Population and Public Health	This work was funded by a grant from the British Columbia Centre for Disease Control Foundation for Population and Public Health.	[Anonymous], 2005, MMWR, V54, P125; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Cameron B, 2010, J MED VIROL, V82, P1684, DOI 10.1002/jmv.21873; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Chia J, 2010, J CLIN PATHOL, V63, P165, DOI 10.1136/jcp.2009.070466; Chiu CY, 2006, CLIN INFECT DIS, V43, pE71, DOI 10.1086/507896; Clayton EW, 2015, JAMA-J AM MED ASSOC, V313, P1101, DOI 10.1001/jama.2015.1346; Fischer DB, 2014, FATIGUE, V2, P93, DOI 10.1080/21641846.2014.906066; Fremont M, 2013, ANAEROBE, V22, P50, DOI 10.1016/j.anaerobe.2013.06.002; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; GOURIEROUX C, 1982, ECONOMETRICA, V50, P63, DOI 10.2307/1912529; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jason LA, 2005, NEUROPSYCHOL REV, V15, P29, DOI 10.1007/s11065-005-3588-2; Koelle DM, 2002, CLIN INFECT DIS, V35, P518, DOI 10.1086/341774; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laurence M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097876; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li SK, 2012, CLIN MICROBIOL INFEC, V18, P1126, DOI 10.1111/j.1469-0691.2011.03690.x; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matsuoka K, 2015, SEMIN IMMUNOPATHOL, V37, P47, DOI 10.1007/s00281-014-0454-4; McLean JS, 2013, GENOME RES, V23, P867, DOI 10.1101/gr.150433.112; Miller RR, 2013, FATIGUE, V1, P185, DOI 10.1080/21641846.2013.812831; Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13; Patrick DM, 2015, CLIN INFECT DIS, V61, P1084, DOI 10.1093/cid/civ470; Peabody MA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0788-5; Rotmistrovsky KAR, 2011, BMTAGGER BEST UNPUB; Rusu C, 2015, HEALTH PROMOT CHRON, V35, P3, DOI 10.24095/hpcdp.35.1.02; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Seth-Smith HMB, 2013, GENOME RES, V23, P855, DOI 10.1101/gr.150037.112; Shukla SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145453; Sorber K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003495; Susilawati TN, 2016, EUR J CLIN MICROBIOL, V35, P1137, DOI 10.1007/s10096-016-2644-6; Tremlett H, 2016, J NEUROL SCI, V363, P153, DOI 10.1016/j.jns.2016.02.042; Uyaguari-Diaz MI, 2015, JOVE-J VIS EXP, DOI 10.3791/52685; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Zhang LH, 2010, J CLIN PATHOL, V63, P156, DOI 10.1136/jcp.2009.072561	41	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165691	10.1371/journal.pone.0165691	http://dx.doi.org/10.1371/journal.pone.0165691			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806082	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500049
J	Tusch, ES; Alperin, BR; Holcomb, PJ; Daffner, KR				Tusch, Erich S.; Alperin, Brittany R.; Holcomb, Phillip J.; Daffner, Kirk R.			Increased Early Processing of Task-Irrelevant Auditory Stimuli in Older Adults	PLOS ONE			English	Article							AGE-RELATED-CHANGES; DOWN SUPPRESSION DEFICIT; WORKING-MEMORY LOAD; NEURAL ACTIVITY; SELECTIVE ATTENTION; INDIVIDUAL-DIFFERENCES; COGNITIVE CONTROL; ANTERIOR SHIFT; INVOLUNTARY ATTENTION; EXECUTIVE FUNCTIONS	The inhibitory deficit hypothesis of cognitive aging posits that older adults' inability to adequately suppress processing of irrelevant information is a major source of cognitive decline. Prior research has demonstrated that in response to task-irrelevant auditory stimuli there is an age-associated increase in the amplitude of the N1 wave, an ERP marker of early perceptual processing. Here, we tested predictions derived from the inhibitory deficit hypothesis that the age-related increase in N1 would be 1) observed under an auditory-ignore, but not auditory-attend condition, 2) attenuated in individuals with high executive capacity (EC), and 3) augmented by increasing cognitive load of the primary visual task. ERPs were measured in 114 well-matched young, middle-aged, young-old, and old-old adults, designated as having high or average EC based on neuropsychological testing. Under the auditory- ignore (visual-attend) task, participants ignored auditory stimuli and responded to rare target letters under low and high load. Under the auditory-attend task, participants ignored visual stimuli and responded to rare target tones. Results confirmed an age-associated increase in N1 amplitude to auditory stimuli under the auditory-ignore but not auditory-attend task. Contrary to predictions, EC did not modulate the N1 response. The load effect was the opposite of expectation: the N1 to task-irrelevant auditory events was smaller under high load. Finally, older adults did not simply fail to suppress the N1 to auditory stimuli in the task-irrelevant modality; they generated a larger response than to identical stimuli in the task-relevant modality. In summary, several of the study's findings do not fit the inhibitory- deficit hypothesis of cognitive aging, which may need to be refined or supplemented by alternative accounts.	[Tusch, Erich S.; Daffner, Kirk R.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Brain Mind Med, Div Cognit & Behav Neurol,Dept Neurol, 221 Longwood Ave, Boston, MA 02115 USA; [Alperin, Brittany R.] Oregon Hlth & Sci Univ, Dept Psychol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Holcomb, Phillip J.] Tufts Univ, Dept Psychol, 490 Boston Ave, Medford, MA 02155 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Oregon Health & Science University; Tufts University	Daffner, KR (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Ctr Brain Mind Med, Div Cognit & Behav Neurol,Dept Neurol, 221 Longwood Ave, Boston, MA 02115 USA.	kdaffner@partners.org		Tusch, Erich/0000-0003-1434-101X	NIH / NIA grant [R01 AG017935]; Wimberly family; Muss family; Mortimer/Grubman family	NIH / NIA grant; Wimberly family; Muss family; Mortimer/Grubman family	This research was funded in part by NIH / NIA grant R01 AG017935 (https://www.nia.nih.gov/) and by generous support from the Wimberly family, the Muss family, and the Mortimer/Grubman family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Lisa Walker, MHA, for her guidance in conducting the audiological evaluations, Sarah Fackler, MA, for her excellent administrative assistance, and Sharon Sanz Simon, BA, for her valuable input. The authors would also like to thank the Wimberly family, the Muss family, and the Mortimer/Grubman family for their generous support of our Lab.	Alain C, 1999, PSYCHOL AGING, V14, P507, DOI 10.1037/0882-7974.14.3.507; Alain C, 2012, HEARING RES, V283, P126, DOI 10.1016/j.heares.2011.10.007; ALHO K, 1994, ELECTROEN CLIN NEURO, V91, P353, DOI 10.1016/0013-4694(94)00173-1; Alperin BR, 2014, NEUROSCI LETT, V577, P6, DOI 10.1016/j.neulet.2014.05.049; Alperin BR, 2014, PSYCHOPHYSIOLOGY, V51, P620, DOI 10.1111/psyp.12206; Alperin BR, 2013, J COGNITIVE NEUROSCI, V25, P2189, DOI 10.1162/jocn_a_00456; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andres P, 2006, NEUROPSYCHOLOGIA, V44, P2564, DOI 10.1016/j.neuropsychologia.2006.05.005; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Benoni H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00522; Berti S, 2003, EUR J NEUROSCI, V17, P1119, DOI 10.1046/j.1460-9568.2003.02527.x; Berti S, 2013, BRAIN RES, V1491, P156, DOI 10.1016/j.brainres.2012.11.009; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Bidelman GM, 2014, NEUROBIOL AGING, V35, P2526, DOI 10.1016/j.neurobiolaging.2014.05.006; Budd TW, 1998, INT J PSYCHOPHYSIOL, V31, P51, DOI 10.1016/S0167-8760(98)00040-3; CARLSON MC, 1995, PSYCHOL AGING, V10, P427, DOI 10.1037/0882-7974.10.3.427; Castel AD, 2007, MEM COGNITION, V35, P689, DOI 10.3758/BF03193307; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; Correa-Jaraba KS, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00129; Daffner K. R., 2014, DEMENTIA COMPREHENSI; Daffner KR, 2006, J COGNITIVE NEUROSCI, V18, P1759, DOI 10.1162/jocn.2006.18.10.1759; Daffner KR, 2015, BIOL PSYCHOL, V105, P83, DOI 10.1016/j.biopsycho.2015.01.002; Daffner KR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00167; Daffner KR, 2011, J COGNITIVE NEUROSCI, V23, P1298, DOI 10.1162/jocn.2010.21540; Daffner KR, 2011, NEUROIMAGE, V54, P427, DOI 10.1016/j.neuroimage.2010.08.006; Daselaar S. M., 2005, COGNITIVE NEUROSCIEN, P325; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; de Fockert Jan W, 2005, Sci Aging Knowledge Environ, V2005, ppe34, DOI 10.1126/sageke.2005.44.pe34; de Fockert JW, 2009, BRAIN RES, V1282, P67, DOI 10.1016/j.brainres.2009.05.060; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Delis DC, 2001, DELIS KAPLAN EXECUTI; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DEMPSTER FN, 1992, DEV REV, V12, P45, DOI 10.1016/0273-2297(92)90003-K; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dien J, 2003, COGNITIVE BRAIN RES, V17, P637, DOI 10.1016/S0926-6410(03)00188-5; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Fabiani M, 2006, J COGNITIVE NEUROSCI, V18, P637, DOI 10.1162/jocn.2006.18.4.637; FABIANI M, 1995, PSYCHOPHYSIOLOGY, V32, P579, DOI 10.1111/j.1469-8986.1995.tb01234.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedman D, 1998, PSYCHOPHYSIOLOGY, V35, P508, DOI 10.1017/S0048577298970664; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Gazzaley A., 2007, HUMAN FRONTAL LOBES, P187; Gazzaley A, 2008, P NATL ACAD SCI USA, V105, P13122, DOI 10.1073/pnas.0806074105; Getzmann S, 2013, NEUROBIOL AGING, V34, P1952, DOI 10.1016/j.neurobiolaging.2013.02.014; Grady CL, 2008, CEREB CORTEX, V18, P189, DOI 10.1093/cercor/bhm045; Grady CL, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00024; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Guerreiro MJS, 2014, J COGNITIVE NEUROSCI, V26, P2827, DOI 10.1162/jocn_a_00685; Guerreiro MJS, 2010, PSYCHOL BULL, V136, P975, DOI 10.1037/a0020731; Haring AE, 2013, BRAIN RES, V1499, P69, DOI 10.1016/j.brainres.2013.01.003; Helfer KS, 2008, EAR HEARING, V29, P87, DOI 10.1097/AUD.0b013e31815d638b; Ivnik RJ, 1996, CLIN NEUROPSYCHOL, V10, P262, DOI 10.1080/13854049608406689; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Kappenman E. S., 2012, OXFORD HDB EVENT REL, P3, DOI DOI 10.1093/OXFORDHB/9780195374148.013.0014; Konstantinou N, 2014, ATTEN PERCEPT PSYCHO, V76, P1985, DOI 10.3758/s13414-014-0742-z; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Leung AWS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068892; Li KZH, 1998, PSYCHOL AGING, V13, P574, DOI 10.1037/0882-7974.13.4.574; LINDENBERGER U, 2014, SCI ENG ETHICS, V18, P7, DOI DOI 10.1016/J.TICS.2013.10.006; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; Lustig C., 2007, INHIBITION COGNITION, P145, DOI [DOI 10.1037/11587-008, 10.1037/11587-008]; Madden DJ, 2004, CEREB CORTEX, V14, P143, DOI 10.1093/cercor/bhg113; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Murphy G, 2016, PSYCHON B REV, V23, P1316, DOI 10.3758/s13423-015-0982-5; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Porto FHG, 2016, NEUROIMAGE, V130, P115, DOI 10.1016/j.neuroimage.2016.01.035; RABBITT P, 1965, J GERONTOL, V20, P233, DOI 10.1093/geronj/20.2.233; Reitan RM, 1985, HALSTEAD REITAN NEUR; Riis JL, 2008, NEUROIMAGE, V39, P441, DOI 10.1016/j.neuroimage.2007.08.034; Riis JL, 2009, BIOL PSYCHOL, V82, P33, DOI 10.1016/j.biopsycho.2009.05.003; Rissman J, 2009, NEUROPSYCHOLOGIA, V47, P1637, DOI 10.1016/j.neuropsychologia.2009.01.036; Ross B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010101; Ross B, 2009, NEUROIMAGE, V47, P678, DOI 10.1016/j.neuroimage.2009.04.051; Rugg MD, 2005, COGNITIVE NEUROSCIEN, P132; Rutman AM, 2010, J COGNITIVE NEUROSCI, V22, P1224, DOI 10.1162/jocn.2009.21257; Ryan J.J., 1992, CLIN NEUROPSYCHOL, V6, P53, DOI DOI 10.1080/; Sandhu R, 2016, EXP BRAIN RES, V234, P1279, DOI 10.1007/s00221-015-4517-0; Sawaki R, 2008, J VISION, V8, DOI 10.1167/8.15.4; Simon SS, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00380; Sommers MS, 1999, PSYCHOL AGING, V14, P458, DOI 10.1037/0882-7974.14.3.458; Sorqvist P, 2015, CURR DIR PSYCHOL SCI, V24, P267, DOI 10.1177/0963721415577356; Sorqvist P, 2014, PSYCH J, V3, P42, DOI 10.1002/pchj.47; Spreen O, 1998, EXECUTIVE FUNCTION A, P171; Townsend J, 2006, NEUROIMAGE, V31, P1682, DOI 10.1016/j.neuroimage.2006.01.045; Tun PA, 2002, PSYCHOL AGING, V17, P453, DOI 10.1037//0882-7974.17.3.453; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Wechsler D., 2012, WAIS 4 KASIKIRJA; West R, 1998, PSYCHOL AGING, V13, P206, DOI 10.1037/0882-7974.13.2.206; West R, 1999, MEM COGNITION, V27, P1064, DOI 10.3758/BF03201235; WOODS DL, 1986, ELECTROEN CLIN NEURO, V65, P297, DOI 10.1016/0168-5597(86)90008-0; Woods DL, 1995, EEG CL N SU, P102; Wurm LH, 2004, PSYCHOL AGING, V19, P523, DOI 10.1037/0882-7974.19.3.523; Yucel G, 2005, NEUROREPORT, V16, P1031, DOI 10.1097/00001756-200507130-00001	97	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165645	10.1371/journal.pone.0165645	http://dx.doi.org/10.1371/journal.pone.0165645			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806081	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500046
J	Wan, T; Han, QX; Xian, L; Cao, Y; Andrew, AA; Pan, XJ; Li, W; Liu, F				Wan, Tao; Han, Qingxiang; Xian, Ling; Cao, Yu; Andrew, Apudo A.; Pan, Xiaojie; Li, Wei; Liu, Fan			Reproductive Allocation in Three Macrophyte Species from Different Lakes with Variable Eutrophic Conditions	PLOS ONE			English	Article							AQUATIC PLANT; HISTORICAL BIOGEOGRAPHY; MYRIOPHYLLUM SPICATUM; SUBMERSED MACROPHYTES; GENERIC PHYLOGENY; CLONAL GROWTH; DISPERSAL; NITROGEN; WATER; PHOTOSYNTHESIS	Reproductive allocation is a key process in the plant life cycle and aquatic plants exhibit great diversity in their reproductive systems. In the present study, we conduct a field investigation of three aquatic macrophytes: Stuckenia pectinata, Myriophyllum spicatum, and Potamogeton perfoliatus. Our results showed that widespread species, including S. pectinata and M. spicatum had greater plasticity in their allocation patterns in the form of increased sexual and asexual reproduction, and greater potential to set seeds and increase fitness in more eutrophic environments. P. perfoliatus also exhibited a capacity to adopt varied sexual reproductive strategies such as setting more offspring for the future, although only in clear conditions with low nutrient levels. Our results establish strategies and mechanisms of some species for tolerating and surviving in varied eutrophic lake conditions.	[Wan, Tao] Fairy Lake Bot Garden, Key Lab Southern Subtrop Plant Divers, Shenzhen, Peoples R China; [Wan, Tao] Chinese Acad Sci, Shenzhen 518004, Peoples R China; [Wan, Tao; Andrew, Apudo A.; Liu, Fan] Chinese Acad Sci, Sino Africa Joint Res Ctr, Wuhan 430074, Peoples R China; [Xian, Ling; Cao, Yu; Andrew, Apudo A.; Li, Wei; Liu, Fan] Chinese Acad Sci, Key Lab Aquat Bot & Watershed Ecol, Wuhan 430074, Peoples R China; [Han, Qingxiang] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan; [Pan, Xiaojie] MWR&CAS, Key Lab Ecol Impacts Hydraul Projects & Restorat, Minist Water Resources, Inst Hydroecol, Wuhan 430074, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Kyoto University; Chinese Academy of Sciences; Ministry of Water Resources	Liu, F (corresponding author), Chinese Acad Sci, Sino Africa Joint Res Ctr, Wuhan 430074, Peoples R China.; Liu, F (corresponding author), Chinese Acad Sci, Key Lab Aquat Bot & Watershed Ecol, Wuhan 430074, Peoples R China.	fanliu@wbgcas.cn			National Natural Science Foundation of China [31370262, 31670369, 31200270]; Project of Sino-Africa Joint Research Center [CAS SAJC201326, CAS SAJC201304]; Strategic Pilot Science and Technology Projects of the Chinese Academy of Sciences [XDAO5090305]; Open fundation of CAS Key Laboratory of Aquatic Botany and Watershed Ecology [Y452711s03]; Three Gorges Follow-up Research Project [2013HXKY2-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Sino-Africa Joint Research Center; Strategic Pilot Science and Technology Projects of the Chinese Academy of Sciences; Open fundation of CAS Key Laboratory of Aquatic Botany and Watershed Ecology; Three Gorges Follow-up Research Project	The work was supported by the following: FL National Natural Science Foundation of China 31370262, http://www.nsfc.gov.cn; FL National Natural Science Foundation of China 31670369, http://www.nsfc.gov.cn; YC National Natural Science Foundation of China 31200270, http://www.nsfc.gov.cn; FL Project of Sino-Africa Joint Research Center, CAS SAJC201326, http://www.wbgcas.cn; TW Project of Sino-Africa Joint Research Center, CAS SAJC201304, http://www.wbgcas.cn; FL The Strategic Pilot Science and Technology Projects of the Chinese Academy of Sciences XDAO5090305, http://www.cas.cn/; TW Open fundation of CAS Key Laboratory of Aquatic Botany and Watershed Ecology Y452711s03, http://www.wbgcas.cn; XP The Three Gorges Follow-up Research Project, 2013HXKY2-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apudo AA, 2016, ENVIRON EXP BOT, V130, P79, DOI 10.1016/j.envexpbot.2016.05.009; BARRETT SCH, 1993, AQUAT BOT, V44, P105, DOI 10.1016/0304-3770(93)90068-8; Best E. P. H., 1988, HDB VEGETATION SCI, V15-1, P155; Cao T, 2007, MAR FRESHWATER RES, V58, P581, DOI 10.1071/MF06090; Cao T, 2011, FRESHWATER BIOL, V56, P1620, DOI 10.1111/j.1365-2427.2011.02601.x; Chen LY, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-30; Chen LY, 2012, MOL PHYLOGENET EVOL, V63, P407, DOI 10.1016/j.ympev.2012.01.016; CNEMC, 2001, EV CLASS EUTR LAK; Cook C.D.K., 1990, AQUATIC PLANT BOOK; DENDENE MA, 1993, AQUAT BOT, V46, P301, DOI 10.1016/0304-3770(93)90010-T; Eckert CG, 2001, EVOL ECOL, V15, P501, DOI 10.1023/A:1016005519651; Eriksson O, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P211; Grant V., 1981, PLANT SPECIATION; Gusewell S, 2002, PERSPECT PLANT ECOL, V5, P37, DOI 10.1078/1433-8319-0000022; Havens KE, 2004, AQUAT BOT, V78, P67, DOI 10.1016/j.aquabot.2003.09.005; HOUSSARD C, 1991, OECOLOGIA, V86, P236, DOI 10.1007/BF00317536; Ikegami M, 2008, ECOL MODEL, V213, P156, DOI 10.1016/j.ecolmodel.2007.11.016; Jeppesen E., 1998, STRUCTURING ROLE SUB; Karlsson P. Staffan, 2005, P1, DOI 10.1016/B978-012088386-8/50001-6; Les DH, 2003, INT J PLANT SCI, V164, P917, DOI 10.1086/378650; Li W, 2014, AQUAT BOT, V118, P62, DOI 10.1016/j.aquabot.2014.07.008; Liu F, 2013, J PLANT ECOL, V6, P499, DOI 10.1093/jpe/rtt021; Liu F, 2013, J SYST EVOL, V51, P461, DOI 10.1111/j.1759-6831.2012.00242.x; Maberly SC, 2014, AQUAT BOT, V118, P4, DOI 10.1016/j.aquabot.2014.06.014; Maurer DA, 2002, OECOLOGIA, V131, P279, DOI 10.1007/s00442-002-0886-8; Nimptsch J, 2007, CHEMOSPHERE, V66, P708, DOI 10.1016/j.chemosphere.2006.07.064; Philbrick CT, 1996, BIOSCIENCE, V46, P813, DOI 10.2307/1312967; Reekie EG, 2005, REPROD ALLOCATION PL; Riis T, 2009, AQUAT BOT, V90, P209, DOI 10.1016/j.aquabot.2008.08.005; Roff Derek A., 1992; Rolland T, 1995, ACTA BOT GALLICA, V142, P733, DOI 10.1080/12538078.1995.10515297; Santamaria L, 2002, ACTA OECOL, V23, P137, DOI 10.1016/S1146-609X(02)01146-3; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; Strand JA, 2001, J ECOL, V89, P166, DOI 10.1046/j.1365-2745.2001.00530.x; Sun XZ, 1992, FLORA REIPUBLICAE PO, P40; Thompson FL, 2004, J EVOLUTION BIOL, V17, P581, DOI 10.1111/j.1420-9101.2004.00701.x; Vari A, 2013, FUND APPL LIMNOL, V183, P15, DOI 10.1127/1863-9135/2013/0328; Xiao KY, 2007, HYDROBIOLOGIA, V589, P265, DOI 10.1007/s10750-007-0740-4; Yu Q, 2015, WATER RES, V83, P385, DOI 10.1016/j.watres.2015.06.053; Zhang L, 2013, ECOL ENG, V58, P91, DOI 10.1016/j.ecoleng.2013.06.006	40	2	2	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165234	10.1371/journal.pone.0165234	http://dx.doi.org/10.1371/journal.pone.0165234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806122	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500023
J	Zhou, J; He, L; Liu, P; Duan, H; Zhang, HZ; Li, WL; Gong, SP; Su, GD; Chen, CL				Zhou, Jing; He, Li; Liu, Ping; Duan, Hui; Zhang, Hanze; Li, Weili; Gong, Shipeng; Su, Guidong; Chen, Chunlin			Outcomes in Adenomyosis Treated with Uterine Artery Embolization Are Associated with Lesion Vascularity: A Long-Term Follow-Up Study of 252 Cases	PLOS ONE			English	Article							SYMPTOMATIC ADENOMYOSIS; QUESTIONNAIRE; MICROSPHERES; FIBROIDS	Purpose To study the therapeutic effects of uterine artery embolization (UAE) on adenomyosis and to investigate the association between uterine blood supply and artery embolization treatment outcomes. Methods Using digital subtraction angiography (DSA) imaging data, we retrospectively evaluated the vascular features of 252 adenomyosis patients treated with UAE. The cases were classified based on the equality of uterine blood supply (equal and unequal subgroups) and the degree of vascularity at the adenomyosis lesion site (hypervascular, isovascular and hypovascular subgroups). Patients were followed-up for 5 years after UAE. Improvements in dysmenorrhea and menorrhagia were evaluated based on the relief of the patients' symptoms. The improvement rates among the different subgroups were analyzed and compared. Results The improvement rates of dysmenorrhea and menorrhagia were 74.0% and 70.9%, respectively, at the short-term (12-month) follow-up and 70.4% and 68.8%, respectively, at the long-term (5-year) follow-up. No statistically significant differences were observed in the improvement rates for dysmenorrhea or menorrhagia between the equal and unequal blood supply subgroups at either the short-or long-term follow-up. The improvement rates for dysmenorrhea among the hypervascular, isovascular and hypovascular subgroups were 86.5%, 71.8% and 58.8%, respectively, at the short-term follow-up (p = 0.002) and 83.6%, 67.3% and 52.8%, respectively, at the long-term follow-up (p = 0.005). The improvement rates for menorrhagia in the hypervascular, isovascular and hypovascular subgroups were 81.0%, 68.3% and 60.7%, respectively, at the short-term follow-up (p = 0.024) and 79.4%, 61.4% and 62.2%, respectively, at the long-term follow-up (p = 0.052). Conclusion UAE is effective in treating patients with adenomyosis in both the short and long term. The outcomes of patients with adenomyosis were significantly correlated with lesion vascularity.	[Zhou, Jing; Liu, Ping; Duan, Hui; Li, Weili; Gong, Shipeng; Su, Guidong; Chen, Chunlin] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [He, Li] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA; [Zhang, Hanze] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA	Southern Medical University - China; Emory University; State University System of Florida; University of South Florida	Chen, CL (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China.	zhou_gyn@126.com			National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2014BAI05B00]	National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program)	This study was funded by National Key Technology Research and Development Program of the Ministry of Science and Technology of China. Award number: 2014BAI05B00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SH, 2015, J VASC INTERV RADIOL, V26, P1290, DOI 10.1016/j.jvir.2015.04.026; Bratby MJ, 2009, EUR J RADIOL, V70, P128, DOI 10.1016/j.ejrad.2007.12.009; Froeling V, 2012, CARDIOVASC INTER RAD, V35, P523, DOI 10.1007/s00270-011-0254-3; Jang D, 2014, J VASC INTERV RADIOL, V25, P833, DOI 10.1016/j.jvir.2014.01.036; Jung DC, 2012, EUR RADIOL, V22, P2044, DOI 10.1007/s00330-012-2436-z; Kim MD, 2007, AM J ROENTGENOL, V188, P176, DOI 10.2214/AJR.05.1613; Kim MD, 2011, J VASC INTERV RADIOL, V22, P497, DOI 10.1016/j.jvir.2011.01.426; Kitamura Y, 2006, AM J ROENTGENOL, V186, P855, DOI 10.2214/AJR.04.1661; Levgur Michael, 2007, Archives of Gynecology and Obstetrics, V276, P1, DOI 10.1007/s00404-006-0299-8; Liang E, 2012, AUST NZ J OBSTET GYN, V52, P106, DOI 10.1111/j.1479-828X.2011.01399.x; Lohle PNM, 2007, J VASC INTERV RADIOL, V18, P835, DOI 10.1016/j.jvir.2007.04.024; Nijenhuis RJ, 2015, CARDIOVASC INTER RAD, V38, P65, DOI 10.1007/s00270-014-0878-1; Popovic M, 2011, J VASC INTERV RADIOL, V22, P901, DOI 10.1016/j.jvir.2011.03.013; Siskin GP, 2001, AM J ROENTGENOL, V177, P297, DOI 10.2214/ajr.177.2.1770297; Smeets AJ, 2012, CARDIOVASC INTER RAD, V35, P815, DOI 10.1007/s00270-011-0203-1; Smith BH, 1997, PAIN, V71, P141, DOI 10.1016/S0304-3959(97)03347-2; Streuli I, 2014, EXPERT OPIN PHARMACO, V15, P2347, DOI 10.1517/14656566.2014.953055; Taran FA, 2013, GEBURTSH FRAUENHEILK, V73, P924, DOI 10.1055/s-0033-1350840; Toh CH, 2003, J FORMOS MED ASSOC, V102, P701	19	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165610	10.1371/journal.pone.0165610	http://dx.doi.org/10.1371/journal.pone.0165610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806072	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500043
J	Cui, DW; Feng, LZ; Chen, Y; Lai, SJ; Zhang, ZK; Yu, F; Zheng, SF; Li, ZJ; Yu, HJ				Cui, Dawei; Feng, Luzhao; Chen, Yu; Lai, Shengjie; Zhang, Zike; Yu, Fei; Zheng, Shufa; Li, Zhongjie; Yu, Hongjie			Clinical and Epidemiologic Characteristics of Hospitalized Patients with Laboratory-Confirmed Respiratory Syncytial Virus Infection in Eastern China between 2009 and 2013: A Retrospective Study	PLOS ONE			English	Article							INFLUENZA-LIKE ILLNESS; TRACT INFECTIONS; VIRAL-INFECTIONS; YOUNG-CHILDREN; ADULTS; INFANTS; BURDEN; LOAD; AGE	Respiratory syncytial virus (RSV) is a leading cause of morbidity and mortality worldwide in children aged <5 years and older adults with acute lower respiratory infections (ALRIs). However, few studies regarding the epidemiology of hospitalizations for RSV infection have been performed previously in China. Here, we aimed to describe the clinical and epidemiologic characteristics of hospitalized patients with laboratory-confirmed RSV infection in eastern China. Active surveillance for hospitalized ALRI patients using a broad case definition based on symptoms was performed from 2009-2013 in 12 sentinel hospitals in eastern China. Clinical and epidemiologic data pertaining to hospitalized patients of all ages with laboratory-confirmed RSV infection by PCR assay were collected and analyzed in this study. From 2009 to 2013, 1046 hospitalized patients with laboratory-confirmed RSV infection were enrolled in this study, and 14.7% of patients had subtype A, 24.2% of patients had subtype B, 23.8% of patients with subtype not performed, and 37.3% of patients had RSV coinfections with other viruses. RSV and influenza coinfections (33.3%) were the most common coinfections noted in this study. Moreover, young children aged <5 years (89.1%, 932/1046), particularly young infants aged <1 year (43.3%, 453/1046), represented the highest proportion of patients with RSV infections. In contrast, older adults aged >= 60 years (1.1%, 12/1046) represented the lowest proportion of patients with RSV infections among enrolled patients. The peak RSV infection period occurred mainly during autumn and winter, and 57% and 66% of patients exhibited symptoms such as fever (body temperature >= 38 degrees C) and cough separately. Additionally, only a small number of patients were treated with broad-spectrum antiviral drugs, and most of patients were treated with antimicrobial drugs that were not appropriate for RSV infection. RSV is a leading viral pathogen and a common cause of viral infection in young children aged <5 years with ALRIs in eastern China. Effective vaccines and antiviral agents targeting RSV are needed to mitigate its large public health impact.	[Cui, Dawei; Chen, Yu; Zhang, Zike; Yu, Fei; Zheng, Shufa] Zhejiang Univ, Affiliated Hosp 1, Dept Lab Med, Coll Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China; [Cui, Dawei; Chen, Yu; Zhang, Zike; Yu, Fei; Zheng, Shufa] Key Lab Clin In Vitro Diagnost Techn Zhejiang Pro, Hangzhou 310003, Zhejiang, Peoples R China; [Feng, Luzhao; Lai, Shengjie; Li, Zhongjie; Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, 155 Changbai Rd, Beijing 102206, Peoples R China; [Yu, Hongjie] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, 130 Dongan Rd, Shanghai 200032, Peoples R China	Zhejiang University; Chinese Center for Disease Control & Prevention; Fudan University	Yu, HJ (corresponding author), Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, 155 Changbai Rd, Beijing 102206, Peoples R China.; Yu, HJ (corresponding author), Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, 130 Dongan Rd, Shanghai 200032, Peoples R China.	cfetpyhj@vip.sina.com	Chen, Yi/HIR-2608-2022; Yu, Hongjie/GZK-5351-2022; Cui, Dawei/ABG-4534-2021; Chen, Yu/Y-3292-2019	Lai, Shengjie/0000-0001-9781-8148; cui, dawei/0000-0003-3840-1486	National Science Fund for Distinguished Young Scholars [81525023]; Ministry of Science and Technology of the People's Republic of China (the National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China) [2012ZX10004-201, 2012ZX10004-210]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Ministry of Science and Technology of the People's Republic of China (the National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China)	This study was supported by grants from the National Science Fund for Distinguished Young Scholars (81525023), and the Ministry of Science and Technology of the People's Republic of China (the National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China, 2012ZX10004-201, 2012ZX10004-210).	Bigogo GM, 2013, J INFECT DIS, V208, pS207, DOI 10.1093/infdis/jit489; Byington CL, 2015, PEDIATRICS, V135, pE24, DOI 10.1542/peds.2014-2151; Falsey AR, 2014, J INFECT DIS, V209, P1873, DOI 10.1093/infdis/jit839; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Feng LZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099419; Fleming DM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1218-z; Fodha I, 2007, J MED VIROL, V79, P1951, DOI 10.1002/jmv.21026; Fry AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015098; Hon KL, 2012, J CRIT CARE, V27, P464, DOI 10.1016/j.jcrc.2011.12.001; Huang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064254; Huo XX, 2013, J INFECT DIS, V208, pS184, DOI 10.1093/infdis/jit518; Jin Y, 2012, CLIN MICROBIOL INFEC, V18, P74, DOI 10.1111/j.1469-0691.2011.03541.x; Kaneko M, 2002, J INFECTION, V44, P240, DOI 10.1053/jinf.2002.0981; Lee N, 2015, J INFECT DIS, V212, P1237, DOI 10.1093/infdis/jiv248; Lu LH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1155-x; Luksic I, 2013, CROAT MED J, V54, P122, DOI 10.3325/cmj.2013.54.122; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Naorat S, 2013, J INFECT DIS, V208, pS238, DOI 10.1093/infdis/jit456; Nolan T, 2015, CLIN INFECT DIS, V60, pE80, DOI 10.1093/cid/civ065; Peng ZB, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0884-1; Pisesky A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150416; Ren L, 2009, CLIN MICROBIOL INFEC, V15, P1146, DOI 10.1111/j.1469-0691.2009.02746.x; Simoes EAF, 2015, J INFECT DIS, V211, pS1, DOI 10.1093/infdis/jiu828; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Yu XF, 2015, J CLIN VIROL, V69, P1, DOI 10.1016/j.jcv.2015.05.015; Zachariah P, 2009, PEDIATR INFECT DIS J, V28, P772, DOI 10.1097/INF.0b013e3181a3e5b6; Zhang QL, 2013, PEDIATR PULM, V48, P390, DOI 10.1002/ppul.22608; Zhang RF, 2010, J CLIN MICROBIOL, V48, P4193, DOI 10.1128/JCM.00179-10; Zhang XB, 2014, WORLD J PEDIATR, V10, P360, DOI 10.1007/s12519-014-0513-x	30	13	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165437	10.1371/journal.pone.0165437	http://dx.doi.org/10.1371/journal.pone.0165437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802292	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000386714200023
J	Pagliari, MT; Lotta, LA; de Haan, HG; Valsecchi, C; Casoli, G; Pontiggia, S; Martinelli, I; Passamonti, SM; Rosendaal, FR; Peyvandi, F				Pagliari, Maria Teresa; Lotta, Luca A.; de Haan, Hugoline G.; Valsecchi, Carla; Casoli, Gloria; Pontiggia, Silvia; Martinelli, Ida; Passamonti, Serena M.; Rosendaal, Frits R.; Peyvandi, Flora			Next-Generation Sequencing and In Vitro Expression Study of ADAMTS13 Single Nucleotide Variants in Deep Vein Thrombosis	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; EARLY ATHEROSCLEROSIS; GENETIC-VARIANTS; MUTATIONS; AUTOANTIBODIES; POLYMORPHISMS; MODULATION; ASSAY; RISK; RARE	Background Deep vein thrombosis (DVT) genetic predisposition is partially known. Objectives This study aimed at assessing the functional impact of nine ADAMTS13 single nucleotide variants (SNVs) previously reported to be associated as a group with DVT in a burden test and the individual association of selected variants with DVT risk in two replication studies. Methods Wild-type and mutant recombinant ADAMTS13 were transiently expressed in HEK293 cells. Antigen and activity of recombinant ADAMTS13 were measured by ELISA and FRETS-VWF73 assays, respectively. The replication studies were performed in an Italian case-control study (Milan study; 298/298 patients/controls) using a next-generation sequencing approach and in a Dutch case-control study (MEGA study; 4306/4887 patients/controls) by TaqMan assays. Results In vitro results showed reduced ADAMTS13 activity for three SNVs (p.Val154IIe [15%; 95% confidence interval [CI] 14-16], p.Asp187His [19%; 95%[CI] 17-21], p.Arg421Cys [24%; 95%[CI] 22-26]) similar to reduced plasma ADAMTS13 levels of patients carriers for these SNVs. Therefore these three SNVs were interrogated for risk association. The first replication study identified 3 heterozygous carriers (2 cases, 1 control) of p.Arg421Cys (odds ratio [OR] 2, 95%[CI] 0.18-22.25). The second replication study identified 2 heterozygous carriers (1 case, 1 control) of p.Asp187His ([OR] 1.14, 95%[CI] 0.07-18.15) and 10 heterozygous carriers (4 cases, 6 controls) of p.Arg421Cys ([OR] 0.76, 95%[CI] 0.21-2.68). Conclusions Three SNVs (p.Val154IIe, p.Asp187His and p.Arg421Cys) showed reduced ex vivo and in vitro ADAMTS13 levels. However, the low frequency of these variants makes it difficult to confirm their association with DVT.	[Pagliari, Maria Teresa; Lotta, Luca A.; Valsecchi, Carla; Casoli, Gloria; Pontiggia, Silvia; Martinelli, Ida; Passamonti, Serena M.; Peyvandi, Flora] Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Fdn IRCCS Ca Granda, Milan, Italy; [Pagliari, Maria Teresa; Lotta, Luca A.; Valsecchi, Carla; Casoli, Gloria; Pontiggia, Silvia; Martinelli, Ida; Passamonti, Serena M.; Peyvandi, Flora] Fdn Luigi Villa, Milan, Italy; [de Haan, Hugoline G.; Rosendaal, Frits R.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Peyvandi, Flora] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Milan	Peyvandi, F (corresponding author), Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Fdn IRCCS Ca Granda, Milan, Italy.; Peyvandi, F (corresponding author), Fdn Luigi Villa, Milan, Italy.; Peyvandi, F (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.	flora.peyvandi@unimi.it	Pagliari, Maria Teresa/AAQ-3384-2021; Rosendaal, Frits/Q-3842-2017; Martinelli, ida/J-2287-2015; valsecchi, carla/AAA-3229-2022; Peyvandi, Flora/AAK-7437-2020	Pagliari, Maria Teresa/0000-0003-0778-2271; Rosendaal, Frits/0000-0003-2558-7496; Martinelli, ida/0000-0001-9218-3622; Peyvandi, Flora/0000-0001-7423-9864; Passamonti, Serena Maria/0000-0003-2875-8860; valsecchi, carla/0000-0003-3414-0119; de Haan, Hugoline/0000-0003-1126-4776; Lotta, Luca Andrea/0000-0002-2619-5956	Italian Ministry of Health [RF-2009-1530493, GR-2011-02351977]; Italo Monzino Foundation	Italian Ministry of Health(Ministry of Health, Italy); Italo Monzino Foundation	The study was supported by the Italian Ministry of Health - Grant No. RF-2009-1530493 (Recipient IM), the Italian Ministry of Health - Grant No. GR-2011-02351977 (Recipient MTP) and the Italo Monzino Foundation (Recipient FP).	BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bettoni G, 2012, J THROMB HAEMOST, V10, P1556, DOI 10.1111/j.1538-7836.2012.04808.x; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Bittar LF, 2011, CLIN APPL THROMB-HEM, V17, P514, DOI 10.1177/1076029610375815; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; De Cock E, 2015, J THROMB HAEMOST, V13, P283, DOI 10.1111/jth.12804; De Cristofaro R, 2005, J BIOL CHEM, V280, P23295, DOI 10.1074/jbc.M501143200; de Vries PS, 2015, BLOOD, V125, P3949, DOI 10.1182/blood-2015-02-629865; Edwards NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038864; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Federici AB, 2004, HAEMATOLOGICA, V89, P77; Gandhi C, 2012, BLOOD, V119, P2385, DOI 10.1182/blood-2011-09-376202; Gardner MD, 2009, BLOOD, V113, P1149, DOI 10.1182/blood-2008-03-144683; Heit JA, 2001, THROMB HAEMOSTASIS, V86, P452, DOI 10.1161/ATVBAHA.108.162545; Jin SY, 2012, ARTERIOSCL THROM VAS, V32, P1817, DOI 10.1161/ATVBAHA.112.247262; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Li Y, 2009, J THROMB HAEMOST, V7, P1802, DOI 10.1111/j.1538-7836.2009.03544.x; Lotta LA, 2013, J THROMB HAEMOST, V11, P1228, DOI 10.1111/jth.12291; Lotta LA, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-7; Maino A, 2015, J THROMB HAEMOST, V13, P1396, DOI 10.1111/jth.13032; Mancini I, 2012, J THROMB HAEMOST, V10, P1439, DOI 10.1111/j.1538-7836.2012.04744.x; Palla R, 2011, THROMB HAEMOSTASIS, V105, P381, DOI 10.1160/TH10-06-0417; Peyvandi F, 2006, HUM MUTAT, V27, P330, DOI 10.1002/humu.20267; Plaimauer B, 2006, BLOOD, V107, P118, DOI 10.1182/blood-2005-06-2482; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Pozzi N, 2012, BIOPHYS CHEM, V160, P1, DOI 10.1016/j.bpc.2011.07.007; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Rovite V, 2014, THROMB RES, V134, P659, DOI 10.1016/j.thromres.2014.07.011; Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; Sonneveld MAH, 2015, BLOOD, V126, P2739, DOI [10.1182/blood-2015-05643338, 10.1182/blood-2015-05-643338]; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165665	10.1371/journal.pone.0165665	http://dx.doi.org/10.1371/journal.pone.0165665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802307	Green Published, Green Submitted, gold			2022-12-27	WOS:000386714200034
J	Young, MK; Isaak, DJ; McKelvey, KS; Wilcox, TM; Bingham, DM; Pilgrim, KL; Carim, KJ; Campbell, MR; Corsi, MP; Horan, DL; Nagel, DE; Schwartz, MK				Young, Michael K.; Isaak, Daniel J.; McKelvey, Kevin S.; Wilcox, Taylor M.; Bingham, Daniel M.; Pilgrim, Kristine L.; Carim, Kellie J.; Campbell, Matthew R.; Corsi, Matthew P.; Horan, Dona L.; Nagel, David E.; Schwartz, Michael K.			Climate, Demography, and Zoogeography Predict Introgression Thresholds in Salmonid Hybrid Zones in Rocky Mountain Streams	PLOS ONE			English	Article							WESTSLOPE CUTTHROAT TROUT; INTRODUCED RAINBOW-TROUT; ONCORHYNCHUS-CLARKI-LEWISI; BIOLOGICAL INVASIONS; STEELHEAD TROUT; TRADE-OFFS; O-MYKISS; HYBRIDIZATION; RIVER; POPULATIONS	Among the many threats posed by invasions of nonnative species is introgressive hybridization, which can lead to the genomic extinction of native taxa. This phenomenon is regarded as common and perhaps inevitable among native cutthroat trout and introduced rainbow trout in western North America, despite that these taxa naturally co-occur in some locations. We conducted a synthetic analysis of 13,315 genotyped fish from 558 sites by building logistic regression models using data from geospatial stream databases and from 12 published studies of hybridization to assess whether environmental covariates could explain levels of introgression between westslope cutthroat trout and rainbow trout in the U. S. northern Rocky Mountains. A consensus model performed well (AUC, 0.78-0.86; classification success, 72-82%; 10-fold cross validation, 70-82%) and predicted that rainbow trout introgression was significantly associated with warmer water temperatures, larger streams, proximity to warmer habitats and to recent sources of rainbow trout propagules, presence within the historical range of rainbow trout, and locations further east. Assuming that water temperatures will continue to rise in response to climate change and that levels of introgression outside the historical range of rainbow trout will equilibrate with those inside that range, we applied six scenarios across a 55,234-km stream network that forecast 9.574.7% declines in the amount of habitat occupied by westslope cutthroat trout populations of conservation value, but not the wholesale loss of such populations. We conclude that introgression between these taxa is predictably related to environmental conditions, many of which can be manipulated to foster largely genetically intact populations of westslope cutthroat trout and help managers prioritize conservation activities.	[Young, Michael K.; McKelvey, Kevin S.; Wilcox, Taylor M.; Bingham, Daniel M.; Pilgrim, Kristine L.; Carim, Kellie J.; Schwartz, Michael K.] US Forest Serv, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, USDA, Missoula, MT 59812 USA; [Isaak, Daniel J.; Horan, Dona L.; Nagel, David E.] US Forest Serv, Rocky Mt Res Stn, Boise, ID USA; [Wilcox, Taylor M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Campbell, Matthew R.] Idaho Dept Fish & Game, Eagle Fish Genet Lab, Eagle, ID USA; [Corsi, Matthew P.] Idaho Dept Fish & Game, Coeur Dalene, ID USA; [Bingham, Daniel M.] Rogue Biol Consultants, Vancouver, WA USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; University of Montana System; University of Montana	Young, MK (corresponding author), US Forest Serv, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, USDA, Missoula, MT 59812 USA.	mkyoung@fs.fed.us	Corsi, Matthew/AAK-8502-2021; Wilcox, Taylor/P-7064-2019	Wilcox, Taylor/0000-0003-3341-7374	Region 1 of the U.S. Forest Service; Rocky Mountain Research Station; U.S. Forest Service Washington Office	Region 1 of the U.S. Forest Service; Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); U.S. Forest Service Washington Office	Funding for this work was provided by Region 1 of the U.S. Forest Service. The funder provided support in the form of salaries for authors [DMB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Funding for this work was provided by Region 1 of the U.S. Forest Service. Institutional support was provided by the National Genomics Center for Wildlife and Fish Conservation, supported by the Rocky Mountain Research Station and U.S. Forest Service Washington Office.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Aboim MA, 2010, J EVOLUTION BIOL, V23, P817, DOI 10.1111/j.1420-9101.2010.01953.x; Al-Chokhachy R, 2014, N AM J FISH MANAGE, V34, P642, DOI 10.1080/02755947.2014.901259; ALLENDORF F W, 1988, Conservation Biology, V2, P170, DOI 10.1111/j.1523-1739.1988.tb00168.x; Allendorf FW, 2004, CONSERV BIOL, V18, P1203, DOI 10.1111/j.1523-1739.2004.00305.x; Allendorf FW, CONSERVATION GENETIC, V2; Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Bean PT, 2013, T AM FISH SOC, V142, P681, DOI 10.1080/00028487.2012.758170; Behnke RJ, 2002, TROUT SALMON N AM; Bennett SN, 2010, ECOL APPL, V20, P263, DOI 10.1890/08-0441.1; Bingham DM, 2016, N AM J FISH MANAGE, V36, P590, DOI 10.1080/02755947.2016.1165765; Bossu CM, 2013, GENETICA, V141, P75, DOI 10.1007/s10709-013-9707-8; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyer MC, 2008, CAN J FISH AQUAT SCI, V65, P658, DOI 10.1139/F08-001; Buehrens TW, 2013, T AM FISH SOC, V142, P221, DOI 10.1080/00028487.2012.728165; Calcagno V, 2013, GLMULTI MODEL SELECT; Carim K, 2015, N AM J FISH MANAGE, V35, P337, DOI 10.1080/02755947.2015.1007182; Childs MR, 1996, EVOLUTION, V50, P2014, DOI 10.1111/j.1558-5646.1996.tb03588.x; Cooter W, 2010, ENVIRON MANAGE, V46, P510, DOI 10.1007/s00267-010-9526-y; Corse E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142592; Corsi MP, 2013, CAN J FISH AQUAT SCI, V70, P895, DOI 10.1139/cjfas-2012-0312; Crete-Lafreniere A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046662; Culumber ZW, 2012, J EVOLUTION BIOL, V25, P1800, DOI 10.1111/j.1420-9101.2012.02562.x; Culumber ZW, 2011, MOL ECOL, V20, P342, DOI 10.1111/j.1365-294X.2010.04949.x; Curran CE, 2016, BLOOMSBURY ACAD COLL, P1; Curry CM, 2014, AM MIDL NAT, V171, P271, DOI 10.1674/0003-0031-171.2.271; DeHaan PW, 2010, CONSERV GENET, V11, P935, DOI 10.1007/s10592-009-9937-6; DeRito JN, 2010, N AM J FISH MANAGE, V30, P866, DOI 10.1577/M09-006.1; Dunham JB, 2004, FISHERIES, V29, P18, DOI 10.1577/1548-8446(2004)29[18:ATCONT]2.0.CO;2; Dunnigan JL, 1997, THESIS; Duvernell DD, 2014, EVOL ECOL, V28, P37, DOI 10.1007/s10682-013-9653-z; DWYER WP, 1975, T AM FISH SOC, V104, P552, DOI 10.1577/1548-8659(1975)104<552:TIOTOS>2.0.CO;2; Elsner MM, 2010, CLIMATIC CHANGE, V102, P225, DOI 10.1007/s10584-010-9855-0; Epifanio J, 2000, REV FISH BIOL FISHER, V10, P339, DOI 10.1023/A:1016673331459; Fausch KD, 2009, CONSERV BIOL, V23, P859, DOI 10.1111/j.1523-1739.2008.01159.x; FERGUSON MM, 1988, CAN J ZOOL, V66, P1389, DOI 10.1139/z88-204; Finstad AG, 2011, GLOBAL CHANGE BIOL, V17, P1703, DOI 10.1111/j.1365-2486.2010.02335.x; Foster G, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044022; Gresswell RE, 2011, N AM J FISH MANAGE, V31, P782, DOI 10.1080/02755947.2011.608980; Gunnell K, 2008, CONSERV GENET, V9, P49, DOI 10.1007/s10592-007-9302-6; Haak AL, 2012, N AM J FISH MANAGE, V32, P387, DOI 10.1080/02755947.2012.678963; Henderson Richard, 2000, North American Journal of Fisheries Management, V20, P584, DOI 10.1577/1548-8675(2000)020&lt;0584:TALOSB&gt;2.3.CO;2; Hitt NP, 2003, CAN J FISH AQUAT SCI, V60, P1440, DOI 10.1139/F03-125; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Isaak DJ, 2016, P NATL ACAD SCI USA, V113, P4374, DOI 10.1073/pnas.1522429113; Isaak DJ, 2015, GLOBAL CHANGE BIOL, V21, P2540, DOI 10.1111/gcb.12879; Isaak DJ, 2013, GLOBAL CHANGE BIOL, V19, P742, DOI 10.1111/gcb.12073; Isaak DJ, 2010, ECOL APPL, V20, P1350, DOI 10.1890/09-0822.1; Kaeding LR, 2003, FED REGISTER, V68, P46989; Kendall NW, 2015, CAN J FISH AQUAT SCI, V72, P319, DOI 10.1139/cjfas-2014-0192; KINDSCHI GA, 1994, PROG FISH CULT, V56, P13, DOI 10.1577/1548-8640(1994)056<0013:PAOCOS>2.3.CO;2; Kovach R. P., 2015, P ROY SOC LOND B BIO, V282, P2014; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Loxterman JL, 2014, CAN J FISH AQUAT SCI, V71, P1050, DOI 10.1139/cjfas-2013-0424; Maindonald J. H., 2015, DAAG DATA ANAL GRAPH; McKay L, 2012, NHDPLUS VERSION 2 US; McKelvey KS, 2016, ECOL EVOL, V6, P688, DOI 10.1002/ece3.1887; Meraner A, 2013, MOL ECOL, V22, P5295, DOI 10.1111/mec.12470; Miller LM, 2004, MOL ECOL, V13, P3379, DOI 10.1111/j.1365-294X.2004.02347.x; Moyle PB, 1996, BIOL CONSERV, V78, P149, DOI 10.1016/0006-3207(96)00024-9; Muhlfeld CC, 2015, N AM J FISH MANAGE, V35, P31, DOI 10.1080/02755947.2014.951807; Muhlfeld CC, 2014, NAT CLIM CHANGE, V4, P620, DOI [10.1038/NCLIMATE2252, 10.1038/nclimate2252]; Muhlfeld CC, 2009, T AM FISH SOC, V138, P1036, DOI 10.1577/T08-235.1; Ostberg CO, 2011, T AM FISH SOC, V140, P334, DOI 10.1080/00028487.2011.567866; Ostberg CO, 2012, NORTHWEST SCI, V86, P198, DOI 10.3955/046.086.0305; Ostberg CO, 2004, MOL ECOL, V13, P2773, DOI 10.1111/j.1365-294X.2004.02268.x; Pereira RJ, 2016, MOL ECOL, V25, P1551, DOI 10.1111/mec.13575; Perrier C, 2013, ECOL EVOL, V3, P2334, DOI 10.1002/ece3.629; Peterson DP, 2014, ECOL FRESHW FISH, V23, P556, DOI 10.1111/eff.12108; Poisot T, 2016, ECOGRAPHY, V39, P402, DOI 10.1111/ecog.01941; Quinn TP, 2004, REV FISH BIOL FISHER, V14, P421, DOI 10.1007/s11160-005-0802-5; R Core Team, 2013, R LANG ENV STAT COMP; Rahel FJ, 2002, ANNU REV ECOL SYST, V33, P291, DOI 10.1146/annurev.ecolsys.33.010802.150429; Rasmussen JB, 2012, BIOL J LINN SOC, V105, P56, DOI 10.1111/j.1095-8312.2011.01768.x; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rieman BE, 2000, ECOL FRESHW FISH, V9, P51, DOI 10.1034/j.1600-0633.2000.90106.x; Rubidge EM, 2005, CONSERV GENET, V6, P369, DOI 10.1007/s10592-005-4972-4; Servedio MR, 2004, PLOS BIOL, V2, P2032, DOI 10.1371/journal.pbio.0020420; Shepard BB, 2005, N AM J FISH MANAGE, V25, P1426, DOI 10.1577/M05-004.1; Sloat MR, 2014, CAN J FISH AQUAT SCI, V71, P491, DOI 10.1139/cjfas-2013-0366; Splendiani A, 2016, BIOL INVASIONS, V18, P2029, DOI 10.1007/s10530-016-1149-7; Stoffels RJ, 2016, OECOLOGIA, V180, P45, DOI 10.1007/s00442-015-3463-7; Taylor EB, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P232; Taylor SA, 2015, TRENDS ECOL EVOL, V30, P398, DOI 10.1016/j.tree.2015.04.010; Utah Division of Wildlife Resources, 2000, UT DIV PUBL; Valiquette E, 2014, EVOL APPL, V7, P625, DOI 10.1111/eva.12160; Van Leeuwen TE, 2011, J ANIM ECOL, V80, P1012, DOI 10.1111/j.1365-2656.2011.01841.x; Vonlanthen P, 2009, J EVOLUTION BIOL, V22, P498, DOI 10.1111/j.1420-9101.2008.01670.x; Wang IJ, 2014, MOL ECOL, V23, P5649, DOI 10.1111/mec.12938; Weigel DE, 2003, ECOL APPL, V13, P38, DOI 10.1890/1051-0761(2003)013[0038:IHBNCT]2.0.CO;2; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Wenger SJ, 2011, CAN J FISH AQUAT SCI, V68, P988, DOI [10.1139/F2011-034, 10.1139/f2011-034]; Wenger SJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008839; Williams I, 2007, T AM FISH SOC, V136, P926, DOI 10.1577/T06-214.1; Winkler KA, 2011, MOL ECOL, V20, P456, DOI 10.1111/j.1365-294X.2010.04961.x; Yau MM, 2013, CONSERV GENET, V14, P885, DOI 10.1007/s10592-013-0485-8; Young MK, 2011, CAN J FISH AQUAT SCI, V68, P941, DOI 10.1139/F2011-023	100	29	29	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0163563	10.1371/journal.pone.0163563	http://dx.doi.org/10.1371/journal.pone.0163563			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828980	Green Submitted, Green Published, gold			2022-12-27	WOS:000387724300007
J	Zahran, R; Leal, JIR; Rodriguez Valverde, MA; Vilchez, MAC				Zahran, R.; Rosales Leal, J. I.; Rodriguez Valverde, M. A.; Cabrerizo Vilchez, M. A.			Effect of Hydrofluoric Acid Etching Time on Titanium Topography, Chemistry, Wettability, and Cell Adhesion	PLOS ONE			English	Article							OSTEOBLAST-LIKE CELLS; SURFACE-TOPOGRAPHY; PROTEIN-SYNTHESIS; POLYMER SURFACES; IMPLANT SURFACES; BONE-FORMATION; IN-VIVO; DIFFERENTIATION; ROUGHNESS; OSSEOINTEGRATION	Titanium implant surface etching has proven an effective method to enhance cell attachment. Despite the frequent use of hydrofluoric (HF) acid, many questions remain unresolved, including the optimal etching time and its effect on surface and biological properties. The objective of this study was to investigate the effect of HF acid etching time on Ti topography, surface chemistry, wettability, and cell adhesion. These data are useful to design improved acid treatment and obtain an improved cell response. The surface topography, chemistry, dynamic wetting, and cell adhesiveness of polished Ti surfaces were evaluated after treatment with HF acid solution for 0, 2; 3, 5, 7, or 10 min, revealing a time-dependent effect of HF acid on their topography, chemistry, and wetting. Roughness and wetting increased with longer etching time except at 10 min, when roughness increased but wetness decreased. Skewness became negative after etching and kurtosis tended to 3 with longer etching time. Highest cell adhesion was achieved after 5-7 min of etching time. Wetting and cell adhesion were reduced on the highly rough surfaces obtained after 10-min etching time.	[Zahran, R.; Rosales Leal, J. I.] Univ Granada, Sch Dent, Dept Prosthodont, Granada, Spain; [Zahran, R.; Rosales Leal, J. I.] Univ Granada, Stomatognat Physiopathol & Prosthodont Res Grp CT, Granada, Spain; [Rosales Leal, J. I.] Univ Granada, Inst Invest Biosanitariaibs GRANADA, Granada, Spain; [Rodriguez Valverde, M. A.; Cabrerizo Vilchez, M. A.] Univ Granada, Sch Sci, Dept Appl Phys, Granada, Spain; [Rodriguez Valverde, M. A.; Cabrerizo Vilchez, M. A.] Univ Granada, Fluid & Biocolloid Phys Res Grp, Granada, Spain	University of Granada; University of Granada; University of Granada; University of Granada; University of Granada	Leal, JIR (corresponding author), Univ Granada, Sch Dent, Dept Prosthodont, Granada, Spain.; Leal, JIR (corresponding author), Univ Granada, Stomatognat Physiopathol & Prosthodont Res Grp CT, Granada, Spain.; Leal, JIR (corresponding author), Univ Granada, Inst Invest Biosanitariaibs GRANADA, Granada, Spain.	irosales@ugr.es	Rodriguez-Valverde, Miguel A/B-7938-2009	Rodriguez-Valverde, Miguel A/0000-0003-4361-6721	Ministerio Espanol de Economia y Competitividad [MAT2014-60615-R]; Junta de Andalucia, Spain [CTS 974]	Ministerio Espanol de Economia y Competitividad(Spanish Government); Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission)	This study was supported by the "Ministerio Espanol de Economia y Competitividad" (project MAT2014-60615-R) and by Research Group #CTS 974 (Junta de Andalucia, Spain).r This study was supported by the "Ministerio Espanol de Economia y Competitividad" (project MAT2014-60615-R) and by Research Group #CTS 974 (Junta de Andalucia, Spain). The authors thank Richard Davies for editorial assistance.	Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x; Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x; Blanco J, 2011, CLIN ORAL IMPLAN RES, V22, P92, DOI 10.1111/j.1600-0501.2010.02009.x; Canabarro A, 2012, SCANNING, V34, P378, DOI 10.1002/sca.21020; Chappard D, 2003, BIOMATERIALS, V24, P1399, DOI 10.1016/S0142-9612(02)00524-0; Cooper LF, 2006, BIOMATERIALS, V27, P926, DOI 10.1016/j.biomaterials.2005.07.009; Dahotre NB, 2010, PHILOS T R SOC A, V368, P1863, DOI 10.1098/rsta.2010.0003; Galdelmawla ES, 2002, J MATER PROCESS TECH, V123, P133; Gittens RA, 2014, ACTA BIOMATER, V10, P3363, DOI 10.1016/j.actbio.2014.03.037; Gittens RA, 2013, ACTA BIOMATER, V9, P6268, DOI 10.1016/j.actbio.2012.12.002; Guo J, 2007, BIOMATERIALS, V28, P5418, DOI 10.1016/j.biomaterials.2007.08.032; Ha SW, 1997, J MATER SCI-MATER M, V8, P891, DOI 10.1023/A:1018562023599; He FM, 2010, ORAL SURG ORAL MED O, V110, pE13, DOI 10.1016/j.tripleo.2010.03.044; Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009; Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O; Korotin D. M., 2012, J BIOMATER NANOBIOTE, V3, P87, DOI DOI 10.4236/JBNB.2012.31011; Kubiak KJ, 2011, SCANNING, V33, P370, DOI 10.1002/sca.20289; Kwon T, 2014, J DENT, V2014, DOI [10.1016/j.jdent, DOI 10.1016/J.JDENT.2014;05-016]; Lamolle SF, 2009, J BIOMED MATER RES A, V88A, P581, DOI 10.1002/jbm.a.31898; Lamolle SF, 2009, BIOMATERIALS, V30, P736, DOI 10.1016/j.biomaterials.2008.10.052; Li YF, 2010, BIOMATERIALS, V31, P3266, DOI 10.1016/j.biomaterials.2010.01.028; Maldelbrot BB, 1983, FRACTAL GEOMETRY NAT; MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314; Monjo M, 2008, BIOMATERIALS, V29, P3771, DOI 10.1016/j.biomaterials.2008.06.001; Ruiz-Cabello FJM, 2011, J ADHES SCI TECHNOL, V25, P2039, DOI 10.1163/016942410X544848; MORRA M, 1990, ADV COLLOID INTERFAC, V32, P79, DOI 10.1016/0001-8686(90)80012-O; Nakagawa M, 2001, Dent Mater J, V20, P305; Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476; Rauscher M, 2008, PHENOMENA NANOFLUIDI, P38; Rodriguez Valverde MA, 1978, MICROSCOPY BOOK SERI, V3; Rodriguez- Rius D, 2005, MED ORAL PATOL ORAL, V10, P58; Rosales Leal JI, 2010, PHYSICOCHEM ENG ASPE, V365, P222; Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518; Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024	35	31	34	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165296	10.1371/journal.pone.0165296	http://dx.doi.org/10.1371/journal.pone.0165296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824875	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200016
J	Bartels, MF; Winterhalter, PR; Yu, J; Liu, Y; Lommel, M; Mohrlen, F; Hu, HY; Feizi, T; Westerlind, U; Ruppert, T; Strahl, S				Bartels, Markus F.; Winterhalter, Patrick R.; Yu, Jin; Liu, Yan; Lommel, Mark; Moehrlen, Frank; Hu, Huaiyu; Feizi, Ten; Westerlind, Ulrika; Ruppert, Thomas; Strahl, Sabine			Protein O-Mannosylation in the Murine Brain: Occurrence of Mono-O-Mannosyl Glycans and Identification of New Substrates	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; DYSTROPHIN-GLYCOPROTEIN COMPLEX; CONGENITAL MUSCULAR-DYSTROPHIES; REDUCTIVE ALKALINE-HYDROLYSIS; WALKER-WARBURG-SYNDROME; ALPHA-DYSTROGLYCAN; BASEMENT-MEMBRANE; MUCIN DOMAIN; MOUSE-BRAIN; MUSCLE	Protein O-mannosylation is a post-translational modification essential for correct development of mammals. In humans, deficient O-mannosylation results in severe congenital muscular dystrophies often associated with impaired brain and eye development. Although various O-mannosylated proteins have been identified in the recent years, the distribution of O-mannosyl glycans in the mammalian brain and target proteins are still not well defined. In the present study, rabbit monoclonal antibodies directed against the O-mannosylated peptide YAT(alpha 1-Man) AV were generated. Detailed characterization of clone RKU-1-3-5 revealed that this monoclonal antibody recognizes O-linked mannose also in different peptide and protein contexts. Using this tool, we observed that mono-O-mannosyl glycans occur ubiquitously throughout the murine brain but are especially enriched at inhibitory GABAergic neurons and at the perineural nets. Using a mass spectrometry-based approach, we further identified glycoproteins from the murine brain that bear single O-mannose residues. Among the candidates identified are members of the cadherin and plexin superfamilies and the perineural net protein neurocan. In addition, we identified neurexin 3, a cell adhesion protein involved in synaptic plasticity, and inter-alpha-trypsin inhibitor 5, a protease inhibitor important in stabilizing the extracellular matrix, as new O-mannosylated glycoproteins.	[Bartels, Markus F.; Winterhalter, Patrick R.; Lommel, Mark; Strahl, Sabine] Heidelberg Univ, Dept Cell Chem, Ctr Organismal Studies, Heidelberg, Germany; [Winterhalter, Patrick R.; Ruppert, Thomas] Heidelberg Univ, Ctr Mol Biol Heidelberg ZMBH, Core Facil Mass Spectrometry & Prote, Heidelberg, Germany; [Yu, Jin; Westerlind, Ulrika] ISAS Leibniz Inst Analyt Sci, Gesell Forderung Analyt Wissensch eV, Dortmund, Germany; [Liu, Yan; Feizi, Ten] Imperial Coll London, Dept Med, Glycosci Lab, Hammersmith Campus, London, England; [Moehrlen, Frank] Heidelberg Univ, Dept Anim Mol Physiol, Ctr Organismal Studies, Heidelberg, Germany; [Hu, Huaiyu] Upstate Med Univ, Inst Human Performance, Dept Neurosci & Physiol, New York, NY USA	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); Imperial College London; Ruprecht Karls University Heidelberg; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Strahl, S (corresponding author), Heidelberg Univ, Dept Cell Chem, Ctr Organismal Studies, Heidelberg, Germany.	sabine.strahl@cos.uni-heidelberg.de	Lommel, Mark/E-3836-2014; Liu, Yan/D-9117-2013; Ruppert, Thomas/AAC-2467-2021	Ruppert, Thomas/0000-0001-9152-2266; Lommel, Mark/0000-0001-6954-3714; Liu, Yan/0000-0002-2566-6867	Deutsche Forschungsgemeinschaft, Sonderforschungsbereich [1036, 11]; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; Senatsverwaltung fur Wirtschaft, Technologie und Forschung des Landes Berlin; Bundesministerium for Bildung and Forschung; Wellcome Trust [WT093378MA, WT099197MA, 108430/Z/15/Z]	Deutsche Forschungsgemeinschaft, Sonderforschungsbereich(German Research Foundation (DFG)); Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; Senatsverwaltung fur Wirtschaft, Technologie und Forschung des Landes Berlin; Bundesministerium for Bildung and Forschung; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 1036, project 11 (to S.S.). S.S. is a member of the excellence cluster CellNetworks. Financial support by the Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen, the Senatsverwaltung fur Wirtschaft, Technologie und Forschung des Landes Berlin, and the Bundesministerium for Bildung and Forschung is gratefully acknowledged (to U.W.). Supported by Wellcome Trust Grants WT093378MA, WT099197MA and 108430/Z/15/Z (to T.F.).	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Beedle AM, 2012, J CLIN INVEST, V122, P3330, DOI 10.1172/JCI63004; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bleckmann C, 2009, BIOL CHEM, V390, P627, DOI 10.1515/BC.2009.044; Bonnemann CG, 2014, NEUROMUSCULAR DISORD, V24, P289, DOI 10.1016/j.nmd.2013.12.011; Breloy I, 2008, J BIOL CHEM, V283, P18832, DOI 10.1074/jbc.M802834200; Breloy I, 2012, BIOL CHEM, V393, P709, DOI 10.1515/hsz-2012-0214; Cabrera PV, 2012, J BIOL CHEM, V287, P22759, DOI 10.1074/jbc.M111.334581; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Che MI, 2014, ONCOTARGET, V5, P3673, DOI 10.18632/oncotarget.1981; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dwyer CA, 2012, NEUROSCIENCE, V220, P47, DOI 10.1016/j.neuroscience.2012.06.026; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FINNE J, 1979, J BIOL CHEM, V254, P295; Friedel RH, 2007, J NEUROSCI, V27, P3921, DOI 10.1523/JNEUROSCI.4710-06.2007; Goddeeris MM, 2013, NATURE, V503, P136, DOI 10.1038/nature12605; HARTIG W, 1992, NEUROREPORT, V3, P869; Himmelfarb M, 2004, CANCER LETT, V204, P69, DOI 10.1016/j.canlet.2003.09.011; Howell MD, 2012, NEUROSCIENCE, V217, P6, DOI 10.1016/j.neuroscience.2012.05.034; Hu HY, 2007, J COMP NEUROL, V501, P168, DOI 10.1002/cne.21238; Hu HY, 2011, J COMP NEUROL, V519, P1320, DOI 10.1002/cne.22572; Judas M, 2009, NEUROPEDIATRICS, V40, P6, DOI 10.1055/s-0029-1224099; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Kogelberg H, 2001, CARBOHYD RES, V331, P393, DOI 10.1016/S0008-6215(01)00051-9; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; Loibl M, 2013, BBA-MOL CELL RES, V1833, P2438, DOI 10.1016/j.bbamcr.2013.02.008; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Mo KF, 2011, J AM CHEM SOC, V133, P14418, DOI 10.1021/ja205473q; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Neubert P, 2016, MOL CELL PROTEOMICS, V15, P1323, DOI 10.1074/mcp.M115.057505; Pacharra S, 2013, J PROTEOME RES, V12, P1764, DOI 10.1021/pr3011028; Pacharra S, 2012, J PROTEOME RES, V11, P3955, DOI 10.1021/pr200996y; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Praissman JL, 2014, BIOCHEMISTRY-US, V53, P3066, DOI 10.1021/bi500153y; Pribiag H, 2014, P NATL ACAD SCI USA, V111, P6810, DOI 10.1073/pnas.1321774111; Sambrook J., 2001, MOL CLONING LAB MANU; Sassoe-Pognetto M, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00004; Stalnaker SH, 2011, J BIOL CHEM, V286, P21180, DOI 10.1074/jbc.M110.203281; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; Tanaka M, 2003, J NEUROSCI, V23, P2804, DOI 10.1523/jneurosci.23-07-02804.2003; Tolu S, 2010, FASEB J, V24, P723, DOI 10.1096/fj.09-139790; Trinidad JC, 2013, MOL CELL PROTEOMICS, V12, P3474, DOI 10.1074/mcp.M113.030007; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Waite A, 2012, TRENDS NEUROSCI, V35, P487, DOI 10.1016/j.tins.2012.04.004; Whitney ER, 2008, J NEUROSCI METH, V168, P42, DOI 10.1016/j.jneumeth.2007.09.009; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Willer T, 2004, P NATL ACAD SCI USA, V101, P14126, DOI 10.1073/pnas.0405899101; Winterhalter PR, 2013, FEBS LETT, V587, P3715, DOI 10.1016/j.febslet.2013.09.041; Wright KM, 2012, NEURON, V76, P931, DOI 10.1016/j.neuron.2012.10.009; Yoshida-Moriguchi T, 2015, GLYCOBIOLOGY, V25, P702, DOI 10.1093/glycob/cwv021; Yuen CT, 1997, J BIOL CHEM, V272, P8924	57	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166119	10.1371/journal.pone.0166119	http://dx.doi.org/10.1371/journal.pone.0166119			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812179	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000103
J	Sarri, CA; Markantoni, M; Stamatis, C; Papa, A; Tsakris, A; Pervanidou, D; Baka, A; Politis, C; Billinis, C; Hadjichristodoulou, C; Mamuris, Z				Sarri, Constantina A.; Markantoni, Maria; Stamatis, Costas; Papa, Anna; Tsakris, Athanasios; Pervanidou, Danai; Baka, Agoritsa; Politis, Constantina; Billinis, Charalambos; Hadjichristodoulou, Christos; Mamuris, Zissis		MALWEST Project	Genetic Contribution of MHC Class II Genes in Susceptibility to West Nile Virus Infection	PLOS ONE			English	Article							T-CELL RESPONSES; NEUROINVASIVE DISEASE; DENGUE-FEVER; HLA; POPULATION; ASSOCIATION; FREQUENCIES; SELECTION; EPIDEMIC; EUROPE	WNV is a zoonotic neurotropic flavivirus that has recently emerged globally as a significant cause of viral encephalitis. The last five years, 624 incidents of WNV infection have been reported in Greece. The risk for severe WNV disease increases among immunosuppressed individuals implying thus the contribution of the MHC locus to the control of WNV infection. In order to investigate a possible association of MHC class II genes, especially HLA-DPA1, HLA-DQA1, HLA-DRB1, we examined 105 WNV patients, including 68 cases with neuroinvasive disease and 37 cases with mild clinical phenotype, collected during the period from 2010 to 2013, and 100 control individuals selected form the Greek population. Typing was performed for exon 2 for all three genes. DQA1*01: 01 was considered to be "protective" against WNV infection (25.4% vs 40.1%, P = 0.004) while DQA1*01: 02 was associated with increased susceptibility (48.0% vs 32.1%, P = 0.003). Protection against neuroinvasion was associated with the presence of DRB1* 11: 02 (4.99% vs 0.0%, P = 0.018). DRB1*16: 02 was also absent from the control cohort (P = 0.016). Three additional population control groups were used in order to validate our results. No statistically significant association with the disease was found for HLA-DPA alleles. The results of the present study provide some evidence that MHC class II is involved in the response to WNV infection, outlining infection "susceptibility" and "CNS-high-risk" candidates. Furthermore, three new alleles were identified while the frequency of all alleles in the study was compared with worldwide data. The characterization of the MHC locus could help to estimate the risk for severe WNV cases in a country.	[Sarri, Constantina A.; Markantoni, Maria; Stamatis, Costas; Mamuris, Zissis] Univ Thessaly, Dept Biochem & Biotechnol, Lab Genet Comparat & Evolutionary Biol, Larisa, Greece; [Papa, Anna] Aristotle Univ Thessaloniki, Arboviruses Reference Lab, Microbiol Lab 1, Thessaloniki, Greece; [Tsakris, Athanasios] Univ Athens, Sch Med, Microbiol Lab, Athens, Greece; [Pervanidou, Danai; Baka, Agoritsa] HCDCP, Attika, Greece; [Politis, Constantina] HCDCP, Hellen Coordinating Hemovigilance Ctr, Attika, Greece; [Billinis, Charalambos] Univ Thessaly, Lab Microbiol & Parasitol, Fac Vet Med, Kardhitsa, Greece; [Hadjichristodoulou, Christos] Univ Thessaly, Lab Hyg & Epidemiol, Fac Med, Larisa, Greece	University of Thessaly; Aristotle University of Thessaloniki; Athens Medical School; National & Kapodistrian University of Athens; University of Thessaly; University of Thessaly	Mamuris, Z (corresponding author), Univ Thessaly, Dept Biochem & Biotechnol, Lab Genet Comparat & Evolutionary Biol, Larisa, Greece.	zmamur@bio.uth.gr	Mamuris, Zissis/AAN-2576-2021	Markantoni, Maria/0000-0002-3616-4344; Hadjichristodoulou, Christos/0000-0002-4769-8376	"Integrated surveillance and control programme for West Nile virus and malaria in Greece" (MALWEST) through the Operational Programme "Human Resources Development" of National Strategic Reference Framework (NSRF)	"Integrated surveillance and control programme for West Nile virus and malaria in Greece" (MALWEST) through the Operational Programme "Human Resources Development" of National Strategic Reference Framework (NSRF)	This work was funded by "Integrated surveillance and control programme for West Nile virus and malaria in Greece" (MALWEST) through the Operational Programme "Human Resources Development" of National Strategic Reference Framework (NSRF) 2007-2013.	Ashraf U, 2015, VIRUSES-BASEL, V7, P219, DOI 10.3390/v7010219; Bigham AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024745; Cangussu LOF, 2011, SCAND J IMMUNOL, V74, P282, DOI 10.1111/j.1365-3083.2011.02568.x; Carson PJ, 2012, EMERG INFECT DIS, V18, P684, DOI 10.3201/eid1804.111313; Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Iacovakis C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074360; James EA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005375; Janeway CA., 2001, IMMUNOBIOLOGY IMMUNE; Kaabinejadian S, 2014, J IMMUNOL S, V192, P43; Koutsogiannouli EA, 2009, MOL ECOL, V18, P4631, DOI 10.1111/j.1365-294X.2009.04394.x; Kumar D, 2004, AM J TRANSPLANT, V4, P1883, DOI 10.1111/j.1600-6143.2004.00592.x; LaFleur C, 2002, HUM IMMUNOL, V63, P1039, DOI 10.1016/S0198-8859(02)00682-1; Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304; Lanteri MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022948; Lim JK, 2010, J INFECT DIS, V201, P178, DOI 10.1086/649426; Louis C, 2012, EMERG INFECT DIS, V18, P78, DOI 10.3201/eid1801.110191; Marka A, 2013, INT J ENV RES PUB HE, V10, P6534, DOI 10.3390/ijerph10126534; Netland J, 2013, VIRUSES-BASEL, V5, P2573, DOI 10.3390/v5102573; O'Leary DR, 2004, VECTOR-BORNE ZOONOT, V4, P61, DOI 10.1089/153036604773083004; Ovsyannikova IG, 2007, VIROLOGY, V364, P87, DOI 10.1016/j.virol.2007.02.028; Panoutsopoulou K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6345; Polizel JR, 2004, MEM I OSWALDO CRUZ, V99, P559, DOI 10.1590/S0074-02762004000600003; Pradier S, 2012, REV SCI TECH OIE, V31, P829; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Ranasinghe S, 2013, NAT MED, V19, P930, DOI 10.1038/nm.3229; Rubicz R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003147; Sanchez-Mazas A, 2011, IMMUNOLOGY, V133, P143, DOI 10.1111/j.1365-2567.2011.03438.x; Sarri CA, HLA; Sarri CA, COMPLETE EXON 2 SEQU; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Sierra B, 2007, HUM IMMUNOL, V68, P531, DOI 10.1016/j.humimm.2007.03.001; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Spiroski M, 2013, HUM IMMUNOL, V74, P389, DOI 10.1016/j.humimm.2012.11.015; TAKAHATA N, 1990, GENETICS, V124, P967; Tamori A, 2013, WORLD J GASTROENTERO, V19, P5395, DOI 10.3748/wjg.v19.i33.5395; THOMPSON J, 2005, GEOGRAPHIC MOSAIC CO, P31, DOI DOI 10.1117/12.604911; Wedekind C, 2005, GENETICS, V170, P1427, DOI 10.1534/genetics.105.040683	39	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165952	10.1371/journal.pone.0165952	http://dx.doi.org/10.1371/journal.pone.0165952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812212	gold, Green Published			2022-12-27	WOS:000386910000084
J	Guiducci, L; Razghandi, K; Bertinetti, L; Turcaud, S; Ruggeberg, M; Weaver, JC; Fratzl, P; Burgert, I; Dunlop, JWC				Guiducci, Lorenzo; Razghandi, Khashayar; Bertinetti, Luca; Turcaud, Sebastien; Rueggeberg, Markus; Weaver, James C.; Fratzl, Peter; Burgert, Ingo; Dunlop, John W. C.			Honeycomb Actuators Inspired by the Unfolding of Ice Plant Seed Capsules	PLOS ONE			English	Article							CELLULOSE FIBRILS; PINE-CONES; SYSTEMS; MESEMBRYANTHEMUM; POMERIDIANA; DISPERSAL; FRUITS; BR	Plant hydro-actuated systems provide a rich source of inspiration for designing autonomously morphing devices. One such example, the pentagonal ice plant seed capsule, achieves complex mechanical actuation which is critically dependent on its hierarchical organization. The functional core of this actuation system involves the controlled expansion of a highly swellable cellulosic layer, which is surrounded by a non-swellable honeycomb framework. In this work, we extract the design principles behind the unfolding of the ice plant seed capsules, and use two different approaches to develop autonomously deforming honeycomb devices as a proof of concept. By combining swelling experiments with analytical and finite element modelling, we elucidate the role of each design parameter on the actuation of the prototypes. Through these approaches, we demonstrate potential pathways to design/develop/construct autonomously morphing systems by tailoring and amplifying the initial material's response to external stimuli through simple geometric design of the system at two different length scales.	[Guiducci, Lorenzo; Razghandi, Khashayar; Bertinetti, Luca; Turcaud, Sebastien; Fratzl, Peter; Dunlop, John W. C.] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Guiducci, Lorenzo; Razghandi, Khashayar] Humboldt Univ, Cluster Excellence Image Knowledge, Berlin, Germany; [Weaver, James C.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Rueggeberg, Markus; Burgert, Ingo] ETHZ, Inst Bldg Mat IfB, Zurich, Switzerland; [Rueggeberg, Markus; Burgert, Ingo] Empa, Appl Wood Mat Lab, Dubendorf, Switzerland	Max Planck Society; Humboldt University of Berlin; Harvard University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Guiducci, L; Razghandi, K (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany.; Guiducci, L; Razghandi, K (corresponding author), Humboldt Univ, Cluster Excellence Image Knowledge, Berlin, Germany.	lorenzo.guiducci@mpikg.mpg.de; khashayar.razghandi@mpikg.mpg.de	Bertinetti, Luca/M-8242-2016; Weaver, James C./AAE-7870-2019; Dunlop, John W C/A-1997-2012; Fratzl, Peter/H-9095-2012	Bertinetti, Luca/0000-0002-4666-9610; Dunlop, John W C/0000-0003-2741-6383; Fratzl, Peter/0000-0003-4437-7830; Razghandi, Khashayar/0000-0003-3419-4870	Max Planck Institute of Colloids and Interfaces of Potsdam; DFG Deutsche Forschungsgemeinschaft through Priority Program: "Biomimetic Materials Research: Functionality by Hierarchical Structuring of Materials" [SPP1420]; "Image Knowledge Gestaltung: An Interdisciplinary Laboratory" Cluster of Excellence at the Humboldt University of Berlin through DFG contract [EXC1027/1]; ETHZ, Institute for Building Materials (IfB) of Zurich, Switzerland; Empa, Applied Wood Materials Laboratory of Dubendorf, Switzerland	Max Planck Institute of Colloids and Interfaces of Potsdam; DFG Deutsche Forschungsgemeinschaft through Priority Program: "Biomimetic Materials Research: Functionality by Hierarchical Structuring of Materials"; "Image Knowledge Gestaltung: An Interdisciplinary Laboratory" Cluster of Excellence at the Humboldt University of Berlin through DFG contract; ETHZ, Institute for Building Materials (IfB) of Zurich, Switzerland; Empa, Applied Wood Materials Laboratory of Dubendorf, Switzerland	This work was financially supported by Max Planck Institute of Colloids and Interfaces of Potsdam, the DFG Deutsche Forschungsgemeinschaft through SPP1420 Priority Program: "Biomimetic Materials Research: Functionality by Hierarchical Structuring of Materials," "Image Knowledge Gestaltung: An Interdisciplinary Laboratory" Cluster of Excellence at the Humboldt University of Berlin through DFG contract EXC1027/1, ETHZ, Institute for Building Materials (IfB) of Zurich, Switzerland, and Empa, Applied Wood Materials Laboratory of Dubendorf, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertinetti L, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.238001; Brown R, 2006, PHYS TESTING RUBBERS; Burgert I, 2009, PHILOS T R SOC A, V367, P1541, DOI 10.1098/rsta.2009.0003; Burgert I, 2009, INTEGR COMP BIOL, V49, P69, DOI 10.1093/icb/icp026; Caulfield DF, 1988, 1988 PAPER PRESERVAT; Dawson J, 1997, NATURE, V390, P668, DOI 10.1038/37745; Elbaum R, 2008, J STRUCT BIOL, V164, P101, DOI 10.1016/j.jsb.2008.06.008; Erb RM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2666; Fratzl P, 2008, FARADAY DISCUSS, V139, P275, DOI 10.1039/b716663j; Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603; Garside S, 1930, ANN BOT-LONDON, V44, P639, DOI 10.1093/oxfordjournals.aob.a090241; Guiducci L, 2014, THESIS; Guiducci L, 2015, ADV MATER INTERFACES, V2, DOI 10.1002/admi.201500011; Guiducci L, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0458; Harrington MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1336; Ionov L, 2013, ADV FUNCT MATER, V23, P4555, DOI 10.1002/adfm.201203692; Kang MK, 2010, J APPL MECH-T ASME, V77, DOI 10.1115/1.4001715; Lockyer S, 1932, ANN BOT-LONDON, V46, P323, DOI 10.1093/oxfordjournals.aob.a090325; Ma MM, 2013, SCIENCE, V339, P186, DOI 10.1126/science.1230262; Neuhaus FH, 1981, ELASTIZITATSZAHLEN V; Rafsanjani A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08064; Razghandi K, 2015, THESIS; Razghandi K, 2014, BIOINSPIR BIOMIM NAN, V3, P169, DOI 10.1680/bbn.14.00016; Reyssat E, 2009, J R SOC INTERFACE, V6, P951, DOI 10.1098/rsif.2009.0184; Ruggeberg M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120718; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAHINPOOR M, 1995, MAT SCI ENG C-BIOMIM, V2, P229, DOI 10.1016/0928-4931(95)00105-0; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; Sinibaldi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102461; Teraoka I, 1996, PROG POLYM SCI, V21, P89, DOI 10.1016/0079-6700(95)00018-6; Timoshenko S, 1925, J OPT SOC AM REV SCI, V11, P233, DOI 10.1364/JOSA.11.000233; Treloar LRG, 1949, THE PHYSICS OF RUBBE; Turcaud S, 2011, INT J MATER RES, V102, P607, DOI 10.3139/146.110517	33	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0163506	10.1371/journal.pone.0163506	http://dx.doi.org/10.1371/journal.pone.0163506			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806052	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500006
J	Alroughani, R; Akhtar, S; Ahmed, S; Behbehani, R; Al-Hashel, J				Alroughani, Raed; Akhtar, Saeed; Ahmed, Samar; Behbehani, Raed; Al-Hashel, Jasem			Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; DISABILITY PROGRESSION; AGE; PREVALENCE; PROGNOSIS; EAST	Background & Objectives Published natural history data on late-onset of multiple sclerosis are limited. We aimed to assess the risk of attaining EDSS 6.0 among patients with late-onset (> 40 years) MS (LOMS) and young-onset (18-40 years) MS (YOMS). Methods This cross-sectional cohort study was conducted to identify LOMS and YOMS patients' with relapsing remitting course at MS diagnosis. Time (years) to reach sustained EDSS 6.0 was compared between LOMS and AOMS patients. Cox proportional hazards model was used to evaluate the demographic and clinical predictors of time to EDSS 6.0 in these cohorts. Results LOMS and YOMS cohorts comprised 99 (10.7%) and 804 (89.3%) patients respectively. Spinal cord presentation at MS onset was more common among LOMS patients (46.5% vs. 32.3%). The proportions of LOMS and YOMS patients reaching EDSS 6.0 during the follow-up period were 19.2% and 15.7% respectively. In multivariable Cox proportional hazards model, older age at MS onset (adjusted hazard ratio (aHR) = 3.96; 95% CI: 2.14-7.32; p < 0.001), male gender (aHR = 1.85; 95% CI: 1.22-2.81; p = 0.004) and spinal cord presentation at onset (aHR = 1.47; 95% CI: 0.98-2.21; p = 0.062) were significantly associated with shorter time to EDSS 6.0. Conclusions LOMS patients attained EDSS 6.0 in a significantly shorter period that was influenced by male gender and spinal cord presentation at MS onset.	[Alroughani, Raed] Amiri Hosp, Div Neurol, Dept Med, Sharq, Kuwait; [Alroughani, Raed] Dasman Diabet Inst, Neurol Clin, Dasman, Dasman, Kuwait; [Akhtar, Saeed] Kuwait Univ, Dept Community Med & Behav Sci, Fac Med, Jabriya, Kuwait; [Ahmed, Samar; Al-Hashel, Jasem] Ibn Sina Hosp, Dept Neurol, Kuwait, Kuwait; [Ahmed, Samar] Menia Univ, Dept Neurol & Psychiat, Al Minya, Egypt; [Behbehani, Raed] Ibn Sina Hosp, Dept Ophthalmol, Kuwait, Kuwait; [Al-Hashel, Jasem] Kuwait Univ, Dept Med, Fac Med, Jabriya, Kuwait	Kuwait University; Egyptian Knowledge Bank (EKB); Minia University; Kuwait University	Alroughani, R (corresponding author), Amiri Hosp, Div Neurol, Dept Med, Sharq, Kuwait.; Alroughani, R (corresponding author), Dasman Diabet Inst, Neurol Clin, Dasman, Dasman, Kuwait.	alroughani@gmail.com	Behbehani, Raed/CAF-0180-2022	Akhtar, Saeed/0000-0002-1261-788X; BEHBEHANI, RAED/0000-0002-6633-3567; Ahmed, Samar Farouk/0000-0002-9026-9219				Al-Hashel J, 2008, NEUROEPIDEMIOLOGY, V31, P129, DOI 10.1159/000151514; Alroughani R, 2014, MULT SCLER J, V20, P543, DOI 10.1177/1352458513504328; Arias M, 2011, NEUROLOGIA, V26, P291, DOI 10.1016/j.nrl.2010.09.008; Awad A, 2010, DRUG AGING, V27, P283, DOI 10.2165/11532120-000000000-00000; Bernitsas E, 2015, MULT SCLER RELAT DIS, V4, P47, DOI 10.1016/j.msard.2014.11.002; Bove RM, 2012, MULT SCLER J, V18, P1472, DOI 10.1177/1352458512438236; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Confavreux C, 2006, BRAIN, V129, P606, DOI 10.1093/brain/awl007; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Cossburn M, 2012, MULT SCLER J, V18, P45, DOI 10.1177/1352458511417479; Delalande S, 2002, REV NEUROL-FRANCE, V158, P1082; Etemadifar M, 2012, ARCH IRAN MED, V15, P596; Kis B, 2008, J NEUROL, V255, P697, DOI 10.1007/s00415-008-0778-x; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Lorscheider J, 2016, BRAIN J NEUROLOGY, DOI [10.1093/brain/aww17321917763, DOI 10.1093/BRAIN/AWW17321917763]; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Marrie RA, 2010, NEUROLOGY, V74, P465, DOI 10.1212/WNL.0b013e3181cf6ec0; Minden SL, 2004, NEUROREHABILITATION, V19, P55; Nociti V, 2005, SPINAL CORD, V43, P731, DOI 10.1038/sj.sc.3101798; NOSEWORTHY J, 1983, NEUROLOGY, V33, P1537, DOI 10.1212/WNL.33.12.1537; Oh J, 2013, NEUROLOGY, V80, P540, DOI 10.1212/WNL.0b013e31828154c5; Patrucco L, 2012, J NEUROL, V259, P1317, DOI 10.1007/s00415-011-6345-x; PHADKE JG, 1990, BRAIN, V113, P1597, DOI 10.1093/brain/113.6.1597; Polliack ML, 2001, J AM GERIATR SOC, V49, P168, DOI 10.1046/j.1532-5415.2001.49038.x; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ribbons KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122686; Rist JM, 2008, J NEUROL SCI, V274, P64, DOI 10.1016/j.jns.2008.04.027; Roohani P, 2014, MULT SCLER RELAT DIS, V3, P444, DOI 10.1016/j.msard.2014.02.004; Sanai SA, 2016, MULT SCLER J, V22, P717, DOI 10.1177/1352458516634871; Scalfari A, 2016, MULT SCLER J, V22, P1750, DOI 10.1177/1352458516630396; Scalfari A, 2011, NEUROLOGY, V77, P1246, DOI 10.1212/WNL.0b013e318230a17d; Shirani A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/451912; Shirani A, 2012, MULT SCLER J, V18, P442, DOI 10.1177/1352458511422097; Sombekke MH, 2013, NEUROLOGY, V80, P69, DOI 10.1212/WNL.0b013e31827b1a67; Tremlett H, 2006, NEUROLOGY, V67, P954, DOI 10.1212/01.wnl.0000237475.01655.9d; Tutuncu M, 2013, MULT SCLER J, V19, P188, DOI 10.1177/1352458512451510	38	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165846	10.1371/journal.pone.0165846	http://dx.doi.org/10.1371/journal.pone.0165846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802328	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200062
J	Li, XF; Wu, Y; Ren, XQ; Deng, SY; Hu, GF; Yu, SY; Tang, SX				Li, Xiufen; Wu, Yue; Ren, Xuqi; Deng, Shuyun; Hu, Guifang; Yu, Shouyi; Tang, Shixing			Characterization of Humoral Immune Responses against Capsid Protein p24 and Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type 1 in China	PLOS ONE			English	Article							B-CELL EPITOPES; MONOCLONAL-ANTIBODIES; HIV; ASSAYS; SEROCONVERSION; INFECTION	The objective of this study was to extend our previous research and to further characterize the humoral immune responses against HIV-1 p24, gp41 and the specific peptides carrying the immunodominant epitopes (IDEs) that react with human serum samples from HIV-1-infected individuals in China. We found that the majority (90.45%, 180/199) of the samples did not react with any of the three HIV-1 p24 peptides carrying IDEs, but did react with the recombinant full-length p24, suggesting that these samples tested in China were primarily directed against the conformational epitopes of HIV-1 p24. In contrast, 84.54% (164/194) of the samples reacted with at least one HIV-1 linear gp41 peptide, in particular the gp41p1 peptide (amino acids 560-616). Both recently and long-term HIV-1-infected individuals displayed similar humoral immune responses against the recombinant gp41. However, samples from long-term HIV-1-infected subjects but not from recently infected subjects, showed a very strong reaction against the gp41-p1 peptide. The different response patterns observed for the two groups against the gp41 and the peptide gp41-p1 were statistically significant (P<0.01, Chi-square test). These results have direct relevance and importance for design of improved HIV-1 p24 detection assays and the gp41-based immunoassay that can be used to reliably distinguish recent and long-term HIV-1 infection.	[Li, Xiufen; Wu, Yue; Hu, Guifang; Yu, Shouyi; Tang, Shixing] Southern Med Univ, Sch Publ Hlth, Dept Epidemiol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China; [Ren, Xuqi] Guangdong Prov Skin Dis & STD Control Ctr, Dept Sexually Transmitted Dis, Guangzhou, Guangdong, Peoples R China; [Deng, Shuyun] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, State Key Lab Organ Failure Res,Guangdong Prov Ke, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Yu, SY; Tang, SX (corresponding author), Southern Med Univ, Sch Publ Hlth, Dept Epidemiol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China.	qingchen@smu.edu.cn; tamgshixing@smu.edu.cn	Ren, Xu-Qi/GRX-4131-2022		Guangzhou Science and Technology Program - Bureau of Science and Information Technology of Guangzhou Municipality [201508020018]; Guangdong Province Public Welfare Research and Capacity Building Project - Guangdong Provincial Department of Science and Technology [20146020212007]	Guangzhou Science and Technology Program - Bureau of Science and Information Technology of Guangzhou Municipality; Guangdong Province Public Welfare Research and Capacity Building Project - Guangdong Provincial Department of Science and Technology	This research is supported by Guangzhou Science and Technology Program sponsored by Bureau of Science and Information Technology of Guangzhou Municipality (no. 201508020018). This research is also supported by Guangdong Province Public Welfare Research and Capacity Building Project sponsored by Guangdong Provincial Department of Science and Technology (no. 20146020212007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. rly.	Atun R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001045; BARIN F, 1985, SCIENCE, V228, P1094, DOI 10.1126/science.2986291; Bentsen C, 2011, J CLIN VIROL, V52, pS57, DOI 10.1016/j.jcv.2011.09.023; Brookmeyer R, 2013, AM J EPIDEMIOL, V177, P264, DOI 10.1093/aje/kws436; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; Dosenovic P, 2009, J IMMUNOL, V183, P3373, DOI 10.4049/jimmunol.0900407; Friedman DS, 2017, INT J STD AIDS, V28, P693, DOI 10.1177/0956462416664674; GAINES H, 1987, LANCET, V1, P1249; Gao ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161183; Hauser A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098038; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; JANVIER B, 1990, J VIROL, V64, P4258, DOI 10.1128/JVI.64.9.4258-4263.1990; Janvier B, 1996, AIDS RES HUM RETROV, V12, P519, DOI 10.1089/aid.1996.12.519; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Kirkpatrick AR, 2016, AIDS RES HUM RETROV, V32, P756, DOI [10.1089/AID.2015.0198, 10.1089/aid.2015.0198]; Liu GJ, 2005, CELL MOL IMMUNOL, V2, P289; Liu GJ, 2007, CELL MOL IMMUNOL, V4, P203; Longosz AF, 2014, AIDS RES HUM RETROV, V30, P339, DOI [10.1089/aid.2013.0169, 10.1089/AID.2013.0169]; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mehandru S, 2004, J VIROL, V78, P14039, DOI 10.1128/JVI.78.24.14039-14042.2004; Moyo S, 2015, VIRUSES-BASEL, V7, P5508, DOI 10.3390/v7102887; Nabel GJ, 2005, SCIENCE, V308, P1878, DOI 10.1126/science.1114854; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Ragupathy V, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-185; Rosenberg NE, 2015, CURR OPIN HIV AIDS, V10, P61, DOI 10.1097/COH.0000000000000121; Serhir B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156023; Tang SX, 2010, CLIN VACCINE IMMUNOL, V17, P1244, DOI 10.1128/CVI.00066-10; Wang Ning, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P541; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Wu JLW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001865; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Yusim K, 2016, LAUR1622283 LANL	37	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165874	10.1371/journal.pone.0165874	http://dx.doi.org/10.1371/journal.pone.0165874			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802337	Green Submitted, Green Published, gold			2022-12-27	WOS:000386714200064
J	Czernekova, M; Jonsson, KI				Czernekova, Michaels; Jonsson, K. Ingemar			Experimentally Induced Repeated Anhydrobiosis in the Eutardigrade Richtersius coronifer	PLOS ONE			English	Article							STORAGE-CELLS; TARDIGRADES; CRYPTOBIOSIS; TOLERANCE; SURVIVAL; LIFE; MACROBIOTIDAE; EVOLUTION	Tardigrades represent one of the main animal groups with anhydrobiotic capacity at any stage of their life cycle. The ability of tardigrades to survive repeated cycles of anhydrobiosis has rarely been studied but is of interest to understand the factors constraining anhydrobiotic survival. The main objective of this study was to investigate the patterns of survival of the eutardigrade Richtersius coronifer under repeated cycles of desiccation, and the potential effect of repeated desiccation on size, shape and number of storage cells. We also analyzed potential change in body size, gut content and frequency of mitotic storage cells. Specimens were kept under non-cultured conditions and desiccated under controlled relative humidity. After each desiccation cycle 10 specimens were selected for analysis of morphometric characteristics and mitosis. The study demonstrates that tardigrades may survive up to 6 repeated desiccations, with declining survival rates with increased number of desiccations. We found a significantly higher proportion of animals that were unable to contract properly into a tun stage during the desiccation process at the 5th and 6th desiccations. Also total number of storage cells declined at the 5th and 6th desiccations, while no effect on storage cell size was observed. The frequency of mitotic storage cells tended to decline with higher number of desiccation cycles. Our study shows that the number of consecutive cycles of anhydrobiosis that R. coronifer may undergo is limited, with increased inability for tun formation and energetic constraints as possible causal factors.	[Czernekova, Michaels; Jonsson, K. Ingemar] Kristianstad Univ, Sch Educ & Environm, Kristianstad, Sweden; [Czernekova, Michaels] Acad Sci Czech Republic, Inst Physiol, Prague, Czech Republic; [Czernekova, Michaels] Charles Univ Prague, Fac Med, Prague, Czech Republic	Kristianstad University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague	Czernekova, M (corresponding author), Kristianstad Univ, Sch Educ & Environm, Kristianstad, Sweden.; Czernekova, M (corresponding author), Acad Sci Czech Republic, Inst Physiol, Prague, Czech Republic.; Czernekova, M (corresponding author), Charles Univ Prague, Fac Med, Prague, Czech Republic.	Czernekovam@seznam.cz			Academy of Sciences of the Czech Republic [RVO: 67985823]; Mobility Fund, Charles University in Prague; Kristianstad University Sweden	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Mobility Fund, Charles University in Prague; Kristianstad University Sweden	MC received funding from the Academy of Sciences of the Czech Republic (RVO: 67985823) and the Mobility Fund, Charles University in Prague (http://wvw.cuni.cz/ukeng-49-version1.txt). MC and KIJ received funding from Kristianstad University Sweden (www.hkr.se).	Alpert P, 2006, J EXP BIOL, V209, P1575, DOI 10.1242/jeb.02179; Alpert P, 2005, INTEGR COMP BIOL, V45, P685, DOI 10.1093/icb/45.5.685; Baumann H., 1922, Zoologische Jahrbuecher Jena Abteilungen f Systematik, V45, P501; Clegg JS, 2001, COMP BIOCHEM PHYS B, V128, P613, DOI 10.1016/S1096-4959(01)00300-1; CROWE J H, 1975, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V32, P37; Czernekova M, 2016, ZOOL J LINN SOC-LOND, V178, P888, DOI 10.1111/zoj.12440; Guidetti R, 2002, J ZOOL, V257, P181, DOI 10.1017/S095283690200078X; Hengherr S, 2008, J ZOOL, V275, P216, DOI 10.1111/j.1469-7998.2008.00427.x; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2005, INTEGR COMP BIOL, V45, P764, DOI 10.1093/icb/45.5.764; Jonsson KI, 2005, INT J RADIAT BIOL, V81, P649, DOI 10.1080/09553000500368453; Jonsson KI, 2001, ZOOL ANZ, V240, P419, DOI 10.1078/0044-5231-00050; Jonsson KI, 2002, J EXP ZOOL, V293, P578, DOI 10.1002/jez.10186; KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013; Lance D., 1896, THESIS; Mobjerg N, 2007, J LIMNOL, V66, P132, DOI 10.4081/jlimnol.2007.s1.132; Nelson DR, 2002, INTEGR COMP BIOL, V42, P652, DOI 10.1093/icb/42.3.652; Neumann S, 2009, COMP BIOCHEM PHYS A, V153, P425, DOI 10.1016/j.cbpa.2009.04.611; Pilato G., 1981, Animalia (Catania), V8, P51; Puhlev I, 2001, CRYOBIOLOGY, V42, P207, DOI 10.1006/cryo.2001.2324; Rebecchi L, 2003, INVERTEBR BIOL, V122, P19; REBECCHI L, 1991, CARYOLOGIA, V44, P301, DOI 10.1080/00087114.1991.10797195; Reuner A, 2010, CURR ZOOL, V56, P259, DOI 10.1093/czoolo/56.2.259; Schill RO, 2009, BIOTECHNOL ADV, V27, P348, DOI 10.1016/j.biotechadv.2009.01.011; Weglarska B., 1994, ACTA BIOL CRACOV, VXXXVI, P41; Wolkers WF, 2002, COMP BIOCHEM PHYS A, V131, P535, DOI 10.1016/S1095-6433(01)00505-0; Wright JC, 2001, ZOOL ANZ, V240, P563, DOI 10.1078/0044-5231-00068; WRIGHT JC, 1992, BIOL REV, V67, P1, DOI 10.1111/j.1469-185X.1992.tb01657.x	28	11	12	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164062	10.1371/journal.pone.0164062	http://dx.doi.org/10.1371/journal.pone.0164062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828978	gold, Green Published			2022-12-27	WOS:000387724300013
J	Scheicher, B; Lorenzer, C; Gegenbauer, K; Partlic, J; Andreae, F; Kirsch, AH; Rosenkranz, AR; Werzer, O; Zimmer, A				Scheicher, Bernhard; Lorenzer, Cornelia; Gegenbauer, Katrin; Partlic, Julia; Andreae, Fritz; Kirsch, Alexander H.; Rosenkranz, Alexander R.; Werzer, Oliver; Zimmer, Andreas			Manufacturing of a Secretoneurin Drug Delivery System with Self-Assembled Protamine Nanoparticles by Titration	PLOS ONE			English	Article							IN-VITRO; OLIGONUCLEOTIDE-NANOPARTICLES; PHYSICOCHEMICAL CHARACTERIZATION; ALBUMIN NANOPARTICLES; GOLD NANOPARTICLES; ENDOTHELIAL-CELLS; SECRETOGRANIN-II; BASIC FGF; ANGIOGENESIS; NEUROPEPTIDE	Since therapeutic peptides and oligonucleotides are gathering interests as active pharmaceutical ingredients (APIs), nanoparticulate drug delivery systems are becoming of great importance. Thereby, the possibility to design drug delivery systems according to the therapeutic needs of APIs enhances clinical implementation. Over the last years, the focus of our group was laid on protamine-oligonucleotide-nanoparticles (so called proticles), however, the possibility to modify the size, zeta potential or loading efficiencies was limited. Therefore, at the present study we integrated a stepwise addition of protamine (titration) into the formation process of proticles loaded with the angiogenic neuropeptide secretoneurin (SN). A particle size around 130 nm was determined when proticles were assembled by the commonly used protamine addition at once. Through application of the protamine titration process it was possible to modify and adjust the particle size between approx. 120 and 1200 nm (dependent on mass ratio) without influencing the SN loading capacity. Dynamic light scattering pointed out that the difference in particle size was most probably the result of a secondary aggregation. Initially-formed particles of early stages in the titration process aggregated towards bigger assemblies. Atomic-force-microscopy images also revealed differences in morphology along with different particle size. In contrast, the SN loading was only influenced by the applied mass ratio, where a slight saturation effect was observable. Up to 65% of deployed SN could be imbedded into the proticle matrix. An in-vivo biodistribution study (i.m.) showed a retarded distribution of SN from the site of injection after the application of a SN-proticle formulation. Further, it was demonstrated that SN loaded proticles can be successfully freeze-dried and resuspended afterwards. To conclude, the integration of the protamine titration process offers new possibilities for the formulation of proticles in order to address key parameters of drug delivery systems as size, API loading or modified drug release.	[Scheicher, Bernhard; Lorenzer, Cornelia; Gegenbauer, Katrin; Partlic, Julia; Werzer, Oliver; Zimmer, Andreas] Graz Univ, Inst Pharmaceut Sci, Dept Pharmaceut Technol, Graz, Austria; [Andreae, Fritz] PiCHEM, Kahngasse 20, Graz, Austria; [Kirsch, Alexander H.; Rosenkranz, Alexander R.] Med Univ Graz, Dept Internal Med, Clin Div Nephrol, Auenbruggerpl 27, Graz, Austria	University of Graz; Medical University of Graz	Zimmer, A (corresponding author), Graz Univ, Inst Pharmaceut Sci, Dept Pharmaceut Technol, Graz, Austria.	andreas.zimmer@uni-graz.at	; Zimmer, Andreas/C-7290-2012; Werzer, Oliver/A-2752-2014	Kirsch, Alexander/0000-0001-6711-7834; Zimmer, Andreas/0000-0003-3127-287X; Werzer, Oliver/0000-0003-0732-4422	CEO of piCHEM	CEO of piCHEM	Dr. Fritz Andreae is the owner and CEO of piCHEM, who provided financial support in the form of salary for Dr. Andreae. piCHEM was the manufacturer of the peptides in this study. piCHEM did not have any additional role in the study design, data collection and analysis as well as the decision to publish our data.	Albrecht-Schgoer K, 2014, ANGIOGENESIS, V17, P27, DOI 10.1007/s10456-013-9375-4; Albrecht-Schgoer K, 2012, CIRCULATION, V126, P2491, DOI 10.1161/CIRCULATIONAHA.111.076950; Almer G, 2014, INT J NANOMED, V9, P4211, DOI 10.2147/IJN.S66830; Bartczak D, 2013, ACS NANO, V7, P5628, DOI 10.1021/nn402111z; Bartczak D, 2012, SMALL, V8, P122, DOI 10.1002/smll.201101422; Bastiat G, 2013, J CONTROL RELEASE, V170, P334, DOI 10.1016/j.jconrel.2013.06.014; Brannon-Peppas L, 2004, ADV DRUG DELIVER REV, V56, P1649, DOI 10.1016/j.addr.2004.02.014; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Budhian A, 2008, INT J PHARMACEUT, V346, P151, DOI 10.1016/j.ijpharm.2007.06.011; Dinauer N, 2004, J CONTROL RELEASE, V96, P497, DOI 10.1016/j.jconrel.2004.02.020; Egger M, 2007, FASEB J, V21, P2906, DOI 10.1096/fj.06-7440com; El-Shabouri MH, 2002, INT J PHARM, V249, P101, DOI 10.1016/S0378-5173(02)00461-1; Essa S, 2011, INT J PHARMACEUT, V411, P178, DOI 10.1016/j.ijpharm.2011.02.039; FINSY R, 1991, PART PART SYST CHAR, V8, P187, DOI 10.1002/ppsc.19910080135; Fischer-Colbrie R, 2005, CURR PROTEIN PEPT SC, V6, P373, DOI 10.2174/1389203054546334; Foged C, 2005, INT J PHARMACEUT, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; Henk M., 2009, PARTICLE SIZE MEASUR; Hiemenz PC, 1986, PRINCIPLES COLLOID S, DOI 10.1201/9781315274287; Hoffmann J A, 1990, Protein Expr Purif, V1, P127, DOI 10.1016/1046-5928(90)90005-J; HOFLEHNER J, 1995, FEBS LETT, V360, P294, DOI 10.1016/0014-5793(95)00127-U; Junghans M, 2001, BBA-PROTEIN STRUCT M, V1544, P177, DOI 10.1016/S0167-4838(00)00219-3; Junghans M, 2000, Nucleic Acids Res, V28, pE45, DOI 10.1093/nar/28.10.e45; Kerkmann M, 2006, OLIGONUCLEOTIDES, V16, P313, DOI 10.1089/oli.2006.16.313; Kirchmair R, 2004, CIRCULATION, V110, P1121, DOI 10.1161/01.CIR.0000139884.81390.56; Kirchmair R, 2004, CIRCULATION, V109, P777, DOI 10.1161/01.CIR.0000112574.07422.C1; KIRCHMAIR R, 1993, NEUROSCIENCE, V53, P359, DOI 10.1016/0306-4522(93)90200-Y; Lochmann D, 2005, EUR J PHARM BIOPHARM, V59, P419, DOI 10.1016/j.ejpb.2004.04.001; Lochmann D, 2004, J MICROENCAPSUL, V21, P625, DOI 10.1080/02652040400000504; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Mayer G, 2005, J CONTROL RELEASE, V106, P181, DOI 10.1016/j.jconrel.2005.04.019; Mori Y, 2010, INT J NANOMED, V5, P147; Pali-Scholl I, 2013, EUR J PHARM BIOPHARM, V85, P656, DOI 10.1016/j.ejpb.2013.03.003; Sadeghi R, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2565-1; Schatz C, 2004, BIOMACROMOLECULES, V5, P1882, DOI 10.1021/bm049786+; Scheicher B, 2015, EUR J PHARM SCI, V75, P54, DOI 10.1016/j.ejps.2015.04.009; Schgoer W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074029; Schgoer W, 2009, CIRC RES, V105, P994, DOI 10.1161/CIRCRESAHA.109.199513; Takikawa M, 2015, J SURG RES, V196, P247, DOI 10.1016/j.jss.2015.03.022; Tilley AJ, 2013, J COLLOID INTERF SCI, V392, P288, DOI 10.1016/j.jcis.2012.09.051; Vogel V, 2005, J CONTROL RELEASE, V103, P99, DOI 10.1016/j.jconrel.2004.11.029; Wernig K, 2008, J CONTROL RELEASE, V130, P192, DOI 10.1016/j.jconrel.2008.06.005	42	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164149	10.1371/journal.pone.0164149	http://dx.doi.org/10.1371/journal.pone.0164149			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828968	Green Submitted, Green Published, gold			2022-12-27	WOS:000387724300014
J	Dzogang, F; Lansdall-Welfare, T; Cristianini, N				Dzogang, Fabon; Lansdall-Welfare, Thomas; Cristianini, Nello		FindMyPast Newspaper Team	Discovering Periodic Patterns in Historical News	PLOS ONE			English	Article							SEASONALITY; WEB	We address the problem of observing periodic changes in the behaviour of a large population, by analysing the daily contents of newspapers published in the United States and United Kingdom from 1836 to 1922. This is done by analysing the daily time series of the relative frequency of the 25K most frequent words for each country, resulting in the study of 50K time series for 31,755 days. Behaviours that are found to be strongly periodic include seasonal activities, such as hunting and harvesting. A strong connection with natural cycles is found, with a pronounced presence of fruits, vegetables, flowers and game. Periodicities dictated by religious or civil calendars are also detected and show a different wave-form than those provoked by weather. States that can be revealed include the presence of infectious disease, with clear annual peaks for fever, pneumonia and diarrhoea. Overall, 2% of the words are found to be strongly periodic, and the period most frequently found is 365 days. Comparisons between UK and US, and between modern and historical news, reveal how the fundamental cycles of life are shaped by the seasons, but also how this effect has been reduced in modern times.	[Dzogang, Fabon; Lansdall-Welfare, Thomas; Cristianini, Nello] Univ Bristol, Intelligent Syst Lab, Bristol BS8 1UB, Avon, England; [FindMyPast Newspaper Team] FindMyPast Newspaper Arch Ltd, Gateway House,Luna Pl,Technol Pk, Dundee DD2 1TP, Scotland	University of Bristol	Cristianini, N (corresponding author), Univ Bristol, Intelligent Syst Lab, Bristol BS8 1UB, Avon, England.	nello.cristianini@bristol.ac.uk		Lansdall-Welfare, Thomas/0000-0002-4246-7616	European Research Council [339365]	European Research Council(European Research Council (ERC)European Commission)	A European Research Council Advanced Grant 339365 "ThinkBIG" granted to NC supported NC, TLW and FD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2012, ANNU REV POLIT SCI, V15, P401, DOI 10.1146/annurev-polisci-031710-101450; Alexander LV, 2000, ATMOS SCI LETT, V1, P142, DOI 10.1006/asle.2001.0025; Ansolabehere S, 2011, AAPOR ANN C PHOEN AZ, P12; Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Ayers JW, 2014, JAMA INTERN MED, V174, P146, DOI 10.1001/jamainternmed.2013.11933; Ayers JW, 2013, AM J PREV MED, V44, P520, DOI 10.1016/j.amepre.2013.01.012; British Association for Shooting and Conservation, 2016, QUARR SPEC SHOOT SEA; Brynjolfsson E, 2011, MANAGE SCI, V57, P1373, DOI 10.1287/mnsc.1110.1371; Burn-Callander R., 2015, DEATH BRIT GOOSEBERR; COCHRAN WT, 1967, PR INST ELECTR ELECT, V55, P1664, DOI 10.1109/PROC.1967.5957; Cole R., 2012, SCI CHRISTMAS FORGOT; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; Crain C., 2006, NEW YORKER, V11, P2006; De Looper M., 2002, AUSTR I HLTH WELFARE, V3; DOUGLAS AS, 1991, SCOT MED J, V36, P76, DOI 10.1177/003693309103600304; Dzogang F, 2016, DRYAD DIGITAL REPOSI; Dzogang Fabon, 2016, 2016 IEEE INT C DAT; Ewing ET, 2013, COMPUTER, V46, P68, DOI 10.1109/MC.2013.205; Feinstein CA, 2002, DEMRES, V6, P469, DOI DOI 10.4054/DemRes.2002.6.17; Flaounas I, P 2011 ACM SIGMOD IN, P1275; FORSYTHE WC, 1995, ECOL MODEL, V80, P87, DOI 10.1016/0304-3800(94)00034-F; Gallup A. M., 2010, GALLUP POLL PUBLIC O; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Helferty M, 2010, CAN MED ASSOC J, V182, P1981, DOI 10.1503/cmaj.100746; Lampos Vasileios, 2010, 2010 2 INT WORKSH CO; Lansdall-Welfare Thomas, 2012, P 21 INT C WORLD WID; Lansdall-Welfare Tom, 2016, 2016 IEEE INT C DAT; Menne MJ, 2012, GLOBAL HIST CLIMATOL; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Nelson R.J., 2002, SEASONAL PATTERNS ST; ODELL RH, 1975, ANN BIOMED ENG, V3, P160, DOI 10.1007/BF02363068; PARKER DE, 1992, INT J CLIMATOL, V12, P317, DOI 10.1002/joc.3370120402; Paul M. J, 2011, ARTIF INTELL; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Royal Horticultural Society, 2016, GROW YOUR OWN GARD A; Royal Horticultural Society, 2016, HELP ADV TIPS RHS AL; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Secord JA, 2002, SCIENCE, V297, P1648, DOI 10.1126/science.297.5587.1648; Spinney L, 2012, NATURE, V488, P24, DOI 10.1038/488024a; SUBAK S, 1999, INDICATORS CLIMATE C, P40; Tse CK, 2010, J EMPIR FINANC, V17, P659, DOI 10.1016/j.jempfin.2010.04.008; Weninger T, 2008, INT WORKSHOP DATABAS, P23, DOI 10.1109/DEXA.2008.12	43	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165736	10.1371/journal.pone.0165736	http://dx.doi.org/10.1371/journal.pone.0165736			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824911	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200031
J	Maharaj, KA; Que, NLS; Hong, F; Huck, JD; Gill, SK; Wu, S; Li, ZH; Gewirth, DT				Maharaj, Kevin A.; Que, Nanette L. S.; Hong, Feng; Huck, John D.; Gill, Sabrina K.; Wu, Shuang; Li, Zihai; Gewirth, Daniel T.			Exploring the Functional Complementation between Grp94 and Hsp90	PLOS ONE			English	Article							ESCHERICHIA-COLI HSP90; TOLL-LIKE RECEPTORS; HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; ENDOPLASMIC-RETICULUM; CONFORMATIONAL-CHANGES; STRUCTURAL-ANALYSIS; STEROID-RECEPTOR; IN-VIVO; IMMUNOGLOBULIN-CHAINS	Grp94 and Hsp90 are the ER and cytoplasmic paralog members, respectively, of the hsp90 family of molecular chaperones. The structural and biochemical differences between Hsp90 and Grp94 that allow each paralog to efficiently chaperone its particular set of clients are poorly understood. The two paralogs exhibit a high degree of sequence similarity, yet also display significant differences in their quaternary conformations and ATPase activity. In order to identify the structural elements that distinguish Grp94 from Hsp90, we characterized the similarities and differences between the two proteins by testing the ability of Hsp90/Grp94 chimeras to functionally substitute for the wild-type chaperones in vivo. We show that the N-terminal domain or the combination of the second lobe of the Middle domain plus the C-terminal domain of Grp94 can functionally substitute for their yeast Hsp90 counterparts but that the equivalent Hsp90 domains cannot functionally replace their counterparts in Grp94. These results also identify the interface between the Middle and C-terminal domains as an important structural unit within the Hsp90 family.	[Maharaj, Kevin A.; Que, Nanette L. S.; Huck, John D.; Gill, Sabrina K.; Gewirth, Daniel T.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Maharaj, Kevin A.; Huck, John D.; Gewirth, Daniel T.] Univ Buffalo, Dept Biol Struct, Buffalo, NY 14228 USA; [Hong, Feng; Wu, Shuang; Li, Zihai] Med Univ South Carolina, Dept Microbiol & Immunol, Hollings Canc Ctr, Charleston, SC USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Medical University of South Carolina	Gewirth, DT (corresponding author), Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA.; Gewirth, DT (corresponding author), Univ Buffalo, Dept Biol Struct, Buffalo, NY 14228 USA.	gewirth@hwi.buffalo.edu			National Cancer Institute [R01-CA095130, P01-CA186866]; National Institute of General Medical Sciences [F31-GM086120]; Richard and Mae Stone Goode Foundation of Buffalo; NATIONAL CANCER INSTITUTE [R01CA095130, P01CA186866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM086120] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Richard and Mae Stone Goode Foundation of Buffalo; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by the National Cancer Institute, R01-CA095130 [www.cancer.gov] to DTG; National Cancer Institute, P01-CA186866 [www.cancer.gov] to DTG; National Institute of General Medical Sciences, F31-GM086120 [www.nigms.nih.gov] to KAM; and Richard and Mae Stone Goode Foundation of Buffalo to DTG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BOHEN SP, 1993, P NATL ACAD SCI USA, V90, P11424, DOI 10.1073/pnas.90.23.11424; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Dollins DE, 2005, J BIOL CHEM, V280, P30438, DOI 10.1074/jbc.M503761200; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Fang L, 2006, P NATL ACAD SCI USA, V103, P18487, DOI 10.1073/pnas.0609163103; FERGUSON J, 1986, NUCLEIC ACIDS RES, V14, P6681, DOI 10.1093/nar/14.16.6681; Hagn F, 2011, NAT STRUCT MOL BIOL, V18, P1086, DOI 10.1038/nsmb.2114; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Hartson SD, 2012, BBA-MOL CELL RES, V1823, P656, DOI 10.1016/j.bbamcr.2011.08.013; Immormino RM, 2004, J BIOL CHEM, V279, P46162, DOI 10.1074/jbc.M405253200; Immormino RM, 2009, J MOL BIOL, V388, P1033, DOI 10.1016/j.jmb.2009.03.071; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Krukenberg KA, 2009, J MOL BIOL, V390, P278, DOI 10.1016/j.jmb.2009.04.080; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li J, 2011, NAT STRUCT MOL BIOL, V18, P61, DOI 10.1038/nsmb.1965; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu B, 2013, P NATL ACAD SCI USA, V110, P6877, DOI 10.1073/pnas.1302933110; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; MELNICK J, 1992, J BIOL CHEM, V267, P21303; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; MINAMI Y, 1994, MOL CELL BIOL, V14, P1459, DOI 10.1128/MCB.14.2.1459; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Morra G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002433; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; NEMOTO T, 1995, EUR J BIOCHEM, V233, P1, DOI 10.1111/j.1432-1033.1995.001_1.x; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Onuoha SC, 2008, J MOL BIOL, V379, P732, DOI 10.1016/j.jmb.2008.02.013; Ostrovsky O, 2009, MOL BIOL CELL, V20, P1855, DOI 10.1091/mbc.E08-04-0346; PALMER G, 1995, MOL BIOCHEM PARASIT, V70, P199, DOI 10.1016/0166-6851(95)00007-N; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Piper PW, 2003, GENE, V302, P165, DOI 10.1016/S0378-1119(02)01102-2; Pursell NW, 2012, EUKARYOT CELL, V11, P1033, DOI 10.1128/EC.00099-12; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; REED SI, 1980, GENETICS, V95, P561; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Rosenbaum M, 2014, GENE DEV, V28, P1165, DOI 10.1101/gad.240762.114; Samant RS, 2012, CELL CYCLE, V11, P1301, DOI 10.4161/cc.19722; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Verba KA, 2016, BIORXIV, DOI [10.1101/040907, DOI 10.1101/040907]; Wayne N, 2007, J BIOL CHEM, V282, P35386, DOI 10.1074/jbc.M703844200; Wayne N, 2010, J MOL BIOL, V401, P931, DOI 10.1016/j.jmb.2010.06.066; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wider D, 2009, MOL BIOCHEM PARASIT, V164, P147, DOI 10.1016/j.molbiopara.2008.12.011; Wu S, 2012, J BIOL CHEM, V287, P6735, DOI 10.1074/jbc.M111.309526; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yue L, 1999, GENETICS, V151, P1065; Zhang YL, 2015, J CLIN INVEST, V125, P859, DOI 10.1172/JCI79014	65	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166271	10.1371/journal.pone.0166271	http://dx.doi.org/10.1371/journal.pone.0166271			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824935	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200081
J	Hawthorne, S; Boissiere, M; Felker, ME; Atmadja, S				Hawthorne, Sandra; Boissiere, Manuel; Felker, Mary Elizabeth; Atmadja, Stibniati			Assessing the Claims of Participatory Measurement, Reporting and Verification (PMRV) in Achieving REDD plus Outcomes: A Systematic Review	PLOS ONE			English	Article							LOCAL PEOPLE; TRADE-OFFS; COMMUNITY; FOREST; BENEFITS; MRV	Participation of local communities in the Measurement, Reporting and Verification (MRV) of forest changes has been promoted as a strategy that lowers the cost of MRV and increases their engagement with REDD+. This systematic review of literature assessed the claims of participatory MRV (PMRV) in achieving REDD+ outcomes. We identified 29 PMRV publications that consisted of 20 peer-reviewed and 9 non peer-reviewed publications, with 14 publications being empirically based studies. The evidence supporting PMRV claims was categorized into empirical finding, citation or assumption. Our analysis of the empirical studies showed that PMRV projects were conducted in 17 countries in three tropical continents and across various forest and land tenure types. Most of these projects tested the feasibility of participatory measurement or monitoring, which limited the participation of local communities to data gathering. PMRV claims of providing accurate local biomass measurements and lowering MRV cost were well-supported with empirical evidence. Claims that PMRV supports REDD+ social outcomes that affect local communities directly, such as increased environmental awareness and equity in benefit sharing, were supported with less empirical evidence than REDD+ technical outcomes. This may be due to the difficulties in measuring social outcomes and the slow progress in the development and implementation of REDD+ components outside of experimental research contexts. Although lessons from other monitoring contexts have been used to support PMRV claims, they are only applicable when the enabling conditions can be replicated in REDD+ contexts. There is a need for more empirical evidence to support PMRV claims on achieving REDD+ social outcomes, which may be addressed with more opportunities and rigorous methods for assessing REDD+ social outcomes. Integrating future PMRV studies into local REDD+ implementations may help create those opportunities, while increasing the participation of local communities as local REDD+ stakeholders. Further development and testing of participatory reporting framework are required to integrate PMRV data with the national database. Publication of empirical PMRV studies is encouraged to guide when, where and how PMRV should be implemented.	[Hawthorne, Sandra; Boissiere, Manuel; Felker, Mary Elizabeth; Atmadja, Stibniati] Ctr Int Forestry Res, Bogor, Indonesia; [Boissiere, Manuel] Ctr Cooperat Int Rech Agron Dev, Montpellier, France	CGIAR; Center for International Forestry Research (CIFOR); CIRAD	Hawthorne, S (corresponding author), Ctr Int Forestry Res, Bogor, Indonesia.	sndhawthorne@gmail.com	Atmadja, Stibniati S./AGY-3388-2022	Dharmadi, Sandra/0000-0003-2271-8606; BOISSIERE, Manuel/0000-0002-2552-7664	United States Agency for International Development (USAID) [MT0069018]; Norwegian Agency for Development (NORAD) [GLO-3945, QZA 12/0882]; International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building; Nuclear Safety (BMUB); CGIAR; CIRAD	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Norwegian Agency for Development (NORAD); International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building; Nuclear Safety (BMUB); CGIAR(CGIAR); CIRAD	This study was part of the 'Participatory MRV: addressing the scale' project, the Consultative Group for International Agricultural Research (CGIAR) Research Program on Forests, Trees and Agroforestry and the Global Comparative Study on REDD+. Funding support came from the United States Agency for International Development (USAID), grant number MT0069018, http://www.usaid.gov, the Norwegian Agency for Development (NORAD), grant number GLO-3945, QZA 12/0882, http://www.norad.no, the International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB), and the CGIAR. The research was carried out by the Center for International Forestry Research (CIFOR) and the Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD), in collaboration with the University of Gadjah Mada (UGM). CIRAD provided support in the form of salaries for author MB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelsen A., 2012, ANAL REDD CHALLENGES, P31; Torres AB, 2014, FORESTS, V5, P3295, DOI 10.3390/f5123295; Torres AB, 2014, FORESTS, V5, P1815, DOI 10.3390/f5081815; Bellfield H, 2015, FORESTS, V6, P133, DOI 10.3390/f6010133; Boissiere M, 2014, FORESTS, V5, P1855, DOI 10.3390/f5081855; Brammer JR, 2016, CONSERV BIOL, V30, P1277, DOI 10.1111/cobi.12727; Brewster J, 2011, COMMUNITY BASED MONI; Brofeldt S, 2014, FORESTS, V5, P1834, DOI 10.3390/f5081834; Burgess ND, 2010, ORYX, V44, P339, DOI 10.1017/S0030605310000554; Casarim FM, 2013, PARTICIPATORY CARBON; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Conn VS, 2003, NURS RES, V52, P256, DOI 10.1097/00006199-200307000-00008; Constantino PAL, 2014, INT SEM PART MON BIO; COP16, 2011, 16 SESS DEC AD C PAR; Danielsen F, 2009, CONSERV BIOL, V23, P31, DOI 10.1111/j.1523-1739.2008.01063.x; Danielsen F, 2013, ECOL SOC, V18, DOI 10.5751/ES-05464-180341; Danielsen F, 2011, CONSERV LETT, V4, P158, DOI 10.1111/j.1755-263X.2010.00159.x; Dharmadi Hawthorne S., 2014, LIT REV PARTICIPATOR; Entenmann SK, 2014, ENVIRON MANAGE, V53, P300, DOI 10.1007/s00267-013-0191-9; Fordham S, COMMUNITY POWERED MO, V4; Fry B, 2011, ENVIRON SCI POLICY, V14, P181, DOI 10.1016/j.envsci.2010.12.004; GOFC-GOLD, 2012, SOURC METH PROC MON; Graham K., 2009, CARBON CLIMATE LAW R, V3, P303; Intergovernmental Panel on Climate Change, 2003, GOOD PRACTICE GUIDAN; Khoa PV, INTEGRATING COMMUNIT, V5; Knowles T, 2010, PATHWAYS IMPLEMENTIN, P156; Larrazabal A, 2012, CURR OPIN ENV SUST, V4, P707, DOI 10.1016/j.cosust.2012.10.008; Lotsch A, 2011, FCPF WORKSH 12 14 SE; Lund JF, 2014, BIODIVERS CONSERV, V23, P237, DOI 10.1007/s10531-013-0596-z; Mant R, PARTICIPATORY BIODIV, V8; Mapedza E, 2003, APPL GEOGR, V23, P1, DOI 10.1016/S0143-6228(02)00070-X; Mukama K., 2012, International Journal of Forestry Research, V2012, P126454; Murdiyarso D., 2006, COMMUNITY FOREST MAN; Nielsen Martin Reinhardt, 2012, Conservation & Society, V10, P1, DOI 10.4103/0972-4923.92188; Paneque-Galvez J, 2014, FORESTS, V5, P1481, DOI 10.3390/f5061481; Pratihast AK, 2014, FORESTS, V5, P2464, DOI 10.3390/f5102464; Pratihast AK, 2013, CARBON MANAG, V4, P91, DOI [10.4155/cmt.12.75, 10.4155/CMT.12.75]; Pratihast AK, 2013, SENSORS-BASEL, V13, P21, DOI 10.3390/s130100021; Scheyvens H., COMMUNITY BASED FORE, V10; Shrestha S, 2014, FORESTS, V5, P2425, DOI 10.3390/f5102425; Sills E., 2009, EVOLVING LANDSCAPE R; Skutsch M., 2009, REALISING REDD NATL, P101; Skutsch M, 2014, FORESTS, V5, P1596, DOI 10.3390/f5071596; Skutsch MM, 2010, FOREST POLICY ECON, V12, P264, DOI 10.1016/j.forpol.2009.12.003; Swan S., PARTICIPATORY FOREST; Torres AB, 2015, FORESTS, V6, P244, DOI 10.3390/f6010244; UNFCCC, 2009, C PART 15 SESS HEL 2; Visseren-Hamakers IJ, 2012, CURR OPIN ENV SUST, V4, P646, DOI 10.1016/j.cosust.2012.10.005	48	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0157826	10.1371/journal.pone.0157826	http://dx.doi.org/10.1371/journal.pone.0157826			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812110	gold, Green Published, Green Submitted			2022-12-27	WOS:000386910000002
J	Imada, Y; Kato, M				Imada, Yume; Kato, Makoto			Bryophyte-Feeders in a Basal Brachyceran Lineage (Diptera: Rhagionidae: Spaniinae): Adult Oviposition Behavior and Changes in the Larval Mouthpart Morphology Accompanied with the Diet Shifts	PLOS ONE			English	Article								Dipteran larval morphology exhibits overwhelming variety, affected by their diverse feeding habits and habitat use. In particular, larval mouthpart morphology is associated with feeding behavior, providing key taxonomic traits. Despite most larval Brachycera being carnivorous, a basal brachyceran family, Rhagionidae, contains bryophyte-feeding taxa with multiple feeding habits. To elucidate the life history, biology, and morphological evolution of the bryophyte-feeding rhagionids, the larval feeding behavior and morphology, and the adult oviposition behavior of four species belonging to three genera of Spaniinae (Spania Meigen, Litoleptis Chillcott and Ptiolina Zetterstedt) are described. Moreover, changes of the larval morphology associated with the evolution of bryophyte-feeding are traced by molecular phylogenetic analyses. Spania and Litoleptis (thallus-miners of thallose liverworts) share a toothed form of apical mandibular sclerite with an orifice on its dorsal surface, which contrasts to those of the other members of Rhagionidae possessing a blade-like mandibular hook with an adoral groove; whereas, Ptiolina (stem borer of mosses) exhibits a weak groove on the adoral surface of mandible and highly sclerotized maxilla with toothed projections. Based on the larval feeding behavior of the thallus-miners, it is inferred that the toothed mandibles with the dorsal orifice facilitate scraping plant tissue and then imbibing it with a great deal of the sap. A phylogeny indicated that the bryophyte-feeding genera formed a clade with Spaniopsis and was sister to Symphoromyia, which presumably are detritivores. This study indicates that the loss or reduction of adoral mandibular groove and mandibular brush is coincident with the evolution of bryophyte-feeding, and it is subsequently followed by the occurrence of dorsal mandibular orifice and the loss of creeping welts accompanying the evolution of thallus-mining.	[Imada, Yume; Kato, Makoto] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshidanihonmatsu Cho, Kyoto 6068501, Japan	Kyoto University	Imada, Y (corresponding author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshidanihonmatsu Cho, Kyoto 6068501, Japan.	imayume.ac@gmail.com	Imada, Yume/AAT-6011-2020	Imada, Yume/0000-0003-2173-7389	Ministry of Education, Science, Sports and Culture [15H02420]; Japan Society for the Promotion of Science [26-160]; Grants-in-Aid for Scientific Research [14J00160] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partly supported by Ministry of Education, Science, Sports and Culture (http://www.mext.go.jp/english/), Grant-in-Aid for Scientific Research (B) 2015-2020 (15H02420) to MK and also by Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html), Grant-in-Aid for JSPS Fellows (No. 26-160) to YI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Brauer OF, 1883, DENKSCHRIFTEN KAI MN, V47, P1; BRINDLE ALLAN, 1959, ENT REC, V71, P126; Chandler PJ, 2010, A DIPTERISTS HDB, P442; COOK E. F., 1949, MICROENTOMOLOGY, V14, P1; Courtney Gregory W., 2000, P85; De Meijere JHC, 1916, ZOOL ANZ, V46, P241; Drummond A.J., MOL EVOLUTION PHYLOG; Friedrich M, 1997, SYST BIOL, V46, P674, DOI 10.2307/2413500; Gibson JF, 2011, ANN ENTOMOL SOC AM, V104, P976, DOI 10.1603/AN10153; Grimaldi D, 2005, EVOLUTION INSECTS, P514; Hennig W, 1973, HDB ZOOLOGIE, VIV, P564; Hernandez MC, 2008, ANN ENTOMOL SOC AM, V101, P1041, DOI 10.1603/0013-8746-101.6.1041; HINTON H. E., 1955, TRANS ROY ENT SOC LONDON, V106, P455; Hobby BM, 1961, ENTOMOL MON MAG, V97, P190; Imada Y, 2016, ZOOTAXA, V4097, P41, DOI 10.11646/zootaxa.4097.1.2; Ingrouille M, 2006, PLANTS DIVERSITY EVO, P197; Kerr PH, 2010, ZOOTAXA, P1; Kovalev VG, 1981, PALEONTOL ZH, V15, P84; Krivosheina MG, 2007, ENTOMOL REV, V87, P1090; LANE RS, 1982, J MED ENTOMOL, V19, P104, DOI 10.1093/jmedent/19.1.104; Mik J, 1896, WEINER ENTOMOLOGISCH, V15, P241; Mostovski MB, 2000, P GEOLOGIST ASSOC, V111, P153, DOI 10.1016/S0016-7878(00)80005-X; Nagatomi A., 1958, Mushi Fukuoka, V32, P33; NAGATOMI A, 1982, J NAT HIST, V16, P31, DOI 10.1080/00222938200770041; Nagatomi Akira, 1998, Entomologist's Monthly Magazine, V134, P95; Nartshuk Emilia P., 1995, Acta Zoologica Fennica, V199, P17; ROBERTS MJ, 1969, J ZOOL, V159, P381; Rotheray GE, 2008, ZOOL J LINN SOC-LOND, V153, P287, DOI 10.1111/j.1096-3642.2008.00395.x; SCHREMMER FRITZ, 1951, OESTERREICH ZOOL ZEITSCHR, V3, P326; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SINCLAIR BJ, 1992, SYST ENTOMOL, V17, P233, DOI 10.1111/j.1365-3113.1992.tb00335.x; SOMMERMAN KATHRYN M., 1962, MOSQUITO NEWS, V22, P116; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stuckenberg Brian R., 2001, Studia Dipterologica, V8, P3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Teskey H.J., 1981, Canada Department of Agriculture Research Branch Monograph, P65; TESKEY HJ, 1970, CAN ENTOMOL, V102, P1130, DOI 10.4039/Ent1021130-9; TSACAS LEONIDAS, 1962, MEM MUS NAT HIST NATUR NOUV SER SER A ZOOL, V27, P147; Wiegmann BM, 2000, ANN ENTOMOL SOC AM, V93, P1031, DOI 10.1603/0013-8746(2000)093[1031:MAROTT]2.0.CO;2; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Woodley N.E., 1989, Agriculture Canada Monograph, P1371; Zhang JF, 2010, GEOBIOS-LYON, V43, P663, DOI 10.1016/j.geobios.2010.06.004	44	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165808	10.1371/journal.pone.0165808	http://dx.doi.org/10.1371/journal.pone.0165808			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812169	gold, Green Published, Green Submitted			2022-12-27	WOS:000386910000063
J	Nakamura, T; Matsumoto, J; Nishimaru, H; Bretas, RV; Takamura, Y; Hori, E; Ono, T; Nishijo, H				Nakamura, Tomoya; Matsumoto, Jumpei; Nishimaru, Hiroshi; Bretas, Rafael Vieira; Takamura, Yusaku; Hori, Etsuro; Ono, Taketoshi; Nishijo, Hisao			A Markerless 3D Computerized Motion Capture System Incorporating a Skeleton Model for Monkeys	PLOS ONE			English	Article							FACIAL EMOTION RECOGNITION; NONHUMAN-PRIMATES; RHESUS-MONKEYS; METHAMPHETAMINE; BEHAVIOR; ANXIETY; PSYCHOPATHOLOGY; SCHIZOPHRENIA; DEFICITS; AMYGDALA	In this study, we propose a novel markerless motion capture system (MCS) for monkeys, in which 3D surface images of monkeys were reconstructed by integrating data from four depth cameras, and a skeleton model of the monkey was fitted onto 3D images of monkeys in each frame of the video. To validate the MCS, first, estimated 3D positions of body parts were compared between the 3D MCS-assisted estimation and manual estimation based on visual inspection when a monkey performed a shuttling behavior in which it had to avoid obstacles in various positions. The mean estimation error of the positions of body parts (3-14 cm) and of head rotation (35-43 degrees) between the 3D MCS-assisted and manual estimation were comparable to the errors between two different experimenters performing manual estimation. Furthermore, the MCS could identify specific monkey actions, and there was no false positive nor false negative detection of actions compared with those in manual estimation. Second, to check the reproducibility of MCS-assisted estimation, the same analyses of the above experiments were repeated by a different user. The estimation errors of positions of most body parts between the two experimenters were significantly smaller in the MCS-assisted estimation than in the manual estimation. Third, effects of methamphetamine (MAP) administration on the spontaneous behaviors of four monkeys were analyzed using the MCS. MAP significantly increased head movements, tended to decrease locomotion speed, and had no significant effect on total path length. The results were comparable to previous human clinical data. Furthermore, estimated data following MAP injection (total path length, walking speed, and speed of head rotation) correlated significantly between the two experimenters in the MCS-assisted estimation (r = 0.863 to 0.999). The results suggest that the presented MCS in monkeys is useful in investigating neural mechanisms underlying various psychiatric disorders and developing pharmacological interventions.	[Nakamura, Tomoya; Matsumoto, Jumpei; Nishimaru, Hiroshi; Bretas, Rafael Vieira; Takamura, Yusaku; Hori, Etsuro; Ono, Taketoshi; Nishijo, Hisao] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Syst Emot Sci, Toyama 9300194, Japan; [Nakamura, Tomoya] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Anat, Toyama 9300194, Japan; [Hori, Etsuro] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Behav Sci, Toyama 9300194, Japan	University of Toyama; University of Toyama; University of Toyama	Nishijo, H (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Syst Emot Sci, Toyama 9300194, Japan.	nishijo@med.u-toyama.ac.jp		Matsumoto, Jumpei/0000-0003-4729-2816	Hokuriku Bank, Toyama, Japan; Japan Society for Promotion of Science (JSPS), Japan [16H04652]	Hokuriku Bank, Toyama, Japan; Japan Society for Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported partly by Young researcher funds (J.M.) from Hokuriku Bank (http://www.hokugin.co.jp/index.html), Toyama, Japan and Grant-in-Aid for Scientific Research (B) (16H04652) (H.Nishijo) from Japan Society for Promotion of Science (JSPS) (https://www.jsps.go.jp/english/index.html), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caligiuri MP, 2005, NEUROPSYCHOPHARMACOL, V30, P2125, DOI 10.1038/sj.npp.1300859; Capitanio JP, 2008, LANCET, V371, P1126, DOI 10.1016/S0140-6736(08)60489-4; CHAMOVE A S, 1984, Primates, V25, P319, DOI 10.1007/BF02382270; Chan SS, 2006, J NEURAL ENG, V3, P327, DOI 10.1088/1741-2560/3/4/010; Coleman K, 2014, ILAR J, V55, P333, DOI 10.1093/ilar/ilu019; Curtis B, 2015, ENVIRON HEALTH PERSP, V123, P579, DOI 10.1289/ehp.1408257; de Gelder B, 2009, NEUROREPORT, V20, P642, DOI 10.1097/WNR.0b013e32832a1e56; DesJardin JT, 2013, J NEUROSCI, V33, P150, DOI 10.1523/JNEUROSCI.2924-12.2013; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Dziobek D, 2015, BRAIN DISORD THER, V4, pe118; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feczko EJ, 2016, PLOS ONE, V11; Fitzsimmons NA, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.003.2009; Foster JD, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046020; Gilja V, 2010, CURR OPIN NEUROBIOL, V20, P676, DOI 10.1016/j.conb.2010.06.007; Grant KM, 2012, J NEUROIMMUNE PHARM, V7, P113, DOI 10.1007/s11481-011-9288-1; Hall DA, 2008, PSYCHOPHARMACOLOGY, V195, P469, DOI 10.1007/s00213-007-0923-8; Hart CL, 2008, NEUROPSYCHOPHARMACOL, V33, P1847, DOI 10.1038/sj.npp.1301578; Hung CC, 2012, NEURON, V74, P1099, DOI 10.1016/j.neuron.2012.04.029; Izquierdo A, P NATL ACAD SCI, V104, P14128; Ji XF, 2010, IEEE T SYST MAN CY C, V40, P13, DOI 10.1109/TSMCC.2009.2027608; JOHANSON CE, 1979, PHARMACOL BIOCHEM BE, V11, P273, DOI 10.1016/0091-3057(79)90134-5; Kalin NH, 2003, ANN NY ACAD SCI, V1008, P189, DOI 10.1196/annals.1301.021; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Kalin NH, 2001, J NEUROSCI, V21, P2067, DOI 10.1523/JNEUROSCI.21-06-02067.2001; Lee SJ, 2010, PSYCHIAT INVEST, V7, P291, DOI 10.4306/pi.2010.7.4.291; Liu YB, 2013, IEEE T PATTERN ANAL, V35, P2720, DOI 10.1109/TPAMI.2013.47; Lu HJ, 2010, J VISION, V10, DOI 10.1167/10.12.13; MACHIYAMA Y, 1992, SCHIZOPHRENIA BULL, V18, P107, DOI 10.1093/schbul/18.1.107; Martin LA, 2008, BRAIN BEHAV IMMUN, V22, P806, DOI 10.1016/j.bbi.2007.12.007; Matsumoto J, 2014, BEHAV BRAIN RES, V272, P16, DOI 10.1016/j.bbr.2014.06.047; Matsumoto J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078460; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Nelson EE, 2009, NEUROPSYCHOPHARMACOL, V34, P90, DOI 10.1038/npp.2008.150; Oram MW, 1996, J NEUROPHYSIOL, V76, P109, DOI 10.1152/jn.1996.76.1.109; Peikon ID, 2009, J NEUROSCI METH, V180, P224, DOI 10.1016/j.jneumeth.2009.03.010; REISBICK S, 1994, PHYSIOL BEHAV, V55, P231, DOI 10.1016/0031-9384(94)90128-7; Ruby S, 2015, AM J PRIMATOL, V77, P1097, DOI 10.1002/ajp.22444; Sellers WI, 2014, BIOL OPEN; Singh RAK, 2012, PHARMACOL BIOCHEM BE, V103, P230, DOI 10.1016/j.pbb.2012.08.013; Smith MJL, 2010, NEUROPSYCHOLOGIA, V48, P2777, DOI 10.1016/j.neuropsychologia.2010.03.008; Takushiro A., 1998, KITAKANTO MED J, V48, P127; Troisi A, 2002, STRESS, V5, P46, DOI 10.1080/10253890290012378; Van Mao C, 2008, REV NEUROSCIENCE, V19, P83; Vargas-Irwin CE, 2010, J NEUROSCI, V30, P9659, DOI 10.1523/JNEUROSCI.5443-09.2010; Watson KK, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-21; Wright MJ, 2012, BRIT J PHARMACOL, V167, P1342, DOI 10.1111/j.1476-5381.2012.02091.x	48	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166154	10.1371/journal.pone.0166154	http://dx.doi.org/10.1371/journal.pone.0166154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812205	gold, Green Published, Green Submitted			2022-12-27	WOS:000386910000105
J	Schlesinger, S; Sonntag, SR; Lieb, W; Maas, R				Schlesinger, Sabrina; Sonntag, Svenja R.; Lieb, Wolfgang; Maas, Renke			Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; FRAMINGHAM OFFSPRING COHORT; ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; DOSE-RESPONSE METAANALYSIS; OXIDE SYNTHASE INHIBITION; CRITICALLY-ILL PATIENTS; ALL-CAUSE MORTALITY; PLASMA ADMA LEVELS; L-ARGININE	Background A growing number of studies linked elevated concentrations of circulating asymmetric (ADMA) and symmetric (SDMA) dimethylarginine to mortality and cardiovascular disease (CVD) events. To summarize the evidence, we conducted a systematic review and quantified associations of ADMA and SDMA with the risks of all-cause mortality and incident CVD in meta-analyses accounting for different populations and methodological approaches of the studies. Methods Relevant studies were identified in PubMed until February 2015. We used random effect models to obtain summary relative risks (RR) and 95% confidence intervals (95% CIs), comparing top versus bottom tertiles. Dose-response relations were assessed by restricted cubic spline regression models and potential non-linearity was evaluated using a likelihood ratio test. Heterogeneity between subgroups was assessed by meta-regression analysis. Results For ADMA, 34 studies (total n = 32,428) investigating associations with all-cause mortality (events = 5,035) and 30 studies (total n = 30,624) investigating the association with incident CVD (events = 3,396) were included. The summary RRs (95% CI) for all-cause mortality were 1.52 (1.37-1.68) and for CVD 1.33 (1.22-1.45), comparing high versus low ADMA concentrations. Slight differences were observed across study populations and methodological approaches, with the strongest association of ADMA being reported with all-cause mortality in critically ill patients. For SDMA, 17 studies (total n = 18,163) were included for all-cause mortality (events = 2,903), and 13 studies (total n = 16,807) for CVD (events = 1,534). High vs. low levels of SDMA, were associated with increased risk of all-cause mortality [summary RR (95% CI): 1.31 (1.18-1.46)] and CVD [summary RR (95% CI): 1.36 (1.10-1.68) Strongest associations were observed in general population samples. Conclusions The dimethylarginines ADMA and SDMA are independent risk markers for all-cause mortality and CVD across different populations and methodological approaches.	[Schlesinger, Sabrina; Sonntag, Svenja R.; Lieb, Wolfgang] Christian Albrechts Univ Kiel, Inst Epidemiol, Kiel, Germany; [Maas, Renke] Friedrich Alexander Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Erlangen, Germany	University of Kiel; University of Erlangen Nuremberg	Schlesinger, S (corresponding author), Christian Albrechts Univ Kiel, Inst Epidemiol, Kiel, Germany.; Maas, R (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Erlangen, Germany.	sabrina.schlesinger@epi.uni-kiel.de; Renke.Maas@pharmakologie.uni-erlangen.de	Schlesinger, Sabrina/GQZ-6436-2022; Lieb, Wolfgang/AAC-7650-2022; Schlesinger, Sabrina/AAE-7640-2020; Schlesinger, Sabrina/AFT-9193-2022	Schlesinger, Sabrina/0000-0003-4244-0832; Schlesinger, Sabrina/0000-0003-4244-0832; 	German Research Foundation (DFG Excellence Cluster Inflammation at Interfaces) [EXC306/2]	German Research Foundation (DFG Excellence Cluster Inflammation at Interfaces)(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (DFG Excellence Cluster Inflammation at Interfaces EXC306/2).	Abedini S, 2010, KIDNEY INT, V77, P44, DOI 10.1038/ki.2009.382; Anderssohn M, 2012, J CARD FAIL, V18, P904, DOI 10.1016/j.cardfail.2012.10.011; Ari H, 2010, TURK KARDIYOL DERN A, V38, P327; Ari H, 2010, HEART VESSELS, V25, P19, DOI 10.1007/s00380-009-1158-x; Atzler D, 2014, CLIN CHEM LAB MED, V52, P1835, DOI 10.1515/cclm-2014-0314; Aucella F, 2009, ATHEROSCLEROSIS, V207, P541, DOI 10.1016/j.atherosclerosis.2009.05.011; Aune D, 2012, ANN ONCOL, V23, P843, DOI 10.1093/annonc/mdr398; Aune D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6617; Ben QW, 2014, GASTROENTEROLOGY, V146, P689, DOI 10.1053/j.gastro.2013.11.003; Bode-Boger SM, 2006, J AM SOC NEPHROL, V17, P1128, DOI 10.1681/ASN.2005101119; Boger RH, 2011, J INTERN MED, V269, P349, DOI 10.1111/j.1365-2796.2010.02322.x; Boger RH, 2007, J NUTR, V137, p1650S, DOI 10.1093/jn/137.6.1650S; Boger RH, 2009, PHARMACOL RES, V60, P481, DOI 10.1016/j.phrs.2009.07.001; Boger RH, 2009, CIRCULATION, V119, P1592, DOI 10.1161/CIRCULATIONAHA.108.838268; Borgeraas H, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/201742; Busch M, 2006, AMINO ACIDS, V30, P225, DOI 10.1007/s00726-005-0268-8; Caplin B, 2012, ARTERIOSCL THROM VAS, V32, P2892, DOI 10.1161/ATVBAHA.112.254078; Carello KA, 2006, AM J PHYSIOL-HEART C, V290, pH209, DOI 10.1152/ajpheart.00208.2005; Cavalca V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048499; Cavusoglu E, 2010, ATHEROSCLEROSIS, V210, P226, DOI 10.1016/j.atherosclerosis.2009.10.034; Cavusoglu E, 2009, CORONARY ARTERY DIS, V20, P112, DOI 10.1097/MCA.0b013e328323982f; Chene G, 1996, AM J EPIDEMIOL, V144, P610; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Davis JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017260; Drew DA, 2014, CLIN J AM SOC NEPHRO, V9, P1426, DOI 10.2215/CJN.00770114; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Gore MO, 2013, ARTERIOSCL THROM VAS, V33, P2682, DOI 10.1161/ATVBAHA.113.301219; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hsu CP, 2012, ATHEROSCLEROSIS, V225, P504, DOI 10.1016/j.atherosclerosis.2012.09.040; Ignjatovic AM, 2013, INT UROL NEPHROL, V45, P1715, DOI 10.1007/s11255-013-0439-6; Jacobi J, 2010, AM J PATHOL, V176, P2559, DOI 10.2353/ajpath.2010.090614; Jiang JL, 2007, BIOCHEM CELL BIOL, V85, P66, DOI 10.1139/O06-146; Kiechl S, 2009, ATHEROSCLEROSIS, V205, P261, DOI 10.1016/j.atherosclerosis.2008.10.040; Kielstein JT, 2006, NEPHROL DIAL TRANSPL, V21, P2446, DOI 10.1093/ndt/gfl292; Kielstein JT, 2004, CIRCULATION, V109, P172, DOI 10.1161/01.CIR.0000105764.22626.B1; Kittel A, 2014, CURR PHARM DESIGN, V20, P3530, DOI 10.2174/13816128113196660750; Koch A, 2013, J CRIT CARE, V28, P947, DOI 10.1016/j.jcrc.2013.05.016; Koch A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/413826; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lajer M, 2008, DIABETES CARE, V31, P747, DOI 10.2337/dc07-1762; Lambden S, 2015, ARTERIOSCL THROM VAS, V35, P1382, DOI 10.1161/ATVBAHA.115.305278; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Leong T, 2008, ARTERIOSCL THROM VAS, V28, P961, DOI 10.1161/ATVBAHA.107.156596; Levin A, 2014, NEPHROL DIAL TRANSPL, V29, P1037, DOI 10.1093/ndt/gft479; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Lu TM, 2003, EUR HEART J, V24, P1912, DOI 10.1016/j.ehj.2003.08.013; Lu TM, 2011, INT J CARDIOL, V153, P135, DOI 10.1016/j.ijcard.2011.06.120; Luneburg N, 2011, J NUTR, V141, P2186, DOI 10.3945/jn.111.148197; Maas R, 2005, VASC MED, V10, pS49, DOI 10.1191/1358863x05vm605oa; Maas R, 2007, CRIT CARE MED, V35, P1876, DOI 10.1097/01.CCM.0000277038.11630.71; Maas R, 2007, J CHROMATOGR B, V851, P220, DOI 10.1016/j.jchromb.2007.01.020; Maas R, 2007, CLIN CHEM, V53, P693, DOI 10.1373/clinchem.2006.081893; Martens-Lobenhoffer J, 2015, J CHROMATOGR B, V975, P59, DOI 10.1016/j.jchromb.2014.11.009; MCDERMOTT JR, 1976, BIOCHEM J, V154, P179, DOI 10.1042/bj1540179; Meinitzer A, 2011, CLIN CHEM, V57, P112, DOI 10.1373/clinchem.2010.150854; Mittermayer F, 2006, ARTERIOSCL THROM VAS, V26, P2536, DOI 10.1161/01.ATV.0000242801.38419.48; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Morales Y, 2016, ARCH BIOCHEM BIOPHYS, V590, P138, DOI 10.1016/j.abb.2015.11.030; Nicholls SJ, 2007, CIRCULATION, V116, P2315, DOI 10.1161/CIRCULATIONAHA.107.693986; Nijveldt RJ, 2003, CLIN NUTR, V22, P23, DOI 10.1054/clnu.2002.0613; OGAWA T, 1987, ARCH BIOCHEM BIOPHYS, V252, P526, DOI 10.1016/0003-9861(87)90060-9; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; Pihlstrom H, 2014, TRANSPLANTATION, V98, P1219, DOI 10.1097/TP.0000000000000205; Pizzarelli F, 2013, AGE, V35, P2465, DOI 10.1007/s11357-013-9523-1; Plicner D, 2014, EUR J CARDIO-THORAC, V45, pE136, DOI 10.1093/ejcts/ezt646; Ravani P, 2005, J AM SOC NEPHROL, V16, P2449, DOI 10.1681/ASN.2005010076; Ronden RA, 2012, AM J PHYSIOL-RENAL, V303, pF149, DOI 10.1152/ajprenal.00045.2012; Schepers E, 2011, CLIN J AM SOC NEPHRO, V6, P2374, DOI 10.2215/CJN.01720211; Schepers E, 2009, NEPHROL DIAL TRANSPL, V24, P1429, DOI 10.1093/ndt/gfn670; Schnabel R, 2005, CIRC RES, V97, P53, DOI 10.1161/01.RES.0000181286.44222.61; Schulman SP, 2006, JAMA-J AM MED ASSOC, V295, P58, DOI 10.1001/jama.295.1.58; Schulze F, 2010, ATHEROSCLEROSIS, V208, P518, DOI 10.1016/j.atherosclerosis.2009.06.039; Schwedhelm E, 2005, VASC MED, V10, pS89, DOI 10.1191/1358863x05vm596oa; Schwedhelm E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096875; Schwedhelm E, 2011, CLIN CHEM LAB MED, V49, P1907, DOI 10.1515/CCLM.2011.679; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; Schwedhelm E, 2009, CLIN CHEM, V55, P1539, DOI 10.1373/clinchem.2009.124263; Shi BL, 2010, EUR J INTERN MED, V21, P444, DOI 10.1016/j.ejim.2010.07.001; Shirakawa T, 2011, MOL MED REP, V4, P615, DOI 10.3892/mmr.2011.488; Siegerink B, 2013, CLIN RES CARDIOL, V102, P193, DOI 10.1007/s00392-012-0515-4; Skoro-Sajer N, 2007, AM J RESP CRIT CARE, V176, P1154, DOI 10.1164/rccm.200702-278OC; Speer T, 2013, IMMUNITY, V38, P754, DOI 10.1016/j.immuni.2013.02.009; Strobel J, 2013, AMINO ACIDS, V45, P989, DOI 10.1007/s00726-013-1556-3; Strobel J, 2012, J MOL CELL CARDIOL, V53, P392, DOI 10.1016/j.yjmcc.2012.06.002; Tang WHW, 2008, EUR HEART J, V29, P2506, DOI 10.1093/eurheartj/ehn360; Tripepi G, 2011, CLIN J AM SOC NEPHRO, V6, P1714, DOI 10.2215/CJN.11291210; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; VALLANCE P, 1992, LANCET, V339, P572; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Visser M, 2012, BRIT J NUTR, V107, P1458, DOI 10.1017/S0007114511004648; Wang ZN, 2009, ARTERIOSCL THROM VAS, V29, P1383, DOI 10.1161/ATVBAHA.109.185645; Willeit P, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001833; Yeo TW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000868; Yilmaz MI, 2014, RHEUMATOLOGY, V53, P2002, DOI 10.1093/rheumatology/keu231; Young JM, 2009, CLIN J AM SOC NEPHRO, V4, P1115, DOI 10.2215/CJN.06671208; Zairis MN, 2012, HEART, V98, P860, DOI 10.1136/heartjnl-2011-301372; Zeller M, 2008, ARTERIOSCL THROM VAS, V28, P954, DOI 10.1161/ATVBAHA.108.162768; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8	99	105	109	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165811	10.1371/journal.pone.0165811	http://dx.doi.org/10.1371/journal.pone.0165811			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812151	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000064
J	Xiao, YQ; Brauer, J; Lauckner, M; Zhai, HC; Jia, FC; Margulies, DS; Friederici, AD				Xiao, Yaqiong; Brauer, Jens; Lauckner, Mark; Zhai, Hongchang; Jia, Fucang; Margulies, Daniel S.; Friederici, Angela D.			Development of the Intrinsic Language Network in Preschool Children from Ages 3 to 5 Years	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; PERISYLVIAN ACTIVATION; TEMPORAL CORTEX; DEFAULT NETWORK; SPEECH; ARCHITECTURE; PERCEPTION; PATTERNS; STREAMS	Resting state studies of spontaneous fluctuations in the functional magnetic resonance imaging (fMRI) blood oxygen level dependent signal have shown great potential in mapping the intrinsic functional connectivity of the human brain underlying cognitive functions. The aim of the present study was to explore the developmental changes in functional networks of the developing human brain exemplified with the language network in typically developing preschool children. To this end, resting-sate fMRI data were obtained from native Chinese children at ages of 3 and 5 years, 15 in each age group. Resting-state functional connectivity (RSFC) was analyzed for four regions of interest; these are the left and right anterior superior temporal gyrus (aSTG), left posterior superior temporal gyrus (pSTG), and left inferior frontal gyrus (IFG). The comparison of these RSFC maps between 3- and 5-year-olds revealed that RSFC decreases in the right aSTG and increases in the left hemisphere between aSTG seed and IFG, between pSTG seed and IFG, as well as between IFG seed and posterior superior temporal sulcus. In a subsequent analysis, functional asymmetry of the language network seeding in aSTG, pSTG and IFG was further investigated. The results showed an increase of left lateralization in both RSFC of pSTG and of IFG from ages 3 to 5 years. The IFG showed a leftward lateralized trend in 3-year-olds, while pSTG demonstrated rightward asymmetry in 5-year-olds. These findings suggest clear developmental trajectories of the language network between 3- and 5-year-olds revealed as a function of age, characterized by increasing long-range connections and dynamic hemispheric lateralization with age. Our study provides new insights into the developmental changes of a well-established functional network in young children and also offers a basis for future cross-culture and cross-age studies of the resting-state language network.	[Xiao, Yaqiong; Brauer, Jens; Friederici, Angela D.] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany; [Lauckner, Mark; Margulies, Daniel S.] Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Neuroanat & Connect, Leipzig, Germany; [Zhai, Hongchang] Guangzhou Univ, Coll Educ, Guangzhou, Guangdong, Peoples R China; [Jia, Fucang] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Max Planck Society; Max Planck Society; Guangzhou University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Xiao, YQ (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany.; Zhai, HC (corresponding author), Guangzhou Univ, Coll Educ, Guangzhou, Guangdong, Peoples R China.	xiao@cbs.mpg.de; zhaihongchang@126.com	Xiao, Yaqiong/L-5548-2019; Xiao, Yaqiong/AAS-4384-2021; Margulies, Daniel/L-4719-2016	XIAO, YAQIONG/0000-0001-8719-5418; Margulies, Daniel/0000-0002-8880-9204				Antonenko D, 2013, NEUROIMAGE, V83, P513, DOI 10.1016/j.neuroimage.2013.07.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brauer J, 2008, NEUROIMAGE, V41, P1484, DOI 10.1016/j.neuroimage.2008.03.027; Brauer J, 2007, J COGNITIVE NEUROSCI, V19, P1609, DOI 10.1162/jocn.2007.19.10.1609; Brauer J, 2011, CEREB CORTEX, V21, P459, DOI 10.1093/cercor/bhq108; Cao M, 2017, CEREB CORTEX, V27, P1949, DOI 10.1093/cercor/bhw038; Chan MY, 2014, P NATL ACAD SCI USA, V111, pE4997, DOI 10.1073/pnas.1415122111; Chang HW, 1986, LINGUISTIC PSYCHOL C; Crinion JT, 2009, HUM BRAIN MAPP, V30, P4108, DOI 10.1002/hbm.20832; Croft LJ, 2014, BRAIN, V137, P2245, DOI 10.1093/brain/awu154; de Bie HMA, 2012, HUM BRAIN MAPP, V33, P1189, DOI 10.1002/hbm.21280; Dehaene-Lambertz G, 2015, NEURON, V88, P93, DOI 10.1016/j.neuron.2015.09.026; Dehaene-Lambertz G, 2006, P NATL ACAD SCI USA, V103, P14240, DOI 10.1073/pnas.0606302103; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2012, TRENDS COGN SCI, V16, P262, DOI 10.1016/j.tics.2012.04.001; Friederici Angela D, 2012, Front Evol Neurosci, V4, P3, DOI 10.3389/fnevo.2012.00003; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Friederici AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020726; Friederici AD, 2009, NEUROREPORT, V20, P563, DOI 10.1097/WNR.0b013e3283297dee; Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018; Gandour J, 2004, NEUROIMAGE, V23, P344, DOI 10.1016/j.neuroimage.2004.06.004; Gao W, 2009, P NATL ACAD SCI USA, V106, P6790, DOI 10.1073/pnas.0811221106; Ge JQ, 2015, P NATL ACAD SCI USA, V112, P2972, DOI 10.1073/pnas.1416000112; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Holland SK, 2007, INT J AUDIOL, V46, P533, DOI 10.1080/14992020701448994; Holland SK, 2001, NEUROIMAGE, V14, P837, DOI 10.1006/nimg.2001.0875; Jeng L, 1991, CHINESE J PSYCHOL; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kinno R, 2008, HUM BRAIN MAPP, V29, P1015, DOI 10.1002/hbm.20441; Knoll LJ, 2012, NEUROIMAGE, V62, P207, DOI 10.1016/j.neuroimage.2012.05.014; Liu HS, 2009, P NATL ACAD SCI USA, V106, P20499, DOI 10.1073/pnas.0908073106; Liu WC, 2008, BRAIN RES, V1223, P42, DOI 10.1016/j.brainres.2008.05.054; Lohmann G, 2010, CEREB CORTEX, V20, P1286, DOI 10.1093/cercor/bhp190; Luo H, 2006, P NATL ACAD SCI USA, V103, P19558, DOI 10.1073/pnas.0607065104; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Muller AM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00228; Nan Y, 2013, HUM BRAIN MAPP, V34, P2045, DOI 10.1002/hbm.22046; Obleser J, 2011, NEUROIMAGE, V56, P2310, DOI 10.1016/j.neuroimage.2011.03.035; Perani D, 2011, P NATL ACAD SCI USA, V108, P16056, DOI 10.1073/pnas.1102991108; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Shu H, 2008, DEVELOPMENTAL SCI, V11, P171, DOI 10.1111/j.1467-7687.2007.00654.x; Skeide MA, 2016, CEREB CORTEX, V26, P2127, DOI 10.1093/cercor/bhv042; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Szaflarski JP, 2006, HUM BRAIN MAPP, V27, P202, DOI 10.1002/hbm.20177; Tomasi D, 2012, MOL PSYCHIATR, V17, P841, DOI 10.1038/mp.2011.177; Tomasi D, 2012, CEREB CORTEX, V22, P1455, DOI 10.1093/cercor/bhr230; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; van den Heuvel MP, 2015, CEREB CORTEX, V25, P3000, DOI 10.1093/cercor/bhu095; Vigneau M, 2011, NEUROIMAGE, V54, P577, DOI 10.1016/j.neuroimage.2010.07.036; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Weiss-Croft LJ, 2015, NEUROIMAGE, V123, P269, DOI 10.1016/j.neuroimage.2015.07.046; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Xiang HD, 2010, CEREB CORTEX, V20, P549, DOI 10.1093/cercor/bhp119; Xiao YQ, 2016, BRAIN IMAGING BEHAV, V10, P50, DOI 10.1007/s11682-015-9362-z; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161; Zheng Y, 2009, INT J AUDIOL, V48, P718, DOI 10.1080/14992020902902658; Zheng Y, 2009, EAR HEARING, V30, P600, DOI 10.1097/AUD.0b013e3181b4aba8; Zhu LL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085880, 10.1371/journal.pone.0102471, 10.1371/journal.pone.0097178]	74	11	11	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165802	10.1371/journal.pone.0165802	http://dx.doi.org/10.1371/journal.pone.0165802			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812160	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000060
J	Cho, YY; Sidorenkov, G; Denig, P				Cho, Yeon Young; Sidorenkov, Grigory; Denig, Petra			Role of Patient and Practice Characteristics in Variance of Treatment Quality in Type 2 Diabetes between General Practices	PLOS ONE			English	Article							PRIMARY-CARE; CARDIOVASCULAR-DISEASE; HEART-DISEASE; PRACTICE SIZE; OF-CARE; ADHERENCE; IMPACT; COMORBIDITY; MEDICATION; GUIDELINES	Background Accounting for justifiable variance is important for fair comparisons of treatment quality. The variance between general practices in treatment quality of type 2 diabetes (T2DM) patients may be attributed to the underlying patient population and practice characteristics. The objective of this study is to describe the between practice differences in treatment, and identify patient and practice level characteristics that may explain these differences. Methods The data of 24,607 T2DM patients from 183 general practices in the Netherlands were used. Treatment variance was assessed in a cross- sectional manner for: glucose- lowering drugs/metformin, lipid- lowering drugs/statins, blood pressure- lowering drugs/ACE- inhibitor or ARB. Patient characteristics tested were age, gender, diabetes duration, comorbidity, comedication. Practice characteristics were number of T2DM patients, practice type, diabetes assistant available. Multilevel logistic regression was used to examine the between practice variance in treatment and the effect of characteristics on this variance. Results Treatment rates varied considerably between practices (IQR 9.5-13.9). The variance at practice level was 7.5% for glucose- lowering drugs, 3.6% for metformin, 3.1% for lipid- lowering drugs, 10.3% for statins, 8.6% for blood pressure- lowering drugs, and 3.9% for ACEinhibitor/ARB. Patient and practice characteristics explained 19.0%, 7.5%, 20%, 6%, 9.9%, and 13.4% of the variance respectively. Age, multiple chronic drugs, and >= 3 glucose- lowering drugs were the most relevant patient characteristics. Number of T2DM patients per practice was the most relevant practice characteristic. Discussion Considerable differences exist between practices in treatment rates. Patients' age was identified as characteristic that may account for justifiable differences in especially lipid- lowering treatment. Other patient or practice characteristics either do not explain or do not justify the differences.	[Cho, Yeon Young; Sidorenkov, Grigory; Denig, Petra] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Cho, Yeon Young] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Epidemiol, Seoul, South Korea	University of Groningen; Seoul National University (SNU)	Sidorenkov, G (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.	g.sidorenkov@umcg.nl	Denig, Petra/L-9865-2014	Denig, Petra/0000-0002-7929-4739; Sidorenkov, Grigory/0000-0002-1926-8862	Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, the Netherlands	Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, the Netherlands	The study was funded by the Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by the Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab E, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-24; Booth GL, 2006, LANCET, V368, P29, DOI 10.1016/S0140-6736(06)68967-8; Botsis T, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-11; Calsbeek H, 2016, AM J MANAG CARE, V22, pE45; Campmans-Kuijpers MJE, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-129; Chen Szu-chi, 2013, Rev Diabet Stud, V10, P88, DOI 10.1900/RDS.2013.10.88; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Dijkstra RF, 2004, DIABETIC MED, V21, P586, DOI 10.1111/j.1464-5491.2004.01195.x; Gnavi R, 2007, EUR J PUBLIC HEALTH, V17, P492, DOI 10.1093/eurpub/ckm005; Greving JP, 2006, SOC SCI MED, V63, P2890, DOI 10.1016/j.socscimed.2006.07.019; Gulliford MC, 2005, J HUM HYPERTENS, V19, P111, DOI 10.1038/sj.jhh.1001787; Hansen DG, 2007, PHARMACOEPIDEM DR S, V16, P458, DOI 10.1002/pds.1364; Health & Social Care Information Centre, QUAL OUTC FRAM QOF 2; Hira Ravi S, 2015, J Am Coll Cardiol, V65, P111, DOI 10.1016/j.jacc.2014.10.035; Hong CS, 2010, JAMA-J AM MED ASSOC, V304, P1107, DOI 10.1001/jama.2010.1287; Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265; Instituut voor Verantwoord Medicijngebruik [Dutch Institute for Rational Use of Medicine], MON VOORSCHR HUIS; Inzucchi SE, 2014, JAMA-J AM MED ASSOC, V312, P2668, DOI 10.1001/jama.2014.15298; Janssen PGH, 2008, SCAND J PRIM HEALTH, V26, P160, DOI 10.1080/08037050802117924; Kramer HU, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-88; Kralewski J, 2015, HEALTH SERV RES, V50, P710, DOI 10.1111/1475-6773.12242; Krein SL, 2002, HEALTH SERV RES, V37, P1159, DOI 10.1111/1475-6773.01102; Lovaglio PG, 2011, INT J MENT HEALTH SY, V5, DOI 10.1186/1752-4458-5-20; Manteuffel M, 2014, J WOMENS HEALTH, V23, P112, DOI 10.1089/jwh.2012.3972; Mathew Elizabeth Mampally, 2013, J Basic Clin Pharm, V5, P15, DOI 10.4103/0976-0105.128251; McGinn J, 2006, DIABETES RES CLIN PR, V72, P162, DOI 10.1016/j.diabres.2005.10.023; Mohammed MA, 2012, MED DECIS MAKING, V32, P498, DOI 10.1177/0272989X12437246; National Committee of Quality Assurance, HEDIS QUAL RAT SYST; National Health Service (NHS), INTR ATL VAR HEALTHC; Nederlands Huisartsengenootschap, 2012, HUISARTS WET, V55, P14; Ng CWL, 2013, BRIT J GEN PRACT, V63, pE604, DOI 10.3399/bjgp13X671588; O'Connor Patrick J, 2008, Prev Chronic Dis, V5, pA15; Parnes BL, 2004, DIABETES CARE, V27, P13, DOI 10.2337/diacare.27.1.13; Pentakota SR, 2012, DIABETES CARE, V35, P1285, DOI 10.2337/dc11-1569; Peyrot M, 2012, DIABETIC MED, V29, P682, DOI 10.1111/j.1464-5491.2012.03605.x; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; Satman I, 2012, DIABETES RES CLIN PR, V98, P75, DOI 10.1016/j.diabres.2012.05.003; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Simmons RK, 2014, DIABETIC MED, V31, P1577, DOI 10.1111/dme.12574; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Struijs JN, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-84; Tahrani AA, 2008, BRIT J GEN PRACT, V58, P576, DOI 10.3399/bjgp08X319729; The Dutch College of General Practitioners [Nederlands Huisartsen Genootschap (NHG)], 2016, QUAL IND PRIM CAR PA; van den Berg MJ, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-1; Van den Bruel A, 2015, FAM PRACT, V32, P127, DOI 10.1093/fampra/cmv008; van Hateren KJJ, 2011, INT J CLIN PRACT, V65, P415, DOI 10.1111/j.1742-1241.2010.02596.x; van Hateren KJJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001387; van Loenen T, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0458-3; Voorham J, 2007, J AM MED INFORM ASSN, V14, P349, DOI 10.1197/jamia.M2128; Woodard LD, 2011, MED CARE, V49, P605, DOI 10.1097/MLR.0b013e31820f0ed0	50	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0166012	10.1371/journal.pone.0166012	http://dx.doi.org/10.1371/journal.pone.0166012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806107	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500077
J	Dabrowski-Tumanski, P; Stasiak, A; Sulkowska, JI				Dabrowski-Tumanski, Pawel; Stasiak, Andrzej; Sulkowska, Joanna I.			In Search of Functional Advantages of Knots in Proteins	PLOS ONE			English	Article							SLIPKNOTTING PATTERNS; ACTIVE-SITE; BINDING; METHYLTRANSFERASE; CONSERVATION; FRUSTRATION; MECHANISM; SURFACES; ENZYME; SPOUT	We analysed the structure of deeply knotted proteins representing three unrelated families of knotted proteins. We looked at the correlation between positions of knotted cores in these proteins and such local structural characteristics as the number of intra-chain contacts, structural stability and solvent accessibility. We observed that the knotted cores and especially their borders showed strong enrichment in the number of contacts. These regions showed also increased thermal stability, whereas their solvent accessibility was decreased. Interestingly, the active sites within these knotted proteins preferentially located in the regions with increased number of contacts that also have increased thermal stability and decreased solvent accessibility. Our results suggest that knotting of polypeptide chains provides a favourable environment for the active sites observed in knotted proteins. Some knotted proteins have homologues without a knot. Interestingly, these unknotted homologues form local entanglements that retain structural characteristics of the knotted cores.	[Dabrowski-Tumanski, Pawel; Sulkowska, Joanna I.] Ctr New Technol, Banacha 2c, PL-02097 Warsaw, Poland; [Dabrowski-Tumanski, Pawel; Sulkowska, Joanna I.] Univ Warsaw, Fac Chem, Pasteura 1, PL-02093 Warsaw, Poland; [Dabrowski-Tumanski, Pawel; Stasiak, Andrzej] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Stasiak, Andrzej] SIB Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland	University of Warsaw; University of Warsaw; University of Lausanne; Swiss Institute of Bioinformatics	Sulkowska, JI (corresponding author), Ctr New Technol, Banacha 2c, PL-02097 Warsaw, Poland.; Sulkowska, JI (corresponding author), Univ Warsaw, Fac Chem, Pasteura 1, PL-02093 Warsaw, Poland.; Stasiak, A (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.; Stasiak, A (corresponding author), SIB Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland.	Andrzej.Stasiak@unil.ch; jsulkowska@chem.uw.edu.pl	Dabrowski-Tumanski, Pawel/O-2581-2019; Dabrowski-Tumanski, Pawel/J-6836-2015; Stasiak, Andrzej/E-5551-2010	Dabrowski-Tumanski, Pawel/0000-0001-9412-1716; Dabrowski-Tumanski, Pawel/0000-0001-9412-1716; Stasiak, Andrzej/0000-0002-0398-1989; Sulkowska, Joanna/0000-0003-2452-0724	National Science Centre Poland [2012/07/E/NZ1/01900]; EMBO Installation Grant [2057]; Swiss National Science Foundation [31003A_166684]; Leverhulme Trust [RP2013-K-017]; University of Warsaw, Faculty of Chemistry [120000-501/86-DSM-112 700]	National Science Centre Poland(National Science Centre, Poland); EMBO Installation Grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leverhulme Trust(Leverhulme Trust); University of Warsaw, Faculty of Chemistry	This work was supported by National Science Centre Poland #2012/07/E/NZ1/01900 (JIS) https:/www.ncn.gov.pl; EMBO Installation Grant #2057 (JIS) http://www.embo.org/; Swiss National Science Foundation 31003A_166684 (AS) http://www.snf.ch; and the Leverhulme Trust RP2013-K-017 (AS) https://www.leverhulme.ac.uk/; University of Warsaw, Faculty of Chemistry 120000-501/86-DSM-112 700 (PD-T) http://www.chem.uw.edu.pl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MT, 2002, FEBS LETT, V519, P35, DOI 10.1016/S0014-5793(02)02693-5; Anantharaman V, 2002, J MOL MICROB BIOTECH, V4, P71; Bolinger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000731; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; COLLIER CD, 1990, J BACTERIOL, V172, P3918, DOI 10.1128/jb.172.7.3918-3924.1990; Dabrowski-Tumanski P, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/35/354109; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104; Jamroz M, 2015, NUCLEIC ACIDS RES, V43, pD306, DOI 10.1093/nar/gku1059; Jenik M, 2012, NUCLEIC ACIDS RES, V40, pW348, DOI 10.1093/nar/gks447; King NP, 2007, J MOL BIOL, V373, P153, DOI 10.1016/j.jmb.2007.07.042; Lim K, 2003, PROTEINS, V51, P56, DOI 10.1002/prot.10323; Liu RJ, 2013, NUCLEIC ACIDS RES, V41, P7828, DOI 10.1093/nar/gkt568; Mallam AL, 2007, STRUCTURE, V15, P111, DOI 10.1016/j.str.2006.11.007; Mallam AL, 2012, NAT CHEM BIOL, V8, P147, DOI 10.1038/nchembio.742; Millett KC, 2013, BIOCHEM SOC T, V41, P533, DOI 10.1042/BST20120339; Nureki O, 2004, STRUCTURE, V12, P593, DOI 10.1016/j.str.2004.03.003; Nureki O, 2002, ACTA CRYSTALLOGR D, V58, P1129, DOI 10.1107/S0907444902006601; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potestio R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000864; Prakash S, 2004, TRENDS BIOCHEM SCI, V29, P593, DOI 10.1016/j.tibs.2004.09.011; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; Rawdon EJ, 2013, BIOCHEM SOC T, V41, P538, DOI 10.1042/BST20120329; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Sayre TC, 2011, PROTEIN ENG DES SEL, V24, P627, DOI 10.1093/protein/gzr024; Shi DS, 2006, PROTEINS, V64, P532, DOI 10.1002/prot.21013; Sulkowska J, 2012, PROTEIN SCI, V21, P222; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P17783, DOI 10.1073/pnas.1201804109; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, pE1715, DOI 10.1073/pnas.1205918109; Sulkowska JI, 2009, P NATL ACAD SCI USA, V106, P3119, DOI 10.1073/pnas.0811147106; Sulkowska JI, 2008, P NATL ACAD SCI USA, V105, P19714, DOI 10.1073/pnas.0805468105; Taylor WR, 2007, COMPUT BIOL CHEM, V31, P151, DOI 10.1016/j.compbiolchem.2007.03.002; Taylor WR, 2000, NATURE, V406, P916, DOI 10.1038/35022623; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Tubiana L, 2011, PROG THEOR PHYS SUPP, P192; van Roon AMM, 2008, P NATL ACAD SCI USA, V105, P9621, DOI 10.1073/pnas.0802494105; Virnau P, 2006, PLOS COMPUT BIOL, V2, P1074, DOI 10.1371/journal.pcbi.0020122; Virnau P, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/3/033101; Yang XJ, 2015, STRUCTURE, V23, P1179, DOI 10.1016/j.str.2015.04.022; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086	39	37	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165986	10.1371/journal.pone.0165986	http://dx.doi.org/10.1371/journal.pone.0165986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806097	Green Submitted, gold, Green Published			2022-12-27	WOS:000386715500076
J	Henquin, JC; Nenquin, M				Henquin, Jean-Claude; Nenquin, Myriam			Dynamics and Regulation of Insulin Secretion in Pancreatic Islets from Normal Young Children	PLOS ONE			English	Article							PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; HUMAN-FETAL; ACTIVATING MUTATIONS; CELL PROLIFERATION; BETA-CELLS; B-CELL; GLUCOSE; MATURATION; INFANT; GLUCOKINASE	Insulin secretion has only exceptionally been investigated in pancreatic islets from healthy young children. It remains unclear whether those islets behave like adult islets despite substantial differences in cellular composition and higher beta-cell replication rates. Islets were isolated from 5 infants/toddlers (11-36 month-old) and perifused to characterize their dynamics of insulin secretion when subjected to various stimuli and inhibitors. Their insulin responses were compared to those previously reported for similarly treated adult islets. Qualitatively, infant islets responded like adult islets to stimulation by glucose, tolbutamide, forskolin (to increase cAMP), arginine and the combination of leucine and glutamine, and to inhibition by diazoxide and CaCl2 omission. This similarity included the concentration-dependency and biphasic pattern of glucose-induced insulin secretion, the dynamics of the responses to non- glucose stimuli and metabolic amplification of these responses. The insulin content was not different, but fractional insulin secretion rates were lower in infant than adult islets irrespective of the stimulus. However, the stimulation index was similar because basal secretion rates were also lower in infant islets. In conclusion, human beta-cells are functionally mature by the age of one year, before expansion of their mass is complete. Their responsiveness (stimulation index) to all stimuli is not smaller than that of adult beta-cells. Yet, under basal and stimulated conditions, they secrete smaller proportions of their insulin stores in keeping with smaller in vivo insulin needs during infancy.	[Henquin, Jean-Claude; Nenquin, Myriam] Univ Louvain, Fac Med, Unit Endocrinol & Metab, Brussels, Belgium	Universite Catholique Louvain	Henquin, JC (corresponding author), Univ Louvain, Fac Med, Unit Endocrinol & Metab, Brussels, Belgium.	jean-claude.henquin@uclouvain.be			Directorate for Scientific Research of the French Community of Belgium [05/10-328]	Directorate for Scientific Research of the French Community of Belgium	This work was funded by Directorate for Scientific Research of the French Community of Belgium (ARC 05/10-328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN A, 1980, Diabetes, V29, P64; Arslanian S, 1997, J CLIN ENDOCR METAB, V82, P1923, DOI 10.1210/jc.82.6.1923; Atiya A W, 1997, J Gastrointest Surg, V1, P251, DOI 10.1016/S1091-255X(97)80117-5; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Balamurugan AN, 2006, DIABETOLOGIA, V49, P1845, DOI 10.1007/s00125-006-0318-0; CAPRIO S, 1989, J PEDIATR-US, V114, P963, DOI 10.1016/S0022-3476(89)80438-X; CAREL JC, 1993, J CLIN INVEST, V92, P509, DOI 10.1172/JCI116595; Chase HP, 2001, J PEDIATR-US, V138, P244, DOI 10.1067/mpd.2001.111274; Detimary P, 1996, ENDOCRINOLOGY, V137, P4671, DOI 10.1210/en.137.11.4671; Dhawan S, 2015, J CLIN INVEST, V125, P2851, DOI 10.1172/JCI79956; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; FALORNI A, 1974, DIABETES, V23, P172, DOI 10.2337/diab.23.3.172; GRASSO S, 1973, DIABETES, V22, P349, DOI 10.2337/diab.22.5.349; Gregg BE, 2012, J CLIN ENDOCR METAB, V97, P3197, DOI 10.1210/jc.2012-1206; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Hauge-Evans AC, 2009, DIABETES, V58, P403, DOI 10.2337/db08-0792; HAWDON JM, 1993, ARCH DIS CHILD-FETAL, V68, P274, DOI 10.1136/adc.68.3_Spec_No.274; Henquin JC, 2006, DIABETES, V55, P3470, DOI 10.2337/db06-0868; Henquin JC, 2015, AM J PHYSIOL-ENDOC M, V309, pE640, DOI 10.1152/ajpendo.00251.2015; Henquin JC, 2013, DIABETES, V62, P1689, DOI 10.2337/db12-1414; Henquin JC, 2011, J CLIN INVEST, V121, P3932, DOI 10.1172/JCI58400; HOFFMAN L, 1982, DIABETOLOGIA, V23, P426; Ishiyama N, 2006, AM J PHYSIOL-ENDOC M, V290, pE540, DOI 10.1152/ajpendo.00032.2005; Jacovetti C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9084; Jaffe R, 1982, Perspect Pediatr Pathol, V7, P137; JAHR H, 1981, DIABETES METAB, V7, P71; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Keskinen P, 2002, DIABETOLOGIA, V45, P1639, DOI 10.1007/s00125-002-0981-8; Manning Fox JE, 2013, ENDOCRINOLOGY, V154, P1392; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; MILNER RDG, 1972, J ENDOCRINOL, V52, P497, DOI 10.1677/joe.0.0520497; OTONKOSKI T, 1988, DIABETES, V37, P286, DOI 10.2337/diabetes.37.3.286; OTONKOSKI T, 1995, J CLIN ENDOCR METAB, V80, P3779, DOI 10.1210/jc.80.12.3779; RAHIER J, 1981, DIABETOLOGIA, V20, P540; REITANO G, 1971, J CLIN ENDOCR METAB, V33, P924, DOI 10.1210/jcem-33-6-924; Richardson CC, 2007, DIABETOLOGIA, V50, P1000, DOI 10.1007/s00125-007-0644-x; ROBERT JJ, 1991, DIABETES CARE, V14, P718, DOI 10.2337/diacare.14.8.718; Sato Y, 1999, ENDOCRINOLOGY, V140, P2252, DOI 10.1210/en.140.5.2252; Sempoux C, 1998, MODERN PATHOL, V11, P444; Stanley CA, 2016, J CLIN ENDOCR METAB, V101, P815, DOI 10.1210/jc.2015-3651; STEFAN Y, 1983, DIABETES, V32, P293, DOI 10.2337/diabetes.32.4.293; Stolovich-Rain M, 2015, DEV CELL, V32, P535, DOI 10.1016/j.devcel.2015.01.002; Stumpp C, 2014, PEDIATR DIABETES, V15, P528, DOI 10.1111/pedi.12122; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Tu J, 1997, J CLIN ENDOCR METAB, V82, P943, DOI 10.1210/jc.82.3.943; WIRDNAM PK, 1981, EARLY HUM DEV, V5, P299, DOI 10.1016/0378-3782(81)90037-2	47	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165961	10.1371/journal.pone.0165961	http://dx.doi.org/10.1371/journal.pone.0165961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806105	Green Submitted, gold, Green Published			2022-12-27	WOS:000386715500073
J	Alves, CJ; Alencastre, IS; Neto, E; Ribas, J; Ferreira, S; Vasconcelos, DM; Sousa, DM; Summavielle, T; Lamghari, M				Alves, Cecilia J.; Alencastre, Ines S.; Neto, Estrela; Ribas, Joao; Ferreira, Sofia; Vasconcelos, Daniel M.; Sousa, Daniela M.; Summavielle, Teresa; Lamghari, Meriem			Bone Injury and Repair Trigger Central and Peripheral NPY Neuronal Pathways	PLOS ONE			English	Article							NEUROPEPTIDE-Y Y1; IMMUNOREACTIVE NERVES; KNOCKOUT MICE; Y-1 RECEPTOR; EXPRESSION; IMMUNE; INHIBITION; DIFFERENTIATION; STABILIZATION; LOCALIZATION	Bone repair is a specialized type of wound repair controlled by complex multi-factorial events. The nervous system is recognized as one of the key regulators of bone mass, thereby suggesting a role for neuronal pathways in bone homeostasis. However, in the context of bone injury and repair, little is known on the interplay between the nervous system and bone. Here, we addressed the neuropeptide Y (NPY) neuronal arm during the initial stages of bone repair encompassing the inflammatory response and ossification phases in femoral-defect mouse model. Spatial and temporal analysis of transcriptional and protein levels of NPY and its receptors, Y1R and Y2R, reported to be involved in bone homeostasis, was performed in bone, dorsal root ganglia (DRG) and hypothalamus after femoral injury. The results showed that NPY system activity is increased in a time- and space-dependent manner during bone repair. Y1R expression was trigged in both bone and DRG throughout the inflammatory phase, while a Y2R response was restricted to the hypothalamus and at a later stage, during the ossification step. Our results provide new insights into the involvement of NPY neuronal pathways in bone repair.	[Alves, Cecilia J.; Alencastre, Ines S.; Neto, Estrela; Vasconcelos, Daniel M.; Sousa, Daniela M.; Summavielle, Teresa; Lamghari, Meriem] Univ Porto, I3S, Oporto, Portugal; [Alves, Cecilia J.; Alencastre, Ines S.; Neto, Estrela; Ribas, Joao; Ferreira, Sofia; Vasconcelos, Daniel M.; Sousa, Daniela M.; Lamghari, Meriem] Univ Porto, Inst Engn Biomed INEB, Oporto, Portugal; [Neto, Estrela] Univ Porto FMUP, Fac Med, Oporto, Portugal; [Vasconcelos, Daniel M.; Lamghari, Meriem] Univ Porto, ICBAS, Oporto, Portugal; [Summavielle, Teresa] Univ Porto, IBMC, Oporto, Portugal; [Summavielle, Teresa] Inst Politecn Porto, Escola Super Tecnol Saude Porto, Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Polytechnic Institute of Porto	Lamghari, M (corresponding author), Univ Porto, I3S, Oporto, Portugal.; Lamghari, M (corresponding author), Univ Porto, Inst Engn Biomed INEB, Oporto, Portugal.; Lamghari, M (corresponding author), Univ Porto, ICBAS, Oporto, Portugal.	lamghari@ineb.up.pt	Neto, Estrela C/M-2561-2013; Summavielle, Teresa/C-9776-2012; Sousa, Daniela/C-1485-2014; Summavielle, Teresa/ABB-5335-2020; Lamghari, Meriem/K-2159-2013	Neto, Estrela C/0000-0003-2334-2292; Summavielle, Teresa/0000-0003-2548-6281; Sousa, Daniela/0000-0001-8498-0664; Summavielle, Teresa/0000-0003-2548-6281; Vasconcelos, Daniel/0000-0003-3474-5193; Lamghari, Meriem/0000-0002-2500-4548; Alencastre, Ines/0000-0002-5591-5596; Alves, Cecilia Juliana/0000-0002-0719-574X; Ferreira, Sofia/0000-0003-2066-6865	Norte Portugal Regional Operational Programme (NORTE) under the PORTUGAL Partnership Agreement, through the European Regional Development Fund (ERDF) [NORTE-01-0145-FEDER-000012]; FCT [SFRH/BPD/63618/2009, SFRH/BPD/75285/2010, SFRH/BD/81152/2011, SFRH/BD/87516/2012]	Norte Portugal Regional Operational Programme (NORTE) under the PORTUGAL Partnership Agreement, through the European Regional Development Fund (ERDF); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This article is a result of the project NORTE-01-0145-FEDER-000012, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). CJA, ISA, EN and DMV are supported by FCT (SFRH/BPD/63618/2009, SFRH/BPD/75285/2010, SFRH/BD/81152/2011, and SFRH/BD/87516/2012, respectively).	Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Allison SJ, 2006, J BIOL CHEM, V281, P23436, DOI 10.1074/jbc.M604839200; Amano S, 2007, BBA-GEN SUBJECTS, V1770, P966, DOI 10.1016/j.bbagen.2007.02.009; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Baldock PA, 2007, J BIOL CHEM, V282, P19092, DOI 10.1074/jbc.M700644200; Baldock PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008415; BJURHOLM A, 1988, J AUTONOM NERV SYST, V25, P119, DOI 10.1016/0165-1838(88)90016-1; Broberger C, 1997, NEUROENDOCRINOLOGY, V66, P393, DOI 10.1159/000127265; Brothers SP, 2010, EMBO MOL MED, V2, P429, DOI 10.1002/emmm.201000100; Brumovsky PR, 2004, BRAIN RES, V1006, P87, DOI 10.1016/j.brainres.2003.09.085; Campbell TM, 2003, CALCIFIED TISSUE INT, V73, P49, DOI 10.1007/s00223-002-2120-4; Chandrasekharan B, 2013, AM J PHYSIOL-GASTR L, V304, pG949, DOI 10.1152/ajpgi.00493.2012; Chen XL, 1997, AM J PHYSIOL-HEART C, V273, pH1737, DOI 10.1152/ajpheart.1997.273.4.H1737; Ekstrand AJ, 2003, P NATL ACAD SCI USA, V100, P6033, DOI 10.1073/pnas.1135965100; Farzi A, 2015, ACTA PHYSIOL, V213, P603, DOI 10.1111/apha.12445; Ferreira-Gomes J, 2012, MOL PAIN, V8, DOI [10.1186/1744-8069-850, 10.1186/1744-8069-8-50]; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Gibbs JL, 2006, PAIN, V124, P167, DOI 10.1016/j.pain.2006.04.013; HILL EL, 1991, CELL TISSUE RES, V264, P469, DOI 10.1007/BF00319037; Hirsch D, 2012, CELL MOL NEUROBIOL, V32, P645, DOI 10.1007/s10571-011-9793-z; Igwe JC, 2009, J CELL BIOCHEM, V108, P621, DOI 10.1002/jcb.22294; Kostic S, 2013, EUR J PAIN, V17, P493, DOI 10.1002/j.1532-2149.2012.00218.x; Lange J, 2010, J ORTHOP RES, V28, P778, DOI 10.1002/jor.21061; Lee NJ, 2011, BONE, V48, P461, DOI 10.1016/j.bone.2010.10.174; Lee NJ, 2010, J BONE MINER RES, V25, P1736, DOI 10.1002/jbmr.61; Li JJ, 2005, PAIN, V118, P232, DOI 10.1016/j.pain.2005.08.023; Long H, 2010, ACTA ORTHOP, V81, P639, DOI 10.3109/17453674.2010.504609; Lundberg P, 2007, J BIOL CHEM, V282, P19082, DOI 10.1074/jbc.M609629200; MANTYH PW, 1994, J NEUROSCI, V14, P3958; Nunes AF, 2010, FEBS J, V277, P263, DOI 10.1111/j.1742-4658.2009.07482.x; Otkjaer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008671; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; Pongratz G, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0504-2; Sapunar D, 2011, PAIN, V152, P1173, DOI 10.1016/j.pain.2011.01.045; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Schmidt-Bleek K, 2012, CELL TISSUE RES, V347, P567, DOI 10.1007/s00441-011-1205-7; Shi YC, 2012, BONE, V50, P430, DOI 10.1016/j.bone.2011.10.001; Silva AP, 2005, BIOL CELL, V97, P457, DOI 10.1042/BC20040102; Singer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057929; Sousa DM, 2013, J ORTHOP RES, V31, P1570, DOI 10.1002/jor.22400; Sousa DM, 2012, BONE, V51, P8, DOI 10.1016/j.bone.2012.03.020; Taylor BK, 2014, NEUROSCIENCE, V256, P178, DOI 10.1016/j.neuroscience.2013.10.054; von Horsten S, 1998, BRAIN RES, V806, P282, DOI 10.1016/S0006-8993(98)00772-0; WAKISAKA S, 1991, NEUROSCI LETT, V124, P200, DOI 10.1016/0304-3940(91)90093-9; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; Wheway J, 2007, CURR TOP MED CHEM, V7, P1743, DOI 10.2174/156802607782341046; Wheway J, 2007, PEPTIDES, V28, P453, DOI 10.1016/j.peptides.2006.09.030; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; ZHANG X, 1994, P NATL ACAD SCI USA, V91, P11738, DOI 10.1073/pnas.91.24.11738	50	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165465	10.1371/journal.pone.0165465	http://dx.doi.org/10.1371/journal.pone.0165465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802308	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200024
J	Cunningham, DJ; Shearer, DA; Drawer, S; Pollard, B; Eager, R; Taylor, N; Cook, CJ; Kilduff, LP				Cunningham, Daniel J.; Shearer, David A.; Drawer, Scott; Pollard, Ben; Eager, Robin; Taylor, Neil; Cook, Christian J.; Kilduff, Liam P.			Movement Demands of Elite Under-20s and Senior International Rugby Union Players	PLOS ONE			English	Article							CREATINE-KINASE RESPONSES; TEAM SOCCER MATCH; PHYSICAL DEMANDS; MOTION ANALYSIS; PLAYING LEVEL; PERFORMANCE; POWER; JUNIOR; SPEED; TIME	This study compared the movement demands of elite international Under-20 age grade (U20s) and senior international rugby union players during competitive tournament match play. Forty elite professional players from an U20 and 27 elite professional senior players from international performance squads were monitored using 10Hz global positioning systems (GPS) during 15 (U20s) and 8 (senior) international tournament matches during the 2014 and 2015 seasons. Data on distances, velocities, accelerations, decelerations, high metabolic load (HML) distance and efforts, and number of sprints were derived. Data files from players who played over 60 min (n = 258) were separated firstly into Forwards and Backs, and more specifically into six positional groups; FR-Front Row (prop & hooker), SR-Second Row, BR-Back Row (Flankers & No. 8), HB-Half Backs (scrum half & outside half), MF-Midfield (centres), B3-Back Three (wings & full back) for match analysis. Linear mixed models revealed significant differences between U20 and senior teams in both the forwards and backs. In the forwards the seniors covered greater HML distance (736.4 +/- 280.3 vs 701.3 +/- 198.7m, p = 0.01) and severe decelerations (2.38 +/- 2.2 vs 2.28 +/- 1.65, p = 0.05) compared to the U20s, but performed less relative HSR (3.1 +/- 1.6 vs 3.2 +/- 1.5, p < 0.01), moderate (19.4 +/- 10.5 vs 23.6 +/- 10.5, p = 0.01) and high accelerations (2.2 +/- 1.9 vs 4.3-2.7, p < 0.01) and sprint center dot min(-1) (0.11 +/- 0.06 vs 0.11 +/- 0.05, p < 0.01). Senior backs covered a greater relative distance (73.3 +/- 8.1 vs 69.1 +/- 7.6 m center dot min(-1), p < 0.01), greater High Metabolic Load (HML) distance (1138.0 +/- 233.5 vs 1060.4 +/- 218.1m, p < 0.01), HML efforts (112.7 +/- 22.2 vs 98.8 +/- 21.7, p < 0.01) and heavy decelerations (9.9 +/- 4.3 vs 9.5 +/- 4.4, p = 0.04) than the U20s backs. However, the U20s backs performed more relative HSR (7.3 +/- 2.1 vs 7.2 +/- 2.1, p < 0.01) and sprint center dot min(-1) (0.26 +/- 0.07 vs 0.25 +/- 0.07, p < 0.01). Further investigation highlighted differences between the 6 positional groups of the teams. The positional groups that differed the most on the variables measured were the FR and MF groups, with the U20s FR having higher outputs on HSR, moderate & high accelerations, moderate, high & severe decelerations, HML distance, HML efforts, and sprints center dot min(-1). For the MF group the senior players produced greater values for relative distance covered,HSR, moderate decelerations, HML distance and sprint center dot min(-1). The BR position group was most similar with the only differences seen on heavy accelerations (U20s higher) and moderate decelerations (seniors higher). Findings demonstrate that U20s internationals appear to be an adequate 'stepping stone' for preparing players for movement characteristics found senior International rugby, however, the current study highlight for the first time that certain positional groups may require more time to be able to match the movement demands required at a higher playing level than others. Conditioning staff must also bear in mind that the U20s players whilst maintaining or improving match movement capabilities may require to gain substantial mass in some positions to match their senior counterparts.	[Cunningham, Daniel J.; Cook, Christian J.; Kilduff, Liam P.] Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales; [Shearer, David A.] Univ South Wales, Sch Psychol & Therapeut Studies, Pontypridd, Wales; [Shearer, David A.; Kilduff, Liam P.] Swansea Univ, Coll Engn, Welsh Inst Performance Sci, Swansea, W Glam, Wales; [Drawer, Scott; Pollard, Ben; Eager, Robin; Taylor, Neil] Rugby Football Union, Greater London, England	Swansea University; University of South Wales; Swansea University	Kilduff, LP (corresponding author), Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales.; Kilduff, LP (corresponding author), Swansea Univ, Coll Engn, Welsh Inst Performance Sci, Swansea, W Glam, Wales.	l.kilduff@swansea.ac.uk	Shearer, David/K-8025-2019	Shearer, David/0000-0002-5877-8160; Cunningham, Dan/0000-0002-5249-0609; Cook, Christian/0000-0001-9677-0306	Rugby Football Union	Rugby Football Union	The author(s) received no specific funding for this work and no authors have any financial or other interest in the products or distributor of the products named in the study. The Rugby Football Union provided support in the form of salaries for authors Scott Drawer, Robin Eager, Ben Pollard and Neil Taylor, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson L, 2016, INT J SPORT PHYSIOL, V11, P1038, DOI 10.1123/ijspp.2015-0672; Anderson L, 2016, J SPORT SCI, V34, P1250, DOI 10.1080/02640414.2015.1106574; Argus CK, 2012, J STRENGTH COND RES, V26, P2698, DOI 10.1519/JSC.0b013e318241382a; Austin DJ, 2013, J STRENGTH COND RES, V27, P14, DOI 10.1519/JSC.0b013e31824e108c; Barr MJ, 2014, J STRENGTH COND RES, V28, P2724, DOI 10.1519/JSC.0000000000000364; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Cahill N, 2013, J SPORT SCI, V31, P229, DOI 10.1080/02640414.2012.727456; Castellano J, 2011, J SPORT SCI MED, V10, P233; Clarke AC, 2017, J STRENGTH COND RES, V31, P1116, DOI 10.1519/JSC.0000000000001576; Cunniffe B, 2011, J SPORT MED PHYS FIT, V51, P329; Cunniffe B, 2010, EUR J APPL PHYSIOL, V108, P113, DOI 10.1007/s00421-009-1200-9; Cunniffe B, 2009, J STRENGTH COND RES, V23, P1195, DOI 10.1519/JSC.0b013e3181a3928b; Cunningham D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153275; Darrall-Jones JD, 2015, J STRENGTH COND RES, V29, P2086, DOI 10.1519/JSC.0000000000000872; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; Duthie G, 2005, J SPORT SCI, V23, P523, DOI 10.1080/02640410410001730188; Eaton C, 2006, PHYS THER SPORT, V7, P22, DOI 10.1016/j.ptsp.2005.08.006; Gabbett TJ, 2016, BRIT J SPORT MED, V50, P273, DOI 10.1136/bjsports-2015-095788; Gabbett TJ, 2013, J STRENGTH COND RES, V27, P1623, DOI 10.1519/JSC.0b013e318274f2af; Gabbett TJ, 2002, BRIT J SPORT MED, V36, P334, DOI 10.1136/bjsm.36.5.334; Gannon EA, 2016, INT J SPORT PHYSIOL, V11, P381, DOI 10.1123/ijspp.2015-0337; Hansen KT, 2011, J STRENGTH COND RES, V25, P2382, DOI 10.1519/JSC.0b013e318201bf48; Harley JA, 2010, J SPORT SCI, V28, P1391, DOI 10.1080/02640414.2010.510142; Higham DG, 2012, J SCI MED SPORT, V15, P277, DOI 10.1016/j.jsams.2011.11.256; Jennings DH, 2012, J STRENGTH COND RES, V26, P947, DOI 10.1519/JSC.0b013e31822e5913; Jones MR, 2015, EUR J SPORT SCI, V15, P488, DOI 10.1080/17461391.2015.1010106; Jones MR, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-38; Jones NMP, 2008, J SPORT SCI, V26, P691, DOI 10.1080/02640410701815170; Lacome M, 2014, J SPORT SCI, V32, P290, DOI 10.1080/02640414.2013.823225; Lindsay A, 2015, EUR J SPORT SCI, V15, P480, DOI 10.1080/17461391.2015.1025858; Lombard WP, 2015, J STRENGTH COND RES, V29, P980, DOI 10.1519/JSC.0000000000000724; McLean DA, 1992, J SPORT SCI, V10, P285, DOI 10.1080/02640419208729927; McLellan CP, 2013, J STRENGTH COND RES, V27, P3266, DOI 10.1519/JSC.0b013e31828f1d74; McLellan CP, 2011, J STRENGTH COND RES, V25, P1703, DOI 10.1519/JSC.0b013e3181ddf678; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Olds T, 2001, J SPORT SCI, V19, P253, DOI 10.1080/026404101750158312; Owen SM, 2015, J SPORT SCI, V33, P2061, DOI 10.1080/02640414.2015.1028086; Preatoni E, 2013, SCAND J MED SCI SPOR, V23, pe178, DOI 10.1111/sms.12048; Quarrie KL, 2013, J SCI MED SPORT, V16, P353, DOI 10.1016/j.jsams.2012.08.005; Reardon C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133410; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; Russell M, 2016, HUM MOVEMENT SCI, V45, P96, DOI 10.1016/j.humov.2015.11.011; Russell M, 2015, J SPORT SCI, V33, P2133, DOI 10.1080/02640414.2015.1064153; Russell M, 2016, J STRENGTH COND RES, V30, P2839, DOI 10.1519/JSC.0000000000000805; Sirotic AC, 2009, J SPORT SCI, V27, P203, DOI 10.1080/02640410802520802; Tierney PJ, 2016, HUM MOVEMENT SCI, V49, P1, DOI 10.1016/j.humov.2016.05.007; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941	47	20	20	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164990	10.1371/journal.pone.0164990	http://dx.doi.org/10.1371/journal.pone.0164990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824865	gold, Green Published, Green Submitted			2022-12-27	WOS:000387615200010
J	Embrey, M; Vialle-Valentin, C; Dillip, A; Kihiyo, B; Mbwasi, R; Semali, IA; Chalker, JC; Liana, J; Lieber, R; Johnson, K; Rutta, E; Kimatta, S; Shekalaghe, E; Valimba, R; Ross-Degnan, D				Embrey, Martha; Vialle-Valentin, Catherine; Dillip, Angel; Kihiyo, Bernard; Mbwasi, Romuald; Semali, Innocent A.; Chalker, John C.; Liana, Jafary; Lieber, Rachel; Johnson, Keith; Rutta, Edmund; Kimatta, Suleiman; Shekalaghe, Elizabeth; Valimba, Richard; Ross-Degnan, Dennis			Understanding the Role of Accredited Drug Dispensing Outlets in Tanzania's Health System	PLOS ONE			English	Article							MALARIA TREATMENT; COMMUNITY; KNOWLEDGE; ACCESS; FEVER; CARE	Introduction People in many low-income countries access medicines from retail drug shops. In Tanzania, a public-private partnership launched in 2003 used an accreditation approach to improve access to quality medicines and pharmaceutical services in underserved areas. The government scaled up the accredited drug dispensing outlet (ADDO) program nationally, with over 9,000 shops now accredited. This study assessed the relationships between community members and their sources of health care and medicines, particularly antimicrobials, with a specific focus on the role ADDOs play in the health care system. Methods Using mixed methods, we collected data in four regions. We surveyed 1,185 households and audited 96 ADDOs and 84 public/nongovernmental health facilities using a list of 17 tracer drugs. To determine practices in health facilities, we interviewed 1,365 exiting patients. To assess dispensing practices, mystery shoppers visited 306 ADDOs presenting one of three scenarios (102 each) about a child's respiratory symptoms. Results and Discussion Of 614 household members with a recent acute illness, 73% sought outside care-30% at a public facility and 31% at an ADDO. However, people bought medicines more often at ADDOs no matter who recommended the treatment; of the 581 medicines that people had received, 49% came from an ADDO. Although health facilities and ADDOs had similar availability of antimicrobials, ADDOs had more pediatric formulations available (p<0.001). The common perception was that drugs from ADDOs are more expensive, but the difference in the median cost to treat pneumonia was relatively minimal (US$0.26 in a public facility and US$0.30 in an ADDO). Over 20% of households said they had someone with a chronic condition, with 93% taking medication, but ADDOs are allowed to sell very few chronic care-related medicines. ADDO dispensers are trained to refer complicated cases to a health facility, and notably, 99% of mystery shoppers presenting a pneumonia scenario received an antimicrobial (54%), a referral (90%), or both (45%), which are recommended practices for managing pediatric pneumonia. However, one-third of the dispensers needlessly sold antibiotics for cold symptoms, and 85% sold an antibiotic on request. In addition, the pneumonia scenario elicited more advice on handling the illness than the cold symptoms scenario (61% vs. 15%; p<0.0001), but overall, only 44% of the dispensers asked any of the shoppers about danger signs potentially associated with pneumonia in a child. Conclusion ADDOs are the principal source of medicines in Tanzania and an important part of a multifaceted health care system. Poor prescribing in health facilities, poor dispensing at ADDOs, and inappropriate patient demand continue to contribute to inappropriate medicines use. Therefore, while accreditation has attempted to address the quality of pharmaceutical services in private sector drug outlets, efforts to improve access to and use of medicines in Tanzania need to target ADDOs, public/nongovernmental health facilities, and the public to be effective.	[Embrey, Martha; Chalker, John C.; Lieber, Rachel; Johnson, Keith; Rutta, Edmund] Management Sci Hlth, Pharmaceut & Hlth Technol Grp, Arlington, VA 22203 USA; [Vialle-Valentin, Catherine; Ross-Degnan, Dennis] Harvard Med Sch, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Drug Policy Res Grp, Boston, MA USA; [Dillip, Angel] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Kihiyo, Bernard] Tanzania Consumer Advocacy Soc, Dar Es Salaam, Tanzania; [Mbwasi, Romuald] St Johns Univ Dodoma, Apotheker Consultancy Ltd T, Dodoma, Tanzania; [Semali, Innocent A.] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth, Dar Es Salaam, Tanzania; [Liana, Jafary; Kimatta, Suleiman; Valimba, Richard] Management Sci Hlth, Pharmaceut & Hlth Technol Grp, Dar Es Salaam, Tanzania; [Shekalaghe, Elizabeth] Pharm Council Tanzania, Dar Es Salaam, Tanzania	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Ifakara Health Institute; Muhimbili University of Health & Allied Sciences	Embrey, M (corresponding author), Management Sci Hlth, Pharmaceut & Hlth Technol Grp, Arlington, VA 22203 USA.	membrey@msh.org		Embrey, Martha/0000-0002-2556-6487	Bill & Melinda Gates Foundation [OPP1017439]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was supported by the Bill & Melinda Gates Foundation, www.gatesfoundation.org/, under grant OPP1017439 to KJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Romuald Mbwasi is employed by Apotheker Consultancy (T) Limited. Apotheker Consultancy (T) Limited provided support in the form of salary for author RM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alba S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-163; [Anonymous], 2013, 6610 WHA; Awor P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115440; Battersby A, 2003, IMPROVING SUPPLY DIS; Beyeler N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117165; Bigdeli M, 2014, MED HLTH SYSTEMS ADV, P74; Center for Pharmaceutical Management, 2001, ACC ESS MED TANZ 200; Chalker JC, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0075-2; Chipwaza B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-252; Chipwaza B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002896; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Dillip A, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0073-4; East Africa Drug Seller Initiative, 2011, EV REP; Geldsetzer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093427; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Hertz JT, 2013, TROP MED INT HEALTH, V18, P1406, DOI 10.1111/tmi.12191; Lagomarsino H, 2009, PUBLIC STEWARDSHIP P; Madden JM, 1997, SOC SCI MED, V45, P1465, DOI 10.1016/S0277-9536(97)00076-2; Management Sciences for Health, 2008, ACCR DRUG DISP OUTL; Metta E, 2014, GLOBAL HEALTH ACTION, V7, P148, DOI 10.3402/gha.v7.23439; Mikkelsen-Lopez I, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-444; Ministry of Health and Social Welfare, 2013, STANDARD TREATMENT G; Ministry of Health and Social Welfare Reproductive and Child Health Section, 2010, NAT FAM PLANN COST I; National Malaria Control Program and Clinton Health Access Initiative. mRDTs, 2014, ADDO PROGR STAK M AR; Rutta D, 2009, PROG COMM HLTH PARTN, p[3, 145], DOI [10.1353/cpr.0.0063PMID: 20208262, DOI 10.1353/CPR.0.0063]; Rutta E, 2014, INT J TUBERC LUNG D, V18, P1108, DOI 10.5588/ijtld.14.0020; Rutta E, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-22; Shah NM, 2011, HEALTH POLICY PLANN, V26, P275, DOI 10.1093/heapol/czq074; The United Republic of Tanzania, 2008, HLTH SECT STRAT PLAN; Tumwikirize W A, 2004, East Afr Med J, VSuppl, pS33; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, GLOB HLTH OBS DAT RE; World Health Organization, 2014, NONC DIS COUNTR PROF; World Health Organization Department of Child Adolescent Health World Health Organization and UNICEF, 2005, HDB IMCI INT MAN CHI	35	24	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164332	10.1371/journal.pone.0164332	http://dx.doi.org/10.1371/journal.pone.0164332			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824876	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200005
J	Lee, N; Ryu, HG; Kwon, JH; Kim, DK; Kim, SR; Wang, HJ; Kim, KT; Choi, KY				Lee, Namgyu; Ryu, Hye Guk; Kwon, Jung-Hee; Kim, Dae-Kyum; Kim, Sae Rom; Wang, Hee Jung; Kim, Kyong-Tai; Choi, Kwan Yong			SIRT6 Depletion Suppresses Tumor Growth by Promoting Cellular Senescence Induced by DNA Damage in HCC	PLOS ONE			English	Article							HISTONE DEACETYLASE SIRT6; HEPATOCELLULAR-CARCINOMA; TELOMERE DYSFUNCTION; CANCER-CELLS; REPAIR; EXPRESSION; METABOLISM; RESISTANCE; MUTATIONS; APOPTOSIS	The role of Sirtuin 6 (SIRT6) as a tumor suppressor or oncogene in liver cancer remains controversial. Thus, we identified the specific role of SIRT6 in the progression of hepatocellular carcinoma (HCC). SIRT6 expression was significantly higher in HCC cell lines and HCC tissues from 138 patients than in an immortalized hepatocyte cell line, THLE-2 and non-tumor tissues, respectively. SIRT6 knockdown by shRNA suppressed the growth of HCC cells and inhibited HCC tumor growth in vivo. In addition, SIRT6 silencing significantly prevented the growth of HCC cell lines by inducing cellular senescence in the p16/Rb- and p53/p21-pathway independent manners. Microarray analysis revealed that the expression of genes involved in nucleosome assembly was apparently altered in SIRT6-depleted Hep3B cells. SIRT6 knockdown promoted G2/M phase arrest and downregulation of genes encoding histone variants associated with nucleosome assembly, which could be attributed to DNA damage. Taken together, our findings suggest that SIRT6 acts as a tumor promoter by preventing DNA damage and cellular senescence, indicating that SIRT6 represents a potential therapeutic target for the treatment of HCC.	[Lee, Namgyu; Ryu, Hye Guk; Kim, Sae Rom; Kim, Kyong-Tai; Choi, Kwan Yong] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, Gyeongbuk, South Korea; [Kwon, Jung-Hee] Cbs Biosci Inc, Daejeon, South Korea; [Kim, Dae-Kyum] Univ Toronto, Donnelly Ctr, Dept Mol Genet, Toronto, ON, Canada; [Kim, Dae-Kyum] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Kim, Dae-Kyum] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Wang, Hee Jung] Ajou Univ, Sch Med, Dept Surg, Suwon, South Korea; [Kim, Kyong-Tai; Choi, Kwan Yong] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, Gyeongbuk, South Korea; [Lee, Namgyu] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA	Pohang University of Science & Technology (POSTECH); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Ajou University; Pohang University of Science & Technology (POSTECH); University of Massachusetts System; University of Massachusetts Worcester	Choi, KY (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang, Gyeongbuk, South Korea.; Choi, KY (corresponding author), Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, Gyeongbuk, South Korea.	kchoi@postech.ac.kr		KIM, KYONG-TAI/0000-0001-7292-2627; Kim, Dae-Kyum/0000-0003-4568-8278; Lee, Namgyu/0000-0002-2980-2758	National Research Foundation of Korea (NRF) grant - Korea government (MEST) [2014R1A2A2A01002931]; Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ011216012016]; CbsBioscience	National Research Foundation of Korea (NRF) grant - Korea government (MEST)(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; CbsBioscience	This study was supported by a grant from the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2014R1A2A2A01002931) and the Next Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (PJ011216012016). The funders provided support in the form of salaries for authors [NL, KYC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. JHK is employees of CbsBioscience, whose company provided support in the form of salary for her, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2014, HEPATOLOGY, V60, P1972, DOI 10.1002/hep.27198; Bauer I, 2012, J BIOL CHEM, V287, P40924, DOI 10.1074/jbc.M112.405837; de Jesus BB, 2012, CIRC RES, V111, P97, DOI 10.1161/CIRCRESAHA.111.247866; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cardus A, 2013, CARDIOVASC RES, V97, P571, DOI 10.1093/cvr/cvs352; Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; DiPaola RS, 2002, CLIN CANCER RES, V8, P3311; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Feng XX, 2015, CANCER SCI, V106, P559, DOI 10.1111/cas.12632; Feser J, 2011, FEBS LETT, V585, P2041, DOI 10.1016/j.febslet.2010.11.016; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Hengstschlager M, 1999, MUTAT RES-REV MUTAT, V436, P1, DOI 10.1016/S1383-5742(98)00022-2; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia GX, 2012, MOL CELL BIOCHEM, V364, P345, DOI 10.1007/s11010-012-1236-8; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Khongkow M, 2013, CARCINOGENESIS, V34, P1476, DOI 10.1093/carcin/bgt098; Kugel S, 2015, CELL REP, V13, P479, DOI 10.1016/j.celrep.2015.09.022; Kwon JH, 2010, CLIN CANCER RES, V16, P5511, DOI 10.1158/1078-0432.CCR-10-0825; Lee N, 2015, ONCOTARGET, V6, P30130, DOI 10.18632/oncotarget.4967; Lee N, 2014, PROTEOMICS, V14, P1610, DOI 10.1002/pmic.201400001; Liu R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/470393; Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x; Lombard DB, 2009, AGING-US, V1, P12, DOI 10.18632/aging.100014; Lopez MF, 2012, AGING-US, V4, P823, DOI 10.18632/aging.100507; Mao ZY, 2012, P NATL ACAD SCI USA, V109, P11800, DOI 10.1073/pnas.1200583109; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Marquardt JU, 2013, HEPATOLOGY, V58, P1054, DOI 10.1002/hep.26413; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590; Minagawa S, 2011, AM J PHYSIOL-LUNG C, V300, pL391, DOI 10.1152/ajplung.00097.2010; Nagai K, 2015, OSTEOARTHR CARTILAGE, V23, P1412, DOI 10.1016/j.joca.2015.03.024; Oberdoerffer P, 2010, NAT CELL BIOL, V12, P1029, DOI 10.1038/ncb1110-1029; Ran LK, 2016, CLIN CANCER RES, V22, P3372, DOI 10.1158/1078-0432.CCR-15-1638; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Sociali G, 2015, EUR J MED CHEM, V102, P530, DOI 10.1016/j.ejmech.2015.08.024; Takasaka N, 2014, J IMMUNOL, V192, P958, DOI 10.4049/jimmunol.1302341; Thirumurthi U, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005076; Wang D, 2014, DNA CELL BIOL, V33, P581, DOI 10.1089/dna.2013.2257	42	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165835	10.1371/journal.pone.0165835	http://dx.doi.org/10.1371/journal.pone.0165835			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824900	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200036
J	Fullston, T; Ohlsson-Teague, EMC; Print, CG; Sandeman, LY; Lane, M				Fullston, Tod; Ohlsson-Teague, E. Maria C.; Print, Cristin G.; Sandeman, Lauren Y.; Lane, Michelle			Sperm microRNA Content Is Altered in a Mouse Model of Male Obesity, but the Same Suite of microRNAs Are Not Altered in Offspring's Sperm	PLOS ONE			English	Article							BODY-MASS INDEX; DIET-INDUCED OBESITY; HIGH-FAT DIET; DNA METHYLTRANSFERASES 3A; SLOW GROWTH PERIOD; PATERNAL OBESITY; TRANSGENERATIONAL INHERITANCE; SUBSEQUENT GENERATIONS; METABOLIC SYNDROME; SPERMATOZOAL RNAS	The prevalence of obesity is increasing worldwide and has tripled in men of reproductive age since the 1970s. Concerningly, obesity is not only comorbid with other chronic diseases, but there is mounting evidence that it increases the non-communicable disease load in their children (eg mortality, obesity, autism). Animal studies have demonstrated that paternal obesity increases the risk of metabolic (eg glucose metabolism defects, obesity) and reproductive disorders in offspring. Epigenetic changes within sperm are clear mechanistic candidates that are associated with both changes to the father's environment and offspring phenotype. Specifically there is emerging evidence that a father's sperm microRNA content both responds to paternal environmental cues and alters the gene expression profile and subsequent development of the early embryo. We used a mouse model of high fat diet (HFD) induced obesity to investigate whether male obesity could modulate sperm microRNA content. We also investigated whether this alteration to a father's sperm microRNA content lead to a similar change in the sperm of male offspring. Our investigations were initially guided by a Taqman PCR array, which indicated the differential abundance of 28 sperm borne microRNAs in HFD mice. qPCR confirmation in a much larger cohort of founder males demonstrated that 13 of these microRNAs were differentially abundant (11 up-regulated; 2 down-regulated) due to HFD feeding. Despite metabolic and reproductive phenotypes also being observed in grand-offspring fathered via the male offspring lineage, there was no evidence that any of the 13 microRNAs were also dysregulated in male offspring sperm. This was presumably due to the variation seen within both groups of offspring and suggests other mechanisms might act between offspring and grand-offspring. Thus 13 sperm borne microRNAs are modulated by a father's HFD and the presumed transfer of this altered microRNA payload to the embryo at fertilisation potentially acts to alter the embryonic molecular makeup post-fertilisation, altering its growth trajectory, ultimately affecting adult offspring phenotype and may contribute to paternal programming.	[Fullston, Tod; Ohlsson-Teague, E. Maria C.; Sandeman, Lauren Y.; Lane, Michelle] Univ Adelaide, Discipline Obstet & Gynaecol, Sch Med, Robinson Res Inst, Adelaide, SA 5005, Australia; [Fullston, Tod; Lane, Michelle] Univ Adelaide, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA 5005, Australia; [Print, Cristin G.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1142, New Zealand; [Print, Cristin G.] Univ Auckland, New Zealand Bioinformat Inst, Auckland 1142, New Zealand; [Lane, Michelle] Monash IVF Grp, Melbourne, Vic 3168, Australia	Robinson Research Institute; University of Adelaide; University of Adelaide; University of Auckland; University of Auckland	Fullston, T (corresponding author), Univ Adelaide, Discipline Obstet & Gynaecol, Sch Med, Robinson Res Inst, Adelaide, SA 5005, Australia.; Fullston, T (corresponding author), Univ Adelaide, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA 5005, Australia.	tod.fullston@adelaide.edu.au		Print, Cristin/0000-0001-8345-7812	Senior Research Fellowship - National Health and Medical Research Council [APP1042089]; Project Grant - National Health and Medical Research Council [APP1022882]; National Health and Medical Research Council [APP1036561]; Robinson Research Institute	Senior Research Fellowship - National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Project Grant - National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Robinson Research Institute	ML was funded by a Senior Research Fellowship (APP1042089) and a Project Grant (APP1022882) awarded by the National Health and Medical Research Council (www.nhmrc.gov.au) to undertake this research TF was awarded an Early Career Fellowship (APP1036561) by the National Health and Medical Research Council (www.nhmrc.gov.au) to undertake this research TF was subsequently awarded a Robinson Research Institute (www.adelaide.edu.au/robinson-research-institute) Career Development Fellowship to undertake this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Bakos HW, 2011, FERTIL STERIL, V95, P1700, DOI 10.1016/j.fertnstert.2010.11.044; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Belleannee C, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110486; Binder NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052304; Bogazzi F, 2013, ENDOCRINOLOGY, V154, P4226, DOI 10.1210/en.2013-1220; Bohacek J, 2015, NAT REV GENET, V16, P641, DOI 10.1038/nrg3964; Bygren LO, 2001, ACTA BIOTHEOR, V49, P53, DOI 10.1023/A:1010241825519; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Chiang PH, 2009, WORLD J GASTROENTERO, V15, P5334, DOI 10.3748/wjg.15.5334; Dadoune JP, 2009, MICROSC RES TECHNIQ, V72, P536, DOI 10.1002/jemt.20697; Danielzik S, 2002, EUR J NUTR, V41, P132, DOI 10.1007/s00394-002-0367-1; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Dong HF, 2013, CHEM REV, V113, P6207, DOI 10.1021/cr300362f; Erel CT, 2009, CURR OPIN OBSTET GYN, V21, P228, DOI 10.1097/GCO.0b013e32832aee96; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Foygel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004109; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Freeman E, 2012, INT J OBESITY, V36, P12, DOI 10.1038/ijo.2011.198; Fullston T, 2012, HUM REPROD, V27, P1391, DOI 10.1093/humrep/des030; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Gapp K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6466; Grandjean V, 2015, SCI REP-UK, V5, DOI 10.1038/srep18193; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Holland ML, 2013, BIOCHEM SOC T, V41, P769, DOI 10.1042/BST20130043; Huang Q, 2014, CELL BIOL INT, V38, P1384, DOI 10.1002/cbin.10334; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Katzmarzyk PT, 2004, CAN J PUBLIC HEALTH, V95, P16, DOI 10.1007/BF03403627; Kawano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044542; Li L, 2009, AM J CLIN NUTR, V89, P551, DOI 10.3945/ajcn.2008.26759; Li Y, 2012, GENE, V497, P330, DOI 10.1016/j.gene.2012.01.038; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Mar JC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-110; McPherson NO, 2014, FERTIL STERIL, V101, P1458, DOI 10.1016/j.fertnstert.2013.12.057; McPherson NO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071459; McPherson NO, 2015, AM J PHYSIOL-ENDOC M; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Murphy SK, 2014, NAT REV ENDOCRINOL, V10, P389, DOI 10.1038/nrendo.2014.81; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; Ng EKO, 2014, TUMOR BIOL, V35, P2591, DOI 10.1007/s13277-013-1341-7; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Nilsson EE, 2015, TRANSL RES, V165, P12, DOI 10.1016/j.trsl.2014.02.003; Nixon B, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132209; Nixon B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135605; Ostermeier GC, 2005, J ANDROL, V26, P70; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Palmer NO, 2012, AM J PHYSIOL-ENDOC M, V302, pE768, DOI 10.1152/ajpendo.00401.2011; Palmer NO, 2011, REPROD FERT DEVELOP, V23, P929, DOI 10.1071/RD10326; Pang RTK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027878; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rato L, 2014, OBES REV, V15, P996, DOI 10.1111/obr.12226; Rodgers AB, 2015, P NATL ACAD SCI US; Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Shayeb AG, 2011, REPROD BIOMED ONLINE, V23, P717, DOI 10.1016/j.rbmo.2011.07.018; Shen JZ, 2014, ONCOL REP, V31, P2035, DOI 10.3892/or.2014.3078; Suren P, 2014, PEDIATRICS, V133, pE1128, DOI 10.1542/peds.2013-3664; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050; Tamashiro KL, 2011, STRESS, V14, P468, DOI 10.3109/10253890.2011.606341; Tunc O, 2011, ANDROLOGIA, V43, P121, DOI 10.1111/j.1439-0272.2009.01032.x; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Wahlqvist ML, 2014, ECOL FOOD NUTR, V53, P81, DOI 10.1080/03670244.2013.772512; Wang Y, 2007, NAT PROTOC, V2, P972, DOI 10.1038/nprot.2007.144; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; Wilson J.S., 2010, WHO LAB MAN EX PROC; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yahagi N, 2003, J BIOL CHEM, V278, P25395, DOI 10.1074/jbc.M302364200; Zhao S, 2011, ARTHRITIS RHEUM-US, V63, P1376, DOI 10.1002/art.30196	74	57	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166076	10.1371/journal.pone.0166076	http://dx.doi.org/10.1371/journal.pone.0166076			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814400	Green Submitted, gold, Green Published			2022-12-27	WOS:000386911100030
J	Grgic, RG; Crespi, SA; De'Sperati, C				Grgic, Regina Gregori; Crespi, Sofia Allegra; de'Sperati, Claudio			Assessing Self-Awareness through Gaze Agency	PLOS ONE			English	Article							TELEOLOGICAL EXPLANATIONS; SENSORY CONSEQUENCES; VOLUNTARY ACTION; NEURAL REUSE; ATTENTION; AUTISM; SCHIZOPHRENIA; MODEL; PREFERENCE; INTENTION	We define gaze agency as the awareness of the causal effect of one's own eye movements in gaze-contingent environments, which might soon become a widespread reality with the diffusion of gaze-operated devices. Here we propose a method for measuring gaze agency based on self-monitoring propensity and sensitivity. In one task, naif observers watched bouncing balls on a computer monitor with the goal of discovering the cause of concurrently presented beeps, which were generated in real-time by their saccades or by other events (Discovery Task). We manipulated observers' self-awareness by pre-exposing them to a condition in which beeps depended on gaze direction or by focusing their attention to their own eyes. These manipulations increased propensity to agency discovery. In a second task, which served to monitor agency sensitivity at the sensori-motor level, observers were explicitly asked to detect gaze agency (Detection Task). Both tasks turned out to be well suited to measure both increases and decreases of gaze agency. We did not find evident oculomotor correlates of agency discovery or detection. A strength of our approach is that it probes self-monitoring propensity-difficult to evaluate with traditional tasks based on bodily agency. In addition to putting a lens on this novel cognitive function, measuring gaze agency could reveal subtle self-awareness deficits in pathological conditions and during development.	[Grgic, Regina Gregori; Crespi, Sofia Allegra; de'Sperati, Claudio] Univ Vita Salute San Raffaele, Fac Psychol, Via Olgettina 58, I-20132 Milan, Italy; [Grgic, Regina Gregori; Crespi, Sofia Allegra; de'Sperati, Claudio] Univ Vita Salute San Raffaele, Lab Act Percept Cognit, Via Olgettina 58, I-20132 Milan, Italy; [Grgic, Regina Gregori; Crespi, Sofia Allegra; de'Sperati, Claudio] IRCCS San Raffaele Sci Inst, Div Neurosci, Expt Psychol Unit, Via Olgettina 60, I-20132 Milan, Italy; [Crespi, Sofia Allegra] IRCCS San Raffaele Sci Inst, Neuroradiol Dept, CERMAC, Via Olgettina 60, I-20132 Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	De'Sperati, C (corresponding author), Univ Vita Salute San Raffaele, Fac Psychol, Via Olgettina 58, I-20132 Milan, Italy.; De'Sperati, C (corresponding author), Univ Vita Salute San Raffaele, Lab Act Percept Cognit, Via Olgettina 58, I-20132 Milan, Italy.	desperati.claudio@hsr.it		de'sperati, claudio/0000-0002-7322-2240	Futuro in ricerca [RBFR1332DJ]; Ministero dell'Istruzione dell'Universita e della Ricerca, SAC	Futuro in ricerca; Ministero dell'Istruzione dell'Universita e della Ricerca, SAC	This work was supported by Futuro in ricerca 2013, http://firb.miur.it/, grant number: RBFR1332DJ; Ministero dell'Istruzione dell'Universita e della Ricerca, SAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht B, 2008, BIOL PSYCHIAT, V64, P615, DOI 10.1016/j.biopsych.2007.12.016; Anderson ML, 2016, DEV MED CHILD NEUROL, V58, P3, DOI 10.1111/dmcn.13039; Anderson ML, 2010, BEHAV BRAIN SCI, V33, P245, DOI 10.1017/S0140525X10000853; Bandura A, 2006, PERSPECT PSYCHOL SCI, V1, P164, DOI 10.1111/j.1745-6916.2006.00011.x; Berger A, 2000, NEUROSCI BIOBEHAV R, V24, P3, DOI 10.1016/S0149-7634(99)00046-9; BRIDGEMAN B, 1994, BEHAV BRAIN SCI, V17, P247, DOI 10.1017/S0140525X00034361; Brown GS, 2005, BEHAV RES METHODS, V37, P436, DOI 10.3758/BF03192712; Cavazzana Annachiara, 2014, Front Hum Neurosci, V8, P651, DOI 10.3389/fnhum.2014.00651; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Crespi S, 2012, J VISION, V12, DOI 10.1167/12.11.30; Daprati E, 1997, COGNITION, V65, P71, DOI 10.1016/S0010-0277(97)00039-5; de'Sperati C, 2003, J COGNITIVE NEUROSCI, V15, P1244, DOI 10.1162/089892903322598184; De'Sperati C, 2008, J NEUROSCI, V28, P4317, DOI 10.1523/JNEUROSCI.0352-08.2008; Deubel H, 2008, PSYCHOL RES-PSYCH FO, V72, P630, DOI 10.1007/s00426-008-0165-3; Dewey JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110118; Dewey JA, 2013, CONSCIOUS COGN, V22, P155, DOI 10.1016/j.concog.2012.12.004; Duchowski A. T., 2006, EYE TRACKING METHODO; Elias DO, 2006, J COMP PHYSIOL A, V192, P785, DOI 10.1007/s00359-006-0116-7; Farb NAS, 2013, CEREB CORTEX, V23, P114, DOI 10.1093/cercor/bhr385; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Fukushima H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072267; Gallagher S, 2004, PSYCHOPATHOLOGY, V37, P8, DOI 10.1159/000077014; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gentsch A, 2012, BIOL PSYCHIAT, V71, P652, DOI 10.1016/j.biopsych.2011.12.022; Gergely G, 1999, EARLY SOCIAL COGNITION, P101; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gibson J.J., 1966, SENSES CONSIDERED PE; Grainger C, 2014, J AUTISM DEV DISORD, V44, P1193, DOI 10.1007/s10803-013-1987-4; Gregori Grgic R, 2015, 16 INT MULTISENSORY; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Haggard P, 2003, NEUROREPORT, V14, P1081, DOI 10.1097/01.wnr.0000073684.00308.c0; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Herwig A, 2015, ANN NY ACAD SCI, V1339, P97, DOI 10.1111/nyas.12672; Herwig A, 2014, J EXP PSYCHOL GEN, V143, P1903, DOI 10.1037/a0036781; Herwig A, 2011, PSYCHON B REV, V18, P531, DOI 10.3758/s13423-011-0063-3; Hill EL, 2002, INFANT CHILD DEV, V11, P159, DOI 10.1002/icd.303; Huestegge L, 2012, PSYCHON B REV, V19, P198, DOI 10.3758/s13423-011-0215-5; Ilg UJ, 1997, PROG NEUROBIOL, V53, P293, DOI 10.1016/S0301-0082(97)00039-7; Jackson P, 2012, J AUTISM DEV DISORD, V42, P697, DOI 10.1007/s10803-011-1296-8; Jeannerod M, 2009, EXP BRAIN RES, V192, P527, DOI 10.1007/s00221-008-1533-3; KALNINS IV, 1973, PERCEPTION, V2, P307, DOI 10.1068/p020307; Keehn B, 2013, NEUROSCI BIOBEHAV R, V37, P164, DOI 10.1016/j.neubiorev.2012.11.014; Kelemen D, 1999, DEV PSYCHOL, V35, P1440, DOI 10.1037/0012-1649.35.6.1440; Khalighinejad N, 2016, P NATL ACAD SCI USA, V113, P8867, DOI 10.1073/pnas.1521223113; Kilbourn K, 2007, 6 NORDC SEM WORKSH D; Limerick H, 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/tnhurn.2014.00643, 10.3389/fnhum.2014.00643]; Lindner A, 2005, CURR BIOL, V15, P1119, DOI 10.1016/j.cub.2005.05.049; Lombrozo T, 2007, PSYCHOL SCI, V18, P999, DOI 10.1111/j.1467-9280.2007.02015.x; Macmillan NA, 2005, DETECTION THEORY USE; Majaranta P., 2014, ADV PHYSL COMPUTING, P39, DOI DOI 10.1007/978-1-4471-6392-3_3; Martinez-Conde S, 2006, PROG BRAIN RES, V154, P151; MENDELSON MJ, 1982, DEV PSYCHOL, V18, P222, DOI 10.1037/0012-1649.18.2.222; Metcalfe J, 2010, COGNITION, V116, P267, DOI 10.1016/j.cognition.2010.05.009; Moore JW, 2012, CONSCIOUS COGN, V21, P59, DOI 10.1016/j.concog.2011.08.010; Moore JW, 2012, CONSCIOUS COGN, V21, P546, DOI 10.1016/j.concog.2011.12.002; Moore JW, 2010, NEUROPSYCHOLOGIA, V48, P1125, DOI 10.1016/j.neuropsychologia.2009.12.014; Mundy P, 2009, AUTISM RES, V2, P2, DOI 10.1002/aur.61; Neisser U., 1976, COGNITION REALITY; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Repp BH, 2007, J EXP PSYCHOL HUMAN, V33, P469, DOI 10.1037/0096-1523.33.2.469; Robino C, 2012, P S EYE TRACK RES AP, P181; Roda C, 2006, COMPUT HUM BEHAV, V22, P557, DOI 10.1016/j.chb.2005.12.005; Roda Claudia, 2011, HUMAN ATTENTION DIGI; ROVEECOLLIER CK, 1980, SCIENCE, V208, P1159, DOI 10.1126/science.7375924; Russell J, 2001, J CHILD PSYCHOL PSYC, V42, P317, DOI 10.1111/1469-7610.00725; Russell J, 1998, J AUTISM DEV DISORD, V28, P177, DOI 10.1023/A:1026009203333; Salvucci DD, 2008, PSYCHOL REV, V115, P101, DOI 10.1037/0033-295X.115.1.101; Sato A, 2005, COGNITION, V94, P241, DOI 10.1016/j.cognition.2004.04.003; Shimojo S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00196; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Synofzik M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00127; Tops M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00429; van Elk M, 2015, COGNITION, V145, P1, DOI 10.1016/j.cognition.2015.08.004; Verschoor SA, 2013, DEVELOPMENTAL SCI, V16, P801, DOI 10.1111/desc.12085; Viviani P, 1990, Rev Oculomot Res, V4, P353; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030884; Weiss C, 2011, COGNITION, V121, P207, DOI 10.1016/j.cognition.2011.06.011; Williams D, 2009, J AUTISM DEV DISORD, V39, P251, DOI 10.1007/s10803-008-0619-x	80	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164682	10.1371/journal.pone.0164682	http://dx.doi.org/10.1371/journal.pone.0164682			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812138	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000012
J	Kallio, A				Kallio, Aleksi			Properties of Fixed-Fixed Models and Alternatives in Presence-Absence Data Analysis	PLOS ONE			English	Article							NULL MODEL; NESTEDNESS; ALGORITHM	Assessing the significance of patterns in presence-absence data is an important question in ecological data analysis, e.g., when studying nestedness. Significance testing can be performed with the commonly used fixed-fixed models, which preserve the row and column sums while permuting the data. The manuscript considers the properties of fixed-fixed models and points out how their strict constraints can lead to limited randomizability. The manuscript considers the question of relaxing row and column sun constraints of the fixed-fixed models. The Rasch models are presented as an alternative with relaxed constraints and sound statistical properties. Models are compared on presence-absence data and surprisingly the fixed-fixed models are observed to produce unreasonably optimistic measures of statistical significance, giving interesting insight into practical effects of limited randomizability.	[Kallio, Aleksi] Aalto Univ, Dept Comp Sci, Espoo, Finland; [Kallio, Aleksi] CSC IT Ctr Sci, Espoo, Finland	Aalto University	Kallio, A (corresponding author), Aalto Univ, Dept Comp Sci, Espoo, Finland.; Kallio, A (corresponding author), CSC IT Ctr Sci, Espoo, Finland.	aleksi.kallio@csc.fi						Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Araujo AIL, 2010, PHYSICA A, V389, P1405, DOI 10.1016/j.physa.2009.11.030; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Cobb GW, 2003, AM MATH MON, V110, P265, DOI 10.2307/3647877; CONNOR EF, 1983, OIKOS, V41, P455, DOI 10.2307/3544105; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; De Bie T, 2011, DATA MIN KNOWL DISC, V23, P407, DOI 10.1007/s10618-010-0209-3; DIAMOND J M, 1976, Emu, V76, P187; Diamond J. M., 1975, ECOLOGY EVOLUTION CO, V342, P444; DIAMOND JM, 1982, OECOLOGIA, V52, P64, DOI 10.1007/BF00349013; Fortelius M., 2007, NEOGENE OLD WORLD DA; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2001, GLOBAL ECOL BIOGEOGR, V10, P337, DOI 10.1046/j.1466-822X.2001.00249.x; Kallio A, 2011, PALAEONTOL ELECTRON, V14; Krause S, 2009, BEHAV ECOL SOCIOBIOL, V63, P1089, DOI 10.1007/s00265-009-0746-1; Maher SP, 2014, METHODS ECOL EVOL, V5, P761, DOI 10.1111/2041-210X.12222; Manceur AM, 2014, METHODS ECOL EVOL, V5, P739, DOI 10.1111/2041-210X.12224; Mannila H, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P480; Moore JE, 2007, OECOLOGIA, V152, P763, DOI 10.1007/s00442-007-0696-0; Navarro-Alberto JA, 2009, POPUL ECOL, V51, P505, DOI 10.1007/s10144-008-0137-x; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Ryser H. J., 1960, B AM MATH SOC, V66, P442, DOI [DOI 10.1090/S0002-9904-1960-10494-6, 10.1090/S0002-9904-1960-10494-6]; Sanderson JG, 1998, OECOLOGIA, V116, P275, DOI 10.1007/s004420050589; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Tsaparas, 2007, ACM T KNOWL DISCOV D, V1, P4, DOI [10.1145/1217299.1217303, DOI 10.1145/1217299.1217303]; Ulrich W, 2006, NESTEDNESS FORTRAN P; Ulrich W, 2012, ECOGRAPHY, V35, P865, DOI 10.1111/j.1600-0587.2012.07671.x; Ulrich W, 2012, ECOL MODEL, V244, P20, DOI 10.1016/j.ecolmodel.2012.06.030; WRIGHT DH, 1992, OECOLOGIA, V92, P416, DOI 10.1007/BF00317469	29	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165456	10.1371/journal.pone.0165456	http://dx.doi.org/10.1371/journal.pone.0165456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812126	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000030
J	Kittinger, C; Lipp, M; Folli, B; Kirschner, A; Baumert, R; Galler, H; Grisold, AJ; Luxner, J; Weissenbacher, M; Farnleitner, AH; Zarfel, G				Kittinger, Clemens; Lipp, Michaela; Folli, Bettina; Kirschner, Alexander; Baumert, Rita; Galler, Herbert; Grisold, Andrea J.; Luxner, Josefa; Weissenbacher, Melanie; Farnleitner, Andreas H.; Zarfel, Gernot			Enterobacteriaceae Isolated from the River Danube: Antibiotic Resistances, with a Focus on the Presence of ESBL and Carbapenemases	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; WATER TREATMENT PLANTS; NDM-1-PRODUCING KLEBSIELLA-PNEUMONIAE; EXTENDED-SPECTRUM; ESCHERICHIA-COLI; WASTE-WATER; CTX-M; ANTIMICROBIAL RESISTANCE; AQUATIC ENVIRONMENT; BACTERIA	In a clinical setting it seems to be normal these days that a relevant proportion or even the majority of different bacterial species has already one or more acquired antibiotic resistances. Unfortunately, the overuse of antibiotics for livestock breeding and medicine has also altered the wild-type resistance profiles of many bacterial species in different environmental settings. As a matter of fact, getting in contact with resistant bacteria is no longer restricted to hospitals. Beside food and food production, the aquatic environment might also play an important role as reservoir and carrier. The aim of this study was the assessment of the resistance patterns of Escherichia coli and Klebsiella spp. out of surface water without prior enrichment and under non-selective culture conditions (for antibiotic resistance). In addition, the presence of clinically important extended spectrum beta lactamase (ESBL) and carbapenmase harboring Enterobacteriaceae should be investigated. During Joint Danube Survey 3 (2013), water samples were taken over the total course of the River Danube. Resistance testing was performed for 21 different antibiotics. Samples were additionally screened for ESBL or carbapenmase harboring Enterobacteriaceae. 39% of all isolated Escherichia coli and 15% of all Klebsiella spp. from the river Danube had at least one acquired resistance. Resistance was found against all tested antibiotics except tigecycline. Taking a look on the whole stretch of the River Danube the proportion of multiresistances did not differ significantly. In total, 35 ESBL harboring Enterobacteriaceae, 17 Escherichia coli, 13 Klebsiella pneumoniae and five Enterobacter spp. were isolated. One Klebsiella pneumoniae harboring NMD-1 carbapenmases and two Enterobacteriaceae with KPC-2 could be identified. Human generated antibiotic resistance is very common in E. coli and Klebsiella spp. in the River Danube. Even isolates with resistance patterns normally associated with intensive care units are present.	[Kittinger, Clemens; Lipp, Michaela; Folli, Bettina; Baumert, Rita; Galler, Herbert; Grisold, Andrea J.; Luxner, Josefa; Weissenbacher, Melanie; Zarfel, Gernot] Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria; [Kirschner, Alexander] Med Univ Vienna, Inst Hyg & Appl Immunol, Water Hyg, Vienna, Austria; [Kirschner, Alexander; Farnleitner, Andreas H.] Vienna Univ Technol, Interuniv Cooperat Ctr Water & Hlth, Vienna, Austria; [Farnleitner, Andreas H.] Vienna Univ Technol, Inst Chem Engn, Res Grp Environm Microbiol & Mol Ecol, Vienna, Austria	Medical University of Graz; Medical University of Vienna; Technische Universitat Wien; Technische Universitat Wien	Zarfel, G (corresponding author), Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria.	gernot.zarfel@medunigraz.at	Kittinger, Clemens/AAK-4360-2020	Kittinger, Clemens/0000-0001-8472-2155; Grisold, Andrea/0000-0002-6937-521X; Zarfel, Gernot/0000-0003-1592-4559; Kirschner, Alexander/0000-0002-9797-3073; Farnleitner, Andreas/0000-0002-0542-5425	Austrian Science Fund (FWF) [P25817-B22]; Austrian Science Fund (FWF) [P 25817] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The study was supported by the Austrian Science Fund (FWF), project nr P25817-B22.	Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; Belmonte O, 2010, PATHOL BIOL, V58, P18, DOI 10.1016/j.patbio.2009.07.021; Blaak H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127752; Bouki C, 2013, ECOTOX ENVIRON SAFE, V91, P1, DOI 10.1016/j.ecoenv.2013.01.016; Boyen F, 2010, VET MICROBIOL, V144, P359, DOI 10.1016/j.vetmic.2010.01.010; Bradford PA, 2004, CLIN INFECT DIS, V39, P55, DOI 10.1086/421495; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Clinical and Laboratory Standards Institute (CLSI), 2008, AUSTRALIA; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; Del Franco M, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0597-z; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Dissanayake DRA, 2014, VET MICROBIOL, V168, P403, DOI 10.1016/j.vetmic.2013.11.028; Eckert C, 2004, ANTIMICROB AGENTS CH, V48, P1249, DOI 10.1128/AAC.48.4.1249-1255.2004; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Gales AC, 2001, J CLIN MICROBIOL, V39, P183, DOI 10.1128/JCM.39.1.183-190.2001; Galler H, 2013, CLIN MICROBIOL INFEC; Hammerum AM, 2010, LANCET INFECT DIS, V10, P829, DOI 10.1016/S1473-3099(10)70276-0; Iredell J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6420; JDS 3. Joint Danube Survey 3, 2015, JDS 3 JOINT DAN SURV; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kiratisin P, 2008, ANTIMICROB AGENTS CH, V52, P2818, DOI 10.1128/AAC.00171-08; Korzeniewska E, 2013, J ENVIRON MANAGE, V128, P904, DOI 10.1016/j.jenvman.2013.06.051; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Kummerer K, 2009, CHEMOSPHERE, V75, P435, DOI 10.1016/j.chemosphere.2008.12.006; Lee K, 2001, CLIN MICROBIOL INFEC, V7, P88, DOI 10.1046/j.1469-0691.2001.00204.x; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Livermore DM, 2012, INT J ANTIMICROB AG, V39, P283, DOI 10.1016/j.ijantimicag.2011.12.012; Luczkiewicz A, 2010, WATER RES, V44, P5089, DOI 10.1016/j.watres.2010.08.007; Markovska R, 2015, APMIS, V123, P887, DOI 10.1111/apm.12433; Mathers AJ, 2015, ADV APPL MICROBIOL, V90, P109, DOI 10.1016/bs.aambs.2014.09.002; Mazzariol A, 2012, EMERG INFECT DIS, V18, P532, DOI [10.3201/eid1803.110389, 10.3201/eid1803.1103890]; Muller A, 2016, SCI TOTAL ENVIRON, V541, P667, DOI 10.1016/j.scitotenv.2015.09.135; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Novovic K, 2015, SCI TOTAL ENVIRON, V511, P393, DOI 10.1016/j.scitotenv.2014.12.072; Ojer-Usoz E, 2014, WATER RES, V56, P37, DOI 10.1016/j.watres.2014.02.041; Paterson DL, 2006, AM J MED, V119, pS20, DOI 10.1016/j.amjmed.2006.03.013; Pietsch M, 2015, VET MICROBIOL; Pignato S, 2010, FOODBORNE PATHOG DIS, V7, P945, DOI 10.1089/fpd.2009.0504; Pitout JDD, 2003, J CLIN MICROBIOL, V41, P3933, DOI 10.1128/JCM.41.8.3933-3935.2003; Poirel L, 2012, ANTIMICROB AGENTS CH, V56, P1662, DOI 10.1128/AAC.05850-11; Poonia Shubra, 2014, Indian J Community Med, V39, P156, DOI 10.4103/0970-0218.137152; Rahube TO, 2012, J APPL MICROBIOL, V112, P1123, DOI 10.1111/j.1365-2672.2012.05301.x; Reinthaler FF, 2013, J WATER HEALTH, V11, P13, DOI 10.2166/wh.2012.207; Reuland EA, 2013, CLIN MICROBIOL INFEC, V19, P542, DOI 10.1111/j.1469-0691.2012.03947.x; Rice LB, 2009, CURR OPIN MICROBIOL, V12, P476, DOI 10.1016/j.mib.2009.08.001; Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032; Schaefer AM, 2009, ECOHEALTH, V6, P33, DOI 10.1007/s10393-009-0221-5; Sola-Gines M, 2015, APPL ENVIRON MICROB, V81, P3604, DOI 10.1128/AEM.04252-14; Taylor NGH, 2011, TRENDS ECOL EVOL, V26, P278, DOI 10.1016/j.tree.2011.03.004; Titilawo Y, 2015, ENVIRON SCI POLLUT R, V22, P10969, DOI 10.1007/s11356-014-3887-3; Torneke K, 2015, J VET PHARMACOL THER, V38, P519, DOI 10.1111/jvp.12226; Toth A, 2010, EUR J CLIN MICROBIOL, V29, P765, DOI 10.1007/s10096-010-0921-3; Viens AM, 2015, PUBLIC HEALTH ETH-UK, V8, P255, DOI 10.1093/phe/phv015; Voulgari E, 2014, J ANTIMICROB CHEMOTH, V69, P2091, DOI 10.1093/jac/dku105; World Health Organization, 2014, SURVEILLANCE ANTIMIC; Zarfel G, 2013, ENVIRON POLLUT, V173, P192, DOI 10.1016/j.envpol.2012.09.019; Zarfel G, 2011, CLIN MICROBIOL INFEC, V17, pE5, DOI 10.1111/j.1469-0691.2011.03659.x; Zhang HN, 2015, ENVIRON SCI POLLUT R, V22, P11488, DOI 10.1007/s11356-015-4387-9; Zhang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111026; Zheng SL, 2011, CHEMOSPHERE, V84, P1677, DOI 10.1016/j.chemosphere.2011.04.076; Zurfluh K, 2013, APPL ENVIRON MICROB, V79, P3021, DOI 10.1128/AEM.00054-13	62	47	50	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165820	10.1371/journal.pone.0165820	http://dx.doi.org/10.1371/journal.pone.0165820			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812159	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000065
J	Lahesaare, A; Ainelo, H; Teppo, A; Kivisaar, M; Heipieper, HJ; Teras, R				Lahesaare, Andrio; Ainelo, Hanna; Teppo, Annika; Kivisaar, Maia; Heipieper, Hermann J.; Teras, Riho			LapF and Its Regulation by Fis Affect the Cell Surface Hydrophobicity of Pseudomonas putida	PLOS ONE			English	Article							BIOFILM FORMATION; ESCHERICHIA-COLI; GENE-EXPRESSION; ADHESION; BACTERIA; PROTEIN; MUTANT; IDENTIFICATION; COLONIZATION; ATTACHMENT	The ability of bacteria to regulate cell surface hydrophobicity is important for the adaptation to different environmental conditions. The hydrophobicity of cell surface can be determined by several factors, including outer membrane and surface proteins. In this study, we report that an adhesin LapF influences cell surface hydrophobicity of Pseudomonas putida. Cells lacking LapF are less hydrophobic than wild-type cells in stationary growth phase. Moreover, the overexpression of the global regulator Fis decreases surface hydrophobicity by repressing the expression of lapF. Flow cytometry analysis revealed that bacteria producing LapF are more viable when confronted with methanol (a hydrophilic compound) but are more susceptible to 1-octanol (a hydrophobic compound). Thus, these results revealed that LapF is the hydrophobicity factor for the cell surface of P. putida.	[Lahesaare, Andrio; Ainelo, Hanna; Teppo, Annika; Kivisaar, Maia; Teras, Riho] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Heipieper, Hermann J.] UFZ Helmholtz Ctr Environm Res, Dept Environm Biotechnol, Leipzig, Germany	University of Tartu; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Teras, R (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia.	riho.teras@ut.ee	Heipieper, Hermann/D-1864-2010; Teras, Riho/ABA-8761-2021	Heipieper, Hermann/0000-0002-3723-9600; Ainelo, Hanna/0000-0003-3340-9120	Targeted Financing Project [SF0180031s08]; Institutional Research Funding from Estonian Ministry of Education and Research [IUT20-19]; European Commission within Project BACSIN [211684]; FEMS Grants [FEMS-RG-2014-0003.R1, FEMS-RG-2015-0051.R1]	Targeted Financing Project; Institutional Research Funding from Estonian Ministry of Education and Research; European Commission within Project BACSIN; FEMS Grants	This work was supported by the funding of the Targeted Financing Project SF0180031s08; the Institutional Research Funding IUT20-19 from Estonian Ministry of Education and Research; the European Commission within its Seventh Framework Program Project BACSIN (Contract No. 211684); and by the FEMS Grants ID #FEMS-RG-2014-0003.R1 and ID #FEMS-RG-2015-0051.R1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adav SS, 2008, BIOTECHNOL ADV, V26, P411, DOI 10.1016/j.biotechadv.2008.05.002; Ali Y., 2001, DISINFECTION STERILI, P229; Baumgarten T, 2012, APPL ENVIRON MICROB, V78, P6217, DOI 10.1128/AEM.01525-12; Bodelon G, 2013, FEMS MICROBIOL REV, V37, P204, DOI 10.1111/j.1574-6976.2012.00347.x; Boyd CD, 2014, J BACTERIOL, V196, P2775, DOI 10.1128/JB.01629-14; Bradley MD, 2007, MICROBIOL-SGM, V153, P2922, DOI 10.1099/mic.0.2007/008565-0; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; Corpe WA, 1980, ADSORPTION MICROORGA, P105; Dalgaard P, 2001, J MICROBIOL METH, V43, P183, DOI 10.1016/S0167-7012(00)00219-0; Dekkers LC, 1998, MOL PLANT MICROBE IN, V11, P763, DOI 10.1094/MPMI.1998.11.8.763; DELORENZO V, 1993, J BACTERIOL, V175, P6902, DOI 10.1128/jb.175.21.6902-6907.1993; Dulla GFJ, 2010, ENVIRON MICROBIOL, V12, P1762, DOI 10.1111/j.1462-2920.2010.02261.x; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; Fuqua C, 2010, MOL MICROBIOL, V77, P533, DOI 10.1111/j.1365-2958.2010.07250.x; Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x; Goulter RM, 2009, LETT APPL MICROBIOL, V49, P1, DOI 10.1111/j.1472-765X.2009.02591.x; Haussler S, 2010, J BACTERIOL, V192, P2941, DOI 10.1128/JB.00332-10; Heipieper HJ, 2007, APPL MICROBIOL BIOT, V74, P961, DOI 10.1007/s00253-006-0833-4; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Higashi JM, 1998, J BIOMED MATER RES, V39, P341, DOI 10.1002/(SICI)1097-4636(19980305)39:3<341::AID-JBM1>3.0.CO;2-J; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8; Jahn A, 1999, BIOFOULING, V14, P49, DOI 10.1080/08927019909378396; Jakovleva J, 2012, MICROBIOL-SGM, V158, P708, DOI 10.1099/mic.0.053355-0; Kobayashi H, 1999, J BACTERIOL, V181, P4493, DOI 10.1128/JB.181.15.4493-4498.1999; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lahesaare A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115901; Liu XW, 2009, BIOTECHNOL ADV, V27, P1061, DOI 10.1016/j.biotechadv.2009.05.020; Lugtenberg BJ, 2014, MICROBIAL PHENAZINES, P163; Lugtenberg BJJ, 2004, PSEUDOMONAS, VOL 1: GENOMICS, LIFE STYLE AND MOLECULAR ARCHITECTURE, P403; Martinez-Gil M, 2014, J BACTERIOL, V196, P1484, DOI 10.1128/JB.01287-13; Martinez-Gil M, 2010, MOL MICROBIOL, V77, P549, DOI 10.1111/j.1365-2958.2010.07249.x; Matilla MA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r179; Montag D, 2012, BIOFOULING, V28, P315, DOI 10.1080/08927014.2012.673219; Moor H, 2014, MICROBIOL-SGM, V160, P2681, DOI 10.1099/mic.0.082503-0; Morath S, 2005, J ENDOTOXIN RES, V11, P348, DOI 10.1179/096805105X67328; Neumann G, 2006, APPL ENVIRON MICROB, V72, P4232, DOI 10.1128/AEM.02904-05; Nolvak H, 2012, SCI TOTAL ENVIRON, V426, P351, DOI 10.1016/j.scitotenv.2012.03.054; Ojangu EL, 2000, J BACTERIOL, V182, P6707, DOI 10.1128/JB.182.23.6707-6713.2000; OSUNA R, 1995, J BACTERIOL, V177, P2021, DOI 10.1128/jb.177.8.2021-2032.1995; PAVEL H, 1994, J BACTERIOL, V176, P7550, DOI 10.1128/JB.176.24.7550-7557.1994; Rodrigues DF, 2009, BIOFOULING, V25, P401, DOI 10.1080/08927010902833443; ROSENBERG M, 1986, ADV MICROB ECOL, V9, P353; Ruhs PA, 2014, COLLOID SURFACE B, V117, P174, DOI 10.1016/j.colsurfb.2014.02.023; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Segura A, 1999, ENVIRON MICROBIOL, V1, P191, DOI 10.1046/j.1462-2920.1999.00033.x; Sharma RC, 1996, BIOTECHNIQUES, V20, P42; Sidhu MS, 1997, MICROBIOL-SGM, V143, P1039, DOI 10.1099/00221287-143-4-1039; Teras R, 2009, MICROBIOL-SGM, V155, P1203, DOI 10.1099/mic.0.022830-0; Torres S, 2011, BIOTECHNOL ADV, V29, P442, DOI 10.1016/j.biotechadv.2011.04.002; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; XU JM, 1995, J BACTERIOL, V177, P938, DOI 10.1128/jb.177.4.938-947.1995; Yeung ATY, 2009, J BACTERIOL, V191, P5592, DOI 10.1128/JB.00157-09; Zahringer U, 1995, Prog Clin Biol Res, V392, P113; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9	57	13	13	8	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166078	10.1371/journal.pone.0166078	http://dx.doi.org/10.1371/journal.pone.0166078			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812186	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000100
J	Damiens, D; Lebon, C; Wilkinson, DA; Dijoux-Millet, D; Le Goff, G; Bheecarry, A; Gouagna, LC				Damiens, David; Lebon, Cyrille; Wilkinson, David A.; Dijoux-Millet, Damien; Le Goff, Gilbert; Bheecarry, Ambicadutt; Gouagna, Louis Clement			Cross-Mating Compatibility and Competitiveness among Aedes albopictus Strains from Distinct Geographic Origins Implications for Future Application of SIT Programs in the South West Indian Ocean Islands	PLOS ONE			English	Article							STANDARD OPERATING PROCEDURES; STERILE INSECT TECHNIQUE; WING SHAPE; DIPTERA-CULICIDAE; AEGYPTI MOSQUITOS; POPULATIONS; SIZE; VECTORS; RELEASE; DENGUE	The production of large numbers of males needed for a sustainable sterile insect technique (SIT) control program requires significant developmental and operational costs. This may constitute a significant economic barrier to the installation of large scale rearing facilities in countries that are undergoing a transition from being largely dependent on insecticide use to be in a position to integrate the SIT against Aedes albopictus. Alternative options available for those countries could be to rely on outsourcing of sterile males from a foreign supplier, or for one centralised facility to produce mosquitoes for several countries, thus increasing the efficiency of the mass-rearing effort. However, demonstration of strain compatibility is a prerequisite for the export of mosquitoes for transborder SIT applications. Here, we compared mating compatibility among Ae. albopictus populations originating from three islands of the South Western Indian Ocean, and assessed both insemination rates and egg fertility in all possible cross-mating combinations. Furthermore, competitiveness between irradiated and non-irradiated males from the three studied strains, and the subsequent effect on female fertility were also examined. Although morphometric analysis of wing shapes suggested phenoptypic differences between Ae. albopictus strains, perfect reproductive compatibility between them was observed. Furthermore, irradiated males from the different islands demonstrated similar levels of competitiveness and induced sterility when confronted with fertile males from any of the other island populations tested. In conclusion, despite the evidence of inter-strain differences based on male wing morphology, collectively, our results provide a new set of expectations for the use of a single candidate strain of mass-reared sterile males for area-wide scale application of SIT against Ae. albopictus populations in different islands across the South Western Indian Ocean. Cross-mating competitiveness tests such as those applied here are necessary to assess the quality of mass reared strains for the trans-border application of sterile male release programs.	[Damiens, David; Le Goff, Gilbert; Gouagna, Louis Clement] IRD, Unite Mixte Rech MIVEGEC, IRD CNRS 5290 UM1 UM2 224, Montpellier, France; [Damiens, David; Lebon, Cyrille; Le Goff, Gilbert; Gouagna, Louis Clement] IRD La Reunion, Plateforme Rech CYROI, St Clotilde, Reunion, France; [Wilkinson, David A.] Univ La Reunion, UMR PIMIT, INSERM U1187 CNRS9192 IRD249, Plateforme Rech CYROI, St Denis, Reunion, France; [Dijoux-Millet, Damien] Univ La Reunion, Inst Univ Technol, Dept Genie Biol, St Pierre, Reunion, France; [Bheecarry, Ambicadutt] Minist Hlth & Qual Life, Vector Biol & Control Div, SSR Bot Garden Rd, Curepipe, Mauritius	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; University of La Reunion	Gouagna, LC (corresponding author), IRD, Unite Mixte Rech MIVEGEC, IRD CNRS 5290 UM1 UM2 224, Montpellier, France.; Gouagna, LC (corresponding author), IRD La Reunion, Plateforme Rech CYROI, St Clotilde, Reunion, France.	louis-clement.gouagna@ird.fr		Le Goff, Gilbert/0000-0001-9913-8736; Gouagna, Louis Clement/0000-0003-0957-4484; Wilkinson, David/0000-0002-9986-6212	Regional SIT feasibility programme [2013-33857]; French Ministry of Health on the phase II SIT program in Reunion Island	Regional SIT feasibility programme; French Ministry of Health on the phase II SIT program in Reunion Island	This work has been performed as part of the "Regional SIT feasibility programme" under the Contract No. 2013-33857 with the European Regional Development Fund (ERDF) within the 2007-2013 European Territorial Cooperation Program on Sustainable Development and Environment. We also gratefully acknowledge the financial contribution of the French Ministry of Health on the phase II SIT program in Reunion Island.	[Anonymous], 2013, INT J BIOCH BIOINFOR; Armbruster P, 2006, ANN ENTOMOL SOC AM, V99, P1234, DOI 10.1603/0013-8746(2006)99[1234:GVOLGI]2.0.CO;2; Atyame CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146834; Ayres C, 2002, MEM I OSWALDO CRUZ, V97, P871, DOI 10.1590/S0074-02762002000600022; Azevedo RBR, 1998, EVOLUTION, V52, P1353, DOI [10.1111/j.1558-5646.1998.tb02017.x, 10.2307/2411305]; Balestrino F, 2014, J MED ENTOMOL, V51, P155, DOI 10.1603/ME13130; Balestrino F, 2012, J MED ENTOMOL, V49, P595, DOI 10.1603/ME11188; Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272; Bellini R., 2007, P505, DOI 10.1007/978-1-4020-6059-5_47; Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048; Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; BLACK WC, 1988, HEREDITY, V61, P439, DOI 10.1038/hdy.1988.136; BLACK WC, 1989, J MED ENTOMOL, V26, P260, DOI 10.1093/jmedent/26.4.260; Bourtzis K, 1996, GENETICS, V144, P1063; Bourtzis K, 2003, CONT T ENT, P217; Bourtzis K., 2006, INSECT SYMBIOSIS VOL, V2, P225, DOI DOI 10.1201/9781420005936.CH14; Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004; Boyer S, 2011, MED VET ENTOMOL, V25, P454, DOI 10.1111/j.1365-2915.2011.00962.x; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; BUSHLAND RC, 1955, SCIENCE, V122, P287, DOI 10.1126/science.122.3163.287; BUSHLAND RC, 1953, J ECON ENTOMOL, V46, P648, DOI 10.1093/jee/46.4.648; COSGROVE JB, 1994, J AM MOSQUITO CONTR, V10, P434; Dame D. A., 1981, CYTOGENETICS GENETIC, P231; Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; Delatte H, 2011, INFECT GENET EVOL, V11, P1769, DOI 10.1016/j.meegid.2011.07.016; Dowell RV, 2021, STERILE INSECT TECHNIQUE, 2 EDITION, P441, DOI 10.1007/1-4020-4051-2_11; Enkerlin W. R., 2004, Proceedings of the 6th International Symposium on fruit flies of economic importance, Stellenbosch, South Africa, 6-10 May 2002, P203; Food and Agriculture Organisation of the United Nations (FAO) / International Atomic Energy Agency (IAEA), 2001, DISCUSSION PAPER ON; Food and Agriculture Organization of the United Nations FAO, 1992, THE NEW WORLD SCREWW; FRIED M, 1971, J ECON ENTOMOL, V64, P869, DOI 10.1093/jee/64.4.869; Gilchrist AS, 2000, EVOL DEV, V2, P114, DOI 10.1046/j.1525-142x.2000.00041.x; Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350; HARRIS E J, 1986, Proceedings of the Hawaiian Entomological Society, V26, P77; Hidalgo K, 2015, ACTA TROP, V143, P79, DOI 10.1016/j.actatropica.2014.12.014; Higgs S, 2006, VECTOR-BORNE ZOONOT, V6, P115, DOI 10.1089/vbz.2006.6.115; Hoffmann AA, 2002, EVOLUTION, V56, P1068, DOI 10.1111/j.0014-3820.2002.tb01418.x; Houle D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-25; IMASHEVA AG, 1995, GENETICA, V96, P303, DOI 10.1007/BF01439584; Iyaloo DP, 2014, ACTA TROP, V132, pS140, DOI 10.1016/j.actatropica.2013.11.011; Jeratthitikul E, 2014, ENTOMOL SCI, V17, P342, DOI 10.1111/ens.12068; Kamgang B, 2010, MED VET ENTOMOL, V24, P132, DOI 10.1111/j.1365-2915.2010.00869.x; Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257; Kean JM, AREA WIDE CONTROL IN, P211; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1; KNIPLING EF, 1968, B WORLD HEALTH ORGAN, V38, P421; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Kolliker-Ott UM, 2003, OIKOS, V100, P563, DOI 10.1034/j.1600-0706.2003.12063.x; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; Leisnham PT, 2008, J MED ENTOMOL, V45, P210, DOI 10.1603/0022-2585(2008)45[210:GVIASA]2.0.CO;2; Lindquist DA, 1993, MANAGEMENT INSECT PE, P319; Lougnon A, 1958, SOUS LE SIGNE DE LA; Lounibos LP, 2003, ANN ENTOMOL SOC AM, V96, P512, DOI 10.1603/0013-8746(2003)096[0512:AEOPDI]2.0.CO;2; LOWE RE, 1980, AM J TROP MED HYG, V29, P695, DOI 10.4269/ajtmh.1980.29.695; Mesbah RA., 2015, J CROP PROT, V4, P207; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797; O'Donnell D, 2009, ANN ENTOMOL SOC AM, V102, P1135, DOI 10.1603/008.102.0623; Oliva CF, 2013, ACTA TROP, V125, P287, DOI 10.1016/j.actatropica.2012.11.010; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; POZZA GD, 1992, J AM MOSQUITO CONTR, V8, P318; POZZA GLD, 1994, J AM MOSQUITO CONTR, V10, P589; Puggioli A, 2013, J MED ENTOMOL, V50, P819, DOI 10.1603/ME13011; Robinson AS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S1; Roff Derek, 2002, pi; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rossler Y, 2000, CROP PROT, V19, P733, DOI 10.1016/S0261-2194(00)00097-1; Sadeghi S, 2009, ODONATOLOGICA, V38, P341; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Stearns S.C., 1992, pi; Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x; Usmani-Brown S, 2009, ANN ENTOMOL SOC AM, V102, P144, DOI 10.1603/008.102.0116; VARGAS RI, 1995, J ECON ENTOMOL, V88, P1279, DOI 10.1093/jee/88.5.1279; Vera MT, 2006, ANN ENTOMOL SOC AM, V99, P387, DOI 10.1603/0013-8746(2006)099[0387:MIAPOT]2.0.CO;2; Villasenor A., 2000, Area-wide control of fruit flies and other insect pests. Joint proceedings of the international conference on area-wide control of insect pests, 28 May-2 June, 1998 and the Fifth International Symposium on Fruit Flies of Economic Importance, Penang, Malaysia, 1-5 June, 1998, P361; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; Walters M. L., 2000, Area-wide control of fruit flies and other insect pests. Joint proceedings of the international conference on area-wide control of insect pests, 28 May-2 June, 1998 and the Fifth International Symposium on Fruit Flies of Economic Importance, Penang, Malaysia, 1-5 June, 1998, P201; Wyss JH, 2000, PROCEEDINGS AREA WID; Yeap HL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-58; Yeap HL, 2013, AM J TROP MED HYG, V89, P78, DOI 10.4269/ajtmh.12-0719; Zhang DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151864; Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194; Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0951-x; Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0631-2	85	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0163788	10.1371/journal.pone.0163788	http://dx.doi.org/10.1371/journal.pone.0163788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806056	gold, Green Submitted, Green Published			2022-12-27	WOS:000386715500007
J	Torres, LS; Okumura, JV; Silva, DGH; Mimura, KKO; Belini, E; Oliveira, RG; Lobo, CLC; Oliani, SM; Bonini-Domingos, CR				Torres, Lidiane S.; Okumura, Jessika V.; Silva, Danilo G. H.; Mimura, Kallyne K. O.; Belini-Junior, Edis; Oliveira, Renan G.; Lobo, Clarisse L. C.; Oliani, Sonia M.; Bonini-Domingos, Claudia R.			Inflammation in Sickle Cell Disease: Differential and Down-Expressed Plasma Levels of Annexin A1 Protein	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION; CLUSTER HAPLOTYPES; ANEMIA; NEUTROPHILS; INJURY; ELECTROPHORESIS; ACTIVATION; RESOLUTION; MEDIATORS	Sickle cell disease (SCD) is an inherited hemolytic anemia whose pathophysiology is driven by polymerization of the hemoglobin S (Hb S), leading to hemolysis and vaso-occlusive events. Inflammation is a fundamental component in these processes and a continuous inflammatory stimulus can lead to tissue damages. Thus, pro-resolving pathways emerge in order to restore the homeostasis. For example there is the annexin A1 (ANXA1), an endogenous anti-inflammatory protein involved in reducing neutrophil-endothelial interactions, accelerating neutrophil apoptosis and stimulating macrophage efferocytosis. We investigated the expression of ANXA1 in plasma of SCD patients and its relation with anemic, hemolytic and inflammatory parameters of the disease. Three SCD genotypes were considered: the homozygous inheritance for Hb S (Hb SS) and the association between Hb S and the hemoglobin variants D-Punjab (Hb SD) and C (Hb SC). ANXA1 and proinflammatory cytokines were quantified by ELISA in plasma of SCD patients and control individuals without hemoglobinopathies. Hematological and biochemical parameters were analyzed by flow cytometry and spectrophotometer. The plasma levels of ANXA1 were about threefold lesser in SCD patients compared to the control group, and within the SCD genotypes the most elevated levels were found in Hb SS individuals (approximately three-fold higher). Proinflammatory cytokines were higher in SCD groups than in the control individuals. Anemic and hemolytic markers were higher in Hb SS and Hb SD genotypes compared to Hb SC patients. White blood cells and platelets count were higher in Hb SS genotype and were positively correlated to ANXA1 levels. We found that ANXA1 is down-regulated and differentially expressed within the SCD genotypes. Its expression seems to depend on the inflammatory, hemolytic and vaso-occlusive characteristics of the diseased. These data may lead to new biological targets for therapeutic intervention in SCD.	[Torres, Lidiane S.; Okumura, Jessika V.; Silva, Danilo G. H.; Belini-Junior, Edis; Oliveira, Renan G.; Bonini-Domingos, Claudia R.] Sao Paulo State Univ UNESP, Dept Biol, Lab Hemoglobin & Hematol Genet Dis, Sao Paulo, Brazil; [Mimura, Kallyne K. O.; Oliani, Sonia M.] Sao Paulo State Univ UNESP, Dept Biol, Lab Immunomorphol, Sao Paulo, Brazil; [Lobo, Clarisse L. C.] Inst Hematol Arthur de Siqueira Cavalcanti HEMORI, Rio De Janeiro, Rio De Janeiro, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Torres, LS (corresponding author), Sao Paulo State Univ UNESP, Dept Biol, Lab Hemoglobin & Hematol Genet Dis, Sao Paulo, Brazil.; Oliani, SM (corresponding author), Sao Paulo State Univ UNESP, Dept Biol, Lab Immunomorphol, Sao Paulo, Brazil.	lidiane.unesp@gmail.com; smoliani@ibilce.unesp.br	Bonini-Domingos, Claudia Regina/Y-4077-2019; Torres, Lidiane S./GQH-1725-2022; Belini, Edis/ABG-3748-2021; Torres, Lidiane/AAL-4450-2020; Belini, Edis/G-4427-2012; Silva, Danilo GH/G-6833-2012; da Silva, Danilo Grünig Humberto/AAI-4688-2021; Bonini-Domingos, Claudia R/F-4964-2012; Oliani, Sonia Maria/E-3476-2012; Mimura, Kallyne/G-6096-2015	Bonini-Domingos, Claudia Regina/0000-0002-4603-9467; Torres, Lidiane S./0000-0002-4598-1899; Belini, Edis/0000-0001-6478-8173; Torres, Lidiane/0000-0002-4598-1899; Belini, Edis/0000-0001-6478-8173; Silva, Danilo GH/0000-0002-5500-9403; da Silva, Danilo Grünig Humberto/0000-0002-5500-9403; Bonini-Domingos, Claudia R/0000-0002-4603-9467; Oliani, Sonia Maria/0000-0003-0918-2130; Mimura, Kallyne/0000-0003-1398-2413	State of Sao Paulo Research Foudation (FAPESP), Brazil [2012/21603-2, 2012/19653-1]; National Council for Scientific and Technological Development (CNPq), Brazil [308144/2014-7]	State of Sao Paulo Research Foudation (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the State of Sao Paulo Research Foudation (FAPESP; grants 2012/21603-2 SMO and 2012/19653-1 LST) and by the National Council for Scientific and Technological Development (CNPq; grant 308144/2014-7 SMO), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI K, 1988, J BIOL CHEM, V263, P5607; Aggarwal BB, 2012, BLOOD, V3, P745; Ballas SK, 2012, SCI WORLD J, DOI 10.1100/2012/949535; Ballas SK, 2012, AM J HEMATOL, V87, P338, DOI 10.1002/ajh.22259; Conran N, 2009, HEMOGLOBIN, V33, P1, DOI 10.1080/03630260802625709; D'Acunto CW, 2014, CELL SIGNAL, V26, P173, DOI 10.1016/j.cellsig.2013.09.020; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Facio FN, 2011, J MOL MED, V89, P51, DOI 10.1007/s00109-010-0684-4; Gastardelo TS, 2009, AM J PATHOL, V174, P177, DOI 10.2353/ajpath.2009.080342; Headland SE, 2015, SEMIN IMMUNOL, V27, P149, DOI 10.1016/j.smim.2015.03.014; Hebbel RP, 2014, HEMATOL ONCOL CLIN N, V28, P181, DOI 10.1016/j.hoc.2013.11.005; Hoppe CC, 2014, HEMATOL ONCOL CLIN N, V28, P265, DOI 10.1016/j.hoc.2013.11.006; Silva DGH, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-108; Kato Gregory J, 2009, Am J Hematol, V84, P618, DOI 10.1002/ajh.21475; La M, 2001, FASEB J, V15, P2247, DOI 10.1096/fj.01-0196com; Lanaro C, 2009, J LEUKOCYTE BIOL, V85, P235, DOI 10.1189/jlb.0708445; Leal MC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00053; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MARENGOROWE AJ, 1965, J CLIN PATHOL, V18, P790, DOI 10.1136/jcp.18.6.790; Monaco C, 2015, INT IMMUNOL, V27, P55, DOI 10.1093/intimm/dxu102; NAGEL R L, 1984, Einstein Quarterly Journal of Biology and Medicine, V2, P53; Nourale M, 2013, HAEMATOLOGICA, V98, P464, DOI 10.3324/haematol.2012.068965; Oliani SM, 2001, AM J PATHOL, V158, P603, DOI 10.1016/S0002-9440(10)64002-3; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Palomo J, 2015, CYTOKINE, V76, P25, DOI 10.1016/j.cyto.2015.06.017; Patel S, 2014, PEDIATR BLOOD CANCER, V61, P1341, DOI 10.1002/pbc.25004; Perretti M, 2004, J LEUKOCYTE BIOL, V76, P25, DOI 10.1189/jlb.1103552; Perretti M, 1997, TRENDS PHARMACOL SCI, V18, P418; POWARS D, 1993, AM J DIS CHILD, V147, P1197, DOI 10.1001/archpedi.1993.02160350071011; POWARS DR, 1991, HEMATOL ONCOL CLIN N, V5, P475, DOI 10.1016/S0889-8588(18)30426-X; Qari MH, 2012, CLIN APPL THROMB-HEM, V18, P195, DOI 10.1177/1076029611420992; Qin CX, 2015, PHARMACOL THERAPEUT, V148, P47, DOI 10.1016/j.pharmthera.2014.11.012; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Rifkind JM, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00500; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sarray S, 2015, CYTOKINE, V72, P43, DOI 10.1016/j.cyto.2014.11.030; Sena A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076969; Serjeant GR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011783; Steinberg MH, 2009, THESCIENTIFICWORLDJO, V9, P46, DOI 10.1100/tsw.2009.10; Sugimoto MA, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8239258; SUTTON M, 1989, AM J HEMATOL, V32, P66, DOI 10.1002/ajh.2830320113; Torres Lidiane de Souza, 2015, Rev. Bras. Hematol. Hemoter., V37, P120, DOI 10.1016/j.bjhh.2015.02.007; Tsai WH, 2013, J CHIN MED ASSOC, V76, P486, DOI 10.1016/j.jcma.2013.05.004; VELLA F, 1968, AM J CLIN PATHOL, V49, P440, DOI 10.1093/ajcp/49.3_ts.440; Zhang DC, 2016, BLOOD, V127, P801, DOI 10.1182/blood-2015-09-618538	45	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165833	10.1371/journal.pone.0165833	http://dx.doi.org/10.1371/journal.pone.0165833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802331	Green Published, Green Submitted, gold			2022-12-27	WOS:000386714200060
J	Hernandez-Trejo, M; Garcia-Rivas, G; Torres-Quintanilla, A; Laresgoiti-Servitje, E				Hernandez-Trejo, Maria; Garcia-Rivas, Gerardo; Torres-Quintanilla, Alejandro; Laresgoiti-Servitje, Estibalitz			Relationship between Irisin Concentration and Serum Cytokines in Mother and Newborn	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; CORD BLOOD IRISIN; CIRCULATING IRISIN; SKELETAL-MUSCLE; OXIDATIVE STRESS; WEIGHT-LOSS; EXERCISE; FETAL; PREGNANCY; FAT	Introduction Irisin is considered to be a myokine and adipokine that may also participate in reproductive functions, as it increases significantly throughout pregnancy. However, the regulation of circulating irisin and its relationship with other cytokines has not been assessed thus far in pregnant women and their offspring. Objective The aim of this study was to evaluate differences in irisin and cytokine concentrations between women at the end of pregnancy and their offspring, as well as the relationship between maternal and newborn irisin and maternal and newborn biomarkers. Methods Twenty-eight mother/newborn pairs were included in this study. The following biomarkers were evaluated in maternal venous and arterial umbilical cord blood samples: irisin, 27 cytokine panel, total antioxidant capacity (TAC), total plasma protein, and free fatty acid concentration. Results The newborns had significantly lower irisin concentrations compared to their mothers (p = 0.03), but this difference was present only in babies born from mothers without labor prior to cesarean section delivery (p = 0.01). No significant differences in maternal and newborn irisin concentrations were found between diabetic and non-diabetic mothers or between overweight/obese and normal weight mothers. A significant positive correlation was found between TAC level and irisin concentration in newborns. Maternal and newborn interleukin (IL)-1 beta, IL-1RA, IL-5, IL-7, and interferon gamma-induced protein (IP)-10 levels were significantly positively correlated with irisin concentrations in both study groups. In addition, maternal IL1 beta, IL-5, IL-7, and IP-10 levels positively predicted maternal irisin concentrations. Furthermore, arterial cord blood TAC and IL-1 beta and IL1-RA levels positively predicted newborn irisin concentrations. Multiple regression analyses showed that maternal IL-13 negatively predicted offspring irisin levels (p = 0.03) and that maternal IL-1 beta positively predicted newborn irisin concentrations (p = 0.046). Conclusion No evidence was found that serum irisin concentrations in mothers at pregnancy termination or those of their newborns correlated with maternal body mass index, the presence of diabetes mellitus, or free fatty acid levels. However, the results of this study indicated that cytokines might predict irisin concentration in mothers and their offspring, although interactions between irisin levels during pregnancy and the newborn have not yet been fully elucidated.	[Hernandez-Trejo, Maria] Inst Nacl Perinatol, Neurobiol Dev, Mexico City, DF, Mexico; [Garcia-Rivas, Gerardo; Torres-Quintanilla, Alejandro] Tecnol Monterrey, Escuela Nacl Med, Catedra Cardiol, Monterrey, Mexico; [Garcia-Rivas, Gerardo] Tecnol Monterrey, Hosp Zambrano Hell, Ctr Invest Biomed, San Pedro Garza Garcia, Mexico; [Laresgoiti-Servitje, Estibalitz] Tecnol Monterrey, TEC ABC Sch Med, Basic Med Sci, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Tecnologico de Monterrey; Tecnologico de Monterrey; Tecnologico de Monterrey	Laresgoiti-Servitje, E (corresponding author), Tecnol Monterrey, TEC ABC Sch Med, Basic Med Sci, Mexico City, DF, Mexico.	estibalitz.laresgoiti@itesm.mx	Torres-Quintanilla, Alejandro/X-3336-2019; Torres Quintanilla, Alejandro Daniel/GXV-9386-2022; García-Rivas, Gerardo/A-9691-2011; Hernandez-Trejo, Maria/AAG-4276-2020; Laresgoiti-Servitje, Estibalitz/B-7658-2014	Torres-Quintanilla, Alejandro/0000-0002-7145-1840; Torres Quintanilla, Alejandro Daniel/0000-0002-7145-1840; García-Rivas, Gerardo/0000-0003-4731-3293; Laresgoiti-Servitje, Estibalitz/0000-0002-3271-9955	National Institute of Perinatology, Mexico [(384) 212250-22651]; CONACYT-Mexico [151136]	National Institute of Perinatology, Mexico; CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by the National Institute of Perinatology, Mexico, Reg (384) 212250-22651 (Maria Hernandez-Trejo). Irisin ELISA detection kits used in this study were supported by CONACYT-Mexico grant 151136.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daghri NM, 2015, EUR J CLIN INVEST, V45, P775, DOI 10.1111/eci.12468; Al-Daghri NM, 2014, CLIN SCI, V126, P837, DOI 10.1042/CS20130426; Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889; Apak R, 2005, FREE RADICAL RES, V39, P949, DOI 10.1080/10715760500210145; Aydin S, 2014, PEPTIDES, V61, P130, DOI 10.1016/j.peptides.2014.09.014; Baka S, 2015, METABOLISM, V64, P1515, DOI 10.1016/j.metabol.2015.07.020; Bakal U, 2016, BIOCHEM INSIGHTS, V9, P11, DOI [10.4137/BCICI.S39671, 10.4137/BCI.S39671]; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Briana D, 2014, ARCH DIS CHILD, V99, pA126, DOI [10.1136/archdischild-2014-307384.336, DOI 10.1136/ARCHDISCHILD-2014-307384.336]; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Caglar M, 2014, J ENDOCRINOL INVEST, V37, P619, DOI 10.1007/s40618-014-0078-5; Choi YK, 2013, DIABETES RES CLIN PR, V100, P96, DOI 10.1016/j.diabres.2013.01.007; Crujeiras AB, 2015, CLIN ENDOCRINOL, V82, P467, DOI 10.1111/cen.12627; Dong J, 2016, INT J OBESITY, V40, P434, DOI 10.1038/ijo.2015.200; Dun SL, 2013, NEUROSCIENCE, V240, P155, DOI 10.1016/j.neuroscience.2013.02.050; DUNCOMBE WG, 1964, CLIN CHIM ACTA, V9, P122, DOI 10.1016/0009-8981(64)90004-X; Ebert T, 2014, CYTOKINE, V65, P153, DOI 10.1016/j.cyto.2013.11.009; Eckardt K, 2014, DIABETOLOGIA, V57, P1087, DOI 10.1007/s00125-014-3224-x; Erickson HP, 2013, ADIPOCYTE, V2, P289, DOI 10.4161/adip.26082; Erol O, 2016, J MATERN-FETAL NEO M, V29, P3590, DOI 10.3109/14767058.2016.1142967; Garces MF, 2014, J CLIN ENDOCR METAB, V99, P2113, DOI 10.1210/jc.2013-4127; Hauguel-de Mouzon S, 2006, PLACENTA, V27, P794, DOI 10.1016/j.placenta.2005.08.009; Huh JY, 2014, J CLIN ENDOCR METAB, V99, pE2154, DOI 10.1210/jc.2014-1437; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Hung TH, 2010, REPROD SCI, V17, P401, DOI 10.1177/1933719109359704; Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001; Jiang LQ, 2013, AM J PHYSIOL-ENDOC M, V305, pE1359, DOI 10.1152/ajpendo.00236.2013; JONES CM, 1982, AM J OBSTET GYNECOL, V144, P149, DOI 10.1016/0002-9378(82)90616-0; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Kuzmicki M, 2014, GYNECOL ENDOCRINOL, V30, P636, DOI 10.3109/09513590.2014.920006; Liu J-J, J DIABETES COMPLICAT, V27, P365, DOI [10.1016/j.jdiaccmp.2013.003.002, DOI 10.1016/J.JDIACCMP.2013.003.002]; Lopez-Legarrea P, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Pantham P, 2015, PLACENTA, V36, P709, DOI 10.1016/j.placenta.2015.04.006; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Park MJ, 2015, CELL SIGNAL, V27, P1831, DOI 10.1016/j.cellsig.2015.04.010; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; PERKINS SL, 1993, CLIN CHEM, V39, P1041; Phoenix Pharmaceuticals I, IRISIN PROTEINS ANTI; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073680; Raschke S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/320724; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Sykes L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/967629; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Toescu V, 2002, CLIN ENDOCRINOL, V57, P609, DOI 10.1046/j.1365-2265.2002.01638.x; Vaughan RA, 2015, J PHYSIOL BIOCHEM, V71, P679, DOI 10.1007/s13105-015-0433-9; Wang C, 2015, ENDOCRINE, V49, P90, DOI 10.1007/s12020-014-0458-9; Wawrusiewicz-Kurylonek N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131171; Williams TJ, 2000, J ALLERGY CLIN IMMUN, V105, P951, DOI 10.1067/mai.2000.106211; Yuksel MA, 2014, DIABETES RES CLIN PR, V104, P171, DOI 10.1016/j.diabres.2013.12.025; Zhao L, 2015, ENDOCR J, V62, P921, DOI 10.1507/endocrj.EJ15-0230	53	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165229	10.1371/journal.pone.0165229	http://dx.doi.org/10.1371/journal.pone.0165229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828992	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300033
J	Reznikov, LR; Meyerholz, DK; Adam, RJ; Abou Alaiwa, M; Jaffer, O; Michalski, AS; Powers, LS; Price, MP; Stoltz, DA; Welsh, MJ				Reznikov, Leah R.; Meyerholz, David K.; Adam, Ryan J.; Abou Alaiwa, Mahmoud; Jaffer, Omar; Michalski, Andrew S.; Powers, Linda S.; Price, Margaret P.; Stoltz, David A.; Welsh, Michael J.			Acid-Sensing Ion Channel 1 alpha Contributes to Airway Hyperreactivity in Mice	PLOS ONE			English	Article							TACHYKININ NK1 RECEPTOR; SMOOTH-MUSCLE; MURINE MODEL; SUBSTANCE-P; ASIC1 CONTRIBUTES; BREATH CONDENSATE; INFLAMMATION; HYPERRESPONSIVENESS; ASTHMA; ACIDIFICATION	Neurons innervating the airways contribute to airway hyperreactivity (AHR), a hallmark feature of asthma. Several observations suggested that acid-sensing ion channels (ASICs), neuronal cation channels activated by protons, might contribute to AHR. For example, ASICs are found in vagal sensory neurons that innervate airways, and asthmatic airways can become acidic. Moreover, airway acidification activates ASIC currents and depolarizes neurons innervating airways. We found ASIC1a protein in vagal ganglia neurons, but not airway epithelium or smooth muscle. We induced AHR by sensitizing mice to ovalbumin and found that ASIC1a(-/-) mice failed to exhibit AHR despite a robust inflammatory response. Loss of ASIC1a also decreased bronchoalveolar lavage fluid levels of substance P, a sensory neuropeptide secreted from vagal sensory neurons that contributes to AHR. These findings suggest that ASIC1a is an important mediator of AHR and raise the possibility that inhibiting ASIC channels might be beneficial in asthma.	[Reznikov, Leah R.; Adam, Ryan J.; Abou Alaiwa, Mahmoud; Jaffer, Omar; Michalski, Andrew S.; Powers, Linda S.; Price, Margaret P.; Stoltz, David A.; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Meyerholz, David K.] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Stoltz, David A.; Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Reznikov, Leah R.; Adam, Ryan J.; Abou Alaiwa, Mahmoud; Powers, Linda S.; Price, Margaret P.; Stoltz, David A.; Welsh, Michael J.] Univ Iowa, Pappajohn Biomed Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Adam, Ryan J.; Stoltz, David A.] Univ Iowa, Coll Engn, Dept Biomed Engn, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.; Welsh, MJ (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.; Welsh, MJ (corresponding author), Univ Iowa, Pappajohn Biomed Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.; Welsh, MJ (corresponding author), Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu	Reznikov, Leah R./J-4314-2019; Meyerholz, David/J-8131-2019	Reznikov, Leah R./0000-0002-4074-9070; Meyerholz, David/0000-0003-1552-3253; Welsh, Michael/0000-0002-1646-6206; Abou Alaiwa, Mahmoud/0000-0003-4525-0217; Stoltz, David/0000-0003-0893-9015; Adam, Ryan/0000-0001-8602-8263	National Institutes of Health [1K99HL119560-01A1, 1P01HL091842]; America Asthma Foundation; Roy J Carver Charitable Trust; Gilead Sciences Research Scholars Program in Cystic Fibrosis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL119560, T32HL007638, P01HL091842, K99HL119560, P01HL051670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); America Asthma Foundation; Roy J Carver Charitable Trust; Gilead Sciences Research Scholars Program in Cystic Fibrosis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was in part supported by the National Institutes of Health 1K99HL119560-01A1 (LRR) and 1P01HL091842 (MJW), the America Asthma Foundation (DAS), and by the Roy J Carver Charitable Trust. DAS was funded by the Gilead Sciences Research Scholars Program in Cystic Fibrosis. MJW is an Investigator of the Howard Hughes Medical Institute.	Adam RJ, 2013, AM J RESP CRIT CARE, V188, P1434, DOI 10.1164/rccm.201307-1268OC; Allen GB, 2009, J APPL PHYSIOL, V107, P1763, DOI 10.1152/japplphysiol.00572.2009; ANTONACCIO MJ, 1973, EUR J PHARMACOL, V23, P311, DOI 10.1016/0014-2999(73)90102-7; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Brunetti L, 2008, ALLERGY ASTHMA PROC, V29, P461, DOI 10.2500/aap.2008.29.3152; Canning B KM, 2013, FASEB FASEB J; Carr MJ, 2001, BRIT J PHARMACOL, V133, P1255, DOI 10.1038/sj.bjp.0704197; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Cheng CF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/709159; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; Crimi E, 1998, AM J RESP CRIT CARE, V157, P4, DOI 10.1164/ajrccm.157.1.9703002; Diochot S, 2007, TOXICON, V49, P271, DOI 10.1016/j.toxicon.2006.09.026; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Du JY, 2014, P NATL ACAD SCI USA, V111, P8961, DOI 10.1073/pnas.1407018111; Dusenkova S, 2014, AM J PHYSIOL-GASTR L, V307, pG922, DOI 10.1152/ajpgi.00129.2014; El-Hashim AZ, 2005, EUR J PHARMACOL, V513, P125, DOI 10.1016/j.ejphar.2005.02.007; Erle DJ, 2014, J CELL BIOL, V205, P621, DOI 10.1083/jcb.201401050; Escoubas P, 2003, PROTEIN SCI, V12, P1332, DOI 10.1110/ps.0307003; Faisy C, 2007, LIFE SCI, V81, P1094, DOI 10.1016/j.lfs.2007.08.026; FEATHERSTONE RL, 1988, EUR RESPIR J, V1, P839; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099; Gu QH, 2006, AM J PHYSIOL-LUNG C, V291, pL58, DOI 10.1152/ajplung.00517.2005; Gu QH, 2011, CURR OPIN PHARMACOL, V11, P238, DOI 10.1016/j.coph.2011.04.005; GUSTAFSSON PM, 1990, ARCH DIS CHILD, V65, P1255, DOI 10.1136/adc.65.11.1255; Hoka S, 1988, J Anesth, V2, P207, DOI 10.1007/s0054080020207; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; Jernigan NL, 2009, AM J PHYSIOL-LUNG C, V297, pL271, DOI 10.1152/ajplung.00020.2009; Jia YL, 2007, BBA-MOL BASIS DIS, V1772, P915, DOI 10.1016/j.bbadis.2007.01.013; Johnson JR, 2015, AM J PHYSIOL-LUNG C, V308, pL658, DOI 10.1152/ajplung.00286.2014; Kang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035225; Kearley J, 2007, J EXP MED, V204, P1289, DOI 10.1084/jem.20062093; Kodric M, 2007, AM J RESP CRIT CARE, V175, P905, DOI 10.1164/rccm.200607-940OC; Kollarik M, 2002, J PHYSIOL-LONDON, V543, P591, DOI 10.1113/jphysiol.2002.022848; Kollarik M, 2007, PULM PHARMACOL THER, V20, P402, DOI 10.1016/j.pupt.2006.11.010; Kostikas K, 2002, AM J RESP CRIT CARE, V165, P1364, DOI 10.1164/rccm.200111-068OC; Lee LY, 2013, PULM PHARMACOL THER, V26, P491, DOI 10.1016/j.pupt.2013.03.010; Lopes FDTQS, 2002, J APPL PHYSIOL, V93, P842, DOI 10.1152/japplphysiol.00013.2002; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; LUNDBERG JM, 1983, ACTA PHYSIOL SCAND, V119, P49, DOI 10.1111/j.1748-1716.1983.tb07304.x; MANZINI S, 1992, BRIT J PHARMACOL, V105, P968, DOI 10.1111/j.1476-5381.1992.tb09086.x; Mazzone Stuart B, 2005, Cough, V1, P2, DOI 10.1186/1745-9974-1-2; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Mhanna MJ, 1999, AM J PHYSIOL-LUNG C, V276, pL51, DOI 10.1152/ajplung.1999.276.1.L51; MURLAS CG, 1993, LUNG, V171, P109, DOI 10.1007/BF00542338; Nassenstein C, 2008, J PHYSIOL-LONDON, V586, P1595, DOI 10.1113/jphysiol.2007.148379; Nenan S, 2001, EUR J PHARMACOL, V421, P201, DOI 10.1016/S0014-2999(01)01036-6; Nitta CH, 2014, AM J PHYSIOL-HEART C, V306, pH41, DOI 10.1152/ajpheart.00269.2013; Padrid PA, 1998, AM J RESP CELL MOL, V18, P453, DOI 10.1165/ajrcmb.18.4.3055; Page AJ, 2004, GASTROENTEROLOGY, V127, P1739, DOI 10.1053/j.gastro.2004.08.061; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Ricciardolo FLM, 2001, AM J MED, V111, P18, DOI 10.1016/S0002-9343(01)00816-6; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Sanders PN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006135; Schuiling M, 1999, CLIN EXP ALLERGY, V29, P48; Schuiling M, 1999, AM J RESP CRIT CARE, V159, P423, DOI 10.1164/ajrccm.159.2.9804125; SCHULTZ HD, 1987, CIRC RES, V60, P337, DOI 10.1161/01.RES.60.3.337; Shah VS, 2016, SCIENCE, V351, P503, DOI 10.1126/science.aad5589; Sluka KA, 2013, ARTHRITIS RHEUM-US, V65, P1194, DOI 10.1002/art.37862; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Thiesse J, 1985, J APPL PHYSIOL, V109, P1960, DOI 10.1152/japplphysiol.01322.2009; Tong J, 2011, J IMMUNOL, V186, P3686, DOI 10.4049/jimmunol.1001346; Tournoy KG, 2003, EUR RESPIR J, V21, P3, DOI 10.1183/09031936.03.00007803; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Vysotskaya ZV, 2014, LUNG, V192, P927, DOI 10.1007/s00408-014-9634-1; Walder RY, 2010, J PAIN, V11, P210, DOI 10.1016/j.jpain.2009.07.004; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Wilder JA, 1999, AM J RESP CELL MOL, V20, P1326, DOI 10.1165/ajrcmb.20.6.3561; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Xiao Lan, 2012, J Allergy (Cairo), V2012, P423612, DOI 10.1155/2012/423612; Yasumitsu R, 1996, EUR J PHARMACOL, V300, P215, DOI 10.1016/0014-2999(95)00881-0; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	73	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166089	10.1371/journal.pone.0166089	http://dx.doi.org/10.1371/journal.pone.0166089			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820848	gold, Green Published, Green Submitted			2022-12-27	WOS:000387614800032
J	Haegele, S; Reiter, S; Wanek, D; Offensperger, F; Pereyra, D; Stremitzer, S; Fleischmann, E; Brostjan, C; Gruenberger, T; Starlinger, P				Haegele, Stefanie; Reiter, Silvia; Wanek, David; Offensperger, Florian; Pereyra, David; Stremitzer, Stefan; Fleischmann, Edith; Brostjan, Christine; Gruenberger, Thomas; Starlinger, Patrick			Perioperative Non-Invasive Indocyanine Green-Clearance Testing to Predict Postoperative Outcome after Liver Resection	PLOS ONE			English	Article							FOR-SIZE SYNDROME; TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; DISEASE; CLASSIFICATION; HEPATECTOMY; SURGERY; MODEL	Background Postoperative liver dysfunction may lead to morbidity and mortality after liver resection. Preoperative liver function assessment is critical to identify preexisting liver dysfunction in patients prior to resection. The aim of this study was to evaluate the predictive potential of perioperative indocyanine green (ICG)-clearance testing to prevent postoperative liver dysfunction and morbidity using standardized outcome parameters in a routine Western-clinical-setting. Study Design 137 patients undergoing partial hepatectomy between 2011 and 2013, at the general hospital of Vienna, were included. ICG-clearance was recorded one day prior to surgery as well as on the first and fifth postoperative day. Postoperative liver dysfunction was defined according to the International Study Group of Liver Surgery and evaluation of morbidity was based on the Dindo-Clavien classification. Statistical analyses were based on non-parametric tests. Results Preoperative reduced ICG-plasma disappearance rate (PDR) as well as increased ICG-retention rate at 15 min (R15) were able to significantly predict postoperative liver dysfunction (Area under the curve = PDR: 0.716, P = 0.018; R15: 0.719, P = 0.016). Furthermore, PDR <17%/min.or R15 >8%, were able to accurately predict postoperative complications prior to surgery. In addition to this, ICG-clearance on postoperative day 1 comparably predicted postoperative liver dysfunction (Area under the curve = PDR: 0.895; R15: 0.893; both P < 0.001), specifically, PDR < 10%/min or R15 > 20% on postoperative day 1 predicted poor postoperative outcome. Conclusion PDR and R15 may represent useful parameters to distinguish preoperative high and low risk patients in a Western collective as well as on postoperative day 1, to identify patients who require closer monitoring for potential complications.	[Haegele, Stefanie; Reiter, Silvia; Wanek, David; Offensperger, Florian; Pereyra, David; Stremitzer, Stefan; Brostjan, Christine; Starlinger, Patrick] Med Univ Vienna, Gen Hosp, Dept Surg, Vienna, Austria; [Fleischmann, Edith] Med Univ Vienna, Gen Hosp, Dept Anesthesiol, Vienna, Austria; [Gruenberger, Thomas] Rudolfstiftung Hosp, Dept Surg 1, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Rudolfstiftung Hospital	Starlinger, P (corresponding author), Med Univ Vienna, Gen Hosp, Dept Surg, Vienna, Austria.; Gruenberger, T (corresponding author), Rudolfstiftung Hosp, Dept Surg 1, Vienna, Austria.	tgruenberger@icloud.com; patrick.starlinger@meduniwien.ac.at	Gruenberger, Thomas/ABA-1661-2020	Gruenberger, Thomas/0000-0002-2671-0540; Pereyra, David/0000-0001-6700-9163; Brostjan, Christine/0000-0003-1462-5397				Akita H, 2008, WORLD J SURG, V32, P2668, DOI 10.1007/s00268-008-9752-0; Carino ND, 2009, EJSO-EUR J SURG ONC, V35, P957, DOI 10.1016/j.ejso.2009.02.003; CHERRICK GR, 1960, J CLIN INVEST, V39, P592, DOI 10.1172/JCI104072; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Dahm F, 2005, AM J TRANSPLANT, V5, P2605, DOI 10.1111/j.1600-6143.2005.01081.x; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Fan ST, 2010, J HEPATO-BIL-PAN SCI, V17, P380, DOI 10.1007/s00534-009-0229-9; Fung J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072306; Gruttadauria S, 2010, WORLD J GASTROENTERO, V16, P5011, DOI 10.3748/wjg.v16.i40.5011; Jiao LR, 2000, BRIT J SURG, V87, P568, DOI 10.1046/j.1365-2168.2000.01399.x; Krieger PM, 2011, ANN SURG ONCOL, V18, P1644, DOI 10.1245/s10434-010-1494-1; Lisotti A, 2014, HEPATOLOGY, V59, P643, DOI 10.1002/hep.26700; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Manizate F, 2010, J HEPATO-BIL-PAN SCI, V17, P385, DOI 10.1007/s00534-009-0228-x; Okochi O, 2002, J SURG RES, V103, P109, DOI 10.1006/jsre.2001.6328; Pang W., 2002, HPB, V4, P100; Pang YY, 2002, HPB, V4, P99, DOI [DOI 10.1080/136518202760378489, 10.1016/S1365-182X(17)30755-4, DOI 10.1016/S1365-182X(17)30755-4]; Quintero J, 2014, LIVER INT, V34, P689, DOI 10.1111/liv.12298; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Sakka SG, 2007, CURR OPIN CRIT CARE, V13, P207, DOI 10.1097/MCC.0b013e328012b268; Starlinger P, 2014, HEPATOLOGY, V60, P257, DOI 10.1002/hep.26950; Stauber RE, 2009, LIVER INT, V29, P1516, DOI 10.1111/j.1478-3231.2009.02104.x; Stockmann M, 2009, ANN SURG, V250, P119, DOI 10.1097/SLA.0b013e3181ad85b5; Tucker ON, 2005, CURR OPIN CRIT CARE, V11, P150, DOI 10.1097/01.ccx.0000157080.11117.45; Wakiya T, 2014, ANN SURG ONCOL, V21, P167, DOI 10.1245/s10434-013-3203-3; Wong GLH, 2011, J GASTROEN HEPATOL, V26, P300, DOI 10.1111/j.1440-1746.2010.06510.x; Wong JSW, 2013, ANN SURG, V257, P922, DOI 10.1097/SLA.0b013e318269d2ec; Yokoyama Y, 2010, BRIT J SURG, V97, P1260, DOI 10.1002/bjs.7084; Zipprich A, 2010, GUT, V59, P963, DOI 10.1136/gut.2010.208595	29	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165481	10.1371/journal.pone.0165481	http://dx.doi.org/10.1371/journal.pone.0165481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812143	gold, Green Published, Green Submitted			2022-12-27	WOS:000386910000031
J	Hussain, A; Yadav, MK; Bose, S; Wang, JH; Lim, D; Song, YK; Ko, SG; Kim, H				Hussain, Ahtesham; Yadav, Mukesh Kumar; Bose, Shambhunath; Wang, Jing-Hua; Lim, Dongwoo; Song, Yun-Kyung; Ko, Seong-Gyu; Kim, Hojun			Daesiho-Tang Is an Effective Herbal Formulation in Attenuation of Obesity in Mice through Alteration of Gene Expression and Modulation of Intestinal Microbiota	PLOS ONE			English	Article							DIET-INDUCED OBESITY; GUT-MICROBIOTA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; FAT; POLYSACCHARIDES; CONTRIBUTES; NPC1L1	Background Obesity has become a major global health challenge due to its increasing prevalence, and the associated health risk. It is the main cause of various metabolic diseases including diabetes, hypertension, cardiovascular disease, stroke and certain forms of cancer. Methods and Results In the present study we evaluated the anti-obesity property of Daesiho-tang (DSHT), an herbal medicine, using high fat diet (HFD)-induced obese mice as a model. Our results showed that DSHT ameliorated body weight gain, decreased total body fat, regulated expression of leptin and adiponectin genes of adipose tissue and exerted an anti-diabetic effect by attenuating fasting glucose level and serum insulin level in HFD-fed animals. In addition, DSHT-treatment significantly reduced total cholesterol (TC), triglycerides (TG) and increased high density lipoprotein-cholesterol (HDL), glutamic pyruvic transaminase (GPT) and glutamic oxaloacetic transaminase (GOT) levels in serum and reduced deposition of fat droplets in liver. DSHT treatment resulted in significantly increased relative abundance of bacteria including Bacteroidetes, Bacteroidetes/ Firmicutes ratio, Akkermansia Bifidobacterium., Lactobacillus, and decreased the level of Firmicutes. Using RT2 profiler PCR array, 39 (46%) genes were found to be differentially expressed in HFD-fed mice compared to normal control. However, normal gene expressions were restored in 36 (92%) genes of HFD-fed mice, when co-exposed to DSHT. Conclusion/Major Findings The results of this study demonstrated that DSHT is an effective herbal formulation in attenuation of obesity in HFD-fed mice through alteration of gene expressions and modulation of intestinal microbiota.	[Hussain, Ahtesham; Wang, Jing-Hua; Kim, Hojun] Dongguk Univ, Dept Rehabil Med Korean Med, Goyang, South Korea; [Yadav, Mukesh Kumar] Korea Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Yadav, Mukesh Kumar] Korea Univ, Inst Med Device Clin Trials, Coll Med, Seoul, South Korea; [Bose, Shambhunath] Appl Surface Technol Inc, Adv Inst Convergence Technol, 11th Floor,Bldg A, Suwon 16229, Gyeonggi Do, South Korea; [Wang, Jing-Hua] Anhui Univ Tradit Chinese Med, Key Lab Xinan Med, Minist Educ, Meishan Rd 103, Hefei, Anhui, Peoples R China; [Lim, Dongwoo] Dongguk Univ, Dept Pathol, Coll Korean Med, Goyang, South Korea; [Song, Yun-Kyung] Gachon Univ, Dept Korean Rehabil Med, Coll Korean Med, Inchon, South Korea; [Ko, Seong-Gyu] Kyung Hee Univ, Dept Prevent Med, Coll Korean Med, Seoul, South Korea	Dongguk University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Anhui University of Chinese Medicine; Dongguk University; Gachon University; Kyung Hee University	Kim, H (corresponding author), Dongguk Univ, Dept Rehabil Med Korean Med, Goyang, South Korea.	kimklar@dongguk.ac.kr	Yadav, Mukesh Kumar/M-9154-2015; Wang, Jing-hua/AAO-2350-2020; Lim, Dongwoo/GLU-0640-2022; Kim, Hojun/AAB-8405-2020	Yadav, Mukesh Kumar/0000-0002-4703-8554; Wang, Jing-hua/0000-0002-2034-7429; Bose, Shambunath/0000-0003-0737-5713; Lim, Dongwoo/0000-0002-3179-9439; Kim, Hojun/0000-0003-1038-0142	Traditional Korean Medicine R&D Project, Ministry for Health & Welfare & Family Affairs, Republic of Korea [HI13C0530]	Traditional Korean Medicine R&D Project, Ministry for Health & Welfare & Family Affairs, Republic of Korea	This study was supported by a grant from the Traditional Korean Medicine R&D Project, Ministry for Health & Welfare & Family Affairs, Republic of Korea (HI13C0530). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella V, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/343746; Aguirre M, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0472-4; [Anonymous], 1996, GUIDE CARE USE LAB A; Bajzer M, 2006, NATURE, V444, P1009, DOI 10.1038/4441009a; Betters JL, 2010, FEBS LETT, V584, P2740, DOI 10.1016/j.febslet.2010.03.030; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; Bray GA, 2000, NUTRITION, V16, P953, DOI 10.1016/S0899-9007(00)00424-X; Bullo M, 2005, OBES SURG, V15, P382, DOI 10.1381/0960892053576776; Butsch WS, 2015, CURR OPIN ENDOCRINOL, V22, P360, DOI 10.1097/MED.0000000000000192; Cani PD, 2013, BRIEF FUNCT GENOMICS, V12, P381, DOI 10.1093/bfgp/elt014; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; Cox AJ, 2015, LANCET DIABETES ENDO, V3, P207, DOI 10.1016/S2213-8587(14)70134-2; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Diamant M, 2011, OBES REV, V12, P272, DOI 10.1111/j.1467-789X.2010.00797.x; DiBaise JK, 2012, AM J GASTROENTEROL S, V1, P22, DOI [10.1038/ajgsup.2012.5, DOI 10.1038/AJGSUP.2012.5]; Dwivedi S, 2014, ELECTRON J BIOTECHN, V17, P238, DOI 10.1016/j.ejbt.2014.07.004; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Fu JY, 2015, CIRC RES, V117, P817, DOI 10.1161/CIRCRESAHA.115.306807; Fuentes-Zaragoza E, 2011, STARCH-STARKE, V63, P406, DOI 10.1002/star.201000099; Ganesh BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074963; Cano PG, 2013, OBESITY, V21, P2310, DOI 10.1002/oby.20330; Gerard P, 2016, CELL MOL LIFE SCI, V73, P147, DOI 10.1007/s00018-015-2061-5; Guerciolini R, 1997, INT J OBESITY, V21, pS12; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Han K, 2015, FOOD FUNCT, V6, P2684, DOI 10.1039/c5fo00232j; Jeffery E, 2015, NAT CELL BIOL, V17, P376, DOI 10.1038/ncb3122; Jeong EJ, 2016, BIOL PHARM BULL, V39, P409, DOI 10.1248/bpb.b15-00849; 여운홍, 2005, [Journal of Physiology & Pathology in Korean Medicine, 동의생리병리학회지], V19, P1573; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Karimi G, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.29273; Kim C.H., 2004, KOREAN J ORIENT MED, V12, P139; Kim JH, 2001, J KOREAN ORI MED, V22, P63; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kzhyshkowska J, 2006, J CELL MOL MED, V10, P635, DOI 10.1111/j.1582-4934.2006.tb00425.x; Lecomte V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126931; Lee SJ, 2014, CLIN NUTR, V33, P973, DOI 10.1016/j.clnu.2013.12.006; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; LONNQVIST F, 1995, NAT MED, V1, P950, DOI 10.1038/nm0995-950; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Miserez AR, 2002, ATHEROSCLEROSIS, V164, P15, DOI 10.1016/S0021-9150(01)00762-6; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Moreno-Indias I, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00190; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Park S.D., 2001, KOREAN J ORIENT MED, V9, P289; Patterson E, 2016, POSTGRAD MED J, V92, P286, DOI 10.1136/postgradmedj-2015-133285; Pichiah PBT, 2012, NUTR RES, V32, P856, DOI 10.1016/j.nutres.2012.09.015; Rha YG, 1991, J ORINT MED PATHOL, V6, P1; Sahin M, 2007, CLIN ENDOCRINOL, V67, P346, DOI 10.1111/j.1365-2265.2007.02888.x; Sanz Y, 2013, PHARMACOL RES, V69, P144, DOI 10.1016/j.phrs.2012.10.021; Shen J, 2013, MOL ASPECTS MED, V34, P39, DOI 10.1016/j.mam.2012.11.001; Su ML, 2016, MOLECULES, V21, DOI 10.3390/molecules21080976; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Tsai Franklin, 2009, Curr Gastroenterol Rep, V11, P307, DOI 10.1007/s11894-009-0045-z; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Van den Ende W, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00247; Wang J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087451, 10.1371/journal.pone.0107012]; Wang JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep08391; World Health Organization,, 2015, OB OV; Yang L, 2015, JAMA INTERN MED, V175, P1412, DOI 10.1001/jamainternmed.2015.2405; Yoo HD, 2012, BIOMOL THER, V20, P371, DOI 10.4062/biomolther.2012.20.4.371; Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011; Zhang ZJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-62; Zhou SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep22474	75	41	45	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165483	10.1371/journal.pone.0165483	http://dx.doi.org/10.1371/journal.pone.0165483			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812119	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000032
J	Marathe, NP; Shetty, SA; Shouche, YS; Larsson, DGJ				Marathe, Nachiket P.; Shetty, Sudarshan A.; Shouche, Yogesh S.; Larsson, D. G. Joakim			Limited Bacterial Diversity within a Treatment Plant Receiving Antibiotic-Containing Waste from Bulk Drug Production	PLOS ONE			English	Article							WATER TREATMENT-PLANT; MICROBIAL DIVERSITY; GENERATION; DEGRADATION; COMMUNITIES	Biological treatment of waste water from bulk drug production, contaminated with high levels of fluoroquinolone antibiotics, can lead to massive enrichment of antibiotic resistant bacteria, resistance genes and associated mobile elements, as previously shown. Such strong selection may be boosted by the use of activated sludge (AS) technology, where microbes that are able to thrive on the chemicals within the wastewater are reintroduced at an earlier stage of the process to further enhance degradation of incoming chemicals. The microbial community structure within such a treatment plant is, however, largely unclear. In this study, Illumina-based 16S rRNA amplicon sequencing was applied to investigate the bacterial communities of different stages from an Indian treatment plant operated by Patancheru Environment Technology Limited (PETL) in Hyderabad, India. The plant receives waste water with high levels of fluoroquinolones and applies AS technology. A total of 1,019,400 sequences from samples of different stages of the treatment process were analyzed. In total 202, 303, 732, 652, 947 and 864 operational taxonomic units (OTUs) were obtained at 3% distance cutoff in the equilibrator, aeration tanks 1 and 2, settling tank, secondary sludge and old sludge samples from PETL, respectively. Proteobacteria was the most dominant phyla in all samples with Gammaproteobacteria and Betaproteobacteria being the dominant classes. Alcaligenaceae and Pseudomonadaceae, bacterial families from PETL previously reported to be highly multidrug resistant, were the dominant families in aeration tank samples. Despite regular addition of human sewage (approximately 20%) to uphold microbial activity, the bacterial diversity within aeration tanks from PETL was considerably lower than corresponding samples from seven, regular municipal waste water treatment plants. The strong selection pressure from antibiotics present may be one important factor in structuring the microbial community in PETL, which may affect not only resistance promotion but also general efficiency of the waste treatment process.	[Marathe, Nachiket P.; Larsson, D. G. Joakim] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Marathe, Nachiket P.; Larsson, D. G. Joakim] Univ Gothenburg, Ctr Antibiot Resistance Res CARe, Gothenburg, Sweden; [Shetty, Sudarshan A.] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Shouche, Yogesh S.] Natl Ctr Cell Sci, MCC, Pune, Maharashtra, India	University of Gothenburg; University of Gothenburg; Wageningen University & Research; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Larsson, DGJ (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden.; Larsson, DGJ (corresponding author), Univ Gothenburg, Ctr Antibiot Resistance Res CARe, Gothenburg, Sweden.	joakim.larsson@fysiologi.gu.se	Shetty, Sudarshan A/N-6785-2014; Larsson, D.G. Joakim/E-5243-2011; Marathe, Nachiket/AAJ-3565-2021	Shetty, Sudarshan A/0000-0001-7280-9915; Larsson, D.G. Joakim/0000-0002-5496-0328; Marathe, Nachiket/0000-0003-2955-3402	Department of Biotechnology (DBT, Government of India); University for Potential Excellence (UPE-II); DBT India under MCC project [BT/PR10054/NDB/52/94/2007]; Swedish Research Council VR; Swedish Research Council FORMAS	Department of Biotechnology (DBT, Government of India)(Department of Biotechnology (DBT) India); University for Potential Excellence (UPE-II); DBT India under MCC project; Swedish Research Council VR(Swedish Research Council); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	The work was funded by the Department of Biotechnology (DBT, Government of India) and University for Potential Excellence (UPE-II) phase program and DBT India under the MCC project grant no. BT/PR10054/NDB/52/94/2007; as well as Swedish Research Councils VR and FORMAS.	Arora PK, 2016, J CHEM-NY, V2016, DOI 10.1155/2016/7589068; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bengtsson-Palme J, 2014, FRONT MICROBIOL, V5; Bintrim SB, 1997, P NATL ACAD SCI USA, V94, P277, DOI 10.1073/pnas.94.1.277; Borneman J, 1996, APPL ENVIRON MICROB, V62, P1935, DOI 10.1128/AEM.62.6.1935-1943.1996; Bramucci M, 2003, APPL MICROBIOL BIOT, V62, P594, DOI 10.1007/s00253-003-1372-x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Central Pollution Control Board India, REP TITL FIN ACT PLA; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Deng YQ, 2012, ENVIRON SCI TECHNOL, V46, P795, DOI 10.1021/es2025998; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fick J, 2009, ENVIRON TOXICOL CHEM, V28, P2522, DOI 10.1897/09-073.1; Gothwal R, 2016, J HAZARDOUS TOXIC RA; Hernandez-Raquet G, 2013, ENV MICROBIOL REP, V5, P588, DOI 10.1111/1758-2229.12053; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jain RK, 2005, CURR SCI INDIA, V89, P101; Jang JH, 2006, J BIOSCI BIOENG, V102, P53, DOI 10.1263/jbb.102.53; Johnning A, 2013, APPL ENVIRON MICROB, V79, P7256, DOI 10.1128/AEM.02141-13; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Larsson DGJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0571; Larsson DGJ, 2010, J HAZARD MATER, V148, P751; Li D, 2010, APPL ENVIRON MICROB, V76, P3444, DOI 10.1128/AEM.02964-09; Li D, 2009, ENVIRON MICROBIOL, V11, P1506, DOI 10.1111/j.1462-2920.2009.01878.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marathe N, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-222; Marathe NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077310; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neumann G, 2004, APPL ENVIRON MICROB, V70, P1907, DOI 10.1128/AEM.70.4.1907-1912.2004; Sanapareddy N, 2009, APPL ENVIRON MICROB, V75, P1688, DOI 10.1128/AEM.01210-08; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SEILER H, 1982, EUR J APPL MICROBIOL, V14, P97, DOI 10.1007/BF00498010; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Vasileiadis S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042671; Wagner M, 2002, CURR OPIN BIOTECH, V13, P218, DOI 10.1016/S0958-1669(02)00315-4; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Ye L, 2013, APPL MICROBIOL BIOT, V97, P2681, DOI 10.1007/s00253-012-4082-4; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	42	6	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165914	10.1371/journal.pone.0165914	http://dx.doi.org/10.1371/journal.pone.0165914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812209	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000080
J	Vallabhaneni, KC; Hassler, MY; Abraham, A; Whitt, J; Mo, YY; Atfi, A; Pochampally, R				Vallabhaneni, Krishna C.; Hassler, Meeves-Yoni; Abraham, Anu; Whitt, Jason; Mo, Yin-Yuan; Atfi, Azeddine; Pochampally, Radhika			Mesenchymal Stem/Stromal Cells under Stress Increase Osteosarcoma Migration and Apoptosis Resistance via Extracellular Vesicle Mediated Communication	PLOS ONE			English	Article							STEM-CELLS; TUMOR STROMA; PULMONARY METASTASIS; MCT1 EXPRESSION; DOWN-REGULATION; BONE-MARROW; CANCER; GROWTH; PROLIFERATION; MICRORNA	Studies have shown that mesenchymal stem/stromal cells (MSCs) from bone marrow are involved in the growth and metastasis of solid tumors but the mechanism remains unclear in osteosarcoma (OS). Previous studies have raised the possibility that OS cells may receive support from associated MSCs in the nutrient deprived core of the tumors through the release of supportive macromolecules and growth factors either in vesicular or non-vesicular forms. In the present study, we used stressed mesenchymal stem cells (SD-MSCs), control MSCs and OS cells to examine the hypothesis that tumor-associated MSCs in nutrient deprived core provide pro-proliferative, anti-apoptotic, and metastatic support to nearby tumor cells. Assays to study of the effects of SD-MSC conditioned media revealed that OS cells maintained proliferation when compared to OS cells grown under serum-starved conditions alone. Furthermore, OS cells in MSCs and SD-MSC conditioned media were significantly resistant to apoptosis and an increased wound healing rate was observed in cells exposed to either conditioned media or EVs from MSCs and SD-MSCs. RT-PCR assays of OS cells incubated with extracellular vesicles (EVs) from SD-MSCs revealed microRNAs that could potentially target metabolism and metastasis associated genes as predicted by in silico algorithms, including monocarboxylate transporters, bone morphogenic receptor type 2, fibroblast growth factor 7, matrix metalloproteinase-1, and focal adhesion kinase-1. Changes in the expression levels of focal adhesion kinase, STK11 were confirmed by quantitative PCR assays. Together, these data indicate a tumor supportive role of MSCs in osteosarcoma growth that is strongly associated with the miRNA content of the EVs released from MSCs under conditions that mimic the nutrient deprived core of solid tumors.	[Vallabhaneni, Krishna C.; Hassler, Meeves-Yoni; Abraham, Anu; Whitt, Jason; Mo, Yin-Yuan; Atfi, Azeddine; Pochampally, Radhika] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA; [Vallabhaneni, Krishna C.] Univ Mississippi, Med Ctr, Dept Radiat Oncol, Jackson, MS 39216 USA; [Mo, Yin-Yuan] Univ Mississippi, Med Ctr, Dept Pharmacol Toxicol, Jackson, MS 39216 USA; [Atfi, Azeddine; Pochampally, Radhika] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Pochampally, R (corresponding author), Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA.; Pochampally, R (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA.	rpochampally@umc.edu	Mo, Yin-Yuan/R-8255-2019		National Cancer Institute [CA151851]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR059070]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Cancer Institute CA151851 and National Institute of Arthritis and Musculoskeletal and Skin Diseases R01AR059070.	Alexandrova AY, 2006, EXP CELL RES, V312, P2066, DOI 10.1016/j.yexcr.2006.03.004; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Beckermann BM, 2008, BRIT J CANCER, V99, P622, DOI 10.1038/sj.bjc.6604508; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Boidot R, 2012, CANCER RES, V72, P939, DOI 10.1158/0008-5472.CAN-11-2474; Boisen MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109430; Bonuccelli G, 2014, ONCOTARGET, V5, P7575, DOI 10.18632/oncotarget.2243; Cai HK, 2015, J SURG RES, V194, P505, DOI 10.1016/j.jss.2014.11.025; De Saedeleer CJ, 2014, ONCOGENE, V33, P4060, DOI 10.1038/onc.2013.454; Ell Brian, 2014, Bonekey Rep, V3, P549, DOI 10.1038/bonekey.2014.44; Geng S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091566; Gong C, 2014, CANCER RES, V74, P4341, DOI 10.1158/0008-5472.CAN-14-0125; Husmann K, 2013, BBA-MOL BASIS DIS, V1832, P347, DOI 10.1016/j.bbadis.2012.11.006; Ji F, 2013, BONE, V56, P220, DOI 10.1016/j.bone.2013.05.020; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Ma WL, 2014, TUMOR BIOL, V35, P12467, DOI 10.1007/s13277-014-2565-x; Mizuno Y, 2009, FEBS LETT, V583, P2263, DOI 10.1016/j.febslet.2009.06.006; Naito Y, 2014, ONCOL REP, V32, P1720, DOI 10.3892/or.2014.3333; Oskowitz AZ, 2008, P NATL ACAD SCI USA, V105, P18372, DOI 10.1073/pnas.0809807105; Pavlides S, 2010, CELL CYCLE, V9, P3485, DOI 10.4161/cc.9.17.12721; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pochampally RR, 2004, BLOOD, V103, P1647, DOI 10.1182/blood-2003-06-1967; Qiao L, 2008, CELL RES, V18, P500, DOI 10.1038/cr.2008.40; Ramasamy R, 2007, LEUKEMIA, V21, P304, DOI 10.1038/sj.leu.2404489; Ren K, 2015, ONCOTARGET, DOI 10.18632/oncotarget.5044; Rubio R, 2014, STEM CELLS, V32, P1136, DOI 10.1002/stem.1647; Satoh H, 2010, CARCINOGENESIS, V31, P1833, DOI 10.1093/carcin/bgq105; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Sung L, 2004, EUR J CANCER, V40, P1878, DOI 10.1016/j.ejca.2004.04.005; Suomi S, 2008, GENE REGUL SYST BIO, V2, P177; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tu B, 2014, EXP CELL RES, V320, P164, DOI 10.1016/j.yexcr.2013.10.013; Tu B, 2012, CANCER LETT, V325, P80, DOI 10.1016/j.canlet.2012.06.006; Tu YT, 2015, CELL REP, V10, P854, DOI 10.1016/j.celrep.2015.01.033; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vallabhaneni KC, 2015, ONCOTARGET, V6, P4953, DOI 10.18632/oncotarget.3211; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; Xu HD, 2014, CELL PHYSIOL BIOCHEM, V33, P1547, DOI 10.1159/000358718; Xu WT, 2009, CANCER LETT, V281, P32, DOI 10.1016/j.canlet.2009.02.022; YAN GC, 1993, MOL CELL BIOL, V13, P4513, DOI 10.1128/MCB.13.8.4513; Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010; Yui Y, 2010, CLIN EXP METASTAS, V27, P619, DOI 10.1007/s10585-010-9352-x; Zhao ZQ, 2014, CANCER LETT, V342, P150, DOI 10.1016/j.canlet.2013.08.042; Zhu Y, 2009, LEUKEMIA, V23, P925, DOI 10.1038/leu.2008.384	48	51	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166027	10.1371/journal.pone.0166027	http://dx.doi.org/10.1371/journal.pone.0166027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812189	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000097
J	Zheng, WB; Zhang, XX; Ma, JG; Li, FC; Zhao, Q; Huang, SY; Zhu, XQ				Zheng, Wen-Bin; Zhang, Xiao-Xuan; Ma, Jian-Gang; Li, Fa-Cai; Zhao, Quan; Huang, Si-Yang; Zhu, Xing-Quan			Molecular Detection and Genetic Characterization of Toxoplasma gondii in Farmed Minks (Neovison vison) in Northern China by PCR-RFLP	PLOS ONE			English	Article							RISK-FACTORS; GENOTYPIC CHARACTERIZATION; NORTHEASTERN CHINA; STRAY CATS; INFECTION; PREVALENCE; PROVINCE; SEROPREVALENCE; IDENTIFICATION; DIVERSITY	Toxoplasma gondii is a worldwide prevalent parasite, affecting a wide range of mammals and human beings. Little information is available about the distribution of genetic diversity of T. gondii infection in minks (Neovison vison). This study was conducted to estimate the prevalence and genetic characterization of T. gondii isolates from minks in China. A total of 418 minks brain tissue samples were collected from Jilin and Hebei provinces, northern China. Genomic DNA were extracted and assayed for T. gondii infection by semi-nested PCR of B1 gene. The positive DNA samples were typed at 10 genetic markers (SAG1, SAG2 (5'+3' SAG2, alter. SAG2), SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1, and Apico) using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technology. 36 (8.6%) of 418 DNA samples were overall positive for T. gondii. Among them, 5 samples were genotyped at all loci, and 1 sample was genotyped for 9 loci. In total, five samples belong to ToxoDB PCR-RFLP genotype#9, one belong to ToxoDB genotye#3. To our knowledge, this is the first report of genetic characterization of T. gondii in minks in China. Meanwhile, these results revealed a distribution of T. gondii infection in minks in China. These data provided base-line information for controlling T. gondii infection in minks.	[Zheng, Wen-Bin; Zhang, Xiao-Xuan; Ma, Jian-Gang; Li, Fa-Cai; Huang, Si-Yang; Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Zheng, Wen-Bin; Zhang, Xiao-Xuan; Ma, Jian-Gang; Zhao, Quan; Zhu, Xing-Quan] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin Province, Peoples R China; [Huang, Si-Yang; Zhu, Xing-Quan] Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Jilin Agricultural University; Yangzhou University	Huang, SY (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.; Huang, SY (corresponding author), Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.	siyang.huang@hotmail.com		Zheng, Wen-Bin/0000-0001-7621-4628	National Natural Science Foundation of China [31230073]; Natural Science Foundation of Gansu Province for Distinguished Young Scholars [1506RJDA133]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Gansu Province for Distinguished Young Scholars	Project support was provided by the National Natural Science Foundation of China (Grant No. 31230073), and Natural Science Foundation of Gansu Province for Distinguished Young Scholars (Grant No. 1506RJDA133).	Ahlers AA, 2015, J WILDLIFE DIS, V51, P488, DOI 10.7589/2014-03-071; Burrells A, 2013, PARASITOLOGY, V140, P1768, DOI 10.1017/S0031182013001169; Chen YM, 1988, CHINESE JOURNAL OF V, V5, P38; Cheng WS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2106-z; Commodaro AG, 2016, EMERG INFECT DIS, V22, P691, DOI 10.3201/eid2204.141819; Cong W, 2016, INFECT GENET EVOL, V39, P9, DOI 10.1016/j.meegid.2016.01.005; Cong W, 2015, CANCER LETT, V359, P307, DOI 10.1016/j.canlet.2015.01.036; Cong W, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-152; Cong W, 2013, KOREAN J PARASITOL, V51, P363, DOI 10.3347/kjp.2013.51.3.363; da Silva MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141700; Dubey JP, 2007, VET PARASITOL, V145, P352, DOI 10.1016/j.vetpar.2006.12.016; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; Findal G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145519; Furtado JM, 2011, J GLOB INFECT DIS, V3, P281, DOI 10.4103/0974-777X.83536; Hill DE, 2006, VET PARASITOL, V141, P9, DOI 10.1016/j.vetpar.2006.05.008; Jiang HH, 2014, VET PARASITOL, V203, P318, DOI 10.1016/j.vetpar.2014.04.016; Jiang HH, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-227; Jung BK, 2015, KOREAN J PARASITOL, V53, P259, DOI 10.3347/kjp.2015.53.3.259; Kannan G, 2010, FOLIA PARASIT, V57, P151, DOI 10.14411/fp.2010.019; Li XR, 2010, J VET DIAGN INVEST, V22, P442, DOI 10.1177/104063871002200318; Qian WF, 2012, VET PARASITOL, V187, P408, DOI 10.1016/j.vetpar.2012.01.026; Qin SY, 2015, VET PARASITOL, V211, P300, DOI 10.1016/j.vetpar.2015.05.015; Qin SY, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0558-7; Rajendran C, 2012, INFECT GENET EVOL, V12, P359, DOI 10.1016/j.meegid.2011.12.010; Rong G, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0459-9; Sepulveda MA, 2011, VET PARASITOL, V175, P60, DOI 10.1016/j.vetpar.2010.09.020; Shwab EK, 2014, PARASITOLOGY, V141, P453, DOI 10.1017/S0031182013001844; Smielewska-Los E, 2004, VET PARASITOL, V122, P201, DOI 10.1016/j.vetpar.2004.02.003; SMITH DD, 1995, J WILDLIFE DIS, V31, P15, DOI 10.7589/0090-3558-31.1.15; Su C, 2006, INT J PARASITOL, V36, P841, DOI 10.1016/j.ijpara.2006.03.003; Su C, 2010, PARASITOLOGY, V137, P1, DOI 10.1017/S0031182009991065; Tian YM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-178; Zhang FK, 2015, PARASITOL INT, V64, P576, DOI 10.1016/j.parint.2015.08.008; Zhang XX, 2014, J PARASITOL, V100, P692, DOI 10.1645/13-381.1; Zhou P, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-165; Zhou P, 2009, PARASITOL INT, V58, P193, DOI 10.1016/j.parint.2009.01.006	36	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165308	10.1371/journal.pone.0165308	http://dx.doi.org/10.1371/journal.pone.0165308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806069	Green Submitted, Green Published, gold			2022-12-27	WOS:000386715500026
J	Tacharoenmuang, R; Komoto, S; Guntapong, R; Ide, T; Sinchai, P; Upachai, S; Yoshikawa, T; Tharmaphornpilas, P; Sangkitporn, S; Taniguchi, K				Tacharoenmuang, Ratana; Komoto, Satoshi; Guntapong, Ratigorn; Ide, Tomihiko; Sinchai, Phakapun; Upachai, Sompong; Yoshikawa, Tetsushi; Tharmaphornpilas, Piyanit; Sangkitporn, Somchai; Taniguchi, Koki			Full Genome Characterization of Novel DS-1-Like G8P[8] Rotavirus Strains that Have Emerged in Thailand: Reassortment of Bovine and Human Rotavirus Gene Segments in Emerging DS-1-Like Intergenogroup Reassortant Strains	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; PROVIDES EVIDENCE; EQUINE-LIKE; PORCINE; GASTROENTERITIS; IDENTIFICATION; CONSTELLATION; PREDOMINANCE; PREVALENCE; DIVERSITY	The emergence and rapid spread of unusual DS-1-like intergenogroup reassortant rotavirus strains have been recently reported in Asia, Australia, and Europe. During rotavirus surveillance in Thailand in 2013 - 2014, novel DS-1-like intergenogroup reassortant strains having G8P[8] genotypes (i.e., strains KKL-17, PCB-79, PCB-84, PCB-85, PCB-103, SKT-107, SWL-12, NP-130, PCB-656, SKT-457, SSKT-269, and SSL-55) were identified in stool samples from hospitalized children with severe diarrhea. In this study, we determined and characterized the complete genomes of these 12 strains (seven strains, KKL-17, PCB-79, PCB-84, PCB-85, PCB-103, SKT-107, and SWL-12, found in 2013 (2013 strains), and five, NP-130, PCB-656, SKT-457, SSKT-269, and SSL-55, in 2014 (2014 strains)). On full genomic analysis, all 12 strains showed a unique genotype constellation comprising a mixture of genogroup 1 and 2 genes: G8-P[8]-I2-R2-C2-M2-A2-N2-T2-E2-H2. With the exception of the G genotype, the unique genotype constellation of the 12 strains (P[8]-I2-R2-C2M2- A2-N2-T2-E2-H2) was found to be shared with DS-1-like intergenogroup reassortant strains. On phylogenetic analysis, six of the 11 genes of the 2013 strains (VP4, VP2, VP3, NSP1, NSP3, and NSP5) appeared to have originated from DS-1-like intergenogroup reassortant strains, while the remaining four (VP7, VP6, VP1, and NSP2) and one (NSP4) gene appeared to be of bovine and human origin, respectively. Thus, the 2013 strains appeared to be reassortant strains as to DS-1-like intergenogroup reassortant, bovine, bovine-like human, and/or human rotaviruses. On the other hand, five of the 11 genes of the 2014 strains (VP4, VP2, VP3, NSP1, and NSP3) appeared to have originated from DS-1-like intergenogroup reassortant strains, while three (VP7, VP1, and NSP2) and one (NSP4) were assumed to be of bovine and human origin, respectively. Notably, the remaining two genes, VP6 and NSP5, of the 2014 strains appeared to have originated from locally circulating DS-1-like G2P[4] human rotaviruses. Thus, the 2014 strains were assumed to be multiple reassortment strains as to DS-1-like intergenogroup reassortant, bovine, bovine-like human, human, and/or locally circulating DS-1-like G2P[4] human rotaviruses. Overall, the great genomic diversity among the DS-1-like intergenogroup reassortant strains seemed to have been generated through additional reassortment events involving animal and human strains. Moreover, all the 11 genes of three of the 2014 strains, NP-130, PCB-656, and SSL-55, were very closely related to those of Vietnamese DS-1-like G8P[8] strains that emerged in 2014-2015, indicating the derivation of these DS-1-like G8P[8] strains from a common ancestor. To our knowledge, this is the first report on full genome-based characterization of DS-1-like G8P[8] strains that have emerged in Thailand. Our observations will add to our growing understanding of the evolutionary patterns of emerging DS-1-like intergenogroup reassortant strains.	[Tacharoenmuang, Ratana; Guntapong, Ratigorn; Sinchai, Phakapun; Upachai, Sompong; Sangkitporn, Somchai] Natl Inst Hlth, Dept Med Sci, Nonthaburi, Thailand; [Komoto, Satoshi; Ide, Tomihiko; Taniguchi, Koki] Fujita Hlth Univ, Dept Virol & Parasitol, Sch Med, Toyoake, Aichi, Japan; [Yoshikawa, Tetsushi] Fujita Hlth Univ, Dept Pediat, Sch Med, Toyoake, Aichi, Japan; [Tharmaphornpilas, Piyanit] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand	Ministry of Public Health - Thailand; Fujita Health University; Fujita Health University; Ministry of Public Health - Thailand	Komoto, S (corresponding author), Fujita Hlth Univ, Dept Virol & Parasitol, Sch Med, Toyoake, Aichi, Japan.	satoshik@fujita-hu.ac.jp			Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development, AMED; Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand	Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand	This study was supported in part by the Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development, AMED (KT), and the Original Rotavirus Vaccine Effectiveness Study Program of the Ministry of Public Health of Thailand (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbemabiese CA, 2015, INFECT GENET EVOL, V35, P184, DOI 10.1016/j.meegid.2015.07.033; Arana A, 2016, INFECT GENET EVOL, V44, P137, DOI 10.1016/j.meegid.2016.06.048; Chieochansin T, 2016, INFECT GENET EVOL, V37, P129, DOI 10.1016/j.meegid.2015.11.011; Cowley D, 2016, J GEN VIROL, V97, P403, DOI 10.1099/jgv.0.000352; Delogu R, 2013, J CLIN MICROBIOL, V51, P1583, DOI 10.1128/JCM.00396-13; Dennis FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100699; Doro R, 2016, ACTA MICROBIOL IMM H, V63, P243, DOI 10.1556/030.63.2016.2.8; El Sherif M, 2011, INFECT GENET EVOL, V11, P1436, DOI 10.1016/j.meegid.2011.05.012; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Fujii Y, 2014, INFECT GENET EVOL, V28, P426, DOI 10.1016/j.meegid.2014.08.001; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; Ghosh S, 2007, ARCH VIROL, V152, P423, DOI 10.1007/s00705-006-0848-2; Ghosh S, 2015, VET MICROBIOL, V180, P286, DOI 10.1016/j.vetmic.2015.09.017; Ghosh S, 2011, FUTURE MICROBIOL, V6, P1049, DOI [10.2217/FMB.11.90, 10.2217/fmb.11.90]; Guntapong R, 2016, J MED VIROL IN PRESS; Heiman EM, 2008, J VIROL, V82, P11106, DOI 10.1128/JVI.01402-08; Hoa-Tran TN, 2016, ARCH VIROL, V161, P479, DOI 10.1007/s00705-015-2682-x; Ide T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124965; Kahn G, 2012, INDIAN PEDIATR, V49, P467, DOI 10.1007/s13312-012-0076-7; Komoto S, 2016, INFECT GENET EVOL, V43, P424, DOI 10.1016/j.meegid.2016.06.023; Komoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148416; Komoto S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141739; Komoto S, 2014, VET MICROBIOL, V174, P577, DOI 10.1016/j.vetmic.2014.09.033; Komoto S, 2014, INFECT GENET EVOL, V27, P277, DOI 10.1016/j.meegid.2014.08.002; Kuzuya M, 2014, J MED VIROL, V86, P1056, DOI 10.1002/jmv.23746; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2006, J CLIN MICROBIOL, V44, P1801, DOI 10.1128/JCM.44.5.1801-1809.2006; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Solberg OD, 2009, VIROLOGY, V385, P58, DOI 10.1016/j.virol.2008.11.026; Tacharoenmuang R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139381; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Yamamoto SP, 2014, EMERG INFECT DIS, V20, P1030, DOI 10.3201/eid2006.131326	40	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165826	10.1371/journal.pone.0165826	http://dx.doi.org/10.1371/journal.pone.0165826			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802339	gold, Green Submitted, Green Published			2022-12-27	WOS:000386714200059
J	Wang, XB; Wang, LF; Shangguan, Z				Wang, Xiubo; Wang, Lifang; Shangguan, Zhouping			Leaf Gas Exchange and Fluorescence of Two Winter Wheat Varieties in Response to Drought Stress and Nitrogen Supply	PLOS ONE			English	Article							WATER-USE EFFICIENCY; CHLOROPHYLL FLUORESCENCE; PHOTOSYSTEM-II; DURUM-WHEAT; PHOTOSYNTHESIS; L.; NUTRITION; CARBON; ROOT; PARAMETERS	Water and nitrogen supply are the two primary factors limiting productivity of wheat (Triticum aestivum L.). In our study, two winter wheat varieties, Xinong 979 and large-spike wheat, were evaluated for their physiological responses to different levels of nitrogen and water status during their seedling stage grown in a phytotron. Our results indicated that drought stress greatly reduced the net photosynthetic rate (P-n), transpiration rate (E), and stomatal conductance (G(s)), but with a greater increase in instantaneous water use efficiency (WUE). At the meantime, the nitrogen (N) supply improved photosynthetic efficiency under water deficit. Parameters inferred from chlorophyll a measurements, i.e., photochemical quenching coefficient (qP), the maximum photochemical efficiency (F-v/F-m), the quantum yield of photosystemII(Phi(PSII)), and the apparent photosynthetic electron transport rate (ETR) decreased under water stress at all nitrogen levels and declined in N-deficient plants. The root-shoot ratio (R/S) increased slightly with water stress at a low N level; the smallest root-shoot ratio was found at a high N level and moderate drought stress treatment. These results suggest that an appropriate nitrogen supply may be necessary to enhance drought resistance in wheat by improving photosynthetic efficiency and relieving photoinhibition under drought stress. However, an excessive N supply had no effect on drought resistance, which even showed an adverse effect on plant growth. Comparing the two cultivars, Xinong 979 has a stronger drought resistance compared with large-spike wheat under N deficiency.	[Shangguan, Zhouping] Chinese Acad Sci, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China; Minist Water Resources, Yangling 712100, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources	Shangguan, Z (corresponding author), Chinese Acad Sci, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China.	shangguan@ms.iswc.ac.cn			National Natural Science Foundation of China [31370425]; National Key Technology RD Program [2015BAD22B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program)	The study was financially supported by the National Natural Science Foundation of China (31370425) and the National Key Technology R&D Program (2015BAD22B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdiyev T, 2016, AGRICULTURE FORESTRY, V62, DOI 10.17707/AgricultForest.62.1.16; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Carvalho P, 2014, J INTEGR PLANT BIOL, V56, P455, DOI 10.1111/jipb.12109; Chaves MM, 2004, J EXP BOT, V55, P2365, DOI 10.1093/jxb/erh269; Chen YH, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0069-4; DaMatta FM, 2002, TREES-STRUCT FUNCT, V16, P555, DOI 10.1007/s00468-002-0205-3; dos Santos CM, 2013, IND CROP PROD, V41, P203, DOI 10.1016/j.indcrop.2012.04.003; Elazab A, 2016, PLANTA, V244, P125, DOI 10.1007/s00425-016-2500-z; Elazab A, 2012, FUNCT PLANT BIOL, V39, P379, DOI 10.1071/FP11237; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; Flexas J, 2006, PHYSIOL PLANTARUM, V127, P343, DOI 10.1111/j.1399-3054.2006.00621.x; Hanachi S, 2014, PHOTOSYNTHETICA, V52, P57, DOI 10.1007/s11099-014-0007-z; Hura T, 2007, ACTA PHYSIOL PLANT, V29, P103, DOI 10.1007/s11738-006-0013-2; Kaur G, 2015, INT J AGRIC BIOL, V17, P531, DOI 10.17957/IJAB/17.3.14.539; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; Lin YC, 2013, J INTEGR AGR, V12, P2164, DOI [10.1016/S2095-3119(13)60346-9, 10.1016/s2095-3119(13)60346-9]; Liu M., 2012, AFR J AGR RES, V7, P4751; Liu RX, 2008, AGR WATER MANAGE, V95, P1261, DOI 10.1016/j.agwat.2008.05.002; Lopes MS, 2006, PHYSIOL PLANTARUM, V126, P435, DOI 10.1111/j.1399-3054.2006.00595.x; Mardanov A, 1998, DEV PLANT SOIL SCI, V82, P147; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Miller AJ, 2005, PLANT SOIL, V274, P1, DOI 10.1007/s11104-004-0965-1; Ostroumov EE, 2014, ADV PHOTOSYNTH RESP, V40, P97, DOI 10.1007/978-94-017-9032-1_4; Pan J, 2012, J PHYS CHEM B, V116, P2014, DOI 10.1021/jp212441b; Pan X, 2011, PHOTOSYNTHETICA, V49, P309, DOI 10.1007/s11099-011-0031-1; Papageorgiou C., 2004, CHLOROPHYLL FLUORESC, P1, DOI DOI 10.1007/978-1-4020-3218-9_1; Papageorgiou GC, 2014, ADV PHOTOSYNTH RESP, V40, P1, DOI 10.1007/978-94-017-9032-1_1; Papageorgiou GC, 2011, J PHOTOCH PHOTOBIO B, V104, P258, DOI 10.1016/j.jphotobiol.2011.03.008; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Rouhi V, 2007, ENVIRON EXP BOT, V59, P117, DOI 10.1016/j.envexpbot.2005.10.001; Said SA, 2013, PHOTOSYNTHETICA, V51, P552, DOI 10.1007/s11099-013-0055-9; Shangguan ZP, 2004, BOT BULL ACAD SINICA, V45, P49; Shangguan ZP, 2000, J PLANT PHYSIOL, V156, P46, DOI 10.1016/S0176-1617(00)80271-0; Shangguan ZP, 2000, ENVIRON EXP BOT, V44, P141, DOI 10.1016/S0098-8472(00)00064-2; Shaw B, 2002, PLANT GROWTH REGUL, V37, P77, DOI 10.1023/A:1020381513976; Silva EN, 2010, J ARID ENVIRON, V74, P1130, DOI 10.1016/j.jaridenv.2010.05.036; Slabbert RM, 2011, PLANT PHYSIOL BIOCH, V49, P978, DOI 10.1016/j.plaphy.2011.05.001; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Tezara W, 2005, PHOTOSYNTHETICA, V43, P37, DOI 10.1007/s11099-005-7045-5; Tezara W, 1999, NATURE, V401, P914, DOI 10.1038/44842; Wang CY, 2014, FIELD CROP RES, V165, P138, DOI 10.1016/j.fcr.2014.04.011; Wang L, 2015, NEW ZEAL J CROP HORT, V43, P182, DOI 10.1080/01140671.2014.994644; Waraich EA, 2011, J PLANT NUTR, V34, P1867, DOI 10.1080/01904167.2011.600413; Wu FZ, 2008, PHOTOSYNTHETICA, V46, P40, DOI 10.1007/s11099-008-0008-x; Yin CY, 2006, PHOTOSYNTHETICA, V44, P62, DOI 10.1007/s11099-005-0159-y; Zhang XC, 2013, PHOTOSYNTHETICA, V51, P593, DOI 10.1007/s11099-013-0059-5; Zhao LJ, 2007, J PLANT NUTR, V30, P947, DOI 10.1080/15226510701375572; Zivcak M, 2014, PLANT SOIL ENVIRON, V60, P210, DOI 10.17221/73/2014-PSE	51	48	51	10	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165733	10.1371/journal.pone.0165733	http://dx.doi.org/10.1371/journal.pone.0165733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802318	Green Published, Green Submitted, gold			2022-12-27	WOS:000386714200047
J	Crowcombe, J; Dhillon, SS; Hurst, RM; Egginton, S; Muller, F; Sik, A; Tarte, E				Crowcombe, James; Dhillon, Sundeep Singh; Hurst, Rhiannon Mary; Egginton, Stuart; Mueller, Ferenc; Sik, Attila; Tarte, Edward			3D Finite Element Electrical Model of Larval Zebrafish ECG Signals	PLOS ONE			English	Article							ACTION-POTENTIAL PROPAGATION; CARDIAC ELECTROPHYSIOLOGY; HEART FIELD; ION-CHANNEL; MEMBRANE; ELECTROCARDIOGRAM; TOMOGRAPHY; SIMULATION; DYNAMICS; PLATFORM	Assessment of heart function in zebrafish larvae using electrocardiography (ECG) is a potentially useful tool in developing cardiac treatments and the assessment of drug therapies. In order to better understand how a measured ECG waveform is related to the structure of the heart, its position within the larva and the position of the electrodes, a 3D model of a 3 days post fertilisation (dpf) larval zebrafish was developed to simulate cardiac electrical activity and investigate the voltage distribution throughout the body. The geometry consisted of two main components; the zebrafish body was modelled as a homogeneous volume, while the heart was split into five distinct regions (sinoatrial region, atrial wall, atrioventricular band, ventricular wall and heart chambers). Similarly, the electrical model consisted of two parts with the body described by Laplace's equation and the heart using a bidomain ionic model based upon the Fitzhugh-Nagumo equations. Each region of the heart was differentiated by action potential (AP) parameters and activation wave conduction velocities, which were fitted and scaled based on previously published experimental results. ECG measurements in vivo at different electrode recording positions were then compared to the model results. The model was able to simulate action potentials, wave propagation and all the major features (P wave, R wave, T wave) of the ECG, as well as polarity of the peaks observed at each position. This model was based upon our current understanding of the structure of the normal zebrafish larval heart. Further development would enable us to incorporate features associated with the diseased heart and hence assist in the interpretation of larval zebrafish ECGs in these conditions.	[Crowcombe, James; Tarte, Edward] Univ Birmingham, Sch Engn, Birmingham, W Midlands, England; [Dhillon, Sundeep Singh; Hurst, Rhiannon Mary; Mueller, Ferenc] Univ Birmingham, Coll Med & Dent Sci, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Dhillon, Sundeep Singh; Hurst, Rhiannon Mary; Sik, Attila] Univ Birmingham, Inst Clin Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Egginton, Stuart] Univ Leeds, Sch Biomed Sci, Fac Biol Sci, Leeds, W Yorkshire, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Leeds	Crowcombe, J (corresponding author), Univ Birmingham, Sch Engn, Birmingham, W Midlands, England.; Sik, A (corresponding author), Univ Birmingham, Inst Clin Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England.	james.crowcombe@gmail.com; a.sik@bham.ac.uk		mueller, ferenc/0000-0002-0996-774X; Egginton, Stuart/0000-0002-3084-9692	British Heart Foundation [NH/12/3/29636]; Engineering and Physical Sciences Research Council studentship	British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council studentship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was funded by the British Heart Foundation (https://www.bhf.org.uk/) awarded to AS, ET, FM and SE (NH/12/3/29636) and JC was funded by an Engineering and Physical Sciences Research Council studentship awarded to the University of Birmingham (https://www.epsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeniran I., 2013, J BIOMED SCI ENG, V6, P47, DOI DOI 10.4236/JBISE.2013.612A007; Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Berenfeld O, 1996, MED ENG PHYS, V18, P615, DOI 10.1016/S1350-4533(96)00028-8; Berghmans Stephane, 2008, Journal of Pharmacological and Toxicological Methods, V58, P59, DOI 10.1016/j.vascn.2008.05.130; Boulakia M, 2010, ANN BIOMED ENG, V38, P1071, DOI 10.1007/s10439-009-9873-0; Bruce D, 2012, ELECTRON PROC THEOR, P1, DOI 10.4204/EPTCS.92.1; Bryson-Richardson RJ, 2004, METHOD CELL BIOL, V76, P37; Butters TD, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0067; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; CLERC L, 1976, J PHYSIOL-LONDON, V255, P335, DOI 10.1113/jphysiol.1976.sp011283; Dhillon SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060552; Dietrich AC, 2014, DEV CELL, V30, P367, DOI 10.1016/j.devcel.2014.06.020; Dokos S, 2007, P 29 ANN INT C IEEE; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Forouhar AS, 2004, P 26 ANN INT C IEEE; Garny A, 2004, ANN NY ACAD SCI, V1015, P133, DOI 10.1196/annals.1302.011; Grimes AC, 2008, TOXICOL SCI, V106, P193, DOI 10.1093/toxsci/kfn154; Gurev V, 2010, BIOPHYS J, V99, P745, DOI 10.1016/j.bpj.2010.05.028; Gurev V, 2011, BIOMECH MODEL MECHAN, V10, P295, DOI 10.1007/s10237-010-0235-5; Hami D, 2011, DEVELOPMENT, V138, P2389, DOI 10.1242/dev.061473; Harrild DM, 2000, CIRC RES, V87, pE25; Hecker L, 2008, ZEBRAFISH, V5, P319, DOI 10.1089/zeb.2008.0550; Henriquez CS, 2014, IEEE T BIO-MED ENG, V61, P1457, DOI 10.1109/TBME.2014.2310515; Jensen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044231; Johnston BM, 2015, MATH BIOSCI, V266, P15, DOI 10.1016/j.mbs.2015.05.008; Just S, 2011, CIRCULATION, V124, P324, DOI 10.1161/CIRCULATIONAHA.110.003301; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kochova P, 2015, J THEOR BIOL, V373, P12, DOI 10.1016/j.jtbi.2015.03.014; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084256; Liebling M, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2061567; Lin E, 2014, AM J PHYSIOL-REG I, V306, pR823, DOI 10.1152/ajpregu.00002.2014; Lines G. T., 2003, Computing and Visualization in Science, V5, P215, DOI 10.1007/s00791-003-0101-4; MacLeod R., 2010, COMPREHENSIVE ELECTR, P247, DOI [10.1007/978-1-84882-046-3_8, DOI 10.1007/978-1-84882-046-3_8]; Malmivuo P., 1995, BIOELECTROMAGNETISM, DOI [DOI 10.1093/ACPROF:OSO/9780195058239.001.0001, 10.1093/acprof:oso/9780195058239.001.0001]; Mickoleit M, 2014, NAT METHODS, V11, P919, DOI [10.1038/NMETH.3037, 10.1038/nmeth.3037]; Milan DJ, 2006, AM J PHYSIOL-HEART C, V291, pH269, DOI 10.1152/ajpheart.00960.2005; Mitchell CC, 2003, B MATH BIOL, V65, P767, DOI 10.1016/S0092-8240(03)00041-7; Nakazaki T, 2003, NATURE, V421, P170, DOI 10.1038/nature01219; Nemtsas P, 2010, J MOL CELL CARDIOL, V48, P161, DOI 10.1016/j.yjmcc.2009.08.034; NOBLE D, 1962, J PHYSIOL-LONDON, V160, P317, DOI 10.1113/jphysiol.1962.sp006849; Okada JI, 2013, PACE, V36, P309, DOI 10.1111/pace.12057; Panakova D, 2010, NATURE, V466, P874, DOI 10.1038/nature09249; Peralta M, 2014, J DEV BIOL, V2, P101, DOI 10.3390/jdb2020101; Potse M, 2006, IEEE T BIO-MED ENG, V53, P2425, DOI 10.1109/TBME.2006.880875; Renz M, 2015, DEV CELL, V32, P181, DOI 10.1016/j.devcel.2014.12.016; ROBERTS DE, 1979, CIRC RES, V44, P701, DOI 10.1161/01.RES.44.5.701; Roberts DE, 1982, CIRCULATION, V50; ROGERS JM, 1994, IEEE T BIO-MED ENG, V41, P743, DOI 10.1109/10.310090; Rohr S, 2004, CARDIOVASC RES, V62, P309, DOI 10.1016/j.cardiores.2003.11.035; Rottbauer W, 2001, DEV CELL, V1, P265, DOI 10.1016/S1534-5807(01)00023-5; Salgao D, ZEBRAFISH ANATOMY PO; Sedmera D, 2003, AM J PHYSIOL-HEART C, V284, pH1152, DOI 10.1152/ajpheart.00870.2002; Sovilj S, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/134208; SPACH MS, 1981, CIRC RES, V48, P39, DOI 10.1161/01.RES.48.1.39; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Stinstra J, 2010, ANN BIOMED ENG, V38, P1399, DOI 10.1007/s10439-009-9883-y; Stinstra JG, 2005, ANN BIOMED ENG, V33, P1743, DOI 10.1007/s10439-005-7257-7; Sun P, 2009, ANN BIOMED ENG, V37, P890, DOI 10.1007/s10439-009-9668-3; Takeuchi JK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1187; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Thomas NA, 2008, DEVELOPMENT, V135, P3789, DOI 10.1242/dev.024083; Trayanova NA, 2011, CIRC RES, V108, P113, DOI 10.1161/CIRCRESAHA.110.223610; Tsai CT, 2011, CLIN CHIM ACTA, V412, P1963, DOI 10.1016/j.cca.2011.07.002; Verkerk AO, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00255; Wang J, 2011, DEVELOPMENT, V138; Yu F, 2010, ZEBRAFISH, V7, P325, DOI 10.1089/zeb.2010.0658; Zemzemi N, 2013, BRIT J PHARMACOL, V168, P718, DOI 10.1111/j.1476-5381.2012.02200.x; Zhang RL, 2013, NATURE, V498, P497, DOI 10.1038/nature12322; Zhang X, 2014, MICR MECH SYST MEMS; Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094	73	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165655	10.1371/journal.pone.0165655	http://dx.doi.org/10.1371/journal.pone.0165655			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824910	Green Published, gold			2022-12-27	WOS:000387615200027
J	Milanovich, JR; Barrett, K; Crawford, JA				Milanovich, Joseph R.; Barrett, Kyle; Crawford, John A.			Detritus Quality and Locality Determines Survival and Mass, but Not Export, of Wood Frogs at Metamorphosis	PLOS ONE			English	Article							LARVAL AMPHIBIANS; BIOMASS EXPORT; CLIMATE-CHANGE; RECIPROCAL SUBSIDIES; EXPERIMENTAL ECOLOGY; SECONDARY COMPOUNDS; EXPERIMENTAL VENUE; SPECIES CHANGES; FOOD WEBS; PONDS	Single-site experiments have demonstrated detritus quality in wetlands can have strongly negative, neutral, and even positive influences on wildlife. However, an examination of the influence of detritus quality across several regions is lacking and can provide information on whether impacts from variation in detritus quality are consistent across species with wide ranges. To address this gap in regional studies we examined effects of emergent and allochthonous detritus of different nutrient qualities on amphibians and assessed a mechanism that may contribute to potential impacts. We used aquatic mesocosms to raise wood frogs (Rana sylvatica) from two regions of the United States with whole plants from purple loosestrife (Lythrum salicaria), leaf litter from native hardwood trees, and a mixture of both. We examined several metrics of amphibian fitness and life history, including survival, number of days to metamorphosis, and size at metamorphosis. Further, we quantified whether the effects of detritus type could translate to variation in anuran biomass or standing stock of nitrogen or phosphorus export. Our results show detritus with high nutrient quality (purple loosestrife) negatively influenced survival of wood frogs, but increased size of metamorphic individuals in two different regions of the United States. Despite the decrease in survival, the increase in size of post-metamorphic anurans raised with high quality detritus resulted in anuran biomass and standing stock of N and P export being similar across treatments at both locations. These results further demonstrate the role of plant quality in shaping wet-land ecosystem dynamics, and represent the first demonstration that effects are consistent within species across ecoregional boundaries.	[Milanovich, Joseph R.] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Barrett, Kyle] Clemson Univ, Dept Forestry & Environm Conservat, Clemson, SC USA; [Crawford, John A.] Lindenwood Univ, Dept Biol Sci, St Charles, MO USA; [Crawford, John A.] Natl Great Rivers Res & Educ Ctr, East Alton, IL USA	Loyola University Chicago; Clemson University	Milanovich, JR (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	jmilanovich@luc.edu			Clemson University Research Grants Committee	Clemson University Research Grants Committee	This project was partially supported by an award from the Clemson University Research Grants Committee to K. Barrett.	Alvarez M. R., 2016, COMPUTATIONAL SOCIAL; Boggs CL, 2005, OECOLOGIA, V144, P353, DOI 10.1007/s00442-005-0076-6; Burkett V, 2000, J AM WATER RESOUR AS, V36, P313, DOI 10.1111/j.1752-1688.2000.tb04270.x; Capps KA, 2015, FRESHWATER BIOL, V60, P500, DOI 10.1111/fwb.12470; Cecala Kristen K., 2007, Herpetological Review, V38, P63; Cohen JS, 2012, ECOL APPL, V22, P218, DOI 10.1890/11-0078.1; Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003; Cothran RD, 2011, J N AM BENTHOL SOC, V30, P893, DOI 10.1899/11-011.1; Earl JE, 2014, OECOLOGIA, V175, P209, DOI 10.1007/s00442-013-2870-x; Earl JE, 2012, OECOLOGIA, V170, P1077, DOI 10.1007/s00442-012-2361-5; Earl JE, 2011, FRESHWATER BIOL, V56, P2473, DOI 10.1111/j.1365-2427.2011.02672.x; Gosner K. L., 1960, Herpetologica, V16, P183; Hautier Y, 2015, SCIENCE, V348, P336, DOI 10.1126/science.aaa1788; HerreraSilveira JA, 1996, LIMNOL OCEANOGR, V41, P1018, DOI 10.4319/lo.1996.41.5.1018; Hocking DJ, 2014, HERPETOL CONSERV BIO, V9, P1; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; Kiesecker JM, 2001, ECOLOGY, V82, P1956, DOI 10.1890/0012-9658(2001)082[1956:EODAPD]2.0.CO;2; Leary S, 2013, AVMA GUIDELINES EUTH; Maerz JC, 2005, FUNCT ECOL, V19, P970, DOI 10.1111/j.1365-2435.2005.01054.x; Maerz JC, 2010, FRESHWATER BIOL, V55, P1694, DOI 10.1111/j.1365-2427.2010.02404.x; Magurran AE, 2016, SCIENCE, V351, P448, DOI 10.1126/science.aad6758; Martin LJ, 2015, OIKOS, V124, P871, DOI 10.1111/oik.01745; Martin LJ, 2013, OECOLOGIA, V173, P449, DOI 10.1007/s00442-013-2624-9; Parris MJ, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P526; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Regester KJ, 2006, OECOLOGIA, V147, P303, DOI 10.1007/s00442-005-0266-2; Richter-Boix A, 2007, J ANIM ECOL, V76, P607, DOI 10.1111/j.1365-2656.2007.01232.x; RIHA VF, 1991, COPEIA, P209, DOI 10.2307/1446264; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Rosa E. A., 2015, CLIMATE CHANGE SOC S; Rubbo MJ, 2008, HYDROBIOLOGIA, V605, P37, DOI 10.1007/s10750-008-9298-z; Rubbo MJ, 2004, ECOLOGY, V85, P2519, DOI 10.1890/03-0653; Schiesari L, 2009, FRESHWATER BIOL, V54, P572, DOI 10.1111/j.1365-2427.2008.02134.x; Schmider E., 2010, METHODOLOGY; Schriever TA, 2013, FRESHWATER BIOL, V58, P223, DOI 10.1111/fwb.12044; SEALE DB, 1980, ECOLOGY, V61, P1531, DOI 10.2307/1939059; Selwood KE, 2015, BIOL REV, V90, P837, DOI 10.1111/brv.12136; Short FT, 2016, AQUATIC BOT; Skelly DK, 2002, ECOLOGY, V83, P2097, DOI 10.1890/0012-9658(2002)083[2097:EVAEOI]2.0.CO;2; Skelly DK, 2002, ECOLOGY, V83, P983, DOI 10.1890/0012-9658(2002)083[0983:FCATPO]2.0.CO;2; Stephens JP, 2013, FRESHWATER BIOL, V58, P1631, DOI 10.1111/fwb.12155; Stoler AB, 2016, ECOLOGY, V97, P1783, DOI 10.1890/15-1786.1; Stoler AB, 2015, OECOLOGIA, V179, P667, DOI 10.1007/s00442-015-3387-2; Stoler AB, 2013, ECOLOGY, V94, P1594, DOI 10.1890/12-2087.1; Stoler AB, 2011, OIKOS, V120, P862, DOI 10.1111/j.1600-0706.2010.18625.x; Watling JI, 2011, OECOLOGIA, V165, P153, DOI 10.1007/s00442-010-1777-z; Watling JI, 2011, OIKOS, V120, P735, DOI 10.1111/j.1600-0706.2010.19255.x; Wilbur HM, 1997, ECOLOGY, V78, P2279, DOI 10.1890/0012-9658(1997)078[2279:EEOFWC]2.0.CO;2; Winkler JD, 2012, FUNCT ECOL, V26, P513, DOI 10.1111/j.1365-2435.2012.01965.x; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	51	6	6	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166296	10.1371/journal.pone.0166296	http://dx.doi.org/10.1371/journal.pone.0166296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824915	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200084
J	He, F; Akbari, P; Mo, R; Zhang, JJ; Hui, CC; Kim, PC; Farhat, WA				He, Fei; Akbari, Pedram; Mo, Rong; Zhang, Jennifer J.; Hui, Chi-Chung; Kim, Peter C.; Farhat, Walid A.			Adult Gli2(+/-);Gli3(Delta 699/+) Male and Female Mice Display a Spectrum of Genital Malformation	PLOS ONE			English	Article							EXTERNAL GENITALIA; ANORECTAL-MALFORMATIONS; MOUSE; CRYPTORCHIDISM; HYPOSPADIAS; SURGERY; TESTIS	Disorders of sexual development (DSD) encompass a broad spectrum of urogenital malformations and are amongst the most common congenital birth defects. Although key genetic factors such as the hedgehog (Hh) family have been identified, a unifying postnatally viable model displaying the spectrum of male and female urogenital malformations has not yet been reported. Since human cases are diagnosed and treated at various stages postnatally, equivalent mouse models enabling analysis at similar stages are of significant interest. Additionally, all non-Hh based genetic models investigating DSD display normal females, leaving female urogenital development largely unknown. Here, we generated compound mutant mice, Gli2(+/-);Gli3 Delta(699/+), which exhibit a spectrum of urogenital malformations in both males and females upon birth, and also carried them well into adulthood. Analysis of embryonic day (E) 18.5 and adult mice revealed shortened anogenital distance (AGD), open ventral urethral groove, incomplete fusion of scrotal sac, abnormal penile size and structure, and incomplete testicular descent with hypoplasia in male mice, whereas female mutant mice displayed reduced AGD, urinary incontinence, and a number of uterine anomalies such as vaginal duplication. Male and female fertility was also investigated via breeding cages, and it was identified that male mice were infertile while females were unable to deliver despite becoming impregnated. We propose that Gli2(+/-);Gli3 Delta(699/+) mice can serve as a genetic mouse model for common DSD such as cryptorchidism, hypospadias, and incomplete fusion of the scrotal sac in males, and a spectrum of uterine and vaginal abnormalities along with urinary incontinence in females, which could prove essential in revealing new insights into their equivalent diseases in humans.	[He, Fei; Akbari, Pedram; Mo, Rong; Zhang, Jennifer J.; Hui, Chi-Chung; Farhat, Walid A.] Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, Toronto, ON, Canada; [Hui, Chi-Chung] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Kim, Peter C.] Childrens Natl Hlth Syst, Sheikh Zayed Inst Pediat Surg Innovat, Washington, DC USA; [Farhat, Walid A.] Univ Toronto, Hosp Sick Children, Div Urol, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Children's National Health System; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Farhat, WA (corresponding author), Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, Toronto, ON, Canada.; Farhat, WA (corresponding author), Univ Toronto, Hosp Sick Children, Div Urol, Dept Surg, Toronto, ON, Canada.	Walid.farhat@sickkids.ca	Farhat, Walid/AAM-4580-2021		Canadian Institutes of Health Research [FRN: 86628]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work is supported by an operating grant (FRN: 86628) from the Canadian Institutes of Health Research (PCK).	Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Blaschko SD, 2012, DIFFERENTIATION, V84, P261, DOI 10.1016/j.diff.2012.06.003; Bose J, 2002, HUM MOL GENET, V11, P1129, DOI 10.1093/hmg/11.9.1129; Cheng W, 2008, J UROLOGY, V180, P1543, DOI 10.1016/j.juro.2008.06.003; Clark AM, 2000, BIOL REPROD, V63, P1825, DOI 10.1095/biolreprod63.6.1825; Haraguchi R, 2001, DEVELOPMENT, V128, P4241; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Kimmel SG, 2000, J PEDIATR SURG, V35, P227, DOI 10.1016/S0022-3468(00)90014-9; Klonisch T, 2004, DEV BIOL, V270, P1, DOI 10.1016/j.ydbio.2004.02.018; Kokorowski PJ, 2010, PEDIATRICS, V126, pE576, DOI 10.1542/peds.2010-0747; Levitt MA, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-33; Lin CX, 2009, DEVELOPMENT, V136, P3959, DOI 10.1242/dev.039768; Marrocco G, 2004, PEDIATR SURG INT, V20, P200, DOI 10.1007/s00383-004-1147-1; Miyagawa S, 2011, ENDOCRINOLOGY, V152, P2894, DOI 10.1210/en.2011-0263; Mo R, 2001, AM J PATHOL, V159, P765, DOI 10.1016/S0002-9440(10)61747-6; Nahum GG, 1998, J REPROD MED, V43, P877; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Nitti V W, 2001, Rev Urol, V3 Suppl 1, pS2; Perriton CL, 2002, DEV BIOL, V247, P26, DOI 10.1006/dbio.2002.0668; Pohl HG, 2007, J UROLOGY, V177, P1646, DOI 10.1016/j.juro.2007.01.058; Rodriguez E, 2011, BIOL REPROD, V85, P1216, DOI 10.1095/biolreprod.111.091504; Ruggeri G, 2012, PEDIATR SURG INT, V28, P797, DOI 10.1007/s00383-012-3121-7; Runck LA, 2014, DIS MODEL MECH, V7, P483, DOI 10.1242/dmm.014530; Tannour-Louet M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015392; Warne SA, 2011, ARCH DIS CHILD, V96, P1072, DOI 10.1136/adc.2009.175034; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Yong WD, 2007, J BIOL CHEM, V282, P5026, DOI 10.1074/jbc.M609360200	27	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165958	10.1371/journal.pone.0165958	http://dx.doi.org/10.1371/journal.pone.0165958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814383	Green Submitted, gold, Green Published			2022-12-27	WOS:000386911100022
J	Kwak, TJ; Nam, YG; Najera, MA; Lee, SW; Strickler, JR; Chang, WJ				Kwak, Tae Joon; Nam, Young Gyu; Najera, Maria Alejandra; Lee, Sang Woo; Strickler, J. Rudi; Chang, Woo-Jin			Convex Grooves in Staggered Herringbone Mixer Improve Mixing Efficiency of Laminar Flow in Microchannel	PLOS ONE			English	Article							OPTIMIZATION; MICROMIXERS	The liquid streams in a microchannel are hardly mixed to form laminar flow, and the mixing issue is well described by a low Reynolds number scheme. The staggered herringbone mixer (SHM) using repeated patterns of grooves in the microchannel have been proved to be an efficient passive micro-mixer. However, only a negative pattern of the staggered herringbone mixer has been used so far after it was first suggested, to the best of our knowledge. In this study, the mixing efficiencies from negative and positive staggered herringbone mixer patterns as well as from opposite flow directions were tested to investigate the effect of the micro-structure geometry on the surrounding laminar flow. The positive herringbone pattern showed better mixing efficiency than the conventionally used negative pattern. Also, generally used forward flow gives better mixing efficiency than reverse flow. The mixing was completed after two cycles of staggered herringbone mixer with both forward and reverse flow in a positive pattern. The traditional negative pattern showed complete mixing after four and five cycles in forward and reverse flow direction, respectively. The mixing effect in all geometries was numerically simulated, and the results confirmed more efficient mixing in the positive pattern than the negative. The results can further enable the design of a more efficient microfluidic mixer, as well as in depth understanding of the phenomena of positive and negative patterns existing in nature with regards to the surrounding fluids.	[Kwak, Tae Joon; Nam, Young Gyu; Chang, Woo-Jin] Univ Wisconsin, Dept Mech Engn, Milwaukee, WI 53201 USA; [Najera, Maria Alejandra] Univ Wisconsin, Dept Ind Engn, Milwaukee, WI 53201 USA; [Lee, Sang Woo] Yonsei Univ, Dept Biomed Engn, Wonju, South Korea; [Strickler, J. Rudi; Chang, Woo-Jin] Univ Wisconsin, Great Lakes Water Inst, Milwaukee, WI 53201 USA; [Nam, Young Gyu] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; Yonsei University; University of Wisconsin System; University of Wisconsin Milwaukee; Texas A&M University System; Texas A&M University College Station	Chang, WJ (corresponding author), Univ Wisconsin, Dept Mech Engn, Milwaukee, WI 53201 USA.; Chang, WJ (corresponding author), Univ Wisconsin, Great Lakes Water Inst, Milwaukee, WI 53201 USA.	wjchang@uwm.edu	Strickler, J. Rudi/A-8926-2009; Kwak, Tae Joon/I-9353-2014	Kwak, Tae Joon/0000-0003-1669-1996	Global Water Center; Research Growth Initiative at the University of Wisconsin-Milwaukee	Global Water Center; Research Growth Initiative at the University of Wisconsin-Milwaukee	This material is based upon work supported by the Global Water Center and the Research Growth Initiative at the University of Wisconsin-Milwaukee.	Afzal A, 2014, SENSOR ACTUAT B-CHEM, V192, P350, DOI 10.1016/j.snb.2013.10.109; Ansari MA, 2007, CHEM ENG SCI, V62, P6687, DOI 10.1016/j.ces.2007.07.059; Aubin J, 2003, CHEM ENG TECHNOL, V26, P1262, DOI 10.1002/ceat.200301848; Bau HH, 2001, SENSOR ACTUAT B-CHEM, V79, P207, DOI 10.1016/S0925-4005(01)00851-6; Camesasca M, 2005, J MICROMECH MICROENG, V15, P2038, DOI 10.1088/0960-1317/15/11/007; Compton Richard G, 2011, UNDERSTANDING VOLTAM, P361; Desmukh A. A., 2000, Technical Digest. Solid-State Sensor and Actuator Workshop (TRF Cat. No.00TRF-0001), P73; Du Y, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3427240; EHRFELD W, 2000, MICROREACTORS NEW TE; FICK A, 1995, J MEMBRANE SCI, V100, P33, DOI 10.1016/0376-7388(94)00230-V; Gobbert MK, 2008, P COMSOL C; He B, 2001, ANAL CHEM, V73, P1942, DOI 10.1021/ac000850x; Hessel V, 2003, AICHE J, V49, P566, DOI 10.1002/aic.690490304; Itomlenskis M, 2008, P COMSOL C; Kamholz AE, 2002, SENSOR ACTUAT B-CHEM, V82, P117, DOI 10.1016/S0925-4005(01)00990-X; Kamholz AE, 2001, BIOPHYS J, V80, P155, DOI 10.1016/S0006-3495(01)76003-1; Lee TW, 2012, CHEM ENG J, V185, P321, DOI 10.1016/j.cej.2012.01.055; Lin D, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/2/025601; Liu RH, 2000, J MICROELECTROMECH S, V9, P190, DOI 10.1109/84.846699; Mei Q, 2008, ANAL CHEM, V80, P6045, DOI 10.1021/ac800843v; Melin J, 2004, LAB CHIP, V4, P214, DOI 10.1039/b314080f; Nguyen NT, 2005, J MICROMECH MICROENG, V15, pR1, DOI 10.1088/0960-1317/15/2/R01; Ottino JM, 2004, PHILOS T R SOC A, V362, P923, DOI 10.1098/rsta.2003.1355; Skurtys O, 2008, FOOD BIOPHYS, V3, P1, DOI 10.1007/s11483-007-9043-6; Stroock AD, 2002, SCIENCE, V295, P647, DOI 10.1126/science.1066238; Sudarsan AP, 2006, P NATL ACAD SCI USA, V103, P7228, DOI 10.1073/pnas.0507976103; Wang HZ, 2003, J MICROMECH MICROENG, V13, P801, DOI 10.1088/0960-1317/13/6/302; White FM., 1991, VISCOUS FLUID FLOW; Wong SH, 2004, SENSOR ACTUAT B-CHEM, V100, P359, DOI 10.1016/j.snb.2004.02.008; Yasuda K, 2000, SENSOR ACTUAT B-CHEM, V64, P128, DOI 10.1016/S0925-4005(99)00495-5	30	26	26	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166068	10.1371/journal.pone.0166068	http://dx.doi.org/10.1371/journal.pone.0166068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814386	Green Published, Green Submitted, gold			2022-12-27	WOS:000386911100029
J	Deiuliis, JA; Syed, R; Duggineni, D; Rutsky, J; Rengasamy, P; Zhang, J; Huang, K; Needleman, B; Mikami, D; Perry, K; Hazey, J; Rajagopalan, S				Deiuliis, Jeffrey A.; Syed, Rafay; Duggineni, Dheeraj; Rutsky, Jessica; Rengasamy, Palanivel; Zhang, Jie; Huang, Kun; Needleman, Bradley; Mikami, Dean; Perry, Kyle; Hazey, Jeffrey; Rajagopalan, Sanjay			Visceral Adipose MicroRNA 223 Is Upregulated in Human and Murine Obesity and Modulates the Inflammatory Phenotype of Macrophages	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; TISSUE INFLAMMATION; EXPRESSION; ACTIVATION; TLR4	Obesity in humans and mice is typified by an activated macrophage phenotype in the visceral adipose tissue (VAT) leading to increased macrophage-mediated inflammation. microRNAs (miRNAs) play an important role in regulating inflammatory pathways in macrophages, and in this study we compared miRNA expression in the VAT of insulin resistant morbidly obese humans to a non-obese cohort with normal glucose tolerance. miR-223-3p was found to be significantly upregulated in the whole omental tissue RNA of 12 human subjects, as were 8 additional miRNAs. We then confirmed that miR-223 upregulation was specific to the stromal vascular cells of human VAT, and found that miR-223 levels were unchanged in adipocytes and circulating monocytes of the non-obese and obese. miR-223 ablation increased basal / unstimulated TLR4 and STAT3 expression and LPS-stimulated TLR4, STAT3, and NOS2 expression in primary macrophages. Conversely, miR-223 mimics decreased TLR4 expression in primary macrophage, at the same time it negatively regulated FBXW7 expression, a well described suppressor of Toll-like receptor 4 (TLR4) signaling. We concluded that the abundance of miR-223 in macrophages significantly modulates macrophage phenotype / activation state and response to stimuli via effects on the TLR4/FBXW7 axis.	[Deiuliis, Jeffrey A.; Syed, Rafay; Rengasamy, Palanivel; Rajagopalan, Sanjay] Univ Maryland, Dept Med, Div Cardiovasc Med, Baltimore, MD 21201 USA; [Deiuliis, Jeffrey A.; Duggineni, Dheeraj; Rutsky, Jessica; Rajagopalan, Sanjay] Ohio State Univ, Coll Med, Dorothy Davis Heart & Lung Inst, Columbus, OH 43210 USA; [Zhang, Jie; Huang, Kun] Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA; [Needleman, Bradley; Mikami, Dean; Perry, Kyle; Hazey, Jeffrey] Ohio State Univ, Coll Med, Dept Surg, Columbus, OH 43210 USA	University System of Maryland; University of Maryland Baltimore; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Deiuliis, JA (corresponding author), Univ Maryland, Dept Med, Div Cardiovasc Med, Baltimore, MD 21201 USA.; Deiuliis, JA (corresponding author), Ohio State Univ, Coll Med, Dorothy Davis Heart & Lung Inst, Columbus, OH 43210 USA.	jeffrey.deiuliis@gmail.com	RENGASAMY, PALANIVEL/GMW-4099-2022	Perry, Kyle/0000-0003-4391-3259; Needleman, Bradley/0000-0002-9186-4028; Syed, Rafay/0000-0001-7831-3005; Deiuliis, Jeffrey/0000-0002-5665-8894				Balamurugan K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2677; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Carvalho MA, 2009, DIABETOLOGIA, V52, P2425, DOI 10.1007/s00125-009-1498-1; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; Deiuliis JA, 2012, AM J PHYSIOL-LUNG C, V302, pL399, DOI 10.1152/ajplung.00261.2011; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Li JH, 2012, J CANCER RES CLIN, V138, P763, DOI 10.1007/s00432-012-1154-x; Matsumoto A, 2006, BIOCHEM BIOPH RES CO, V350, P114, DOI 10.1016/j.bbrc.2006.09.003; Matsumoto A, 2011, CANCER SCI, V102, P749, DOI 10.1111/j.1349-7006.2011.01851.x; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Noronha BT, 2005, DIABETES, V54, P1082, DOI 10.2337/diabetes.54.4.1082; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Onoyama I, 2011, J CLIN INVEST, V121, P342, DOI 10.1172/JCI40725; Pescador N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077251; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Tu KS, 2012, MOL MED REP, V6, P525, DOI 10.3892/mmr.2012.953; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Xu YF, 2010, J BIOL CHEM, V285, P34439, DOI 10.1074/jbc.M110.152306; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	25	39	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165962	10.1371/journal.pone.0165962	http://dx.doi.org/10.1371/journal.pone.0165962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812198	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000085
J	Samaneka, WP; Mandozana, G; Tinago, W; Nhando, N; Mgodi, NM; Bwakura-Dangarembizi, MF; Munjoma, MW; Gomo, ZAR; Chirenje, ZM; Hakim, JG				Samaneka, Wadzanai P.; Mandozana, Gibson; Tinago, Willard; Nhando, Nehemiah; Mgodi, Nyaradzo M.; Bwakura-Dangarembizi, Mutsawashe F.; Munjoma, Marshall W.; Gomo, Zvenyika A. R.; Chirenje, Zvavahera M.; Hakim, James G.			Adult Hematology and Clinical Chemistry Laboratory Reference Ranges in a Zimbabwean Population	PLOS ONE			English	Article							REFERENCE VALUES; REFERENCE INTERVALS; HEALTHY-ADULTS; COUNT; SERUM	Background Laboratory reference ranges used for clinical care and clinical trials in various laboratories in Zimbabwe were derived from textbooks and research studies conducted more than ten years ago. Periodic verification of these ranges is essential to track changes over time. The purpose of this study was to establish hematology and chemistry laboratory reference ranges using more rigorous methods. Methods A community-based cross-sectional study was carried out in Harare, Chitungwiza, and Mutoko. A multistage sampling technique was used. Samples were transported from the field for analysis at the ISO15189 certified University of Zimbabwe-University of California San Francisco Central Research Laboratory. Hematology and clinical chemistry reference ranges lower and upper reference limits were estimated at the 2.5 th and 97.5 th percentiles respectively. Results A total of 769 adults (54% males) aged 18 to 55 years were included in the analysis. Median age was 28 [IQR: 23-35] years. Males had significantly higher red cell counts, hemoglobin, hematocrit, and mean corpuscular hemoglobin compared to females. Females had higher white cell counts, platelets, absolute neutrophil counts, and absolute lymphocyte counts compared to males. There were no gender differences in eosinophils, monocytes, and absolute basophil count. Males had significantly higher levels of urea, sodium, potassium, calcium, creatinine, amylase, total protein, albumin and liver enzymes levels compared to females. Females had higher cholesterol and lipase compared with males. There are notable differences in the white cell counts, neutrophils, cholesterol, and creatinine kinase when compared with the currently used reference ranges. Conclusion Data from this study provides new country specific reference ranges which should be immediately adopted for routine clinical care and accurate monitoring of adverse events in research studies.	[Samaneka, Wadzanai P.; Nhando, Nehemiah; Mgodi, Nyaradzo M.; Munjoma, Marshall W.; Chirenje, Zvavahera M.; Hakim, James G.] Univ Zimbabwe Univ Calif San Francisco Collaborat, Harare, Zimbabwe; [Mandozana, Gibson; Tinago, Willard] Univ Zimbabwe, Coll Hlth Sci, Dept Community Med, Harare, Zimbabwe; [Bwakura-Dangarembizi, Mutsawashe F.] Univ Zimbabwe, Coll Hlth Sci, Dept Pediat, Harare, Zimbabwe; [Gomo, Zvenyika A. R.] Univ Zimbabwe, Coll Hlth Sci, Dept Chem Pathol, Harare, Zimbabwe; [Hakim, James G.] Univ Zimbabwe, Coll Hlth Sci, Dept Med, Harare, Zimbabwe; [Munjoma, Marshall W.; Chirenje, Zvavahera M.] Univ Zimbabwe, Coll Hlth Sci, Dept Obstet & Gynecol & Reprod Hlth Sci, Harare, Zimbabwe; [Mandozana, Gibson; Hakim, James G.] Univ Zimbabwe, Clin Res Ctr, Harare, Zimbabwe	University of Zimbabwe; University of Zimbabwe; University of Zimbabwe; University of Zimbabwe; University of Zimbabwe; University of Zimbabwe	Samaneka, WP (corresponding author), Univ Zimbabwe Univ Calif San Francisco Collaborat, Harare, Zimbabwe.	wsamaneka@uzcrc.co.zw	; Bwakura-Dangarembizi, Mutsa/D-5686-2018	Tinago, Willard/0000-0001-6858-9606; Bwakura-Dangarembizi, Mutsa/0000-0001-7751-6177				Aina O, 2005, CLIN DIAGN LAB IMMUN, V12, P525, DOI 10.1128/CDLI.12.4.525-530.2005; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; CROSS JP, 1983, S AFR MED J, V63, P480; Doran B, 2014, CIRCULATION, V130, P546, DOI 10.1161/CIRCULATIONAHA.114.010001; Eller LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003919; Emmanuel J C, 1977, Cent Afr J Med, V23, P4; Ezeilo G C, 1974, East Afr Med J, V51, P936; EZEILO GC, 1972, LANCET, V2, P1003; Gomani P, 2015, CLIN LAB, V61, P101, DOI 10.7754/Clin.Lab.2014.140506; GOMO ZAR, 1985, CLIN CHEM, V31, P1390; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Horowitz GL., 2008, CLIN LAB STAND I CLS, V3rd ed.; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Lawrie D, 2009, SAMJ S AFR MED J, V99, P243; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Maphephu SM, 2011, SAMJ S AFR MED J, V101, P546; MARIMAMATARIRA HT, 1985, CENT AFR J MED, V31, P98; MUKIIBI JM, 1987, CENT AFR J MED, V33, P99; Musabayane C. T., 1995, Central African Journal of Medicine, V41, P204; National Institutes of Health, 2004, NIH DIV AIDS TABL GR; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; Scott MG, 2006, TIETZ TXB CLIN CHEM, pP984; Segolodi TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093034; TAYLOR EH, 1989, CLIN CHEM, V35, P710; TIKLY M, 1987, S AFR MED J, V72, P135; Woldemichael K, 2012, ETHIOP J HEALTH SCI, V22, P51	27	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165821	10.1371/journal.pone.0165821	http://dx.doi.org/10.1371/journal.pone.0165821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812172	gold, Green Submitted, Green Published			2022-12-27	WOS:000386910000066
J	Sun, S; Cai, J; Yang, Q; Zhu, YP; Zhao, SM; Wang, ZH				Sun, Si; Cai, Jing; Yang, Qiang; Zhu, Yapei; Zhao, Simei; Wang, Zehua			Prognostic Value and Implication for Chemotherapy Treatment of ABCB1 in Epithelial Ovarian Cancer: A Meta-Analysis	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE GENE; P-GLYCOPROTEIN EXPRESSION; DRUG-RESISTANCE; CARCINOMA PATIENTS; IN-VITRO; GST-PI; MDR1; POLYMORPHISMS; PROTEIN; CHEMORESISTANCE	Background Chemotherapy resistance is reported to correlate with up-regulation of anti-tumor agent transporter ABCB1 (p-gp) in epithelial ovarian cancer (EOC), but the results remain controversial. To reconcile the results, a systematic review followed by meta-analysis was performed to assess the association between high ABCB1 status or ABCB1 gene variants and overall survival (OS), progression free survival (PFS), and total response rate (TR) in patients with EOC. Materials and Methods Electronic searches were performed using Pubmed, EMBASE, Web of Science and Chinese Wanfang databases from January 1990 to February 2016. Summary hazard ratio (HR), risk ratio (RR) and 95% confidence intervals (CIs) were combined using fixed or random-effects models as appropriate. Results Thirty-eight retrospective studies of 8607 cases qualified for meta-analysis were identified. Our results suggested that ABCB1 over-expression was significantly associated with unfavorable OS (HR = 1.54; 95% CI, 1.25-1.90), PFS (HR = 1.49; 95% CI, 1.22-1.82) and TR (RR = 0.63; 95% CI, 0.54-0.75). After adjustment for age, clinical stage, residual disease, histological type and tumor grade, high ABCB1 status remained to be a significant risk factor for adverse OS and PFS. Patients with recurrent ABCB1 positivity suffered from poorer OS than those with primary ABCB1 positivity. However, stratified by chemotherapy regimen, inverse correlation between high ABCB1 status and poor OS, PFS and TR were only found in patients underwent platinum-based chemotherapy but not in patients received standard platinum/paclitaxel-based chemotherapy. No evidence was found for any association between ABCB1 gene polymorphisms and OS, PFS or TR. Conclusion High ABCB1 status is significantly associated with chemo-resistance and poor prognosis in patients with EOC. Large-scale, prospective studies are needed to assess the clinical value of ABCB1 expression in EOC more accurately.	[Sun, Si; Cai, Jing; Yang, Qiang; Zhu, Yapei; Zhao, Simei; Wang, Zehua] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Obstet & Gynecol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Wang, ZH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Obstet & Gynecol, Wuhan, Hubei, Peoples R China.	zehuawang@163.net			National Natural Science Foundation of China [81272860, 81472443, 81572572]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 81272860 National Natural Science Foundation of China http://www.nsfc.gov.cn ZW, 81472443 National Natural Science Foundation of China http://www.nsfc.gov.cn ZW, and 81572572 National Natural Science Foundation of China http://www.nsfc.gov JC.	Ali AY, 2012, ANN NY ACAD SCI, V1271, P58, DOI 10.1111/j.1749-6632.2012.06734.x; ARAO S, 1994, CANCER RES, V54, P1355; Arts HJG, 1999, CLIN CANCER RES, V5, P2798; Baekelandt MM, 2000, ANTICANCER RES, V20, P1061; Bergmann TK, 2011, EUR J CLIN PHARMACOL, V67, P693, DOI 10.1007/s00228-011-1007-6; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Choi MK, 2006, ARCH PHARM RES, V29, P1067, DOI 10.1007/BF02969293; Codegoni AM, 1997, GYNECOL ONCOL, V65, P130, DOI 10.1006/gyno.1996.4609; Coley Helen M., 1997, Keio Journal of Medicine, V46, P142; Covens A, 2002, GYNECOL ONCOL, V85, P71, DOI 10.1006/gyno.2001.6552; Dabholkar M, 2000, BIOCHEM PHARMACOL, V60, P1611, DOI 10.1016/S0006-2952(00)00448-2; DALTON WS, 1986, CANCER RES, V46, P5125; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Galani E, 2002, ANTICANCER RES, V22, P2275; Goto T, 2006, ONCOL REP, V15, P1265; Grimm C, 2010, ANTICANCER RES, V30, P3487; Harries M, 2002, LANCET ONCOL, V3, P537, DOI 10.1016/S1470-2045(02)00847-1; Harries M, 2002, LANCET ONCOL, V3, P529, DOI 10.1016/S1470-2045(02)00846-X; HENDRICKS CB, 1992, CANCER RES, V52, P2268; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hille S, 2006, ANTI-CANCER DRUG, V17, P1041, DOI 10.1097/01.cad.0000231480.07654.b5; HOLZMAYER TA, 1992, J NATL CANCER I, V84, P1486, DOI 10.1093/jnci/84.19.1486; Horiuchi A, 2003, GYNECOL ONCOL, V88, P309, DOI 10.1016/S0090-8258(02)00104-X; Ikeda K, 2003, INT J GYNECOL CANCER, V13, P776, DOI 10.1111/j.1525-1438.2003.13381.x; Itamochi H, 2002, OBSTET GYNECOL, V100, P281, DOI 10.1016/S0029-7844(02)02040-9; IZQUIERDO MA, 1995, JNCI-J NATL CANCER I, V87, P1230; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Jean S, 2016, ONCOTARGET, DOI 10.18632/oncotarget.9373; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Johnatty SE, 2013, GYNECOL ONCOL, V131, P8, DOI 10.1016/j.ygyno.2013.07.107; Johnatty SE, 2008, CLIN CANCER RES, V14, P5594, DOI 10.1158/1078-0432.CCR-08-0606; Joncourt F, 1998, GYNECOL ONCOL, V70, P176, DOI 10.1006/gyno.1998.5085; Kamazawa S, 2002, GYNECOL ONCOL, V86, P171, DOI 10.1006/gyno.2002.6738; Kavallaris M, 1996, CANCER LETT, V102, P7, DOI 10.1016/0304-3835(96)04143-2; Khalifa MA, 1997, INT J GYNECOL PATHOL, V16, P69, DOI 10.1097/00004347-199701000-00011; Kim H, 2012, ANTICANCER RES, V32, P589; Ledermann JA, 2013, ANN ONCOL, V24, P24, DOI 10.1093/annonc/mdt333; Liu KJ, 2013, INT J CANCER, V132, P224, DOI 10.1002/ijc.27649; Lu D, 2011, BRIT J BIOMED SCI, V68, P69, DOI 10.1080/09674845.2011.11730326; Lu LG, 2007, ONCOL RES, V16, P395; Ludwig JA, 2006, CANCER RES, V66, P4808, DOI 10.1158/0008-5472.CAN-05-3322; MANTEL N, 1959, J NATL CANCER I, V22, P719; Materna V, 2004, GYNECOL ONCOL, V94, P152, DOI 10.1016/j.ygyno.2004.03.035; Matsuo K, 2014, GYNECOL ONCOL, V133, P473, DOI 10.1016/j.ygyno.2014.03.563; Nakayama K, 2002, INT J CANCER, V101, P488, DOI 10.1002/ijc.10608; O'Toole SA, 2007, GYNECOL ONCOL, V104, P345, DOI 10.1016/j.ygyno.2006.08.039; Oda Y, 2007, CANCER SCI, V98, P1020, DOI 10.1111/j.1349-7006.2007.00492.x; Orata H, 2006, ANTICANCER RES, V26, P2227; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Penson RT, 2004, GYNECOL ONCOL, V93, P98, DOI 10.1016/j.ygyno.2003.11.053; Ramalingam P, 2016, ONCOLOGY-NY, V30, P166; Raspollini MR, 2005, INT J GYNECOL CANCER, V15, P255, DOI 10.1111/j.1525-1438.2005.15212.x; Raspollini MR, 2003, J CHEMOTHERAPY, V15, P380, DOI 10.1179/joc.2003.15.4.380; Raspollini MR, 2002, J CHEMOTHERAPY, V14, P518, DOI 10.1179/joc.2002.14.5.518; Scohndorf T, 2003, RECENT RES CANCER, V161, P111; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Shukla S, 2011, CURR DRUG TARGETS, V12, P621, DOI 10.2174/138945011795378540; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith RA, 2015, CA-CANCER J CLIN, V65, P30, DOI 10.3322/caac.21261; Stordal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040717; Surowiak P, 2006, CANCER LETT, V235, P272, DOI 10.1016/j.canlet.2005.04.035; Tecza K, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0124-y; Tian CQ, 2012, GYNECOL ONCOL, V124, P575, DOI 10.1016/j.ygyno.2011.11.022; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; VANDERZEE AGJ, 1995, J CLIN ONCOL, V13, P70, DOI 10.1200/JCO.1995.13.1.70; VENERONI S, 1994, EUR J CANCER, V30A, P1002, DOI 10.1016/0959-8049(94)90132-5; Wang S, 1998, J Tongji Med Univ, V18, P58; WEBSTER L, 1993, J NATL CANCER I, V85, P1685, DOI 10.1093/jnci/85.20.1685; Wei Feng-hua, 2007, Zhonghua Yi Xue Za Zhi, V87, P1187; White KL, 2013, CANCER EPIDEM BIOMAR, V22, P987, DOI 10.1158/1055-9965.EPI-13-0028; WILS P, 1994, BIOCHEM PHARMACOL, V48, P1528, DOI 10.1016/0006-2952(94)90580-0; Xia YZ, 2016, ONCOTARGET, DOI 10.18632/oncotarget.10890; Yakirevich E, 2006, GYNECOL ONCOL, V100, P152, DOI 10.1016/j.ygyno.2005.08.050; Yokoyama Y, 1999, J Obstet Gynaecol Res, V25, P387; Yu M, 2013, CANCER METAST REV, V32, P211, DOI 10.1007/s10555-012-9402-8; Zajchowski DA, 2012, MOL CANCER THER, V11, P492, DOI 10.1158/1535-7163.MCT-11-0746; Zhu L, 1997, Zhonghua Fu Chan Ke Za Zhi, V32, P462	78	30	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166058	10.1371/journal.pone.0166058	http://dx.doi.org/10.1371/journal.pone.0166058			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812204	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000098
J	van den Noort, JC; Kortier, HG; van Beek, N; Veeger, DHEJ; Veltink, PH				van den Noort, Josien C.; Kortier, Henk G.; van Beek, Nathalie; Veeger, DirkJan H. E. J.; Veltink, Peter H.			Measuring 3D Hand and Finger Kinematics-A Comparison between Inertial Sensing and an Opto-Electronic Marker System	PLOS ONE			English	Article							MAGNETIC SENSORS; INDEX FINGER; GLOVE; THUMB; DEFINITIONS; MOVEMENTS	Objective analysis of hand and finger kinematics is important to increase understanding of hand function and to quantify motor symptoms for clinical diagnosis. The aim of this paper is to compare a new 3D measurement system containing multiple miniature inertial sensors (PowerGlove) with an opto-electronic marker system during specific finger tasks in three healthy subjects. Various finger movements tasks were performed: flexion, fast flexion, tapping, hand open/closing, ab/adduction and circular pointing. 3D joint angles of the index finger joints and position of the thumb and index were compared between systems. Median root mean square differences of the main joint angles of interest ranged between 3.3 and 8.4deg. Largest differences were found in fast and circular pointing tasks, mainly in range of motion. Smallest differences for all 3D joint angles were observed in the flexion tasks. For fast finger tapping, the thumb/index amplitude showed a median difference of 15.8mm. Differences could be explained by skin movement artifacts caused by relative marker movements of the marker system, particularly during fast tasks; large movement accelerations and angular velocities which exceeded the range of the inertial sensors; and by differences in segment calibrations between systems. The PowerGlove is a system that can be of value to measure 3D hand and finger kinematics and positions in an ambulatory setting. The reported differences need to be taken into account when applying the system in studies understanding the hand function and quantifying hand motor symptoms in clinical practice.	[van den Noort, Josien C.; Kortier, Henk G.; Veltink, Peter H.] Univ Twente, MIRA Res Inst Biomed Technol & Tech Med, Biomed Signals & Syst Grp, Enschede, Netherlands; [van Beek, Nathalie; Veeger, DirkJan H. E. J.] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam, Netherlands; [van den Noort, Josien C.] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Dept Rehabil Med, Med Ctr, Amsterdam, Netherlands	University of Twente; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van den Noort, JC (corresponding author), Univ Twente, MIRA Res Inst Biomed Technol & Tech Med, Biomed Signals & Syst Grp, Enschede, Netherlands.; van den Noort, JC (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Dept Rehabil Med, Med Ctr, Amsterdam, Netherlands.	j.vandennoort@vumc.nl	van den Noort, Josien/ABG-7503-2021	van den Noort, Josien/0000-0002-2305-498X; veeger, dirkjan/0000-0003-0292-6520; van den Noort, Josien/0000-0001-5753-4183	Dutch Technology Foundation STW (PowerSensor), part of the Netherlands Organization for Scientific Research (NWO); European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate program [2011-0015]	Dutch Technology Foundation STW (PowerSensor), part of the Netherlands Organization for Scientific Research (NWO); European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate program	This research is funded by the Dutch Technology Foundation STW (PowerSensor), part of the Netherlands Organization for Scientific Research (NWO); and the European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate program (2011-0015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cole KJ, 2010, EXP BRAIN RES, V201, P239, DOI 10.1007/s00221-009-2030-z; Coupier J, 2014, J BIOMECH, V47, P1299, DOI 10.1016/j.jbiomech.2014.02.017; Cutti AG, 2008, MED BIOL ENG COMPUT, V46, P169, DOI 10.1007/s11517-007-0296-5; de Monsabert BG, 2014, J BIOMECH, V47, P2590, DOI 10.1016/j.jbiomech.2014.05.025; de Vries WHK, 2010, J BIOMECH, V43, P1983, DOI 10.1016/j.jbiomech.2010.03.007; Dipietro L, 2008, IEEE T SYST MAN CY C, V38, P461, DOI 10.1109/TSMCC.2008.923862; Fahn S., 1987, RECENT DEV PARKINSON, P153; Gentner R, 2009, J NEUROSCI METH, V178, P138, DOI 10.1016/j.jneumeth.2008.11.005; Iaquinto JM, 2014, MED ENG PHYS, V36, P391, DOI 10.1016/j.medengphy.2013.08.013; Kessler G.D., 1995, ACM T COMPUT-HUM INT, V2, P263, DOI DOI 10.1145/212430.212431; Kortier HG, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-70; Lang CE, 2004, J NEUROPHYSIOL, V92, P2802, DOI 10.1152/jn.00480.2004; Latash ML, 2006, MOTOR CONTROL AND LEARNING, P141, DOI 10.1007/0-387-28287-4_13; Nataraj R, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024753; Oess NP, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-2; Parker WL, 2013, PLAST RECONSTR SURG, V132, P1706, DOI 10.1097/PRS.0b013e3182a807af; Patrick SK, 2001, IEEE T NEUR SYS REH, V9, P31, DOI 10.1109/7333.918274; Post B, 2005, MOVEMENT DISORD, V20, P1577, DOI 10.1002/mds.20640; Ryu JH, 2006, J BIOMECH, V39, P844, DOI 10.1016/j.jbiomech.2005.02.001; Shen ZLL, 2012, GAIT POSTURE, V36, P643, DOI 10.1016/j.gaitpost.2012.04.012; SODERKVIST I, 1993, J BIOMECH, V26, P1473, DOI 10.1016/0021-9290(93)90098-Y; Sultana SS, 2013, J HAND THER, V26, P1, DOI 10.1016/j.jht.2012.06.006; van Beek N, 2015, PROCEEDINGS OF 25TH; van den Noort JC, 2013, MED BIOL ENG COMPUT, V51, P377, DOI 10.1007/s11517-012-1006-5; Zatsiorsky VM, 2000, EXP BRAIN RES, V131, P187, DOI 10.1007/s002219900261; Zyluk Andrzej, 2014, Pol Orthop Traumatol, V79, P30	26	14	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164889	10.1371/journal.pone.0164889	http://dx.doi.org/10.1371/journal.pone.0164889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812139	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000016
J	Ekowati, D; Hofstee, C; Praputra, AV; Sheil, D				Ekowati, Dian; Hofstee, Carola; Praputra, Andhika Vega; Sheil, Douglas			Motivation Matters: Lessons for REDD plus Participatory Measurement, Reporting and Verification from Three Decades of Child Health Participatory Monitoring in Indonesia	PLOS ONE			English	Article							CONSERVATION; OPPORTUNITIES; BIODIVERSITY; LEADERSHIP; PRIORITIES	Participatory Measurement, Reporting and Verification (PMRV), in the context of reducing emissions from deforestation and forest degradation with its co-benefits (REDD+) requires sustained monitoring and reporting by community members. This requirement appears challenging and has yet to be achieved. Other successful, long established, community self-monitoring and reporting systems may provide valuable lessons. The Indonesian integrated village healthcare program (Posyandu) was initiated in the 1980s and still provides effective and successful participatory measurement and reporting of child health status across the diverse, and often remote, communities of Indonesia. Posyandu activities focus on the growth and development of children under the age of five by recording their height and weight and reporting these monthly to the Ministry of Health. Here we focus on the local Posyandu personnel (kaders) and their motivations and incentives for contributing. While Posyandu and REDD+ measurement and reporting activities differ, there are sufficient commonalities to draw useful lessons. We find that the Posyandu kaders are motivated by their interests in health care, by their belief that it benefits the community, and by encouragement by local leaders. Recognition from the community, status within the system, training opportunities, competition among communities, and small payments provide incentives to sustain participation. We examine these lessons in the context of REDD+.	[Ekowati, Dian; Hofstee, Carola; Praputra, Andhika Vega; Sheil, Douglas] Ctr Int Forestry Res, Bogor, Indonesia; [Sheil, Douglas] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway	CGIAR; Center for International Forestry Research (CIFOR); Norwegian University of Life Sciences	Ekowati, D (corresponding author), Ctr Int Forestry Res, Bogor, Indonesia.	dee.ekowati@gmail.com	Sheil, Douglas/N-3291-2019; Sheil, Douglas/A-3867-2015	Sheil, Douglas/0000-0002-1166-6591	US Agency for International Development (USAID) [MTO069018]; Norwegian Agency for Development Cooperation (NORAD) [GLO-3945, QZA 12/0882]; Federal Minister for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB) [KI II 7 - 42206-6/75]; Consultative Group for International Agricultural Research (CGIAR), under Forests, Tree and Agroforestry: Livelihoods, Landscapes and Governance (FTA) [TF 069018]	US Agency for International Development (USAID)(United States Agency for International Development (USAID)); Norwegian Agency for Development Cooperation (NORAD); Federal Minister for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB); Consultative Group for International Agricultural Research (CGIAR), under Forests, Tree and Agroforestry: Livelihoods, Landscapes and Governance (FTA)	This work was supported by the US Agency for International Development (USAID) (http://www.usaid.gov/), grant number MTO069018; the Norwegian Agency for Development Cooperation (NORAD) (http://www.norad.no/), grant number GLO-3945, QZA 12/0882; The Republic of Germany, represented by the Federal Minister for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB) (http://www.bmub.bund.de/en/), grant number KI II 7 - 42206-6/75; and the Consultative Group for International Agricultural Research (CGIAR), under Forests, Tree and Agroforestry: Livelihoods, Landscapes and Governance (FTA) (http://www.cgiar.org/), grant number TF 069018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the local communities, Posyandu kader, village midwives/nurses, the public healthcare staff at the sub-district level, district health services, provincial health services in Mamberamo Raya, Kapuas Hulu and Wonosobo; and the Ministry of Health for their participation in the research. They thank Manuel Boissiere for providing continuous and valuable comments during the development of the research approach, the fieldwork and paper writing. They thank the team members: Indah Waty Bong, Guillaume Beaudoin, Wahid Ullah, Mary Elizabeth Felker Gilang Aria Seta, and Serge Rafanoharana for their valuable comments and discussion through the development of the paper. They also thank Glen Mulcahy, the two anonymous reviewers, and the editors of PLoS ONE for their valuable comments and editing. They thank Hannah Watson for her review and discussion, especially with the introduction. They acknowledge the US Agency for International Development (USAID), the Norwegian Agency for Development Cooperation (NORAD), The Republic of Germany, represented by the Federal Minister for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB), and the Consultative Group for International Agricultural Research (CGIAR), under Forests, Tree and Agroforestry: Livelihoods, Landscapes and Governance (FTA) for their financial support. This research was carried out by the Center for International Forestry Research (CIFOR) and the Centre de cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD), as part of the CGIAR Research Programon Forests, Trees and Agroforestry.	Angelsen A, 2013, WIDER WORK PAP, V135, P24; [Anonymous], 2008, PARTICIPATORY MONITO; [Anonymous], UN REDD PROGR REDD; Anwar F, 2010, NUTR RES PRACT, V4, P208, DOI 10.4162/nrp.2010.4.3.208; Arwida SD, 2015, 120 CIFOR; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Bandura A, 2006, PERSPECT PSYCHOL SCI, V1, P164, DOI 10.1111/j.1745-6916.2006.00011.x; BBC, 2010, PAP KEMB DEM ANT; Bell S, 2008, BIODIVERS CONSERV, V17, P3443, DOI 10.1007/s10531-008-9357-9; Bellfield H, 2015, FORESTS, V6, P133, DOI 10.3390/f6010133; Bhattacharyya K, 2001, COMMUNITY HLTH WORKE; Boissiere M, 2014, FORESTS, V5, P1855, DOI 10.3390/f5081855; Bossiere M, 2014, CONDITIONS INVOLVING, V30; Bratman GN, 2012, ANN NY ACAD SCI, V1249, P118, DOI 10.1111/j.1749-6632.2011.06400.x; Cherrington A, 2010, ETHNIC DIS, V20, P189; Clayton S., 2015, CONSERVATION PSYCHOL; Contreras-Hermosilla A., 2005, STRENGTHENING FOREST; Cromberg M, 2014, FORESTS, V5, P579, DOI 10.3390/f5040579; CUNDILL G, 2010, ECOL SOC, V15; Danielsen F, 2013, ECOL SOC, V18, DOI 10.5751/ES-05464-180341; Darrington JW, 2011, J FINANC MANAG PROP, V16, P42, DOI 10.1108/13664381111116070; Dharmadi Hawthorne S., 2014, LIT REV PARTICIPATOR; Duchelle AE, 2014, WORLD DEV, V55, P53, DOI 10.1016/j.worlddev.2013.01.014; Eldridge C, 2009, HEALTH POLICY PLANN, V24, P160, DOI 10.1093/heapol/czp002; Fehr E, 2002, IZA DISCUSS PAP SER, V507; Feintrenie L, 2010, SMALL-SCALE FOR, V9, P379, DOI 10.1007/s11842-010-9122-2; Fry B, 2011, ENVIRON SCI POLICY, V14, P181, DOI 10.1016/j.envsci.2010.12.004; GARDNER T, 2012, MONITORING FOREST BI; German L., 2013, INTEGRATED NATURAL R, DOI [10.4324/9780203139189-11, DOI 10.4324/9780203139189-11]; Gibson T, 2007, CONTEMP ANTHR RELIG, P1, DOI 10.1057/9780230605084; Graham K, 2007, CARBON CLIM LAW REV, P303; Guijt Irene, 2007, NEGOTIATED LEARNING; Helman CG, 2007, CULTURE HLTH ILLNESS; IIED (International Institute for Environment and Development), 2014, WHAT PEOPL WANT REDD; Index Mundi, 2014, IND MORT RAT; Jack BA, 2012, PALLIATIVE MED, V26, P753, DOI 10.1177/0269216311413628; Janzen DH, 2004, J APPL ECOL, V41, P181, DOI 10.1111/j.1365-2664.2004.00879.x; Jaweng RE, 2011, ANAL CSIS, V40; Kapuas Hulu District Government (Pemerintah Kabupaten Kapuas Hulu), GEOGR; Kellert S. R., 1995, BIOPHILIA HYPOTHESIS; Kementrian Kesehatan RI, 2014, DAT KES PROP; Kementrian Kesehatan RI, 2011, KEL KERJ OP POKJ POS; Lavides M, 2004, COMMUNICATING PROTEC, P46; Levang E, 2005, FORESTS TREES LIVELI, V15, P211; Loft L, 2014, LESSONS PAYMENTS ECO; Madeira EM, SHARING BENEFITS RED; Meijaard E, 2013, PLOS ONE, V8; Mercado Jr AR, 2000, LANDCARE EXPERIENCE; Minang P. A., 2014, CLIM POLICY, P1; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Novotny V, 1991, TAXONOMY BIODIVERSIT; Nugent JB, 2006, LINK FORM INFORMAL E, P1; Nugent JB, 2005, VOLUNTARY CONTRIBUTI, V19; Ohler H, 2011, DOES CONDITIONALITY; Padmanaba M, 2007, BIODIVERS CONSERV, V16, P137, DOI 10.1007/s10531-006-9009-x; Pellier AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103005; Pemerintah Kabupaten Mamberamo Raya, 2010, PROF KES KAB MAMB RA; Pemerintah Kabupaten Wonosobo, 2014, GEOGR KAB WON; Pfund JL, 2011, ENVIRON MANAGE, V48, P334, DOI 10.1007/s00267-011-9689-1; Pink D.H., 2010, DRIVE SURPRISING TRU; Pratihast AK, 2013, CARBON MANAG, V4, P91, DOI [10.4155/cmt.12.75, 10.4155/CMT.12.75]; Priyono E, 2008, I DIMENSIONS SCALING; Rahmawati R., 2008, SODALITY JURNAL SOSI, DOI [10.22500/sodality.v2i2.5886, DOI 10.22500/SODALITY.V2I2.5886]; Reis T, 1990, Int Q Community Health Educ, V11, P19, DOI 10.2190/TFP4-V0DQ-NU0V-Y1TX; Russell R, 2013, ANNU REV ENV RESOUR, V38, P473, DOI 10.1146/annurev-environ-012312-110838; Saito A., 2006, CRITICAL RADICAL GEO; Sanders David, 1999, Food and Nutrition Bulletin, V20, P307; Sassen M, 2010, TAK STOCK NAT PARTIC, P113; Sheil D, 2006, NATURE, V440, P868, DOI 10.1038/440868d; Sheil D, 2006, AMBIO, V35, P17, DOI 10.1579/0044-7447-35.1.17; Sheil D, 2004, TRENDS ECOL EVOL, V19, P634, DOI 10.1016/j.tree.2004.09.019; Sheil D, 2001, CONSERV BIOL, V15, P1179, DOI 10.1046/j.1523-1739.2001.0150041179.x; Sheil D, 2015, ECOL SOC, V20, DOI 10.5751/ES-07625-200239; Skutsch M., 2009, REALISING REDD NATL, P101; Skutsch M.M., 2009, CASE STUDIES MEASURI; Statistics Indonesia (Badan Pusat Statistik), 2011, VILL POT STAT; Sutton AM, 2014, MAR POLICY, V50, P261, DOI 10.1016/j.marpol.2014.07.014; Tim Kerja MRV Satgas REDD+, 2013, STRAT DAN RENC IMPL, P1; Vermeulen S, 2007, ORYX, V41, P434, DOI 10.1017/S0030605307001056; Wai-Poi M., 2011, 3 ESSAYS DEV EC HOUS; Wertz-Kanounnikoff S., 2008, MOVING AHEAD REDD IS, P87; Wertz-Kanounnikoff S., 2012, ANAL REDD CHALLENGES, P233; Widagdo L, 2006, MAKARA J HEALTH RES, V10, P54, DOI 10.7454/msk.v10i2.173; Wigfield A, 2000, CONTEMP EDUC PSYCHOL, V25, P68, DOI 10.1006/ceps.1999.1015; World Health Organization, 2014, UND 5 MORT DAT COUNT, P2014	85	2	2	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0159480	10.1371/journal.pone.0159480	http://dx.doi.org/10.1371/journal.pone.0159480			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806053	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000386715500003
J	Dobson, R; Ramagopalan, S; Topping, J; Smith, P; Solanky, B; Schmierer, K; Chard, D; Giovannoni, G				Dobson, Ruth; Ramagopalan, Sreeram; Topping, Joanne; Smith, Paul; Solanky, Bhavana; Schmierer, Klaus; Chard, Declan; Giovannoni, Gavin			A Risk Score for Predicting Multiple Sclerosis	PLOS ONE			English	Article							RADIOLOGICALLY ISOLATED SYNDROME; CLINICALLY ISOLATED SYNDROMES; EPSTEIN-BARR-VIRUS; SEX-RATIO; MRI; MS; SUSCEPTIBILITY; METAANALYSIS; ASSOCIATION; DIAGNOSIS	Objective Multiple sclerosis (MS) develops as a result of environmental influences on the genetically susceptible. Siblings of people with MS have an increased risk of both MS and demonstrating asymptomatic changes in keeping with MS. We set out to develop an MS risk score integrating both genetic and environmental risk factors. We used this score to identify siblings at extremes of MS risk and attempted to validate the score using brain MRI. Methods 78 probands with MS, 121 of their unaffected siblings and 103 healthy controls were studied. Personal history was taken, and serological and genetic analysis using the illumina immunochip was performed. Odds ratios for MS associated with each risk factor were derived from existing literature, and the log values of the odds ratios from each of the risk factors were combined in an additive model to provide an overall score. Scores were initially calculated using log odds ratio from the HLA-DRB1*1501 allele only, secondly using data from all MS-associated SNPs identified in the 2011 GWAS. Subjects with extreme risk scores underwent validation studies. MRI was performed on selected individuals. Results There was a significant difference in the both risk scores between people with MS, their unaffected siblings and healthy controls (p<0.0005). Unaffected siblings had a risk score intermediate to people with MS and controls (p<0.0005). The best performing risk score generated an AUC of 0.82 (95% CI 0.75 +/- 0.88). Interpretations The risk score demonstrates an AUC on the threshold for clinical utility. Our score enables the identification of a high-risk sibling group to inform pre-symptomatic longitudinal studies.	[Dobson, Ruth; Ramagopalan, Sreeram; Topping, Joanne; Schmierer, Klaus; Giovannoni, Gavin] Queen Mary Univ London, London, England; [Dobson, Ruth; Ramagopalan, Sreeram; Topping, Joanne; Schmierer, Klaus; Giovannoni, Gavin] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, London, England; [Smith, Paul; Schmierer, Klaus; Giovannoni, Gavin] Barts Hlth NHS Trust, Royal London Hosp, London, England; [Solanky, Bhavana; Chard, Declan] UCL, NMR Res Unit, Queen Sq Multiple Sclerosis Ctr, Inst Neurol, London, England; [Chard, Declan] Univ Coll London Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Dobson, R (corresponding author), Queen Mary Univ London, London, England.; Dobson, R (corresponding author), Barts & London Queen Marys Sch Med & Dent, Blizard Inst, London, England.	ruth.dobson@qmul.ac.uk	Schmierer, Klaus/W-3253-2019	Chard, Declan/0000-0003-3076-2682; Solanky, Bhavana/0000-0002-5946-7604	MS Society of Great Britain and Northern Ireland [940/10]	MS Society of Great Britain and Northern Ireland	This study was funded by the MS Society of Great Britain and Northern Ireland (Grant ref 940/10). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Bostrom I, 2013, MULT SCLER J, V19, P46, DOI 10.1177/1352458512446169; Charil A, 2006, LANCET NEUROL, V5, P841, DOI 10.1016/S1474-4422(06)70572-5; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Dahl AK, 2013, OBESITY, V21, P1293, DOI 10.1002/oby.20299; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; Dobson R, 2012, J NEUROLNEUROSURG PS; Dobson R, 2012, MULT SCLER J, V18, P600, DOI 10.1177/1352458511426740; Gianfrancesco MA, 2014, OBES RES CLIN PRACT, V8, pE435, DOI 10.1016/j.orcp.2014.01.002; Granberg T, 2013, MULT SCLER J, V19, P271, DOI 10.1177/1352458512451943; Haghighi S, 2004, ACTA NEUROL SCAND, V109, P97, DOI 10.1034/j.1600-0404.2003.00197.x; Handel AE, 2012, MULT SCLER RELAT DIS, V1, P39, DOI 10.1016/j.msard.2011.08.005; Handel AE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016149, 10.1371/journal.pone.0014606]; Hedstrom AK, 2015, EUR J NEUROL, V22, P578, DOI 10.1111/ene.12620; KURTZKE JF, 1980, ACTA NEUROL SCAND, V62, P65, DOI 10.1111/j.1600-0404.1980.tb03006.x; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; LYNCH SG, 1990, NEUROLOGY, V40, P900, DOI 10.1212/WNL.40.6.900; Miller D, 2005, LANCET NEUROL, V4, P281, DOI 10.1016/S1474-4422(05)70071-5; Montalban X, 2010, NEUROLOGY, V74, P427, DOI 10.1212/WNL.0b013e3181cec45c; Morris Z, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3016; Mowry EM, 2010, ANN NEUROL, V67, P618, DOI 10.1002/ana.21972; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Okuda DT, 2009, NEUROLOGY, V72, P800, DOI 10.1212/01.wnl.0000335764.14513.1a; Orton SM, 2011, NEUROLOGY, V76, P425, DOI 10.1212/WNL.0b013e31820a0a9f; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sundstrom P, 2004, NEUROLOGY, V62, P2277, DOI 10.1212/01.WNL.0000130496.51156.D7; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; TIENARI PJ, 1992, J NEUROL NEUROSUR PS, V55, P883, DOI 10.1136/jnnp.55.10.883; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0164992	10.1371/journal.pone.0164992	http://dx.doi.org/10.1371/journal.pone.0164992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802296	Green Published, Green Submitted, gold			2022-12-27	WOS:000386714200014
J	Pellicelli, M; Picard, C; Wang, DS; Lavigne, P; Moreau, A				Pellicelli, Martin; Picard, Cynthia; Wang, DaShen; Lavigne, Patrick; Moreau, Alain			E2F1 and TFDP1 Regulate PITX1 Expression in Normal and Osteoarthritic Articular Chondrocytes	PLOS ONE			English	Article							ENDOCHONDRAL OSSIFICATION; TRANSCRIPTION FACTORS; DNA-DAMAGE; APOPTOSIS; P53; ACCUMULATION; SENESCENCE; FAMILY; GENES; DP-1	We previously reported a loss-of-PITX1 expression in patients suffering of knee/hip osteo-arthritis (OA). Search for the mechanism underlying this event led us to discover that PITX1 repression was triggered by the aberrant nuclear accumulation of Prohibitin (PHB1), an E2F1 co-repressor, in OA articular chondrocytes. In the current study, we assessed in details the involvement of E2F transcription factors in regulating PITX1 expression. We also analyzed other genes that are similarly regulated by E2F in regard to osteoarthritis. The transcriptional regulation of the PITX1 promoter by E2F1 was analyzed with the luciferase reporter assay, and chromatin immunoprecipitation assays, which confirmed direct E2F1-PITX1 interactions. The probable binding sites for E2F1 in the PITX1 promoter were identified by DNA pulldown experiments. In silico and in vitro analyses show that the PITX1 proximal promoter region contains 2 specific sequences that are bound by E2F1. Overexpression of E2F1 enhances PITX1 promoter activity and mRNA transcription. In primary control and osteoarthritis chondrocytes, real time RT-PCR was used to measure the mRNA expression levels of candidate genes under E2F1 transcriptional control. Transcription Factor Dp-1 (TFDP1) knockdown experiments confirmed that the E2F1-TFDP1 complex regulates PITX1. Knockdown of TFDP1, an E2F1 dimerization partner, inhibits the activating effect of E2F1 and reduces both PITX1 promoter activity and mRNA transcription. Real time RT-PCR results reveal reduced expression of TFDP1 and a similar downregulation of their targets PITX1, BRCA1, CDKN1A, and RAD51 in mid-stage OA chondrocytes. Collectively, our data define a previously uncharacterized role for E2F1 and TFDP1 in the transcriptional regulation of PITX1 in articular chondrocytes. Additional E2F1 targets may be affected in OA pathogenesis.	[Pellicelli, Martin; Picard, Cynthia; Wang, DaShen; Moreau, Alain] St Justine Univ, Hosp Res Ctr, Viscogliosi Lab Mol Genet Musculoskeletal Dis, Montreal, PQ, Canada; [Pellicelli, Martin; Picard, Cynthia; Moreau, Alain] Univ Montreal, Dept Biochem & Mol Med, Fac Med, Montreal, PQ, Canada; [Lavigne, Patrick] Maisonneuve Rosemont Hosp, Orthoped Div, Montreal, PQ, Canada; [Lavigne, Patrick] Univ Montreal, Dept Surg, Fac Med, Montreal, PQ, Canada; [Moreau, Alain] Univ Montreal, Dept Stomatol, Fac Dent, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Moreau, A (corresponding author), St Justine Univ, Hosp Res Ctr, Viscogliosi Lab Mol Genet Musculoskeletal Dis, Montreal, PQ, Canada.; Moreau, A (corresponding author), Univ Montreal, Dept Biochem & Mol Med, Fac Med, Montreal, PQ, Canada.; Moreau, A (corresponding author), Univ Montreal, Dept Stomatol, Fac Dent, Montreal, PQ, Canada.	alain.moreau@recherche-ste-justine.qc.ca		Picard, Cynthia/0000-0003-1107-6839	Canadian Institute of Health Research [MOP-62791]; RSBO-FRSQ; Canadian Institute of Health Research/MENTOR; Fonds de la recherche en sante du Quebec	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); RSBO-FRSQ; Canadian Institute of Health Research/MENTOR; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by a research grant from The Canadian Institute of Health Research (MOP-62791) to Dr. Moreau. Dr. Martin Pellicelli is a recipient of the RSBO-FRSQ doctoral scholarship. Dr. Cynthia Picard is a recipient of the Canadian Institute of Health Research/MENTOR training program PhD Scholarship and is also a recipient of the Fonds de la recherche en sante du Quebec doctoral scholarship.	Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Ding M, 2012, J CELL PHYSIOL, V227, P3446, DOI 10.1002/jcp.24045; Fei Q, 2016, JOINT BONE SPINE, V83, P545, DOI 10.1016/j.jbspin.2015.09.001; Finger F, 2003, ARTHRITIS RHEUM-US, V48, P3395, DOI 10.1002/art.11341; Gibson G, 1998, MICROSC RES TECHNIQ, V43, P191, DOI 10.1002/(SICI)1097-0029(19981015)43:2<191::AID-JEMT10>3.0.CO;2-T; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kowalik TF, 1998, CELL GROWTH DIFFER, V9, P113; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Liu DX, 2007, CELL DEATH DIFFER, V14, P1893, DOI 10.1038/sj.cdd.4402209; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Perlman H, 2003, J IMMUNOL, V170, P838, DOI 10.4049/jimmunol.170.2.838; Picard C, 2007, CLIN ORTHOP RELAT R, P59, DOI 10.1097/BLO0b013e3180d09d9c; Picard C, 2013, ARTHRITIS RHEUM-US, V65, P993, DOI 10.1002/art.37837; Qin YL, 2012, AM J CANCER RES, V2, P540; Raderschall E, 2002, J CELL SCI, V115, P153; Rose J, 2012, OSTEOARTHR CARTILAGE, V20, P1020, DOI 10.1016/j.joca.2012.05.009; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sesselmann S, 2009, OSTEOARTHR CARTILAGE, V17, P507, DOI 10.1016/j.joca.2008.09.006; Sorensen TS, 1996, MOL CELL BIOL, V16, P5888; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Zamli Z, 2011, INT J RHEUM DIS, V14, P159, DOI 10.1111/j.1756-185X.2011.01618.x	25	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165951	10.1371/journal.pone.0165951	http://dx.doi.org/10.1371/journal.pone.0165951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802335	gold, Green Published, Green Submitted			2022-12-27	WOS:000386714200071
J	Richter, MJ; Tiede, SL; Sommer, N; Schmidt, T; Seeger, W; Ghofrani, HA; Schermuly, R; Gall, H				Richter, Manuel Jonas; Tiede, Svenja Lena; Sommer, Natascha; Schmidt, Thomas; Seeger, Werner; Ghofrani, Hossein Ardeschir; Schermuly, Ralph; Gall, Henning			Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CONGESTIVE-HEART-FAILURE; ARTERIAL-HYPERTENSION; PLASMA ANGIOPOIETIN-1; RECEPTOR TIE-2; MARKER; ANGIOGENESIS; PATHWAY; TRANSPLANTATION; ASSOCIATION	Background Circulating angiopoietin-1 (Ang-1) has been linked to pulmonary hypertension (PH) in experimental studies. However, the clinical relevance of Ang-1 as a biomarker in PH remains unknown. We aimed to investigate the prognostic and clinical significance of Ang-1 in PH using data from the prospectively recruiting Giessen PH Registry. Methods Patients with suspected PH (without previous specific pulmonary arterial hypertension [PAH] therapy) who underwent initial right heart catheterization (RHC) in our national referral center between July 2003 and May 2012 and who agreed to optional biomarker analysis were included if they were diagnosed with idiopathic PAH, connective tissue disease-associated PAH (CTD-PAH), PH due to left heart disease (PH-LHD), or chronic thromboembolic PH (CTEPH), or if PH was excluded by RHC (non-PH controls). The association of Ang-1 levels with disease severity (6-minute walk distance and pulmonary hemodynamics) was assessed using linear regression, and the impact of Ang-1 levels on transplant-free survival (primary endpoint)and clinical worsening was assessed using Kaplan-Meier curves, receiver operating characteristic (ROC) analyses, and Cox regression. Results 151 patients (39, 39, 32, and 41 with idiopathic PAH, CTD-PAH, PH-LHD, and CTEPH, respectively) and 41 non-PH controls were included. Ang-1 levels showed no significant difference between groups (p = 0.8), and no significant associations with disease severity in PH subgroups (p >= 0.07). In Kaplan-Meier analyses, Ang-1 levels (stratified by quartile) had no significant impact on transplant-free survival (p >= 0.27) or clinical worsening (p >= 0.51) in PH subgroups. Regression models found no significant association between Ang-1 levels and outcomes (p >= 0.31). ROC analyses found no significant cut-off that would maximize sensitivity and specificity. Conclusions Despite a strong pathophysiological association in experimental studies, this first comprehensive analysis of Ang-1 in PH subgroups suggests that Ang-1 is not a predictive and clinically relevant biomarker in PH.	[Richter, Manuel Jonas; Tiede, Svenja Lena; Sommer, Natascha; Schmidt, Thomas; Seeger, Werner; Ghofrani, Hossein Ardeschir; Schermuly, Ralph; Gall, Henning] Univ Giessen, Dept Internal Med, UGMLC, Giessen, Germany; [Richter, Manuel Jonas; Tiede, Svenja Lena; Sommer, Natascha; Schmidt, Thomas; Seeger, Werner; Ghofrani, Hossein Ardeschir; Schermuly, Ralph; Gall, Henning] German Ctr Lung Res DZL, Giessen, Germany; [Richter, Manuel Jonas; Ghofrani, Hossein Ardeschir] Kerckhoff Heart Rheuma & Thorac Ctr, Dept Pneumol, Bad Nauheim, Germany; [Ghofrani, Hossein Ardeschir] Imperial Coll London, Dept Med, London, England	Justus Liebig University Giessen; Kerckhoff Clinic; Imperial College London	Gall, H (corresponding author), Univ Giessen, Dept Internal Med, UGMLC, Giessen, Germany.; Gall, H (corresponding author), German Ctr Lung Res DZL, Giessen, Germany.	Henning.Gall@innere.med.uni-giessen.de	Ghofrani, Ardeschir/AAD-5293-2020; Sommer, Natascha/AAD-5406-2020; Ghofrani, Hossein Ardeschir/AAD-2856-2022	Ghofrani, Ardeschir/0000-0002-2029-4419; Schermuly, Ralph/0000-0002-5167-6970; Seeger, Werner/0000-0003-1946-0894; Sommer, Natascha/0000-0002-8915-7762				Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Belly MJ, 2012, J HEART LUNG TRANSPL, V31, P1109, DOI 10.1016/j.healun.2012.08.014; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Caine GJ, 2003, EUR J CLIN INVEST, V33, P883, DOI 10.1046/j.1365-2362.2003.01243.x; Chong AY, 2004, J AM COLL CARDIOL, V43, P423, DOI 10.1016/j.jacc.2003.08.042; Chong AY, 2004, EUR J CLIN INVEST, V34, P9, DOI 10.1111/j.1365-2362.2004.01284.x; Chu D, 2004, ANN THORAC SURG, V77, P449, DOI 10.1016/S0003-4975(03)01350-X; David S, 2009, AM J KIDNEY DIS, V53, P770, DOI 10.1053/j.ajkd.2008.11.030; Dewachter L, 2006, AM J RESP CRIT CARE, V174, P1025, DOI 10.1164/rccm.200602-304OC; Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Gashouta MA, 2014, PRESSE MED, V43, pE293, DOI 10.1016/j.lpm.2014.06.007; Gouw ASH, 2010, HEPATOLOGY, V52, P540, DOI 10.1002/hep.23700; Hampole CV, 2009, AM J CARDIOL, V104, P868, DOI 10.1016/j.amjcard.2009.05.016; Hassoun PM, 2015, AM J RESP CRIT CARE, V192, P1102, DOI 10.1164/rccm.201507-1398OC; Hato T, 2009, BIOCHEM BIOPH RES CO, V381, P218, DOI 10.1016/j.bbrc.2009.02.030; Hoeper MM, 2007, EUR RESPIR J, V29, P944, DOI 10.1183/09031936.00134506; Hughes DP, 2003, CIRC RES, V92, P630, DOI 10.1161/01.RES.0000063422.38690.DC; Kasztelan-Szczerbinska B, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/673032; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kim Won, 2008, Electrolyte Blood Press, V6, P22, DOI 10.5049/EBP.2008.6.1.22; Kumpers P, 2010, EUR HEART J, V31, P2291, DOI 10.1093/eurheartj/ehq226; Kugathasan L, 2005, CHEST, V128, p633S, DOI 10.1378/chest.128.6_suppl.633S; Kugathasan L, 2009, J EXP MED, V206, P2221, DOI 10.1084/jem.20090389; Lee KW, 2004, CIRCULATION, V110, P2355, DOI 10.1161/01.CIR.0000138112.90641.7F; Leuchte HH, 2007, CHEST, V131, P402, DOI 10.1378/chest.06-1758; Lukasz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066861; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mandriota SJ, 1998, CIRC RES, V83, P852, DOI 10.1161/01.RES.83.8.852; McLaughlin VV, 2013, J AM COLL CARDIOL, V62, pD73, DOI 10.1016/j.jacc.2013.10.034; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Nadar SK, 2004, J INTERN MED, V256, P331, DOI 10.1111/j.1365-2796.2004.01367.x; Oh H, 1999, J BIOL CHEM, V274, P15732, DOI 10.1074/jbc.274.22.15732; Olsson KM, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0194-6; Pepke-Zaba J, 2011, CIRCULATION, V124, P1973, DOI 10.1161/CIRCULATIONAHA.110.015008; Poss J, 2015, CLIN RES CARDIOL, V104, P380, DOI 10.1007/s00392-014-0787-y; Post S, 2008, J VASC RES, V45, P244, DOI 10.1159/000112939; Puri MC, 1999, DEVELOPMENT, V126, P4569; RICKHAM PP, 1964, BRIT MED J, V2, P173; Rubens C, 2001, CHEST, V120, P1562, DOI 10.1378/chest.120.5.1562; Shah SJ, 2008, CIRCULATION, V117, P2475, DOI 10.1161/CIRCULATIONAHA.107.719500; Singh S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158908; Sitbon O, 2010, EUR RESPIR REV, V19, P272, DOI 10.1183/09059180.00008210; Sullivan CC, 2003, P NATL ACAD SCI USA, V100, P12331, DOI 10.1073/pnas.1933740100; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Thistlethwaite PA, 2001, J THORAC CARDIOV SUR, V122, P65, DOI 10.1067/mtc.2001.113753; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Tiede SL, 2015, EUR RESPIR J, V46, P1390, DOI 10.1183/13993003.00187-2015; Torbicki A, 2003, CIRCULATION, V108, P844, DOI 10.1161/01.CIR.0000084544.54513.E2; van der Plas MN, 2010, ANN THORAC SURG, V89, P347, DOI 10.1016/j.athoracsur.2009.08.001; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Woolf AS, 2009, J AM SOC NEPHROL, V20, P239, DOI 10.1681/ASN.2008020243; Zhao YD, 2003, CIRC RES, V92, P984, DOI 10.1161/01.RES.0000070587.79937.F0	54	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165982	10.1371/journal.pone.0165982	http://dx.doi.org/10.1371/journal.pone.0165982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802345	Green Published, Green Submitted, gold			2022-12-27	WOS:000386714200073
J	Balaraman, S; Schafer, JJ; Tseng, AM; Wertelecki, W; Yevtushok, L; Zymak-Zakutnya, N; Chambers, CD; Miranda, RC				Balaraman, Sridevi; Schafer, Jordan J.; Tseng, Alexander M.; Wertelecki, Wladimir; Yevtushok, Lyubov; Zymak-Zakutnya, Natalya; Chambers, Christina D.; Miranda, Rajesh C.			Plasma miRNA Profiles in Pregnant Women Predict Infant Outcomes following Prenatal Alcohol Exposure	PLOS ONE			English	Article							MATERNAL RISK-FACTORS; ACID ETHYL-ESTERS; ETHANOL EXPOSURE; MICRORNA EXPRESSION; MESSENGER-RNA; SPECTRUM DISORDERS; ENDOTHELIAL-CELLS; FETAL; RAT; PREVALENCE	Fetal alcohol spectrum disorders (FASD) are difficult to diagnose since many heavily exposed infants, at risk for intellectual disability, do not exhibit craniofacial dysmorphology or growth deficits. Consequently, there is a need for biomarkers that predict disability. In both animal models and human studies, alcohol exposure during pregnancy resulted in significant alterations in circulating microRNAs (miRNAs) in maternal blood. In the current study, we asked if changes in plasma miRNAs in alcohol-exposed pregnant mothers, either alone or in conjunction with other clinical variables, could predict infant outcomes. Sixtyeight pregnant women at two perinatal care clinics in western Ukraine were recruited into the study. Detailed health and alcohol consumption histories, and 2nd and 3rd trimester blood samples were obtained. Birth cohort infants were assessed by a geneticist and classified as unexposed (UE), heavily prenatally exposed and affected (HEa) or heavily exposed but apparently unaffected (HEua). MiRNAs were assessed in plasma samples using qRT-PCR arrays. ANOVA models identified 11 miRNAs that were all significantly elevated in maternal plasma from the HEa group relative to HEua and UE groups. In a random forest analysis classification model, a combination of high variance miRNAs, smoking history and socioeconomic status classified membership in HEa and UE groups, with a misclassification rate of 13%. The RFA model also classified 17% of the HEua group as UE-like, whereas 83% were HEa-like, at least at one stage of pregnancy. Collectively our data indicate that maternal plasma miRNAs predict infant outcomes, and may be useful to classify difficult-to-diagnose FASD subpopulations.	[Balaraman, Sridevi; Tseng, Alexander M.; Miranda, Rajesh C.] Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, Coll Med, Bryan, TX USA; [Schafer, Jordan J.; Wertelecki, Wladimir; Chambers, Christina D.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Wertelecki, Wladimir; Yevtushok, Lyubov; Zymak-Zakutnya, Natalya] Omni Net Ukraine Birth Defects Prevent Program, Rivne, Ukraine; [Yevtushok, Lyubov] Rivne Prov Med Diagnost Ctr, Rivne, Ukraine; [Yevtushok, Lyubov] OMNI Net Ctr, Rivne, Ukraine; [Zymak-Zakutnya, Natalya] Khmelnytsky City Perinatal Ctr, Khmelnytsky, Ukraine; [Zymak-Zakutnya, Natalya] OMNI Net Ctr, Khmelnytsky, Ukraine; [Chambers, Christina D.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Wertelecki, Wladimir; Yevtushok, Lyubov; Zymak-Zakutnya, Natalya; Chambers, Christina D.; Miranda, Rajesh C.] CIFASD, San Diego, CA 92120 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of California System; University of California San Diego; University of California System; University of California San Diego	Miranda, RC (corresponding author), Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, Coll Med, Bryan, TX USA.; Miranda, RC (corresponding author), CIFASD, San Diego, CA 92120 USA.	Miranda@medicine.tamhsc.edu		Miranda, Rajesh/0000-0002-8359-892X; Chambers, Christina D/0000-0003-4675-7722	NIH Office of Dietary Supplements;  [NIH-U01AA014835];  [R01AA013440];  [NIH-U24AA014811]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA014811, U01AA014835, R01AA013440] Funding Source: NIH RePORTER	NIH Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by NIH-U01AA014835 and the NIH Office of Dietary Supplements to CDC, and by R01AA013440 and a pilot grant subcontract from CIFASD.org (from NIH-U24AA014811) to RCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Obstet Gynecol, V118, P383, DOI 10.1097/AOG.0b013e31822c9906; Baer JS, 2003, ARCH GEN PSYCHIAT, V60, P377, DOI 10.1001/archpsyc.60.4.377; Bakhireva LN, 2013, ALCOHOL CLIN EXP RES, V37, P1008, DOI 10.1111/acer.12045; Bala S, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/498232; Balaraman S, 2014, ALCOHOL CLIN EXP RES, V38, P1390, DOI 10.1111/acer.12378; Balaraman S, 2012, ALCOHOL CLIN EXP RES, V36, P1669, DOI 10.1111/j.1530-0277.2012.01793.x; Bearer CF, 2005, J PEDIATR-US, V146, P824, DOI 10.1016/j.jpeds.2005.01.048; Beninson LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108748; BONTHIUS DJ, 1990, ALCOHOL CLIN EXP RES, V14, P107, DOI 10.1111/j.1530-0277.1990.tb00455.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Chambers CD, 2014, ALCOHOL CLIN EXP RES, V38, P1012, DOI 10.1111/acer.12318; Chen CY, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131250; Chiu RWK, 2006, CLIN CHEM, V52, P313, DOI 10.1373/clinchem.2005.059691; Coles Claire D, 2015, Matern Child Health J, V19, P2605, DOI 10.1007/s10995-015-1779-x; Corbacho AM, 2002, J ENDOCRINOL, V173, P219, DOI 10.1677/joe.0.1730219; Dhahbi JM, 2013, PHYSIOL GENOMICS, V45, P990, DOI 10.1152/physiolgenomics.00129.2013; Diwadkar VA, 2013, HUM BRAIN MAPP, V34, P1931, DOI 10.1002/hbm.22042; Dolganiuc A, 2009, ALCOHOL CLIN EXP RES, V33, P1704, DOI 10.1111/j.1530-0277.2009.01007.x; Dutton PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039784; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Gardiner AS, 2016, ALCOHOL CLIN EXP RES, V40, P826, DOI 10.1111/acer.13026; Gidlof O, 2013, BLOOD, V121, P3908, DOI 10.1182/blood-2012-10-461798; Go Attie T. J. J., 2008, V444, P291, DOI 10.1007/978-1-59745-066-9_23; Goldman-Wohl D, 2004, PLACENTA, V25, P623, DOI 10.1016/j.placenta.2004.01.016; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gundogan F, 2015, PLACENTA, V36, P523, DOI 10.1016/j.placenta.2015.02.010; Gundogan F, 2010, ALCOHOL CLIN EXP RES, V34, P415, DOI 10.1111/j.1530-0277.2009.01106.x; Guo YQ, 2012, ALCOHOL CLIN EXP RES, V36, P1058, DOI 10.1111/j.1530-0277.2011.01689.x; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hellemans KGC, 2010, NEUROSCI BIOBEHAV R, V34, P791, DOI 10.1016/j.neubiorev.2009.06.004; Hoyme HE, 2005, PEDIATRICS, V115, P39, DOI 10.1542/peds.2004-0259; Hu YL, 2009, CLIN CHEM LAB MED, V47, P923, DOI 10.1515/CCLM.2009.228; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ignacio C, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00103; Jacobson SW, 2008, ALCOHOL CLIN EXP RES, V32, P365, DOI 10.1111/j.1530-0277.2007.00585.x; Jacobson SW, 2002, PEDIATRICS, V109, P815, DOI 10.1542/peds.109.5.815; James J, 2015, INTRO STAT LEARNING; Jong HL, 2013, PHYSIOL GENOMICS, V45, P256, DOI 10.1152/physiolgenomics.00071.2012; Kambe S, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121616; Kokkinos MI, 2010, PLACENTA, V31, P747, DOI 10.1016/j.placenta.2010.06.017; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Lewohl JM, 2011, ALCOHOL CLIN EXP RES, V35, P1928, DOI 10.1111/j.1530-0277.2011.01544.x; Lucas A, 2015, CARDIOVASC RES, V108, P254, DOI 10.1093/cvr/cvv219; Matlow JN, 2012, J POPUL THER CLIN PH, V19, pE473; May PA, 2005, AM J PUBLIC HEALTH, V95, P1190, DOI 10.2105/AJPH.2003.037093; May PA, 2004, AM J MED GENET C, V127C, P10, DOI 10.1002/ajmg.c.30011; Meng FY, 2012, AM J PATHOL, V181, P804, DOI 10.1016/j.ajpath.2012.06.010; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MURPHY JF, 1971, AM J OBSTET GYNECOL, V111, P22, DOI 10.1016/0002-9378(71)90920-3; O'Connor MJ, 2009, DEV DISABIL RES REV, V15, P225, DOI 10.1002/ddrr.74; Pappalardo-Carter DL, 2013, ALCOHOL CLIN EXP RES, V37, P1657, DOI 10.1111/acer.12139; Peterson J, 2008, J PEDIATR, V152, P788, DOI 10.1016/j.jpeds.2007.11.009; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Poon LLM, 2000, CLIN CHEM, V46, P1832; Popova S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043024; RUSSELL CS, 1968, BRIT J PREV SOC MED, V22, P119; Sampson HW, 2011, EXP BIOL MED, V236, P1389, DOI 10.1258/ebm.2011.011207; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Schneider ML, 2002, PSYCHONEUROENDOCRINO, V27, P285, DOI 10.1016/S0306-4530(01)00050-6; Selvamani A, 2014, CLIN SCI, V127, P77, DOI 10.1042/CS20130565; SOBELL LC, 1988, BRIT J ADDICT, V83, P393; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Srinivas SK, 2009, J PERINATOL, V29, P680, DOI 10.1038/jp.2009.83; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Tapocik JD, 2013, PHARMACOGENOMICS J, V13, P286, DOI 10.1038/tpj.2012.17; Tsai PC, 2014, BIOL OPEN, V3, P741, DOI 10.1242/bio.20147765; Tsui Nancy B. Y., 2006, V336, P123; Turchinovich A., 2013, Frontiers in Genetics, V4, P119, DOI 10.3389/fgene.2013.00119; van Steenwyk G, 2013, BRAIN SCI, V3, P744, DOI 10.3390/brainsci3020744; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Williams JF, 2015, PEDIATRICS, V136, pE1395, DOI 10.1542/peds.2015-3113; Yadav S, 2011, J BIOL CHEM, V286, P37347, DOI 10.1074/jbc.M111.235531; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhou M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081232; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	82	37	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165081	10.1371/journal.pone.0165081	http://dx.doi.org/10.1371/journal.pone.0165081			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828986	gold, Green Published, Green Submitted			2022-12-27	WOS:000387724300030
J	Holmes, IA; Mautz, WJ; Rabosky, ARD				Holmes, Iris A.; Mautz, William J.; Rabosky, Alison R. Davis			Historical Environment Is Reflected in Modern Population Genetics and Biogeography of an Island Endemic Lizard (Xantusia riversiana reticulata)	PLOS ONE			English	Article							SAN-CLEMENTE-ISLAND; BAJA-CALIFORNIA; NIGHT LIZARDS; R-PACKAGE; DIVERSITY; ERADICATION; LIKELIHOOD; EVOLUTION; SOFTWARE; PROGRAMS	The restricted distribution and isolation of island endemics often produces unique genetic and phenotypic diversity of conservation interest to management agencies. However, these isolated species, especially those with sensitive life history traits, are at high risk for the adverse effects of genetic drift and habitat degradation by non-native wildlife. Here, we study the population genetic diversity, structure, and stability of a classic "island giant" (Xantusia riversiana, the Island Night Lizard) on San Clemente Island, California following the removal of feral goats. Using DNA microsatellites, we found that this population is reasonably genetically robust despite historical grazing, with similar effective population sizes and genetic diversity metrics across all sampling locations irrespective of habitat type and degree of degradation. However, we also found strong site-specific patterns of genetic variation and low genetic diversity compared to mainland congeners, warranting continued special management as an island endemic. We identify both high and low elevation areas that remain valuable repositories of genetic diversity and provide a case study for other low-dispersal coastal organisms in the face of future climate change.	[Holmes, Iris A.; Rabosky, Alison R. Davis] Univ Michigan, Dept Ecol & Evolutionary Biol, 1109 Geddes Ave, Ann Arbor, MI 48103 USA; [Mautz, William J.] Univ Hawaii, Dept Biol, Hilo, HI 96720 USA; [Rabosky, Alison R. Davis] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, 1156 High St, Santa Cruz, CA 95064 USA	University of Michigan System; University of Michigan; University of Hawaii System; University Hawaii Hilo; University of California System; University of California Santa Cruz	Rabosky, ARD (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, 1109 Geddes Ave, Ann Arbor, MI 48103 USA.; Rabosky, ARD (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, 1156 High St, Santa Cruz, CA 95064 USA.	ardr@umich.edu		Holmes, Iris/0000-0001-6150-6150	STEPS Institute for Innovation in Environmental Research at the University of California; University of Michigan	STEPS Institute for Innovation in Environmental Research at the University of California; University of Michigan(University of Michigan System)	Funding for molecular work was provided by the STEPS Institute for Innovation in Environmental Research at the University of California (http://www1.ucsc.edu/currents/01-02/04-08/institute.html, Davis2012) Santa Cruz and by start-up funds from the University of Michigan to ARDR (https://www.lsa.umich.edu/eeb/, Davis2014).; We thank the U.S. Department of the Navy for supporting field collection and for granting access to San Clemente Island. Funding for molecular work was provided by the STEPS Institute for Innovation in Environmental Research at the University of California, Santa Cruz and by start-up funds from the University of Michigan to ARDR. WJM is contracted as a Biological Consultant for San Clemente Island by the U.S. Navy.	Bezy RL, 1980, CALIFORNIA ISLANDS, P565; COBLENTZ BE, 1978, BIOL CONSERV, V13, P279, DOI 10.1016/0006-3207(78)90038-1; Crouch JK, 1979, GEOLOGICAL SOC AM B, V90, P3; Culver M, 2008, ANIM CONSERV, V11, P104, DOI 10.1111/j.1469-1795.2007.00154.x; Davis AR, 2012, BEHAV ECOL, V23, P18, DOI 10.1093/beheco/arr144; Davis AR, 2011, P ROY SOC B-BIOL SCI, V278, P1507, DOI 10.1098/rspb.2010.1703; Davis Alison R., 2007, Herpetological Review, V38, P402; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R, 2015, MOL ECOL, V24, P2610, DOI 10.1111/mec.13139; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gow JL, 2006, MOL ECOL NOTES, V6, P873, DOI 10.1111/j.1471-8286.2006.01382.x; Grueber CE, 2013, MOL ECOL, V22, P4470, DOI 10.1111/mec.12404; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Haasl RJ, 2010, MOL BIOL EVOL, V27, P2702, DOI 10.1093/molbev/msq164; Hastie T., 2015, GAM GEN ADDITIVE MOD; Hauksson E, 2014, GEOPHYS J INT, V196, P1619, DOI 10.1093/gji/ggt467; Hedrick PW, 2010, CONSERV GENET, V11, P615, DOI 10.1007/s10592-009-9999-5; Hijmans RJ, 2015, **DATA OBJECT**, DOI DOI 10.HTTPS://CRAN.R-PROJECT.ORG/WEB/PACKAGES/RASTER/INDEX.HTML; Holland R.F., 1986, PRELIMINARY DESCRIPT; Horton BP, 2014, QUATERNARY SCI REV, V84, P1, DOI 10.1016/j.quascirev.2013.11.002; Imad H.H., 2015, EGPT J FOREN SCI, V5, P150; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kappes PJ, 2014, BIODIVERS CONSERV, V23, P503, DOI 10.1007/s10531-013-0608-z; KEEGAN DR, 1994, WILDLIFE SOC B, V22, P56; Kimmel M, 1998, GENETICS, V148, P1921; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Langkilde T, 2006, J EXP BIOL, V209, P1035, DOI 10.1242/jeb.02112; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Lusini I, 2014, CONSERV GENET, V15, P283, DOI 10.1007/s10592-013-0537-0; Martiinez-Cabrera HI, 2006, REV PALAEOBOT PALYNO, V138, P141, DOI 10.1016/j.revpalbo.2006.01.001; Mautz William J., 1993, P417; MAUTZ WJ, 1987, AM ZOOL, V27, pA147; Mautz WJ., 2007, ISLAND NIGHT LIZARD; McRae B., 2013, NAT CONSERV; MERIFIEL.PM, 1971, GEOL SOC AM BULL, V82, P1989, DOI 10.1130/0016-7606(1971)82[1989:GOCSCI]2.0.CO;2; Monks JM, 2014, BIOL INVASIONS, V16, P167, DOI 10.1007/s10530-013-0511-2; Mouret V, 2011, J BIOGEOGR, V38, P1717, DOI 10.1111/j.1365-2699.2011.02514.x; MUHS DR, 1983, QUATERNARY RES, V20, P322, DOI 10.1016/0033-5894(83)90016-9; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nachman MW, 2000, GENETICS, V156, P297; National Geophysical Data Center, 2012, US COAST REL MOD SO; Noel F, 2013, BIOL CONSERV, V158, P167, DOI 10.1016/j.biocon.2012.07.029; Noonan BP, 2013, MOL PHYLOGENET EVOL, V69, P109, DOI 10.1016/j.ympev.2013.05.017; Paolucci EM, 2013, DIVERS DISTRIB, V19, P988, DOI 10.1111/ddi.12073; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Porcasi P., 1999, PACIFIC COAST ARCHAE, V35, P1; Powell TWR, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/025024; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ringsby TH, 2006, CONSERV BIOL, V20, P1761, DOI 10.1111/j.1523-1739.2006.00568.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rumeu B, 2014, DIVERS DISTRIB, V20, P272, DOI 10.1111/ddi.12163; Sinclair EA, 2004, AM NAT, V164, P396, DOI 10.1086/381404; Spatz DR, 2014, CONSERV BIOL, V28, P1282, DOI 10.1111/cobi.12279; STOCK JM, 1994, TECTONICS, V13, P1472, DOI 10.1029/94TC01808; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Tabak MA, 2014, BIOL INVASIONS, V16, P341, DOI 10.1007/s10530-013-0524-x; van Oosterhout C, 2006, MOL ECOL NOTES, V6, P255, DOI 10.1111/j.1471-8286.2005.01082.x; Vicario S, 2003, MOL PHYLOGENET EVOL, V26, P243, DOI 10.1016/S1055-7903(02)00313-5; Ward SN, 1996, GEOPHYS J INT, V126, P712, DOI 10.1111/j.1365-246X.1996.tb04699.x; Wilson GA, 2003, GENETICS, V163, P1177; Wright S, 1931, GENETICS, V16, P0097; Wylie J., 2012, VEGETATION CHANGE SA	69	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0163738	10.1371/journal.pone.0163738	http://dx.doi.org/10.1371/journal.pone.0163738			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828958	Green Submitted, Green Published, gold			2022-12-27	WOS:000387724300010
J	Wei, XL; McCune, B; Lumbsch, HT; Li, H; Leavitt, S; Yamamoto, Y; Tchabanenko, S; Wei, JC				Wei, Xinli; McCune, Bruce; Lumbsch, H. Thorsten; Li, Hui; Leavitt, Steven; Yamamoto, Yoshikazu; Tchabanenko, Svetlana; Wei, Jiangchun			Limitations of Species Delimitation Based on Phylogenetic Analyses: A Case Study in the Hypogymnia hypotrypa Group (Parmeliaceae, Ascomycota)	PLOS ONE			English	Article							PAIR CONCEPT; SEQUENCE ALIGNMENT; RIBOSOMAL DNA; BETA-TUBULIN; MOLECULAR PHYLOGENY; GENE FLOW; INFERENCE; EVOLUTION; LICHENS; NUCLEAR	Delimiting species boundaries among closely related lineages often requires a range of independent data sets and analytical approaches. Similar to other organismal groups, robust species circumscriptions in fungi are increasingly investigated within an empirical framework. Here we attempt to delimit species boundaries in a closely related Glade of lichen-forming fungi endemic to Asia, the Hypogymnia hypotrypa group (Parmeliaceae). In the current classification, the Hypogymnia hypotrypa group includes two species: H. hypotrypa and H. flavida, which are separated based on distinctive reproductive modes, the former producing soredia but absent in the latter. We reexamined the relationship between these two species using phenotypic characters and molecular sequence data (ITS, GPD, and MCM7sequences) to address species boundaries in this group. In addition to morphological investigations, we used Bayesian clustering to identify potential genetic groups in the H. hypotrypa/H. flavida Glade. We also used a variety of empirical, sequence-based species delimitation approaches, including: the "Automatic Barcode Gap Discovery" (ABGD), the Poisson tree process model (PTP), the General Mixed Yule Coalescent (GMYC), and the multispecies coalescent approach BPP. Different species delimitation scenarios were compared using Bayes factors delimitation analysis, in addition to comparisons of pairwise genetic distances, pairwise fixation indices (FST). The majority of the species delimitation analyses implemented in this study failed to support H. hypotrypa and H. flavida as distinct lineages, as did the Bayesian clustering analysis. However, strong support for the evolutionary independence of H. hypotrypa and H. flavida was inferred using BPP and further supported by Bayes factor delimitation. In spite of rigorous morphological comparisons and a wide range of sequence-based approaches to delimit species, species boundaries in the H. hypotrypa group remain uncertain. This study reveals the potential limitations of relying on distinct reproductive strategies as diagnostic taxonomic characters for Hypogymnia and also the challenges of using popular sequence-based species delimitation methods in groups with recent diversification histories.	[Wei, Xinli; Li, Hui; Wei, Jiangchun] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [McCune, Bruce] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Lumbsch, H. Thorsten] Field Museum, Sci & Educ, Chicago, IL USA; [Li, Hui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Leavitt, Steven] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Yamamoto, Yoshikazu] Akita Prefectural Univ, Fac Bioresource Sci, Dept Bioprod Sci, Akita, Japan; [Tchabanenko, Svetlana] Sakhalin Bot Garden, Yuzhno Sakhalinsk, Russia	Chinese Academy of Sciences; Institute of Microbiology, CAS; Oregon State University; Field Museum of Natural History (Chicago); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Brigham Young University; Akita Prefectural University; Russian Academy of Sciences; Botanical Garden Institute of the Far Eastern Branch of the Russian Academy of Sciences	Wei, XL; Wei, JC (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	weixl@im.ac.cn; weijc2004@126.com	Leavitt, Steven D./AAC-6462-2021; wei, jiang/GRX-7907-2022	Leavitt, Steven D./0000-0002-5034-9724; Lumbsch, Thorsten/0000-0003-1512-835X	National Natural Science Foundation of China [31200018]; Ministry of Science and Technology of China [2012FY111600, 2014FY120100]; Youth Innovation Promotion Association, Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Youth Innovation Promotion Association, Chinese Academy of Sciences	Support was provided by: the National Natural Science Foundation of China (31200018; http://www.nsfc.gov.cn; XLW); Ministry of Science and Technology of China (2012FY111600, 2014FY120100; http://www.most.gov.cn; XLW); the Youth Innovation Promotion Association, Chinese Academy of Sciences (http://www.yicas. cry, XLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello A, 2007, BIOL J LINN SOC, V91, P455, DOI 10.1111/j.1095-8312.2007.00810.x; Articus K, 2002, MYCOL RES, V106, P412, DOI 10.1017/S0953756202005786; ASAHINA YASUHIKO, 1950, ACTA PHYTOTAX ET GEOBOT, V14, P33; AWASTHI D D, 1984, Kavaka, V12, P87; Bitter G., 1901, HEDWIGIA, V40, P171; Buschbom J, 2006, MOL BIOL EVOL, V23, P574, DOI 10.1093/molbev/msj063; Crespo A, 2007, MOL PHYLOGENET EVOL, V44, P812, DOI 10.1016/j.ympev.2006.11.029; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2010, TAXON, V59, P1735, DOI 10.1002/tax.596008; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; Cubero OF, 2004, MYCOL RES, V108, P498, DOI 10.1017/s095375620400975x; CULBERSON CF, 1972, J CHROMATOGR, V72, P113, DOI 10.1016/0021-9673(72)80013-X; CULBERSON CF, 1970, J CHROMATOGR, V46, P85, DOI 10.1016/S0021-9673(00)83967-9; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Molina MD, 2011, LICHENOLOGIST, V43, P585, DOI 10.1017/S0024282911000521; Del-Prado R, 2010, MOL PHYLOGENET EVOL, V56, P125, DOI 10.1016/j.ympev.2010.04.014; Divakar PK, 2005, LICHENOLOGIST, V37, P37, DOI 10.1017/S0024282904014641; Divakar PK, 2010, FUNGAL DIVERS, V42, P47, DOI 10.1007/s13225-010-0027-3; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Falush D, 2003, GENETICS, V164, P1567; Ferencova Z, 2010, LICHENOLOGIST, V42, P449, DOI 10.1017/S0024282909990739; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Galloway DJ, 2008, LICHEN BIOLOGY, 2ND EDITION, P315, DOI 10.1017/CBO9780511790478.017; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grishkan I, 2003, P ROY SOC B-BIOL SCI, V270, P13, DOI 10.1098/rspb.2002.2194; Grummer JA, 2014, SYST BIOL, V63, P119, DOI 10.1093/sysbio/syt069; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hey J, 1997, GENETICS, V145, P833; Hodkinson BP, 2011, BIBL LICHENOL, V106, P115; HUDSON RR, 1992, GENETICS, V132, P583; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kis-Papo T, 2003, P NATL ACAD SCI USA, V100, P14970, DOI 10.1073/pnas.2036284100; Lai M. J, 1980, Q J TAIWAN MUSEUM, V33, P209; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leavitt S.D., 2015, RECENT ADV LICHENOLO, P11, DOI 10.1007/978-81-322-2235-4_2; Leavitt SD, 2016, SCI REP-UK, V6, DOI 10.1038/srep22262; Leavitt SD, 2011, AM J BOT, V98, P175, DOI 10.3732/ajb.1000230; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lohtander K, 1998, BRYOLOGIST, V101, P404; Lohtander K, 1998, LICHENOLOGIST, V30, P341, DOI 10.1006/lich.1998.0154; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Martinez I, 2012, FUNGAL BIOL-UK, V116, P1192, DOI 10.1016/j.funbio.2012.09.005; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; MATTSSON JE, 1989, TAXON, V38, P238, DOI 10.2307/1220840; McCune B, 2001, MYCOTAXON, V79, P23; Miadlikowska J, 2011, BRYOLOGIST, V114, P392, DOI 10.1639/0007-2745-114.2.392; Miller M.A., 2010, P GAT COMP ENV WORKS; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Monte M., 1993, Aerobiologia, V9, P169, DOI 10.1007/BF02066258; Myllys L, 2002, LICHENOLOGIST, V34, P237, DOI 10.1006/lich.2002.0390; Myllys L, 2001, MYCOLOGIA, V93, P335, DOI 10.2307/3761655; Ott S, 2004, LICHENOLOGIST, V36, P227, DOI 10.1017/S0024282904014306; Parnmen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052245; Pino-Bodas R, 2012, LICHENOLOGIST, V44, P121, DOI 10.1017/S002428291100065X; Pino-Bodas R, 2012, MYCOL PROG, V11, P269, DOI 10.1007/s11557-011-0746-1; POELT J., 1963, PHYTON ANN REI BOT, V10, P206; Poelt J., 1970, NEUE FOLGE, V4, P187; POELT VJ, 1972, BOT NOTISER, V125, P77; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Prieto M, 2012, AM J BOT, V99, P23, DOI 10.3732/ajb.1100239; Pritchard JK, 2000, GENETICS, V155, P945; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rannala B, 2013, GENETICS, V194, P245, DOI 10.1534/genetics.112.149039; Rassadina KA, 1967, BOT MAT NOT SYST SEC, V20, P297; Rassadina KA, 1960, BOT MAT OTD SPOROV B, V13, P23; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seymour Fabian A., 2005, Mycologist, V19, P51, DOI 10.1017/S0269915X05002016; Spribille T, 2011, MOL PHYLOGENET EVOL, V59, P603, DOI 10.1016/j.ympev.2011.03.021; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TEHLER A, 1982, TAXON, V31, P708, DOI 10.2307/1219689; Tehler A, 2009, TAXON, V58, P438, DOI 10.1002/tax.582010; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tolpysheva T. Yu., 2008, Moscow University Biological Sciences Bulletin, V63, P170, DOI 10.3103/S0096392508040068; Velmala S, 2009, LICHENOLOGIST, V41, P231, DOI 10.1017/S0024282909008573; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Vondrak J, 2009, LICHENOLOGIST, V41, P571, DOI 10.1017/S0024282909008317; Wei J.C., 1991, ENUMERATION LICHENS; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wirtz N, 2012, ORG DIVERS EVOL, V12, P17, DOI 10.1007/s13127-011-0066-y; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Yang ZH, 2015, CURR ZOOL, V61, P854, DOI 10.1093/czoolo/61.5.854; Yang ZH, 2014, MOL BIOL EVOL, V31, P3125, DOI 10.1093/molbev/msu279; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yoshimura I., 1974, LICHEN FLORA JAPAN C; ZAHLBRUCKNER A., 1934, HEDWIGIA, V74, P195; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhao JD, 1964, ACTA PHYTOTAXONOMICA, V9, P139; [No title captured]	91	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0163664	10.1371/journal.pone.0163664	http://dx.doi.org/10.1371/journal.pone.0163664			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828951	Green Submitted, Green Published, gold			2022-12-27	WOS:000387724300009
J	Zhou, Q; Long, L; Zhou, T; Tian, J; Zhou, B				Zhou, Qiao; Long, Li; Zhou, Ting; Tian, Juan; Zhou, Bin			Demethylation of MicroRNA-124a Genes Attenuated Proliferation of Rheumatoid Arthritis Derived Fibroblast-Like Synoviocytes and Synthesis of Tumor Necrosis Factor-alpha	PLOS ONE			English	Article							DNA METHYLATION; SECRETION; CELLS	Objective To examine the impact of 5-Aza-2'-deoxycytidine (5-AzadC) on methylation status of miR-124a genes in rheumatoid arthritis (RA) associated fibroblast-like synoviocytes (FLS) and its effect on RA-FLS proliferation and TNF-alpha expression. Materials and Methods FLS were isolated from seven RA-derived synovial tissues and cultured in vitro. The expression of miR-124a was measured by real time quantitative polymerase chain reaction (PCR) in FLS with or without 5-AzadC treatment. MiR-124a gene methylation was detected by methylation-specific PCR. FLS were divided into three groups as control, IL-1 beta and IL-1 beta/5 5-AzadC, respectively. The cells in the IL-1 beta group were treated with 5 mu g/L of IL-1 beta for 24 hours, whereas the cells in the IL-1 beta/5-AzadC group were first treated with IL-1 beta exactly as those in the IL-1 beta group for 24 h but further treated with 1 mu M 5-AzadC for additional 3 days. The cell growth was estimated based on absorbance at UV450nm. Secreted TNF-alpha from the cells was evaluated by enzyme-linked immunosorbent assay. After that, RA-FLS treated with IL-1 beta plus 5-AzadC were further transfected with miR-124a inhibitor or scrambled control. After culturing for 3 days, cell growth and TNF-a concentrations were measured. Results After 5-AzadC treatment, the expression of miR-124a was significantly increased compared with the control group (1.545 +/- 0.189 vs 0.836 +/- 0.166, p = 0.001). On the other hand, 5-AzadC significantly reduced IL-1 beta-mediated cell proliferation by nearly 2.5 fold (p = 0.006). Also, the level of TNF-alpha secreted from the cells treated with IL-1 beta plus 5-AzadC was considerably less than that from the cells treated with IL-1 beta alone (324.99 +/- 22.73 ng/L vs 387.91 +/- 58.51 ng/L, p = 0.022). After transfection with miR-124a inhibitor in RA-FLS treated with IL-1 beta plus 5-AzadC, the cell proliferation was increased by 18.2% and the TNF-alpha expression was increased by 19.0% (p = 0.001 and 0.011, respectively). Conclusion Methylation of miR-124a genes contributed to IL-1 beta-mediated RA-FLS proliferation and TNF-alpha expression.	[Zhou, Qiao] Sichuan Acad Med Sci, Dept Rheumatol & Immunol, 1st Ring Rd, Chengdu 610072, Sichuan, Peoples R China; Sichuan Prov Peoples Hosp, 1st Ring Rd, Chengdu 610072, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Zhou, Q (corresponding author), Sichuan Acad Med Sci, Dept Rheumatol & Immunol, 1st Ring Rd, Chengdu 610072, Sichuan, Peoples R China.	22922934@qq.com	Zhou, Qiao/HDN-2716-2022	Zhou, Qiao/0000-0003-2666-2283	Doctoral Foundation of Sichuan Provincial People's Hospital [30305030587191]	Doctoral Foundation of Sichuan Provincial People's Hospital	The study was funded by the Doctoral Foundation of Sichuan Provincial People's Hospital (No.30305030587191, http://www.samsph.com/news_hos/27/16394/1/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett FC, 1987, ARTHR RHEUM, V1988, P315, DOI DOI 10.1002/ART.1780310302; Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Chen XY, 2013, INVEST OPHTH VIS SCI, V54, P2248, DOI 10.1167/iovs.12-10977; Cooles FAH, 2011, CURR OPIN RHEUMATOL, V23, P233, DOI 10.1097/BOR.0b013e32834518a3; Firestein GS, 1996, ARTHRITIS RHEUM, V39, P1781, DOI 10.1002/art.1780391103; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Miao CG, 2013, CELL SIGNAL, V25, P1118, DOI 10.1016/j.cellsig.2013.01.024; Motegi K, 2005, LAB INVEST, V85, P342, DOI 10.1038/labinvest.3700234; Nakamachi Y, 2009, ARTHRITIS RHEUM-US, V60, P1294, DOI 10.1002/art.24475; Nakano K, 2013, ANN RHEUM DIS, V72, P110, DOI 10.1136/annrheumdis-2012-201526; Nervi C, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0157-2; Qiao Z, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/207987; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Yang S, 2013, CELL RES, V23, P1270, DOI [10.1038/cr.2013.116, DOI 10.1038/CR.2013.116]	14	12	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164207	10.1371/journal.pone.0164207	http://dx.doi.org/10.1371/journal.pone.0164207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824863	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200002
J	Delaney, JT; Moranz, RA; Debinski, DM; Engle, DM; Miller, JR				Delaney, John T.; Moranz, Raymond A.; Debinski, Diane M.; Engle, David M.; Miller, James R.			Exotic-Dominated Grasslands Show Signs of Recovery with Cattle Grazing and Fire	PLOS ONE			English	Article							BRITISH BUTTERFLIES; ECOSYSTEM PROCESSES; MOTH COMMUNITIES; PLANT COMMUNITY; ALIEN PLANTS; MANAGEMENT; BIODIVERSITY; RESTORATION; RESPONSES; DEGRADATION	In grasslands, overgrazing by domestic livestock, fertilization, and introduction of exotic forage species leads to plant communities consisting of a mixture of native and exotic species. These degraded grasslands present a problem for land managers, farmers, and restoration ecologists concerned with improving biodiversity while continuing to use the land for livestock production. Here we assessed the response of butterfly and plant community composition to the use of fire and moderate grazing by domestic cattle on degraded grasslands dominated by exotic plants. We evaluated change by comparing experimental pastures to two reference sites that were grasslands dominated by native plants. We used two burning and grazing treatments: 1) patch-burn graze, a heterogeneously managed treatment, where one third of the pasture is burned each year and cattle have free access to the entire pasture, and 2) graze-and-burn, a homogenously managed treatment, where the entire pasture is grazed each year and burned in its entirety every three years. We tested for change in the butterfly and plant community composition over seven years using Bray-Curtis dissimilarity measures. Over the course of seven years, degraded pastures in both treatments became more similar to reference sites with respect to the butterfly and plant communities. Only two butterfly species and two plant functional guilds exhibited significant linear trends over time, with varying responses. Compositional changes in both the butterfly and plant communities indicate that the use of moderate grazing and fire may shift butterfly and plant communities of exotic-dominated grasslands to be more similar to reference tall-grass prairies over time.	[Delaney, John T.; Debinski, Diane M.] Iowa State Univ, Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Moranz, Raymond A.; Engle, David M.] Oklahoma State Univ, Nat Resource Ecol & Management, Stillwater, OK 74078 USA; [Miller, James R.] Univ Illinois, Nat Resources & Environm Sci, Urbana, IL USA	Iowa State University; Oklahoma State University System; Oklahoma State University - Stillwater; University of Illinois System; University of Illinois Urbana-Champaign	Delaney, JT (corresponding author), Iowa State Univ, Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	johntdelaney@gmail.com		Delaney, John/0000-0003-1038-0265	Oklahoma Agricultural Experiment Station; Iowa Department of Natural Resources; Iowa Agricultural and Home Economics Experiment Station; Iowa State Wildlife Grants program [T-1-R-15, U-2-R-1]; U.S. Fish and Wildlife Service, Wildlife and Sport Fish Restoration Program	Oklahoma Agricultural Experiment Station; Iowa Department of Natural Resources; Iowa Agricultural and Home Economics Experiment Station; Iowa State Wildlife Grants program; U.S. Fish and Wildlife Service, Wildlife and Sport Fish Restoration Program	This research was supported by the Oklahoma Agricultural Experiment Station, Iowa Department of Natural Resources, and the Iowa Agricultural and Home Economics Experiment Station. Partial funding for this project was through the Iowa State Wildlife Grants program grants T-1-R-15 and U-2-R-1 in cooperation with the U.S. Fish and Wildlife Service, Wildlife and Sport Fish Restoration Program.; This research was supported by the Oklahoma Agricultural Experiment Station, Iowa Department of Natural Resources, and the Iowa Agricultural and Home Economics Experiment Station. Partial funding for this project was through the Iowa State Wildlife Grants program grants T-1-R-15 and U-2-R-1 in cooperation with the U.S. Fish and Wildlife Service, Wildlife and Sport Fish Restoration Program. We wish to thank Jason Burkum, Anna Holtermann, Meghan Kirkwood, Jacob Mortensen, Ben Nagel, Matthew Nielsen, Calla Olson, Toni Pro escholdt, Michael Rausch, Shannon Rusk, and Laura Winkler for their work in the field, and special thanks to Ryan Harr for managing almost every field aspect of our research project. Finally, we pay our respects to the late Sheri Svehla for initiating our work in the field and the lab.	Archibald S, 2004, INT J WILDLAND FIRE, V13, P377, DOI 10.1071/WF03070; BELSKY JA, 1992, J VEG SCI, V3, P187, DOI 10.2307/3235679; Biondini ME, 1998, ECOL APPL, V8, P469, DOI 10.1890/1051-0761(1998)008[0469:GIAEPI]2.0.CO;2; Boggs C., 2003, BUTTERFLIES ECOLOGY; Brereton T, 2011, J INSECT CONSERV, V15, P139, DOI 10.1007/s10841-010-9333-z; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cummings DC, 2007, RANGELAND ECOL MANAG, V60, P253, DOI 10.2111/1551-5028(2007)60[253:IAGSOI]2.0.CO;2; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; De Bruijn SL, 2006, BIOL CONTROL, V36, P305, DOI 10.1016/j.biocontrol.2005.10.007; Debinski DM, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00226.1; Delaney JT, 2014, UTILIZING NOVEL GRAS; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Engst K, 2016, J APPL ECOL, V53, P751, DOI 10.1111/1365-2664.12623; Erhardt A., 1991, Symposia of the Royal Entomological Society of London, P213; Ewel JJ, 2004, FRONT ECOL ENVIRON, V2, P354, DOI 10.1890/1540-9295(2004)002[0354:apfasi]2.0.co;2; FIRN J, 2013, ECOL PROCESS, V2, pNIL1, DOI DOI 10.1186/2192-1709-2-26; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Fuhlendorf SD, 2004, J APPL ECOL, V41, P604, DOI 10.1111/j.0021-8901.2004.00937.x; Fuhlendorf SD, 2001, BIOSCIENCE, V51, P625, DOI 10.1641/0006-3568(2001)051[0625:RHOREM]2.0.CO;2; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Gardener M. R., 2005, Plant Protection Quarterly, V20, P36; Gioria M, 2010, BIOL CONSERV, V143, P1125, DOI 10.1016/j.biocon.2010.02.007; Graves SD, 2003, BIOL CONSERV, V110, P413, DOI 10.1016/S0006-3207(02)00233-1; Hadar L, 1999, J VEG SCI, V10, P673, DOI 10.2307/3237082; Hickman KR, 2004, J RANGE MANAGE, V57, P58, DOI 10.2307/4003955; Hill JK, 2003, J TROP ECOL, V19, P35, DOI 10.1017/S0266467403003055; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Isbell FI, 2011, PLANT ECOL, V212, P1663, DOI 10.1007/s11258-011-9939-6; Kristensen NP, 2007, ZOOTAXA, V1668, pe747; Maccherini S, 2009, ACTA OECOL, V35, P311, DOI 10.1016/j.actao.2008.12.002; Maes D, 2001, BIOL CONSERV, V99, P263, DOI 10.1016/S0006-3207(00)00182-8; Martin LM, 2014, OECOLOGIA, V175, P687, DOI 10.1007/s00442-014-2911-0; Mascaro J, 2012, ECOL MONOGR, V82, P221, DOI 10.1890/11-1014.1; McGranahan DA, 2011, SPECIES RICHNESS FIR; McGranahan DA, 2012, NAT AREA J, V32, P208, DOI 10.3375/043.032.0214; McGranahan DA, 2013, LAND-BASEL, V2, P328, DOI 10.3390/land2030328; Memmott J, 2002, P ROY SOC B-BIOL SCI, V269, P2395, DOI 10.1098/rspb.2002.2174; New TR, 1997, J INSECT CONSERV, V1, P5, DOI 10.1023/A:1018433406701; Novotny V, 2003, ECOL ENTOMOL, V28, P704, DOI 10.1111/j.1365-2311.2003.00558.x; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Olson BE, 1997, WEED TECHNOL, V11, P176, DOI 10.1017/S0890037X00041543; Papanastasis VP, 2009, RESTOR ECOL, V17, P441, DOI 10.1111/j.1526-100X.2009.00567.x; Pieper R. D., 1994, Ecological implications of herbivory in the west.., P177; Pillsbury FC, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00154.1; Pinheiro J, 2020, R PACKAGE VERSION 31; POLLARD E, 1988, J APPL ECOL, V25, P819, DOI 10.2307/2403748; Pollard E, 1977, BIOL CONSERV, V12, P115; Popay I, 1996, WEED TECHNOL, V10, P217, DOI 10.1017/S0890037X00045942; Poyry J, 2004, ECOL APPL, V14, P1656, DOI 10.1890/03-5151; Pywell RF, 2010, GRASS FORAGE SCI, V65, P159, DOI 10.1111/j.1365-2494.2010.00735.x; Scasta JD, 2014, IMPLICATIONS PYRIC H; Schaffers AP, 2008, ECOLOGY, V89, P782, DOI 10.1890/07-0361.1; Seastedt TR, 2008, FRONT ECOL ENVIRON, V6, P547, DOI 10.1890/070046; Shapiro AM, 2002, DIVERS DISTRIB, V8, P31, DOI 10.1046/j.1366-9516.2001.00120.x; Shuey JA, 2012, AM MIDL NAT, V167, P273, DOI 10.1674/0003-0031-167.2.273; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Sivicek VA, 2011, ECOL INDIC, V11, P1251, DOI 10.1016/j.ecolind.2011.01.003; Stahlheber KA, 2013, BIOL CONSERV, V157, P300, DOI 10.1016/j.biocon.2012.09.008; Sternberg M, 2000, J APPL ECOL, V37, P224, DOI 10.1046/j.1365-2664.2000.00491.x; Stohlgren TJ, 1998, J RANGE MANAGE, V51, P164, DOI 10.2307/4003202; Su JC, 2004, CONSERV BIOL, V18, P167, DOI 10.1111/j.1523-1739.2004.00337.x; Swengel SR, 2011, J INSECT CONSERV, V15, P327, DOI 10.1007/s10841-010-9323-1; The Nature Conservancy, 2008, GRAND RIVER IN PRESS; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; TILMAN D, 1989, P136; TNC-Missouri, 2012, GRAND RIV GRASSL PRA; van Swaay C, 2006, J INSECT CONSERV, V10, P189, DOI 10.1007/s10841-006-6293-4; Vermeire LT, 2004, J RANGE MANAGE, V57, P248, DOI 10.2307/4003792; WallisDeVries MF, 2001, RESTOR ECOL, V9, P179, DOI 10.1046/j.1526-100x.2001.009002179.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wenzel M, 2006, BIOL CONSERV, V128, P542, DOI 10.1016/j.biocon.2005.10.022; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilsey BJ, 2011, PERSPECT PLANT ECOL, V13, P265, DOI 10.1016/j.ppees.2011.07.002; Wilsey BJ, 2009, ECOL LETT, V12, P432, DOI 10.1111/j.1461-0248.2009.01298.x; Woodcock BA, 2012, BIOL CONSERV, V155, P50, DOI 10.1016/j.biocon.2012.05.013; Woodcock BA, 2011, J APPL ECOL, V48, P1070, DOI 10.1111/j.1365-2664.2011.02029.x; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	78	10	10	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165758	10.1371/journal.pone.0165758	http://dx.doi.org/10.1371/journal.pone.0165758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820838	Green Published, gold, Green Submitted			2022-12-27	WOS:000387614800017
J	Lundquist, I; Al-Amily, IM; Abaraviciene, SM; Salehi, A				Lundquist, Ingmar; Al-Amily, Israa Mohammed; Abaraviciene, Sandra Meidute; Salehi, Albert			Metformin Ameliorates Dysfunctional Traits of Glibenclamide- and Glucose-Induced Insulin Secretion by Suppression of Imposed Overactivity of the Islet Nitric Oxide Synthase-NO System	PLOS ONE			English	Article							PROTEIN S-NITROSYLATION; HUMAN PANCREATIC-ISLETS; BETA-CELL DYSFUNCTION; CHRONIC EXPOSURE; TYROSINE NITRATION; HORMONE-RELEASE; RAT ISLETS; EXPRESSION; GLP-1; ROSIGLITAZONE	Metformin lowers diabetic blood glucose primarily by reducing hepatic gluconeogenesis and increasing peripheral glucose uptake. However, possible effects by metformin on beta-cell function are incompletely understood. We speculated that metformin might positively influence insulin secretion through impacting the beta-cell nitric oxide synthase (NOS)-NO system, a negative modulator of glucose-stimulated insulin release. In short-time incubations with isolated murine islets either glibenclamide or high glucose augmented insulin release associated with increased NO production from both neural and inducible NOS. Metformin addition suppressed the augmented NO generation coinciding with amplified insulin release. Islet culturing with glibenclamide or high glucose revealed pronounced fluorescence of inducible NOS in the beta-cells being abolished by metformin co-culturing. These findings were reflected in medium nitrite-nitrate levels. A glucose challenge following islet culturing with glibenclamide or high glucose revealed markedly impaired insulin response. Metformin co-culturing restored this response. Culturing murine islets and human islets from controls and type 2 diabetics with high glucose or high glucose + glibenclamide induced a pronounced decrease of cell viability being remarkably restored by metformin co-culturing. We show here, that imposed overactivity of the beta-cell NOS-NO system by glibenclamide or high glucose leads to insulin secretory dysfunction and reduced cell viability and also, importantly, that these effects are relieved by metformin inhibiting beta-cell NO overproduction from both neural and inducible NOS thus ameliorating a concealed negative influence by NO induced by sulfonylurea treatment and/or high glucose levels. This double-edged effect of glibenclamide on the beta-cellsuggests sulfonylurea monotherapy in type 2 diabetes being avoided.	[Lundquist, Ingmar; Al-Amily, Israa Mohammed; Abaraviciene, Sandra Meidute; Salehi, Albert] Lund Univ, Div Islet Cell Physiol, SUS, Dept Clin Sci, Malmo, Sweden; [Lundquist, Ingmar] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Abaraviciene, Sandra Meidute] Vilnius Univ, Dept Physiol Biochem Microbiol & Lab Med, Vilnius, Lithuania; [Abaraviciene, Sandra Meidute] Ctr Innovat Med, State Res Inst, Dept Regenerat Med, Vilnius, Lithuania; [Salehi, Albert] Univ Gothenburg, Metab Res Unit, Dept Neurosci & Physiol, Gothenburg, Sweden	Lund University; Lund University; Vilnius University; State Research Institute Centre for Innovative Medicine; University of Gothenburg	Salehi, A (corresponding author), Lund Univ, Div Islet Cell Physiol, SUS, Dept Clin Sci, Malmo, Sweden.; Salehi, A (corresponding author), Univ Gothenburg, Metab Res Unit, Dept Neurosci & Physiol, Gothenburg, Sweden.	S_Albert.Salehi@med.lu.se	Salehi, Albert/F-7768-2018	Salehi, Albert/0000-0001-6120-3539				Abaraviciene SM, 2008, CELL MOL LIFE SCI, V65, P2256, DOI 10.1007/s00018-008-8100-8; Akesson B, 1999, J ENDOCRINOL, V163, P39, DOI 10.1677/joe.0.1630039; Akesson B, 1999, ENDOCRINE, V11, P99, DOI 10.1385/ENDO:11:1:99; Akesson B, 1996, DIABETES RES, V31, P91; Alm P, 1999, DIABETOLOGIA, V42, P978, DOI 10.1007/s001250051256; Berglund LM, 2016, DIABETES, V65, P239, DOI 10.2337/db15-0122; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buse JB, 2016, DIABETES CARE, V39, P198, DOI 10.2337/dc15-0488; Butler PC, 2013, DIABETES CARE, V36, P2118, DOI 10.2337/dc12-2713; Chang-Chen KJ, 2008, REV ENDOCR METAB DIS, V9, P329, DOI 10.1007/s11154-008-9101-5; Cho YM, 2011, DIABETOLOGIA, V54, P219, DOI 10.1007/s00125-010-1986-3; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Drews G, 2010, PFLUG ARCH EUR J PHY, V460, P703, DOI 10.1007/s00424-010-0862-9; Eizirik DL, 1996, DIABETOLOGIA, V39, P875; Fu A, 2013, MOL CELL ENDOCRINOL, V366, P127, DOI 10.1016/j.mce.2012.06.020; Gale EAM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1263; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Henningsson R, 2002, AM J PHYSIOL-CELL PH, V283, pC296, DOI 10.1152/ajpcell.00537.2001; Henningsson R, 2001, AM J PHYSIOL-CELL PH, V280, pC1242, DOI 10.1152/ajpcell.2001.280.5.C1242; Henningsson R, 2000, AM J PHYSIOL-ENDOC M, V279, pE95, DOI 10.1152/ajpendo.2000.279.1.E95; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Holst JJ, 2012, CLIN DRUG INVEST, V32, P1, DOI 10.2165/11595370-000000000-00000; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jimenez-Feltstrom J, 2005, CELL TISSUE RES, V319, P221, DOI 10.1007/s00441-004-1013-4; Jimenez-Feltstrom J, 2011, REGUL PEPTIDES, V170, P43, DOI 10.1016/j.regpep.2011.04.011; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Koeck T, 2009, ARCH BIOCHEM BIOPHYS, V484, P221, DOI 10.1016/j.abb.2009.01.021; Lajoix AD, 2001, DIABETES, V50, P1311, DOI 10.2337/diabetes.50.6.1311; Maida A, 2011, DIABETOLOGIA, V54, P339, DOI 10.1007/s00125-010-1937-z; Marchetti P, 2004, J CLIN ENDOCR METAB, V89, P5535, DOI 10.1210/jc.2004-0150; Marshak S, 1999, DIABETES, V48, P1230, DOI 10.2337/diabetes.48.6.1230; Masini M, 2014, DIABETES RES CLIN PR, V104, P163, DOI 10.1016/j.diabres.2013.12.031; Mezghenna K, 2011, DIABETOLOGIA, V54, P2856, DOI 10.1007/s00125-011-2264-8; Mosen H, 2008, REGUL PEPTIDES, V151, P139, DOI 10.1016/j.regpep.2008.07.002; Muhammed SJ, 2012, DIABETES OBES METAB, V14, P1010, DOI 10.1111/j.1463-1326.2012.01632.x; Patane G, 2000, DIABETES, V49, P735, DOI 10.2337/diabetes.49.5.735; Salehi A, 1996, AM J PHYSIOL-CELL PH, V270, pC1634, DOI 10.1152/ajpcell.1996.270.6.C1634; Salehi A, 2001, ENDOCRINE, V16, P97, DOI 10.1385/ENDO:16:2:097; Salehi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002165; Shimabukuro M, 1997, J CLIN INVEST, V100, P290, DOI 10.1172/JCI119534; Takahashi T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004581; Takamura T, 1998, J BIOL CHEM, V273, P2493, DOI 10.1074/jbc.273.5.2493; Tsuura Y, 1998, BIOCHEM BIOPH RES CO, V252, P34, DOI 10.1006/bbrc.1998.9601; Wiseman DA, 2012, CURR DIABETES REV, V8, P303, DOI 10.2174/157339912800840514	47	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165668	10.1371/journal.pone.0165668	http://dx.doi.org/10.1371/journal.pone.0165668			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820841	gold, Green Published			2022-12-27	WOS:000387614800015
J	Tan, MK; Raman, H; Chambers, G; Sharma, I; Chen, ZL; Deshpande, N; Wilkins, MR				Tan, Mui-Keng; Raman, Harsh; Chambers, Grant; Sharma, Indu; Chen, Zhiliang; Deshpande, Nandan; Wilkins, Marc R.			Characterization of SNP and Structural Variations in the Mitochondrial Genomes of Tilletia indica and Its Closely Related Species Formed Basis for a Simple Diagnostic Assay	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; GROUP-I INTRONS; KARNAL BUNT; RIBOSOMAL-RNA; LARGE SUBUNIT; WHEAT; RISK; LAMP	Tilletia indica causes the disease Karnal bunt in wheat. The disease is under international quarantine regulations. Comparative mitochondrial (mt) genome analysis of T. indica (KX394364 and DQ993184) and T. walkeri (EF536375) has found 325 to 328 SNPs, 57 to 60 short InDels (from 1 to 13 nt), two InDels (30 and 61 nt) and five (>200 nt) presence/absence variations (PAVs) between the two species. The mt genomes of both species have identical gene order. The numbers of SNPs and InDels between the mt genomes of the two species are approximately nine times of the corresponding numbers between the two T. indica isolates. There are eight SNPs between T. indica and T. walkeri that resulted in amino acid substitutions in the mt genes of cob, nad2 and nad5. In contrast, there is no amino acid substitution in the mt genes of the T. indica isolates from the SNPs found. The five PAVs present in T. indica (DQ993184) are absent in T. walkeri. Four PAVs are more than 1 kb and are not present in every T. indica isolate. Analysis of their presence and absence separates a collection of T. indica isolates into 11 subgroups. Two PAVs have ORFs for the LAGLIDAG endonuclease and two have ORFs for the GIY-YIG endonuclease family, which are representatives of homing endonuclease genes (HEGs). These intronencoded HEGs confer intron mobility and account for their fluid distribution in T. indica isolates. The small PAV of 221 bp, present in every T. indica isolate and unique to the species, was used as the genetic fingerprint for the successful development of a rapid, highly sensitive and specific loop mediated isothermal amplification (LAMP) assay. The simple procedure of the LAMP assay and the easy detection formats will enable the assay to be automated for high throughput diagnosis.	[Tan, Mui-Keng; Chambers, Grant] Elizabeth Macarthur Agr Inst, NSW Dept Primary Ind, Menangle, NSW, Australia; [Raman, Harsh] Wagga Wagga Agr Res Inst, NSW Dept Primary Ind, Wagga Wagga, NSW, Australia; [Sharma, Indu] Punjab Agr Univ, Dept Plant Breeding Genet & Biotechnol, Ludhiana, Punjab, India; [Chen, Zhiliang; Deshpande, Nandan; Wilkins, Marc R.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Kensington, NSW, Australia; [Wilkins, Marc R.] Univ New South Wales, Ramaciotti Ctr Genom, Kensington, NSW, Australia	NSW Department of Primary Industries; NSW Department of Primary Industries; Punjab Agricultural University; University of New South Wales Sydney; University of New South Wales Sydney	Tan, MK (corresponding author), Elizabeth Macarthur Agr Inst, NSW Dept Primary Ind, Menangle, NSW, Australia.	mui-keng.tan@dpi.nsw.gov.au	RAMAN, HARSH/N-8891-2016	RAMAN, HARSH/0000-0001-9761-1518	New South Wales Department of Primary Industries and Bioplatforms Australia, New South Wales, Australia; Australian Federal Government NCRIS; New South Wales State Government RAAP; University of New South Wales	New South Wales Department of Primary Industries and Bioplatforms Australia, New South Wales, Australia; Australian Federal Government NCRIS(Australian GovernmentDepartment of Industry, Innovation and Science); New South Wales State Government RAAP; University of New South Wales	This research was financially supported by New South Wales Department of Primary Industries and Bioplatforms Australia, New South Wales, Australia. Our funding for the bioinformatics team comes from the Australian Federal Government NCRIS scheme, New South Wales State Government RAAP scheme, and the University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan JP, 2004, P 48 ANN C AUSTR AGR; Castlebury LA, 2005, MYCOLOGIA, V97, P888, DOI 10.3852/mycologia.97.4.888; Castlebury LA, 1999, MYCOLOGIA, V91, P121, DOI 10.2307/3761200; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Da Luz WC, 1993, FITOPATOLOGIA BRAS S, V18, P329; DURAN R, 1972, CAN J BOT, V50, P2569, DOI 10.1139/b72-329; Gao Y, 2016, AUSTRALAS PLANT PATH, V45, P361, DOI 10.1007/s13313-016-0422-7; Hafi A, 2015, 152 ABARES DEP AGR; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Hausner G, 2003, APPLIED MYCOLOGY AND BIOTECHNOLOGY, VOL 3, P101; Holst-Jensen A, 1999, MOL BIOL EVOL, V16, P114, DOI 10.1093/oxfordjournals.molbev.a026031; LAMBOWITZ AM, 1993, ANNU REV BIOCHEM, V62, P587, DOI 10.1146/annurev.bi.62.070193.003103; Levy L, 2001, PHYTOPATHOLOGY, V91, P935, DOI 10.1094/PHYTO.2001.91.10.935; Mitra M, 1931, ANN APPL BIOL, V18, P178, DOI 10.1111/j.1744-7348.1931.tb02294.x; Mitra M, 1935, INDIAN J AGR SCI, V5, P51; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Murray GM, 1998, AUSTRALAS PLANT PATH, V27, P212, DOI 10.1071/AP98024; Niessen L, 2010, INT J FOOD MICROBIOL, V140, P183, DOI 10.1016/j.ijfoodmicro.2010.03.036; Nosek J, 1998, TRENDS GENET, V14, P184, DOI 10.1016/S0168-9525(98)01443-7; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Owens SR, 2002, EMBO REP, V3, P111, DOI 10.1093/embo-reports/kvf043; Rigano LA, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-86; Sansford C, 2006, PEST RISK ANAL TILLE; Sansford CE, 2008, PLANT PATHOL, V57, P603, DOI 10.1111/j.1365-3059.2008.01825.x; Schoch CL, 2001, PLANT DIS, V85, P941, DOI [10.1094/PDIS.2001.85.9.941, 10.1094/PDIS.2001.85.5.561B]; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan MK, 2006, MYCOL RES, V110, P203, DOI 10.1016/j.mycres.2005.08.006; Tan MK, 1997, J MOL EVOL, V44, P637, DOI 10.1007/PL00006187; Tan Mui-Keng, 2014, Mycology, V5, P52; Tan MK, 2013, AUSTRALAS PLANT PATH, V42, P95, DOI 10.1007/s13313-012-0176-9; Tana MK, 2009, AUSTRALAS PLANT PATH, V38, P101, DOI 10.1071/AP08088; Thiery O, 2010, MOL PHYLOGENET EVOL, V55, P599, DOI 10.1016/j.ympev.2010.02.013; Torarbi M., 1996, Seed and Plant, V12, P8; VISSER W, 1995, ANTON LEEUW INT J G, V67, P243, DOI 10.1007/BF00873688; WARHAM EJ, 1986, TROP PEST MANAGE, V32, P229; Wei-chuan Z, 2010, J PLANT PATHOL, V92, P367; Ykema RE, 1996, PLANT DIS, V80, P1207, DOI 10.1094/PD-80-1207B	38	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166086	10.1371/journal.pone.0166086	http://dx.doi.org/10.1371/journal.pone.0166086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814391	gold, Green Submitted, Green Published			2022-12-27	WOS:000386911100032
J	Garbati, MA; Fagbo, SF; Fang, VJ; Skakni, L; Joseph, M; Wani, TA; Cowling, BJ; Peiris, M; Hakawi, A				Garbati, Musa A.; Fagbo, Shamsudeen F.; Fang, Vicky J.; Skakni, Leila; Joseph, Mercy; Wani, Tariq A.; Cowling, Benjamin J.; Peiris, Malik; Hakawi, Ahmed			A Comparative Study of Clinical Presentation and Risk Factors for Adverse Outcome in Patients Hospitalised with Acute Respiratory Disease Due to MERS Coronavirus or Other Causes	PLOS ONE			English	Article							SAUDI-ARABIA; INFECTION; OUTBREAK	Middle East Respiratory syndrome (MERS) first emerged in Saudi Arabia in 2012 and remains a global health concern. The objective of this study was to compare the clinical features and risk factors for adverse outcome in patients with RT-PCR confirmed MERS and in those with acute respiratory disease who were MERS-CoV negative, presenting to the King Fahad Medical City (KFMC) in Riyadh between October 2012 and May 2014. The demographics, clinical and laboratory characteristics and clinical outcomes of patients with RT-PCR confirmed MERS-CoV infection was compared with those testing negative MERS-CoV PCR. Health care workers (HCW) with MERS were compared with MERS patients who were not health care workers. One hundred and fifty nine patients were eligible for inclusion. Forty eight tested positive for MERS CoV, 44 (92%) being hospital acquired infections and 23 were HCW. There were 111 MERS-CoV negative patients with acute respiratory illnesses included in this study as "negative controls". Patient with confirmed MERS-CoV infection were not clinically distinguishable from those with negative MERS-CoV RT-PCR results although diarrhoea was commoner in MERS patients. A high level of suspicion in initiating laboratory tests for MERS-CoV is therefore indicated. Variables associated with adverse outcome were older age and diabetes as a co-morbid illness. Interestingly, co-morbid illnesses other than diabetes were not significantly associated with poor outcome. Health care workers with MERS had a markedly better clinical outcome compared to non HCW MERS patients.	[Garbati, Musa A.; Fagbo, Shamsudeen F.; Skakni, Leila; Joseph, Mercy; Wani, Tariq A.; Hakawi, Ahmed] King Fahad Med City, Riyadh, Saudi Arabia; [Fang, Vicky J.; Cowling, Benjamin J.; Peiris, Malik] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Hakawi, A (corresponding author), King Fahad Med City, Riyadh, Saudi Arabia.; Peiris, M (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	malik@hku.hk; ahakawi@kfmc.med.sa	Cowling, Benjamin John/C-4263-2009; Fagbo, Shamsudeen/GYE-1971-2022; Peiris, Joseph Sriyal Malik/C-4380-2009	Cowling, Benjamin John/0000-0002-6297-7154; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Fagbo, Shamsudeen/0000-0003-3448-6136; Garbati, Musa/0000-0003-3438-421X	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201400006C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract number HHSN272201400006C.	Al-Tawfiq JA, 2014, CLIN INFECT DIS, V59, P160, DOI 10.1093/cid/ciu226; Alraddadi B, 2016, ANN THORAC MED, V11, P128, DOI 10.4103/1817-1737.180027; Alraddadi BM, 2016, EMERG INFECT DIS, V22, P49, DOI 10.3201/eid2201.151340; Arabi YM, 2014, ANN INTERN MED, V160, P389, DOI 10.7326/M13-2486; Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Fagbo SF, 2015, EMERG INFECT DIS, V21, P1981, DOI 10.3201/eid2111.150944; Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4; Hastings DL, 2016, EMERG INFECT DIS, V22, P794, DOI 10.3201/eid2205.151797; Korea Centers for Disease Control and Prevention, 2015, Osong Public Health Res Perspect, V6, P269, DOI 10.1016/j.phrp.2015.08.006; Memish ZA, 2013, NEW ENGL J MED, V369, P884, DOI 10.1056/NEJMc1308698; Oboho IK, 2015, NEW ENGL J MED, V372, P846, DOI 10.1056/NEJMoa1408636; Peiris JSM, 2007, EMERG INFECT, V7, P23; World Health Organization, MIDDL E RESP SYNDR C; World Health Organization, 2015, LAB TEST MIDDL E SYN; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	16	73	78	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165978	10.1371/journal.Pone.0165978	http://dx.doi.org/10.1371/journal.Pone.0165978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812197	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000088
J	Muduma, G; Saunders, R; Odeyemi, I; Pollock, RF				Muduma, Gorden; Saunders, Rhodri; Odeyemi, Isaac; Pollock, Richard F.			Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant	PLOS ONE			English	Article							PROLONGED-RELEASE TACROLIMUS; PROSPECTIVE RANDOMIZED-TRIAL; MYCOPHENOLATE-MOFETIL; FOLLOW-UP; MICROEMULSIFIED CYCLOSPORINE; RENAL DYSFUNCTION; C INFECTION; RECIPIENTS; HEPATITIS; EFFICACY	Background and Aims Several meta-analyses comparing ciclosporin with tacrolimus have been conducted since the 1994 publication of the tacrolimus registration trials, but most captured data from randomized controlled trials (RCTs) predating recent improvements in waiting list prioritization, induction protocols and concomitant medications. The present study comprised a systematic review and meta-analysis of ciclosporin and tacrolimus in liver transplant recipients using studies published since January 2000. Methods Searches of PubMed, the Cochrane Library and EMBASE identified RCTs of tacrolimus and ciclosporin as the immunosuppressant in adult primary liver transplant recipients, published between January 2000 and August 6, 2014. A random effects meta-analysis was conducted to evaluate the relative risk of death, graft loss, acute rejection (AR), new-onset diabetes after transplantation (NODAT) and hypertension with tacrolimus relative to ciclosporin at 12 months. Results The literature search identified 11 RCTs comparing ciclosporin with tacrolimus. Relative to ciclosporin, tacrolimus was associated with significantly improved outcomes in terms of patient mortality (risk ratio [RR] with ciclosporin of 1.26; 95% confidence interval [95% CI] 1.01-1.58). Tacrolimus was superior to ciclosporin in terms of hypertension (RR with ciclosporin 1.26; 95% CI 1.07-.47), but inferior in terms of NODAT (RR with ciclosporin 0.60; 95% CI 0.47-0.77). There were no significant differences between ciclosporin and tacrolimus in terms of graft loss or AR. Conclusions Meta-analysis of RCTs published since 2000 showed tacrolimus to be superior to ciclosporin in terms of patient mortality and hypertension, while ciclosporin was superior in terms of NODAT. No significant differences were identified in terms of graft loss or AR. These findings provide further evidence supporting the use of tacrolimus as the cornerstone of immunosuppressive therapy in liver transplant recipients.	[Muduma, Gorden; Odeyemi, Isaac] Astellas Pharma Europe Ltd, Chertsey, England; [Saunders, Rhodri; Pollock, Richard F.] Ossian Hlth Econ & Commun GmbH, Basel, Switzerland	Astellas Pharmaceuticals	Pollock, RF (corresponding author), Ossian Hlth Econ & Commun GmbH, Basel, Switzerland.	pollock@ossianconsulting.com	Saunders, Rhodri/GXH-8656-2022	Saunders, Rhodri/0000-0003-1463-4656; Pollock, Richard/0000-0002-9873-7507	Astellas Pharma Europe Limited	Astellas Pharma Europe Limited(Astellas Pharmaceuticals)	Ossian Health Economics and Communications GmbH received consultancy fees from Astellas Pharma Europe Limited to conduct the literature review and meta-analysis and prepare the manuscript. The funders had no role in the study design, data collection or analysis and the decision to publish was not contingent on a specific outcome, but the funders reviewed the manuscript prior to submission.	Adam R, 2015, AM J TRANSPLANT, V15, P1267, DOI 10.1111/ajt.13171; Akkina SK, 2012, LIVER TRANSPLANT, V18, P395, DOI 10.1002/lt.23398; Berenguer M, 2006, LIVER TRANSPLANT, V12, P762, DOI 10.1002/lt.20655; BUSUTTIL RW, 1994, NEW ENGL J MED, V331, P1110; Busuttil RW, 1998, TRANSPLANT P, V30, P2174, DOI 10.1016/S0041-1345(98)00579-X; Cholongitas E, 2012, ANN GASTROENTEROL, V25, P6; Cholongitas E, 2011, CLIN TRANSPLANT, V25, P614, DOI 10.1111/j.1399-0012.2010.01321.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eberlin M, 2013, TRANSPL P, V45, P2314, DOI 10.1016/j.transproceed.2012.10.037; Fink MA, 2005, LIVER TRANSPLANT, V11, P621, DOI 10.1002/lt.20428; Fisher RA, 2004, CLIN TRANSPLANT, V18, P463, DOI 10.1111/j.1399-0012.2004.00192.x; Florman S, 2005, TRANSPLANT P, V37, P1211, DOI 10.1016/j.transproceed.2004.11.086; Garrison LP, 2007, VALUE HEALTH, V10, P326, DOI 10.1111/j.1524-4733.2007.00186.x; Gehr Bernhard T, 2006, BMC Med Res Methodol, V6, P25, DOI 10.1186/1471-2288-6-25; Glanemann M, 2000, TRANSPLANT P, V32, P522, DOI 10.1016/S0041-1345(00)00872-1; Gonzalez-Pinto IM, 2005, TRANSPL P, V37, P1713, DOI 10.1016/j.transproceed.2005.03.128; Greig P, 2003, LIVER TRANSPLANT, V9, P587, DOI 10.1053/jlts.2003.50102; Haddad EM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005161; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hopewell S, 2006, J CLIN EPIDEMIOL, V59, P681, DOI 10.1016/j.jclinepi.2005.09.016; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Irish WD, 2011, AM J TRANSPLANT, V11, P1676, DOI 10.1111/j.1600-6143.2011.03508.x; Kuypers DRJ, 2013, TRANSPLANTATION, V95, P333, DOI 10.1097/TP.0b013e3182725532; Levy G, 2014, AM J TRANSPLANT, V14, P635, DOI 10.1111/ajt.12620; Levy G, 2006, LIVER TRANSPLANT, V12, P1464, DOI 10.1002/lt.20802; Liu ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107057; Loinaz C, 2001, TRANSPL P, V33, P3439, DOI 10.1016/S0041-1345(01)02482-4; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martin P, 2004, LIVER TRANSPLANT, V10, P1258, DOI 10.1002/lt.20222; McCarron CE, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-64; McKenna GJ, 2012, AM J TRANSPLANT, V12, P521, DOI 10.1111/j.1600-6143.2011.03922.x; Muhlbacher F, 2001, TRANSPLANT P, V33, P1339, DOI 10.1016/S0041-1345(00)02500-8; NEUHAUS P, 1994, LANCET, V344, P423; O'Grady JG, 2002, LANCET, V360, P1119, DOI 10.1016/S0140-6736(02)11196-2; Otto MG, 1998, TRANSPLANTATION, V66, P1632, DOI 10.1097/00007890-199812270-00011; Penninga L, 2010, EUR J CLIN PHARMACOL, V66, P1177, DOI 10.1007/s00228-010-0902-6; Reich DJ, 2005, TRANSPLANTATION, V80, P18, DOI 10.1097/01.TP.0000165118.00988.D7; Rostaing L, 2012, TRANSPLANT REV-ORLAN, V26, P246, DOI 10.1016/j.trre.2012.06.002; Saliba F, 2007, LIVER TRANSPLANT, V13, P136, DOI 10.1002/lt.21010; Shenoy S, 2008, LIVER TRANSPLANT, V14, P173, DOI 10.1002/lt.21355; STARZL TE, 1985, SEMIN LIVER DIS, V5, P334, DOI 10.1055/s-2008-1040630; Tam VC, 2008, J CLIN ONCOL, V26, P2205, DOI 10.1200/JCO.2007.14.6795; Therapondos G, 2002, LIVER TRANSPLANT, V8, P690, DOI 10.1053/jlts.2002.34381; Timmermann W, 2002, TRANSPLANT P, V34, P1516, DOI 10.1016/S0041-1345(02)02953-6; Toma M, 2006, JAMA-J AM MED ASSOC, V295, P1281, DOI 10.1001/jama.295.11.1281; Trunecka P, 2010, AM J TRANSPLANT, V10, P2313, DOI 10.1111/j.1600-6143.2010.03255.x; van Onzenoort HAW, 2011, HYPERTENSION, V58, P573, DOI 10.1161/HYPERTENSIONAHA.111.171074; Villamil F, 2006, TRANSPL P, V38, P2964, DOI 10.1016/j.transproceed.2006.08.131; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Wiesner RH, 1998, TRANSPLANTATION, V66, P493, DOI 10.1097/00007890-199808270-00014; Wiesner RH, 2011, LIVER TRANSPLANT, V17, pS1, DOI 10.1002/lt.22410	53	40	43	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0160421	10.1371/journal.pone.0160421	http://dx.doi.org/10.1371/journal.pone.0160421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812112	gold, Green Submitted, Green Published			2022-12-27	WOS:000386910000003
J	Speidel, A; Felk, S; Reinhardt, P; Sterneckert, J; Gillardon, F				Speidel, Anna; Felk, Sandra; Reinhardt, Peter; Sterneckert, Jared; Gillardon, Frank			Leucine-Rich Repeat Kinase 2 Influences Fate Decision of Human Monocytes Differentiated from Induced Pluripotent Stem Cells	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; GENOME-WIDE ASSOCIATION; PARKINSONS-DISEASE; MICROGLIAL ACTIVATION; BLOOD MONOCYTES; IN-VIVO; G2019S MUTATION; GENE-EXPRESSION; LRRK2 MUTATION; IMMUNE	Mutations in Leucine-rich repeat kinase 2 (LRRK2) are strongly associated with familial Parkinson's disease (PD). High expression levels in immune cells suggest a role of LRRK2 in regulating the immune system. In this study, we investigated the effect of the LRRK2 (G2019S) mutation in monocytes, using a human stem cell-derived model expressing LRRK2 at endogenous levels. We discovered alterations in the differentiation pattern of LRRK2 mutant, compared to non-mutant isogenic controls, leading to accelerated monocyte production and a reduction in the non-classical CD14+ CD16+ monocyte subpopulation in the LRRK2 mutant cells. LPS-treatment of the iPSC-derived monocytes significantly increased the release of pro-inflammatory cytokines, demonstrating a functional response without revealing any significant differences between the genotypes. Assessment of the migrational capacity of the differentiated monocytes revealed moderate deficits in LRRK2 mutant cells, compared to their respective controls. Our findings indicate a pivotal role of LRRK2 in hematopoietic fate decision, endorsing the involvement of the immune system in the development of PD.	[Speidel, Anna; Felk, Sandra; Gillardon, Frank] Boehringer Ingelheim Pharma GmbH & Co KG, CNS Dis Res, Biberach, Germany; [Reinhardt, Peter; Sterneckert, Jared] CRTD DFG Ctr Regenerat Therapies Dresden, Dresden, Germany	Boehringer Ingelheim; Technische Universitat Dresden	Gillardon, F (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, CNS Dis Res, Biberach, Germany.	frank.gillardon@boehringer-ingelheim.com		Sterneckert, Jared/0000-0002-7688-3124	Boehringer Ingelheim Pharma GmbH Co. KG.	Boehringer Ingelheim Pharma GmbH Co. KG.(Boehringer Ingelheim)	This work was supported by Boehringer Ingelheim Pharma GmbH & Co. KG. The funder provided financial support in the form of authors' salaries [Anna Speidel, Sandra Felk and Frank Gillardon] and research materials, but did not have any additional role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ackermann M, 2015, EMBO MOL MED, V7, P1388, DOI 10.15252/emmm.201505301; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Azzinnari D, 2014, NEUROPHARMACOLOGY, V85, P328, DOI 10.1016/j.neuropharm.2014.05.039; Blesa J, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00091; Caesar M, 2014, GLIA, V62, P1075, DOI 10.1002/glia.22663; Choi I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9255; Daher JPL, 2014, P NATL ACAD SCI USA, V111, P9289, DOI 10.1073/pnas.1403215111; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dzamko N, 2015, NEUROSCIENCE, V302, P89, DOI 10.1016/j.neuroscience.2014.10.028; Dzamko N, 2012, BIOCHEM SOC T, V40, P1134, DOI 10.1042/BST20120119; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Funk N, 2013, MOVEMENT DISORD, V28, P392, DOI 10.1002/mds.25300; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Gillardon F, 2012, NEUROSCIENCE, V208, P41, DOI 10.1016/j.neuroscience.2012.02.001; Goldwurm S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.035568; Greggio E, 2012, BIOCHEM SOC T, V40, P1058, DOI 10.1042/BST20120054; Grozdanov V, 2014, ACTA NEUROPATHOL, V128, P651, DOI 10.1007/s00401-014-1345-4; Gullo F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00361; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Infante J, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.026; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034693; Kubo M, 2010, J NEUROIMMUNOL, V229, P123, DOI 10.1016/j.jneuroim.2010.07.021; Kwan W, 2012, J CLIN INVEST, V122, P4737, DOI 10.1172/JCI64484; Lewis PA, 2012, BIOCHEM SOC T, V40, P1039, DOI 10.1042/BST20120178; Liu XH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/431232; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marker DF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-261; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Menk M, 2015, INFLAMMATION, V38, P1690, DOI 10.1007/s10753-015-0146-9; Moehle MS, 2015, HUM MOL GENET, V24, P4250, DOI 10.1093/hmg/ddv157; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Muffat J, 2016, NAT MED; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Niwa A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022261; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Panicker LM, 2014, STEM CELLS, V32, P2338, DOI 10.1002/stem.1732; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Reynolds A, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00054; Rideout HJ, 2014, NEUROCHEM RES, V39, P576, DOI 10.1007/s11064-013-1073-5; Russo I, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0449-7; Russo I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-52; Saeki K, 2009, STEM CELLS, V27, P59, DOI 10.1634/stemcells.2007-0980; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schulz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020820; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Sgambato JA, 2015, STEM CELL TRANSL MED, V4, P878, DOI 10.5966/sctm.2014-0213; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Sulahian TH, 2001, J IMMUNOL METHODS, V252, P25, DOI 10.1016/S0022-1759(01)00328-3; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; van Wilgenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071098; Wandu WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128906; Waschbisch A, 2016, J IMMUNOL, V196, P1558, DOI 10.4049/jimmunol.1501960; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Yanagimachi MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059243; Ziegler-Heitbrock HWL, 2000, J LEUKOCYTE BIOL, V67, P603, DOI 10.1002/jlb.67.5.603; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	65	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165949	10.1371/journal.pone.0165949	http://dx.doi.org/10.1371/journal.pone.0165949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812199	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000083
J	Su, CH; Lin, IH; Tzeng, TY; Hsieh, WT; Hsu, MT				Su, Chia-Hsin; Lin, I-Hsuan; Tzeng, Tsai-Yu; Hsieh, Wen-Ting; Hsu, Ming-Ta			Regulation of IL-20 Expression by Estradiol through KMT2B-Mediated Epigenetic Modification	PLOS ONE			English	Article							NF-KAPPA-B; BREAST-CANCER; ESTROGEN-RECEPTOR; TGF-BETA; T-CELLS; ALPHA; GENE; MLL; ACTIVATION; CYTOKINES	Cytokines are low molecular weight regulatory proteins, or glycoproteins, with both tumorpromoting and inhibitory effects on breast cancer growth. Different cytokines play important roles in breast cancer initiation and progression. Here, we show that of the 39 interleukin (IL) genes, IL-20 is the only gene over-expressed in MCF-7 cells treated with estradiol (E2) and that induction of IL-20 expression by estrogen was epigenetically regulated. Methylation of histone H3K4 in the IL-20 promoter was shown to occur via the specific recruitment of KMT2B by estrogen receptor alpha (ER alpha), but not by other members of the mixed-lineage leukemia (MLL) family of histone methyltransferases. Depletion of KMT2B, or IL-20, disrupts estrogen signaling, attenuates cell proliferation, reduces colony formation, and results in cell cycle arrest. Furthermore, we demonstrated that KMT2B-mediated epigenetic modification also affected the expression of several ER alpha target genes. IL-20 and KMT2B expression were also associated with ER alpha-positive breast cancer tissues. We have revealed an important role for KMT2B in the epigenetic transcriptional regulation of cytokine IL-20, and other ER alpha-responsive genes, in breast cancer cells. Inhibition of IL-20 and KMT2B may have therapeutic benefits in ER alpha-positive breast cancer.	[Su, Chia-Hsin; Hsieh, Wen-Ting; Hsu, Ming-Ta] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Sch Life Sci, Taipei 11221, Taiwan; [Lin, I-Hsuan] Taipei Med Univ, Ctr Translat Med, Taipei, Taiwan; [Tzeng, Tsai-Yu] Natl Yang Ming Univ, Univ Syst Taiwan, VYM Genome Res Ctr, Taipei 11221, Taiwan; [Hsu, Ming-Ta] Chien Tien Hsu Canc Res Fdn, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University; Taipei Medical University; National Yang Ming Chiao Tung University	Hsu, MT (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Sch Life Sci, Taipei 11221, Taiwan.; Hsu, MT (corresponding author), Chien Tien Hsu Canc Res Fdn, Taipei 11221, Taiwan.	mth@ym.edu.tw	Lin, I-Hsuan/N-6501-2013	Lin, I-Hsuan/0000-0002-6207-1299; Hsieh, Wen-Ting/0000-0003-3201-7547; Tzeng, Tsai-Yu/0000-0001-7334-6270	Ministry of Education, Aim for the Top University Plan	Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This work was supported by a grant from the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari KI, 2012, BRIT J CANCER, V107, P315, DOI 10.1038/bjc.2012.263; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Blot E, 2003, BRIT J CANCER, V88, P1207, DOI 10.1038/sj.bjc.6600872; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Chen YY, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/294320; Cho YA, 2013, CANCER RES TREAT, V45, P210, DOI 10.4143/crt.2013.45.3.210; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Esquivel-Velazquez M, 2015, J INTERF CYTOK RES, V35, P1, DOI 10.1089/jir.2014.0026; Ferrari F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-446; Gaughan L, 2013, NUCLEIC ACIDS RES, V41, P6892, DOI 10.1093/nar/gkt469; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hsu YH, 2012, J IMMUNOL, V188, P1981, DOI 10.4049/jimmunol.1102843; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kashiwagi S, 2010, BRIT J CANCER, V103, P249, DOI 10.1038/sj.bjc.6605735; KOBAYASHI Y, 1993, BLOOD, V82, P3220; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nicolini A, 2006, CYTOKINE GROWTH F R, V17, P325, DOI 10.1016/j.cytogfr.2006.07.002; Nicolini A, 2006, BIOMED PHARMACOTHER, V60, P548, DOI 10.1016/j.biopha.2006.07.086; PRIGOGINA EL, 1986, HUM GENET, V73, P137, DOI 10.1007/BF00291604; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Reed JR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2246; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rivas MA, 2008, EXP CELL RES, V314, P509, DOI 10.1016/j.yexcr.2007.10.005; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schraets D, 2003, ONCOGENE, V22, P3655, DOI 10.1038/sj.onc.1206438; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Singh G, 2010, J BIOL CHEM, V285, P27241, DOI 10.1074/jbc.M110.100438; Strehl S, 2003, ONCOGENE, V22, P157, DOI 10.1038/sj.onc.1206042; Su CH, 2014, NUCLEIC ACIDS RES, V42, P3073, DOI 10.1093/nar/gkt1341; Svotelis A, 2011, EMBO J, V30, P3947, DOI 10.1038/emboj.2011.284; Tan G, 2016, BIOINFORMATICS, V32, P1555, DOI 10.1093/bioinformatics/btw024; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Vega VB, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r82; Wade MA, 2015, NUCLEIC ACIDS RES, V43, P196, DOI 10.1093/nar/gku1298; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Yang J, 2014, HISTOCHEM CELL BIOL, V142, P401, DOI 10.1007/s00418-014-1222-1; Zou JX, 2014, MOL CANCER RES, V12, P539, DOI 10.1158/1541-7786.MCR-13-0459	47	12	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0166090	10.1371/journal.pone.0166090	http://dx.doi.org/10.1371/journal.pone.0166090			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806114	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500082
J	Zhai, YM; Yang, Q; Wu, YY				Zhai, Yaming; Yang, Qian; Wu, Yunyu			Soil Salt Distribution and Tomato Response to Saline Water Irrigation under Straw Mulching	PLOS ONE			English	Article							BLOSSOM-END ROT; DRIP-IRRIGATION; DEFICIT IRRIGATION; PROCESSING TOMATO; USE EFFICIENCY; FRUIT-QUALITY; GROWN TOMATO; ROOT-ZONE; YIELD; CALCIUM	To investigate better saline water irrigation scheme for tomatoes that scheduling with the compromise among yield (Y-t), quality, irrigation water use efficiency (IWUE) and soil salt residual, an experiment with three irrigation quotas and three salinities of irrigation water was conducted under straw mulching in northern China. The irrigation quota levels were 280 mm (W1), 320 mm (W2) and 360 mm (W3), and the salinity levels were 1.0 dS/m (F), 3.0 dS/m (S1) and 5.0 dS/m (S2). Compared to freshwater, saline water irrigations decreased the maximum leaf area index (LAI(m)) of tomatoes, and the LAI(m) presented a decline tendency with higher salinity and lower irrigation quota. The best overall quality of tomato was obtained by S2W1, with the comprehensive quality index of 3.61. A higher salinity and lower irrigation quota resulted in a decrease of individual fruit weight and an increase of the blossom-end rot incidence, finally led to a reduction in the tomato Yt and marketable yield (Y-m). After one growth season of tomato, the mass fraction of soil salt in plough layer under S2W1 treatment was the highest, and which presented a decline trend with an increasing irrigation quota. Moreover, compared to W1, soil salts had a tendency to move to the deeper soil layer when using W2 and W3 irrigation quota. According to the calculation results of projection pursuit model, S1W3 was the optimal treatment that possessed the best comprehensive benefit (tomato overall quality, Y-t, Y-m, IWUE and soil salt residual), and was recommended as the saline water irrigation scheme for tomatoes in northern China.	[Zhai, Yaming; Wu, Yunyu] Hohai Univ, Key Lab Efficient Irrigat Drainage & Agr Soil Wat, Nanjing 210098, Jiangsu, Peoples R China; [Zhai, Yaming; Wu, Yunyu] Hohai Univ, Coll Water Conservancy & Hydropower, Nanjing 210098, Jiangsu, Peoples R China; [Yang, Qian] Henan Vocat Coll Agr, Dept Gardening, Zhengzhou, Peoples R China	Hohai University; Hohai University	Wu, YY (corresponding author), Hohai Univ, Key Lab Efficient Irrigat Drainage & Agr Soil Wat, Nanjing 210098, Jiangsu, Peoples R China.; Wu, YY (corresponding author), Hohai Univ, Coll Water Conservancy & Hydropower, Nanjing 210098, Jiangsu, Peoples R China.	njwuyunyu@126.com			Natural Science Foundation of Jiangsu province [BK20130838]; Natural Science Foundation of China [51409086]	Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financed by Natural Science Foundation of Jiangsu province (BK20130838) and Natural Science Foundation of China (51409086), received by Zhai, http://www.jstd.gov.cn/, http//www.nsfc.gov.cn/.; This work was financed by Natural Science Foundation of Jiangsu province (BK20130838) and Natural Science Foundation of China (51409086).	ADAMS P, 1993, PLANT SOIL, V154, P127, DOI 10.1007/BF00011081; Akhtar SS, 2014, AGR WATER MANAGE, V138, P37, DOI 10.1016/j.agwat.2014.02.016; Beckles DM, 2012, POSTHARVEST BIOL TEC, V63, P129, DOI 10.1016/j.postharvbio.2011.05.016; CHALMERS DJ, 1975, ANN BOT-LONDON, V39, P423, DOI 10.1093/oxfordjournals.aob.a084956; Chen LJ, 2014, AGR WATER MANAGE, V146, P24, DOI 10.1016/j.agwat.2014.07.021; Conesa MA, 2014, POSTHARVEST BIOL TEC, V93, P114, DOI 10.1016/j.postharvbio.2014.02.014; de Marsily Ghislain, 2007, Ecohydrology & Hydrobiology, V7, P147; DEKOCK PC, 1982, J SCI FOOD AGR, V33, P509, DOI 10.1002/jsfa.2740330603; Dorais M., 2001, Horticultural Reviews, V26, P239; EHRET DL, 1986, ANN BOT-LONDON, V58, P679, DOI 10.1093/oxfordjournals.aob.a087230; Gao XB, 2013, PROCED EARTH PLAN SC, V7, P280, DOI 10.1016/j.proeps.2013.03.052; Gawad GA, 2005, AGR WATER MANAGE, V78, P39, DOI 10.1016/j.agwat.2005.04.024; Hou MM, 2012, J FOOD AGRIC ENVIRON, V10, P1284; Hou MM, 2017, ARCH AGRON SOIL SCI, V63, P74, DOI 10.1080/03650340.2016.1182159; Hou MM, 2016, ZEMDIRBYSTE, V103, P221, DOI 10.13080/z-a.2016.103.029; Hou MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154799; Hou MM, 2014, SCI WORLD J, DOI 10.1155/2014/953675; Huang Z, 2010, AGR SCI CHINA, V9, P1150, DOI 10.1016/S1671-2927(09)60202-9; Incrocci L, 2006, SCI HORTIC-AMSTERDAM, V107, P365, DOI 10.1016/j.scienta.2005.12.001; Jensen CR, 2010, AGR WATER MANAGE, V98, P403, DOI 10.1016/j.agwat.2010.10.018; Kanzari S, 2012, COMPUT ELECTRON AGR, V86, P34, DOI 10.1016/j.compag.2011.09.010; Katerji N, 1998, AGR WATER MANAGE, V38, P59, DOI 10.1016/S0378-3774(98)00051-1; Kumar P, 2015, AGR WATER MANAGE, V148, P72, DOI 10.1016/j.agwat.2014.09.014; Kuscu H, 2014, AGR WATER MANAGE, V133, P92, DOI 10.1016/j.agwat.2013.11.008; Li CJ, 2015, SOIL TILL RES, V146, P99, DOI 10.1016/j.still.2014.03.013; Li XB, 2015, SOIL TILL RES, V146, P159, DOI 10.1016/j.still.2014.10.005; Li YL, 2002, SCI HORTIC-AMSTERDAM, V93, P267, DOI 10.1016/S0304-4238(01)00329-6; Liu JG, 2013, GLOBAL ENVIRON CHANG, V23, P633, DOI 10.1016/j.gloenvcha.2013.02.002; Lu ShaoWei, 2012, China Vegetables, P56; Maggio A, 2004, EUR J AGRON, V21, P149, DOI 10.1016/S1161-0301(03)00092-3; Malash N, 2005, AGR WATER MANAGE, V78, P25, DOI 10.1016/j.agwat.2005.04.016; Mohamed A. A. K., 1989, Mesopotamia Journal of Agriculture, V21, P65; Nebauer SG, 2013, PLANT PHYSIOL BIOCH, V63, P61, DOI 10.1016/j.plaphy.2012.11.006; Nonami H, 1995, ACTA HORTIC, P107, DOI 10.17660/ActaHortic.1995.396.11; Olle M, 2009, J HORTIC SCI BIOTECH, V84, P577, DOI 10.1080/14620316.2009.11512568; OShaughnessy S.A., 2014, ENCY AGR FOOD SYSTEM, P521, DOI [10.1016/B978-0-444-52512-3.00235-7, DOI 10.1016/B978-0-444-52512-3.00235-7]; Patane C, 2011, SCI HORTIC-AMSTERDAM, V129, P590, DOI 10.1016/j.scienta.2011.04.030; Qiu RJ, 2013, AGR WATER MANAGE, V130, P44, DOI 10.1016/j.agwat.2013.08.013; Reina-Sanchez A, 2005, AGR WATER MANAGE, V78, P54, DOI 10.1016/j.agwat.2005.04.021; Sanchez-Rodriguez E, 2012, PLANT SCI, V188, P89, DOI 10.1016/j.plantsci.2011.12.019; Saure MC, 2001, SCI HORTIC-AMSTERDAM, V90, P193, DOI 10.1016/S0304-4238(01)00227-8; Selby, 1896, OHIO AGR EXP STA B, V73, P146; Shao GC, 2014, SCI WORLD J, DOI 10.1155/2014/457937; Shao GC, 2014, EUR J AGRON, V53, P1, DOI 10.1016/j.eja.2013.10.005; Shao HB, 2007, COLLOID SURFACE B, V55, P251, DOI 10.1016/j.colsurfb.2006.12.001; Shao X, 2013, RES CROP, V14, P1159; Shao XH, 2012, ENRGY PROCED, V16, P747, DOI 10.1016/j.egypro.2012.01.120; Sperry W. J., 1996, HortTechnology, V6, P21; Subramanian KS, 2006, SCI HORTIC-AMSTERDAM, V107, P245, DOI 10.1016/j.scienta.2005.07.006; Taylor MD, 2004, HORTSCIENCE, V39, P1110, DOI 10.21273/HORTSCI.39.5.1110; Tomato R., 1998, SCI HORTICULTURAE, V78, P83; Topcu S, 2007, EUR J AGRON, V26, P64, DOI 10.1016/j.eja.2006.08.004; Tuna AL, 2007, ENVIRON EXP BOT, V59, P173, DOI 10.1016/j.envexpbot.2005.12.007; Wan SQ, 2007, AGR WATER MANAGE, V90, P63, DOI 10.1016/j.agwat.2007.02.011; Wan SQ, 2010, AGR WATER MANAGE, V98, P105, DOI 10.1016/j.agwat.2010.08.003; Wang CT, 2011, PROCEDIA ENVIRON SCI, V10, P1595, DOI 10.1016/j.proenv.2011.09.253; Wang D, 2007, AGR WATER MANAGE, V87, P180, DOI 10.1016/j.agwat.2006.06.021; Wang GD, 2014, PLANT PHYSIOL BIOCH, V82, P95, DOI 10.1016/j.plaphy.2014.05.011; Wang HX, 2002, ADV AGRON, V75, P135; Wang RS, 2014, AGR WATER MANAGE, V131, P41, DOI 10.1016/j.agwat.2013.09.011; [王伟娜 Wang Weina], 2014, [河海大学学报. 自然科学版, Journal of Hohai University. Natural Sciences], V42, P372; Wang YR, 2007, PEDOSPHERE, V17, P303, DOI 10.1016/S1002-0160(07)60037-X; Wang Yu, 2012, WATER SAVING IRRIGAT, V18, P2060; Wu Y, 2015, WATER SAVING IRRIGAT, V7, P21; Yang JianGuo, 2010, Acta Agriculturae Zhejiangensis, V22, P813; Yao RJ, 2014, AGR WATER MANAGE, V131, P115, DOI 10.1016/j.agwat.2013.09.014; Yi LL, 2011, J ENVIRON SCI-CHINA, V23, P1585, DOI 10.1016/S1001-0742(10)60627-4; Zhai YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142204; Zhou J, 2013, FOREST ECOL MANAG, V300, P33, DOI 10.1016/j.foreco.2013.01.007; Zotarelli L, 2009, AGR WATER MANAGE, V96, P23, DOI 10.1016/j.agwat.2008.06.007	70	11	11	6	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165985	10.1371/journal.pone.0165985	http://dx.doi.org/10.1371/journal.pone.0165985			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806098	Green Submitted, Green Published, gold			2022-12-27	WOS:000386715500075
J	Gong, WW; Wei, XL; Liang, YJ; Zou, GY; Hu, RY; Deng, SM; Zhang, ZT; Pan, J; Choi, BCK; Yu, M				Gong, Weiwei; Wei, Xiaolin; Liang, Yujia; Zou, Guanyang; Hu, Ruying; Deng, Simin; Zhang, Zhitong; Pan, Jing; Choi, Bernard C. K.; Yu, Min			Urban and Rural Differences of Acute Cardiovascular Disease Events: A Study from the Population-Based Real-Time Surveillance System in Zhejiang, China in 2012	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; STROKE INCIDENCE; GLOBAL BURDEN; EPIDEMIOLOGY; RISK; PREVALENCE; MORTALITY; MIDDLE; COMMUNITIES; SUBTYPES	Zhejiang province, China, has implemented a population based, real-time surveillance system that tracks acute cardiovascular diseases (CVDs) events since 2001. This study aimed to describe the system and report CVD incidence, mortality and case-fatality between urban and rural areas in Zhejiang in 2012. The surveillance system employs a stratified random sampling method covering all permanent residents of 30 counties/districts in Zhejiang. Acute CVD events such as coronary heart disease (CHD) and stroke were defined, registered and reviewed based on the adapted MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) definitions. Data were collected from health facilities, vital registries, supplementary surveys, and additional investigations, and were checked for data quality before input in the system. We calculated the rates and compared them by gender, age and region. In 2012, the incidence, mortality and case-fatality of total acute CVD events were 367.0 (CHD 59.1, stroke 307.9), 127.1 (CHD 43.3, stroke 83.8) per 100,000 and 34.6% (CHD 73.2%, stroke 27.2%), respectively. Compared with rural areas, urban areas reported higher incidence and mortality but lower case-fatality rates for CHD (P<0.001), while lower incidence but higher mortality and case-fatality rates for stroke (P<0.001). We found significant differences on CHD and stroke epidemics between urban and rural areas in Zhejiang. Special attentions need to be given to stroke control, especially in rural areas.	[Gong, Weiwei; Hu, Ruying; Pan, Jing; Yu, Min] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Wei, Xiaolin; Choi, Bernard C. K.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Clin Publ Hlth, Toronto, ON, Canada; [Wei, Xiaolin; Choi, Bernard C. K.] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Liang, Yujia; Zou, Guanyang; Deng, Simin; Zhang, Zhitong] China Global Hlth Res & Dev, Shenzhen, Peoples R China	University of Toronto; University of Toronto	Yu, M (corresponding author), Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	myu@cdc.zj.com			UK aid from the UK government; Department for International Development (DFID) [201025] Funding Source: researchfish	UK aid from the UK government(CGIAR); Department for International Development (DFID)	The authors would like to thank the county and municipality CDC, hospitals and health care facilities in Zhejiang who reported and quality checked the cardiovascular events. We also thank Nilam Ashra-McGrath for editorial support. This study obtained data-analysis guidance from COMDIS-HSD, a research consortium funded by UK aid from the UK government: however, the views expressed do not necessarily reflect the UK government's official policies.	Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Allender S, 2012, CORONARY HEART DIS S; Barrett-Connor E., 2011, NATIONWIDE FRAMEWORK; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Diseases CNCfC, 2012, REP CARD DIS CHIN; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Giampaoli S, 2007, EUR J CARDIOV PREV R, V14, pS23, DOI 10.1097/01.hjr.0000277987.10473.6f; Hata J, 2013, CIRC J, V77, P1923, DOI 10.1253/circj.CJ-13-0786; Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Moran A. E., 2014, CIRCULATION; Moran A, 2010, CIRC-CARDIOVASC QUAL, V3, P243, DOI 10.1161/CIRCOUTCOMES.109.910711; OECD, 2011, HOSP MORT FOLL AC MY; Ounpuu S, 2001, AM HEART J, V141, P711, DOI 10.1067/mhj.2001.114974; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Statistics ZPBo, 2013, STAT YB ZHEJ; Sun HX, 2013, J STROKE, V15, P109, DOI 10.5853/jos.2013.15.2.109; Tang X, 2013, J AM COLL CARDIOLOGY, V61; Teo K, 2013, JAMA-J AM MED ASSOC, V309, P1613, DOI 10.1001/jama.2013.3519; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Tsai CF, 2013, NEUROLOGY, V81, P264, DOI 10.1212/WNL.0b013e31829bfde3; Turin TC, 2007, CIRC J, V71, P1617, DOI 10.1253/circj.71.1617; Wang JH, 2015, NEUROLOGY, V84, P374, DOI 10.1212/WNL.0000000000001175; WANG Xiao-ping WY-k, 2007, CHINESE PRIMARY HLTH, V21; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Wegner M. V., 2010, Chronic disease epidemiology and control, P95; Wei XL, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-354; Wei XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054169; WHO, 1999, WHO MONICA MAN; World Health Organization, 2015, RAIS BLOOD PRESS SBP; World Health Organization, TOB US DAT COUNTR; Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499; Wu ZS, 2001, CIRCULATION, V103, P462; Xu H, 2015, AM HEART J; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; [俞敏 Yu Min], 2002, [中国卫生统计, Chinese Journal of Health Statistics], V19, P151; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C; Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423; Zhang YN, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/436125	45	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165647	10.1371/journal.pone.0165647	http://dx.doi.org/10.1371/journal.pone.0165647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802321	gold, Green Published, Green Submitted			2022-12-27	WOS:000386714200033
J	Shapiro, JM; Chung, WH; Ogawa, K; Barker, L; Carlson, R; Wands, JR; Li, JS				Shapiro, Jason M.; Chung, Waihong; Ogawa, Kosuke; Barker, Luke; Carlson, Rolf; Wands, Jack R.; Li, Jisu			Identification of Tumor Antigen AF20 as Glycosylated Transferrin Receptor 1 in Complex with Heat Shock Protein 90 and/or Transporting ATPase	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; MEDIATED ENDOCYTOSIS; MALIGNANT PHENOTYPE; CANCER-CELLS; EXPRESSION; ANTIBODY; THERAPY; PROLIFERATION; LEUKEMIA; TISSUES	We previously isolated AF20, a murine monoclonal antibody that recognizes a cell surface glycoprotein of approximately 90-110 kDa. The AF20 antigen is specifically expressed in human hepatoma and colon cancer cell lines, and thus could serve as a cancer biomarker. To uncover the molecular identity of the AF20 antigen, a combination of ion-exchange chromatography, immunoprecipitation, and SDS-polyacrylamide gel electrophoresis was employed to purify the AF20 antigen followed by trypsin digestion and mass spectrometry. Surprisingly, three host proteins were thus purified from human hepatoma and colon cancer cell lines: transferrin receptor 1 (TFR1), heat shock protein 90 (HSP90), and Na+/K+ ATPase or Mg++ ATPase. Co-immunoprecipitation followed by Western blot analysis confirmed interaction among the three proteins. However, only the cDNA encoding TFR1 conferred strong cell surface staining by the AF20 antibody following its transient transfection into a cell line lacking endogenous AF20. In support of the molecular identity of AF20 as TFR1, diferric but not iron-free transferrin could prevent AF20 antigen-antibody interaction during immunoprecipitation. Moreover, very similar patterns of AF20 and TFR1 overexpression was documented in colon cancer tissues. In conclusion, AF20 is glycosylated TFR1. This finding could explain the molecular structure of AF20, its cell surface localization, as well as overexpression in cancer cells. Glycosylated TFR1 should serve as a usefulness target for anti-cancer therapy, or a vehicle for delivery of anti-tumor drugs with high affinity and specificity. The biological significance of the complex formation between TFR1, HSP90, and/or transporting ATPase warrants further investigation.	[Shapiro, Jason M.; Chung, Waihong; Ogawa, Kosuke; Barker, Luke; Carlson, Rolf; Wands, Jack R.; Li, Jisu] Brown Univ, Rhode Isl Hosp, Liver Res Ctr, Providence, RI 02903 USA; [Shapiro, Jason M.; Chung, Waihong; Ogawa, Kosuke; Barker, Luke; Carlson, Rolf; Wands, Jack R.; Li, Jisu] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Shapiro, Jason M.] Hasbro Childrens Hosp, Div Pediat Gastroenterol Nutr & Liver Dis, Providence, RI USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Hasbro Children's Hospital	Li, JS (corresponding author), Brown Univ, Rhode Isl Hosp, Liver Res Ctr, Providence, RI 02903 USA.; Li, JS (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.	Ji_Su_Li_MD@brown.edu		Barker, Luke/0000-0003-4202-5428	National Institutes of Health [T32DK066415, CA123544, R21AI107618]; NIH [T32DK066415, CA123544, R21AI107618]; NATIONAL CANCER INSTITUTE [R01CA123544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health (grant number T32DK066415, CA123544 and R21AI107618, http://nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grants T32DK066415, CA123544 to JRW, and R21AI107618 to JL.	BLEIL JD, 1982, EMBO J, V1, P351, DOI 10.1002/j.1460-2075.1982.tb01173.x; Brookes MJ, 2006, GUT, V55, P1449, DOI 10.1136/gut.2006.094060; Callens C, 2008, LEUKEMIA, V22, P42, DOI 10.1038/sj.leu.2404958; Daniels TR, 2012, BBA-GEN SUBJECTS, V1820, P291, DOI 10.1016/j.bbagen.2011.07.016; Daniels TR, 2011, J IMMUNOTHER, V34, P500, DOI 10.1097/CJI.0b013e318222ffc8; Daniels-Wells TR, 2013, TOXICOL IN VITRO, V27, P220, DOI 10.1016/j.tiv.2012.10.006; Das Gupta A, 1990, Hematol Pathol, V4, P37; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Fan KL, 2012, NAT NANOTECHNOL, V7, P459, DOI [10.1038/nnano.2012.90, 10.1038/NNANO.2012.90]; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; HABESHAW JA, 1983, LANCET, V1, P498; Jones DT, 2006, CANCER RES, V66, P2749, DOI 10.1158/0008-5472.CAN-05-3857; KONDO K, 1990, CHEST, V97, P1367, DOI 10.1378/chest.97.6.1367; Magro G, 2011, THYROID, V21, P267, DOI 10.1089/thy.2010.0173; Mohr L, 2004, GASTROENTEROLOGY, V127, pS225, DOI 10.1053/j.gastro.2004.09.037; MORADPOUR D, 1995, HEPATOLOGY, V22, P1527, DOI 10.1016/0270-9139(95)90161-2; Ng PP, 2002, P NATL ACAD SCI USA, V99, P10706, DOI 10.1073/pnas.162362999; PRIOR R, 1990, VIRCHOWS ARCH A, V416, P491, DOI 10.1007/BF01600299; RECKHOW CL, 1988, J BIOL CHEM, V263, P7297; Rodriguez JA, 2011, LEUKEMIA LYMPHOMA, V52, P2169, DOI 10.3109/10428194.2011.596964; Ryschich E, 2004, EUR J CANCER, V40, P1418, DOI 10.1016/j.ejca.2004.01.036; Sakurai K, 2014, HEPATO-GASTROENTEROL, V61, P426, DOI 10.5754/hge13969; SEYMOUR GJ, 1987, UROL RES, V15, P341; Smilevska T, 2006, LEUKEMIA RES, V30, P183, DOI 10.1016/j.leukres.2005.06.006; SUTHERLAND R, 1981, P NATL ACAD SCI-BIOL, V78, P4515, DOI 10.1073/pnas.78.7.4515; Tortorella S, 2014, J MEMBRANE BIOL, V247, P291, DOI 10.1007/s00232-014-9637-0; Wands JR, 1997, J VIRAL HEPATITIS, V4, P60, DOI 10.1111/j.1365-2893.1997.tb00181.x; WILSON B, 1988, P NATL ACAD SCI USA, V85, P3140, DOI 10.1073/pnas.85.9.3140; Yang DC, 2001, ANTICANCER RES, V21, P541	29	3	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165227	10.1371/journal.pone.0165227	http://dx.doi.org/10.1371/journal.pone.0165227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802297	Green Published, Green Submitted, gold			2022-12-27	WOS:000386714200020
J	Vaiman, D; Miralles, F				Vaiman, Daniel; Miralles, Francisco			An Integrative Analysis of Preeclampsia Based on the Construction of an Extended Composite Network Featuring Protein-Protein Physical Interactions and Transcriptional Relationships	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; GENE-EXPRESSION; BIOLOGICAL NETWORKS; TERMINAL FRAGMENT; MICROARRAY EXPERIMENTS; HYPOXIA; STRA13; PLZF; DEC1; REPRESSION	Preeclampsia (PE) is a pregnancy disorder defined by hypertension and proteinuria. This disease remains a major cause of maternal and fetal morbidity and mortality. Defective placentation is generally described as being at the root of the disease. The characterization of the transcriptome signature of the preeclamptic placenta has allowed to identify differentially expressed genes (DEGs). However, we still lack a detailed knowledge on how these DEGs impact the function of the placenta. The tools of network biology offer a methodology to explore complex diseases at a systems level. In this study we performed a cross-platform meta-analysis of seven publically available gene expression datasets comparing non-pathological and preeclamptic placentas. Using the rank product algorithm we identified a total of 369 DEGs consistently modified in PE. The DEGs were used as seeds to build both an extended physical protein-protein interactions network and a transcription factors regulatory network. Topological and clustering analysis was conducted to analyze the connectivity properties of the networks. Finally both networks were merged into a composite network which presents an integrated view of the regulatory pathways involved in preeclampsia and the crosstalk between them. This network is a useful tool to explore the relationship between the DEGs and enable hypothesis generation for functional experimentation.	[Vaiman, Daniel; Miralles, Francisco] Inst Cochin, INSERM, U1016, Paris, France; [Vaiman, Daniel; Miralles, Francisco] CNRS, UMR8104, Paris, France; [Vaiman, Daniel; Miralles, Francisco] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Vaiman, Daniel; Miralles, Francisco] PRES Sorbonne Paris, DHU Risques & Grossesse, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Miralles, F (corresponding author), Inst Cochin, INSERM, U1016, Paris, France.; Miralles, F (corresponding author), CNRS, UMR8104, Paris, France.; Miralles, F (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.; Miralles, F (corresponding author), PRES Sorbonne Paris, DHU Risques & Grossesse, Paris, France.	francisco.miralles@inserm.fr	Vaiman, Daniel/O-6030-2015	Vaiman, Daniel/0000-0002-1915-0717	CNRS (Centre National de la Recherche Scientifique); INSERM (Institut National de la Sante et la Recherche Medicale)	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); INSERM (Institut National de la Sante et la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was conducted in a laboratory supported by the CNRS (Centre National de la Recherche Scientifique) and INSERM (Institut National de la Sante et la Recherche Medicale).	Armant DR, 2015, PLACENTA, V36, P270, DOI 10.1016/j.placenta.2014.12.006; Armant DR, 2006, DEVELOPMENT, V133, P751, DOI 10.1242/dev.02237; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bader S, 2008, FEBS LETT, V582, P1220, DOI 10.1016/j.febslet.2008.02.015; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; BASS KE, 1994, DEV BIOL, V164, P550, DOI 10.1006/dbio.1994.1223; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Choi SM, 2008, NUCLEIC ACIDS RES, V36, P6372, DOI 10.1093/nar/gkn620; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Ebi M, 2010, BIOCHEM BIOPH RES CO, V402, P449, DOI 10.1016/j.bbrc.2010.09.130; Faxen M, 1998, AM J PERINAT, V15, P9, DOI 10.1055/s-2007-993890; Feige E, 2011, P NATL ACAD SCI USA, V108, pE924, DOI 10.1073/pnas.1106351108; Furlong LI, 2013, TRENDS GENET, V29, P150, DOI 10.1016/j.tig.2012.11.004; Gustafsson M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0082-6; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620; Ivanova AV, 2001, J BIOL CHEM, V276, P15306, DOI 10.1074/jbc.M010516200; Jebbink JM, 2015, PLACENTA, V36, P160, DOI 10.1016/j.placenta.2014.12.001; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kinugasa Y, 2007, J BIOL CHEM, V282, P14797, DOI 10.1074/jbc.M611036200; Kleinrouweler CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068991; Koukourakis MI, 2006, CANCER SCI, V97, P582, DOI 10.1111/j.1349-7006.2006.00220.x; Leach RE, 2004, DEV BIOL, V266, P223, DOI 10.1016/j.ydbio.2003.09.026; Leach RE, 2002, LANCET, V360, P1215, DOI 10.1016/S0140-6736(02)11283-9; Li YH, 2006, INT J MOL MED, V18, P713; Liu TM, 2016, STEM CELLS, V34, P277, DOI 10.1002/stem.2270; Liu Y, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-65; Liu ZP, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav095; Louwen F, 2012, ONCOTARGET, V3, P759; Ma WS, 2013, ONCOL REP, V30, P2957, DOI 10.3892/or.2013.2774; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Moslehi R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02407; Mutter WP, 2008, MICROVASC RES, V75, P1, DOI 10.1016/j.mvr.2007.04.009; Nakamura H, 2008, ONCOGENE, V27, P4200, DOI 10.1038/onc.2008.58; Nanba D, 2003, J CELL BIOL, V163, P489, DOI 10.1083/jcb.200303017; Nishizawa H, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-107; Ow JR, 2014, CURR TOP DEV BIOL, V110, P317, DOI 10.1016/B978-0-12-405943-6.00009-9; Payne SG, 1999, J CELL PHYSIOL, V180, P263, DOI 10.1002/(SICI)1097-4652(199908)180:2<263::AID-JCP14>3.0.CO;2-H; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Sadler AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7795; Sadler AJ, 2015, P NATL ACAD SCI USA, V112, P1535, DOI 10.1073/pnas.1409728112; Sato F, 2016, J CANCER, V7, P153, DOI 10.7150/jca.13748; Schaefer MH, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00260; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singer H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130416; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Smith S, 2002, PLACENTA, V23, P322, DOI 10.1053/plac.2001.0783; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Suliman Bandar Ali, 2012, Front Oncol, V2, P74, DOI 10.3389/fonc.2012.00074; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Sun H, 2007, J CELL BIOL, V177, P647, DOI 10.1083/jcb.200609007; Tejera E, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-97; Toki F, 2005, J CELL PHYSIOL, V202, P839, DOI 10.1002/jcp.20175; Tsai S, 2011, PLACENTA, V32, P175, DOI 10.1016/j.placenta.2010.11.014; Vaiman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065498; van Uitert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132468; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043137; Winn VD, 2009, ENDOCRINOLOGY, V150, P452, DOI 10.1210/en.2008-0990; Xia JG, 2013, NUCLEIC ACIDS RES, V41, pW63, DOI 10.1093/nar/gkt338; Xiang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059753; Xiao GQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121318; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004	77	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165849	10.1371/journal.pone.0165849	http://dx.doi.org/10.1371/journal.pone.0165849			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802351	Green Published, Green Submitted, gold			2022-12-27	WOS:000386714200063
J	Chen, WJ; Kinsler, VA; Macmillan, D; Di, WL				Chen, Wenjie; Kinsler, Veronica A.; Macmillan, Derek; Di, Wei-Li			Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold - A Potential Therapeutic Intervention for Skin Diseases	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTOR-2; AMINO-ACID-SEQUENCE; NETHERTON-SYNDROME; SERINE-PROTEASE; STRATUM-CORNEUM; ALPHA-CHYMOTRYPSIN; ACYL TRANSFER; GENE-THERAPY; MECHANISM; SFTI-1	Tissue kallikreins (KLKs), in particular KLK5, 7 and 14 are the major serine proteases in the skin responsible for skin shedding and activation of inflammatory cell signaling. In the normal skin, their activities are controlled by an endogenous protein protease inhibitor encoded by the SPINK5 gene. Loss-of-function mutations in SPINK5 leads to enhanced skin kallikrein activities and cause the skin disease Netherton Syndrome (NS). We have been developing inhibitors based on the Sunflower Trypsin Inhibitor 1 (SFTI-1) scaffold, a 14 amino acids head-to-tail bicyclic peptide with a disulfide bond. To optimize a previously reported SFTI-1 analogue (I10H), we made five analogues with additional substitutions, two of which showed improved inhibition. We then combined those substitutions and discovered a variant (Analogue 6) that displayed dual inhibition of KLK5 (tryptic) and KLK7 (chymotryptic). Analogue 6 attained a tenfold increase in KLK5 inhibition potency with an Isothermal Titration Calorimetry (ITC) K-d of 20nM. Furthermore, it selectively inhibits KLK5 and KLK14 over seven other serine proteases. Its biological function was ascertained by full suppression of KLK5-induced Protease-Activated Receptor 2 (PAR-2) dependent intracellular calcium mobilization and postponement of Interleukin-8 (IL-8) secretion in cell model. Moreover, Analogue 6 permeates through the cornified layer of in vitro organotypic skin equivalent culture and inhibits protease activities therein, providing a potential drug lead for the treatment of NS.	[Chen, Wenjie; Di, Wei-Li] UCL GOS Inst Child Hlth, Immunobiol Sect, Infect Immun & Inflammat Programme, London, England; [Kinsler, Veronica A.] UCL GOS Inst Child Hlth, Genet & Genom Med Programme, London, England; [Macmillan, Derek] UCL, Dept Chem, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Di, WL (corresponding author), UCL GOS Inst Child Hlth, Immunobiol Sect, Infect Immun & Inflammat Programme, London, England.	w.di@ucl.ac.uk	陈, 文杰·/HHN-5495-2022; Kinsler, Veronica A./AAO-8195-2021	陈, 文杰·/0000-0003-0556-7391; 	UK charity Sparks [13ICH03]; Ichthyosis Support Group; Sparks Charity [13ICH03] Funding Source: researchfish	UK charity Sparks; Ichthyosis Support Group; Sparks Charity	WC received support from the UK charity Sparks www.sparks.org.uk (Grant Number 13ICH03) and Ichthyosis Support Group www.ichthyosis.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin Saif G, 2007, INT J DERMATOL, V46, P290; BIRK Y, 1967, BIOCHIM BIOPHYS ACTA, V147, P402, DOI 10.1016/0005-2795(67)90424-2; BIRK Y, 1961, BIOCHIM BIOPHYS ACTA, V54, P378, DOI 10.1016/0006-3002(61)90387-0; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; CHAPMAN SJ, 1991, ARCH DERMATOL RES, V283, P167, DOI 10.1007/BF00372057; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cowper B, 2015, ORG BIOMOL CHEM, V13, P7469, DOI 10.1039/c5ob01029b; de Veer SJ, 2015, J MED CHEM, V58, P8257, DOI 10.1021/acs.jmedchem.5b01148; de Veer SJ, 2015, BIOCHEM J, V469, P243, DOI 10.1042/BJ20150412; de Veer SJ, 2013, BIOPOLYMERS, V100, P510, DOI [10.1002/bip.22231, 10.1002/peps.22231]; de Veer SJ, 2016, BIOL CHEM; Debela M, 2007, J MOL BIOL, V373, P1017, DOI 10.1016/j.jmb.2007.08.042; Debowski D, 2016, J THERM ANAL CALORIM, V123, P807, DOI 10.1007/s10973-015-4993-2; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Di WL, 2013, HUM GENE THER CL DEV, V24, P182, DOI 10.1089/humc.2013.195; Di WL, 2011, MOL THER, V19, P408, DOI 10.1038/mt.2010.201; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Flohr S, 2010, Kallikrein 7 modulators, Patent No. [US 2010/0256144 A1, 20100256144]; Fontao L, 2011, J INVEST DERMATOL, V131, P1947, DOI 10.1038/jid.2011.124; Furio L, 2014, J EXP MED, V211, P499, DOI 10.1084/jem.20131797; GILFIX BM, 1984, J CELL PHYSIOL, V119, P172, DOI 10.1002/jcp.1041190205; Goettig P, 2010, BIOCHIMIE, V92, P1546, DOI 10.1016/j.biochi.2010.06.022; Hou L, 1998, IMMUNOLOGY, V94, P356, DOI 10.1046/j.1365-2567.1998.00528.x; Hovnanian A, 2015, patent WO, Patent No. [2015/114144A1.2015, 2015114144]; Jendrny C, 2016, CHEMBIOCHEM, V17, P719, DOI 10.1002/cbic.201500539; Komatsu N, 2007, BRIT J DERMATOL, V156, P875, DOI 10.1111/j.1365-2133.2006.07743.x; Komatsu N, 2007, EXP DERMATOL, V16, P513, DOI 10.1111/j.1600-0625.2007.00562.x; Krastel P., 2009, Cyclic Depsipeptides, Patent No. [US 2009/0156472 A1, 20090156472, 2009/0156472A1]; Long YQ, 2001, BIOORG MED CHEM LETT, V11, P2515, DOI 10.1016/S0960-894X(01)00493-0; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Macmillan D, 2011, CHEMBIOCHEM, V12, P2133, DOI 10.1002/cbic.201100364; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Meyer-Hoffert U, 2011, J INVEST DERM SYMP P, V15, P16, DOI 10.1038/jidsymp.2011.2; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; Mitsudo K, 2003, BIOCHEMISTRY-US, V42, P3874, DOI 10.1021/bi027029v; Mulvenna JP, 2005, J BIOL CHEM, V280, P32245, DOI 10.1074/jbc.M506060200; ODANI S, 1977, J BIOCHEM-TOKYO, V82, P1523, DOI 10.1093/oxfordjournals.jbchem.a131846; ODANI S, 1971, P JPN ACAD, V47, P621, DOI 10.2183/pjab1945.47.621; Oliveira JPC, 2014, ACS MED CHEM LETT, V5, P128, DOI 10.1021/ml4003698; Prassas I, 2015, NAT REV DRUG DISCOV, V14, P183, DOI 10.1038/nrd4534; Renner ED, 2009, J ALLERGY CLIN IMMUN, V124, P536, DOI 10.1016/j.jaci.2009.06.009; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shariff L, 2014, TETRAHEDRON, V70, P7675, DOI 10.1016/j.tet.2014.06.059; Shpacovitch VM, 2002, J INVEST DERMATOL, V118, P380, DOI 10.1046/j.0022-202x.2001.01658.x; Stefansson K, 2008, J INVEST DERMATOL, V128, P18, DOI 10.1038/sj.jid.5700965; Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008; Tan X, 2015, J MED CHEM, V58, P598, DOI 10.1021/jm500988d; Tan X, 2013, BIOORG MED CHEM LETT, V23, P4547, DOI 10.1016/j.bmcl.2013.06.039; Vasileiou Z, 2010, BIOPOLYMERS, V94, P339, DOI 10.1002/bip.21376; Voegeli R, 2009, BRIT J DERMATOL, V161, P70, DOI 10.1111/j.1365-2133.2009.09142.x; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Yoshida N, 2007, INT J MOL MED, V19, P335; Zablotna E, 2002, LETT PEPT SCI, V9, P131	58	27	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166268	10.1371/journal.pone.0166268	http://dx.doi.org/10.1371/journal.pone.0166268			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824929	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200080
J	Christensen, AP; Akyuz, N; Corey, DP				Christensen, Adam P.; Akyuz, Nurunisa; Corey, David P.			The Outer Pore and Selectivity Filter of TRPA1	PLOS ONE			English	Article							ION-CHANNEL TRPA1; COVALENT MODIFICATION; DIRECT ACTIVATION; CALCIUM-IONS; PERMEATION; TRPV1; CA2+; COLD; PERMEABILITY; CONDUCTANCE	TRPA1 ((t) under bar ransient-(r) under bar eceptor-(p) under bar otential-related ion channel with ankyrin domains) is a direct receptor or indirect effector for a wide variety of nociceptive signals, and thus is a compelling target for development of analgesic pharmaceuticals such as channel blockers. Recently, the structure of TRPA1 was reported, providing insights into channel assembly and pore architecture. Here we report whole-cell and single-channel current recordings of wild-type human TRPA1 as well as TRPA1 bearing point mutations of key charged residues in the outer pore. These measurements demonstrate that the glutamate at position 920 plays an important role in collecting cations into the mouth of the pore, by changing the effective surface potential by similar to 16 mV, while acidic residues further out have little effect on permeation. Electrophysiology experiments also confirm that the aspartate residue at position 915 represents a constriction site of the TRPA1 pore and is critical in controlling ion permeation.	[Christensen, Adam P.; Corey, David P.] Harvard Med Sch, Program Neurosci, 220 Longwood Ave, Boston, MA 02115 USA; [Christensen, Adam P.; Akyuz, Nurunisa; Corey, David P.] Harvard Med Sch, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA; [Christensen, Adam P.; Akyuz, Nurunisa; Corey, David P.] Harvard Med Sch, Howard Hughes Med Inst, 220 Longwood Ave, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Corey, DP (corresponding author), Harvard Med Sch, Program Neurosci, 220 Longwood Ave, Boston, MA 02115 USA.; Corey, DP (corresponding author), Harvard Med Sch, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.; Corey, DP (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, 220 Longwood Ave, Boston, MA 02115 USA.	dcorey@hms.harvarrd.edu		Akyuz, Nurunisa/0000-0002-6340-1915; Corey, David/0000-0003-4497-6016	NIH [R01-DC000304]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000304] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by NIH grant R01-DC000304 to DPC.; Authors would like to thank David Clapham, Gary Yellen and Marcos Sotomayor for critical reading of the manuscript. Supported by R01-DC000304 to DPC. NA is an Associate and DPC is an Investigator of the Howard Hughes Medical Institute.	ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; Alam A, 2007, P NATL ACAD SCI USA, V104, P15334, DOI 10.1073/pnas.0707324104; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Banke TG, 2010, AM J PHYSIOL-CELL PH, V298, pC1457, DOI 10.1152/ajpcell.00489.2009; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Bobkov YV, 2011, BBA-BIOMEMBRANES, V1808, P1120, DOI 10.1016/j.bbamem.2010.12.024; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Carvacho I, 2008, J GEN PHYSIOL, V131, P147, DOI 10.1085/jgp.200709862; Cavanaugh EJ, 2008, NEUROSCIENCE, V154, P1467, DOI 10.1016/j.neuroscience.2008.04.048; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; Darre L, 2015, J MOL BIOL, V427, P537, DOI 10.1016/j.jmb.2014.11.016; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Farris HE, 2004, J PHYSIOL-LONDON, V558, P769, DOI 10.1113/jphysiol.2004.061267; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; GREEN WN, 1991, ANNU REV PHYSIOL, V53, P341, DOI 10.1146/annurev.ph.53.030191.002013; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; JORDAN PC, 1987, BIOPHYS J, V51, P297, DOI 10.1016/S0006-3495(87)83336-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Karashima Y, 2010, BIOPHYS J, V98, P773, DOI 10.1016/j.bpj.2009.11.007; Kukic P, 2013, J AM CHEM SOC, V135, P16968, DOI 10.1021/ja406995j; Kwan KY, 2009, J GEN PHYSIOL, V133, P251, DOI 10.1085/jgp.200810146; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; LLC. Schrodinger, PYMOL MOL GRAPH SYST; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Mathias RT, 1992, ELECTRIFIED INTERFAC, V355, P473; MCCLESKEY EW, 1985, P NATL ACAD SCI USA, V82, P7149, DOI 10.1073/pnas.82.20.7149; Meyers JR, 2003, J NEUROSCI, V23, P4054; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Samad A, 2011, BIOCHEM J, V433, P197, DOI 10.1042/BJ20101256; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; STANFIELD PR, 1983, REV PHYSIOL BIOCH P, V97, P1, DOI 10.1007/BFb0035345; Stepanyan RS, 2011, JARO-J ASSOC RES OTO, V12, P729, DOI 10.1007/s10162-011-0288-x; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; TANG SQ, 1993, NEURON, V11, P1013, DOI 10.1016/0896-6273(93)90215-D; Taylor-Clark TE, 2009, MOL PHARMACOL, V75, P820, DOI 10.1124/mol.108.054445; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	58	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166167	10.1371/journal.pone.0166167	http://dx.doi.org/10.1371/journal.pone.0166167			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824920	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200065
J	Ding, Y; Yang, QH; Wang, BJ; Ye, GL; Tong, XQ				Ding, Yong; Yang, Qihua; Wang, Bojun; Ye, Guoliang; Tong, Xiaoqiong			The Correlation of MGMT Promoter Methylation and Clinicopathological Features in Gastric Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ABERRANT DNA METHYLATION; CPG ISLAND METHYLATION; C677T GENETIC-POLYMORPHISM; HELICOBACTER-PYLORI; MLH1 METHYLATION; MULTIPLE GENES; HMLH1 GENES; CARCINOMA; HYPERMETHYLATION; CARCINOGENESIS	The silencing of the tumor suppressor gene O-6-methylguanine-DNA methyltransferase (MGMT) by promoter methylation commonly occurs in human cancers. The relationship between MGMT promoter methylation and gastric cancer (GC) remains inconsistent. This study aimed to evaluate the potential value of MGMT promoter methylation in GC patients. Electronic databases were searched to identify eligible studies. The pooled odds ratio (OR) and the corresponding 95% confidence interval (95% CI) were used to evaluate the effects of MGMT methylation on GC risk and clinicopathological characteristics. In total, 31 eligible studies including 2988 GC patients and 2189 nonmalignant controls were involved in metaanalysis. In the pooled analysis, MGMT promoter methylation was significantly associated with GC risk (OR = 3.34, P < 0.001) and substantial heterogeneity (P < 0.001). Meta-regression and subgroup analyses based on the testing method, sample material and ethnicity failed to explain the sources of heterogeneity. Interestingly, MGMT methylation showed a trend associated with gender, and methylation is lower in males compared with females (OR = 0.76, 95% CI = 0.56-1.03). We did not find a significant association in relation to tumor types, clinical stage, age status or H. pylori status in cancer (all P > 0.1). MGMT promoter methylation may be correlated with the prognosis of GCs in disease free survival (DFS) or overall survival (OS) for univariate analysis. MGMT promoter methylation may play a crucial role in the carcinogenesis and prognosis of GC. MGMT methylation was not correlated with tumor types, clinical stage, age status, H. pylori status. However, the result of the association of MGMT methylation and gender should be considered with caution.	[Ding, Yong; Yang, Qihua; Wang, Bojun; Ye, Guoliang] Ningbo Univ, Affiliated Hosp, Ningbo 315020, Zhejiang, Peoples R China; [Tong, Xiaoqiong] Ningbo Univ, Coll Foreign Studies, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University; Ningbo University	Ding, Y; Ye, GL (corresponding author), Ningbo Univ, Affiliated Hosp, Ningbo 315020, Zhejiang, Peoples R China.	dingy138@sina.com; ndfyygl@163.com						Alvarez MC, 2013, WORLD J GASTROENTERO, V19, P3043, DOI 10.3748/wjg.v19.i20.3043; Asiaf A, 2015, TUMOR BIOL, V36, P6485, DOI 10.1007/s13277-015-3339-9; Atakpo P, 2016, J DERMATOL SCI, V82, P69, DOI 10.1016/j.jdermsci.2016.02.005; Athanasiou T, 2004, ANN THORAC SURG, V77, P745, DOI 10.1016/j.athoracsur.2003.07.002; Bernal C, 2008, BIOL RES, V41, P303, DOI [10.4067/S0716-97602008000300007, /S0716-97602008000300007]; Bodmer W. F., 1999, Annals Academy of Medicine Singapore, V28, P323; Cai Jian-Chun, 2007, Zhonghua Zhongliu Zazhi, V29, P510; Chang MS, 2006, CLIN CANCER RES, V12, P2995, DOI 10.1158/1078-0432.CCR-05-1601; Corson TW, 2007, GENE CHROMOSOME CANC, V46, P617, DOI 10.1002/gcc.20457; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Etcheverry A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104455; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Guo He, 2014, Zhonghua Yi Xue Za Zhi, V94, P2193; Handa Y, 1996, J GASTROENTEROL, V31, P29; Hibi K, 2009, ANTICANCER RES, V29, P5053; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hiraki M, 2010, ANN SURG ONCOL, V17, P1177, DOI 10.1245/s10434-009-0815-8; Hong SH, 2005, J KOREAN MED SCI, V20, P236, DOI 10.3346/jkms.2005.20.2.236; Huang T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08897; Jin J, 2014, GENET MOL RES, V13, P4140, DOI 10.4238/2014.May.30.9; Kang GH, 2003, LAB INVEST, V83, P519, DOI 10.1097/01.LAB.0000064704.53132.65; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; Karsli-Ceppioglu S, 2014, EPIGENOMICS-UK, V6, P651, DOI [10.2217/EPI.14.59, 10.2217/epi.14.59]; Khan Shafqat Ali, 2015, World J Biol Chem, V6, P333, DOI 10.4331/wjbc.v6.i4.333; Kolesnikova EV, 2008, ANN NY ACAD SCI, V1137, P226, DOI 10.1196/annals.1448.009; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Ksiaa F, 2009, CLIN CHIM ACTA, V404, P128, DOI 10.1016/j.cca.2009.03.044; Kupcinskaite-Noreikiene R, 2013, MED LITH, V49, P361; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Leung WK, 2005, BRIT J CANCER, V92, P2190, DOI 10.1038/sj.bjc.6602636; Li YZ, 2015, GASTRIC CANCER, V18, P280, DOI 10.1007/s10120-014-0370-2; Mitsuno M, 2007, J GASTROENTEROL, V42, P866, DOI 10.1007/s00535-007-2113-1; Motoshita J, 2005, CANCER SCI, V96, P474, DOI 10.1111/j.1349-7006.2005.00074.x; Oue N, 2001, INT J CANCER, V93, P805, DOI 10.1002/ijc.1403; Oue N, 2003, CANCER SCI, V94, P901, DOI 10.1111/j.1349-7006.2003.tb01373.x; Oue N, 2006, CANCER-AM CANCER SOC, V106, P1250, DOI 10.1002/cncr.21754; Oue N, 2001, PATHOBIOLOGY, V69, P143, DOI 10.1159/000048769; Park TJ, 2001, CANCER, V92, P2760, DOI 10.1002/1097-0142(20011201)92:11<2760::AID-CNCR10123>3.0.CO;2-8; Peleteiro B, 2014, DIGEST DIS SCI, V59, P1698, DOI 10.1007/s10620-014-3063-0; Sabbioni Silvia, 2003, Mol Diagn, V7, P201, DOI 10.2165/00066982-200307030-00010; Schneider BG, 2010, INT J CANCER, V127, P2588, DOI 10.1002/ijc.25274; Sharma S, 2009, ANTICANCER RES, V29, P3759; Shi J, 2012, AM J CANCER RES, V2, P116; Song BB, 2013, PAK J MED SCI, V29, P1338; Suijkerbuijk K P M, 2007, Ned Tijdschr Geneeskd, V151, P907; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Ushijima T, 2006, J GASTROENTEROL, V41, P401, DOI 10.1007/s00535-006-1846-6; Ushijima T, 2004, CANCER CELL, V5, P121, DOI 10.1016/S1535-6108(04)00033-9; Wang MM, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0988-2; Xiong HL, 2013, ASIAN PAC J CANCER P, V14, P3139, DOI 10.7314/APJCP.2013.14.5.3139; Yousuf A, 2014, CELL ONCOL, V37, P245, DOI 10.1007/s13402-014-0179-3; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141; Zhao YF, 2007, INT J SURG PATHOL, V15, P242, DOI 10.1177/1066896907302117; Zintzaras E, 2005, BIOINFORMATICS, V21, P3672, DOI 10.1093/bioinformatics/bti536; Zou XP, 2009, HUM PATHOL, V40, P1534, DOI 10.1016/j.humpath.2009.01.029	57	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165509	10.1371/journal.pone.0165509	http://dx.doi.org/10.1371/journal.pone.0165509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824946	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200021
J	Gong, AGW; Huang, VY; Wang, HY; Lin, HQ; Dong, TTX; Tsim, KWK				Gong, Amy G. W.; Huang, Vincent Y.; Wang, Huai Y.; Lin, Huang Q.; Dong, Tina T. X.; Tsim, Karl W. K.			Ferulic Acid Orchestrates Anti-Oxidative Properties of Danggui Buxue Tang, an Ancient Herbal Decoction: Elucidation by Chemical Knock-Out Approach	PLOS ONE			English	Article							RADIX ANGELICAE SINENSIS; OXIDATIVE STRESS; ASTRAGALI RADIX; CARDIOVASCULAR-DISEASE; SIGNALING PATHWAY; INDUCED APOPTOSIS; ANGIOTENSIN-II; NITRIC-OXIDE; ACTIVATION; CELLS	Ferulic acid, a phenolic acid derived mainly from a Chinese herb Angelica Sinensis Radix (ASR), was reported to reduce the formation of free radicals. Danggui Buxue Tang (DBT), a herbal decoction composing of Astragali Radix (AR) and ASR, has been utilized for more than 800 years in China having known anti-oxidative property. Ferulic acid is a major active ingredient in DBT; however, the role of ferulic acid within the herbal mixture has not been resolved. In order to elucidate the function of ferulic acid within this herbal decoction, a ferulic acid-depleted herbal decoction was created and named as DBT Delta fa. The anti-oxidative properties of chemically modified DBT decoction were systemically compared in cultured H9C2 rat cardiomyoblast cell line. The application of DBT and DBT Delta fa into the cultures showed functions in (i) decreasing the reactive oxygen species (ROS) formation, detected by laser confocal; (ii) increasing of the activation of Akt; (iii) increasing the transcriptional activity of anti-oxidant response element (ARE); and (iv) increasing the expressions of antioxidant enzymes, i.e. NQO1 and GCLM. In all scenario, the aforementioned anti-oxidative properties of DBT Delta fa in H9C2 cells were significantly reduced, as compared to authentic DBT. Thus, ferulic acid could be an indispensable chemical in DBT to orchestrate multicomponents of DBT as to achieve maximal anti-oxidative functions.	[Gong, Amy G. W.; Huang, Vincent Y.; Wang, Huai Y.; Lin, Huang Q.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay, Hong Kong, Peoples R China; [Gong, Amy G. W.; Huang, Vincent Y.; Wang, Huai Y.; Lin, Huang Q.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Clear Water Bay, Hong Kong, Peoples R China; [Wang, Huai Y.] HKUST Shenzhen Res Inst, Hitech Pk, Shenzhen 518000, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay, Hong Kong, Peoples R China.; Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Ctr Chinese Med, Clear Water Bay, Hong Kong, Peoples R China.	botsim@ust.hk		Wang, Huai-You/0000-0003-1407-9912	Hong Kong Research Grants Council Theme-based Research Scheme [T13-607/12R]; ITF [UIM/254]; GRF [663012, 662713, M-HKUST604/13, TUYF15SC01]; Hong Kong Jockey Club Charities Trust [HKJCCT12SC01]; Foundation of The Awareness of Nature [TAON12SC01]	Hong Kong Research Grants Council Theme-based Research Scheme(Hong Kong Research Grants Council); ITF; GRF; Hong Kong Jockey Club Charities Trust; Foundation of The Awareness of Nature	Supported by Hong Kong Research Grants Council Theme-based Research Scheme (T13-607/12R), ITF (UIM/254), GRF (663012, 662713, M-HKUST604/13), TUYF15SC01, The Hong Kong Jockey Club Charities Trust (HKJCCT12SC01) and Foundation of The Awareness of Nature (TAON12SC01) to Karl Tsim.	Alam B, 2013, AVICENNA J PHYTOMEDI, V3, P112; Cai Zhiyou, 2013, J Biochem Pharmacol Res, V1, P15; Carlsen MH, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-37; Chan PH, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/567893; Chen KJ, 1999, CHINESE MED J-PEKING, V112, P934; Cui L, 2015, J CHEM INF MODEL, V55, P2455, DOI 10.1021/acs.jcim.5b00449; Cutler D, 2006, J ECON PERSPECT, V20, P97, DOI 10.1257/jep.20.3.97; Dong TTX, 2006, J AGR FOOD CHEM, V54, P2767, DOI 10.1021/jf053163l; Fang B, 2014, BIOCHEM BIOPH RES CO, V448, P443, DOI 10.1016/j.bbrc.2014.04.123; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Gan XT, 2012, MOL CELL BIOCHEM, V363, P323, DOI 10.1007/s11010-011-1185-7; Giugliano D, 2000, NUTR METAB CARDIOVAS, V10, P38; Gong AGW, 2016, PLANTA MED, V82, P418, DOI 10.1055/s-0035-1558332; Gong AGW, 2015, J ETHNOPHARMACOL, V168, P150, DOI 10.1016/j.jep.2015.03.033; Hou YZ, 2004, EUR J PHARMACOL, V499, P85, DOI 10.1016/j.ejphar.2004.07.107; Huang CY, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-358; Joung EJ, 2007, ANTIOXID REDOX SIGN, V9, P2087, DOI 10.1089/ars.2007.1827; Jun HO, 2011, EXP MOL MED, V43, P53, DOI 10.3858/emm.2011.43.1.006; Kris-Etherton PM, 2002, AM J MED, V113, P71, DOI 10.1016/S0002-9343(01)00995-0; Kumar SVR, 2014, NAT REV NEPHROL, V10, P545, DOI 10.1038/nrneph.2014.156; Li SM, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/459264; Li XC, 2009, MOLECULES, V14, P5349, DOI 10.3390/molecules14125349; Ma XQ, 2002, J AGR FOOD CHEM, V50, P4861, DOI 10.1021/jf0202279; Maiwulanjiang M, 2014, J ETHNOPHARMACOL, V153, P491, DOI 10.1016/j.jep.2014.03.010; Mak DHF, 2006, PHYTOTHER RES, V20, P561, DOI 10.1002/ptr.1904; Mathew S, 2004, CRIT REV BIOTECHNOL, V24, P59, DOI 10.1080/07388550490491467; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Alok SP, 2007, J MOL CELL CARDIOL, V43, P580, DOI 10.1016/j.yjmcc.2007.08.003; Song ZH, 2004, PLANTA MED, V70, P1222, DOI 10.1055/s-2004-835855; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Tan Yong, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P1412; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wang Xiao-ling, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P1093; Wen XD, 2008, J CHROMATOGR B, V865, P99, DOI 10.1016/j.jchromb.2008.02.024; Xin YF, 2007, BASIC CLIN PHARMACOL, V101, P421, DOI 10.1111/j.1742-7843.2007.00144.x; Yu CL, 2016, MOL NEUROBIOL, V53, P6489, DOI 10.1007/s12035-015-9555-x; Zhan JYX, 2013, PLANTA MED, V79, P533, DOI 10.1055/s-0032-1328261; Zhang AH, 2010, PLANTA MED, V76, P2026, DOI 10.1055/s-0030-1250542; Zhang WDL, 2013, PHYTOMEDICINE, V20, P1076, DOI 10.1016/j.phymed.2013.04.016; Zhao KJ, 2003, J AGR FOOD CHEM, V51, P2576, DOI 10.1021/jf026178h	40	12	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165486	10.1371/journal.pone.0165486	http://dx.doi.org/10.1371/journal.pone.0165486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824860	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200019
J	Ivliev, AE; 't Hoen, PAC; Borisevich, D; Nikolsky, Y; Sergeeva, MG				Ivliev, Alexander E.; 't Hoen, Peter A. C.; Borisevich, Dmitrii; Nikolsky, Yuri; Sergeeva, Marina G.			Drug Repositioning through Systematic Mining of Gene Coexpression Networks in Cancer	PLOS ONE			English	Article							BREAST-CANCER; TUMOR MICROENVIRONMENT; EXPRESSION PROFILES; BRAIN TRANSCRIPTOME; MICROARRAY DATA; SIGNATURES; DISEASE; SENSITIVITY; PATHWAYS; PACKAGE	Gene coexpression network analysis is a powerful "data-driven" approach essential for understanding cancer biology and mechanisms of tumor development. Yet, despite the completion of thousands of studies on cancer gene expression, there have been few attempts to normalize and integrate co-expression data from scattered sources in a concise "meta-analysis" framework. We generated such a resource by exploring gene coexpression networks in 82 microarray datasets from 9 major human cancer types. The analysis was conducted using an elaborate weighted gene coexpression network (WGCNA) methodology and identified over 3,000 robust gene coexpression modules. The modules covered a range of known tumor features, such as proliferation, extracellular matrix remodeling, hypoxia, inflammation, angiogenesis, tumor differentiation programs, specific signaling pathways, genomic alterations, and biomarkers of individual tumor subtypes. To prioritize genes with respect to those tumor features, we ranked genes within each module by connectivity, leading to identification of module-specific functionally prominent hub genes. To showcase the utility of this network information, we positioned known cancer drug targets within the coexpression networks and predicted that Anakinra, an anti-rheumatoid therapeutic agent, may be promising for development in colorectal cancer. We offer a comprehensive, normalized and well documented collection of >3000 gene coexpression modules in a variety of cancers as a rich data resource to facilitate further progress in cancer research.	[Ivliev, Alexander E.; Sergeeva, Marina G.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Ivliev, Alexander E.] Thomson Reuters, IP & Sci, Boston, MA USA; ['t Hoen, Peter A. C.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Borisevich, Dmitrii] Lomonosov Moscow State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Nikolsky, Yuri] Inst Gen Genet, Moscow, Russia; [Nikolsky, Yuri] George Mason Univ, Fairfax, VA 22030 USA; [Nikolsky, Yuri] Prosapia Genet, Solana Beach, CA USA	Lomonosov Moscow State University; Clarivate; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Lomonosov Moscow State University; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; George Mason University	Ivliev, AE (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.; Ivliev, AE (corresponding author), Thomson Reuters, IP & Sci, Boston, MA USA.	ivliev.alexa@gmail.com	Sergeeva, Marina/G-3439-2012; Hoen, Peter A 't/D-3950-2018	Hoen, Peter A 't/0000-0003-4450-3112; Borisevich, Dmitrii/0000-0002-1686-3578; Sergeeva, Marina/0000-0003-3424-6431	Russian Science Foundation [16-15-10298]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation, grant #16-15-10298 (M. Sergeeva and D. Borisevich). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Russian Science Foundation, grant #16-15-10298 (M. Sergeeva and D. Borisevich).	Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Emig D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060618; Fang H, 2013, CANCER RES, V73, P4965, DOI 10.1158/0008-5472.CAN-13-0661; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Ivliev AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035618; Ivliev AE, 2010, CANCER RES, V70, P10060, DOI 10.1158/0008-5472.CAN-10-2465; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee YS, 2015, CANCER GENOM PROTEOM, V12, P153; Liang Y, 2005, BMC CLIN PATHOL, V5, DOI 10.1186/1472-6890-5-6; Mertens M, 2009, J RHEUMATOL, V36, P1118, DOI 10.3899/jrheum.090074; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Nayak RR, 2009, GENOME RES, V19, P1953, DOI 10.1101/gr.097600.109; Penrod NM, 2014, GENOME MED, V6, DOI 10.1186/gm550; Pikor L, 2013, CANCER METAST REV, V32, P341, DOI 10.1007/s10555-013-9429-5; Rhodes DR, 2009, P NATL ACAD SCI USA, V106, P10284, DOI 10.1073/pnas.0900351106; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Sounni NE, 2013, CLIN CHEM, V59, P85, DOI 10.1373/clinchem.2012.185363; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Tan TZ, 2013, EMBO MOL MED, V5, P1051, DOI 10.1002/emmm.201201823; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Vitucci M, 2011, BRIT J CANCER, V104, P545, DOI 10.1038/sj.bjc.6606031; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Watari K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099568; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002656	50	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165059	10.1371/journal.pone.0165059	http://dx.doi.org/10.1371/journal.pone.0165059			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824868	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200013
J	Jaime-Acuna, OE; Meza-Villezcas, A; Vasquez-Pena, M; Raymond-Herrera, O; Villavicencio-Garcia, H; Petranovskii, V; Vazquez-Duhalt, R; Huerta-Saquero, A				Jaime-Acuna, O. E.; Meza-Villezcas, A.; Vasquez-Pena, M.; Raymond-Herrera, O.; Villavicencio-Garcia, H.; Petranovskii, V.; Vazquez-Duhalt, R.; Huerta-Saquero, A.			Synthesis and Complete Antimicrobial Characterization of CEOBACTER, an Ag-Based Nanocomposite	PLOS ONE			English	Article							SILVER NANOPARTICLES; ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITY; BACTERICIDAL ACTION; ZEOLITE; COMPOSITES; IONS; MECHANISMS; MORDENITE; EFFICACY	The antimicrobial activity of silver nanoparticles (AgNPs) is currently used as an alternative disinfectant with diverse applications, ranging from decontamination of aquatic environments to disinfection of medical devices and instrumentation. However, incorporation of AgNPs to the environment causes collateral damage that should be avoided. In this work, a novel Ag-based nanocomposite (CEOBACTER) was successfully synthetized. It showed excellent antimicrobial properties without the spread of AgNPs into the environment. The complete CEOBACTER antimicrobial characterization protocol is presented herein. It is straightforward and reproducible and could be considered for the systematic characterization of antimicrobial nanomaterials. CEOBACTER showed minimal bactericidal concentration of 3 mu g/ml, bactericidal action time of 2 hours and re-use capacity of at least five times against E. coli cultures. The bactericidal mechanism is the release of Ag ions. CEOBACTER displays potent bactericidal properties, long lifetime, high stability and re-use capacity, and it does not dissolve in the solution. These characteristics point to its potential use as a bactericidal agent for decontamination of aqueous environments.	[Jaime-Acuna, O. E.; Meza-Villezcas, A.; Vasquez-Pena, M.; Raymond-Herrera, O.; Villavicencio-Garcia, H.; Petranovskii, V.; Vazquez-Duhalt, R.; Huerta-Saquero, A.] Univ Nacl Autonoma Mexico, Ctr Nanociencias & Nanotecnol, Ensenada, Baja California, Mexico	Universidad Nacional Autonoma de Mexico	Huerta-Saquero, A (corresponding author), Univ Nacl Autonoma Mexico, Ctr Nanociencias & Nanotecnol, Ensenada, Baja California, Mexico.	saquero@cnyn.unam.mx	Huerta-Saquero, Alejandro/P-3499-2019; Saquero, Alejandro Huerta/E-2734-2016; Vazquez-Duhalt, Rafael/AGO-6764-2022; Vazquez-Duhalt, Rafael/E-2751-2016; Herrera, Oscar Raymond/E-3329-2016	Huerta-Saquero, Alejandro/0000-0002-0156-6773; Saquero, Alejandro Huerta/0000-0002-0156-6773; Vazquez-Duhalt, Rafael/0000-0003-1612-2996; Vazquez-Duhalt, Rafael/0000-0003-1612-2996; Herrera, Oscar Raymond/0000-0001-7832-1486; Petranovskii, Vitalii/0000-0002-8794-0593; Meza-Villezcas, Anaid/0000-0003-4993-3656	Matematike Grant [1010/295/2014 C-477/2014]; Direccion General de Asuntos del Personal Academic (DGAPA) [RN204815, IN110315]	Matematike Grant; Direccion General de Asuntos del Personal Academic (DGAPA)	This work was supported by Matematike Grant 1010/295/2014 C-477/2014 to AMV, and Direccion General de Asuntos del Personal Academic (DGAPA) Grants RN204815 to AH-S and IN110315 to OR-H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri S, 2014, RSC ADV, V4, P3974, DOI 10.1039/c3ra44507k; Agnihotri S, 2013, NANOSCALE, V5, P7328, DOI 10.1039/c3nr00024a; Akhigbe L, 2014, ENVIRON SCI POLLUT R, V21, P10940, DOI 10.1007/s11356-014-2888-6; Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089; Chen ZH, 2013, J PHYS CHEM C, V117, P19346, DOI 10.1021/jp406508y; Crist B.V., 2000, HDB MONOCHROMATIC XP; Dong B, 2014, NANOSCALE, V6, P10859, DOI 10.1039/c4nr03169e; Ferreira L, 2012, MICROPOR MESOPOR MAT, V160, P126, DOI 10.1016/j.micromeso.2012.05.006; Finberg RW, 2004, CLIN INFECT DIS, V39, P1314, DOI 10.1086/425009; FIZ Karlsruhe, 2015, VERSION 3 3 0; Greulich C, 2012, RSC ADV, V2, P6981, DOI 10.1039/c2ra20684f; Guerra R, 2012, MICROPOR MESOPOR MAT, V147, P267, DOI 10.1016/j.micromeso.2011.06.031; Harry Robson, 2001, VERIFIED SYNTHESES Z; Hedberg J, 2014, ENVIRON SCI TECHNOL, V48, P7314, DOI 10.1021/es500234y; Hoflund GB, 2000, PHYS REV B, V62, P11126, DOI 10.1103/PhysRevB.62.11126; Hsueh YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144306; Ivask A, 2014, ACS NANO, V8, P374, DOI 10.1021/nn4044047; Jaime-Acuna OE, 2016, CATAL COMMUN, V75, P103, DOI 10.1016/j.catcom.2015.11.009; Jaime-Acuna OE, 2014, CHEM MATER, V26, P6152, DOI 10.1021/cm5024585; Jiraroj D, 2014, POWDER TECHNOL, V264, P418, DOI 10.1016/j.powtec.2014.05.049; Lalueza P, 2011, MATER RES BULL, V46, P2070, DOI 10.1016/j.materresbull.2011.06.041; Lalueza P, 2011, CHEM COMMUN, V47, P680, DOI 10.1039/c0cc03905e; Lin JJ, 2013, ACS APPL MATER INTER, V5, P433, DOI 10.1021/am302534k; Lv M, 2010, ADV MATER, V22, P5463, DOI 10.1002/adma.201001934; Maillard JY, 2013, CRIT REV MICROBIOL, V39, P373, DOI 10.3109/1040841X.2012.713323; Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003; MBITHI JN, 1993, J CLIN MICROBIOL, V31, P2988, DOI 10.1128/JCM.31.11.2988-2995.1993; McFarland J, 1907, J AMER MED ASSOC, V49, P1176; McQuillan JS, 2014, NANOTOXICOLOGY, V8, P177, DOI 10.3109/17435390.2013.870243; Michael T, 2014, BROCK BIOL MICROORGA; Mock JJ, 2002, J CHEM PHYS, V116, P6755, DOI 10.1063/1.1462610; Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972; Patrick Murray, 2012, MED MICROBIOLOGY; Rai M, 2015, STRATEGIC ROLE SELEC; Raymond O, 2003, MAT SCI ENG A-STRUCT, V360, P202, DOI 10.1016/S0921-5093(03)00463-5; Raymond-Herrera O, 2014, SINTESIS NANOCOMPUES, p1/62; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Shameli K, 2015, RES CHEM INTERMEDIAT, V41, P251, DOI 10.1007/s11164-013-1188-y; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Sotiriou GA, 2010, ENVIRON SCI TECHNOL, V44, P5649, DOI 10.1021/es101072s; Su HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021125; Vilaca N, 2011, J MATER SCI, V46, P7511, DOI 10.1007/s10853-011-5722-2; Yang SY, 2014, EXPRESS POLYM LETT, V8, P425, DOI 10.3144/expresspolymlett.2014.46; Zhang Y, 2014, CHEM SOC REV, V43, P3762, DOI 10.1039/c3cs60338e; Zhou YZ, 2014, RSC ADV, V4, P5283, DOI 10.1039/c3ra44750b	45	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166205	10.1371/journal.pone.0166205	http://dx.doi.org/10.1371/journal.pone.0166205			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824932	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200071
J	Oyama, K; Kawada-Matsuo, M; Oogai, Y; Hayashi, T; Nakamura, N; Komatsuzawa, H				Oyama, Kentaro; Kawada-Matsuo, Miki; Oogai, Yuichi; Hayashi, Tetsuya; Nakamura, Norifumi; Komatsuzawa, Hitoshi			Antibacterial Effects of Glycyrrhetinic Acid and Its Derivatives on Staphylococcus aureus	PLOS ONE			English	Article							REDUCED VANCOMYCIN SUSCEPTIBILITY; GLYCYRRHIZIC ACID; LICORICE; INFECTIONS; EMERGENCE; VIRULENCE	Staphylococcus aureus is a major pathogen in humans and causes serious problems due to antibiotic resistance. We investigated the antimicrobial effect of glycyrrhetinic acid (GRA) and its derivatives against 50 clinical S. aureus strains, including 18 methicillin-resistant strains. The minimum inhibitory concentrations (MICs) of GRA, dipotassium glycyrrhizate, disodium succinoyl glycyrrhetinate (GR-SU), stearyl glycyrrhetinate and glycyrrhetinyl stearate were evaluated against various S. aureus strains. Additionally, we investigated the bactericidal effects of GRA and GR-SU against two specific S. aureus strains. DNA microarray analysis was also performed to clarify the mechanism underlying the antibacterial activity of GR-SU. We detected the antimicrobial activities of five agents against S. aureus strains. GRA and GR-SU showed strong antibacterial activities compared to the other three agents tested. At a higher concentration (above 2x MIC), GRA and GR-SU showed bactericidal activity, whereas at a concentration of 1x MIC, they showed a bacteriostatic effect. Additionally, GRA and GR-SU exhibited a synergistic effect with gentamicin. The expression of a large number of genes (including transporters) and metabolic factors (carbohydrates and amino acids) was altered by the addition of GR-SU, suggesting that the inhibition of these metabolic processes may influence the degree of the requirement for carbohydrates or amino acids. In fact, the requirement for carbohydrates or amino acids was increased in the presence of either GRA or GR-SU. GRA and GR-SU exhibited strong antibacterial activity against several S. aureus strains, including MRSA. This activity may be partly due to the inhibition of several pathways involved in carbohydrate and amino acid metabolism.	[Oyama, Kentaro; Kawada-Matsuo, Miki; Oogai, Yuichi; Komatsuzawa, Hitoshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Microbiol, Kagoshima, Japan; [Oyama, Kentaro; Nakamura, Norifumi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral maxillofacial Surg, Kagoshima, Japan; [Hayashi, Tetsuya] Kyushu Univ, Dept Bacteriol, Fac Med Sci, Fukuoka, Japan	Kagoshima University; Kagoshima University; Kyushu University	Komatsuzawa, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Microbiol, Kagoshima, Japan.	hkomatsu@dent.kagoshima-u.ac.jp	Hayashi, Tetsuya/ABA-1074-2020; Komatsuzawa, Hitoshi/AAC-7731-2019		Ministry of Education, Culture, Sports, Sciences, and Technology of Japan [25462868]	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in-Aid for Scientific Research (C) (Grant No: 25462868) from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Kaori Yasuda, Cell Innovator Inc. for assistance with microarray data acquisition. This study was supported in part by Grants-in-Aid for Scientific Research (C) (Grant No: 25462868) from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan.	Chung KT, 1998, CRIT REV FOOD SCI, V38, P421, DOI 10.1080/10408699891274273; CORTHOUT J, 1994, PLANTA MED, V60, P460, DOI 10.1055/s-2006-959532; Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x; Finks J, 2009, EMERG INFECT DIS, V15, P943, DOI 10.3201/eid1506.081312; FINNEY RSH, 1958, J PHARM PHARMACOL, V10, P613, DOI 10.1111/j.2042-7158.1958.tb10349.x; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Fukai T, 2002, FITOTERAPIA, V73, P536, DOI 10.1016/S0367-326X(02)00168-5; Green AE, 2012, FEMS MICROBIOL LETT, V333, P54, DOI 10.1111/j.1574-6968.2012.02598.x; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Hatano T, 2005, PHYTOCHEMISTRY, V66, P2047, DOI 10.1016/j.phytochem.2005.01.013; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Hoever G, 2005, J MED CHEM, V48, P1256, DOI 10.1021/jm0493008; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Iino S, 2001, HEPATOL RES, V19, P31, DOI 10.1016/S1386-6346(00)00079-6; INOUE H, 1989, BRIT J PHARMACOL, V96, P204, DOI 10.1111/j.1476-5381.1989.tb11801.x; INOUE H, 1993, J PHARM PHARMACOL, V45, P1067, DOI 10.1111/j.2042-7158.1993.tb07182.x; Kao TC, 2010, J AGR FOOD CHEM, V58, P8623, DOI 10.1021/jf101841r; Kim JK, 2006, BIOCHEM BIOPH RES CO, V345, P1215, DOI 10.1016/j.bbrc.2006.05.035; Komatsuzawa H, 2004, MOL MICROBIOL, V53, P1221, DOI 10.1111/j.1365-2958.2004.04200.x; Kumada H, 2002, ONCOLOGY-BASEL, V62, P94, DOI 10.1159/000048283; Li HE, 2012, FITOTERAPIA, V83, P241, DOI 10.1016/j.fitote.2011.10.018; Long DR, 2013, ANTIMICROB AGENTS CH, V57, P241, DOI 10.1128/AAC.01023-12; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Manders SM, 1998, J AM ACAD DERMATOL, V39, P383, DOI 10.1016/S0190-9622(98)70314-7; Marty FM, 2006, J CLIN MICROBIOL, V44, P595, DOI 10.1128/JCM.44.2.595-597.2006; Ming LJ, 2013, NAT PROD COMMUN, V8, P415; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Park HY, 2004, ARCH PHARM RES, V27, P57, DOI 10.1007/BF02980047; Shimada K, 1995, JPN J CHEMOTHER, V43, P1048; Taleb H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00198; Taylor Peter W, 2005, Food Sci Technol Bull, V2, P71, DOI 10.1616/1476-2137.14184; THYAGARAJAN SP, 2002, J GASTROEN HEPATOL, V17, P370, DOI DOI 10.1046/J.1440-1746.17.S3.30.X; Wang LQ, 2015, ACTA PHARM SIN B, V5, P310, DOI [10.1016/j.apsb.2015.05.005, 10.1016//j.apsb.2015.05.005]; YANO S, 1989, CHEM PHARM BULL, V37, P2500, DOI 10.1248/cpb.37.2500; Yarwood JM, 2003, J CLIN INVEST, V112, P1620, DOI 10.1172/JCI200320442	36	31	31	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165831	10.1371/journal.pone.0165831	http://dx.doi.org/10.1371/journal.pone.0165831			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820854	Green Published, Green Submitted, gold			2022-12-27	WOS:000387614800024
J	Harris, JC; Martinez, JM; Grozdanov, PN; Bergeson, SE; Grammas, P; MacDonald, CC				Harris, Jaryse C.; Martinez, Joseph M.; Grozdanov, Petar N.; Bergeson, Susan E.; Grammas, Paula; MacDonald, Clinton C.			The Cstf2t Polyadenylation Gene Plays a Sex-Specific Role in Learning Behaviors in Mice	PLOS ONE			English	Article							PRE-MESSENGER-RNA; B-CELL DIFFERENTIATION; ALTERNATIVE POLYADENYLATION; PROTEIN TAU-CSTF-64; BINDING PROTEINS; WATER-MAZE; CSTF-64; MEMORY; BRAIN; SPERMATOGENESIS	Polyadenylation is an essential mechanism for the processing of mRNA 30 ends. CstF-64 (the 64,000 M-r subunit of the cleavage stimulation factor; gene symbol Cstf2) is an RNA-binding protein that regulates mRNA polyadenylation site usage. We discovered a paralogous form of CstF-64 called tau CstF-64 (Cstf2t). The Cstf2t gene is conserved in all eutherian mammals including mice and humans, but the tCstF-64 protein is expressed only in a subset of mammalian tissues, mostly testis and brain. Male mice that lack Cstf2t (Cstf2(-/-) mice) experience disruption of spermatogenesis and are infertile, although female fertility is unaffected. However, a role for tCstF-64 in the brain has not yet been determined. Given the importance of RNA polyadenylation and splicing in neuronal gene expression, we chose to test the hypothesis that tCstF-64 is important for brain function. Male and female 185-day old wild type and Cstf2t(-/-) mice were examined for motor function, general activity, learning, and memory using rotarod, open field activity, 8-arm radial arm maze, and Morris water maze tasks. Male wild type and Cstf2t(-/-) mice did not show differences in learning and memory. However, female Cstf2t(-/-) mice showed significantly better retention of learned maze tasks than did female wild type mice. These results suggest that tCstf-64 is important in memory function in female mice. Interestingly, male Cstf2t (-/-) mice displayed less thigmotactic behavior than did wild type mice, suggesting that Cstf2t may play a role in anxiety in males. Taken together, our studies highlight the importance of mRNA processing in cognition and behavior as well as their established functions in reproduction.	[Harris, Jaryse C.; Grozdanov, Petar N.; MacDonald, Clinton C.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Martinez, Joseph M.; Bergeson, Susan E.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA; [Grammas, Paula] Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Rhode Island	MacDonald, CC (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.	clint.macdonald@ttuhsc.edu		MacDonald, Clinton/0000-0003-3209-1982	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [HD037109]; Laura W. Bush Institute for Women's Health; National Institutes of Health [AG020569, AG028367]; Wilson Foundation, Dallas, Texas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020569, R01AG028367] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Laura W. Bush Institute for Women's Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wilson Foundation, Dallas, Texas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under award number HD037109, the Laura W. Bush Institute for Womens Health (to CCM), the National Institutes of Health (AG020569 and AG028367), and the Wilson Foundation, Dallas, Texas (to PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARA SG, 1984, MOL CELL BIOL, V4, P2151, DOI 10.1128/MCB.4.10.2151; Anthony K, 2010, BRAIN RES, V1338, P67, DOI 10.1016/j.brainres.2010.03.008; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Chan SL, 2014, GENE DEV, V28, P2370, DOI 10.1101/gad.250993.114; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Costessi L, 2006, NUCLEIC ACIDS RES, V34, P243, DOI 10.1093/nar/gkj425; Costessi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058879; Dass B, 2002, GENOMICS, V80, P509, DOI 10.1006/geno.2002.6862; Dass B, 2001, J BIOL CHEM, V276, P8044, DOI 10.1074/jbc.M009091200; Dass B, 2007, P NATL ACAD SCI USA, V104, P20374, DOI 10.1073/pnas.0707589104; Davis MJ, 2012, BEHAV BRAIN RES, V229, P21, DOI 10.1016/j.bbr.2011.12.037; Deka P, 2005, J MOL BIOL, V347, P719, DOI 10.1016/j.jmb.2005.01.046; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; FOULKES NS, 1993, NATURE, V362, P264, DOI 10.1038/362264a0; Frick KM, 2000, NEUROSCIENCE, V95, P293; Gillies GE, 2010, PHARMACOL REV, V62, P155, DOI 10.1124/pr.109.002071; Grozdanov PN, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134684; Hartley CA, 2012, P NATL ACAD SCI USA, V109, P5493, DOI 10.1073/pnas.1202044109; Hockert JA, 2010, J BIOL CHEM, V285, P695, DOI 10.1074/jbc.M109.061705; Hockert KJ, 2011, J REPROD IMMUNOL, V89, P26, DOI 10.1016/j.jri.2011.01.018; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Huber Z, 2005, ANN NY ACAD SCI, V1061, P163, DOI 10.1196/annals.1336.017; Hwang HW, 2016, CELL REP, V15, P423, DOI 10.1016/j.celrep.2016.03.023; Idler RK, 2012, J ANDROL, V33, P309, DOI 10.2164/jandrol.111.014167; Ivshina M, 2014, ANNU REV CELL DEV BI, V30, P393, DOI 10.1146/annurev-cellbio-101011-155831; Kleene KC, 2013, REPRODUCTION, V146, pR1, DOI 10.1530/REP-12-0362; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048373; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lutz CS, 2011, WIRES RNA, V2, P22, DOI 10.1002/wrna.47; MACDONALD CC, 1994, MOL CELL BIOL, V14, P6647, DOI 10.1128/MCB.14.10.6647; MacDonald CC, 2010, WIRES RNA, V1, P494, DOI 10.1002/wrna.29; Maldonado R, 1999, P NATL ACAD SCI USA, V96, P14094, DOI 10.1073/pnas.96.24.14094; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Martincic K, 1998, P NATL ACAD SCI USA, V95, P11095, DOI 10.1073/pnas.95.19.11095; Miura P, 2013, GENOME RES, V23, P812, DOI 10.1101/gr.146886.112; Mizuno K, 2010, TRENDS NEUROSCI, V33, P285, DOI 10.1016/j.tins.2010.03.001; Monarez RR, 2007, BIOCHEM J, V401, P651, DOI 10.1042/BJ20061097; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nazim M, 2017, NUCLEIC ACIDS RES, V45, P1455, DOI 10.1093/nar/gkw823; OLTON DS, 1979, AM PSYCHOL, V34, P583, DOI 10.1037/0003-066X.34.7.583; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Reimann-Philipp U, 2001, J NEUROSCI RES, V64, P654, DOI 10.1002/jnr.1119; Rouget C, 2006, J BIOL CHEM, V281, P28687, DOI 10.1074/jbc.M601116200; Ruepp MD, 2011, MOL BIOL CELL, V22, P91, DOI 10.1091/mbc.E10-06-0543; Sartini BL, 2008, BIOL REPROD, V78, P472, DOI 10.1095/biolreprod.107.064774; Schonemann L, 2014, GENE DEV, V28, P2381, DOI 10.1101/gad.250985.114; Seil FJ, 2014, NEUROSCI BIOBEHAV R, V45, P212, DOI 10.1016/j.neubiorev.2014.06.003; Shankarling GS, 2013, GENE, V529, P220, DOI 10.1016/j.gene.2013.08.007; Shankarling GS, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-22; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; TAKAGAKI Y, 1992, P NATL ACAD SCI USA, V89, P1403, DOI 10.1073/pnas.89.4.1403; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Taliaferro JM, 2016, MOL CELL, V61, P821, DOI 10.1016/j.molcel.2016.01.020; Tardif S, 2010, BIOL REPROD, V83, P464, DOI 10.1095/biolreprod.109.083238; Tian B, 2012, WIRES RNA, V3, P385, DOI 10.1002/wrna.116; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Van Epps H, 2010, DEVELOPMENT, V137, P2237, DOI 10.1242/dev.049692; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wallace AM, 2004, BIOL REPROD, V70, P1080, DOI 10.1095/biolreprod.103.022947; Wallace AM, 1999, P NATL ACAD SCI USA, V96, P6763, DOI 10.1073/pnas.96.12.6763; Wang H, 2006, BIOL REPROD, V75, P318, DOI 10.1095/biolreprod.106.052209; Wang L, 2014, BIOESSAYS, V36, P39, DOI 10.1002/bies.201300100; WATZMAN N, 1964, J PHARM SCI, V53, P1429, DOI 10.1002/jps.2600531142; Wolfer DP, 1998, NEWS PHYSIOL SCI, V13, P118, DOI 10.1152/physiologyonline.1998.13.3.118; Yao CG, 2013, RNA, V19, P1781, DOI 10.1261/rna.042317.113; Yao CG, 2012, P NATL ACAD SCI USA, V109, P18773, DOI 10.1073/pnas.1211101109; Youngblood BA, 2014, NUCLEIC ACIDS RES, V42, P8330, DOI 10.1093/nar/gku551; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	74	10	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165976	10.1371/journal.pone.0165976	http://dx.doi.org/10.1371/journal.pone.0165976			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812195	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000086
J	Lachmair, M; Fernandez, SR; Bury, NA; Gerjets, P; Fischer, MH; Bock, OL				Lachmair, Martin; Fernandez, Susana Ruiz; Bury, Nils-Alexander; Gerjets, Peter; Fischer, Martin H.; Bock, Otmar L.			How Body Orientation Affects Concepts of Space, Time and Valence: Functional Relevance of Integrating Sensorimotor Experiences during Word Processing	PLOS ONE			English	Article							MENTAL TIMELINE; COGNITION; LANGUAGE; REPRESENTATION; HYPOTHESIS; MECHANISMS; FUTURE; FLIES; LINE; MIND	The aim of the present study was to test the functional relevance of the spatial concepts UP or DOWN for words that use these concepts either literally (space) or metaphorically (time, valence). A functional relevance would imply a symmetrical relationship between the spatial concepts and words related to these concepts, showing that processing words activate the related spatial concepts on one hand, but also that an activation of the concepts will ease the retrieval of a related word on the other. For the latter, the rotation angle of participant's body position was manipulated either to an upright or a head-down tilted body position to activate the related spatial concept. Afterwards participants produced in a within-subject design previously memorized words of the concepts space, time and valence according to the pace of a metronome. All words were related either to the spatial concept UP or DOWN. The results including Bayesian analyses show (1) a significant interaction between body position and words using the concepts UP and DOWN literally, (2) a marginal significant interaction between body position and temporal words and (3) no effect between body position and valence words. However, post-hoc analyses suggest no difference between experiments. Thus, the authors concluded that integrating sensorimotor experiences is indeed of functional relevance for all three concepts of space, time and valence. However, the strength of this functional relevance depends on how close words are linked to mental concepts representing vertical space.	[Lachmair, Martin; Fernandez, Susana Ruiz; Gerjets, Peter] Leibniz Knowledge Media Res Ctr, Tubingen, Germany; [Bury, Nils-Alexander; Bock, Otmar L.] German Sport Univ Cologne, Inst Physiol & Anat, Cologne, Germany; [Fischer, Martin H.] Univ Potsdam, Dept Psychol, Potsdam, Germany	Leibniz Institut fur Wissensmedien; German Sport University Cologne; University of Potsdam	Lachmair, M (corresponding author), Leibniz Knowledge Media Res Ctr, Tubingen, Germany.	m.lachmair@iwm-tuebingen.de	Lachmair, Martin/HCH-2667-2022; Gerjets, Peter/AAD-2017-2020; Fischer, Martin H./D-9965-2017	Fischer, Martin H./0000-0003-3818-7272; Lachmair, Martin/0000-0002-0469-9168				Ansorge U, 2010, COGNITION, V116, P303, DOI 10.1016/j.cognition.2010.05.010; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bonato M, 2012, NEUROSCI BIOBEHAV R, V36, P2257, DOI 10.1016/j.neubiorev.2012.08.007; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Casasanto D, 2010, COGNITIVE SCI, V34, P387, DOI 10.1111/j.1551-6709.2010.01094.x; Dudschig C, 2012, MEM COGNITION, V40, P1081, DOI 10.3758/s13421-012-0201-9; Just MA, 2013, COGNITIVE PROCESSES; Lachmair M, 2014, ACTA PSYCHOL, V148, P107, DOI 10.1016/j.actpsy.2013.12.004; Lachmair M, 2011, PSYCHON B REV, V18, P1180, DOI 10.3758/s13423-011-0158-x; LAKOFF G, 1980, COGNITIVE SCI, V4, P195, DOI 10.1207/s15516709cog0402_4; Loetscher T, 2008, CURR BIOL, V18, pR60, DOI 10.1016/j.cub.2007.11.015; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Masson MEJ, 2003, CAN J EXP PSYCHOL, V57, P203, DOI 10.1037/h0087426; Matlock T., 2013, P 35 ANN C COGN SCI, P3789; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Morey Richard D., 2015, BAYESFACTOR COMPUTAT; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; RISKIND JH, 1983, SOC COGNITION, V2, P62, DOI 10.1521/soco.1983.2.1.62; Rolke B, 2013, COGN PROCESS, V14, P231, DOI 10.1007/s10339-013-0537-5; Rouder JN, 2016, PSYCHOL METHODS; Ruiz Fernandez S., 2014, P 6 INT C MED SPAC E; Santiago J, 2007, PSYCHON B REV, V14, P512, DOI 10.3758/BF03194099; Setic M, 2007, LANG COGNITIVE PROC, V22, P297, DOI 10.1080/01690960600732430; Ulrich R, 2012, MEM COGNITION, V40, P483, DOI 10.3758/s13421-011-0162-4; Ulrich R, 2010, COGNITION, V117, P126, DOI 10.1016/j.cognition.2010.08.001; Weger UW, 2008, PSYCHON B REV, V15, P426, DOI 10.3758/PBR.15.2.426; Zwaan RolfA., 2005, GROUNDING COGNITION, P224, DOI DOI 10.1017/CBO9780511499968.010	29	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165795	10.1371/journal.pone.0165795	http://dx.doi.org/10.1371/journal.pone.0165795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812155	Green Submitted, gold, Green Published			2022-12-27	WOS:000386910000057
J	Tang, FR; Wang, JW; Tang, Z; Kang, M; Deng, QL; Yu, JM				Tang, Furong; Wang, Jiwei; Tang, Zheng; Kang, Mei; Deng, Qinglong; Yu, Jinming			Quality of Life and Its Association with Physical Activity among Different Types of Cancer Survivors	PLOS ONE			English	Article							COMORBID CHRONIC DISEASES; BREAST-CANCER; CLINICAL-TRIALS; LUNG-CANCER; INTERVENTION; SUPPORT; COHORT	Purpose The main goal of this study was to compare the quality of life (QOL) and its association with physical activity (PA) among patients diagnosed with different types of cancer. Based on the results, we tentatively present suggestions for the cancer health care model. Method A cross-sectional study was conducted with 2915 cancer survivors recruited from multi-community cancer rehabilitation centers, all of which were affiliated with the Shanghai Cancer Rehabilitation Club. We collected data including socio-demographic characteristics and information about PA. All the subjects included were asked to complete the European Organization for Research and Treatment Quality of Life Questionnaires (EORTC QLQ-C30) and Functional Assessment of Cancer Therapy-General Questionnaire (FACT-G). Multiple linear regression models were employed to control the potential confounding factors. Results Lung cancer survivors reported the worst dyspnea. Colorectal cancer survivors claimed the highest level of constipation and diarrhea. Liver cancer survivors indicated greatest loss of appetite and financial difficulties. Generally, survivors with PA tended to reported better QOL, although these associations among liver cancer survivors were not statistically significant. Moreover, survivors of all cancer types who performed PA did not report significant lower level of constipation or diarrhea. The relationship between PA frequency and QOL among cancer survivors remained unexplored. Conclusions Both QOL and its association with PA vary among survivors of different cancer types. The detailed results can assist clinicians and public health practitioners with improving health care management.	[Tang, Furong; Wang, Jiwei; Tang, Zheng; Kang, Mei; Deng, Qinglong; Yu, Jinming] Fudan Univ, Inst Epidemiol & Hlth Stat, Sch Publ Hlth, Shanghai, Peoples R China	Fudan University	Yu, JM (corresponding author), Fudan Univ, Inst Epidemiol & Hlth Stat, Sch Publ Hlth, Shanghai, Peoples R China.	jmy@fudan.edu.cn						AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Akin S, 2008, EUR J ONCOL NURS, V12, P449, DOI 10.1016/j.ejon.2008.07.006; Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub3, 10.1002/14651858.CD005381.pub2]; Aziz NM, 2007, ACTA ONCOL, V46, P417, DOI 10.1080/02841860701367878; Bairamov R B, 2013, Klin Khir, P18; Chui PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139952; Friedenreich CM, 2001, CANCER EPIDEM BIOMAR, V10, P287; Fu MR, 2015, J PERS MED, V5, P229, DOI 10.3390/jpm5030229; Ganti AK, 2016, AM J CLIN ONCOL-CANC, V39, P142, DOI 10.1097/COC.0000000000000040; Hamidou Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096848; Joly F, 2014, INT J GYNECOL CANCER, V24, P1693, DOI 10.1097/IGC.0000000000000299; Jordhoy MS, 2001, BRIT J CANCER, V85, P1478, DOI 10.1054/bjoc.2001.2116; Kao HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139252; Kim AR, 2012, ANN SURG, V256, P1008, DOI 10.1097/SLA.0b013e31827661c9; Knols R, 2005, J CLIN ONCOL, V23, P3830, DOI 10.1200/JCO.2005.02.148; Kumar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089851; Lin Tsai-Rung, 2013, Hu Li Za Zhi, V60, P68, DOI 10.6224/JN.60.6.68; Mishra SI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007566.pub2; Moro-Valdezate D, 2014, BREAST CANCER-TOKYO, V21, P442, DOI 10.1007/s12282-012-0402-x; Moseholm E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148463; Ramadas Amutha, 2015, Asian Pac J Cancer Prev, V16, P1479; Sajjad S, 2016, EUR J ONCOL NURS, V21, P75, DOI 10.1016/j.ejon.2016.01.006; Sheean P, 2015, J ACAD NUTR DIET, V115, P1690, DOI 10.1016/j.jand.2015.03.017; Smits A, 2015, GYNECOL ONCOL, V139, P546, DOI 10.1016/j.ygyno.2015.10.002; Turgay AS, 2008, CANCER NURS, V31, pE19, DOI 10.1097/01.NCC.0000339248.37829.c2; van Roekel EH, 2015, MED SCI SPORT EXER, V47, P2493, DOI 10.1249/MSS.0000000000000698; Wang JW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2240-1; Wang JW, 2015, SUPPORT CARE CANCER, V23, P1383, DOI 10.1007/s00520-014-2494-7; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]; Yi M, 2011, J CLIN ONCOL, V29, P4654, DOI 10.1200/JCO.2011.38.3174; Zackrisson S, 2007, J MED SCREEN, V14, P138, DOI 10.1258/096914107782066239; Zhang B, 2000, HEPATO-GASTROENTEROL, V47, P414	33	17	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164971	10.1371/journal.pone.0164971	http://dx.doi.org/10.1371/journal.pone.0164971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812130	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000018
J	Zhang, ZQ; Luo, GY; Tang, HF; Cheng, CC; Wang, P				Zhang, Zhiqiao; Luo, Guanying; Tang, Hongfeng; Cheng, Canchang; Wang, Peng			Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis	PLOS ONE			English	Article							GROWTH-FACTOR-C; IMMUNOHISTOCHEMICAL EXPRESSION; CLINICAL-SIGNIFICANCE; LYMPHANGIOGENESIS; METAANALYSIS; METASTASIS; OVEREXPRESSION; ASSOCIATION	Background The prognostic significance of vascular endothelial growth factor C (VEGF-C) expression in breast cancer (BC) patients remains controversial. Therefore, this meta-analysis was performed to determine the prognostic significance of VEGF-C expression in BC patients. Materials and Methods Several electronic databases were searched from January 1991 to August 2016. The pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated to evaluate the prognostic significance of VEGF-C expression for disease free survival (DFS) and overall survival (OS). Results The present meta analysis totally included 21 eligible studies and 2828 patients with BC. The combined HRs were 1.87(95% CI 1.25-2.79, P = 0.001) for DFS and 1.96(95% CI 1.15-3.31, P = 0.001) for OS. The pooled HRs of non-Asian subgroup were 2.04(95% CI 1.36-3.05, P = 0.001) for DFS and 2.61(95% CI 1.51-4.52, P = 0.001) for OS, which were significantly higher than that of Asian subgroup. The funnel plot for publication bias was symmetrical. The further Egger's test and Begg's test did not detect significant publication bias (all P>0.05). Conclusions The present meta analysis strongly supported the prognostic role of VEGF-C expression for DFS and OS in BC patients, especially for patients in non-Asian countries. Furthermore, stratification by VEGF-C expression may help to optimize the treatments and the integrated managements for BC patients.	[Zhang, Zhiqiao; Wang, Peng] First Peoples Hosp Shunde, Dept Infect Dis, Shunde, Guangdong, Peoples R China; [Luo, Guanying; Cheng, Canchang] First Peoples Hosp Shunde, Dept Internal Med, Chencun Affiliated Hosp, Shunde, Guangdong, Peoples R China; [Tang, Hongfeng] First Peoples Hosp Shunde, Dept Sci & Educ, Shunde, Guangdong, Peoples R China		Wang, P (corresponding author), First Peoples Hosp Shunde, Dept Infect Dis, Shunde, Guangdong, Peoples R China.	sdgrxjbk@163.com		zhang, zhiqiao/0000-0003-4631-8818	Guangdong Provincial Health Department [A2013695, A2016450]; Finance Department of Guangdong Province [RMB 15000]	Guangdong Provincial Health Department; Finance Department of Guangdong Province	This study was funded in part by Guangdong Provincial Health Department. The Grant Numbers were No: A2013695 (Grant Recipient: Peng Wang) and No: A2016450 (Grant Recipient: Zhiqiao Zhang). The total funding account was RMB 15000. The funding was given by Finance Department of Guangdong Province. The received authors of the funding was Peng Wang (No: A2013695) and Zhiqiao Zhang (A2016450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando H, 2006, ONCOL REP, V15, P653; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Callagy GM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-153; [曹友德 Cao Youde], 2003, [实用肿瘤杂志, Journal of Practical oncology], V18, P206; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gao S, 2014, TUMOR BIOL, V35, P1523, DOI 10.1007/s13277-013-1211-3; Gisterek I, 2010, PATHOL ONCOL RES, V16, P337, DOI 10.1007/s12253-009-9211-8; Gu Y, 2008, CLIN EXP METASTAS, V25, P717; Hayes DF, 2005, BREAST, V14, P493, DOI 10.1016/j.breast.2005.08.023; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang H, 2014, CLIN CHIM ACTA, V427, P94, DOI 10.1016/j.cca.2013.10.002; Kinoshita J, 2001, BREAST CANCER RES TR, V66, P159, DOI 10.1023/A:1010692132669; [李鹏 LI Peng], 2009, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V36, P207; Liang B, 2014, IRAN J PUBLIC HEALTH, V43, P128; Lin Y, 2015, INT J CLIN EXP PATHO, V8, P8028; Linardou H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3354; Liu XL, 2013, ACAD J SEC MIL MED U, V10, P1078; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mohammed RAA, 2007, BRIT J CANCER, V96, P1092, DOI 10.1038/sj.bjc.6603678; Mylona E, 2007, EJSO-EUR J SURG ONC, V33, P294, DOI 10.1016/j.ejso.2006.10.015; Nakamura Y, 2006, CLIN CANCER RES, V12, P1201, DOI 10.1158/1078-0432.CCR-05-1269; Nakamura Y, 2003, MODERN PATHOL, V16, P309, DOI 10.1097/01.MP.0000062858.98295.9F; Ni XJ, 2013, J BIOMED RES, V27, P478, DOI 10.7555/JBR.27.20130021; Ran Sophia, 2010, Pathophysiology, V17, P229, DOI 10.1016/j.pathophys.2009.11.003; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tezuka K, 2008, ONCOL REP, V20, P25; Tsutsui S, 2010, ONCOL REP, V23, P621, DOI 10.3892/or_00000677; Wang F, 2016, BREAST, V28, P45, DOI 10.1016/j.breast.2016.04.016; Wang J, 2012, MOL BIOL REP, V39, P11153, DOI 10.1007/s11033-012-2024-y; Watanabe O, 2005, J EXP CLIN CANC RES, V24, P75; Yang WT, 2002, CANCER, V94, P2855, DOI 10.1002/cncr.10553; Zhang Gui-hong, 2006, Zhonghua Bing Li Xue Za Zhi, V35, P473; Zhang XH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-4; Zhao YC, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-165; Zhou L, 2004, CARCINOGENESIS TERAT, V17, P291; Zong SQ, 2016, CLIN CHIM ACTA, V458, P106, DOI 10.1016/j.cca.2016.04.037	37	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165725	10.1371/journal.pone.0165725	http://dx.doi.org/10.1371/journal.pone.0165725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812168	Green Submitted, gold, Green Published			2022-12-27	WOS:000386910000053
J	Eissa, MM; Mostafa, DK; Ghazy, AA; El Azzouni, MZ; Boulos, LM; Younis, LK				Eissa, Maha M.; Mostafa, Dalia K.; Ghazy, Amany A.; El Azzouni, Mervat Z.; Boulos, Laila M.; Younis, Layla K.			Anti-Arthritic Activity of Schistosoma mansoni and Trichinella spiralis Derived-Antigens in Adjuvant Arthritis in Rats: Role of FOXP3(+) Treg Cells	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; REGULATORY T-CELLS; RHEUMATOID-ARTHRITIS; AUTOIMMUNE ARTHRITIS; HELMINTH INFECTIONS; HYGIENE HYPOTHESIS; ALLERGIC DISEASES; FREUNDS-ADJUVANT; REDUCES SEVERITY; MECHANISMS	A growing body of evidence supports the concept of helminths therapy in a variety of autoimmune diseases. Here, we aimed to investigate the protective effects of autoclaved Schistosoma mansoni antigen (ASMA) and Trichinella spiralis antigen (ATSA) on the clinical and immunopathological features of rheumatoid arthritis (RA). Adjuvant arthritis was induced by subcutaneous and intradermal injections of complete Freund's adjuvant into the plantar surface of the right hind paw and the root of the tail, respectively. Rats were randomly assigned to serve as normal control, untreated arthritis, ASMA or ATSA-treated arthritis groups. Antigens were given by intradermal injection in two doses, two weeks apart. The development, progression of arthritic features, and the impact on animals' gait and body weight were followed up for 4 weeks. The associated changes in serum cytokines (IL-17, IFN-gamma and IL-10), joints' histopathology and immunohistochemistry of Foxp3(+) T regulatory cells (Tregs) were evaluated at the end of the study. Treatment with either ASMA or ATSA attenuated the progression of clinical features of polyarthritis, improved gait and body weight gain, reduced the elevated serum IL-17 and further increased both IFN-gamma and IL-10. Histopathologically, this was associated with a remarkable regression of paws' inflammation that was limited only to the subcutaneous tissue, and a significant increase in the number of Foxp3+ cells versus the untreated arthritis group. In conclusion, both Schistosoma mansoni and Trichinella spiralis derived antigens exerted protective effect against adjuvant arthritis with better effect achieved by ASMA treatment. This anti-arthritic activity is attributed to upregulation of the Foxp3(+) Tregs, with subsequent favorable modulation of both pro-and anti-inflammatory cytokines. The use of autoclaved parasitic antigens excludes the deleterious effects of imposing helminthic infection by using live parasites, which may pave the way to a new therapeutic modality in treating RA.	[Eissa, Maha M.; El Azzouni, Mervat Z.; Boulos, Laila M.] Univ Alexandria, Dept Med Parasitol, Fac Med, Alexandria, Egypt; [Mostafa, Dalia K.] Univ Alexandria, Dept Clin Pharmacol, Fac Med, Alexandria, Egypt; [Ghazy, Amany A.] Kafrelsheikh Univ, Dept Med Microbiol & Immunol, Fac Med, Kafrelsheikh, Egypt; [Younis, Layla K.] Univ Alexandria, Dept Pathol, Fac Med, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Egyptian Knowledge Bank (EKB); Alexandria University	Mostafa, DK (corresponding author), Univ Alexandria, Dept Clin Pharmacol, Fac Med, Alexandria, Egypt.	dalia.kashishy@alexmed.edu.eg	Ghazy, Amany/AAP-9170-2021; Ghazy, Amany/ABC-7510-2020; Mostafa, Dalia/AAL-9118-2021; Eissa, M M/S-4230-2019	Ghazy, Amany/0000-0002-5603-1303; Mostafa, Dalia/0000-0002-5057-2491; Eissa, M M/0000-0003-4723-6427; Eissa, Maha/0000-0001-9572-2820				Alunno A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/751793; Ashour DS, 2014, J HELMINTHOL, V88, P210, DOI 10.1017/S0022149X13000059; Ashour DS, 2013, EXPERT REV CLIN IMMU, V9, P669, DOI 10.1586/1744666X.2013.811187; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Beiting DP, 2007, J IMMUNOL, V178, P1039, DOI 10.4049/jimmunol.178.2.1039; Bendele A. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P377; Bevaart L, 2010, ARTHRITIS RHEUM-US, V62, P2192, DOI 10.1002/art.27503; Boissier MC, 2009, JOINT BONE SPINE, V76, P10, DOI 10.1016/j.jbspin.2008.08.002; Cetre C, 1999, INFECT IMMUN, V67, P2713; Chabaud M, 2001, ARTHRITIS RES, V3, P168, DOI 10.1186/ar294; Cooles FAH, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0352-0; Darani HY, 1997, PARASITOLOGY, V115, P237, DOI 10.1017/S0031182097001303; Darwish SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079284; Dief AE, 2015, EUR REV MED PHARMACO, V19, P1537; Doodes PD, 2010, J IMMUNOL, V184, P1552, DOI 10.4049/jimmunol.0902907; Drury R.A, 1980, CARLETONS HISTOLOGIC; Eissa MM, 2012, EXP PARASITOL, V131, P310, DOI 10.1016/j.exppara.2012.05.001; Eissa Maha M., 2003, Journal of the Egyptian Society of Parasitology, V33, P541; El Aswad BEW, 2011, IMMUNOBIOLOGY, V216, P379, DOI 10.1016/j.imbio.2010.06.014; El-Malky M, 2011, PARASITE IMMUNOL, V33, P589, DOI 10.1111/j.1365-3024.2011.01324.x; Finlay CM, 2016, J IMMUNOL, V196, P703, DOI 10.4049/jimmunol.1501820; Fleming JO, 2015, PARASITE IMMUNOL, V37, P277, DOI 10.1111/pim.12175; Greenwood BM, 1986, LANCET, V2, P380; Gruden-Movsesijan A, 2010, PARASITE IMMUNOL, V32, P450, DOI 10.1111/j.1365-3024.2010.01207.x; Hawkins P, 2015, INFLAMMOPHARMACOLOGY, V23, P131, DOI 10.1007/s10787-015-0241-4; He Y, 2010, BMC IMMUNOL, V11, P128; Ilic N, 2011, PARASITE IMMUNOL, V33, P572, DOI 10.1111/j.1365-3024.2011.01322.x; Kondrashova A, 2013, APMIS, V121, P478, DOI 10.1111/apm.12023; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Lee SY, 2016, IMMUNOL LETT, V172, P56, DOI 10.1016/j.imlet.2016.02.011; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Maizels RM, 2016, CLIN MICROBIOL INFEC, V22, P481, DOI 10.1016/j.cmi.2016.04.024; Matisz Chelsea E., 2011, Journal of Parasitology Research, P942616, DOI 10.1155/2011/942616; Matthys P, 1999, J IMMUNOL, V163, P3503; McGrath JC, 2015, BRIT J PHARMACOL, V172, P1179, DOI 10.1111/bph.13008; Mellor AL, 2011, J IMMUNOL, V186, P4535, DOI 10.4049/jimmunol.1002937; Sempere-Ortells JM, 2009, AUTOIMMUNITY, V42, P636, DOI 10.3109/08916930903061491; Moudgil KD, 2011, CURR RHEUMATOL REP, V13, P456, DOI 10.1007/s11926-011-0200-z; Ngoi SM, 2011, DISCOV MED, V12, P405; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Osada Y, 2009, INT J PARASITOL, V39, P457, DOI 10.1016/j.ijpara.2008.08.007; Park HK, 2011, EXP PARASITOL, V127, P539, DOI 10.1016/j.exppara.2010.10.004; Pellegrino J, 1968, Adv Parasitology, V6, P233, DOI 10.1016/S0065-308X(08)60475-3; Pica-Mattoccia L, 2004, INT J PARASITOL, V34, P527, DOI 10.1016/j.ijpara.2003.12.003; Rajaiah R, 2011, J BIOL CHEM, V286, P2817, DOI 10.1074/jbc.M110.187013; Romano A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004306; Rzepecka J, 2015, J AUTOIMMUN, V60, P59, DOI 10.1016/j.jaut.2015.04.005; Saunders KA, 2007, INFECT IMMUN, V75, P397, DOI 10.1128/IAI.00664-06; Sega Y, 2015, HAREFUAH, V154, P469; Sega Y, 2015, HAREFUAH, V154, P470; Sega Yahel, 2015, Harefuah, V154, P428; Sun X, 2010, PARASITE IMMUNOL, V32, P739, DOI 10.1111/j.1365-3024.2010.01240.x; Wang SS, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-015-1288-1; Wang T, 2015, ANN RHEUM DIS, V74, P1293, DOI 10.1136/annrheumdis-2013-204228; Wang XL, 2009, VET PARASITOL, V159, P249, DOI 10.1016/j.vetpar.2008.10.052; WASSOM DL, 1988, J PARASITOL, V74, P283, DOI 10.2307/3282457; Weinstock JV, 2002, J LAB CLIN MED, V139, P334, DOI 10.1067/mlc.2002.124343; Weng L, 2010, ANN RHEUM DIS, V69, P1519, DOI 10.1136/ard.2009.121111; Wu HX, 2016, JOINT BONE SPINE, V83, P525, DOI 10.1016/j.jbspin.2015.09.002; Yang XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096454; Zaccone P, 2006, PARASITE IMMUNOL, V28, P515, DOI 10.1111/j.1365-3024.2006.00879.x	62	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165916	10.1371/journal.pone.0165916	http://dx.doi.org/10.1371/journal.pone.0165916			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802332	gold, Green Published			2022-12-27	WOS:000386714200067
J	Fritz, J; Fritz, B; Dellon, AL				Fritz, Jan; Fritz, Benjamin; Dellon, A. Lee			Sacrotuberous Ligament Healing following Surgical Division during Transgluteal Pudendal Nerve Decompression: A 3-Tesla MR Neurography Study	PLOS ONE			English	Article							TRANSVERSE CARPAL LIGAMENT; MAGNETIC-RESONANCE NEUROGRAPHY; TUNNEL-SYNDROME; PELVIC LIGAMENTS; PAIN; ENTRAPMENT; RELEASE; TRANSPOSITION; NEUROLYSIS; NEURALGIA	Pelvic pain due to chronic pudendal nerve (PN) compression, when treated surgically, is approached with a transgluteal division of the sacrotuberous ligament (STL). Controversy exists as to whether the STL heals spontaneously or requires grafting. Therefore, the aim of this study was to determine how surgically divided and unrepaired STL heal. A retrospective evaluation of 10 patients who had high spatial resolution 3-Tesla magnetic resonance imaging (3T MRI) exams of the pelvis was done using an IRB-approved protocol. Each patient was referred for residual pelvic pain after a transgluteal STL division for chronic pudendal nerve pain. Of the 10 patients, 8 had the STL divided and not repaired, while 2 had the STL divided and reconstructed with an allograft tendon. Of the 8 that were left unrepaired, 6 had bilateral surgery. Outcome variables included STL integrity and thickness. Normative data for the STL were obtained through a control group of 20 subjects. STL integrity and thickness were measured directly on 3 T MR Neurography images, by two independent Radiologists. The integrity and thickness of the post-surgical STL was evaluated 39 months (range, 9-55) after surgery. Comparison was made with the native contra-lateral STL in those who had unilateral STL division, and with normal, non-divided STL of subjects of the control group. The normal STL measured 3 mm (minimum and maximum of absolute STL thickness, 2-3 mm). All post-operative STL were found to be continuous regardless of the surgical technique used. Measured at level of Alcock's canal in the same plane as the obturator internus tendon posterior to the ischium, the mean anteroposterior STL diameter was 5 mm (range, 4-5 mm) in the group of prior STL division without repair and 8 mm (range, 8-9 mm) in the group with the STL reconstructed with grafts (p<0.05). The group of healed STLs were significantly thicker than the normal STL (p<0.05). We conclude that a surgically divided STL will heal spontaneously and will be significantly thicker after healing.	[Fritz, Jan] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, 600 N Wolfe St, Baltimore, MD 21287 USA; [Fritz, Benjamin] Orthoped Univ, Hosp Balgrist, Dept Radiol, Forchstr 340, CH-8008 Zurich, Switzerland; [Dellon, A. Lee] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, 600 N Wolfe St, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University	Dellon, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, 600 N Wolfe St, Baltimore, MD 21287 USA.	aldellon@dellon.com	Fritz, Benjamin/AAW-1140-2021	Fritz, Benjamin/0000-0001-8733-131X				Abdelfattah A, 2014, INJURY, V45, P1599, DOI 10.1016/j.injury.2014.05.026; Citron ND, 1997, J HAND SURG-BRIT EUR, V22B, P317, DOI 10.1016/S0266-7681(97)80393-2; Conza NE, 2007, J BIOMECH, V40, P1599, DOI 10.1016/j.jbiomech.2006.07.001; Dellon AL, 2015, J RECONSTR MICROSURG, V31, P283, DOI 10.1055/s-0034-1396896; Filler Aaron G, 2009, Neurosurg Focus, V26, pE9, DOI 10.3171/FOC.2009.26.2.E9; Fritz J, 2008, AM J ROENTGENOL, V191, P1717, DOI 10.2214/AJR.08.1075; Fritz J, 2015, MAGN RESON IMAGING C, V23, P533, DOI 10.1016/j.mric.2015.05.010; Fritz J, 2014, NEUROIMAG CLIN N AM, V24, P211, DOI 10.1016/j.nic.2013.03.028; Hibner M, 2012, J MINIM INVAS GYN, V19, P325, DOI 10.1016/j.jmig.2011.12.022; Hibner M, 2010, J MINIM INVAS GYN, V17, P148, DOI 10.1016/j.jmig.2009.11.003; JAKAB E, 1991, J HAND SURG-AM, V16A, P202, DOI 10.1016/S0363-5023(10)80097-8; Karlsson MK, 1997, SCAND J PLAST RECONS, V31, P65, DOI 10.3109/02844319709010507; Kluge W, 1996, J HAND SURG-BRIT EUR, V21B, P205, DOI 10.1016/S0266-7681(96)80098-2; Loukas M, 2006, SURG RADIOL ANAT, V28, P163, DOI 10.1007/s00276-006-0082-3; Mauillon J, 1999, DIS COLON RECTUM, V42, P186, DOI 10.1007/BF02237125; Popeney C, 2007, NEUROUROL URODYNAM, V26, P820, DOI 10.1002/nau.20421; RICHMAN JA, 1989, J HAND SURG-AM, V14A, P852, DOI 10.1016/S0363-5023(89)80089-9; Robert R, 2005, EUR UROL, V47, P403, DOI 10.1016/j.eururo.2004.09.003; Robert R, 2007, ADV TECH STAND NEURO, V32, P41, DOI 10.1007/978-3-211-47423-5_3; Sayegh ET, 2015, CLIN ORTHOP RELAT R, V473, P1120, DOI 10.1007/s11999-014-3835-z; SIMONIAN PT, 1994, CLIN ORTHOP RELAT R, P245; Varga E, 2008, INJURY, V39, P858, DOI 10.1016/j.injury.2008.01.017; VRAHAS M, 1995, ORTHOPEDICS, V18, P271	23	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165239	10.1371/journal.pone.0165239	http://dx.doi.org/10.1371/journal.pone.0165239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828983	Green Submitted, Green Published, gold			2022-12-27	WOS:000387724300034
J	Hornigold, K; Lake, I; Dolman, P				Hornigold, Karen; Lake, Iain; Dolman, Paul			Recreational Use of the Countryside: No Evidence that High Nature Value Enhances a Key Ecosystem Service	PLOS ONE			English	Article							BIODIVERSITY; BENEFITS; TOURISM; AREAS	In Western Europe, recreational amenity is presented as an important cultural ecosystem service that, along with other values, helps justify policies to conserve biodiversity. However, whether recreational use by the public is enhanced at protected areas designated for nature conservation is unknown. This is the first study to model outdoor recreation at a national scale, examining habitat preferences with statutory designation (Site of Special Scientific Interest) as an indicator of nature conservation importance. Models were based on a massive, three year national household survey providing spatially-referenced recreational visits to the natural environment. Site characteristics including land cover were compared between these observed visit sites (n = 31,502) and randomly chosen control sites (n = 63,000). Recreationists preferred areas of coast, freshwater, broadleaved woodland and higher densities of footpaths and avoided arable, coniferous woodland and lowland heath. Although conservation designation offers similar or greater public access than undesignated areas of the same habitat, statutory designation decreased the probability of visitation to coastal and freshwater sites and gave no effect for broadleaved woodland. Thus general recreational use by the public did not represent an important ecosystem service of protected high-nature-value areas, so that intrinsic and existence values remain as the primary justifications for conservation of high nature value areas. Management of 'green infrastructure' sites of lower conservation value that offer desirable habitats and enhanced provision of footpaths, could mitigate recreational impacts on nearby valuable conservation areas.	[Hornigold, Karen; Lake, Iain; Dolman, Paul] Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England	University of East Anglia	Hornigold, K (corresponding author), Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England.	K.Hornigold@uea.ac.uk	lake, iain r/C-9917-2011; Dolman, Paul M./AAK-3914-2020	Lake, Iain Richard/0000-0003-4407-5357; Dolman, Paul/0000-0002-9340-2791	Natural Environment Research Council (NERC) [NE/K500896/1]; Natural Environment Research Council [1210123] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	KH was funded by a Natural Environment Research Council (NERC) Research Studentship (Directed) NE/K500896/1 (http://www.nerc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Monitor of the Engagement with the Natural Environment teams at Natural England and TNS for providing the MENE data and to the Centre for Ecology and Hydrology for the licence to use the LCM2007 25m Raster. We also thank all participants in the MENE survey and all contributors to OpenStreetMap. We are grateful to Alastair Grant for comments on an earlier version of the manuscript. This work was supported by the Natural Environment Research Council [grant number NE/K500896/1]. We are grateful for comments from anonymous reviewers and the editor that helped us improve an earlier version of the manuscript.	[Anonymous], 2013, CONT ORD SURV DAT CR; [Anonymous], 2013, OS MERIDIAN 2 CONTAI; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Beyer H.L., GEOSPATIAL MODELLING; Boughey KL, 2011, BIOL CONSERV, V144, P2300, DOI 10.1016/j.biocon.2011.06.008; Clarke RT, 2006, VISITOR ACCESS PATTE; Committee of Public Accounts, DEFRA NAT ENGL ROL; Dallimer M, 2012, BIOSCIENCE, V62, P47, DOI 10.1525/bio.2012.62.1.9; Defra, 2007, CONS BIOD THE UK APP; Defra, 2011, BIOD 2020 STRAT ENGL; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dolman P., 2000, ENV SCI ENV MANAGEME, P119; Eigenbrod F, 2009, P ROY SOC B-BIOL SCI, V276, P2903, DOI 10.1098/rspb.2009.0528; GADM, 2013, DAT GLOB ADM AR; Gimingham C.H., 1972, ECOLOGY HEATHLANDS; Hill GW, 2006, FORESTRY, V79, P185, DOI 10.1093/forestry/cpl005; Jones A., 2010, Sustainability, V2, P684; Keniger LE, 2013, INT J ENV RES PUB HE, V10, P913, DOI 10.3390/ijerph10030913; Liley D, 2005, VISITOR ACCESS PATTE; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Manly B.F.J., 2002, RESOURCE SELECTION A; MEA (Millennium Ecosystem Assessment), 2005, EC HUM WELL BEING DE; Molloy D, 2011, RSPB RESERVES AND LO; Morton D., 2011, 1107NERC CTR EC HYDR; Naidoo R, 2005, ENVIRON DEV ECON, V10, P159, DOI 10.1017/S1355770X0400186X; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; National Records of Scotland, CENS EST US RES POP; Natural England, 2012, NE356; Natural England, 2011, NE3062011; Natural England, GIS DIG BOUND DAT CO; Natural England, 2012, 0952012 NECR; Office for National Statistics, 2011, 2011 CENS HEADC HOUS; OpenStreetMap, LIC OP DAT COMM OP D; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pickering CM, 2007, J ENVIRON MANAGE, V85, P791, DOI 10.1016/j.jenvman.2006.11.021; Ratcliffe DA, 1977, NATURE CONSERVATION, V1; Reed SE, 2008, CONSERV LETT, V1, P146, DOI 10.1111/j.1755-263X.2008.00019.x; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sandifer PA, 2015, ECOSYST SERV, V12, P1, DOI 10.1016/j.ecoser.2014.12.007; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sen A, 2014, ENVIRON RESOUR ECON, V57, P233, DOI 10.1007/s10640-013-9666-7; Siikamaki P, 2015, BIODIVERS CONSERV, V24, P2521, DOI 10.1007/s10531-015-0941-5; UKDS, 2013, POSTC DIR; Vickery Juliet, 1995, P42	45	13	14	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165043	10.1371/journal.pone.0165043	http://dx.doi.org/10.1371/journal.pone.0165043			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828990	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000387724300026
J	Butler, DC; Joshi, SN; De Genst, E; Baghel, AS; Dobson, CM; Messer, A				Butler, David C.; Joshi, Shubhada N.; De Genst, Erwin; Baghel, Ankit S.; Dobson, Christopher M.; Messer, Anne			Bifunctional Anti-Non-Amyloid Component alpha-Synuclein Nanobodies Are Protective In Situ	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; MUTANT HUNTINGTIN AGGREGATION; IMPAIRS MACROAUTOPHAGY; INTRABODY; DISEASE; EXPRESSION; MODELS; OVEREXPRESSION; NEUROTOXICITY; INCLUSIONS	Misfolding, abnormal accumulation, and secretion of alpha-Synuclein (alpha-Syn) are closely associated with synucleinopathies, including Parkinson's disease (PD). VH14 is a human single domain intrabody selected against the non-amyloid component (NAC) hydrophobic interaction region of alpha-Syn, which is critical for initial aggregation. Using neuronal cell lines, we show that as a bifunctional nanobody fused to a proteasome targeting signal, VH14PEST can counteract heterologous proteostatic effects of mutant alpha-Syn on mutant huntingtin Exon1 and protect against alpha-Syn toxicity using propidium iodide or Annexin V readouts. We compared this anti-NAC candidate to NbSyn87, which binds to the C-terminus of alpha-Syn. NbSyn87PEST degrades alpha-Syn as well or better than VH14PEST. However, while both candidates reduced toxicity, VH14PEST appears more effective in both proteostatic stress and toxicity assays. These results show that the approach of reducing intracellular monomeric targets with novel antibody engineering technology should allow in vivo modulation of proteostatic pathologies.	[Butler, David C.; Messer, Anne] Neural Stem Cell Inst, Rensselaer, NY 12144 USA; [Butler, David C.; Messer, Anne] SUNY Albany, Dept Biomed Sci, Albany, NY 12208 USA; [Butler, David C.; Joshi, Shubhada N.; Baghel, Ankit S.; Messer, Anne] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA; [De Genst, Erwin; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [Baghel, Ankit S.] Stanford Univ, Palo Alto, CA 94304 USA; [De Genst, Erwin] AstraZeneca UK Ltd, Cambridge CB2 0AA, England	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Wadsworth Center; University of Cambridge; Stanford University; AstraZeneca	Messer, A (corresponding author), Neural Stem Cell Inst, Rensselaer, NY 12144 USA.; Messer, A (corresponding author), SUNY Albany, Dept Biomed Sci, Albany, NY 12208 USA.; Messer, A (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA.	annemesser@neuralsci.org		Baghel, Ankit/0000-0001-7853-1109	Michael J Fox Foundation; NIH/NINDS [NS053912, NS073415, NS061257]; Albany Medical College; Medical Research Council [MRC G1002272]; MRC [G1002272] Funding Source: UKRI	Michael J Fox Foundation; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Albany Medical College; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work by AM and DCB was supported by the Michael J Fox Foundation, and NIH/NINDS [NS053912, NS073415 and NS061257]. Student stipend for SNJ was provided by Albany Medical College during portions of this work. EDG and CMD are grateful for support obtained by the Medical Research Council (MRC G1002272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029199; Chanez-Cardenas Maria Elena, 2012, J Biophys, V2012, P606172, DOI 10.1155/2012/606172; Corrochano S, 2012, AUTOPHAGY, V8, P431, DOI 10.4161/auto.19259; Corrochano S, 2012, HUM MOL GENET, V21, P485, DOI 10.1093/hmg/ddr477; da Fonseca TL, 2015, BIOMOLECULES, V5, P435, DOI 10.3390/biom5020435; De Genst E, 2014, BBA-PROTEINS PROTEOM, V1844, P1907, DOI 10.1016/j.bbapap.2014.08.016; De Genst EJ, 2010, J MOL BIOL, V402, P326, DOI 10.1016/j.jmb.2010.07.001; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; El-Turk F, 2016, BIOCHEMISTRY-US, V55, P3116, DOI 10.1021/acs.biochem.6b00149; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Furlong RA, 2000, BIOCHEM J, V346, P577, DOI 10.1042/0264-6021:3460577; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Guilliams T, 2013, J MOL BIOL, V425, P2397, DOI 10.1016/j.jmb.2013.01.040; Hornykiewicz O, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.2_Suppl_2.S2; Huston J S, 1993, Int Rev Immunol, V10, P195, DOI 10.3109/08830189309061696; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Joshi SN, 2012, MABS-AUSTIN, V4, P686, DOI 10.4161/mabs.21696; Khoshnan A, 2002, P NATL ACAD SCI USA, V99, P1002, DOI 10.1073/pnas.022631799; Kvam E, 2010, PROTEIN ENG DES SEL, V23, P489, DOI 10.1093/protein/gzq022; Kvam E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005727; Lea A, 2014, P NATL ACAD SCI USA, V111, P12486, DOI 10.1073/pnas.1402012111; Lecerf JM, 2001, P NATL ACAD SCI USA, V98, P4764, DOI 10.1073/pnas.071058398; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lynch SM, 2008, J MOL BIOL, V377, P136, DOI 10.1016/j.jmb.2007.11.096; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; Messer A, 2013, NEUROTHERAPEUTICS, V10, P447, DOI 10.1007/s13311-013-0193-6; Mezey E, 1998, MOL PSYCHIATR, V3, P493, DOI 10.1038/sj.mp.4000446; Muyldermans S, 2001, J Biotechnol, V74, P277; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Pinotsi D, 2016, P NATL ACAD SCI USA, V113, P3815, DOI 10.1073/pnas.1516546113; Pocas GM, 2015, HUM MOL GENET, V24, P1898, DOI 10.1093/hmg/ddu606; Ravikumar B, 2004, NEUROREPORT, V15, P2443, DOI 10.1097/00001756-200411150-00001; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tomas-Zapico C, 2012, HUM MOL GENET, V21, P495, DOI 10.1093/hmg/ddr507; Valera E, 2016, NEUROTHERAPEUTICS, V13, P179, DOI 10.1007/s13311-015-0397-z; van Genderen H, 2006, NAT PROTOC, V1, P363, DOI 10.1038/nprot.2006.55; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Xin W, 2015, BIOMOLECULES, V5, P1634, DOI 10.3390/biom5031634; Yan JQ, 2014, MOL NEUROBIOL, V50, P685, DOI 10.1007/s12035-014-8738-1; Yerbury JJ, 2016, J NEUROCHEM, V137, P489, DOI 10.1111/jnc.13575; Zhao XN, 1999, METHOD ENZYMOL, V302, P32, DOI 10.1016/S0076-6879(99)02006-6; Zhou C, 2004, MOL THER, V10, P1023, DOI 10.1016/j.ymthe.2004.08.019	48	37	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165964	10.1371/journal.pone.0165964	http://dx.doi.org/10.1371/journal.pone.0165964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824888	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200051
J	Ebner, L; Walti, LN; Rauch, A; Furrer, H; Cusini, A; Meyer, AMJ; Weiler, S; Huynh-Do, U; Heverhagen, J; Arampatzis, S; Christe, A				Ebner, Lukas; Walti, Laura N.; Rauch, Andri; Furrer, Hansjakob; Cusini, Alexia; Meyer, Andreas M. J.; Weiler, Stefan; Huynh-Do, Uyen; Heverhagen, Johannes; Arampatzis, Spyridon; Christe, Andreas			Clinical Course, Radiological Manifestations, and Outcome of Pneumocystis jirovecii Pneumonia in HIV Patients and Renal Transplant Recipients	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; HIGH-RESOLUTION CT; CARINII-PNEUMONIA; AIDS PATIENTS; INFECTION; ACCURACY; PATTERNS; FEATURES	Background Pneumocystis jirovecii pneumonia (PCP) is a frequent opportunistic infection in immuno-compromised patients. In literature, presentation and outcome of PCP differs between patients with human immunodeficiency virus (HIV) infection and renal transplant recipients (RTRs). Methods We conducted a cross-sectional study of patients with PCP based on the HIV and renal transplant registries at our institution. Radiological and clinical data from all confirmed PCP cases between 2005 and 2012 were compared. Results Forty patients were included: 16 with HIV and 24 RTRs. Radiologically, HIV patients had significantly more areas of diffuse lung affection (81% HIV vs. 25% RTR; p = 0.02), more ground glass nodules 5-10 mm (69% vs. 4%; p = <0.001) and enlarged hilar lymph nodes were found only in HIV patients (44%). Cough and dyspnea were the most common clinical signs (>80%) in both groups. Duration from illness onset to hospital presentation was longer in the HIV patients (median of 18 vs. 10 days (p = 0.02)), implying a less fulminant clinical course. Sixty percent of PCP cases in RTRs occurred >12 months after transplantation. Lengths of hospitalization, admission rates to the intensive care unit, and requirements for mechanical ventilation were similar. Outcome in both groups was favourable. Conclusions While important differences in radiological presentation of PCP between HIV patients and RTRs were found, clinical presentation was similar. PCP only rarely presented with fulminant respiratory symptoms requiring ICU admission, with similar results and outcomes for HIV patients and RTRs. Early diagnosis and treatment is mandatory for clinical success.	[Ebner, Lukas; Heverhagen, Johannes; Christe, Andreas] Univ Bern, Univ Hosp Bern, Inselspital, Dept Diagnost Intervent & Pediat Radiol, Bern, Switzerland; [Walti, Laura N.; Rauch, Andri; Furrer, Hansjakob; Cusini, Alexia] Univ Bern, Univ Hosp Bern, Inselspital, Dept Infect Dis, Bern, Switzerland; [Meyer, Andreas M. J.; Weiler, Stefan; Huynh-Do, Uyen; Arampatzis, Spyridon] Univ Bern, Univ Hosp Bern, Inselspital, Dept Hypertens Nephrol & Clin Pharmacol, Bern, Switzerland; [Ebner, Lukas] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Weiler, Stefan] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, Zurich, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Duke University; University of Zurich; University Zurich Hospital	Arampatzis, S (corresponding author), Univ Bern, Univ Hosp Bern, Inselspital, Dept Hypertens Nephrol & Clin Pharmacol, Bern, Switzerland.	spiros.arampatzis@insel.ch	weiler, stefan/ABE-8932-2021; Furrer, Hansjakob/G-6768-2013; Walti, Laura/ABD-8601-2020; Rauch, Andri/E-9948-2017	Furrer, Hansjakob/0000-0002-1375-3146; Rauch, Andri/0000-0001-5297-6062; Ebner, Lukas/0000-0001-5117-6047; Walti, Laura Naemi/0000-0002-7048-6590; Arampatzis, Spyridon/0000-0002-6959-0411; Heverhagen, Johannes/0000-0002-5416-6650				Catherinot E, 2010, INFECT DIS CLIN N AM, V24, P107, DOI 10.1016/j.idc.2009.10.010; Christe A, 2013, EUR J RADIOL, V82, pE142, DOI 10.1016/j.ejrad.2012.09.025; Denis B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094183; Fritzsche C, 2013, NEPHROLOGY, V18, P382, DOI 10.1111/nep.12054; Fujii Takeshi, 2007, Journal of Infection and Chemotherapy, V13, P1, DOI 10.1007/s10156-006-0484-5; GERRARD JG, 1995, MED J AUSTRALIA, V162, P233, DOI 10.5694/j.1326-5377.1995.tb139873.x; Goto N, 2011, TRANSPL INFECT DIS, V13, P551, DOI 10.1111/j.1399-3062.2011.00691.x; Gruden JF, 1997, AM J ROENTGENOL, V169, P967, DOI 10.2214/ajr.169.4.9308446; Hardak E, 2010, LUNG, V188, P159, DOI 10.1007/s00408-009-9214-y; HARTMAN TE, 1994, AM J ROENTGENOL, V162, P547, DOI 10.2214/ajr.162.3.8109494; Hidalgo A, 2003, EUR RADIOL, V13, P1179, DOI 10.1007/s00330-002-1641-6; Kanne JP, 2012, AM J ROENTGENOL, V198, pW555, DOI 10.2214/AJR.11.7329; KOVACS JA, 1984, ANN INTERN MED, V100, P663, DOI 10.7326/0003-4819-100-5-663; Mansharamani NG, 2000, CHEST, V118, P704, DOI 10.1378/chest.118.3.704; McCaughan JA, 2012, NEPHROL DIAL TRANSPL, V27, P13, DOI 10.1093/ndt/gfr444; Morris A, 2008, CLIN INFECT DIS, V46, P634, DOI 10.1086/526779; Neff RT, 2009, TRANSPLANTATION, V88, P135, DOI 10.1097/TP.0b013e3181aad256; Nuesch R, 1999, CLIN INFECT DIS, V29, P1519, DOI 10.1086/313534; Radisic M, 2003, Transpl Infect Dis, V5, P84, DOI 10.1034/j.1399-3062.2003.00018.x; SEPKOWITZ KA, 1992, JAMA-J AM MED ASSOC, V267, P832, DOI 10.1001/jama.267.6.832; Tasaka S, 2010, INTERNAL MED, V49, P273, DOI 10.2169/internalmedicine.49.2871; Walzer PD, 2008, CLIN INFECT DIS, V46, P625, DOI 10.1086/526778; Wang EHZ, 2012, TRANSPL INFECT DIS, V14, P519, DOI 10.1111/j.1399-3062.2012.00740.x; Yale SH, 1996, MAYO CLIN PROC, V71, P5, DOI 10.4065/71.1.5	24	19	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164320	10.1371/journal.pone.0164320	http://dx.doi.org/10.1371/journal.pone.0164320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824870	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000387615200004
J	Kemleu, S; Guelig, D; Moukoko, CE; Essangui, E; Diesburg, S; Mouliom, A; Melingui, B; Manga, J; Donkeu, C; Epote, A; Texier, G; LaBarre, P; Burton, R; Ayong, L				Kemleu, Sylvie; Guelig, Dylan; Moukoko, Carole Eboumbou; Essangui, Estelle; Diesburg, Steven; Mouliom, Abas; Melingui, Bernard; Manga, Jeanne; Donkeu, Christiane; Epote, Annie; Texier, Gaetan; LaBarre, Paul; Burton, Robert; Ayong, Lawrence			A Field-Tailored Reverse Transcription Loop-Mediated Isothermal Assay for High Sensitivity Detection of Plasmodium falciparum Infections	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; SEQUENCE-BASED AMPLIFICATION; REAL-TIME PCR; MALARIA ELIMINATION; ASYMPTOMATIC MALARIA; BLOOD-DONORS; DNA; CHALLENGES; PARASITES; STRATEGIES	Highly sensitive and field deployable molecular diagnostic tools are critically needed for detecting submicroscopic, yet transmissible levels of malaria parasites prevalent in malaria endemic countries worldwide. A reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay was developed and evaluated in comparison with thick blood smear microscopy, an antigen-based rapid diagnostic test (RDT), and an in-house RT-PCR targeting the same RT-LAMP transcript. The optimized assay detected Plasmodium falciparum infections in as little as 0.25ng of total parasite RNA, and exhibited a detection limit of 0.08 parasites/mu L when tested directly on infected whole blood lysates, or similar to 0.0008 parasites/mu L when using RNA extracts. Assay positivity was observed as early as eight minutes from initiation of the RT-LAMP and in most cases the reaction was complete before twenty minutes. Clinical evaluation of the assay on 132 suspected malaria cases resulted in a positivity rate of 90% for RT-LAMP using extracted RNA, and 85% when using whole blood lysates. The positivity rates were 70% for P. falciparum-specific RDT, 83% for RT-PCR, and 74% for thick blood smear microscopy (Mean parasite density = 36,986 parasites/mu L). Concordance rates between the developed RT-LAMP and comparator tests were greater than 75%, the lowest being with light microscopy (78%, McNemar's test: P = 0.0002), and the highest was with RT-PCR (87%, McNemar's test: P = 0.0523). Compared to reference RT-PCR, assay sensitivity was 90% for RT-LAMP on whole blood, and 96% for RT-LAMP using corresponding RNA extracts. Electricity-free heaters were further developed and evaluated in comparison with a battery-operated isothermal amplification machine for use with the developed test in resource-limited settings. Taken together, the data highlight the benefits of targeting high abundant RNA transcripts in molecular diagnosis, as well as the potential usefulness of the developed RT-LAMP-assay in malaria diagnosis in low to high parasite density settings.	[Kemleu, Sylvie; Moukoko, Carole Eboumbou; Essangui, Estelle; Donkeu, Christiane; Ayong, Lawrence] Ctr Pasteur Cameroun, Malaria Res Unit, Yaounde, Cameroon; [Guelig, Dylan; Diesburg, Steven; Burton, Robert] PATH, Seattle, WA USA; [Moukoko, Carole Eboumbou] Univ Douala, Fac Med & Pharmaceut Sci, Douala, Cameroon; [Essangui, Estelle] Univ Douala, Fac Sci, Douala, Cameroon; [Mouliom, Abas; Melingui, Bernard; Manga, Jeanne; Epote, Annie] Ctr Pasteur Cameroun, Hematol Unit, Yaounde, Cameroon; [Texier, Gaetan] Ctr Pasteur Cameroun, Publ Hlth & Epidemiol Unit, Yaounde, Cameroon	Centre Pasteur du Cameroun; Centre Pasteur du Cameroun; Centre Pasteur du Cameroun	Ayong, L (corresponding author), Ctr Pasteur Cameroun, Malaria Res Unit, Yaounde, Cameroon.	layong05@yahoo.co.uk		MANGA MESSINA MBETI, JEANNE/0000-0002-6108-3140	Institut Pasteur International Division [G4]; NIH [R01EB012641-01A1]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012641] Funding Source: NIH RePORTER	Institut Pasteur International Division; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded through a Capacity Building and Training grant (G4 Award) from the Institut Pasteur International Division to LA and an NIH grant R01EB012641-01A1 to RB.	Abdullah S, 2016, PARASITOL RES, V115, P35, DOI 10.1007/s00436-015-4808-1; Amoah LE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1159-z; Aydin-Schmidt B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103905; Baker J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129; Baltzell KA, 2013, AM J TROP MED HYG, V88, P289, DOI 10.4269/ajtmh.2012.12-0095; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Britton S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1158-0; Chander Y, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00395; Connolly Michael A, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4104; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Douamba Zoenabo, 2014, Malar Res Treat, V2014, P390513, DOI 10.1155/2014/390513; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gillet P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002180; Guerin PJ, 2002, LANCET INFECT DIS, V2, P564, DOI 10.1016/S1473-3099(02)00372-9; Hayashida K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003578; Hodgson SH, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0541-6; Hofmann N, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001788; Houze S, 2011, J CLIN MICROBIOL, V49, P2694, DOI 10.1128/JCM.00281-11; Houze S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-211; Hoyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045797; Kamau E, 2011, J CLIN MICROBIOL, V49, P2946, DOI 10.1128/JCM.00276-11; Karunaweera ND, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-59; Kitchen AD, 2014, VOX SANG, V107, P123, DOI 10.1111/vox.12142; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Kubota Ryo, 2011, Biol Eng Trans, V4, P69; Kumar N, 2013, ACTA TROP, V125, P119, DOI 10.1016/j.actatropica.2012.09.015; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau YL, 2016, AM J TROP MED HYG, V94, P336, DOI 10.4269/ajtmh.15-0569; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lee JH, 2014, J CLIN MICROBIOL, V52, P3784, DOI 10.1128/JCM.01797-14; Leshem E, 2011, J CLIN MICROBIOL, V49, P2331, DOI 10.1128/JCM.00307-11; Li Y, 2013, J MOL DIAGN, V15, P634, DOI 10.1016/j.jmoldx.2013.05.005; Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Luchavez J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-286; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P399, DOI 10.1111/1469-0691.12151; McCutchan TF, 2008, EMERG INFECT DIS, V14, P1750, DOI 10.3201/eid1411.080840; Meatherall B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-377; Mohan A, 2014, NATL MED J INDIA, V27, P297; Mohon A, 2016, DIAGN MICR INFEC DIS, V85, P149, DOI 10.1016/j.diagmicrobio.2015.11.009; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Moya-Alvarez V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-271; Murphy SC, 2012, AM J TROP MED HYG, V86, P383, DOI 10.4269/ajtmh.2012.10-0658; Nakao R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-296; Newby G, 2015, AM J TROP MED HYG, V93, P125, DOI 10.4269/ajtmh.14-0254; Nkouawa A, 2010, J CLIN MICROBIOL, V48, P3350, DOI 10.1128/JCM.00697-10; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; O'Brien SF, 2015, TRANSFUS MED REV, V29, P162, DOI 10.1016/j.tmrv.2015.03.004; Oladeinde BH, 2014, IRAN J PARASITOL, V9, P415; Olawumi Hannah O, 2015, Afr J Infect Dis, V9, P10, DOI 10.4314/ajid.v9i1.3; Oriero EC, 2015, J ANTIMICROB CHEMOTH, V70, P2, DOI 10.1093/jac/dku343; Oriero EC, 2015, EXPERT REV MOL DIAGN, V15, P1419, DOI 10.1586/14737159.2015.1090878; Polley SD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-62; Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10; Rio DC., 2010, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5439, DOI 10.1101/PDB.PROT5439]; Schneider P, 2005, J CLIN MICROBIOL, V43, P402, DOI 10.1128/JCM.43.1.402-405.2005; Schoone GJ, 2000, J CLIN MICROBIOL, V38, P4072, DOI 10.1128/JCM.38.11.4072-4075.2000; Sema M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0559-9; Shah Sajid Ali, 2015, J Ayub Med Coll Abbottabad, V27, P721; Shakely D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072912; Singleton J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113693; Singleton J, 2013, PROC SPIE, V8615, DOI 10.1117/12.2005928; Slater HC, 2015, NATURE, V528, pS94, DOI 10.1038/nature16040; Stresman G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-353; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; Xiao Hui-hui, 2014, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V32, P474	70	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165506	10.1371/journal.pone.0165506	http://dx.doi.org/10.1371/journal.pone.0165506			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824866	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200020
J	Coward, S; Kareemi, H; Clement, F; Zimmer, S; Dixon, E; Ball, CG; Heitman, SJ; Swain, M; Ghosh, S; Kaplan, GG				Coward, Stephanie; Kareemi, Hashim; Clement, Fiona; Zimmer, Scott; Dixon, Elijah; Ball, Chad G.; Heitman, Steven J.; Swain, Mark; Ghosh, Subrata; Kaplan, Gilaad G.			Incidence of Appendicitis over Time: A Comparative Analysis of an Administrative Healthcare Database and a Pathology-Proven Appendicitis Registry	PLOS ONE			English	Article							SUSPECTED APPENDICITIS; EPIDEMIOLOGY; DISEASE; APPENDECTOMY; INFECTION	Importance At the turn of the 21(st) century, studies evaluating the change in incidence of appendicitis over time have reported inconsistent findings. Objectives We compared the differences in the incidence of appendicitis derived from a pathology registry versus an administrative database in order to validate coding in administrative data-bases and establish temporal trends in the incidence of appendicitis. Design We conducted a population-based comparative cohort study to identify all individuals with appendicitis from 2000 to2008. Setting & Participants Two population-based data sources were used to identify cases of appendicitis: 1) a pathology registry (n = 8,822); and 2) a hospital discharge abstract database (n = 10,453). Intervention & Main Outcome The administrative database was compared to the pathology registry for the following a priori analyses: 1) to calculate the positive predictive value (PPV) of administrative codes; 2) to compare the annual incidence of appendicitis; and 3) to assess differences in temporal trends. Temporal trends were assessed using a generalized linear model that assumed a Poisson distribution and reported as an annual percent change (APC) with 95% confidence intervals (CI). Analyses were stratified by perforated and non-perforated appendicitis. Results The administrative database (PPV = 83.0%) overestimated the incidence of appendicitis (100.3 per 100,000) when compared to the pathology registry (84.2 per 100,000). Codes for perforated appendicitis were not reliable (PPV = 52.4%) leading to overestimation in the incidence of perforated appendicitis in the administrative database (34.8 per 100,000) as compared to the pathology registry (19.4 per 100,000). The incidence of appendicitis significantly increased over time in both the administrative database (APC = 2.1%; 95% CI: 1.3, 2.8) and pathology registry (APC = 4.1; 95% CI: 3.1, 5.0). Conclusion & Relevance The administrative database overestimated the incidence of appendicitis, particularly among perforated appendicitis. Therefore, studies utilizing administrative data to analyze perforated appendicitis should be interpreted cautiously.	[Coward, Stephanie; Kareemi, Hashim; Heitman, Steven J.; Swain, Mark; Ghosh, Subrata; Kaplan, Gilaad G.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Coward, Stephanie; Clement, Fiona; Dixon, Elijah; Heitman, Steven J.; Kaplan, Gilaad G.] Univ Calgary, Community Hlth Sci, Calgary, AB, Canada; [Zimmer, Scott] Alberta Hlth Serv, Informat Management & Disseminat, Med, Calgary, AB, Canada; [Dixon, Elijah; Ball, Chad G.] Univ Calgary, Dept Surg, Calgary, AB, Canada	University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary	Kaplan, GG (corresponding author), Univ Calgary, Dept Med, Calgary, AB, Canada.; Kaplan, GG (corresponding author), Univ Calgary, Community Hlth Sci, Calgary, AB, Canada.	ggkaplan@ucalgary.ca	Ghosh, Subrata/AAC-2676-2021; Kaplan, Gil/AAH-2335-2021	Ghosh, Subrata/0000-0002-1713-7797; Kaplan, Gil/0000-0003-2719-0556	New Investigator Award from the Canadian Institute of Health Research; Population Health Investigator Award from Alberta-Innovates Health-Solutions; Eyes High Doctoral Recruitment Scholarship from the University of Calgary	New Investigator Award from the Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Population Health Investigator Award from Alberta-Innovates Health-Solutions; Eyes High Doctoral Recruitment Scholarship from the University of Calgary	Dr. Kaplan is supported through a New Investigator Award from the Canadian Institute of Health Research and a Population Health Investigator Award from Alberta-Innovates Health Solutions. Stephanie Coward is supported by an Eyes High Doctoral Recruitment Scholarship from the University of Calgary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Kaplan is supported through a New Investigator Award from the Canadian Institute of Health Research and a Population Health Investigator Award from Alberta-Innovates Health-Solutions. This study is based in part on data provided by Alberta Health. The interpretation and conclusions contained herein are those of the researchers and do not necessarily represent the views of the Government of Alberta. Neither the Government nor Alberta Health express any opinion in relation to this study.; Stephanie Coward is supported by an Eyes High Doctoral Recruitment Scholarship from the University of Calgary.	Aarabi S, 2011, J PEDIATR SURG, V46, P1106, DOI 10.1016/j.jpedsurg.2011.03.039; ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; Al-Omran M, 2003, CAN J SURG, V46, P263; Alder AC, 2010, ARCH SURG-CHICAGO, V145, P63, DOI 10.1001/archsurg.2009.250; Anderson JE, 2012, WORLD J SURG, V36, P2787, DOI 10.1007/s00268-012-1749-z; ANDERSSON R, 1994, BRIT MED J, V308, P107, DOI 10.1136/bmj.308.6921.107; Andersson R, 1999, EUR J SURG, V165, P481, DOI 10.1080/110241599750006749; [Anonymous], 2009, 2009ICD9CM; Ball CG, 2014, CAN J SURG, V57, P194, DOI 10.1503/cjs.019912; Buckius MT, 2012, J SURG RES, V175, P185, DOI 10.1016/j.jss.2011.07.017; Carr N J, 2000, Ann Diagn Pathol, V4, P46, DOI 10.1016/S1092-9134(00)90011-X; Davies GM, 2004, SURG INFECT LARCHMT, V5, P160, DOI DOI 10.1089/; Ferris M, 2010, AM COLL GAS IN PRESS; Gagne JP, 2007, SURG ENDOSC, V21, P1383, DOI 10.1007/s00464-007-9227-7; Kaplan GG, 2013, ENVIRON HEALTH PERSP, V121, P939, DOI 10.1289/ehp.1206085; Kaplan GG, 2014, INFLAMM BOWEL DIS, V20, P1777, DOI 10.1097/MIB.0000000000000161; Kaplan GG, 2009, CAN MED ASSOC J, V181, P591, DOI 10.1503/cmaj.082068; Kelly HA, 1905, VERMIFORM APPENDIX D, P26; Livingston EH, 2007, ANN SURG, V245, P886, DOI 10.1097/01.sla.0000256391.05233.aa; Molodecky NA, 2011, INFLAMM BOWEL DIS, V17, P1792, DOI 10.1002/ibd.21511; Negron ME, 2014, CAN J GASTROENTEROL, V28, P373, DOI 10.1155/2014/914303; Sadot E, 2013, AM J SURG, V206, P805, DOI 10.1016/j.amjsurg.2013.05.002; Seetahal SA, 2011, AM J SURG, V201, P433, DOI 10.1016/j.amjsurg.2010.10.009; Teixeira Pedro G R, 2013, Adv Surg, V47, P119; To T, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-250; WILLIAMS GR, 1983, ANN SURG, V197, P495, DOI 10.1097/00000658-198305000-00001; World Health Organization (WHO), 2010, ICD 10 VERSION 2010	27	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165161	10.1371/journal.pone.0165161	http://dx.doi.org/10.1371/journal.pone.0165161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820826	Green Published, Green Submitted, gold			2022-12-27	WOS:000387614800007
J	Siddiqi, A; Stoppani, J; Anadon, LD; Narayanamurti, V				Siddiqi, Afreen; Stoppani, Jonathan; Anadon, Laura Diaz; Narayanamurti, Venkatesh			Scientific Wealth in Middle East and North Africa: Productivity, Indigeneity, and Specialty in 1981-2013	PLOS ONE			English	Article							KNOWLEDGE; INNOVATION; TEAMS; COLLABORATION; PERSPECTIVE; SCIENCE; NATIONS; IMPACT	Several developing countries seek to build knowledge-based economies by attempting to expand scientific research capabilities. Characterizing the state and direction of progress in this arena is challenging but important. Here, we employ three metrics: a classical metric of productivity (publications per person), an adapted metric which we denote as Revealed Scientific Advantage (developed from work used to compare publications in scientific fields among countries) to characterize disciplinary specialty, and a new metric, scientific indigeneity (defined as the ratio of publications with domestic corresponding authors) to characterize the locus of scientific activity that also serves as a partial proxy for local absorptive capacity. These metrics-using population and publications data that are available for most countries-allow the characterization of some key features of national scientific enterprise. The trends in productivity and indigeneity when compared across other countries and regions can serve as indicators of strength or fragility in the national research ecosystems, and the trends in specialty can allow regional policy makers to assess the extent to which the areas of focus of research align (or not align) with regional priorities. We apply the metrics to study the Middle East and North Africa (MENA)-a region where science and technology capacity will play a key role in national economic diversification. We analyze 9.8 million publication records between 1981-2013 in 17 countries of MENA from Morocco to Iraq and compare it to selected countries throughout the world. The results show that international collaborators increasingly drove the scientific activity in MENA. The median indigeneity reached 52% in 2013 (indicating that almost half of the corresponding authors were located in foreign countries). Additionally, the regional disciplinary focus in chemical and petroleum engineering is waning with modest growth in the life sciences. We find repeated patterns of stagnation and contraction of scientific activity for several MENA countries contributing to a widening productivity gap on an international comparative yardstick. The results prompt questions about the strength of the developing scientific enterprise and highlight the need for consistent long-term policy for effectively addressing regional challenges with domestic research.	[Siddiqi, Afreen; Anadon, Laura Diaz; Narayanamurti, Venkatesh] Harvard Univ, John F Kennedy Sch Govt, Belfer Ctr Sci & Int Affairs, Cambridge, MA 02138 USA; [Siddiqi, Afreen] MIT, Inst Data Syst & Soc, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Stoppani, Jonathan] Haute Ecole Specialisee Suisse Occidentale, Blvd Perolles 80, CH-1700 Fribourg, Switzerland; [Anadon, Laura Diaz] Univ Cambridge, Dept Polit & Int Studies, Cambridge, England; [Narayanamurti, Venkatesh] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); University of Cambridge; Harvard University	Siddiqi, A (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Belfer Ctr Sci & Int Affairs, Cambridge, MA 02138 USA.; Siddiqi, A (corresponding author), MIT, Inst Data Syst & Soc, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	afreen_siddiqi@hks.harvard.edu			Kuwait Program at Harvard Kennedy School	Kuwait Program at Harvard Kennedy School	This research was supported by a grant from the Kuwait Program at Harvard Kennedy School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J., 2011, EXPLORING CHANGING L; Adams J, 2013, NATURE, V497, P557, DOI 10.1038/497557a; Albuquerque E., 2015, DEV NATL SYSTEMS INN; Cimini G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113470; COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553; COILE RC, 1977, J AM SOC INFORM SCI, V28, P366, DOI 10.1002/asi.4630280610; FREEMAN C, 1995, CAMBRIDGE J ECON, V19, P5; Freeman C, 1987, TECHNOLOGY POLICY EC; Gonzalez-Brambila CN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151328; Hajjar D P, 2014, INT J HIGH ED, V3, P45; Hicks D., 2012, HDB THEORY PRACTICE; Hicks D, 2015, NATURE, V520, P429, DOI 10.1038/520429a; JAFFE AB, 1993, Q J ECON, V108, P577, DOI 10.2307/2118401; Jones BF, 2008, SCIENCE, V322, P1259, DOI 10.1126/science.1158357; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; Leydesdorff L, 2009, J AM SOC INF SCI TEC, V60, P348, DOI 10.1002/asi.20967; May RM, 1997, SCIENCE, V275, P793, DOI 10.1126/science.275.5301.793; McKelvey M, 2003, RES POLICY, V32, P483, DOI 10.1016/S0048-7333(02)00020-3; Narula R, 2003, 0402 DAN RES U IND D; National Science Board, 2014, SCI ENG IND 2014; Richard Nelson R, 1993, NATL INNOVATION SYST; Schumpeter Joseph, 1934, THEORY EC DEV INQUIR; Siddiqi A, HIGHER ED I IN PRESS; Siddiqi A, SCI TECHNOL IN PRESS; SOLOW RM, 1957, REV ECON STAT, V39, P312, DOI 10.2307/1926047; Sorenson O, 2006, RES POLICY, V35, P994, DOI 10.1016/j.respol.2006.05.002; Toivanen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122098; Tzabbar D, 2015, ORGAN SCI, V26, P811, DOI 10.1287/orsc.2015.0969; Uzzi B, 2005, AM J SOCIOL, V111, P447, DOI 10.1086/432782; Walsh JP, 2007, J COMPUT-MEDIAT COMM, V12, P712, DOI 10.1111/j.1083-6101.2007.00346.x; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Zahlan A., 2012, SCI DEV SOVEREIGNTY; Zewail A, 2014, NAT MATER, V13, P38	33	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0164500	10.1371/journal.pone.0164500	http://dx.doi.org/10.1371/journal.pone.0164500			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BB	27820831	gold, Green Published			2022-12-27	WOS:000387614800001
J	Irum, B; Khan, SY; Ali, M; Kaul, H; Kabir, F; Rauf, B; Fatima, F; Nadeem, R; Khan, AO; Al Obaisi, S; Naeem, MA; Nasir, IA; Khan, SN; Husnain, T; Riazuddin, S; Akram, J; Eghrari, AO; Riazuddin, SA				Irum, Bushra; Khan, Shahid Y.; Ali, Muhammad; Kaul, Haiba; Kabir, Firoz; Rauf, Bushra; Fatima, Fareeha; Nadeem, Raheela; Khan, Arif O.; Al Obaisi, Saif; Naeem, Muhammad Asif; Nasir, Idrees A.; Khan, Shaheen N.; Husnain, Tayyab; Riazuddin, Sheikh; Akram, Javed; Eghrari, Allen O.; Riazuddin, S. Amer			Mutation in LIM2 Is Responsible for Autosomal Recessive Congenital Cataracts	PLOS ONE			English	Article							INTRINSIC MEMBRANE-PROTEIN; CONSANGUINEOUS PAKISTANI FAMILIES; NONSENSE MUTATION; MISSENSE MUTATION; BOVINE LENS; LOCUS; GENE; MP19; IDENTIFICATION; LOCALIZATION	Purpose To identify the molecular basis of non-syndromic autosomal recessive congenital cataracts (arCC) in a consanguineous family. Methods All family members participating in the study received a comprehensive ophthalmic examination to determine their ocular phenotype and contributed a blood sample, from which genomic DNA was extracted. Available medical records and interviews with the family were used to compile the medical history of the family. The symptomatic history of the individuals exhibiting cataracts was confirmed by slit-lamp biomicroscopy. A genome-wide linkage analysis was performed to localize the disease interval. The candidate gene, LIM2 (lens intrinsic membrane protein 2), was sequenced bi-directionally to identify the disease-causing mutation. The physical changes caused by the mutation were analyzed in silico through homology modeling, mutation and bioinformatic algorithms, and evolutionary conservation databases. The physiological importance of LIM2 to ocular development was assessed in vivo by real-time expression analysis of Lim2 in a mouse model. Results Ophthalmic examination confirmed the diagnosis of nuclear cataracts in the affected members of the family; the inheritance pattern and cataract development in early infancy indicated arCC. Genome-wide linkage analysis localized the critical interval to chromosome 19q with a two-point logarithm of odds (LOD) score of 3.25. Bidirectional sequencing identified a novel missense mutation, c.233G> A (p.G78D) in LIM2. This mutation segregated with the disease phenotype and was absent in 192 ethnically matched control chromosomes. In silico analysis predicted lower hydropathicity and hydrophobicity but higher polarity of the mutant LIM2-encoded protein (MP19) compared to the wild-type. Moreover, these analyses predicted that the mutation would disrupt the secondary structure of a transmembrane domain of MP19. The expression of Lim2, which was detected in the mouse lens as early as embryonic day 15 (E15) increased after birth to a level that was sustained through the postnatal time points. Conclusion A novel missense mutation in LIM2 is responsible for autosomal recessive congenital cataracts.	[Irum, Bushra; Khan, Shahid Y.; Ali, Muhammad; Kaul, Haiba; Kabir, Firoz; Rauf, Bushra; Eghrari, Allen O.; Riazuddin, S. Amer] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Irum, Bushra; Rauf, Bushra; Fatima, Fareeha; Nadeem, Raheela; Naeem, Muhammad Asif; Nasir, Idrees A.; Khan, Shaheen N.; Husnain, Tayyab; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan; [Khan, Arif O.; Al Obaisi, Saif] King Khalid Eye Specialist Hosp, Riyadh 12329, Saudi Arabia; [Riazuddin, Sheikh; Akram, Javed] Univ Hlth Sci, Allama Iqbal Med Coll, Lahore 54550, Pakistan; [Riazuddin, Sheikh; Akram, Javed] Shaheed Zulfiqar Ali Bhutto Med Univ, Natl Ctr Genet Dis, Islamabad 44000, Pakistan; [Riazuddin, S. Amer] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; King Khaled Eye Specialist Hospital; University of Health Science - Pakistan; Johns Hopkins University	Riazuddin, SA (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA.; Riazuddin, SA (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	riazuddin@jhmi.edu	Eghrari, Allen/AAI-9282-2021; Eghrari, Allen/ABH-4964-2020; Husnain, Tayyab/AAE-9033-2019; Nasir, Idrees Ahmad/T-7695-2019	Eghrari, Allen/0000-0003-2798-038X; Naeem, Muhammad Asif/0000-0001-8547-6419; Kaul, Haiba/0000-0001-8257-4128; Alobaisi, Saif/0000-0002-5493-8315	National Eye Institute [R01EY022714]; Knights Templar Eye Foundation grant; King Khaled Eye Specialist Hospital-Johns Hopkins University collaboration grant; National Academy of Sciences, Washington DC USA; Higher Education Commission, Islamabad Pakistan; NATIONAL EYE INSTITUTE [R01EY022714] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Knights Templar Eye Foundation grant; King Khaled Eye Specialist Hospital-Johns Hopkins University collaboration grant; National Academy of Sciences, Washington DC USA; Higher Education Commission, Islamabad Pakistan(Higher Education Commission of Pakistan); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by the National Eye Institute, grant R01EY022714 (SAR), the Knights Templar Eye Foundation grant (SAR), King Khaled Eye Specialist Hospital-Johns Hopkins University collaboration grant (SAR), the National Academy of Sciences, Washington DC USA, and the Higher Education Commission, Islamabad Pakistan.	Abu Safieh L, 2009, MOL VIS, V15, P980; Aldahmesh MA, 2012, HUM MUTAT, V33, P960, DOI 10.1002/humu.22071; Arneson ML, 1998, EXP EYE RES, V66, P495, DOI 10.1006/exer.1998.0477; Butt T, 2007, MOL VIS, V13, P1635; Chen JJ, 2011, AM J HUM GENET, V88, P827, DOI 10.1016/j.ajhg.2011.05.008; Chen T, 2002, MOL VIS, V8, P372; Cohen D, 2007, INVEST OPHTH VIS SCI, V48, P2208, DOI 10.1167/iovs.06-1019; GUTEKUNST KA, 1990, CURR EYE RES, V9, P955, DOI 10.3109/02713689009069931; Heon E, 2001, AM J HUM GENET, V68, P772, DOI 10.1086/318798; Jiao XD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157005; Jiaox X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137973; Kaul H, 2010, MOL VIS, V16, P511; Kaul H, 2010, MOL VIS, V16, P240; Khan SY, 2015, INVEST OPHTH VIS SCI, V56, P4919, DOI 10.1167/iovs.14-16253; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LOUIS CF, 1989, J BIOL CHEM, V264, P19967; Maher GJ, 2012, EXP EYE RES, V103, P115, DOI 10.1016/j.exer.2011.08.006; MERIN S, 1971, CAN J OPHTHALMOLOGY, V6, P178; MULDERS JWM, 1988, CURR EYE RES, V7, P207, DOI 10.3109/02713688808995750; Ponnam SPG, 2008, MOL VIS, V14, P1204; Ponnam SPG, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050138; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Pras E, 2004, INVEST OPHTH VIS SCI, V45, P1940, DOI 10.1167/iovs.03-1117; Pras E, 2002, AM J HUM GENET, V70, P1363, DOI 10.1086/340318; Pras E, 2001, ISR MED ASSOC J, V3, P559; Ramachandran RD, 2007, HUM GENET, V121, P475, DOI 10.1007/s00439-006-0319-6; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P623, DOI 10.1167/iovs.04-0955; ROBINSON GC, 1987, AM J DIS CHILD, V141, P1321, DOI 10.1001/archpedi.1987.04460120087041; Sabir N, 2010, MOL VIS, V16, P2911; Sabir N, 2010, MOL VIS, V16, P2634; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Shi YR, 2011, INVEST OPHTH VIS SCI, V52, P7332, DOI 10.1167/iovs.11-7724; Shiels A, 2007, ARCH OPHTHALMOL-CHIC, V125, P165, DOI 10.1001/archopht.125.2.165; Smaoui N, 2004, INVEST OPHTH VIS SCI, V45, P2716, DOI 10.1167/iovs.03-1370; Steele E C Jr, 1997, Mol Vis, V3, P5; TENBROEK E, 1992, J CELL SCI, V103, P245; Yasmeen A, 2010, MOL VIS, V16, P682; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650; Zhou L, 2001, MOL VIS, V7, P79	41	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0162620	10.1371/journal.pone.0162620	http://dx.doi.org/10.1371/journal.pone.0162620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814360	gold, Green Published, Green Submitted			2022-12-27	WOS:000386911100002
J	Lou, XD; Li, Y; Gu, WW; Zhang, J				Lou, Xiaodan; Li, Yong; Gu, Weiwei; Zhang, Jiang			The Atlas of Chinese World Wide Web Ecosystem Shaped by the Collective Attention Flows	PLOS ONE			English	Article								The web can be regarded as an ecosystem of digital resources connected and shaped by collective successive behaviors of users. Knowing how people allocate limited attention on different resources is of great importance. To answer this, we embed the most popular Chinese web sites into a high dimensional Euclidean space based on the open flow network model of a large number of Chinese users' collective attention flows, which both considers the connection topology of hyperlinks between the sites and the collective behaviors of the users. With these tools, we rank the web sites and compare their centralities based on flow distances with other metrics. We also study the patterns of attention flow allocation, and find that a large number of web sites concentrate on the central area of the embedding space, and only a small fraction of web sites disperse in the periphery. The entire embedding space can be separated into 3 regions(core, interim, and periphery). The sites in the core (1%) occupy a majority of the attention flows (40%), and the sites (34%) in the interim attract 40%, whereas other sites (65%) only take 20% flows. What's more, we clustered the web sites into 4 groups according to their positions in the space, and found that similar web sites in contents and topics are grouped together. In short, by incorporating the open flow network model, we can clearly see how collective attention allocates and flows on different web sites, and how web sites connected each other.	[Lou, Xiaodan; Gu, Weiwei; Zhang, Jiang] Beijing Normal Univ, Sch Syst Sci, Beijing, Peoples R China; [Li, Yong] Northwest Normal Univ, Coll Comp Sci & Engn, Lanzhou, Peoples R China	Beijing Normal University; Northwest Normal University - China	Zhang, J (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing, Peoples R China.	zhangjiang@bnu.edu.cn			Fundamental Research Funds for the Central Universities [2015KJJCB13]; National Natural Science Foundation of China [61673070, 71263046, 61662070]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The Fundamental Research Funds for the Central Universities with grant number of 2015KJJCB13, National Natural Science Foundation of China 61673070, National Natural Science Foundation of China 71263046, and National Natural Science Foundation of China 61662070.	Banerjee A, 2001, 1 SIAM C, P143; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Bucklin RE, 2002, MARKET LETT, V13, P245, DOI 10.1023/A:1020231107662; Cheriyan A, 2011, SONGLIAO J, V12, P149; Delia M, 1998, SCIENCE, V280, P95; Demange G, 2014, J DYN GAMES, V1, P17, DOI 10.3934/jdg.2014.1.17; Gleeson JP, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.048701; Golder SA, 2006, J INF SCI, V32, P198, DOI 10.1177/0165551506062337; Grabowicz PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029358; Guo LZ, 2015, PHYSICA A, V437, P235, DOI 10.1016/j.physa.2015.05.070; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Huberman B.A., 2009, SOCIAL ATTENTION AGE, P62; Huberman BA, 1998, SCIENCE, V280, P95, DOI 10.1126/science.280.5360.95; Huberman BA, 2008, COMPUTER, V41, P103, DOI 10.1109/MC.2008.450; Lee Kyumin, 2013, ICWSM; Li Y, 2015, J COMPUT SCI TECH-CH, V30, P1175, DOI 10.1007/s11390-015-1592-4; Lskold A., ATTENTION EC OVERVIE; Meiss M. R., 2008, P INT C WEB SEARCH W, P65, DOI DOI 10.1145/1341531.1341543; Moussaid M, 2009, ARXIV09092757; Page L, 1990, PAGERANK CITATION RA, P1999; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Richards TJ, 2015, APPL EC; Romero D. M., 2011, P 20 INT C WORLD WID, P695, DOI [10.1145/1963405.1963503, DOI 10.1145/1963405.1963503]; Saito S, 2015, ARCH PEDIAT ADOL MED, V165, P1006, DOI [10.1371/journal.pone.0139085, DOI 10.1371/J0URNAL.P0NE.0139085]; Sasahara K, 2013, PLOS ONE, V8, P95, DOI [10.1371/journal.pone.0061823, DOI 10.1371/J0URNAL.P0NE.0061823]; Shi PT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136243; Simon HA, 1970, DESIGNING ORG INFORM, P37; Takhteyev Y, 2012, SOC NETWORKS, V34, P73, DOI 10.1016/j.socnet.2011.05.006; Tutte W. T., 1963, P LOND MATH SOC, Vs3-s13, P743, DOI DOI 10.1112/PLMS/S3-13.1.743; Weng L, 2012, SCI REP-UK, V2, P1, DOI 10.1038/srep00335; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104; Wu LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102646; Wu LF, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026113; Wu S., 2011, P 20 INT C WORLD WID, V20, P705, DOI [DOI 10.1145/1963405.1963504, 10.1145/1963405.1963504]	34	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165240	10.1371/journal.pone.0165240	http://dx.doi.org/10.1371/journal.pone.0165240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812133	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000024
J	Mank, A; van Zanten, HA; Meyer, MP; Pauws, S; Lopriore, E; te Pas, AB				Mank, Arenda; van Zanten, Henriette A.; Meyer, Michael P.; Pauws, Steffen; Lopriore, Enrico; te Pas, Arjan B.			Hypothermia in Preterm Infants in the First Hours after Birth: Occurrence, Course and Risk Factors	PLOS ONE			English	Article							WEIGHT INFANTS; TEMPERATURE; NEWBORNS; CARE; ADMISSION; OUTCOMES; DEATH	Background Hypothermia is associated with increased morbidity and mortality rates. Preterm infants frequently have hypothermia when they are admitted to the NICU, but there is no data on the occurrence of hypothermia during the first hours after admission. Objective To investigate the occurrence of hypothermia in preterm infants in the first three hours of admission and to identify risk factors. Methods Infants < 32 weeks of gestation included in a randomized trial with admission temperature as primary outcome were retrospectively analyzed for the occurrence of hypothermia (< 36.5 E degrees C) in the first three hours after admission. Risk factors were identified using linear regression analysis and logistic regression. Results In total 80 infants were included with a median (IQR) gestational age at birth of 29 (27-30) weeks. In 93% of the infants hypothermia occurred in the first three hours after admission. The median (IQR) duration of hypothermia was 101 (34-162) minutes, of which 24 (7-52) minutes the hypothermia was mild, 45 (4-111) minutes moderate, severe hypothermia hardly occurred. Gestational age and the occurrence of hypothermia at birth were independent risk factors for the occurrence of moderate and severe hypothermia and significantly correlated with duration of hypothermia. Conclusions Hypothermia occurred often and for a long period in preterm infants in the first three hours of life, low gestational age and admission temperature were independent risk factors	[Mank, Arenda; van Zanten, Henriette A.; Lopriore, Enrico; te Pas, Arjan B.] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands; [Meyer, Michael P.] Middlemore Hosp, Div Neonatol, Dept Pediat, Auckland, New Zealand; [Pauws, Steffen] Philips Res Healthcare, Eindhoven, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Philips; Philips Healthcare	te Pas, AB (corresponding author), Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands.	a.b.te_pas@lumc.nl	Lopriore, Enrico/ABE-3576-2021; pas, arjan te/AAA-9019-2020	Lopriore, Enrico/0000-0002-3513-5066; pas, arjan te/0000-0001-7831-8797				de Almeida MFB, 2014, J PEDIATR-US, V164, P271, DOI 10.1016/j.jpeds.2013.09.049; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; DAGA AS, 1991, J TROP PEDIATRICS, V37, P53, DOI 10.1093/tropej/37.2.53; Gentles TL, 1997, J THORAC CARDIOV SUR, V114, P392, DOI 10.1016/S0022-5223(97)70184-3; Helder OK, 2012, ACTA PAEDIATR, V101, pe240, DOI 10.1111/j.1651-2227.2011.02583.x; JOHANSON RB, 1992, ACTA PAEDIATR, V81, P859, DOI 10.1111/j.1651-2227.1992.tb12123.x; Laptook AR, 2007, PEDIATRICS, V119, pE643, DOI 10.1542/peds.2006-0943; McCall EM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004210.pub4; Meyer MP, 2001, PEDIATRICS, V108, P395, DOI 10.1542/peds.108.2.395; Miller SS, 2011, J PERINATOL, V31, pS49, DOI 10.1038/jp.2010.177; Pas ABT, 2010, PEDIATRICS, V125, pE1427, DOI 10.1542/peds.2009-2656; Perlman JM, 2006, PEDIATRICS, V117, pE978, DOI 10.1542/ped.2006-0350; SARMAN I, 1989, ARCH DIS CHILD, V64, P687, DOI 10.1136/adc.64.5.687; Silveira SMD, 2003, J TROP PEDIATRICS, V49, P115, DOI 10.1093/tropej/49.2.115; *WHO, 1993, THERM CONTR NEWB PRA	15	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164817	10.1371/journal.pone.0164817	http://dx.doi.org/10.1371/journal.pone.0164817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812148	Green Submitted, gold, Green Published			2022-12-27	WOS:000386910000013
J	Moure-Rodriguez, L; Pineiro, M; Varela, MC; Rodriguez-Holguin, S; Cadaveira, F; Caamano-Isorna, F				Moure-Rodriguez, Lucia; Pineiro, Maria; Varela, Montserrat Corral; Rodriguez-Holguin, Socorro; Cadaveira, Fernando; Caamano-Isorna, Francisco			Identifying Predictors and Prevalence of Alcohol Consumption among University Students: Nine Years of Follow-Up	PLOS ONE			English	Article							HEAVY EPISODIC DRINKING; BINGE DRINKING; COLLEGE-STUDENTS; SAMPLE; RISK; ADOLESCENCE; GENDER; EXPECTANCIES; ADULTHOOD; HISTORY	Aim To evaluate the prevalence of alcohol consumption among university students during late adolescence and young adulthood and to identify the associated factors. Material and Methods Cohort study among university students in Spain (n = 1382). Heavy Episodic Drinking (HED) and Risky Consumption (RC) were measured with the Alcohol Use Disorders Identification Test (AUDIT) at ages 18, 20, 22, 24 and 27 years. Data on potential factors associated with alcohol use were obtained with an additional questionnaire. Multilevel logistic regression for repeated measures was used to obtain adjusted OR (Odds Ratios). Results The rates of prevalence of RC were lower, but not statistically significant, in women. The age-related changes in these rates were similar in both genders, and the prevalence of RC peaked at 20 years. By contrast, the prevalence of HED was significantly lower in women and peaked at 18 years in women and at 22 years in men. Multivariate models showed that early age of onset of alcohol use (OR = 10.6 and OR = 6.9 for women; OR = 8.3 and OR = 8.2 for men) and positive expectations about alcohol (OR = 7.8 and OR = 4.5 for women; OR = 3.6 and OR = 3.3 for men) were the most important risk factors for RC and HED. Living away from the family home was also a risk factor for both consumption patterns among women (OR = 3.16 and OR = 2.34), while a high maternal education level was a risk factor for RC among both genders (OR = 1.62 for women; OR = 2.49 for men). Conclusions Alcohol consumption decreases significantly at the end of youth, with higher rates of prevalence and a later peak among men. Prevention strategies should focus on beliefs and expectations about alcohol and on delaying the age of onset. Women are at particular risk for these consumption patterns if they live away from their parents. Belonging to a high-income family is a strong risk factor for RC.	[Moure-Rodriguez, Lucia; Pineiro, Maria; Caamano-Isorna, Francisco] Univ Santiago de Compostela, Dept Prevent Med, CIBER Epidemiol & Salud Publ CIBERESP, Santiago De Compostela, Spain; [Varela, Montserrat Corral; Rodriguez-Holguin, Socorro; Cadaveira, Fernando] Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Moure-Rodriguez, L (corresponding author), Univ Santiago de Compostela, Dept Prevent Med, CIBER Epidemiol & Salud Publ CIBERESP, Santiago De Compostela, Spain.	lucia.moure@rai.usc.es	Caamano-Isorna, Francisco/AAL-3770-2020; Holguín, Socorro Rodríguez/D-1800-2010; Varela, Montserrat Corral/AEP-7949-2022; Cadaveira, Fernando/C-5981-2011; /AAD-1740-2020; Cadaveira, Fernando/ABE-7827-2021	Holguín, Socorro Rodríguez/0000-0003-1502-987X; Varela, Montserrat Corral/0000-0003-3068-3415; Cadaveira, Fernando/0000-0001-6198-1541; Cadaveira, Fernando/0000-0001-6198-1541; Caamano-Isorna, Francisco/0000-0001-8995-3673; Pineiro-Lamas, Maria/0000-0003-3655-100X; Moure-Rodriguez, Lucia/0000-0002-9084-6047	Spanish National Plan on Drugs (PND) [SPI/3462/2010]	Spanish National Plan on Drugs (PND)	Funding for this study was provided by the Spanish National Plan on Drugs (PND, SPI/3462/2010). PND played no further role in this study.	Bachman JG, 2003, INT J BEHAV DEV, V27, P301, DOI 10.1080/01650250244000281; Bewick BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-163; Caamano-Isorna F, 2008, J STUD ALCOHOL DRUGS, V69, P308, DOI 10.15288/jsad.2008.69.308; Caamano-Isorna F, 2011, INT J PUBLIC HEALTH, V56, P247, DOI 10.1007/s00038-010-0204-x; Callas PW, 2004, ADDICT BEHAV, V29, P1503, DOI 10.1016/j.addbeh.2004.02.028; Chassin L, 2002, J CONSULT CLIN PSYCH, V70, P67, DOI 10.1037//0022-006X.70.1.67; CHEN K, 1995, AM J PUBLIC HEALTH, V85, P41, DOI 10.2105/AJPH.85.1.41; Choquet M, 2008, ALCOHOL ALCOHOLISM, V43, P73, DOI 10.1093/alcalc/agm060; Cranford JA, 2006, ALCOHOL CLIN EXP RES, V30, P1896, DOI 10.1111/j.1530-0277.2006.00234.x; D'Alessio M, 2006, ADDICT BEHAV, V31, P2328, DOI 10.1016/j.addbeh.2006.03.002; Dantzer C, 2006, J AM COLL HEALTH, V55, P83, DOI 10.3200/JACH.55.2.83-90; Defensor del Menor de la Comunidad de Madrid, 2002, DEFENSOR MENOR COMUN, P307; Delegacion del Gobierno para el Plan Nacional sobre Drogas. Observatorio Espanol sobre Drogas (OED), 2009, INF 2009 SIT TEND PR; Grant JD, 2006, PSYCHOL MED, V36, P109, DOI 10.1017/S0033291705006045; Kelly AB, 2011, J STUD ALCOHOL DRUGS, V72, P399, DOI 10.15288/jsad.2011.72.399; LAIXUTHAI A, 1993, CONTEMP POLICY ISSUE, V11, P70, DOI 10.1111/j.1465-7287.1993.tb00402.x; Leeman RF, 2012, J STUD ALCOHOL DRUGS, V73, P238, DOI 10.15288/jsad.2012.73.238; Lopez-Caneda E, 2014, ALCOHOL, V48, P407, DOI 10.1016/j.alcohol.2014.01.009; Lopez-Caneda E, 2013, ALCOHOL ALCOHOLISM, V48, P464, DOI 10.1093/alcalc/agt046; Lundahl LH, 1997, ADDICT BEHAV, V22, P115, DOI 10.1016/S0306-4603(96)00022-6; Mora-Rios J, 2001, SALUD PUBLICA MEXICO, V43, P89, DOI 10.1590/S0036-36342001000200002; Mota N, 2013, DRUG ALCOHOL DEPEN, V133, P108, DOI 10.1016/j.drugalcdep.2013.05.024; Mota N, 2010, GAC SANIT, V24, P372, DOI 10.1016/j.gaceta.2010.02.013; Moure-Rodriguez L, 2016, GAC SANIT; Moure-Rodriguez L, 2014, GAC SANIT, V28, P376, DOI 10.1016/j.gaceta.2014.02.017; Muthen BO, 2000, J STUD ALCOHOL, V61, P290, DOI 10.15288/jsa.2000.61.290; Organization WH, 2009, GLOB HLTH RISKS MORT; Penafiel E., 2009, PULSO REV EDUCACION, V32, P147; Plant M, 2001, BRIT MED J, V323, P1183, DOI 10.1136/bmj.323.7322.1183; Richter M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-289; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Secedes R, 2001, INTERVENCION FAMILIA, P58; Sher KJ, 1996, J ABNORM PSYCHOL, V105, P561, DOI 10.1037/0021-843X.105.4.561; Sher KJ, 1999, DEV PSYCHOPATHOL, V11, P933, DOI 10.1017/S0954579499002394; Stafstrom M, 2005, J STUD ALCOHOL, V66, P776, DOI 10.15288/jsa.2005.66.776; Tuunanen M, 2007, DRUG ALCOHOL REV, V26, P295, DOI 10.1080/09595230701247756; Varela J., 2005, VALIDATION AUDIT GAL; Wechsler H, 2002, J AM COLL HEALTH, V50, P223, DOI 10.1080/07448480209595714; Weitzman ER, 2005, J EPIDEMIOL COMMUN H, V59, P1065, DOI 10.1136/jech.2005.033183; Wicki M, 2010, ADDICT BEHAV, V35, P913, DOI 10.1016/j.addbeh.2010.06.015	40	30	30	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165514	10.1371/journal.pone.0165514	http://dx.doi.org/10.1371/journal.pone.0165514			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812131	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000033
J	Aw-Yong, KL; Sam, IC; Koh, MT; Chan, YF				Aw-Yong, Kam Leng; Sam, I-Ching; Koh, Mia Tuang; Chan, Yoke Fun			Immunodominant IgM and IgG Epitopes Recognized by Antibodies Induced in Enterovirus A71-Associated Hand, Foot and Mouth Disease Patients	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODY; 71 VACCINE; SYNTHETIC PEPTIDE; INFECTION; IDENTIFICATION; PROTECTION; CHILDREN; MALAYSIA	Enterovirus A71 (EV-A71) is one of the main causative agents of hand, foot and mouth disease (HFMD). Unlike other enteroviruses that cause HFMD, EV-A71 is more frequently associated with severe neurological complications and fatality. To date, no effective licensed antivirals are available to combat EV-A71 infection. Little is known about the immunogenicity of viral non-structural proteins in humans. Previous studies have mainly focused on characterization of epitopes of EV-A71 structural proteins by using immunized animal antisera. In this study, we have characterized human antibody responses against the structural and non-structural proteins of EV-A71. Each viral protein was cloned and expressed in either bacterial or mammalian systems, and tested with antisera by western blot. Results revealed that all structural proteins (VP1-4), and non-structural proteins 2A, 3C and 3D were targets of EV-A71 IgM, whereas EV-A71 IgG recognized all the structural and non-structural proteins. Sixty three synthetic peptides predicted to be immunogenic in silico were synthesized and used for the characterization of EV-A71 linear B-cell epitopes. In total, we identified 22 IgM and four IgG dominant epitopes. Synthetic peptide PEP27, corresponding to residues 142 - 156 of VP1, was identified as the EV-A71 IgM-specific immunodominant epitope. PEP23, mapped to VP1 41 - 55, was recognized as the EV-A71 IgG cross-reactive immunodominant epitope. The structural protein VP1 is the major immunodominant site targeted by anti-EV-A71 IgM and IgG antibodies, but epitopes against non-structural proteins were also detected. These data provide new understanding of the immune response to EV-A71 infection, which benefits the development of diagnostic tools, potential therapeutics and subunit vaccine candidates.	[Aw-Yong, Kam Leng; Sam, I-Ching; Chan, Yoke Fun] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia; [Koh, Mia Tuang] Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Chan, YF (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.	chanyf@ummc.edu.my	Sam, Jamal I-Ching/B-8688-2010; KOH, MIA TUANG/B-8797-2010; abubakar, sazaly/B-3957-2010; Chan, Yoke Fun/B-5351-2010; Ibrahim, Essam Hassan/G-1960-2018	Sam, Jamal I-Ching/0000-0002-1296-7898; abubakar, sazaly/0000-0002-9267-1420; Chan, Yoke Fun/0000-0001-7089-0510; Ibrahim, Essam Hassan/0000-0003-0130-2257; Aw-Yong, Kam Leng/0000-0002-6418-7287	University of Malaya [E000013-20001, RG522-13HTM, PG036-2013B]	University of Malaya(Universiti Malaya)	This study was supported by grants from the University of Malaya (High Impact Research Grant E000013-20001, University Malaya Research Grant RG522-13HTM and Postgraduate Research Grant PG036-2013B).	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Aw-Yong KL, 2016, TROP BIOMED, V33, P238; Bergmann IE, 2003, ARCH VIROL, V148, P891, DOI 10.1007/s00705-002-0965-5; Bronsvoort Barend M deC, 2006, BMC Vet Res, V2, P30, DOI 10.1186/1746-6148-2-30; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Cao RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064024; Cao RY, 2010, CLIN INFECT DIS, V50, P125, DOI 10.1086/649012; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan YF, 2011, NEUROL ASIA, V16, P1; Chang HW, 2011, J VIROL METHODS, V173, P189, DOI 10.1016/j.jviromet.2011.02.003; Clavijo A, 2004, VET J, V167, P9, DOI 10.1016/S1090-0233(03)00087-X; Deng YQ, 2015, APPL MICROBIOL BIOT, V99, P7663, DOI 10.1007/s00253-015-6652-8; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Foo DGW, 2008, VIRAL IMMUNOL, V21, P215, DOI 10.1089/vim.2007.0089; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; Gao F, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-26; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; HAGIWARA A, 1978, INTERVIROLOGY, V9, P60, DOI 10.1159/000148922; Hofmeister Y, 2011, J VIROL, V85, P1896, DOI 10.1128/JVI.02155-10; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Jiang LP, 2015, VACCINE, V33, P6596, DOI 10.1016/j.vaccine.2015.10.104; Kam YW, 2012, J VIROL, V86, P13005, DOI 10.1128/JVI.01780-12; Kiener TK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002895; Kiener TK, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-55; Lee H, 2013, J VIROL, V87, P11363, DOI 10.1128/JVI.01926-13; Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224; Li XL, 2009, BIOCHEM BIOPH RES CO, V390, P1126, DOI 10.1016/j.bbrc.2009.09.103; Lim XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029751; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Ma LN, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-419; NikNadia NMN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004562; NikNadia NMN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148767; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodrigo WWSI, 2009, VIROLOGY, V394, P175, DOI 10.1016/j.virol.2009.09.024; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shingler KL, 2015, J VIROL, V89, P1900, DOI 10.1128/JVI.03098-14; Sorensen KJ, 2005, ARCH VIROL, V150, P805, DOI 10.1007/s00705-004-0455-z; Tan CW, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-14; Tan SG, 2013, J IMMUNOL, V191, P1637, DOI 10.4049/jimmunol.1301439; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Xu LF, 2014, THERANOSTICS, V4, P498, DOI 10.7150/thno.7457; YANG C, 2011, BMC BIOINFORMATICS, V12, DOI DOI 10.1186/1743-422X-8-306; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923	49	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165659	10.1371/journal.pone.0165659	http://dx.doi.org/10.1371/journal.pone.0165659			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806091	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500047
J	Rosso, DE; Marti, AP; d'Errico, F				Rosso, Daniela Eugenia; Marti, Africa Pitarch; d'Errico, Francesco			Middle Stone Age Ochre Processing and Behavioural Complexity in the Horn of Africa: Evidence from Porc-Epic Cave, Dire Dawa, Ethiopia	PLOS ONE			English	Article							DIE KELDERS; OBSIDIAN ARTIFACTS; PERSONAL ORNAMENTS; SOUTHERN AFRICA; WESTERN CAPE; BLOMBOS CAVE; SYMBOLIC USE; SHELL BEADS; RED OCHRE; SITE	Ochre is a common feature at Middle Stone Age (MSA) sites and has often been interpreted as a proxy for the origin of modern behaviour. However, few ochre processing tools, ochre containers, and ochre-stained artefacts from MSA contexts have been studied in detail within a theoretical framework aimed at inferring the technical steps involved in the acquisition, production and use of these artefacts. Here we analyse 21 ochre processing tools, i.e. upper and lower grindstones, and two ochre-stained artefacts from the MSA layers of Porc-Epic Cave, Dire Dawa, Ethiopia, dated to ca. 40 cal kyr BP. These tools, and a large proportion of the 4213 ochre fragments found at the site, were concentrated in an area devoted to ochre processing. Lower grindstones are made of a variety of raw materials, some of which are not locally available. Traces of use indicate that different techniques were employed to process ochre. Optical microscopy, XRD, mu-Raman spectroscopy, and SEM-EDS analyses of residues preserved on worn areas of artefacts show that different types of ferruginous rocks were processed in order to produce ochre powder of different coarseness and shades. A round stone bearing no traces of having been used to process ochre is half covered with residues as if it had been dipped in a liquid ochered medium to paint the object or to use it as a stamp to apply pigment to a soft material. We argue that the ochre reduction sequences identified at Porc-Epic Cave reflect a high degree of behavioural complexity, and represent ochre use, which was probably devoted to a variety of functions.	[Rosso, Daniela Eugenia; Marti, Africa Pitarch; d'Errico, Francesco] Univ Bordeaux, UMR CNRS Prehist Actuel Culture Environm & Anthro, Pessac, France; [Rosso, Daniela Eugenia] Univ Barcelona, SERF, Dept Prehist Hist Antiga & Arqueol, Barcelona, Spain; [Marti, Africa Pitarch] Univ Autonoma Barcelona, Grp Recerca Aplicada Patrimoni Cultural GRAPAC, Dept Biol Anim Biol Vegetal & Ecol, Bellaterra, Spain; [d'Errico, Francesco] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [d'Errico, Francesco] Univ Witwatersrand, DST NRF Ctr Excellence Palaeosci, Johannesburg, South Africa; [d'Errico, Francesco] Univ Witwatersrand, Sch Geosci, Johannesburg, South Africa	UDICE-French Research Universities; Universite de Bordeaux; University of Barcelona; Autonomous University of Barcelona; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Rosso, DE (corresponding author), Univ Bordeaux, UMR CNRS Prehist Actuel Culture Environm & Anthro, Pessac, France.; Rosso, DE (corresponding author), Univ Barcelona, SERF, Dept Prehist Hist Antiga & Arqueol, Barcelona, Spain.	d.rosso@pacea.u-bordeaux1.fr	Rosso, Daniela Eugenia/ABB-2595-2021	Rosso, Daniela Eugenia/0000-0003-0499-0497; Pitarch Marti, Africa/0000-0002-8396-9487	Generalitat de Catalunya (Ajuts per a la contractacio de personal investigador novell, FI-DGR); Doctoral Research scholarship Programme of the Martine Aublet Foundation; Eiffel Excellence Scholarship Programme of the French Ministry of Foreign Affairs and International Development; Generalitat de Catalunya (Beatriu de Pinos postdoctoral fellowship) [2014 BP-A 00122]; Wenner-Gren Foundation [8786]; LaScArBx research programme - ANR [ANR-10-LABX-52]; European Research Council [249587]	Generalitat de Catalunya (Ajuts per a la contractacio de personal investigador novell, FI-DGR); Doctoral Research scholarship Programme of the Martine Aublet Foundation; Eiffel Excellence Scholarship Programme of the French Ministry of Foreign Affairs and International Development; Generalitat de Catalunya (Beatriu de Pinos postdoctoral fellowship)(Generalitat de Catalunya); Wenner-Gren Foundation; LaScArBx research programme - ANR(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission)	Research by DR was funded by the Generalitat de Catalunya (Ajuts per a la contractacio de personal investigador novell, FI-DGR), the Doctoral Research scholarship Programme of the Martine Aublet Foundation, and the Eiffel Excellence Scholarship Programme of the French Ministry of Foreign Affairs and International Development. Research by AP was funded by the Generalitat de Catalunya (Beatriu de Pinos postdoctoral fellowship, 2014 BP-A 00122). This research was conducted with the financial support of the Wenner-Gren Foundation (Gr. 8786), the LaScArBx research programme, supported by the ANR ANR-10-LABX-52, and the European Research Council Advanced Grant, TRACSYMBOLS No. 249587 awarded under the FP7 program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1939, P 15 C UISPP 2006 SE; Ambrose SH, 1998, J ARCHAEOL SCI, V25, P377, DOI 10.1006/jasc.1997.0277; [Anonymous], 1989, THESIS U ILLINOIS UR; [Anonymous], 1930, ANTHROPOLOGIE; [Anonymous], BRIT ARCHAEOLOGICAL; [Anonymous], 2005, J AFRICAN ARCHAEOLOG, DOI DOI 10.3213/1612-1651-10040; [Anonymous], 2002, DESOLATE LANDSCAPES; [Anonymous], 1984, AFR ARCHAEOL REV, DOI DOI 10.1007/BF01117225; Anovitz LM, 1999, J ARCHAEOL SCI, V26, P735, DOI 10.1006/jasc.1998.0342; Assefa Z, 2008, CURR ANTHROPOL, V49, P746, DOI 10.1086/589509; Assefa Z, 2006, J HUM EVOL, V51, P50, DOI 10.1016/j.jhevol.2006.01.004; Avery G, 1997, J FIELD ARCHAEOL, V24, P263, DOI 10.1179/009346997792208131; Avery G., 2008, S AFRI ARCHAEOL SOC, V10, P66, DOI [10.2307/40650020, DOI 10.2307/40650020]; Barham LS, 2002, CURR ANTHROPOL, V43, P181, DOI 10.1086/338292; Bird MI, 2002, QUATERNARY SCI REV, V21, P1061, DOI 10.1016/S0277-3791(01)00058-0; Bordes F, 1952, BULL SOC PREHIST FR, V49, P169, DOI 10.3406/bspf.1952.8040; Brandt SA, 2012, QUATERN INT, V274, P38, DOI 10.1016/j.quaint.2012.03.047; Breuil H, 1934, ANTHROPOLOGIE, V44, P473; Breuil H, 1951, ANTHROPOLOGIE, V55, P219; Carciumaru M., 2009, ANN U VALAHIA TARGOV, VXI, P7; Carciumaru M, 2015, CR PALEVOL, V14, P31, DOI 10.1016/j.crpv.2014.05.003; Caron F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021545; Carter PL, 1988, INT SERIES, V406; Clark J. D., 1978, ANN ETHIOPIE, V11, P19, DOI DOI 10.3406/ETHIO.1978.902; Clark JD, 2001, J ARCHAEOL SCI, V28, P305, DOI 10.1006/jasc.2000.0563; Clarkson C, 2015, J HUM EVOL, V83, P46, DOI 10.1016/j.jhevol.2015.03.014; Combier F, 1989, ARCHEOLOGIE FRANCE 3; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; d'Errico F, 2016, J HUM EVOL, V93, P91, DOI 10.1016/j.jhevol.2016.01.002; d'Errico F, 2012, J ARCHAEOL SCI, V39, P942, DOI 10.1016/j.jas.2011.10.032; d'Errico F, 2011, PHILOS T R SOC B, V366, P1060, DOI 10.1098/rstb.2010.0340; d'Errico F, 2010, J ARCHAEOL SCI, V37, P3099, DOI 10.1016/j.jas.2010.07.011; d'Errico F, 2009, P NATL ACAD SCI USA, V106, P16051, DOI 10.1073/pnas.0903532106; Dayer L, 2014, J ARCHAEOL SCI, V44, P180, DOI 10.1016/j.jas.2014.01.032; Dayet L, 2013, J ARCHAEOL SCI, V40, P3492, DOI 10.1016/j.jas.2013.01.025; De Beaune S, 1989, GALLIA PREHISTOIRE, V31, P27, DOI DOI 10.3406/GALIP.1989.2264; de Beaune S., 2000, ARCHE OLOGIE GESTE B; de Beaune S., 1993, LASCAUX COMPLEX RECO, P137; de Beaune S, 1995, MOUDRE BROYER INTERP, P22; de la Torre I, 2013, J ARCHAEOL SCI, V40, P313, DOI 10.1016/j.jas.2012.08.007; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; dErrico F., 2008, CURRENT THEMES MIDDL, V10, P168; Downs R. T., 2006, PROGR ABSTR 19 GEN M, V3, P13; Dubreuil L, 2004, J ARCHAEOL SCI, V31, P1613, DOI 10.1016/j.jas.2004.04.003; Dubreuil L., 2002, THESIS; Dubreuil L, 2001, B CRFJ NUM, V9, P73; Dubreuil L, 2015, MAN ARCHAEOL METH, P105, DOI 10.1007/978-3-319-08257-8_7; Dubreuil L, 2014, J ARCHAEOL SCI, V48, P139, DOI 10.1016/j.jas.2013.06.023; Gibson N. E., 2004, SOUTH AFR HUMANIT, V16, P1; Goren-Inbar N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0353; GRINE FE, 1991, J HUM EVOL, V21, P363, DOI 10.1016/0047-2484(91)90113-A; Hamon C, BRIT ARCHAEOLOGICAL; Hamon C, 2008, J ARCHAEOL SCI, V35, P1502, DOI 10.1016/j.jas.2007.10.017; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Heyes PJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22159; Hodgskiss T, 2012, SOUTH AFR HUMANIT, V24, P99; Hodgskiss T, 2010, J ARCHAEOL SCI, V37, P3344, DOI 10.1016/j.jas.2010.08.003; Hovers E, 2003, CURR ANTHROPOL, V44, P491, DOI 10.1086/375869; Huysecom E., 2009, JAHRESBERICHT SLSA 2, P71; Huysecom E, 2008, JAHRESBERICHT SLSA 2, P43; Kaplan J, 1990, SOUTH AFR HUMANIT, P94; Kozowyk PRB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150436; Kraybill N, 1977, ORIGINS AGR, P485, DOI DOI 10.1515/9783110813487.485; Larsson L, 1996, ASPECTS AFRICAN ARCH, P201; Leplongeon A, 2013, THESIS; Leplongeon A, 2014, QUATERN INT, V343, P100, DOI 10.1016/j.quaint.2013.12.002; Logan E.N., 1993, KIVA, V58, P415; Louw A. W., 1969, S AFRICAN ARCHAEOLOG, V24, P39, DOI DOI 10.2307/3887660; Marean CA., 1984, AFR ARCHAEOL REV, V2, P37, DOI DOI 10.1007/BF01117225; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; MARSHACK A, 1981, CURR ANTHROPOL, V22, P188, DOI 10.1086/202650; Mayer DEBY, 2009, J HUM EVOL, V56, P307, DOI 10.1016/j.jhevol.2008.10.005; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Mercader J, 2009, SCIENCE, V326, P1680, DOI 10.1126/science.1173966; Mercader J, 2009, J HUM EVOL, V57, P63, DOI 10.1016/j.jhevol.2009.03.005; Negash A, 2006, ARCHAEOMETRY, V48, P1, DOI 10.1111/j.1475-4754.2006.00239.x; Nicolae, 2015, ANN U VALAHIA TARGOV, VXVII, P7; Peresani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068572; PERLES C, 1974, ANTHROPOLOGIE, V78, P529; Peyrony D, 1930, REV ANTHR, V40, P155; Peyrony D., 1930, REV ANTHR, V40, p[48, 155]; Pleurdeau D, 2003, ANTHROPOLOGIE, V107, P15, DOI 10.1016/S0003-5521(02)00003-1; PLEURDEAU D, 2005, AFR ARCHAEOL REV, V22, P177, DOI DOI 10.1007/S10437-006-9000-7); Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Ridings R, 1996, AM ANTIQUITY, V61, P136, DOI 10.2307/282308; Rifkin RF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136090; Rifkin RF, 2015, S AFR J SCI, V111, P65; Rifkin RF, 2012, J ANTHROPOL ARCHAEOL, V31, P174, DOI 10.1016/j.jaa.2011.11.004; Rifkin RF, 2011, J AFR ARCHAEOL, V9, P131, DOI 10.3213/2191-5784-10199; ROBERTS RG, 1994, QUATERNARY SCI REV, V13, P575, DOI 10.1016/0277-3791(94)90080-9; Roebroeks W, 2012, P NATL ACAD SCI USA, V109, P1889, DOI 10.1073/pnas.1112261109; Rossano MJ, 2010, CURR ANTHROPOL, V51, pS89, DOI 10.1086/650481; Rosso DE, 2014, QUATERN INT, V343, P85, DOI 10.1016/j.quaint.2013.10.019; Rosso DE, 2011, THESIS; Saiomon H., 2009, THESIS; Sajnerova-Duskova A, 2009, NONFLINT RAW MAT USE, P1; San J. C., 1990, PALEO, V2, P229, DOI [10.3406/pal.1990.1002, DOI 10.3406/PAL.1990.1002]; Serradimigni M., 2012, PINTADERAS NEL QUADR, V46b, P181; Singer R., 1982, MIDDLE STONE AGE KLA; Smith R. Q., 2007, THESIS; Soressi M, 2007, NEANDERTALIENS BIOL, P297; SORESSI M, 2009, MEM SOC PREHIST FR, V47, P95; Soriano S, 2009, J AFR ARCHAEOL, V7, P41, DOI 10.3213/1612-1651-10121; Taborin Y., 2003, ECHANGES DIFFUSION P, P113; Tegegn F, 1985, GEOLOGICAL MAP DIRE; Teilhard de Chardin P, 1940, ANTHROPOLOGIE, V49, P497; Thackeray AI, 2000, J HUM EVOL, V38, P147, DOI 10.1006/jhev.1999.0354; Thieme H., 1975, KOLNER JB VOR UND FR, V15, P24; Tryon CA, 2013, CURR ANTHROPOL, V54, pS234, DOI 10.1086/673752; Vallois HV, 1951, ANTHROPOLOGIE, V55, P231; Van Peer P, 2003, J HUM EVOL, V45, P187, DOI 10.1016/S0047-2484(03)00103-9; Van Peer P., 2004, FARMING, V2004, P1, DOI [DOI 10.3828/BFARM.2004.3.1, 10.3828/bfarm.2004.3.1]; Vanhaeren M, 2006, SCIENCE, V312, P1785, DOI 10.1126/science.1128139; Verbaas A., 2008, EXCAVATIONS GELEEN J, P191; Villa P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131273; Vogel N, 2006, J ARCHAEOL SCI, V33, P1749, DOI 10.1016/j.jas.2006.03.008; Wadley L, 2005, J HUM EVOL, V49, P587, DOI 10.1016/j.jhevol.2005.06.007; Wadley L, 2004, ANTIQUITY, V78, P661, DOI 10.1017/S0003598X00113298; Wadley L., 2005, FARMING, V3, P1, DOI DOI 10.3828/BFARM.2005.3.1; Wadley L, 2010, J ARCHAEOL SCI, V37, P2397, DOI 10.1016/j.jas.2010.04.012; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Walker NJ., 1995, STUDIES AFRICAN ARCH; Watts I, 2002, S AFR ARCHAEOL BULL, V57, P1, DOI 10.2307/3889102; Watts I, 2010, J HUM EVOL, V59, P392, DOI 10.1016/j.jhevol.2010.07.006; Whitney DL, 2010, AM MINERAL, V95, P185, DOI 10.2138/am.2010.3371; Williamson BS, 2004, S AFR J SCI, V100, P174; Wynn T, 2010, CURR ANTHROPOL, V51, pS5, DOI 10.1086/650526; Yunker PJ, 2011, NATURE, V476, P308, DOI 10.1038/nature10344; Zilhao J, 2007, J ARCHAEOL RES, V15, P1, DOI 10.1007/s10814-006-9008-1; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	130	27	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0164793	10.1371/journal.pone.0164793	http://dx.doi.org/10.1371/journal.pone.0164793			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EA6DJ	27806067	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500013
J	Morita, M; Sato, Y; Iwasaki, R; Kobayashi, T; Watanabe, R; Oike, T; Miyamoto, K; Toyama, Y; Matsumoto, M; Nakamura, M; Kawana, H; Nakagawa, T; Miyamoto, T				Morita, Mayu; Sato, Yuiko; Iwasaki, Ryotaro; Kobayashi, Tami; Watanabe, Ryuichi; Oike, Takatsugu; Miyamoto, Kana; Toyama, Yoshiaki; Matsumoto, Morio; Nakamura, Masaya; Kawana, Hiromasa; Nakagawa, Taneaki; Miyamoto, Takeshi			Selective Estrogen Receptor Modulators Suppress Hif1 alpha Protein Accumulation in Mouse Osteoclasts	PLOS ONE			English	Article							VERTEBRAL FRACTURE RISK; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; CLINICAL-TRIAL; TISSUE-SPECIFICITY; BREAST-CANCER; CORTICAL BONE; FEMALE MICE; OSTEOPOROSIS; ALPHA	Anti-bone resorptive drugs such as bisphosphonates, the anti-RANKL antibody (denosumab), or selective estrogen receptor modulators (SERMs) have been developed to treat osteoporosis. Mechanisms underlying activity of bisphosphonates or denosumab in this context are understood, while it is less clear how SERMs like tamoxifen, raloxifene, or bazedoxifene inhibit bone resorption. Recently, accumulation of hypoxia inducible factor 1 alpha (Hif1 alpha) in osteoclasts was shown to be suppressed by estrogen in normal cells. In addition, osteoclast activation and decreased bone mass seen in estrogen-deficient conditions was found to require Hif1a. Here, we used western blot analysis of cultured osteoclast precursor cells to show that tamoxifen, raloxifene, or bazedoxifene all suppress Hif1 alpha protein accumulation. The effects of each SERM on osteoclast differentiation differed in vitro. Our results suggest that interventions such as the SERMs evaluated here could be useful to inhibit Hif1 alpha and osteoclast activity under estrogen-deficient conditions.	[Morita, Mayu; Iwasaki, Ryotaro; Kawana, Hiromasa; Nakagawa, Taneaki] Keio Univ, Div Oral & Maxillofacial Surg, Dept Dent & Oral Surg, Sch Med,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan; [Sato, Yuiko; Kobayashi, Tami; Watanabe, Ryuichi; Oike, Takatsugu; Miyamoto, Kana; Toyama, Yoshiaki; Matsumoto, Morio; Nakamura, Masaya; Miyamoto, Takeshi] Keio Univ, Dept Orthoped Surg, Sch Med, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan; [Kobayashi, Tami] Keio Univ, Dept Musculoskeletal Reconstruct & Regenerat Surg, Sch Med, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan; [Sato, Yuiko; Miyamoto, Takeshi] Keio Univ, Dept Adv Therapy Musculoskeletal Disorders, Sch Med, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan	Keio University; Keio University; Keio University; Keio University	Miyamoto, T (corresponding author), Keio Univ, Dept Orthoped Surg, Sch Med, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.; Miyamoto, T (corresponding author), Keio Univ, Dept Adv Therapy Musculoskeletal Disorders, Sch Med, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	miyamoto@z5.keio.jp	Nakamura, Masaya/K-4111-2013		Japan Agency for Medical Research and Development; Chugai Scientific foundation; Pfizer Japan Inc.; Eli Lilly Scientific foundation; Grants-in-Aid for Scientific Research [16K10917] Funding Source: KAKEN	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Chugai Scientific foundation; Pfizer Japan Inc.(Pfizer); Eli Lilly Scientific foundation(Eli Lilly); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by Grant-in-aid for Scientific Research in Japan and a grant from Japan Agency for Medical Research and Development. This study was also funded in part by a research grant from Chugai Scientific foundation, Pfizer Japan Inc. and Eli Lilly Scientific foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2013, J CLIN INVEST, V123, P394, DOI 10.1172/JCI65910; CHRISTIANSEN C, 1981, LANCET, V1, P459; Collin-Osdoby P, 2003, METH MOLEC MED, V80, P153; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Delmas PD, 2002, LANCET, V359, P2018, DOI 10.1016/S0140-6736(02)08827-X; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Diez-Perez Adolfo, 2006, Arq Bras Endocrinol Metab, V50, P720, DOI 10.1590/S0004-27302006000400017; Edwards BJ, 2013, J BONE JOINT SURG AM, V95A, P297, DOI 10.2106/JBJS.K.01181; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Gedmintas L, 2013, J BONE MINER RES, V28, P1729, DOI 10.1002/jbmr.1893; Kostenuik PJ, 2009, J BONE MINER RES, V24, P182, DOI [10.1359/jbmr.081112, 10.1359/JBMR.081112]; Layton D, 2005, OSTEOPOROSIS INT, V16, P490, DOI 10.1007/s00198-004-1710-6; Lello S, 2011, CLIN CASES MINER BON, V8, P29; Li BJ, 2011, J CELL BIOCHEM, V112, P1229, DOI 10.1002/jcb.23049; Li FX, 2016, CANCER CHEMOTH PHARM, V77, P895, DOI 10.1007/s00280-016-2959-0; LOVE RR, 1992, NEW ENGL J MED, V326, P852, DOI 10.1056/NEJM199203263261302; Luckey M, 2004, MENOPAUSE, V11, P405, DOI 10.1097/01.GME.0000119981.77837.1F; Maatta JA, 2013, FASEB J, V27, P478, DOI 10.1096/fj.12-213587; Maeda SS, 2014, ARQ BRAS ENDOCRINOL, V58, P162, DOI 10.1590/0004-2730000003039; Martin-Millan M, 2010, MOL ENDOCRINOL, V24, P323, DOI 10.1210/me.2009-0354; Martinkovich S, 2014, CLIN INTERV AGING, V9, P1437, DOI 10.2147/CIA.S66690; Martino S, 2005, CURR MED RES OPIN, V21, P1441, DOI 10.1185/030079905X61839; Matsumoto T, 2011, BONE, V49, P605, DOI 10.1016/j.bone.2011.07.011; Mazziotti G, 2012, ENDOCRINE, V41, P58, DOI 10.1007/s12020-011-9570-2; Melville KM, 2014, J BONE MINER RES, V29, P370, DOI 10.1002/jbmr.2082; Miller CP, 2001, J MED CHEM, V44, P1654, DOI 10.1021/jm010086m; Miyamoto K, 2011, J EXP MED, V208, P2175, DOI 10.1084/jem.20101890; Miyauchi Y, 2013, P NATL ACAD SCI USA, V110, P16568, DOI 10.1073/pnas.1308755110; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Pinkerton JV, 2014, J STEROID BIOCHEM, V142, P142, DOI 10.1016/j.jsbmb.2013.12.011; PIPER K, 1992, ANAT EMBRYOL, V186, P291; Powles T, 1996, J CLIN ONCOL, V14, P78, DOI 10.1200/JCO.1996.14.1.78; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Ronkin S, 2005, OBSTET GYNECOL, V105, P1397, DOI 10.1097/01.AOG.0000163253.27610.b9; Ryan HE, 2000, CANCER RES, V60, P4010; Sato Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111845; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Silverman SL, 2008, J BONE MINER RES, V23, P1923, DOI 10.1359/JBMR.080710; Tando T, 2016, BIOCHEM BIOPH RES CO, V470, P391, DOI 10.1016/j.bbrc.2016.01.033; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Vanderschueren D, 2014, ENDOCR REV, V35, P906, DOI 10.1210/er.2014-1024; Whyte MP, 2008, J BONE MINER RES, V23, P1698, DOI [10.1359/jbmr.080511, 10.1359/JBMR.080511]; Zhang X, 1998, MOL ENDOCRINOL, V12, P513, DOI 10.1210/me.12.4.513	46	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165922	10.1371/journal.pone.0165922	http://dx.doi.org/10.1371/journal.pone.0165922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802325	gold, Green Published, Green Submitted			2022-12-27	WOS:000386714200069
J	Raffray, L; Giry, C; Vandroux, D; Kuli, B; Randrianjohany, A; Pequin, AM; Renou, F; Jaffar-Bandjee, MC; Gasque, P				Raffray, Loic; Giry, Claude; Vandroux, David; Kuli, Barbara; Randrianjohany, Andry; Pequin, Anne-Marie; Renou, Frederic; Jaffar-Bandjee, Marie-Christine; Gasque, Philippe			Major Neutrophilia Observed in Acute Phase of Human Leptospirosis Is Not Associated with Increased Expression of Granulocyte Cell Activation Markers	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; CHEMOKINE RECEPTOR; INFLAMMATION; LEUKOCYTES; MIGRATION; CORRELATE; CXCR2	It has long been known that pathogenic Leptospira can mobilize the immune system but the specific contribution of neutrophils to control the infectious challenge remains to be clarified. We herein analyzed the phenotype of circulating neutrophils of patients with leptospirosis and healthy controls for the expression of toll-like receptor (TLR) type 2 (TLR2, to sense the leptospiral LPS) and several activation markers: interleukin 8 chemokine receptor CD182 (CXCR2), CD11b of the integrin/opsonin complement receptor type 3 (CR3) and CD15 (ligand of the selectin). The plasmatic level of the main CD182 ligand, interleukin 8 (CXCL8), was measured by ELISA. Hospitalized leptospirosis cases showed marked neutrophilia, particularly in the most severe cases. Interestingly, TLR2 was significantly increased in leptospirosis but identical levels of CD182 and CD11b were detected when compared to controls. CD15 was significantly decreased on neutrophils in leptospirosis but returned to normal within 1 month. Basal levels of IL-8 were measured in control subjects and were not increased in leptospirosis cases at the initial stage of the disease. In conclusion, we observed that neutrophils failed to regulate the expression of several of the receptors involved in cell activation and recruitment. This study further emphasizes the paradigm that neutrophils may be impaired in their overall capacity to thwart bacterial infection in leptospirosis patients.	[Raffray, Loic; Giry, Claude; Jaffar-Bandjee, Marie-Christine; Gasque, Philippe] Univ La Reunion, Unite Mixte Proc Infectieux Milieu Insulaire Trop, Plateforme Technol CYROI, CNRS 9192,INSERM U1187,IRD 249,CHU La Reunion, St Clotilde, Reunion, France; [Raffray, Loic; Gasque, Philippe] CHU La Reunion Site Felix Guyon, Lab Immunol Clin & Expt ZOI LICE OI, St Denis, Reunion, France; [Raffray, Loic; Renou, Frederic] CHU La Reunion Site Felix Guyon, Internal Med Unit, St Denis, Reunion, France; [Giry, Claude; Jaffar-Bandjee, Marie-Christine] CHU La Reunion Site Felix Guyon, Microbiol Virol Lab, St Denis, Reunion, France; [Vandroux, David] CHU La Reunion Site Felix Guyon, Intens Care Unit, St Denis, Reunion, France; [Kuli, Barbara] CHU La Reunion Site Felix Guyon, Infect Dis Unit, St Denis, Reunion, France; [Randrianjohany, Andry] GHER Hosp, Internal Med Unit, St Benoit, Reunion, France; [Pequin, Anne-Marie] CHU La Reunion Site Felix Guyon, Hematol Lab, St Denis, Reunion, France	CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion	Raffray, L (corresponding author), Univ La Reunion, Unite Mixte Proc Infectieux Milieu Insulaire Trop, Plateforme Technol CYROI, CNRS 9192,INSERM U1187,IRD 249,CHU La Reunion, St Clotilde, Reunion, France.; Raffray, L (corresponding author), CHU La Reunion Site Felix Guyon, Lab Immunol Clin & Expt ZOI LICE OI, St Denis, Reunion, France.; Raffray, L (corresponding author), CHU La Reunion Site Felix Guyon, Internal Med Unit, St Denis, Reunion, France.	loic.raffray@chu-reunion.fr	Vandroux, David/AAK-2574-2020		"Contrat de Projets Etat-Region/Fonds Europeen de Developpement Regional" (CPER/FEDER) [32648]	"Contrat de Projets Etat-Region/Fonds Europeen de Developpement Regional" (CPER/FEDER)	This study was supported financially by "Contrat de Projets Etat-Region/Fonds Europeen de Developpement Regional" (CPER/FEDER), grant number 32648 coordinated by PG.	Alves JC, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e3181818466; Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Araujo AM, 2014, AM J TROP MED HYG, V90, P719, DOI 10.4269/ajtmh.13-0667; Atzingen MV, 2009, J INFECTION, V59, P264, DOI 10.1016/j.jinf.2009.07.010; Bernardi FD, 2012, HUM PATHOL, V43, P1601, DOI 10.1016/j.humpath.2011.11.017; Cedola M, 2015, ACTA TROP, V146, P73, DOI 10.1016/j.actatropica.2015.03.007; Chishti AD, 2004, INTENS CARE MED, V30, P605, DOI 10.1007/s00134-004-2175-y; CINCO M, 1993, J GEN MICROBIOL, V139, P2959, DOI 10.1099/00221287-139-12-2959; Cinco M, 2000, J MOL MICROB BIOTECH, V2, P575; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Craig SB, 2013, TROP BIOMED, V30, P579; Craig SB, 2009, ANN TROP MED PARASIT, V103, P333, DOI 10.1179/136485909X435058; Cummings CJ, 1999, J IMMUNOL, V162, P2341; De Silva Nipun Lakshitha, 2014, Int Arch Med, V7, P31, DOI 10.1186/1755-7682-7-31; DOBRINA A, 1995, INFECT IMMUN, V63, P2995, DOI 10.1128/IAI.63.8.2995-2999.1995; Fortunati E, 2009, CLIN EXP IMMUNOL, V155, P559, DOI 10.1111/j.1365-2249.2008.03791.x; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Goeijenbier M, 2015, J INFECTION, V71, P437, DOI 10.1016/j.jinf.2015.05.016; Goris MGA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018279; Harter L, 2004, SHOCK, V22, P403, DOI 10.1097/01.shk.0000142256.23382.5d; Januszkiewicz A, 2002, CLIN EXP IMMUNOL, V130, P263, DOI 10.1046/j.1365-2249.2002.01983.x; Jean-Baptiste Eddy, 2007, J Intensive Care Med, V22, P63, DOI 10.1177/0885066606297123; Kyriakidis I, 2011, CYTOKINE, V54, P117, DOI 10.1016/j.cyto.2011.01.014; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Meri T, 2005, MICROB PATHOGENESIS, V39, P139, DOI 10.1016/j.micpath.2005.07.003; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Murgia R, 2002, INFECT IMMUN, V70, P7172, DOI 10.1128/IAI.70.12.7172-7175.2002; Papa A, 2015, T ROY SOC TROP MED H, V109, P749, DOI 10.1093/trstmh/trv095; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Raffray L, 2015, MICROBES INFECT, V17, P451, DOI 10.1016/j.micinf.2015.04.001; Reis EAG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002457; Remick DG, 2005, CRIT CARE MED, V33, pS466, DOI 10.1097/01.CCM.0000186783.34908.18; Rizvi M, 2011, ANN TROP MED PARASIT, V105, P499, DOI 10.1179/1364859411Y.0000000041; Russwurm S, 2002, SHOCK, V17, P263, DOI 10.1097/00024382-200204000-00004; Sabroe I, 2005, CLIN INFECT DIS, V41, pS421, DOI 10.1086/431992; Sabroe I, 2005, IMMUNOLOGY, V115, P90, DOI 10.1111/j.1365-2567.2005.02133.x; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Scharrig E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003927; SCOCCHI M, 1993, INFECT IMMUN, V61, P3081, DOI 10.1128/IAI.61.7.3081-3083.1993; Stadtmann A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00263; Troxell B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084625; Wagenaar JFP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000453; WANG B, 1984, INFECT IMMUN, V44, P459, DOI 10.1128/IAI.44.2.459-464.1984; Weinschenk NP, 2000, J PEDIATR-US, V137, P345, DOI 10.1067/mpd.2000.107846; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354	48	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165716	10.1371/journal.pone.0165716	http://dx.doi.org/10.1371/journal.pone.0165716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802348	Green Submitted, Green Published, gold			2022-12-27	WOS:000386714200044
J	McNabb, RW; Womble, JN; Prakash, A; Gens, R; Haselwimmer, CE				McNabb, Robert W.; Womble, Jamie N.; Prakash, Anupma; Gens, Rudiger; Haselwimmer, Christian E.			Quantification and Analysis of Icebergs in a Tidewater Glacier Fjord Using an Object-Based Approach	PLOS ONE			English	Article							BAY NATIONAL-PARK; ALASKA; IMAGERY; ABUNDANCE; CLASSIFICATION; CONSERVATION	Tidewater glaciers are glaciers that terminate in, and calve icebergs into, the ocean. In addition to the influence that tidewater glaciers have on physical and chemical oceanography, floating icebergs serve as habitat for marine animals such as harbor seals (Phoca vitulina richardii). The availability and spatial distribution of glacier ice in the fjords is likely a key environmental variable that influences the abundance and distribution of selected marine mammals; however, the amount of ice and the fine-scale characteristics of ice in fjords have not been systematically quantified. Given the predicted changes in glacier habitat, there is a need for the development of methods that could be broadly applied to quantify changes in available ice habitat in tidewater glacier fjords. We present a case study to describe a novel method that uses object-based image analysis (OBIA) to classify floating glacier ice in a tidewater glacier fjord from high-resolution aerial digital imagery. Our objectives were to (i) develop workflows and rule sets to classify high spatial resolution airborne imagery of floating glacier ice; (ii) quantify the amount and fine-scale characteristics of floating glacier ice; (iii) and develop processes for automating the object-based analysis of floating glacier ice for large number of images from a representative survey day during June 2007 in Johns Hopkins Inlet (JHI), a tidewater glacier fjord in Glacier Bay National Park, southeastern Alaska. On 18 June 2007, JHI was comprised of brash ice ((x) over bar = 45.2%, SD = 41.5%), water ((x) over bar = 52.7%, SD = 42.3%), and icebergs ((x) over bar = 2.1%, SD = 1.4%). Average iceberg size per scene was 5.7 m(2) (SD = 2.6 m(2)). We estimate the total area (+/- uncertainty) of iceberg habitat in the fjord to be 455,400 +/- 123,000 m(2). The method works well for classifying icebergs across scenes (classification accuracy of 75.6%); the largest classification errors occur in areas with densely-packed ice, low contrast between neighboring ice cover, or dark or sediment-covered ice, where icebergs may be misclassified as brash ice about 20% of the time. OBIA is a powerful image classification tool, and the method we present could be adapted and applied to other ice habitats, such as sea ice, to assess changes in ice characteristics and availability.	[McNabb, Robert W.; Prakash, Anupma; Gens, Rudiger; Haselwimmer, Christian E.] Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK 99775 USA; [Womble, Jamie N.] Natl Pk Serv, Glacier Bay Field Stn, Juneau, AK 99801 USA; [McNabb, Robert W.] Univ Oslo, Dept Geosci, Oslo, Norway; [Haselwimmer, Christian E.] Chevron Energy Technol Co, San Ramon, CA USA	University of Alaska System; University of Alaska Fairbanks; United States Department of the Interior; University of Oslo; Chevron	Womble, JN (corresponding author), Natl Pk Serv, Glacier Bay Field Stn, Juneau, AK 99801 USA.	jamie_womble@nps.gov	Gens, Rudiger/ABE-8762-2021	Womble, Jamie/0000-0002-6635-1490; McNabb, Robert/0000-0003-0016-493X	Glacier Bay National Park [H991080028]; National Science Foundation grant [OIA-1208927]; National Park Service Coastal Cluster Program; Endeavour Fellowship Program; Alaska EPSCoR NSF award [OIA-1208927]	Glacier Bay National Park; National Science Foundation grant(National Science Foundation (NSF)); National Park Service Coastal Cluster Program; Endeavour Fellowship Program; Alaska EPSCoR NSF award	This study was supported by the Glacier Bay National Park Cooperative Ecosystem Studies Unit grant #H991080028 and National Science Foundation grant OIA-1208927. JNW was supported in part by the National Park Service Coastal Cluster Program and by the Endeavour Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded and supported by Glacier Bay National Park (GLBA) (CESU Award Number H991080028) and the National Park Service Coastal Cluster Program. Prakash would like to acknowledge the additional support from Alaska EPSCoR NSF award #OIA-1208927 and the state of Alaska. We would like to thank John Jansen (NOAA-NMML) for assistance in the implementation of the aerial survey method in Glacier Bay and for thoughtful discussions regarding harbor seals in tidewater glacier fjords. We are greatly appreciative to Avery Gast for safely conducting aerial surveys and assistance with acquiring airborne imagery. Evelina Augustsson (University of Karlstad) assisted with data processing and Chris Waigl (University of Alaska Fairbanks) provided assistance with plotting data. We would like to acknowledge Lisa Etherington and Scott Gende for supporting this project and John Jansen and Jay Ver Hoef for discussions related to harbor seals and ice.	Amundson JM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001405; Arendt A, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000436; Arendt AA, 2002, SCIENCE, V297, P382, DOI 10.1126/science.1072497; Arimitsu ML, 2012, FISH OCEANOGR, V21, P148, DOI 10.1111/j.1365-2419.2012.00616.x; Barclay DJ, 2009, QUATERNARY SCI REV, V28, P2034, DOI 10.1016/j.quascirev.2009.01.016; Berthier E, 2010, NAT GEOSCI, V3, P92, DOI 10.1038/NGEO737; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Blaschke T, 2014, ISPRS J PHOTOGRAMM, V87, P180, DOI 10.1016/j.isprsjprs.2013.09.014; Blundell GM, 2011, MAR ECOL PROG SER, V429, P277, DOI 10.3354/meps09073; Bock Michael, 2005, Journal for Nature Conservation (Jena), V13, P75, DOI 10.1016/j.jnc.2004.12.002; CALAMBOKIDIS J, 1987, CAN J ZOOL, V65, P1391, DOI 10.1139/z87-219; Clift PD., 2011, EOS T AM GEOPHYS UN, V92, P205, DOI [10.1029/2011EO240006, DOI 10.1029/2011EO240006, 10.1029/2011EO370001, DOI 10.1029/2011EO370001]; Congalton R.G., 2008, ASSESSING ACCURACY R, V2nd, DOI [10.1201/9781420055139, DOI 10.1201/9781420055139]; Council NR, 2001, MAR PROT AR TOOLS SU; Evans W, 2014, BIOGEOSCIENCES, V11, P365, DOI 10.5194/bg-11-365-2014; Field WO, 1947, GEOGR REV, V37, P369, DOI 10.2307/211127; Goebel ME, 2015, POLAR BIOL, V38, P619, DOI 10.1007/s00300-014-1625-4; HALL DK, 1995, PHYS GEOGR, V16, P27, DOI 10.1080/02723646.1995.10642541; Hodgson AB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059561, 10.1371/journal.pone.0079556]; Hoef JMV, 2015, J AGR BIOL ENVIR ST, V20, P1, DOI 10.1007/s13253-014-0192-z; Hoover AA, 1983, BEHAV ECOLOGY HARBOR; Hoover-Miller A, 2011, MAR ECOL PROG SER, V424, P259, DOI 10.3354/meps08987; Jansen JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129798; Jansen JK, 2015, MAR MAMMAL SCI, V31, P66, DOI 10.1111/mms.12140; Kobler A, 2006, ECOL MODEL, V191, P83, DOI 10.1016/j.ecolmodel.2005.08.002; Laidre KL, 2015, CONSERV BIOL, V29, P724, DOI 10.1111/cobi.12474; Larsen CF, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000586; Larue MA, 2014, CONSERV BIOL, V28, P1731, DOI 10.1111/cobi.12367; LaRue MA, 2011, POLAR BIOL, V34, P1727, DOI 10.1007/s00300-011-1023-0; Lydersen C, 2014, J MARINE SYST, V129, P452, DOI 10.1016/j.jmarsys.2013.09.006; Mallinis G, 2008, ISPRS J PHOTOGRAMM, V63, P237, DOI 10.1016/j.isprsjprs.2007.08.007; Mathews EA, 2006, MAR MAMMAL SCI, V22, P167, DOI 10.1111/j.1748-7692.2006.00011.x; McMahon CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092613; McNabb RW, 2015, J GEOPHYS RES-EARTH, V120, P120, DOI 10.1002/2014JF003276; McNabb RW, 2014, J GEOPHYS RES-EARTH, V119, P153, DOI 10.1002/2013JF002915; O'Neel S, 2015, BIOSCIENCE, V65, P499, DOI 10.1093/biosci/biv027; Pfeffer WT, 2014, J GLACIOL, V60, P537, DOI 10.3189/2014JoG13J176; Soh LK, 1999, IEEE T GEOSCI REMOTE, V37, P780, DOI 10.1109/36.752194; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Sweeney KL, 2016, J UNMANNED VEH SYST, V4, P70, DOI 10.1139/juvs-2015-0010; Ver Hoef Jay M., 2007, ENVIRONMETRICS, V18, P697, DOI DOI 10.1002/ENV.873; Womble JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055386; Womble JN, 2010, MAR MAMMAL SCI, V26, P686, DOI 10.1111/j.1748-7692.2009.00360.x; Zohmann M, 2013, ECOL MODEL, V254, P22, DOI 10.1016/j.ecolmodel.2013.01.008	44	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164444	10.1371/journal.pone.0164444	http://dx.doi.org/10.1371/journal.pone.0164444			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828967	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300016
J	Thieler, ER; Zeigler, SL; Winslow, LA; Hines, MK; Read, JS; Walker, JI				Thieler, E. Robert; Zeigler, Sara L.; Winslow, Luke A.; Hines, Megan K.; Read, Jordan S.; Walker, Jordan I.			Smartphone-Based Distributed Data Collection Enables Rapid Assessment of Shorebird Habitat Suitability	PLOS ONE			English	Article							BAYESIAN NETWORK; PIPING PLOVERS; ASSISTED GPS; ECOLOGY; CONSERVATION; ACCURACY	Understanding and managing dynamic coastal landscapes for beach-dependent species requires biological and geological data across the range of relevant environments and habitats. It is difficult to acquire such information; data often have limited focus due to resource constraints, are collected by non-specialists, or lack observational uniformity. We developed an open-source smartphone application called iPlover that addresses these difficulties in collecting biogeomorphic information at piping plover (Charadrius melodus) nest sites on coastal beaches. This paper describes iPlover development and evaluates data quality and utility following two years of collection (n = 1799 data points over 1500 km of coast between Maine and North Carolina, USA). We found strong agreement between field user and expert assessments and high model skill when data were used for habitat suitability prediction. Methods used here to develop and deploy a distributed data collection system have broad applicability to interdisciplinary environmental monitoring and modeling.	[Thieler, E. Robert; Zeigler, Sara L.] US Geol Survey, Woods Hole, MA 02543 USA; [Winslow, Luke A.; Hines, Megan K.; Read, Jordan S.; Walker, Jordan I.] US Geol Survey, Middleton, WI USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Thieler, ER (corresponding author), US Geol Survey, Woods Hole, MA 02543 USA.	rthieler@usgs.gov		Zeigler, Sara/0000-0002-5472-769X; thieler, e/0000-0003-4311-9717	North Atlantic Landscape Conservation Cooperative; U.S. Geological Survey Coastal and Marine Geology Program	North Atlantic Landscape Conservation Cooperative; U.S. Geological Survey Coastal and Marine Geology Program(United States Geological Survey)	This work was supported by the North Atlantic Landscape Conservation Cooperative through the U.S. Department of the Interior Hurricane Sandy recovery program under the Disaster Relief Appropriations Act of 2013, and the U.S. Geological Survey Coastal and Marine Geology Program.; This work was supported by the North Atlantic Landscape Conservation Cooperative through the U.S. Department of the Interior Hurricane Sandy recovery program under the Disaster Relief Appropriations Act of 2013, and the U.S. Geological Survey Coastal and Marine Geology Program.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; BAYES T, 1958, BIOMETRIKA, V45, P296; Boccardo P, 2015, SENSORS-BASEL, V15, P15717, DOI 10.3390/s150715717; BURGER J, 1987, CONDOR, V89, P811, DOI 10.2307/1368529; Cohen JB, 2009, WILDLIFE MONOGR, P1, DOI 10.2193/2007-553; Cubasch U., 2013, CLIMATE CHANGE 2013; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Faundeen JL, 2013, USGS OPEN-FILE REP, P4, DOI [10.3133/ofr20131265, DOI 10.3133/ofr20131265]; Galbraith H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108899; Gieder KD, 2014, ECOL MODEL, V276, P38, DOI 10.1016/j.ecolmodel.2014.01.005; Godfrey P., 1976, TECHN P 1976 BARR IS, P5; Gregory R., 2012, STRUCTURED DECISION, DOI [DOI 10.1002/9781444398557, 10.1002/9781444398557]; Gutierrez BT, 2015, J GEOPHYS RES-EARTH, V120, P2452, DOI 10.1002/2015JF003671; Gutierrez BT, 2011, J GEOPHYS RES-EARTH, V116, DOI [10.1029/20101F001891, 10.1029/2010JF001891]; Hecht A, 2009, WATERBIRDS, V32, P64, DOI 10.1675/063.032.0107; Hermoso V, 2015, J BIOGEOGR, V42, P218, DOI 10.1111/jbi.12393; Jensen F. V., 2007, BAYESIAN NETWORKS DE, DOI DOI 10.1007/978-0-387-68282-2; Karlen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099266; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Martin J, 2009, ECOL APPL, V19, P1079, DOI 10.1890/08-0255.1; Martin R.C., 2003, AGILE SOFTWARE DEV P, V2; Moser S. C., 2014, CLIMATE CHANGE IMPAC, P579, DOI DOI 10.7930/J0MS3QNW; Sturdivant E., 2016, **DATA OBJECT**, DOI 10.5066/F70V89X3; Takeuchi K, 2010, COMPUT GEOSCI-UK, V36, P573, DOI 10.1016/j.cageo.2009.09.012; Teacher AGF, 2013, ECOL EVOL, V3, P5268, DOI 10.1002/ece3.888; U.S. Fish and Wildlife Service, 1996, PIP PLOV CHAR MEL AT; U.S. Fish and Wildlife Service, 2015, PREL 2012 ATL COAST; U.S. Fish and Wildlife Service [USFWS], 1985, FED REGISTER, V50, P50726; Vogels W, 2009, COMMUN ACM, V52, P40, DOI 10.1145/1435417.1435432; WILCOX LEROY, 1959, AUK, V76, P129; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361; Zandbergen PA, 2011, J NAVIGATION, V64, P381, DOI 10.1017/S0373463311000051; Zandbergen PA, 2009, T GIS, V13, P5, DOI 10.1111/j.1467-9671.2009.01152.x	35	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164979	10.1371/journal.pone.0164979	http://dx.doi.org/10.1371/journal.pone.0164979			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828974	Green Submitted, Green Published, gold			2022-12-27	WOS:000387724300023
J	Leyvraz, M; Rohner, F; Konan, AG; Esso, LJCE; Woodruff, BA; Norte, A; Adiko, AF; Bonfoh, B; Aaron, GJ				Leyvraz, Magali; Rohner, Fabian; Konan, Amoin G.; Esso, Lasme J. C. E.; Woodruff, Bradley A.; Norte, Augusto; Adiko, Adiko F.; Bonfoh, Bassirou; Aaron, Grant J.			High Awareness but Low Coverage of a Locally Produced Fortified Complementary Food in Abidjan, Cote d'Ivoire: Findings from a Cross-Sectional Survey	PLOS ONE			English	Article							ANEMIA; INFANT	Poor complementary feeding practices among infants and young children in Cote d'Ivoire are major contributing factors to the country's high burden of malnutrition. As part of a broad effort to address this issue, an affordable, nutritious, and locally produced fortified complementary food product was launched in the Cote d'Ivoire in 2011. The objective of the current research was to assess various levels of coverage of the program and to identify coverage barriers. A cross-sectional household survey was conducted among caregivers of children less than 2-years of age living in Abidjan, Cote d'Ivoire. Four measures of coverage were assessed: "message coverage" (i.e., has the caregiver ever heard of the product?), "contact coverage" (i.e., has the caregiver ever fed the child the product?), "partial coverage" (i.e., has the caregiver fed the child the product in the previous month?), and "effective coverage" (i.e., has the caregiver fed the child the product in the previous 7 days?). A total of 1,113 caregivers with children between 0 and 23 months of age were interviewed. Results showed high message coverage (85.0%), moderate contact coverage (37.8%), and poor partial and effective coverages (8.8% and 4.6%, respectively). Product awareness was lower among caregivers from poorer households, but partial and effective coverages were comparable in both poor and non-poor groups. Infant and young child feeding (IYCF) practices were generally poor and did not appear to have improved since previous assessments. In conclusion, the results from the present study indicate that availability on the market and high awareness among the target population is not sufficient to achieve high and effective coverage. With market-based delivery models, significant efforts are needed to improve demand. Moreover, given the high prevalence of malnutrition and poor IYCF practices, additional modes of delivering IYCF interventions and improving IYCF practices should be considered.	[Leyvraz, Magali; Aaron, Grant J.] Global Alliance Improved Nutr, Geneva, Switzerland; [Rohner, Fabian; Woodruff, Bradley A.; Norte, Augusto] GroundWork, Flasch, Switzerland; [Konan, Amoin G.; Esso, Lasme J. C. E.; Adiko, Adiko F.; Bonfoh, Bassirou] Ctr Suisse Rech Sci Cote Divoire, Abidjan, Cote Ivoire; [Konan, Amoin G.; Esso, Lasme J. C. E.; Adiko, Adiko F.] Univ Felix Houphouet Boigny, Abidjan, Cote Ivoire; [Bonfoh, Bassirou] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute	Leyvraz, M (corresponding author), Global Alliance Improved Nutr, Geneva, Switzerland.	magali.leyvraz@gmail.com	Rohner, Fabian/I-5088-2019	Rohner, Fabian/0000-0003-0579-6952; Rios-Leyvraz, Magali/0000-0003-0455-197X	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163176; Aaron GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162462; Alkire S, 2014, WORLD DEV, V59, P251; [Anonymous], 2014, RECH FORM PRAT AL NO; [Anonymous], 2011, HOUSEHOLD HUNGER SCA; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Daelmans B, 2009, FOOD NUTR BULL, V30, pS256, DOI 10.1177/15648265090302S210; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; FAO, 2013, STATE HUNGER BUILDIN; Glinz D, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0872-3; Global Alliance for Improved Nutrition, 2014, CAS STUD INV COT IV; Guevarra E, 2014, FIELD EXCHANGE, V47; Institut National de la Statistique (INS) ICF International, DEM SANT IND MULT CO; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Lauritsen JM, 2004, EPIDATA ENTRY V3 1 C; Meinzen-Derr JK, 2006, J NUTR, V136, P452, DOI 10.1093/jn/136.2.452; Rohner F, 2014, PUBLIC HEALTH NUTR, V17, P2016, DOI 10.1017/S136898001300222X; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; United Nations High Commissioner for Refugees World Food Programme, 2011, GUID SEL FEED MAN MA; Wijnhoven TMA, 2009, COLLATE REV DATA COM	21	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166295	10.1371/journal.pone.0166295	http://dx.doi.org/10.1371/journal.pone.0166295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824917	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000387615200083
J	Li, QF; Lu, YQ; Pan, CL; Yao, MM; Zhang, JP; Yang, XM; Liu, WH; Li, XQ; Xi, YJ; Li, LH				Li, Qingfeng; Lu, Yuqing; Pan, Cuili; Yao, Miaomiao; Zhang, Jinpeng; Yang, Xinming; Liu, Weihua; Li, Xiuquan; Xi, Yajun; Li, Lihui			Chromosomal Localization of Genes Conferring Desirable Agronomic Traits from Wheat-Agropyron cristatum Disomic Addition Line 5113	PLOS ONE			English	Article							RESISTANCE GENE; RUST RESISTANCE; COMMON WHEAT; BARLEY; IDENTIFICATION; GENOME; HYBRIDS; 6P	Creation of wheat-alien disomic addition lines and localization of desirable genes on alien chromosomes are important for utilization of these genes in genetic improvement of common wheat. In this study, wheat-Agropyron cristatum derivative line 5113 was characterized by genomic in situ hybridization (GISH) and specific-locus amplified fragment sequencing (SLAF-seq), and was demonstrated to be a novel wheat-A. cristatum disomic-6P addition line. Compared with its parent Fukuhokomugi (Fukuho), 5113 displayed multiple elite agronomic traits, including higher uppermost internode/plant height ratio, larger flag leaf, longer spike length, elevated grain number per spike and spikelet number per spike, more kernel number in the middle spikelet, more fertile tiller number per plant, and enhanced resistance to powdery mildew and leaf rust. Genes conferring these elite traits were localized on the A. cristatum 6P chromosome by using SLAF-seq markers and biparental populations (F-1, BC1F1 and BC1F2 populations) produced from the crosses between Fukuho and 5113. Taken together, chromosomal localization of these desirable genes will facilitate transferring of high-yield and high-resistance genes from A. cristatum into common wheat, and serve as the foundation for the utilization of 5113 in wheat breeding.	[Li, Qingfeng; Xi, Yajun] Northwest A&F Univ, Coll Agron, Yangling 712100, Shaanxi, Peoples R China; [Li, Qingfeng; Lu, Yuqing; Pan, Cuili; Yao, Miaomiao; Zhang, Jinpeng; Yang, Xinming; Liu, Weihua; Li, Xiuquan; Li, Lihui] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Xi, YJ (corresponding author), Northwest A&F Univ, Coll Agron, Yangling 712100, Shaanxi, Peoples R China.; Li, LH (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China.	xiyajun2002@126.com; lilihui@caas.cn			National Key Technology Support Program of China [2013BAD01B02]; National Natural Science Foundation of China [31271714]; CMS Innovation Team Project	National Key Technology Support Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CMS Innovation Team Project	This work was funded by the National Key Technology Support Program of China (No. 2013BAD01B02), the National Natural Science Foundation of China (No. 31271714), and the CMS Innovation Team Project.; This work was funded by the National Key Technology Support Program of China (No. 2013BAD01B02), the National Natural Science Foundation of China (No. 31271714), and the CAAS Innovation Team Project.	Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; Bilgic H, 2007, GENOME, V50, P898, DOI 10.1139/G07-059; CAI XW, 1989, THEOR APPL GENET, V77, P81, DOI 10.1007/BF00292320; Cao ZJ, 2008, PLANT SCI, V174, P544, DOI 10.1016/j.plantsci.2008.02.007; Chen Q, 1996, THEOR APPL GENET, V93, P679, DOI 10.1007/BF00224062; Chen SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065122; Chen SY, 2004, PLANT SCI, V167, P773, DOI 10.1016/j.plantsci.2004.05.010; Darko E, 2015, EUPHYTICA, V203, P491, DOI 10.1007/s10681-014-1245-7; Dewey DR, 1984, GENOMIC SYSTEM CLASS; Dolezel J, 2004, CHROMOSOME RES, V12, P77, DOI 10.1023/B:CHRO.0000009293.15189.e5; DONG YS, 1992, HEREDITAS, V116, P175, DOI 10.1111/j.1601-5223.1992.tb00224.x; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Han HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091066; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Jauhar PP, 2006, PLANT BREEDING, V125, P19, DOI 10.1111/j.1439-0523.2006.01176.x; Khlestkina EK, 2011, CEREAL RES COMMUN, V39, P465, DOI 10.1556/CRC.39.2011.4.1; Kishii M, 2004, THEOR APPL GENET, V109, P255, DOI 10.1007/s00122-004-1631-y; Li GR, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0202-z; Li HJ, 2002, PLANT DIS, V86, P423, DOI 10.1094/PDIS.2002.86.4.423; Li L.H., 1997, ACTA GENET SIN, V24, P154; Li Li-hui, 1998, Acta Genetica Sinica, V25, P538; Li M, 2016, J GENET GENOMICS, V43, P209, DOI 10.1016/j.jgg.2015.11.005; Li QF, 2016, CROP SCI, V56, P2390, DOI 10.2135/cropsci2015.10.0638; Li RD, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0331-4; Lu Y.T., 2016, IEEE MTT S INT MICRO, P1, DOI [10.1109/iccs.2016.7833643, DOI 10.1109/ICCS.2016.7833643]; Maestra B, 2002, CHROMOSOME RES, V10, P655, DOI 10.1023/A:1021564327226; Murai K, 1997, EUPHYTICA, V96, P281, DOI 10.1023/A:1003025501591; Niu ZX, 2011, GENETICS, V187, P1011, DOI 10.1534/genetics.110.123588; Qi LL, 2007, CHROMOSOME RES, V15, P3, DOI 10.1007/s10577-006-1108-8; Qi LL, 1996, GENOME, V39, P191, DOI 10.1139/g96-025; Qi ZJ, 2010, THEOR APPL GENET, V121, P589, DOI 10.1007/s00122-010-1332-7; Qi ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104871; RILEY R, 1968, NATURE, V217, P383, DOI 10.1038/217383a0; Rubiales D, 2001, EUPHYTICA, V122, P369, DOI 10.1023/A:1012952819255; Schneider A, 2008, EUPHYTICA, V163, P1, DOI 10.1007/s10681-007-9624-y; SHENG BQ, 1991, BEIJING AGR SCI, V1, P38; Song LQ, 2016, THEOR APPL GENET, V129, P1023, DOI 10.1007/s00122-016-2680-8; Stakman E.C., 1962, E617 USDAARS; Suchankova P, 2006, THEOR APPL GENET, V113, P651, DOI 10.1007/s00122-006-0329-8; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Nguyen V, 2015, THEOR APPL GENET, V128, P953, DOI 10.1007/s00122-015-2482-4; Xu SS, 2005, CHROMOSOME RES, V13, P559, DOI 10.1007/s10577-005-0981-x; Ye XL, 2015, THEOR APPL GENET, V128, P797, DOI 10.1007/s00122-015-2466-4; Zhang PX, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/376527; Zhang QP, 2005, EUPHYTICA, V145, P317, DOI 10.1007/s10681-005-1743-8; Zhang RQ, 2015, THEOR APPL GENET, V128, P2415, DOI 10.1007/s00122-015-2596-8; Zhang Y., 2013, MATH PROB ENG, V2013, DOI DOI 10.4018/JIIT.2013010101; Zhang Y, 2015, PLANTA, V242, P1335, DOI 10.1007/s00425-015-2372-7; Zhao PanPan, 2013, Journal of Henan Agricultural Sciences, V42, P91; Zhao TT, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0737-0; Zhou Jingyu, 2014, ScientificWorldJournal, V2014, P530942, DOI 10.1155/2014/530942	51	9	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165957	10.1371/journal.pone.0165957	http://dx.doi.org/10.1371/journal.pone.0165957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824906	Green Submitted, Green Published, gold			2022-12-27	WOS:000387615200050
J	Panda, S; Jena, S; Sharma, S; Dhawan, B; Nath, G; Singh, DV				Panda, Sasmita; Jena, Smrutiti; Sharma, Savitri; Dhawan, Benu; Nath, Gopal; Singh, Durg Vijai			Identification of Novel Sequence Types among Staphylococcus haemolyticus Isolated from Variety of Infections in India	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; GENOME; METHICILLIN; RESISTANCE; UNIT	The aim of this study was to determine sequence types of 34 S. haemolyticus strains isolated from a variety of infections between 2013 and 2016 in India by MLST. The MEGA5.2 software was used to align and compare the nucleotide sequences. The advanced cluster analysis was performed to define the clonal complexes. MLST analysis showed 24 new sequence types (ST) among S. haemolyticus isolates, irrespective of sources and place of isolation. The finding of this study allowed to set up an MLST database on the PubMLST. org website using BIGSdb software and made available at http://pubmlst.org/shaemolyticus/. The data of this study thus suggest that MLST can be used to study population structure and diversity among S. haemolyticus isolates.	[Panda, Sasmita; Jena, Smrutiti; Singh, Durg Vijai] Inst Life Sci, Infect Dis Biol, Nalco Sq, Bhubaneswar 751023, Orissa, India; [Sharma, Savitri] LV Prasad Eye Inst, Jhaveri Microbiol Ctr, Kellam Anji Reddy Campus,LV Prasad Marg, Hyderabad 500034, Andhra Pradesh, India; [Dhawan, Benu] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India; [Nath, Gopal] Banaras Hindu Univ, Inst Med Sci, Dept Microbiol, Varanasi 221005, Uttar Pradesh, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); L. V. Prasad Eye Institute; All India Institute of Medical Sciences (AIIMS) New Delhi; Banaras Hindu University (BHU)	Singh, DV (corresponding author), Inst Life Sci, Infect Dis Biol, Nalco Sq, Bhubaneswar 751023, Orissa, India.	durg_singh@yahoo.co.in	Singh, Durg Vijai/ADU-5699-2022; Singh, Durg Vijai/C-3336-2009; NATH, GOPAL/GSN-5212-2022	Singh, Durg Vijai/0000-0002-9258-073X; NATH, GOPAL/0000-0003-2722-1308	Science and Engineering Research Board, New Delhi [SB/SO/HS-0203/2012]; Indian Council of Medical Research, New Delhi; Department of Science and Technology, New Delhi	Science and Engineering Research Board, New Delhi; Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR)); Department of Science and Technology, New Delhi(Department of Science & Technology (India))	DVS was supported by a grant from Science and Engineering Research Board, New Delhi (Grant no. SB/SO/HS-0203/2012). SP and SJ were supported by Senior Research Fellowships from Indian Council of Medical Research, New Delhi and Department of Science and Technology, New Delhi. The funder had no role in study design, data collection, and analysis, decision to publish or preparation of the manuscript.	Pereira PMA, 2014, DIAGN MICR INFEC DIS, V78, P85, DOI 10.1016/j.diagmicrobio.2013.06.026; Barros EM, 2012, J CLIN MICROBIOL, V50, P166, DOI 10.1128/JCM.05563-11; Cavanagh JP, 2012, J MICROBIOL METH, V89, P159, DOI 10.1016/j.mimet.2012.03.014; FROGGATT JW, 1989, ANTIMICROB AGENTS CH, V33, P460, DOI 10.1128/AAC.33.4.460; Hirotaki S, 2011, J CLIN MICROBIOL, V49, P3627, DOI 10.1128/JCM.00488-11; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Makki AR, 2011, INVEST OPHTH VIS SCI, V52, P9018, DOI 10.1167/iovs.11-7777; Mehta G, 1997, ANN TROP PAEDIATR, V17, P15, DOI 10.1080/02724936.1997.11747857; Panda S, 2014, FEMS MICROBIOL LETT, V352, P114, DOI 10.1111/1574-6968.12383; Takeuchi F, 2005, J BACTERIOL, V187, P7292, DOI 10.1128/JB.187.21.7292-7308.2005	10	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166193	10.1371/journal.pone.0166193	http://dx.doi.org/10.1371/journal.pone.0166193			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824930	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200069
J	Askari, A; Naghizadeh, MM; Homayounfar, R; Shahi, A; Afsarian, MH; Paknahad, A; Kennedy, D; Ataollahi, MR				Askari, Alireza; Naghizadeh, Mohammad Mehdi; Homayounfar, Reza; Shahi, Abbas; Afsarian, Mohammad Hosein; Paknahad, Abbas; Kennedy, Derek; Ataollahi, Mohammad Reza			Increased Serum Levels of IL-17A and IL-23 Are Associated with Decreased Vitamin D3 and Increased Pain in Osteoarthritis	PLOS ONE			English	Article							INTERLEUKIN-17; CHONDROCYTES; CARTILAGE; KNEE; ACTIVATION; CYTOKINES	Introduction Osteoarthritis (OA) is the most common type of arthritis and proinflammatory cytokines have been considered as the main etiologic factor in the pathogenesis of the disease. Serum levels of cytokines, that are associated with innate immunity and TH1 cells, have been analyzed in OA patients, however, there is limited research that profiles cytokines associated with Th17 cells and their relation to vitamin D3 and pain. Material and methods The sera from 131 patients with OA and 262 healthy controls were evaluated for serum levels of IL-17A, IL-21, IL-23 and vitamin D3 using ELISA. Results Serum levels of IL-17A, and IL-23 were statistically higher in OA patients than in healthy controls, while IL-21 and vitamin D3 were significantly lower in OA patients when compared to controls. A significant positive correlation was found between the serum levels of IL-17A and IL-23 using WOMAC pain scores and vitamin D3 serum levels. Discussion The results suggest that IL-17A plays a significant role in OA pathogenesis and the induction of pain. Decreased serum levels of vitamin D3 may reflect a positive role played by the factor in the regulation of immune responses in OA patients.	[Askari, Alireza; Naghizadeh, Mohammad Mehdi; Homayounfar, Reza; Afsarian, Mohammad Hosein; Ataollahi, Mohammad Reza] Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran; [Shahi, Abbas] Fasa Univ Med Sci, Student Res Comm, Fasa, Iran; [Paknahad, Abbas] Hormozgan Univ Med Sci, Student Res Comm, Bandar Abbas, Iran; [Kennedy, Derek] Griffith Univ Nathan, Eskitis Inst Drug Discovery, Sch Nat Sci, Nathan, Qld, Australia	Griffith University	Homayounfar, R; Ataollahi, MR (corresponding author), Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran.	r_homayounfar@yahoo.com; ataollahim@gmail.com	Homayounfar, R/L-8813-2017; Askari, Alireza/Z-2099-2019; Afsariyan, Mohammad Hossein/N-3153-2017; Ataollahi, MohammadReza/P-9042-2017; Kennedy, Hendrick/A-7635-2010; Naghizadeh, Mohammad Mehdi/O-4889-2017	Homayounfar, R/0000-0001-5398-9519; Afsariyan, Mohammad Hossein/0000-0003-3444-9319; Kennedy, Hendrick/0000-0001-7937-3069; Naghizadeh, Mohammad Mehdi/0000-0001-5562-103X; Ataollahi, Mohammadreza/0000-0001-8007-4736	Fasa University of Medical Sciences [93165]	Fasa University of Medical Sciences	This study has been financially supported by grant number 93165 from the Fasa University of Medical Sciences.	ALSALAMEH S, 1990, ARTHRITIS RHEUM, V33, P1477, DOI 10.1002/art.1780331004; Arababadi MK, 2014, ARCH VIROL, V159, P1883, DOI 10.1007/s00705-014-2002-x; Arababadi MK, 2010, HEPAT MON, V10, P31; Benderdour M, 2002, J RHEUMATOL, V29, P1262; Felson DT, 2006, NEW ENGL J MED, V354, P841, DOI 10.1056/NEJMcp051726; Goula T, 2015, J ORTHOP TRAUMATOL, V16, P35, DOI 10.1007/s10195-014-0322-y; Honorati MC, 2002, OSTEOARTHR CARTILAGE, V10, P799, DOI 10.1053/joca.2002.0829; Imamura M, 2015, INT J INFLAMM, V2015, DOI 10.1155/2015/329792; Jamali Z, 2013, CLIN LAB, V59, P407, DOI 10.7754/Clin.Lab.2012.120908; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kim J, 2013, ANN LAB MED, V33, P52, DOI 10.3343/alm.2013.33.1.52; Koga T, 2017, CLIN IMMUNOL, V185, P95, DOI 10.1016/j.clim.2016.04.010; Laslett LL, 2014, ANN RHEUM DIS, V73, P697, DOI 10.1136/annrheumdis-2012-202831; Li JK, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0833-9; Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197; Lubberts E, 2000, ARTHRITIS RHEUM-US, V43, P1300, DOI 10.1002/1529-0131(200006)43:6<1300::AID-ANR12>3.0.CO;2-D; Martel-Pelletier J, 1999, ARTHRITIS RHEUM-US, V42, P2399, DOI 10.1002/1529-0131(199911)42:11<2399::AID-ANR19>3.0.CO;2-Y; Massicotte F, 2002, OSTEOARTHR CARTILAGE, V10, P491, DOI 10.1053/joca.2002.0528; Onuora S, 2016, NATURE REV RHEUMATOL, V12, P252; Pacquelet S, 2002, J RHEUMATOL, V29, P2602; Upala S, 2016, PHOTODERMATOL PHOTO, V32, P181, DOI 10.1111/phpp.12241; Wang X, 2015, INT J ENDOCRINOL, V2015, DOI DOI 10.1155/2015/28529026681939; Wojdasiewicz P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/561459; Wu CW, 2005, SEMINARS ARTHRITIS R; Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496	25	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0164757	10.1371/journal.pone.0164757	http://dx.doi.org/10.1371/journal.pone.0164757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820818	gold, Green Submitted, Green Published			2022-12-27	WOS:000387614800003
J	De Samber, B; Niemiec, MJ; Laforce, B; Garrevoet, J; Vergucht, E; De Rycke, R; Cloetens, P; Urban, CF; Vincze, L				De Samber, Bjorn; Niemiec, Maria J.; Laforce, Brecht; Garrevoet, Jan; Vergucht, Eva; De Rycke, Riet; Cloetens, Peter; Urban, Constantin F.; Vincze, Laszlo			Probing Intracellular Element Concentration Changes during Neutrophil Extracellular Trap Formation Using Synchrotron Radiation Based X-Ray Fluorescence	PLOS ONE			English	Article							MICRO-XRF; QUANTIFICATION; PATHOGENESIS; LIBRARY; NETOSIS; REVEAL	High pressure frozen (HPF), cryo-substituted microtome sections of 2 mu m thickness containing human neutrophils (white blood cells) were analyzed using synchrotron radiation based X-ray fluorescence (SR nano-XRF) at a spatial resolution of 50 nm. Besides neutrophils from a control culture, we also analyzed neutrophils stimulated for 1-2 h with phorbol myristate acetate (PMA), a substance inducing the formation of so-called Neutrophil Extracellular Traps (or NETs), a defense system again pathogens possibly involving proteins with metal chelating properties. In order to gain insight in metal transport during this process, precise local evaluation of elemental content was performed reaching limits of detection (LODs) of 1 ppb. Mean weight fractions within entire neutrophils, their nuclei and cytoplasms were determined for the three main elements P, S and Cl, but also for the 12 following trace elements: K, Ca, Mn, Fe, Co, Ni, Cu, Zn, Se, Br, Sr and Pb. Statistical analysis, including linear regression provided objective analysis and a measure for concentration changes. The nearly linear Ca and Cl concentration changes in neutrophils could be explained by already known phenomena such as the induction of Ca channels and the uptake of Cl under activation of NET forming neutrophils. Linear concentration changes were also found for P, S, K, Mn, Fe, Co and Se. The observed linear concentration increase for Mn could be related to scavenging of this metal from the pathogen by means of the neutrophil protein calprotectin, whereas the concentration increase of Se may be related to its antioxidant function protecting neutrophils from the reactive oxygen species they produce against pathogens. We emphasize synchrotron radiation based nanoscopic X-ray fluorescence as an enabling analytical technique to study changing (trace) element concentrations throughout cellular processes, provided accurate sample preparation and data-analysis.	[De Samber, Bjorn; Laforce, Brecht; Vergucht, Eva; Vincze, Laszlo] Univ Ghent, Dept Analyt Chem, Ghent, Belgium; [Niemiec, Maria J.; Urban, Constantin F.] Umea Univ, Dept Clin Microbiol, MIMS, Umea, Sweden; [Niemiec, Maria J.] Leibniz Inst Nat Prod Res & Infect Biol, Microbial Immunol Res Grp, Hans Knoll Inst, Jena, Germany; [Garrevoet, Jan] DESY, Hamburg, Germany; [De Rycke, Riet] Univ Ghent VIB, Inflammat Res Ctr, Ghent, Belgium; [De Rycke, Riet] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [De Rycke, Riet] Univ Ghent VIB, Dept Plant Syst Biol, Ghent, Belgium; [De Rycke, Riet] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Cloetens, Peter] European Synchrotron Radiat Facil, Grenoble, France	Ghent University; Umea University; Hans Knoll Institute (HKI); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; European Synchrotron Radiation Facility (ESRF)	De Samber, B (corresponding author), Univ Ghent, Dept Analyt Chem, Ghent, Belgium.	Bjorn.DeSamber@UGent.be	Laforce, Brecht/AAF-9215-2021; Vincze, Laszlo/AAP-3914-2020; Urban, Constantin/H-5121-2019; Laforce, Brecht/GPX-2175-2022; Cloetens, Peter/AAJ-6131-2020; De Samber, Bjorn/K-9636-2015	Urban, Constantin/0000-0003-1438-1134; Cloetens, Peter/0000-0002-4129-9091; Niemiec, Maria Joanna/0000-0001-5667-6032; De Samber, Bjorn/0000-0002-6759-4195	FWO Vlaanderen [1263313N]; FWO grant [V.4.114.10.N.00]; J.C. Kempe Memorial Fund; Flemish Institute for the Promotion of Scientific and Technological Research in Industry (IWT Flanders, Belgium); Swedish Research Council [521-2014-2281]; Medical Faculty Umea University; Ake Wiberg Foundation [M15-0108]	FWO Vlaanderen(FWO); FWO grant(FWO); J.C. Kempe Memorial Fund; Flemish Institute for the Promotion of Scientific and Technological Research in Industry (IWT Flanders, Belgium); Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty Umea University; Ake Wiberg Foundation	Bjorn De Samber acknowledges his postdoctoral research grant from FWO Vlaanderen (application nr. 1263313N), FWO grant for a long stay abroad (application nr. V.4.114.10.N.00) and statistical consult from Ghent University FIRE (Fostering Innovative Research based on Evidence). Maria J. Niemiec acknowledges financial support from the J.C. Kempe Memorial Fund. Eva Vergucht, Brecht Laforce and Jan Garrevoet were funded by a PhD grant from the Flemish Institute for the Promotion of Scientific and Technological Research in Industry (IWT Flanders, Belgium). Constantin F. Urban acknowledges support from the Swedish Research Council (521-2014-2281), Medical Faculty Umea University and the Ake Wiberg Foundation (M15-0108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akong-Moore K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042984; Almyroudis NG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00045; Aron AT, 2015, ACCOUNTS CHEM RES, V48, P2434, DOI 10.1021/acs.accounts.5b00221; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Brophy MB, 2015, ACS CHEM BIOL, V10, P641, DOI 10.1021/cb500792b; Brunetti A, 2004, SPECTROCHIM ACTA B, V59, P1725, DOI 10.1016/j.sab.2004.03.014; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; de Jonge MD, 2010, P NATL ACAD SCI USA, V107, P15676, DOI 10.1073/pnas.1001469107; De Samber B, 2008, ANAL BIOANAL CHEM, V390, P267, DOI 10.1007/s00216-007-1694-0; De Samber B, 2013, ANAL BIOANAL CHEM, V405, P6061, DOI 10.1007/s00216-013-7019-6; De Samber B, 2010, J ANAL ATOM SPECTROM, V25, P544, DOI 10.1039/b918624g; Douda DN, 2015, P NATL ACAD SCI USA, V112, P2817, DOI 10.1073/pnas.1414055112; Ellwanger Joel H., 2016, AN ACAD BRAS CIENC; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Germain RN, 2004, NAT MED, V10, P1307, DOI 10.1038/nm1159; Giewekemeyer K, 2014, J SYNCHROTRON RADIAT, V21, P1167, DOI 10.1107/S1600577514013411; Gupta AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097088; Haas KL, 2009, CHEM REV, V109, P4921, DOI 10.1021/cr900134a; Hemonnot CYJ, 2016, ACS NANO, V10, P3553, DOI 10.1021/acsnano.5b07871; Hyman LM, 2012, COORDIN CHEM REV, V256, P2333, DOI 10.1016/j.ccr.2012.03.009; Kempenaers L, 2000, SPECTROCHIM ACTA B, V55, P651, DOI 10.1016/S0584-8547(00)00207-X; Krenkel M, 2014, P SPIE, V9212; Krenkel M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09973; LCPW R. R., 1979, MICR AN BIOL; Martinez-Criado G, 2012, J SYNCHROTRON RADIAT, V19, P10, DOI 10.1107/S090904951104249X; McRae R, 2009, CHEM REV, V109, P4780, DOI 10.1021/cr900223a; Moore KL, 2014, NEW PHYTOL, V201, P104, DOI 10.1111/nph.12497; Niemiec MJ, 2015, METALLOMICS, V7, P996, DOI 10.1039/c4mt00346b; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Piazza V, 2014, ACS NANO, V8, P12228, DOI 10.1021/nn5041526; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Schoonjans T, 2011, P SPIE; Schoonjans T, 2013, SPECTROCHIM ACTA B, V82, P36, DOI 10.1016/j.sab.2012.12.011; Schoonjans T, 2012, SPECTROCHIM ACTA B, V70, P10, DOI 10.1016/j.sab.2012.03.011; Schoonjans T, 2012, SPECTROCHIM ACTA B, V67, P32, DOI 10.1016/j.sab.2011.12.006; Schoonjans T, 2011, SPECTROCHIM ACTA B, V66, P776, DOI 10.1016/j.sab.2011.09.011; Schropp A, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4729942; SHERMAN J, 1955, SPECTROCHIM ACTA, V7, P283, DOI 10.1016/0371-1951(55)80081-1; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Van Malderen SJM, 2015, J ANAL ATOM SPECTROM, V30, P119, DOI 10.1039/c4ja00137k; VEKEMANS B, 1994, X-RAY SPECTROM, V23, P278, DOI 10.1002/xrs.1300230609; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; YAROM R, 1976, P NATL ACAD SCI USA, V73, P3690, DOI 10.1073/pnas.73.10.3690	45	12	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165604	10.1371/journal.pone.0165604	http://dx.doi.org/10.1371/journal.pone.0165604			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812122	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000037
J	Liu, G; Dong, CP; Liu, L				Liu, Gang; Dong, Chuanpeng; Liu, Lei			Integrated Multiple "-omics" Data Reveal Subtypes of Hepatocellular Carcinoma	PLOS ONE			English	Article							EXPRESSION; GENE; MIR-203; H19	Hepatocellular carcinoma is one of the most heterogeneous cancers, as reflected by its multiple grades and difficulty to subtype. In this study, we integrated copy number variation, DNA methylation, mRNA, and miRNA data with the developed "cluster of cluster" method and classified 256 HCC samples from TCGA (The Cancer Genome Atlas) into five major subgroups (S1-S5). We observed that this classification was associated with specific mutations and protein expression, and we detected that each subgroup had distinct molecular signatures. The subclasses were associated not only with survival but also with clinical observations. S1 was characterized by bulk amplification on 8q24, TP53 mutation, low lipid metabolism, highly expressed onco-proteins, attenuated tumor suppressor proteins and a worse survival rate. S2 and S3 were characterized by telomere hypomethylation and a low expression of TERT and DNMT1/3B. Compared to S2, S3 was associated with less copy number variation and some good prognosis biomarkers, including CRP and CYP2E1. In contrast, the mutation rate of CTNNB1 was higher in S3. S4 was associated with bulk amplification and various molecular characteristics at different biological levels. In summary, we classified the HCC samples into five subgroups using multiple "-omics" data. Each subgroup had a distinct survival rate and molecular signature, which may provide information about the pathogenesis of subtypes in HCC.	[Liu, Gang; Dong, Chuanpeng; Liu, Lei] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Fudan University	Liu, L (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China.	liulei_sibs@163.com			National High-tech R&D Program (863 Program) [2015AA020104, 2012AA02A602]; National Science and Technology Major Project [2012ZX10002010]	National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Science and Technology Major Project	This work was supported by National High-tech R&D Program (863 Program) 2015AA020104 to Lei Liu; National High-tech R&D Program (863 Program) 2012AA02A602 to Lei Liu; and National Science and Technology Major Project 2012ZX10002010 to Lei Liu.	Austinat M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-21; Borel F, 2012, J HEPATOL, V56, P1371, DOI 10.1016/j.jhep.2011.11.026; Brisbin AG, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-156; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Dong H, 2015, GENOM DATA, V6, P1, DOI 10.1016/j.gdata.2015.07.018; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; Iizuka N, 2004, ANTICANCER RES, V24, P4085; Inokawa Y, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-65; Kim JM, 2013, WORLD J SURG ONCOL, V11; Kim KS, 1997, CANCER LETT, V119, P143, DOI 10.1016/S0304-3835(97)00264-4; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Liu YR, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0214-0; Man XB, 2004, WORLD J GASTROENTERO, V10, P1565, DOI 10.3748/wjg.v10.i11.1565; Marquardt Jens U, 2012, Biology (Basel), V1, P383, DOI 10.3390/biology1020383; Matter MS, 2014, J HEPATOL, V60, P855, DOI 10.1016/j.jhep.2013.11.031; Morishita A, 2015, HEPATOL RES, V45, P128, DOI 10.1111/hepr.12386; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pei YF, 2009, ACTA BIOCH BIOPH SIN, V41, P1, DOI 10.1093/abbs/gmn001; Shen J, 2012, HEPATOLOGY, V55, P1799, DOI 10.1002/hep.25569; Song JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110074; Therneau T.M., 2000, MODELING SURVIVAL DA; Wang Z, 2015, MOL CLIN ONCOL, V3, P936, DOI 10.3892/mco.2015.569; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Xu HT, 2015, J CANCER, V6, P247, DOI 10.7150/jca.10747; Yang H, 2010, EXP BIOL MED, V235, P32, DOI 10.1258/ebm.2009.009252; Zhang F, 2014, CANCER LETT, V342, P121, DOI 10.1016/j.canlet.2013.08.037; Zhang HE, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-244; Zheng ZY, 2013, INT J MED SCI, V10, P653, DOI 10.7150/ijms.6050	34	17	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165457	10.1371/journal.pone.0165457	http://dx.doi.org/10.1371/journal.pone.0165457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806083	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500030
J	Mertens, C; Akam, EA; Rehwald, C; Brune, B; Tomat, E; Jung, M				Mertens, Christina; Akam, Eman Abureida; Rehwald, Claudia; Bruene, Bernhard; Tomat, Elisa; Jung, Michaela			Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression	PLOS ONE			English	Article							BREAST-CANCER; SALMONELLA-TYPHIMURIUM; MEDIATED REGULATION; HOMEOSTASIS; METABOLISM; CARCINOMA; CELLS; LIPOCALIN-2; ACTIVATION; FERRITIN	A growing body of evidence suggests that macrophage polarization dictates the expression of iron-regulated genes. Polarization towards iron sequestration depletes the microenvironment, whereby extracellular pathogen growth is limited and inflammation is fostered. In contrast, iron release contributes to cell proliferation, which is important for tissue regeneration. Moreover, macrophages constitute a major component of the infiltrates in most solid tumors. Considering the pivotal role of macrophages for iron homeostasis and their presence in association with poor clinical prognosis in tumors, we approached the possibility to target macrophages with intracellular iron chelators. Analyzing the expression of iron-regulated genes at mRNA and protein level in primary human macrophages, we found that the iron-release phenotype is a characteristic of polarized macrophages that, in turn, stimulate tumor cell growth and progression. The application of the intracellular iron chelator (TC3-S)(2) shifted the macrophage phenotype from iron release towards sequestration, as determined by the iron-gene profile and atomic absorption spectroscopy (AAS). Moreover, whereas the addition of macrophage supernatants to tumor cells induced tumor growth and metastatic behavior, the supernatant of chelator-treated macrophages reversed this effect. Iron chelators demonstrated potent anti-neoplastic properties in a number of cancers, both in cell culture and in clinical trials. Our results suggest that iron chelation could affect not only cancer cells but also the tumor microenvironment by altering the iron-release phenotype of tumor-associated macrophages (TAMs). The study of iron chelators in conjunction with the effect of TAMs on tumor growth could lead to an improved understanding of the role of iron in cancer biology and to novel therapeutic avenues for iron chelation approaches.	[Mertens, Christina; Rehwald, Claudia; Bruene, Bernhard; Jung, Michaela] Goethe Univ Frankfurt, Inst Biochem 1, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Akam, Eman Abureida; Tomat, Elisa] Univ Arizona, Dept Chem & Biochem, 1306 E,Univ Blvd, Tucson, AZ 85721 USA	Goethe University Frankfurt; University of Arizona	Jung, M (corresponding author), Goethe Univ Frankfurt, Inst Biochem 1, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.; Tomat, E (corresponding author), Univ Arizona, Dept Chem & Biochem, 1306 E,Univ Blvd, Tucson, AZ 85721 USA.	tomat@email.arizona.edu; m.jung@biochem.uni-frankfurt.de	Tomat, Elisa/M-9802-2018	Tomat, Elisa/0000-0002-7075-9501; Mertens, Christina/0000-0002-0767-4759	Fritz Thyssen Stiftung [Az.10.12.2.156]; Goethe-University Frankfurt; Doktor Robert Pfleger Stiftung; University of Arizona Office of Research and Development; University of Arizona Global Initiatives; Deutsche Krebshilfe [111578]	Fritz Thyssen Stiftung; Goethe-University Frankfurt; Doktor Robert Pfleger Stiftung; University of Arizona Office of Research and Development; University of Arizona Global Initiatives; Deutsche Krebshilfe(Deutsche Krebshilfe)	The study was supported by the Fritz Thyssen Stiftung (Az.10.12.2.156 to MJ), Goethe-University Frankfurt (Focus Line B to MJ), and the Doktor Robert Pfleger Stiftung (awarded to MJ). We thank the University of Arizona Office of Research and Development for financial support (New Faculty Start-Up Funds to ET) and University of Arizona Global Initiatives for travel funds to initiate collaborative research work. Additional funding came from Deutsche Krebshilfe (111578 to BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akam EA, 2014, METALLOMICS, V6, P1905, DOI 10.1039/c4mt00153b; Alkhateeb AA, 2013, BREAST CANCER RES TR, V137, P733, DOI 10.1007/s10549-012-2405-x; Baby SM, 2003, HISTOCHEM CELL BIOL, V120, P343, DOI 10.1007/s00418-003-0588-2; BLATT J, 1991, LEUKEMIA RES, V15, P391, DOI 10.1016/0145-2126(91)90015-L; Bories G, 2013, CIRC RES, V113, P1196, DOI 10.1161/CIRCRESAHA.113.301656; Cairo G, 2011, TRENDS IMMUNOL, V32, P241, DOI 10.1016/j.it.2011.03.007; Cairo G, 2010, HAEMATOL-HEMATOL J, V95, P1801, DOI 10.3324/haematol.2010.030239; Chang TM, 2013, DALTON T, V42, P7846, DOI 10.1039/c3dt50824b; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Coombs GS, 2012, ONCOGENE, V31, P213, DOI 10.1038/onc.2011.228; Corna G, 2010, HAEMATOL-HEMATOL J, V95, P1814, DOI 10.3324/haematol.2010.023879; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; DORNER MH, 1980, SCIENCE, V209, P1019, DOI 10.1126/science.6967622; Freitas I, 2007, ANTICANCER RES, V27, P3059; Habashy HO, 2010, BREAST CANCER RES TR, V119, P283, DOI 10.1007/s10549-009-0345-x; Hatcher HC, 2009, FUTURE MED CHEM, V1, P1643, DOI 10.4155/FMC.09.121; Jezequel P, 2012, INT J CANCER, V131, P426, DOI 10.1002/ijc.26397; Jian JL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-307; Jiang XP, 2010, ANTICANCER RES, V30, P759; Jung M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21950; Jung M, 2015, IMMUNOBIOLOGY, V220, P295, DOI 10.1016/j.imbio.2014.09.011; Jung M, 2012, KIDNEY INT, V81, P969, DOI 10.1038/ki.2011.446; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; LEONARDI E, 1992, J CLIN PATHOL, V45, P416, DOI 10.1136/jcp.45.5.416; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Ludwiczek S, 2003, BLOOD, V101, P4148, DOI 10.1182/blood-2002-08-2459; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Marques O, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2228-y; Miller LD, 2011, CANCER RES, V71, P6728, DOI 10.1158/0008-5472.CAN-11-1870; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nairz M, 2008, EUR J IMMUNOL, V38, P1923, DOI 10.1002/eji.200738056; Nairz M, 2015, EUR J IMMUNOL, V45, P3073, DOI 10.1002/eji.201545569; Nairz M, 2013, J EXP MED, V210, P855, DOI 10.1084/jem.20121946; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Niewiadomska H, 1998, J EXP CLIN CANC RES, V17, P503; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scitranslmed.3001127, 10.1126/scisignal.3001127]; Pogribny IP, 2013, INT J ONCOL, V42, P1822, DOI 10.3892/ijo.2013.1855; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Recalcati S, 2012, SEMIN IMMUNOL, V24, P393, DOI 10.1016/j.smim.2013.01.001; Recalcati S, 2012, AUTOIMMUN REV, V11, P883, DOI 10.1016/j.autrev.2012.03.003; Recalcati S, 2010, ANTIOXID REDOX SIGN, V13, P1593, DOI 10.1089/ars.2009.2983; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; Richardson DR, 2009, BBA-GEN SUBJECTS, V1790, P702, DOI 10.1016/j.bbagen.2008.04.003; ROSSIELLO R, 1984, J CLIN PATHOL, V37, P51, DOI 10.1136/jcp.37.1.51; Ruffell B, 2012, P NATL ACAD SCI USA, V109, P2796, DOI 10.1073/pnas.1104303108; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Siddiq A, 2007, NEUROCHEM RES, V32, P931, DOI 10.1007/s11064-006-9268-7; Sola A, 2011, J PATHOL, V225, P597, DOI 10.1002/path.2982; Tchekmedyian NS, 2002, ONCOLOGY-NY, V16, P17; Torti Suzy V., 2013, Critical Reviews in Oncogenesis, V18, P435; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Wang W, 2014, CANCER RES, V74, P497, DOI 10.1158/0008-5472.CAN-13-1224; Weiss G, 2005, BEST PRACT RES CL HA, V18, P183, DOI 10.1016/j.beha.2004.09.001; Yu Y, 2007, CELL CYCLE, V6, P1982, DOI 10.4161/cc.6.16.4603; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076147	56	53	55	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0166164	10.1371/journal.pone.0166164	http://dx.doi.org/10.1371/journal.pone.0166164			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806101	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500083
J	Zhang, Q; Zhang, QZ; Sornette, D				Zhang, Qun; Zhang, Qunzhi; Sornette, Didier			Early Warning Signals of Financial Crises with Multi-Scale Quantile Regressions of Log-Periodic Power Law Singularities	PLOS ONE			English	Article							STOCK-MARKET; CRITICAL TRANSITIONS; BUBBLE; PREDICTABILITY; EXPECTATIONS; PREDICTION; CRASHES; RUPTURE; FUTURE	We augment the existing literature using the Log-Periodic Power Law Singular (LPPLS) structures in the log-price dynamics to diagnose financial bubbles by providing three main innovations. First, we introduce the quantile regression to the LPPLS detection problem. This allows us to disentangle (at least partially) the genuine LPPLS signal and the a priori unknown complicated residuals. Second, we propose to combine the many quantile regressions with a multi-scale analysis, which aggregates and consolidates the obtained ensembles of scenarios. Third, we define and implement the so-called DS LPPLS Confidence (TM) and Trust (TM) indicators that enrich considerably the diagnostic of bubbles. Using a detailed study of the "S&P 500 1987" bubble and presenting analyses of 16 historical bubbles, we show that the quantile regression of LPPLS signals contributes useful early warning signals. The comparison between the constructed signals and the price development in these 16 historical bubbles demonstrates their significant predictive ability around the real critical time when the burst/rally occurs.	[Zhang, Qun] Guangdong Univ Foreign Studies, Sch Finance, Guangzhou, Guangdong, Peoples R China; [Zhang, Qun; Zhang, Qunzhi; Sornette, Didier] Swiss Fed Inst Technol, Dept Management Technol & Econ, Zurich, Switzerland; [Sornette, Didier] Univ Geneva, Swiss Finance Inst, Geneva, Switzerland	Guangdong University of Foreign Studies; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva	Sornette, D (corresponding author), Swiss Fed Inst Technol, Dept Management Technol & Econ, Zurich, Switzerland.; Sornette, D (corresponding author), Univ Geneva, Swiss Finance Inst, Geneva, Switzerland.	dsornette@ethz.ch			Eidgenossische Technische Hochschule grant on "Quantifying Financial (in-)stability and self-amplication of crashes via reflextivity" [0-20067-14]; Guangzhou Municipal Government [JY201413]	Eidgenossische Technische Hochschule grant on "Quantifying Financial (in-)stability and self-amplication of crashes via reflextivity"; Guangzhou Municipal Government	The research was partially supported by the Eidgenossische Technische Hochschule grant 0-20067-14 on "Quantifying Financial (in-)stability and self-amplication of crashes via reflextivity". QZ also offers special thanks to the Oversea Study Program of Guangzhou Elites Project (No. JY201413) supported by Guangzhou Municipal Government.	ABARBANEL HDI, 1993, REV MOD PHYS, V65, P1331, DOI 10.1103/RevModPhys.65.1331; Abergel F, 2015, ECONOPHYSICS DATA DR, DOI [10.1007/978-3-319-08473-2, DOI 10.1007/978-3-319-08473-2]; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Arneodo A, 1998, EUR PHYS J B, V2, P277, DOI 10.1007/s100510050250; Bacry E, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026103; Barnes M. L., 2002, SSRN ELECT J, DOI DOI 10.2139/SSRN.458522; BARRODALE I, 1974, COMMUN ACM, V17, P319, DOI 10.1145/355616.361024; BLACK F, 1986, J FINANC, V41, P529, DOI 10.2307/2328481; Calvet L, 2002, REV ECON STAT, V84, P381, DOI 10.1162/003465302320259420; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Filimonov V, 2013, PHYSICA A, V392, P3698, DOI 10.1016/j.physa.2013.04.012; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gao ZK, 2016, IEEE T INSTRUM MEAS, V65, P1690, DOI 10.1109/TIM.2016.2540862; Gluzman S, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036142; Guttal V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144198; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Husler A, 2013, J ECON BEHAV ORGAN, V92, P304, DOI 10.1016/j.jebo.2013.06.005; Ide K, 2002, PHYSICA A, V307, P63, DOI 10.1016/S0378-4371(01)00585-4; Jiang ZQ, 2010, J ECON BEHAV ORGAN, V74, P149, DOI 10.1016/j.jebo.2010.02.007; Johansen A, 2000, EUR PHYS J B, V17, P319, DOI 10.1007/s100510070147; Johansen A., 2000, INT J THEOR APPL FIN, V2, P219, DOI [DOI 10.1142/S0219024900000115, 10.1142/S0219024900000115]; Johansen A., 2001, INT J THEOR APPL FIN, V4, P853, DOI [10.1142/S0219024901001218, DOI 10.1142/S0219024901001218]; Johansen A., 1999, J RISK, V1, P5, DOI DOI 10.21314/JOR.1999.014; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Leiss M, 2015, J ECON DYN CONTROL, V55, P1, DOI 10.1016/j.jedc.2015.03.005; Lenton TM, 2012, PHILOS T R SOC A, V370, P1185, DOI 10.1098/rsta.2011.0304; MCNEES SK, 1992, J FORECASTING, V11, P703, DOI 10.1002/for.3980110807; Muzy J.-F., 2001, Quantitative Finance, V1, P131, DOI 10.1088/1469-7688/1/1/310; Roubini Nouriel, 2010, CRISIS EC CRASH COUR; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Siegel J.J., 2003, EUR FINANC MANAG, V9, P11, DOI [10.1111/1468-036X.00206, DOI 10.1111/1468-036X.00206]; Sornette D, 2006, INT J FORECASTING, V22, P153, DOI 10.1016/j.ijforecast.2005.02.004; Sornette D, 1996, J PHYS I, V6, P167, DOI 10.1051/jp1:1996135; Sornette D, 1998, PHYS REP, V297, P239, DOI 10.1016/S0370-1573(97)00076-8; Sornette D, 2002, P NATL ACAD SCI USA, V99, P2522, DOI 10.1073/pnas.022581999; Sornette D., 2015, J RISK MANAGEMENT FI, V8, P83; Sornette D., 2010, BRUSSELS EC REV CAHI, V53, P201; Sornette D., 2010, FINANCIAL BUBBLES RE; Sornette D, 2009, WHY STOCK MARKETS CR; Sornette D, 2015, REV BEHAV ECON, V2, P279, DOI 10.1561/105.00000035; Sornette D, 2015, J INVEST STRATEG, V4, P77, DOI 10.21314/JOIS.2015.063; Sornette D, 2014, RISKS, V2, P103, DOI 10.3390/risks2020103; Sornette D, 2009, PHYSICA A, V388, P1571, DOI 10.1016/j.physa.2009.01.011; Steeb WH, 2005, NONLINEAR WORKBOOK C; van Bothmer HCG, 2003, PHYSICA A, V320, P539, DOI 10.1016/S0378-4371(02)01535-2; Zhou WX, 2005, P ROY SOC B-BIOL SCI, V272, P439, DOI 10.1098/rspb.2004.2970	49	16	17	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165819	10.1371/journal.pone.0165819	http://dx.doi.org/10.1371/journal.pone.0165819			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806093	gold, Green Published			2022-12-27	WOS:000386715500058
J	Kotecha, D; Ahmed, A; Calvert, M; Lencioni, M; Terwee, CB; Lane, DA				Kotecha, Dipak; Ahmed, Amar; Calvert, Melanie; Lencioni, Mauro; Terwee, Caroline B.; Lane, Deirdre A.			Patient-Reported Outcomes for Quality of Life Assessment in Atrial Fibrillation: A Systematic Review of Measurement Properties	PLOS ONE			English	Review							METHODOLOGICAL QUALITY; RHYTHM-CONTROL; QUESTIONNAIRE; INSTRUMENTS; DISEASE; COSMIN; METAANALYSIS; EFFICACY	Background Atrial fibrillation is a large and growing burden across all types of healthcare. Both incidence and prevalence are expected to double in the next 20 years, with huge impact on hospital admissions, costs and patient quality of life. Patient wellbeing determines the management strategy for atrial fibrillation, including the use of rhythm control therapy and the clinical success of heart rate control. Hence, evaluation of quality of life is an emerging and important part of the assessment of patients with atrial fibrillation. Although a number of questionnaires to assess quality of life in atrial fibrillation are available, a comprehensive overview of their measurement properties is lacking. Methods and Results We performed a systematic review of the measurement properties of atrial fibrillation-specific health-related quality of life questionnaires. Methodological quality was assessed using the Consensus based Standards for selection of health Measurement Instruments (COSMIN) checklist, with measurement properties rated for quality against optimal criteria and levels of evidence. We screened 2,216 articles, of which eight articles describing five questionnaires were eligible for inclusion: Atrial Fibrillation 6 (AF6), Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT), Atrial Fibrillation Quality of Life Questionnaire (AFQLQ), Atrial Fibrillation Quality of Life (AFQoL), and Quality of Life in Atrial Fibrillation (QLAF). Good reliability (internal consistency and test-retest reliability) was demonstrated for AF6, AFEQT, AFQLQ and AFQoL. Content, construct and criterion validity were positively rated only in AFEQT. Responsiveness was positively rated only in AFEQT, but with limited evidence. Overall, AFEQT showed strong positive evidence for 2 of 9 measurement properties, compared to one for AFQoL and none for the remaining questionnaires. Interpretation Given the low ratings for many measurement properties, no single questionnaire can be recommended, although AFEQT performed strongest. Further studies to robustly assess reliability, validity and responsiveness of AF-specific quality of life questionnaires are required. This review consolidates the current evidence for quality of life assessment in patients with atrial fibrillation and identifies priority areas for future research.	[Kotecha, Dipak; Ahmed, Amar; Lane, Deirdre A.] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England; [Kotecha, Dipak; Lane, Deirdre A.] Sandwell & West Birmingham Hosp NHS Trust, City Hosp, Birmingham, W Midlands, England; [Calvert, Melanie] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Kotecha, Dipak; Lencioni, Mauro] Univ Hosp Birmingham NHS Trust, Birmingham, W Midlands, England; [Terwee, Caroline B.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Terwee, Caroline B.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	University of Birmingham; University of Birmingham; University of Birmingham; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Kotecha, D (corresponding author), Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England.; Kotecha, D (corresponding author), Sandwell & West Birmingham Hosp NHS Trust, City Hosp, Birmingham, W Midlands, England.; Kotecha, D (corresponding author), Univ Hosp Birmingham NHS Trust, Birmingham, W Midlands, England.	d.kotecha@bham.ac.uk	Kotecha, Dipak/Q-2827-2016; Calvert, Melanie/F-7055-2011; Lane, Deirdre/AAX-1866-2020	Kotecha, Dipak/0000-0002-2570-9812; Calvert, Melanie/0000-0002-1856-837X; Lane, Deirdre/0000-0002-5604-9378; Terwee, Caroline/0000-0003-4570-2826	University of Birmingham; EW Kite Bequest; National Institute for Health Research (NIHR) as part of the RAte control Therapy Evaluation in Atrial Fibrillation (RATE-AF) trial;  [CDF-2015-08-074]; National Institute for Health Research [CDF-2015-08-074] Funding Source: researchfish	University of Birmingham; EW Kite Bequest; National Institute for Health Research (NIHR) as part of the RAte control Therapy Evaluation in Atrial Fibrillation (RATE-AF) trial(National Institute for Health Research (NIHR)); ; National Institute for Health Research(National Institute for Health Research (NIHR))	AA was supported by the University of Birmingham and funded by the EW Kite Bequest. DK is funded by the National Institute for Health Research (NIHR) as part of the RAte control Therapy Evaluation in Atrial Fibrillation (RATE-AF) trial (www.birmingham.ac.uk/rate-af) and a Career Development Fellowship (CDF-2015-08-074). The opinions expressed are those of the authors and do not represent the NIHR or the UK Department of Health. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Al-Khatib SM, 2014, ANN INTERN MED, V160, P760, DOI 10.7326/M13-1467; Aliot E, 2014, EUROPACE, V16, P787, DOI 10.1093/europace/eut369; Arribas F, 2010, EUROPACE, V12, P364, DOI 10.1093/europace/eup421; Badia X, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-37; Braganca EOV, 2010, INT J CARDIOL, V143, P391, DOI 10.1016/j.ijcard.2009.03.087; Caldeira D, 2012, ARCH CARDIOVASC DIS, V105, P226, DOI 10.1016/j.acvd.2011.11.005; de Vries M, 2005, J VASC SURG, V41, P261, DOI 10.1016/j.jvs.2004.11.022; Dobson F, 2012, OSTEOARTHR CARTILAGE, V20, P1548, DOI 10.1016/j.joca.2012.08.015; Dorian P, 2013, AM HEART J, V166, P381, DOI 10.1016/j.ahj.2013.04.015; Elbers RG, 2012, QUAL LIFE RES, V21, P925, DOI 10.1007/s11136-011-0009-2; FDA, 2009, GUID IND PAT REP OUT; Harden M, 2010, J INTERV CARD ELECTR, V28, P185, DOI 10.1007/s10840-010-9487-3; Harden M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-65; Institute of Cardiovascular Sciences; University of Birmingham Chief Investigator Kotecha D, 2015, RAT CONTR THER EV PE; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Kotecha D, 2015, EUR HEART J, V36, P3250, DOI 10.1093/eurheartj/ehv513; Kotecha D, 2014, LANCET, V384, P2235, DOI 10.1016/S0140-6736(14)61373-8; Moreira RSL, 2016, ARQ BRAS CARDIOL, V106, P171, DOI 10.5935/abc.20160026; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-22; Reeve B, 2013, QUAL LIFE RES, V22, P1889, DOI 10.1007/s11136-012-0344-y; Reynolds MR, 2008, J CARDIOVASC ELECTR, V19, P762, DOI 10.1111/j.1540-8167.2007.01091.x; Scholtes VA, 2011, INJURY, V42, P236, DOI 10.1016/j.injury.2010.11.042; Spertus J, 2011, CIRC-ARRHYTHMIA ELEC, V4, P15, DOI 10.1161/CIRCEP.110.958033; Stewart S, 2004, HEART, V90, P286, DOI 10.1136/hrt.2002.008748; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Terwee CB, 2009, QUAL LIFE RES, V18, P1115, DOI 10.1007/s11136-009-9528-5; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Waktare JEP, 2002, CIRCULATION, V106, P14, DOI 10.1161/01.CIR.0000022730.66617.D9; Weldam SWM, 2013, INT J NURS STUD, V50, P688, DOI 10.1016/j.ijnurstu.2012.07.017; Wheelwright S, 2013, SUPPORT CARE CANCER, V21, P2625, DOI 10.1007/s00520-013-1881-9; White J, 2016, QUAL LIFE RES, V25, P1571, DOI 10.1007/s11136-015-1194-1; World Health Organization, 1997, MEASURING QUALITY OF; Yamashita T, 2005, JPN J ELECTROCARDIOL, V25, P488; Yamashita T, 2003, JPN J ELECTROCARDIOL, V23, P332; Ziff OJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4451	37	30	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165790	10.1371/journal.pone.0165790	http://dx.doi.org/10.1371/journal.pone.0165790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6CX	27802324	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200054
J	Lee, D; Park, SM				Lee, Donghoon; Park, Sang Min			Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies to Prevent Perinatal Transmission in North Korea: Selective Vaccination vs. Universal Vaccination	PLOS ONE			English	Article							VERTICAL TRANSMISSION; ECONOMIC-EVALUATION; VIRUS HBV; E-ANTIGEN; IMMUNIZATION; IMMUNOPROPHYLAXIS; AFFORDABILITY; EXPERIENCE; MOZAMBIQUE; INFECTION	Background To tackle the high prevalence of Hepatitis B virus (HBV) infection in North Korea, it is essential that birth doses of HBV vaccines should be administered within 24 hours of birth. As the country fails to provide a Timely Birth Dose (TBD) of HBV vaccine, the efforts of reducing the high prevalence of HBV have been significantly hampered. Methods To examine the cost-effectiveness of vaccination strategies to prevent perinatal transmission of HBV in North Korea, we established a decision tree with a Markov model consisting of selective, universal, and the country's current vaccination program against HBV. The cost-effectiveness analysis was performed from societal and payer's perspectives and evaluated by Disability Adjusted Life Year (DALY). Results The results suggest that introducing the universal vaccination would prevent 1,866 cases of perinatal infections per 100,000 of the birth cohort of 2013. Furthermore, 900 cases of perinatal infections per 100,000 could be additionally averted if switching to the selective vaccination. The current vaccination is a dominated strategy both from the societal and payer's perspective. The Incremental Cost-Effectiveness Ratio (ICER) between universal and selective vaccination is $267 from the societal perspective and is reported as $ 273 from the payer's perspective. Conclusion Based on the assumption that the 2012 Gross Domestic Product (GDP) per capita in North Korea, $582.6 was set for cost-effectiveness criteria, the result of this study indicates that selective vaccination may be a highly cost-effective strategy compared to universal vaccination.	[Lee, Donghoon] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea; [Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.; Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea.	smpark_snuh@gmail.com	Park, Sang Min/V-9194-2019					Adibi P, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-31; Amnesty International, 2010, CRUMBL STAT HLTH CAR; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P405; [Anonymous], GLOB BURD DIS 2004 U; BEASLEY RP, 1977, AM J EPIDEMIOL, V105, P94, DOI 10.1093/oxfordjournals.aje.a112370; Chen HL, 2012, GASTROENTEROLOGY, V142, P773, DOI 10.1053/j.gastro.2011.12.035; Chen SCC, 2013, PEDIATRICS, V131, pE1135, DOI 10.1542/peds.2012-1262; Choi HR, 1999, J KOREAN ACAD FAM ME, V20, P1778; Edejer T.T.-T., 2003, MAKING CHOICES HLTH, V1; Edmunds WJ, 1996, EPIDEMIOL INFECT, V117, P313, DOI 10.1017/S0950268800001497; Evans AA, 2015, VACCINE, V33, P3010, DOI 10.1016/j.vaccine.2015.01.054; Fan L, 2014, OBSTET GYNECOL, V123, P929, DOI 10.1097/AOG.0000000000000124; GHENDON Y, 1987, J VIROL METHODS, V17, P69, DOI 10.1016/0166-0934(87)90070-X; Global Alliance for Vaccines and Immunization, 2002, PROP HEP B MON VACC; Global Alliance for Vaccines and Immunization, 2011, COMPR MULT PLAN IMM; Global Alliance for Vaccines and Immunization, ALL COUNTR COMM AND; Global Alliance for Vaccines and Immunization, 2011, PROP DTP HEPB HIB PE; Goe LC, 2005, PUBLIC HEALTH, V119, P347, DOI 10.1016/j.puhe.2004.05.024; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Griffiths UK, 2005, HEALTH POLICY PLANN, V20, P50, DOI 10.1093/heapol/czi006; Grundy J, 2009, INT J HEALTH PLAN M, V24, P113, DOI 10.1002/hpm.958; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; Jeong EC., 2012, THESIS KYUNGPOOK NAT; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kim SY, 2007, B WORLD HEALTH ORGAN, V85, P833, DOI 10.2471/BLT.06.038893; Klingler C, 2012, VACCINE, V31, P252, DOI 10.1016/j.vaccine.2012.08.007; Lu SQ, 2013, VACCINE, V31, P1864, DOI 10.1016/j.vaccine.2013.01.020; MARGOLIS HS, 1995, JAMA-J AM MED ASSOC, V274, P1201, DOI 10.1001/jama.274.15.1201; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; SEHGAL A, 1992, J TROP PEDIATRICS, V38, P247, DOI 10.1093/tropej/38.5.247; Sendi PP, 2001, HEALTH ECON, V10, P675; Siddiqui MR, 2011, VACCINE, V29, P466, DOI 10.1016/j.vaccine.2010.10.075; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; Stouthard MEA, 1997, DISABILITY WEIGHTS D; Tandon A, 2002, MEASURING HLTH SYSTE; Tu Hong Anh T, 2012, Value Health Reg Issues, V1, P7, DOI 10.1016/j.vhri.2012.03.007; UNICEF Supplies and Logistics, VACC PRIC DAT DTP HE; United Nations, UN DAT DPR KOR; Vaccines and Immunization, 2014, ANN PROGR REP 2013 K; Vimolket Thosporn, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P693; WHEELEY SM, 1991, J MED VIROL, V35, P212, DOI 10.1002/jmv.1890350312; *WHO, 2009, WHO COUNTR COOP STRA; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; Wiseman E, 2009, MED J AUSTRALIA, V190, P489, DOI 10.5694/j.1326-5377.2009.tb02524.x; WONG VCW, 1984, LANCET, V1, P921; World Health Organization, 2013, EPI FACTSH DPR KOR 2; World Health Organization, GLOB HLTH OBS DAT RE; World Health Organization, 2001, HEPATITIS B SURFACE; World Health Organization, 2003, WHO COUNTR COOP STRA; ZANETTI AR, 1986, J MED VIROL, V18, P327, DOI 10.1002/jmv.1890180405; ZANETTI AR, 1983, DEV BIOLOGICALS, V54, P383	51	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165879	10.1371/journal.pone.0165879	http://dx.doi.org/10.1371/journal.pone.0165879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802340	Green Submitted, Green Published, gold			2022-12-27	WOS:000386714200065
J	Myhrvold, NP				Myhrvold, Nathan P.			Dinosaur Metabolism and the Allometry of Maximum Growth Rate	PLOS ONE			English	Article							BODY TEMPERATURES; PATTERNS; EVOLUTION; REPRODUCTION; FALLACY; MASS; CURVATURE; MODELS; BIRDS; POWER	The allometry of maximum somatic growth rate has been used in prior studies to classify the metabolic state of both extant vertebrates and dinosaurs. The most recent such studies are reviewed, and their data is reanalyzed. The results of allometric regressions on growth rate are shown to depend on the choice of independent variable; the typical choice used in prior studies introduces a geometric shear transformation that exaggerates the statistical power of the regressions. The maximum growth rates of extant groups are found to have a great deal of overlap, including between groups with endothermic and ectothermic metabolism. Dinosaur growth rates show similar overlap, matching the rates found for mammals, reptiles and fish. The allometric scaling of growth rate with mass is found to have curvature (on a log-log scale) for many groups, contradicting the prevailing view that growth rate allometry follows a simple power law. Reanalysis shows that no correlation between growth rate and basal metabolic rate (BMR) has been demonstrated. These findings drive a conclusion that growth rate allometry studies to date cannot be used to determine dinosaur metabolism as has been previously argued.	[Myhrvold, Nathan P.] Intellectual Ventures, Bellevue, WA 98005 USA	Intellectual Ventures	Myhrvold, NP (corresponding author), Intellectual Ventures, Bellevue, WA 98005 USA.	nathanm@intven.com		Myhrvold, Nathan/0000-0003-3994-5143				Agutter PS, 2004, THEOR BIOL MED MODEL, V1, P1, DOI DOI 10.1186/1742-4682-1-13; Apanius V., 1998, AVIAN GROWTH DEV EVO; Botelho JF, 2015, EVOL DEV, V17, P221, DOI 10.1111/ede.12126; Brusatte SL, 2015, CURR BIOL, V25, pR888, DOI 10.1016/j.cub.2015.08.003; Bueno J, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00061; Burnham KP, 2003, MODEL SELECTION INFE; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; CALDER WA, 1982, J ZOOL, V198, P215; Calder WA., 1984, SIZE FUNCTION LIFE H; Capellini I, 2010, ECOLOGY, V91, P2783, DOI 10.1890/09-0817.1; Carey N, 2013, J EXP MAR BIOL ECOL, V439, P7, DOI 10.1016/j.jembe.2012.10.013; CASE TJ, 1978, PALEOBIOLOGY, V4, P320, DOI 10.1017/S0094837300006023; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Centers for Disease Control and Prevention, NHANES 2013 2014; Chinsamy Anusuya, 1993, Modern Geology, V18, P319; Clarke A, 2010, BIOL REV, V85, P703, DOI 10.1111/j.1469-185X.2010.00122.x; Cubo J, 2008, EVOL DEV, V10, P217, DOI 10.1111/j.1525-142X.2008.00229.x; D'Emic MD, 2015, SCIENCE, V348, DOI [10.1126/science.1260061, 10.1126/science.1260410]; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Eagle RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9296; Ehnes RB, 2011, ECOL LETT, V14, P993, DOI 10.1111/j.1461-0248.2011.01660.x; Elftman H, 1946, AM J PHYS ANTHROP-NE, V4, P116, DOI 10.1002/ajpa.1330040117; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Erickson GM, 2014, ANNU REV EARTH PL SC, V42, P675, DOI 10.1146/annurev-earth-060313-054858; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Erickson GM, 2009, ANAT REC, V292, P1514, DOI 10.1002/ar.20992; Glazier DS, 2009, COMP BIOCHEM PHYS A, V153, P403, DOI 10.1016/j.cbpa.2009.03.020; Grady JM, 2015, SCIENCE, V348, DOI 10.1126/science.1260299; Grady JM, 2014, SCIENCE, V344, P1268, DOI 10.1126/science.1253143; HAYSSEN V, 1985, COMP BIOCHEM PHYS A, V81, P741, DOI 10.1016/0300-9629(85)90904-1; Jasienski M, 1999, OIKOS, V84, P321, DOI 10.2307/3546729; Kaitaniemi P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001932; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; Kleiber M., 1961, FIRE LIFE, DOI DOI 10.1002/JPS.2600510525; Kolokotrones T, 2010, NATURE, V464, P753, DOI 10.1038/nature08920; Langford E, 2001, AM STAT, V55, P322, DOI 10.1198/000313001753272286; Lee AH, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P217; Legendre L., 2015, DID CROCODILES BECOM; Legendre LJ, 2016, SOC SYST BIOL, P1; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; Lovegrove BG, 2009, J COMP PHYSIOL B, V179, P391, DOI 10.1007/s00360-008-0322-4; Lucas J, 2014, J FISH BIOL, V84, P1171, DOI 10.1111/jfb.12306; Marquet PA, 2005, J EXP BIOL, V208, P1749, DOI 10.1242/jeb.01588; McNab B.K., 2012, EXTREME MEASURES ECO; Moran D, 2007, COMP BIOCHEM PHYS A, V148, P611, DOI 10.1016/j.cbpa.2007.08.006; Muller DWH, 2012, OIKOS, V121, P102, DOI 10.1111/j.1600-0706.2011.19505.x; Myhrvold NP, 2015, ANAT REC, V298, P489, DOI 10.1002/ar.23101; Myhrvold NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081917; Nespolo RF, 2005, BIOL RES, V38, P27, DOI 10.4067/S0716-97602005000100004; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; PIANTADOSI S, 1988, AM J EPIDEMIOL, V127, P893, DOI 10.1093/oxfordjournals.aje.a114892; Portnov BA, 2007, J EXPO SCI ENV EPID, V17, P106, DOI 10.1038/sj.jes.7500533; Prondvai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031392; Reid R.E.H., 1990, Modern Geology, V15, P19; RICKLEFS RE, 1984, ECOLOGY, V65, P1602, DOI 10.2307/1939139; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; RICKLEFS RE, 1969, ECOLOGY, V50, P1031, DOI 10.2307/1936894; RICKLEFS RE, 1968, IBIS, V110, P419, DOI 10.1111/j.1474-919X.1968.tb00058.x; Robinson WS, 2011, INT J EPIDEMIOL, V40, P1134, DOI [10.1093/ije/dyn357, 10.1093/ije/dyr082]; Sander PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078573; Savage VM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000171; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Seymour RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069361; Seymour RS, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1051, DOI 10.1086/422766; WELSH AH, 1988, AM NAT, V132, P277, DOI 10.1086/284850; Werner J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088834; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2007, ECOLOGY, V88, P315, DOI 10.1890/05-1883; White CR, 2014, COMPR PHYSIOL, V4, P231, DOI 10.1002/cphy.c110049; White CR, 2011, AM NAT, V178, P746, DOI 10.1086/662666; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; ZULLINGER EM, 1984, J MAMMAL, V65, P607, DOI 10.2307/1380844	77	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0163205	10.1371/journal.pone.0163205	http://dx.doi.org/10.1371/journal.pone.0163205			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828977	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300006
J	Poizot-Martin, I; Allavena, C; Duvivier, C; Cano, CE; de Salvador, FG; Rey, D; Dellamonica, P; Cuzin, L; Cheret, A; Hoen, B				Poizot-Martin, Isabelle; Allavena, Clotilde; Duvivier, Claudine; Cano, Carla Eliana; de Salvador, Francine Guillouet; Rey, David; Dellamonica, Pierre; Cuzin, Lise; Cheret, Antoine; Hoen, Bruno		Dat'AIDS Study Grp	CMV plus Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART	PLOS ONE			English	Article							T-CELL-ACTIVATION; ANTIRETROVIRAL THERAPY; CD4/CD8 RATIO; LARGE COHORT; INFLAMMATION; INDIVIDUALS; MORTALITY; RECOVERY; CD4(+)	Cytomegalovirus (CMV) infection is common among HIV-infected patients but its repercussion on the course of CD4+ and CD8+ T cells after cART initiation remains elusive. The French Dat'AIDS cohort enrolled 5,688 patients on first-line cART, from which we selected patients who achieved HIV suppression for at least 12 months without modification of cART, and for whom CMV serostatus was available. Five hundred and three patients fulfilled the selection criteria (74% male, median age 43 yrs, 15.5% CDC stage C), of whom 444 (88.3%) were seropositive for CMV (CMV+). Multivariate analyses using mixed-linear models adjusted for the time from HIV suppression, sex, age, transmission risk group, duration of HIV follow-up, the interaction between time from HIV suppression and CMV+ serology, and the nadir CD4 count revealed a negative correlation between CMV+ and CD4: CD8 ratio (coeff. = -0.16; p = 0.001). This correlation was also observed among patients displaying optimal CD4 recovery (>= 500 cells/mm3 at M12; coeff. = -0.24; p = 0.002). Hence, CMV+ serostatus antagonizes normalization of the CD4: CD8 ratio, although further analyses of the impact of co-morbidities that associate with CMV serostatus, like HCV infection, are needed to elucidate this antagonism formally. However, this might reflect a premature T cell senescence, thus advocating for a close monitoring of T cells in CMV co-infected patients. In addition, our results raise the question of the benefit of treatment for asymptomatic CMV co-infection in HIV-infected patients.	[Poizot-Martin, Isabelle; Cano, Carla Eliana] Aix Marseille Univ, APHM Hop St Marguerite, Immunohematol Clin, Marseille, France; [Poizot-Martin, Isabelle] INSERM, U912, SESSTIM, Marseille, France; [Allavena, Clotilde] CHU Hotel Dieu, Serv Malad Infect, Nantes, France; [Duvivier, Claudine] Univ Paris 05, IHU Imagine Paris, AP HP, Hop Necker,Serv Malad Infect & Trop,Ctr Infectiol, Paris, France; [Duvivier, Claudine] Inst Pasteur, Ctr Med, Ctr Infectiol Necker Pasteur, Paris, France; [Duvivier, Claudine] Univ Paris 05, Sorbonne Paris Cite, EA7327, Paris, France; [de Salvador, Francine Guillouet] CHU Archet 1, Serv Malad Infect & Trop, Nice, France; [Rey, David] Hop Univ Strasbourg, Ctr HIV Care, Strasbourg, France; [Dellamonica, Pierre] Univ Nice Sophia Antipolis, CHU Nice, Dept Infect Dis, Nice, France; [Cuzin, Lise] Toulouse III Univ, INSERM, CHU Toulouse, COREVIH Toulouse,UMR 1027, F-31000 Toulouse, France; [Cheret, Antoine] Paris Descartes Univ, Sorbonne Paris Cite, EA 3620, Paris, France; [Cheret, Antoine] Necker Enfants Malades Hosp, Virol Lab, Paris, France; [Hoen, Bruno] Univ Antilles, Fac Med Hyacinthe Bastaraud, EA 4537, Pointe A Pitre, Guadeloupe, France; [Hoen, Bruno] CHU Pointe a Pitre, INSERM, Serv Malad Infect & Trop, CIC1424,Dermatol,Med Interne, Pointe A Pitre, Guadeloupe, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite des Antilles; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm)	Poizot-Martin, I (corresponding author), Aix Marseille Univ, APHM Hop St Marguerite, Immunohematol Clin, Marseille, France.; Poizot-Martin, I (corresponding author), INSERM, U912, SESSTIM, Marseille, France.	isabelle.poizot@ap-hm.fr	Allavena, Clotilde/AAH-4310-2019	Poizot-Martin, Isabelle/0000-0002-5676-5411				Appay V, 2011, AIDS, V25, P1813, DOI 10.1097/QAD.0b013e32834640e6; Barrett L, 2014, AIDS, V28, P2045, DOI 10.1097/QAD.0000000000000405; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; BOWEN DL, 1985, ANN INTERN MED, V103, P704, DOI 10.7326/0003-4819-103-5-704; Buggert M, 2014, J IMMUNOL, V192, P2099, DOI 10.4049/jimmunol.1302596; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Helleberg M, 2015, J INFECT DIS, V211, P1726, DOI 10.1093/infdis/jiu669; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Kapetanovic S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120474; Lee SA, 2014, J INFECT DIS, V210, P374, DOI 10.1093/infdis/jiu109; Lichtner M, 2015, J INFECT DIS, V211, P178, DOI 10.1093/infdis/jiu417; Ndumbi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117039; Pugliese P, 2003, PRESSE MED, V32, P299; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Serrano-Villar S, 2013, J INFECTION, V66, P57, DOI 10.1016/j.jinf.2012.09.013; Tassiopoulos K, 2012, J INFECT DIS, V205, P1730, DOI 10.1093/infdis/jis260; Turner JE, 2014, AGE, V36, P287, DOI 10.1007/s11357-013-9557-4; WIKBY A, 1994, EXP GERONTOL, V29, P531, DOI 10.1016/0531-5565(94)90036-1	21	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165774	10.1371/journal.pone.0165774	http://dx.doi.org/10.1371/journal.pone.0165774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824907	Green Submitted, Green Published, gold			2022-12-27	WOS:000387615200032
J	De Regge, N; Cay, B				De Regge, Nick; Cay, Brigitte			Comparison of PRRSV Nucleic Acid and Antibody Detection in Pen-Based Oral Fluid and Individual Serum Samples in Three Different Age Categories of Post-Weaning Pigs from Endemically Infected Farms	PLOS ONE			English	Article							RESPIRATORY-SYNDROME-VIRUS; POLYMERASE CHAIN-REACTION; SPECIMENS; COLLECTION; SURVEILLANCE; EUROPE; ASSAYS; WILD; PCR	Background Porcine reproductive and respiratory syndrome virus (PRRSV) is the causative agent of an economically important disease in swine. Since it has been shown that PRRSV and PRRSV specific antibodies can be detected in oral fluid, many different aspects have been studied to show that oral fluid could be a worthy alternative diagnostic sample to serum for monitoring and surveillance of this disease. Thorough field evaluations are however missing to convincingly show its usefulness under representative field conditions. Methodology Pen-based oral fluid samples and serum samples from all individual pigs in the corresponding pens were collected from post-weaning pigs of three different age categories in eight endemically PRRSV infected farms and one PRRSV free farm in Belgium. All samples were tested by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and ELISA to detect PRRSV RNA and PRRSV specific antibodies, respectively. Results While the relative specificity of PRRSV detection by qRT-PCR in pen-based oral fluid compared to serum collected from individual pigs was high in all age categories (>90%), the relative sensitivity decreased with the age of the pigs (89, 93 and 10% in 8-12w, 16-20w and 24-28w old pigs, respectively). The latter correlated with a lower percentage of PRRSV positive pigs in serum/pen in the different age categories (55, 29 and 6%, respectively). Irrespective of the age category, pen-based oral fluid samples were always found PCR positive when at least 30% of the individual pigs were positive in serum. PRRSV specific antibody detection in oral fluid by ELISA showed a 100% relative sensitivity to detection in serum since oral fluid samples were always positive as soon as one pig in the pen was positive in serum. On the other hand, two false positive oral fluid samples in 11 pens without serum positive pigs were found, resulting in a relative specificity of 82%. Indications are however present that the oral fluid result indicated the correct infection status but the absence of a golden standard test makes it difficult to define definitive test characteristics. Conclusions Overall it can be concluded that oral fluid seems to be a useful matrix for diagnosis of PRRSV under field conditions and that differences in kinetics of PRRSV and PRRSV specific antibody detection in oral fluid and serum of individual pigs can also be reflected in pen-based oral fluid results.	[De Regge, Nick; Cay, Brigitte] CODA CERVA, Operat Direct Viral Dis, Enzoot & Reemerging Dis, Groeselenberg 99, B-1180 Uccle, Belgium		De Regge, N (corresponding author), CODA CERVA, Operat Direct Viral Dis, Enzoot & Reemerging Dis, Groeselenberg 99, B-1180 Uccle, Belgium.	nick.deregge@coda-cerva.be			Federal Public Service of Health, Food Chain Safety and Environment, Belgium [RF 10/6235]	Federal Public Service of Health, Food Chain Safety and Environment, Belgium	This study was funded by the Federal Public Service of Health, Food Chain Safety and Environment (RF 10/6235), Belgium. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albina E, 1997, VET MICROBIOL, V55, P309, DOI 10.1016/S0378-1135(96)01322-3; Balka G, 2015, VIRUS RES, V200, P1, DOI 10.1016/j.virusres.2015.01.014; Chittick WA, 2011, J VET DIAGN INVEST, V23, P248, DOI 10.1177/104063871102300208; Decorte I, 2015, J VET DIAGN INVEST, V27, P47, DOI 10.1177/1040638714561252; Decorte I, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-134; Decorte I, 2013, VET J, V197, P224, DOI 10.1016/j.tvjl.2013.02.001; Gerber PF, 2013, J CLIN MICROBIOL, V51, P547, DOI 10.1128/JCM.02685-12; Kittawornrat A, 2014, VET MICROBIOL, V168, P331, DOI 10.1016/j.vetmic.2013.11.035; Kittawornrat A, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-61; Kittawornrat A, 2012, J VET DIAGN INVEST, V24, P262, DOI 10.1177/1040638711435679; Kittawornrat A, 2010, VIRUS RES, V154, P170, DOI 10.1016/j.virusres.2010.07.025; Kuiek AM, 2015, TROP ANIM HEALTH PRO, V47, P1337, DOI 10.1007/s11250-015-0868-6; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Langenhorst RJ, 2012, CLIN VACCINE IMMUNOL, V19, P180, DOI 10.1128/CVI.05372-11; Linhares DCL, 2012, J VET DIAGN INVEST, V24, P328, DOI 10.1177/1040638711429492; Trang NT, 2014, J VET SCI, V15, P361, DOI 10.4142/jvs.2014.15.3.361; Nodelijk G, 1997, VET MICROBIOL, V56, P21, DOI 10.1016/S0378-1135(96)01349-1; Olsen C, 2013, VET J, V198, P158, DOI 10.1016/j.tvjl.2013.06.014; Olsen C, 2013, J VET DIAGN INVEST, V25, P328, DOI 10.1177/1040638713481471; Ouyang K, 2013, CLIN VACCINE IMMUNOL, V20, P1305, DOI 10.1128/CVI.00276-13; Pepin BJ, 2015, TRANSBOUND EMERG DIS, V62, P295, DOI 10.1111/tbed.12135; Prickett J, 2008, J VET DIAGN INVEST, V20, P156, DOI 10.1177/104063870802000203; Prickett JR, 2010, J SWINE HEALTH PROD, V18, P187; Ramirez A, 2012, PREV VET MED, V104, P292, DOI 10.1016/j.prevetmed.2011.11.008; Sattler T, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0388-7; Seddon YM, 2012, VET J, V193, P180, DOI 10.1016/j.tvjl.2011.11.008; Stadejek T, 2013, VET MICROBIOL, V165, P21, DOI 10.1016/j.vetmic.2013.02.029; Steinrigl A, 2014, BERL MUNCH TIERARZTL, V127, P216, DOI 10.2376/0005-9366-127-216; Wills RW, 1997, VET MICROBIOL, V57, P69, DOI 10.1016/S0378-1135(97)00079-5	29	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166300	10.1371/journal.pone.0166300	http://dx.doi.org/10.1371/journal.pone.0166300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820859	Green Published, gold, Green Submitted			2022-12-27	WOS:000387614800044
J	Bartholomaus, A; Wibberg, D; Winkler, A; Puhler, A; Schluter, A; Varrelmann, M				Bartholomaeus, Anika; Wibberg, Daniel; Winkler, Anika; Puehler, Alfred; Schlueter, Andreas; Varrelmann, Mark			Deep Sequencing Analysis Reveals the Mycoviral Diversity of the Virome of an Avirulent Isolate of Rhizoctonia solani AG-2-2 IV	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; MOLECULAR CHARACTERIZATION; GENOME SEQUENCE; ROSELLINIA-NECATRIX; VEGETATIVE GROWTH; CHESTNUT BLIGHT; VIRUSES; HYPOVIRULENCE; VIRULENCE; MEGABIRNAVIRUS	Rhizoctonia solani represents an important plant pathogenic Basidiomycota species complex and the host of many different mycoviruses, as indicated by frequent detection of dsRNA elements in natural populations of the fungus. To date, eight different mycoviruses have been characterized in Rhizoctonia and some of them have been reported to modulate its virulence. DsRNA extracts of the avirulent R. solani isolate DC17 (AG2-2-IV) displayed a diverse pattern, indicating multiple infections with mycoviruses. Deep sequencing analysis of the dsRNA extract, converted to cDNA, revealed that this isolate harbors at least 17 different mycovirus species. Based on the alignment of the conserved RNA-dependent RNApolymerase (RdRp) domain, this viral community included putative members of the families Narnaviridae, Endornaviridae, Partitiviridae and Megabirnaviridae as well as of the order Tymovirales. Furthermore, viruses, which could not be assigned to any existing family or order, but showed similarities to so far unassigned species like Sclerotinia sclerotiorum RNA virus L, Rhizoctonia solani dsRNA virus 1, Aspergillus foetidus slow virus 2 or Rhizoctonia fumigata virus 1, were identified. This is the first report of a fungal isolate infected by 17 different viral species and a valuable study case to explore the diversity of mycoviruses infecting R. solani.	[Bartholomaeus, Anika; Varrelmann, Mark] Inst Sugar Beet Res, D-37077 Gottingen, Germany; [Wibberg, Daniel; Winkler, Anika; Puehler, Alfred; Schlueter, Andreas] Univ Bielefeld, CeBiTec, Inst Genome Res & Syst Biol, D-33501 Bielefeld, Germany	University of Bielefeld	Bartholomaus, A; Varrelmann, M (corresponding author), Inst Sugar Beet Res, D-37077 Gottingen, Germany.	bartholomaeus@ifz-goettingen.de; varrelmann@ifz-goettingen.de		Schluter, Andreas/0000-0003-4830-310X; Puhler, Alfred/0000-0003-4723-2960				Anees M, 2010, SOIL BIOL BIOCHEM, V42, P1661, DOI 10.1016/j.soilbio.2010.05.013; BANDY BP, 1990, AM POTATO J, V67, P189, DOI 10.1007/BF02987071; Bharathan N, 2005, PLANT PATHOL, V54, P196, DOI 10.1111/j.1365-3059.2005.01159.x; BHARATHAN N, 1990, PHYTOPATHOLOGY, V80, P631, DOI 10.1094/Phyto-80-631; Boehr DD, 2014, NUCLEIC ACIDS MOL BI, V30, P309, DOI 10.1007/978-3-642-39796-7_14; Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277; Cerny J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096070; Chiba S, 2009, J VIROL, V83, P12801, DOI 10.1128/JVI.01830-09; CHOI GH, 1992, SCIENCE, V257, P800, DOI 10.1126/science.1496400; Cubeta MA, 1997, PHYTOPATHOLOGY, V87, P480, DOI 10.1094/PHYTO.1997.87.4.480; Darissa O, 2012, EUR J PLANT PATHOL, V134, P181, DOI 10.1007/s10658-012-9977-5; Das S, 2014, FUNGAL BIOL-UK, V118, P924, DOI 10.1016/j.funbio.2014.08.003; Dawe AL, 2001, ANNU REV GENET, V35, P1, DOI 10.1146/annurev.genet.35.102401.085929; FROUSSARD P, 1992, NUCLEIC ACIDS RES, V20, P2900, DOI 10.1093/nar/20.11.2900; Ghabrial SA, 2015, VIROLOGY, V479, P356, DOI 10.1016/j.virol.2015.02.034; Garcia VG, 2006, SPAN J AGRIC RES, V4, P55; Hillman BI, 2013, ADV VIRUS RES, V86, P149, DOI 10.1016/B978-0-12-394315-6.00006-4; Howitt RLJ, 2006, ARCH VIROL, V151, P563, DOI 10.1007/s00705-005-0621-y; Howitt RLJ, 2001, J GEN VIROL, V82, P67, DOI 10.1099/0022-1317-82-1-67; Jian JH, 1997, MOL PLANT MICROBE IN, V10, P1002, DOI 10.1094/MPMI.1997.10.8.1002; Jian JH, 1998, MOL PLANT MICROBE IN, V11, P601, DOI 10.1094/MPMI.1998.11.7.601; Kanematsu S, 2014, VIROLOGY, V450, P308, DOI 10.1016/j.virol.2013.12.002; Kanematsu S, 2010, PHYTOPATHOLOGY, V100, P922, DOI 10.1094/PHYTO-100-9-0922; Kim JM, 2015, VIRUS RES, V197, P8, DOI 10.1016/j.virusres.2014.11.016; Kim SO, 1996, FEMS MICROBIOL LETT, V141, P203, DOI 10.1016/0378-1097(96)00222-4; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Kitahara R, 2014, ARCH VIROL, V159, P2157, DOI 10.1007/s00705-014-1999-1; Koonin EV, 2015, VIROLOGY, V479, P2, DOI 10.1016/j.virol.2015.02.039; Koonin EV, 2014, MICROBIOL MOL BIOL R, V78, P278, DOI 10.1128/MMBR.00049-13; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Kozlakidis Z, 2013, ARCH VIROL, V158, P2625, DOI 10.1007/s00705-013-1779-3; Lakshman DK, 1998, P NATL ACAD SCI USA, V95, P6425, DOI 10.1073/pnas.95.11.6425; Li W, 2014, ARCH VIROL, V159, P1213, DOI 10.1007/s00705-013-1893-2; Li YQ, 2015, ARCH VIROL, V160, P2371, DOI 10.1007/s00705-015-2483-2; Liu HQ, 2009, J VIROL, V83, P1981, DOI 10.1128/JVI.01897-08; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Marzano SYL, 2016, J VIROL, V90, P6846, DOI 10.1128/JVI.00357-16; Marzano SYL, 2016, VIRUS RES, V219, P11, DOI 10.1016/j.virusres.2016.05.012; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Nerva L, 2016, VIRUS RES, V219, P22, DOI 10.1016/j.virusres.2015.10.028; Nuss DL, 2005, NAT REV MICROBIOL, V3, P632, DOI 10.1038/nrmicro1206; Okubara PA, 2014, PLANT SCI, V228, P61, DOI 10.1016/j.plantsci.2014.02.001; Pearson MN, 2009, MOL PLANT PATHOL, V10, P115, DOI 10.1111/j.1364-3703.2008.00503.x; Roossinck MJ, 2015, PHYTOPATHOLOGY, V105, P716, DOI 10.1094/PHYTO-12-14-0356-RVW; Roossinck MJ, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00767; Roossinck MJ, 2011, J GEN VIROL, V92, P2674, DOI 10.1099/vir.0.034702-0; Rosario K, 2011, CURR OPIN VIROL, V1, P289, DOI 10.1016/j.coviro.2011.06.004; Sasaki A, 2016, VIRUS RES, V219, P73, DOI 10.1016/j.virusres.2015.12.009; Simmonds P, 2015, J GEN VIROL, V96, P1193, DOI 10.1099/jgv.0.000016; SNEH B, 1989, CAN J BOT, V67, P2135, DOI 10.1139/b89-270; Son M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005172; Soueidan H, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00739; Strauss EE, 2000, J GEN VIROL, V81, P549, DOI 10.1099/0022-1317-81-2-549; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; te Velthuis AJW, 2014, CELL MOL LIFE SCI, V71, P4403, DOI 10.1007/s00018-014-1695-z; Urayama S, 2010, J GEN VIROL, V91, P3085, DOI 10.1099/vir.0.025411-0; Vainio EJ, 2015, J GEN VIROL, V96, P714, DOI 10.1099/jgv.0.000003; VALVERDE RA, 1990, PLANT DIS, V74, P255; van Diepeningen AD, 2006, FUNGAL GENET BIOL, V43, P446, DOI 10.1016/j.fgb.2006.01.014; Wang MH, 2015, J VIROL, V89, P8567, DOI 10.1128/JVI.00243-15; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wibberg D, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2561-1; Wibberg D, 2011, J BIOTECHNOL, V155, P50, DOI 10.1016/j.jbiotec.2011.01.010; Xie J, 2006, J GEN VIROL, V87, P241, DOI 10.1099/vir.0.81522-0; Xie JT, 2014, ANNU REV PHYTOPATHOL, V52, P45, DOI 10.1146/annurev-phyto-102313-050222; Xu X, 2003, NUCLEIC ACIDS RES, V31, P7117, DOI 10.1093/nar/gkg916; Yu X, 2013, P NATL ACAD SCI USA, V110, P1452, DOI 10.1073/pnas.1213755110; Zanotto PMD, 1996, J VIROL, V70, P6083, DOI 10.1128/JVI.70.9.6083-6096.1996; ZANZINGER DH, 1984, J GEN VIROL, V65, P1601, DOI 10.1099/0022-1317-65-9-1601; Zhang R, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.1, 10.1038/nmicrobiol.2015.1]; Zhang T, 2015, ARCH VIROL, V160, P1815, DOI 10.1007/s00705-015-2431-1; Zheng L, 2014, VIROLOGY, V456, P220, DOI 10.1016/j.virol.2014.03.029; Zheng L, 2013, ARCH VIROL, V158, P1609, DOI 10.1007/s00705-013-1637-3; Zhong J, 2015, VIRUS GENES, V51, P167, DOI 10.1007/s11262-015-1219-4	75	39	40	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165965	10.1371/journal.pone.0165965	http://dx.doi.org/10.1371/journal.pone.0165965			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814394	gold, Green Published, Green Submitted			2022-12-27	WOS:000386911100023
J	Chen, YH; Tarng, DC; Chen, HS				Chen, Yu-Hsin; Tarng, Der-Cherng; Chen, Harn-Shen			Renal Outcomes of Pioglitazone Compared with Acarbose in Diabetic Patients: A Randomized Controlled Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; MELLITUS; ALPHA; RATS; THIAZOLIDINEDIONES; ROSIGLITAZONE; DECLINE; EDEMA	Objective To assess the effect of pioglitazone on renal outcome, including urinary albumin excretion and estimated glomerular filtration rate (eGFR), in diabetic patients. Design A prospective, randomized, open-labeled, controlled study. Setting Taipei Veterans General Hospital. Patients Sixty type 2 diabetic patients treated with sulfonylureas and metformin, whose glycated hemoglobin (HbA1c) levels were between 7% and 10% and eGFR was between 45 and 125 mL/min/1.73 m(2). Intervention The patients were randomized to receive acarbose or pioglitazone and followed up for 6 months. Thirty patients were randomly assigned to receive acarbose, and 30 patients were assigned to receive pioglitazone. Measurements The primary study endpoint was the changes in the urinary albumin-to-creatinine ratio (UACR). The secondary endpoint was the changes in eGFR and other parameters. Results After 6 months of treatment, the mean changes in UACR were -18 +/- 104 and 12 +/- 85 (p = 0.25, between groups) for the acarbose and pioglitazone groups, respectively. The mean changes in eGFR were 0 +/- 14 and -7 +/- 16 mL/min/1.73 m(2) (p = 0.09, between groups) for the acarbose and pioglitazone groups, respectively. The reductions in HbA1c were similar in both groups. Fasting blood glucose was lower in the pioglitazone group than in the acarbose group. Significant body weight gain was observed in the pioglitazone group as compared with the acarbose group (1.3 +/- 2.8 vs. -0.6 +/- 1.5 kg, p = 0.002). Conclusion In type 2 diabetic patients who were treated with sulfonylureas and metformin and possessed HbA1c levels between 7% and 10%, additional acarbose or pioglitazone for 6 months provided similar glycemic control and eGFR and UACR changes. In the pioglitazone group, the patients exhibited significant body weight gain.	[Chen, Yu-Hsin; Tarng, Der-Cherng] Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Chen, Harn-Shen] Taipei Vet Gen Hosp, Div Endocrinol & Metab, Dept Med, Taipei, Taiwan; [Chen, Yu-Hsin; Chen, Harn-Shen] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan; [Tarng, Der-Cherng] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei, Taiwan; [Tarng, Der-Cherng] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, HS (corresponding author), Taipei Vet Gen Hosp, Div Endocrinol & Metab, Dept Med, Taipei, Taiwan.; Chen, HS (corresponding author), Natl Yang Ming Univ, Fac Med, Taipei, Taiwan.	chenhs@vghtpe.gov.tw			Taipei Veterans General Hospital [V100C-204]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by grants from Taipei Veterans General Hospital (V100C-204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2000, BBA-MOL CELL RES, V1497, P148, DOI 10.1016/S0167-4889(00)00054-9; Bays H, 2004, J CLIN ENDOCR METAB, V89, P463, DOI 10.1210/jc.2003-030723; BRESNICK GH, 1986, OPHTHALMOLOGY, V93, P989; Chang YT, 2014, DIABETES CARE, V37, P277, DOI 10.2337/dc13-0781; Chen YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129922; COHEN MP, 1995, GEN PHARMACOL-VASC S, V26, P1355, DOI 10.1016/0306-3623(94)00283-S; Feldman L, 2010, J NEPHROL, V23, P350; Guan YF, 2001, KIDNEY INT, V60, P14, DOI 10.1046/j.1523-1755.2001.00766.x; Isshiki K, 2000, DIABETES, V49, P1022, DOI 10.2337/diabetes.49.6.1022; Kalantarinia K, 2003, KIDNEY INT, V64, P1208, DOI 10.1046/j.1523-1755.2003.00237.x; Kim Mee Kyoung, 2009, Korean Journal of Internal Medicine, V24, P227, DOI 10.3904/kjim.2009.24.3.227; McCarthy KJ, 2000, KIDNEY INT, V58, P2341, DOI 10.1046/j.1523-1755.2000.00418.x; Moriwaki Y, 2003, METABOLISM, V52, P605, DOI 10.1053/meta.2003.50096; Mudaliar Sunder, 2003, Endocr Pract, V9, P406; Niemeyer NV, 2002, PHARMACOTHERAPY, V22, P924, DOI 10.1592/phco.22.11.924.33626; Ruilope L, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-180; Sarafidis PA, 2006, KIDNEY INT, V70, P1223, DOI 10.1038/sj.ki.5001620; Sarafidis PA, 2010, AM J KIDNEY DIS, V55, P835, DOI 10.1053/j.ajkd.2009.11.013; Schneider CA, 2008, J AM SOC NEPHROL, V19, P182, DOI 10.1681/ASN.2007060678; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Wang AYM, 2011, J DIABETES, V3, P119, DOI 10.1111/j.1753-0407.2011.00113.x; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	22	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165750	10.1371/journal.pone.0165750	http://dx.doi.org/10.1371/journal.pone.0165750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812149	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000055
J	Khan, MI; Czarnecka, AM; Lewicki, S; Helbrecht, I; Brodaczewska, K; Koch, I; Zdanowski, R; Krol, M; Szczylik, C				Khan, Mohammed I.; Czarnecka, Anna M.; Lewicki, Slawomir; Helbrecht, Igor; Brodaczewska, Klaudia; Koch, Irena; Zdanowski, Robert; Krol, Magdalena; Szczylik, Cezary			Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; INTEGRIN-LINKED KINASE; FACTOR-ALPHA; THERAPEUTIC TARGET; INITIATING ABILITY; PROGENITOR CELLS; ENDOGLIN CD105; RESISTANCE	Background Recent advancement in cancer research has shown that tumors are highly heterogeneous, and multiple phenotypically different cell populations are found in a single tumor. Cancer development and tumor growth are driven by specific types of cells-stem cell-like cancer cells (SCLCCs)-which are also responsible for metastatic spread and drug resistance. This research was designed to verify the presence of SCLCCs in renal cell cancer cell lines. Subsequently, we aimed to characterize phenotype and cell biology of CD105+ cells, defined previously as renal cell carcinoma tumor-initiating cells. The main goal of the project was to describe the gene-expression profile of stem cell-like cancer cells of primary tumor and metastatic origin. Materials and Methods Real-time PCR analysis of stemness genes (Oct-4, Nanog and Ncam) and soft agar colony formation assay were conducted to check the stemness properties of renal cell carcinoma (RCC) cell lines. FACS analysis of CD105+ and CD133+ cells was performed on RCC cells. Isolated CD105+ cells were verified for expression of mesenchymal markers-CD24, CD146, CD90, CD73, CD44, CD11b, CD19, CD34, CD45, HLA-DR and alkaline phosphatase. Hanging drop assay was used to investigate CD105+ cell-cell cohesion. Analysis of free-floating 3D spheres formed by isolated CD105+ was verified, as spheres have been hypothesized to contain undifferentiated multipotent progenitor cells. Finally, CD105+ cells were sorted from primary (Caki-2) and metastatic (ACHN) renal cell cancer cell lines. Gene-expression profiling of sorted CD105+ cells was performed with Agilent's human GE 4x44K v2 microarrays. Differentially expressed genes were further categorized into canonical pathways. Network analysis and downstream analysis were performed with Ingenuity Pathway Analysis. Results Metastatic RCC cell lines (ACHN and Caki-1) demonstrated higher colony-forming ability in comparison to primary RCC cell lines. Metastatic RCC cell lines harbor numerous CD105+ cell subpopulations and have higher expression of stemness genes (Oct-4 and Nanog). CD105+ cells adopt 3D grape-like floating structures under handing drop conditions. Sorted CD105+ cells are positive for human mesenchymal stem cell (MSC) markers CD90, CD73, CD44, CD146, and alkaline phosphatase activity, but not for CD24 and hematopoietic lineage markers CD34, CD11b, CD19, CD45, and HLA-DR. 1411 genes are commonly differentially expressed in CD105+ cells (both from primary [Caki-2] and metastatic RCC [ACHN] cells) in comparison to a healthy kidney epithelial cell line (ASE-5063). TGF-beta, Wnt/beta-catenine, epithelial-mesenchymal transition (EMT), Rap1 signaling, PI3K-Akt signaling, and Hippo signaling pathway are deregulated in CD105+ cells. TGFB1, ERBB2, and TNF are the most significant transcriptional regulators activated in these cells. Conclusions All together, RCC-CD105+ cells present stemlike properties. These stem cell-like cancer cells may represent a novel target for therapy. A unique gene-expression profile of CD105+ cells could be used as initial data for subsequent functional studies and drug design.	[Khan, Mohammed I.; Czarnecka, Anna M.; Helbrecht, Igor; Brodaczewska, Klaudia; Szczylik, Cezary] Mil Inst Med, Dept Oncol, Mol Oncol Lab, Warsaw, Poland; [Lewicki, Slawomir; Zdanowski, Robert] Mil Inst Hyg & Epidemiol, Dept Regenerat Med, Warsaw, Poland; [Krol, Magdalena] WULS, Dept Physiol Sci, Fac Vet Med, Warsaw, Poland; [Helbrecht, Igor] Warsaw Univ, Inst Genet & Biotechnol, Fac Biol, Warsaw, Poland; [Koch, Irena] Inst Mother & Child Hlth, Dept Pathomorphol, Warsaw, Poland	Military Institute of Aviation Medicine; Military Institute of Hygiene & Epidemiology (MIHE); Warsaw University of Life Sciences; University of Warsaw	Khan, MI; Czarnecka, AM (corresponding author), Mil Inst Med, Dept Oncol, Mol Oncol Lab, Warsaw, Poland.	mkhan@wim.mil.pl; aczarnecka@wim.mil.pl	Khan, Mohammed I/I-9621-2017; Lewicki, Sławomir/AAZ-4709-2020; Czarnecka, Anna M/A-1388-2009; Koch, Irena/Z-1092-2018; Krol, Magdalena/A-5554-2019	Khan, Mohammed I/0000-0003-3020-1324; Lewicki, Sławomir/0000-0002-0539-0680; Czarnecka, Anna M/0000-0002-2107-3810; Szczylik, Cezary/0000-0002-2524-2810; Helbrecht, Igor/0000-0002-8078-3935; Koch, Irena/0000-0003-3546-9469; Krol, Magdalena/0000-0003-0421-5167; Zdanowski, Robert/0000-0003-0455-1072; Brodaczewska, Klaudia K./0000-0003-2374-3600	Foundation for Polish Science project [TEAM/2010-6/8]	Foundation for Polish Science project	This work was supported by the Foundation for Polish Science project TEAM/2010-6/8. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno-Cruz V, 2015, CANCER RES, V75, P924, DOI 10.1158/0008-5472.CAN-14-3225; Bachmeier BE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-129; Banerjee M, 2006, CYTOTECHNOLOGY, V51, P1, DOI 10.1007/s10616-006-9001-z; Bertazza L, 2010, CURR MED CHEM, V17, P3337, DOI 10.2174/092986710793176339; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BORDER WA, 1995, KIDNEY INT, V47, pS59; Bruno S, 2006, AM J PATHOL, V169, P2223, DOI 10.2353/ajpath.2006.060498; Buczek M, 2014, BBA-REV CANCER, V1845, P31, DOI 10.1016/j.bbcan.2013.10.001; Buhring HJ, 2009, ANN NY ACAD SCI, V1176, P124, DOI 10.1111/j.1749-6632.2009.04564.x; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Canis M, 2013, TUMOR BIOL, V34, P437, DOI 10.1007/s13277-012-0568-z; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Costa LJ, 2007, ONCOLOGIST, V12, P1404, DOI 10.1634/theoncologist.12-12-1404; Czarnecka AM, 2013, CURR SIGNAL TRANSD T, V8, P203; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Ferrajoli A, 2002, BLOOD, V100, P1215, DOI 10.1182/blood.V100.4.1215.h81602001215_1215_1219; Flanigan Robert C, 2003, Curr Treat Options Oncol, V4, P385, DOI 10.1007/s11864-003-0039-2; Fonsatti E, 2003, ONCOGENE, V22, P6557, DOI 10.1038/sj.onc.1206813; Foty R, 2011, JOVE-J VIS EXP, DOI 10.3791/2720; Galleggiante V, 2014, J UROLOGY, V192, P1831, DOI 10.1016/j.juro.2014.06.070; Garcia-Tunon I, 2006, CANCER SCI, V97, P1044, DOI 10.1111/j.1349-7006.2006.00277.x; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; Garner JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125838; Gassenmaier M, 2013, STEM CELLS, V31, P1467, DOI 10.1002/stem.1407; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hara S, 2005, ANN ONCOL, V16, P928, DOI 10.1093/annonc/mdi182; Ho MY, 2012, MOL CANCER RES, V10, P1109, DOI 10.1158/1541-7786.MCR-12-0160; Hong BX, 2015, INT J CANCER, V136, P34, DOI 10.1002/ijc.28958; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khan MI, 2016, AM J PHYSIOL-RENAL, V311, pF424, DOI 10.1152/ajprenal.00138.2016; Khan MI, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0177-z; Khan MI, 2013, CURR SIGNAL TRANSD T, V8, P240; Kim GR, 2015, ONCOL LETT, V9, P1641, DOI 10.3892/ol.2015.2918; Kim K, 2011, ONCOL LETT, V2, P1095, DOI 10.3892/ol.2011.368; Kim SY, 2013, CELL SIGNAL, V25, P961, DOI 10.1016/j.cellsig.2013.01.007; Kim YH, 2012, STEM CELLS DEV, V21, P2958, DOI 10.1089/scd.2011.0349; Klein U, 2011, CANCER CELL, V20, P556, DOI 10.1016/j.ccr.2011.10.026; Knoefel B, 1997, J INTERF CYTOK RES, V17, P95, DOI 10.1089/jir.1997.17.95; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee SH, 2012, BIOCHEM BIOPH RES CO, V424, P58, DOI 10.1016/j.bbrc.2012.06.065; Lin TT, 2006, CELL RES, V16, P857, DOI 10.1038/sj.cr.7310107; Liu XQ, 2015, CURR PHARM DESIGN, V21, P1279, DOI 10.2174/1381612821666141211115611; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Lu JZ, 2013, ONCOL LETT, V5, P1903, DOI 10.3892/ol.2013.1270; LYONS RM, 1990, EUR J BIOCHEM, V187, P467, DOI 10.1111/j.1432-1033.1990.tb15327.x; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Michalaki V, 2004, BRIT J CANCER, V90, P2312, DOI 10.1038/sj.bjc.6601814; Micucci C, 2015, BRIT J CANCER, V113, P1178, DOI 10.1038/bjc.2015.338; Miles FL, 2008, CLIN EXP METASTAS, V25, P305, DOI 10.1007/s10585-007-9098-2; Mitropoulos D, 2004, UROL RES, V32, P317, DOI 10.1007/s00240-003-0360-z; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2014, LANCET ONCOL, V15, P286, DOI 10.1016/S1470-2045(14)70030-0; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Nishizawa S, 2012, CANCER RES, V72, P2844, DOI 10.1158/0008-5472.CAN-11-3062; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pfeiffer MJ, 2010, EUR UROL, V57, P246, DOI 10.1016/j.eururo.2009.01.015; Rahman MT, 2012, AM J CLIN PATHOL, V138, P535, DOI 10.1309/AJCPKDLRQ8F3EWNS; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Roemer A, 2004, J UROLOGY, V172, P2162, DOI 10.1097/01.ju.0000144602.01322.49; Saroufim A, 2014, BRIT J CANCER, V110, P1778, DOI 10.1038/bjc.2014.71; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serrano I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3976; Sjolund J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023057; Sobiesiak M, 2010, STEM CELLS DEV, V19, P669, DOI 10.1089/scd.2009.0290; Stankiewicz AM, 2014, BMC NEUROSCI, V15, DOI 10.1186/s12868-014-0130-6; Stefkova K, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/628368; Sturm I, 2003, CELL DEATH DIFFER, V10, P477, DOI 10.1038/sj.cdd.4401194; Szlosarek PW, 2006, MOL CANCER THER, V5, P382, DOI 10.1158/1535-7163.MCT-05-0303; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Torisawa YS, 2007, BIOMATERIALS, V28, P559, DOI 10.1016/j.biomaterials.2006.08.054; Tsukada S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt168; Ueda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075463; Varna M, 2015, CLIN CANCER RES, V21, P916, DOI 10.1158/1078-0432.CCR-14-0666; Walther MM, 1998, J UROLOGY, V159, P718, DOI 10.1016/S0022-5347(01)63709-1; Wang L, 2011, CANCER RES, P71, DOI [10.1158/1538-7445.Am2011-293, DOI 10.1158/1538-7445.AM2011-293]; Wang L, 2015, J CANCER RES CLIN, V141, P1013, DOI 10.1007/s00432-014-1883-0; Wang X, 2008, ACTA PHARMACOL SIN, V29, P1275, DOI 10.1111/j.1745-7254.2008.00889.x; Wu ST, 2011, EXP BIOL MED, V236, P1022, DOI 10.1258/ebm.2011.011058; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Yu DH, 2000, BIOESSAYS, V22, P673, DOI 10.1002/1521-1878(200007)22:7<673::AID-BIES10>3.0.CO;2-A; Zecchini S, 2011, EMBO MOL MED, V3, P480, DOI 10.1002/emmm.201100152	102	36	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165718	10.1371/journal.pone.0165718	http://dx.doi.org/10.1371/journal.pone.0165718			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812180	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000052
J	Lee, BJ; Kim, JY				Lee, Bum Ju; Kim, Jong Yeol			Identification of Hemoglobin Levels Based on Anthropometric Indices in Elderly Koreans	PLOS ONE			English	Article							WAIST CIRCUMFERENCE; IRON-DEFICIENCY; ANEMIA; OLDER; PREVALENCE; OBESITY; INDICATORS; FEMALES; GENDER; HEALTH	Objectives Anemia is independently and strongly associated with an increased risk of mortality in older people and is also strongly associated with obesity. The objectives of the present study were to examine the associations between the hemoglobin level and various anthropometric indices, to predict low and normal hemoglobin levels using combined anthropometric indices, and to assess differences in the hemoglobin level and anthropometric indices between Korean men and women. Methods A total of 7,156 individuals ranging in age from 53-90 years participated in this retrospective cross-sectional study. Binary logistic regression (LR) and naive Bayes (NB) models were used to identify significant differences in the anthropometric indices between subjects with low and normal hemoglobin levels and to assess the predictive power of these indices for the hemoglobin level. Results Among all of the variables, age displayed the strongest association with the hemoglobin level in both men (p < 0.0001, odds ratio [OR] = 0.487, area under the receiver operating characteristic curve based on the LR [LR-AUC] = 0.702, NB-AUC = 0.701) and women (p < 0.0001, OR = 0.636, LR-AUC = 0.625, NB-AUC = 0.624). Among the anthropometric indices, weight and body mass index (BMI) were the best predictors of the hemoglobin level. The predictive powers of all of the variables were higher in men than in women. The AUC values for the NB-Wrapper and LR-Wrapper predictive models generated using combined anthropometric indices were 0.734 and 0.723, respectively, for men and 0.649 and 0.652, respectively, for women. The use of combined anthropometric indices may improve the predictive power for the hemoglobin level. Discussion Among the various anthropometric indices, with the exception of age, we did not identify any indices that were better predictors than weight and BMI for low and normal hemoglobin levels. In addition, none of the ratios between pairs of indices were good indicators of the hemoglobin level. Finally, the Korean men tended to have higher associations between the anthropometric indices and anemia than the women.	[Lee, Bum Ju; Kim, Jong Yeol] Korea Inst Oriental Med, KM Fundamental Res Div, Deajeon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Lee, BJ (corresponding author), Korea Inst Oriental Med, KM Fundamental Res Div, Deajeon, South Korea.	bjlee@kiom.re.kr	Yeol, Kim Jong/AAP-5998-2020	Lee, Bum Ju/0000-0003-2682-5716	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2006-2005173, NRF-2012-0009830, NRF-2009-0090900]; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [NRF-2015M3A9B6027139]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP	This research was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2006-2005173, NRF-2012-0009830, and NRF-2009-0090900). This research was also supported by the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (NRF-2015M3A9B6027139).	Al-Hashem FH, 2007, SAUDI MED J, V28, P41; Ausk KJ, 2008, OBESITY, V16, P2356, DOI 10.1038/oby.2008.353; Cepeda-Lopez AC, 2011, AM J CLIN NUTR, V93, P975, DOI 10.3945/ajcn.110.005439; Cesari M, 2004, J GERONTOL A-BIOL, V59, P249; Choi CW, 2004, AM J HEMATOL, V77, P26, DOI 10.1002/ajh.20140; Esmaillzadeh A, 2004, INT J OBESITY, V28, P1325, DOI 10.1038/sj.ijo.0802757; Frith-Terhune AL, 2000, AM J CLIN NUTR, V72, P963; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Izaks GJ, 1999, JAMA-J AM MED ASSOC, V281, P1714, DOI 10.1001/jama.281.18.1714; Jang E, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/604842; KARIO K, 1992, AM J HEMATOL, V41, P252, DOI 10.1002/ajh.2830410406; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Lee BJ, 2014, IEEE J BIOMED HEALTH, V19, P1618; Lee BJ, 2015, COMPUT BIOL MED, V57, P201, DOI 10.1016/j.compbiomed.2014.12.005; Lee BJ, 2014, IEEE J BIOMED HEALTH, V18, P555, DOI 10.1109/JBHI.2013.2264509; Lee BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084897; Lee HyunSook, 2004, Korean Journal of Community Nutrition, V9, P589; LIPSCHITZ DA, 1981, AM J HEMATOL, V11, P47, DOI 10.1002/ajh.2830110106; MARTI B, 1989, ATHEROSCLEROSIS, V75, P111, DOI 10.1016/0021-9150(89)90167-6; Neymotin F, 2011, OBESITY, V19, P191, DOI 10.1038/oby.2010.112; Odagiri K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088873; Patel KV, 2008, SEMIN HEMATOL, V45, P210, DOI 10.1053/j.seminhematol.2008.06.006; Qin Y, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-10; SALIVE ME, 1992, J AM GERIATR SOC, V40, P489, DOI 10.1111/j.1532-5415.1992.tb02017.x; Semba RD, 2009, EUR J CLIN NUTR, V63, P93, DOI 10.1038/sj.ejcn.1602889; Snijder MB, 2004, INT J OBESITY, V28, P402, DOI 10.1038/sj.ijo.0802567; Takeda M, 2011, GERIATR GERONTOL INT, V11, P377, DOI 10.1111/j.1447-0594.2011.00736.x; TIMIRAS ML, 1987, J AM GERIATR SOC, V35, P639, DOI 10.1111/j.1532-5415.1987.tb04340.x; Vuong J, 2014, AM J HEMATOL, V89, P671, DOI 10.1002/ajh.23713; Wasikowski M, 2010, IEEE T KNOWL DATA EN, V22, P1388, DOI 10.1109/TKDE.2009.187; Wu JL, 2010, MED CARE, V48, pS106, DOI 10.1097/MLR.0b013e3181de9e17; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214	35	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165622	10.1371/journal.pone.0165622	http://dx.doi.org/10.1371/journal.pone.0165622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812118	gold, Green Published, Green Submitted			2022-12-27	WOS:000386910000039
J	Bartholome, J; Bink, MCAM; van Heerwaarden, J; Chancerel, E; Boury, C; Lesur, I; Isik, F; Bouffier, L; Plomion, C				Bartholome, Jerome; Bink, Marco C. A. M.; van Heerwaarden, Joost; Chancerel, Emilie; Boury, Christophe; Lesur, Isabelle; Isik, Fikret; Bouffier, Laurent; Plomion, Christophe			Linkage and Association Mapping for Two Major Traits Used in the Maritime Pine Breeding Program: Height Growth and Stem Straightness	PLOS ONE			English	Article							WOOD PROPERTY TRAITS; CANDIDATE GENES; TAEDA L.; COMPLEX TRAITS; PINASTER AIT.; FOREST TREES; ADAPTIVE TRAIT; QTL ANALYSIS; GENETICS; SELECTION	Background Increasing our understanding of the genetic architecture of complex traits, through analyses of genotype-phenotype associations and of the genes/polymorphisms accounting for trait variation, is crucial, to improve the integration of molecular markers into forest tree breeding. In this study, two full-sib families and one breeding population of maritime pine were used to identify quantitative trait loci (QTLs) for height growth and stem straightness, through linkage analysis (LA) and linkage disequilibrium (LD) mapping approaches. Results The populations used for LA consisted of two unrelated three-generation full-sib families (n = 197 and n = 477). These populations were assessed for height growth or stem straightness and genotyped for 248 and 217 markers, respectively. The population used for LD mapping consisted of 661 founders of the first and second generations of the breeding program. This population was phenotyped for the same traits and genotyped for 2,498 single-nucleotide polymorphism (SNP) markers corresponding to 1,652 gene loci. The gene-based reference genetic map of maritime pine was used to localize and compare the QTLs detected by the two approaches, for both traits. LA identified three QTLs for stem straightness and two QTLs for height growth. The LD study yielded seven significant associations (P <= 0.001): four for stem straightness and three for height growth. No colocalisation was found between QTLs identified by LA and SNPs detected by LD mapping for the same trait. Conclusions This study provides the first comparison of LA and LD mapping approaches in maritime pine, highlighting the complementary nature of these two approaches for deciphering the genetic architecture of two mandatory traits of the breeding program.	[Bartholome, Jerome; Chancerel, Emilie; Boury, Christophe; Lesur, Isabelle; Bouffier, Laurent; Plomion, Christophe] Univ Bordeaux, INRA, BIOGECO, F-33610 Cestas, France; [Bink, Marco C. A. M.; van Heerwaarden, Joost] Univ Wageningen & Res Ctr, Biometris, NL-6700 AC Wageningen, Netherlands; [Lesur, Isabelle] HelixVenture, Merignac, France; [Isik, Fikret] North Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC USA	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Wageningen University & Research; University of North Carolina; North Carolina State University	Plomion, C (corresponding author), Univ Bordeaux, INRA, BIOGECO, F-33610 Cestas, France.	christophe.plomion@inra.fr	Isik, Fikret/AAR-1220-2020; van Heerwaarden, Joost/A-1424-2014; Bartholomé, Jérôme/S-9333-2019	Isik, Fikret/0000-0003-2833-7919; van Heerwaarden, Joost/0000-0002-4959-3914; Bartholomé, Jérôme/0000-0002-0855-3828; plomion, christophe/0000-0002-3176-2767	Agence national de la recherche (ERANET SUSTAINPINE project, the COTE Cluster of Excellence) [ANR-10-LABX-45]; European Union [211868, 289841]; Conseil General des Landes; Conseil Regional d'Aquitaine [20030304002FA, 20040305003FA]; European Union, FEDER [2003227]; Investissements d'avenir [ANR-10-EQPX-16-01]; Conseil Regional d'Aquitaine; Direction Regionale de l'Alimentation, de l'Agriculture et de la Foret d'Aquitaine	Agence national de la recherche (ERANET SUSTAINPINE project, the COTE Cluster of Excellence)(French National Research Agency (ANR)); European Union(European Commission); Conseil General des Landes(Region Nouvelle-Aquitaine); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); European Union, FEDER(European Commission); Investissements d'avenir(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Direction Regionale de l'Alimentation, de l'Agriculture et de la Foret d'Aquitaine	This study was carried out with financial support from the Agence national de la recherche (http://www.agence-nationale-recherche.fr/, ERANET SUSTAINPINE project, the COTE Cluster of Excellence, ANR-10-LABX-45), the European Union Sixth and Seventh Framework Programmes (https://ec.europa.eu/research/fp7/index_en.cfm, Noveltree (no. 211868) and Procogen (no. 289841)). JB was supported by a postdoctoral fellowship from the Conseil General des Landes. The F2 mapping population was genotyped at the Genomic and Transcriptomic Facility of Bordeaux (grants from the Conseil Regional d'Aquitaine, nos. 20030304002FA and 20040305003FA, the European Union, FEDER no. 2003227 and Investissements d'avenir, ANR-10-EQPX-16-01). The public funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. IL is employed by the commercial company: HelixVenture. This funder provided support in the form of salaries for author IL, but did not have any additional role in the study design, data collection, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; We thank J Brach, D Charon and the staff of the experimental unit of INRA Pierroton (especially C Gauvrit, L Severin, H Lataillade, N Cheval, and B Issenhuth) for the experimental follow-up of the F2 and G2 mapping populations. The authors are thankful to GIS Groupe Pin Maritime du Futur for installing and measuring progeny tests. The Groupe Pin Maritime du Futur is supported by the Conseil Regional d'Aquitaine and by the Direction Regionale de l'Alimentation, de l'Agriculture et de la Foret d'Aquitaine.	Cabezas JA, 2015, TREE PHYSIOL, V35, P1000, DOI 10.1093/treephys/tpv050; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Beaulieu J, 2011, GENETICS, V188, P197, DOI 10.1534/genetics.110.125781; Beavis WD, 1998, MOL DISSECTION COMPL, P145, DOI DOI 10.1093/MP/SSR111; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouffier L, 2008, HEREDITY, V101, P156, DOI 10.1038/hdy.2008.41; Brautigam K, 2013, ECOL EVOL, V3, P399, DOI 10.1002/ece3.461; Brendel O, 2002, PLANT CELL ENVIRON, V25, P945, DOI 10.1046/j.1365-3040.2002.00872.x; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Broman KW, 2011, GUIDE QTL MAPPING R; Budde KB, 2014, NEW PHYTOL, V201, P230, DOI 10.1111/nph.12483; Canales J, 2014, PLANT BIOTECHNOL J, V12, P286, DOI 10.1111/pbi.12136; Cappa EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081267; Carvalho Ana, 2013, Mol Biol Int, V2013, P974324, DOI 10.1155/2013/974324; Chagne D, 2002, ANN FOREST SCI, V59, P627, DOI 10.1051/forest:2002048; Chancerel E, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-50; Chancerel E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-368; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Chhatre VE, 2013, TREE GENET GENOMES, V9, P1161, DOI 10.1007/s11295-013-0624-x; Costa P, 1996, CAN J FOREST RES, V26, P1209, DOI 10.1139/x26-135; Cumbie WP, 2011, HEREDITY, V107, P105, DOI 10.1038/hdy.2010.168; DANJON F, 1994, THEOR APPL GENET, V89, P911, DOI 10.1007/BF00224517; de Miguel M, 2015, GENOME BIOL EVOL, V7, P2799, DOI 10.1093/gbe/evv185; de Miguel M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-464; Devey ME, 2004, THEOR APPL GENET, V108, P516, DOI 10.1007/s00122-003-1471-1; Dillon SK, 2010, GENETICS, V185, P1477, DOI 10.1534/genetics.110.116582; Du QZ, 2016, NEW PHYTOL, V209, P1067, DOI 10.1111/nph.13695; Durel C, 1995, REVUE FRANCAISE, P5, DOI [10.4267/2042.26674, DOI 10.4267/2042.26674]; Eckert AJ, 2012, NEW PHYTOL, V193, P890, DOI 10.1111/j.1469-8137.2011.03976.x; Emebiri LC, 1998, THEOR APPL GENET, V97, P1053, DOI 10.1007/s001220050991; Endelman JB, 2014, BIOINFORMATICS, V30, P1623, DOI 10.1093/bioinformatics/btu091; Eu-ahsunthornwattana J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004445; Evans LM, 2014, NAT GENET, V46, P1089, DOI 10.1038/ng.3075; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Gion JM, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0795-0; Gonzalez-Martinez S. C., 2011, Genetics, genomics and breeding of conifers, P239; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Grattapaglia D, 2009, CURR OPIN PLANT BIOL, V12, P148, DOI 10.1016/j.pbi.2008.12.008; Heuertz M, 2006, GENETICS, V174, P2095, DOI 10.1534/genetics.106.065102; Holliday JA, 2010, NEW PHYTOL, V188, P501, DOI 10.1111/j.1469-8137.2010.03380.x; Illy G, 1966, ANN SCI FORESTIERES; Ingvarsson PK, 2011, NEW PHYTOL, V189, P909, DOI 10.1111/j.1469-8137.2010.03593.x; Isik F, 2016, PLANT SCI, V242, P108, DOI 10.1016/j.plantsci.2015.08.006; Jaramillo-Correa JP, 2015, ADV BOT RES, V74, P265, DOI 10.1016/bs.abr.2015.04.003; Kaya Z, 1999, THEOR APPL GENET, V98, P586, DOI 10.1007/s001220051108; Khan MA, 2012, J EXP BOT, V63, P4045, DOI 10.1093/jxb/ers105; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; KREMER A, 1981, ANN SCI FOREST, V38, P331, DOI 10.1051/forest:19810303; Lepoittevin C, 2012, TREE GENET GENOMES, V8, P113, DOI 10.1007/s11295-011-0426-y; Lepoittevin C, 2011, ANN FOREST SCI, V68, P873, DOI 10.1007/s13595-011-0084-0; Mackay J, 2012, PLANT MOL BIOL, V80, P555, DOI 10.1007/s11103-012-9961-7; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; Marguerit E, 2014, J EXP BOT, V65, P4757, DOI 10.1093/jxb/eru226; Markussen T, 2003, SILVAE GENET, V52, P8; Mather K, 1941, J GENET, V41, P159, DOI 10.1007/BF02983019; Moritsuka E, 2012, GENETICS, V190, P1145, DOI 10.1534/genetics.111.136697; Muranty H, 2014, TREE GENET GENOMES, V10, P1491, DOI 10.1007/s11295-014-0790-5; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Neale DB, 2004, TRENDS PLANT SCI, V9, P325, DOI 10.1016/j.tplants.2004.05.006; Neves LG, 2013, PLANT J, V75, P146, DOI 10.1111/tpj.12193; Nuzhdin SV, 2012, TRENDS GENET, V28, P421, DOI 10.1016/j.tig.2012.06.003; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Parchman TL, 2012, MOL ECOL, V21, P2991, DOI 10.1111/j.1365-294X.2012.05513.x; Pavy N, 2012, HEREDITY, V108, P273, DOI 10.1038/hdy.2011.72; Pelgas B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-145; Perez P, 2010, PLANT GENOME-US, V3, P106, DOI 10.3835/plantgenome2010.04.0005; Plomion C, 2016, MOL ECOL RESOUR, V16, P574, DOI 10.1111/1755-0998.12464; Plomion C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-171; Pot D, 2005, NEW PHYTOL, V167, P101, DOI 10.1111/j.1469-8137.2005.01417.x; Pot D, 2006, TREE GENET GENOMES, V2, P10, DOI 10.1007/s11295-005-0026-9; Prunier J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-368; Ritland K., 2011, Genetics, genomics and breeding of conifers, P196; Shepherd M, 2002, ANN FOR SCI, V59, P617, DOI 10.1051/forest:2002047; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Thavamanikumar S, 2014, TREE GENET GENOMES, V10, P1661, DOI [10.1007/s11295-01, 10.1007/s11295-014-0787-0]; Thavamanikumar S, 2013, TREE GENET GENOMES, V9, P627, DOI 10.1007/s11295-013-0594-z; Tocquard K, 2014, SPRINGER SER WOOD, P107, DOI 10.1007/978-3-642-10814-3_4; Uchiyama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079866; Ukrainetz NK, 2008, TREE GENET GENOMES, V4, P159, DOI 10.1007/s11295-007-0097-x; Van Ooijen, 2011, JOINMAP 4 1 SOFTWARE; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wegrzyn JL, 2014, GENETICS, V196, P891, DOI 10.1534/genetics.113.159996; Westbrook JW, 2013, NEW PHYTOL, V199, P89, DOI 10.1111/nph.12240; Wilcox P. L., 2007, Association mapping in plants, P211, DOI 10.1007/978-0-387-36011-9_10; Wimmer V, 2012, BIOINFORMATICS, V28, P2086, DOI 10.1093/bioinformatics/bts335; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Xu SZ, 2003, GENETICS, V165, P2259; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	94	18	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165323	10.1371/journal.pone.0165323	http://dx.doi.org/10.1371/journal.pone.0165323			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806077	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500027
J	Cong, ME; Pau, CP; Heneine, W; Garcia-Lerma, JG				Cong, Mian-er; Pau, Chou-Pong; Heneine, Walid; Garcia-Lerma, J. Gerardo			Antiretroviral Drug Activity in Macaques Infected during Pre-Exposure Prophylaxis Has a Transient Effect on Cell-Associated SHIV DNA Reservoirs	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; PRIMARY HIV-1 INFECTION; IMMUNODEFICIENCY-VIRUS; AFRICAN WOMEN; TRANSMISSION; EMTRICITABINE; SHIVSF162P3; EFFICACY; THERAPY; VIREMIA	Background Pre-exposure prophylaxis (PrEP) with emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) is a novel HIV prevention strategy. Suboptimal PrEP adherence and HIV infection creates an opportunity for continued antiretroviral drug activity during undiagnosed infection. We previously showed that macaques infected with SHIV during PrEP with FTC/TDF display reduced acute plasma viremias and limited virus diversity. We investigated the effect of PrEP on acute SHIV DNA dynamics and on the size of the persistent virus reservoir in lymphoid tissues. Design Cell-associated SHIV DNA levels in PBMCs were measured in 8 macaques infected during PrEP with FTC/TDF or single-agent TAF and was compared to those seen in untreated infections (n = 10). PrEP breakthrough infections continued treatment with 1-2 weekly drug doses to model suboptimal drug exposure during undiagnosed HIV infection in humans. SHIV DNA was also measured in lymphoid tissues collected from FTC/TDF PrEP breakthroughs after 1 year of infection. Results Compared to untreated controls, PrEP infections had reduced plasma RNA viremias both at peak and throughout weeks 1-12 (p<0.005). SHIV DNA levels were also reduced at peak and during the first 12 weeks of infection (p<0.043) but not throughout weeks 12-20. At 1 year, SHIV DNA reservoirs in lymphoid tissues were similar in size among macaques that received PrEP or placebo. Conclusions Antiviral drug activity due to PrEP limits acute SHIV replication but has only a transient effect on cell-associated SHIV DNA levels. Our model suggests that suboptimal drug exposure in persons that are taking PrEP and become infected with HIV may not be sufficient to reduce the pool of HIV-infected cells, and that treatment intensification may be needed to sustain potential virological benefits from the PrEP regimen.	[Cong, Mian-er; Pau, Chou-Pong; Heneine, Walid; Garcia-Lerma, J. Gerardo] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Garcia-Lerma, JG (corresponding author), Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA.	GGarcia-Lerma@cdc.gov			CDC intramural funds	CDC intramural funds	This work was supported by CDC intramural funds.	Amico KR, 2014, CLIN INFECT DIS, V59, pS55, DOI 10.1093/cid/ciu266; Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Anderson PL, 2014, J ANTIMICROB CHEMOTH, V69, P2470, DOI 10.1093/jac/dku162; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Cheret A, 2014, TOP ANTIVIR MED, V22, P189; Donnell D, 2014, JAIDS-J ACQ IMM DEF, V66, P340, DOI 10.1097/QAI.0000000000000172; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Garcia-Lerma JG, 2011, J VIROL, V85, P6610, DOI 10.1128/JVI.00311-11; Garcia-Lerma JG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000391; Gianella S, 2011, ANTIVIR THER, V16, P535, DOI 10.3851/IMP1776; Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Henning TR, 2014, AIDS RES HUM RETROV, V30, P1125, DOI 10.1089/aid.2014.0238; Kersh EN, 2012, J INFECT DIS, V206, P770, DOI 10.1093/infdis/jis422; Laanani M, 2015, CLIN INFECT DIS, V60, P1715, DOI 10.1093/cid/civ171; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Massud I, 2013, J VIROL, V87, P8952, DOI 10.1128/JVI.01204-13; Pau CP, 2010, J VIROL METHODS, V164, P55, DOI 10.1016/j.jviromet.2009.11.027; Radzio J, 2014, AIDS, V28, P1431, DOI 10.1097/QAD.0000000000000294; Radzio J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050632; Ruone S, 2016, JAIDS-J ACQ IMM DEF, V72, P129, DOI 10.1097/QAI.0000000000000921; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Zheng Q, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-40	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0164821	10.1371/journal.pone.0164821	http://dx.doi.org/10.1371/journal.pone.0164821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806064	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500014
J	Duncan, CA; Ingram, TGJ; Mansfield, A; Byrne, JM; McIlroy, WE				Duncan, Carolyn A.; Ingram, Tony G. J.; Mansfield, Avril; Byrne, Jeannette M.; McIlroy, William E.			Population Differences in Postural Response Strategy Associated with Exposure to a Novel Continuous Perturbation Stimuli: Would Dancers Have Better Balance on a Boat?	PLOS ONE			English	Article							UPRIGHT STANCE; MOVEMENTS	Central or postural set theory suggests that the central nervous system uses short term, trial to trial adaptation associated with repeated exposure to a perturbation in order to improve postural responses and stability. It is not known if longer-term prior experiences requiring challenging balance control carryover as long-term adaptations that influence ability to react in response to novel stimuli. The purpose of this study was to determine if individuals who had long-term exposure to balance instability, such as those who train on specific skills that demand balance control, will have improved ability to adapt to complex continuous multidirectional perturbations. Healthy adults from three groups: 1) experienced maritime workers (n = 14), 2) novice individuals with no experience working in maritime environments (n = 12) and 3) individuals with training in dance (n = 13) participated in the study. All participants performed a stationary standing task while being exposed to five 6 degree of freedom motions designed to mimic the motions of a ship at sea. The balance reactions (change-in-support (CS) event occurrences and characteristics) were compared between groups. Results indicate dancers demonstrated significantly fewer CS events than novices during the first trial, but did not perform as well as those with offshore experience. Linear trend analyses revealed that short-term adaptation across all five trials was dependent on the nature of participant experience, with dancers achieving postural stability earlier than novices, but later than those with offshore experience. These results suggest that long term previous experiences also have a significant influence on the neural control of posture and balance in the development of compensatory responses.	[Duncan, Carolyn A.; McIlroy, William E.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Duncan, Carolyn A.; Mansfield, Avril; McIlroy, William E.] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada; [Ingram, Tony G. J.; Mansfield, Avril] Dalhousie Univ, Lab Brain Recovery & Funct, Halifax, NS, Canada; [Mansfield, Avril; McIlroy, William E.] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [McIlroy, William E.] Sunnybrook Res Inst, Hurvitz Brain Sci Res Program, Evaluat Clin Sci, Toronto, ON, Canada; [Byrne, Jeannette M.] Mem Univ, Sch Human Kinet & Recreat, St John, NF, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Waterloo; Dalhousie University; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Memorial University Newfoundland	Duncan, CA (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada.; Duncan, CA (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada.	carolyn.duncan@mun.ca	Mansfield, Avril/B-8589-2013	Mansfield, Avril/0000-0002-0396-5815; Ingram, Tony/0000-0003-1213-7920; McIlroy, William/0000-0003-2319-1746	MITACS Accelerate [IT02671]; Petroleum Research Board and Newfoundland and Labrador (MITACS grant); SLEIPNIR LIFT Management (MITACS grant)	MITACS Accelerate; Petroleum Research Board and Newfoundland and Labrador (MITACS grant); SLEIPNIR LIFT Management (MITACS grant)	This work was funded by MITACS Accelerate IT02671 (www.maws.ca), Petroleum Research Board and Newfoundland and Labrador (as industry partner for the MITACS grant) (http:IIpr-ac.ca/), and SLEIPNIR LIFT Management (as industry partner for the MITACS grant) (http://www.sleipnirlogistics.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkin AL, 2008, NEUROSCI LETT, V435, P120, DOI 10.1016/j.neulet.2008.02.018; Asseman F, 2004, NEUROSCI LETT, V358, P83, DOI 10.1016/j.neulet.2003.12.102; BOX GEP, 1953, BIOMETRIKA, V40, P318, DOI 10.1093/biomet/40.3-4.318; Bruyneel AV, 2010, NEUROSCI LETT, V485, P228, DOI 10.1016/j.neulet.2010.09.017; Chapman DW, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2006.033688; COHEN J, 1962, J ABNORM PSYCHOL, V65, P145, DOI 10.1037/h0045186; Duncan CA, 2014, WORLD C BIOM BOST MA; Duncan CA, 2014, INT J IND ERGONOM, V44, P874, DOI 10.1016/j.ergon.2014.06.005; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Gerbino PG, 2007, GAIT POSTURE, V26, P501, DOI 10.1016/j.gaitpost.2006.11.205; Glass G. V., 1981, METAANALYSIS SOCIAL; Hedges L. V., 1981, J ED STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Horak FB, 1997, PHYS THER, V77, P517, DOI 10.1093/ptj/77.5.517; HORAK FB, 1989, J NEUROPHYSIOL, V62, P841, DOI 10.1152/jn.1989.62.4.841; Jacobs JV, 2007, J NEURAL TRANSM, V114, P1339, DOI 10.1007/s00702-007-0657-0; Jakobsen MD, 2011, EUR J APPL PHYSIOL, V111, P521, DOI 10.1007/s00421-010-1669-2; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Keller M, 2012, SCAND J MED SCI SPOR, V22, P471, DOI 10.1111/j.1600-0838.2010.01268.x; Kiefer Adam W, 2013, J Dance Med Sci, V17, P126; Langlois RG, 2009, INT J MARITIME ENG, V151; Lloyd ARJM., 1993, SEAKEEPING SHIP BEHA; Maki BE, 1997, PHYS THER, V77, P488, DOI 10.1093/ptj/77.5.488; Maki BE, 2003, IEEE ENG MED BIOL, V22, P20, DOI 10.1109/MEMB.2003.1195691; Mansfield A, 2010, PHYS THER, V90, P476, DOI 10.2522/ptj.20090070; MCILROY WE, 1994, NEUROSCI LETT, V175, P13, DOI 10.1016/0304-3940(94)91066-9; MCILROY WE, 1993, BRAIN RES, V616, P30, DOI 10.1016/0006-8993(93)90188-S; MCILROY WE, 1995, GAIT POSTURE, V3, P43; Mochizuki G, 2008, CLIN NEUROPHYSIOL, V119, P1626, DOI 10.1016/j.clinph.2008.03.020; NASHNER LM, 1981, EXP BRAIN RES, V43, P395; PROCHAZKA A, 1989, PROG NEUROBIOL, V33, P281, DOI 10.1016/0301-0082(89)90004-X; Schmidt R. A, 2011, MOTOR CONTROL LEARNI; Simmons RW, 2005, INT J NEUROSCI, V115, P1193, DOI 10.1080/00207450590914572; Stoffregen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066949; Terpstra T, 1952, INDAGATIONES MATHEMA, V14, P327; Zhang JG, 2008, GAIT POSTURE, V27, P697, DOI 10.1016/j.gaitpost.2007.09.004	36	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165735	10.1371/journal.pone.0165735	http://dx.doi.org/10.1371/journal.pone.0165735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806129	Green Submitted, Green Published, gold			2022-12-27	WOS:000386715500053
J	Sacamano, PL; Farley, JE				Sacamano, Paul L.; Farley, Jason E.			Behavioral and Other Characteristics Associated with HIV Viral Load in an Outpatient Clinic	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; RISK BEHAVIORS; UNITED-STATES; DRUG-USERS; MOLECULAR EPIDEMIOLOGY; ANTIRETROVIRAL THERAPY; MEDICATION ADHERENCE; SEXUAL-BEHAVIOR; CARE; TRANSMISSION	Persons living with HIV (PLWH) who are engaged in care, yet not virally suppressed, represent a risk for transmission and opportunity for risk reduction interventions. This study describes characteristics of an outpatient clinic cohort of PLWH by laboratory confirmed viral suppression status and examines associations with demographics and sexual and drug use behaviors gathered through questionnaire. From a sample of 500 clinic patients, 438 were prescribed antiretroviral treatment (ART) and 62 were not. Among the 438 on ART, 72 (16.4%) were not virally suppressed at the most recent lab draw. Compared to individuals with a suppressed viral load, those that were unsuppressed were more likely to: be black (79.2% vs. 64.2%; p = 0.014); earn below $ 25,000/year (88.9% vs. 65.0%; p < 0.001); be of a younger age (47.8 vs. 50.0 mean years; p = 0.009); be on opiate substitution (14.1% vs. 6.3%; p = 0.023); and acknowledge poly-substance (38.9% vs. 24.4%; p = 0.012) and excessive alcohol use (13.9% vs. 6.0%; p = 0.019). Conversely, a smaller proportion of those with an unsuppressed viral load had multiple sex partners in the previous 30 days (39.8% vs. 58.5%; p = 0.003). In multivariable regression of those on ART, the prevalence of an unsuppressed viral load was 3% lower with each increasing year of age (aPR: 0.97; 95% CI: 0.95, 0.99) and 47% lower with income over $ 25,000/year (aPR: 0.33; 95% CI: 0.16, 0.70). In a separate analysis of all 500 subjects, ART was less frequently prescribed to blacks compared to whites, heterosexuals, those with lower education and income, and persons with active substance use. Findings confirm that a large proportion of PLWH and engaged in care were not virally suppressed and continued behaviors that risk transmission, indicating the need for screening, prevention counseling and access to ancillary services to lower the incidence of HIV infections.	[Sacamano, Paul L.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Farley, Jason E.] Johns Hopkins Univ, Sch Nursing, Dept Community & Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Sacamano, PL (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	psacama1@jhu.edu		Farley, Jason/0000-0002-6896-0134; Sacamano, Paul/0000-0002-7709-8283	Johns Hopkins Institute for Clinical and Translational Research (ICTR); National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH); NIH Roadmap for Medical Research; Johns Hopkins ICTR; NCATS or NIH; Robert Wood Johnson Foundation Nurse Faculty Scholars Program [70324]	Johns Hopkins Institute for Clinical and Translational Research (ICTR); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins ICTR; NCATS or NIH; Robert Wood Johnson Foundation Nurse Faculty Scholars Program(Robert Wood Johnson Foundation (RWJF))	This publication was made possible by the Johns Hopkins Institute for Clinical and Translational Research (ICTR); the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH); and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the Johns Hopkins ICTR, NCATS or NIH. The Robert Wood Johnson Foundation Nurse Faculty Scholars Program (Grant # 70324) provided support for the parent study.	[Anonymous], GUIDELINES USE ANTIR; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Bradley H, 2014, MMWR-MORBID MORTAL W, V63, P1113; Celentano DD, 2007, CLIN INFECT DIS, V45, pS318, DOI 10.1086/522557; Celentano David D, 2008, Curr HIV/AIDS Rep, V5, P212, DOI 10.1007/s11904-008-0030-4; Centers for Disease Control and Prevention, 2010, 9 CDCP; Centers for Disease Control and Prevention, 2011, HIV SURV REP, P23; Centers for Disease Control and Prevention Health Resources and Services Administration National Institutes of Health American Academy of HIV Medicine Association of Nurses in AIDS Care International Association of Providers of AIDS Care the National Minority AIDS Council Urban Coalition for HIV/AIDS Prevention Services, 2014, REC HIV PREV AD AD H, V2014; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Farley JE, 2008, AM J INFECT CONTROL, V36, P644, DOI 10.1016/j.ajic.2008.05.005; Farley JE, 2015, AM J INFECT CONTROL, V43, P329, DOI 10.1016/j.ajic.2014.12.024; Farley JE, 2013, AM J INFECT CONTROL, V41, P199, DOI 10.1016/j.ajic.2012.03.028; Flickinger TE, 2013, AIDS PATIENT CARE ST, V27, P416, DOI 10.1089/apc.2012.0426; Hall HI, 2013, AIDS BEHAV, V17, P1632, DOI 10.1007/s10461-013-0426-z; Hasse B, 2010, CLIN INFECT DIS, V51, P1314, DOI 10.1086/656809; Hazelton PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090306; Hinkin CH, 2007, AIDS BEHAV, V11, P185, DOI 10.1007/s10461-006-9152-0; Kalichman SC, 2014, INT J BEHAV MED, V21, P811, DOI 10.1007/s12529-013-9353-7; Kalichman SC, 2011, AM J PUBLIC HEALTH, V101, P531, DOI 10.2105/AJPH.2010.197608; Kerr T, 2012, DRUG ALCOHOL DEPEN, V124, P108, DOI 10.1016/j.drugalcdep.2011.12.019; Malta M, 2008, ADDICTION, V103, P1242, DOI 10.1111/j.1360-0443.2008.02269.x; Maranda MJ, 2004, J PSYCHOACTIVE DRUGS, V36, P315, DOI 10.1080/02791072.2004.10400032; Maryland Department of Health and Mental Hygiene, 2012, HIV BALT CIT EP PROF; McCarty-Caplan D, 2014, AIDS BEHAV, V18, P1339, DOI 10.1007/s10461-013-0622-x; Mellins CA, 2009, AIDS CARE, V21, P168, DOI 10.1080/09540120802001705; Mizuno Y, 2014, AIDS, V28, P407, DOI 10.1097/QAD.0000000000000057; Morin SF, 2007, JAIDS-J ACQ IMM DEF, V44, P213, DOI 10.1097/QAI.0b013e31802c0cae; Newville H, 2010, AIDS CARE, V22, P1259, DOI 10.1080/09540121003615111; Ojikutu B, 2014, AIDS CARE, V26, P731, DOI 10.1080/09540121.2013.855299; Purcell DW, 2006, J URBAN HEALTH, V83, P656, DOI 10.1007/s11524-006-9066-1; Seth P, 2011, WOMEN HEALTH ISS, V21, P130, DOI 10.1016/j.whi.2010.10.005; Vosburgh HW, 2012, AIDS BEHAV, V16, P1394, DOI 10.1007/s10461-011-0131-8	32	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0166016	10.1371/journal.pone.0166016	http://dx.doi.org/10.1371/journal.pone.0166016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806109	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500078
J	del Rio, R; Ochoa, C; Alarcon, A; Arnaez, J; Blanco, D; Garcia-Alix, A				del Rio, Ruth; Ochoa, Carlos; Alarcon, Ana; Arnaez, Juan; Blanco, Dorotea; Garcia-Alix, Alfredo			Amplitude Integrated Electroencephalogram as a Prognostic Tool in Neonates with Hypoxic-Ischemic Encephalopathy: A Systematic Review	PLOS ONE			English	Review							FULL-TERM INFANTS; NEAR-INFRARED SPECTROSCOPY; PREDICTIVE-VALUE; NEUROLOGIC EXAMINATION; HYPOTHERMIA TREATMENT; ASPHYXIATED INFANTS; PERINATAL ASPHYXIA; EEG; ACCURACY; BIRTH	Introduction Perinatal management and prognostic value of clinical evaluation and diagnostic tools have changed with the generalization of therapeutic hypothermia (TH) in infants with hypoxic- ischemic encephalopathy (HIE) Aim to ascertain the prognostic value of amplitude integrated electroencephalogram (aEEG) in neonates with HIE considering hours of life and treatment with TH. Methods A systematic review was performed. Inclusion criteria were studies including data of neonates with HIE, treated or not with TH, monitored with aEEG and with neurodevelopmental follow-up of at least 12 months. The period of bibliographic search was until February 2016. No language restrictions were initially applied. Consulted databases were MEDLINE, Scopus, CINHAL and the Spanish language databases GuiaSalud and Bravo. Article selection was performed by two independent reviewers. Quality for each individual paper selected was evaluated using QUADAS-2. Review Manager (RevMan) version 5.3 software was used. Forest plots were constructed to graphically show sensitivity and specificity for all included studies, separating patients treated or not with hypothermia. Summary statistics were estimated using bivariate models and random effects approaches with the R package MADA from summary ROC curves. Meta-regression was used to estimate heterogeneity and trends. Results from the 403 articles initially identified, 17 were finally included and critically reviewed. In infants not treated with hypothermia the maximum reliability of an abnormal aEEG background to predict death or moderate/severe disability was at 36 hours of life, when a positive post-test probability of 97.90% was achieved (95% CI 88.40 to 99.40%). Positive likelihood ratio (+LR) at these hours of life was 26.60 (95% CI 4.40 to 94.90) and negative likelihood ratio (-LR) was 0.23 (95% CI 0.10 to 0.44). A high predictive value was already present at 6 hours of life in this group of patients, with a positive post-test probability of 88.20% (95% CI 79.80 to 93%) and a +LR of 4.34 (95% CI 2.31 to 7.73). In patients treated with TH the maximum predictive reliability was achieved at 72 hours of life (post-test probability of 95.70%, 95% CI 84.40 to 98.50%). +LR at this age was 24.30 (95% CI 5.89 to 71.30) and -LR was 0.40 (95% CI 0.25 to 0.57). Predictive value of aEEG at 6 hours of life was low in these patients (59.10%, 95% CI 55.70 to 63%). Conclusion This study confirms that aEEG's background activity, as recorded during the first 72 hours after birth, has a strong predictive value in infants with HIE treated or not with TH. Predictive values of traces throughout the following 72 hours are a helpful guide when considering and counselling parents about the foreseeable long-term neurological outcome	[del Rio, Ruth; Alarcon, Ana; Garcia-Alix, Alfredo] Hosp St Joan de Deu, Inst Recerca Pediat, Dept Neonatol, Barcelona, Spain; [Ochoa, Carlos] Hosp Virgen de la Concha, Res Unit, Zamora, Spain; [Alarcon, Ana] Oxford Univ Hosp NHS Fdn Trust, Dept Neonatol, Oxford, England; [Arnaez, Juan] Hosp Univ Burgos, Dept Neonatol, Burgos, Spain; [Blanco, Dorotea] Hosp Univ Gregorio Maranon, Dept Neonatol, Madrid, Spain	University of Barcelona; Oxford University Hospitals NHS Foundation Trust; General University Gregorio Maranon Hospital	del Rio, R (corresponding author), Hosp St Joan de Deu, Inst Recerca Pediat, Dept Neonatol, Barcelona, Spain.	rdelrio@hsjdbcn.org	Arnaez, Juan/ABF-4338-2020; Garcia-Alix, Alfredo/AAG-4474-2019	Arnaez, Juan/0000-0001-8883-5181; Alarcon Allen, Ana/0000-0001-7223-2028	Agencia de Qualitat i Avaluacio Sanitaries de Catalunya	Agencia de Qualitat i Avaluacio Sanitaries de Catalunya	This review was part of the Spanish National Health System Clinical Practice Guideline (CPG) on HIE. Funding was received for the development of the whole CPG from the Agencia de Qualitat i Avaluacio Sanitaries de Catalunya (public quality agency linked to the Health Department of the Catalan Government).	al Naqeeb N, 1999, PEDIATRICS, V103, P1263, DOI 10.1542/peds.103.6.1263; Ancora G, 2013, BRAIN DEV-JPN, V35, P26, DOI 10.1016/j.braindev.2011.09.008; Ancora G, 2010, BRAIN DEV-JPN, V32, P835, DOI 10.1016/j.braindev.2009.11.008; [Anonymous], 2015, GRUP TRAB GUIA PRACT; [Anonymous], 2012, PAEDIAT CHILD HLTH, V17, P41; Azzopardi D, 2014, ARCH DIS CHILD-FETAL, V99, pF80, DOI 10.1136/archdischild-2013-303710; Blanco D., 2011, AN PEDIAT BARC, V75, P1, DOI [10.1016/j.anpedi.2011.07.012, DOI 10.1016/J.ANPEDI.2011.07.012]; Chalak L, NEONATAL GUIDELINE H; Cseko AJ, 2013, ACTA PAEDIATR, V102, P707, DOI 10.1111/apa.12226; EKEN P, 1995, ARCH DIS CHILD-FETAL, V73, pF75, DOI 10.1136/fn.73.2.F75; Garcia-Alix A, 2009, AN PEDIATR, V71, P319, DOI 10.1016/j.anpedi.2009.07.021; Gucuyener K, 2012, BRAIN DEV-JPN, V34, P280, DOI 10.1016/j.braindev.2011.06.005; Gunn AJ, 2008, J PEDIATR-US, V152, P55, DOI 10.1016/j.jpeds.2007.06.003; Hallberg B, 2010, ACTA PAEDIATR, V99, P531, DOI 10.1111/j.1651-2227.2009.01653.x; Hellstrom Westas L, 2006, NEOREVIEWS, V7, pe76; Hellstrom-Westas, 2013, ACTA PAEDIATR, V102, P678, DOI [10.1111/apa.12287, DOI 10.1111/APA.12287]; Hellstrom-Westas L., 2003, ATLAS AMPLITUDE INTE; HELLSTROMWESTAS L, 1995, ARCH DIS CHILD-FETAL, V72, pF34, DOI 10.1136/fn.72.1.F34; HELLSTROMWESTAS L, 1992, ACTA PAEDIATR, V81, P812, DOI 10.1111/j.1651-2227.1992.tb12109.x; Horan M, 2007, EARLY HUM DEV, V83, P69, DOI 10.1016/j.earlhumdev.2006.05.004; National Institute for Health and Clinical Excellence, THER HYP INTR TEMP M; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Roka A, 2008, PEDIATRICS, V121, pE844, DOI 10.1542/peds.2007-1987; Rutherford M, 2010, EARLY HUM DEV, V86, P351, DOI 10.1016/j.earlhumdev.2010.05.014; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Shah DK, 2008, PEDIATRICS, V121, P1146, DOI 10.1542/peds.2007-1839; Shalak LF, 2003, PEDIATRICS, V111, P351, DOI 10.1542/peds.111.2.351; Shankaran S, 2012, J PEDIATR-US, V160, P567, DOI 10.1016/j.jpeds.2011.09.018; Shankaran S, 2011, PEDIATRICS, V128, pE112, DOI 10.1542/peds.2010-2036; Shany E, 2006, PEDIATR NEUROL, V35, P335, DOI 10.1016/j.pediatrneurol.2006.06.007; Smith J, 2000, BRIT J OBSTET GYNAEC, V107, P461, DOI 10.1111/j.1471-0528.2000.tb13262.x; Spitzmiller RE, 2007, J CHILD NEUROL, V22, P1069, DOI 10.1177/0883073807306258; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; ter Horst H, 2004, PEDIATR RES, V55, P1026, DOI 10.1203/01.pdr.0000127019.52562.8c; Thoresen M, 2010, PEDIATRICS, V126, pE131, DOI 10.1542/peds.2009-2938; Thoresen M, 2008, CLIN PERINATOL, V35, P749, DOI 10.1016/j.clp.2008.07.018; THORNBERG E, 1994, ACTA PAEDIATR, V83, P596; Toet MC, 2002, PEDIATRICS, V109, P772, DOI 10.1542/peds.109.5.772; Toet MC, 1999, ARCH DIS CHILD-FETAL, V81, pF19, DOI 10.1136/fn.81.1.F19; van Laerhoven H, 2013, PEDIATRICS, V131, P88, DOI 10.1542/peds.2012-1297; van Rooij LGM, 2005, ARCH DIS CHILD-FETAL, V90, P245, DOI 10.1136/adc.2004.064964; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	42	58	59	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165744	10.1371/journal.pone.0165744	http://dx.doi.org/10.1371/journal.pone.0165744			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802300	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200049
J	Veldhoen, N; Hobbs, J; Ikonomou, G; Hii, M; Lesperance, M; Helbing, CC				Veldhoen, Nik; Hobbs, Jared; Ikonomou, Georgios; Hii, Michael; Lesperance, Mary; Helbing, Caren C.			Implementation of Novel Design Features for qPCR-Based eDNA Assessment	PLOS ONE			English	Article							ENVIRONMENTAL DNA; WATER SAMPLES; TOOL	Environmental stewardship requires timely, accurate information related to the status of a given ecosystem and the species that occupy it. Recent advances in the application of the highly sensitive real-time quantitative polymerase chain reaction (qPCR) towards identification of constituents within environmental DNA (eDNA) now allow targeted detection of the presence of species-specific biological material within a localized geographic region. However, as with all molecular techniques predicated on the specificity and sensitivity of the PCR assay, careful validation of each eDNA qPCR assay in development must be performed both under controlled laboratory conditions and when challenged with field-derived eDNA samples. Such a step-wise approach forms the basis for incorporation of innovative qPCR design features that strengthen the implementation and interpretation of the eDNA assay. This includes empirical determination that the qPCR assay is refractory to the presence of human DNA and the use of a tripartite assay approach comprised of 1) a primer set targeting plant chloroplast that evaluates the presence of amplifiable DNA from field samples to increase confidence in a negative result, 2) an animal group primer set to increase confidence in the assay result, and 3) a species-specific primer set to assess presence of DNA from the target species. To demonstrate this methodology, we generated eDNA assays specific for the North American bullfrog (Lithobates (Rana) catesbeiana) and the Rocky Mountain tailed frog (Ascaphus montanus) and characterized each with respect to detection sensitivity and specificity with demonstrated performance in a field survey scenario. The qPCR design features presented herein address specific challenges of eDNA assays thereby increasing their interpretative power.	[Veldhoen, Nik; Ikonomou, Georgios; Hii, Michael; Helbing, Caren C.] Univ Victoria, Dept Biochem & Microbiol, STN CSC, POB 3055, Victoria, BC V8W 2Y2, Canada; [Hobbs, Jared] Hemmera Envirochem Inc, 303-1221 Broad St, Victoria, BC V8W 2A4, Canada; [Lesperance, Mary] Univ Victoria, Dept Math & Stat, 3800 Finnerty Rd, Victoria, BC V8P 5C2, Canada	University of Victoria; University of Victoria	Helbing, CC (corresponding author), Univ Victoria, Dept Biochem & Microbiol, STN CSC, POB 3055, Victoria, BC V8W 2Y2, Canada.	chelbing@uvic.ca		Helbing, Caren/0000-0002-8861-1070	Natural Sciences and Engineering Research Council of Canada (NSERC) [EGP 477388-14]; Hemmera; NSERC; CCH	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Hemmera; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CCH	This work was supported in part by a Natural Sciences and Engineering Research Council of Canada (NSERC) Engage grant #EGP 477388-14 to CCH and a research agreement between Hemmera and CCH. NSERC provided support in the form of research materials and salary for NV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by a Natural Sciences and Engineering Research Council of Canada (NSERC) Engage grant #EGP 477388-14 to CCH and a research agreement between Hemmera and CCH. NSERC provided support in the form of research materials and salary for NV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. A patent is pending on the concept and some data presented in this study (US provisional application number 62/406,802). The patent is owned by the University of Victoria who will handle commercial and academic licensing agreements. JH is an employee of Hemmera Envirochem Inc. JH was involved with the conceptualization of the overall research goals, identification of appropriate tailed frog survey sites, and water sample collection at these sites. Hemmera provided support for research materials, but did not play a role in the qPCR assay design, data collection and analysis, decision to publish, or preparation of the manuscript with the exception of critical review of the manuscript by JH. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The specific roles of authors are articulated in the 'author contributions' section.	Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Carim KJ, 2016, CONSERV GENET RESOUR, V8, P197, DOI 10.1007/s12686-016-0531-1; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Goldberg CS, 2015, BIOL CONSERV, V183, P1, DOI 10.1016/j.biocon.2014.11.040; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Herder J., 2014, ENV DNA A REV POSSIB; Iulia L, 2013, ROM BIOTECH LETT, V18, P8007; Muhl H, 2010, DIAGN MICR INFEC DIS, V66, P41, DOI 10.1016/j.diagmicrobio.2008.07.011; Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13; Orchard S, 2012, UPDATE BULLFROG CONT; Peterson AC, 2013, BIOL INVASIONS, V15, P2179, DOI 10.1007/s10530-013-0442-y; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; SOMERVILLE CC, 1989, APPL ENVIRON MICROB, V55, P548, DOI 10.1128/AEM.55.3.548-554.1989; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520	24	18	19	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0164907	10.1371/journal.pone.0164907	http://dx.doi.org/10.1371/journal.pone.0164907			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802293	Green Published, Green Submitted, gold			2022-12-27	WOS:000386714200012
J	Cramer, CA; de Sousa, LM				Cramer, Christian Andreas; de Sousa, Leandro Melo			A New Species of Tiger Pleco Panaqolus (Siluriformes: Loricariidae) from the Xingu Basin, Brazil	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; DIVERSIFICATION; IDENTIFICATION; GENERA	Panaqolus tankei is described from the Xingu River, Brazil. The new species is diagnosed from P. albomaculatus, P. dentex, P. nix, P. nocturnus, and P. koko by its color pattern consisting of dark and light diagonal bars on the body and bands on the fins (vs. body and fins without bars or bands); from P. albivermis, P. maccus, and P. purusiensis by the width of the dark bars being more or less the same of the light bars (vs. dark bars at least two or three times wider than light bars) and from P. changae by the absence of vermiculation on the head (vs. vermiculation present on head). The new species differs from P. gnomus by the orientation of the bars from posterodorsal to anteroventral direction (vs. anterodorsal to posteroventral direction), and from P. claustellifer by the orientation of the bands in the dorsal fin that are not parallel to the margin (vs. parallel to the margin). The barcoding region (COI) was sequenced for the new species, sequences were deposited in GenBank and were compared with congeners from other drainages. With regard to the current construction of a hydroelectric power plant (a so-called mega dam) in the Xingu River, herewith we increase knowledge of the river Xingu's ichthyofauna and, thus improve the assessment of the impacts of that construction on the river.	[Cramer, Christian Andreas] Philipps Univ Marburg, Ctr Human Genet, Fac Med, Marburg, Germany; [Cramer, Christian Andreas] Univ Fed Rondonia, Dept Biol, Lab Ictiol & Pesca, Porto Velho, Rondonia, Brazil; [de Sousa, Leandro Melo] Fed Univ Para, Fac Ciencias Biol, Lab Ictiol, Altamira, Para, Brazil	Philipps University Marburg; Universidade Federal de Rondonia; Universidade Federal do Para	Cramer, CA (corresponding author), Philipps Univ Marburg, Ctr Human Genet, Fac Med, Marburg, Germany.; Cramer, CA (corresponding author), Univ Fed Rondonia, Dept Biol, Lab Ictiol & Pesca, Porto Velho, Rondonia, Brazil.	Cramerc@gmx.de	de Sousa, Leandro Melo/I-6108-2012	de Sousa, Leandro Melo/0000-0002-0793-9737	CAC Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [350674/2010-8]; Three-years-studentship; LMS Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [486376/2013-3]; Xingu River; NSF [DEB-1257813]	CAC Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Three-years-studentship; LMS Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Xingu River; NSF(National Science Foundation (NSF))	This work was supported by CAC Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cupq.br), No. 350674/2010-8, Three-years-studentship, LMS Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br), No. 486376/2013-3, and Research-grant for fieldwork at the Xingu River, Fieldwork supported in part by NSF DEB-1257813 (CoPI Mark Sabaj Perez).	Camargo M, 2013, LORICARIIDS MIDDLE X; Costa-Silva GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135075; Cramer CA, NEOTROPICAL IN PRESS; Cramer CA, 2014, NEOTROP ICHTHYOL, V12, P61, DOI 10.1590/S1679-62252014000100006; Cramer CA, 2011, MOL PHYLOGENET EVOL, V59, P43, DOI 10.1016/j.ympev.2011.01.002; Fisch-Muller S, 2012, CYBIUM, V36, P163; Garcia-Davilla C, 2013, GENETICA, V141, P347, DOI 10.1007/s10709-013-9734-5; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2007, MOL ECOL, V16, P2115, DOI 10.1111/j.1365-294X.2007.03267.x; Lucena CAS, 2013, B SOC BRAS ICTIOL, V105, P20; Lujan NK, 2015, MOL PHYLOGENET EVOL, V82, P269, DOI 10.1016/j.ympev.2014.08.020; Lujan NK, 2013, ZOOTAXA, V3691, P192, DOI 10.11646/zootaxa.3691.1.8; Lujan NK, 2010, COPEIA, P676, DOI 10.1643/CI-09-185; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Montoya-Burgos JI, 2003, MOL ECOL, V12, P1855, DOI 10.1046/j.1365-294X.2003.01857.x; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Ribeiro ED, 2013, DIVERSIDADE MOL ANCI; Roxo FF, 2015, ZOOKEYS, P109, DOI 10.3897/zookeys.481.8755; Sabaj Perez MH, 2013, STANDARD SYMBOLIC CO; Stawikowski R, 1998, AQUARIEN TERRARIEN Z, V51, P686; Stawikowski R, 1988, AQUARIEN TERRARIEN Z, V41, P556; Stawikowski R, 1994, AQUARIEN TERRARIEN Z, V47, P416; Stawikowski R, 1990, AQUARIEN TERRARIEN Z, V43, P647; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan M, 2016, NEOTROP ICHTHYOL, V14, DOI 10.1590/1982-0224-20150033; Tanke A, 2013, AQUARIEN TERRARIEN Z, V66, P28; Tanke A, 2009, AQUARIEN TERRARIEN Z, V62, P22; TAYLOR W R, 1985, Cybium, V9, P107; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Werner A, 2005, AQUARIEN TERRARIEN Z, V58, P56; Werner A, 2005, AQUARIEN TERRARIEN Z, V58, P32; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x	34	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165388	10.1371/journal.pone.0165388	http://dx.doi.org/10.1371/journal.pone.0165388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828981	gold, Green Submitted, Green Published			2022-12-27	WOS:000387724300041
J	O'Dea, MA; Jackson, B; Jackson, C; Xavier, P; Warren, K				O'Dea, Mark A.; Jackson, Bethany; Jackson, Carol; Xavier, Pally; Warren, Kristin			Discovery and Partial Genomic Characterisation of a Novel Nidovirus Associated with Respiratory Disease in Wild Shingleback Lizards (Tiliqua rugosa)	PLOS ONE			English	Article							VIRUS; POPULATION; INFECTIONS; REPTILES; IDENTIFICATION; TRANSMISSION; SALMONELLA; TORTOISES	A respiratory disease syndrome has been observed in large numbers of wild shingleback lizards (Tiliqua rugosa) admitted to wildlife care facilities in the Perth metropolitan region of Western Australia. Mortality rates are reportedly high without supportive treatment and care. Here we used next generation sequencing techniques to screen affected and unaffected individuals admitted to Kanyana Wildlife Rehabilitation Centre in Perth between April and December 2015, with the resultant discovery of a novel nidovirus significantly associated with cases of respiratory disease according to a case definition based on clinical signs. Interestingly this virus was also found in 12% of apparently healthy individuals, which may reflect testing during the incubation period or a carrier status, or it may be that this agent is not causative in the disease process. This is the first report of a nidovirus in lizards globally. In addition to detection of this virus, characterisation of a 23,832 nt segment of the viral genome revealed the presence of characteristic nidoviral genomic elements providing phylogenetic support for the inclusion of this virus in a novel genus alongside Ball Python nidovirus, within the Torovirinae sub-family of the Coronaviridae. This study highlights the importance of next generation sequencing technologies to detect and describe emerging infectious diseases in wildlife species, as well as the importance of rehabilitation centres to enhance early detection mechanisms through passive and targeted health surveillance. Further development of diagnostic tools from these findings will aid in detection and control of this agent across Australia, and potentially in wild lizard populations globally.	[O'Dea, Mark A.; Jackson, Bethany; Xavier, Pally; Warren, Kristin] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia; [Jackson, Carol] Kanyana Wildlife Rehabil Ctr, 120 Gilchrist Rd, Lesmurdie, WA, Australia	Murdoch University	O'Dea, MA (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia.	m.odea@murdoch.edu.au		Jackson, Bethany/0000-0002-8622-8035; O'Dea, Mark/0000-0002-2757-7585; Warren, Kristin/0000-0002-9328-2013	Murdoch University School of Veterinary and Life Sciences; National Significant Disease Investigation Program	Murdoch University School of Veterinary and Life Sciences; National Significant Disease Investigation Program	This work was supported using funds provided by the Murdoch University School of Veterinary and Life Sciences, and through the National Significant Disease Investigation Program, managed by Animal Health Australia with assistance from Wildlife Health Australia and DAFWA.	Abbas MD, 2011, VET MICROBIOL, V150, P70, DOI 10.1016/j.vetmic.2011.01.010; Aiello CM, 2014, ANIM CONSERV, V17, P27, DOI 10.1111/acv.12147; Allender MC, 2015, FUNGAL ECOL, V17, P187, DOI 10.1016/j.funeco.2015.05.003; Benton CH, 2015, EUR J WILDLIFE RES, V61, P1, DOI 10.1007/s10344-014-0882-4; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Bodewes R, 2014, J GEN VIROL, V95, P2480, DOI 10.1099/vir.0.068700-0; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Bouma MJ, 2007, PARASITOL RES, V100, P949, DOI 10.1007/s00436-006-0379-5; Braun J, 2014, J WILDLIFE DIS, V50, P757, DOI 10.7589/2013-09-231; Bruniche-Olsen A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147875; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Bull CM, 2012, MOL ECOL, V21, P4386, DOI 10.1111/j.1365-294X.2012.05653.x; Chen Y, 2009, P NATL ACAD SCI USA, V106, P3484, DOI 10.1073/pnas.0808790106; Cogger H.G., 1975, P1; Cox-Witton K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095127; Dunowska M, 2012, VET MICROBIOL, V156, P418, DOI 10.1016/j.vetmic.2011.11.013; Giles J, 2016, VIROLOGY, V491, P20, DOI 10.1016/j.virol.2016.01.005; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Grange ZL, 2016, MICROB ECOL, V71, P1020, DOI 10.1007/s00248-015-0721-5; Guthrie AL, 2016, J WILDLIFE DIS, V52, P143, DOI 10.7589/2015-04-093.1; Gyawali P., 2013, International Journal of Veterinary Science, V2, P17; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hyndman T, 2011, AUST VET J, V89, P232, DOI 10.1111/j.1751-0813.2011.00712.x; Hyndman TH, 2013, VET MICROBIOL, V165, P200, DOI 10.1016/j.vetmic.2013.04.002; Hyndman TH, 2012, VET MICROBIOL, V161, P77, DOI 10.1016/j.vetmic.2012.07.030; Jackson B, 2014, NEW ZEAL VET J, V62, P297, DOI 10.1080/00480169.2014.909750; Jacobson ER, 2014, VET J, V201, P257, DOI 10.1016/j.tvjl.2014.05.039; Kanyana Wildlife Centre, 2015, 2014 2015 ANN REP; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; King A. M. Q., 2012, 9 INT COMM TAX VIR; Lamirande EW, 1999, VIRUS RES, V63, P135, DOI 10.1016/S0168-1702(99)00067-2; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Levinson J, 2013, EMERG INFECT DIS, V19, P743, DOI 10.3201/eid1905.121042; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Marschang RE, 2002, J ZOO WILDLIFE MED, V33, P317, DOI 10.1638/1042-7260(2002)033[0317:PARIIW]2.0.CO;2; Miller KA, 2012, CONSERV BIOL, V26, P790, DOI 10.1111/j.1523-1739.2012.01902.x; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Ng TFF, 2015, J VIROL, V89, P5340, DOI 10.1128/JVI.00064-15; Origgi FC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134897; Parsons SK, 2015, APPL ENVIRON MICROB, V81, P5804, DOI 10.1128/AEM.00997-15; Pees M, 2007, DEUT TIERARZTL WOCH, V114, P388, DOI 10.2377/0341-6593-114-388; Randall N., 2011, THESIS; Read JL, 2015, J HERPETOL, V49, P64, DOI 10.1670/13-208; Rivas AE, 2014, HUM-WILDL INTERACT, V8, P78; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Schumacher J, 2006, J EXOT PET MED, V15, P18, DOI 10.1053/j.jepm.2005.11.004; Schumacher Juergen, 2011, Veterinary Clinics of North America Exotic Animal Practice, V14, P207, DOI 10.1016/j.cvex.2011.03.010; Smallridge CJ, 2000, PARASITOL RES, V86, P655, DOI 10.1007/PL00008547; Smyth AK, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140257; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sperry SM, 2005, J VIROL, V79, P3391, DOI 10.1128/JVI.79.6.3391-3400.2005; Stenglein MD, 2014, MBIO, V5, DOI 10.1128/mBio.01484-14; Stohr AC, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-84; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tokarz R, 2015, J GEN VIROL, V96, P2188, DOI 10.1099/vir.0.000166; Uccellini L, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-144; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang RC, 2013, EXP PARASITOL, V133, P144, DOI 10.1016/j.exppara.2012.11.012	59	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165209	10.1371/journal.pone.0165209	http://dx.doi.org/10.1371/journal.pone.0165209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828982	Green Submitted, gold, Green Published			2022-12-27	WOS:000387724300032
J	Ahlers, LRH; Bastos, RG; Hiroyasu, A; Goodman, AG				Ahlers, Laura R. H.; Bastos, Reginaldo G.; Hiroyasu, Aoi; Goodman, Alan G.			Invertebrate Iridescent Virus 6, a DNA Virus, Stimulates a Mammalian Innate Immune Response through RIG-I-Like Receptors	PLOS ONE			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; VESICULAR STOMATITIS-VIRUS; CYCLIC GMP-AMP; ANTIVIRAL IMMUNITY; ENDOPLASMIC-RETICULUM; GROWTH ARREST; CYTOSOLIC DNA; INTERFERON; HELICASE	Insects are not only major vectors of mammalian viruses, but are also host to insect-restricted viruses that can potentially be transmitted to mammals. While mammalian innate immune responses to arboviruses are well studied, less is known about how mammalian cells respond to viruses that are restricted to infect only invertebrates. Here we demonstrate that IIV-6, a DNA virus of the family Iridoviridae, is able to induce a type I interferondependent antiviral immune response in mammalian cells. Although IIV-6 is a DNA virus, we demonstrate that the immune response activated during IIV-6 infection is mediated by the RIG-I-like receptor 9RLR) pathway, and not the canonical DNA sensing pathway via cGAS/STING. We further show that RNA polymerase III is required for maximal IFN-beta secretion, suggesting that viral DNA is transcribed by this enzyme into an RNA species capable of activating the RLR pathway. Finally, we demonstrate that the RLR-driven mammalian innate immune response to IIV-6 is functionally capable of protecting cells from subsequent infection with the arboviruses Vesicular Stomatitis virus and Kunjin virus. These results represent a novel example of an invertebrate DNA virus activating a canonically RNA sensing pathway in the mammalian innate immune response, which reduces viral load of ensuing arboviral infection.	[Ahlers, Laura R. H.; Bastos, Reginaldo G.; Hiroyasu, Aoi; Goodman, Alan G.] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA; [Ahlers, Laura R. H.] Washington State Univ, NIH Prot Biotechnol Grad Training Program, Pullman, WA 99164 USA	Washington State University; Washington State University	Goodman, AG (corresponding author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.	agoodman@vetmed.wsu.edu	Goodman, Alan/AAQ-1108-2020	Goodman, Alan/0000-0001-6394-332X	National Institutes of Health [R00 AI106963]; National Institutes of Health/National Institute of General Medical Sciences [T32 GM008336]; Washington State University; NIH [R00 AI106963]; NIH/NIGMS [T32 GM008336]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI106963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Washington State University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health Grant R00 AI106963 to A. G. Goodman, National Institutes of Health/National Institute of General Medical Sciences-funded pre-doctoral fellowship T32 GM008336 to L. R. H. Ahlers, and funds from Washington State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by NIH Grant R00 AI106963 to A.G. Goodman, NIH/NIGMS-funded pre-doctoral fellowship T32 GM008336 to L.R.H. Ahlers, and funds from Washington State University.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Benitez AA, 2015, CELL REP, V13, P1456, DOI 10.1016/j.celrep.2015.10.020; Bogerd HP, 2014, J VIROL, V88, P8065, DOI 10.1128/JVI.00985-14; Bronkhorst AW, 2012, P NATL ACAD SCI USA, V109, pE3604, DOI 10.1073/pnas.1207213109; Brunette RL, 2012, J EXP MED, V209, P1969, DOI 10.1084/jem.20121960; Burgess DJ, 2013, NAT REV GENET, V14, P821, DOI 10.1038/nrg3616; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Chinchar VG, 2002, ARCH VIROL, V147, P447, DOI 10.1007/s007050200000; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cui YZ, 2001, GENOMICS, V78, P129, DOI 10.1006/geno.2001.6661; Cullen BR, 2013, CELL HOST MICROBE, V14, P374, DOI 10.1016/j.chom.2013.09.011; D'Costa SM, 2012, ARCH VIROL, V157, P2171, DOI 10.1007/s00705-012-1417-5; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13; Freaney JE, 2013, CELL REP, V4, P959, DOI 10.1016/j.celrep.2013.07.043; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; FUKAYA M, 1966, Applied Entomology and Zoology, V1, P69; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gitlin L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000734; Goodman AG, 2010, J VIROL, V84, P2027, DOI 10.1128/JVI.01595-09; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; HOWE JG, 1989, CELL, V57, P825, DOI 10.1016/0092-8674(89)90797-6; Huang F, 1999, GENE, V236, P125, DOI 10.1016/S0378-1119(99)00244-9; Huang F, 1999, ONCOGENE, V18, P3546, DOI 10.1038/sj.onc.1202715; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jakob NJ, 2001, VIROLOGY, V286, P182, DOI 10.1006/viro.2001.0963; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Johnson KN, 1999, J INVERTEBR PATHOL, V73, P248, DOI 10.1006/jipa.1998.4830; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486; Kim K, 2006, COLD SPRING HARB SYM, V71, P39, DOI 10.1101/sqb.2006.71.008; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lam E, 2014, J VIROL, V88, P974, DOI 10.1128/JVI.02702-13; Lau L, 2015, SCIENCE, V350, P568, DOI 10.1126/science.aab3291; Lee E, 2000, J VIROL, V74, P8867, DOI 10.1128/JVI.74.19.8867-8875.2000; Levy DE, 2002, J INTERF CYTOK RES, V22, P87, DOI 10.1089/107999002753452692; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Ma Z, 2015, P NATL ACAD SCI USA, V112, pE4306, DOI 10.1073/pnas.1503831112; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Minamitani T, 2011, J VIROL, V85, P4035, DOI 10.1128/JVI.02160-10; Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107; Mukherjee S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-127; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Pan X., 2012, P NATL ACAD SCI USA, V109, pE23, DOI DOI 10.1073/pnas.1116932108; Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109; Pastorino B, 2010, ANTIVIR RES, V87, P281, DOI 10.1016/j.antiviral.2010.04.014; Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309; Pfeffer LM, 2004, J BIOL CHEM, V279, P31304, DOI 10.1074/jbc.M308975200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Rustagi A, 2013, METHODS, V59, P225, DOI 10.1016/j.ymeth.2012.05.011; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; Sarkar D, 2008, P NATL ACAD SCI USA, V105, P17040, DOI 10.1073/pnas.0804956105; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun YW, 1997, RIG I HUMAN HOMOLOG; Takeuchi O, 2008, NAT IMMUNOL, V9, P1327, DOI 10.1038/ni1208-1327; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Williams T, 2008, NEOTROP ENTOMOL, V37, P615, DOI 10.1590/S1519-566X2008000600001; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yamaguchi T, 2010, P NATL ACAD SCI USA, V107, P17286, DOI 10.1073/pnas.1009823107; Yoneda M., 2016, J IMMUNOL; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	84	22	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166088	10.1371/journal.pone.0166088	http://dx.doi.org/10.1371/journal.pone.0166088			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824940	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200061
J	Jin, HJ; Fang, W; Zhu, ML; Yu, ZZ; Fang, Y; Yan, H; Zhang, MF; Wang, Q; Che, XJ; Xie, YY; Huang, JY; Hu, CH; Zhang, HF; Mou, S; Ni, ZH				Jin, Haijiao; Fang, Wei; Zhu, Mingli; Yu, Zanzhe; Fang, Yan; Yan, Hao; Zhang, Minfang; Wang, Qin; Che, Xiajing; Xie, Yuanyuan; Huang, Jiaying; Hu, Chunhua; Zhang, Haifen; Mou, Shan; Ni, Zhaohui			Urgent-Start Peritoneal Dialysis and Hemodialysis in ESRD Patients: Complications and Outcomes	PLOS ONE			English	Article							BREAK-IN PERIOD; ACCESS; ASSOCIATIONS; MORTALITY; OPTION	Background Several studies have suggested that urgent-start peritoneal dialysis (PD) is a feasible alternative to hemodialysis (HD) in patients with end-stage renal disease (ESRD), but the impact of the dialysis modality on outcome, especially on short-term complications, in urgent-start dialysis has not been directly evaluated. The aim of the current study was to compare the complications and outcomes of PD and HD in urgent-start dialysis ESRD patients. Methods In this retrospective study, ESRD patients who initiated dialysis urgently without a preestablished functional vascular access or PD catheter at a single center from January 2013 to December 2014 were included. Patients were grouped according to their dialysis modality (PD and HD). Each patient was followed for at least 30 days after catheter insertion (until January 2016). Dialysis-related complications and patient survival were compared between the two groups. Results Our study enrolled 178 patients (56.2% male), of whom 96 and 82 patients were in the PD and HD groups, respectively. Compared with HD patients, PD patients had more cardiovascular disease, less heart failure, higher levels of serum potassium, hemoglobin, serum albumin, serum pre-albumin, and lower levels of brain natriuretic peptide. There were no significant differences in gender, age, use of steroids, early referral to a nephrologist, prevalence of primary renal diseases, prevalence of co-morbidities, and other laboratory characteristics between the groups. The incidence of dialysis-related complications during the first 30 days was significantly higher in HD than PD patients. HD patients had a significantly higher probability of bacteremia compared to PD patients. HD was an independent predictor of short-term (30-day) dialysis-related complications. There was no significant difference between PD and HD patients with respect to patient survival rate. Conclusion In an experienced center, PD is a safe and feasible dialysis alternative to HD for ESRD patients with an urgent need for dialysis.	[Jin, Haijiao; Fang, Wei; Zhu, Mingli; Yu, Zanzhe; Fang, Yan; Yan, Hao; Zhang, Minfang; Wang, Qin; Che, Xiajing; Xie, Yuanyuan; Huang, Jiaying; Hu, Chunhua; Zhang, Haifen; Mou, Shan; Ni, Zhaohui] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nephrol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Ni, ZH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nephrol, Shanghai, Peoples R China.	profnizh@126.com		mou, shan/0000-0003-4160-1681	National Natural Science Foundation of China [81370794]; National "Twelfth Five-Year" Plan for Science and Technology [2011BAI10B08]; Research Project of Health Public Welfare Industry in China [201502023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science and Technology; Research Project of Health Public Welfare Industry in China	This work was supported by the National Natural Science Foundation of China (81370794, http://www.nsfc.gov.cn) and the National "Twelfth Five-Year" Plan for Science and Technology (2011BAI10B08, http://prograrm.most.gov.cn) to Dr Ni, as well as the Research Project of Health Public Welfare Industry in China (201502023, http://www.moh.gov.cn) to Dr Lin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (grant No. 81370794), the National "Twelfth Five-Year" Plan for Science & Technology (grant No. 2011BAI10B08), and the Research Project of Health Public Welfare Industry in China (grant No. 201502023).	Alkatheeri AMA, 2016, PERITON DIALYSIS INT, V36, P171, DOI 10.3747/pdi.2014.00148; [Anonymous], 2001, AM J KIDNEY DIS, V37, p137 ; Dean D, 2016, SEMIN DIAL; Dias DB, 2016, INT UROL NEPHROL, V48, P901, DOI 10.1007/s11255-016-1243-x; Dombros N., 2005, NEPHROL DIAL TRANSPL, V20, pix8, DOI DOI 10.1093/NDT/GFI1117; Figueiredo A, 2010, PERITON DIALYSIS INT, V30, P424, DOI 10.3747/pdi.2010.00087; Ghaffari A, 2012, AM J KIDNEY DIS, V59, P400, DOI 10.1053/j.ajkd.2011.08.034; Johnson DW, 2009, AM J KIDNEY DIS, V53, P290, DOI 10.1053/j.ajkd.2008.06.032; Koch M, 2012, NEPHROL DIAL TRANSPL, V27, P375, DOI 10.1093/ndt/gfr262; Lee T, 2005, AM J KIDNEY DIS, V46, P501, DOI 10.1053/j.ajkd.2005.05.024; Liangos O, 2006, SEMIN DIALYSIS, V19, P158, DOI 10.1111/j.1525-139X.2006.00143.x; Liu FX, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000293; Liu YR, 2014, PERITON DIALYSIS INT, V34, P49, DOI 10.3747/pdi.2012.00293; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Lobbedez T, 2008, NEPHROL DIAL TRANSPL, V23, P3290, DOI 10.1093/ndt/gfn213; Lok CE, 2013, CLIN J AM SOC NEPHRO, V8, P1213, DOI 10.2215/CJN.01690213; Lorenzo V, 2004, AM J KIDNEY DIS, V43, P999, DOI 10.1053/j.ajkd.2004.02.012; Povlsen JV, 2006, NEPHROL DIAL TRANSPL, V21, DOI 10.1093/ndt/gfl192; Ravani P, 2013, J AM SOC NEPHROL, V24, P465, DOI 10.1681/ASN.2012070643; Rehman R, 2009, CLIN J AM SOC NEPHRO, V4, P456, DOI 10.2215/CJN.03840808; Sharma AP, 2008, NEPHROLOGY, V13, P672, DOI 10.1111/j.1440-1797.2008.01000.x; United States Renal Data System, 2014, USRDS 2014 ANN DAT R, V2; United States Renal Data System, 2015, USRDS 2015 ANN DAT R, V2; United States Renal Data System, 2014, USRDS 2014 ANN DAT R, V1; US Renal Data System, 2011, AM J KIDNEY DIS, V57, P1, DOI [10.1053/j.ajkd.2010.11.005, DOI 10.1053/J.AJKD.2010.11.005]	25	45	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166181	10.1371/journal.pone.0166181	http://dx.doi.org/10.1371/journal.pone.0166181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824950	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200067
J	Lee, L; Cui, JZ; Cua, M; Esfandiarei, M; Sheng, XY; Chui, WA; Xu, MH; Sarunic, MV; Beg, MF; van Breemen, C; Sandor, GGS; Tibbits, GF				Lee, Ling; Cui, Jason Z.; Cua, Michelle; Esfandiarei, Mitra; Sheng, Xiaoye; Chui, Winsey Audrey; Xu, Michael Haoying; Sarunic, Marinko V.; Beg, Mirza Faisal; van Breemen, Cornelius; Sandor, George G. S.; Tibbits, Glen F.			Aortic and Cardiac Structure and Function Using High-Resolution Echocardiography and Optical Coherence Tomography in a Mouse Model of Marfan Syndrome	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; LEFT-VENTRICULAR FUNCTION; AXIS SYSTOLIC FUNCTION; BIOPHYSICAL PROPERTIES; DIASTOLIC DYSFUNCTION; ARTERIAL STIFFNESS; THORACIC AORTA; YOUNG-ADULTS; ANEURYSM; MICE	Marfan syndrome (MFS) is an autosomal-dominant disorder of connective tissue caused by mutations in the fibrillin-1 (FBN1) gene. Mortality is often due to aortic dissection and rupture. We investigated the structural and functional properties of the heart and aorta in a [Fbn1(C1039G/+)] MFS mouse using high-resolution ultrasound (echo) and optical coherence tomography (OCT). Echo was performed on 6- and 12-month old wild type (WT) and MFS mice (n = 8). In vivo pulse wave velocity (PWV), aortic root diameter, ejection fraction, stroke volume, left ventricular (LV) wall thickness, LV mass and mitral valve early and atrial velocities (E/A) ratio were measured by high resolution echocardiography. OCT was performed on 12-month old WT and MFS fixed mouse hearts to measure ventricular volume and mass. The PWV was significantly increased in 6-mo MFS vs. WT (366.6 +/- 19.9 vs. 205.2 +/- 18.1 cm/s; p = 0.003) and 12-mo MFS vs. WT (459.5 +/- 42.3 vs. 205.3 +/- 30.3 cm/s; p< 0.0001). PWV increased with age in MFS mice only. We also found a significantly enlarged aortic root and decreased E/A ratio in MFS mice compared with WT for both age groups. The [Fbn1(C1039G/+)] mouse model of MFS replicates many of the anomalies of Marfan patients including significant aortic dilation, central aortic stiffness, LV systolic and diastolic dysfunction. This is the first demonstration of the direct measurement in vivo of pulse wave velocity non-invasively in the aortic arch of MFS mice, a robust measure of aortic stiffness and a critical clinical parameter for the assessment of pathology in the Marfan syndrome.	[Lee, Ling; Cui, Jason Z.; Esfandiarei, Mitra; Sheng, Xiaoye; Xu, Michael Haoying; van Breemen, Cornelius; Sandor, George G. S.; Tibbits, Glen F.] Child & Family Res Inst, Dept Cardiovasc Sci, Vancouver, BC, Canada; [Lee, Ling; Sheng, Xiaoye; Tibbits, Glen F.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Cua, Michelle; Chui, Winsey Audrey; Sarunic, Marinko V.; Beg, Mirza Faisal] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada; [Esfandiarei, Mitra; van Breemen, Cornelius] Univ British Columbia, Fac Med, Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [Cui, Jason Z.; Sandor, George G. S.] Univ British Columbia, Dept Pediat, Div Cardiol, Vancouver, BC, Canada; [Esfandiarei, Mitra] Midwestern Univ, Dept Biomed Sci, Glendale, AZ USA	Child & Family Research Institute; Simon Fraser University; Simon Fraser University; University of British Columbia; University of British Columbia; Midwestern University	Tibbits, GF (corresponding author), Child & Family Res Inst, Dept Cardiovasc Sci, Vancouver, BC, Canada.; Tibbits, GF (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada.	tibbits@sfu.ca	Esfandiarei, Mitra/R-9903-2019; Esfandiarei, Mitra/V-1258-2019	Esfandiarei, Mitra/0000-0003-3218-7781; Sandor, George/0000-0002-9930-5140; Beg, Mirza Faisal/0000-0001-6706-8630; Sarunic, Marinko/0000-0002-5636-9056	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research, www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpendurada F, 2010, EUR J HEART FAIL, V12, P1085, DOI 10.1093/eurjhf/hfq127; Angtuaco MJ, 2012, J ULTRAS MED, V31, P1609; Arnlov J, 2004, EUR HEART J, V25, P2220, DOI 10.1016/j.ehj.2004.10.021; Bradley TJ, 2005, AM J CARDIOL, V96, P1317, DOI 10.1016/j.amjcard.2005.06.080; Campens L, 2015, PEDIATR RES, V78, P256, DOI 10.1038/pr.2015.110; Chatrath R, 2003, AM J CARDIOL, V91, P914, DOI 10.1016/S0002-9149(03)00039-0; Child AH, 2004, MED INTELL UNIT, P13; Chung AWY, 2007, BRIT J PHARMACOL, V152, P305, DOI 10.1038/sj.bjp.0707391; Chung AWY, 2007, BRIT J PHARMACOL, V150, P1075, DOI 10.1038/sj.bjp.0707181; Chung AWY, 2007, CIRC RES, V101, P512, DOI 10.1161/CIRCRESAHA.107.157776; Cook JR, 2014, J CLIN INVEST, V124, P1329, DOI 10.1172/JCI71059; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Cua M, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.11.116007; Cui JZ, 2014, J STRUCT BIOL, V187, P242, DOI 10.1016/j.jsb.2014.07.003; Das BB, 2006, PEDIATR CARDIOL, V27, P256, DOI 10.1007/s00246-005-1139-5; Di Lascio N, 2014, ATHEROSCLEROSIS, V237, P31, DOI 10.1016/j.atherosclerosis.2014.08.033; Dietz HC, 2005, AM J MED GENET C, V139C, P4, DOI 10.1002/ajmg.c.30068; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; El-Hamamsy I, 2009, NAT REV CARDIOL, V6, P771, DOI 10.1038/nrcardio.2009.191; FREED C, 1977, WESTERN J MED, V126, P87; Gao Shumin, 2011, Curr Protoc Mouse Biol, V1, P71; Groenink M, 2001, RADIOLOGY, V219, P535, DOI 10.1148/radiology.219.2.r01ma01535; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hartley CJ, 1997, AM J PHYSIOL-HEART C, V273, pH494, DOI 10.1152/ajpheart.1997.273.1.H494; HIRATA K, 1991, J AM COLL CARDIOL, V18, P57, DOI 10.1016/S0735-1097(10)80218-9; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Hucker WJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2975826; JEREMY RW, 1994, AM J CARDIOL, V74, P369, DOI 10.1016/0002-9149(94)90405-7; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Keane MG, 2008, CIRCULATION, V117, P2802, DOI 10.1161/CIRCULATIONAHA.107.693523; Kiotsekoglou A, 2008, EUR J ECHOCARDIOGR, V9, P605, DOI 10.1093/ejechocard/jen003; Kiotsekoglou A, 2011, ECHOCARDIOGR-J CARD, V28, P29, DOI 10.1111/j.1540-8175.2010.01241.x; Kiotsekoglou A, 2010, HELL J CARDIOL, V51, P501; Kroner ESJ, 2013, INT J CARDIOL, V167, P2977, DOI 10.1016/j.ijcard.2012.08.057; Laurent S, 2003, STROKE, V34, P1203, DOI 10.1161/01.STR.0000065428.03209.64; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Leloup AJA, 2014, HYPERTENSION, V64, P195, DOI 10.1161/HYPERTENSIONAHA.114.03312; Little WC, 2009, CIRCULATION, V120, P802, DOI 10.1161/CIRCULATIONAHA.109.869602; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Nollen GJ, 2004, EUR HEART J, V25, P1146, DOI 10.1016/j.ehj.2004.04.033; Okamura H, 2014, CIRC-CARDIOVASC IMAG, V7, P690, DOI 10.1161/CIRCIMAGING.114.001658; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Rabben SI, 2004, J BIOMECH, V37, P1615, DOI 10.1016/j.jbiomech.2003.12.031; Ram R, 2011, AM J PHYSIOL-HEART C, V301, pH1765, DOI 10.1152/ajpheart.00559.2011; Rhoades R, 2013, MED PHYSL PRINCIPLES, pxvi; Roth DM, 2002, AM J PHYSIOL-HEART C, V282, pH2134, DOI 10.1152/ajpheart.00845.2001; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Syyong HT, 2009, BRIT J PHARMACOL, V158, P1597, DOI 10.1111/j.1476-5381.2009.00439.x; Tae HJ, 2015, AM J PHYSIOL-HEART C, DOI [10.1152/ajpheart.00354.2015ajpheart.00354.2015, DOI 10.1152/AJPHEART.00354.2015AJPHEART]; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Westenberg JJM, 2011, J MAGN RESON IMAGING, V34, P526, DOI 10.1002/jmri.22646; Williams R, 2007, ULTRASOUND MED BIOL, V33, P1368, DOI 10.1016/j.ultrasmedbio.2007.03.012; Yetman AT, 2003, J AM COLL CARDIOL, V41, P329, DOI 10.1016/S0735-1097(02)02699-2	59	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164778	10.1371/journal.pone.0164778	http://dx.doi.org/10.1371/journal.pone.0164778			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824871	Green Submitted, Green Published, gold			2022-12-27	WOS:000387615200007
J	Sugita, N				Sugita, Norimasa			Homosexual Fellatio: Erect Penis Licking between Male Bonin Flying Foxes Pteropus pselaphon	PLOS ONE			English	Article							BEHAVIOR; BATS; ETHOGRAM; ALECTO	A recent focus of interest has been on the functional significance of genital licking (fellatio and cunnilingus) in relation to sexual selection in Pteropodid bats. In the present paper, a form of fellatio in wild Bonin flying foxes, Pteropus pselaphon, performed between adult males has been reported. During the mating season, adult flying foxes roost in same-sex groups, forming ball-shaped clusters which provide warmth. The female clusters may also contain a few males. Unassociated with allogrooming, same-sex genital licking occurred among males in the all male clusters. As such, male-male fellatio can be considered as homosexual behavior, two functional explanations could account for this behavior; the social bonding and the social tension regulation hypotheses suggested in a previous review. Given that neither the simpler alternative that in all male groups such fellatio may represent misdirected sexual behavior, nor the two previously proposed functional hypotheses were supported by the data, I propose another functional hypothesis. Homosexual fellatio in this species could help males solve inconsistent situations in the roost when there are conflicts between cooperative behavior for social thermoregulation and competition for mating.	[Sugita, Norimasa] Rikkyo Univ, Coll Sci, Toshima Ku, Tokyo, Japan; [Sugita, Norimasa] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan	Rikkyo University; National Museum of Nature and Science	Sugita, N (corresponding author), Rikkyo Univ, Coll Sci, Toshima Ku, Tokyo, Japan.; Sugita, N (corresponding author), Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan.	nsugita@rikkyo.ac.jp		Sugita, Norimasa/0000-0002-5239-9872				Bagemihl B, 1999, BIOL EXUBERANCE; Bailey NW, 2009, TRENDS ECOL EVOL, V24, P439, DOI 10.1016/j.tree.2009.03.014; Courts SE, 1996, DODO, V32, P15; DEWAAL FBM, 1995, CHIC SEX HIST SOC, P37; EAST ML, 1993, BEHAV ECOL SOCIOBIOL, V33, P355; Gebhard Paul H., 1979, KINSEY DATA MARGINAL; Grant Gilbert S., 1999, Australian Mammalogy, V21, P111; Greenhall A. M., 1965, Mammalia, V29, P441, DOI 10.1515/mamm.1965.29.4.441; Inaba M., 2005, OGASAWARA RES, V30, P15; Ishii N., 2008, 2008 IUCN RED LIST T; Kinjo K, 1829, WILD MAMMALS JAPAN, P56; MacFarlane GR, 2016, BEHAV PROCESS, V126, P21, DOI 10.1016/j.beproc.2016.02.016; Markus N, 2002, ACTA CHIROPTEROL, V4, P137, DOI 10.3161/001.004.0203; Markus N, 2002, ACTA CHIROPTEROL, V4, P153, DOI 10.3161/001.004.0204; Maruthupandian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059743; NELSON JE, 1965, ANIM BEHAV, V13, P544, DOI 10.1016/0003-3472(65)90118-1; Ogawa H., 2006, WILY MONKEYS SOCIAL; R Development Core Team, 2016, R LANG ENV STAT COMP; Riccucci M, 2011, HYSTRIX, V22, P139, DOI 10.4404/Hystrix-22.1-4478; Sugita N, 2014, MAMM STUDY, V39, P185, DOI 10.3106/041.039.0301; Sugita N, 2013, MAMM BIOL, V78, P455, DOI 10.1016/j.mambio.2013.07.078; Sugita N, 2013, MAMM STUDY, V38, P225, DOI 10.3106/041.038.0301; Sugita N, 2009, J MAMMAL, V90, P195, DOI 10.1644/07-MAMM-A-368.1; Tan M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007595; Vasey P. L., 2006, HOMOSEXUAL BEHAV ANI, P3; Vasey PL, 2006, ARCH SEX BEHAV, V35, P523, DOI 10.1007/s10508-006-9111-x	26	7	9	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166024	10.1371/journal.pone.0166024	http://dx.doi.org/10.1371/journal.pone.0166024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824953	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200054
J	Zheng, LZ; Lin, VC; Mu, YG				Zheng, Liangzhen; Lin, Valerie Chunling; Mu, Yuguang			Exploring Flexibility of Progesterone Receptor Ligand Binding Domain Using Molecular Dynamics	PLOS ONE			English	Article							FREE-ENERGY LANDSCAPE; CATION-PI INTERACTIONS; NORMAL-MODE ANALYSIS; CRYSTAL-STRUCTURE; RETINOIC ACID; MAMMARY-GLAND; FORCE-FIELD; C-TERMINUS; PROTEIN; SIMULATIONS	Progesterone receptor (PR), a member of nuclear receptor (NR) superfamily, plays a vital role for female reproductive tissue development, differentiation and maintenance. PR ligand, such as progesterone, induces conformation changes in PR ligand binding domain (LBD), thus mediates subsequent gene regulation cascades. PR LBD may adopt different conformations upon an agonist or an antagonist binding. These different conformations would trigger distinct transcription events. Therefore, the dynamics of PR LBD would be of general interest to biologists for a deep understanding of its structure-function relationship. However, no apo-form (non-ligand bound) of PR LBD model has been proposed either by experiments or computational methods so far. In this study, we explored the structural dynamics of PR LBD using molecular dynamics simulations and advanced sampling tools in both ligand-bound and the apo-forms. Resolved by the simulation study, helix 11, helix 12 and loop 895-908 (the loop between these two helices) are quite flexible in antagonistic conformation. Several residues, such as Arg899 and Glu723, could form salt-bridging interaction between helix 11 and helix 3, and are important for the PR LBD dynamics. And we also propose that helix 12 in apo-form PR LBD, not like other NR LBDs, such as human estrogen receptor a (ER alpha) LBD, may not adopt a totally extended conformation. With the aid of umbrella sampling and meta-dynamics simulations, several stable conformations of apo-form PR LBD have been sampled, which may work as critical structural models for further large scale virtual screening study to discover novel PR ligands for therapeutic application.	[Zheng, Liangzhen; Lin, Valerie Chunling; Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Mu, YG (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	ygmu@ntu.edu.sg	Liangzhen, ZHENG/CAJ-5666-2022; Zheng, Liangzhen/AAA-6885-2020		Nanyang Technological University [RG 138/15]	Nanyang Technological University(Nanyang Technological University)	The authors recevied fund from Nanyang Technological University, fund name is Tier 1 Grant RG 138/15. Funder's website: http://www.ntu.edu.sg/Pages/home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported and financed by Nanyang Technological University Tier 1 Grant RG 138/15.	Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; Arora K, 2007, P NATL ACAD SCI USA, V104, P18496, DOI 10.1073/pnas.0706443104; Awuni Y, 2015, MOLECULES, V20, P5152, DOI 10.3390/molecules20035152; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Baker ME, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-24; Banavali NK, 2005, J AM CHEM SOC, V127, P6866, DOI 10.1021/ja050482k; Banerjee S, 2011, J AM SOC MASS SPECTR, V22, P1707, DOI 10.1007/s13361-011-0188-7; Barducci A, 2006, J AM CHEM SOC, V128, P2705, DOI 10.1021/ja057076l; Barducci A, 2013, P NATL ACAD SCI USA, V110, pE4708, DOI 10.1073/pnas.1320077110; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Batista MRB, 2013, BIOPHYS J, V105, P1670, DOI 10.1016/j.bpj.2013.07.032; Bellance C, 2013, MOL BIOL CELL, V24, P1363, DOI 10.1091/mbc.E12-11-0807; Blondel A, 1999, J MOL BIOL, V291, P101, DOI 10.1006/jmbi.1999.2879; Bonomi M, 2009, J COMPUT CHEM, V30, P1615, DOI 10.1002/jcc.21305; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Branduardi D, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2432340; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Bussi G, 2006, J AM CHEM SOC, V128, P13435, DOI 10.1021/ja062463w; Case D.A., 2022, AMBER 2020; Celik L, 2007, BIOCHEMISTRY-US, V46, P1743, DOI 10.1021/bi061656t; Chiu CC, 2013, BIOPHYS J, V105, P1227, DOI 10.1016/j.bpj.2013.07.029; Cohen RN, 2001, MOL ENDOCRINOL, V15, P1049, DOI 10.1210/me.15.7.1049; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Favia AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025375; Fernandez-Valdivia R, 2005, SEMIN REPROD MED, V23, P22, DOI 10.1055/s-2005-864031; Frisch M., 2009, GAUSSIAN 09 REVISION, P200; Fujii S, 2014, EUR J MED CHEM, V84, P264, DOI 10.1016/j.ejmech.2014.07.034; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GUIOCHONMANTEL A, 1989, CELL, V57, P1147, DOI 10.1016/0092-8674(89)90052-4; Harvey S.C., 1988, DYNAMICS PROTEINS NU; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hill KK, 2012, MOL CELL ENDOCRINOL, V348, P418, DOI 10.1016/j.mce.2011.07.017; Hsin Jen, 2008, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0507s24; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Khan JA, 2013, MOL ENDOCRINOL, V27, P909, DOI 10.1210/me.2012-1328; Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; LANZ RB, 1994, ENDOCRINOLOGY, V135, P2183, DOI 10.1210/en.135.5.2183; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Leonhardt SA, 2003, STEROIDS, V68, P761, DOI 10.1016/S0039-128X(03)00129-6; Letz M, 1999, BBA-PROTEIN STRUCT M, V1429, P391, DOI 10.1016/S0167-4838(98)00249-0; Limongelli V, 2012, P NATL ACAD SCI USA, V109, P1467, DOI 10.1073/pnas.1112181108; LobaccaroHenri C, 1996, J STEROID BIOCHEM, V59, P63, DOI 10.1016/S0960-0760(96)00091-X; Lusher SJ, 2012, J BIOL CHEM, V287, P20333, DOI 10.1074/jbc.M111.308403; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; Madauss KP, 2004, J MED CHEM, V47, P3381, DOI 10.1021/jm030640n; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mecozzi S, 1996, P NATL ACAD SCI USA, V93, P10566, DOI 10.1073/pnas.93.20.10566; MEYER ME, 1990, EMBO J, V9, P3923, DOI 10.1002/j.1460-2075.1990.tb07613.x; Miao YL, 2014, CHEM BIOL DRUG DES, V83, P237, DOI 10.1111/cbdd.12233; Mu YG, 2005, PROTEINS, V58, P45, DOI 10.1002/prot.20310; Nettles KW, 2008, NAT CHEM BIOL, V4, P241, DOI 10.1038/nchembio.76; Palmer D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0696; Perryman AL, 2004, PROTEIN SCI, V13, P1108, DOI 10.1110/ps.03468904; Petit-Topin I, 2014, J STEROID BIOCHEM, V144, P427, DOI 10.1016/j.jsbmb.2014.08.008; Petit-Topin I, 2009, MOL PHARMACOL, V75, P1317, DOI 10.1124/mol.108.054312; Pfaendtner J, 2009, P NATL ACAD SCI USA, V106, P12723, DOI 10.1073/pnas.0902092106; Piana S, 2007, J PHYS CHEM B, V111, P4553, DOI 10.1021/jp067873l; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Pietrucci F, 2009, J CHEM THEORY COMPUT, V5, P2197, DOI 10.1021/ct900202f; Pronk S., 2013, BIOINFORMATICS; Raaijmakers HCA, 2009, J BIOL CHEM, V284, P19572, DOI 10.1074/jbc.M109.007872; Lopez-Blanco JR, 2011, BIOINFORMATICS, V27, P2843, DOI 10.1093/bioinformatics/btr497; Recouvreux MS, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-2240; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Rho YA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002524; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schapira M, 2003, J MED CHEM, V46, P3045, DOI 10.1021/jm0300173; Schnecke V, 1999, Proc Int Conf Intell Syst Mol Biol, P242; Seeber M, 2007, BIOINFORMATICS, V23, P2625, DOI 10.1093/bioinformatics/btm378; Seeber M, 2011, J COMPUT CHEM, V32, P1183, DOI 10.1002/jcc.21688; Soderhjelm P, 2012, P NATL ACAD SCI USA, V109, P5170, DOI 10.1073/pnas.1201940109; Spitz IM, 2003, EXPERT OPIN INV DRUG, V12, P1693, DOI 10.1517/eoid.12.10.1693.21837; Sutto L, 2013, P NATL ACAD SCI USA, V110, P10616, DOI 10.1073/pnas.1221953110; Takimoto GS, 2003, J STEROID BIOCHEM, V85, P209, DOI 10.1016/S0960-0760(03)00197-3; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Tiwary P, 2015, J PHYS CHEM B, V119, P736, DOI 10.1021/jp504920s; VEGETO E, 1992, CELL, V69, P703, DOI 10.1016/0092-8674(92)90234-4; Wang JN, 2014, J PHYS CHEM B, V118, P134, DOI 10.1021/jp4105129; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Xu JM, 1996, P NATL ACAD SCI USA, V93, P12195, DOI 10.1073/pnas.93.22.12195; Zhang SM, 1996, MOL ENDOCRINOL, V10, P24, DOI 10.1210/me.10.1.24	92	10	10	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165824	10.1371/journal.pone.0165824	http://dx.doi.org/10.1371/journal.pone.0165824			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824891	Green Submitted, gold, Green Published			2022-12-27	WOS:000387615200034
J	Gregorio, AC; Fonseca, NA; Moura, V; Lacerda, M; Figueiredo, P; Simoes, S; Diaz, S; Moreira, JN				Gregorio, Ana C.; Fonseca, Nuno A.; Moura, Vera; Lacerda, Manuela; Figueiredo, Paulo; Simoes, Sergio; Diaz, Sergio; Moreira, Joao Nuno			Inoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine Model	PLOS ONE			English	Article							MOUSE MAMMARY-TUMOR; PEGYLATED LIPOSOMAL DOXORUBICIN; MONITORING TREATMENT RESPONSE; SOLID TUMORS; IN-VIVO; CARCINOMA; MICROENVIRONMENT; INHIBITION; CHALLENGES; NECROSIS	4T1 metastatic breast cancer model have been widely used to study stage IV human breast cancer. However, the frequent inoculation of a large number of cells, gives rise to fast growing tumors, as well as to a surprisingly low metastatic take rate. The present work aimed at establishing the conditions enabling high metastatic take rate of the triple-negative murine 4T1 syngeneic breast cancer model. An 87% 4T1 tumor incidence was observed when as few as 500 cancer cells were implanted. 4T1 cancer cells colonized primarily the lungs with 100% efficiency, and distant lesions were also commonly identified in the mesentery and pancreas. The drastic reduction of the number of inoculated cells resulted in increased tumor doubling times and decreased specific growth rates, following a Gompertzian tumor expansion. The established conditions for the 4T1 mouse model were further validated in a therapeutic study with peguilated liposomal doxorubicin, in clinical used in the setting of metastatic breast cancer. Inoculated cell density was proven to be a key methodological aspect towards the reproducible development of macrometastases in the 4T1 mouse model and a more reliable pre-clinical assessment of antimetastatic therapies.	[Gregorio, Ana C.; Fonseca, Nuno A.; Moura, Vera; Simoes, Sergio; Moreira, Joao Nuno] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Gregorio, Ana C.] Univ Coimbra, UC Inst Interdisciplinary Res, Coimbra, Portugal; [Fonseca, Nuno A.; Simoes, Sergio; Moreira, Joao Nuno] Univ Coimbra, FFUC Fac Pharm, Polo Ciencias Saude, Coimbra, Portugal; [Moura, Vera] TREAT U SA, Coimbra, Portugal; [Lacerda, Manuela] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, Oporto, Portugal; [Figueiredo, Paulo] IPOFG EPE Portuguese Inst Oncol Francisco Gentil, Coimbra, Portugal; [Diaz, Sergio] Univ Lisbon, IMM, Fac Med, Lisbon, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade do Porto; Universidade de Coimbra; Universidade de Lisboa	Moreira, JN (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.; Moreira, JN (corresponding author), Univ Coimbra, FFUC Fac Pharm, Polo Ciencias Saude, Coimbra, Portugal.	jmoreira@ff.uc.pt	Fonseca, Nuno/AAF-1747-2020; Moreira, João Nuno/F-3180-2010; Dias, Sergio/L-1250-2014	Moreira, João Nuno/0000-0003-3449-0522; Moura, Vera/0000-0001-5820-9964; Gregorio, Ana/0000-0001-7265-0019; Simoes, Sergio/0000-0002-8898-7625; Fonseca, Nuno A. C./0000-0003-4970-7288; Dias, Sergio/0000-0002-7603-4616	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/51190/2010]; FCT [PTDC/SAU-BMA/121028/2010]; FEDER/COMPETE [UID/NEU/04539/2013]; TREAT U	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER/COMPETE(European Commission); TREAT U	Ana Cristina Gregorio is a student of the international PhD program in Experimental Biology and Biomedicine (PDBEB) from the Institute for Interdisciplinary Research, University of Coimbra and recipient of the fellowship SFRH/BD/51190/2010 from the Portuguese Foundation for Science and Technology (FCT). The work was supported by the grants PTDC/SAU-BMA/121028/2010 (FCT) and UID/NEU/04539/2013 (FEDER/COMPETE 2020/FCT). TREAT U provided support in the form of salaries for author VM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abu N, 2015, DRUG DES DEV THER, V9, P1401, DOI 10.2147/DDDT.S67976; Adler EP, 2003, IMMUNOL LETT, V90, P187, DOI 10.1016/j.imlet.2003.09.013; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bailey-Downs LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098624; Benzekry S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003800; Bos PD, 2010, CURR OPIN PHARMACOL, V10, P571, DOI 10.1016/j.coph.2010.06.003; BURTON AC, 1966, GROWTH, V30, P157; Carballido EM, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-014-0404-2; Carstens E, 2000, ILAR J, V41, P62; Charrois GJR, 2003, J PHARMACOL EXP THER, V306, P1058, DOI 10.1124/jpet.103.053413; Chen F, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0278-7; Comen E, 2011, NAT REV CLIN ONCOL, V8, P369, DOI 10.1038/nrclinonc.2011.64; DEXTER DL, 1978, CANCER RES, V38, P3174; Dupre SA, 2007, INT J EXP PATHOL, V88, P351, DOI 10.1111/j.1365-2613.2007.00539.x; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Dupre SA, 2008, EXP MOL PATHOL, V85, P174, DOI 10.1016/j.yexmp.2008.05.002; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Ferrari-Amorotti G, 2014, NEOPLASIA, V16, P1047, DOI 10.1016/j.neo.2014.10.006; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Gabizon A, 1998, J CONTROL RELEASE, V53, P275, DOI 10.1016/S0168-3659(97)00261-7; Gabizon A, 1997, DRUGS, V54, P15, DOI 10.2165/00003495-199700544-00005; Gao ZG, 2011, J CONTROL RELEASE, V152, P84, DOI 10.1016/j.jconrel.2011.01.021; Gould SE, 2015, NAT MED, V21, P431, DOI 10.1038/nm.3853; Haddad TC, 2008, MICE WOMEN IS THIS A, DOI [10.1200/JCO.2007.14.9062, DOI 10.1200/JCO.2007.14.9062]; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Heimburg J, 2006, NEOPLASIA, V8, P939, DOI 10.1593/neo.06493; HIRANO T, 2011, INHIBITION TUMOR GRO; Hori K, 2014, CANCER SCI, V105, P1196, DOI 10.1111/cas.12477; Huang Y, 2015, ONCOTARGET; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Kim EJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2927; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kurt RA, 2001, CELL IMMUNOL, V207, P81, DOI 10.1006/cimm.2000.1754; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Nguyen L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-522; Lirdprapamongkol K, 2005, EUR J PHARM SCI, V25, P57, DOI 10.1016/j.ejps.2005.01.015; LUDDEN TM, 1994, J PHARMACOKINET BIOP, V22, P431, DOI 10.1007/BF02353864; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; McKeown E, 2014, J CANCER, V5, P31, DOI 10.7150/jca.7987; Mehrara E, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-31; MILLER FR, 1983, INVAS METAST, V3, P22; Nasti TH, 2015, LIFE SCI, V131, P11, DOI 10.1016/j.lfs.2015.02.025; NORTON L, 1988, CANCER RES, V48, P7067; Parham F, 2005, WILEY SER PROBAB ST, P239; Pastorino F, 2008, CLIN CANCER RES, V14, P7320, DOI 10.1158/1078-0432.CCR-08-0804; Peiris PM, 2015, J PHARM SCI-US, V104, P2600, DOI 10.1002/jps.24518; Poeschinger T, 2013, MOL IMAGING BIOL, V15, P28, DOI 10.1007/s11307-012-0559-x; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Proskuryakov SY, 2010, CURR PHARM DESIGN, V16, P56, DOI 10.2174/138161210789941793; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Quang CT, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.14; Samant RS, 2006, CANCER LETT, V235, P260, DOI 10.1016/j.canlet.2005.04.032; Sato M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126483; Singh M, 2012, NAT BIOTECHNOL, V30, P648, DOI 10.1038/nbt.2286; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Tevaarwerk AJ, 2013, CANCER-AM CANCER SOC, V119, P1140, DOI 10.1002/cncr.27819; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Vitiello PF, 2004, IMMUNOL LETT, V91, P239, DOI 10.1016/j.imlet.2003.12.009; Waight JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027690; Wallace TJ, 2014, J CANCER, V5, P3, DOI 10.7150/jca.7709; Weber GF, 2013, CANCER LETT, V328, P207, DOI 10.1016/j.canlet.2012.09.025; Welch DR, 1997, CLIN EXP METASTAS, V15, P272, DOI 10.1023/A:1018477516367; Weng DS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3102; Wenzel J, 2010, CLIN EXP METASTAS, V27, P25, DOI 10.1007/s10585-009-9299-y; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yan HH, 2010, CANCER RES, V70, P6139, DOI 10.1158/0008-5472.CAN-10-0706; Yokoi K, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.SABCS14-P1-07-13; Zhou R, 2002, CANCER RES, V62, P2561	72	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165817	10.1371/journal.pone.0165817	http://dx.doi.org/10.1371/journal.pone.0165817			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820870	gold, Green Published, Green Submitted			2022-12-27	WOS:000387614800021
J	Li, XS; Wang, GB; Sun, Y; Liu, W; He, YZ; Wang, FC; Jiang, YR; Qin, L				Li, Xi-Sheng; Wang, Guo-Bao; Sun, Ying; Liu, Wei; He, Ying-Zi; Wang, Feng-Cheng; Jiang, Yi-Ren; Qin, Li			Transcriptome Analysis of the Midgut of the Chinese Oak Silkworm Antheraea pernyi Infected with Antheraea pernyi Nucleopolyhedrovirus	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CYTOPLASMIC POLYHEDROSIS-VIRUS; RNA-SEQ DATA; GENE-EXPRESSION; SERINE PROTEASES; REFERENCE GENOME; DROSOPHILA; HOST; QUANTIFICATION; MICROARRAY	The Antheraea pernyi nucleopolyhedrovirus (ApNPV) is an exclusive pathogen of A. pernyi. The intense interactions between ApNPV and A. pernyi cause a series of physiological and pathological changes to A. pernyi. However, no detailed report exists regarding the molecular mechanisms underlying the interactions between ApNPV and A. pernyi. In this study, four cDNA libraries of the A. pernyi midgut, including two ApNPV-infected groups and two control groups, were constructed for transcriptomic analysis to provide new clues regarding the molecular mechanisms that underlie these interactions. The transcriptome of the A. pernyi midgut was de novo assembled using the Trinity platform because of the lack of a genome resource for A. pernyi. Compared with the controls, a total of 5,172 differentially expressed genes (DEGs) were identified, including 2,183 up-regulated and 2,989 down-regulated candidates, of which 2,965 and 911 DEGs were classified into different GO categories and KEGG pathways, respectively. The DEGs involved in A. pernyi innate immunity were classified into several categories, including heat-shock proteins, apoptosis-related proteins, serpins, serine proteases and cytochrome P450s. Our results suggested that these genes were related to the immune response of the A. pernyi midgut to ApNPV infection via their essential roles in regulating a variety of physiological processes. Our results may serve as a basis for future research not only on the molecular mechanisms of ApNPV invasion but also on the anti-ApNPV mechanism of A. pernyi.	[Li, Xi-Sheng; Sun, Ying; Qin, Li] Shenyang Agr Univ, Coll Plant Protect, Shenyang 110866, Peoples R China; [Li, Xi-Sheng; Wang, Guo-Bao; Sun, Ying; Liu, Wei; Jiang, Yi-Ren; Qin, Li] Shenyang Agr Univ, Liaoning Engn & Technol Res Ctr Insect Resources, Coll Biosci & Biotechnol, Shenyang, Peoples R China; [Li, Xi-Sheng; He, Ying-Zi; Wang, Feng-Cheng] Sericulture Res Inst Liaoning Prov, Fengcheng 118100, Peoples R China	Shenyang Agricultural University; Shenyang Agricultural University	Qin, L (corresponding author), Shenyang Agr Univ, Coll Plant Protect, Shenyang 110866, Peoples R China.; Jiang, YR; Qin, L (corresponding author), Shenyang Agr Univ, Liaoning Engn & Technol Res Ctr Insect Resources, Coll Biosci & Biotechnol, Shenyang, Peoples R China.	jiangyiren56@126.com; qinli1963@163.com			National Modern Agriculture Industry Technology System Construction Project; Magnitude Science and Technology Projects of Liaoning Province; Cultivation Plan for Youth Agricultural Science and Technology Innovative Talents of Liaoning Province [2014040]; Scientific Research Project for the Education Department of Liaoning Province [L2014255]	National Modern Agriculture Industry Technology System Construction Project; Magnitude Science and Technology Projects of Liaoning Province; Cultivation Plan for Youth Agricultural Science and Technology Innovative Talents of Liaoning Province; Scientific Research Project for the Education Department of Liaoning Province	This work was supported by the National Modern Agriculture Industry Technology System Construction Project (Silkworm and Mulberry) and the Magnitude Science and Technology Projects of Liaoning Province to LQ; the Cultivation Plan for Youth Agricultural Science and Technology Innovative Talents of Liaoning Province (2014040) and the Scientific Research Project for the Education Department of Liaoning Province (L2014255) to YRJ.	Ahmad ST, 2009, P NATL ACAD SCI USA, V106, P12168, DOI 10.1073/pnas.0903134106; Bao YY, 2009, GENOMICS, V94, P138, DOI 10.1016/j.ygeno.2009.04.003; Brackney DE, 2008, AM J TROP MED HYG, V79, P267, DOI 10.4269/ajtmh.2008.79.267; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Gao K, 2014, J INVERTEBR PATHOL, V115, P8, DOI 10.1016/j.jip.2013.10.016; Goley ED, 2006, SCIENCE, V314, P464, DOI 10.1126/science.1133348; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRANADOS RR, 1981, VIROLOGY, V108, P297, DOI 10.1016/0042-6822(81)90438-4; HAAS AL, 1998, THE FASEB JOURNAL, V11, P1257; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Kolliopoulou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121447; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liew KJL, 2006, J VIROL METHODS, V131, P47, DOI 10.1016/j.jviromet.2005.07.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McTaggart SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1499-z; Merrill AH, 1999, CHEM PHYS LIPIDS, V102, P131, DOI 10.1016/S0009-3084(99)00081-X; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Narayanan K, 2004, CURR SCI INDIA, V86, P800; Pederson T, 2005, MOL BIOL CELL, V16, P5055, DOI 10.1091/mbc.E05-07-0656; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Provost B, 2011, INSECT BIOCHEM MOLEC, V41, P582, DOI 10.1016/j.ibmb.2011.03.010; Reichhart JM, 2005, TRENDS CELL BIOL, V15, P659, DOI 10.1016/j.tcb.2005.10.001; Ren XX, 2014, PEERJ, V2, DOI 10.7717/peerj.584; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Smartt CT, 2009, AM J TROP MED HYG, V81, P258, DOI 10.4269/ajtmh.2009.81.258; Tang H, 2008, DEV CELL, V15, P617, DOI 10.1016/j.devcel.2008.08.017; Tezel G, 2004, BRAIN RES BULL, V62, P473, DOI 10.1016/S0361-9230(03)00074-1; Thiem SM, 2009, IN VITRO CELL DEV-AN, V45, P111, DOI 10.1007/s11626-008-9170-5; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang GB, 2015, J INVERTEBR PATHOL, V128, P37, DOI 10.1016/j.jip.2015.04.001; Wu P, 2011, MOL BIOL REP, V38, P333, DOI 10.1007/s11033-010-0112-4	36	8	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165959	10.1371/journal.pone.0165959	http://dx.doi.org/10.1371/journal.pone.0165959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820844	Green Published, gold, Green Submitted			2022-12-27	WOS:000387614800027
J	Osorio, R; Alfonso-Rodriguez, CA; Medina-Castillo, AL; Alaminos, M; Toledano, M				Osorio, Raquel; Andres Alfonso-Rodriguez, Camilo; Medina-Castillo, Antonio L.; Alaminos, Miguel; Toledano, Manuel			Bioactive Polymeric Nanoparticles for Periodontal Therapy	PLOS ONE			English	Article							EXTRACELLULAR CALCIUM; DEPENDENT PATHWAY; ALVEOLAR BONE; PHOSPHATE; CYTOTOXICITY; EXPRESSION; PARTICLES; FIBROBLAST; COMPOSITE; DENTIN	Aims to design calcium and zinc-loaded bioactive and cytocompatible nanoparticles for the treatment of periodontal disease. Methods PolymP-nActive nanoparticles were zinc or calcium loaded. Biomimetic calcium phosphate precipitation on polymeric particles was assessed after 7 days immersion in simulated body fluid, by scanning electron microscopy attached to an energy dispersive analysis system. Amorphous mineral deposition was probed by X-ray diffraction. Cell viability analysis was performed using oral mucosa fibroblasts by: 1) quantifying the liberated deoxyribonucleic acid from dead cells, 2) detecting the amount of lactate dehydrogenase enzyme released by cells with damaged membranes, and 3) by examining the cytoplasmic esterase function and cell membranes integrity with a fluorescence-based method using the Live/Dead commercial kit. Data were analyzed by Kruskal-Wallis and Mann-Whitney tests. Results Precipitation of calcium and phosphate on the nanoparticles surfaces was observed in calcium- loaded nanoparticles. Non-loaded nanoparticles were found to be non-toxic in all the assays, calcium and zinc-loaded particles presented a dose dependent but very low cytotoxic effect. Conclusions The ability of calcium- loaded nanoparticles to promote precipitation of calcium phosphate deposits, together with their observed non-toxicity may offer new strategies for periodontal disease treatment.	[Osorio, Raquel; Toledano, Manuel] Univ Granada, Colegio Maximo, Dent Sch, Campus Cartuja S-N, Granada 18017, Spain; [Andres Alfonso-Rodriguez, Camilo; Alaminos, Miguel] Univ Granada, Dept Histol, Tissue Engn Grp, Granada 18012, Spain; [Medina-Castillo, Antonio L.] NanoMyP Spin Off Enterprise Univ Granada, Edificio BIC Granada,Av Innovac 1, Granada 18016, Spain	University of Granada; University of Granada	Osorio, R (corresponding author), Univ Granada, Colegio Maximo, Dent Sch, Campus Cartuja S-N, Granada 18017, Spain.	rosorio@ugr.es	Toledano, Manuel/E-7923-2017; Osorio, Raquel/E-7913-2017; Medina-Castillo, Antonio L/E-9799-2018; Castillo, Antonio Luis Medina/ABD-7194-2020; ALAMINOS, MIGUEL/N-9960-2016	Toledano, Manuel/0000-0002-2172-7896; Osorio, Raquel/0000-0001-7679-6840; Medina-Castillo, Antonio L/0000-0002-0308-9878; ALAMINOS, MIGUEL/0000-0003-4876-2672	Ministry of Economy and Competitiveness; European Regional Development Fund [MAT2014-52036-P]	Ministry of Economy and Competitiveness; European Regional Development Fund(European Commission)	This work was supported by the Ministry of Economy and Competitiveness and European Regional Development Fund, Grant: MAT2014-52036-P to MT, RO, ALMC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Al Machot E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/786353; [Anonymous], 233172012 ISO; Arzate H, 2015, PERIODONTOL 2000, V67, P211, DOI 10.1111/prd.12062; Bartold PM, 2016, J PERIODONTAL RES, V51, P1, DOI 10.1111/jre.12275; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; Besinis A, 2012, DENT MATER, V28, P1012, DOI 10.1016/j.dental.2012.05.007; Bizenjima T, 2016, CLIN ORAL IMPLAN RES, V27, P1360, DOI 10.1111/clr.12744; Breitwieser GE, 2008, INT J BIOCHEM CELL B, V40, P1467, DOI 10.1016/j.biocel.2008.01.019; Chai YC, 2012, ACTA BIOMATER, V8, P3876, DOI 10.1016/j.actbio.2012.07.002; Chiara G, 2012, INT J MOL SCI, V13, P737, DOI 10.3390/ijms13010737; Elangovan S, 2013, J PERIODONTOL, V84, P117, DOI 10.1902/jop.2012.120012; Feuser PE, 2014, MACROMOL SYMP, V343, P65, DOI 10.1002/masy.201300194; Gamal AY, 2013, J PERIODONTOL, V84, P1730, DOI 10.1902/jop.2013.120701; Hadjicharalambous C, 2015, J BIOMED MATER RES A, V103, P3834, DOI 10.1002/jbm.a.35527; Hashimoto M, 2016, J BIOMED MATER RES B, V104, P241, DOI 10.1002/jbm.b.33377; Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004; Jain RK, 2014, J CLIN DIAGN RES, V8, pZC21, DOI [10.7860/JCDR/2014/9535.5047, 10.7860/JCDR/2014/8339.4554]; Kanaya S, 2013, BONE, V56, P398, DOI 10.1016/j.bone.2013.06.031; Kanaya S, 2010, BONE, V47, P564, DOI 10.1016/j.bone.2010.05.042; Leonor IB, 2009, J BIOMED MATER RES B, V91B, P239, DOI 10.1002/jbm.b.31395; Li JH, 2013, BIOMATERIALS, V34, P6738, DOI 10.1016/j.biomaterials.2013.05.046; Liu HW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007330; Liu Y, 2011, J DENT RES, V90, P953, DOI 10.1177/0022034510391799; Lopez-Lopez MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133878; Medina-Castillo AL, 2012, J POLYM SCI POL CHEM, V50, P3944, DOI 10.1002/pola.26203; Medina-Castillo AL, 2010, MACROMOLECULES, V43, P5804, DOI 10.1021/ma100841c; Munchow EA, 2015, DENT MATER, V31, P1038, DOI 10.1016/j.dental.2015.06.004; Munchow EA, 2016, CLIN ORAL INVEST, V20, P1921, DOI 10.1007/s00784-015-1671-5; Nandakumar A, 2010, LANGMUIR, V26, P7380, DOI 10.1021/la904406b; Osorio R, 2014, J DENT RES, V93, P1258, DOI 10.1177/0022034514551608; Osorio R, 2011, J DENT, V39, P148, DOI 10.1016/j.jdent.2010.11.005; Osorio R, 2016, CLIN ORAL INVEST, V20, P2411, DOI 10.1007/s00784-016-1738-y; PAGE RC, 1991, J PERIODONTAL RES, V26, P230, DOI 10.1111/j.1600-0765.1991.tb01649.x; Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003; Quan CY, 2016, J BIOMED MATER RES B, V104, P576, DOI 10.1002/jbm.b.33428; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Riss TL, 2004, ASSAY DRUG DEV TECHN, V2, P51, DOI 10.1089/154065804322966315; Sanz M, 2011, J CLIN PERIODONTOL, V38, P3, DOI 10.1111/j.1600-051X.2010.01681.x; Sariibrahimoglu K, 2015, J BIOMED MATER RES A, V103, P1930, DOI 10.1002/jbm.a.35327; Seker S, 2014, TOXICOL IN VITRO, V28, P1349, DOI 10.1016/j.tiv.2014.06.016; Seol YJ, 2010, J BIOMED MATER RES A, V94A, P649, DOI 10.1002/jbm.a.32738; Shimauchi H, 2013, JPN DENT SCI REV, V49, P118, DOI 10.1016/j.jdsr.2013.05.001; Song J, 2003, J AM CHEM SOC, V125, P1236, DOI 10.1021/ja028559h; Suarez P, 2013, MACROMOL BIOSCI, V13, P1174, DOI 10.1002/mabi.201300141; Sugino A, 2008, J MATER SCI-MATER M, V19, P2269, DOI 10.1007/s10856-007-3327-8; Sundaram MN, 2016, J BIOMED MATER RES B, V104, P761, DOI 10.1002/jbm.b.33480; Suto M, 2013, ARCH ORAL BIOL, V58, P1021, DOI 10.1016/j.archoralbio.2013.02.014; Suzuki O, 2010, ACTA BIOMATER, V6, P3379, DOI 10.1016/j.actbio.2010.04.002; Szivek JA, 2007, J BIOMED MATER RES A, V81A, P939, DOI 10.1002/jbm.a.31116; Tada H, 2010, BIOCHEM BIOPH RES CO, V394, P1093, DOI 10.1016/j.bbrc.2010.03.135; Wilhelmi V, 2012, TOXICOL IN VITRO, V26, P323, DOI 10.1016/j.tiv.2011.12.006; Yamauchi K, 2010, INT J ORAL MAX SURG, V39, P1000, DOI 10.1016/j.ijom.2010.05.008; Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019	53	38	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166217	10.1371/journal.pone.0166217	http://dx.doi.org/10.1371/journal.pone.0166217			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820866	Green Published, Green Submitted, gold			2022-12-27	WOS:000387614800041
J	Annequin, M; Lert, F; Spire, B; Dray-Spira, R				Annequin, Margot; Lert, France; Spire, Bruno; Dray-Spira, Rosemary		ANRS-Vespa2 Study Grp	Increase in Unemployment over the 2000's: Comparison between People Living with HIV and the French General Population	PLOS ONE			English	Article							EMPLOYMENT STATUS; CHRONICALLY ILL; HEALTH-STATUS; FRANCE; INFECTION; CHANCES; DISEASE; ILLNESS; IMPACT; ERA	Background Despite improved health, unemployment has increased among people living with HIV (PlwHIV) over the last decade. However, since the economic recession of 2008, unemployment also increased in the French general population. This paper aimed to determine if the increase in the unemployment rate in the HIV population was higher than that in the French general population. Methods We used data from the ANRS-Vespa study, a repeated cross-sectional survey among two national representative samples of PlwHIV followed at hospitals in France in 2003 and 2011. We compared employment and unemployment rates between HIV-infected people (overall and according to period of HIV diagnosis) and the French general population in 2003 and 2011, using multivariate Poisson regressions adjusted for individual sociodemographic characteristics. Results The employment rate among PlwHIV was consistently lower than that in the general population in 2003 and 2011. In contrast, there was a trend of an increasing unemployment rate difference between PlwHIV and the general population: PlwHIV's unemployment rate was 1.48 (95% confidence interval [CI]: 1.16-1.90) times higher than that of the general population in 2003, versus 1.62 (95% CI: 1.34-1.96) times higher in 2011. This unemployment rate difference was the highest for PlwHIV diagnosed in or after 2008 (adjusted prevalence rate ratio: 2.06; 95% CI: 1.59-2.67). Conclusions These results suggest that in time of economic recession, an increasing proportion of PlwHIV may be excluded from the labor market although they are willing to re-enter it. This constitutes a major issue relative to social consequences of chronic disease.	[Annequin, Margot; Dray-Spira, Rosemary] UPMC Univ Paris 06, Sorbonne Univ, INSERM,Dept Social Epidemiol, Inst Pierre Louis Epidemiol & Sante Publ IPLES UM, F-75012 Paris, France; [Lert, France] Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Villejuif, France; [Spire, Bruno] INSERM, UMR912, Econ & Social Sci Appl Hlth & Anal Med Informat S, Marseille, France; [Spire, Bruno] Aix Marseille Univ, UMR S912, IRD, Marseille, France; [Spire, Bruno] Southeastern Hlth Reg Observ, ORS PACA, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Annequin, M (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, INSERM,Dept Social Epidemiol, Inst Pierre Louis Epidemiol & Sante Publ IPLES UM, F-75012 Paris, France.; Annequin, M (corresponding author), INSERM, U1136, 27 Rue Chaligny, F-75571 Paris 12, France.	margot.annequin@inserm.fr	Spire, Bruno/F-5546-2013	Spire, Bruno/0000-0002-3546-8020; Dray-Spira, Rosemary/0000-0001-7646-3667; Carrieri, Patrizia/0000-0002-6794-4837	ANRS (Agence Nationale de Recherches sur le SIDA et les Hepatites Virales); EHESP (Ecole des Hautes Etudes en Sante Publique [School of Public Health]), Rennes	ANRS (Agence Nationale de Recherches sur le SIDA et les Hepatites Virales)(ANRSFrench National Research Agency (ANR)); EHESP (Ecole des Hautes Etudes en Sante Publique [School of Public Health]), Rennes	The ANRS-Vespal and ANRS-Vespa2 surveys were sponsored and funded by the ANRS (Agence Nationale de Recherches sur le SIDA et les Hepatites Virales). Margot Annequin is the recipient of a PhD grant from the EHESP (Ecole des Hautes Etudes en Sante Publique [School of Public Health]), Rennes.	Annequin M, 2015, AIDS, V29, P1537, DOI 10.1097/QAD.0000000000000722; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bartley M, 2004, J EPIDEMIOL COMMUN H, V58, P501, DOI 10.1136/jech.2003.009878; BARTLEY M, 1994, J EPIDEMIOL COMMUN H, V48, P333, DOI 10.1136/jech.48.4.333; Berkman LF, 2014, INT J EPIDEMIOL, V43, P1517, DOI 10.1093/ije/dyu110; Burstrom B, 2000, INT J HEALTH SERV, V30, P435, DOI 10.2190/6PP1-TDEQ-H44D-4LJQ; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Castagnone E, 2013, 26 MAFE, V26, P43; de Boer AGEM, 2009, JAMA-J AM MED ASSOC, V301, P753, DOI 10.1001/jama.2009.187; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Del Amo J, 2011, EUR J PUBLIC HEALTH, V21, P620, DOI 10.1093/eurpub/ckq150; Dray-Spira R, 2008, OCCUP ENVIRON MED, V65, P112, DOI 10.1136/oem.2007.034363; Dray-Spira R, 2006, EUR J PUBLIC HEALTH, V16, P89, DOI 10.1093/eurpub/cki153; Dray-Spira R, 2003, AIDS CARE, V15, P739, DOI 10.1080/09540120310001618595; Dray-Spira R, 2007, AM J PUBLIC HEALTH, V97, P552, DOI 10.2105/AJPH.2005.081083; Dray-Spira R, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000255082.31728.52; Dray-Spira R, 2012, AIDS, V26, P207, DOI 10.1097/QAD.0b013e32834dcf61; Duguet E, 2014, REV ECON POLIT, V124, P437, DOI 10.3917/redp.243.0437; Evans-Lacko S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069792; Goldman DP, 2004, HEALTH SERV RES, V39, P1691, DOI 10.1111/j.1475-6773.2004.00313.x; Gross M, 2016, INT J PUBLIC HEALTH, V61, P593, DOI 10.1007/s00038-015-0750-3; Hamers FF, 2004, LANCET, V364, P83, DOI 10.1016/S0140-6736(04)16594-X; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Heggebo K, 2015, SOC SCI MED, V130, P115, DOI 10.1016/j.socscimed.2015.02.010; Holland P, 2011, INT J HEALTH SERV, V41, P395, DOI 10.2190/HS.41.3.a; INSEE, 2011, EMPL CONT VERS FPR 2; INSEE, 2016, CONT LAB FORC SURV 2; Kaye HS, 2010, MON LABOR REV, V133, P19; Le Barbanchon T, 2013, 142 ILO, V142, P45; Legarth R, 2014, AIDS, V28, P1489, DOI 10.1097/QAD.0000000000000257; Marsicano E, 2014, AIDS CARE, V26, pS97, DOI 10.1080/09540121.2014.907385; Minton JW, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2316; Morlat P., 2013, MED CARE PEOPLE LIVI; Morlat P, 2014, AIDS, V28, P1181, DOI 10.1097/QAD.0000000000000222; Nadal J-M, 1997, B EPIDEMIOL HEBD, V23, P107; Peretti-Watel P, 2005, POPULATION, V60, P525, DOI 10.2307/4150781; Rabkin JG, 2004, PSYCHOSOM MED, V66, P72, DOI 10.1097/01.PSY.0000108083.43147.6D; Rijken M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-803; Roelfs DJ, 2011, SOC SCI MED, V72, P840, DOI 10.1016/j.socscimed.2011.01.005; Schuring M, 2013, SCAND J WORK ENV HEA, V39, P134, DOI 10.5271/sjweh.3321; Tron L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107451; van der Wel KA, 2011, SOC SCI MED, V73, P1608, DOI 10.1016/j.socscimed.2011.09.012; Velche D, 2009, THEMATIC REPORT IMPL; Virtanen P, 2013, PUBLIC HEALTH, V127, P46, DOI 10.1016/j.puhe.2012.10.016	44	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165634	10.1371/journal.pone.0165634	http://dx.doi.org/10.1371/journal.pone.0165634			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8TH	27814374	Green Published, Green Submitted, gold			2022-12-27	WOS:000386911100012
J	Lazarus, R; Kelly, S; Snape, MD; Vandermeulen, C; Voysey, M; Hoppenbrouwers, K; Hens, A; Van Damme, P; Pepin, S; Leroux-Roels, I; Leroux-Roels, G; Pollard, AJ				Lazarus, Rajeka; Kelly, Sarah; Snape, Matthew D.; Vandermeulen, Corinne; Voysey, Merryn; Hoppenbrouwers, Karel; Hens, Annick; Van Damme, Pierre; Pepin, Stephanie; Leroux-Roels, Isabel; Leroux-Roels, Geert; Pollard, Andrew J.			Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly Adults	PLOS ONE			English	Article							RANDOMIZED-TRIAL; IMMUNOGENICITY; SAFETY; IMMUNITY	Avian influenza continues to circulate and remains a global health threat not least because of the associated high mortality. In this study antibody persistence, booster vaccine response and cross-clade immune response between two influenza A(H5N1) vaccines were compared. Participants aged over 18-years who had previously been immunized with a clade 1, A/Vietnam vaccine were re-immunized at 6-months with 7.5 mu g of the homologous strain or at 22-months with a clade 2, alum-adjuvanted, A/Indonesia vaccine. Blood sampled at 6, 15 and 22-months after the primary course was used to assess antibody persistence. Antibody concentrations 6-months after primary immunisation with either A/Vietnam vaccine 30 mu g alum-adjuvanted vaccine or 7.5 mu g dose vaccine were lower than 21days after the primary course and waned further with time. Re-immunization with the clade 2, 30 mu g alum-adjuvanted vaccine confirmed cross-clade reactogenicity. Antibody crossreactivity between A(H5N1) clades suggests that in principle a prime-boost vaccination strategy may provide both early protection at the start of a pandemic and improved antibody responses to specific vaccination once available.	[Lazarus, Rajeka; Kelly, Sarah; Snape, Matthew D.; Pollard, Andrew J.] Univ Oxford, Oxford Vaccine Grp, Dept Paediat, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Lazarus, Rajeka; Kelly, Sarah; Snape, Matthew D.; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Vandermeulen, Corinne; Hoppenbrouwers, Karel] Leuven Univ, Ctr Environm & Hlth, Leuven, Belgium; [Vandermeulen, Corinne] Leuven Univ, Vaccinol Ctr, Leuven, Belgium; [Voysey, Merryn] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Hens, Annick; Van Damme, Pierre] Univ Antwerp, Ctr Evaluat Vaccinat, Vaccine & Infect Dis Inst, Antwerp, Belgium; [Pepin, Stephanie] Sanofi Pasteur, Marcy Letoile, France; [Leroux-Roels, Isabel; Leroux-Roels, Geert] Univ Ghent, Ctr Vaccinol, Ghent, Belgium; [Leroux-Roels, Isabel; Leroux-Roels, Geert] Ghent Univ Hosp, Ghent, Belgium	University of Oxford; University of Oxford; KU Leuven; KU Leuven; University of Oxford; University of Antwerp; Ghent University; Ghent University; Ghent University Hospital	Lazarus, R (corresponding author), Univ Oxford, Oxford Vaccine Grp, Dept Paediat, Ctr Clin Vaccinol & Trop Med, Oxford, England.; Lazarus, R (corresponding author), NIHR Oxford Biomed Res Ctr, Oxford, England.	rajeka@doctors.org.uk	Vandermeulen, Corinne/GZM-2495-2022; Vandermeulen, Corinne/AAK-8690-2020	Vandermeulen, Corinne/0000-0002-1954-7554; Snape, Matthew/0000-0003-0531-5426; Voysey, Merryn/0000-0001-6324-6559; van damme, pierre/0000-0002-8642-1249				Banzhoff A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004384; Brady RC, 2009, VACCINE, V27, P5091, DOI 10.1016/j.vaccine.2009.06.057; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Committee for Human Medicinal Products, 2007, GUID INFL VACC PREP; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Gillard P, 2013, INFLUENZA OTHER RESP, V7, P55, DOI 10.1111/j.1750-2659.2012.00349.x; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; Heijmans S, 2011, J INFECT DIS, V203, P1054, DOI 10.1093/infdis/jiq174; Jennings LC, 2008, LANCET INFECT DIS, V8, P650, DOI 10.1016/S1473-3099(08)70232-9; Khurana S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095496; Langley JM, 2015, VACCINE, V33, P559, DOI 10.1016/j.vaccine.2014.11.018; Langley JM, 2011, J INFECT DIS, V203, P1729, DOI 10.1093/infdis/jir172; Leroux-Roels I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001665; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Leroux-Roels I, 2010, VACCINE, V28, P849, DOI 10.1016/j.vaccine.2009.10.017; Leroux-Roels I, 2009, VACCINE, V27, P6918, DOI 10.1016/j.vaccine.2009.08.110; Levie K, 2008, J INFECT DIS, V198, P642, DOI 10.1086/590913; Lin JT, 2009, J INFECT DIS, V199, P184, DOI 10.1086/595832; Nicholson KG, 2011, LANCET INFECT DIS, V11, P91, DOI 10.1016/S1473-3099(10)70296-6; Qi X, 2013, BMJ-BRIT MED J, V347, P4752, DOI DOI 10.1136/BMJ.F4752; Risi G, 2011, VACCINE, V29, P6408, DOI 10.1016/j.vaccine.2011.04.072; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; Wu J, 2009, CLIN INFECT DIS, V48, P1087, DOI 10.1086/597401	24	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165384	10.1371/journal.pone.0165384	http://dx.doi.org/10.1371/journal.pone.0165384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814377	Green Published, Green Submitted, gold			2022-12-27	WOS:000386911100010
J	Pohjoismaki, JLO; Kahanpaa, J; Mutanen, M				Pohjoismaki, Jaakko L. O.; Kahanpaa, Jere; Mutanen, Marko			DNA Barcodes for the Northern European Tachinid Flies (Diptera: Tachinidae)	PLOS ONE			English	Article							OSTRINIA-NUBILALIS; EVOLUTION; COMMUNITY; GENUS; CLASSIFICATION; LEPIDOPTERA; PARASITOIDS; DIVERSITY; ECOLOGY; BIOLOGY	This data release provides COI barcodes for 366 species of parasitic flies (Diptera: Tachinidae), enabling the DNA based identification of the majority of northern European species and a large proportion of Palearctic genera, regardless of the developmental stage. The data will provide a tool for taxonomists and ecologists studying this ecologically important but challenging parasitoid family. A comparison of minimum distances between the nearest neighbors revealed the mean divergence of 5.52% that is approximately the same as observed earlier with comparable sampling in Lepidoptera, but clearly less than in Coleoptera. Full barcode-sharing was observed between 13 species pairs or triplets, equaling to 7.36% of all species. Delimitation based on Barcode Index Number (BIN) system was compared with traditional classification of species and interesting cases of possible species oversplits and cryptic diversity are discussed. Overall, DNA barcodes are effective in separating tachinid species and provide novel insight into the taxonomy of several genera.	[Pohjoismaki, Jaakko L. O.] Univ Eastern Finland, Dept Environm & Biol Sci, POB 111, Joensuu 80101, Finland; [Kahanpaa, Jere] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland; [Mutanen, Marko] Univ Oulu, Dept Genet & Physiol, POB 3000, Oulu 90014, Finland	University of Eastern Finland; University of Helsinki; University of Oulu	Pohjoismaki, JLO (corresponding author), Univ Eastern Finland, Dept Environm & Biol Sci, POB 111, Joensuu 80101, Finland.	Jaakko.Pohjoismaki@uef.fi	Pohjoismaeki, Jaakko L. O./AAC-7995-2019	Pohjoismaeki, Jaakko L. O./0000-0002-1185-3610; Kahanpaa, Jere/0000-0003-1485-5272	Koneen Saatio [2011/12]; Suomen Kulttuurirahasto [27/02/2013]; Suomen Akatemia [277984]; Government of Canada through Genome Canada; Ontario Genomics Institute	Koneen Saatio; Suomen Kulttuurirahasto; Suomen Akatemia; Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute	This work was supported by Koneen Saatio (Grant Number 2011/12), Suomen Kulttuurirahasto (Grant Number 27/02/2013), Suomen Akatemia (Grant Number 277984). In addition, the Barcode of Life Project, funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute contributed to the sequencing costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen Stig, 1996, Fauna Entomologica Scandinavica, V33, P1; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cerretti P, 2012, ZOOKEYS, P5, DOI 10.3897/zookeys.205.3409; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; de Jong Yde, 2014, Biodivers Data J, pe4034, DOI 10.3897/BDJ.2.e4034; DeWaard Jeremy R., 2008, V410, P275; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; GODWIN PA, 1984, ENVIRON ENTOMOL, V13, P1059, DOI 10.1093/ee/13.4.1059; Hara J.E., 2004, MEMOIRS ENTOMOLOGY I, V18; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herting B, 1993, CATALOGUE PALAEARCTI, p[118, 624]; Inclan DJ, 2014, LANDSCAPE ECOL, V29, P879, DOI 10.1007/s10980-014-0024-0; Kress WJ, 2015, TRENDS ECOL EVOL, V30, P25, DOI 10.1016/j.tree.2014.10.008; Lutovinovas E, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.13901; Maczey N, 2016, BIOCONTROL SCI TECHN, V26, P447, DOI 10.1080/09583157.2015.1123675; Mesnil LP, 1975, LARVAEVORINAE LARVAV; Mesnil LP, 1944, LARVAEVORINAE SALMAC; Mesnil LP, 1956, LARVAEVORINAE PHOROC; Mitterboeck TF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1128; Mutanen M, 2016, SYST BIOL, V65, P1024, DOI 10.1093/sysbio/syw044; O'Hara JE, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.316.5132; Pentinsaari M, 2016, UTILITY DNA BARCODES; Pentinsaari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108651; Peris D, 2016, GEOSCIENCE IN PRESS; Pohjoismaki J, 2015, ZOOTAXA, V4059, P581, DOI 10.11646/zootaxa.4059.3.9; Pohjoismaki J, 2014, ZOOKEYS, P383, DOI 10.3897/zookeys.441.7252; QUEDNAU FW, 1993, CAN ENTOMOL, V125, P749, DOI 10.4039/Ent125749-4; Rahal Y, 1995, ENTOMOPHAGA, V40, P329, DOI 10.1007/BF02373720; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; SANDLAN KP, 1983, ENVIRON ENTOMOL, V12, P174, DOI 10.1093/ee/12.1.174; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Stireman JO, 2006, P ROY SOC B-BIOL SCI, V273, P523, DOI 10.1098/rspb.2005.3363; Stireman JO, 2006, ANNU REV ENTOMOL, V51, P525, DOI 10.1146/annurev.ento.51.110104.151133; Stireman JO, 2008, ANN ENTOMOL SOC AM, V101, P362, DOI 10.1603/0013-8746(2008)101[362:ADOATP]2.0.CO;2; Stireman JO, 2016, CURR OPIN INSECT SCI, V14, P87, DOI 10.1016/j.cois.2016.02.002; Tachi T, 2013, MOL PHYLOGENET EVOL, V66, P401, DOI 10.1016/j.ympev.2012.10.017; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tschorsnig Hans-Peter, 1994, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V506, P1; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Winkler IS, 2015, MOL PHYLOGENET EVOL, V88, P38, DOI 10.1016/j.ympev.2015.03.021; Wirta H, 2015, MOL ECOL RESOUR; Wirta HK, 2015, ECOL EVOL, V5, P3842, DOI 10.1002/ece3.1647; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	45	14	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0164933	10.1371/journal.pone.0164933	http://dx.doi.org/10.1371/journal.pone.0164933			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814365	Green Published, Green Submitted, gold			2022-12-27	WOS:000386911100005
J	Deliens, T; Deforche, B; Annemans, L; De Bourdeaudhuij, I; Clarys, P				Deliens, Tom; Deforche, Benedicte; Annemans, Lieven; De Bourdeaudhuij, Ilse; Clarys, Peter			Effectiveness of Pricing Strategies on French Fries and Fruit Purchases among University Students: Results from an On-Campus Restaurant Experiment	PLOS ONE			English	Article							COLLEGE-STUDENTS; FOOD CHOICES; WEIGHT-GAIN; DETERMINANTS; CONSUMPTION; EDUCATION; FRESHMAN; BEHAVIORS; SUBSIDIES; PATTERNS	Objectives This study examined the effect of a 10 and 20% meal price increase when choosing French fries and a 10 and 20% meal price reduction when choosing fruit for dessert on university students' purchasing behaviour in an on-campus restaurant. The moderating effect of gender was also investigated. Secondly, this study aimed at gaining further insight into reasons why these price manipulations did or did not change students' purchasing behaviour. Materials and Methods This two-phased mixed-methods study was conducted in a Belgian on-campus university restaurant with approximately 1200 to 1300 student visitors per day. In a first phase (French fries experiment), data were collected during a control week (no price manipulation) and two separate intervention weeks (10 and 20% meal price increase when students chose French fries). In a second phase (fruit experiment), following the same protocol but carried out a few weeks later, meal prices were reduced by 10 and 20% when students chose fruit for dessert. French fries and fruit sale counts relative to the total number of items sold were used as outcome measure. Short interviews were conducted in convenient subsamples of student customers to assess influences on food choice. Key findings Increasing the meal price by 10 and 20% when choosing French fries was associated with respective 10.9 and 21.8% absolute reductions in French fries purchases, while reducing the meal price by 10 and 20% when choosing fruit for dessert was associated with absolute increases in fruit purchases of respectively 25.1 and 42.4% (all p<0.001). No moderating effect of gender was detected. Besides price, food/taste preference, eating habits, health, availability and accessibility, and body satisfaction influenced students' food choices, with taste being the most frequently mentioned factor. Significance Pricing may be a promising strategy to improve university students' eating behaviour. The likelihood of intervention success may increase when combining pricing strategies with offering healthy, tasty and meal matching starchy alternatives to French fries and offering a variety of fresh and appealing fruits.	[Deliens, Tom; Deforche, Benedicte; Clarys, Peter] Vrije Univ Brussel, Dept Movement & Sport Sci, Brussels, Belgium; [Deforche, Benedicte; Annemans, Lieven] Univ Ghent, Dept Publ Hlth, Ghent, Belgium; [De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium	Vrije Universiteit Brussel; Ghent University; Ghent University	Deliens, T (corresponding author), Vrije Univ Brussel, Dept Movement & Sport Sci, Brussels, Belgium.	Tom.Deliens@vub.ac.be	De+Bourdeaudhuij, Ilse/AAC-5528-2019	De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Deliens, Tom/0000-0002-8165-4617				An RP, 2013, PUBLIC HEALTH NUTR, V16, P1215, DOI 10.1017/S1368980012004715; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Block JP, 2010, AM J PUBLIC HEALTH, V100, P1427, DOI 10.2105/AJPH.2009.175687; Crombie AP, 2009, NUTR REV, V67, P83, DOI 10.1111/j.1753-4887.2008.00143.x; Deforche B, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0173-9; Deliens T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-53; Deliens T, 2013, APPETITE, V65, P111, DOI 10.1016/j.appet.2013.01.024; Epstein LH, 2012, AM J CLIN NUTR, V95, P789, DOI 10.3945/ajcn.111.024380; Epstein LH, 2010, PSYCHOL SCI, V21, P406, DOI 10.1177/0956797610361446; Giesen JCAH, 2011, AM J CLIN NUTR, V93, P689, DOI 10.3945/ajcn.110.008193; Greaney ML, 2009, J NUTR EDUC BEHAV, V41, P281, DOI 10.1016/j.jneb.2008.04.354; Cardenas MK, 2015, PUBLIC HEALTH NUTR, V18, P2742, DOI 10.1017/S1368980014002730; LaCaille LJ, 2011, J AM COLL HEALTH, V59, P531, DOI 10.1080/07448481.2010.523855; Lachat CK, 2009, BRIT J NUTR, V102, P1030, DOI 10.1017/S000711450930389X; Michels KB, 2008, J AM COLL NUTR, V27, P6, DOI 10.1080/07315724.2008.10719669; Nederkoorn C, 2011, APPETITE, V56, P760, DOI 10.1016/j.appet.2011.03.002; Nelson MC, 2009, J NUTR EDUC BEHAV, V41, P287, DOI 10.1016/j.jneb.2008.05.005; Niebylski ML, 2015, NUTRITION, V31, P787, DOI 10.1016/j.nut.2014.12.010; Racette SB, 2005, J AM COLL HEALTH, V53, P245, DOI 10.3200/JACH.53.6.245-251; Silverman D., 2004, QUALITATIVE RES THEO, V2; Steenhuis IHM, 2011, PUBLIC HEALTH NUTR, V14, P2220, DOI 10.1017/S1368980011001637; Stok FM, 2015, PUBLIC HEALTH NUTR, V18, P1044, DOI 10.1017/S1368980014001268; Vella-Zarb RA, 2009, J AM COLL HEALTH, V58, P161, DOI 10.1080/07448480903221392; Waterlander WE, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-59; Waterlander WE, 2013, AM J CLIN NUTR, V97, P886, DOI 10.3945/ajcn.112.041632; Waterlander WE, 2014, APPETITE, V78, P32, DOI 10.1016/j.appet.2014.03.012	26	19	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165298	10.1371/journal.pone.0165298	http://dx.doi.org/10.1371/journal.pone.0165298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812123	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000026
J	Jaruthamsophon, K; Sriplung, H; Charalsawadi, C; Limprasert, P				Jaruthamsophon, Kanoot; Sriplung, Hutcha; Charalsawadi, Chariyawan; Limprasert, Pornprot			Maternal Age-Specific Rates for Trisomy 21 and Common Autosomal Trisomies in Fetuses from a Single Diagnostic Center in Thailand	PLOS ONE			English	Article							LIVE BIRTH PREVALENCE; DOWN-SYNDROME RISK; ABNORMALITIES; AMNIOCENTESIS; ASCERTAINMENT; GESTATION; OLDER	To provide maternal age-specific rates for trisomy 21 (T21) and common autosomal trisomies (including trisomies 21, 18 and 13) in fetuses. We retrospectively reviewed prenatal cytogenetic results obtained between 1990 and 2009 in Songklanagarind Hospital, a university teaching hospital, in southern Thailand. Maternal age-specific rates of T21 and common autosomal trisomies were established using different regression models, from which only the fittest models were used for the study. A total of 17,819 records were included in the statistical analysis. The fittest models for predicting rates of T21 and common autosomal trisomies were regression models with 2 parameters (Age and Age 2). The rate of T21 ranged between 2.67 per 1,000 fetuses at the age of 34 and 71.06 per 1,000 at the age of 48. The rate of common autosomal trisomies ranged between 4.54 per 1,000 and 99.65 per 1,000 at the same ages. This report provides the first maternal age-specific rates for T21 and common autosomal trisomies fetuses in a Southeast Asian population and the largest case number of fetuses have ever been reported in Asians.	[Jaruthamsophon, Kanoot; Charalsawadi, Chariyawan; Limprasert, Pornprot] Prince Songkla Univ, Dept Pathol, Human Genet Unit, Fac Med, Hat Yai, Songkhla, Thailand; [Sriplung, Hutcha] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songkhla, Thailand	Prince of Songkla University; Prince of Songkla University	Limprasert, P (corresponding author), Prince Songkla Univ, Dept Pathol, Human Genet Unit, Fac Med, Hat Yai, Songkhla, Thailand.	Lpornpro@medicine.psu.ac.th	Limprasert, Pornprot/L-1820-2013; Limprasert, Pornprot/N-5236-2019	Limprasert, Pornprot/0000-0001-5022-5361; Limprasert, Pornprot/0000-0001-5022-5361; Jaruthamsophon, Kanoot/0000-0003-1563-0024; Charalsawadi, Chariyawan/0000-0002-3841-3818				Barch MJ, 1997, AGT CYTOGENETICS LAB; Bray I, 1998, PRENATAL DIAG, V18, P9, DOI 10.1002/(SICI)1097-0223(199801)18:1<9::AID-PD210>3.3.CO;2-6; FERGUSONSMITH MA, 1984, PRENATAL DIAG, V4, P5, DOI 10.1002/pd.1970040704; Hecht CA, 1996, AM J MED GENET, V62, P376, DOI 10.1002/(SICI)1096-8628(19960424)62:4<376::AID-AJMG10>3.0.CO;2-L; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; Huether CA, 1998, J MED GENET, V35, P482, DOI 10.1136/jmg.35.6.482; Kim Young Joo, 2013, Obstet Gynecol Sci, V56, P160, DOI 10.5468/ogs.2013.56.3.160; Leoncini E, 2010, AM J MED GENET A, V152A, P1670, DOI 10.1002/ajmg.a.33493; Metneki J, 2005, EUR J EPIDEMIOL, V20, P525, DOI 10.1007/s10654-005-4261-z; Morris JK, 2005, PRENATAL DIAG, V25, P275, DOI 10.1002/pd.1059; Morris JK, 2002, J MED SCREEN, V9, P2, DOI 10.1136/jms.9.1.2; Park IY, 2010, FETAL DIAGN THER, V27, P214, DOI 10.1159/000309136; Pighin S, 2015, PRENATAL DIAG, V35, P777, DOI 10.1002/pd.4606; Savva GM, 2010, PRENATAL DIAG, V30, P57, DOI 10.1002/pd.2403; Sheu BC, 1998, PRENATAL DIAG, V18, P675; Snijders RJM, 1999, ULTRASOUND OBST GYN, V13, P167, DOI 10.1046/j.1469-0705.1999.13030167.x; Yaegashi N, 1998, J HUM GENET, V43, P85, DOI 10.1007/s100380050046	17	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165859	10.1371/journal.pone.0165859	http://dx.doi.org/10.1371/journal.pone.0165859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812158	Green Submitted, gold, Green Published			2022-12-27	WOS:000386910000072
J	Karathanasis, N; Tsamardinos, I; Lagani, V				Karathanasis, Nestoras; Tsamardinos, Ioannis; Lagani, Vincenzo			omicsNPC: Applying the Non-Parametric Combination Methodology to the Integrative Analysis of Heterogeneous Omics Data	PLOS ONE			English	Article							DNA METHYLATION; DIFFERENTIAL EXPRESSION; GLUCOSE-METABOLISM; SCHIZOPHRENIA; INFLAMMATION; GENES; GLIOBLASTOMA; METAANALYSIS; VALIDATION; POWERFUL	Background The advance of omics technologies has made possible to measure several data modalities on a system of interest. In this work, we illustrate how the Non-Parametric Combination methodology, namely NPC, can be used for simultaneously assessing the association of different molecular quantities with an outcome of interest. We argue that NPC methods have several potential applications in integrating heterogeneous omics technologies, as for example identifying genes whose methylation and transcriptional levels are jointly deregulated, or finding proteins whose abundance shows the same trends of the expression of their encoding genes. Results We implemented the NPC methodology within "omicsNPC", an R function specifically tailored for the characteristics of omics data. We compare omicsNPC against a range of alternative methods on simulated as well as on real data. Comparisons on simulated data point out that omicsNPC produces unbiased / calibrated p-values and performs equally or significantly better than the other methods included in the study; furthermore, the analysis of real data show that omicsNPC (a) exhibits higher statistical power than other methods, (b) it is easily applicable in a number of different scenarios, and (c) its results have improved biological interpretability. Conclusions The omicsNPC function competitively behaves in all comparisons conducted in this study. Taking into account that the method (i) requires minimal assumptions, (ii) it can be used on different studies designs and (iii) it captures the dependences among heterogeneous data modalities, omicsNPC provides a flexible and statistically powerful solution for the integrative analysis of different omics data.	[Karathanasis, Nestoras] Fdn Res & Technol Hellas, Inst Comp Sci, Iraklion, Greece; [Tsamardinos, Ioannis; Lagani, Vincenzo] Univ Crete, Dept Comp Sci, Iraklion, Greece	Foundation for Research & Technology - Hellas (FORTH); University of Crete	Lagani, V (corresponding author), Univ Crete, Dept Comp Sci, Iraklion, Greece.	vlagani@csd.uoc.gr	Lagani, Vincenzo/H-2820-2019	Lagani, Vincenzo/0000-0002-6552-6076	STATegra EU FP7 project [306000]; EPILOGEAS GSRT ARISTEIA II project [3446]; European Research Council (ERC) project CAUSALPATH-Next Generation Causal Analysis [617393]	STATegra EU FP7 project; EPILOGEAS GSRT ARISTEIA II project; European Research Council (ERC) project CAUSALPATH-Next Generation Causal Analysis(European Research Council (ERC))	NK and VL were partially funded by the STATegra EU FP7 project, No 306000. IT was partially funded by the EPILOGEAS GSRT ARISTEIA II project, No 3446. IT and VL were also partially funded by the European Research Council (ERC) project CAUSALPATH-Next Generation Causal Analysis, No 617393.	Aberg KA, 2013, JAMA PSYCHIAT, V70, P573, DOI 10.1001/jamapsychiatry.2013.288; Alashwal H, 2012, NEUROTOXICOLOGY, V33, P1450, DOI 10.1016/j.neuro.2012.06.008; Annibali D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5632; Battke F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016345; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2008, BIOMETRICS, V64, P1215, DOI 10.1111/j.1541-0420.2007.00984.x; Bin Cho K, 2010, CANCER LETT, V293, P230, DOI 10.1016/j.canlet.2010.01.013; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bonadona V, 2011, JAMA-J AM MED ASSOC, V305, P2304, DOI 10.1001/jama.2011.743; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brombin C, 2015, J NONPARAMETR STAT, V27, P460, DOI 10.1080/10485252.2015.1071811; Brombin C, 2013, STAT METHODS MED RES, V22, P643, DOI 10.1177/0962280211403659; Brown SB, 2015, STEROIDS, V99, P8, DOI 10.1016/j.steroids.2014.12.013; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; DAI H., 2012, J BIOM BIOSTAT, P3, DOI DOI 10.4172/2155-6180.1000E117; Dai HY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00032; de Jong S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039498; Debnath M, 2014, SCHIZOPHRENIA BULL, V40, P1412, DOI 10.1093/schbul/sbu049; Degu A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0188-4; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Garcia-Alcalde F, 2011, BIOINFORMATICS, V27, P137, DOI 10.1093/bioinformatics/btq594; Hanson DR, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-7; Harrison PJ, 2015, J PSYCHOPHARMACOL, V29, P85, DOI 10.1177/0269881114553647; Heskes T, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0367-1; Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Huang KC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S5-S10; Hunt JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010674; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kar SP, 2016, CANCER DISCOV, V6, P1052, DOI 10.1158/2159-8290.CD-15-1227; Kirkpatrick B, 2013, SCHIZOPHRENIA BULL, V39, P1174, DOI 10.1093/schbul/sbt141; Kost JT, 2002, STAT PROBABIL LETT, V60, P183, DOI 10.1016/S0167-7152(02)00310-3; Lagani V, 2016, BIOMED CENTRAL, V17, pS194, DOI [10.1186/s12859-016-1038-1, DOI 10.1186/S12859-016-1038-1]; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leek JT, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1673; Leek JT, 2015, DKS DOUBLE KOLMOGORO; Manu P, 2014, WORLD PSYCHIATRY, V13, P189, DOI 10.1002/wps.20117; May D, 2008, P NATL ACAD SCI USA, V105, P282, DOI 10.1073/pnas.0707778105; Mayr M, 2009, J MOL CELL CARDIOL, V46, P268, DOI 10.1016/j.yjmcc.2008.10.008; MCCLISH DK, 1989, MED DECIS MAKING, V9, P190, DOI 10.1177/0272989X8900900307; McGuffin P, 2013, AM J PSYCHIAT, V170, P821, DOI 10.1176/appi.ajp.2013.13030336; Monari P, 2009, STAT METHODS EVALUAT; Muller N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00372; Nguyen SA, 2014, CLIN CANCER RES, V20, P4894, DOI 10.1158/1078-0432.CCR-13-1856; Nilsson E, 2014, DIABETES, V63, P2962, DOI 10.2337/db13-1459; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Park SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08502; Pawitan Y, 2016, OCPLUS OPERATING CHA, V1460; Pesarin F., 2010, PERMUTATION TESTS CO; Pesarin F., 1992, STAT METHOD APPL-GER, V1, P87, DOI [10.1007/BF02589052, DOI 10.1007/BF02589052]; Phipson B, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1585; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Renner M, 2013, BIOMED CENTRAL, V14, pr137, DOI [10.1186/gb-2013-14-12-r137, DOI 10.1186/GB-2013-14-12-R137]; Rhodes DR, 2002, CANCER RES, V62, P4427; Salmaso L, 2005, METRIKA, V62, P331, DOI 10.1007/s00184-005-0416-x; Schwender H, SCRIME ANAL HIGH DIM, V133; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soneson C, 2014, BIOINFORMATICS, V30, P2517, DOI 10.1093/bioinformatics/btu324; STATegra Consortia, 2014, STATEGRA CLASS METH; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Wang G, 2015, ARCH BIOCHEM BIOPHYS, V580, P84, DOI 10.1016/j.abb.2015.07.005; Winkler AM, 2016, HUM BRAIN MAPP, V37, P1486, DOI 10.1002/hbm.23115; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	71	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165545	10.1371/journal.pone.0165545	http://dx.doi.org/10.1371/journal.pone.0165545			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812137	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000034
J	Kessel, KA; Lettner, S; Kessel, C; Bier, H; Biedermann, T; Friess, H; Herrschbach, P; Gschwend, JE; Meyer, B; Peschel, C; Schmid, R; Schwaiger, M; Wolff, KD; Combs, SE				Kessel, Kerstin A.; Lettner, Sabrina; Kessel, Carmen; Bier, Henning; Biedermann, Tilo; Friess, Helmut; Herrschbach, Peter; Gschwend, Juergen E.; Meyer, Bernhard; Peschel, Christian; Schmid, Roland; Schwaiger, Markus; Wolff, Klaus-Dietrich; Combs, Stephanie E.			Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients' Attitude towards CAM in a University-Based Oncology Center in Germany	PLOS ONE			English	Article							COMPREHENSIVE CANCER CENTER; RADIATION-THERAPY; DIETARY ANTIOXIDANTS; INCREASE SURVIVAL; CHEMOTHERAPY; ACUPUNCTURE; RADIOTHERAPY; AUSTRALIA; NUTRIENTS; WOMEN	Introduction To understand if and which patients would be open-minded to Complementary and Alternative Medicine (CAM) use parallel to their oncological treatment. Moreover, we sought to determine which methods are most accepted and which are the primary motivators to use CAM. Methods We developed and anonymously conducted a questionnaire for patients in the oncology center (TU Munich). Questions focus on different CAM methods, previous experiences, and willingness to apply or use CAM when offered in a university-based setting. Results A total of 171 of 376 patients (37.4% women, 62.0% men, 0.6% unknown) participated. This corresponds to a return rate of 45%. Median age was 64 years (17-87 years). Of all participants, 15.2% used CAM during their oncological therapy; 32.7% have used it in the past. The majority (81.9%) was not using CAM during therapy; 55.5% have not used CAM in the past respectively. The analysis revealed a significant correlation between education and CAM use during therapy (r = 0.18; p = 0.02), and CAM use in the past (r = 0.17; p = 0.04). Of all patients using CAM during therapy, favored methods were food supplements (42.3%), vitamins/minerals (42.3%), massage (34.6%). Motivations are especially the reduction of side effect and stress, the positive effect of certain CAM-treatments on the immune system and tumor therapy. Results showed no difference between women and men. Most patients not having had any experience with CAM complain about the deficiency of information by their treating oncologist (31.4%) as well as missing treatment possibilities (54.3%). Conclusion Since many patients believe in study results demonstrating the efficacy of CAM, it stresses our task to develop innovative study protocols to investigate the outcomes of certain CAM on symptom reduction or other endpoints. Thus, prospective trials and innovative evidence-based treatment concepts to include CAM into high-end oncology is what patients demand and what a modern oncology center should offer.	[Kessel, Kerstin A.; Lettner, Sabrina; Kessel, Carmen; Combs, Stephanie E.] TUM, Dept Radiat Oncol, Ismaninger Str 22, Munich, Germany; [Kessel, Kerstin A.; Combs, Stephanie E.] Helmholtz Zentrum Munchen, Inst Innovat Radiotherapy IRT, Ingolstadter Landstr 1, Neuherberg, Germany; [Kessel, Carmen; Combs, Stephanie E.] TUM, Onkol Zentrum, RHCCC, Klinikum Rechts Isar, Ismaninger Str 22, Munich, Germany; [Bier, Henning] TUM, Dept Otorhinolaryngol, Ismaninger Str 22, Munich, Germany; [Biedermann, Tilo] TUM, Dept Dermatol & Allergy Biederstein, Biedersteiner Str 29, Munich, Germany; [Friess, Helmut] TUM, Dept Surg, Ismaninger Str 22, Munich, Germany; [Herrschbach, Peter] TUM, Roman Herzog Krebszentrum Comprehens Canc Ctr RHC, Trogerstr 26, Munich, Germany; [Gschwend, Juergen E.] TUM, Dept Urol, Ismaninger Str 22, Munich, Germany; [Meyer, Bernhard] TUM, Dept Neurosurg, Ismaninger Str 22, Munich, Germany; [Peschel, Christian] TUM, Dept Internal Med 3, Ismaninger Str 22, Munich, Germany; [Schmid, Roland] TUM, Dept Internal Med 2, Ismaninger Str 22, Munich, Germany; [Schwaiger, Markus] TUM, Dept Nucl Med, Ismaninger Str 22, Munich, Germany; [Wolff, Klaus-Dietrich] TUM, Dept Oral & Maxillofacial Surg, Ismaninger Str 22, Munich, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich	Kessel, KA (corresponding author), TUM, Dept Radiat Oncol, Ismaninger Str 22, Munich, Germany.; Kessel, KA (corresponding author), Helmholtz Zentrum Munchen, Inst Innovat Radiotherapy IRT, Ingolstadter Landstr 1, Neuherberg, Germany.	Kerstin.Kessel@tum.de		Biedermann, Tilo/0000-0002-5352-5105; Kessel, Carmen/0000-0002-3791-0206				Abdallah R, 2015, INT J GYNECOL CANCER, V25, P1724, DOI 10.1097/IGC.0000000000000549; Adams J, 2015, INTEGR CANCER THER, V14, P359, DOI 10.1177/1534735415583555; Akpunar Dercan, 2015, Asian Pac J Cancer Prev, V16, P7847; AlBedah Abdullah M, 2015, Asian Pac J Cancer Prev, V16, P6799; Asadpour R, 2016, ADV RAD ONCOLOGY; Barnes P., 2007, COMPLEMENTARY ALTERN; Begbie SD, 1996, MED J AUSTRALIA, V165, P545, DOI 10.5694/j.1326-5377.1996.tb138639.x; Burstein HJ, 1999, NEW ENGL J MED, V340, P1733, DOI 10.1056/NEJM199906033402206; Cassileth BR, 2001, CANCER, V91, P1390, DOI 10.1002/1097-0142(20010401)91:7<1390::AID-CNCR1143>3.0.CO;2-C; Correa-Velez I, 2003, PALLIATIVE MED, V17, P695, DOI 10.1191/0269216303pm834oa; D'Andrea GM, 2005, CA-CANCER J CLIN, V55, P319, DOI 10.3322/canjclin.55.5.319; Enblom A, 2012, ANN ONCOL, V23, P1353, DOI 10.1093/annonc/mdr402; Endres HG, 2005, SCHMERZ, V19, P201, DOI 10.1007/s00482-004-0345-z; Endres HG, 2007, AKUPUNKTUR BEI CHRON; Gunawan S, 2016, PEDIATR BLOOD CANCER, V63, P118, DOI 10.1002/pbc.25689; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Horneber M, 2012, INTEGR CANCER THER, V11, P187, DOI 10.1177/1534735411423920; Huebner J, 2009, ONKOLOGE, DOI [10.1007/s00761-009-1764-3, DOI 10.1007/S00761-009-1764-3]; Huebner J, 2014, ONCOL RES TREAT, V37, DOI 10.1159/000362616; Hyodo I, 2005, J CLIN ONCOL, V23, P2645, DOI 10.1200/JCO.2005.04.126; Knight Aishah, 2015, Asian Pac J Cancer Prev, V16, P3125; Labriola D, 1999, ONCOLOGY-NY, V13, P1003; Lawenda BD, 2008, JNCI-J NATL CANCER I, V100, P773, DOI 10.1093/jnci/djn148; Magi T, 2015, USE COMPLEMENTARY AL, V10, DOI [10.1371/journal.pone.0145787, DOI 10.1371/JOURNAL.PONE.0145787]; Mani J, 2015, USE COMPLEMENTARY AL, P1407, DOI [10.2147/PPA.S90061, DOI 10.2147/PPA.S90061]; Micke O, 2009, EUR J INTEGR MED, V1, P19, DOI 10.1016/j.eujim.2009.02.001; Molassiotis A, 2005, ANN ONCOL, V16, P655, DOI 10.1093/annonc/mdi110; Molassiotis A, 2006, EUROPEAN J, DOI [10.1111/j.1365-2354.2005.00615.x/pdf, DOI 10.1111/J.1365-2354.2005.00615.X/PDF]; Montazeri A, 2007, EUR J CANCER CARE, V16, P144, DOI 10.1111/j.1365-2354.2006.00722.x; Montazeri A, 2005, SUPPORT CARE CANCER, V13, P339, DOI 10.1007/s00520-004-0709-z; Naja F, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0969-9; Nakayama A, 2011, CANCER INVEST, V29, P655, DOI 10.3109/07357907.2011.626479; National Institutes of Health Bethesda MD (US), 2002, ACT HUM GEN NOM COMM, DOI [10.2172/804185, DOI 10.2172/804185]; Nazik E, 2012, ASIAN PAC J CANCER P, V13, P21, DOI 10.7314/APJCP.2012.13.1.021; Nissen N, 2012, FORSCH KOMPLEMENTMED, V19, P9, DOI 10.1159/000342710; Ojukwu M, 2015, INTEGR CANCER THER, V14, P503, DOI 10.1177/1534735415589347; Paul M, 2013, J CANCER RES CLIN, V139, P1515, DOI 10.1007/s00432-013-1460-y; Rausch SM, 2011, SUPPORT CARE CANCER, V19, P521, DOI 10.1007/s00520-010-0846-5; Richardson MA, 2000, J CLIN ONCOL, V18, P2505, DOI 10.1200/JCO.2000.18.13.2505; Risberg T, 2003, QUAL LIFE RES, V12, P539, DOI 10.1023/A:1025063705413; Robotin M, 2012, COMPLEMENT THER MED, V20, P345, DOI 10.1016/j.ctim.2012.04.001; Shumer G, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-360; Simcock R, 2013, ANN ONCOL, V24, P776, DOI 10.1093/annonc/mds515; Simone CB, 2007, ALTERN THER HEALTH M, V13, P40; Simone CB, 2007, ALTERN THER HEALTH M, V13, P22; Sullivan A, 2015, INTEGR CANCER THER, V14, P350, DOI 10.1177/1534735415580679; Ustundag S, 2015, HOLIST NURS PRACT, V29, P357, DOI 10.1097/HNP.0000000000000113; Vickers A, 2004, HEALTH TECHNOL ASSES, V8, DOI [10.3310/hta8480, DOI 10.3310/HTA8480]; Vickers AJ, 2004, J CLIN ONCOL, V22, P1731, DOI 10.1200/JCO.2004.04.102; Yates JS, 2005, SUPPORT CARE CANCER, V13, P806, DOI 10.1007/s00520-004-0770-7; Yeung K Simon, 2007, J Soc Integr Oncol, V5, P113, DOI 10.2310/7200.2007.008; Yidirim Y, 2006, EUR J GYNAECOL ONCOL, V27, P81	52	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165801	10.1371/journal.pone.0165801	http://dx.doi.org/10.1371/journal.pone.0165801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812163	gold, Green Submitted, Green Published			2022-12-27	WOS:000386910000059
J	Bachelet, D; Hassler, S; Mbogning, C; Link, J; Ryner, M; Ramanujam, R; Auer, M; Jensen, PEH; Koch-Henriksen, N; Warnke, C; Ingenhoven, K; Buck, D; Grummel, V; Lawton, A; Donnellan, N; Hincelin-Mery, A; Sikkema, D; Pallardy, M; Kieseier, B; Hemmer, B; Hartung, HP; Sorensen, PS; Deisenhammer, F; Donnes, P; Davidson, J; Fogdell-Hahn, A; Broet, P				Bachelet, Delphine; Hassler, Signe; Mbogning, Cyprien; Link, Jenny; Ryner, Malin; Ramanujam, Ryan; Auer, Michael; Jensen, Poul Erik Hyldgaard; Koch-Henriksen, Nils; Warnke, Clemens; Ingenhoven, Kathleen; Buck, Dorothea; Grummel, Verena; Lawton, Andy; Donnellan, Naoimh; Hincelin-Mery, Agnes; Sikkema, Dan; Pallardy, Marc; Kieseier, Bernd; Hemmer, Bernard; Hartung, Hans Peter; Sorensen, Per Soelberg; Deisenhammer, Florian; Donnes, Pierre; Davidson, Julie; Fogdell-Hahn, Anna; Broet, Philippe		ABIRISK Consortium	Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis	PLOS ONE			English	Article							INTERVAL-CENSORED-DATA; NEUTRALIZING ANTIBODIES; IFN-BETA; VITAMIN-D; BINDING-ANTIBODIES; CONTROLLED-TRIAL; T-CELLS; THERAPY; IMMUNOGENICITY; AUTOIMMUNITY	Immunogenicity of biopharmaceutical products in multiple sclerosis is a frequent side effect which has a multifactorial etiology. Here we study associations between anti-drug antibody (ADA) occurrence and demographic and clinical factors. Retrospective data from routine ADA test laboratories in Sweden, Denmark, Austria and Germany (Dusseldorf group) and from one research study in Germany (Munich group) were gathered to build a collaborative multi-cohort dataset within the framework of the ABIRISK project. A subset of 5638 interferon-beta (IFN beta)-treated and 3440 natalizumab-treated patients having data on at least the first two years of treatment were eligible for interval-censored time-to-event analysis. In multivariate Cox regression, IFN beta-1a subcutaneous and IFN beta-1b subcutaneous treated patients were at higher risk of ADA occurrence compared to IFN beta-1a intramuscular-treated patients (pooled HR = 6.4, 95% CI 4.9-8.4 and pooled HR = 8.7, 95% CI 6.6-11.4 respectively). Patients older than 50 years at start of IFN beta therapy developed ADA more frequently than adult patients younger than 30 (pooled HR = 1.8, 95% CI 1.4-2.3). Men developed ADA more frequently than women (pooled HR = 1.3, 95% CI 1.1-1.6). Interestingly we observed that in Sweden and Germany, patients who started IFN beta in April were at higher risk of developing ADA (HR = 1.6, 95% CI 1.1-2.4 and HR = 2.4, 95% CI 1.5-3.9 respectively). This result is not confirmed in the other cohorts and warrants further investigations. Concerning natalizumab, patients older than 45 years had a higher ADA rate (pooled HR = 1.4, 95% CI 1.0-1.8) and women developed ADA more frequently than men (pooled HR = 1.4, 95% CI 1.0-2.0). We confirmed previously reported differences in immunogenicity of the different types of IFN beta. Differences in ADA occurrence by sex and age are reported here for the first time. These findings should be further investigated taking into account other exposures and biomarkers.	[Bachelet, Delphine; Hassler, Signe; Mbogning, Cyprien; Broet, Philippe] Univ Paris Saclay, Univ Paris Sud, UVSQ, CESP,INSERM, Villejuif, France; [Link, Jenny; Ryner, Malin; Ramanujam, Ryan; Fogdell-Hahn, Anna] Karolinska Inst, Dept Clin Neurosci, Clin Neuroimmunol, Stockholm, Sweden; [Ramanujam, Ryan] KTH Royal Inst Technol, Stockholm, Sweden; [Auer, Michael; Deisenhammer, Florian] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Jensen, Poul Erik Hyldgaard; Sorensen, Per Soelberg] Rigshosp, Dept Neurol, Danish MS Ctr, Copenhagen Univ Hosp, Copenhagen, Denmark; [Koch-Henriksen, Nils] Rigshosp, Copenhagen Univ Hosp, Danish Multiple Sclerosis Registry, Copenhagen, Denmark; [Koch-Henriksen, Nils] Univ Aarhus, Dept Clin Epidemiol, Aarhus, Denmark; [Warnke, Clemens; Ingenhoven, Kathleen; Kieseier, Bernd; Hartung, Hans Peter] Univ Dusseldorf, Fac Med, Dept Neurol, Dusseldorf, Germany; [Buck, Dorothea; Grummel, Verena; Hemmer, Bernard] Tech Univ Munich, Dept Neurol, Munich, Germany; [Lawton, Andy; Sikkema, Dan; Davidson, Julie] GlaxoSmithKline, Uxbridge, Middx, England; [Donnellan, Naoimh] IPSEN, Slough, Berks, England; [Hincelin-Mery, Agnes] Sanofi, Chilly Mazarin, France; [Pallardy, Marc] Univ Paris Saclay, Univ Paris Sud, INSERM UMR 996, Fac Pharm, Chatenay Malabry, France; [Hemmer, Bernard] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Donnes, Pierre] SciCross AB, Skovde, Sweden; [Broet, Philippe] Hop Paul Brousse, AP HP, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet; Royal Institute of Technology; Medical University of Innsbruck; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; Heinrich Heine University Dusseldorf; Technical University of Munich; GlaxoSmithKline; Ipsen; Sanofi-Aventis; Sanofi France; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Munich; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP	Bachelet, D; Hassler, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, UVSQ, CESP,INSERM, Villejuif, France.	delphine.bachelet@inserm.fr; signe.hassler@inserm.fr	Ramanujam, Ryan/ABE-2426-2020; Bachelet, Delphine/AAD-8385-2022; Mbogning, Cyprien/AAI-1788-2020	Mbogning, Cyprien/0000-0002-6619-3883; Fogdell-Hahn, Anna/0000-0002-0311-9184; BROET, PHILIPPE/0000-0001-9122-2810; Donnes, Pierre/0000-0002-4613-2952; Link, Jenny/0000-0002-6134-9404; /0000-0003-2185-151X; Ramanujam, Ryan/0000-0001-7360-1497; Sorensen, Per Soelberg/0000-0002-2818-3780	Innovative Medicines Initiative Joint Undertaking [115303]; European Union; EFPIA companies; German Competence Network for multiple sclerosis	Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); EFPIA companies; German Competence Network for multiple sclerosis	The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no [115303], resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies. A. Lawton, N. Donnellan, A. Hincelin-Mery, D. Sikkema, J. Davidson: belong to EFPIA (European Federation of Pharmaceutical Industries and Association) member companies in the IMI JU and costs related to their part in the research were carried by the respective companies as in kind contributions under the IMI JU scheme. Bernard Hemmer and Dorothea Buck were supported by the German Competence Network for multiple sclerosis.	Gonzalez DA, 2010, IMMUNOL LETT, V133, P6, DOI 10.1016/j.imlet.2010.07.001; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Bertolotto A, 2007, J IMMUNOL METHODS, V321, P19, DOI 10.1016/j.jim.2006.12.012; Bertolotto A, 2014, NEUROL SCI, V35, P307, DOI 10.1007/s10072-013-1616-1; Buck D, 2011, ARCH NEUROL-CHICAGO, V68, P480, DOI 10.1001/archneurol.2011.65; Calabresi PA, 2007, NEUROLOGY, V69, P1391, DOI 10.1212/01.wnl.0000277457.17420.b5; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Deisenhammer F, 2014, J INTERF CYTOK RES, V34, P938, DOI 10.1089/jir.2012.0135; Deisenhammer F, 2009, CNS DRUGS, V23, P379, DOI 10.2165/00023210-200923050-00003; Disanto G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-69; Dobson R, 2013, J NEUROL NEUROSUR PS, V84, P427, DOI 10.1136/jnnp-2012-303934; Dorr J, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-15; Fay MP, 2010, J STAT SOFTW, V36, P1; GENTLEMAN R, 1994, BIOMETRIKA, V81, P618; Handunnetthi L, 2010, NEUROLOGY, V74, P1905, DOI 10.1212/WNL.0b013e3181e24124; Hegen H, 2014, MULT SCLER J, V20, P577, DOI 10.1177/1352458513503597; Hermanrud C, 2014, J INTERF CYTOK RES, V34, P498, DOI 10.1089/jir.2013.0097; Hesse D, 2007, EUR J NEUROL, V14, P850, DOI 10.1111/j.1468-1331.2007.01769.x; Hoffmann S, 2008, AM J HUM GENET, V83, P219, DOI 10.1016/j.ajhg.2008.07.006; Johnson PLF, 2014, IMMUNOLOGY, V142, P167, DOI 10.1111/imm.12244; Jones JL, 2013, P NATL ACAD SCI USA, V110, P20200, DOI 10.1073/pnas.1313654110; Jungedal R, 2012, MULT SCLER J, V18, P1775, DOI 10.1177/1352458512446036; KAWADE Y, 1986, METHOD ENZYMOL, V119, P558; Kilpatrick RD, 2008, J IMMUNOL, V180, P1499, DOI 10.4049/jimmunol.180.3.1499; Krupica T, 2006, CLIN IMMUNOL, V120, P121, DOI 10.1016/j.clim.2006.04.569; Lam R, 2008, J IMMUNOL METHODS, V336, P113, DOI 10.1016/j.jim.2008.03.014; Link J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090479; Lundkvist M, 2010, MULT SCLER J, V16, P796, DOI 10.1177/1352458510373112; Mackall CL, 1996, J IMMUNOL, V156, P4609; Mokry LE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001866; Nunez C, 2014, J MED GENET, V51, P395, DOI 10.1136/jmedgenet-2014-102348; Oliver-Martos B, 2013, J NEUROL; Pachner AR, 2003, NEUROLOGY, V61, P1444, DOI 10.1212/01.WNL.0000094198.37489.11; Pan W, 2000, BIOMETRICS, V56, P199, DOI 10.1111/j.0006-341X.2000.00199.x; Ross C, 2000, ANN NEUROL, V48, P706, DOI 10.1002/1531-8249(200011)48:5<706::AID-ANA3>3.3.CO;2-M; Rot U, 2008, J INT MED RES, V36, P1418, DOI 10.1177/147323000803600631; Rudick RA, 1998, NEUROLOGY, V50, P1266, DOI 10.1212/WNL.50.5.1266; Sauce D, 2012, J IMMUNOL, V189, P5541, DOI 10.4049/jimmunol.1201235; Sauerborn M, 2013, J CLIN IMMUNOL, V33, P255, DOI 10.1007/s10875-012-9783-z; Sheremata WA, 1999, NEUROLOGY, V52, P1072, DOI 10.1212/WNL.52.5.1072; Smolders J, 2011, J NEUROL SCI, V311, P44, DOI 10.1016/j.jns.2011.04.013; Sominanda A, 2007, MULT SCLER, V13, P208, DOI 10.1177/1352458506070762; Sorensen PS, 2005, EUR J NEUROL, V12, P817, DOI 10.1111/j.1468-1331.2005.01386.x; Sorensen PS, 2005, NEUROLOGY, V65, P33, DOI 10.1212/01.WNL.0000166049.51502.6A; Sorensen PS, 2003, LANCET, V362, P1184, DOI 10.1016/S0140-6736(03)14541-2; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Stewart N, 2012, NEUROLOGY, V79, P254, DOI 10.1212/WNL.0b013e31825fded9; Szalma S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-68; Ternant D, 2015, CLIN PHARMACOKINET, V54, P1107, DOI 10.1007/s40262-015-0296-9; TURNBULL BW, 1976, J R STAT SOC B, V38, P290; van Beers MMC, 2010, J INTERF CYTOK RES, V30, P767, DOI 10.1089/jir.2010.0086	52	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0162752	10.1371/journal.pone.0162752	http://dx.doi.org/10.1371/journal.pone.0162752			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806057	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500005
J	Bong, IW; Felker, ME; Maryudi, A				Bong, Indah Waty; Felker, Mary Elizabeth; Maryudi, Ahmad			How Are Local People Driving and Affected by Forest Cover Change? Opportunities for Local Participation in REDD plus Measurement, Reporting and Verification	PLOS ONE			English	Article							TROPICAL FORESTS; CO-BENEFITS; TRADE-OFFS; DEFORESTATION; MANAGEMENT; SUSTAINABILITY; SAFEGUARDS; INDONESIA; PROJECTS; BORNEO	Deforestation and forest degradation are complex and dynamic processes that vary from place to place. They are driven by multiple causes. Local communities are, to some extent, driving and also affected by some of these processes. Can their knowledge aid and add to place-specific assessment and monitoring of Deforestation and forest Degradation (DD) drivers? Our research was conducted in seven villages across three provinces of Indonesia (Papua, West Kalimantan and Central Java). Household surveys and focus group discussions were used to investigate how local community knowledge of DD drivers contributes to place-specific assessment and monitoring of DD drivers. We analyzed the link between drivers and local livelihoods to see how attempts to address deforestation and forest degradation might affect local communities and how this link might influence their participation in climate change mitigation measures such as Reducing Emissions from Deforestation and Forest Degradation (REDD+) and Measuring, Reporting and Verifying (MRV) activities. We found that local knowledge is fundamental to capturing the variety of drivers particularly in countries like Indonesia where forest and socio-economic conditions are diverse. Better understanding of drivers and their importance for local livelihoods will not only contribute to a more locally appropriate design of REDD+ and monitoring systems but will also foster local participation.	[Bong, Indah Waty; Felker, Mary Elizabeth] Ctr Int Forestry Res, Jl CIFOR, Bogor 16115, Indonesia; [Maryudi, Ahmad] Univ Gadjah Mada, Fac Forestry, Bulaksumur 55281, Yogyakarta, Indonesia	CGIAR; Center for International Forestry Research (CIFOR); Gadjah Mada University	Bong, IW (corresponding author), Ctr Int Forestry Res, Jl CIFOR, Bogor 16115, Indonesia.	i.waty@cgiar.org	Maryudi, Ahmad/T-8029-2019	Maryudi, Ahmad/0000-0001-5051-7217	U.S. Agency for International Development (USAID) [MT0069018]; Norwegian Agency for Development Cooperation (NORAD) [GL0-3945, QZA 12/0882]	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Norwegian Agency for Development Cooperation (NORAD)	Our research is funded by :1. The U.S. Agency for International Development (USAID), grant number MT0069018, http://www.usaid.gov/; 2. The Norwegian Agency for Development Cooperation (NORAD), grant number GL0-3945, QZA 12/0882, http://www.norad.no/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom B, 2010, ENVIRON SCI POLICY, V13, P164, DOI 10.1016/j.envsci.2010.01.002; Boissiere M, 2014, FORESTS, V5, P1855, DOI 10.3390/f5081855; Brewster J, 2012, COMMUNITY BASED MONI; Byron N, 1999, WORLD DEV, V27, P789, DOI 10.1016/S0305-750X(99)00025-X; Chhatre A, 2012, CURR OPIN ENV SUST, V4, P654, DOI 10.1016/j.cosust.2012.08.006; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Christie P, 2005, OCEAN COAST MANAGE, V48, P468, DOI 10.1016/j.ocecoaman.2005.04.006; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Danielsen F, 2011, CONSERV LETT, V4, P158, DOI 10.1111/j.1755-263X.2010.00159.x; Dharmadi Hawthorne S., 2014, LIT REV PARTICIPATOR; Fisher RJ, 1997, ASIA PACIFIC FORESTR; Force RT, 2012, STRAT IMPL PLAN REDD; Fraser EDG, 2006, J ENVIRON MANAGE, V78, P114, DOI 10.1016/j.jenvman.2005.04.009; Fry B, 2011, ENVIRON SCI POLICY, V14, P181, DOI 10.1016/j.envsci.2010.12.004; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Holck MH, 2008, BIODIVERS CONSERV, V17, P2023, DOI 10.1007/s10531-007-9273-4; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; Houghton RA, 2012, CURR OPIN ENV SUST, V4, P597, DOI 10.1016/j.cosust.2012.06.006; Huang R., RQDA R BASED QUALITA; Indrabudi H, 1998, LAND DEGRAD DEV, V9, P311, DOI 10.1002/(SICI)1099-145X(199807/08)9:4<311::AID-LDR294>3.0.CO;2-X; Indrarto GB, 2012, CONTEXT REDD INDONE; Joseph S, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034038; Kissinger G., 2012, SYNTHESIS REPORT RED, V48; Kothari CR, 2011, REMETHODOLOGY METH; Langner A, 2007, GLOBAL CHANGE BIOL, V13, P2329, DOI 10.1111/j.1365-2486.2007.01442.x; Larrazabal A, 2012, CURR OPIN ENV SUST, V4, P707, DOI 10.1016/j.cosust.2012.10.008; Lawlor K, 2010, GLOBAL ENVIRON POLIT, V10, P1, DOI 10.1162/GLEP_a_00028; Lederer M, 2011, ECOL ECON, V70, P1900, DOI 10.1016/j.ecolecon.2011.02.003; McCall K., 2010, LOCAL PARTICIPATION; Microsoft, 2010, MICR EXC; Mukama K, 2012, INT J FORESTRY RES, V2011; Murdiyarso D., 2008, ECOHYDROLOGY MAMBERA; Olander LP, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/2/025011; Peres CA, 2006, TRENDS ECOL EVOL, V21, P227, DOI 10.1016/j.tree.2006.03.007; Peters-Guarin G, 2010, COMMUNITY CARBON FOR; Pratihast AK, 2013, CARBON MANAG, V4, P91, DOI [10.4155/cmt.12.75, 10.4155/CMT.12.75]; Rana EB, 2008, INITIATION, V2, P91; Romijn E, 2013, ENVIRON SCI POLICY, V33, P246, DOI 10.1016/j.envsci.2013.06.002; Salvini G, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074004; Sanchez-Azofeifa GA, 2009, ECOL APPL, V19, P480, DOI 10.1890/08-1149.1; Skutsch M, 2011, COMMUNITY FOREST MON; Skutsch M, 2009, COMMUNITY MONITORING, P101; Skutsch M.M., 2009, CASE STUDIES MEASURI; Skutsch Margaret M, 2011, Carbon Balance Manag, V6, P16, DOI 10.1186/1750-0680-6-16; Skutsch MM, 2005, CLIM POLICY, V5, P433; Verplanke J., 2009, FIELD GUIDE ASSESSIN; Visseren-Hamakers IJ, 2012, CURR OPIN ENV SUST, V4, P646, DOI 10.1016/j.cosust.2012.10.005	48	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0145330	10.1371/journal.pone.0145330	http://dx.doi.org/10.1371/journal.pone.0145330			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806044	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500001
J	Han, YJ; Zhang, J; Zheng, YL; Huo, DZ; Olopade, OI				Han, Yoo-Jeong; Zhang, Jing; Zheng, Yonglan; Huo, Dezheng; Olopade, Olufunmilayo I.			Genetic and Epigenetic Regulation of TOX3 Expression in Breast Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; AFRICAN ANCESTRY; RISK; WOMEN; METHYLATION; VARIANTS	Genome wide association studies (GWAS) have identified low penetrance and high frequency single nucleotide polymorphisms (SNPs) that contribute to genetic susceptibility of breast cancer. The SNPs at 16q12, close to the TOX3 and CASC16 genes, represent one of the susceptibility loci identified by GWAS, showing strong evidence for breast cancer association across various populations. To examine molecular mechanisms of TOX3 regulation in breast cancer, we investigated both genetic and epigenetic factors using cell lines and datasets derived from primary breast tumors available through The Cancer Genome Atlas (TCGA). TOX3 expression is highly up-regulated in luminal subtype tumors compared to normal breast tissues or basal-like tumors. Expression quantitative trait loci (eQTL) analyses revealed significant associations of rs3803662 and rs4784227 genotypes with TOX3 expression in breast tumors. Bisulfite sequencing of four CpG islands in the TOX3 promoter showed a clear difference between luminal and basal-like cancer cell lines. 5-Aza-2'-deoxy-cytidine treatment of a basal-like cancer cell line increased expression of TOX3. TCGA dataset verified significantly lower levels of methylation of the promoter in luminal breast tumors with an inverse correlation between methylation and expression of TOX3. Methylation QTL (mQTL) analyses showed a weak or no correlation of rs3803662 or rs4784227 with TOX3 promoter methylation in breast tumors, indicating an independent relationship between the genetic and epigenetic events. These data suggest a complex system of TOX3 regulation in breast tumors, driven by germline variants and somatic epigenetic modifications in a subtype specific manner.	[Han, Yoo-Jeong; Zhang, Jing; Zheng, Yonglan; Olopade, Olufunmilayo I.] Univ Chicago, Dept Med, Ctr Clin Canc Genet & Global Hlth, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Han, Yoo-Jeong; Zhang, Jing; Zheng, Yonglan; Olopade, Olufunmilayo I.] Univ Chicago, Dept Med, Sect Hematol & Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Huo, Dezheng] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Han, YJ; Olopade, OI (corresponding author), Univ Chicago, Dept Med, Ctr Clin Canc Genet & Global Hlth, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Han, YJ; Olopade, OI (corresponding author), Univ Chicago, Dept Med, Sect Hematol & Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yjhan@medicine.bsd.uchicago.edu; folopade@medicine.bsd.uchicago.edu	Zheng, Yonglan/O-4112-2019	Zheng, Yonglan/0000-0001-6597-7072	NIH [R01 CM 42996-01]; NIH Specialized Program of Research Excellence in Breast Cancer [P50 CA125183]; Breast Cancer Research Foundation; Ralph and Marion Falk Medical Research Trust; NATIONAL CANCER INSTITUTE [R01CA142996, P50CA125183] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Specialized Program of Research Excellence in Breast Cancer; Breast Cancer Research Foundation; Ralph and Marion Falk Medical Research Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH R01 CM 42996-01 (OIO), NIH Specialized Program of Research Excellence in Breast Cancer P50 CA125183 (OIO), Breast Cancer Research Foundation (YH and OIO), and the Ralph and Marion Falk Medical Research Trust (OIO). OIO is American Cancer Society Clinical Research Professor.; The authors thank Dr. Charles M. Perou (University of North Carolina, Chapel Hill, NC) for generously providing the University of North Carolina dataset and Dr. Albert C. Yeh (University of Chicago) for critically reviewing the manuscript. We also thank Dr. Tatyana Grushko and Ms. Maria Gomez for assistance with FISH experiments and data interpretation, and Ms. Mariann Coyle for assistance with the cell culturing. This work was supported by NIH R01 CA142996-01 (OIO), NIH Specialized Program of Research Excellence in Breast Cancer P50 CA125183 (OIO), Breast Cancer Research Foundation (YH and OIO), and the Ralph and Marion Falk Medical Research Trust (OIO). OK) is American Cancer Society Clinical Research Professor.	Baumgartner A, 2006, J HISTOCHEM CYTOCHEM, V54, P1363, DOI 10.1369/jhc.6A6974.2006; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Chen F, 2011, HUM MOL GENET, V20, P4491, DOI 10.1093/hmg/ddr367; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Dittmer S, 2011, J CELL SCI, V124, P252, DOI 10.1242/jcs.068759; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gudmundsdottir ET, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-621; Han W, 2011, CANCER EPIDEM BIOMAR, V20, P793, DOI 10.1158/1055-9965.EPI-10-1282; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Huo DZ, 2012, CARCINOGENESIS, V33, P835, DOI 10.1093/carcin/bgs093; Jones JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074102; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Long JR, 2010, CANCER EPIDEM BIOMAR, V19, P2357, DOI 10.1158/1055-9965.EPI-10-0054; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Millis RM, 2011, CURR HYPERTENS REP, V13, P21, DOI 10.1007/s11906-010-0173-8; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Riaz M, 2012, BREAST CANCER RES TR, V133, P843, DOI 10.1007/s10549-011-1663-3; Ruiz-Narvaez EA, 2010, CANCER EPIDEM BIOMAR, V19, P1320, DOI 10.1158/1055-9965.EPI-09-1250; Shan JX, 2013, CANCER RES, V73, P2840, DOI 10.1158/0008-5472.CAN-12-4313; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Vo AT, 2012, OBSTET GYNECOL INT, V2012, DOI [10.1156/2012/6022720, DOI 10.1156/2012/6022720]; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Wei MJ, 2005, CANCER RES, V65, P10692, DOI 10.1158/0008-5472.CAN-05-1277; Zheng YL, 2013, CARCINOGENESIS, V34, P1520, DOI 10.1093/carcin/bgt090	28	19	19	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165559	10.1371/journal.pone.0165559	http://dx.doi.org/10.1371/journal.pone.0165559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806084	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500037
J	Chang, WF; Hwu, YM; Xu, J; Lin, CJ; Wang, SW; Cheng, AS; Lu, J; Lu, CH; Sung, LY				Chang, Wei-Fang; Hwu, Yuh-Ming; Xu, Jie; Lin, Chen-Ju; Wang, Sheng-Wen; Cheng, An-Sheng; Lu, Jean; Lu, Chung-Hao; Sung, Li-Ying			Derivation of Patient Specific Pluripotent Stem Cells Using Clinically Discarded Cumulus Cells	PLOS ONE			English	Article							DIFFERENTIATION; IDENTIFICATION; INDUCTION	Induced pluripotent stem cells (iPSCs) are powerful tools for basic and translational research, as well as regenerative medicine. In routine human in vitro fertilization (IVF) practices, cumulus cells (CCs) are discarded, representing a potential source of biological materials for regenerative medicine. In this study, we derived patient-specific iPSCs using CCs from human infertility clinics for the first time. The human cumulus cell derived iPSCs (hc-iPSCs) were characterized for growth, karyotype, expression of pluripotency genes, and were subjected to embryoid bodies (EBs) and teratoma assays to evaluate their differentiation capacity. Hc-iPSCs display typical iPSC characteristics, and are capable of differentiating into all germ layers in vitro and in vivo. We further show that putative primordial germ cell like cells (PGCLCs) can be derived using hc-iPSCs. Our data demonstrate the feasibility of deriving patient-specific pluripotent stem cells using CCs.	[Chang, Wei-Fang; Wang, Sheng-Wen; Sung, Li-Ying] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [Hwu, Yuh-Ming; Lin, Chen-Ju; Lu, Chung-Hao] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Hwu, Yuh-Ming; Lin, Chen-Ju] Mackay Med Coll, Dept Obstet & Gynecol, New Taipei, Taiwan; [Hwu, Yuh-Ming] Mackay Jr Coll Med Nursing & Management, Dept Obstet & Gynecol, Taipei, Taiwan; [Xu, Jie] Univ Michigan, Med Ctr, Ctr Adv Models Translat Sci & Therapeut, Ann Arbor, MI USA; [Cheng, An-Sheng] Yupintang Tradit Chinese Med Fdn, Kaohsiung, Taiwan; [Lu, Jean] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Sung, Li-Ying] Natl Taiwan Univ, Ctr Biotechnol, Taipei, Taiwan; [Sung, Li-Ying] Natl Taiwan Univ, Anim Resource Ctr, Taipei, Taiwan; [Sung, Li-Ying] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan	National Taiwan University; Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management; University of Michigan System; University of Michigan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Sung, LY (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan.; Lu, CH (corresponding author), Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.; Sung, LY (corresponding author), Natl Taiwan Univ, Ctr Biotechnol, Taipei, Taiwan.; Sung, LY (corresponding author), Natl Taiwan Univ, Anim Resource Ctr, Taipei, Taiwan.; Sung, LY (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan.	d95642001@gmail.com; liyingsung@ntu.edu.tw		SUNG, LI-YING/0000-0003-1221-2476	Yupintang Traditional Chinese Medicine Foundation (Kaohsiung, Taiwan); Ministry of Science and Technology, Taiwan [104-2313-B-002-035-MY3, 104-2314-B-195-012, 104-2811-B-002-071]; Human Disease iPSC Service Consortium of the National Research Program for Biopharmaceuticals (NRPB) of, the Ministry of Science and Technology (MOST) [MOST 104-2325-B-001-010]	Yupintang Traditional Chinese Medicine Foundation (Kaohsiung, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Human Disease iPSC Service Consortium of the National Research Program for Biopharmaceuticals (NRPB) of, the Ministry of Science and Technology (MOST)	This study was supported by grants from Yupintang Traditional Chinese Medicine Foundation (Kaohsiung, Taiwan) and Ministry of Science and Technology, Taiwan (Grant Number 104-2313-B-002-035-MY3 to L.Y. Sung, 104-2314-B-195-012 to C.H. Lu and 104-2811-B-002-071 to W.F. Chang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. John Yu and Bei-Chia Yang kindly sharing the ESC culture method. We thank the Human Disease iPSC Service Consortium (MOST 104-2325-B-001-010) of the National Research Program for Biopharmaceuticals (NRPB) of, the Ministry of Science and Technology (MOST), for the hb-iPSC generation and technical support. Thanks Dr. Shau-Pin Lin and Chu-Fan Mo sharing the method for neuronal differentiation. We appreciate the technical assistance provide by Chen-Chi Lee. We thank Joint Center for Instruments and Researches, College of Bioresources and Agriculture in National Taiwan University for providing the service for the laser-scanning confocal microscopy and flow cytometry.	Alvarado AS, 2014, CELL, V157, P110, DOI 10.1016/j.cell.2014.02.041; Anchan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119275; Chang WF, 2015, BRAIN STRUCT FUNCT, V220, P1539, DOI 10.1007/s00429-014-0743-7; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Cho JK, 2002, THERIOGENOLOGY, V57, P1819, DOI 10.1016/S0093-691X(01)00699-9; Chuang CY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0005-5; Di KQ, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124958; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Huang ZW, 2010, MOL HUM REPROD, V16, P715, DOI 10.1093/molehr/gaq031; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Kimbrel EA, 2015, NAT REV DRUG DISCOV, V14, P681, DOI 10.1038/nrd4738; La Marca A, 2007, HUM REPROD, V22, P766, DOI 10.1093/humrep/del421; La Marca A, 2011, REPROD BIOMED ONLINE, V22, P341, DOI 10.1016/j.rbmo.2010.11.005; La Marca A, 2014, HUM REPROD UPDATE, V20, P124, DOI 10.1093/humupd/dmt037; Li W, 2012, P NATL ACAD SCI USA, V109, P20853, DOI 10.1073/pnas.1219181110; Lin MH, 2013, FERTIL STERIL, V100, P1296, DOI 10.1016/j.fertnstert.2013.07.1976; Lourenco Barbara, 2014, J Reprod Infertil, V15, P15; Lu CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074602; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Qin H, 2014, CELL, V158, P449, DOI 10.1016/j.cell.2014.05.040; Sasaki K, 2015, CELL STEM CELL, V17, P178, DOI 10.1016/j.stem.2015.06.014; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Soldner F, 2012, SCIENCE, V338, P1155, DOI 10.1126/science.1227682; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2015, DEVELOPMENT, V142, P3274, DOI 10.1242/dev.114249; Tian X Cindy, 2003, Reprod Biol Endocrinol, V1, P98, DOI 10.1186/1477-7827-1-98; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020	35	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165715	10.1371/journal.pone.0165715	http://dx.doi.org/10.1371/journal.pone.0165715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802323	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200043
J	Ebner-Karestinos, D; Thonnard, JL; Bleyenheuft, Y				Ebner-Karestinos, Daniela; Thonnard, Jean-Louis; Bleyenheuft, Yannick			Precision Grip Control while Walking Down a Stair Step	PLOS ONE			English	Article							OBJECT TRANSPORT; ARM MOVEMENTS; GENDER-DIFFERENCES; FINGERTIP FORCES; LOAD FORCE; GAIT; COORDINATION; PERFORMANCE; STABILITY; CHILDREN	The aim of this study was to determine whether the internal model regulating grip force (GF)/load force (LF) coordination during a brisk load increase is preserved when the lower extremities produce a perturbation during a single step-down task. We observed the coordination of the vertical ground reaction force (vGRF), GF and LF while holding a handheld object during a single step-down task. The 3 forces (vGRF, GF and LF) decreased during the start of the task. While the subject was descending, LF and GF became dissociated from vGRF and increased in value, probably to anticipate the first foot contact. Coordination of LF and GF was maintained until the maximal vGRF (knee extension). LF peaked in the same time window as vGRF, whereas GF peaked about 70 ms later. This desynchronization, which was previously observed in direct load increase on a handheld object, was interpreted to be a predictive action to ensure the smooth management of the brisk increase in load induced by the lower extremities. Incidentally, in this group, kinematic and dynamic differences were observed between men and women, which may highlight a gender-specific strategy to perform the step-down task. In conclusion, these results suggest that the internal model of precision grip is able to integrate a brisk load change, whatever its origin, and regulate the forces to provide an ideal GF to dampen a brisk load increase and secure the object.	[Ebner-Karestinos, Daniela; Thonnard, Jean-Louis; Bleyenheuft, Yannick] Catholic Univ Louvain, Inst Neurosci, Brussels, Belgium; [Thonnard, Jean-Louis] Catholic Univ Louvain, Phys & Rehabil Med Dept, Clin Univ St Luc, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Bleyenheuft, Y (corresponding author), Catholic Univ Louvain, Inst Neurosci, Brussels, Belgium.	yannick.bleyenheuft@uclouvain.be	Bleyenheuft, Yannick/ABA-1472-2021	Bleyenheuft, Yannick/0000-0002-6688-932X; Ebner Karestinos, Daniela/0000-0002-5941-8706				Augurelle AS, 2003, J NEUROPHYSIOL, V89, P665, DOI 10.1152/jn.00249.2002; Bleyenheuft Y, 2010, J MOTOR BEHAV, V42, P169, DOI 10.1080/00222891003765843; Bleyenheuft Y, 2010, NEUROREHAB NEURAL RE, V24, P318, DOI 10.1177/1545968309353327; Bleyenheuft Y, 2009, J MOTOR BEHAV, V41, P411, DOI 10.3200/35-08-084; DAVIS BL, 1993, J BIOMECH, V26, P593, DOI 10.1016/0021-9290(93)90020-F; Delevoye-Turrell YN, 2003, Q J EXP PSYCHOL-A, V56, P1113, DOI 10.1080/02724980245000025; Descoins M, 2006, EXP BRAIN RES, V172, P331, DOI 10.1007/s00221-005-0340-3; Dierick F, 2004, GAIT POSTURE, V20, P299, DOI 10.1016/j.gaitpost.2003.11.001; Diermayr G, 2008, EXP BRAIN RES, V190, P337, DOI 10.1007/s00221-008-1476-8; Ferber R, 2003, CLIN BIOMECH, V18, P350, DOI 10.1016/S0268-0033(03)00025-1; FLANAGAN JR, 1995, EXP BRAIN RES, V105, P455; FLANAGAN JR, 1993, EXP BRAIN RES, V95, P131; FLANAGAN JR, 1993, NEUROSCI LETT, V152, P53, DOI 10.1016/0304-3940(93)90481-Y; Gysin P, 2003, EXP BRAIN RES, V149, P371, DOI 10.1007/s00221-003-1380-1; Gysin P, 2009, SENSORIMOTOR CONTROL, P219; Gysin P, 2008, J NEUROPHYSIOL, V100, P2477, DOI 10.1152/jn.90561.2008; Hamel KA, 2004, J AM GERIATR SOC, V52, P563, DOI 10.1111/j.1532-5415.2004.52162.x; Hollman JH, 2011, AM J MENS HEALTH, V5, P11, DOI 10.1177/1557988309357232; Hsue BJ, 2014, ARCH PHYS MED REHAB, V95, P1860, DOI 10.1016/j.apmr.2014.05.001; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P72; LACQUANITI F, 1993, J NEUROPHYSIOL, V69, P1443, DOI 10.1152/jn.1993.69.5.1443; LACQUANITI F, 1992, J NEUROSCI, V12, P1750; Marasovic Tea, 2009, WSEAS Transactions on Systems, V8, P1105; Oh-Park M, 2013, AGING CLIN EXP RES, V25, P99, DOI 10.1007/s40520-013-0014-0; Prabhu SB, 2011, DEV MED CHILD NEUROL, V53, P865, DOI 10.1111/j.1469-8749.2011.04061.x; Turrell YN, 1999, EXP BRAIN RES, V128, P86, DOI 10.1007/s002210050822; WESTLING G, 1984, EXP BRAIN RES, V53, P277; White O, 2005, EXP BRAIN RES, V163, P324, DOI 10.1007/s00221-004-2175-8; White O, 2011, NEUROSCIENCE, V189, P269, DOI 10.1016/j.neuroscience.2011.04.055; White O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044291; Witney AG, 1999, J NEUROPHYSIOL, V82, P2039, DOI 10.1152/jn.1999.82.5.2039; Yan J, 2007, HDB BIOMECHANICS HUM, P565; Yan JH, 1995, J COMP PE SPORT, V17, P38; Yogev-Seligmann G, 2010, PHYS THER, V90, P177, DOI 10.2522/ptj.20090043; ZACHAZEWSKI JE, 1993, J REHABIL RES DEV, V30, P412	35	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165549	10.1371/journal.pone.0165549	http://dx.doi.org/10.1371/journal.pone.0165549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802343	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200026
J	Prada, E; Atuyambe, LM; Blades, NM; Bukenya, JN; Orach, CG; Bankole, A				Prada, Elena; Atuyambe, Lynn M.; Blades, Nakeisha M.; Bukenya, Justine N.; Orach, Christopher Garimoi; Bankole, Akinrinola			Incidence of Induced Abortion in Uganda, 2013: New Estimates Since 2003	PLOS ONE			English	Article							SEX WORKERS; CARE; MISOPROSTOL; COUNTRIES	Background In Uganda, abortion is permitted only when the life of a woman is in danger. This restriction compels the perpetuation of the practice in secrecy and often under unsafe conditions. In 2003, 294,000 induced abortions were estimated to occur each year in Uganda. Since then, no other research on abortion incidence has been conducted in the country. Methods Data from 418 health facilities were used to estimate the number and rate of induced abortion in 2013. An indirect estimation methodology was used to calculate the annual incidence of induced abortions-nationally and by major regions. The use of a comparable methodology in an earlier study permits assessment of trends between 2003 and 2013. Results In 2013, an estimated 128,682 women were treated for abortion complications and an estimated 314,304 induced abortions occurred, both slightly up from 110,000 and 294,000 in 2003, respectively. The national abortion rate was 39 abortions per 1,000 women aged 15-49, down from 51 in 2003. Regional variation in abortion rates is very large, from as high as an estimated 77 per 1,000 women 15-49 in Kampala region, to as low as 18 per 1,000 women in Western region. The overall pregnancy rate also declined from 326 to 288; however the proportion of pregnancies that were unintended increased slightly, from 49% to 52%. Conclusion Unsafe abortion remains a major problem confronting Ugandan women. Although the overall pregnancy rate and the abortion rate declined in the past decade, the majority of pregnancies to Ugandan women are still unintended. These findings reflect the increase in the use of modern contraception but also suggest that a large proportion of women are still having difficulty practicing contraception effectively. Improved access to contraceptive services and abortion-related care are still needed.	[Atuyambe, Lynn M.; Bukenya, Justine N.; Orach, Christopher Garimoi] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Blades, Nakeisha M.; Bankole, Akinrinola] Guttmacher Inst, 125 Maiden Lane, New York, NY USA	Makerere University	Atuyambe, LM (corresponding author), Makerere Univ, Sch Publ Hlth, Kampala, Uganda.	eprada@guttmacher.org			UK Government [203177-101]; Dutch Ministry of Foreign Affairs [24590]; Norwegian Agency for Development Cooperation [1300340]	UK Government; Dutch Ministry of Foreign Affairs; Norwegian Agency for Development Cooperation	Funding to support this research was provided by: the UK Government (https://www.gov.uk/government/organisations/department-for-international-development), grant number: 203177-101; the Dutch Ministry of Foreign Affairs (https://www.government.nl/ministries/ministry-of-foreign-affairs), grant number: 24590; and the Norwegian Agency for Development Cooperation (https://www.norad.no/en/front/), grant number: 1300340. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguzu Ronald, 2014, BMC Res Notes, V7, P153, DOI 10.1186/1756-0500-7-153; [Anonymous], UNWANTED PREGNANCY I; Atukunda EC, 2015, SOC SCI MED, V130, P242, DOI 10.1016/j.socscimed.2015.02.022; Basinga P., 2012, UNINTENDED PREGNANCY; Basinga P, 2012, STUD FAMILY PLANN, V43, P11, DOI 10.1111/j.1728-4465.2012.00298.x; Bellizzi S, 2015, HUM REPROD, V30, P973, DOI 10.1093/humrep/deu348; Bongaarts J, 1983, FERTILITY BIOL BEHAV; Center for Health Human Rights and Development, 2016, FAC UG LAW AB EXP WO; Haddad Lisa B, 2009, Rev Obstet Gynecol, V2, P122; Harlap S, 1980, HUMAN EMBRYONIC FETA, P145; Hussain R, 2013, 2 GUTTM I; International Organization for Migration, 2008, HIV HOT SPOT MAPP SI; Jagwe-Wadda G, 2006, 26 GUTTM I; Kakaire O., 2014, OPEN J OBSTET GYNECO, V4, P1087; Kiggundu C., 2008, UGANDA ABORTION SITU; Lakwo A., 2008, W NILE PROFILING REP; Leridon H., 1977, HUMAN FERTILITY BASI; Marlow HM, 2014, CULT HEALTH SEX, V16, P931, DOI 10.1080/13691058.2014.922218; Mbonye AK, 2007, INT J GYNECOL OBSTET, V96, P220, DOI 10.1016/j.ijgo.2006.12.017; Morris CN, 2006, SEX TRANSM INFECT, V82, P368, DOI 10.1136/sti.2006.020933; Paccione G., 2016, ANN GLOB HEALTH, V82, P375, DOI [10.1016/j.aogh.2016.04.614, DOI 10.1016/J.AOGH.2016.04.614]; Prada E, 2005, ABORTION POSTABORTIO, V17; Prada E., 2005, 17 GUTTM I; Prada E, 2011, INT PERSPECT SEX R H, V37, P114, DOI 10.1363/3711411; Remez Alyssa., 2010, METHODOLOGIES ESTIMA, P71; Scorgie F, 2013, CULT HEALTH SEX, V15, P450, DOI 10.1080/13691058.2012.763187; Singh S, 2005, INT FAM PLAN PERSPEC, V31, P183, DOI 10.1363/3118305; Singh S., 2014, ADD COSTS BEN INV SE; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Singh S, 2010, INT PERSPECT SEX R H, V36, P16, DOI 10.1363/ipsrh.36.016.10; Sundaram A, 2013, INT PERSPECT SEX R H, V39, P174, DOI 10.1363/3917413; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; Uganda Bureau of Statistics, 2001, UG DEM HLTH SURV 200; Uganda Bureau of Statistics, 2012, UG DEM HLTH SURV 201; Uganda Bureau of Statistics Macro International Inc, 2007, UG DEM HLTH SURV 200; Uganda Ministry of Finance Planning and Economic Development, 2010, MILL DEV GOALS REP U; Uganda Ministry of Health, 2007, ROADM ACC RED MAT NE; Uganda Ministry of Health, 2010, HLTH SECT STRAT PLAN; Uganda Ministry of Health World Health Organization, 2006, SERV AV MAPP UG; United Nation Children's Fund, 2007, UG UNICEF HUM SIT RE; United Nations Department of Economic and Social Affairs, WORLD POP PROSP 2015; United Nations Department of Economic and Social Affairs Population Division, 2010, STESASERA293 UN DEP; United Nations Department of Economic and Social Affairs Population Division, 2014, AB POL REPR HLTH WOR; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD CONTR PATT 201; Vlassoff M, 2012, HLTH POLICY PLANNING, V29, P56, DOI [10.1093/heapol/czs133, DOI 10.1093/HEAPOL/CZS133]; Weeks A, 2005, OBSTET GYNECOL, V106, P540, DOI 10.1097/01.AOG.0000173799.82687.dc; Westoff C., 2012, 28 ICF INT; World Health Organization, 2013, UNS AB GLOB REG EST	48	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165812	10.1371/journal.pone.0165812	http://dx.doi.org/10.1371/journal.pone.0165812			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6CX	27802338	Green Submitted, Green Published, gold			2022-12-27	WOS:000386714200057
J	Weber, L; Thoelken, C; Volk, M; Remes, B; Lechner, M; Klug, G				Weber, Lennart; Thoelken, Clemens; Volk, Marcel; Remes, Bernhard; Lechner, Marcus; Klug, Gabriele			The Conserved Dcw Gene Cluster of R. sphaeroides Is Preceded by an Uncommonly Extended 5' Leader Featuring the sRNA UpsM	PLOS ONE			English	Article							CELL-ENVELOPE BIOSYNTHESIS; REGULATORY SMALL RNAS; ESCHERICHIA-COLI; RHODOBACTER-SPHAEROIDES; MESSENGER-RNA; PHOTOOXIDATIVE STRESS; RIBONUCLEIC-ACID; DIVISION GENES; SINGLET OXYGEN; E. COLI	Cell division and cell wall synthesis mechanisms are similarly conserved among bacteria. Consequently some bacterial species have comparable sets of genes organized in the dcw (division and cell wall) gene cluster. Dcw genes, their regulation and their relative order within the cluster are outstandingly conserved among rod shaped and gram negative bacteria to ensure an efficient coordination of growth and division. A well studied representative is the dcw gene cluster of E. coli. The first promoter of the gene cluster (mraZ1p) gives rise to polycistronic transcripts containing a 38 nt long 5' UTR followed by the first gene mraZ. Despite reported conservation we present evidence for a much longer 5' UTR in the gram negative and rod shaped bacterium Rhodobacter sphaeroides and in the family of Rhodo-bacteraceae. This extended 268 nt long 5' UTR comprises a Rho independent terminator, which in case of termination gives rise to a non-coding RNA (UpsM). This sRNA is conditionally cleaved by RNase E under stress conditions in an Hfq- and very likely target mRNA-dependent manner, implying its function in trans. These results raise the question for the regulatory function of this extended 5' UTR. It might represent the rarely described case of a trans acting sRNA derived from a riboswitch with exclusive presence in the family of Rhodobacteraceae.	[Weber, Lennart; Volk, Marcel; Remes, Bernhard; Klug, Gabriele] Univ Giessen, IFZ, Inst Microbiol & Mol Biol, Giessen, Germany; [Thoelken, Clemens; Lechner, Marcus] Philipps Univ Marburg, Inst Pharmaceut Chem, Marburg, Germany	Justus Liebig University Giessen; Philipps University Marburg	Klug, G (corresponding author), Univ Giessen, IFZ, Inst Microbiol & Mol Biol, Giessen, Germany.	Gabriele.Klug@mikro.bio.uni-giessen.de	Klug, Gabriele/K-5322-2014	Klug, Gabriele/0000-0002-3527-5093; Tholken, Clemens/0000-0003-4328-9193	Deutsche Forschungsgemeinschaft [DFG KI563/20]; DFG International Research Training Group [GRK1384]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG International Research Training Group(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/) (DFG KI563/20) and the DFG funded International Research Training Group (GRK1384) (LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnan F, 2015, RNA BIOL, V12, P569, DOI 10.1080/15476286.2015.1031948; APIRION D, 1978, GENETICS, V90, P659; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; Berghoff BA, 2011, MOL MICROBIOL, V80, P1479, DOI 10.1111/j.1365-2958.2011.07658.x; Berghoff BA, 2009, MOL MICROBIOL, V74, P1497, DOI 10.1111/j.1365-2958.2009.06949.x; Billenkamp F, 2015, J BACTERIOL, V197, P1839, DOI 10.1128/JB.02475-14; Bilusic I, 2014, RNA BIOL, V11, P641, DOI 10.4161/rna.29299; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Carrion M, 1999, BIOCHIMIE, V81, P879, DOI 10.1016/S0300-9084(00)87172-2; Chao YJ, 2016, MOL CELL, V61, P352, DOI 10.1016/j.molcel.2015.12.023; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; de la Fuente A, 2001, BIOCHIMIE, V83, P109, DOI 10.1016/S0300-9084(00)01212-8; Dufour YS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002929; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eraso JM, 2014, J BACTERIOL, V196, P2053, DOI 10.1128/JB.01370-13; Garst AD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003533; Glaeser J, 2005, MICROBIOL-SGM, V151, P1927, DOI 10.1099/mic.0.27789-0; GOLDBLUM K, 1981, J BACTERIOL, V146, P128, DOI 10.1128/JB.146.1.128-132.1981; Hara H, 1997, J BACTERIOL, V179, P5802, DOI 10.1128/jb.179.18.5802-5811.1997; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Ikeda Y, 2011, MOL MICROBIOL, V79, P419, DOI 10.1111/j.1365-2958.2010.07454.x; JANZON L, 1986, FEMS MICROBIOL LETT, V33, P193; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; Kim HM, 2014, NUCLEIC ACIDS RES, V42, P2003, DOI 10.1093/nar/gkt1071; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lovett PS, 1996, MICROBIOL REV, V60, P366, DOI 10.1128/MMBR.60.2.366-385.1996; Mank NN, 2012, P NATL ACAD SCI USA, V109, P16306, DOI 10.1073/pnas.1207067109; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mengin-Lecreulx D, 1998, J BACTERIOL, V180, P4406, DOI 10.1128/JB.180.17.4406-4412.1998; Mingorance J, 2004, J MOL RECOGNIT, V17, P481, DOI 10.1002/jmr.718; Miyakoshi M, 2015, EMBO J, V34, P1478, DOI 10.15252/embj.201490546; Miyakoshi M, 2015, CURR OPIN MICROBIOL, V24, P132, DOI 10.1016/j.mib.2015.01.013; Nuss AM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005087; Nuss AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079520; Nuss AM, 2010, J BACTERIOL, V192, P2613, DOI 10.1128/JB.01605-09; Nuss AM, 2009, J BACTERIOL, V191, P220, DOI 10.1128/JB.00925-08; Papenfort K, 2015, P NATL ACAD SCI USA, V112, pE766, DOI 10.1073/pnas.1500203112; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeiffer V, 2009, NAT STRUCT MOL BIOL, V16, P840, DOI 10.1038/nsmb.1631; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Raghavan R, 2011, GENOME RES, V21, P1487, DOI 10.1101/gr.119370.110; Remes B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-794; Saramago M, 2014, CURR OPIN MICROBIOL, V18, P105, DOI 10.1016/j.mib.2014.02.009; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tamames J, 2001, TRENDS GENET, V17, P124, DOI 10.1016/S0168-9525(00)02212-5; Tamames J, 2001, GENOME BIOL, V2; Vicente M, 1998, CELL MOL LIFE SCI, V54, P317, DOI 10.1007/s000180050158; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Will S, 2012, RNA, V18, P900, DOI 10.1261/rna.029041.111; Wolfinger MT, 2004, J PHYS A-MATH GEN, V37, P4731, DOI 10.1088/0305-4470/37/17/005	59	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165694	10.1371/journal.pone.0165694	http://dx.doi.org/10.1371/journal.pone.0165694			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802301	gold, Green Published, Green Submitted			2022-12-27	WOS:000386714200039
J	Gupta, J; Misra, S; Misra-Bhattacharya, S				Gupta, Jyoti; Misra, Sweta; Misra-Bhattacharya, Shailja			Immunization with Brugia malayi Myosin as Heterologous DNA Prime Protein Boost Induces Protective Immunity against B-malayi Infection in Mastomys coucha	PLOS ONE			English	Article							LYMPHATIC FILARIASIS; MULTIVALENT VACCINE; ANTIGEN-B; RESPONSES; CHALLENGE; LARVAE; PARAMYOSIN; CANDIDATE; GENE; TROPOMYOSIN	The current control strategies employing chemotherapy with diethylcarbamazine, ivermectin and albendazole have reduced transmission in some filaria-endemic areas, there is growing interest for complementary approaches, such as vaccines especially in light of threat of parasite developing resistance to mainstay drugs. We earlier demonstrated recombinant heavy chain myosin of B. malayi (Bm-Myo) as a potent vaccine candidate whose efficacy was enhanced by heterologous DNA prime/protein boost (Myo-pcD+Bm-Myo) vaccination in BALB/c mice. BALB/c mouse though does not support the full developmental cycle of B. malayi, however, the degree of protection may be studied in terms of transformation of challenged infective larvae (L3) to next stage (L4) with an ease of delineating the generated immunological response of host. In the current investigation, DNA vaccination with Bm-Myo was therefore undertaken in susceptible rodent host, Mastomys coucha (M. coucha) which sustains the challenged L3 and facilitates their further development to sexually mature adult parasites with patent microfilaraemia. Immunization schedule consisted of Myo-pcD and Myo-pcD+Bm-Myo followed by B. malayi L3 challenge and the degree of protection was evaluated by observing microfilaraemia as well as adult worm establishment. Myo-pcD+Bm-Myo immunized animals not only developed 78.5% reduced blood microfilarial density but also decreased adult worm establishment by 75.3%. In addition, 75.4% of the recovered live females revealed sterilization over those of respective control animals. Myo-pcD+BmMyo triggered higher production of specific IgG and its isotypes which induced marked cellular adhesion and cytotoxicity (ADCC) to microfilariae (mf) and L3 in vitro. Both Th1 and Th2 cytokines were significantly up-regulated displaying a mixed immune response conferring considerable protection against B. malayi establishment by engendering a long-lasting effective immune response and therefore emerges as a potential vaccination method against LF.	[Gupta, Jyoti; Misra, Sweta; Misra-Bhattacharya, Shailja] Cent Drug Res Inst, CSIR, Div Parasitol, BS 10-1,Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India; [Gupta, Jyoti; Misra, Sweta; Misra-Bhattacharya, Shailja] Acad Sci & Innovat Res, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Academy of Scientific & Innovative Research (AcSIR)	Misra-Bhattacharya, S (corresponding author), Cent Drug Res Inst, CSIR, Div Parasitol, BS 10-1,Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.; Misra-Bhattacharya, S (corresponding author), Acad Sci & Innovat Res, New Delhi, India.	shailja_bhattacharya@cdri.res.in			Council of Scientific and Industrial Research (CSIR), New Delhi; CSIR-Network project SPIenDID	Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India); CSIR-Network project SPIenDID	The financial support was received in the form of research fellowship from Council of Scientific and Industrial Research (CSIR), New Delhi, to JG, SM. Authors also wish to acknowledge funding support provided to SMB via the CSIR-Network project SPIenDID. The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alekseeva Ekaterina, 2009, Genet Vaccines Ther, V7, P7, DOI 10.1186/1479-0556-7-7; Arumugam S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-43; Babayan SA, 2006, INT J PARASITOL, V36, P903, DOI 10.1016/j.ijpara.2006.04.013; Babu S, 2006, J IMMUNOL, V176, P3248, DOI 10.4049/jimmunol.176.5.3248; Babu S, 2014, PARASITE IMMUNOL, V36, P338, DOI 10.1111/pim.12081; Bergquist NR, 1998, PARASITOL TODAY, V14, P99, DOI 10.1016/S0169-4758(97)01207-6; Cassataro J, 2007, CLIN VACCINE IMMUNOL, V14, P869, DOI 10.1128/CVI.00472-06; Catmull J, 1999, VACCINE, V17, P31, DOI 10.1016/S0264-410X(98)00147-9; CHANDRASHEKAR R, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P15; CHANDRASHEKAR R, 1985, PARASITE IMMUNOL, V7, P633, DOI 10.1111/j.1365-3024.1985.tb00107.x; Dakshinamoorthy G, 2013, VACCINE, V32, P19, DOI 10.1016/j.vaccine.2013.10.083; Dakshinamoorthy G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034077; Diefenbach A, 1998, IMMUNITY, V8, P77, DOI 10.1016/S1074-7613(00)80460-4; Dimock KA, 1996, INFECT IMMUN, V64, P2962, DOI 10.1128/IAI.64.8.2962-2967.1996; Dunachie SJ, 2003, J EXP BIOL, V206, P3771, DOI 10.1242/jeb.00642; ELSON LH, 1995, J INFECT DIS, V171, P652, DOI 10.1093/infdis/171.3.652; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; Fonseca Cristina Toscano, 2012, J Parasitol Res, V2012, P541268, DOI 10.1155/2012/541268; Gobert GN, 1998, PARASITOL TODAY, V14, P115, DOI 10.1016/S0169-4758(97)01205-2; Gregory WF, 2000, INFECT IMMUN, V68, P4174, DOI 10.1128/IAI.68.7.4174-4179.2000; Gupta J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142548; Harrison RA, 1999, VACCINE, V18, P647, DOI 10.1016/S0264-410X(99)00274-1; Harrison RA, 2000, PARASITE IMMUNOL, V22, P249, DOI 10.1046/j.1365-3024.2000.00304.x; Jenkins RE, 1998, P NATL ACAD SCI USA, V95, P7550, DOI 10.1073/pnas.95.13.7550; Kalyanasundaram R, 2011, RES REP TROP MED, V2, P45, DOI 10.2147/RRTM.S13679; Kushwaha S, 2012, PARASITE IMMUNOL, V34, P199, DOI 10.1111/j.1365-3024.2012.01352.x; Kushwaha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072585; Kushwaha S, 2012, MICROBES INFECT, V14, P1330, DOI 10.1016/j.micinf.2012.08.006; LACLETTE JP, 1987, J PARASITOL, V73, P121, DOI 10.2307/3282356; LACLETTE JP, 1991, MOL BIOCHEM PARASIT, V44, P287, DOI 10.1016/0166-6851(91)90015-X; Li BW, 1999, VACCINE, V18, P76, DOI 10.1016/S0264-410X(99)00182-6; Liang R, 2005, VACCINE, V23, P5252, DOI 10.1016/j.vaccine.2005.06.025; Linehan LA, 1998, J IMMUNOL, V161, P302; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loukas A, 2001, INFECT IMMUN, V69, P3646, DOI 10.1128/IAI.69.6.3646-3651.2001; Marcilla A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045974; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Nag JK, 2013, COMP IMMUNOL MICROB, V36, P25, DOI 10.1016/j.cimid.2012.09.004; Ramachandran S, 2004, MICROBIOL IMMUNOL, V48, P945, DOI 10.1111/j.1348-0421.2004.tb03624.x; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Saeftel M, 2003, INFECT IMMUN, V71, P6978, DOI 10.1128/IAI.71.12.6978-6985.2003; Shakya S, 2009, PARASITOL INT, V58, P346, DOI 10.1016/j.parint.2009.07.007; Shrivastava N, 2013, COMP IMMUNOL MICROB, V36, P507, DOI 10.1016/j.cimid.2013.05.003; SIM BKL, 1982, T ROY SOC TROP MED H, V76, P362, DOI 10.1016/0035-9203(82)90191-2; Singh M, 2012, J BIOTECHNOL, V157, P351, DOI 10.1016/j.jbiotec.2011.12.003; Singh PK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/590281; Specht S, 2004, INFECT IMMUN, V72, P6287, DOI 10.1128/IAI.72.11.6287-6293.2004; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; Taylor MJ, 1996, PARASITE IMMUNOL, V18, P219, DOI 10.1046/j.1365-3024.1996.d01-93.x; Thirugnanam S, 2007, EXP PARASITOL, V116, P483, DOI 10.1016/j.exppara.2007.02.017; Vaine M, 2010, VACCINE, V28, P2999, DOI 10.1016/j.vaccine.2010.02.006; Vanam U, 2009, AM J TROP MED HYG, V80, P319, DOI 10.4269/ajtmh.2009.80.319; Vedi S, 2008, VACCINE, V26, P5997, DOI 10.1016/j.vaccine.2008.08.073; Veerapathran A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000457	54	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164991	10.1371/journal.pone.0164991	http://dx.doi.org/10.1371/journal.pone.0164991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828973	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300024
J	Palm, MM; Dallinga, MG; van Dijk, E; Klaassen, I; Schlingemann, RO; Merks, RMH				Palm, Margriet M.; Dallinga, Marchien G.; van Dijk, Erik; Klaassen, Ingeborg; Schlingemann, Reinier O.; Merks, Roeland M. H.			Computational Screening of Tip and Stalk Cell Behavior Proposes a Role for Apelin Signaling in Sprout Progression	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; IN-VITRO; UP-REGULATION; VASCULAR DEVELOPMENT; ANGIOGENIC FACTOR; BLOOD-VESSELS; TUMOR-GROWTH; NOTCH; VEGF; EXPRESSION	Angiogenesis involves the formation of new blood vessels by sprouting or splitting of existing blood vessels. During sprouting, a highly motile type of endothelial cell, called the tip cell, migrates from the blood vessels followed by stalk cells, an endothelial cell type that forms the body of the sprout. To get more insight into how tip cells contribute to angiogenesis, we extended an existing computational model of vascular network formation based on the cellular Potts model with tip and stalk differentiation, without making a priori assumptions about the differences between tip cells and stalk cells. To predict potential differences, we looked for parameter values that make tip cells (a) move to the sprout tip, and (b) change the morphology of the angiogenic networks. The screening predicted that if tip cells respond less effectively to an endothelial chemoattractant than stalk cells, they move to the tips of the sprouts, which impacts the morphology of the networks. A comparison of this model prediction with genes expressed differentially in tip and stalk cells revealed that the endothelial chemoattractant Apelin and its receptor APJ may match the model prediction. To test the model prediction we inhibited Apelin signaling in our model and in an in vitro model of angiogenic sprouting, and found that in both cases inhibition of Apelin or of its receptor APJ reduces sprouting. Based on the prediction of the computational model, we propose that the differential expression of Apelin and APJ yields a "self-generated" gradient mechanisms that accelerates the extension of the sprout.	[Palm, Margriet M.; van Dijk, Erik; Merks, Roeland M. H.] Ctr Wiskunde & Informat, Life Sci Grp, Amsterdam, Netherlands; [Dallinga, Marchien G.; Klaassen, Ingeborg; Schlingemann, Reinier O.] Acad Med Ctr, Ocular Angiogenesis Grp, Amsterdam, Netherlands; [Merks, Roeland M. H.] Leiden Univ, Math Inst, Leiden, Netherlands; [Palm, Margriet M.] Leiden Univ, LACDR, Div Toxicol, Leiden, Netherlands; [van Dijk, Erik] Vrije Univ Amsterdam, Ctr Integrat Bioinformat, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Merks, RMH (corresponding author), Ctr Wiskunde & Informat, Life Sci Grp, Amsterdam, Netherlands.; Merks, RMH (corresponding author), Leiden Univ, Math Inst, Leiden, Netherlands.	merks@cwi.nl	Klaassen, Ingeborg/F-7333-2015; Merks, Roeland/A-2249-2008; Palm, Margriet/H-4077-2019	Merks, Roeland/0000-0002-6152-687X; Klaassen, Ingeborg/0000-0003-1695-9403; van Dijk, Erik/0000-0002-6272-2039	Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO); programme "Innovational Research Incentives Scheme Vidi Cross-divisional ALW" [864.10.009]; Netherlands Organisation for Scientific Research (NWO); Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANWB); Stichting Blinden-Penning; Landelijke Stichting voor Blinden en Slechtzienden (LSBS); Stichting MD fonds [UitZicht2012-17]; Nederlandse Vereniging ter Verbetering van het Lot der Blinden; Rotterdamse Stichting Blindenbelangen; Stichting voor Ooglijders; Stichting Nederlands Oogheelkundig Onderzoek	Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); programme "Innovational Research Incentives Scheme Vidi Cross-divisional ALW"; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANWB); Stichting Blinden-Penning; Landelijke Stichting voor Blinden en Slechtzienden (LSBS); Stichting MD fonds; Nederlandse Vereniging ter Verbetering van het Lot der Blinden; Rotterdamse Stichting Blindenbelangen; Stichting voor Ooglijders; Stichting Nederlands Oogheelkundig Onderzoek	This work was financed by the Netherlands Consortium for Systems Biology (NCSB), which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO). The work is part of the research programme "Innovational Research Incentives Scheme Vidi Cross-divisional 2010 ALW" with project number 864.10.009, which is (partly) financed by the Netherlands Organisation for Scientific Research (NWO). The in vitro work was supported by grants from the following Dutch eye funds: Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANWB), Stichting Blinden-Penning, Landelijke Stichting voor Blinden en Slechtzienden (LSBS), Stichting MD fonds (all together cooperated by UitZicht, project # UitZicht2012-17), Nederlandse Vereniging ter Verbetering van het Lot der Blinden, Rotterdamse Stichting Blindenbelangen, Stichting voor Ooglijders and the Stichting Nederlands Oogheelkundig Onderzoek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2010, ENCYCL RES, V2, P897; Angelini TE, 2011, P NATL ACAD SCI USA, V108, P4714, DOI 10.1073/pnas.1010059108; Arima S, 2011, DEVELOPMENT, V138, P4763, DOI 10.1242/dev.068023; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Artel A, 2011, TISSUE ENG PT A, V17, P2133, DOI [10.1089/ten.tea.2010.0571, 10.1089/ten.TEA.2010.0571]; Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445; Bautch VL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006452; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Bentley K, 2014, NAT CELL BIOL, V16, P309, DOI 10.1038/ncb2926; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Boas SEM, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0222-7; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Califano JP, 2008, CELL MOL BIOENG, V1, P122, DOI 10.1007/s12195-008-0022-x; Caolo V, 2010, J BIOL CHEM, V285, P40681, DOI 10.1074/jbc.M110.176065; Claxton S, 2004, GENE EXPR PATTERNS, V5, P123, DOI 10.1016/j.modgep.2004.05.004; Coelho L.P., 2013, JORS, V1, pe3, DOI [10.5334/jors.ac, DOI 10.5334/JORS.AC]; Cox CM, 2006, DEV BIOL, V296, P177, DOI 10.1016/j.ydbio.2006.04.452; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Dougherty ER, 2003, SPIE TUTORIAL TEXTS; Eyries M, 2008, CIRC RES, V103, P432, DOI 10.1161/CIRCRESAHA.108.179333; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Funahashi Yasuhiro, 2010, J Angiogenes Res, V2, P3, DOI 10.1186/2040-2384-2-3; Gamba A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118101; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Graham R. L., 1972, Information Processing Letters, V1, P132, DOI 10.1016/0020-0190(72)90045-2; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Guidolin D, 2004, MICROVASC RES, V67, P117, DOI 10.1016/j.mvr.2003.11.002; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Hara C, 2013, INVEST OPHTH VIS SCI, V54, P4321, DOI 10.1167/iovs.13-11611; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Jackson T, 2010, B MATH BIOL, V72, P830, DOI 10.1007/s11538-009-9471-1; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jakobsson L, 2009, BIOCHEM SOC T, V37, P1233, DOI 10.1042/BST0371233; Kalin RE, 2007, DEV BIOL, V305, P599, DOI 10.1016/j.ydbio.2007.03.004; Kasai A, 2004, BIOCHEM BIOPH RES CO, V325, P395, DOI 10.1016/j.bbrc.2004.10.042; Kasai A, 2008, ARTERIOSCL THROM VAS, V28, P1717, DOI 10.1161/ATVBAHA.108.163402; Kasai A, 2013, ANGIOGENESIS, V16, P723, DOI 10.1007/s10456-013-9349-6; Kidoya H, 2008, EMBO J, V27, P522, DOI 10.1038/sj.emboj.7601982; Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996; Kohn-Luque A, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/066007; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Long BL, 2013, J THEOR BIOL, V326, P43, DOI 10.1016/j.jtbi.2012.11.030; Manoussaki D, 1996, ACTA BIOTHEOR, V44, P271, DOI 10.1007/BF00046533; MCCUTCHEON M, 1946, PHYSIOL REV, V26, P319, DOI 10.1152/physrev.1946.26.3.319; Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Merks RMH, 2006, DEV BIOL, V289, P44, DOI 10.1016/j.ydbio.2005.10.003; Merks RMH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000163; Milde F, 2008, BIOPHYS J, V95, P3146, DOI 10.1529/biophysj.107.124511; Namy P, 2004, J THEOR BIOL, V227, P103, DOI 10.1016/j.jtbi.2003.10.015; Palm MM, 2015, METHODS MOL BIOL, V1189, P301, DOI 10.1007/978-1-4939-1164-6_20; Palm MM, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012725; PARK JE, 1994, J BIOL CHEM, V269, P25646; Parsa H, 2011, P NATL ACAD SCI USA, V108, P5133, DOI 10.1073/pnas.1007508108; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Qutub AA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-13; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; Ribatti D, 2011, INT J DEV BIOL, V55, P261, DOI 10.1387/ijdb.103167dr; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Savill NJ, 1997, J THEOR BIOL, V184, P229, DOI 10.1006/jtbi.1996.0237; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Serini G, 2003, EMBO J, V22, P1771, DOI 10.1093/emboj/cdg176; Shirinifard A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002440; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Siemerink MJ, 2012, ANGIOGENESIS, V15, P151, DOI 10.1007/s10456-011-9251-z; Strasser GA, 2010, BLOOD, V115, P5102, DOI 10.1182/blood-2009-07-230284; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8; Szabo A, 2010, MATH MODEL NAT PHENO, V5, P106, DOI 10.1051/mmnp/20105105; Szabo A, 2008, BIOPHYS J, V95, P2702, DOI 10.1529/biophysj.108.129668; Szabo A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.038102; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; Tranqui L, 2000, CR ACAD SCI III-VIE, V323, P31, DOI 10.1016/S0764-4469(00)00110-4; Travasso RDM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019989; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; van Oers RFM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003774; vanHengel J, 1997, J CELL BIOL, V137, P1103, DOI 10.1083/jcb.137.5.1103; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000	104	18	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0159478	10.1371/journal.pone.0159478	http://dx.doi.org/10.1371/journal.pone.0159478			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828952	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300002
J	Veljkovic, V; Veljkovic, N; Paessler, S; Goeijenbier, M; Perovic, V; Glisic, S; Muller, CP				Veljkovic, Veljko; Veljkovic, Nevena; Paessler, Slobodan; Goeijenbier, Marco; Perovic, Vladimir; Glisic, Sanja; Muller, Claude P.			Predicted Enhanced Human Propensity of Current Avian-Like H1N1 Swine Influenza Virus from China	PLOS ONE			English	Article							H5N1; HEMAGGLUTININ; CONSEQUENCES; INFECTION; EVOLUTION	Influenza A virus (IAV) subtypes against which little or no pre-existing immunity exists in humans represent a serious threat to global public health. Monitoring of IAV in animal hosts is essential for early and rapid detection of potential pandemic IAV strains to prevent their spread. Recently, the increased pandemic potential of the avian-like swine H1N1 IAV A/swine/Guangdong/104/2013 has been suggested. The virus is infectious in humans and the general population seems to lack neutralizing antibodies against this virus. Here we present an in silico analysis that shows a strong human propensity of this swine virus further confirming its pandemic potential. We suggest mutations which would further enhance its human propensity. We also propose conserved antigenic determinants which could serve as a component of a prepandemic vaccine. The bioinformatics tool, which can be used to further monitor the evolution of swine influenza viruses towards a pandemic virus, are described here and are made publically available (http://www.vin.bg.ac.rs/180/tools/iav_ mon.php;http://www.biomedprotection.com/iav_mon.php).	[Veljkovic, Veljko; Veljkovic, Nevena; Perovic, Vladimir; Glisic, Sanja] Univ Belgrade, Inst Nucl Sci Vince, Ctr Multidisciplinary Res, Mihajla Petrovica 12-14, Belgrade 11001, Serbia; [Paessler, Slobodan] Univ Texas Med Branch, Dept Pathol, Galveston Natl Lab, 301 Univ Blvd, Galveston, TX 77555 USA; [Goeijenbier, Marco] Erasmus Univ, Med Ctr Rotterdam, Dept Virosci, Rotterdam, Netherlands; [Muller, Claude P.] Luxembourg Inst Hlth, Dept Infect & Immun, 29 Rue Henri Koch, L-4534 Esch Sur Alzette, Grand Duchy Of, Luxembourg	University of Belgrade; University of Texas System; University of Texas Medical Branch Galveston; Erasmus University Rotterdam; Erasmus MC; Luxembourg Institute of Health	Veljkovic, V (corresponding author), Univ Belgrade, Inst Nucl Sci Vince, Ctr Multidisciplinary Res, Mihajla Petrovica 12-14, Belgrade 11001, Serbia.	vv@vinca.rs	Glisic, Sanja/AAE-8590-2019	Glisic, Sanja/0000-0001-5691-1055; Goeijenbier, Marco/0000-0002-3165-8193; Perovic, Vladimir/0000-0002-3700-6452; Veljkovic, Nevena/0000-0001-6562-5800	Ministry of Education, Science and Technological Development of the Republic of Serbia [173001]	Ministry of Education, Science and Technological Development of the Republic of Serbia	This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant no. 173001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant no. 173001).	Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; Perovic VR, 2013, J MATH CHEM, V51, P2238, DOI 10.1007/s10910-013-0212-1; Perovic VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061572; Schmier S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11434; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Veljkovic N, 2008, CURR PROTEIN PEPT SC, V9, P493, DOI 10.2174/138920308785915245; Veljkovic V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01456; Veljkovic V, 2014, VACCINE, V32, P6569, DOI 10.1016/j.vaccine.2014.07.007; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-62; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-21; Wang DY, 2013, EMERG INFECT DIS, V19, P1709, DOI 10.3201/eid1910.130420; Yang HL, 2016, P NATL ACAD SCI USA, V113, P392, DOI 10.1073/pnas.1522643113	12	0	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165451	10.1371/journal.pone.0165451	http://dx.doi.org/10.1371/journal.pone.0165451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828989	Green Submitted, Green Published, gold			2022-12-27	WOS:000387724300047
J	Becker-Bense, S; Buchholz, HG; Baier, B; Schreckenberger, M; Bartenstein, P; Zwergal, A; Brandt, T; Dieterich, M				Becker-Bense, Sandra; Buchholz, Hans-Georg; Baier, Bernhard; Schreckenberger, Mathias; Bartenstein, Peter; Zwergal, Andreas; Brandt, Thomas; Dieterich, Marianne			Functional Plasticity after Unilateral Vestibular Midbrain Infarction in Human Positron Emission Tomography	PLOS ONE			English	Article							BRAIN-STEM; INTERSTITIAL NUCLEUS; THALAMIC ASTASIA; OCULAR TORSION; COMPENSATION; LESION; TILT; CONNECTIVITY; SUBSTITUTION; STIMULATION	The aim of the study was to uncover mechanisms of central compensation of vestibular function at brainstem, cerebellar, and cortical levels in patients with acute unilateral midbrain infarctions presenting with an acute vestibular tone imbalance. Eight out of 17 patients with unilateral midbrain infarctions were selected on the basis of signs of a vestibular tone imbalance, e.g., graviceptive (tilts of perceived verticality) and oculomotor dysfunction (skew deviation, ocular torsion) in F18-fluordeoxyglucose (FDG)-PET at two time points: A) in the acute stage, and B) after recovery 6 months later. Lesion-behavior mapping analyses with MRI verified the exact structural lesion sites. Group subtraction analyses and comparisons with healthy controls were performed with Statistic Parametric Mapping for the PET data. A comparison of PET A of acute-stage patients with that of healthy controls showed increases in glucose metabolism in the cerebellum, motion-sensitive visual cortex areas, and inferior temporal lobe, but none in vestibular cortex areas. At the supratentorial level bilateral signal decreases dominated in the thalamus, frontal eye fields, and anterior cingulum. These decreases persisted after clinical recovery in contrast to the increases. The transient activations can be attributed to ocular motor and postural recovery (cerebellum) and sensory substitution of vestibular function for motion perception (visual cortex). The persisting deactivation in the thalamic nuclei and frontal eye fields allows alternative functional interpretations of the thalamic nuclei: either a disconnection of ascending sensory input occurs or there is a functional mismatch between expected and actual vestibular activity. Our data support the view that both thalami operate separately for each hemisphere but receive vestibular input from ipsilateral and contralateral midbrain integration centers. Normally they have gatekeeper functions for multisensory input to the cortex and automatic motor output to subserve balance and locomotion, as well as sensorimotor integration.	[Becker-Bense, Sandra; Zwergal, Andreas; Dieterich, Marianne] Univ Munich, Dept Neurol, Munich, Germany; [Becker-Bense, Sandra; Bartenstein, Peter; Zwergal, Andreas; Brandt, Thomas; Dieterich, Marianne] Univ Munich, German Ctr Vertigo & Balance Disorders IFB, Munich, Germany; [Buchholz, Hans-Georg; Schreckenberger, Mathias] Johannes Gutenberg Univ Mainz, Dept Nucl Med, Mainz, Germany; [Baier, Bernhard] Johannes Gutenberg Univ Mainz, Dept Neurol, Mainz, Germany; [Bartenstein, Peter] Univ Munich, Dept Nucl Med, Munich, Germany; [Bartenstein, Peter; Dieterich, Marianne] Univ Munich, Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Brandt, Thomas] Univ Munich, Inst Clin Neurosci, Munich, Germany	University of Munich; University of Munich; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Munich; University of Munich; University of Munich	Becker-Bense, S (corresponding author), Univ Munich, Dept Neurol, Munich, Germany.; Becker-Bense, S (corresponding author), Univ Munich, German Ctr Vertigo & Balance Disorders IFB, Munich, Germany.	sandra.bense@med.uni-muenchen.de			German Research Foundation (Deutsche Forschungsgemeinschaft) [DI 379/4-3]; Foundation "Stiftung Rheinland-Pfalz fur Innovation" [961-386261 /759]; German Federal Ministry of Education and Research [01 EO 0901, 01 EO 1401]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Foundation "Stiftung Rheinland-Pfalz fur Innovation"; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study is not industry-sponsored. This work was undertaken at the University Hospitals in Mainz and Munich. The study is supported by the German Research Foundation (Deutsche Forschungsgemeinschaft DI 379/4-3), the Foundation "Stiftung Rheinland-Pfalz fur Innovation" (961-386261 /759), and the German Federal Ministry of Education and Research (grant code 01 EO 0901 and 01 EO 1401 IFB LMU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057596; Alessandrini M, 2009, EUR ARCH OTO-RHINO-L, V266, P1547, DOI 10.1007/s00405-009-0953-4; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; [Anonymous], 2014, BRAIN STRUCT FUNCT, V221, P159, DOI 10.1007/s00429-014-0899-1; Baier B, 2016, NEUROLOGY, V86, P134, DOI 10.1212/WNL.0000000000002238; Baier B, 2012, J NEUROSCI, V32, P14854, DOI 10.1523/JNEUROSCI.0770-12.2012; BARTLETT EJ, 1988, J CEREBR BLOOD F MET, V8, P502, DOI 10.1038/jcbfm.1988.91; Becker-Bense S, 2014, BRAIN STRUCT FUNCT, V219, P1355, DOI 10.1007/s00429-013-0573-z; Becker-Bense S, 2013, NEUROLOGY, V80, P1103, DOI 10.1212/WNL.0b013e31828868a6; Bense S, 2004, ANN NEUROL, V56, P624, DOI 10.1002/ana.20244; Beraneck Mathieu, 2012, Front Neurol, V3, P25, DOI 10.3389/fneur.2012.00025; BERTHOZ A, 1986, PROG BRAIN RES, V64, P325; Brandt T, 1997, ADV NEUROL, V73, P297; Brandt T, 1998, BRAIN, V121, P1749, DOI 10.1093/brain/121.9.1749; Brandt T, 2002, ANN NY ACAD SCI, V956, P230, DOI 10.1111/j.1749-6632.2002.tb02822.x; BRANDT T, 1994, ANN NEUROL, V36, P337, DOI 10.1002/ana.410360304; Brandt T, 1999, LANCET, V354, P746, DOI 10.1016/S0140-6736(99)03179-7; Brandt T, 1998, NEURO-OPHTHALMOLOGY, V19, P83, DOI 10.1076/noph.19.2.83.3944; Brandt T, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00047; Brodoehl S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10515; Buttner-Ennever J.A., 2014, OLSZEWSKI BAXTERS CY; BUTTNERENNEVER JA, 1982, BRAIN, V105, P125, DOI 10.1093/brain/105.1.125; Carrera E, 2004, STROKE, V35, P2826, DOI 10.1161/01.STR.0000147039.49252.2f; Chen AH, 2011, J NEUROSCI, V31, P3082, DOI 10.1523/JNEUROSCI.4476-10.2011; Choi JW, 2015, EUR ARCH OTO-RHINO-L, V272, P1613, DOI 10.1007/s00405-014-2952-3; Cutfield NJ, 2014, NEUROIMAGE-CLIN, V4, P274, DOI 10.1016/j.nicl.2013.12.013; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056; DIETERICH M, 1992, ANN NEUROL, V31, P399, DOI 10.1002/ana.410310409; Dieterich M, 2005, BRAIN, V128, P2052, DOI 10.1093/brain/awh551; DIETERICH M, 1993, ANN NEUROL, V33, P292, DOI 10.1002/ana.410330311; Dieterich M, 2008, BRAIN, V131, P2538, DOI 10.1093/brain/awn042; Dieterich M, 2007, BRAIN, V130, P2108, DOI 10.1093/brain/awm130; Dieterich M, 2015, ANN NY ACAD SCI, V1343, P10, DOI 10.1111/nyas.12585; Dutia MB, 2010, CURR OPIN OTOLARYNGO, V18, P420, DOI 10.1097/MOO.0b013e32833de71f; Elwischger K, 2012, NEUROLOGY, V78, P146, DOI 10.1212/WNL.0b013e31823efc82; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032; Eulenburg PZ, 2010, ANN NEUROL, V68, P241, DOI 10.1002/ana.22063; Frank SM, 2014, J NEUROPHYSIOL, V112, P2481, DOI 10.1152/jn.00078.2014; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1990, HUM BRAIN MAPP, V13, P1038; Gottlich M, 2014, NEUROIMAGE-CLIN, V4, P488, DOI 10.1016/j.nicl.2014.03.003; Guillery RW, 2002, PHILOS T R SOC B, V357, P1809, DOI 10.1098/rstb.2002.1171; Helmchen C, 2002, NEUROLOGY, V59, P1956, DOI 10.1212/01.WNL.0000038387.90128.8D; Helmchen C, 2011, J NEUROL NEUROSUR PS, V82, P309, DOI 10.1136/jnnp.2010.204925; Helmchen C, 2009, ANN NY ACAD SCI, V1164, P104, DOI 10.1111/j.1749-6632.2008.03745.x; Horn AKE, 2000, J COMP NEUROL, V420, P19, DOI 10.1002/(SICI)1096-9861(20000424)420:1<19::AID-CNE2>3.0.CO;2-D; Hufner K, 2011, HIPPOCAMPUS, V21, P855, DOI 10.1002/hipo.20801; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; JONGKEES L B, 1962, Pract Otorhinolaryngol (Basel), V24, P65; Kirsch V, 2016, BRAIN STRUCT FUNCT, V221, P1291, DOI 10.1007/s00429-014-0971-x; Kokkoroyannis T, 1996, J NEUROPHYSIOL, V75, P725, DOI 10.1152/jn.1996.75.2.725; Lopez C., 2012, NEUROSCIENCE, V60, P162; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; MASDEU JC, 1988, ANN NEUROL, V23, P596, DOI 10.1002/ana.410230612; Mossmann S, 1997, NEUROLOGY, V49, P1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rorden C, 2009, NEUROIMAGE, V44, P1355, DOI 10.1016/j.neuroimage.2008.09.031; SALMASO D, 1985, CORTEX, V21, P533, DOI 10.1016/S0010-9452(58)80003-9; Schaltenbrandt G, 1977, ATLAS STEREOTAXY HUM; Schmahmann JD, 2000, MRI ATLAS HUMAN BRAI; Schroeter M, 2009, J CEREBR BLOOD F MET, V29, P1216, DOI 10.1038/jcbfm.2009.36; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Shinder ME, 2014, J NEUROPHYSIOL, V111, P2445, DOI 10.1152/jn.00731.2013; Smith AT, 2012, CEREB CORTEX, V22, P1068, DOI 10.1093/cercor/bhr179; Varrone A, 2009, EUR J NUCL MED MOL I, V36, P2103, DOI 10.1007/s00259-009-1264-0; WESTHEIMER G, 1975, EXP BRAIN RES, V24, P89; WIENHARD K, 1992, J COMPUT ASSIST TOMO, V16, P804, DOI 10.1097/00004728-199209000-00024; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Wuehr M, 2013, GAIT POSTURE, V37, P214, DOI 10.1016/j.gaitpost.2012.07.003; Yang TH, 2014, NEUROLOGY, V82, P1968, DOI 10.1212/WNL.0000000000000480; Zwergal A, 2016, BRAIN STRUCT FUNCT, V221, P159, DOI 10.1007/s00429-014-0899-1; Zwergal A, 2013, NEUROLOGY, V80, P634, DOI 10.1212/WNL.0b013e318281cc43	74	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165935	10.1371/journal.pone.0165935	http://dx.doi.org/10.1371/journal.pone.0165935			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824897	gold, Green Published, Green Submitted			2022-12-27	WOS:000387615200046
J	Plummer, MP; Finnis, ME; Phillips, LK; Kar, P; Bihari, S; Biradar, V; Moodie, S; Horowitz, M; Shaw, JE; Deane, AM				Plummer, Mark P.; Finnis, Mark E.; Phillips, Liza K.; Kar, Palash; Bihari, Shailesh; Biradar, Vishwanath; Moodie, Stewart; Horowitz, Michael; Shaw, Jonathan E.; Deane, Adam M.			Stress Induced Hyperglycemia and the Subsequent Risk of Type 2 Diabetes in Survivors of Critical Illness	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; BLOOD-GLUCOSE; MELLITUS; ADMISSION; IMPACT; PREVALENCE; NIDDM	Objective Stress induced hyperglycemia occurs in critically ill patients who have normal glucose tolerance following resolution of their acute illness. The objective was to evaluate the association between stress induced hyperglycemia and incident diabetes in survivors of critical illness. Design Retrospective cohort study. Setting All adult patients surviving admission to a public hospital intensive care unit (ICU) in South Australia between 2004 and 2011. Patients Stress induced hyperglycemia was defined as a blood glucose >= 11.1 mmol/L (200 mg/dL) within 24 hours of ICU admission. Prevalent diabetes was identified through ICD-10 coding or prior registration with the Australian National Diabetes Service Scheme (NDSS). Incident diabetes was identified as NDSS registration beyond 30 days after hospital discharge until July 2015. The predicted risk of developing diabetes was described as sub-hazard ratios using competing risk regression. Survival was assessed using Cox proportional hazards regression. Main Results Stress induced hyperglycemia was identified in 2,883 (17%) of 17,074 patients without diabetes. The incidence of type 2 diabetes following critical illness was 4.8% (821 of 17,074). The risk of diabetes in patients with stress induced hyperglycemia was approximately double that of those without (HR 1.91 (95% CI 1.62, 2.26), p<0.001) and was sustained regardless of age or severity of illness. Conclusions Stress induced hyperglycemia identifies patients at subsequent risk of incident diabetes.	[Plummer, Mark P.; Finnis, Mark E.; Kar, Palash; Moodie, Stewart; Deane, Adam M.] Royal Adelaide Hosp, Dept Crit Care Serv, Adelaide, SA, Australia; [Plummer, Mark P.; Finnis, Mark E.; Kar, Palash; Deane, Adam M.] Univ Adelaide, Discipline Acute Care Med, Level 5 Eleanor Harrald Bldg, Adelaide, SA, Australia; [Phillips, Liza K.; Horowitz, Michael] Univ Adelaide, Discipline Med, Level 6 Eleanor Harrald Bldg, Adelaide, SA, Australia; [Phillips, Liza K.; Horowitz, Michael] Royal Adelaide Hosp, Dept Endocrinol, Adelaide, SA, Australia; [Bihari, Shailesh] Flinders Univ S Australia, Dept Crit Care Med, Bedford Pk, SA, Australia; [Bihari, Shailesh] Flinders Med Ctr, Dept Intens Care Med, Bedford Pk, SA, Australia; [Biradar, Vishwanath] Lyell McEwin Hosp, Dept Intens Care Med, Elizabeth Vale, SA, Australia; [Shaw, Jonathan E.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Royal Adelaide Hospital; University of Adelaide; University of Adelaide; Royal Adelaide Hospital; Flinders University South Australia; Flinders Medical Centre; Lyell McEwin Hospital; Baker Heart and Diabetes Institute	Plummer, MP (corresponding author), Royal Adelaide Hosp, Dept Crit Care Serv, Adelaide, SA, Australia.; Plummer, MP (corresponding author), Univ Adelaide, Discipline Acute Care Med, Level 5 Eleanor Harrald Bldg, Adelaide, SA, Australia.	mark.philip.plummer@gmail.com	Biradar, Vishwanath/HGF-2417-2022; Deane, Adam/AAF-7370-2020; Horowitz, Michael/AAY-3397-2021	Deane, Adam/0000-0002-7620-5577; Horowitz, Michael/0000-0002-0942-0306; Phillips, Liza/0000-0002-9066-717X; Plummer, Mark/0000-0002-9640-1911; Bihari, Shailesh/0000-0001-7553-8620	Diabetes Australia Research Trust; University of Adelaide, Discipline of Acute Care Medicine Maurice Sando Project Grant	Diabetes Australia Research Trust; University of Adelaide, Discipline of Acute Care Medicine Maurice Sando Project Grant	Salary support was provided to Mark Plummer (National Health and Medical Research Council Postgraduate Scholarship), Liza Phillips (Royal Adelaide Hospital Early Career Fellowship), Palash Kar (Royal Adelaide Hospital A.R. Clarkson Postgraduate Scholarship), Jonathan Shaw (National Health and Medical Research Council of Australia Senior Research Fellow) and Adam Deane (National Health and Medical Research Council of Australia Early Career Fellowship). Data collection was supported by project grants from the Diabetes Australia Research Trust and a University of Adelaide, Discipline of Acute Care Medicine Maurice Sando Project Grant.	Ali Abdelhamid Y, CRITICAL CA IN PRESS; American Diabetes Association, 2002, SCREEN DIAB DIAB S1, V25, P521; [Anonymous], 2011, 2033 0 55 001 CENSUS; [Anonymous], 2015, ISAAC REFERENCE MANU; Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7921; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Buchanan TA, 2001, J CLIN ENDOCR METAB, V86, P989, DOI 10.1210/jc.86.3.989; Carpenter DL, 2015, CRIT CARE MED, V43, pE541, DOI 10.1097/CCM.0000000000001353; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Egi M, 2008, CRIT CARE MED, V36, P2249, DOI 10.1097/CCM.0b013e318181039a; Egi M, 2006, J CRIT CARE, V21, P197, DOI 10.1016/j.jcrc.2006.03.003; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gornik I, 2010, CRIT CARE, V14, DOI 10.1186/cc9101; Gray CS, 2004, AGE AGEING, V33, P71, DOI 10.1093/ageing/afh026; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Kim C, 2007, DIABETES CARE, V30, P1314, DOI 10.2337/dc06-2517; Kim C, 2007, DIABETES CARE, V30, P1102, DOI 10.2337/dc06-2237; MacIntyre EJ, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2012.01.026; McAllister DA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001708; Medicine TSoCC, 2016, CRIT CAR STAT 2016; Okosieme OE, 2008, DIABETES CARE, V31, P1955, DOI 10.2337/dc08-0197; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Plummer MP, 2016, CLIN CHEST MED, V37, P309, DOI 10.1016/j.ccm.2016.01.010; Plummer MP, 2014, INTENS CARE MED, V40, P973, DOI 10.1007/s00134-014-3287-7; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Spijkerman AMW, 2003, DIABETES CARE, V26, P2604, DOI 10.2337/diacare.26.9.2604; Stow PJ, 2006, J CRIT CARE, V21, P133, DOI 10.1016/j.jcrc.2005.11.010; Van Ackerbroeck S, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1064-9; Williams TA, 2008, CRIT CARE MED, V36, P1523, DOI 10.1097/CCM.0b013e318170a405	30	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165923	10.1371/journal.pone.0165923	http://dx.doi.org/10.1371/journal.pone.0165923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824898	Green Published, gold			2022-12-27	WOS:000387615200044
J	Racovita, RC; Jetter, R				Racovita, Radu C.; Jetter, Reinhard			Identification of In-Chain-Functionalized Compounds and Methyl-Branched Alkanes in Cuticular Waxes of Triticum aestivum cv. Bethlehem	PLOS ONE			English	Article							SECONDARY ALCOHOLS; BETA-DIKETONES; LEAF WAX; EPICUTICULAR WAX; ESTERS; LEAVES; BIOSYNTHESIS; KETONES; HYDROCARBONS; DERIVATIVES	In this work, cuticular waxes from flag leaf blades and peduncles of Triticum aestivum cv.Bethlehem were investigated in search for novel wax compounds. Seven wax compound classes were detected that had previously not been reported, and their structures were elucidated using gas chromatography-mass spectrometry of various derivatives. Six of the classes were identified as series of homologs differing by two methylene units, while the seventh was a homologous series with homologs with single methylene unit differences. In the waxes of flag leaf blades, secondary alcohols (predominantly C-27 and C-33), primary/secondary diols (predominantly C-28) and esters of primary/secondary diols (predominantly C-50, combining C-28 diol with C-22 acid) were found, all sharing similar secondary hydroxyl group positions at and around C-12 or omega-12. 7- and 8-hydroxy-2-alkanol esters (predominantly C-35), 7- and 8-oxo-2-alkanol esters (predominantly C-35), and 4-alkylbutan-4-olides (predominantly C28) were found both in flag leaf and peduncle wax mixtures. Finally, a series of even- and odd-numbered alkane homologs was identified in both leaf and peduncle waxes, with an internal methyl branch preferentially on C-11 and C-13 of homologs with even total carbon number and on C-12 of odd-numbered homologs. Biosynthetic pathways are suggested for all compounds, based on common structural features and matching chain length profiles with other wheat wax compound classes.	[Racovita, Radu C.; Jetter, Reinhard] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Jetter, Reinhard] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Jetter, R (corresponding author), Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada.; Jetter, R (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada.	reinhard.jetter@botany.ubc.ca	Racovita, Radu C/Q-8089-2016	Racovita, Radu C/0000-0002-6396-9869	Natural Sciences and Engineering Research Council (Canada) [262461]	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by the Natural Sciences and Engineering Research Council (Canada) Discovery grant #262461 to RJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski NM, 2013, PLANT J, V74, P989, DOI 10.1111/tpj.12185; Ali M, 2001, INDIAN J CHEM B, V40, P698; Basas-Jaumandreu J, 2014, PHYTOCHEM LETT, V10, P240, DOI 10.1016/j.phytol.2014.10.009; BIANCHI G, 1992, PHYTOCHEMISTRY, V31, P3503, DOI 10.1016/0031-9422(92)83716-C; BIANCHI G, 1977, PHYTOCHEMISTRY, V16, P943, DOI 10.1016/S0031-9422(00)86700-X; Buschhaus C, 2013, PHYTOCHEMISTRY, V91, P249, DOI 10.1016/j.phytochem.2012.07.018; Busta L, 2016, PHYTOCHEMISTRY, V121, P38, DOI 10.1016/j.phytochem.2015.10.007; DIEKMAN J, 1967, J ORG CHEM, V32, P3904, DOI 10.1021/jo01287a040; DIERICKX PJ, 1973, PHYTOCHEMISTRY, V12, P1498, DOI 10.1016/0031-9422(73)80597-7; Dong XQ, 2012, HORTIC ENVIRON BIOTE, V53, P288, DOI 10.1007/s13580-012-0036-0; EVANS D, 1975, PHYTOCHEMISTRY, V14, P2447, DOI 10.1016/0031-9422(75)80362-1; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; Hen-Avivi S, 2016, PLANT CELL, V28, P1440, DOI 10.1105/tpc.16.00197; HORN DHS, 1964, AUST J CHEM, V17, P464, DOI 10.1071/CH9640464; HUSSAIN RA, 1982, PHYTOCHEMISTRY, V21, P1393, DOI 10.1016/0031-9422(82)80149-0; Jenks MA, 2002, HORTSCIENCE, V37, P673, DOI 10.21273/HORTSCI.37.4.673; Jetter R, 1999, PHYTOCHEMISTRY, V50, P1359, DOI 10.1016/S0031-9422(98)00369-0; Jetter R, 2000, J CHEM ECOL, V26, P399, DOI 10.1023/A:1005409405771; Jetter R, 2000, PHYTOCHEMISTRY, V55, P169, DOI 10.1016/S0031-9422(00)00274-0; Jetter R, 1996, CAN J BOT, V74, P419, DOI 10.1139/b96-052; Jetter R, 1999, PHYTOCHEMISTRY, V52, P907, DOI 10.1016/S0031-9422(99)00309-X; Jetter R, 2006, ANNU PLANT REV, V23, P145; Ji XF, 2008, PHYTOCHEMISTRY, V69, P1197, DOI 10.1016/j.phytochem.2007.12.008; KINGSTON DG, 1974, CHEM REV, V74, P215, DOI 10.1021/cr60288a004; KOLATTUKUDY PE, 1970, LIPIDS, V5, P259, DOI 10.1007/BF02532477; Kunst L, 2006, ANNU PLANT REV, V23, P182; MANHEIM BS, 1978, PHYTOCHEMISTRY, V17, P1799, DOI 10.1016/S0031-9422(00)88704-X; Mata R, 2003, PHYTOCHEMISTRY, V64, P285, DOI 10.1016/S0031-9422(03)00217-6; MCCLOSKEY JA, 1968, ANAL CHEM, V40, P233, DOI 10.1021/ac60257a071; MCFADDEN WH, 1965, ANAL CHEM, V37, P89, DOI 10.1021/ac60220a022; Mejanelle L, 2003, ORG GEOCHEM, V34, P527, DOI 10.1016/S0146-6380(02)00246-2; MIKKELSEN JD, 1978, ARCH BIOCHEM BIOPHYS, V188, P172, DOI 10.1016/0003-9861(78)90370-3; Millet E, 2013, EUPHYTICA, V190, P1, DOI 10.1007/s10681-012-0725-x; MOLD JD, 1966, BIOCHEMISTRY-US, V5, P455, DOI 10.1021/bi00866a009; Nawrath C, 2006, CURR OPIN PLANT BIOL, V9, P281, DOI 10.1016/j.pbi.2006.03.001; NELSON DR, 1975, J LIPID RES, V16, P12; NETTING AG, 1976, ARCH BIOCHEM BIOPHYS, V174, P613, DOI 10.1016/0003-9861(76)90390-8; NORDBY HE, 1994, J AGR FOOD CHEM, V42, P708, DOI 10.1021/jf00039a021; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Racovita RC, 2016, PHYTOCHEMISTRY, V130, P182, DOI 10.1016/j.phytochem.2016.05.003; Racovita RC, 2015, PHYTOCHEMISTRY, V113, P183, DOI 10.1016/j.phytochem.2014.08.005; RIEDERER M, 1989, PHYSIOL PLANTARUM, V77, P373, DOI 10.1111/j.1399-3054.1989.tb05656.x; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Schneider LM, 2016, J EXP BOT, V67, P2715, DOI 10.1093/jxb/erw105; Speelman EN, 2009, ORG GEOCHEM, V40, P628, DOI 10.1016/j.orggeochem.2009.02.001; STRANSKY K, 1970, COLLECT CZECH CHEM C, V35, P882, DOI 10.1135/cccc19700882; TANTISEWIE B, 1969, Pharmaceutisch Weekblad, V104, P1341; TULLOCH AP, 1969, CAN J CHEMISTRY, V47, P3119, DOI 10.1139/v69-516; TULLOCH AP, 1973, PHYTOCHEMISTRY, V12, P2217, DOI 10.1016/0031-9422(73)85123-4; TULLOCH AP, 1971, PHYTOCHEMISTRY, V10, P871, DOI 10.1016/S0031-9422(00)97158-9; Vermeer CP, 2003, PHYTOCHEMISTRY, V62, P433, DOI 10.1016/S0031-9422(02)00560-5; von Wettstein-Knowles P, 2012, PLANT WAXES ELS, P1; von Wettstein-Knowles P, 2007, PLANT J, V49, P250, DOI 10.1111/j.1365-313X.2006.02956.x; VONWETTSTEINKNOWLES P, 1976, CARLSBERG RES COMMUN, V41, P225, DOI 10.1007/BF02906259; VONWETTSTEINKNOWLES P, 1984, CARLSBERG RES COMMUN, V49, P611, DOI 10.1007/BF02907493; VONWETTSTEINKNOWLES P, 1984, CARLSBERG RES COMMUN, V49, P57, DOI 10.1007/BF02913965; VONWETTSTEINKNOWLES P, 1976, LIPIDS, V11, P478, DOI 10.1007/BF02532839; Wang Y., 2015, J NANOMATER, V2015, P1, DOI DOI 10.1038/SREP18296; Wen M, 2007, PHYTOCHEMISTRY, V68, P2563, DOI 10.1016/j.phytochem.2007.05.029; Wen M, 2006, PHYTOCHEMISTRY, V67, P2494, DOI 10.1016/j.phytochem.2006.08.016; Wen M, 2009, J EXP BOT, V60, P1811, DOI 10.1093/jxb/erp061; Zhao XY, 2015, J NANOMATER, V2015, DOI 10.1155/2015/104193	62	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165827	10.1371/journal.pone.0165827	http://dx.doi.org/10.1371/journal.pone.0165827			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820857	Green Published, gold, Green Submitted			2022-12-27	WOS:000387614800023
J	Schreurs, TJL; Hectors, SJ; Jacobs, I; Grull, H; Nicolay, K; Strijkers, GJ				Schreurs, Tom J. L.; Hectors, Stefanie J.; Jacobs, Igor; Grull, Holger; Nicolay, Klaas; Strijkers, Gustav J.			Quantitative Multi-Parametric Magnetic Resonance Imaging of Tumor Response to Photodynamic Therapy	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; PROSTATE-CANCER; MULTICENTER; ABLATION	Objective The aim of this study was to characterize response to photodynamic therapy (PDT) in a mouse cancer model using a multi-parametric quantitative MRI protocol and to identify MR parameters as potential biomarkers for early assessment of treatment outcome. Methods CT26.WT colon carcinoma tumors were grown subcutaneously in the hind limb of BALB/c mice. Therapy consisted of intravenous injection of the photosensitizer Bremachlorin, followed by 10 min laser illumination (200 mW/cm(2)) of the tumor 6 h post injection. MRI at 7 T was performed at baseline, directly after PDT, as well as at 24 h, and 72 h. Tumor relaxation time constants (T-1 and T-2) and apparent diffusion coefficient (ADC) were quantified at each time point. Additionally, Gd-DOTA dynamic contrast-enhanced (DCE) MRI was performed to estimate transfer constants (K trans) and volume fractions of the extravascular extracellular space (V-e) using standard Tofts-Kermode tracer kinetic modeling. At the end of the experiment, tumor viability was characterized by histology using NADH-diaphorase staining. Results The therapy induced extensive cell death in the tumor and resulted in significant reduction in tumor growth, as compared to untreated controls. Tumor T-1 and T2 relaxation times remained unchanged up to 24 h, but decreased at 72 h after treatment. Tumor ADC values significantly increased at 24 h and 72 h. DCE-MRI derived tracer kinetic parameters displayed an early response to the treatment. Directly after PDT complete vascular shutdown was observed in large parts of the tumors and reduced uptake (decreased K trans) in remaining tumor tissue. At 24 h, contrast uptake in most tumors was essentially absent. Out of 5 animals that were monitored for 2 weeks after treatment, 3 had tumor recurrence, in locations that showed strong contrast uptake at 72 h. Conclusion DCE-MRI is an effective tool for visualization of vascular effects directly after PDT. Endogenous contrast parameters T-1, T-2, and ADC, measured at 24 to 72 h after PDT, are also potential biomarkers for evaluation of therapy outcome.	[Schreurs, Tom J. L.; Jacobs, Igor; Grull, Holger; Nicolay, Klaas] Eindhoven Univ Technol, Biomed NMR, Biomed Engn, Eindhoven, Netherlands; [Hectors, Stefanie J.] Icahn Sch Med Mt Sinai, Dept Radiol, Translat & Mol Imaging Inst, New York, NY 10029 USA; [Grull, Holger] Philips Res, Dept Oncol Solut, Eindhoven, Netherlands; [Strijkers, Gustav J.] Acad Med Ctr, Biomed Engn & Phys, Amsterdam, Netherlands	Eindhoven University of Technology; Icahn School of Medicine at Mount Sinai; Philips; Philips Research; University of Amsterdam; Academic Medical Center Amsterdam	Schreurs, TJL (corresponding author), Eindhoven Univ Technol, Biomed NMR, Biomed Engn, Eindhoven, Netherlands.	t.j.l.schreurs@tue.nl		Hectors, Stefanie/0000-0001-9457-6606; Strijkers, Gustav/0000-0001-6700-5058; Grull, Holger/0000-0002-0993-9300	NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands; project Molecular Imaging [T3-C-2.1]	NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands; project Molecular Imaging	This work was supported by NanoNextNL (www.nanonextnl.nl), a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners, project Molecular Imaging (grant T3-C-2.1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author HG was employed by a commercial company (PhilipsResearch). The funder provided support in the form of salaries for author HG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section; We kindly thank Arno Ras (Philips Research, The Netherlands) for providing technical support for the custom laser treatment setup. This work is supported by NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners.	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Anderson JK, 2007, J ENDOUROL, V21, P223, DOI 10.1089/end.2005.1128; D'Cruz AK, 2004, HEAD NECK-J SCI SPEC, V26, P232, DOI 10.1002/hed.10372; DEICHMANN R, 1992, J MAGN RESON, V96, P608, DOI 10.1016/0022-2364(92)90347-A; DODD NJF, 1989, BRIT J CANCER, V60, P164, DOI 10.1038/bjc.1989.244; DOUGHERTY TJ, 1975, J NATL CANCER I, V55, P115, DOI 10.1093/jnci/55.1.115; Douillard S, 2009, PHOTOCH PHOTOBIO SCI, V8, P405, DOI 10.1039/b817175k; Dowell NG, 2007, MAGN RESON MED, V58, P622, DOI 10.1002/mrm.21368; Fei B, 2007, P SPIE MED IMAGING P, V6511, P1; Fei BW, 2007, LASER SURG MED, V39, P723, DOI 10.1002/lsm.20576; Fingar V H, 1996, J Clin Laser Med Surg, V14, P323; Fruytier AC, 2014, MAGN RESON MED, V72, P602, DOI 10.1002/mrm.25297; Haider MA, 2007, RADIOLOGY, V244, P196, DOI 10.1148/radiol.2441060398; Hamstra DA, 2007, J CLIN ONCOL, V25, P4104, DOI 10.1200/JCO.2007.11.9610; Hectors SJCG, 2016, MAGN RESON MED, V75, P302, DOI 10.1002/mrm.25758; Hectors SJCG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099936; Huang Z, 2006, LASER SURG MED, V38, P672, DOI 10.1002/lsm.20375; Jacobs I, 2015, NMR BIOMED, V28, P1443, DOI 10.1002/nbm.3406; KENNEDY SD, 1994, MAGNET RESON MED, V31, P292, DOI 10.1002/mrm.1910310308; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; LEVITT MH, 1981, J MAGN RESON, V43, P65, DOI 10.1016/0022-2364(81)90082-2; LIU YH, 1995, MAGN RESON IMAGING, V13, P251, DOI 10.1016/0730-725X(94)00107-E; Morton C, 2006, ARCH DERMATOL, V142, P729, DOI 10.1001/archderm.142.6.729; Mroz Pawel, 2011, Cancers (Basel), V3, P2516, DOI 10.3390/cancers3022516; Overholt BF, 2005, GASTROINTEST ENDOSC, V62, P488, DOI 10.1016/j.gie.2005.06.047; Park EK, 2008, IMMUNOLOGY, V124, P461, DOI 10.1111/j.1365-2567.2007.02797.x; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Trachtenberg J, 2008, BJU INT, V102, P556, DOI 10.1111/j.1464-410X.2008.07753.x; VACHA J, 1975, PHYSIOL BOHEMOSLOV, V24, P413; Vander Elst L, 2013, P INT SOC MAG RESON, P746; Wang HS, 2010, J MAGN RESON IMAGING, V32, P409, DOI 10.1002/jmri.22247; Winsborrow BG, 1997, PHOTOCHEM PHOTOBIOL, V66, P847, DOI 10.1111/j.1751-1097.1997.tb03236.x; Yankeelov TE, 2014, NAT REV CLIN ONCOL, V11, P670, DOI 10.1038/nrclinonc.2014.134; Zilberstein J, 2001, PHOTOCHEM PHOTOBIOL, V73, P257, DOI 10.1562/0031-8655(2001)073<0257:ATOSMT>2.0.CO;2	34	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165759	10.1371/journal.pone.0165759	http://dx.doi.org/10.1371/journal.pone.0165759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820832	Green Submitted, Green Published, gold			2022-12-27	WOS:000387614800018
J	Stene-Johansen, K; Yaqoob, N; Overbo, J; Aberra, H; Desalegn, H; Berhe, N; Johannessen, A				Stene-Johansen, Kathrine; Yaqoob, Nadeem; Overbo, Joakim; Aberra, Hanna; Desalegn, Hailemichael; Berhe, Nega; Johannessen, Asgeir			Dry Blood Spots a Reliable Method for Measurement of Hepatitis B Viral Load in Resource-Limited Settings	PLOS ONE			English	Article							C VIRUS-RNA; DRIED BLOOD; ENTECAVIR THERAPY; PLASMA; INFECTION; CIRRHOSIS; SAMPLES; LEVEL; RISK; DNA	Background & Aims Hepatitis B virus (HBV) quantification is essential in the management of chronic hepatitis B, both to determine treatment eligibility and in the monitoring of treatment effect. This test, however, is rarely available in resource-limited settings due to high costs and stringent requirements for shipment and storage of plasma. Dried Blood Spots (DBS) can be a convenient alternative to plasma, but its use for HBV monitoring has not been investigated under real-life conditions in Africa. Methods The performance of DBS in HBV quantification was investigated using a modified commercial test (Abbott RealTime HBV assay). Paired DBS and plasma samples were collected from an HBV positive cohort in Addis Ababa, Ethiopia. DBS were stored at ambient temperature for 4-39 days before shipment to the laboratory. Results Twenty-six paired samples were selected covering the total range of quantification, from 2.14 log IU/ml to >7 log IU/ml. HBV was detected in 21 of 21 (100%) DBS from patients with a corresponding plasma viral load above 2.70 log IU/ml. The mean difference between plasma and DBS was 0.59 log IU/ml, and the correlation was strong (R2 = 0.92). In stability studies there was no significant change in DBS viral load after storage at room temperature for up to 12 weeks. Conclusions This study suggests that DBS can be a feasible and reliable alternative to plasma for quantification of HBV in resource-limited settings. DBS can expand access to antiviral treatment for patients in low-and middle-income countries.	[Stene-Johansen, Kathrine; Yaqoob, Nadeem; Overbo, Joakim] Norwegian Inst Publ Hlth, Dept Virol, Oslo, Norway; [Aberra, Hanna; Desalegn, Hailemichael] St Pauls Hosp Millennium Med Coll, Dept Med, Addis Ababa, Ethiopia; [Berhe, Nega] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Berhe, Nega; Johannessen, Asgeir] Oslo Univ Hosp, Ctr Imported & Trop Dis, Oslo, Norway; [Johannessen, Asgeir] Vestre Viken HF, Dept Microbiol, Baerum, Norway	Norwegian Institute of Public Health (NIPH); Addis Ababa University; University of Oslo	Johannessen, A (corresponding author), Oslo Univ Hosp, Ctr Imported & Trop Dis, Oslo, Norway.; Johannessen, A (corresponding author), Vestre Viken HF, Dept Microbiol, Baerum, Norway.	johannessen.asgeir@gmail.com		Johannessen, Asgeir/0000-0001-5966-7166	Norwegian Research Council [220622/H10]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was funded in part by The Norwegian Research Council (www.forskningsradet.no), through a postdoc grant to AJ (grant number 220622/H10). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alidjinou EK, 2014, DIAGN MICR INFEC DIS, V78, P229, DOI 10.1016/j.diagmicrobio.2013.09.019; Bennett S, 2012, J CLIN VIROL, V54, P106, DOI 10.1016/j.jcv.2012.02.004; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brambilla D, 2003, J CLIN MICROBIOL, V41, P1888, DOI 10.1128/JCM.41.5.1888-1893.2003; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Garrido C, 2009, J CLIN MICROBIOL, V47, P1031, DOI 10.1128/JCM.02099-08; GE Life Sciences GHL, 2016, 903 PROT SAV CARD 20; Gish RG, 2007, GASTROENTEROLOGY, V133, P1437, DOI 10.1053/j.gastro.2007.08.025; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Jardi R, 2004, HEPATOLOGY, V40, P133, DOI 10.1002/hep.20275; Johannessen A, 2009, CLIN INFECT DIS, V49, P976, DOI 10.1086/605502; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Lira R, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-153; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Mohamed S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061077; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Santos C, 2012, J VIROL METHODS, V179, P17, DOI 10.1016/j.jviromet.2011.06.012; Tuaillon E, 2010, HEPATOLOGY, V51, P752, DOI 10.1002/hep.23407; Vinikoor MJ, 2015, J CLIN VIROL, V72, P20, DOI 10.1016/j.jcv.2015.08.019; WHO, 2015, WHO GUID PREV CAR TR	23	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166201	10.1371/journal.pone.0166201	http://dx.doi.org/10.1371/journal.pone.0166201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820845	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000387614800040
J	Tonosu, J; Inanami, H; Oka, H; Katsuhira, J; Takano, Y; Koga, H; Yuzawa, Y; Shiboi, R; Oshima, Y; Baba, S; Tanaka, S; Matsudaira, K				Tonosu, Juichi; Inanami, Hirohiko; Oka, Hiroyuki; Katsuhira, Junji; Takano, Yuichi; Koga, Hisashi; Yuzawa, Yohei; Shiboi, Ryutaro; Oshima, Yasushi; Baba, Satoshi; Tanaka, Sakae; Matsudaira, Ko			Diagnosing Discogenic Low Back Pain Associated with Degenerative Disc Disease Using a Medical Interview	PLOS ONE			English	Article							LUMBAR INTERVERTEBRAL DISC; 10-YEAR MATCHED COHORT; PROVOCATIVE DISCOGRAPHY; PREVALENCE; INDIVIDUALS	Purposes To evaluate the usefulness of our original five questions in a medical interview for diagnosing discogenic low back pain (LBP), and to establish a support tool for diagnosing discogenic LBP. Materials and Methods The degenerative disc disease (DDD) group (n = 42) comprised patients diagnosed with discogenic LBP associated with DDD, on the basis of magnetic resonance imaging findings and response to analgesic discography (discoblock). The control group (n = 30) comprised patients with LBP due to a reason other than DDD. We selected patients from those who had been diagnosed with lumbar spinal stenosis and had undergone decompression surgery without fusion. Of them, those whose postoperative LBP was significantly decreased were included in the control group. We asked patients in both groups whether they experienced LBP after sitting too long, while standing after sitting too long, squirming in a chair after sitting too long, while washing one's face, and in the standing position with flexion. We analyzed the usefulness of our five questions for diagnosing discogenic LBP, and performed receiver operating characteristic (ROC) curve analysis to develop a diagnostic support tool. Results There were no significant differences in baseline characteristics, except age, between the groups. There were significant differences between the groups for all five questions. In the age-adjusted analyses, the odds ratios of LBP after sitting too long, while standing after sitting too long, squirming in a chair after sitting too long, while washing one's face, and in standing position with flexion were 10.5, 8.5, 4.0, 10.8, and 11.8, respectively. The integer scores were 11, 9, 4, 11, and 12, respectively, and the sum of the points of the five scores ranged from 0 to 47. Results of the ROC analysis were as follows: cut-off value, 31 points; area under the curve, 0.92302; sensitivity, 100%; and specificity, 71.4%. Conclusions All five questions were useful for diagnosing discogenic LBP. We established the scoring system as a support tool for diagnosing discogenic LBP.	[Tonosu, Juichi] Kanto Rosai Hosp, Dept Orthoped Surg, Kawasaki, Kanagawa, Japan; [Inanami, Hirohiko; Takano, Yuichi; Koga, Hisashi; Yuzawa, Yohei] Inanami Spine & Joint Hosp, Dept Orthoped Surg, Tokyo, Japan; [Inanami, Hirohiko; Takano, Yuichi; Koga, Hisashi; Yuzawa, Yohei; Shiboi, Ryutaro; Baba, Satoshi] Iwai Orthopaed Med Hosp, Dept Orthoped Surg, Tokyo, Japan; [Oka, Hiroyuki; Matsudaira, Ko] Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Fac Med, Tokyo, Japan; [Oka, Hiroyuki; Oshima, Yasushi; Matsudaira, Ko] Univ Tokyo, Dept Orthoped Surg, Fac Med, Tokyo, Japan; [Katsuhira, Junji] Niigata Univ Hlth & Welf, Fac Med Technol, Dept Prosthet & Orthot & Assist Technol, Niigata, Japan	University of Tokyo; University of Tokyo; Niigata University	Tonosu, J (corresponding author), Kanto Rosai Hosp, Dept Orthoped Surg, Kawasaki, Kanagawa, Japan.	juichitohnosu@yahoo.co.jp	Takano, Yuichi/GVU-0109-2022; Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414; BABA, SATOSHI/0000-0003-3606-8587				ADAMS MA, 1983, SPINE, V8, P665, DOI 10.1097/00007632-198309000-00013; Carragee EJ, 2000, SPINE, V25, P1373, DOI 10.1097/00007632-200006010-00009; Carragee EJ, 2006, SPINE, V31, P2115, DOI 10.1097/01.brs.0000231436.30262.dd; Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Cuellar JM, 2016, SPINE J, V16, P273, DOI 10.1016/j.spinee.2015.06.051; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Eck JC, 2014, J NEUROSURG-SPINE, V21, P37, DOI 10.3171/2014.4.SPINE14269; Endean A, 2011, SPINE, V36, P160, DOI 10.1097/BRS.0b013e3181cd9adb; Fairbank J C, 1980, Physiotherapy, V66, P271; Fujii T, 2013, EUR SPINE J, V22, P432, DOI 10.1007/s00586-012-2439-0; Fujiwara A, 2003, SPINE, V28, P1601, DOI 10.1097/00007632-200307150-00023; Grotle M, 2013, ACTA ORTHOP, V84, P196, DOI [10.3109/17453674.2013.786634, DOI 10.3109/1743674.2013.786634]; Jones ADR, 2014, EUR SPINE J, V23, P135, DOI 10.1007/s00586-013-2964-5; Kjaer P, 2005, SPINE, V30, P1173, DOI 10.1097/01.brs.0000162396.97739.76; Krismer M, 2007, BEST PRACT RES CL RH, V21, P77, DOI 10.1016/j.berh.2006.08.004; Manchikanti Laxmaiah, 2013, Pain Physician, V16, pSE55; McMillan DW, 1996, ANN RHEUM DIS, V55, P880, DOI 10.1136/ard.55.12.880; NACHEMSON A., 1966, CLIN ORTHO RELAT RES, V45, P107; Nachemson A, 1970, Scand J Rehabil Med Suppl, V1, P1; NACHEMSON AL, 1981, SPINE, V6, P93, DOI 10.1097/00007632-198101000-00020; Neckelmann G, 2013, SKELETAL RADIOL, V42, P1593, DOI [10.1007/s00256-013-1077-x, DOI 10.1007/S00256-013-1700-23982421]; Ohtori Seiji, 2009, Spine (Phila Pa 1976), V34, P1345, DOI 10.1097/BRS.0b013e3181a401bf; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Sato K, 1999, SPINE, V24, P2468, DOI 10.1097/00007632-199912010-00008; SCHWARZER AC, 1995, SPINE, V20, P1878, DOI 10.1097/00007632-199509000-00007; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Young Sharon, 2003, Spine J, V3, P460, DOI 10.1016/S1529-9430(03)00151-7	30	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166031	10.1371/journal.pone.0166031	http://dx.doi.org/10.1371/journal.pone.0166031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820861	Green Published, gold, Green Submitted			2022-12-27	WOS:000387614800029
J	Armstead, MY; Bitzer-Creathers, L; Wilson, M				Armstead, Mindy Yeager; Bitzer-Creathers, Leah; Wilson, Mandee			The Effects of Elevated Specific Conductivity on the Chronic Toxicity of Mining Influenced Streams Using Ceriodaphnia dubia	PLOS ONE			English	Article							METAL TOXICITY; MAJOR IONS; SULFATE; SENSITIVITY; SALINITY; CHLORIDE; EFFLUENTS; HARDNESS; FIELD; PH	Salinization of freshwater ecosystems as a result of human activities has markedly increased in recent years. Much attention is currently directed at evaluating the effects of increased salinity on freshwater biota. In the Central Appalachian region of the eastern United States, specific conductance from alkaline discharges associated with mountain top mining practices has been implicated in macroinvertebrate community declines in streams receiving coal mining discharges. Whole effluent toxicity testing of receiving stream water was used to test the hypothesis that mine discharges are toxic to laboratory test organisms and further, that toxicity is related to ionic concentrations as indicated by conductivity. Chronic toxicity testing using Ceriodaphnia dubia was conducted by contract laboratories at 72 sites with a total of 129 tests over a 3.5 year period. The database was evaluated to determine the ionic composition of mine effluent dominated streams and whether discharge constituents were related to toxicity in C. dubia. As expected, sulfate was found to be the dominant anion in streams receiving mining discharges with bicarbonate variable and sometimes a substantial component of the dissolved solids. Overall, the temporal variability in conductance was low at each site which would indicate fairly stable water quality conditions. Results of the toxicity tests show no relationship between conductance and survival of C. dubia in the mining influenced streams with the traditional toxicity test endpoints. However, consideration of the entire dataset revealed a significant inverse relationship between conductivity and neonate production. While conductivity explained very little of the high variability in the offspring production (r(2) = 0.1304), the average numbers of offspring were consistently less than 20 neonates at the highest conductivities.	[Armstead, Mindy Yeager; Bitzer-Creathers, Leah; Wilson, Mandee] Marshall Univ, Dept Integrated Sci & Technol, Huntington, WV 25755 USA; [Armstead, Mindy Yeager; Bitzer-Creathers, Leah] Potesta & Associates Inc, Charleston, WV USA	Marshall University	Armstead, MY (corresponding author), Marshall Univ, Dept Integrated Sci & Technol, Huntington, WV 25755 USA.; Armstead, MY (corresponding author), Potesta & Associates Inc, Charleston, WV USA.	m.armstead@marshall.edu			Marshall University; Potesta & Associates, Inc.; Appalachian Research Initiative for Environmental Sciences (ARIES), an industrial affiliates program at Virginia Tech; Norfolk Southern Corporation; Patriot Coal Corporation; TECO Coal Corporation; Natural Resource Partners; Arch Coal; Alpha Natural Resources	Marshall University; Potesta & Associates, Inc.; Appalachian Research Initiative for Environmental Sciences (ARIES), an industrial affiliates program at Virginia Tech; Norfolk Southern Corporation; Patriot Coal Corporation; TECO Coal Corporation; Natural Resource Partners; Arch Coal; Alpha Natural Resources	The study was funded by Marshall University. Potesta & Associates, Inc. provided support in the form of salaries for the authors (MYA, LBC) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The authors, recognizing the need for evaluating ecological risks and the availability of the toxicity data, conceived the study independently and sought cooperation from the mining companies involved and the funding agency. Two mining companies, Alpha Natural Resources and Patriot Mining, were required to collect toxicity data from high ionic strength discharges pursuant to United States Environmental Protection Agency agreements. These data were made available to the authors at our request. Researchers' (MYA and MW) time for conducting the evaluation and preparing the manuscript was supported by the Appalachian Research Initiative for Environmental Sciences (ARIES), an industrial affiliates program at Virginia Tech, which is supported by members that include companies in the energy sector (Norfolk Southern Corporation, Patriot Coal Corporation, TECO Coal Corporation, Natural Resource Partners, Arch Coal and Alpha Natural Resources). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Beketov MA, 2013, P NATL ACAD SCI USA, V110, P11039, DOI 10.1073/pnas.1305618110; Bernhardt ES, 2011, ANN NY ACAD SCI, V1223, P39, DOI 10.1111/j.1749-6632.2011.05986.x; Bryant G, 2003, SURVEY WATER QUALITY; Canedo-Arguelles M, 2013, ENVIRON POLLUT, V173, P157, DOI 10.1016/j.envpol.2012.10.011; Dow CL, 2000, ENVIRON MANAGE, V26, P437, DOI 10.1007/s002670010101; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; Elphick JR, 2011, ENVIRON TOXICOL CHEM, V30, P247, DOI 10.1002/etc.363; Elphick JRF, 2011, ENVIRON TOXICOL CHEM, V30, P239, DOI 10.1002/etc.365; Fritz KM, 2010, J N AM BENTHOL SOC, V29, P673, DOI 10.1899/09-060.1; Goodfellow WL, 2000, ENVIRON TOXICOL CHEM, V19, P175, DOI 10.1002/etc.5620190121; Horning W. B., 1985, EPA600485014, P58; Jaeger KL, 2015, GEOMORPHOLOGY, V236, P25, DOI 10.1016/j.geomorph.2015.02.007; Kefford BJ, 2006, CAN J FISH AQUAT SCI, V63, P1865, DOI 10.1139/F06-080; Kefford BJ, 2011, ENVIRON POLLUT, V159, P302, DOI 10.1016/j.envpol.2010.08.025; Kefford BJ, 2004, ENVIRON POLLUT, V129, P355, DOI 10.1016/j.envpol.2003.12.005; Kennedy AJ, 2005, ARCH ENVIRON CON TOX, V49, P155, DOI 10.1007/s00244-004-0034-z; Kennedy AJ, 2003, ARCH ENVIRON CON TOX, V44, P324, DOI 10.1007/s00244-002-2062-x; Kratzer EB, 2006, J N AM BENTHOL SOC, V25, P954, DOI 10.1899/0887-3593(2006)025[0954:MDIRTL]2.0.CO;2; Kunz JL, 2013, ENVIRON TOXICOL CHEM, V32, P2826, DOI 10.1002/etc.2391; Lasier PJ, 2010, ENVIRON TOXICOL CHEM, V29, P347, DOI 10.1002/etc.29; Lindberg TT, 2011, P NATL ACAD SCI USA, V108, P20929, DOI 10.1073/pnas.1112381108; Merricks TC, 2007, ENVIRON MONIT ASSESS, V129, P359, DOI 10.1007/s10661-006-9369-4; Mount DR, 1997, ENVIRON TOXICOL CHEM, V16, P2009, DOI 10.1002/etc.5620161005; PAGENKOPF GK, 1983, ENVIRON SCI TECHNOL, V17, P342, DOI 10.1021/es00112a007; PARSONS JD, 1968, ARCH HYDROBIOL, V65, P25; Pickering QH, 1996, ENVIRON TOXICOL CHEM, V15, P353, DOI [10.1897/1551-5028(1996)015&lt;0353:SSOOFA&gt;2.3.CO;2, 10.1002/etc.5620150320]; Pond GJ, 2008, J N AM BENTHOL SOC, V27, P717, DOI 10.1899/08-015.1; Pond GJ, 2010, HYDROBIOLOGIA, V641, P185, DOI 10.1007/s10750-009-0081-6; Poteat MD, 2014, ENVIRON SCI TECHNOL, V48, P887, DOI 10.1021/es405529n; Soucek DJ, 2011, ENVIRON TOXICOL CHEM, V30, P930, DOI 10.1002/etc.454; Soucek DJ, 2007, ENVIRON TOXICOL CHEM, V26, P773, DOI 10.1897/06-229R.1; Soucek DJ, 2005, ENVIRON TOXICOL CHEM, V24, P1204, DOI 10.1897/04-142.1; Struewing KA, 2015, CHEMOSPHERE, V139, P597, DOI 10.1016/j.chemosphere.2014.04.096; van Dam RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106857; van Dam RA, 2010, ENVIRON TOXICOL CHEM, V29, P410, DOI 10.1002/etc.56; WARNER R W, 1971, Ohio Journal of Science, V71, P202; Wiley J. B, 2003, 03133 US DEP INT US	38	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165683	10.1371/journal.pone.0165683	http://dx.doi.org/10.1371/journal.pone.0165683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814378	gold, Green Published, Green Submitted			2022-12-27	WOS:000386911100015
J	Korrodi-Gregorio, L; Soto-Cerrato, V; Vitorino, R; Fardilha, M; Perez-Tomas, R				Korrodi-Gregorio, Luis; Soto-Cerrato, Vanessa; Vitorino, Rui; Fardilha, Margarida; Perez-Tomas, Ricardo			From Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical Research	PLOS ONE			English	Article							GENE-EXPRESSION; NEDD8-ACTIVATING ENZYME; NUCLEAR ANTIGEN; PROGNOSTIC-SIGNIFICANCE; SURVIVIN EXPRESSION; CASEIN KINASE-2; PROTEIN; CARCINOMA; TISSUE; P53	Lung cancer is a serious health problem and the leading cause of cancer death worldwide. The standard use of cell lines as in vitro pre-clinical models to study the molecular mechanisms that drive tumorigenesis and access drug sensitivity/effectiveness is of undisputable importance. Label-free mass spectrometry and bioinformatics were employed to study the proteomic profiles of two representative lung cancer cell lines and to unravel the specific biological processes. Adenocarcinoma A549 cells were enriched in proteins related to cellular respiration, ubiquitination, apoptosis and response to drug/hypoxia/oxidative stress. In turn, squamous carcinoma SW900 cells were enriched in proteins related to translation, apoptosis, response to inorganic/organic substances and cytoskeleton organization. Several proteins with differential expression were related to cancer transformation, tumor resistance, proliferation, migration, invasion and metastasis. Combined analysis of proteome and interactome data highlighted key proteins and suggested that adenocarcinoma might be more prone to PI3K/Akt/mTOR and topoisomerase IIa inhibitors, and squamous carcinoma to Ck2 inhibitors. Moreover, ILF3 overexpression in adenocarcinoma, and PCNA and NEDD8 in squamous carcinoma shows them as promising candidates for therapeutic purposes. This study highlights the functional proteomic differences of two main subtypes of lung cancer models and hints several targeted therapies that might assist in this type of cancer.	[Korrodi-Gregorio, Luis; Soto-Cerrato, Vanessa; Perez-Tomas, Ricardo] Univ Barcelona, Canc Cell Biol Res Grp, Dept Pathol & Expt Therapeut, Fac Med, Campus Bellvitge,Feixa Llarga S-N, Lhospitalet De Llobregat 08907, Spain; [Korrodi-Gregorio, Luis; Fardilha, Margarida] Univ Aveiro, Lab Signal Transduct, Dept Med Sci, Inst Res Biomed iBiMED,Hlth Sci Program, Campus Santiago, P-3810193 Aveiro, Portugal; [Vitorino, Rui] Univ Aveiro, Dept Med Sci, Hlth Sci Program, Inst Res Biomed iBiMED, Campus Santiago, P-3810193 Aveiro, Portugal; [Vitorino, Rui] Univ Porto, Dept Physiol & Cardiothorac Surg, Fac Med, P-4200319 Oporto, Portugal	University of Barcelona; Universidade de Aveiro; Universidade de Aveiro; Universidade do Porto	Perez-Tomas, R (corresponding author), Univ Barcelona, Canc Cell Biol Res Grp, Dept Pathol & Expt Therapeut, Fac Med, Campus Bellvitge,Feixa Llarga S-N, Lhospitalet De Llobregat 08907, Spain.; Fardilha, M (corresponding author), Univ Aveiro, Lab Signal Transduct, Dept Med Sci, Inst Res Biomed iBiMED,Hlth Sci Program, Campus Santiago, P-3810193 Aveiro, Portugal.	mfardilha@ua.pt; rperez@ub.edu	Fardilha, Margarida/G-3182-2010; Vitorino, Rui/G-7356-2014; Soto-Cerrato, Vanessa/AAB-4392-2020; Korrodi-Gregório, Luís/N-6796-2013; Vitorino, Rui/AAJ-3621-2021	Fardilha, Margarida/0000-0001-7459-9173; Vitorino, Rui/0000-0003-3636-5805; Soto-Cerrato, Vanessa/0000-0001-5835-3595; Korrodi-Gregório, Luís/0000-0002-2811-8081; Vitorino, Rui/0000-0003-3636-5805; Perez-Tomas, Ricardo/0000-0003-3226-1240	Spanish Government; EU funds [FIS PI13/ 00089]; La Marato de TV3 Foundation [20132730]; FCT (Fundacao para a Ciencia e a Tecnologia) [UID/BIM/04501/2013]; Proteostasis COST Action [BM1307]; FCT [SFRH/BPD/91766/2012]	Spanish Government(Spanish GovernmentEuropean Commission); EU funds; La Marato de TV3 Foundation; FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); Proteostasis COST Action; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grants from the Spanish Government and EU funds (FIS PI13/ 00089), from La Marato de TV3 Foundation (20132730) and from FCT (Fundacao para a Ciencia e a Tecnologia), to the RNEM (Portuguese Mass Spectrometry Network) through the project UID/BIM/04501/2013 and Proteostasis COST Action (BM1307). This work was also supported by an individual grant from FCT to Luis Korrodi-Gregorio (SFRH/BPD/91766/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Lizarbe MA, 2013, INT J MOL SCI, V14, P2652, DOI 10.3390/ijms14022652; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Balbin OA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3617; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Cantor JM, 2012, J CELL SCI, V125, P1373, DOI 10.1242/jcs.096040; Capo-chichi CD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-28; Chernyavsky AI, 2015, INT IMMUNOPHARMACOL, V29, P36, DOI 10.1016/j.intimp.2015.05.033; Chung LY, 2012, CLIN CANCER RES, V18, P4037, DOI 10.1158/1078-0432.CCR-11-3348; Cleator S, 2006, BREAST CANCER RES TR, V95, P229, DOI 10.1007/s10549-005-9009-7; DAYAMAKIN M, 1994, CANCER RES, V54, P2262; De Petris L, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-9; Deng SS, 2013, ONCOL LETT, V5, P107, DOI 10.3892/ol.2012.959; Dixit D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.10; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; EBINA M, 1994, CANCER RES, V54, P2496; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Ertel A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-55; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Forbus J, 2006, PROTEOMICS, V6, P2656, DOI 10.1002/pmic.200500652; Gaudio E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078610; Gellert P, 2010, BIOINFORMATICS, V26, P2328, DOI 10.1093/bioinformatics/btq417; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gottschling S, 2012, LUNG CANCER, V75, P45, DOI 10.1016/j.lungcan.2011.05.020; Grossi F, 2003, EUR J CANCER, V39, P1242, DOI 10.1016/S0959-8049(03)00232-6; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Han SW, 2006, CANCER RES, V66, P315, DOI 10.1158/0008-5472.CAN-05-2367; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsu YL, 2013, CARCINOGENESIS, V34, P1370, DOI 10.1093/carcin/bgt040; Inada H, 2001, J CELL BIOL, V155, P415, DOI 10.1083/jcb.200103078; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; KASAHARA K, 1992, J NATL CANCER I, V84, P113, DOI 10.1093/jnci/84.2.113; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Kikuchi T, 2012, MOL CELL PROTEOMICS, V11, P916, DOI 10.1074/mcp.M111.015370; Kim TY, 2013, P NATL ACAD SCI USA, V110, P16868, DOI 10.1073/pnas.1306358110; Kumar M, 2015, MOL ASPECTS MED, V45, P55, DOI 10.1016/j.mam.2015.06.009; Langevin SM, 2015, TRANSL RES, V165, P74, DOI 10.1016/j.trsl.2014.03.001; Li JH, 2016, TUMOR BIOL, V37, P2387, DOI 10.1007/s13277-015-4017-7; Li LH, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju083; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; LONG BH, 1986, CANCER RES, V46, P3809; Lu HY, 2015, BIOMATERIALS, V42, P30, DOI 10.1016/j.biomaterials.2014.11.029; Luo ZG, 2012, CANCER RES, V72, P3360, DOI 10.1158/0008-5472.CAN-12-0388; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Mahoney CL, 2009, BRIT J CANCER, V100, P370, DOI 10.1038/sj.bjc.6604886; Matsuzaki S, 2014, EXPERT OPIN THER TAR, V18, P403, DOI 10.1517/14728222.2014.882323; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Nakamura N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013243; Nawrocki ST, 2012, EXPERT OPIN INV DRUG, V21, P1563, DOI 10.1517/13543784.2012.707192; Nguyen VN, 2000, ACTA HISTOCHEM, V102, P323, DOI 10.1078/S0065-1281(04)70039-2; Nie W, 2015, LAB INVEST, V95, P56, DOI 10.1038/labinvest.2014.124; Ning JF, 2013, ONCOL RES, V21, P67, DOI 10.3727/096504013X13747716581417; Oji Y, 2014, INT J ONCOL, V44, P1461, DOI 10.3892/ijo.2014.2318; Okano T, 2006, PROTEOMICS, V6, P3938, DOI 10.1002/pmic.200500883; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; Orvis T, 2014, CANCER RES, V74, P6486, DOI 10.1158/0008-5472.CAN-14-0061; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Patel VJ, 2009, J PROTEOME RES, V8, P3752, DOI 10.1021/pr900080y; Porebska Irena, 2010, Cancer Genomics & Proteomics, V7, P331; Recchi C, 2012, BIOCHEM SOC T, V40, P1398, DOI 10.1042/BST20120199; Rubporn Atchara, 2009, Cancer Genomics & Proteomics, V6, P229; Salton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023882; Sandberg R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r65; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHAPIRO GI, 1995, CANCER RES, V55, P6200; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Sun PL, 2013, VIRCHOWS ARCH, V463, P427, DOI 10.1007/s00428-013-1462-9; Sun QL, 2011, J CANCER RES CLIN, V137, P521, DOI 10.1007/s00432-010-0913-9; Sun RF, 2015, TUMOR BIOL, V36, P7195, DOI 10.1007/s13277-015-3361-y; Tanaka T, 2012, MOL ONCOL, V6, P267, DOI 10.1016/j.molonc.2012.01.003; Travis WD, 2012, MODERN PATHOL, V25, pS18, DOI 10.1038/modpathol.2011.150; Tuncbag N, 2012, NUCLEIC ACIDS RES, V40, pW505, DOI 10.1093/nar/gks445; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Virtanen C, 2002, P NATL ACAD SCI USA, V99, P12357, DOI 10.1073/pnas.192240599; Wang XH, 2010, AM J PATHOL, V177, P586, DOI 10.2353/ajpath.2010.091217; Watson IR, 2011, CANCER CELL, V19, P168, DOI 10.1016/j.ccr.2011.01.002; Wei YH, 2011, J PROTEOME RES, V10, P161, DOI 10.1021/pr100491e; WIETHEGE T, 1995, J CANCER RES CLIN, V121, P371, DOI 10.1007/BF01225691; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Wistuba II, 1999, CLIN CANCER RES, V5, P991; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xiao ZX, 2013, CANCER CELL, V23, P527, DOI 10.1016/j.ccr.2013.03.009; Yang SY, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-83; Yang XQ, 2011, PHYSIOL GENOMICS, V43, P457, DOI 10.1152/physiolgenomics.00178.2010; Yonesaka K, 2016, ONCOGENE, V35, P878, DOI 10.1038/onc.2015.142; Yoon YK, 2010, MOL CARCINOGEN, V49, P353, DOI 10.1002/mc.20607; Yu GC, 2011, MOL BIOSYST, V7, P472, DOI 10.1039/c0mb00055h; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhang W, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-74; Zhang W, 2014, PROTEOMICS, V14, P795, DOI 10.1002/pmic.201300382; Zhao HJ, 2011, MOL CANCER THER, V10, P29, DOI 10.1158/1535-7163.MCT-10-0778; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	103	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165973	10.1371/journal.pone.0165973	http://dx.doi.org/10.1371/journal.pone.0165973			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814385	Green Published, Green Submitted, gold			2022-12-27	WOS:000386911100024
J	Alvaro-Meca, A; Diaz, A; Diez, JDM; Resino, R; Resino, S				Alvaro-Meca, Alejandro; Diaz, Asuncion; de Miguel Diez, Javier; Resino, Rosa; Resino, Salvador			Environmental Factors Related to Pulmonary Tuberculosis in HIV-Infected Patients in the Combined Antiretroviral Therapy (cART) Era	PLOS ONE			English	Article							CASE-CROSSOVER DESIGN; VITAMIN-D LEVELS; AIR-POLLUTION; SEASONAL-VARIATION; DISEASE; RISK; STATISTICS; PARTICLES; DIAGNOSIS; SUNLIGHT	The aim of our study was to evaluate the seasonal variations and whether short-term exposure to environmental risk factors, such as climate and air pollution, is associated with PTB-related hospital admissions in human immunodeficiency virus (HIV)-infected patients in Spain during the era of combined antiretroviral therapy (cART). A retrospective study was carried out using data from the Minimum Basic Data Set (MBDS) and the State Meteorological Agency (AEMET) of Spain. The primary outcome variable was hospital admissions with PTB diagnosis. The environmental risk factors evaluated were season, temperature, humidity, NO2, SO2, O-3, PM10, and CO. Overall, HIV-infected patients had a lower frequency of PTB-related hospital admissions in summer (22.8%) and autumn (22.4%), but higher values in winter (26.6%) and spring (28.2%). Using a Bayesian temporal model, PTB-related hospital admissions were less frequent in summer-autumn and more abundant in winter-spring during the first years of follow-up. During the later years of follow-up, the seasonal trends continued resulting in the lowest values in autumn and the highest in spring. When considering short-term exposure to environmental risk factors, lower temperatures at 1 week (odds ratio (OR) = 1.03; p = 0.008), 1.5 weeks (OR = 1.03; p< 0.001), 2 weeks (OR = 1.04; p< 0.001), and 3 weeks (OR = 1.03; p< 0.001) prior to PTB admission. In addition, higher concentration of NO2 at the time of admission were significantly associated with higher likelihoods of PTB-related hospital admission in HIV-infected patients when 1.5 weeks (OR = 1.1; p = 0.044) and 2 weeks (OR = 1.21; p< 0.001) were used as controls. Finally, higher concentration of SO2 at 1.5 weeks prior to PTB admission was significantly associated with a higher likelihood of PTB-related hospital admissions (OR = 0.92; p = 0.029). In conclusion, our data suggest an apparent seasonal variation in hospital admissions of HIV-infected patients with a PTB diagnosis (summer/autumn vs. winter/spring), as well as a link to short-term exposure to environmental risk factors, such as temperature and ambient NO2 and SO2.	[Alvaro-Meca, Alejandro] Rey Juan Carlos Univ, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Diaz, Asuncion] Inst Hlth Carlos III, Natl Ctr Epidemiol, Unit HIV Surveillance & Behav Monitoring, Madrid, Spain; [Diaz, Asuncion] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Network Biomed Res Ctr Epidemiol & Publ Hlth, Madrid, Spain; [de Miguel Diez, Javier] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Serv Pneumol, Madrid, Spain; [Resino, Rosa] Univ Complutense Madrid, Fac Geog & Hist, Dept Human Geog, Madrid, Spain; [Resino, Salvador] Inst Hlth Carlos III, Natl Ctr Microbiol, Unit Viral Infect & Immun, Madrid, Spain	Universidad Rey Juan Carlos; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Complutense University of Madrid; General University Gregorio Maranon Hospital; Complutense University of Madrid; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Alvaro-Meca, A (corresponding author), Rey Juan Carlos Univ, Dept Prevent Med & Publ Hlth, Madrid, Spain.; Resino, S (corresponding author), Inst Hlth Carlos III, Natl Ctr Microbiol, Unit Viral Infect & Immun, Madrid, Spain.	alejandro.alvaro@urjc.es; sresino@isciii.es	Resino, Salvador/B-2430-2008; Diaz, Asuncion/Q-6016-2017	Resino, Salvador/0000-0001-8783-0450; Diaz, Asuncion/0000-0002-8309-4270; de Miguel-Diez, Javier/0000-0003-4543-573X; Alvaro-Meca, Alejandro/0000-0003-1315-4386; RESINO GARCIA, ROSA/0000-0002-9324-6397	Instituto de Salud Carlos III [PI14CIII/00011, PI12/00019]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work has been supported by a grant from "Instituto de Salud Carlos III" (Ref. PI14CIII/00011 to SR and PI12/00019 to AAM) (http://www.isciii.es).	Alvaro-Meca A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19906; Atun RA, 2005, EUR J PUBLIC HEALTH, V15, P350, DOI 10.1093/eurpub/cki018; Bauer RN, 2012, J ALLERGY CLIN IMMUN, V129, P14, DOI 10.1016/j.jaci.2011.11.004; Boura M, 2014, J INT AIDS SOC, V17, P204, DOI 10.7448/IAS.17.4.19826; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Dangor Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091464; Delfosse VC, 2015, ENVIRON TOXICOL, V30, P589, DOI 10.1002/tox.21936; ECDC/WHO, 2011, HIV AIDS SURV EUR 20; ECDC/WHO, 2013, TUB SURV MON EUR 201; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2014, TUB SURV MON EUR 201; Fares A, 2013, INT J PREVENTIVE MED, V4, P128; Fares A, 2011, J GLOB INFECT DIS, V3, P46, DOI 10.4103/0974-777X.77296; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Gomez-Barroso D, 2013, INT J TUBERC LUNG D, V17, P745, DOI 10.5588/ijtld.12.0702; Griffin AT, 2012, AIDS PATIENT CARE ST, V26, P516, DOI 10.1089/apc.2012.0145; Grupo de Trabajo de la Encuesta Hospitalaria. [Working Group of the Hospital Survey], 2014, ENC HOSP PAC CON VIH, P1; Guzman-Fulgencio M, 2014, J INFECTION, V68, P176, DOI 10.1016/j.jinf.2013.10.011; Hildebrandt K, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-25; Hwang SS, 2014, KOREAN J INTERN MED, V29, P183, DOI 10.3904/kjim.2014.29.2.183; Iwai K, 2005, ENVIRON RES, V99, P106, DOI 10.1016/j.envres.2004.11.004; Jaakkola JJK, 2003, EUR RESPIR J, V21, p81S, DOI 10.1183/09031936.03.00402703; Jassal MS, 2013, PUBLIC HEALTH, V127, P268, DOI 10.1016/j.puhe.2012.12.030; Jiang RW, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0071-3; Kavasery R, 2009, JAIDS-J ACQ IMM DEF, V50, P360, DOI 10.1097/QAI.0b013e318198a800; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057752; Laumbach RJ, 2012, J ALLERGY CLIN IMMUN, V129, P3, DOI 10.1016/j.jaci.2011.11.021; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MacLachlan JH, 2012, EMERG INFECT DIS, V18, P1879, DOI 10.3201/eid1811.120456; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108; Muga R, 2007, AIDS, V21, P2521, DOI 10.1097/QAD.0b013e3282f1c933; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Oliva J, 2014, GAC SANIT, V28, P116, DOI 10.1016/j.gaceta.2013.06.009; Oliva J, 2010, ENFERM INFEC MICR CL, V28, P583, DOI 10.1016/j.eimc.2010.02.013; Onozuka D, 2015, INT J BIOMETEOROL, V59, P1107, DOI 10.1007/s00484-014-0924-3; Organization WH, 2009, GLOB HLTH RISKS MORT; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Portilla J, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18945; R Core Team, 2011, R LANG ENV STAT COMP; Rice MB, 2013, AM J RESP CRIT CARE, V188, P1351, DOI 10.1164/rccm.201308-1414OC; Rios M, 2000, EUR J EPIDEMIOL, V16, P483, DOI 10.1023/A:1007653329972; Rodger A, 2003, BRIT MED J, V326, P909, DOI 10.1136/bmj.326.7395.909; Ronacher K, 2015, IMMUNOL REV, V264, P121, DOI 10.1111/imr.12257; Rue H., 2014, INLA FUNCTIONS WHICH; Santos LG, 2012, TUBERCULOSIS, V92, P293, DOI 10.1016/j.tube.2012.03.006; Sarkar S, 2012, J IMMUNOL, V188, P2778, DOI 10.4049/jimmunol.1101380; Shilova M V, 2004, Probl Tuberk Bolezn Legk, P17; Smith G.S., 2016, ENV HLTH PERSPECT; Smith GS, 2014, INT J ENVIRON HEAL R, V24, P103, DOI 10.1080/09603123.2013.800959; TB Stop partnership, 2011, GLOB PLAN STOP TB 20; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Tremblay GA, 2007, INT J TUBERC LUNG D, V11, P722; Vallecillo G, 2010, CURR HIV RES, V8, P641, DOI 10.2174/157016210794088272; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Wingfield T, 2014, J INFECT DIS, V210, P774, DOI 10.1093/infdis/jiu121; World Health Organization, 2015, GLOB TUB REP 2015; Yang XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108369	58	26	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165944	10.1371/journal.pone.0165944	http://dx.doi.org/10.1371/journal.pone.0165944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812194	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000082
J	Clare, DS; Spencer, M; Robinson, LA; Frid, CLJ				Clare, David S.; Spencer, Matthew; Robinson, Leonie A.; Frid, Christopher L. J.			Species-Specific Effects on Ecosystem Functioning Can Be Altered by Interspecific Interactions	PLOS ONE			English	Article							AMPHIPOD COROPHIUM-VOLUTATOR; NEREIS-DIVERSICOLOR MULLER,O.F.; RAGWORM HEDISTE-DIVERSICOLOR; POPULATION-DYNAMICS; TEMPORAL VARIATION; NORTH-ATLANTIC; EAST ENGLAND; BIODIVERSITY; SEDIMENT; COMMUNITIES	Biological assemblages are constantly undergoing change, with species being introduced, extirpated and experiencing shifts in their densities. Theory and experimentation suggest that the impacts of such change on ecosystem functioning should be predictable based on the biological traits of the species involved. However, interspecific interactions could alter how species affect functioning, with the strength and sign of interactions potentially depending on environmental context (e.g. homogenous vs. heterogeneous conditions) and the function considered. Here, we assessed how concurrent changes to the densities of two common marine benthic invertebrates, Corophium volutator and Hediste diversicolor, affected the ecological functions of organic matter consumption and benthic-pelagic nutrient flux. Complementary experiments were conducted within homogenous laboratory microcosms and naturally heterogeneous field plots. When the densities of the species were increased within microcosms, interspecific interactions enhanced effects on organic matter consumption and reduced effects on nutrient flux. Trait-based predictions of how each species would affect functioning were only consistently supported when the density of the other species was low. In field plots, increasing the density of either species had a positive effect on organic matter consumption (with no significant interspecific interactions) but no effect on nutrient flux. Our results indicate that species-specific effects on ecosystem functioning can be altered by interspecific interactions, which can be either facilitative (positive) or antagonistic (negative) depending on the function considered. The impacts of biodiversity change may therefore not be predictable based solely on the biological traits of the species involved. Possible explanations for why interactions were detected in microcosms but not in the field are discussed.	[Clare, David S.; Spencer, Matthew; Robinson, Leonie A.; Frid, Christopher L. J.] Univ Liverpool, Sch Environm Sci, Brownlow St, Liverpool L69 3GP, Merseyside, England; [Frid, Christopher L. J.] Griffith Univ, Griffith Sch Environm, Gold Coast Campus,G24 Parklands Dr, Southport, Qld 4222, Australia	University of Liverpool; Griffith University	Clare, DS (corresponding author), Univ Liverpool, Sch Environm Sci, Brownlow St, Liverpool L69 3GP, Merseyside, England.	David.Clare@liverpool.ac.uk		Frid, Christopher/0000-0002-7565-635X	University of Liverpool	University of Liverpool	This work was funded by the University of Liverpool as part of David Clare's PhD research.	Auguie B, 2017, GRIDEXTRA MISCELLANE; Barbeau MA, 2009, J CRUSTACEAN BIOL, V29, P491, DOI 10.1651/08-3067.1; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Braeckman U, 2010, MAR ECOL PROG SER, V399, P173, DOI 10.3354/meps08336; Bremner J, 2003, MAR ECOL PROG SER, V254, P11, DOI 10.3354/meps254011; Bremner J, 2008, J EXP MAR BIOL ECOL, V366, P37, DOI 10.1016/j.jembe.2008.07.007; Bulling M, 2008, OECOLOGIA, V158, P511, DOI 10.1007/s00442-008-1160-5; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cesar CP, 2012, MAR ECOL PROG SER, V466, P35, DOI 10.3354/meps09938; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; CHEVENET F, 1994, FRESHWATER BIOL, V31, P295, DOI 10.1111/j.1365-2427.1994.tb01742.x; Clare DS, 2016, MAR ECOL PROG SER, V547, P149, DOI 10.3354/meps11650; Clare DS, 2015, MAR ENVIRON RES, V107, P24, DOI 10.1016/j.marenvres.2015.03.012; de Deckere EMGT, 2000, HYDROBIOLOGIA, V426, P37, DOI 10.1023/A:1003978714382; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Ehlers A, 2008, MAR ECOL PROG SER, V355, P1, DOI 10.3354/meps07369; Einfeldt AL, 2015, BIOL J LINN SOC, V115, P288, DOI 10.1111/bij.12507; Einfeldt AL, 2014, INVERTEBR BIOL, V133, P232, DOI 10.1111/ivb.12060; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gamenick I, 1996, MAR ECOL PROG SER, V144, P73, DOI 10.3354/meps144073; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; GERDOL V, 1994, MAR ECOL PROG SER, V114, P103, DOI 10.3354/meps114103; Godbold JA, 2011, P ROY SOC B-BIOL SCI, V278, P2510, DOI 10.1098/rspb.2010.2414; Godbold JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007423; Godbold JA, 2009, OIKOS, V118, P77, DOI 10.1111/j.1600-0706.2008.17072.x; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hale R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06463; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes RG, 1997, ESTUAR COAST SHELF S, V44, P621, DOI 10.1006/ecss.1996.0146; Inger R, 2015, ECOL LETT, V18, P28, DOI 10.1111/ele.12387; JACKSON D, 1985, OECOLOGIA, V65, P406, DOI 10.1007/BF00378916; Jousset A, 2011, ECOL LETT, V14, P537, DOI 10.1111/j.1461-0248.2011.01613.x; Kristensen E., 1988, SCOPE, V33, P275; Maestre FT, 2010, PHILOS T R SOC B, V365, P2057, DOI 10.1098/rstb.2010.0016; McGill BJ, 2015, TRENDS ECOL EVOL, V30, P104, DOI 10.1016/j.tree.2014.11.006; MEADOWS PS, 1966, J ZOOL, V150, P387; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; MURDOCH MH, 1986, J EXP MAR BIOL ECOL, V103, P235, DOI 10.1016/0022-0981(86)90143-7; Nixon SW, 1981, ESTUARIES NUTRIENTS, P111, DOI DOI 10.1007/978-1-4612-5826-1_6; OLAFSSON EB, 1986, J EXP MAR BIOL ECOL, V103, P103, DOI 10.1016/0022-0981(86)90135-8; Orvain F, 2006, J SEA RES, V55, P54, DOI 10.1016/j.seares.2005.10.002; PELEGRI SP, 1994, MAR ECOL PROG SER, V105, P285, DOI 10.3354/meps105285; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Peres CA, 2000, OECOLOGIA, V122, P175, DOI 10.1007/PL00008845; Polley HW, 2003, ECOL LETT, V6, P248, DOI 10.1046/j.1461-0248.2003.00422.x; RIISGARD HU, 1991, MAR ECOL PROG SER, V70, P29, DOI 10.3354/meps070029; RONN C, 1988, J EXP MAR BIOL ECOL, V116, P143, DOI 10.1016/0022-0981(88)90052-4; Scaps P, 2002, HYDROBIOLOGIA, V470, P203, DOI 10.1023/A:1015681605656; Schuckel U, 2013, ESTUAR COAST SHELF S, V117, P210, DOI 10.1016/j.ecss.2012.11.008; Schumacher J, 1930, HELGOLAND MAR RES, V68, P289; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Strong JA, 2015, ESTUAR COAST SHELF S, V161, P46, DOI 10.1016/j.ecss.2015.04.008; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Tornroos A, 2015, J EXP MAR BIOL ECOL, V472, P32, DOI 10.1016/j.jembe.2015.06.015; Venables WN., 2002, MODERN APPL STAT S 4; Widdows J, 1998, ESTUARIES, V21, P552, DOI 10.2307/1353294; Ysebaert T, 2005, HYDROBIOLOGIA, V540, P197, DOI 10.1007/s10750-004-7144-5; Ysebaert T, 2002, MAR ECOL PROG SER, V244, P105, DOI 10.3354/meps244105	65	7	7	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165739	10.1371/journal.pone.0165739	http://dx.doi.org/10.1371/journal.pone.0165739			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812164	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000054
J	Dodo, Y; Murakami, T; Unoki, N; Ogino, K; Uji, A; Yoshitake, S; Yoshimura, N				Dodo, Yoko; Murakami, Tomoaki; Unoki, Noriyuki; Ogino, Ken; Uji, Akihito; Yoshitake, Shin; Yoshimura, Nagahisa			White Dots as a Novel Marker of Diabetic Retinopathy Severity in Ultrawide Field Imaging	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COHERENCE TOMOGRAPHIC CHARACTERISTICS; MICROANEURYSMS; PREVALENCE; TRIAL; RISK	Purpose To characterize white dots in diabetic retinopathy (DR) and their association with disease severity using ultra-wide-field scanning laser ophthalmoscopy. Methods We randomly selected 125 eyes of 77 patients (25 eyes from individual categories of the international classification of DR severity) for which ultrawide field photographs were obtained. We characterized white dots, which were delineated by higher signal levels on green but not red laser images, and evaluated the relationship between the number of white dots and the international severity scale of DR. Results Most white dots were located in nonperfused areas, and the number of total white dots was significantly correlated to that of dots in nonperfused areas. White dots corresponded to microaneurysms around the boundary between nonperfused areas and perfused areas or unknown lesions in nonperfused areas. Eyes with DR had significantly more white dots than those with no apparent retinopathy. The numbers of white dots in moderate nonproliferative diabetic retinopathy (NPDR) or more severe grades were significantly higher than in mild NPDR. The area under the receiver operating characteristics curve (AROC) analyses demonstrated that the number of white dots had the significance in the diagnosis of DR (0.908-0.986) and moderate NPDR or more severe grades (0.888-0.974). Conclusions These data suggest the clinical relevance of white dots seen on ultrawide field images in the diagnosis of the severity of DR.	[Dodo, Yoko; Murakami, Tomoaki; Unoki, Noriyuki; Ogino, Ken; Uji, Akihito; Yoshitake, Shin; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan	Kyoto University	Murakami, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	mutomo@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Sciences	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; [Anonymous], 1991, OPHTHALMOLOGY, V98, P823; [Anonymous], 1976, AM J OPHTHALMOL, V81, P383; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Arichika S, 2013, INVEST OPHTH VIS SCI, V54, P4394, DOI 10.1167/iovs.12-11138; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; BEK T, 1994, ACTA OPHTHALMOL, V72, P409; Bolz M, 2009, OPHTHALMOLOGY, V116, P914, DOI 10.1016/j.ophtha.2008.12.039; BRESNICK GH, 1977, ARCH OPHTHALMOL-CHIC, V95, P1215, DOI 10.1001/archopht.1977.04450070113010; Byeon SH, 2009, OPHTHALMOLOGY, V116, P1949, DOI 10.1016/j.ophtha.2009.06.066; Cunningham ET, 2005, OPHTHALMOLOGY, V112, P1747, DOI 10.1016/j.ophtha.2005.06.007; De Venecia G, 1976, Arch Ophthalmol, V94, P1766; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Horii T, 2010, AM J OPHTHALMOL, V150, P840, DOI 10.1016/j.ajo.2010.06.015; Ito H, 2013, RETINA-J RET VIT DIS, V33, P732, DOI 10.1097/IAE.0b013e31826b0bd7; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEIN R, 1995, ARCH OPHTHALMOL-CHIC, V113, P1386, DOI 10.1001/archopht.1995.01100110046024; Kohner EM, 1999, DIABETOLOGIA, V42, P1107, DOI 10.1007/s001250051278; Mackenzie PJ, 2007, RETINA-J RET VIT DIS, V27, P1119, DOI 10.1097/IAE.0b013e3180592b5c; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Murakami T, 2012, DIABETES, V61, P1573, DOI 10.2337/db11-1367; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Shin YU, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.036; Silva PS, 2013, OPHTHALMOLOGY, V120, P2587, DOI 10.1016/j.ophtha.2013.05.004; Vujosevic S, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/491835; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wilson PJ, 2010, OPHTHALMOLOGICA, V224, P251, DOI 10.1159/000284351; Yanoff M, 1984, SURV OPHTHALMOL S, V28, P505; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165906	10.1371/journal.pone.0165906	http://dx.doi.org/10.1371/journal.pone.0165906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812207	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000076
J	Komatsu, H; Inui, A; Umetsu, S; Tsunoda, T; Sogo, T; Konishi, Y; Fujisawa, T				Komatsu, Haruki; Inui, Ayano; Umetsu, Shuichiro; Tsunoda, Tomoyuki; Sogo, Tsuyoshi; Konishi, Yasuhiro; Fujisawa, Tomoo			Evaluation of the G145R Mutant of the Hepatitis B Virus as a Minor Strain in Mother-to-Child Transmission	PLOS ONE			English	Article							REAL-TIME PCR; PERIPHERAL-BLOOD LEUKOCYTES; NUCLEIC-ACID PROBES; SURFACE-ANTIGEN; S GENE; IMMUNOPROPHYLAXIS FAILURE; IMMUNE GLOBULIN; POSTNATAL IMMUNOPROPHYLAXIS; INFANT TRANSMISSION; VACCINE FAILURE	The role of the hepatitis B virus (HBV) mutant G145R, with a single change in amino acid 145 of the surface protein, as a minor population remains unknown in mother-to-child transmission. The minor strain as well as the major strain of the G145R mutant were evaluated in three cohorts using a locked nucleic acid probe-based real-time PCR. The breakthrough cohort consisted of children who were born to HBV carrier mothers and became HBV carriers despite immnoprophylaxis (n = 25). The control cohort consisted of HBV carriers who had no history of receiving the hepatitis B vaccine, hepatitis B immunoglobulin or antiviral treatment (n = 126). The pregnant cohort comprised pregnant women with chronic HBV infection (n = 31). In the breakthrough cohort, 6 showed positive PCR results (major, 2; minor, 4). In the control cohort, 13 showed positive PCR results (major, 0; minor, 13). HBeAg-positive patients were prone to have the G145R mutant as a minor population. Deep sequencing was performed in a total of 32 children (PCR positive, n = 13; negative, n = 19). In the breakthrough cohort, the frequency of the G145R mutant ranged from 0.54% to 6.58%. In the control cohort, the frequency of the G145R mutant ranged from 0.42% to 4.1%. Of the 31 pregnant women, 4 showed positive PCR results (major, n = 0; minor, n = 4). All of the pregnant women were positive for HBeAg and showed a high viral load. Three babies born to 3 pregnant women with the G145R mutant were evaluated. After the completion of immunoprophylaxis, 2 infants became negative for HBsAg. The remaining infant became negative for HBsAg after the first dose of HB vaccine. G145R was detected in one-fourth of the children with immunoprophylaxis failure. However, the pre-existence of the G145R mutant as a minor population in pregnant women does not always cause breakthrough infection in infants.	[Komatsu, Haruki] Toho Univ, Dept Pediat, Sakura Med Ctr, Chiba, Japan; [Komatsu, Haruki; Inui, Ayano; Umetsu, Shuichiro; Tsunoda, Tomoyuki; Sogo, Tsuyoshi; Fujisawa, Tomoo] Eastern Yokohama Hosp, Dept Pediat Hepatol & Gastroenterol, Yokohama, Kanagawa, Japan; [Konishi, Yasuhiro] Eastern Yokohama Hosp, Dept Obstet & Gynecol, Yokohama, Kanagawa, Japan	Toho University	Komatsu, H (corresponding author), Toho Univ, Dept Pediat, Sakura Med Ctr, Chiba, Japan.; Komatsu, H (corresponding author), Eastern Yokohama Hosp, Dept Pediat Hepatol & Gastroenterol, Yokohama, Kanagawa, Japan.	haruki-komatsu@chive.ocn.ne.jp			JSPS KAKENHI [15K09701]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (Grant-in-Aid for Scientific Research) grant number 15K09701.	Ayres A, 2014, J VIRAL HEPATITIS, V21, P809, DOI 10.1111/jvh.12212; BEASLEY RP, 1983, LANCET, V2, P1099; Buchanan C, 2010, CLIN LIVER DIS, V14, P495, DOI 10.1016/j.cld.2010.05.008; Bzowej Natalie H, 2010, Curr Hepat Rep, V9, P197, DOI 10.1007/s11901-010-0059-x; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; Chakravarty R, 2002, VIRUS RES, V90, P133, DOI 10.1016/S0168-1702(02)00147-8; Cooreman MP, 2001, J BIOMED SCI, V8, P237, DOI 10.1007/BF02256597; Datta S, 2009, J VIROL, V83, P9983, DOI 10.1128/JVI.01905-08; Dunkelberg JC, 2014, J PERINATOL, V34, P882, DOI 10.1038/jp.2014.167; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Francois G, 2001, VACCINE, V19, P3799, DOI 10.1016/S0264-410X(01)00108-6; Gambarin-Gelwan Maya, 2007, Clin Liver Dis, V11, P945, DOI 10.1016/j.cld.2007.08.004; Hige S, 2010, J CLIN MICROBIOL, V48, P4487, DOI 10.1128/JCM.00731-10; HINO K, 1995, DIGEST DIS SCI, V40, P566, DOI 10.1007/BF02064370; Hsu HY, 2013, J INFECT DIS, V207, P1047, DOI 10.1093/infdis/jis943; Hsu HY, 2004, GUT, V53, P1499, DOI 10.1136/gut.2003.034223; Hsu HY, 1997, HEPATOLOGY, V26, P786, DOI 10.1053/jhep.1997.v26.pm0009303514; Jonas MM, 2009, LIVER INT, V29, P133, DOI 10.1111/j.1478-3231.2008.01933.x; Kitab B, 2011, J INFECTION, V63, P66, DOI 10.1016/j.jinf.2011.05.007; Komatsu H, 2002, J MED VIROL, V66, P28, DOI 10.1002/jmv.2107; Komatsu Haruki, 2012, BMC Res Notes, V5, P22, DOI 10.1186/1756-0500-5-22; Kumar A, 2012, INDIAN J GASTROENTER, V31, P43, DOI 10.1007/s12664-012-0174-4; Lada O, 2006, J VIROL, V80, P2968, DOI 10.1128/JVI.80.6.2968-2975.2006; Lazarevic I, 2010, J MED VIROL, V82, P1160, DOI 10.1002/jmv.21810; Lee PI, 1997, J INFECT DIS, V176, P427, DOI 10.1086/514060; Liu Y, 2007, J CLIN MICROBIOL, V45, P553, DOI 10.1128/JCM.00709-06; Liu Y, 2012, J MICROBIOL METH, V91, P483, DOI 10.1016/j.mimet.2012.10.002; Matsumoto T, 1997, J MED VIROL, V53, P255, DOI 10.1002/(SICI)1096-9071(199711)53:3<255::AID-JMV13>3.0.CO;2-G; MITAMURA K, 1991, PROG CLIN BIOL RES, V364, P81; Miyake Y, 1996, TOHOKU J EXP MED, V180, P233, DOI 10.1620/tjem.180.233; Nainan OV, 2002, J MED VIROL, V68, P319, DOI 10.1002/jmv.10206; Ngui SL, 1997, J INFECT DIS, V176, P1360, DOI 10.1086/514133; Ntziora F, 2013, J CLIN MICROBIOL, V51, P2893, DOI 10.1128/JCM.00936-13; Ogura Y, 1999, J INFECT DIS, V180, P1444, DOI 10.1086/315094; OKAMOTO H, 1992, PEDIATR RES, V32, P264, DOI 10.1203/00006450-199209000-00002; OKAMOTO H, 1987, JPN J EXP MED, V57, P231; Osiowy C, 2002, J CLIN MICROBIOL, V40, P2566, DOI 10.1128/JCM.40.7.2566-2571.2002; Osiowy C, 2006, J VIROL, V80, P10307, DOI 10.1128/JVI.00996-06; Pan CVQ, 2012, CLIN GASTROENTEROL H, V10, P452, DOI 10.1016/j.cgh.2011.10.041; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Patton H, 2014, NAT REV GASTRO HEPAT, V11, P402, DOI 10.1038/nrgastro.2014.30; Rodriguez-Frias F, 1999, LIVER, V19, P177, DOI 10.1111/j.1478-3231.1999.tb00032.x; Rodriguez-Frias F, 2013, WORLD J GASTROENTERO, V19, P6995, DOI 10.3748/wjg.v19.i41.6995; Sa-nguanmoo P, 2012, J MED VIROL, V84, P1177, DOI 10.1002/jmv.23260; Singh AE, 2011, J VIRAL HEPATITIS, V18, P468, DOI 10.1111/j.1365-2893.2010.01333.x; Song BC, 2005, J MED VIROL, V76, P194, DOI 10.1002/jmv.20354; Sun Z, 2007, GENOMICS, V89, P151, DOI 10.1016/j.ygeno.2006.07.011; Tadokoro K, 2006, J VIROL METHODS, V138, P30, DOI 10.1016/j.jviromet.2006.07.014; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Wang Q, 2012, EXP THER MED, V3, P503, DOI 10.3892/etm.2011.442; Warshawsky I, 2011, J CLIN PATHOL, V64, P905, DOI 10.1136/jclinpath-2011-200086; World Health Organization (WHO), 2016, MED CTR HEP B; Xu HM, 2006, J INFECT DIS, V193, P88, DOI 10.1086/498573; Zhang L, 2014, EUR J PEDIATR, V173, P1161, DOI 10.1007/s00431-014-2305-7; Zhang M, 2002, HEPATOLOGY, V36, P723, DOI 10.1053/jhep.2002.35346; Zou H, 2012, J VIRAL HEPATITIS, V19, pE18, DOI 10.1111/j.1365-2893.2011.01492.x	56	9	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165674	10.1371/journal.pone.0165674	http://dx.doi.org/10.1371/journal.pone.0165674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812178	gold, Green Published, Green Submitted			2022-12-27	WOS:000386910000047
J	Liu, BY; Tai, Y; Caceres, AI; Achanta, S; Balakrishna, S; Shao, XM; Fang, JF; Jordt, SE				Liu, Boyi; Tai, Yan; Caceres, Ana I.; Achanta, Satyanarayana; Balakrishna, Shrilatha; Shao, Xiaomei; Fang, Junfan; Jordt, Sven-Eric			Oxidized Phospholipid OxPAPC Activates TRPA1 and Contributes to Chronic Inflammatory Pain in Mice	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; RECEPTOR POTENTIAL A1; COVALENT MODIFICATION; HYDROGEN-PEROXIDE; PROSTAGLANDIN E-2; OXIDATIVE STRESS; ION CHANNELS; LUNG INJURY; IN-VITRO; IDENTIFICATION	Oxidation products of the naturally occurring phospholipid 1-palmitoyl-2-arachidonoyl-sn-glycerol-3-phosphatidylcholine (PAPC), which are known as OxPAPC, accumulate in atherosclerotic lesions and at other sites of inflammation in conditions such as septic inflammation and acute lung injury to exert pro-or anti-inflammatory effects. It is currently unknown whether OxPAPC also contributes to inflammatory pain and peripheral neuronal excitability in these conditions. Here, we observed that OxPAPC dose-dependently and selectively activated human TRPA1 nociceptive ion channels expressed in HEK293 cells in vitro, without any effect on other TRP channels, including TRPV1, TRPV4 and TRPM8. OxPAPC agonist activity was dependent on essential cysteine and lysine residues within the N-terminus of the TRPA1 channel protein. OxPAPC activated calcium influx into a subset of mouse sensory neurons which were also sensitive to the TRPA1 agonist mustard oil. Neuronal OxPAPC responses were largely abolished in neurons isolated from TRPA1-deficient mice. Intraplantar injection of OxPAPC into the mouse hind paw induced acute pain and persistent mechanical hyperalgesia and this effect was attenuated by the TRPA1 inhibitor, HC-030031. More importantly, we found levels of OxPAPC to be significantly increased in inflamed tissue in a mouse model of chronic inflammatory pain, identified by the binding of an OxPAPC-specific antibody. These findings suggest that TRPA1 is a molecular target for OxPAPC and OxPAPC may contribute to chronic inflammatory pain through TRPA1 activation. Targeting against OxPAPC and TRPA1 signaling pathway may be promising in inflammatory pain treatment.	[Liu, Boyi; Shao, Xiaomei; Fang, Junfan] Zhejiang Chinese Med Univ, Clin Med Coll 3, Dept Neurobiol & Acupuncture Res, Hangzhou, Zhejiang, Peoples R China; [Tai, Yan] Zhejiang Chinese Med Univ, Dept Lab & Equipment Adm, Hangzhou, Zhejiang, Peoples R China; [Tai, Yan; Caceres, Ana I.; Achanta, Satyanarayana; Jordt, Sven-Eric] Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27703 USA; [Balakrishna, Shrilatha] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Duke University; Yale University	Jordt, SE (corresponding author), Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27703 USA.	sven.jordt@duke.edu	Jordt, Sven-Eric/ABE-6517-2020; Achanta, Satyanarayana/I-8440-2017; tai, yh/GRR-4574-2022; Caceres, Ana I/E-5542-2012	Jordt, Sven-Eric/0000-0001-6171-5622; Achanta, Satyanarayana/0000-0001-7121-5445; Caceres, Ana I/0000-0001-7219-8851	National Institute of Environmental Health Sciences [U01 ES015674]; National Institute of Arthritis and Musculoskeletal and Skin Disease [R21 AR070554]; National Center for Advancing Translational Sciences [UL1TR001117]; Duke Anesthesiology Dream Innovation Grant [2015-DIG LIU]; National Natural Science Foundation of China [81603676]; Zhejiang Provincial Natural Science Funds for Distinguished Young Scholars [LR17H270001]; Zhejiang Chinese Medical University Starting-up Funding [722223A08301/001/004]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR070554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES015674] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Arthritis and Musculoskeletal and Skin Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Duke Anesthesiology Dream Innovation Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Funds for Distinguished Young Scholars; Zhejiang Chinese Medical University Starting-up Funding; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project is supported by funding from the National Institute of Environmental Health Sciences U01 ES015674 (http://www.niehs.nih.gov/), National Institute of Arthritis and Musculoskeletal and Skin Disease R21 AR070554 (http://www.niams.nih.gov/) to S.E.J. and from National Center for Advancing Translational Sciences UL1TR001117 (https://ncats.nih.gov), Duke Anesthesiology Dream Innovation Grant 2015-DIG LIU (http://anesthesia.mc.dke.edu/), National Natural Science Foundation of China 81603676 (http://www.nsfc.gov.cn/), Zhejiang Provincial Natural Science Funds for Distinguished Young Scholars LR17H270001 (http://www.zjnsf.gov.cn/index.aspx), Zhejiang Chinese Medical University Starting-up Funding 722223A08301/001/004 (http://www.zcmu.edu.cn/) to B.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	af Forselles KJ, 2011, BRIT J PHARMACOL, V164, P1847, DOI 10.1111/j.1476-5381.2011.01495.x; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Asgar J, 2015, NEUROSCIENCE, V310, P206, DOI 10.1016/j.neuroscience.2015.09.042; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Awasthi D, 2016, FREE RADICAL BIO MED, V93, P190, DOI 10.1016/j.freeradbiomed.2016.01.004; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Bellono NW, 2013, P NATL ACAD SCI USA, V110, P2383, DOI 10.1073/pnas.1215555110; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Bessac BF, 2009, FASEB J, V23, P1102, DOI 10.1096/fj.08-117812; Birukov KG, 2004, MICROVASC RES, V67, P18, DOI 10.1016/j.mvr.2003.09.004; Bluml S, 2005, J IMMUNOL, V175, P501, DOI 10.4049/jimmunol.175.1.501; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Bochkov VN, 2002, BLOOD, V99, P199, DOI 10.1182/blood.V99.1.199; da Costa DSM, 2010, PAIN, V148, P431, DOI 10.1016/j.pain.2009.12.002; Dall'Acqua MC, 2014, LIFE SCI, V105, P7, DOI 10.1016/j.lfs.2014.02.031; Earley S, 2009, CIRC RES, V104, P987, DOI 10.1161/CIRCRESAHA.108.189530; Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200; Fernandes ES, 2011, ARTHRITIS RHEUM-US, V63, P819, DOI 10.1002/art.30150; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Furnkranz A, 2005, ARTERIOSCL THROM VAS, V25, P633, DOI 10.1161/01.ATV.0000153106.03644.a0; Grace M, 2012, THORAX, V67, P891, DOI 10.1136/thoraxjnl-2011-201443; Gruber F, 2007, J BIOL CHEM, V282, P16934, DOI 10.1074/jbc.M702523200; Gruber F, 2010, FASEB J, V24, P39, DOI 10.1096/fj.09-133520; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Kadl A, 2011, FREE RADICAL BIO MED, V51, P1903, DOI 10.1016/j.freeradbiomed.2011.08.026; Kadl A, 2009, ARTHRITIS RHEUM-US, V60, P1362, DOI 10.1002/art.24448; KEERY RJ, 1988, BRIT J PHARMACOL, V94, P745, DOI 10.1111/j.1476-5381.1988.tb11584.x; Li RS, 2006, CIRC RES, V98, P642, DOI 10.1161/01.RES.0000207394.39249.fc; Liu BY, 2013, PAIN, V154, P2169, DOI 10.1016/j.pain.2013.06.043; Liu BY, 2013, FASEB J, V27, P3549, DOI 10.1096/fj.13-229948; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Meliton AY, 2015, AM J PHYSIOL-LUNG C, V308, pL550, DOI 10.1152/ajplung.00248.2014; Nassini R, 2014, REV PHYSIOL BIOCH P, V167, P1, DOI 10.1007/112_2014_18; Nassini R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042454; Oskolkova OV, 2010, J IMMUNOL, V185, P7706, DOI 10.4049/jimmunol.0903594; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Pitcher GM, 1999, J NEUROSCI METH, V87, P185, DOI 10.1016/S0165-0270(99)00004-7; Romanoski CE, 2011, CIRC RES, V109, pE27, DOI 10.1161/CIRCRESAHA.111.241869; Springstead JR, 2012, J LIPID RES, V53, P1304, DOI 10.1194/jlr.M025320; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Thimmulappa RK, 2012, BIOCHEM BIOPH RES CO, V426, P253, DOI 10.1016/j.bbrc.2012.08.076; Trevisan G, 2016, BRAIN; Trevisan G, 2014, FREE RADICAL BIO MED, V72, P200, DOI 10.1016/j.freeradbiomed.2014.04.021; Trevisan G, 2013, ARTHRITIS RHEUM-US, V65, P2984, DOI 10.1002/art.38112; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; VILE GF, 1995, FREE RADICAL BIO MED, V18, P721, DOI 10.1016/0891-5849(94)00192-M; WOODWARD DF, 1995, BIOCHEM PHARMACOL, V50, P1731, DOI 10.1016/0006-2952(95)02035-7; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692	51	34	35	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165200	10.1371/journal.pone.0165200	http://dx.doi.org/10.1371/journal.pone.0165200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812120	gold, Green Published, Green Submitted			2022-12-27	WOS:000386910000023
J	Niedz, RP				Niedz, Randall P.			ARS-Media for Excel: A Spreadsheet Tool for Calculating Media Recipes Based on Ion-Specific Constraints	PLOS ONE			English	Article							TISSUE-CULTURE MEDIUM; IN-VITRO CULTURE; MINERAL-COMPOSITION; OLIVE TREES; MICROPROPAGATION; POTASSIUM; GROWTH; SODIUM; CULTIVARS; NUTRITION	ARS-Media for Excel is an ion solution calculator that uses "Microsoft Excel" to generate recipes of salts for complex ion mixtures specified by the user. Generating salt combinations (recipes) that result in pre-specified target ion values is a linear programming problem. Excel's Solver add-on solves the linear programming equation to generate a recipe. Calculating a mixture of salts to generate exact solutions of complex ionic mixtures is required for at least 2 types of problems-1) formulating relevant ecological/biological ionic solutions such as those from a specific lake, soil, cell, tissue, or organ and, 2) designing ion confounding-free experiments to determine ion-specific effects where ions are treated as statistical factors. Using ARS-Media for Excel to solve these two problems is illustrated by 1) exactly reconstructing a soil solution representative of a loamy agricultural soil and, 2) constructing an ion-based experiment to determine the effects of substituting Na+ for K+ on the growth of a Valencia sweet orange nonembryogenic cell line.	[Niedz, Randall P.] ARS, USDA, US Hort Res Lab, Ft Pierce, FL 34945 USA	United States Department of Agriculture (USDA)	Niedz, RP (corresponding author), ARS, USDA, US Hort Res Lab, Ft Pierce, FL 34945 USA.	randall.niedz@ars.usda.gov						Anderson M.J., 2016, RSM SIMPLIFIED OPTIM; ANGLE JS, 1991, APPL ENVIRON MICROB, V57, P3674, DOI 10.1128/AEM.57.12.3674-3676.1991; [Anonymous], 2003, MINEQL CHEM EQUILIBR; Ashrafi EN, 2010, J FOOD AGRIC ENVIRON, V8, P325; Erel R, 2015, J PLANT PHYSIOL, V177, P1, DOI 10.1016/j.jplph.2015.01.005; Erel R, 2014, TREE PHYSIOL, V34, P1102, DOI 10.1093/treephys/tpu081; Evens TJ, 2008, SCHOLARLY RES EXCHAN, DOI [10.3814/2008/761829, DOI 10.3814/2008/761829]; Goncalves S, 2005, BIOL PLANTARUM, V49, P277, DOI 10.1007/s10535-005-7280-4; Oberschelp GPJ, 2015, IN VITRO CELL DEV-PL, V51, P626, DOI 10.1007/s11627-015-9715-8; Krishnasamy K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00631; LITVAY JD, 1981, I PAPER CHEM TECH PA, V115, P1; Monteiro ACBD, 2000, IN VITRO CELL DEV-PL, V36, P527, DOI 10.1007/s11627-000-0094-3; Morard P, 1998, J PLANT NUTR, V21, P1565, DOI 10.1080/01904169809365504; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURASHIGE T., 1969, Proceedings 1st int. Citrus Symp., Univ. California, Riverside 1968., V3, P1155; Nas MN, 2013, TURK J BOT, V37, P1134, DOI 10.3906/bot-1302-49; Nas MN, 2004, SCI HORTIC-AMSTERDAM, V101, P189, DOI 10.1016/j.scienta.2003.10.004; Niedz RP, 2007, IN VITRO CELL DEV-PL, V43, P370, DOI 10.1007/s11627-007-9062-5; Niedz RP, 2006, NAT METHODS, V3, P417, DOI 10.1038/nmeth0606-417; Smith EJ, 2002, WATER RES, V36, P1286, DOI 10.1016/S0043-1354(01)00341-4; Staikidou I, 2006, J HORTIC SCI BIOTECH, V81, P537, DOI 10.1080/14620316.2006.11512100; Wakeel A, 2011, CRIT REV PLANT SCI, V30, P401, DOI 10.1080/07352689.2011.587728	22	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166025	10.1371/journal.pone.0166025	http://dx.doi.org/10.1371/journal.pone.0166025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812202	gold, Green Submitted, Green Published			2022-12-27	WOS:000386910000095
J	Sebri, I; Bartier, JC; Pelaccia, T				Sebri, Isabelle; Bartier, Jean-Claude; Pelaccia, Thierry			How Do Nursing Students Use Digital Tools during Lectures?	PLOS ONE			English	Article							CLICKERS	Objectives Teachers often wonder what students are doing during lectures, in drafting their institutional policy concerning the use of digital tools in class.behind their computers, mobile phones and other digital tools. This study aimed to document the type of tools used during lectures by nursing students and what they do with them. Methods We carried out a descriptive, prospective, multicentre study including 1446 nursing students in Alsace (France). The students filled in an anonymous questionnaire at the end of a lesson they had just attended. Results 99% of the students had taken at least one digital tool to the lesson. 90% had a mobile phone with them. It was mainly used for entertainment (particularly for sending and/or receiving text messages and consulting emails). 52% had a laptop with them. It was essentially used for academic tasks (taking notes, working on other teaching units or revising for exams). Conclusion Most nursing students take a phone or laptop to lectures with them with the intention of using them for entertainment and learning respectively. These results could guide training establishmentsin drafting their institutional policy concerning the use of digital tools in class.	[Sebri, Isabelle] St Vincent Nursing Sch, Strasbourg, France; [Bartier, Jean-Claude] Emergency Dept Network Alsace RESURAL, Strasbourg, France; [Pelaccia, Thierry] Univ Strasbourg, Fac Med, Ctr Training & Res Hlth Sci Educ CFRPS, Strasbourg, France; [Pelaccia, Thierry] Strasbourg Univ Hosp, Prehosp Emergency Care Serv SAMU 67, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Pelaccia, T (corresponding author), Univ Strasbourg, Fac Med, Ctr Training & Res Hlth Sci Educ CFRPS, Strasbourg, France.; Pelaccia, T (corresponding author), Strasbourg Univ Hosp, Prehosp Emergency Care Serv SAMU 67, Strasbourg, France.	pelaccia@unistra.fr						Blasco-Arcas L, 2013, COMPUT EDUC, V62, P102, DOI 10.1016/j.compedu.2012.10.019; Brown J.S., 2000, CHANGE MAGAZINE HIGH, V32(2), P11, DOI [DOI 10.1080/00091380009601719, 10.1080/00091380009601719]; Caldwell Jane E, 2007, CBE Life Sci Educ, V6, P9, DOI 10.1187/cbe.06-12-0205; Ellaway R, 2008, MED TEACH, V30, P455, DOI [10.1080/01421590802108349, 10.1080/01421590802108331]; Fusaro M, 2012, ETUDE MODALITE APPRE; Homme J, 2004, MED EDUC, V38, P575, DOI 10.1111/j.1365-2929.2004.01888.x; Mayer RE, 2009, CONTEMP EDUC PSYCHOL, V34, P51, DOI 10.1016/j.cedpsych.2008.04.002; Mueller PA, 2014, PSYCHOL SCI, V25, P1159, DOI 10.1177/0956797614524581; Piolat A, 2003, AROB SE, V7, P118; Prensky M, 2001, HORIZON, V9; Sana F, 2013, COMPUT EDUC, V62, P24, DOI 10.1016/j.compedu.2012.10.003	11	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165714	10.1371/journal.pone.0165714	http://dx.doi.org/10.1371/journal.pone.0165714			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812170	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000051
J	Ushie, BA; Ugal, DB; Ingwu, JA				Ushie, Boniface Ayanbekongshie; Ugal, David Betelwhobel; Ingwu, Justin Agorye			Overdependence on For-Profit Pharmacies: A Descriptive Survey of User Evaluation of Medicines Availability in Public Hospitals in Selected Nigerian States	PLOS ONE			English	Article							HEALTH-CARE; AFFORDABILITY; VENDORS; ACCESS; INCOME; DRUGS; URBAN	Objective Lower availability of medicines in Nigerian public health facilities D the most affordable option for the masses D undermines global health reforms to improve access to health for all, especially the chronically ill and poor. Thus, a sizeable proportion of healthcare users, irrespective of purchasing power, buy medicines at higher costs from for-profit pharmacies. We examined user evaluation of medicine availability in public facilities and how this influences their choice of where to buy medicines in selected states D Cross River, Enugu and Oyo D in Nigeria. Methods We approached and interviewed 1711 healthcare users using a semi-structured, interviewer-administered questionnaire as they exited for-profit pharmacies after purchasing medicines. This ensured that both clients who had presented at health facilities (private/public) and those who did not were included. Information was collected on why respondents could not buy medicines at the hospitals they attended, their views of medicine availability and whether their choice of where to buy medicines is influenced by non-availability. Principal Findings Respondents' mean age was 37.7 +/- 14.4 years; 52% were males, 59% were married, 82% earned >= NGN18, 000 (US$57.19) per month, and 72% were not insured. Majority (66%) had prescriptions; of this, 70% were from public facilities. Eighteen percent of all respondents indicated that all their medicines were usually available at the public facilities, most (29%), some (44%) and not always available (10%). Reasons for using for-profit pharmacies included: health workers attitudes (43%), referral by providers (43%); inadequate money to purchase all prescribed drugs (42%) and cumbersome processes for obtaining medicines. Conclusions Lower availability of medicines has serious implications for healthcare behavior, especially because of poverty. It is crucial for government to fulfill its mandate of equitable access to care for all by making medicines available and cheap through reviving and sustaining the drug revolving fund scheme and encouraging the prescription of generic drugs in all public health facilities.	[Ushie, Boniface Ayanbekongshie] Univ Ibadan, Inst Child Hlth, Coll Med, Ibadan, Nigeria; [Ugal, David Betelwhobel] Fed Univ Lafia, Dept Sociol, Lafia, Nigeria; [Ingwu, Justin Agorye] Univ Nigeria, Dept Nursing Sci, Nsukka, Nigeria	University of Ibadan; University of Nigeria	Ushie, BA (corresponding author), Univ Ibadan, Inst Child Hlth, Coll Med, Ibadan, Nigeria.	boniface.ushie@gmail.com		Ushie, Boniface Ayanbekongshie/0000-0001-6579-6327	Tertiary Education Trust Fund; Federal Government of Nigeria	Tertiary Education Trust Fund; Federal Government of Nigeria	The authors received funding for this work from the Tertiary Education Trust Fund, which is provided by the Federal Government of Nigeria; http://www.tetfund.gov.ng/.	Abegunde K. A., 2013, J COMMUNITY MED PRIM, V26, P1; Adesina, 2002, CURRENTS PERSPECTIVE, P212; Alubo O, 2001, HEALTH POLICY PLANN, V16, P313, DOI 10.1093/heapol/16.3.313; Alubo S. O., 1999, SOC SCI MED, V38, P97; Babar ZUD, 2013, PHARMACOECONOMICS, V31, P1063, DOI 10.1007/s40273-013-0095-9; Bigdeli M, 2013, HEALTH POLICY PLANN, V28, P692, DOI 10.1093/heapol/czs108; Brieger WR, 2004, HEALTH POLICY PLANN, V19, P177, DOI 10.1093/heapol/czh021; Brinda EM, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-5; BROCK DW, 1987, J MED PHILOS, V12, P1; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Chandler CIR, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-13; Eke Christopher Bismarck, 2014, BMC Res Notes, V7, P800, DOI 10.1186/1756-0500-7-800; Fadare J. O., 2015, EXPERT REV PHARM OUT, P1; FMOH, 2005, INV HLTH FAC NIG; Foster S.D., 1990, IMPROVING SUPPLY USE; Garg CC, 2009, HEALTH POLICY PLANN, V24, P116, DOI 10.1093/heapol/czn046; Iloh GUP, 2012, NIGER J CLIN PRACT, V15, P469, DOI 10.4103/1119-3077.104529; Iyioha IO, 2016, COMP HLTH LAW POLICY; Jitta J, 2003, HEALTH POLICY, V65, P167, DOI 10.1016/S0168-8510(03)00003-4; Johnson O. E., 2015, J COMMUNITY MED PRIM, V27, P73; Kotwani A, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-285; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Muhammed KA, 2013, J PUBLIC HEALTH AFR, V4, P64, DOI 10.4081/jphia.2013.e13; NHA, 2006, NAT HLTH ACC NHA 200; Niens LM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000333; Odusanya O. O., 1999, NIGERIAN Q J HOSP ME, V9, DOI [10.4314/nqjhm.v9i4.12397, DOI 10.4314/NQJHM.V9I4.12397]; Odusanya OO, 2004, J COMMUNITY MED PRIM, V16, P21; Okafor C., 2015, AFRICAN RES REV, V9, P333; Oparah C. A., 2001, INT J PHARM PRACT, V9, P191; Orem JN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-175; OSHINAME FO, 1992, SOC SCI MED, V35, P1477, DOI 10.1016/0277-9536(92)90050-Z; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Sado E, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0572-3; Salako L. A., 2004, J CLIN EPIDEMIOL, V45, P15; Shabangu K, 2015, AFR J PRIM HEALTH CA, V7, DOI [10.4102/phcfm.v7i1.829, 10.4102/PHCFM.V7I1.829]; Uche I., 2014, ACAD J INTERDISCIPLI, V3, P501; Umoru A, 2016, VALUE HEALTH, V19, pA35, DOI 10.1016/j.jval.2016.03.380; UNDP, 2007, HUMAN DEV REPORT; Uzochukwu B, 2005, HEALTH POLICY, V75, P1, DOI 10.1016/j.healthpol.2005.01.019; Wang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116897; WHO, 2004, WORLD MED SITUATION; Wirtz VJ, 2012, VALUE HEALTH, V15, P593, DOI 10.1016/j.jval.2012.01.006; World Health Organization, 2004, EQ ACC ESS MED FRAM	43	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165707	10.1371/journal.pone.0165707	http://dx.doi.org/10.1371/journal.pone.0165707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812177	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000049
J	Nashta-ali, D; Motahari, SA; Hosseinkhalaj, B				Nashta-ali, Damoun; Motahari, Seyed Abolfazl; Hosseinkhalaj, Babak			Breaking Lander-Waterman's Coverage Bound	PLOS ONE			English	Article							NANOPORE	Lander-Waterman's coverage bound establishes the total number of reads required to cover the whole genome of size G bases. In fact, their bound is a direct consequence of the well-known solution to the coupon collector's problem which proves that for such genome, the total number of bases to be sequenced should be O(G ln G). Although the result leads to a tight bound, it is based on a tacit assumption that the set of reads are first collected through a sequencing process and then are processed through a computation process, i.e., there are two different machines: one for sequencing and one for processing. In this paper, we present a significant improvement compared to Lander-Waterman's result and prove that by combining the sequencing and computing processes, one can re-sequence the whole genome with as low as O(G) sequenced bases in total. Our approach also dramatically reduces the required computational power for the combined process. Simulation results are performed on real genomes with different sequencing error rates. The results support our theory predicting the log G improvement on coverage bound and corresponding reduction in the total number of bases required to be sequenced.	[Nashta-ali, Damoun; Hosseinkhalaj, Babak] Sharif Univ Technol, Dept Elect Engn, Tehran, Iran; [Motahari, Seyed Abolfazl] Sharif Univ Technol, Dept Comp Engn, Tehran, Iran	Sharif University of Technology; Sharif University of Technology	Hosseinkhalaj, B (corresponding author), Sharif Univ Technol, Dept Elect Engn, Tehran, Iran.	khalaj@sharif.edu	Khalaj, Babak/AAP-6223-2020; Motahari, Seyed Abolfazl/ABB-2459-2020	Khalaj, Babak/0000-0002-9289-2338; 				Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Ku CS, 2013, EXPERT REV MED DEVIC, V10, P1, DOI [10.1586/erd.12.63, 10.1586/ERD.12.63]; LANDER E S, 1988, Genomics, V2, P231; Meller A, 2002, ELECTROPHORESIS, V23, P2583, DOI 10.1002/1522-2683(200208)23:16<2583::AID-ELPS2583>3.0.CO;2-H; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nashta-ali D, 2016, BIORXIV	7	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0164888	10.1371/journal.pone.0164888	http://dx.doi.org/10.1371/journal.pone.0164888			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806058	Green Submitted, gold, Green Published			2022-12-27	WOS:000386715500016
J	Nordell, CJ; Hache, S; Bayne, EM; Solymos, P; Foster, KR; Godwin, CM; Krikun, R; Pyle, P; Hobson, KA				Nordell, Cameron J.; Hache, Samuel; Bayne, Erin M.; Solymos, Peter; Foster, Kenneth R.; Godwin, Christine M.; Krikun, Richard; Pyle, Peter; Hobson, Keith A.			Within-Site Variation in Feather Stable Hydrogen Isotope (delta H-2(f)) Values of Boreal Songbirds: Implications for Assignment to Molt Origin	PLOS ONE			English	Article							MIGRATORY CONNECTIVITY; DELTA-D; BREEDING DISPERSAL; ANIMAL MIGRATION; LIFE-HISTORY; DATA CLONING; BIRDS; DISTANCE; DEUTERIUM; RATIOS	Understanding bird migration and dispersal is important to inform full life-cycle conservation planning. Stable hydrogen isotope ratios from feathers (delta H-2(f)) can be linked to amount-weighted long-term, growing season precipitation delta H-2 (delta H-2(p)) surfaces to create delta H-2(f) isoscapes for assignment to molt origin. However, transfer functions linking delta H-2(p) with delta H-2(f) are influenced by physiological and environmental processes. A better understanding of the causes and consequences of variation in delta H-2(f) values among individuals and species will improve the predictive ability of geographic assignment tests. We tested for effects of species, land cover, forage substrate, nest substrate, diet composition, body mass, sex, and phylogenetic relatedness on delta H-2(f) from individuals at least two years old of 21 songbird species captured during the same breeding season at a site in northeastern Alberta, Canada. For four species, we also tested for a year x species interaction effect on delta H-2(f). A model including species as single predictor received the most support (AIC weight = 0.74) in explaining variation in delta H-2(f). A species-specific variance parameter was part of all best-ranked models, suggesting variation in delta H-2(f) was not consistent among species. The second best-ranked model included a forage substrate x diet interaction term (AIC weight = 0.16). There was a significant year x species interaction effect on delta H-2(f) suggesting that interspecific differences in delta H-2(f) can differ among years. Our results suggest that within and among-year interspecific variation in delta H-2(f) is the most important source of variance typically not being explicitly quantified in geographic assignment tests using non-specific transfer functions to convert delta H-2(p) into delta H-2(f). However, this source of variation is consistent with the range of variation from the transfer functions most commonly being propagated in assignment tests of geographic origins for passerines breeding in North America.	[Nordell, Cameron J.; Hache, Samuel; Bayne, Erin M.; Solymos, Peter] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Hache, Samuel] Environm & Climate Change Canada, Yellowknife, NT, Canada; [Foster, Kenneth R.; Godwin, Christine M.] Owl Moon Environm Inc, Ft McMurray, AB, Canada; [Krikun, Richard] Lesser Slave Lake Bird Observ, Slave Lake, AB, Canada; [Pyle, Peter] Inst Bird Populat, Point Reyes Stn, CA USA; [Hobson, Keith A.] Environm & Climate Change Canada, Saskatoon, SK, Canada; [Hobson, Keith A.] Univ Western Ontario, Dept Biol, London, ON, Canada	University of Alberta; Environment & Climate Change Canada; Environment & Climate Change Canada; Western University (University of Western Ontario)	Hache, S (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.; Hache, S (corresponding author), Environm & Climate Change Canada, Yellowknife, NT, Canada.	samuel.hache@canada.ca	Sólymos, Péter/B-2775-2008; Hobson, Keith/Q-9306-2019	Sólymos, Péter/0000-0001-7337-1740; Bayne, Erin/0000-0002-0679-4521; Nordell, Cameron/0000-0001-5142-6827	Owl Moon Environmental Inc.	Owl Moon Environmental Inc.	Owl Moon Environmental Inc. supported the salaries of K.F and C.G., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2014, R LANG ENV STAT COMP; Betini GS, 2009, CAN J ZOOL, V87, P767, DOI 10.1139/Z09-069; Birchall J, 2005, J ANIM ECOL, V74, P877, DOI 10.1111/j.1365-2656.2005.00979.x; Blancher P., 2003, IMPORTANCE CANADAS B; Bohning-Gaese K, 1999, EVOL ECOL RES, V1, P347; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chabot AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043627; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Clark I., 1997, ENV ISOTOPES HYDROGE; Clark RG, 2006, CAN J ZOOL, V84, P1395, DOI 10.1139/Z06-135; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Cooper CB, 2008, ECOLOGY, V89, P3349, DOI 10.1890/08-0315.1; Crysler ZJ, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0067-8; DAWSON WR, 1982, COMP BIOCHEM PHYS A, V71, P495, DOI 10.1016/0300-9629(82)90198-0; DeSante DF, 2011, MAPS MANUAL 2011 PRO; DONOVAN TM, 1995, J FIELD ORNITHOL, V66, P247; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Flockhart DTT, 2010, J FIELD ORNITHOL, V81, P373, DOI 10.1111/j.1557-9263.2010.00293.x; Fraser KC, 2011, J TROP ECOL, V27, P563, DOI 10.1017/S0266467411000332; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; Hache S, 2012, CAN J ZOOL, V90, P722, DOI 10.1139/Z2012-039; Hache S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094437; Hobson KA, 2008, TERR ECOL SER, V2, P45, DOI 10.1016/S1936-7961(07)00003-6; Hobson KA, 2015, AUK, V132, P540, DOI 10.1642/AUK-14-260.1; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035137; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Langin KM, 2007, OECOLOGIA, V152, P449, DOI 10.1007/s00442-007-0669-3; Legagneux P, 2012, P ROY SOC B-BIOL SCI, V279, P876, DOI 10.1098/rspb.2011.1351; Lele SR, 2010, J AM STAT ASSOC, V105, P1617, DOI 10.1198/jasa.2010.tm09757; Mahon CL, 2016, FOREST ECOL MANAG, V361, P99, DOI 10.1016/j.foreco.2015.11.007; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; McKechnie AE, 2004, OECOLOGIA, V140, P191, DOI 10.1007/s00442-004-1564-9; McKinnon EA, 2012, J FIELD ORNITHOL, V83, P306, DOI 10.1111/j.1557-9263.2012.00380.x; Moran JA, 2013, J ORNITHOL, V154, P423, DOI 10.1007/s10336-012-0906-3; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; Pienaar J, 2013, ECOL LETT, V16, P571, DOI 10.1111/ele.12077; Plummer M, 2014, JAGS VERSION 3 4 0 M; Pyle P, 1997, IDENTIFICATION GUIDE; Pyle Peter, 2009, Marine Ornithology, V37, P219; Pyle P, 2009, CONDOR, V111, P583, DOI 10.1525/cond.2009.090085; Quinlan SP, 2011, J ORNITHOL, V152, P93, DOI 10.1007/s10336-010-0553-5; Rezende EL, 2001, AUK, V118, P781, DOI 10.1642/0004-8038(2001)118[0781:SACEOA]2.0.CO;2; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Rundel CW, 2013, MOL ECOL, V22, P4163, DOI 10.1111/mec.12393; Rushing CS, 2014, ECOL APPL, V24, P445, DOI 10.1890/13-1091.1; Sessions AL, 1999, ORG GEOCHEM, V30, P1193, DOI 10.1016/S0146-6380(99)00094-7; Sessions AL, 2005, GEOCHIM COSMOCHIM AC, V69, P593, DOI 10.1016/j.gca.2004.08.005; Solymos P, 2010, R J, V2, P29; Streby HM, 2011, CONDOR, V113, P817, DOI 10.1525/cond.2011.110012; Studds CE, 2012, DIVERS DISTRIB, V18, P919, DOI 10.1111/j.1472-4642.2012.00931.x; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; van Dijk JGB, 2014, J AVIAN BIOL, V45, P103, DOI 10.1111/j.1600-048X.2013.00232.x; Vander Zanden HB, 2014, METHODS ECOL EVOL, V5, P891, DOI 10.1111/2041-210X.12229; Vitz AC, 2006, BIOL CONSERV, V127, P477, DOI 10.1016/j.biocon.2005.09.011; Wassenaar LI, 2008, TERR ECOL SER, V2, P21, DOI 10.1016/S1936-7961(07)00002-4; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wunder MB, ANAL DESIGN ISOTOPE, P107; Zanden HBV, 2015, J AVIAN BIOL, V46, P658, DOI 10.1111/jav.00656	64	13	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0163957	10.1371/journal.pone.0163957	http://dx.doi.org/10.1371/journal.pone.0163957			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806037	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500008
J	Bix, L; Seo, DC; Ladoni, M; Brunk, E; Becker, MW				Bix, Laura; Seo, Do Chan; Ladoni, Moslem; Brunk, Eric; Becker, Mark W.			Evaluating Varied Label Designs for Use with Medical Devices: Optimized Labels Outperform Existing Labels in the Correct Selection of Devices and Time to Select	PLOS ONE			English	Article								Purpose Effective standardization of medical device labels requires objective study of varied designs. Insufficient empirical evidence exists regarding how practitioners utilize and view labeling. Objective Measure the effect of graphic elements (boxing information, grouping information, symbol use and color-coding) to optimize a label for comparison with those typical of commercial medical devices. Design Participants viewed 54 trials on a computer screen. Trials were comprised of two labels that were identical with regard to graphics, but differed in one aspect of information (e.g., one had latex, the other did not). Participants were instructed to select the label along a given criteria (e.g., latex containing) as quickly as possible. Dependent variables were binary (correct selection) and continuous (time to correct selection). Participants Eighty-nine healthcare professionals were recruited at Association of Surgical Technologists (AST) conferences, and using a targeted e-mail of AST members. Results Symbol presence, color coding and grouping critical pieces of information all significantly improved selection rates and sped time to correct selection (a alpha = 0.05). Conversely, whencritical information was graphically boxed, probability of correct selection and time to selection were impaired (alpha = 0.05). Subsequently, responses from trials containing optimal treatments (color coded, critical information grouped with symbols) were compared to two labels created based on a review of those commercially available. Optimal labels yielded a significant positive benefit regarding the probability of correct choice ((P<0.0001) LSM; UCL, LCL: 97.3%; 98.4%, 95.5%)), as compared to the two labels we created based on commercial designs (92.0%; 94.7%, 87.9% and 89.8%; 93.0%, 85.3%) and time to selection. Conclusions Our study provides data regarding design factors, namely: color coding, symbol use and grouping of critical information that can be used to significantly enhance the performance of medical device labels.	[Bix, Laura; Seo, Do Chan; Brunk, Eric] Michigan State Univ, Sch Packaging, E Lansing, MI 48824 USA; [Becker, Mark W.] Michigan State Univ, Dept Psychol, Cognit & Cognit Neurosci Grp, E Lansing, MI 48824 USA; [Ladoni, Moslem] Michigan State Univ, Ctr Stat Consulting, CANR Biometry Grp, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Bix, L (corresponding author), Michigan State Univ, Sch Packaging, E Lansing, MI 48824 USA.	bixlaura@msu.edu	Bix, Laura/T-5117-2019	Bix, Laura/0000-0002-5779-7474	Blue Cross Blue Shield of Michigan Foundation; Healthcare Packaging Immersion Experience (HcPIE); USDA National Institute of Food and Agriculture, Hatch project [MICL02263]	Blue Cross Blue Shield of Michigan Foundation; Healthcare Packaging Immersion Experience (HcPIE); USDA National Institute of Food and Agriculture, Hatch project	Work presented here was partially funded by an Investigator Initiated Grant provided by the Blue Cross Blue Shield of Michigan Foundation. Additional funds were provided by proceeds from the Healthcare Packaging Immersion Experience (HcPIE). A portion of Dr. Bix's salary is supported by the USDA National Institute of Food and Agriculture, Hatch project MICL02263. CR Bard and Teleflex Medical provided several cases of urinary catheters so that we could survey the symbols that were in commercial use. These supporters had no role in designing the study; collecting, analyzing or interpreting the data; writing the publication or deciding to submit.; Work presented here was partially funded by an Investigator Initiated Grant provided by the Blue Cross Blue Shield of Michigan Foundation; we are grateful for this financial support. Additional funds were provided by proceeds from the Healthcare Packaging Immersion Experience (HcPIE). A portion of Dr. Bix's salary is supported by the USDA National Institute of Food and Agriculture, Hatch project MICL02263. CR Bard and Teleflex Medical provided several cases of urinary catheters so that we could survey the symbols that were in commercial use. These supporters had no role in designing the study; collecting, analyzing or interpreting the data; writing the publication or deciding to submit.	[Anonymous], 2000, DOING WHAT COUNTS PA; [Anonymous], 2016, USE SYMBOLS LABELING; Baker G, 2001, SYSTEMATIC REV ANAL; Burns LR, 2007, HEALTH AFFAIR, V26, pW436, DOI 10.1377/hlthaff.26.3.w436; Cai M., 2012, PERCEPTIONS MED DEVI; DeVenio D., 2009, VISUAL LANGUAGE CAN, P31; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Raab G Gregory, 2006, J Am Coll Radiol, V3, P694, DOI 10.1016/j.jacr.2006.02.005; Runciman WB, 2001, IATROGENIC INJURY AU; Seo DC., 2014, ASSESSING EFFECT VAR; Small SD, 2004, JAMA-J AM MED ASSOC, V291, P367, DOI 10.1001/jama.291.3.367; Songara RK, 2010, J ADV PHARM TECHNOL, V1, P127; Stifano T, 2013, HEALTHCARE PROVIDER, P42; Ventola C Lee, 2008, P T, V33, P348	14	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165002	10.1371/journal.pone.0165002	http://dx.doi.org/10.1371/journal.pone.0165002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824873	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200011
J	Holder, A; Mella, S; Palmer, DB; Aspinall, R; Catchpole, B				Holder, Angela; Mella, Stephanie; Palmer, Donald B.; Aspinall, Richard; Catchpole, Brian			An Age-Associated Decline in Thymic Output Differs in Dog Breeds According to Their Longevity	PLOS ONE			English	Article							RECEPTOR EXCISION CIRCLES; T-CELL POOL; LIFE-SPAN; AGING RESEARCH; BODY-SIZE; INVOLUTION; DELETION; BLOOD; YOUNG; GENE	The age associated decline in immune function is preceded in mammals by a reduction in thymic output. Furthermore, there is increasing evidence of a link between immune competence and lifespan. One approach to determining thymic output is to quantify signal joint T cell receptor excision circles (sj-TRECs), a method which has been developed and used in several mammalian species. Life expectancy and the rate of aging vary in dogs depending upon their breed. In this study, we quantified sj-TRECs in blood samples from dogs of selected breeds to determine whether there was a relationship between longevity and thymic output. In Labrador retrievers, a breed with a median expected lifespan of 11 years, there was an age-associated decline in sj-TREC values, with the greatest decline occurring before 5 years of age, but with sj-TREC still detectable in some geriatric animals, over 13 years of age. In large short-lived breeds (Burnese mountain dogs, Great Danes and Dogue de Bordeaux), the decline in sj-TREC values began earlier in life, compared with small long-lived breeds (Jack Russell terriers and Yorkshire terriers), and the presence of animals with undetectable sj-TRECs occurred at a younger age in the short-lived breeds. The study findings suggest that age-associated changes in canine sj-TRECs are related to breed differences in longevity, and this research highlights the use of dogs as a potential model of immunosenescence.	[Holder, Angela; Mella, Stephanie; Catchpole, Brian] Royal Vet Coll, Dept Pathol & Pathogen Biol, N Mymms, Herts, England; [Palmer, Donald B.] Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Aspinall, Richard] Anglia Ruskin Univ, Postgrad Med Inst, Hlth & Wellbeing Acad, Chelmsford, Essex, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; Anglia Ruskin University	Catchpole, B (corresponding author), Royal Vet Coll, Dept Pathol & Pathogen Biol, N Mymms, Herts, England.	bcatchpole@rvc.ac.uk		Aspinall, Richard/0000-0002-1648-1887	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J011800/1]; Biotechnology and Biological Sciences Research Council [1233476] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) (http://www.bbsrc.ac.uk/) grant number: BB/J011800/1 to BC, DBP, RA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; Andrew D, 2002, EXP GERONTOL, V37, P455, DOI 10.1016/S0531-5565(01)00213-3; Aspinall R, 2010, J COMP PATHOL, V141, pS111, DOI 10.1016/j.jcpa.2009.10.022; Aspinall R, 2001, Dev Immunol, V8, P95, DOI 10.1155/2001/17064; Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x; Aw D, 2012, BIOGERONTOLOGY, V13, P77, DOI 10.1007/s10522-011-9349-0; Aw D, 2011, AGING DIS, V2, P437; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; Betjes MGH, 2011, KIDNEY INT, V80, P209, DOI 10.1038/ki.2011.110; Cicin-Sain L, 2010, J IMMUNOL, V184, P6739, DOI 10.4049/jimmunol.0904193; Day MJ, 2010, J COMP PATHOL, V141, pS60, DOI [10.1016/j.jepa.2009.10.011, 10.1016/j.jcpa.2009.10.011]; DEVILLARTAY JP, 1988, NATURE, V335, P170, DOI 10.1038/335170a0; Diesel G, 2010, VET REC, V166, P455, DOI 10.1136/vr.b4798; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Favier RP, 2001, J ENDOCRINOL, V170, P479, DOI 10.1677/joe.0.1700479; Ferrando-Martinez S, 2013, AGE, V35, P251, DOI 10.1007/s11357-011-9341-2; Fick LJ, 2012, CELL REP, V2, P1530, DOI 10.1016/j.celrep.2012.11.021; Fleming JM, 2011, J VET INTERN MED, V25, P187, DOI 10.1111/j.1939-1676.2011.0695.x; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Geenen V, 2003, J ENDOCRINOL, V176, P305, DOI 10.1677/joe.0.1760305; Gilmore KM, 2015, EXP GERONTOL, V71, P14, DOI 10.1016/j.exger.2015.08.008; Greer KA, 2011, AGE, V33, P475, DOI 10.1007/s11357-010-9182-4; Hart BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102241; Hazenberg MD, 2003, NAT IMMUNOL, V4, P97, DOI 10.1038/ni0203-97; Hince M, 2008, CELL IMMUNOL, V252, P122, DOI 10.1016/j.cellimm.2007.10.007; HOCKETT RD, 1988, P NATL ACAD SCI USA, V85, P9694, DOI 10.1073/pnas.85.24.9694; Hoffman JM, 2013, J VET INTERN MED, V27, P747; Ito G, 2015, VET IMMUNOL IMMUNOP, V166, P1, DOI 10.1016/j.vetimm.2015.05.003; Kilpatrick RD, 2008, J IMMUNOL, V180, P1499, DOI 10.4049/jimmunol.180.3.1499; Kong FK, 1999, P NATL ACAD SCI USA, V96, P1536, DOI 10.1073/pnas.96.4.1536; Kraus C, 2013, AM NAT, V181, P492, DOI 10.1086/669665; Lang PO, 2011, J IMMUNOL METHODS, V369, P133, DOI 10.1016/j.jim.2011.05.002; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; Michell AR, 1999, VET REC, V145, P625, DOI 10.1136/vr.145.22.625; Mitchell WA, 2010, CLIN EXP IMMUNOL, V161, P497, DOI 10.1111/j.1365-2249.2010.04209.x; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Pido-Lopez J, 2001, CLIN EXP IMMUNOL, V125, P409, DOI 10.1046/j.1365-2249.2001.01640.x; Ploemen JPHTM, 2003, TOXICOL PATHOL, V31, P214, DOI 10.1080/01926230390183706; Prelog M, 2008, ARTHRITIS RHEUM-US, V58, P2153, DOI 10.1002/art.23599; Savino W, 2002, SCAND J IMMUNOL, V55, P442, DOI 10.1046/j.1365-3083.2002.01077.x; Seksenyan A, 2010, J CELL MOL MED, V14, P2470, DOI 10.1111/j.1582-4934.2009.00863.x; Sempowski GD, 2002, MOL IMMUNOL, V39, P379, DOI 10.1016/S0161-5890(02)00112-8; Shanley DP, 2009, TRENDS IMMUNOL, V30, P374, DOI 10.1016/j.it.2009.05.001; Sodora DL, 2000, EUR J IMMUNOL, V30, P1145, DOI 10.1002/(SICI)1521-4141(200004)30:4<1145::AID-IMMU1145>3.0.CO;2-7; Sutherland JS, 2005, J IMMUNOL, V175, P2741, DOI 10.4049/jimmunol.175.4.2741; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Targonski PV, 2007, VACCINE, V25, P3066, DOI 10.1016/j.vaccine.2007.01.025; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Vallabhajosyula P, 2011, TRANSPLANTATION, V92, P634, DOI 10.1097/TP.0b013e31822b9287; Vallejo AN, 2009, P NATL ACAD SCI USA, V106, P11252, DOI 10.1073/pnas.0807025106; Waters DJ, 2011, ILAR J, V52, P97, DOI 10.1093/ilar.52.1.97; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; YANG TJ, 1989, LAB ANIM, V23, P143, DOI 10.1258/002367789780863619; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725	54	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165968	10.1371/journal.pone.0165968	http://dx.doi.org/10.1371/journal.pone.0165968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824893	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200052
J	Kwok, MK; Leung, GM; Schooling, CM				Kwok, Man Ki; Leung, Gabriel M.; Schooling, C. Mary			Glucose-6-Phosphate Dehydrogenase Deficiency and Physical and Mental Health until Adolescence	PLOS ONE			English	Article							X-CHROMOSOME MARKERS; MANIC-DEPRESSIVE ILLNESS; SICKLE-CELL TRAIT; DIABETES-MELLITUS; BLOOD-PRESSURE; BIPOLAR DISORDER; GENETIC-LINKAGE; CHINESE; METAANALYSIS; IMPUTATION	Background To examine the association of glucose-6-phosphate dehydrogenase (G6PD) deficiency with adolescent physical and mental health, as effects of G6PD deficiency on health are rarely reported. Methods In a population-representative Chinese birth cohort: "Children of 1997" (n = 8,327), we estimated the adjusted associations of G6PD deficiency with growth using generalized estimating equations, with pubertal onset using interval censored regression, with hospitalization using Cox proportional hazards regression and with size, blood pressure, pubertal maturation and mental health using linear regression with multiple imputation and inverse probability weighting. Results Among 5,520 screened adolescents (66% follow-up), 4.8% boys and 0.5% girls had G6PD deficiency. G6PD-deficiency was not associated with birth weight-for-gestational age or length/height gain into adolescence, but was associated with lower childhood body mass index (BMI) gain (-0.38 z-score, 95% confidence interval (CI) -0.57, -0.20), adjusted for sex and parental education, and later onset of pubic hair development (time ratio = 1.029, 95% CI 1.007, 1.050). G6PD deficiency was not associated with blood pressure, height, BMI or mental health in adolescence, nor with serious infectious morbidity until adolescence. Conclusions G6PD deficient adolescents had broadly similar physical and mental health indicators, but transiently lower BMI gain and later pubic hair development, whose long-term implications warrant investigation.	[Kwok, Man Ki; Leung, Gabriel M.; Schooling, C. Mary] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Schooling, C. Mary] CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA	University of Hong Kong; City University of New York (CUNY) System	Schooling, CM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.; Schooling, CM (corresponding author), CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA.	cms1l@hku.hk		Schooling, Mary/0000-0001-9933-5887; Leung, Gabriel/0000-0002-2503-6283; Kwok, Man Ki/0000-0003-3777-4766	Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR [HCPF] [216106]; Health and Health Services Research Fund [HHSRF] [03040771]; University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong; Health and Health Services Research Fund [HHSRF], Government of the Hong Kong SAR [07080841, 07080751, 08090761, 09101061]	Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR [HCPF]; Health and Health Services Research Fund [HHSRF]; University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong(University of Hong Kong); Health and Health Services Research Fund [HHSRF], Government of the Hong Kong SAR	This work was a sub-study of the "Children of 1997" birth cohort which was initially supported by the Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR [HCPF Grant # 216106] and re-established in 2005 funded by the Health and Health Services Research Fund [HHSRF Grant # 03040771] and the University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong. This sub-study was funded by the Health and Health Services Research Fund [HHSRF Grants # 07080841, # 07080751, # 08090761 and # 09101061], Government of the Hong Kong SAR. The study sponsors have no role in: (1) study design; (2) the collection, analysis, and interpretation of data; (3) the writing of the report; and (4) the decision to submit the paper for publication. The authors have no conflict of interest, financial or otherwise. No honorarium, grant, or other form of payment was given to the authors to produce the manuscript.	[Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; BARON M, 1994, NAT GENET, V7, P461, DOI 10.1038/ng0894-461a; Battle J., 1992, CULTURE FREE SELF ES; BERRETTINI WH, 1990, ARCH GEN PSYCHIAT, V47, P366; BOCCHETTA A, 1994, NAT GENET, V6, P224, DOI 10.1038/ng0394-224; Bocchetta Alberto, 2003, Ann Gen Hosp Psychiatry, V2, P6, DOI 10.1186/1475-2832-2-6; Cai X, 2014, ASIAN J ANDROL, V16, P146, DOI 10.4103/1008-682X.122346; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Cocco P, 2008, QJM-INT J MED, V101, P161, DOI 10.1093/qjmed/hcm129; Cocco P, 1998, BLOOD, V91, P706, DOI 10.1182/blood.V91.2.706.706_706_709; DELISI LE, 1991, BRIT J PSYCHIAT, V158, P630, DOI 10.1192/bjp.158.5.630; DELZOMPO M, 1984, ACTA PSYCHIAT SCAND, V70, P282; DERN RJ, 1963, J LAB CLIN MED, V62, P319; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; FIEVE RR, 1965, J PSYCHIAT RES, V3, P255, DOI 10.1016/0022-3956(65)90006-3; Fok TF, 2003, ARCH DIS CHILD-FETAL, V88, pF229, DOI 10.1136/fn.88.3.F229; Health Canada, 2014, SUMM SAF REV TEST RE; HELLER P, 1979, NEW ENGL J MED, V300, P1001, DOI 10.1056/NEJM197905033001801; Heymann Anthony D, 2012, Diabetes Care, V35, pe58, DOI 10.2337/dc11-2527; Kwok MK, 2013, J HYPERTENS, V31, P1785, DOI 10.1097/HJH.0b013e3283622ea0; Lam S. T. S, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P73; Lee W, 2008, BODY DISSATISFACTION; Lo KS, 2011, HUM GENET, V129, P307, DOI 10.1007/s00439-010-0925-1; Meloni L, 2008, J INHERIT METAB DIS, V31, P412, DOI 10.1007/s10545-008-0704-5; MENDLEWICZ J, 1980, BRIT J PSYCHIAT, V137, P337, DOI 10.1192/bjp.137.4.337; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Muntoni S, 2008, J NUTRIGENET NUTRIGE, V1, P49, DOI 10.1159/000109874; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; NIAZI GA, 1991, INT J HEMATOL, V54, P295; NWANKWO MU, 1990, GENET EPIDEMIOL, V7, P211, DOI 10.1002/gepi.1370070305; PETO R, 1973, ROY STAT SOC C-APP, V22, P86; Pinna A, 2013, INT J MED SCI, V10, P1907, DOI 10.7150/ijms.6776; Reriani MK, 2011, EUR J CARDIOV PREV R, V18, P704, DOI 10.1177/1741826711398430; Saeed T K, 1985, Diabet Med, V2, P110; SAHA N, 1979, J MED GENET, V16, P431, DOI 10.1136/jmg.16.6.431; Santana MS, 2014, AM J TROP MED HYG, V91, P74, DOI 10.4269/ajtmh.13-0032; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schooling CM, 2012, INT J EPIDEMIOL, V41, P611, DOI 10.1093/ije/dyq243; Seaman SR, 2012, BIOMETRICS, V68, P129, DOI 10.1111/j.1541-0420.2011.01666.x; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Swerdlow DI, 2015, LANCET, V385, P351, DOI 10.1016/S0140-6736(14)61183-1; Utriainen P, 2013, J CLIN ENDOCR METAB, V98, pE87, DOI 10.1210/jc.2012-2783; WHO, 2007, WHO GROWTH REF 5 19; WIESENFELD SL, 1970, NEW ENGL J MED, V282, P1001, DOI 10.1056/NEJM197004302821804; WONG CK, 1988, ACTA PSYCHIAT SCAND, V78, P11, DOI 10.1111/j.1600-0447.1988.tb06295.x; World Health Organization, 2005, WHO CHILD GROWTH STA; World Health Organization (WHO) & Vietnam Ministry of Health of, 2012, HLTH SERV DEL PROF; Worthman CM, 2005, AM J HUM BIOL, V17, P95, DOI 10.1002/ajhb.20096	51	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166192	10.1371/journal.pone.0166192	http://dx.doi.org/10.1371/journal.pone.0166192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824927	gold, Green Published			2022-12-27	WOS:000387615200068
J	Rumrich, IK; Viluksela, M; Vahakangas, K; Gissler, M; Surcel, HM; Hanninen, O				Rumrich, Isabel Katharina; Viluksela, Matti; Vahakangas, Kirsi; Gissler, Mika; Surcel, Helja-Marja; Hanninen, Otto			Maternal Smoking and the Risk of Cancer in Early Life - A Meta-Analysis	PLOS ONE			English	Article							CHILDHOOD BRAIN-TUMORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; NATIONWIDE CASE-CONTROL; CENTRAL-NERVOUS-SYSTEM; PARENTAL CIGARETTE-SMOKING; CHILDRENS ONCOLOGY GROUP; SELF-REPORTED SMOKING; GERM-CELL TUMORS; ALCOHOL-CONSUMPTION; PRENATAL EXPOSURE	Background In spite of the well-known harmful effects on the fetus, many women continue smoking during pregnancy. Smoking as an important source of toxic chemicals may contribute to the developmental origin of diseases. Objectives The aim of this work was to pursue the possible association between maternal smoking and cancer in early life. Specifically, we wanted to identify the associated early life cancer types, and to quantify the associations. Methods In a systematic literature search 825 articles were identified in PubMed and Web of Science, and 55 more through the reference lists. Of these 62 fulfilled the criteria for inclusion in meta-analyses. Using Mantel-Haenszel or DerSimonian and Laird method, depending on heterogeneity of the studies, pooled estimates and 95% confidence intervals for eight cancer types were calculated. Results Smoking during pregnancy was associated with an increased risk for for brain and central nervous system tumors (OR = 1.09; 95% CI = 1.02-1.17). Although the risk for lymphoma was also associated (OR = 1.21; 95% CI = 1.05-1.34), it did not hold up in subgroup analyses. Leukemia was not found to be associated with maternal smoking. Five other cancer types (bone, soft tissue, renal, hepatic, and germ cell cancer) were also examined, but the number of studies was too limited to exclude the possibility of maternal smoking as a risk factor for cancer in offspring. Conclusions According to our meta-analyses, maternal smoking is associated with nervous system cancers, but not with leukemia in early life. Confirming or rejecting associations of maternal smoking with lymphoma and the five other cancer types requires further studies.	[Rumrich, Isabel Katharina; Viluksela, Matti] Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland; [Rumrich, Isabel Katharina; Viluksela, Matti; Hanninen, Otto] Natl Inst Hlth & Welf, Dept Hlth Protect, Kuopio, Finland; [Vahakangas, Kirsi] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm Toxicol, Kuopio, Finland; [Gissler, Mika] Natl Inst Hlth & Welf, Dept Informat Serv, Helsinki, Finland; [Gissler, Mika] Karolinska Inst, Div Family Med, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Surcel, Helja-Marja] Natl Inst Hlth & Welf, Dept Hlth Protect, Oulu, Finland	University of Eastern Finland; Finland National Institute for Health & Welfare; University of Eastern Finland; Finland National Institute for Health & Welfare; Karolinska Institutet; Finland National Institute for Health & Welfare	Rumrich, IK (corresponding author), Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland.; Rumrich, IK (corresponding author), Natl Inst Hlth & Welf, Dept Hlth Protect, Kuopio, Finland.	Isabell.Rumrich@thl.fi	Rumrich, Isabell/GQZ-6196-2022; Hänninen, Otto/C-7951-2012	Hänninen, Otto/0000-0002-4868-4822; Gissler, Mika/0000-0001-8254-7525; Rumrich, Isabell Katharina/0000-0002-7991-2752	Juho Vainio Foundation [201510322, 201610405]; Ministry of Social Affairs and Health [STM/1069/2015]; National Institute for Health and Welfare; University of Eastern Finland	Juho Vainio Foundation; Ministry of Social Affairs and Health; National Institute for Health and Welfare; University of Eastern Finland	This work was supported by Juho Vainio Foundation (Grant numbers 201510322 and 201610405; http://www.juhovainionsaatio.fi/pages/in-english/home.php), the Ministry of Social Affairs and Health (agreement STM/1069/2015) and intramural funding from the National Institute for Health and Welfare and the University of Eastern Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi-Korek I, 2006, J OCCUP ENVIRON MED, V48, P165, DOI 10.1097/01.jom.0000183343.81485.7c; Alexander FE, 2001, CANCER RES, V61, P2542; Castro-Jimenez MA, 2011, PREV CHRONIC DIS, V8; Antonopoulos CN, 2011, INT J CANCER, V129, P2694, DOI 10.1002/ijc.25929; Balansky R, 2012, INT J CANCER, V130, P1001, DOI 10.1002/ijc.26103; Baldwin RT, 2004, TOXICOL APPL PHARM, V199, P118, DOI 10.1016/j.taap.2003.12.029; Boffetta P, 2000, ENVIRON HEALTH PERSP, V108, P73, DOI 10.2307/3454298; Britton GRA, 2004, JOGNN-J OBST GYN NEO, V33, P306, DOI 10.1177/0884217504264866; Brondum J, 1999, CANCER-AM CANCER SOC, V85, P1380, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1380::AID-CNCR23>3.0.CO;2-O; Brooks DR, 2004, CANCER CAUSE CONTROL, V15, P997, DOI 10.1007/s10552-004-1123-z; Buck GM, 2001, PAEDIATR PERINAT EP, V15, P47; BUCKLEY JD, 1989, CANCER, V64, P1169, DOI 10.1002/1097-0142(19890901)64:5<1169::AID-CNCR2820640534>3.0.CO;2-I; BUNIN GR, 1994, CANCER EPIDEM BIOMAR, V3, P197; Chen Z, 2005, CANCER-AM CANCER SOC, V103, P1064, DOI 10.1002/cncr.20894; CORDIER S, 1994, INT J CANCER, V59, P776, DOI 10.1002/ijc.2910590612; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; England LJ, 2015, AM J PREV MED, V49, P286, DOI 10.1016/j.amepre.2015.01.015; Euro-Peristat Project, 2013, EUROPEAN PERINATAL H; Farioli A, 2014, CANCER CAUSE CONTROL, V25, P683, DOI 10.1007/s10552-014-0371-9; Ferreira JD, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00151; Filippini G, 2002, INT J CANCER, V100, P206, DOI 10.1002/ijc.10465; Filippini G, 2000, PAEDIATR PERINAT EP, V14, P78; FILIPPINI G, 1994, INT J CANCER, V57, P769, DOI 10.1002/ijc.2910570602; Ford RPK, 1997, J EPIDEMIOL COMMUN H, V51, P246, DOI 10.1136/jech.51.3.246; GOLD EB, 1993, AM J EPIDEMIOL, V137, P620, DOI 10.1093/oxfordjournals.aje.a116719; Grando SA, 2014, NAT REV CANCER, V14, P419, DOI 10.1038/nrc3725; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; GRUFFERMAN S, 1993, CANCER CAUSE CONTROL, V4, P217; GRUFFERMAN S, 1982, JNCI-J NATL CANCER I, V68, P107; Haferlach T, 2015, LANCET ONCOL, V16, P1577, DOI 10.1016/S1470-2045(15)00440-4; Heck JE, 2016, INT J CANCER, V139, P613, DOI 10.1002/ijc.30111; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, COCHR HDB SYST REV I; HOLLY EA, 1992, AM J EPIDEMIOL, V135, P122, DOI 10.1093/oxfordjournals.aje.a116265; HOWE GR, 1989, CANCER RES, V49, P4349; Hu JF, 2000, ACTA ONCOL, V39, P979; Huang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102910; Huncharek M, 2002, J NEURO-ONCOL, V57, P51, DOI 10.1023/A:1015734921470; IARC (International Agency for Research on Cancer), 2012, MONOGR EVAL CARCINOG, V100E, P43; Infante-Rivard C, 2000, CANCER CAUSE CONTROL, V11, P547, DOI 10.1023/A:1008976116512; IPCS (International Programme on Chemical Safety), 2006, ENV HLTH CRIT, V237, P115; JOHN EM, 1991, AM J EPIDEMIOL, V133, P123, DOI 10.1093/oxfordjournals.aje.a115851; Johnson KJ, 2013, CANCER EPIDEM BIOMAR, V22, P1837, DOI 10.1158/1055-9965.EPI-13-0432; Karttunen V, 2010, TOXICOL LETT, V197, P75, DOI 10.1016/j.toxlet.2010.04.028; Klebanoff MA, 1996, AM J EPIDEMIOL, V144, P1028, DOI 10.1093/oxfordjournals.aje.a008874; Klimentopoulou A, 2012, PEDIATR BLOOD CANCER, V58, P344, DOI 10.1002/pbc.23347; KRAMER S, 1987, JNCI-J NATL CANCER I, V78, P797; Lariou MS, 2013, CANCER EPIDEMIOL, V37, P146, DOI 10.1016/j.canep.2012.10.012; Licht SD, 2012, INT J CANCER, V131, pE555, DOI 10.1002/ijc.27351; Lindqvist R, 2002, ACTA OBSTET GYN SCAN, V81, P240; Linet MS, 2003, PEDIATRICS, V112, P218; Linet MS, 1996, CANCER CAUSE CONTROL, V7, P437, DOI 10.1007/BF00052670; MAGNANI C, 1990, TUMORI, V76, P413, DOI 10.1177/030089169007600501; MAGNANI C, 1989, TUMORI, V75, P396, DOI 10.1177/030089168907500418; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mattioli S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111028; MCCREDIE M, 1994, INT J CANCER, V56, P6; Menegaux F, 2007, PAEDIATR PERINAT EP, V21, P293, DOI 10.1111/j.1365-3016.2007.00824.x; Michaelis J, 2000, ZBL NEUROCHIR, V61, P80, DOI 10.1055/s-2000-8264; Milne E, 2013, INT J CANCER, V133, P253, DOI 10.1002/ijc.28004; Milne E, 2012, AM J EPIDEMIOL, V175, P43, DOI 10.1093/aje/kwr275; Momen NC, 2016, CANCER CAUSE CONTROL, V27, P341, DOI 10.1007/s10552-015-0707-0; Mucci LA, 2004, CANCER EPIDEM BIOMAR, V13, P1528; Norman MA, 1996, CANCER EPIDEM BIOMAR, V5, P127; Oksuzyan S, 2012, CANCER EPIDEMIOL, V36, pE359, DOI 10.1016/j.canep.2012.08.002; OLSHAN AF, 1993, CANCER, V72, P938, DOI 10.1002/1097-0142(19930801)72:3<938::AID-CNCR2820720345>3.0.CO;2-C; Orsi L, 2015, CANCER CAUSE CONTROL, V26, P1003, DOI 10.1007/s10552-015-0593-5; Petridou E, 1997, BRIT J CANCER, V76, P1241, DOI 10.1038/bjc.1997.541; Petridou ET, 2015, EUR J CANCER PREV, V24, P535, DOI 10.1097/CEJ.0000000000000122; Pettersson A, 2007, INT J CANCER, V120, P2044, DOI 10.1002/ijc.22523; Pickett KE, 2005, PAEDIATR PERINAT EP, V19, P368, DOI 10.1111/j.1365-3016.2005.00660.x; Pirini F, 2015, INT J ENV RES PUB HE, V12, P1135, DOI 10.3390/ijerph120201135; Plichart M, 2008, EUR J CANCER PREV, V17, P376, DOI 10.1097/CEJ.0b013e3282f75e6f; Podvin D, 2006, PAEDIATR PERINAT EP, V20, P312, DOI 10.1111/j.1365-3016.2006.00731.x; PRESTONMARTIN S, 1982, CANCER RES, V42, P5240; Rosenbaum PF, 2005, PAEDIATR PERINAT EP, V19, P152, DOI 10.1111/j.1365-3016.2005.00634.x; Rudant J, 2008, CANCER CAUSE CONTROL, V19, P1277, DOI 10.1007/s10552-008-9199-5; Schraw JM, 2014, CANCER CAUSE CONTROL, V25, P73, DOI 10.1007/s10552-013-0309-7; Schuz J, 1999, INT J EPIDEMIOL, V28, P631, DOI 10.1093/ije/28.4.631; Schuz J, 2001, MED PEDIATR ONCOL, V36, P274, DOI 10.1002/1096-911X(20010201)36:2<274::AID-MPO1065>3.3.CO;2-4; Schuz J, 2001, J CLIN EPIDEMIOL, V54, P702, DOI 10.1016/S0895-4356(00)00339-5; Schuz J, 2001, EUR J PEDIATR, V160, P333, DOI 10.1007/PL00008443; SEVERSON RK, 1993, CANCER EPIDEM BIOMAR, V2, P433; Shu XO, 1999, JNCI-J NATL CANCER I, V91, P1765, DOI 10.1093/jnci/91.20.1765; Shu XO, 1996, JNCI-J NATL CANCER I, V88, P24, DOI 10.1093/jnci/88.1.24; SHU XO, 1995, CANCER CAUSE CONTROL, V6, P187, DOI 10.1007/BF00051790; Slater ME, 2011, PAEDIATR PERINAT EP, V25, P559, DOI 10.1111/j.1365-3016.2011.01229.x; Swamy GK, 2011, J MATERN-FETAL NEO M, V24, P86, DOI 10.3109/14767051003758887; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; Tuomisto J, 2009, EUR J CANCER, V45, P1640, DOI 10.1016/j.ejca.2009.01.017; Vahakangas K, 2009, BRIT J PHARMACOL, V158, P665, DOI 10.1111/j.1476-5381.2009.00336.x; Vahakangas KH, 2011, REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY, P1051, DOI 10.1016/B978-0-12-382032-7.10079-7; VANDUIJN CM, 1994, CANCER EPIDEM BIOMAR, V3, P457; Walsh RA, 1996, ADDICT BEHAV, V21, P675, DOI 10.1016/0306-4603(95)00097-6; Wan Joanne, 2006, Birth Defects Research, V78, P326, DOI 10.1002/bdrc.20080; Web DA, 2003, J PUBLIC HEALTH MAN, V9, P322; Wigle DT, 2008, J TOXICOL ENV HEAL B, V11, P373, DOI 10.1080/10937400801921320; Yan KK, 2015, PEDIATR BLOOD CANCER, V62, P1162, DOI 10.1002/pbc.25443; Yang QH, 2000, CANCER EPIDEM BIOMAR, V9, P967	100	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165040	10.1371/journal.pone.0165040	http://dx.doi.org/10.1371/journal.pone.0165040			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824869	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200012
J	Suchacek, J; Sed'a, P; Friedrich, V; Wachowiak-Smolikova, R; Wachowiak, MP				Suchacek, Jan; Sed'a, Petr; Friedrich, Vaclav; Wachowiak-Smolikova, Renata; Wachowiak, Mark P.			From Regional to National Clouds: TV Coverage in the Czech Republic	PLOS ONE			English	Article							NEWS; FORCES	Media, and particularly TV media, have a great impact on the general public. In recent years, spatial patterns of information and the relevance of intangible geographies have become increasingly important. Gatekeeping plays a critical role in the selection of information that is transformed into media. Therefore, gatekeeping, through national media, also co-forms the generation of mental maps. In this paper, correspondence analysis (a statistical method) combined with cloud lines (a new visual analytics technique) is used to analyze how individual major regional events in one of the post-communist countries, the Czech Republic, penetrate into the media on a national scale. Although national news should minimize distortions about regions, this assumption has not been verified by our research. Impressions presented by the media of selected regions that were markedly influenced by one or several events in those regions demonstrate that gatekeepers, especially news reporters, functioned as a filter by selecting only a few specific, and in many cases, unusual events for dissemination.	[Suchacek, Jan] VSB Tech Univ Ostrava, Fac Econ, Dept Reg & Environm Econ, Ostrava, Czech Republic; [Sed'a, Petr; Friedrich, Vaclav] VSB Tech Univ Ostrava, Dept Math Methods Econ, Fac Econ, Ostrava, Czech Republic; [Wachowiak-Smolikova, Renata; Wachowiak, Mark P.] Nipissing Univ, Dept Comp Sci & Math, North Bay, ON, Canada	Technical University of Ostrava; Technical University of Ostrava; Nipissing University	Wachowiak-Smolikova, R (corresponding author), Nipissing Univ, Dept Comp Sci & Math, North Bay, ON, Canada.	rsmolikova@ieee.org	Friedrich, Václav/J-9265-2012; Seďa, Petr/X-1866-2018; Suchacek, Jan/ABH-4495-2020	Friedrich, Václav/0000-0003-0076-5233; Seďa, Petr/0000-0002-2205-6377; Suchacek, Jan/0000-0001-9508-6959	Natural Sciences and Engineering Research Council of Canada [386586-2011]; VSB-TU Ostrava; Operational Programme Education for Competitiveness [CZ.1.07/2.3.00/20.0296]; JS PS	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); VSB-TU Ostrava; Operational Programme Education for Competitiveness; JS PS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by http://www.nserc-crsng.gc.ca./index_eng.asp, Natural Sciences and Engineering Research Council of Canada, [386586-2011], MW; https://www.rvvi.cz/cep?s=jednoduche-vyhledavani&ss=detail&n=0&h=EE2.3.20.0296, VSB-TU Ostrava, Operational Programme Education for Competitiveness, [CZ.1.07/2.3.00/20.0296], JS PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner W, 2011, HUM-COMPUT INT-SPRIN, P1, DOI 10.1007/978-0-85729-079-3; [Anonymous], 2016, DENN SLED; Barzilai-Nahon K, 2008, J AM SOC INF SCI TEC, V59, P1493, DOI 10.1002/asi.20857; Beh EJ, 2010, J STAT PLAN INFER, V140, P2582, DOI 10.1016/j.jspi.2010.03.018; Bendix J, 1999, ANN ASSOC AM GEOGR, V89, P658, DOI 10.1111/0004-5608.00166; BERKOWITZ D, 1990, J BROADCAST ELECTRON, V34, P55; BERKOWITZ D, 1991, J BROADCAST ELECTRON, V35, P245, DOI 10.1080/08838159109364121; Brighton P., 2007, NEWS VALUES; Carroll CE, 2011, PSYCHOL BEHAV ASPECT, P199; Chakrapani C., 2009, STAT MARKET RES; Chan J, 2008, REV ECON STUD, V75, P699, DOI 10.1111/j.1467-937X.2008.00495.x; Czech Statistical Office [Internet], NAR STRUKT OB; De Fleur M.L., 2009, MASS COMMUNICATION T; FRANKLIN BOB, 1991, MAKING LOCAL NEWS LO; GALTUNG J, 1965, J PEACE RES, P64; Graber D. A., 2009, MASS MEDIA AM POLITI; Greenacre M., 2007, CORRES ANAL PRACTICE; Gregory D., 2009, DICT HUMAN GEOGRAPHY; Groseclose T, 2005, Q J ECON, V120, P1191, DOI 10.1162/003355305775097542; Herman E.S., 1988, POLITICAL EC MASS ME; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Huxford J., 2007, JOURNALISM, V8, P657, DOI [10.1177/1464884907083117, DOI 10.1177/1464884907083117]; Javed W, 2010, IEEE T VIS COMPUT GR, V16, P927, DOI 10.1109/TVCG.2010.162; Kaid, 2004, HDB POLITICAL COMMUN; Karlsson C, 2011, NEW HORIZ REG SCI, P1; Kotler P., 1993, MARKETING PLACES ATT; Kraska-Miller M., 2013, NONPARAMETRIC STAT S; Krstajic M, 2011, IEEE T VIS COMPUT GR, V17, P2432, DOI 10.1109/TVCG.2011.179; Kuypers J.A., 2014, PARTISAN JOURNALISM; McCombs M., 2005, JOURNALISM STUD, V6, P543, DOI [https://doi.org/10.1080/14616700500250438, 10.1080/14616700500250438, DOI 10.1080/14616700500250438]; McCombs M.E., 2014, AGENDA SETTING THEOR, V2nd; McCombs ME, 2014, MASS COMMUN SOC, V17, P781, DOI 10.1080/15205436.2014.964871; MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990; McQuaill D., 1994, MASS COMMUNICATION T; Meloun M., 2005, POCITACOVA ANAL VICE; Molle W, 2007, REG CITIES, V34, P1; Necas V., CESKA ZAHRANICN; Necas V., 2008, CESKA ZAHRANICNI POL, P41; O'Neill D, 2009, INT COMMUN ASSOC HAN, P161; Palmer J., 2008, MEDIA INTRO, P117; Ramos M, 2011, HIGH EDUC, V61, P629, DOI 10.1007/s10734-010-9353-3; Rencher AC, 2002, METHODS MULTIVARIATE; Riley R, 2009, SOC SCI MED, V69, P215, DOI 10.1016/j.socscimed.2009.04.023; Shoemaker Pamela J., 2009, GATEKEEPING THEORY; Shoemaker PJ, 2001, JOURNALISM MASS COMM, V78, P233, DOI 10.1177/107769900107800202; Smith ML, 2010, TRANSITIONS ONLINE; Suchacek J, 2015, TRANSFORM BUS ECON, V14, P544; Suchacek J, 2014, E M EKON MANAG, V17, P125, DOI 10.15240/tul/001/2014-4-010; Tufte E., 2001, THE VISUAL DISPLAY O; Vlachova A K, 2013, ACTA U AGR SILVIC ME, V61, P329; Wachowiak M. P., 2015, Environment and Pollution, V4, P42; Walgrave S, 2006, J COMMUN, V56, P88, DOI 10.1111/j.1460-2466.2006.00005.x; Weaver DH, 2007, J COMMUN, V57, P142, DOI 10.1111/j.1460-2466.2006.00333.x	53	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165527	10.1371/journal.pone.0165527	http://dx.doi.org/10.1371/journal.pone.0165527			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BE	27824947	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200022
J	Juste, RA; Alonso-Hearn, M; Garrido, JM; Abendano, N; Sevilla, IA; Gortazar, C; de la Fuente, J; Dominguez, L				Juste, Ramon A.; Alonso-Hearn, Marta; Garrido, Joseba M.; Abendano, Naiara; Sevilla, Iker A.; Gortazar, Christian; de la Fuente, Jose; Dominguez, Lucas			Increased Lytic Efficiency of Bovine Macrophages Trained with Killed Mycobacteria	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINE; TUBERCULOSIS; PHAGOCYTOSIS; IMMUNITY; CATTLE	Innate immunity is evolutionarily conserved in multicellular organisms and was considered to lack memory until very recently. One of its more characteristic mechanisms is phagocytosis, the ability of cells to engulf, process and eventually destroy any injuring agent. We report the results of an ex vivo experiment in bovine macrophages in which improved clearance of Mycobacterium bovis (M. bovis) was induced by pre-exposure to a heat killed M. bovis preparation. The effects were independent of humoral and cellular adaptive immune responses and lasted up to six months. Specifically, our results demonstrate the existence of a training effect in the lytic phase of phagocytosis that can be activated by killed mycobacteria, thus suggesting a new mechanism of vaccine protection. These findings are compatible with the recently proposed concept of trained immunity, which was developed to explain the observation that innate immune responses provide unspecific protection against pathogens including other than those that originally triggered the immune response.	[Juste, Ramon A.; Alonso-Hearn, Marta; Garrido, Joseba M.; Abendano, Naiara; Sevilla, Iker A.] NEIKER Tecnalia, Dept Anim Hlth, Berreaga 1, Derio 48160, Bizkaia, Spain; [Gortazar, Christian; de la Fuente, Jose] UCLM, JCCM, CSIC, SaBio,Inst Invest Recursos Cineget,IREC, Ciudad Real 13071, Spain; [de la Fuente, Jose] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, 250 McElroy Hall, Stillwater, OK 74078 USA; [Dominguez, Lucas] Univ Complutense, Ctr Vigilancia Sanitaria Vet VISAVET, Ave Puerta Hierro, E-28040 Madrid, Spain; [Juste, Ramon A.] SERIDA, Carretera Oviedo, Villaviciosa 33300, Asturias, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Oklahoma State University System; Oklahoma State University - Stillwater; Complutense University of Madrid; Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA	Juste, RA (corresponding author), NEIKER Tecnalia, Dept Anim Hlth, Berreaga 1, Derio 48160, Bizkaia, Spain.; Juste, RA (corresponding author), SERIDA, Carretera Oviedo, Villaviciosa 33300, Asturias, Spain.	rajuste@serida.org	Sevilla, Iker A/O-6060-2014; Abendaño, Naiara/L-3535-2017; Dominguez Rodriguez, Lucas/B-9668-2014; Gortazar, Christian/E-7918-2012	Sevilla, Iker A/0000-0003-3968-3390; Abendaño, Naiara/0000-0001-9719-0688; Dominguez Rodriguez, Lucas/0000-0001-8843-0010; Joseba M., Garrido/0000-0002-7559-0653; Alonso-Hearn, Marta/0000-0001-5979-347X; Gortazar, Christian/0000-0003-0012-4006	EU project WildTBVac [613799]; Institute Nacional de Investigacion y Tencologia Agraria y alimentaria (INIA) [RTA2011-00049]; Ministry of Science (MINECO) [AGL2014-56305]; European Funds Regional Development (FEDER)	EU project WildTBVac; Institute Nacional de Investigacion y Tencologia Agraria y alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); Ministry of Science (MINECO); European Funds Regional Development (FEDER)	Funding for these studies was provided by the EU project WildTBVac (Contract #613799) and by grants from the Institute Nacional de Investigacion y Tencologia Agraria y alimentaria (INIA, RTA2011-00049) and the Ministry of Science (MINECO, AGL2014-56305) and European Funds Regional Development (FEDER).	Aaby P, 2012, P NATL ACAD SCI USA, V109, P17317, DOI 10.1073/pnas.1215761109; Abendano N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104238; Abendano N, 2013, VET MICROBIOL, V163, P325, DOI 10.1016/j.vetmic.2012.12.042; Alonso-Hearn M, 2012, J DAIRY SCI, V95, P618, DOI 10.3168/jds.2009-2860; Andersen A, 2013, VACCINE, V31, P2137, DOI 10.1016/j.vaccine.2013.02.050; [Anonymous], 2011, ROITTS ESSENTIAL IMM; Beltran-Beck B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098048; Billau A, 2011, J LEUKOCYTE BIOL, V70, P849; Buffen K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004485; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; De la Fuente IM, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00016; De La Fuente J, 2016, EXPERT REV VACCINES, V15, P275, DOI 10.1586/14760584.2016.1125294; Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; Good M., 2010, VET HDB HERD MANAGEM; Gordon S, 2016, IMMUNITY, V44, P463, DOI 10.1016/j.immuni.2016.02.026; Hollm-Delgado MG, 2014, PEDIATRICS, V133, pE73, DOI 10.1542/peds.2013-2218; Naranjo V, 2006, FEMS IMMUNOL MED MIC, V46, P298, DOI 10.1111/j.1574-695X.2005.00035.x; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Ritz N, 2013, VACCINE, V31, P3098, DOI 10.1016/j.vaccine.2013.03.059; Roth O, 2009, DEV COMP IMMUNOL, V33, P1151, DOI 10.1016/j.dci.2009.04.005; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086	22	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165607	10.1371/journal.pone.0165607	http://dx.doi.org/10.1371/journal.pone.0165607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820836	Green Published, gold, Green Submitted			2022-12-27	WOS:000387614800014
J	Nandi, D; Balakrishnan, R				Nandi, Diptarup; Balakrishnan, Rohini			Spatio-Temporal Dynamics of Field Cricket Calling Behaviour: Implications for Female Mate Search and Mate Choice	PLOS ONE			English	Article							SEXUAL SELECTION; GRYLLUS-CAMPESTRIS; TELEOGRYLLUS-COMMODUS; POPULATION-DENSITIES; CHORUS TENURE; COMPONENTS; SIGNALS; DETERMINANTS; ORTHOPTERA; STRATEGIES	Amount of calling activity (calling effort) is a strong determinant of male mating success in species such as orthopterans and anurans that use acoustic communication in the context of mating behaviour. While many studies in crickets have investigated the determinants of calling effort, patterns of variability in male calling effort in natural choruses remain largely unexplored. Within-individual variability in calling activity across multiple nights of calling can influence female mate search and mate choice strategies. Moreover, calling site fidelity across multiple nights of calling can also affect the female mate sampling strategy. We therefore investigated the spatio-temporal dynamics of acoustic signaling behaviour in a wild population of the field cricket species Plebeiogryllus guttiventris. We first studied the consistency of calling activity by quantifying variation in male calling effort across multiple nights of calling using repeatability analysis. Callers were inconsistent in their calling effort across nights and did not optimize nightly calling effort to increase their total number of nights spent calling. We also estimated calling site fidelity of males across multiple nights by quantifying movement of callers. Callers frequently changed their calling sites across calling nights with substantial displacement but without any significant directionality. Finally, we investigated trade-offs between within-night calling effort and energetically expensive calling song features such as call intensity and chirp rate. Calling effort was not correlated with any of the calling song features, suggesting that energetically expensive song features do not constrain male calling effort. The two key features of signaling behaviour, calling effort and call intensity, which determine the duration and spatial coverage of the sexual signal, are therefore uncorrelated and function independently.	[Nandi, Diptarup; Balakrishnan, Rohini] Indian Inst Sci, Ctr Ecol Sci, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Nandi, D; Balakrishnan, R (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore, Karnataka, India.	diptarup@ces.iisc.ernet.in; rohini@ces.iisc.ernet.in	Balakrishnan, Rohini/Z-5881-2019		Council of Scientific and Industrial Research, Government of India [CSIR/HRD/37 (1434)/10 EMR-II]; Department of Biotechnology, Ministry of Science & Technology, Government of India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Ministry of Science & Technology, Government of India(Department of Biotechnology (DBT) India)	This project was supported by funding received by RB from the Council of Scientific and Industrial Research, Government of India, (No. CSIR/HRD/37 (1434)/10 EMR-II) and the Department of Biotechnology, Ministry of Science & Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arak A., 1983, P181; BAILEY WJ, 1993, J EXP BIOL, V178, P21; Bertram SM, 2011, ANIM BEHAV, V82, P1255, DOI 10.1016/j.anbehav.2011.08.021; Bertram SM, 2005, ANIM BEHAV, V70, P477, DOI 10.1016/j.anbehav.2004.09.024; Bertram SM, 2012, ECOL EVOL, V2, P181, DOI 10.1002/ece3.76; Bevier CR, 1997, HERPETOLOGICA, V53, P297; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Burt John M., 2005, P320, DOI 10.1017/CBO9780511610363.019; CADE WH, 1992, ANIM BEHAV, V43, P49, DOI 10.1016/S0003-3472(05)80070-3; Callander S, 2013, BEHAV ECOL, V24, P1251, DOI 10.1093/beheco/art059; CAMPBELL DJ, 1990, ANIM BEHAV, V39, P1051, DOI 10.1016/S0003-3472(05)80777-8; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Castellano S, 2011, J THEOR BIOL, V274, P161, DOI 10.1016/j.jtbi.2011.01.001; Chopard L., 1969, FAUNA INDIA ADJACENT; Crawley M.J., 2007, R BOOK; Deb R, 2014, BEHAV ECOL, V25, P967, DOI 10.1093/beheco/aru072; Deb R, 2012, ANIM BEHAV, V84, P137, DOI 10.1016/j.anbehav.2012.04.020; Falconer D. S., 1996, INTRO QUANTITATIVE G; FORREST T G, 1991, Bioacoustics, V3, P93; FORREST TG, 1994, BEHAV ECOL, V5, P293, DOI 10.1093/beheco/5.3.293; FRENCH BW, 1989, J INSECT BEHAV, V2, P105, DOI 10.1007/BF01053621; FRENCH BW, 1987, BEHAV ECOL SOCIOBIOL, V21, P157, DOI 10.1007/BF00303205; Friedl TWP, 2005, ANIM BEHAV, V70, P1141, DOI 10.1016/j.anbehav.2005.01.017; Gerhardt HC, 1996, BEHAV ECOL, V7, P7, DOI 10.1093/beheco/7.1.7; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GREEN AJ, 1990, ANIM BEHAV, V39, P620, DOI 10.1016/S0003-3472(05)80373-2; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; HISSMANN K, 1990, ECOL ENTOMOL, V15, P281, DOI 10.1111/j.1365-2311.1990.tb00810.x; Holzer B, 2003, BEHAV ECOL, V14, P353, DOI 10.1093/beheco/14.3.353; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Hunt J, 2005, AM NAT, V166, P79, DOI 10.1086/430672; JANETOS AC, 1980, BEHAV ECOL SOCIOBIOL, V7, P107, DOI 10.1007/BF00299515; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Luttbeg B, 1996, BEHAV ECOL, V7, P451, DOI 10.1093/beheco/7.4.451; Mazalov V, 1996, AM NAT, V148, P123, DOI 10.1086/285914; McClelland BE, 1996, J EXP BIOL, V199, P1907; Mhatre N, 2008, J EXP BIOL, V211, P2779, DOI 10.1242/jeb.017756; Mhatre N, 2007, J EXP BIOL, V210, P3661, DOI 10.1242/jeb.003764; Mhatre N, 2006, ANIM BEHAV, V72, P1045, DOI 10.1016/j.anbehav.2006.02.022; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Morris GK, 2002, CAN J ZOOL, V80, P271, DOI 10.1139/z02-003; Murphy CG, 1998, EVOLUTION, V52, P8, DOI 10.1111/j.1558-5646.1998.tb05133.x; MURPHY CG, 1994, BEHAV ECOL SOCIOBIOL, V34, P285; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nandi D, 2013, ANIM BEHAV, V86, P1003, DOI 10.1016/j.anbehav.2013.09.003; Nityananda V, 2008, ANIM BEHAV, V76, P723, DOI 10.1016/j.anbehav.2008.04.015; Parker G.A., 1983, P141; PRESTWICH KN, 1994, AM ZOOL, V34, P625, DOI 10.1093/icb/34.6.625; R Development Core Team, 2014, R LANG ENV STAT COMP; REAL L, 1990, AM NAT, V136, P376, DOI 10.1086/285103; Ritz MS, 2007, ECOL ENTOMOL, V32, P384, DOI 10.1111/j.1365-2311.2007.00887.x; Ritz MS, 2010, EVOL ECOL, V24, P985, DOI 10.1007/s10682-009-9328-y; Rodriguez-Munoz R, 2010, SCIENCE, V328, P1269, DOI 10.1126/science.1188102; Rodriguez-Munoz R, 2011, CURR BIOL, V21, P1716, DOI 10.1016/j.cub.2011.08.053; ROST R, 1987, BEHAV ECOL SOCIOBIOL, V21, P279, DOI 10.1007/BF00299965; Scheuber H, 2003, P ROY SOC B-BIOL SCI, V270, P1779, DOI 10.1098/rspb.2003.2449; Scheuber H, 2004, P ROY SOC B-BIOL SCI, V271, P2453, DOI 10.1098/rspb.2004.2907; Scheuber H, 2003, ANIM BEHAV, V65, P721, DOI 10.1006/anbe.2003.2083; Segev O, 2012, ACTA HERPETOL, V7, P331; Sokal RR., 2011, BIOMETRY; TEJEDO M, 1992, ANIM BEHAV, V44, P557, DOI 10.1016/0003-3472(92)90065-H; WAGNER WE, 1995, ANIM BEHAV, V49, P305, DOI 10.1006/anbe.1995.0044; Wagner WE, 1999, ANIM BEHAV, V57, P89, DOI 10.1006/anbe.1998.0964; Wells K.D., 2006, HEARING SOUND COMMUN, P44, DOI [10.1007/978-0-387-47796-1_3, DOI 10.1007/978-0-387-47796-1]; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; Whattam EM, 2011, ANIM BEHAV, V81, P135, DOI 10.1016/j.anbehav.2010.09.024; Wiegmann DD, 2007, J THEOR BIOL, V249, P654, DOI 10.1016/j.jtbi.2007.08.027; Wittenberger J.F., 1983, P435; Zajitschek F, 2009, AM NAT, V173, P792, DOI 10.1086/598486; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	72	4	3	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165807	10.1371/journal.pone.0165807	http://dx.doi.org/10.1371/journal.pone.0165807			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820868	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000387614800020
J	Abbasi, SA; Shah, RV; McNulty, SE; Hernandez, AF; Semigran, MJ; Lewis, GD; Jerosch-Herold, M; Kim, RJ; Redfield, MM; Kwong, RY				Abbasi, Siddique A.; Shah, Ravi V.; McNulty, Steven E.; Hernandez, Adrian F.; Semigran, Marc J.; Lewis, Gregory D.; Jerosch-Herold, Michael; Kim, Raymond J.; Redfield, Margaret M.; Kwong, Raymond Y.			Left Atrial Structure and Function in Heart Failure with Preserved Ejection Fraction: A RELAX Substudy	PLOS ONE			English	Article							EXERCISE CAPACITY; CARDIAC STRUCTURE; TRIAL; VOLUME	Given the emerging recognition of left atrial structure and function as an important marker of disease in heart failure with preserved ejection fraction (HF-pEF), we investigated the association between left atrial volume and function with markers of disease severity and cardiac structure in HF-pEF. We studied 100 patients enrolled in the PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial who underwent cardiac magnetic resonance (CMR), cardiopulmonary exercise testing, and blood collection before randomization. Maximal left atrial volume index (LAVi; N = 100), left atrial emptying fraction (LAEF; N = 99; including passive and active components (LAEF(P), LAEF(A); N = 80, 79, respectively) were quantified by CMR. After adjustment for multiple testing, maximal LAVi was only associated with age (rho = 0.39), transmitral filling patterns (medial E/e' rho = 0.43), and N-terminal pro-BNP (NT-proBNP; rho = 0.65; all p< 0.05). Lower LAEF was associated with older age, higher transmitral E/A ratio and higher NT-proBNP. Peak VO2 and V-E/VCO2 slope were not associated with left atrial structure or function. After adjustment for age, sex, transmitral E/A ratio, CMR LV mass, LV ejection fraction, and creatinine clearance, NT-proBNP remained associated with maximal LAVi (beta = 0.028, p = 0.0007) and total LAEF (beta = -0.033, p = 0.001). Passive and active LAEF were most strongly associated with age and NT-proBNP, but not gas exchange or other markers of ventricular structure or filling properties. Left atrial volume and emptying function are associated most strongly with NT-proBNP and diastolic filling properties, but not significantly with gas exchange, in HFpEF. Further research to explore the relevance of left atrial structure and function in HF-pEF is warranted.	[Abbasi, Siddique A.; Jerosch-Herold, Michael; Kwong, Raymond Y.] Brigham & Womens Hosp, Noninvas Cardiovasc Imaging Sect, 75 Francis St, Boston, MA 02115 USA; [Shah, Ravi V.; Semigran, Marc J.; Lewis, Gregory D.] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; [McNulty, Steven E.; Hernandez, Adrian F.] Duke Clin Res Inst, Durham, NC USA; [Kim, Raymond J.] Duke Univ, Med Ctr, Duke Cardiovasc Magnet Resonance Ctr, Durham, NC USA; [Redfield, Margaret M.] Mayo Clin Rochester, Rochester, MN USA; [Abbasi, Siddique A.] Providence VA Med Ctr, Div Cardiol, Providence, RI USA; [Abbasi, Siddique A.] Brown Univ, Alpert Med Sch, Cardiovasc Inst, Providence, RI 02912 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Duke University; Duke University; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University	Kwong, RY (corresponding author), Brigham & Womens Hosp, Noninvas Cardiovasc Imaging Sect, 75 Francis St, Boston, MA 02115 USA.	rykwong@partners.org	Kwong, Raymond Y/R-1925-2016; Kim, Raymond J/B-1426-2008; Jerosch-Herold, Michael/R-9824-2019; Hernandez, Adrian F/A-7818-2016; Abbasi, Siddique/B-8425-2016	Kwong, Raymond Y/0000-0001-8212-0759; Hernandez, Adrian F/0000-0003-3387-9616; Abbasi, Siddique/0000-0002-9601-7565	National Heart, Lung, and Blood Institute [U10HL084904, U10HL084861, U10HL084875, U10HL084877, U10HL084889, U10HL084890, U10HL084891, U10HL084899, U10HL084907, U10HL084931]; Heart Failure National Institutes of Health Clinical Research Network [U01-HL084877]; National Institutes of Health [5T32HL094301-04]; NIH [5R01HL091157]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL110337, K23HL127099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103652] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Heart Failure National Institutes of Health Clinical Research Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants U10HL084904 (for the data coordinating center), and U10HL084861, U10HL084875, U10HL084877, U10HL084889, U10HL084890, U10HL084891, U10HL084899, U10HL084907, and U10HL084931 (for the clinical centers) from the National Heart, Lung, and Blood Institute. Dr. Shah was supported by a training grant from the Heart Failure National Institutes of Health Clinical Research Network (U01-HL084877). Dr. Abbasi was supported by a T32 training grant (5T32HL094301-04) from the National Institutes of Health. Dr. Kwong was supported by NIH 5R01HL091157. Pfizer provided study drug (sildenafil and matched placebo). All other authors have no financial disclosures relevant to the content of this manuscript.	Abhayaratna WP, 2008, AM J CARDIOL, V101, P1626, DOI 10.1016/j.amjcard.2008.01.051; Barclay JL, 2006, AM J CARDIOL, V98, P98, DOI 10.1016/j.amjcard.2006.01.057; Edelmann F, 2013, INT J CARDIOL, V169, P408, DOI 10.1016/j.ijcard.2013.10.018; Gelsomino S, 2014, ANN CARDIOTHORAC SUR, V3, P70, DOI 10.3978/j.issn.2225-319X.2013.12.03; Hoit BD, 2014, J AM COLL CARDIOL, V63, P493, DOI 10.1016/j.jacc.2013.10.055; Hundley WG, 2001, J AM COLL CARDIOL, V38, P796, DOI 10.1016/S0735-1097(01)01447-4; Kadappu KK, 2012, EUR HEART J-CARD IMG, V13, P1016, DOI 10.1093/ehjci/jes084; Kramer CM, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-35; Maeder MT, 2009, RESP MED, V103, P1337, DOI 10.1016/j.rmed.2009.03.015; Mazzone C, 2014, ECHOCARDIOGR-J CARD, V31, P123, DOI 10.1111/echo.12325; Melenovsky V, 2015, CIRC HEART FAIL; Redfield MM, 2012, CIRC-HEART FAIL, V5, P653, DOI 10.1161/CIRCHEARTFAILURE.112.969071; Shah AM, 2014, CIRC-HEART FAIL, V7, P104, DOI 10.1161/CIRCHEARTFAILURE.113.000887; Shah AM, 2012, EUR HEART J, V33, P1716, DOI 10.1093/eurheartj/ehs124; Trojnarska O, 2010, INT J CARDIOL, V139, P241, DOI 10.1016/j.ijcard.2008.10.025; Zakeri R, 2014, CIRC-HEART FAIL, V7, P123, DOI 10.1161/CIRCHEARTFAILURE.113.000568; Zile MR, 2011, CIRCULATION, V124, P2491, DOI 10.1161/CIRCULATIONAHA.110.011031	17	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164914	10.1371/journal.pone.0164914	http://dx.doi.org/10.1371/journal.pone.0164914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812147	Green Published, Green Submitted, gold			2022-12-27	WOS:000386910000017
J	Thiebaut, R; Esmiol, S; Lecine, P; Mahfouz, B; Hermant, A; Nicoletti, C; Parnis, S; Perroy, J; Borg, JP; Pascoe, L; Hugot, JP; Ollendorff, V				Thiebaut, Raphaele; Esmiol, Sophie; Lecine, Patrick; Mahfouz, Batoul; Hermant, Aurelie; Nicoletti, Cendrine; Parnis, Stephane; Perroy, Julie; Borg, Jean-Paul; Pascoe, Leigh; Hugot, Jean-Pierre; Ollendorff, Vincent			Characterization and Genetic Analyses of New Genes Coding for NOD2 Interacting Proteins	PLOS ONE			English	Article							NF-KAPPA-B; GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; PROTEOME-SCALE MAP; CROHNS-DISEASE; OLIGOMERIZATION DOMAIN-2; SUSCEPTIBILITY LOCI; INTERACTION NETWORK; PANCREATIC-CANCER; MURAMYL DIPEPTIDE	NOD2 contributes to the innate immune response and to the homeostasis of the intestinal mucosa. In response to its bacterial ligand, NOD2 interacts with RICK and activates the NF-.B and MAPK pathways, inducing gene transcription and synthesis of proteins required to initiate a balanced immune response. Mutations in NOD2 have been associated with an increased risk of Crohn's Disease (CD), a disabling inflammatory bowel disease (IBD). Because NOD2 signaling plays a key role in CD, it is important to further characterize the network of protein interacting with NOD2. Using yeast two hybrid (Y2H) screens, we identified new NOD2 interacting proteins (NIP). The primary interaction was confirmed by coimmunoprecipitation and/or bioluminescence resonance energy transfer (BRET) experiments for 11 of these proteins (ANKHD1, CHMP5, SDCCAG3, TRIM41, LDOC1, PPP1R12C, DOCK7, VIM, KRT15, PPP2R3B, and C10Orf67). These proteins are involved in diverse functions, including endosomal sorting complexes required for transport (ESCRT), cytoskeletal architecture and signaling regulation. Additionally, we show that the interaction of 8 NIPs is compromised with the 3 main CD associated NOD2 mutants (R702W, G908R and 1007fs). Furthermore, to determine whether these NOD2 protein partners could be encoded by IBD susceptibility genes, a transmission disequilibrium test (TDT) was performed on 101 single nucleotide polymorphisms (SNPs) and the main corresponding haplotypes in genes coding for 15 NIPs using a set of 343 IBD families with 556 patients. Overall this work did not increase the number of IBD susceptibility genes but extends the NOD2 protein interaction network and suggests that NOD2 interactome and signaling depend upon the NOD2 mutation profile in CD.	[Esmiol, Sophie; Ollendorff, Vincent] Univ Montpellier, INRA, DMEM, UMR866, Montpellier, France; [Thiebaut, Raphaele; Mahfouz, Batoul; Hugot, Jean-Pierre] INSERM, UMR1149, F-75018 Paris, France; [Thiebaut, Raphaele; Mahfouz, Batoul; Hugot, Jean-Pierre] Univ Paris Diderot, Sorbonne Paris Cite, F-75018 Paris, France; [Hugot, Jean-Pierre] Hop Robert Debre, AP HP, Serv Gastroenterol Pediat, F-75019 Paris, France; [Lecine, Patrick; Hermant, Aurelie; Borg, Jean-Paul] Aix Marseille Univ, CNRS, INSERM,Inst Paoli Calmettes,CRCM, Cell Polar Cell Signaling & Canc Equipe Labellise, Marseille, France; [Nicoletti, Cendrine; Parnis, Stephane] Aix Marseille Univ, CNRS, Cent Marseille, ISM2 UMR7313, F-13397 Marseille, France; [Perroy, Julie] CNRS, UMR 5203, Inst Genom Fonct, F-34094 Montpellier, France; [Perroy, Julie] INSERM, U1191, F-34094 Montpellier, France; [Perroy, Julie] Univ Montpellier, UMR 5203, F-34094 Montpellier, France; [Pascoe, Leigh] Fdn Jean Dausset, CEPH, Paris, France; [Esmiol, Sophie] Aix Marseille Univ, APHM, Dept Pediat Hematol Oncol, La Timone Hosp, Marseille, France; [Lecine, Patrick] BIOASTER, 40 Ave Tony Gamier, F-69007 Lyon, France	INRAE; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Foundation Jean Dausset-CEPH; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Ollendorff, V (corresponding author), Univ Montpellier, INRA, DMEM, UMR866, Montpellier, France.	vincent.ollendorff@supagro.inra.fr	Lecine, Patrick/H-9338-2016; Borg, Jean-Paul/AAX-8096-2020	Borg, Jean-Paul/0000-0001-8418-3382; Hugot, Jean-Pierre/0000-0002-8446-6056; Ollendorff, Vincent/0000-0001-9751-2202; Lecine, Patrick/0000-0002-8091-7286; perroy, julie/0000-0001-6199-0448; Cendrine, Nicoletti/0000-0002-0086-6707	INRA; INSERM; Agence National pour la Recherche, Investissements d'Avenir programme Sorbonne-Paris-Cite Laboratoire d'excellence INFLAMEX [ANR-11-IDEX-0005-02]; Universite Paris-Diderot; Broad Medical Research Program; Association Francois Aupetit; Mairie de Paris; French Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale; INCa (Marseille Proteomics platform); Institut Paoli-Calmettes	INRA; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence National pour la Recherche, Investissements d'Avenir programme Sorbonne-Paris-Cite Laboratoire d'excellence INFLAMEX(French National Research Agency (ANR)); Universite Paris-Diderot; Broad Medical Research Program; Association Francois Aupetit; Mairie de Paris(Region Ile-de-France); French Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); INCa (Marseille Proteomics platform); Institut Paoli-Calmettes	Financial support was provided by INRA, INSERM, Agence National pour la Recherche, Investissements d'Avenir programme ANR-11-IDEX-0005-02 Sorbonne-Paris-Cite Laboratoire d'excellence INFLAMEX, Universite Paris-Diderot, the Broad Medical Research Program, the Association Francois Aupetit, and the Mairie de Paris. R. Thiebaut and S. Esmiol received a grant from the French Ministere de l'Enseignement Superieur et de la Recherche. R. Thiebaut was the recipient of a fellowship from the Fondation pour la Recherche Medicale. JPB is funded by INCa (Marseille Proteomics platform), and Institut Paoli-Calmettes.	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Alvarez C, 2001, J BIOL CHEM, V276, P2693, DOI 10.1074/jbc.M007957200; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Boyle JP, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140178; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Chen D, 2007, J BIOL CHEM, V282, P33776, DOI 10.1074/jbc.M703320200; Ciruela F, 2010, TRENDS BIOTECHNOL, V28, P407, DOI 10.1016/j.tibtech.2010.05.002; Claes AK, 2015, PHYSIOLOGY, V30, P241, DOI 10.1152/physiol.00025.2014; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eitel J, 2008, J IMMUNOL, V181, P2664, DOI 10.4049/jimmunol.181.4.2664; Fenner BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008799; Franke A, 2008, GASTROENTEROLOGY, V135, P1207, DOI 10.1053/j.gastro.2008.07.017; Fukuyama H, 2013, P NATL ACAD SCI USA, V110, P10717, DOI 10.1073/pnas.1304380110; Greenblatt MB, 2015, J EXP MED, V212, P1283, DOI 10.1084/jem.20150407; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hofer-Warbinek R, 2004, CELL DEATH DIFFER, V11, P1317, DOI 10.1038/sj.cdd.4401502; Homer CR, 2012, J BIOL CHEM, V287, P25565, DOI 10.1074/jbc.M111.326835; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Lambert JC, 2010, J ALZHEIMERS DIS, V20, P1107, DOI 10.3233/JAD-2010-100018; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lavelle EC, 2010, MUCOSAL IMMUNOL, V3, P17, DOI 10.1038/mi.2009.124; Lecine P, 2007, J BIOL CHEM, V282, P15197, DOI 10.1074/jbc.M606242200; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Magenta A, 2008, MOL CELL BIOL, V28, P873, DOI 10.1128/MCB.00480-07; Maminska A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0848; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; McGough IJ, 2014, J CELL SCI, V127, P4940, DOI 10.1242/jcs.156299; Menning M, 2013, FEBS LETT, V587, P2137, DOI 10.1016/j.febslet.2013.05.037; Minin AA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1453, DOI 10.1134/S0006297908130063; Nagasaki K, 2003, INT J CANCER, V105, P454, DOI 10.1002/ijc.11122; Nakamura N, 2014, NATURE, V509, P240, DOI 10.1038/nature13133; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Neznanov N, 2005, DNA CELL BIOL, V24, P777, DOI 10.1089/dna.2005.24.777; Nimmo ER, 2011, GASTROENTEROLOGY, V141, P972, DOI 10.1053/j.gastro.2011.05.043; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rosenstiel P, 2009, SEMIN IMMUNOL, V21, P334, DOI 10.1016/j.smim.2009.10.001; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Sellge G, 2015, SEMIN IMMUNOL, V27, P75, DOI 10.1016/j.smim.2015.03.009; Seok J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-78; Shim JH, 2006, J CELL BIOL, V172, P1045, DOI 10.1083/jcb.200509041; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stevens C, 2013, GUT, V62, P695, DOI 10.1136/gutjnl-2011-301775; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thalappilly S, 2008, PROTEOMICS, V8, P3071, DOI 10.1002/pmic.200701157; Theibaut R, 2011, INFLAMM BOWEL DIS, V17, P1055, DOI 10.1002/ibd.21406; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67; Warner N, 2014, J BIOL CHEM, V289, P28213, DOI 10.1074/jbc.M114.574756; Warner N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003305; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JC133145, 10.1172/JCI33145]; Watanabe T, 2006, IMMUNITY, V25, P473, DOI 10.1016/j.immuni.2006.06.018; Yamamoto-Furusho JK, 2006, J BIOL CHEM, V281, P36060, DOI 10.1074/jbc.M602383200; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016; Zurek B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041255	77	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165420	10.1371/journal.pone.0165420	http://dx.doi.org/10.1371/journal.pone.0165420			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812135	gold, Green Published, Green Submitted			2022-12-27	WOS:000386910000029
J	Zhang, SH; Wang, ZY				Zhang, Sihai; Wang, Zhiyang			Inferring Passenger Denial Behavior of Taxi Drivers from Large-Scale Taxi Traces	PLOS ONE			English	Article							COMMUNICATION; STRATEGIES	How to understand individual human actions is a fundamental question to modern science, which drives and incurs many social, technological, racial, religious and economic phenomena. Human dynamics tries to reveal the temporal pattern and internal mechanism of human actions in letter or electronic communications, from the perspective of continuous interactions among friends or acquaintances. For interactions between stranger to stranger, taxi industry provide fruitful phenomina and evidence to investigate the action decisions. In fact, one striking disturbing events commonly reported in taxi industry is passenger refusing or denial, whose reasons vary, including skin color, blind passenger, being a foreigner or too close destination, religion reasons and anti specific nationality, so that complaints about taxi passenger refusing have to be concerned and processed carefully by local governments. But more universal factors for this phenomena are of great significance, which might be fulfilled by big data research to obtain novel insights in this question. In this paper, we demonstrate the big data analytics application in revealing novel insights from massive taxi trace data, which, for the first time, validates the passengers denial in taxi industry and estimates the denial ratio in Beijing city. We first quantify the income differentiation facts among taxi drivers. Then we find out that choosing the drop-off places also contributes to the high income for taxi drivers, compared to the previous explanation of mobility intelligence. Moreover, we propose the pick-up, drop-off and grid diversity concepts and related diversity analysis suggest that, high income taxi drivers will deny passengers in some situations, so as to choose the passengers' destination they prefer. Finally we design an estimation method for denial ratio and infer that high income taxi drivers will deny passengers with 8.52% likelihood in Beijing. Our work exhibits the power of big data analysis in revealing some dark side investigation.	[Zhang, Sihai; Wang, Zhiyang] Univ Sci & Technol China, Chinese Acad Sci, Key Lab Wireless Opt Commun, Hefei 230017, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhang, SH (corresponding author), Univ Sci & Technol China, Chinese Acad Sci, Key Lab Wireless Opt Commun, Hefei 230017, Anhui, Peoples R China.	shzhang@ustc.edu.cn			Natural Science Foundation of China [61461136002]; Key Program of National Natural Science Foundation of China [61631018]; Fundamental Research Funds for the Central Universities; Huawei Technology Innovative Research on Wireless Big Data	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Huawei Technology Innovative Research on Wireless Big Data	This work was supported by Natural Science Foundation of China (Grant No. 61461136002), Key Program of National Natural Science Foundation of China (Grant No. 61631018), the Fundamental Research Funds for the Central Universities, and Huawei Technology Innovative Research on Wireless Big Data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, HUFFINGTON POST; Burgel BJ, 2012, J URBAN HEALTH, V89, P717, DOI 10.1007/s11524-012-9685-7; Chin HC, 2009, TRANSPORT RES REC, P47, DOI 10.3141/2114-06; Chung H., 2015, KOREA OBSERVER; Cordeschi N, 2015, IEEE T VEH TECHNOL, V64, P2528, DOI 10.1109/TVT.2014.2345767; Emma Glanfield, 2016, DAILY MAIL; Farber HS, 2008, AM ECON REV, V98, P1069, DOI 10.1257/aer.98.3.1069; Gao Y, 2012, LECT NOTES COMPUT SC, V7432, P275, DOI 10.1007/978-3-642-33191-6_27; Goodwin H., 1910, NAVAL I P, V36, P735; Hart Y, 2015, NAT METHODS, V12, P233, DOI [10.1038/NMETH.3254, 10.1038/nmeth.3254]; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Huang L, 2017, IEEE T IND INFORM, V13, P782, DOI 10.1109/TII.2016.2597744; Jovanovik M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09346; Karnruzzaman M, 2015, TRANSPORT POLICY, V42, P187, DOI 10.1016/j.tranpol.2015.06.003; Liu SY, 2014, IEEE T VEH TECHNOL, V63, P464, DOI 10.1109/TVT.2013.2272792; Liu W, 2015, SCI REP-UK, V5, DOI 10.1038/srep13192; Magierowski RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120901; Meik JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131435; Modalsli J, 2015, J ECON INEQUAL, V13, P225, DOI 10.1007/s10888-014-9279-6; Mumtaz S, 2015, IEEE COMMUN MAG, V53, P109, DOI 10.1109/MCOM.2015.7158273; Palchykov V, 2014, SCI REP-UK, V4, DOI 10.1038/srep06174; Rivoli D, 2015, NEW YORK DAILY NEWS; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Song H, 2002, TRANSP RES BOARD 88; Sun YC, 2017, J NETW COMPUT APPL, V83, P204, DOI 10.1016/j.jnca.2015.10.018; Sun YC, 2016, IEEE ACCESS, V4, P766, DOI 10.1109/ACCESS.2016.2529723; Taxi Association Cndemns'NO JAPANESE PASSENGERS' Sign, 2015, KHAOSOD ENGLISH 0121; Wan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100661; Whitehead H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060901; You C, 2016, IEEE J SEL AREA COMM, V34, P1757, DOI 10.1109/JSAC.2016.2545382; Yuan J, 2013, IEEE T KNOWL DATA EN, V25, P220, DOI 10.1109/TKDE.2011.200; Yuan NJ, 2013, IEEE T KNOWL DATA EN, V25, P2390, DOI 10.1109/TKDE.2012.153; Zhang DQ, 2015, IEEE T INTELL TRANSP, V16, P123, DOI 10.1109/TITS.2014.2328231; Zhang FZ, 2015, ACM T INTEL SYST TEC, V6, DOI 10.1145/2644828	34	25	25	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165597	10.1371/journal.pone.0165597	http://dx.doi.org/10.1371/journal.pone.0165597			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812121	gold, Green Published, Green Submitted			2022-12-27	WOS:000386910000036
J	Bragazzi, NL; Dini, G; Toletone, A; Brigo, F; Durando, P				Bragazzi, Nicola Luigi; Dini, Guglielmo; Toletone, Alessandra; Brigo, Francesco; Durando, Paolo			Leveraging Big Data for Exploring Occupational Diseases-Related Interest at the Level of Scientific Community, Media Coverage and Novel Data Streams: The Example of Silicosis as a Pilot Study	PLOS ONE			English	Article							EBOLA RESEARCH; UNITED-STATES; WEB; INFORMATION; INTERNET; SCIENCE; TRENDS; SURVEILLANCE; WIKIPEDIA; MEDICINE	Objective Silicosis is an untreatable but preventable occupational disease, caused by exposure to silica. It can progressively evolve to lung impairment, respiratory failure and death, even after exposure has ceased. However, little is known about occupational diseases-related interest at the level of scientific community, media coverage and web behavior. This article aims at filling in this gap of knowledge, taking the silicosis as a case study. Methods We investigated silicosis-related web-activities using Google Trends (GT) for capturing the Internet behavior worldwide in the years 2004-2015. GT-generated data were, then, compared with the silicosis-related scientific production (i.e., PubMed and Google Scholar), the media coverage (i.e., Google news), the Wikipedia traffic (i.e, Wikitrends) and the usage of new media (i.e., YouTube and Twitter). Results A peak in silicosis-related web searches was noticed in 2010-2011: interestingly, both scientific articles production and media coverage markedly increased after these years in a statistically significant way. The public interest and the level of the public engagement were witnessed by an increase in likes, comments, hashtags, and re-tweets. However, it was found that only a small fraction of the posted/uploaded material contained accurate scientific information. Conclusions GT could be useful to assess the reaction of the public and the level of public engagement both to novel risk-factors associated to occupational diseases, and possibly related changes in disease natural history, and to the effectiveness of preventive workplace practices and legislative measures adopted to improve occupational health. Further, occupational clinicians should become aware of the topics most frequently searched by patients and proactively address these concerns during the medical examination. Institutional bodies and organisms should be more present and active in digital tools and media to disseminate and communicate scientifically accurate information. This manuscript should be intended as preliminary, exploratory communication, paving the way for further studies.	[Bragazzi, Nicola Luigi] Univ Genoa, Postgrad Sch Publ Hlth, Dept Hlth Sci, Genoa, Italy; [Dini, Guglielmo; Toletone, Alessandra; Durando, Paolo] Univ Genoa, Dept Hlth Sci, Postgrad Sch Occupat Med, Genoa, Italy; [Brigo, Francesco] Franz Tappeiner Hosp, Dept Neurol, Merano, Italy; [Brigo, Francesco] Univ Verona, Dept Neurol Biomed & Movement Sci, Verona, Italy; [Durando, Paolo] IRCCS AOU San Martino IST, Occupat Med Unit, Genoa, Italy	University of Genoa; University of Genoa; Ospedale Franz Tappeiner; University of Verona; University of Genoa; IRCCS AOU San Martino IST	Dini, G (corresponding author), Univ Genoa, Dept Hlth Sci, Postgrad Sch Occupat Med, Genoa, Italy.	guglielmo.dini@edu.unige.it	Bragazzi, Nicola Luigi/G-1672-2011; Brigo, Francesco/H-6513-2013	Bragazzi, Nicola Luigi/0000-0001-8409-868X; Brigo, Francesco/0000-0003-0928-1577				Alicino C, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0090-9; Althouse BM, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0054-0; Althouse BM, 2014, AM J PREV MED, V46, P166, DOI 10.1016/j.amepre.2013.10.008; Ayers John W, 2016, JMIR Public Health Surveill, V2, pe16, DOI 10.2196/publichealth.5304; Ayers JW, 2016, JAMA INTERN MED, V176, P552, DOI 10.1001/jamainternmed.2016.0003; Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Bakan ND, 2011, CHEST, V140, P1300, DOI 10.1378/chest.10-1856; Bang KM, 2015, MMWR-MORBID MORTAL W, V64, P117; Bowman S., 2003, WE MEDIA AUDIENCES S; Bragazzi NL, 2014, PSYCHOL RES BEHAV MA, V7, P1, DOI 10.2147/PRBM.S44084; Bragazzi NL, 2013, PATIENT PREFER ADHER, V7, P353, DOI 10.2147/PPA.S38578; Brigo F, 2015, EPILEPTIC DISORD, V17, P460, DOI 10.1684/epd.2015.0772; Brigo F, 2015, J CLIN NEUROSCI, V22, P1170, DOI 10.1016/j.jocn.2015.02.006; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Chaplin E, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008055; Cruz-Calderon S, 2015, TRAVEL MED INFECT DI, V13, P202, DOI 10.1016/j.tmaid.2015.02.007; Cullinan P, 2013, PRIM CARE RESP J, V22, P249, DOI 10.4104/pcrj.2013.00055; Curti S, 2016, OCCUP ENVIRON MED, V73, P353, DOI 10.1136/oemed-2015-103209; Delgado CK, 2015, RESP CARE, V60, P1276, DOI 10.4187/respcare.03716; Dove ES, 2013, EMBO REP, V14, P113, DOI 10.1038/embor.2012.205; Duplaga M, 2013, TELEMED E-HEALTH, V19, P683, DOI 10.1089/tmj.2012.0306; Eysenbach G, 1998, BRIT MED J, V316, P72, DOI 10.1136/bmj.316.7124.72; Filios MS, 2015, MMWR-MORBID MORTAL W, V62, P81, DOI 10.15585/mmwr.mm6254a6; FREUND E, 1989, JAMA-J AM MED ASSOC, V262, P3041, DOI 10.1001/jama.262.21.3041; Freund E, 1990, MMWR Recomm Rep, V39, P19; Friedman GK, 2015, MMWR-MORBID MORTAL W, V64, P129; Hinkle D.E., 2003, APPL STAT BEHAV SCI; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Leas EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159885; Leung CC, 2012, LANCET, V379, P2008, DOI 10.1016/S0140-6736(12)60235-9; Manzoli L, 2015, EPIDEMIOL PREV, V39, P81; Nelson G, 2010, ENVIRON HEALTH PERSP, V118, P421, DOI 10.1289/ehp.0900918; Noar Seth M., 2013, Journal of the National Cancer Institute Monographs, P188, DOI 10.1093/jncimonographs/lgt017; Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Paolucci Valentina, 2015, Arch Bronconeumol, V51, pe57, DOI 10.1016/j.arbres.2014.12.010; Peters HP, 2013, P NATL ACAD SCI USA, V110, P14102, DOI 10.1073/pnas.1212745110; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Segev E, 2016, PUBLIC UNDE IN PRESS; Steenland K, 2014, CA-CANCER J CLIN, V64, P63, DOI 10.3322/caac.21214; Strekalova YA, 2016, HLTH ED BEH IN PRESS; ter Meulen J, 2015, J CLIN VIROL, V64, P107, DOI 10.1016/j.jcv.2014.12.008; Thomas CR, 2010, ENVIRON HEALTH INSIG, V4, P21; Voncken-Brewster V, 2015, INT J CHRONIC OBSTR, V10, P1061, DOI 10.2147/COPD.S81295; Wildevuur SE, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3687; Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]; Winandy M, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4480; Yi Fengyun, 2016, BMC Res Notes, V9, P221, DOI 10.1186/s13104-016-2026-2	48	27	30	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0166051	10.1371/journal.pone.0166051	http://dx.doi.org/10.1371/journal.pone.0166051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806115	gold, Green Submitted, Green Published			2022-12-27	WOS:000386715500080
J	Goodall, KJ; Finch-Edmondson, ML; van Vuuren, J; Yeoh, GC; Gentle, IE; Vince, JE; Ekert, PG; Vaux, DL; Callus, BA				Goodall, Katharine J.; Finch-Edmondson, Megan L.; van Vuuren, Joanne; Yeoh, George C.; Gentle, Ian E.; Vince, James E.; Ekert, Paul G.; Vaux, David L.; Callus, Bernard A.			Cycloheximide Can Induce Bax/Bak Dependent Myeloid Cell Death Independently of Multiple BH3-Only Proteins	PLOS ONE			English	Article							PROSURVIVAL BCL-2 PROTEINS; SIGNALING PATHWAY; DOWN-REGULATION; APOPTOSIS; MCL-1; PUMA; BIM; BAK; PHOSPHORYLATION; FAMILY	Apoptosis mediated by Bax or Bak is usually thought to be triggered by BH3-only members of the Bcl-2 protein family. BH3-only proteins can directly bind to and activate Bax or Bak, or indirectly activate them by binding to anti-apoptotic Bcl-2 family members, thereby relieving their inhibition of Bax and Bak. Here we describe a third way of activation of Bax/Bak dependent apoptosis that does not require triggering by multiple BH3-only proteins. In factor dependent myeloid (FDM) cell lines, cycloheximide induced apoptosis by a Bax/Bak dependent mechanism, because Bax(-/-)Bak(-/-) lines were profoundly resistant, whereas FDM lines lacking one or more genes for BH3-only proteins remained highly sensitive. Addition of cycloheximide led to the rapid loss of Mcl-1 but did not affect the expression of other Bcl-2 family proteins. In support of these findings, similar results were observed by treating FDM cells with the CDK inhibitor, roscovitine. Roscovitine reduced Mcl-1 abundance and caused Bax/Bak dependent cell death, yet FDM lines lacking one or more genes for BH3-only proteins remained highly sensitive. Therefore Bax/Bak dependent apoptosis can be regulated by the abundance of anti-apoptotic Bcl-2 family members such as Mcl-1, independently of several known BH3-only proteins.	[Goodall, Katharine J.; Gentle, Ian E.; Vince, James E.; Ekert, Paul G.; Vaux, David L.; Callus, Bernard A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Bundoora, Vic, Australia; [Finch-Edmondson, Megan L.; Yeoh, George C.; Callus, Bernard A.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [van Vuuren, Joanne; Yeoh, George C.] QEII Med Ctr, Harry Perkins Inst Med Res, Nedlands, WA, Australia; [van Vuuren, Joanne; Yeoh, George C.] Univ Western Australia, Med Res Ctr, Crawley, WA, Australia; [Gentle, Ian E.] Inst Med Microbiol & Hyg, Hermann Herder Str 11, D-79104 Freiburg, Germany; [Vince, James E.; Ekert, Paul G.; Vaux, David L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Vince, James E.; Vaux, David L.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Ekert, Paul G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Callus, Bernard A.] Univ Notre Dame Australia, Sch Hlth Sci, Fremantle, WA, Australia	La Trobe University; University of Western Australia; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; Walter & Eliza Hall Institute; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Notre Dame Australia	Goodall, KJ (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Bundoora, Vic, Australia.	katharine.goodall@monash.edu	Vaux, David L/C-7249-2013; Ekert, Paul/Q-1842-2015; Gentle, Ian/X-2888-2019; Finch-Edmondson, Megan/S-7340-2017	Vaux, David L/0000-0003-2703-1651; Ekert, Paul/0000-0002-2976-8617; Gentle, Ian/0000-0002-6707-7809; Finch-Edmondson, Megan/0000-0002-9628-5842; Goodall, Katharine/0000-0001-5812-8515	Association of International Cancer Research project [09-0084]; Cancer Council of WA project [1010749, 1067515]; National Health and Medical Research Council (Canberra, Australia) [384404, 1016701, 461221]; Australian Government IRISS; Victorian State Government OIS	Association of International Cancer Research project; Cancer Council of WA project(Cancer Council Western Australia); National Health and Medical Research Council (Canberra, Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government IRISS(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government OIS	This work was supported by an Association of International Cancer Research project grant (09-0084) and Cancer Council of WA project grants (1010749 and 1067515) and fellowship to BAC, and National Health and Medical Research Council (Canberra, Australia) Project grant (384404), fellowship (1016701), and Program Grant (461221) to DLV, and operational infrastructure grants through the Australian Government IRISS and the Victorian State Government OIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by an Association of International Cancer Research project grant (09-0084) and Cancer Council of WA project grants (1010749 and 1067515) and fellowship to BAC, and National Health and Medical Research Council (Canberra, Australia) Project grant (384404), fellowship (1016701), and Program Grant (461221) to DLV, and operational infrastructure grants through the Australian Government IRISS and the Victorian State Government OIS. We generously thank Andreas Strasser for providing Bcl-2 antibody, Lorraine O'Reilly for providing Bcl-w and Bcl-xL antibodies, David Huang for providing A1 antibody and Mcl-1 and Bcl-2 cDNAs and Doug Fairlie for providing BimS2A cDNA.	Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; Callus BA, 2008, J MOL BIOL, V384, P313, DOI 10.1016/j.jmb.2008.09.041; Chen HC, 2015, NAT CELL BIOL, V17, P1270, DOI 10.1038/ncb3236; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Coultas L, 2004, MOL CELL BIOL, V24, P1570, DOI 10.1128/MCB.24.4.1570-1581.2004; Coultas L, 2007, J CELL SCI, V120, P2044, DOI 10.1242/jcs.002063; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; De Biasio A, 2007, J BIOL CHEM, V282, P23919, DOI 10.1074/jbc.M700938200; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; GILDEN RV, 1966, J BACTERIOL, V91, P1295, DOI 10.1128/JB.91.3.1295-1297.1966; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Ink B, 1997, MOL CELL BIOL, V17, P2468, DOI 10.1128/MCB.17.5.2468; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; Labi V, 2008, J EXP MED, V205, P641, DOI 10.1084/jem.20071658; Lee EF, 2008, J CELL BIOL, V180, P341, DOI 10.1083/jcb.200708096; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lindqvist LM, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.149; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Muer A, 2012, J BIOL CHEM, V287, P17343, DOI 10.1074/jbc.M111.314898; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; O'Neill KL, 2016, GENE DEV, V30, P973, DOI 10.1101/gad.276725.115; PERKINS AC, 1993, EMBO J, V12, P3835, DOI 10.1002/j.1460-2075.1993.tb06062.x; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VAUX DL, 1993, MOL CELL BIOL, V13, P7000, DOI 10.1128/MCB.13.11.7000; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Willis SN, 2005, GENE DEV, V18, P18; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	43	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0164003	10.1371/journal.pone.0164003	http://dx.doi.org/10.1371/journal.pone.0164003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806040	Green Published, gold			2022-12-27	WOS:000386715500009
J	Itthitaetrakool, U; Pinlaor, P; Pinlaor, S; Chomvarin, C; Dangtakot, R; Chaidee, A; Wilailuckana, C; Sangka, A; Lulitanond, A; Yongvanit, P				Itthitaetrakool, Upsornsawan; Pinlaor, Porntip; Pinlaor, Somchai; Chomvarin, Chariya; Dangtakot, Rungtiwa; Chaidee, Apisit; Wilailuckana, Chotechana; Sangka, Arunnee; Lulitanond, Aroonlug; Yongvanit, Puangrat			Chronic Opisthorchis viverrini Infection Changes the Liver Microbiome and Promotes Helicobacter Growth	PLOS ONE			English	Article							SYRIAN-HAMSTERS; SP NOV.; PYLORI; SEQUENCES; BACTERIA; CANCER; SPP.; METAGENOMICS; CARCINOMA; BILE	Adults of Opisthorchis viverrini reside in the biliary system, inducing inflammation of bile ducts and cholangitis, leading to hepatobiliary disease (HBD) including cholangiocarcinoma. O. viverrini infection also has major implications for the bacterial community in bile ducts and liver. To investigate this in chronic O. viverrini infection (>= 8 months p.i.), bacterial genomic DNA from livers of hamsters and from worms was investigated using culture techniques, PCR for Helicobacter spp. and high-throughput next-generation sequencing targeting the V3-V4 hypervariable regions of prokaryotic 16S rRNA gene. Of a total of 855,046 DNA sequence reads, 417,953 were useable after filtering. Metagenomic analyses assigned these to 93 operational taxonomic units (OTUs) consisting of 80 OTUs of bacteria, including 6 phyla and 42 genera. In the chronic O. viverrini-infected group, bacterial community composition and diversity were significantly increased compared to controls. Sequences of Fusobacterium spp. were the most common (13.81%), followed by Streptococcus luteciae (10.76%), Escherichia coli (10.18%), and Bifidobacterium spp. (0.58%). In addition, Helicobacter pylori (0.17% of sequences) was also identified in the liver of chronic O. viverrini infections, but not in normal liver. The presence of H. pylori was confirmed by PCR and by use of an antibody against bacterial antigen, supporting the metagenomics data. The identities of bacteria cultured for enrichment suggested that chronic O. viverrini infection changes the liver microbiome and promotes Helicobacter spp. growth. There may be synergy between O. viverrini and the liver microbiome in enhancing immune response-mediated hepatobiliary diseases.	[Itthitaetrakool, Upsornsawan] Khon Kaen Univ, Grad Sch, Program Biomed Sci, Khon Kaen, Thailand; [Itthitaetrakool, Upsornsawan; Pinlaor, Porntip; Dangtakot, Rungtiwa; Wilailuckana, Chotechana; Sangka, Arunnee; Lulitanond, Aroonlug] Khon Kaen Univ, Fac Associated Med Sci, Ctr Res & Dev, Med Diagnost Labs, Khon Kaen 40002, Thailand; [Pinlaor, Somchai; Chaidee, Apisit] Khon Kaen Univ, Fac Med, Dept Parasitol, Khon Kaen 40002, Thailand; [Dangtakot, Rungtiwa] Khon Kaen Univ, Sci Program Med Technol, Fac Associated Med Sci, Khon Kaen 40002, Thailand; [Chomvarin, Chariya] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen 40002, Thailand; [Yongvanit, Puangrat] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen 40002, Thailand; [Itthitaetrakool, Upsornsawan; Pinlaor, Porntip; Pinlaor, Somchai; Chomvarin, Chariya; Dangtakot, Rungtiwa; Chaidee, Apisit; Yongvanit, Puangrat] Khon Kaen Univ, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen 40002, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Pinlaor, P (corresponding author), Khon Kaen Univ, Fac Associated Med Sci, Ctr Res & Dev, Med Diagnost Labs, Khon Kaen 40002, Thailand.; Pinlaor, P (corresponding author), Khon Kaen Univ, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen 40002, Thailand.	porawa@kku.ac.th	Lulitanond, Aroonlug/W-1278-2019; /ABI-5967-2020; Chaidee, Apisit/ABH-6755-2020	Lulitanond, Aroonlug/0000-0002-4735-5074; /0000-0001-6495-0951; Pinlaor, Somchai/0000-0002-8187-7247	grant of The Thailand Research Fund; Khon Kaen University Research Foundation, Thailand [TRG5680032]; Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission, through the Health Cluster (SHeP-GMS); National Research Project of Khon Kaen University, Thailand [NRU580216]	grant of The Thailand Research Fund; Khon Kaen University Research Foundation, Thailand; Higher Education Research Promotion and National Research University Project of Thailand; Office of the Higher Education Commission, through the Health Cluster (SHeP-GMS); National Research Project of Khon Kaen University, Thailand	This work was supported by a grant of The Thailand Research Fund and Khon Kaen University Research Foundation, Thailand (TRG5680032), and the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, through the Health Cluster (SHeP-GMS), The National Research Project of Khon Kaen University, Thailand (NRU580216).	Abu Al-Soud W, 2008, DIGEST LIVER DIS, V40, P126, DOI 10.1016/j.dld.2007.09.011; Akinsanya MA, 2015, GENOM DATA, V6, P159, DOI 10.1016/j.gdata.2015.09.004; Andersen LP, 2001, DIGEST DIS, V19, P112, DOI 10.1159/000050664; Aviles-Jimenez F, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.10.008; Boonyanugomol W, 2012, HPB, V14, P177, DOI 10.1111/j.1477-2574.2011.00423.x; Bragazzi MC., 2011, TRANSL GASTROINTEST, V1, P21; Bragg L, 2014, METHODS MOL BIOL, V1096, P183, DOI 10.1007/978-1-62703-712-9_15; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carpenter HA, 1998, MAYO CLIN PROC, V73, P473; Catalano OA, 2009, RADIOGRAPHICS, V29, P2059, DOI 10.1148/rg.297095051; Charoensuk L, 2014, FOLIA PARASIT, V61, P512, DOI 10.14411/fp.2014.063; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Deenonpoe Raksawan, 2015, Asian Pac J Cancer Prev, V16, P1751; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fox JG, 2009, J CLIN MICROBIOL, V47, P3673, DOI 10.1128/JCM.00879-09; Franklin CL, 1996, J CLIN MICROBIOL, V34, P2952, DOI 10.1128/JCM.34.12.2952-2958.1996; Fukugaiti MH, 2015, BRAZ J MICROBIOL, V46, P1135, DOI 10.1590/S1517-838246420140665; Goldman CG, 2010, HELICOBACTER, V15, P69, DOI 10.1111/j.1523-5378.2010.00780.x; Hsieh PS, 2012, HELICOBACTER, V17, P466, DOI 10.1111/j.1523-5378.2012.00992.x; IARC, 2012, IARC MONOGR EVAL C B, V100, P341; Keku TO, 2013, TRENDS MICROBIOL, V21, P506, DOI 10.1016/j.tim.2013.08.004; Khuntikeo N, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1475-7; Kirchner GI, 2011, INT J CLIN EXP MED, V4, P26; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; Li QR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034939; Maeda H, 1998, Gan To Kagaku Ryoho, V25, P1474; MAIRIANG E, 1993, T ROY SOC TROP MED H, V87, P194, DOI 10.1016/0035-9203(93)90489-D; Manolis EN, 2008, J GASTROINTEST LIVER, V17, P179; Morgan XC, 2013, TRENDS GENET, V29, P51, DOI 10.1016/j.tig.2012.09.005; Murano A, 1999, MICROBIOL IMMUNOL, V43, P1009, DOI 10.1111/j.1348-0421.1999.tb01230.x; Ong SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060811; Pace F, 2015, MINERVA GASTROENTERO, V61, P273; Patterson MM, 2000, J CLIN MICROBIOL, V38, P3722, DOI 10.1128/JCM.38.10.3722-3728.2000; Pinlaor S, 2013, KOREAN J PARASITOL, V51, P703, DOI 10.3347/kjp.2013.51.6.703; Plieskatt JL, 2013, FASEB J, V27, P4572, DOI 10.1096/fj.13-232751; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneeberger PHH, 2016, INFECT GENET EVOL, V40, P389, DOI 10.1016/j.meegid.2015.08.044; Simmons JH, 2000, J CLIN MICROBIOL, V38, P1811, DOI 10.1128/JCM.38.5.1811-1817.2000; Sirica AE, 2012, NAT REV GASTRO HEPAT, V9, P44, DOI 10.1038/nrgastro.2011.222; Sithithaworn P, 2012, PARASITOL INT, V61, P10, DOI 10.1016/j.parint.2011.08.014; Sripa B, 2012, TRENDS PARASITOL, V28, P395, DOI 10.1016/j.pt.2012.07.006; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Worku ML, 2004, J MED MICROBIOL, V53, P807, DOI 10.1099/jmm.0.45636-0; Zenner L, 1999, COMP IMMUNOL MICROB, V22, P41, DOI 10.1016/S0147-9571(98)00018-6	48	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165798	10.1371/journal.pone.0165798	http://dx.doi.org/10.1371/journal.pone.0165798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806126	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500057
J	Mercurio, P; Mueller, JF; Eaglesham, G; O'Brien, J; Flores, F; Negri, AP				Mercurio, Philip; Mueller, Jochen F.; Eaglesham, Geoff; O'Brien, Jake; Flores, Florita; Negri, Andrew P.			Degradation of Herbicides in the Tropical Marine Environment: Influence of Light and Sediment	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PESTICIDE DEGRADATION; WATER; EXPOSURE; ATRAZINE; LAGOON; DIURON; FATE; TRANSFORMATION; PERSISTENCE	Widespread contamination of nearshore marine systems, including the Great Barrier Reef (GBR) lagoon, with agricultural herbicides has long been recognised. The fate of these contaminants in the marine environment is poorly understood but the detection of photosystem II (PSII) herbicides in the GBR year-round suggests very slow degradation rates. Here, we evaluated the persistence of a range of commonly detected herbicides in marine water under field-relevant concentrations and conditions. Twelve-month degradation experiments were conducted in large open tanks, under different light scenarios and in the presence and absence of natural sediments. All PSII herbicides were persistent under control conditions (dark, no sediments) with half-lives of 300 d for atrazine, 499 d diuron, 1994 d hexazinone, 1766 d tebuthiuron, while the non-PSII herbicides were less persistent at 147 d for metolachlor and 59 d for 2,4-D. The degradation of herbicides was 2-10 fold more rapid in the presence of a diurnal light cycle and coastal sediments; apart from 2,4-D which degraded more slowly in the presence of light. Despite the more rapid degradation observed for most herbicides in the presence of light and sediments, the half-lives remained > 100 d for the PS II herbicides. The effects of light and sediments on herbicide persistence were likely due to their influence on microbial community composition and its ability to utilise the herbicides as a carbon source. These results help explain the year-round presence of PSII herbicides in marine systems, including the GBR, but more research on the transport, degradation and toxicity on a wider range of pesticides and their transformation products is needed to improve their regulation in sensitive environments.	[Mercurio, Philip; Flores, Florita; Negri, Andrew P.] Australian Inst Marine Sci, Townsville, Qld, Australia; [Mercurio, Philip; Mueller, Jochen F.; Eaglesham, Geoff; O'Brien, Jake] Univ Queensland, Natl Res Ctr Environm Toxicol, Coopers Plains, Qld, Australia	Australian Institute of Marine Science; University of Queensland	Mercurio, P (corresponding author), Australian Inst Marine Sci, Townsville, Qld, Australia.; Mercurio, P (corresponding author), Univ Queensland, Natl Res Ctr Environm Toxicol, Coopers Plains, Qld, Australia.	pmercurio@gmail.com	Negri, Andrew P/G-9909-2017; O'Brien, Jake William/C-4749-2015; O'Brien, Jake William/AAD-9103-2019; Mueller, Jochen F/C-6241-2008	Negri, Andrew P/0000-0003-1388-7395; O'Brien, Jake William/0000-0001-9336-9656; Mueller, Jochen/0000-0002-0000-1973	Australian Government's National Environmental Research Program NERP Tropical Ecosystems Hub Project [4.2]; Australian Government's Caring; ARC future fellowship [FF120100546]; National Environmental Research Program (NERP)	Australian Government's National Environmental Research Program NERP Tropical Ecosystems Hub Project(Australian Government); Australian Government's Caring(Australian Government); ARC future fellowship(Australian Research Council); National Environmental Research Program (NERP)	This research was conducted with the support of funding from the Australian Government's National Environmental Research Program (http://www.environment.gov.au/index.html) NERP Tropical Ecosystems Hub Project 4.2 and the Australian Government's Caring for our Country initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Scott Turner from Queensland Health for advice on sediment extraction and Cassandra Thompson for technical assistance. Jochen F. Mueller acknowledges funding by an ARC future fellowship (FF120100546). We also thank the three anonymous reviewers whose constructive comments helped improve the paper. This project was co-funded through the National Environmental Research Program (NERP) and the Australian Government's Caring for our Country initiative.	Ahtiainen J, 2003, CHEMOSPHERE, V51, P529, DOI 10.1016/S0045-6535(02)00861-5; Angly FE, 2016, PEERJ, V4, DOI 10.7717/peerj.1758; ATLAS RM, 1981, MICROBIOL REV, V45, P180, DOI 10.1128/MMBR.45.1.180-209.1981; Barcelo D., 1997, TRACE DETERMINATION, V19, P1; Bentley C, 2012, PESTICIDE MONITORING, P1; Beulke S, 2001, BIOL FERT SOILS, V33, P558, DOI 10.1007/s003740100364; Bocquene G, 2005, MAR POLLUT BULL, V51, P612, DOI 10.1016/j.marpolbul.2005.06.026; Cessna AJ, 2008, TRIAZINE HERBICIDES: 50 YEARS REVOLUTIONIZING AGRICULTURE, P329, DOI 10.1016/B978-044451167-6.50026-X; CROSBY DG, 1966, J AGR FOOD CHEM, V14, P596, DOI 10.1021/jf60148a012; Davies-Colley RJ, 2001, J AM WATER RESOUR AS, V37, P1085, DOI 10.1111/j.1752-1688.2001.tb03624.x; Davis AM, 2014, SCI TOTAL ENVIRON, V490, P81, DOI 10.1016/j.scitotenv.2014.04.005; Davis AM, 2012, MAR POLLUT BULL, V65, P182, DOI 10.1016/j.marpolbul.2011.08.025; Devlin MJ, 2012, MAR POLLUT BULL, V65, P224, DOI 10.1016/j.marpolbul.2012.03.001; Egli T, 2010, WATER RES, V44, P4826, DOI 10.1016/j.watres.2010.07.023; Fenner K, 2013, SCIENCE, V341, P752, DOI 10.1126/science.1236281; Flores F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075798; Ganapathy C, 1996, ENV FATE HEXAZINONE, P1; GBRMPA, 2009, REEF WATER QUALITY P; GBRMPA, 2010, **NON-TRADITIONAL**; HORVATH RS, 1972, BACTERIOL REV, V36, P146, DOI 10.1128/MMBR.36.2.146-155.1972; Howard PH, 1991, HANDBOOK OF ENVIRONM, VIII; KEMP WM, 1983, MAR TECHNOL SOC J, V17, P78; Kennedy K, 2012, MAR POLLUT BULL, V64, P1495, DOI 10.1016/j.marpolbul.2012.05.014; Kennedy K, 2012, MAR POLLUT BULL, V65, P292, DOI 10.1016/j.marpolbul.2011.10.029; King J, 2013, AGR ECOSYST ENVIRON, V180, P54, DOI 10.1016/j.agee.2012.07.001; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Laabs V, 2007, CHEMOSPHERE, V67, P975, DOI 10.1016/j.chemosphere.2006.10.067; Lazartigues A, 2013, CHEMOSPHERE, V91, P530, DOI 10.1016/j.chemosphere.2012.12.032; Lewis SE, 2012, MAR POLLUT BULL, V65, P280, DOI 10.1016/j.marpolbul.2011.11.009; Lewis SE, 2009, ENVIRON POLLUT, V157, P2470, DOI 10.1016/j.envpol.2009.03.006; Lin CH, 2008, J ENVIRON QUAL, V37, P196, DOI 10.2134/jeq2006.0503; Magnusson M, 2008, MAR POLLUT BULL, V56, P1545, DOI 10.1016/j.marpolbul.2008.05.023; Magnusson M, 2012, MAR POLLUT BULL, V65, P363, DOI 10.1016/j.marpolbul.2011.09.029; Mandelbaum RT, 2008, TRIAZINE HERBICIDES: 50 YEARS REVOLUTIONIZING AGRICULTURE, P301, DOI 10.1016/B978-044451167-6.50025-8; Mercurio P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136391; Mercurio P, 2014, MAR POLLUT BULL, V85, P385, DOI 10.1016/j.marpolbul.2014.01.021; Moncada A., 2004, ENVIRONMENTAL FATE O, P1; Navarro S, 2004, SCI TOTAL ENVIRON, V329, P87, DOI 10.1016/j.scitotenv.2004.03.013; Negri AP, 2015, AQUAT TOXICOL, V165, P73, DOI 10.1016/j.aquatox.2015.05.007; O'Brien DS, 2013, REPORT TO THE REEF R; OECD, 1992, ORGAN EC COOP DEV, P1; OECD, 2000, OECD GUID TEST CHEM, DOI DOI 10.1787/9789264069602-EN; Okamura H, 2002, CHEMOSPHERE, V48, P43, DOI 10.1016/S0045-6535(02)00025-5; Packett R, 2009, MAR POLLUT BULL, V58, P976, DOI 10.1016/j.marpolbul.2009.02.017; Pathiratne A, 2016, ENVIRON TOXICOL CHEM, V35, P419, DOI 10.1002/etc.3199; Potter TL, 2013, MAR POLLUT BULL, V67, P36, DOI 10.1016/j.marpolbul.2012.12.004; Rice PJ, 2004, ENVIRON TOXICOL CHEM, V23, P1145, DOI 10.1897/03-110; Salvat B, 2015, ENV SCI POLLUT R, P1, DOI [10.1007/s11356-015-4396-9, DOI 10.1007/S11356-015-4396-9]; Santilio A, 2011, J ENVIRON SCI HEAL B, V46, P535, DOI 10.1080/03601234.2011.583876; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Shaw CM, 2008, MAR POLLUT BULL, V57, P473, DOI 10.1016/j.marpolbul.2008.04.002; Shaw M, 2010, MAR POLLUT BULL, V60, P113, DOI 10.1016/j.marpolbul.2009.08.026; Smith R, 2012, MAR POLLUT BULL, V65, P117, DOI 10.1016/j.marpolbul.2011.08.010; Starner K., 1999, P TECHN M CHARL SC, P89; Stasinakis AS, 2009, WATER RES, V43, P1471, DOI 10.1016/j.watres.2008.12.040; Steen RJCA, 2000, J ENVIRON MONITOR, V2, P597, DOI 10.1039/b004734l; Thouand G, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00164; Zepp RG, 2003, COMP SER PHOTOCHEM, V1, P137	58	26	27	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165890	10.1371/journal.pone.0165890	http://dx.doi.org/10.1371/journal.pone.0165890			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806103	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500069
J	Senguttuvan, NB; Kumar, S; Lee, WS; Mishra, S; Cho, JH; Kwon, JE; Hyeon, SH; Jeong, YS; Won, H; Shin, SY; Lee, KJ; Kim, TH; Kim, CJ; Kim, SW				Senguttuvan, Nagendra Boopathy; Kumar, Sharath; Lee, Wang-Soo; Mishra, Sundeep; Cho, Jun Hwan; Kwon, Jee Eun; Hyeon, Seong Hyeop; Jeong, Yun Sang; Won, Hoyoun; Shin, Seung Yong; Lee, Kwang Je; Kim, Tae Ho; Kim, Chee Jeong; Kim, Sang-Wook			Plaque Vulnerability as Assessed by Radiofrequency Intravascular Ultrasound in Patients with Valvular Calcification	PLOS ONE			English	Article							MITRAL ANNULAR CALCIFICATION; AORTIC-VALVE CALCIFICATION; CORONARY-ARTERY-DISEASE; RISK-FACTORS; CALCIFIED ATHEROSCLEROSIS; CARDIOVASCULAR MORBIDITY; MORTALITY; HEART; ANGIOGRAPHY; HYPERCHOLESTEROLEMIA	Background Cardiac valvular calcification is associated with the overall coronary plaque burden and considered an independent cardiovascular risk and prognostic factor. The purpose of this study was to evaluate the relationship between the presence of valvular calcification and plaque morphology and/or vulnerability. Methods Transthoracic echocardiography was used to assess valvular calcification in 280 patients with coronary artery disease who underwent radiofrequency intravascular ultrasound (Virtual Histology IVUS, VH-IVUS). A propensity score-matched cohort of 192 patients (n = 96 in each group) was analyzed. Thin-capped fibroatheroma (TCFA) was defined as a necrotic core (NC) >10% of the plaque area with a plaque burden >40% and NC in contact with the lumen for >= 3 image slices. A remodeling index (lesion/reference vessel area) >1.05 was considered to be positive. Results Patients were divided into two groups: any calcification in at least one valve (152 patients) vs. no detectable valvular calcification (128 patients). Groups were similar in terms of age, risk factors, clinical diagnosis, and angiographic analysis after propensity score-matched analysis. Gray-scale IVUS analysis showed that the vessel size, plaque burden, minimal lumen area, and remodeling index were similar. By VH-IVUS, % NC and % dense calcium (DC) were greater in patients with valvular calcification (p = 0.024, and p = 0.016, respectively). However, only % DC was higher at the maximal NC site by propensity scorematched analysis (p = 0.029). The frequency of VH-TCFA occurrence was higher depending on the complexity (p = 0.0064) and severity (p = 0.013) of valvular calcification. Conclusions There is a significant relationship between valvular calcifications and VH-IVUS assessment of TCFAs. Valvular calcification indicates a greater atherosclerosis disease complexity (increased calcification of the coronary plaque) and vulnerable coronary plaques (higher incidence of VH-TCFA).	[Senguttuvan, Nagendra Boopathy; Kumar, Sharath; Lee, Wang-Soo; Cho, Jun Hwan; Kwon, Jee Eun; Hyeon, Seong Hyeop; Jeong, Yun Sang; Won, Hoyoun; Shin, Seung Yong; Lee, Kwang Je; Kim, Tae Ho; Kim, Chee Jeong; Kim, Sang-Wook] Chung Ang Univ Hosp, Heart Res Inst, Seoul 06973, South Korea; [Mishra, Sundeep] All India Inst Med Sci, New Delhi 110029, India	Chung Ang University; Chung Ang University Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi	Lee, WS (corresponding author), Chung Ang Univ Hosp, Heart Res Inst, Seoul 06973, South Korea.	wslee1227@cau.ac.kr	Shin, Seung Yong/AAF-7226-2019; Lee, Wang-Soo/AAS-1477-2021	Lee, Wang-Soo/0000-0002-8264-0866; Kim, Sang-Wook/0000-0002-7208-8596; Shin, Seung Yong/0000-0002-3408-6899; SENGUTTUVAN, NAGENDRA BOOPATHY/0000-0003-4979-596X				Adler Y, 1998, AM J CARDIOL, V82, P1183, DOI 10.1016/S0002-9149(98)00596-7; Allison MA, 2006, CIRCULATION, V113, P861, DOI 10.1161/CIRCULATIONAHA.105.552844; Allison MA, 2012, ARTERIOSCL THROM VAS, V32, P140, DOI 10.1161/ATVBAHA.111.235234; Barasch E, 2006, AM J CARDIOL, V97, P1281, DOI 10.1016/j.amjcard.2005.11.065; Boon A, 1997, HEART, V78, P472, DOI 10.1136/hrt.78.5.472; Bozbas H, 2008, ATHEROSCLEROSIS, V198, P115, DOI 10.1016/j.atherosclerosis.2007.09.044; Chaves Paulo H M, 2004, Am J Geriatr Cardiol, V13, P137, DOI 10.1111/j.1076-7460.2004.02120.x; Cheitlin MD, 2003, J AM COLL CARDIOL, V42, P954, DOI 10.1016/S0735-1097(03)01065-9; Corciu AI, 2010, INT J CARDIOL, V142, P288, DOI 10.1016/j.ijcard.2009.01.021; Dawber TR, 1951, AM J PUBLIC HEALTH N, V41, P279, DOI 10.2105/ajph.41.3.279; Fox CS, 2003, CIRCULATION, V107, P1492, DOI 10.1161/01.CIR.0000058168.26163.BC; Hoshino T, 2009, AM J PHYSIOL-HEART C, V297, pH802, DOI 10.1152/ajpheart.00318.2009; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Katz R, 2006, CIRCULATION, V113, P2113, DOI 10.1161/CIRCULATIONAHA.105.598086; Kohsaka S, 2008, JACC-CARDIOVASC IMAG, V1, P617, DOI 10.1016/j.jcmg.2008.07.006; Messika-Zeitoun D, 2007, ARTERIOSCL THROM VAS, V27, P642, DOI 10.1161/01.ATV.0000255952.47980.c2; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Nair Anuja, 2007, EuroIntervention, V3, P113; Schoenhagen P, 2000, CIRCULATION, V101, P598, DOI 10.1161/01.CIR.101.6.598; Simon A, 1997, CIRCULATION, V96, P2449; Taniguchi H, 2004, AM HEART J, V148, P137, DOI 10.1016/j.ahj.2004.03.008; Tonstad S, 1996, ARTERIOSCL THROM VAS, V16, P984, DOI 10.1161/01.ATV.16.8.984; Utsunomiya H, 2010, ATHEROSCLEROSIS, V213, P166, DOI 10.1016/j.atherosclerosis.2010.08.070; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Volzke H, 2010, ATHEROSCLEROSIS, V209, P606, DOI 10.1016/j.atherosclerosis.2009.10.030; Wasserman BA, 2008, STROKE, V39, P329, DOI 10.1161/STROKEAHA.107.498634; WEISSMAN NJ, 1994, AM J CARDIOL, V73, P1080, DOI 10.1016/0002-9149(94)90287-9	28	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165885	10.1371/journal.pone.0165885	http://dx.doi.org/10.1371/journal.pone.0165885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806099	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500068
J	Zea, L; Prasad, N; Levy, SE; Stodieck, L; Jones, A; Shrestha, S; Klaus, D				Zea, Luis; Prasad, Nripesh; Levy, Shawn E.; Stodieck, Louis; Jones, Angela; Shrestha, Shristi; Klaus, David			A Molecular Genetic Basis Explaining Altered Bacterial Behavior in Space	PLOS ONE			English	Article							ESCHERICHIA-COLI; ACID RESISTANCE; CELL-DENSITY; MICROGRAVITY; EXPRESSION; FLIGHT; TRANSPORT; SYSTEMS; PH; ANTIBIOTICS	Bacteria behave differently in space, as indicated by reports of reduced lag phase, higher final cell counts, enhanced biofilm formation, increased virulence, and reduced susceptibility to antibiotics. These phenomena are theorized, at least in part, to result from reduced mass transport in the local extracellular environment, where movement of molecules consumed and excreted by the cell is limited to diffusion in the absence of gravity-dependent convection. However, to date neither empirical nor computational approaches have been able to provide sufficient evidence to confirm this explanation. Molecular genetic analysis findings, conducted as part of a recent spaceflight investigation, support the proposed model. This investigation indicated an overexpression of genes associated with starvation, the search for alternative energy sources, increased metabolism, enhanced acetate production, and other systematic responses to acidity-all of which can be associated with reduced extracellular mass transport.	[Zea, Luis; Stodieck, Louis; Klaus, David] Univ Colorado, Dept Aerosp Engn Sci, BioServe Space Technol, Boulder, CO 80309 USA; [Prasad, Nripesh; Levy, Shawn E.; Jones, Angela; Shrestha, Shristi] HudsonAlpha Inst Biotechnol, Genom Serv Lab, Huntsville, AL USA; [Shrestha, Shristi] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA	University of Colorado System; University of Colorado Boulder; HudsonAlpha Institute for Biotechnology; University of Alabama System; University of Alabama Huntsville	Zea, L (corresponding author), Univ Colorado, Dept Aerosp Engn Sci, BioServe Space Technol, Boulder, CO 80309 USA.	Luis.Zea@Colorado.edu		Shrestha, Shristi/0000-0003-4519-1712; Levy, Shawn/0000-0002-1369-5740	International Space Station (ISS) National Laboratory through the Center for the Advancement of Science in Space, Inc. (CASIS) [GA-2014-146]; NASA [NNH11CD70A]; German Academic Exchange Service (DAAD); German Aerospace Center (DLR); DLR Aerospace Medicine Institute	International Space Station (ISS) National Laboratory through the Center for the Advancement of Science in Space, Inc. (CASIS); NASA(National Aeronautics & Space Administration (NASA)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Aerospace Center (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); DLR Aerospace Medicine Institute	The data analysis effort for this investigation was funded under Grant Agreement (GA-2014-146) as part of the International Space Station (ISS) National Laboratory through the Center for the Advancement of Science in Space, Inc. (CASIS) in accordance with NASA Cooperative Agreement No. NNH11CD70A (http://www.iss-casis.org/). LZ's work in Germany was funded by the German Academic Exchange Service (DAAD) and the German Aerospace Center (DLR) for their support through the DAAD Research Fellowship for Doctoral Candidates and Young Scientists (https://www.daad.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Luis Zea thanks the German Academic Exchange Service (DAAD) and the German Aerospace Center (DLR) for their support through the DAAD Research Fellowship for Doctoral Candidates and Young Scientists. The authors would like to thank Paul Koenig, and Christine Fanchiang from BioServe for their assistance with the payload hardware preparation, Mark Rupert, Shankini Doraisingam, Chris Nie and Kirstyn Johnson, for their support with the operation activities, and Vale Zins for his help with the pH measurements; Jolien Tyler for her advice with light microscopy; Megan Leahy for her graphic design of the biomolecular process; Dr. Ralf Moller, Dr. Gunther Reitz, Andrea Schroder, Stefan Leuko and Vanessa Neumann from the DLR Aerospace Medicine Institute for their support; NASA astronauts Rick Mastracchio and Mike Hopkins for conducting the AES-1 operations onboard the ISS, and everybody in the space program that made this experiment possible.	Albrecht-Buehler G, 1991, GRAVIT SPACE RES, V4; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; ANDREWS JC, 1985, J BACTERIOL, V161, P484, DOI 10.1128/JB.161.2.484-492.1985; Arnold C. N., J BACTERIO, V183, P2178; Benoit M, 2005, MICROBIOL-SGM, V151, P69, DOI 10.1099/mic.0.27062-0; Benoit MR, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/4/046007; Benoit MR, 2007, ADV SPACE RES, V39, P1225, DOI 10.1016/j.asr.2006.10.009; Benoit MR, 2006, APPL MICROBIOL BIOT, V70, P403, DOI 10.1007/s00253-005-0098-3; BERTRAND K, 1976, J MOL BIOL, V103, P319, DOI 10.1016/0022-2836(76)90315-6; Bjorkman T., 1988, NASA C PUBLICATION; Brown R.B, 1999, THESIS U COLORADO BO; Brown RB, 2002, MICROGRAVITY SCI TEC, V13, P24, DOI 10.1007/BF02881678; Buchanan R.E, 1975, BERGEYS MANUAL DETER; Chang Y.-Y., MOL MICROBIO, V11, P1019; CIFERRI O, 1986, NATURWISSENSCHAFTEN, V73, P418, DOI 10.1007/BF00367284; Crabbe A, 2011, APPL ENVIRON MICROB, V77, P1221, DOI 10.1128/AEM.01582-10; FERENCI T, 1980, J BACTERIOL, V144, P7, DOI 10.1128/JB.144.1.7-11.1980; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gigliobianco T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-148; GORGP, 2015, PANTHER GEN LIST AN; Hoehn Alexander, 2004, J Gravit Physiol, V11, P39; Hommais F., MICROBIO, V150, P61; Horneck G, 2010, MICROBIOL MOL BIOL R, V74, P121, DOI 10.1128/MMBR.00016-09; Ilyin VK, 2005, ACTA ASTRONAUT, V56, P839, DOI 10.1016/j.actaastro.2005.01.009; Johnson J, 2003, J CLIN MICROBIOL, V41, P5798, DOI 10.1128/JCM.41.12.5798-5802.2003; Juergensmeyer MA, 1999, MICROGRAVITY SCI TEC, V12, P41; Kacena MA, 1999, APPL MICROBIOL BIOT, V51, P229, DOI 10.1007/s002530051386; KELLERMANN O, 1974, EUR J BIOCHEM, V47, P139, DOI 10.1111/j.1432-1033.1974.tb03677.x; Kim W, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-241; Kim W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062437; Kitts C., 2007, 21 ANN AIAA USU C SM; Kitts C., 2009, P 23 ANN AIAA USU C; Klaus D, 1997, MICROBIOL-SGM, V143, P449, DOI 10.1099/00221287-143-2-449; Klaus D, J GRAVIT PHYSIO, V11, P17; Klaus D, 2001, P C MICR TRANSP PROC, VII, P527; Klaus DM, 1998, TRENDS BIOTECHNOL, V16, P369, DOI 10.1016/S0167-7799(98)01197-4; LAPCHINE L, 1986, DRUG EXP CLIN RES, V12, P933; Leonardi R, 2004, J BIOL CHEM, V279, P17054, DOI 10.1074/jbc.M312714200; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; Liu P, 2012, COMPUT STRUCT BIOTEC, V3, DOI 10.5936/csbj.201210011; Ma Z., MOL MICROBIO, V49, P1309; MARNETT LJ, 1985, MUTAT RES, V148, P25; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; McLean RJC, 2001, FEMS MICROBIOL LETT, V195, P115, DOI 10.1016/S0378-1097(00)00549-8; Minelli G., 2008, P 22 ANN AIAA USU C; MOATTI N, 1986, NATURWISSENSCHAFTEN, V73, P413, DOI 10.1007/BF00367282; Moreau PL, 2007, J BACTERIOL, V189, P2249, DOI 10.1128/JB.01306-06; Nicholson WL, 2011, ASTROBIOLOGY, V11, P951, DOI 10.1089/ast.2011.0714; Novikova ND, 2004, MICROB ECOL, V47, P127, DOI 10.1007/s00248-003-1055-2; Owen RB, 2002, APPL OPTICS, V41, P3927, DOI 10.1364/AO.41.003927; Parra M., 2008, GRAVIT SPACE BIOL, V21, P9; POLLARD EC, 1965, J THEOR BIOL, V8, P113, DOI 10.1016/0022-5193(65)90097-4; Price SB, 2004, APPL ENVIRON MICROB, V70, P4792, DOI 10.1128/AEM.70.8.4792-4799.2004; Ricco A., 2010, 2010 SOLID STATE SEN, P110; Ricco A. J., 2007, SOL STAT SENS ACT MI, P33; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Shin S, 2001, MOL MICROBIOL, V41, P1133, DOI 10.1046/j.1365-2958.2001.02570.x; TIXADOR R, 1985, AVIAT SPACE ENVIR MD, V56, P748; TIXADOR R, 1985, ACTA ASTRONAUT, V12, P131, DOI 10.1016/0094-5765(85)90082-7; TIXADOR R, 1994, AVIAT SPACE ENVIR MD, V65, P551; Tucker DL, 2002, J BACTERIOL, V184, P6551, DOI 10.1128/JB.184.23.6551-6558.2002; VANDERHORN PB, 1993, J BACTERIOL, V175, P982, DOI 10.1128/JB.175.4.982-992.1993; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wang YF, 1997, J MOL BIOL, V272, P56, DOI 10.1006/jmbi.1997.1224; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; YEE L, 1992, BIO-TECHNOL, V10, P1550, DOI 10.1038/nbt1292-1550; Zea L., 2015, 66 INT ASTR C JER IS; Zea L., 2015, THESIS	69	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0164359	10.1371/journal.pone.0164359	http://dx.doi.org/10.1371/journal.pone.0164359			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806055	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500010
J	Rosado, D; Gramegna, G; Cruz, A; Lira, BS; Freschi, L; de Setta, N; Rossi, M				Rosado, Daniele; Gramegna, Giovanna; Cruz, Aline; Lira, Bruno Silvestre; Freschi, Luciano; de Setta, Nathalia; Rossi, Magdalena			Phytochrome Interacting Factors (PIFs) in Solanum lycopersicum: Diversity, Evolutionary History and Expression Profiling during Different Developmental Processes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; LEAF SENESCENCE; GENE DUPLICATION; MOLECULAR CLOCK; TOMATO; ARABIDOPSIS; BIOSYNTHESIS; GROWTH; DEPHYTYLATION; METABOLISM	Although the importance of light for tomato plant yield and edible fruit quality is well known, the PHYTOCHROME INTERACTING FACTORS (PIFs), main components of phytochrome-mediated light signal transduction, have been studied almost exclusively in Arabidopsis thaliana. Here, the diversity, evolution and expression profile of PIF gene subfamily in Solanum lycopersicum was characterized. Eight tomato PIF loci were identified, named SlPIF1a, SlPIF1b, SlPIF3, SlPIF4, SlPIF7a, SlPIF7b, SlPIF8a and SlPIF8b. The duplication of SlPIF1, SlPIF7 and SlPIF8 genes were dated and temporally coincided with the whole-genome triplication event that preceded tomato and potato divergence. Different patterns of mRNA accumulation in response to light treatments were observed during seedling deetiolation, dark-induced senescence, diel cycle and fruit ripening. SlPIF4 showed similar expression profile as that reported for A. thaliana homologs, indicating an evolutionary conserved function of PIF4 clade. A comprehensive analysis of the evolutionary and transcriptional data allowed proposing that duplicated SlPIFs have undergone sub- and neofunctionalization at mRNA level, pinpointing the importance of transcriptional regulation for the maintenance of duplicated genes. Altogether, the results indicate that genome polyploidization and functional divergence have played a major role in diversification of the Solanum PIF gene subfamily.	[Rosado, Daniele; Gramegna, Giovanna; Cruz, Aline; Lira, Bruno Silvestre; Freschi, Luciano; Rossi, Magdalena] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil; [de Setta, Nathalia] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC)	Rossi, M (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil.	mmrossi@usp.br	Freschi, Luciano/B-3807-2008; Lira, Bruno Silvestre/G-2874-2017; de Setta, Nathalia/C-6069-2012; Rossi, Magdalena/B-7847-2012	Freschi, Luciano/0000-0002-0737-3438; Lira, Bruno Silvestre/0000-0002-0820-6682; de Setta, Nathalia/0000-0002-4807-5410; Rossi, Magdalena/0000-0003-3650-772X; Rosado, Daniele/0000-0002-9319-9041; GRAMEGNA, GIOVANNA/0000-0001-8585-7801	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	DR and MR were recipients of fellowships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/), Brazil. DR, GG and BL were recipients of fellowships from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/), Sao Paulo, Brazil. This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azari R, 2010, BIOTECHNOL ADV, V28, P108, DOI 10.1016/j.biotechadv.2009.10.003; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Bino RJ, 2005, NEW PHYTOL, V166, P427, DOI 10.1111/j.1469-8137.2005.01362.x; Chow CN, 2016, NUCLEIC ACIDS RES, V44, pD1154, DOI 10.1093/nar/gkv1035; Cordeiro AM, 2016, BBA-GENE REGUL MECH, V1859, P393, DOI 10.1016/j.bbagrm.2015.12.008; Di Rienzo J, 2012, FGSTATISTICS STAT SO; Force A, 1999, AM ZOOL, V39, p78A; Fujisawa M, 2012, PLANTA, V235, P1107, DOI 10.1007/s00425-011-1561-2; Groszmann M, 2011, PLANT J, V68, P816, DOI 10.1111/j.1365-313X.2011.04732.x; Gupta SK, 2014, PLANT CELL ENVIRON, V37, P1688, DOI 10.1111/pce.12279; Guyer L, 2014, PLANT PHYSIOL, V166, P44, DOI 10.1104/pp.114.239541; Hauser BA, 1995, PLANT MOL BIOL, V29, P1143, DOI 10.1007/BF00020458; Husaineid SSH, 2007, J EXP BOT, V58, P615, DOI 10.1093/jxb/erl253; Inoue K, 2016, PLANT CELL, V28, P1406, DOI 10.1105/tpc.15.01063; Kamenetzky L, 2010, PLANT PHYSIOL, V152, P1772, DOI 10.1104/pp.109.150532; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Kidokoro S, 2009, PLANT PHYSIOL, V151, P2046, DOI 10.1104/pp.109.147033; Kumar I, 2016, J EXP BOT, V67, P4231, DOI 10.1093/jxb/erw217; Lee CM, 2012, P NATL ACAD SCI USA, V109, P15054, DOI 10.1073/pnas.1211295109; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Leivar P, 2014, PLANT CELL, V26, P56, DOI 10.1105/tpc.113.120857; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Lira BS, 2016, PLANT CELL PHYSIOL, V57, P642, DOI 10.1093/pcp/pcw021; Lira BS, 2014, GENE, V546, P359, DOI 10.1016/j.gene.2014.05.051; Liu YS, 2004, P NATL ACAD SCI USA, V101, P9897, DOI 10.1073/pnas.0400935101; Llorente B, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00263; Llorente B, 2016, PLANT J, V85, P107, DOI 10.1111/tpj.13094; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Melo NKG, 2016, PLANT PHYSIOL, V170, P2278, DOI 10.1104/pp.16.00023; Mohan V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152907; Monte E, 2004, P NATL ACAD SCI USA, V101, P16091, DOI 10.1073/pnas.0407107101; Moon J, 2008, P NATL ACAD SCI USA, V105, P9433, DOI 10.1073/pnas.0803611105; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pedmale UV, 2016, CELL, V164, P233, DOI 10.1016/j.cell.2015.12.018; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pires N, 2010, PLANT SIGNAL BEHAV, V5, P911, DOI 10.4161/psb.5.7.12100; Powell ALT, 2012, SCIENCE, V336, P1711, DOI 10.1126/science.1222218; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; Quadrana L, 2013, PLANT MOL BIOL, V81, P309, DOI 10.1007/s11103-012-0001-4; Rensing SA, 2014, CURR OPIN PLANT BIOL, V17, P43, DOI 10.1016/j.pbi.2013.11.002; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sakuraba Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5636; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Song Y, 2014, MOL PLANT, V7, P1776, DOI 10.1093/mp/ssu109; Soy J, 2014, J EXP BOT, V65, P2925, DOI 10.1093/jxb/ert465; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teufel AI, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0616-1; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Wang Y, 2008, GENETICS, V180, P391, DOI 10.1534/genetics.108.087981; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Weller JL, 2000, PLANT J, V24, P345, DOI 10.1046/j.1365-313x.2000.00879.x; Wilke T, 2009, AM MALACOL BULL, V27, P25, DOI 10.4003/006.027.0203; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060781, 10.1371/journal.pone.0053931, 10.1371/journal.pone.0061922]; Zhang YQ, 2015, PLANT SCI, V237, P57, DOI 10.1016/j.plantsci.2015.05.010	56	30	37	6	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165929	10.1371/journal.pone.0165929	http://dx.doi.org/10.1371/journal.pone.0165929			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802334	Green Published, gold			2022-12-27	WOS:000386714200070
J	Tibely, G; Sousa-Rodrigues, D; Pollner, P; Palla, G				Tibely, Gergely; Sousa-Rodrigues, David; Pollner, Peter; Palla, Gergely			Comparing the Hierarchy of Keywords in On-Line News Portals	PLOS ONE			English	Article							ONTOLOGIES; NETWORKS; DYNAMICS	Hierarchical organization is prevalent in networks representing a wide range of systems in nature and society. An important example is given by the tag hierarchies extracted from large on-line data repositories such as scientific publication archives, file sharing portals, blogs, on-line news portals, etc. The tagging of the stored objects with informative keywords in such repositories has become very common, and in most cases the tags on a given item are free words chosen by the authors independently. Therefore, the relations among keywords appearing in an on-line data repository are unknown in general. However, in most cases the topics and concepts described by these keywords are forming a latent hierarchy, with the more general topics and categories at the top, and more specialized ones at the bottom. There are several algorithms available for deducing this hierarchy from the statistical features of the keywords. In the present work we apply a recent, co-occurrence- based tag hierarchy extraction method to sets of keywords obtained from four different on-line news portals. The resulting hierarchies show substantial differences not just in the topics rendered as important (being at the top of the hierarchy) or of less interest (categorized low in the hierarchy), but also in the underlying network structure. This reveals discrepancies between the plausible keyword association frameworks in the studied news portals.	[Tibely, Gergely] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Sousa-Rodrigues, David] Open Univ, Fac Maths Comp & Technol, Design Grp, Walton Hall, Milton Keynes, Bucks, England; [Pollner, Peter; Palla, Gergely] Hungarian Acad Sci, MTA ELTE Stat & Biol Phys Res Grp, Budapest, Hungary	Eotvos Lorand University; Open University - UK; Hungarian Academy of Sciences	Tibely, G (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary.	tibelyg@hal.elte.hu	Tibely, Gergely/AAE-6348-2019; Palla, Gergely/H-1767-2016; Pollner, Peter/N-3975-2016; Rodrigues, David/E-7180-2010	Palla, Gergely/0000-0002-3406-4200; Pollner, Peter/0000-0003-0464-4893; Rodrigues, David/0000-0001-7512-7338	Hungarian National Science Fund/Orszagos Tudomanyos Kutatasi Alapprogramok [OTKA K105447]	Hungarian National Science Fund/Orszagos Tudomanyos Kutatasi Alapprogramok	The research was supported by the Hungarian National Science Fund/Orszagos Tudomanyos Kutatasi Alapprogramok, grant no. OTKA K105447 (httpllotkahu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi A.-L., 2016, NETWORK SCI; Batty M., 1994, FRACTAL CITIES A GEO; Brandenburg FJ, 2013, J COMB OPTIM, V26, P310, DOI 10.1007/s10878-012-9467-x; Cattuto C, 2007, P NATL ACAD SCI USA, V104, P1461, DOI 10.1073/pnas.0610487104; Cattuto C, 2009, P NATL ACAD SCI USA, V106, P10511, DOI 10.1073/pnas.0901136106; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Corominas-Murtra B, 2013, P NATL ACAD SCI USA, V110, P13316, DOI 10.1073/pnas.1300832110; Corominas-Murtra B, 2011, CHAOS, V21, DOI 10.1063/1.3562548; Czegel D, 2015, SCI REP-UK, V5, DOI 10.1038/srep17994; Damme C.V., 2007, SOC NETWORKS, V2, P57; Dorogovtsev SN, 2014, EVOLUTION OF NETWORK; Eldredge N., 1985, UNFINISHED SYNSIS; Fattore M, 2013, MULTI INDICATOR SYST, P69; Floeck F, 2010, ADV INTEL SOFT COMPU, V76, P75; Fushing H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017817; Goessmann C, 2000, BEHAV ECOL SOCIOBIOL, V48, P418, DOI 10.1007/s002650000222; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Heymann P., 2006, COLLABORATIVE CREATI; HIRATA H, 1985, J THEOR BIOL, V116, P321, DOI 10.1016/S0022-5193(85)80271-X; Juszczyszyn K, 2010, STUD COMPUT INTELL, V289, P275; Kaiser M., 2010, FRONT NEUROINFORM, V4, P112, DOI DOI 10.3389/FNINF.2010.00112; Krugman P, 1996, J JPN INT ECON, V10, P399, DOI 10.1006/jjie.1996.0023; Lambiotte R, 2006, LECT NOTES COMPUT SC, V3993, P1114; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; McShea DW, 2001, PALEOBIOLOGY, V27, P405, DOI 10.1666/0094-8373(2001)027<0405:THSOOA>2.0.CO;2; Mika P, 2005, LECT NOTES COMPUT SC, V3729, P522, DOI 10.1007/11574620_38; Mones E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033799; Nagy M, 2013, P NATL ACAD SCI USA, V110, P13049, DOI 10.1073/pnas.1305552110; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Palla G, 2015, PALGR COMMUN, V1, DOI 10.1057/palcomms.2015.16; Perotti JI, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062825; Plangprasopchok A., 2011, P 4 ACM WEB SEARCH D; Pollner P, 2006, EUROPHYS LETT, V73, P478, DOI 10.1209/epl/i2005-10414-6; Pumain D, 2006, METHODS SER, V3, P1, DOI 10.1007/1-4020-4127-6; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schmitz P, 2006, PROC OF COLLABORATIV; Spyns P, 2006, LECT NOTES COMPUT SC, V4275, P738; Tibely G, 2016, PARTIAL ORDER SIMILA; Tibely G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084133; Tibely G, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/053009; Valverde S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046118; Voss Jakob, 2007, TAGGING FOLKSONOMY C; WICKEN JS, 1988, J SOC BIOL STRUCT, V11, P369, DOI 10.1016/0140-1750(88)90066-8; Wimberley ET, 2009, NESTED ECOLOGY THE P; Zlatic V, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036118	47	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165728	10.1371/journal.pone.0165728	http://dx.doi.org/10.1371/journal.pone.0165728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802319	Green Published, Green Submitted, gold			2022-12-27	WOS:000386714200046
J	Lauritzen, HB; Larose, TL; Oien, T; Odland, JO; van de Bor, M; Jacobsen, GW; Sandanger, TM				Lauritzen, Hilde B.; Larose, Tricia L.; Oien, Torbjorn; Odland, Jon O.; van de Bor, Margot; Jacobsen, Geir W.; Sandanger, Torkjel M.			Factors Associated with Maternal Serum Levels of Perfluoroalkyl Substances and Organochlorines: A Descriptive Study of Parous Women in Norway and Sweden	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS PCBS; POLYFLUOROALKYL SUBSTANCES; PLASMA-CONCENTRATIONS; PREGNANT-WOMEN; HUMAN-MILK; PERFLUORINATED CHEMICALS; DIETARY EXPOSURE; BIRTH-WEIGHT; FETAL-GROWTH; TIME TRENDS	Introduction Perfluoroalkyl substances (PFASs) and organochlorines (OCs) are ubiquitous and persistent in the environment and proposed endocrine disrupting chemicals (EDCs). They can be transferred across the placenta during pregnancy, and studies suggest that the prenatal period may be particularly sensitive for influences on fetal growth and development. Several studies have investigated socio-demographic and pregnancy related factors associated with maternal serum PFAS and OC levels, but few studies have been conducted in time periods with increasing emissions of PFASs and recent emissions of OCs. Methods Serum from 424 pregnant women participating in the NICHD Scandinavian Successive Small-for-gestational Age (SGA) births study was collected in 1986-1988, and analyses of two PFASs and six OCs were conducted. Associations between EDCs and geographic, time dependent, socio-demographic and pregnancy related variables were evaluated by using multivariable linear regression models. Results Previous breastfeeding duration, time since last breastfeeding period, sampling date and country of residence were important factors associated with serum levels of PFOS and PFOA. Smoking status and pre-pregnancy BMI were negatively associated with PFOS, and maternal height was borderline negatively associated with PFOS and PFOA. Glomerular filtration rate (GFR) was negatively associated with PFOS in a sub-sample. Maternal serum levels of OCs were positively associated with maternal age, and negatively associated with previous breastfeeding duration and sampling date. Smoking had a consistently negative association with PCB 118 in a dose-dependent manner. Education level, pre-pregnancy BMI and alcohol consumption varied in importance according to the compound under study. Conclusions Several maternal factors, including potentially modifiable factors, markers of pregnancy physiology and factors also related to perinatal outcomes were associated with EDC levels. Results from this study are relevant to populations with still high PFAS and OC levels, i.e. developing countries. Moreover, we can use this knowledge about associated factors on emerging EDCs with similar properties.	[Lauritzen, Hilde B.; Larose, Tricia L.; Oien, Torbjorn; Jacobsen, Geir W.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Trondheim, Norway; [Odland, Jon O.; Sandanger, Torkjel M.] Arctic Univ Norway, Univ Tromso, Dept Community Med, Tromso, Norway; [van de Bor, Margot] Vrije Univ, Sect Hlth & Life Sci, Amsterdam, Netherlands; [Odland, Jon O.] Univ Pretoria, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa; [Sandanger, Torkjel M.] NILU Norwegian Inst Air Res, Tromso, Norway	Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; Vrije Universiteit Amsterdam; University of Pretoria; Norwegian Institute for Air Research	Lauritzen, HB (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Trondheim, Norway.	hilde.b.lauritzen@ntnu.no	Odland, Jon Oyvind/L-5096-2017	Odland, Jon Oyvind/0000-0002-2756-0732	Liaison Committee	Liaison Committee	This work was funded by grants from the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAP, 2015, AMAP ASS 2015 HUM HL; Apelberg BJ, 2007, ENVIRON HEALTH PERSP, V115, P1670, DOI 10.1289/ehp.10334; Bach CC, 2015, CRIT REV TOXICOL, V45, P53, DOI 10.3109/10408444.2014.952400; BAKKETEIG LS, 1993, ACTA OBSTET GYN SCAN, V72, P273, DOI 10.3109/00016349309068037; Barr DB, 2007, REPROD TOXICOL, V23, P260, DOI 10.1016/j.reprotox.2007.03.003; Berg V, 2015, ENVIRON INT, V77, P63, DOI 10.1016/j.envint.2015.01.007; Berg V, 2014, ENVIRON INT, V69, P58, DOI 10.1016/j.envint.2014.04.010; Boekelheide K, 2012, ENVIRON HEALTH PERSP, V120, P1353, DOI 10.1289/ehp.1204934; Brantsaeter AL, 2013, ENVIRON INT, V54, P74, DOI 10.1016/j.envint.2012.12.014; Brouwer A, 1999, ENVIRON HEALTH PERSP, V107, P639, DOI 10.2307/3434557; Butenhoff JL, 2006, ENVIRON HEALTH PERSP, V114, P1776, DOI 10.1289/ehp.9060; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Covaci A, 2006, SCI TOTAL ENVIRON, V366, P361, DOI 10.1016/j.scitotenv.2006.03.006; Deutch B, 2003, ARCH ENVIRON HEALTH, V58, P30, DOI 10.3200/AEOH.58.1.30-36; Dewailly E, 1999, ENVIRON HEALTH PERSP, V107, P823, DOI 10.2307/3454581; Dirtu AC, 2013, ENVIRON SCI TECHNOL, V47, P12441, DOI 10.1021/es400657t; Domingo JL, 2012, ENVIRON INT, V40, P187, DOI 10.1016/j.envint.2011.08.001; Faniband M, 2014, ASIAN J ANDROL, V16, P5, DOI 10.4103/1008-682X.122197; Faupel-Badger JM, 2007, CANCER EPIDEM BIOMAR, V16, P1720, DOI 10.1158/1055-9965.EPI-07-0311; Fei CY, 2007, ENVIRON HEALTH PERSP, V115, P1677, DOI 10.1289/ehp.10506; Glynn A, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-2; Glynn A, 2012, ENVIRON SCI TECHNOL, V46, P9071, DOI 10.1021/es301168c; Govarts E, 2012, ENVIRON HEALTH PERSP, V120, P162, DOI 10.1289/ehp.1103767; Grandjean P, 2008, BASIC CLIN PHARMACOL, V102, P94, DOI 10.1111/j.1742-7843.2007.00167.x; Gyllenhammar I, 2015, ENVIRON RES, V140, P673, DOI 10.1016/j.envres.2015.05.019; Hagmar L, 2006, CHEMOSPHERE, V64, P1507, DOI 10.1016/j.chemosphere.2005.12.054; Halldorsson TI, 2008, ENVIRON SCI TECHNOL, V42, P8971, DOI 10.1021/es801907r; Hansen S, 2014, ENVIRON INT, V68, P41; Hanssen L, 2013, SCI TOTAL ENVIRON, V447, P430, DOI 10.1016/j.scitotenv.2013.01.029; Hardell E, 2010, SCI TOTAL ENVIRON, V408, P4412, DOI 10.1016/j.scitotenv.2010.06.029; HOVINGA ME, 1992, ARCH ENVIRON CON TOX, V22, P362, DOI 10.1007/BF00212554; Kato K, 2014, ENVIRON SCI TECHNOL, V48, P9600, DOI 10.1021/es501811k; Kato K, 2011, ENVIRON SCI TECHNOL, V45, P8037, DOI 10.1021/es1043613; Kim SK, 2011, ENVIRON POLLUT, V159, P169, DOI 10.1016/j.envpol.2010.09.008; Koetje PMJL, 2011, REPROD SCI, V18, P456, DOI 10.1177/1933719110387831; KOOPMANESSEBOOM C, 1994, CHEMOSPHERE, V28, P1721, DOI 10.1016/0045-6535(94)90428-6; Lackmann Gerd-Michael, 2006, Int J Biomed Sci, V2, P178; Laden F, 1999, ENVIRON HEALTH PERSP, V107, P75, DOI 10.2307/3434292; Larsen JC, 2006, MOL NUTR FOOD RES, V50, P885, DOI 10.1002/mnfr.200500247; Lee DH, 2014, ENDOCR REV, V35, P557, DOI 10.1210/er.2013-1084; Lehmler HJ, 2005, CHEMOSPHERE, V58, P1471, DOI 10.1016/j.chemosphere.2004.11.078; Lim JS, 2011, INT J OBESITY, V35, P744, DOI 10.1038/ijo.2010.188; Milbrath MO, 2009, ENVIRON HEALTH PERSP, V117, P417, DOI 10.1289/ehp.11781; Morken NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101897; Natland ST, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-179; Nost TH, 2014, ENVIRON INT, V67, P43, DOI 10.1016/j.envint.2014.02.011; Nost TH, 2013, ENVIRON HEALTH PERSP, V121, P1292, DOI 10.1289/ehp.1206317; Ode A, 2013, ENVIRON SCI POLLUT R, V20, P7970, DOI 10.1007/s11356-013-1573-5; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; PHILLIPS DL, 1989, ARCH ENVIRON CON TOX, V18, P495, DOI 10.1007/BF01055015; Powley CR, 2005, ANAL CHEM, V77, P6353, DOI 10.1021/ac0508090; Richardson DB, 2007, EPIDEMIOLOGY, V18, P441, DOI 10.1097/EDE.0b013e318060d25c; ROGAN WJ, 1986, AM J PUBLIC HEALTH, V76, P172, DOI 10.2105/AJPH.76.2.172; Rylander L, 1997, SCI TOTAL ENVIRON, V207, P55, DOI 10.1016/S0048-9697(97)00245-3; Sagiv SK, 2015, ENVIRON SCI TECHNOL, V49, P11849, DOI 10.1021/acs.est.5b02489; Sandanger TM, 2003, J ENVIRON MONITOR, V5, P689, DOI 10.1039/b302025h; Sandanger TM, 2007, ENVIRON HEALTH PERSP, V115, P1429, DOI 10.1289/ehp.10303; SVENSSON BG, 1995, SCAND J WORK ENV HEA, V21, P96, DOI 10.5271/sjweh.16; Uehara R, 2007, CHEMOSPHERE, V68, P915, DOI 10.1016/j.chemosphere.2007.01.050; van den Berg M, 2017, ARCH TOXICOL, V91, P83, DOI 10.1007/s00204-016-1802-z; Verner MA, 2015, ENVIRON HEALTH PERSP, V123, P1317, DOI 10.1289/ehp.1408837; Vestergren R, 2012, ENVIRON INT, V49, P120, DOI 10.1016/j.envint.2012.08.016; WHO/UNEP, 2013, TOXICOL LETT, DOI DOI 10.1016/J.TOXLET.2012.03.020; Wolff MS, 2007, CANCER EPIDEM BIOMAR, V16, P1925, DOI 10.1158/1055-9965.EPI-07-0394	64	28	28	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166127	10.1371/journal.pone.0166127	http://dx.doi.org/10.1371/journal.pone.0166127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824939	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200063
J	Lee, SY; Oh, SJ; Kim, EJ; Oum, CY; Park, SH; Oh, J; Kim, JS; Kim, BK; Park, S; Chang, HJ; Hong, GR; Ko, YG; Kang, SM; Choi, D; Ha, JW; Hong, MK; Jang, Y; Chung, N; Lee, SH				Lee, Soo Youn; Oh, Seung-Jin; Kim, Eung Ju; Oum, Chi-Yoon; Park, Sung Hwan; Oh, Jaewon; Kim, Jung-Sun; Kim, Byeong-Keuk; Park, Sungha; Chang, Hyuk-Jae; Hong, Geu-Ru; Ko, Young-Guk; Kang, Seok-Min; Choi, Donghoon; Ha, Jong-Won; Hong, Myeong-Ki; Jang, Yangsoo; Chung, Namsik; Lee, Sang-Hak			Statin Intensity and Clinical Outcome in Patients with Stable Coronary Artery Disease and Very Low LDL-Cholesterol	PLOS ONE			English	Article							TRIAL; THERAPY	Background Although intensive statin therapy is recommended for high risk patients, evidence of its benefit in patients with stable coronary artery disease (CAD) and very low low-density lipoprotein-cholesterol (LDL-C) has been very rare. In this study, we investigated whether higher statin intensity reduces cardiovascular risks in this population. Methods In this retrospective study, a total of 5234 patients with stable CAD were screened at three tertiary hospitals in Korea; 449 patients (mean age: 65 years, male: 69%) with LDL-C <80 mg/dL were finally analyzed. The statin intensities were classified according to the 2013 American College of Cardiology/American Heart Association guidelines. Patients who received statins equivalent to or weaker than atorvastatin 10 mg (group 1) were compared with those who took statins equivalent to or stronger than atorvastatin 20 mg (group 2). The impact of statin intensity on major adverse cardiac events (MACE) was evaluated during follow-up. Results Group 1 and group 2 consisted of 181 patients (40.3%) and 268 patients (59.7%), respectively. The mean LDL-C level decreased to 52 and 57 mg/dL in group 1 and group 2, respectively, during follow-up. In a median follow-up of 4.5 years, patients of group 2 had a lower incidence of MACE (30 [16.6%] vs. 12 [4.5%], p < 0.001), which were mostly related to a lower incidence of coronary revascularization. Cox proportional hazard analyses identified the statin intensity of group 2 (adjusted hazard ratio: 0.25, confidence interval: 0.11-0.55, p < 0.001) and the baseline high-density lipoprotein-cholesterol level as independent determinants of MACE. Conclusion This study provides evidence that higher intensity statins are beneficial for cardiovascular outcomes in patients with stable CAD and very low LDL-C. Statins equivalent to or stronger than atorvastatin 20 mg are more effective than lower intensity statins.	[Lee, Soo Youn; Oh, Jaewon; Kim, Jung-Sun; Kim, Byeong-Keuk; Park, Sungha; Chang, Hyuk-Jae; Hong, Geu-Ru; Ko, Young-Guk; Kang, Seok-Min; Choi, Donghoon; Ha, Jong-Won; Hong, Myeong-Ki; Jang, Yangsoo; Chung, Namsik; Lee, Sang-Hak] Yonsei Univ, Severance Hosp, Div Cardiol, Coll Med,Dept Internal Med, Seoul, South Korea; [Lee, Soo Youn; Oh, Jaewon; Kim, Jung-Sun; Kim, Byeong-Keuk; Park, Sungha; Chang, Hyuk-Jae; Hong, Geu-Ru; Ko, Young-Guk; Kang, Seok-Min; Choi, Donghoon; Ha, Jong-Won; Hong, Myeong-Ki; Jang, Yangsoo; Chung, Namsik; Lee, Sang-Hak] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea; [Oh, Seung-Jin] NHIS Ilsan Hosp, Div Cardiol, Dept Internal Med, Goyang, South Korea; [Kim, Eung Ju] Korea Univ, Dept Cardiol, Ctr Cardiovasc, Guro Hosp, Seoul, South Korea; [Oum, Chi-Yoon; Park, Sung Hwan] Yonsei Univ, Grad Sch, Dept Biostat & Comp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; National Health Insurance Service; NHIS Ilsan Hospital; Korea University; Korea University Medicine (KU Medicine); Yonsei University	Lee, SH (corresponding author), Yonsei Univ, Severance Hosp, Div Cardiol, Coll Med,Dept Internal Med, Seoul, South Korea.; Lee, SH (corresponding author), Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea.	shl1106@yuhs.ac		Kim, Jung-Sun/0000-0003-2263-3274; Kim, Byeong-Keuk/0000-0003-2493-066X; Chang, Hyuk-Jae/0000-0002-6139-7545; Choi, Donghoon/0000-0002-2009-9760; Hong, Myeong-Ki/0000-0002-2090-2031; Kim, Eung Ju/0000-0003-2322-6267; Jang, Yangsoo/0000-0002-2169-3112; Ko, Young-Guk/0000-0001-7748-5788; Hong, Geu-Ru/0000-0003-4981-3304; Ha, Jong-Won/0000-0002-8260-2958; Kang, Seok-Min/0000-0001-9856-9227; Oh, Jaewon/0000-0002-4585-1488; Park, Sungha/0000-0001-5362-478X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2012R1A4A1029061, 2014R1A1A2056104]; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [2015M3A9B6029138]; National Research Council of Science & Technology (NST) grant by the Korean government (MSIP) [CAP-12-2-KBSI]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP; National Research Council of Science & Technology (NST) grant by the Korean government (MSIP)	This research was financially supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2012R1A4A1029061 and 2014R1A1A2056104), the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (2015M3A9B6029138), and the National Research Council of Science & Technology (NST) grant by the Korean government (MSIP) (No. CAP-12-2-KBSI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Heo JH, 2016, J STROKE, V18, P87, DOI 10.5853/jos.2015.01578; Jang JY, 2015, KOREAN CIRC J, V45, P225, DOI 10.4070/kcj.2015.45.3.225; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Natsuaki M, 2012, CIRC J, V76, P1369, DOI 10.1253/circj.CJ-11-1356; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Robinson JG, 2006, AM J CARDIOL, V98, P1405, DOI 10.1016/j.amjcard.2006.06.039; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Son Ho-Young, 2008, Korean Journal of Internal Medicine, V23, P22; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a	16	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166246	10.1371/journal.pone.0166246	http://dx.doi.org/10.1371/journal.pone.0166246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824924	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200077
J	Patankar, HV; Assaha, DVM; Al-Yahyai, R; Sunkar, R; Yaish, MW				Patankar, Himanshu V.; Assaha, Dekoum V. M.; Al-Yahyai, Rashid; Sunkar, Ramanjulu; Yaish, Mahmoud W.			Identification of Reference Genes for Quantitative Real-Time PCR in Date Palm (Phoenix dactylifera L.) Subjected to Drought and Salinity	PLOS ONE			English	Article							HOUSEKEEPING GENES; RT-PCR; INTERNAL CONTROL; SALT-TOLERANCE; NORMALIZATION; EXPRESSION; STRESS; VALIDATION; AQUAPORINS; RESPONSES	Date palm is an important crop plant in the arid and semi-arid regions supporting human population in the Middle East and North Africa. These areas have been largely affected by drought and salinity due to insufficient rainfall and improper irrigation practices. Date palm is a relatively salt-and drought-tolerant plant and more recently efforts have been directed to identifying genes and pathways that confer stress tolerance in this species. Quantitative real-time PCR (qPCR) is a promising technique for the analysis of stress-induced differential gene expression, which involves the use of stable reference genes for normalizing gene expression. In an attempt to find the best reference genes for date palm's drought and salinity research, we evaluated the stability of 12 most commonly used reference genes using the geNorm, NormFinder, BestKeeper statistical algorithms and the comparative.CT method. The comprehensive results revealed that HEAT SHOCK PROTEIN (HSP), UBIQUITIN (UBQ) and YTH domain-containing family protein (YT521) were stable in drought-stressed leaves whereas GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (GAPDH), ACTIN and TUBULIN were stable in drought-stressed roots. On the other hand, SMALL SUBUNIT RIBOSOMAL RNA (25S), YT521 and 18S ribosomal RNA (18S); and UBQ, ACTIN and ELONGATION FACTOR 1-ALPHA (eEF1a) were stable in leaves and roots, respectively, under salt stress. The stability of these reference genes was verified by using the abiotic stress-responsive CYTOSOLIC Cu/Zn SUPEROXIDE DISMUTASE (Cyt-Cu/Zn SOD), an ABA RECEPTOR, and a PROLINE TRANSPORTER 2 (PRO) genes. A combination of top 2 or 3 stable reference genes were found to be suitable for normalization of the target gene expression and will facilitate gene expression analysis studies aimed at identifying functional genes associated with drought and salinity tolerance in date palm.	[Patankar, Himanshu V.; Assaha, Dekoum V. M.; Yaish, Mahmoud W.] Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman; [Al-Yahyai, Rashid] Sultan Qaboos Univ, Dept Crop Sci, Coll Agr & Marine Sci, Muscat, Oman; [Sunkar, Ramanjulu] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Sultan Qaboos University; Sultan Qaboos University; Oklahoma State University System; Oklahoma State University - Stillwater	Yaish, MW (corresponding author), Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman.	myaish@squ.edu.om	Patankar, Himanshu/L-9643-2019; Al-Yahyai, Rashid/B-9273-2011; Yaish, Mahmoud W/F-7168-2014; Assaha, Dekoum/AAM-3386-2020	Patankar, Himanshu/0000-0001-6739-2895; Al-Yahyai, Rashid/0000-0001-7628-6218; Yaish, Mahmoud W/0000-0002-5171-3014; Assaha, Dekoum/0000-0001-8352-8000	Research Council of Oman [151]	Research Council of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman)	Support was provided by The Research Council of Oman number 151.	Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Al-Mssallem IS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3274; Al-Yahyai R., 2015, DATE PALM GENETIC RE, P207, DOI [10.1007/978-94-017-9707-8_6, DOI 10.1007/978-94-017-9707-8_6]; Amil-Ruiz F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070603; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chao CT, 2007, HORTSCIENCE, V42, P1077, DOI 10.21273/HORTSCI.42.5.1077; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; El-Juhany L.I., 2010, AUST J BASIC APPL SC, V4, P3998, DOI DOI 10.1016/J.RADPHYSCHEM.2006.10.004; Ellis Danielle R., 2004, BMC Plant Biology, V4, P1, DOI 10.1186/1471-2229-4-1; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Gargouri-Bouzid R, 2009, MOL BIOTECHNOL, V41, P63, DOI [10.1007/s12033-008-9104-1, DOI 10.1007/S12033-008-914-1]; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Hazzouri KM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9824; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Liu CL, 2012, EXTREMOPHILES, V16, P419, DOI 10.1007/s00792-012-0441-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maathuis FJM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00467; Malash NM, 2008, IRRIGATION SCI, V26, P313, DOI 10.1007/s00271-007-0095-7; Mathur P. B., 2004, International Arachis Newsletter, P33; Maurel C, 2002, INT REV CYTOL, V215, P105; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radwan O, 2015, TROP PLANT BIOL, V8, P74, DOI 10.1007/s12042-015-9155-y; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Sah SK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00571; Saha P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106308; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sinha P, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.2015.01071, 10.3389/fpls.2015.01065]; Sinha P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122847; STANGER G, 1985, AGR WATER MANAGE, V9, P269, DOI 10.1016/0378-3774(85)90038-1; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wang X, 2015, MOLECULES, V20, P4833, DOI 10.3390/molecules20034833; Wen LZ, 2018, CANCER RES, V78, P4680, DOI 10.1158/0008-5472.CAN-17-3896; Xiao Y, 2012, PLANT OMICS, V5, P584; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yaish MW, 2015, GENET MOL RES, V14, P9943, DOI 10.4238/2015.August.19.30; Yaish MW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00946; Yaish MW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00348; Yang ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119569; Zhao TJ, 2006, J BIOL CHEM, V281, P10752, DOI 10.1074/jbc.M510535200; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	52	17	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166216	10.1371/journal.pone.0166216	http://dx.doi.org/10.1371/journal.pone.0166216			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824922	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200072
J	Vesselinova, N; Alexandrov, BS; Wall, ME				Vesselinova, Neda; Alexandrov, Boian S.; Wall, Michael E.			Dynamical Model of Drug Accumulation in Bacteria: Sensitivity Analysis and Experimentally Testable Predictions	PLOS ONE			English	Article							ESCHERICHIA-COLI; EFFLUX; RESISTANCE; PERMEABILITY; SPECIFICITY; AGENTS	We present a dynamical model of drug accumulation in bacteria. The model captures key features in experimental time courses on ofloxacin accumulation: initial uptake; two-phase response; and long-term acclimation. In combination with experimental data, the model provides estimates of import and export rates in each phase, the time of entry into the second phase, and the decrease of internal drug during acclimation. Global sensitivity analysis, local sensitivity analysis, and Bayesian sensitivity analysis of the model provide information about the robustness of these estimates, and about the relative importance of different parameters in determining the features of the accumulation time courses in three different bacterial species: Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. The results lead to experimentally testable predictions of the effects of membrane permeability, drug efflux and trapping (e.g., by DNA binding) on drug accumulation. A key prediction is that a sudden increase in ofloxacin accumulation in both E. coli and S. aureus is accompanied by a decrease in membrane permeability.	[Vesselinova, Neda; Alexandrov, Boian S.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Vesselinova, Neda] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Wall, Michael E.] Los Alamos Natl Lab, Comp Computat & Stat Sci Div, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Los Alamos National Laboratory	Wall, ME (corresponding author), Los Alamos Natl Lab, Comp Computat & Stat Sci Div, Los Alamos, NM 87545 USA.	mewall@lanl.gov	Alexandrov, Boian/D-2488-2010	Alexandrov, Boian/0000-0001-8636-4603; Wall, Michael/0000-0003-1000-688X	US Department of Energy [DE-AC52-06NA25396]	US Department of Energy(United States Department of Energy (DOE))	This study was supported by the US Department of Energy under Contract DE-AC52-06NA25396 through the Laboratory-Directed Research and Development Program at Los Alamos National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the reviewers for their comments, which led to substantial improvements in the paper. This study was performed under the auspices of the Laboratory-Directed Research and Development Program at Los Alamos National Laboratory, which is managed for the US Department of Energy by Los Alamos National Security, LLC under contract DE-AC52-06NA25396.	ASUQUO AE, 1993, J ANTIMICROB CHEMOTH, V31, P865, DOI 10.1093/jac/31.6.865; BRATBAK G, 1984, APPL ENVIRON MICROB, V48, P755, DOI 10.1128/AEM.48.4.755-757.1984; Brown DG, 2014, J MED CHEM, V57, P10144, DOI 10.1021/jm501552x; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Campos M, 2014, CELL, V159, P1433, DOI 10.1016/j.cell.2014.11.022; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; DIVER JM, 1990, J ANTIMICROB CHEMOTH, V25, P319, DOI 10.1093/jac/25.3.319; Gustafson P, 1995, BAYESIAN STAT, V5, P631; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Kourtesi Christina, 2013, Open Microbiol J, V7, P34, DOI 10.2174/1874285801307010034; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Lim SP, 2010, ANTIMICROB AGENTS CH, V54, P1800, DOI 10.1128/AAC.01714-09; Nagano K, 2009, P NATL ACAD SCI USA, V106, P5854, DOI 10.1073/pnas.0901695106; NIKAIDO H, 1987, MOL MICROBIOL, V1, P29, DOI 10.1111/j.1365-2958.1987.tb00523.x; NIKAIDO H, 1993, ANTIMICROB AGENTS CH, V37, P1393, DOI 10.1128/AAC.37.7.1393; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Oakley JE, 2004, J R STAT SOC B, V66, P751, DOI 10.1111/j.1467-9868.2004.05304.x; SALTELLI A, 1993, COMPUT STAT DATA AN, V15, P211, DOI 10.1016/0167-9473(93)90193-W; Saltelli A., 2008, GLOBAL SENSITIVITY A; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Savageau M.A., 2013, QUANTITATIVE BIOL MO, P23; SHEN LL, 1989, BIOCHEMISTRY-US, V28, P3879, DOI 10.1021/bi00435a038; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sobol I.M., 1990, MAT MODEL, V2, P112, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; SOBOL IM, 1993, COMP MATH MATH PHYS+, V33, P1391; THANASSI DG, 1995, J BACTERIOL, V177, P998, DOI 10.1128/jb.177.4.998-1007.1995; Vasquez-Laslop N, 2001, J BACTERIOL, V183, P2399, DOI 10.1128/JB.183.8.2399-2404.2001; Vihola M, 2012, STAT COMPUT, P22; Weiss R, 1996, J ROY STAT SOC B MET, V58, P739	29	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165899	10.1371/journal.pone.0165899	http://dx.doi.org/10.1371/journal.pone.0165899			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824914	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200041
J	Yao, W; Wu, FG; Zhang, X; Zheng, ZM; Wang, Z; Wang, WH; Qiu, WJ				Yao, Wang; Wu, Faguo; Zhang, Xiao; Zheng, Zhiming; Wang, Zhao; Wang, Wenhua; Qiu, Wangjie			A Fast Color Image Encryption Algorithm Using 4-Pixel Feistel Structure	PLOS ONE			English	Article							CHAOTIC MAP; SCHEME; CRYPTOSYSTEM; PERMUTATION; TRANSFORM; SYSTEMS	Algorithms using 4-pixel Feistel structure and chaotic systems have been shown to resolve security problems caused by large data capacity and high correlation among pixels for color image encryption. In this paper, a fast color image encryption algorithm based on the modified 4-pixel Feistel structure and multiple chaotic maps is proposed to improve the efficiency of this type of algorithm. Two methods are used. First, a simple round function based on a piecewise linear function and tent map are used to reduce computational cost during each iteration. Second, the 4-pixel Feistel structure reduces round number by changing twist direction securely to help the algorithm proceed efficiently. While a large number of simulation experiments prove its security performance, additional special analysis and a corresponding speed simulation show that these two methods increase the speed of the proposed algorithm (0.15s for a 256*256 color image) to twice that of an algorithm with a similar structure (0.37s for the same size image). Additionally, the method is also faster than other recently proposed algorithms.	[Yao, Wang; Wu, Faguo; Zhang, Xiao; Zheng, Zhiming; Wang, Zhao] Minist Educ, Key Lab Math Informat & Behav Semant, Beijing 100191, Peoples R China; [Yao, Wang; Wu, Faguo; Zhang, Xiao; Zheng, Zhiming] Beihang Univ, Sch Math & Syst Sci, Beijing 100191, Peoples R China; [Wang, Zhao] Beihang Univ, Sinofrench Engineer Sch, Ecole Cent Pekin, Beijing 100191, Peoples R China; [Wang, Wenhua] AVIC Econ & Technol Res Estab, Beijing 100029, Peoples R China; [Qiu, Wangjie] Minist Educ, Educ Equipment Res & Dev Ctr, Beijing 100080, Peoples R China	Beihang University; Beihang University; Aviation Industry Corporation of China (AVIC)	Zhang, X; Zheng, ZM (corresponding author), Minist Educ, Key Lab Math Informat & Behav Semant, Beijing 100191, Peoples R China.; Zhang, X; Zheng, ZM (corresponding author), Beihang Univ, Sch Math & Syst Sci, Beijing 100191, Peoples R China.	09621@buaa.edu.cn; zzheng@pku.edu.cn			Major Program of National Natural Science Foundation of China [11290141]; National Natural Science Foundation of China [61402030]; Fundamental Research of Civil Aircraft [MJ-F-2012-04]	Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research of Civil Aircraft	This work is supported by Major Program of National Natural Science Foundation of China (11290141), National Natural Science Foundation of China (61402030), and Fundamental Research of Civil Aircraft no. MJ-F-2012-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by Major Program of National Natural Science Foundation of China (11290141), NSFC(61402030), Fundamental Research of Civil Aircraft no. MJ-F-2012-04.	Chen GR, 2004, CHAOS SOLITON FRACT, V21, P749, DOI 10.1016/j.chaos.2003.12.022; Fu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115773; Fu C, 2013, COMPUT BIOL MED, V43, P1000, DOI 10.1016/j.compbiomed.2013.05.005; Gao HJ, 2006, CHAOS SOLITON FRACT, V29, P393, DOI 10.1016/j.chaos.2005.08.110; Hussain I, 2014, J VIB CONTROL, V20, P2133, DOI 10.1177/1077546313482960; Jiang X, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013022; Kanso A, 2012, COMMUN NONLINEAR SCI, V17, P2943, DOI 10.1016/j.cnsns.2011.11.030; Lang J, 2015, OPT COMMUN, V338, P181, DOI 10.1016/j.optcom.2014.10.049; Liu HJ, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/567898; Liu HJ, 2015, SIGNAL PROCESS, V113, P104, DOI 10.1016/j.sigpro.2015.01.016; Liu HJ, 2010, COMPUT MATH APPL, V59, P3320, DOI 10.1016/j.camwa.2010.03.017; Mao YB, 2004, INT J BIFURCAT CHAOS, V14, P3613, DOI 10.1142/S021812740401151X; Matthews R., 1984, CRYPTOLOGIA, V8, P29; Mirzaei O, 2012, NONLINEAR DYNAM, V67, P557, DOI 10.1007/s11071-011-0006-6; Mohamed FK, 2014, OPT LASER TECHNOL, V64, P145, DOI 10.1016/j.optlastec.2014.05.012; Murillo-Escobar MA, 2015, SIGNAL PROCESS, V109, P119, DOI 10.1016/j.sigpro.2014.10.033; Ozturk I, 2015, NONLINEAR DYNAM, V80, P1147, DOI 10.1007/s11071-015-1932-5; Pareek NK, 2006, IMAGE VISION COMPUT, V24, P926, DOI 10.1016/j.imavis.2006.02.021; Patidar V, 2009, COMMUN NONLINEAR SCI, V14, P3056, DOI 10.1016/j.cnsns.2008.11.005; Ping P, 2014, SIGNAL PROCESS, V105, P419, DOI 10.1016/j.sigpro.2014.06.020; Ragulskis M, 2012, COMMUN NONLINEAR SCI, V17, P4304, DOI 10.1016/j.cnsns.2012.03.017; Shuang-Shuang H., 2014, TELKOMNIKA INDONES J, V12, P685, DOI DOI 10.11591/TELK0MNIKA.V12I1.3204; Som S, 2015, NONLINEAR DYNAM, V80, P615, DOI 10.1007/s11071-015-1893-8; Sun YY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084655, 10.1371/journal.pone.0086232]; Tang ST, 2015, PHYSICA A, V432, P363, DOI 10.1016/j.physa.2015.03.046; Tong XJ, 2015, NONLINEAR DYNAM, V80, P1493, DOI 10.1007/s11071-015-1957-9; Tong XJ, 2016, NONLINEAR DYNAM, V84, P2333, DOI 10.1007/s11071-016-2648-x; Wang K, 2005, PHYS LETT A, V343, P432, DOI 10.1016/j.physleta.2005.05.040; Wang XY, 2015, OPT COMMUN, V342, P51, DOI 10.1016/j.optcom.2014.12.043; Wang XY, 2012, SIGNAL PROCESS, V92, P1101, DOI 10.1016/j.sigpro.2011.10.023; Wang XY, 2011, NONLINEAR DYNAM, V63, P587, DOI 10.1007/s11071-010-9821-4; Wu JH, 2014, OPTIK, V125, P4474, DOI 10.1016/j.ijleo.2014.02.026; Wu XJ, 2016, INFORM SCIENCES, V349, P137, DOI 10.1016/j.ins.2016.02.041; Wu XJ, 2014, COMMUN NONLINEAR SCI, V19, P1884, DOI 10.1016/j.cnsns.2013.10.025; Xiang T, 2006, PHYS LETT A, V349, P109, DOI 10.1016/j.physleta.2005.02.083; Yao W, 2015, NONLINEAR DYNAM, V81, P151, DOI 10.1007/s11071-015-1979-3; Zhang LB, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/913476; Zhou Q, 2008, CHAOS SOLITON FRACT, V38, P1081, DOI 10.1016/j.chaos.2007.01.034	38	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165937	10.1371/journal.pone.0165937	http://dx.doi.org/10.1371/journal.pone.0165937			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824894	Green Submitted, Green Published, gold			2022-12-27	WOS:000387615200047
J	Kamura, Y; Iwata, M; Maede, S; Shinmura, S; Koshimizu, Y; Honoki, H; Fukuda, K; Ishiki, M; Usui, I; Fukushima, Y; Takano, A; Kato, H; Murakami, S; Higuchi, K; Kobashi, C; Tobe, K				Kamura, Yutaka; Iwata, Minoru; Maede, Shiro; Shinmura, Satomi; Koshimizu, Yukiko; Honoki, Hisae; Fukuda, Kazuhito; Ishiki, Manabu; Usui, Isao; Fukushima, Yasuo; Takano, Atsuko; Kato, Hiromi; Murakami, Shihou; Higuchi, Kiyohiro; Kobashi, Chikaaki; Tobe, Kazuyuki			FTO Gene Polymorphism Is Associated with Type 2 Diabetes through Its Effect on Increasing the Maximum BMI in Japanese Men	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OBESITY-ASSOCIATED GENE; BODY-FAT DISTRIBUTION; WEIGHT-GAIN; EARLY-ONSET; RISK; MASS; VARIANT; GENOTYPE; CHILDREN	Aim Several studies have demonstrated that polymorphisms within the fat-mass and obesity-associated gene (FTO) are associated with type 2 diabetes (T2D). However, whether the effects of the FTO locus on T2D susceptibility are independent of fat-mass increases remains controversial. To investigate this issue, we examined the association of FTO variants with T2D and various aspects of BMI history during adult life in a Japanese population. Methods We genotyped SNPs within FTO (rs1121980 and rs1558902) in 760 Japanese patients with T2D who had reached a lifetime maximum BMI (BMImax) before or at the time of diagnosis and 693 control individuals with information regarding their BMImax. Results The BMImax showed the strongest association with T2D risk among the BMIs evaluated in this study. In the sex-combined analysis, FTO SNPs were not associated with any of the BMI variables or with T2D, but in sex-stratified analyses, both SNPs were significantly associated with the BMImax and rs1558902 was associated with T2D in men. The association of the SNPs with T2D remained significant after adjustments for the current BMI and age, whereas the T2D association of the SNP was no longer significant after adjustments for BMImax and age. Conclusions These results suggest that the effects of FTO polymorphisms on T2D susceptibility in Japanese men are mediated through their effect on increasing the BMImax before or at the time of diagnosis.	[Kamura, Yutaka; Iwata, Minoru; Shinmura, Satomi; Koshimizu, Yukiko; Honoki, Hisae; Fukuda, Kazuhito; Ishiki, Manabu; Usui, Isao; Tobe, Kazuyuki] Toyama Univ, Fac Med, Dept Internal Med 1, Toyama, Japan; [Iwata, Minoru] Toyama Univ, Hlth Adm Ctr, Toyama, Japan; [Maede, Shiro] RIKEN Ctr Genom Med, Lab Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Maede, Shiro] Univ Ryukyus, Grad Sch Med, Dept Adv Genom & Lab Med, Okinawa, Japan; [Maede, Shiro] Univ Ryukyus Hosp, Div Clin Lab & Blood Transfus, Okinawa, Japan; [Fukushima, Yasuo] Asahi Gen Hosp, Dept Internal Med, Asahi, Toyama, Japan; [Takano, Atsuko] Saiseikai Takaoka Hosp, Dept Internal Med, Div Endocrinol & Metab, Takaoka, Toyama, Japan; [Kato, Hiromi] Takaoka Fushiki Hosp, Japan Community Hlth Care Org, Dept Internal Med, Div Endocrinol & Metab, Takaoka, Toyama, Japan; [Murakami, Shihou] Toyama Rosai Hosp, Dept Internal Med, Div Endocrinol & Metab, Uozu, Toyama, Japan; [Higuchi, Kiyohiro] Kouseiren Itoigawa Gen Hosp, Dept Internal Med, Itoigawa, Niigata, Japan; [Kobashi, Chikaaki] Kamiichi Gen Hosp, Dept Internal Med, Kamiichi, Toyama, Japan	University of Toyama; University of Toyama; RIKEN; University of the Ryukyus; University of the Ryukyus	Iwata, M (corresponding author), Toyama Univ, Fac Med, Dept Internal Med 1, Toyama, Japan.; Iwata, M (corresponding author), Toyama Univ, Hlth Adm Ctr, Toyama, Japan.	iwamino-tym@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24510276]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (approved number 24510276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; Aschard H, 2015, AM J HUM GENET, V96, P329, DOI 10.1016/j.ajhg.2014.12.021; CASEY VA, 1991, AM J CLIN NUTR, V53, P1493, DOI 10.1093/ajcn/53.6.1493; CLINE MG, 1989, HUM BIOL, V61, P415; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; FUJIMOTO WY, 1991, INT J OBESITY, V15, P111; Gavin JR, 1999, DIABETES CARE, V22, pS5; Han LY, 2014, BIOMED REP, V2, P681, DOI 10.3892/br.2014.293; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Hertel JK, 2011, DIABETES, V60, P1637, DOI 10.2337/db10-1340; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Horikawa Y, 2008, J CLIN ENDOCR METAB, V93, P3136, DOI 10.1210/jc.2008-0452; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Iwata M, 2012, DIABETES CARE, V35, P1763, DOI 10.2337/dc11-2006; Jacobsson JA, 2008, BIOCHEM BIOPH RES CO, V368, P476, DOI 10.1016/j.bbrc.2008.01.087; Jacobsson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020158; KADOWAKI T, 1984, DIABETOLOGIA, V26, P44, DOI 10.1007/BF00252262; Karasawa S, 2010, ENDOCR J, V57, P293, DOI 10.1507/endocrj.K09E-305; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Kring SII, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002958; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Liu Y, 2010, OBESITY, V18, P1619, DOI 10.1038/oby.2009.469; Maeda S, 2005, J HUM GENET, V50, P283, DOI 10.1007/s10038-005-0253-9; Masunari N, 2007, OSTEOPOROSIS INT, V18, P1493, DOI 10.1007/s00198-007-0392-2; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meyre D, 2012, DIABETOLOGIA, V55, P873, DOI 10.1007/s00125-012-2478-4; Miyake K, 2009, J HUM GENET, V54, P236, DOI 10.1038/jhg.2009.17; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Park JY, 1997, DIABETES RES CLIN PR, V35, P49, DOI 10.1016/S0168-8227(96)01363-0; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Qian Y, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-86; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Scott RA, 2010, EUR J HUM GENET, V18, P1339, DOI 10.1038/ejhg.2010.131; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shahid A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/324093; Shimaoka I, 2010, HYPERTENS RES, V33, P214, DOI 10.1038/hr.2009.215; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tabara Y, 2009, INT J OBESITY, V33, P1243, DOI 10.1038/ijo.2009.161; Takeuchi F, 2011, DIABETOLOGIA, V54, P1350, DOI 10.1007/s00125-011-2086-8; Tamakoshi K, 2003, INT J OBESITY, V27, P247, DOI 10.1038/sj.ijo.802195; Tanaka M, 2012, J ATHEROSCLER THROMB, V19, P633, DOI 10.5551/jat.11940; Tanaka S, 2011, J ATHEROSCLER THROMB, V18, P115, DOI 10.5551/jat.5926; Xi B, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-107; Xi B, 2009, BIOMED ENVIRON SCI, V22, P449, DOI 10.1016/S0895-3988(10)60001-3; Yajnik CS, 2009, DIABETOLOGIA, V52, P247, DOI 10.1007/s00125-008-1186-6; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Yoshizawa S, 2014, DIABETIC MED, V31, P1378, DOI 10.1111/dme.12471; Zhang XM, 2012, DIABETES, V61, P3005, DOI 10.2337/db11-1799	53	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165523	10.1371/journal.pone.0165523	http://dx.doi.org/10.1371/journal.pone.0165523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820839	Green Published, Green Submitted, gold			2022-12-27	WOS:000387614800011
J	Bu, Y; Liu, F; Jia, QA; Yu, SN				Bu, Yang; Liu, Fang; Jia, Qing-An; Yu, Song-Ning			Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							CYCLIC-DI-GMP; I IFN; CANCER; SENSOR; CELLS; ACTIVATION; IMMUNITY; AMP; DNA	Hepatocellular carcinoma (HCC) is one of the most lethal cancer types, and chronic infection with Hepatitis B Virus (HBV) is identified as the strongest risk factor for HCC. Transmembrane Protein 173 (TMEM173) is a pattern recognition receptor which functions as a major regulator of the innate immune response to viral and bacterial infections. However, the prognostic value of TMEM173 in HCC remains elusive. Thus, we aimed to evaluate the potential prognostic significance of TMEM173 expression in HCC patients following curative resection. Immunohistochemistry was used to detect TMEM173 expression in 96 HCC patients. We found that TMEM173 protein expression was remarkably decreased in tumor tissues compared to non-tumor tissues, and that TMEM173 staining intensity was inversely correlated with tumor size, tumor invasion TNM stage and overall survival (OS) in HCC patients. Multivariate analysis supported TMEM173 as an independent prognostic factor, and identified that combining TMEM173 expression with TNM stage showed better prognostic efficiency for OS in HCC patients. In summary, TMEM173 was discovered having an independent prognostic value and may serve as a potential immunotherapeutic target for HCC.	[Bu, Yang; Yu, Song-Ning] Ningxia Med Univ, Gen Hosp, Hepatobiliary Surg, Yinchuan, Peoples R China; [Liu, Fang] Ningxia Med Univ, Gen Hosp, Med Examinat Ctr, Yinchuan, Peoples R China; [Jia, Qing-An] Xi An Jiao Tong Univ, Affiliated Hosp 1, Hepatobiliary Surg, Xian, Peoples R China	Ningxia Medical University; Ningxia Medical University; Xi'an Jiaotong University	Yu, SN (corresponding author), Ningxia Med Univ, Gen Hosp, Hepatobiliary Surg, Yinchuan, Peoples R China.	YSN_NXYC@163.com			Ningxia Natural Science Foundation [NZ15130]; National Natural Science Foundation of China [81502694]; Postdoctoral Science Foundation of China [2015M570330]	Ningxia Natural Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This research project was supported by Key project of Ningxia Natural Science Foundation (NZ15130) for YB, and The National Natural Science Foundation of China (81502694) and Postdoctoral Science Foundation of China (2015M570330) for Q-AJ. YB was in charge of study design, data collection and analysis and preparation of the manuscript. Q-AJ was in charge of preparation of the manuscript.	Anghelina D, 2016, J VIROL, V90, P5915, DOI 10.1128/JVI.00500-16; Blaauboer SM, 2014, J IMMUNOL, V192, P492, DOI 10.4049/jimmunol.1301812; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Camp JT, 2011, MOL CANCER RES, V9, P3, DOI 10.1158/1541-7786.MCR-10-0372; Chan SL, 2016, J CLIN ONCOL, V34, P83, DOI 10.1200/JCO.2015.61.5724; Ho SSW, 2016, IMMUNITY, V44, P1177, DOI 10.1016/j.immuni.2016.04.010; Huitzil-Melendez FD, 2010, J CLIN ONCOL, V28, P2889, DOI 10.1200/JCO.2009.25.9895; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Karimi-Googheri M, 2015, ARCH IRAN MED, V18, P351, DOI 015186/AIM.005; Melkil I, 2015, CURR OPIN IMMUNOL, V37, P1, DOI 10.1016/j.coi.2015.07.008; Nakamura T, 2015, J CONTROL RELEASE, V216, P149, DOI 10.1016/j.jconrel.2015.08.026; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Su YC, 2012, ACTA CRYSTALLOGR F, V68, P906, DOI 10.1107/S1744309112024372; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Tang CHA, 2016, CANCER RES, V76, P2137, DOI 10.1158/0008-5472.CAN-15-1885; Villa E, 2016, GUT, V65, P861, DOI 10.1136/gutjnl-2014-308483; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	23	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165681	10.1371/journal.pone.0165681	http://dx.doi.org/10.1371/journal.pone.0165681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814372	Green Submitted, gold, Green Published			2022-12-27	WOS:000386911100014
J	Patel, MC; Wang, W; Pletneva, LM; Rajagopala, SV; Tan, Y; Hartert, TV; Boukhvalova, MS; Vogel, SN; Das, SR; Blanco, JCG				Patel, Mira C.; Wang, Wei; Pletneva, Lioubov M.; Rajagopala, Seesandra V.; Tan, Yi; Hartert, Tina V.; Boukhvalova, Marina S.; Vogel, Stefanie N.; Das, Suman R.; Blanco, Jorge C. G.			Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus)	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; HUMAN RHINOVIRUS-87; 2014 OUTBREAK; D68; EMERGENCE; CHILDREN; REPLICATION; CHALLENGE; SEROTYPE; PROVIDES	In recent years, there has been a significant increase in detection of Enterovirus D-68 (EV-D68) among patients with severe respiratory infections worldwide. EV-D68 is now recognized as a re-emerging pathogen; however, due to lack of a permissive animal model for EV-D68, a comprehensive understanding of the pathogenesis and immune response against EV-D68 has been hampered. Recently, it was shown that EV-D68 has a strong affinity for alpha 2,6-linked sialic acids (SAs) and we have shown previously that a2,6-linked SAs are abundantly present in the respiratory tract of cotton rats (Sigmodon hispidus). Thus, we hypothesized that cotton rats could be a potential model for EV-D68 infection. Here, we evaluated the ability of two recently isolated EV-D68 strains (VANBT/1 and MO/14/49), along with the historical prototype Fermon strain (ATCC), to infect cotton rats. We found that cotton rats are permissive to EV-D68 infection without virus adaptation. The different strains of EV-D68 showed variable infection profiles and the ability to produce neutralizing antibody (NA) upon intranasal infection or intramuscular immunization. Infection with the VANBT/1 resulted in significant induction of pulmonary cytokine gene expression and lung pathology. Intramuscular immunization with live VANBT/1 or MO/14/49 induced strong homologous antibody responses, but a moderate heterologous NA response. We showed that passive prophylactic administration of serum with high content of NA against VANBT/1 resulted in an efficient antiviral therapy. VANBT/1-immunized animals showed complete protection from VANBT/1 challenge, but induced strong pulmonary Th1 and Th2 cytokine responses and enhanced lung pathology, indicating the generation of exacerbated immune response by immunization. In conclusion, our data illustrate that the cotton rat is a powerful animal model that provides an experimental platform to investigate pathogenesis, immune response, anti-viral therapies and vaccines against EV-D68 infection.	[Patel, Mira C.; Pletneva, Lioubov M.; Boukhvalova, Marina S.; Blanco, Jorge C. G.] Sigmovir Biosyst Inc, Rockville, MD 20850 USA; [Patel, Mira C.; Vogel, Stefanie N.] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Wang, Wei; Rajagopala, Seesandra V.; Tan, Yi; Das, Suman R.] J Craig Venter Inst, Infect Dis Grp, Rockville, MD 20850 USA; [Hartert, Tina V.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA	University System of Maryland; University of Maryland Baltimore; J. Craig Venter Institute; Vanderbilt University	Blanco, JCG (corresponding author), Sigmovir Biosyst Inc, Rockville, MD 20850 USA.; Das, SR (corresponding author), J Craig Venter Inst, Infect Dis Grp, Rockville, MD 20850 USA.; Das, SR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Ctr Translat Immunol & Infect Dis, Nashville, TN USA.	suman.r.das@vanderbilt.edu; j.blanco@sigmovir.com	Das, Suman/ABB-7273-2020; Blanco, Jorge/AAW-3752-2020	Das, Suman/0000-0003-2496-9724; Rajagopala, Seesandra/0000-0001-7176-5770; Blanco, Jorge/0000-0002-6173-0213	Sigmovir Biosystems Inc. (SBI); NIH [R01AI104541, AI104541]; J. Craig Venter Institute; NIAID/NIH Genomic Centers for Infectious Diseases (GCID) program [U19-AI110819]; SBI;  [AI110819]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI077930, U19AI110819] Funding Source: NIH RePORTER	Sigmovir Biosystems Inc. (SBI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. Craig Venter Institute; NIAID/NIH Genomic Centers for Infectious Diseases (GCID) program; SBI(Indian Council of Agricultural Research (ICAR)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by Sigmovir Biosystems Inc.'s (SBI) corporate funds, NIH grants R01AI104541 (to SNV at the University of Maryland and JCGB at SBI). This work was also partly supported by J. Craig Venter Institute internal funding and the sequence characterization of the viruses used in this study was supported by the NIAID/NIH Genomic Centers for Infectious Diseases (GCID) program (U19-AI110819 to SRD). MCP, LMP, MSB, JCGB have affiliation and are supported by SBI and NIH grant AI104541. WW, SVR, YT, SRD were partially supported by AI110819. SBI, through JCGB, MCP, and MSB has been involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. All other SBI's funders did not have any role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. SBI has provided support in the form of authors' salaries for MCP, LMP, MSB, and JCGB, as well as for research animals and materials.	ARMSTRONG CHARLES, 1939, PUBL HEALTH REPTS, V54, P2302, DOI 10.2307/4583135; Baggen J, 2016, P NATL ACAD SCI USA, V113, P1399, DOI 10.1073/pnas.1524498113; Blanco JCG, 2004, J INTERF CYTOK RES, V24, P21, DOI 10.1089/107999004772719873; Blanco JCG, 2015, VACCINE, V33, P5371, DOI 10.1016/j.vaccine.2015.08.071; Blanco Jorge C G, 2014, Trials Vaccinol, V3, P52; Blanco JCG, 2013, J VIROL, V87, P2036, DOI 10.1128/JVI.00638-12; Blomqvist S, 2002, J CLIN MICROBIOL, V40, P4218, DOI 10.1128/JCM.40.11.4218-4223.2002; Boukhvalova M, 2016, BONE MARROW TRANSPL, V51, P119, DOI 10.1038/bmt.2015.212; Boukhvalova M, 2015, J VIROL, V89, P9825, DOI 10.1128/JVI.01387-15; Boukhvalova MS, 2007, J VIROL, V81, P9443, DOI 10.1128/JVI.00102-07; Boukhvalova MS, 2006, VACCINE, V24, P5027, DOI 10.1016/j.vaccine.2006.03.064; Boukhvalova MS, 2013, CURR TOP MICROBIOL, V372, P347, DOI 10.1007/978-3-642-38919-1_17; Boukhvalova MS, 2009, BIOLOGICALS, V37, P152, DOI 10.1016/j.biologicals.2009.02.017; CHATTERJEE S, 1970, BRIT J OPHTHALMOL, V54, P628, DOI 10.1136/bjo.54.9.628; Connor E, 1997, PEDIATRICS, V99, P93; Du J, 2015, PLOS ONE, V10, DOI [10.13717journal.pone.0144208, DOI 10.13717JOUMAL.PONE.0144208]; Eichelberger MC, 2006, CELL IMMUNOL, V243, P67, DOI 10.1016/j.cellimm.2006.12.005; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Furuse Y, 2015, J CLIN MICROBIOL, V53, P1015, DOI 10.1128/JCM.03362-14; Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9; Harvala H, 2014, J GEN VIROL, V95, P403, DOI 10.1099/vir.0.059048-0; Harvala H, 2011, J VIROL, V85, P4480, DOI 10.1128/JVI.02285-10; Holm-Hansen CC, 2016, LANCET INFECT DIS, V16, pE64, DOI 10.1016/S1473-3099(15)00543-5; Huang WH, 2015, SCI REP-UK, V5, DOI 10.1038/srep15223; Ikeda T, 2012, MICROBIOL IMMUNOL, V56, P139, DOI 10.1111/j.1348-0421.2012.00411.x; Imamura T, 2015, REV MED VIROL, V25, P102, DOI 10.1002/rmv.1820; Imamura T, 2014, J VIROL, V88, P2374, DOI 10.1128/JVI.03070-13; Imamura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074221; Imamura T, 2011, EMERG INFECT DIS, V17, P1430, DOI 10.3201/eid1708.101328; Ishiko H, 2002, INTERVIROLOGY, V45, P136, DOI 10.1159/000065866; Junttila N, 2007, J MED VIROL, V79, P393, DOI 10.1002/jmv.20825; Kaida A, 2011, EMERG INFECT DIS, V17, P1494, DOI 10.3201/eid1708.110028; Khetsuriani N, 2006, MMWR SURVEILL SUMM, V55, P1, DOI DOI 10.1016/j.alit.2017.04.003; KONO R, 1972, LANCET, V1, P1191; KOROLEVA GA, 1980, VOP VIRUSOL+, P185; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Lang M, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.44.20952; Lauinger IL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036005; Linsuwanon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035190; Liu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9865; Lu QB, 2014, J MED MICROBIOL, V63, P408, DOI 10.1099/jmm.0.068247-0; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; Meijer A, 2014, EURO SURVEILL, V19; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Messacar K, 2015, LANCET, V385, P1662, DOI 10.1016/S0140-6736(14)62457-0; Midgley Claire M, 2014, MMWR Morb Mortal Wkly Rep, V63, P798; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Ottolini MG, 2000, VIRAL IMMUNOL, V13, P231, DOI 10.1089/vim.2000.13.231; Ottolini MG, 2005, J GEN VIROL, V86, P2823, DOI 10.1099/vir.0.81145-0; Pfeiffer HC, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.10.21062; Pfeuffer J, 2003, J VIROL, V77, P150, DOI 10.1128/JVI.77.1.150-158.2003; Piralla A, 2014, J MED VIROL, V86, P1590, DOI 10.1002/jmv.23821; Pletneva LM, 2008, J GEN VIROL, V89, P261, DOI 10.1099/vir.0.83294-0; Pletneva LM, 2006, J INTERF CYTOK RES, V26, P914, DOI 10.1089/jir.2006.26.914; Royston L, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010016; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693; Schuster JE, 2015, J CLIN VIROL, V70, P77, DOI 10.1016/j.jcv.2015.07.298; Sejvar JJ, 2016, CLIN INFECT DIS; Smura TP, 2007, J GEN VIROL, V88, P849, DOI 10.1099/vir.0.82510-0; Straight TM, 2006, VACCINE, V24, P6264, DOI 10.1016/j.vaccine.2006.05.092; Sun YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep34299; Tan Y, 2016, J VIROL, V90, P1997, DOI 10.1128/JVI.02418-15; Tokarz R, 2012, J GEN VIROL, V93, P1952, DOI 10.1099/vir.0.043935-0; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; Waghmare A, 2015, BLOOD, V125, P1724, DOI 10.1182/blood-2014-12-616516; Wang Z, 2010, MICROB ECOL, V59, P623, DOI 10.1007/s00248-010-9636-3; WYDE PR, 1992, P SOC EXP BIOL MED, V201, P80, DOI 10.3181/00379727-201-43483; Yim KC, 2005, J VIROL, V79, P14632, DOI 10.1128/JVI.79.23.14632-14639.2005	69	17	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166336	10.1371/journal.pone.0166336	http://dx.doi.org/10.1371/journal.pone.0166336			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814404	gold, Green Published, Green Submitted			2022-12-27	WOS:000386911100039
J	Sawano, S; Komiya, Y; Ichitsubo, R; Ohkawa, Y; Nakamura, M; Tatsumi, R; Ikeuchi, Y; Mizunoya, W				Sawano, Shoko; Komiya, Yusuke; Ichitsubo, Riho; Ohkawa, Yasuyuki; Nakamura, Mako; Tatsumi, Ryuichi; Ikeuchi, Yoshihide; Mizunoya, Wataru			A One-Step Immunostaining Method to Visualize Rodent Muscle Fiber Type within a Single Specimen	PLOS ONE			English	Article							HEAVY-CHAIN ISOFORMS; MYOFIBRILLAR ATPASE ACTIVITY; SOLEUS MUSCLE; MYOSIN; ANTIBODIES; EXPRESSION; ANTIGENS; PROTOCOL	In this study, we present a quadruple immunostaining method for rapid muscle fiber typing of mice and rats using antibodies specific to the adult myosin heavy chain (MyHC) isoforms MyHC1, 2A, 2X, and 2B, which are common marker proteins of distinct muscle fiber types. We developed rat monoclonal antibodies specific to each MyHC isoform and conjugated these four antibodies to fluorophores with distinct excitation and emission wavelengths. By mixing the four types of conjugated antibodies, MyHC1, 2A, 2X, and 2B could be distinguished within a single specimen allowing for facile delineation of skeletal muscle fiber types. Furthermore, we could observe hybrid fibers expressing MyHC2X and MyHC2B together in single longitudinal muscle sections from mice and rats, that was not attained in previous techniques. This staining method is expected to be applied to study muscle fiber type transition in response to environmental factors, and to ultimately develop techniques to regulate animal muscle fiber types.	[Sawano, Shoko; Komiya, Yusuke; Ichitsubo, Riho; Nakamura, Mako; Tatsumi, Ryuichi; Ikeuchi, Yoshihide; Mizunoya, Wataru] Kyushu Univ, Dept Bioresource Sci, Fac Agr, Fukuoka, Japan; [Ohkawa, Yasuyuki] Kyushu Univ, Med Inst Bioregulat, Div Transcript, Fukuoka, Japan; [Ohkawa, Yasuyuki] JST, CREST, Saitama, Japan; [Sawano, Shoko] Fukuoka Womens Jr Coll, Dept Food Nutr, Dazaifu, Japan	Kyushu University; Kyushu University; Japan Science & Technology Agency (JST)	Mizunoya, W (corresponding author), Kyushu Univ, Dept Bioresource Sci, Fac Agr, Fukuoka, Japan.	mizunoya.wataru.185@m.kyushu-u.ac.jp	Ohkawa, Yasuyuki/ABG-1839-2021; Mizunoya, Wataru/W-1674-2019	Ohkawa, Yasuyuki/0000-0001-6440-9954; Mizunoya, Wataru/0000-0002-2258-1964; Komiya, Yusuke/0000-0003-3225-2491; Nakamura, Mako/0000-0002-6129-7560	Japan Society for the Promotion of Science (JSPS) KAKENHI [26712023, 22580136, 20404056, 26850083, 14J40234, 11J40017]; Faculty of Agriculture, Kyushu University; Grants-in-Aid for Scientific Research [16H02585, 26450391] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Faculty of Agriculture, Kyushu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Japan Society for the Promotion of Science (JSPS; http://www.jsps.go.jp/english/e-grants/index.html) KAKENHI #26712023, 22580136, and 20404056 to WM, and #26850083, 14J40234, and 11J40017 to SS. The cost of English proofreading service was supported by a Research Grant for Young Investigators of Faculty of Agriculture, Kyushu University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; BILLETER R, 1980, HISTOCHEMISTRY, V65, P249, DOI 10.1007/BF00493174; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; Caiozzo VJ, 1997, AM J PHYSIOL-CELL PH, V273, pC944, DOI 10.1152/ajpcell.1997.273.3.C944; D'Amico A, 2008, CURR NEUROL NEUROSCI, V8, P73, DOI 10.1007/s11910-008-0012-3; DRABER P, 1995, J IMMUNOL METHODS, V181, P37, DOI 10.1016/0022-1759(94)00326-R; Ellefsen S, 2014, SCAND J MED SCI SPOR, V24, pE332, DOI 10.1111/sms.12185; Engel WK, 2015, BBA-MOL BASIS DIS, V1852, P563, DOI 10.1016/j.bbadis.2014.11.015; FITZSIMONS DP, 1990, J APPL PHYSIOL, V68, P1950, DOI 10.1152/jappl.1990.68.5.1950; Goding J., 1986, MONOCLONAL ANTIBODIE, P108; Gregorevic P, 2008, MUSCLE NERVE, V37, P104, DOI 10.1002/mus.20877; IZUMO S, 1986, SCIENCE, V231, P597, DOI 10.1126/science.3945800; Jackson KA, 2004, STEM CELLS, V22, P180, DOI 10.1634/stemcells.22-2-180; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; KISHIRO Y, 1995, CELL STRUCT FUNCT, V20, P151, DOI 10.1247/csf.20.151; Komiya Y, 2015, ANAL BIOCHEM, V482, P22, DOI 10.1016/j.ab.2015.03.034; Korn ED, 2000, P NATL ACAD SCI USA, V97, P12559, DOI 10.1073/pnas.230441597; Lucas CA, 2000, BIOCHEM BIOPH RES CO, V272, P303, DOI 10.1006/bbrc.2000.2768; Mizunoya W, 2008, ANAL BIOCHEM, V377, P111, DOI 10.1016/j.ab.2008.02.021; Mizunoya W, 2014, ANIM SCI J, V85, P293, DOI 10.1111/asj.12143; Mizunoya W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080152; Mundegar RR, 2008, J HISTOCHEM CYTOCHEM, V56, P969, DOI 10.1369/jhc.2008.950105; Pette D, 1998, ACTA PHYSIOL SCAND, V162, P367, DOI 10.1046/j.1365-201X.1998.0296e.x; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Rayment I, 1996, J BIOL CHEM, V271, P15850, DOI 10.1074/jbc.271.27.15850; Ribaric S, 2013, CELLS TISSUES ORGANS, V197, P312, DOI 10.1159/000345424; Rivero JLL, 1999, HISTOCHEM CELL BIOL, V111, P277, DOI 10.1007/s004180050358; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; SALMONS S, 1976, NATURE, V263, P30, DOI 10.1038/263030a0; Sato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1748, DOI 10.1271/bbb.90085; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567, DOI 10.1152/ajpendo.1989.257.4.E567; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; STARON RS, 1986, HISTOCHEMISTRY, V86, P19, DOI 10.1007/BF00492341; Talmadge RJ, 2004, BIOCHEM BIOPH RES CO, V325, P296, DOI 10.1016/j.bbrc.2004.10.030; Talmadge RJ, 1985, J APPL PHYSIOL, V78, P1256; Tang XB, 2007, J NEUROSCI, V27, P5837, DOI 10.1523/JNEUROSCI.5048-06.2007; Toniolo L, 2005, J EXP BIOL, V208, P4243, DOI 10.1242/jeb.01904; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Yoshihara H, 2006, J NUTR SCI VITAMINOL, V52, P183, DOI 10.3177/jnsv.52.183; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	43	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166080	10.1371/journal.pone.0166080	http://dx.doi.org/10.1371/journal.pone.0166080			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814384	Green Published, Green Submitted, gold			2022-12-27	WOS:000386911100031
J	Chan, SW; Ismail, Z; Sumintono, B				Chan, Shiau Wei; Ismail, Zaleha; Sumintono, Bambang			A Framework for Assessing High School Students' Statistical Reasoning	PLOS ONE			English	Article							MISCONCEPTIONS; ABILITY; SENSE	Based on a synthesis of literature, earlier studies, analyses and observations on high school students, this study developed an initial framework for assessing students' statistical reasoning about descriptive statistics. Framework descriptors were established across five levels of statistical reasoning and four key constructs. The former consisted of idiosyncratic reasoning, verbal reasoning, transitional reasoning, procedural reasoning, and integrated process reasoning. The latter include describing data, organizing and reducing data, representing data, and analyzing and interpreting data. In contrast to earlier studies, this initial framework formulated a complete and coherent statistical reasoning framework. A statistical reasoning assessment tool was then constructed from this initial framework. The tool was administered to 10 tenth-grade students in a task-based interview. The initial framework was refined, and the statistical reasoning assessment tool was revised. The ten students then participated in the second task-based interview, and the data obtained were used to validate the framework. The findings showed that the students' statistical reasoning levels were consistent across the four constructs, and this result confirmed the framework's cohesion. Developed to contribute to statistics education, this newly developed statistical reasoning framework provides a guide for planning learning goals and designing instruction and assessments.	[Chan, Shiau Wei] Univ Tun Hussein Onn Malaysia, Fac Technol Management & Business, Dept Prod & Operat Management, Batu Pahat, Johor, Malaysia; [Ismail, Zaleha] Univ Teknol Malaysia, Dept Educ Sci Math & Creat Multimedia, Fac Educ, Skudai, Johor, Malaysia; [Sumintono, Bambang] Univ Malaya, Inst Educ Leadership, Kuala Lumpur, Malaysia	University of Tun Hussein Onn Malaysia; Universiti Teknologi Malaysia; Universiti Malaya	Chan, SW (corresponding author), Univ Tun Hussein Onn Malaysia, Fac Technol Management & Business, Dept Prod & Operat Management, Batu Pahat, Johor, Malaysia.	swchan@uthm.edu.my	Sumintono, Bambang/AAE-6612-2019; Ismail, Zaleha/AAN-2984-2020; Chan, Shiau Wei/H-7571-2014	Sumintono, Bambang/0000-0002-5490-3665; Chan, Shiau Wei/0000-0002-9134-5025	Universiti Tun Hussein Onn Malaysia (UTHM) [U431]	Universiti Tun Hussein Onn Malaysia (UTHM)	This work was supported by Universiti Tun Hussein Onn Malaysia (UTHM) under grant no. U431.	Aquilonius BC, 2005, THESIS; Bakker A, 2004, CURRICULAR DEV STAT; Bakker A., 2005, EDUC STUD MATH, V60, P333, DOI [10.1007/s10649-005-5536-8, DOI 10.1007/S10649-005-5536-8]; Ben-Zvi D., 2001, EDUC STUD MATH, V45, P35, DOI [DOI 10.1023/A:1013809201228, 10.1023/A:1013809201228]; Biehler R, 1996, RES ROLE TECHNOLOGY, P169; Biggs J., 2011, TEACHING QUALITY LEA, V4th; Biggs J. B., 1982, EVALUATING QUALITY L; BIGGS JB, 1991, INTELLIGENCE : RECONCEPTUALIZATION AND MEASUREMENT, P57; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Chan S. W., 2014, TURKISH ONLINE J ED, V13, P29; Chan SW, 2013, PROCD SOC BEHV, V93, P1478, DOI 10.1016/j.sbspro.2013.10.067; Chan SW, 2014, PROCD SOC BEHV, V129, P133, DOI 10.1016/j.sbspro.2014.03.658; Chan SW, 2014, PROCD SOC BEHV, V116, P4338, DOI 10.1016/j.sbspro.2014.01.943; Ciancetta MA, 2007, THESIS; Clark J., 2007, SUCCESSFUL STUDENTS; Clark J. M., 2007, FUNDAMENTAL THEOREM; Cooper L. L., 2008, J STAT ED, V16, P1; DelMas, 2004, CHALLENGE DEV STAT L, P79, DOI [10.1007/1-4020-2278-6_4, DOI 10.1007/1-4020-2278-6_4]; delMas R, 2005, P 4 INT RES FOR STAT; Friel SN, 2001, J RES MATH EDUC, V32, P124, DOI 10.2307/749671; Garfield J, 2002, J STAT ED, V10, P58; Garfield J, 2007, THINKING DATA, P87; Garfield J.B., 2000, MATH THINK LEARN, V2, P99, DOI [DOI 10.1207/S15327833MTL0202_, 10.1207/S15327833MTL0202_5]; Garfield J, 2007, INT STAT REV, V75, P372, DOI 10.1111/j.1751-5823.2007.00029.x; Garfield JB, 2008, DEVELOPING STUDENTS STATISTICAL REASONING, pVII; Goldin G. A., 1997, MONOGRAPH NATL COUNC, P40, DOI DOI 10.2307/749946; Groth R. E., 2003, THESIS; Hahn C, 2014, EDUC STUD MATH, V86, P239, DOI 10.1007/s10649-011-9363-9; Ismail Z, 2015, AIP CONF PROC, V1643, P93, DOI 10.1063/1.4907430; Jones G.A., 2000, MATH THINK LEARN, V2, P269, DOI [10.1207/S15327833MTL0204_3, DOI 10.1207/S15327833MTL0204_3]; Jones GA, 1996, J RES MATH EDUC, V27, P310, DOI 10.2307/749367; Jones GA., 1997, EDUC STUD MATH, V32, P101, DOI [DOI 10.1023/A:1002981520728, 10.1023/A:1002981520728]; Jones GA, 1994, EDUC STUD MATH, V27, P117, DOI [10.1007/BF01278918, DOI 10.1007/BF01278918]; Kourkoulos M, 2010, BSHM BULL, V25, P168, DOI 10.1080/17498430903526384; Leavy A, 2006, J MATH TEACH EDUC, V9, P53, DOI 10.1007/s10857-006-9003-y; Lee C, 2002, P 6 INT C TEACH STAT; Meletiou-Mavrotheris M, 2003, P 3 INT RES FOR STAT; Mevarech Z. R., 1983, ED STUDIES MATH, V14, P415; Mooney E.S., 2002, MATH THINK LEARN, V4, P23, DOI [10.1207/S15327833MTL0401_2, DOI 10.1207/S15327833MTL0401_2]; Morgan G.A., 2011, IBM SPSS INTERMEDIAT, V4; Olani A, 2011, ELECTRON J RES EDUC, V9, P49; Panizzon D, 2005, P ANN C AUSTR ASS RE; Pegg J, 2005, ZDM-MATH EDUC, V37, P468, DOI 10.1007/BF02655855; Pollatsek A.D.W.A., ED STUDIES MATH, P191, DOI [10.1007/BF00305621, DOI 10.1007/BF00305621]; Reading C., 2006, STAT ED RES J, V5, P4; Reading C., 2004, CHALLENGE DEV STAT L, P201, DOI [10.1007/1-4020-2278-6_9, DOI 10.1007/1-4020-2278-6_9]; Sharma S, 2008, PAC ASIAN ED J, V20, P29; Shaughnessy J.M., 1996, INT HDB MATH ED, Vvol. 4, P205; Silva C. B., 2008, JOINT ICMI IASE STUD; Slauson L. V., 2008, THESIS; Tarr JE., 1997, MATH EDUC RES J, V9, P39, DOI [10.1007/BF03217301, DOI 10.1007/BF03217301]	51	1	1	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0163846	10.1371/journal.pone.0163846	http://dx.doi.org/10.1371/journal.pone.0163846			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812091	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000005
J	Douguet, L; Cherfils-Vicini, J; Bod, L; Lengagne, R; Gilson, E; Prevost-Blondel, A				Douguet, Laetitia; Cherfils-Vicini, Julien; Bod, Lloyd; Lengagne, Renee; Gilson, Eric; Prevost-Blondel, Armelle			Nitric Oxide Synthase 2 Improves Proliferation and Glycolysis of Peripheral gamma delta T Cells	PLOS ONE			English	Article							SUPPRESSOR-CELLS; LYMPHOCYTES; SURVIVAL; RECOGNITION; METABOLISM; INDUCTION; INFECTION; APOPTOSIS; IMMUNITY; RELEASE	gamma delta T cells play critical roles in host defense against infections and cancer. Although advances have been made in identifying gamma delta TCR ligands, it remains essential to understand molecular mechanisms responsible for in vivo expansion of gamma delta T cells in periphery. Recent findings identified the expression of the inducible NO synthase (NOS2) in lymphoid cells and highlighted novel immunoregulatory functions of NOS2 in alpha beta T cell differentiation and B cell survival. In this context, we wondered whether NOS2 exerts an impact on gamma delta T cell properties. Here, we show that gamma delta T cells express NOS2 not only in vitro after TCR triggering, but also directly ex vivo. Nos2 deficient mice have fewer gamma delta T cells in peripheral lymph nodes (pLNs) than their wild-type counterparts, and these cells exhibit a reduced ability to produce IL-2. Using chemical NOS inhibitors and Nos2 deficient gamma delta T cells, we further evidence that the inactivation of endogenous NOS2 significantly reduced gamma delta T cell proliferation and glycolysis metabolism that can be restored in presence of exogenous IL-2. Collectively, we demonstrate the crucial role of endogenous NOS2 in promoting optimal IL-2 production, proliferation and glycolysis of gamma delta T cells that may contribute to their regulation at steady state.	[Douguet, Laetitia; Bod, Lloyd; Lengagne, Renee; Prevost-Blondel, Armelle] Inst Cochin, INSERM, U1016, Paris, France; [Douguet, Laetitia; Bod, Lloyd; Lengagne, Renee; Prevost-Blondel, Armelle] CNRS, UMR8104, Paris, France; [Douguet, Laetitia; Bod, Lloyd; Lengagne, Renee; Prevost-Blondel, Armelle] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Cherfils-Vicini, Julien; Gilson, Eric] Univ Nice, Inst Rech Canc & Vieillissement, CNRS UMR7284, INSERM U1081, Nice, France; [Cherfils-Vicini, Julien; Gilson, Eric] CHU Nice, Hop Archet, Dept Genet Med, Nice, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Prevost-Blondel, A (corresponding author), Inst Cochin, INSERM, U1016, Paris, France.; Prevost-Blondel, A (corresponding author), CNRS, UMR8104, Paris, France.; Prevost-Blondel, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.	armelle.blondel@inserm.fr	Prevost-Blondel, Armelle/N-7643-2017; Cherfils-Vicini, Julien/L-1997-2019; Bod, Lloyd/AAG-2345-2020	Cherfils-Vicini, Julien/0000-0001-7813-1527; Bod, Lloyd/0000-0003-3663-2571; Douguet, Laetitia/0000-0003-4319-491X; Prevost-Blondel, Armelle/0000-0002-7268-5905	SI LAB Jean Paufique foundation; "Ligue contre le Cancer"; Paris VII University; "Fondation de France"; french fondation "ARC" for the Cancer Research; Comite "Ile de France" from Ligue contre le Cancer; Conseil general, FEDER, le Ministere de l'Enseignement Superieur, la Region PACA; INSERM	SI LAB Jean Paufique foundation; "Ligue contre le Cancer"(Ligue nationale contre le cancer); Paris VII University; "Fondation de France"(Fondation de France); french fondation "ARC" for the Cancer Research; Comite "Ile de France" from Ligue contre le Cancer; Conseil general, FEDER, le Ministere de l'Enseignement Superieur, la Region PACA(Region Provence-Alpes-Cote d'Azur); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the SI LAB Jean Paufique foundation. LD was supported by the "Ligue contre le Cancer" and Paris VII University. JCV was supported by the "Fondation de France". APB's team is supported by the french fondation "ARC" for the Cancer Research and Comite "Ile de France" from Ligue contre le Cancer. CytoMed were supported by le Conseil general, FEDER, le Ministere de l'Enseignement Superieur, la Region PACA and INSERM.	Atre N, 2006, INT J CANCER, V119, P1368, DOI 10.1002/ijc.21966; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; CARDING SR, 1990, GENE DEV, V4, P1304, DOI 10.1101/gad.4.8.1304; Chang CH, 2016, NAT IMMUNOL, V17, P364, DOI 10.1038/ni.3415; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Cidad P, 2004, BIOCHEM J, V384, P629, DOI 10.1042/BJ20040886; Coloff JL, 2011, J BIOL CHEM, V286, P5921, DOI 10.1074/jbc.M110.179101; Crowley MP, 1997, J EXP MED, V185, P1223, DOI 10.1084/jem.185.7.1223; Douguet L, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1208878; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Jayaraman P, 2012, J IMMUNOL, V188, P5365, DOI 10.4049/jimmunol.1103553; Lanca T, 2013, J IMMUNOL, V190, P6673, DOI 10.4049/jimmunol.1300434; Lukacs-Kornek V, 2011, NAT IMMUNOL, V12, P1096, DOI 10.1038/ni.2112; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MATIS LA, 1989, SCIENCE, V245, P746, DOI 10.1126/science.2528206; McVay LD, 1996, J IMMUNOL, V157, P2873; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Niedbala W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5575; Obermajer N, 2013, J EXP MED, V210, P1433, DOI 10.1084/jem.20121277; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ribot JC, 2012, J IMMUNOL, V189, P1202, DOI 10.4049/jimmunol.1200268; Saini AS, 2014, NAT IMMUNOL, V15, P275, DOI 10.1038/ni.2806; Sciorati C, 1997, J BIOL CHEM, V272, P23211, DOI 10.1074/jbc.272.37.23211; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Sheridan BS, 2013, IMMUNITY, V39, P184, DOI 10.1016/j.immuni.2013.06.015; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Siegert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027618; Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904; STUEHR DJ, 1985, P NATL ACAD SCI USA, V82, P7738, DOI 10.1073/pnas.82.22.7738; Tumurkhuu G, 2010, CELL IMMUNOL, V261, P122, DOI 10.1016/j.cellimm.2009.11.009; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wang T, 2006, J IMMUNOL, V177, P1825, DOI 10.4049/jimmunol.177.3.1825; Yang JJ, 2013, J EXP MED, V210, P1447, DOI 10.1084/jem.20122494	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165639	10.1371/journal.pone.0165639	http://dx.doi.org/10.1371/journal.pone.0165639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812136	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000042
J	Janssen, KJH; Hoebe, CJPA; Dukers-Muijrers, NHTM; Eppings, L; Lucchesi, M; Wolffs, PFG				Janssen, Kevin J. H.; Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.; Eppings, Lisanne; Lucchesi, Mayk; Wolffs, Petra F. G.			Viability-PCR Shows That NAAT Detects a High Proportion of DNA from Non-Viable Chlamydia trachomatis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PROPIDIUM MONOAZIDE; GENITAL-INFECTION; PERFORMANCE; TIME; DIAGNOSIS; ASSAYS	Objectives According to the current guidelines for laboratory diagnosis of sexually transmitted infections (STIs), nucleic acid amplification tests (NAATs) are the preferred diagnostic method for Chlamydia trachomatis (CT) infections. However, NAATs amplify the available target DNA without discriminating between DNA originating from viable or non-viable CT. Assessing CT viability will provide more insights in the clinical and public health relevance of a CT positive test result. The aim of this study was to technically validate and implement viability-PCR (V-PCR) to asses CT viability. Methods Technical validation of V-PCR was performed by the assessment of predefined viability ratios of CT. Samples were subjected to V-PCR which consisted of propidium monoazide (PMA) treatment prior to DNA extraction followed by quantitative PCR (qPCR) targeting the ompA gene for the detection of CT DNA. Finally, V-PCR was applied to vaginal swabs of 50 CT positive patients, as indicated by routine NAAT, collected at our outpatient STD clinics before antimicrobial treatment. Results Technical validation of V-PCR showed that PMA treatment of heat-inactivated CT culture resulted in an almost complete loss of qPCR signal. PMA treated samples of the fresh viable CT culture showed no marked reduction of PCR signal, indicating that all DNA from viable CT could be detected. Applying V-PCR to clinical samples showed that in 36% of samples (18/50) less than 1% of CT DNA originated from viable bacteria. Conclusions V-PCR showed to be a fast and easy method to assess CT viability in clinical samples, without the need of traditional challenging cell culture methods. Furthermore, V-PCR results of clinical samples have indicated that a substantial amount of the amplified CT DNA originated from non-viable cells. Although results might be influenced by cell death during transport, this study suggests that there is a potential overestimation of quantitative CT positivity by currently used NAATs.	[Janssen, Kevin J. H.; Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.; Eppings, Lisanne; Lucchesi, Mayk; Wolffs, Petra F. G.] Maastricht Univ, Med Ctr MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands; [Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.; Eppings, Lisanne] South Limburg Publ Hlth Serv GGD South Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Wolffs, PFG (corresponding author), Maastricht Univ, Med Ctr MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands.	p.wolffs@mumc.nl	Dukers-Muijrers, Nicole/M-7178-2014	Wolffs, Petra/0000-0002-5326-3985; Janssen, Kevin J.H./0000-0001-5521-0521; Eppings, Lisanne/0000-0001-7501-8801				Black CM, 1997, CLIN MICROBIOL REV, V10, P160, DOI 10.1128/CMR.10.1.160; Dirks JAMC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145693; Dirks JAMC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121433; Dukers-Muijrers NHTM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1721-x; Dukers-Muijrers NHTM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081236; Gaydos CA, 1998, J INFECT DIS, V177, P417, DOI 10.1086/514207; Gaydos CA, 2013, J CLIN MICROBIOL, V51, P1666, DOI 10.1128/JCM.03461-12; Geelen Tanja H, 2013, Diagn Microbiol Infect Dis, V77, P101, DOI 10.1016/j.diagmicrobio.2013.06.020; Geisler WM, 2013, J INFECT DIS, V207, P1850, DOI 10.1093/infdis/jit094; Geisler WM, 2010, J INFECT DIS, V201, pS104, DOI 10.1086/652402; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Jalal H, 2006, J CLIN MICROBIOL, V44, P206, DOI 10.1128/JCM.44.1.206-213.2006; Kobayashi H, 2009, J ORTHOP RES, V27, P1243, DOI 10.1002/jor.20872; Lanjouw E, 2016, INT J STD AIDS, V27, P333, DOI 10.1177/0956462415618837; Liang NJ, 2011, J FOOD SCI, V76, pM234, DOI 10.1111/j.1750-3841.2011.02123.x; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Nocker A, 2006, APPL ENVIRON MICROB, V72, P1997, DOI 10.1128/AEM.72.3.1997-2004.2006; Nocker A, 2007, J MICROBIOL METH, V70, P252, DOI 10.1016/j.mimet.2007.04.014; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Nogva HK, 2003, BIOTECHNIQUES, V34, P804, DOI 10.2144/03344rr02; Nwokolo NC, 2016, INT J STD AIDS, V27, P251, DOI 10.1177/0956462415615443; Renault CA, 2011, SEX HEALTH, V8, P69, DOI 10.1071/SH10030; Trembizki E, 2015, PATHOLOGY, V47, P219, DOI 10.1097/PAT.0000000000000239; Van Der Pol B, 2012, J CLIN MICROBIOL, V50, P2244, DOI 10.1128/JCM.06481-11; van Dommelen L, 2010, SEX TRANSM INFECT, V86, P355, DOI 10.1136/sti.2010.042598; Varma M, 2009, WATER RES, V43, P4790, DOI 10.1016/j.watres.2009.05.031; Vodstrcil LA, 2015, J INFECT DIS, V211, P1628, DOI 10.1093/infdis/jiu670; VOGELS WHM, 1993, J CLIN MICROBIOL, V31, P1103, DOI 10.1128/JCM.31.5.1103-1107.1993; Williams JA, 2014, SEX TRANSM DIS, V41, P215, DOI 10.1097/OLQ.0000000000000102; WORKOWSKI KA, 1993, JAMA-J AM MED ASSOC, V270, P2071, DOI 10.1001/jama.270.17.2071	30	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165920	10.1371/journal.pone.0165920	http://dx.doi.org/10.1371/journal.pone.0165920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812208	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000081
J	Muscella, A; Vetrugno, C; Cossa, LG; Antonaci, G; De Nuccio, F; De Pascali, SA; Fanizzi, FP; Marsigliante, S				Muscella, Antonella; Vetrugno, Carla; Cossa, Luca Giulio; Antonaci, Giovanna; De Nuccio, Francesco; De Pascali, Sandra Angelica; Fanizzi, Francesco Paolo; Marsigliante, Santo			In Vitro and In Vivo Antitumor Activity of [Pt (O,O'-acac)(gamma-acac)(DMS)] in Malignant Pleural Mesothelioma	PLOS ONE			English	Article							CISPLATIN-INDUCED APOPTOSIS; ACTIVATED PROTEIN-KINASE; XENOGRAFT MODEL; CELL-LINES; C-DELTA; PT(O,O'-ACAC)(GAMMA-ACAC)(DMS); BCL-2; PT(O,O-ACAC)(GAMMA-ACAC)(DMS); INVOLVEMENT; CASPASE	Malignant pleural mesothelioma (MPM) is an aggressive malignancy highly resistant to chemotherapy. There is an urgent need for effective therapy inasmuch as resistance, intrinsic and acquired, to conventional therapies is common. Among Pt(II) antitumor drugs, [Pt (O,O'-acac)(gamma-acac)(DMS)] (Ptac2S) has recently attracted considerable attention due to its strong in vitro and in vivo antiproliferative activity and reduced toxicity. The purpose of this study was to examine the efficacy of Ptac2S treatment in MPM. We employed the ZL55 human mesothelioma cell line in vitro and in a murine xenograft model in vivo, to test the antitumor activity of Ptac2S. Cytotoxicity assays and Western blottings of different apoptosis and survival proteins were thus performed. Ptac2S increases MPM cell death in vitro and in vivo compared with cisplatin. Ptac2S was more efficacious than cisplatin also in inducing apoptosis characterized by: (a) mitochondria depolarization, (b) increase of bax expression and its cytosol-to-mitochondria translocation and decrease of Bcl-2 expression, (c) activation of caspase-7 and -9. Ptac2S activated full-length PKC-delta and generated a PKC-delta fragment. Full-length PKC-delta translocated to the nucleus and membrane, whilst PKC-delta fragment concentrated to mitochondria. Ptac2S was also responsible for the PKC-epsilon activation that provoked phosphorylation of p38. Both PKC-delta and PKC-epsilon inhibition (by PKC-siRNA) reduced the apoptotic death of ZL55 cells. Altogether, our results confirm that Ptac2S is a promising therapeutic agent for malignant mesothelioma, providing a solid starting point for its validation as a suitable candidate for further pharmacological testing.	[Muscella, Antonella; Vetrugno, Carla] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lab Cell Pathol, Lecce, Italy; [Cossa, Luca Giulio; Antonaci, Giovanna; Marsigliante, Santo] Univ Salento, DiSTeBA, Lab Cell Physiol, Lecce, Italy; [De Nuccio, Francesco] Univ Salento, DiSTeBA, Lab Human Anat & Neurosci, Lecce, Italy; [De Pascali, Sandra Angelica; Fanizzi, Francesco Paolo] Univ Salento, DiSTeBA, Inorgan Chem Lab, Lecce, Italy	University of Salento; University of Salento; University of Salento; University of Salento	Muscella, A (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, Lab Cell Pathol, Lecce, Italy.	antonella.muscella@unisalento.it	De Nuccio, Francesco/GSD-5516-2022; Muscella, Antonella/AAE-8075-2019; Fanizzi, Francesco Paolo/K-5766-2012	Muscella, Antonella/0000-0002-2822-9929; Fanizzi, Francesco Paolo/0000-0003-3073-5772; De Nuccio, Francesco/0000-0003-2041-0149; MARSIGLIANTE, Santo/0000-0001-6535-3286	Ministero dell'Istruzione, dell'Universita e della Ricerca [FIRB CAROMICS RBAP11B2SX_008]; Consorzio Interuniversitario di Ricerca in Chimica dei Metalli nei Sistemi Biologici (CIRCMSB), Bari, Italy	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Consorzio Interuniversitario di Ricerca in Chimica dei Metalli nei Sistemi Biologici (CIRCMSB), Bari, Italy	This work was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca (FIRB CAROMICS RBAP11B2SX_008) and by the Consorzio Interuniversitario di Ricerca in Chimica dei Metalli nei Sistemi Biologici (CIRCMSB), Bari, Italy.	Allen RT, 1998, CELL MOL LIFE SCI, V54, P427, DOI 10.1007/s000180050171; Barbieri F, 2011, BIOCHEM PHARMACOL, V82, P1467, DOI 10.1016/j.bcp.2011.07.073; Basu A, 2001, CELL DEATH DIFFER, V8, P899, DOI 10.1038/sj.cdd.4400885; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Colussi PA, 1998, J BIOL CHEM, V273, P26566, DOI 10.1074/jbc.273.41.26566; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; De Pascali SA, 2005, EUR J INORG CHEM, P788, DOI 10.1002/ejic.200400665; De Pascali SA, 2009, DALTON T, P7786, DOI 10.1039/b909209a; Delgermaa V, 2011, B WORLD HEALTH ORGAN, V89, P716, DOI 10.2471/BLT.11.086678; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Fan MY, 2001, DRUG RESIST UPDATE, V4, P253, DOI 10.1054/drup.2001.0214; Favoni RE, 2011, TRENDS PHARMACOL SCI, V32, P463, DOI 10.1016/j.tips.2011.03.011; Fennell DA, 2004, LANCET ONCOL, V5, P354, DOI 10.1016/S1470-2045(04)01492-5; Galan A, 2000, J BIOL CHEM, V275, P11418, DOI 10.1074/jbc.275.15.11418; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Grimaldi M, 2016, HISTOCHEM CELL BIOL, V145, P587, DOI 10.1007/s00418-015-1396-1; Henkels KM, 1999, CANCER RES, V59, P3077; Kindler HL, 2008, CURR TREAT OPTION ON, V9, P171, DOI 10.1007/s11864-008-0071-3; Ko HW, 2000, J NEUROCHEM, V74, P2455, DOI 10.1046/j.1471-4159.2000.0742455.x; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Mujoomdar AA, 2010, J THORAC CARDIOV SUR, V140, P352, DOI 10.1016/j.jtcvs.2009.11.072; Muscella A, 2008, BRIT J PHARMACOL, V153, P34, DOI 10.1038/sj.bjp.0707576; Muscella A, 2016, BRIT J PHARMACOL, V173, P2633, DOI 10.1111/bph.13543; Muscella A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.554; Muscella A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.315; Muscella A, 2007, BIOCHEM PHARMACOL, V74, P28, DOI 10.1016/j.bcp.2007.03.027; Muscella A, 2015, BIOCHEM PHARMACOL, V98, P29, DOI 10.1016/j.bcp.2015.08.103; Muscella A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112186; Muscella A, 2011, BIOCHEM PHARMACOL, V81, P1271, DOI 10.1016/j.bcp.2011.03.007; Muscella A, 2011, BIOCHEM PHARMACOL, V81, P91, DOI 10.1016/j.bcp.2010.09.012; Muscella A, 2010, BRIT J PHARMACOL, V160, P1362, DOI 10.1111/j.1476-5381.2010.00782.x; Narasimhan SR, 1998, AM J PHYSIOL-LUNG C, V275, pL165, DOI 10.1152/ajplung.1998.275.1.L165; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Orengo AM, 1999, EUR RESPIR J, V13, P527, DOI 10.1183/09031936.99.13352799; SCHMITTER D, 1992, INT J CANCER, V51, P296, DOI 10.1002/ijc.2910510220; Soini Y, 1999, CLIN CANCER RES, V5, P3508; Urso L, 2005, BIOCHEM BIOPH RES CO, V337, P297, DOI 10.1016/j.bbrc.2005.09.046; Vetrugno C, 2014, BRIT J PHARMACOL, V171, P5139, DOI 10.1111/bph.12831; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Wust AP, 2003, INT J CANCER, V106, P1660; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	42	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165154	10.1371/journal.pone.0165154	http://dx.doi.org/10.1371/journal.pone.0165154			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806086	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500020
J	Song, FL; Wang, Y; Jiang, DW; Wang, TC; Zhang, YQ; Ma, H; Kang, YF				Song, Fanglong; Wang, Yi; Jiang, Dawei; Wang, Tianchen; Zhang, Yinquan; Ma, Hui; Kang, Yifan			Cyclic Compressive Stress Regulates Apoptosis in Rat Osteoblasts: Involvement of PI3K/Akt and JNK MAPK Signaling Pathways	PLOS ONE			English	Article							CELL-DEATH; BONE; CANCER; INHIBITION; ACTIVATION; EXPRESSION; SURVIVAL; RECEPTOR; KINASE; LIGAND	It is widely accepted that physiological mechanical stimulation suppresses apoptosis and induces synthesis of extracellular matrix by osteoblasts; however, the effect of stress overloading on osteoblasts has not been fully illustrated. In the present study, we investigated the effect of cyclic compressive stress on rat osteoblasts apoptosis, using a novel liquid drop method to generate mechanical stress on osteoblast monolayers. After treatment with different levels of mechanical stress, apoptosis of osteoblasts and activations of mitogenactivated protein kinases (MAPKs) and PI3-kinase (PI3K)/Akt signaling pathways were investigated. Osteoblasts apoptosis was observed after treated with specific inhibitors prior to mechanical stimulation. Protein levels of Bax/Bcl-2/caspase-3 signaling were determined using western blot with or without inhibitors of PI3K/Akt and phosphorylation of c-jun N- terminal kinase (JNK) MAPK. Results showed that mechanical stimulation led to osteoblasts apoptosis in a dose-dependent manner and a remarkable activation of MAPKs and PI3K/Akt signaling pathways. Activation of PI3K/Akt protected against apoptosis, whereas JNK MAPK increased apoptosis via regulation of Bax/Bcl-2/caspase-3 activation. In summary, the PI3K/Akt and JNK MAPK signaling pathways played opposing roles in osteoblasts apoptosis, resulting in inhibition of apoptosis upon small-magnitude stress and increased apoptosis upon large-magnitude stress.	[Song, Fanglong; Wang, Yi; Jiang, Dawei; Wang, Tianchen; Zhang, Yinquan; Ma, Hui; Kang, Yifan] PLA Second Mil Med Univ, Affiliated Hosp 3, Dept Orthoped, Shanghai 200433, Peoples R China	Naval Medical University	Kang, YF (corresponding author), PLA Second Mil Med Univ, Affiliated Hosp 3, Dept Orthoped, Shanghai 200433, Peoples R China.	kangyf11@163.com	Wang, Yi/AAH-8970-2020	Wang, Yi/0000-0003-3489-5183; Kang, Yifan/0000-0002-5856-6643	National Natural Science Foundation of China [81371974]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81371974).	Ackler S, 2010, CANCER CHEMOTH PHARM, V66, P869, DOI 10.1007/s00280-009-1232-1; Aisha MD, 2015, EXP CELL RES, V337, P87, DOI 10.1016/j.yexcr.2015.07.002; Bakker AD, 2016, J CELL PHYSIOL, V231, P1283, DOI 10.1002/jcp.25228; Bucaro MA, 2004, ANN NY ACAD SCI, V1027, P64, DOI 10.1196/annals.1324.007; Cheng WP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123235; Chuang WL, 2016, MOLECULES, V21, DOI 10.3390/molecules21040460; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davis WJ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00024; Geng B, 2016, EXP CELL RES, V343, P208, DOI 10.1016/j.yexcr.2016.03.014; Geng B, 2015, BIOCHEM BIOPH RES CO, V466, P117, DOI 10.1016/j.bbrc.2015.08.117; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Green DR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a006080; HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706; Iura A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141345; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Jilka RL, 2014, J BONE MINER RES, V29, P103, DOI 10.1002/jbmr.2007; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2; Koff JL, 2015, INT J MOL SCI, V16, P2942, DOI 10.3390/ijms16022942; Kong DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069403; Matsui H, 2014, J BIOL CHEM, V289, P6438, DOI 10.1074/jbc.M113.536300; Nithianandarajah-Jones GN, 2012, CELL SIGNAL, V24, P2187, DOI 10.1016/j.cellsig.2012.07.007; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Pavalko FM, 2003, J CELL PHYSIOL, V194, P194, DOI 10.1002/jcp.10221; Plotkin LI, 2015, J BIOL CHEM, V290, P18934, DOI 10.1074/jbc.M115.642090; Roymans D, 2001, EUR J BIOCHEM, V268, P487, DOI 10.1046/j.1432-1327.2001.01936.x; Shoham N, 2012, AM J PHYSIOL-CELL PH, V302, pC429, DOI 10.1152/ajpcell.00167.2011; Song HH, 2016, CELL BIOL INT, V40, P832, DOI 10.1002/cbin.10622; Srivastava K, 2013, PHYTOMEDICINE, V20, P470, DOI 10.1016/j.phymed.2012.12.021; Tahimic CGT, 2016, J BIOL CHEM, V291, P8140, DOI 10.1074/jbc.M115.693598; Takeda K, 2011, ANTIOXID REDOX SIGN, V15, P719, DOI 10.1089/ars.2010.3392; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Vazquez M, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00208; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075973; Yanagisawa M, 2008, ARCH ORAL BIOL, V53, P214, DOI 10.1016/j.archoralbio.2007.08.012; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yu DD, 2015, INT J MOL MED, V36, P345, DOI 10.3892/ijmm.2015.2258; Yuan L, 2013, FOOD CHEM TOXICOL, V53, P62, DOI [10.1016/j.fct.2013.02.003, 10.1016/j.fct.2012.11.048]; Zhang K, 2016, APOPTOSIS, V21, P13, DOI 10.1007/s10495-015-1180-7; Zhang L, 2013, TRENDS BIOCHEM SCI, V38, P612, DOI 10.1016/j.tibs.2013.10.001; Zheng DW, 2015, ONCOL LETT, V10, P182, DOI 10.3892/ol.2015.3218; Zhong W, 2008, ORAL DIS, V14, P270, DOI 10.1111/j.1601-0825.2007.01375.x	42	24	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165845	10.1371/journal.pone.0165845	http://dx.doi.org/10.1371/journal.pone.0165845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806136	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500061
J	Zhang, N; McHale, LK; Finer, JJ				Zhang, Ning; McHale, Leah K.; Finer, John J.			A Leader Intron of a Soybean Elongation Factor 1A (eEF1A) Gene Interacts with Proximal Promoter Elements to Regulate Gene Expression in Synthetic Promoters	PLOS ONE			English	Article							NONSENSE-MEDIATED DECAY; IN-VITRO; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; TUBULIN GENE; SPLICE SITES; 1ST INTRONS; ENHANCEMENT; MAIZE; SIGNALS	Introns, especially the first intron in the 5' untranslated region (5'UTR), can significantly impact gene expression via intron-mediated enhancement (IME). In this study, we demonstrate the leader intron of a soybean elongation factor 1A (eEF1A) gene (GmScreamM8) was essential for the high activity of the native promoter. Furthermore, the interaction of the GmScreamM8 leader intron with regulatory element sequences from several soybean eEF1A promoters was studied using synthetic promoters, which consisted of element tetramers upstream of a core promoter used to regulate a green fluorescent protein (gfp) reporter gene. Element tetramers, placed upstream of a GmScreamM8 core promoter, showed very high activity using both transient expression in lima bean cotyledons and stable expression in soybean hairy roots, only if the native leader intron was included, suggesting an interaction between intronic sequences and promoter elements. Partial deletions of the leader intron showed that a 222 bp intronic sequence significantly contributed to very high levels of GFP expression. Generation of synthetic intron variants with a monomeric or trimeric repeat of the 222 bp intronic sequence, yielded almost two-fold higher expression compared to the original intron, while partial deletion of the 222 bp intronic repeated sequence significantly decreased gene expression, indicating that this intronic sequence was essential for the intron-element interaction enhancement.	[Zhang, Ning; Finer, John J.] Ohio State Univ, Dept Hort & Crop Sci, Wooster, OH 44691 USA; [McHale, Leah K.] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Finer, JJ (corresponding author), Ohio State Univ, Dept Hort & Crop Sci, Wooster, OH 44691 USA.	finer.1@osu.edu	Finer, John/N-4713-2014	Finer, John/0000-0001-8004-5468	United Soybean Board [RC371-252/4353848]; State and Federal funds; OARDC Director's Associateship Program	United Soybean Board; State and Federal funds; OARDC Director's Associateship Program	Salaries and research support were provided by the United Soybean Board (grant #RC371-252/4353848), and by State and Federal funds appropriated to The Ohio State University/Ohio Agricultural Research and Development Center.; We thank Drs. Feng Qu and Esther van der Knaap for critically reviewing this manuscript. We also thank the OARDC Director's Associateship Program for support to NZ. Mention of trademark or proprietary products does not constitute a guarantee or warranty of the product by OSU/OARDC and also does not imply approval to the exclusion of other products that may also be suitable. Department of Horticulture and Crop Science journal article tracking No HCS-16-23.	Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Bianchi M, 2009, GENE, V448, P88, DOI 10.1016/j.gene.2009.08.013; CALLIS J, 1987, GENE DEV, V1, P1183, DOI 10.1101/gad.1.10.1183; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chiera JM, 2007, PLANT CELL REP, V26, P1501, DOI 10.1007/s00299-007-0359-y; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Chung Eunsook, 2009, Journal of Plant Biotechnology, V36, P255; Clancy M, 2002, PLANT PHYSIOL, V130, P918, DOI 10.1104/pp.008235; CURIE C, 1993, MOL GEN GENET, V238, P428, DOI 10.1007/BF00292002; De La Torre CM, 2015, PLANT CELL REP, V34, P111, DOI 10.1007/s00299-014-1691-7; DONATH M, 1995, PLANT MOL BIOL, V28, P667, DOI 10.1007/BF00021192; DURSO NA, 1994, PROTOPLASMA, V180, P99, DOI 10.1007/BF01507846; Fincher K.L., 2006, U.S. Patent, Patent No. [No. 7,141,722, 7141722]; Finer J. J., 2011, Plant transformation technologies, P109; Finer J.J., 2008, HDB NEW TECHNOLOGIES, P103; FINER JJ, 1992, PLANT CELL REP, V11, P323, DOI 10.1007/BF00233358; Finer JE, 2007, PLANT CELL TISS ORG, V91, P299, DOI 10.1007/s11240-007-9292-6; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; FU HY, 1995, PLANT CELL, V7, P1395, DOI 10.1105/tpc.7.9.1395; Furger A, 2002, GENE DEV, V16, P2792, DOI 10.1101/gad.983602; Gallegos JE, 2015, PLANT SCI, V237, P8, DOI 10.1016/j.plantsci.2015.04.017; GOODALL GJ, 1990, PLANT MOL BIOL, V14, P727, DOI 10.1007/BF00016505; Hernandez-Garcia CM, 2016, PLANT CELL REP, V35, P303, DOI 10.1007/s00299-015-1885-7; Hernandez-Garcia Carlos M, 2010, J Vis Exp, DOI 10.3791/1733; Hernandez-Garcia CM, 2014, PLANT SCI, V217, P109, DOI 10.1016/j.plantsci.2013.12.007; Hernandez-Garcia CM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-237; Jeon JS, 2000, PLANT PHYSIOL, V123, P1005, DOI 10.1104/pp.123.3.1005; Jeong YM, 2006, PLANT PHYSIOL, V140, P196, DOI 10.1104/pp.105.071316; Kertesz S, 2006, NUCLEIC ACIDS RES, V34, P6147, DOI 10.1093/nar/gkl737; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li ZY, 1999, ACTA BOT SIN, V41, P800; LIU K, 1995, P NATL ACAD SCI USA, V92, P7724, DOI 10.1073/pnas.92.17.7724; LUEHRSEN KR, 1994, PLANT MOL BIOL, V24, P449, DOI 10.1007/BF00024113; MASCARENHAS D, 1990, PLANT MOL BIOL, V15, P913, DOI 10.1007/BF00039430; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; MORELLI JK, 1994, PLANT PHYSIOL, V106, P897, DOI 10.1104/pp.106.3.897; Morello L, 2008, CURR GENOMICS, V9, P227, DOI 10.2174/138920208784533629; Morello L, 2006, PLANTA, V223, P479, DOI 10.1007/s00425-005-0105-z; Morello L, 2002, PLANT J, V29, P33, DOI 10.1046/j.0960-7412.2001.01192.x; Ott CJ, 2009, J CELL MOL MED, V13, P680, DOI 10.1111/j.1582-4934.2008.00621.x; Park SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-526; Parra G, 2011, NUCLEIC ACIDS RES, V39, P5328, DOI 10.1093/nar/gkr043; Qi XT, 2007, BIOCHEM BIOPH RES CO, V356, P273, DOI 10.1016/j.bbrc.2007.02.124; Rasband W., 2006, IMAGEJ; Remans T, 2005, BIOTECHNIQUES, V38, P209, DOI 10.2144/05382ST01; RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K; Rose AB, 2008, CURR TOP MICROBIOL, V326, P277; Rose AB, 2004, PLANT J, V40, P744, DOI 10.1111/j.1365-313X.2004.02247.x; Rose AB, 2000, PLANT PHYSIOL, V122, P535, DOI 10.1104/pp.122.2.535; Rose AB, 2008, PLANT CELL, V20, P543, DOI 10.1105/tpc.107.057190; Rushton PJ, 2002, PLANT CELL, V14, P749, DOI 10.1105/tpc.010412; Salgueiro S, 2000, PLANT MOL BIOL, V42, P615, DOI 10.1023/A:1006331831858; SAMBROOK J, 1977, NATURE, V268, P101, DOI 10.1038/268101a0; Sasikumar AN, 2012, WIRES RNA, V3, P543, DOI 10.1002/wrna.1118; Shin D, 2009, PLANT SCI, V177, P156, DOI 10.1016/j.plantsci.2009.05.003; SINIBALDI RM, 1992, PROG NUCLEIC ACID RE, V42, P229, DOI 10.1016/S0079-6603(08)60577-2; Stewart CN, 2001, PLANT CELL REP, V20, P376, DOI 10.1007/s002990100346; Szczesniak MW, 2013, PLANT CELL PHYSIOL, V54, pE10, DOI 10.1093/pcp/pct001; URSIN VM, 1991, PLANT CELL, V3, P583, DOI 10.1105/tpc.3.6.583; Vain P, 1996, PLANT CELL REP, V15, P489, DOI 10.1007/BF00232980; Wu CL, 2008, IN VITRO CELL DEV-PL, V44, P540, DOI 10.1007/s11627-008-9126-1; Xu YF, 1999, BIOTECHNIQUES, V26, P639, DOI 10.2144/99264bm10; Zhang N, 2015, PLANT SCI, V241, P189, DOI 10.1016/j.plantsci.2015.10.010	64	6	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0166074	10.1371/journal.pone.0166074	http://dx.doi.org/10.1371/journal.pone.0166074			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806110	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500081
J	Jella, KK; Yu, L; Yue, Q; Friedman, D; Duke, BJ; Alli, AA				Jella, Kishore Kumar; Yu, Ling; Yue, Qiang; Friedman, Daniel; Duke, Billie J.; Alli, Abdel A.			Exosomal GAPDH from Proximal Tubule Cells Regulate ENaC Activity	PLOS ONE			English	Article							EPITHELIAL SODIUM-CHANNEL; XENOPUS 2F3 CELLS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; NA+ CHANNELS; INTRACELLULAR CALCIUM; ANIONIC PHOSPHOLIPIDS; GLYCOLYTIC-ENZYMES; GAMMA-SUBUNIT; A6 CELLS; PROTEIN	Exosomes are nanometer-scale, cell-derived vesicles that contain various molecules including nucleic acids, proteins, and lipids. These vesicles can release their cargo into adjacent or distant cells and mediate intercellular communication and cellular function. Here we examined the regulation of epithelial sodium channels in mpkCCD cells and distal tubule Xenopus 2F3 cells by exosomes isolated from proximal tubule LLC-PK1 cells. Cultured mpkCCD cells were stained with CTX coupled to a green fluorophore in order to label the cell membranes and freshly isolated exosomes from LLC-PK1 cells were labeled with the red lipophilic dye PKH26 in order to visualize uptake of exosomes into the cells. Single-channel patch clamp recordings showed the open probability of ENaC in Xenopus 2F3 cells and in freshly isolated split-open tubules decreased in response to exogenous application of exosomes derived from LLC-PK1 proximal tubule cells. Active GAPDH was identified within exosomes derived from proximal tubule LLC-PK1 cells. The effect on ENaC activity in Xenopus 2F3 cells was blunted after application of exosomes transfected with the GAPDH inhibitor heptelidic acid. Also, we show GAPDH and ENaC subunits associate in mpkCCD cells. These studies examine a potential role for exosomes in the regulation of ENaC activity and examine a possible mechanism for communication from proximal tubule cells to distal tubule and collecting duct cells.	[Alli, Abdel A.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL USA; [Alli, Abdel A.] Univ Florida, Coll Med, Dept Med, Div Nephrol Hypertens & Renal Transplantat, Gainesville, FL USA; [Jella, Kishore Kumar] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA USA; [Yue, Qiang; Friedman, Daniel; Duke, Billie J.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA USA; [Yu, Ling] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Emory University; Emory University; Nanjing Agricultural University	Alli, AA (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL USA.; Alli, AA (corresponding author), Univ Florida, Coll Med, Dept Med, Div Nephrol Hypertens & Renal Transplantat, Gainesville, FL USA.	aalli@ufl.edu			US National Aeronautics and Space Administration award [NNX15AD63G]; Robert P. Apkarian Integrated Electron Microscopy Core; Integrated Cellular Imaging Microscopy Core at Emory University;  [K01 DK099617]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK099617] Funding Source: NIH RePORTER	US National Aeronautics and Space Administration award; Robert P. Apkarian Integrated Electron Microscopy Core; Integrated Cellular Imaging Microscopy Core at Emory University; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a K01 DK099617 to MA, a US National Aeronautics and Space Administration award NNX15AD63G to WSD, and in part by the Robert P. Apkarian Integrated Electron Microscopy Core and the Integrated Cellular Imaging Microscopy Core at Emory University.	Alli AA, 2015, AM J PHYSIOL-RENAL, V309, pF456, DOI 10.1152/ajprenal.00631.2014; Alli AA, 2012, AM J PHYSIOL-RENAL, V303, pF800, DOI 10.1152/ajprenal.00703.2011; Alli AA, 2012, J BIOL CHEM, V287, P30073, DOI 10.1074/jbc.M111.338574; Antonyak MA, 2015, P NATL ACAD SCI USA, V112, P3589, DOI 10.1073/pnas.1502590112; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; CANTIELLO HF, 1991, AM J PHYSIOL, V261, pC882, DOI 10.1152/ajpcell.1991.261.5.C882; Chen RW, 1999, J NEUROSCI, V19, P9654; Cueille N, 2007, J PROTEOME RES, V6, P2640, DOI 10.1021/pr070081z; Gildea JJ, 2014, CLIN BIOCHEM, V47, P89, DOI 10.1016/j.clinbiochem.2014.06.018; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; Haerteis S, 2012, PFLUG ARCH EUR J PHY, V464, P353, DOI 10.1007/s00424-012-1138-3; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Ilatovskaya DV, 2011, FASEB J, V25, P2688, DOI 10.1096/fj.10-167262; Jella KK, 2014, RADIAT RES, V181, P138, DOI 10.1667/RR13337.1; Jovov B, 1999, J BIOL CHEM, V274, P37845, DOI 10.1074/jbc.274.53.37845; Karpushev AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008827; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; KUMAGAI H, 1983, J BIOCHEM-TOKYO, V93, P1259, DOI 10.1093/oxfordjournals.jbchem.a134260; Ma HP, 2005, J AM SOC NEPHROL, V16, P3182, DOI 10.1681/ASN.2005040434; Ma HP, 2002, AM J PHYSIOL-RENAL, V282, pF501, DOI 10.1152/ajprenal.00147.2001; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Malik B, 2006, AM J PHYSIOL-RENAL, V290, pF1285, DOI 10.1152/ajprenal.00432.2005; Mazzochi C, 2006, AM J PHYSIOL-RENAL, V291, pF1113, DOI 10.1152/ajprenal.00195.2006; Mazzochi C, 2006, J BIOL CHEM, V281, P6528, DOI 10.1074/jbc.M509386200; MINASCHEK G, 1992, EUR J CELL BIOL, V58, P418; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Patel AB, 2012, AM J PHYSIOL-RENAL, V303, pF540, DOI 10.1152/ajprenal.00133.2012; Patterson RL, 2005, P NATL ACAD SCI USA, V102, P1357, DOI 10.1073/pnas.0409657102; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reifenberger MS, 2014, AM J PHYSIOL-RENAL, V307, pF86, DOI 10.1152/ajprenal.00251.2013; Renigunta A, 2011, CELL PHYSIOL BIOCHEM, V28, P663, DOI 10.1159/000335761; ROBBINS AR, 1995, J CELL BIOL, V130, P1093, DOI 10.1083/jcb.130.5.1093; Sun Y, 2011, ACTA PHARMACOL SIN, V32, P789, DOI 10.1038/aps.2011.72; Taruno A, 2008, AM J PHYSIOL-RENAL, V294, pF177, DOI 10.1152/ajprenal.00250.2007; Thai TL, 2015, J BIOL CHEM, V290, P28805, DOI 10.1074/jbc.M115.668293; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vallon V, 2011, AM J PHYSIOL-RENAL, V301, pF463, DOI 10.1152/ajprenal.00236.2011; van Balkom BWM, 2011, KIDNEY INT, V80, P1138, DOI 10.1038/ki.2011.292; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zeringer Emily, 2015, Cold Spring Harb Protoc, V2015, P319, DOI 10.1101/pdb.top074476	44	45	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165763	10.1371/journal.pone.0165763	http://dx.doi.org/10.1371/journal.pone.0165763			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802315	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200050
J	Sastre, N; Francino, O; Curti, JN; Armenta, TC; Fraser, DL; Kelly, RM; Hunt, E; Silbermayr, K; Zewe, C; Sanchez, A; Ferrer, L				Sastre, Natalia; Francino, Olga; Curti, Joseph N.; Armenta, Tiffany C.; Fraser, Devaughn L.; Kelly, Rochelle M.; Hunt, Erin; Silbermayr, Katja; Zewe, Christine; Sanchez, Armand; Ferrer, Lluis			Detection, Prevalence and Phylogenetic Relationships of Demodex spp and further Skin Prostigmata Mites (Acari, Arachnida) in Wild and Domestic Mammals	PLOS ONE			English	Article							NATURAL TRANSMISSION; GENE-SEQUENCES; GENOMIC DNA; FOLLICULORUM; DEMODICOSIS; EXTRACTION; SOFTWARE; BIOLOGY; CANIS; MODEL	This study was conceived to detect skin mites in social mammals through real-time qPCR, and to estimate taxonomic Demodex and further Prostigmata mite relationships in different host species by comparing sequences from two genes: mitochondrial 16S rRNA and nuclear 18S rRNA. We determined the mite prevalence in the hair follicles of marmots (13%) and bats (17%). The high prevalence found in marmots and bats by sampling only one site on the body may indicate that mites are common inhabitants of their skin. Since we found three different mites (Neuchelacheles sp, Myobia sp and Penthaleus sp) in three bat species (Miotis yumanensis, Miotis californicus and Corynorhinus townsendii) and two different mites (both inferred to be members of the Prostigmata order) in one marmot species (Marmota flaviventris), we tentatively concluded that these skin mites 1) cannot be assigned to the same genus based only on a common host, and 2) seem to evolve according to the specific habitat and/or specific hair and sebaceous gland of the mammalian host. Moreover, two M. yumanensis bats harbored identical Neuchelacheles mites, indicating the possibility of interspecific cross-infection within a colony. However, some skin mites species are less restricted by host species than previously thought. Specifically, Demodex canis seems to be more transmissible across species than other skin mites. D. canis have been found mostly in dogs but also in cats and captive bats. In addition, we report the first case of D. canis infestation in a domestic ferret (Mustela putorius). All these mammalian hosts are related to human activities, and D. canis evolution may be a consequence of this relationship. The monophyletic Demodex clade showing closely related dog and human Demodex sequences also supports this likely hypothesis.	[Sastre, Natalia; Curti, Joseph N.; Armenta, Tiffany C.; Fraser, Devaughn L.; Sanchez, Armand] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Sastre, Natalia; Francino, Olga] Univ Autonoma Barcelona, Ser Vet Genet Mol, Bellaterra, Spain; [Armenta, Tiffany C.] Rocky Mt Biol Labs, Crested Butte, CO USA; [Kelly, Rochelle M.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Hunt, Erin] Calif Wolf Ctr, Julian, CA USA; [Silbermayr, Katja] Vetmeduni Vienna, Inst Parasitol, Dept Pathobiol, Vienna, Austria; [Zewe, Christine; Ferrer, Lluis] Tufts Univ, Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA USA	University of California System; University of California Los Angeles; Autonomous University of Barcelona; University of Washington; University of Washington Seattle; University of Veterinary Medicine Vienna; Tufts University	Sastre, N (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA.; Sastre, N (corresponding author), Univ Autonoma Barcelona, Ser Vet Genet Mol, Bellaterra, Spain.	natalia.sastre@uab.cat	Francino, Olga/K-5683-2017; Curti, Joseph/AAZ-5011-2020; Armenta, Tiffany C/M-9612-2017; Sanchez, Armand/L-7905-2015; ferrer, lluis/ABE-5179-2020	Francino, Olga/0000-0002-9022-3835; Curti, Joseph/0000-0003-4630-9073; Armenta, Tiffany C/0000-0002-5000-5315; Sanchez, Armand/0000-0001-9160-1124; ferrer, lluis/0000-0003-1537-0074; Sastre Alaiz, Natalia/0000-0002-0758-9124	University of California, Los Angeles	University of California, Los Angeles(University of California System)	We are grateful to the personnel from the California Wolf Center, especially to Norm Switzer, for supplying wolf hair samples. We thank Ivan Ravera and Diana Ferreira from the Veterinary School, Universitat Autonoma de Barcelona for describing morphologically the Demodex samples and Melissa Nashat from the Rockefeller University, Memorial Sloan-Kettering Cancer Center for providing the 18S rDNA primers. Thanks are due also to Robert K. Wayne from the University of California, Los Angeles for supporting this research.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Alvarez L, 2007, ANN TROP MED PARASIT, V101, P529, DOI 10.1179/136485907X193888; ARMITAGE KB, 1991, ANNU REV ECOL SYST, V22, P379, DOI 10.1146/annurev.es.22.110191.002115; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Beale K, 2012, J FELINE MED SURG, V14, P209, DOI 10.1177/1098612X12439268; Bochkov AV, 2004, INVERTEBR SYST, V18, P547, DOI 10.1071/IS04013; Brigham RM, 1997, J MAMMAL, V78, P1231, DOI 10.2307/1383066; Cao Yong-Sheng, 2009, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V27, P271; CONROY JD, 1982, J AM ANIM HOSP ASSOC, V18, P405; de Rojas M, 2012, PARASITOL RES, V110, P227, DOI 10.1007/s00436-011-2476-3; DESCH C, 1972, J PARASITOL, V58, P169, DOI 10.2307/3278267; DESCH C, 1979, CORNELL VET, V69, P280; Desch CE, 2003, J MED ENTOMOL, V40, P146, DOI 10.1603/0022-2585-40.2.146; Desch Clifford E. Jr., 1996, International Journal of Acarology, V22, P187; Erbagci Z, 1998, INT J DERMATOL, V37, P421, DOI 10.1046/j.1365-4362.1998.00218.x; FAIN A, 1994, INT J PARASITOL, V24, P1273, DOI 10.1016/0020-7519(94)90194-5; Feldman SH, 2011, COMPARATIVE MED, V61, P484; Ferreira D, 2015, VET DERMATOL, V26, P239, DOI 10.1111/vde.12206; FISHER WF, 1980, VET PARASITOL, V7, P233, DOI 10.1016/0304-4017(80)90027-8; Frank LA, 2013, VET DERMATOL, V24, P367, DOI 10.1111/vde.12030; FRASE B A, 1980, Mammalian Species, P1, DOI 10.2307/3503965; GARVEN HSD, 1946, LANCET, V251, P44; GREVE JH, 1966, J AM VET MED ASSOC, V148, P1043; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Ivarez-Castaneda S., 2008, MYOTIS LUCIFUGUS THE; Izdebska JN, 2014, J PARASITOL, V100, P784, DOI 10.1645/14-532.1; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kethley JB, 1982, ACARIFORMES SYNOPSIS, P117; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kligman AM, 2011, J INVEST DERMATOL, V131, P8, DOI 10.1038/jid.2010.335; Klompen H, 2007, MOL PHYLOGENET EVOL, V43, P936, DOI 10.1016/j.ympev.2006.10.024; Lacey N, 2011, DERMATOLOGY, V222, P128, DOI 10.1159/000323009; Lankton JS, 2013, J ZOO WILDLIFE MED, V44, P124, DOI 10.1638/1042-7260-44.1.124; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindquist EE, 1996, ERIOPHYOID MITES THE, V6, P301, DOI DOI 10.1016/S1572-4379(96)80019-4; Lowenstein C, 2005, VET REC, V157, P290, DOI 10.1136/vr.157.10.290; Mangold AJ, 1998, PARASITOL RES, V84, P31, DOI 10.1007/s004360050352; Mangold AJ, 1998, PARASITOL RES, V84, P478, DOI 10.1007/s004360050433; Mech LD, 1999, CAN J ZOOL, V77, P1196, DOI 10.1139/cjz-77-8-1196; Mech LD, 1970, THE WOLF THE ECOLOGY; Mueller RS, 2004, VET DERMATOL, V15, P75, DOI 10.1111/j.1365-3164.2004.00344.x; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nei M, 1975, MOL POPULATION GENET; NUTTING W B, 1975, New Zealand Journal of Zoology, V2, P219; NUTTING WB, 1976, CORNELL VET, V66, P214; Palopoli MF, 2015, P NATL ACAD SCI USA, V112, P15958, DOI 10.1073/pnas.1512609112; Palopoli MF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1124; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ravera I, 2013, VET DERMATOL, V24, P168, DOI 10.1111/j.1365-3164.2012.01099.x; Ravera I, 2011, PARASITOL RES, V108, P305, DOI 10.1007/s00436-010-2062-0; Saridomichelakis M, 1999, J SMALL ANIM PRACT, V40, P529, DOI 10.1111/j.1748-5827.1999.tb03014.x; Sastre N, 2013, PARASITOL RES, V112, P3369, DOI 10.1007/s00436-013-3531-z; Sastre N, 2012, VET DERMATOL, V23, DOI 10.1111/vde.12001; Scott D, 2001, PARASITIC SKIN DIS M, P457; Silbermayr K, 2015, PARASITOL RES, V114, P747, DOI 10.1007/s00436-014-4243-8; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thoemmes MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106265; Toops E, 2010, INT J APPL RES VET M, V8, P31; Tsao WC, 2008, ZOOL STUD, V47, P633; Umina PA, 2004, EXP APPL ACAROL, V34, P211, DOI 10.1007/s10493-004-1804-z; Woolley TA, 1988, ACAROLOGY MITES AND; Yabsley Michael J, 2013, ISRN Parasitol, V2013, P342918, DOI 10.5402/2013/342918; Zhao YE, 2012, PARASITOL RES, V111, P1113, DOI 10.1007/s00436-012-2941-7; Zhao YE, 2012, EXP PARASITOL, V131, P45, DOI 10.1016/j.exppara.2012.02.025; Zhao Ya-E, 2009, Acta Entomologica Sinica, V52, P1273; Zhou CF, 2013, NATURE, V500, P163, DOI 10.1038/nature12429	69	17	18	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165765	10.1371/journal.pone.0165765	http://dx.doi.org/10.1371/journal.pone.0165765			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802314	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200051
J	Budak, F; Bal, SH; Tezcan, G; Guvenc, F; Akalin, EH; Goral, G; Deniz, G; Oral, HB				Budak, Ferah; Bal, S. Haldun; Tezcan, Gulcin; Guvenc, Furkan; Akalin, E. Halis; Goral, Guher; Deniz, Gunnur; Oral, H. Barbaros			MicroRNA Expression Patterns of CD8+T Cells in Acute and Chronic Brucellosis	PLOS ONE			English	Article							T-LYMPHOCYTES; UP-REGULATION; DIFFERENTIAL EXPRESSION; PROSTATE-CANCER; DOWN-REGULATION; POOR-PROGNOSIS; SERUM MIRNAS; HEPATITIS-B; PROLIFERATION; MELITENSIS	Although our knowledge about Brucella virulence factors and the host response increase rapidly, the mechanisms of immune evasion by the pathogen and causes of chronic disease are still unknown. Here, we aimed to investigate the immunological factors which belong to CD8+ T cells and their roles in the transition of brucellosis from acute to chronic infection. Using miRNA microarray, more than 2000 miRNAs were screened in CD8+ T cells of patients with acute or chronic brucellosis and healthy controls that were sorted from peripheral blood with flow cytometry and validated through qRT-PCR. Findings were evaluated using GeneSpring GX (Agilent) 13.0 software and KEGG pathway analysis. Expression of two miRNAs were determined to display a significant fold change in chronic group when compared with acute or control groups. Both miRNAs (miR-126-5p and miR-47533p) were decreased (p <0.05 or fold change > 2). These miRNAs have the potential to be the regulators of CD8+ T cell-related marker genes for chronic brucellosis infections. The differentially expressed miRNAs and their predicted target genes are involved in MAPK signaling pathway, cytokine-cytokine receptor interactions, endocytosis, regulation of actin cytoskeleton, and focal adhesion indicating their potential roles in chronic brucellosis and its progression. It is the first study of miRNA expression analysis of human CD8+ T cells to clarify the mechanism of inveteracy in brucellosis.	[Budak, Ferah; Bal, S. Haldun; Oral, H. Barbaros] Uludag Univ, Dept Immunol, Fac Med, Bursa, Turkey; [Tezcan, Gulcin] Uludag Univ, Fac Med, Dept Med Biol, Bursa, Turkey; [Guvenc, Furkan] Univ Toronto, Fac Med, Dept Mol Genet, Toronto, ON, Canada; [Akalin, E. Halis] Uludag Univ, Fac Med, Dept Clin Microbiol & Infect Dis, Bursa, Turkey; [Goral, Guher] Uludag Univ, Dept Med Microbiol, Fac Med, Bursa, Turkey; [Deniz, Gunnur] Istanbul Univ, Aziz Sancar Inst Expt Med, Dept Immunol, Istanbul, Turkey	Uludag University; Uludag University; University of Toronto; Uludag University; Uludag University; Istanbul University	Oral, HB (corresponding author), Uludag Univ, Dept Immunol, Fac Med, Bursa, Turkey.	oralb@uludag.edu.tr	Tezcan, Gulcin/F-8554-2017; Deniz, Gunnur/AAC-2909-2020; Budak, Ferah/F-4657-2014; Tezcan, Gulcin/AAH-3843-2020; Akalin, Halis/AAU-8952-2020; ORAL, HALUK BARBAROS Haluk/K-7285-2012	ORAL, HALUK BARBAROS Haluk/0000-0003-0463-6818; Guvenc, Furkan/0000-0002-6978-8217; Tezcan, Gulcin/0000-0002-5956-8755	Uludag University, Bursa, Turkey [UAP(T)-2011/15]	Uludag University, Bursa, Turkey(Uludag University)	This work was supported by the grant from Uludag University, Bursa, Turkey (grant number UAP(T)-2011/15).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ander BP, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0029-9; Araj GF, 2010, INT J ANTIMICROB AG, V36, pS12, DOI 10.1016/j.ijantimicag.2010.06.014; ARIZA J, 1992, CLIN INFECT DIS, V14, P131, DOI 10.1093/clinids/14.1.131; Asahchop EL, 2016, AIDS, V30, P2021, DOI 10.1097/QAD.0000000000001160; Atluri VL, 2011, ANNU REV MICROBIOL, V65, P523, DOI 10.1146/annurev-micro-090110-102905; Aygen B, 2002, MED MALADIES INFECT, V32, P485, DOI 10.1016/S0399-077X(02)00403-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Budak F, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4591468; Cassataro J, 2005, INFECT IMMUN, V73, P6537, DOI 10.1128/IAI.73.10.6537-6546.2005; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheng JW, 2016, ONCOTARGET, V7, P30702, DOI [10.18632/oncotarget.8930, 10.16632/oncotarget.8930]; Choi Y, 2001, EUR J IMMUNOL, V31, P2179, DOI 10.1002/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO;2-X; Chowdhari S, 2014, J CELL PHYSIOL, V229, P1630, DOI 10.1002/jcp.24608; Das K, 2013, TUBERCULOSIS, V93, pS47, DOI 10.1016/S1472-9792(13)70010-6; de Figueiredo P, 2015, AM J PATHOL, V185, P1505, DOI 10.1016/j.ajpath.2015.03.003; Doganay Mehmet, 2003, International Journal of Infectious Diseases, V7, P173, DOI 10.1016/S1201-9712(03)90049-X; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Durward M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034925; Durward MA, 2010, INFECT IMMUN, V78, P168, DOI 10.1128/IAI.00994-09; Durward-Diloia M, 2015, INFECT IMMUN, V83, P4759, DOI 10.1128/IAI.01184-15; Ferooz Jonathan, 2010, BMC Res Notes, V3, P333, DOI 10.1186/1756-0500-3-333; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Fricke A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0424-z; GALDIERO M, 1995, RES MICROBIOL, V146, P507, DOI 10.1016/0923-2508(96)80296-8; Galinska EM, 2013, ANN AGR ENV MED, V20, P233; Geyik MF, 2002, SWISS MED WKLY, V132, P98, DOI 10.57187/smw.2002.09900; Hamam R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25997; He YQ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00002; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Jin BX, 2015, SCI REP-UK, V5, DOI 10.1038/srep15026; Jinushi T, 2014, CANCER MED-US, V3, P1544, DOI 10.1002/cam4.309; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim JH, 2013, THER ADV MUSCULOSKEL, V5, P13, DOI 10.1177/1759720X12466608; Kojima M, 2015, PLOS ONE, V10; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lee KH, 2014, BBA-MOL CELL RES, V1843, P2055, DOI 10.1016/j.bbamcr.2014.06.001; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li J, 2015, BIO-MED MATER ENG, V26, pS1985, DOI 10.3233/BME-151502; Li L, 2016, CANCER LETT, V373, P234, DOI 10.1016/j.canlet.2016.01.028; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; Moreno-Lafont MC, 2002, T ROY SOC TROP MED H, V96, P340, DOI 10.1016/S0035-9203(02)90119-7; MORENOLAFONT MC, 1995, CLIN DIAGN LAB IMMUN, V2, P377, DOI 10.1128/CDLI.2.3.377-380.1995; Murphy EA, 2001, FEMS IMMUNOL MED MIC, V32, P85, DOI 10.1111/j.1574-695X.2001.tb00536.x; Mutlu S, 2015, EUR REV MED PHARMACO, V19, P2384; Norman FF, 2016, TRAVEL MED INFECT DI, V14, P182, DOI 10.1016/j.tmaid.2016.05.005; OLIVEIRA SC, 1995, EUR J IMMUNOL, V25, P2551, DOI 10.1002/eji.1830250922; Pu Q, 2016, THORAC CANCER, V7, P348, DOI 10.1111/1759-7714.12317; Sallustio F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068296; Scian R, 2012, INFECT IMMUN, V80, P2333, DOI 10.1128/IAI.00208-12; Shan L, 2007, CELL HOST MICROBE, V1, P167, DOI 10.1016/j.chom.2007.04.008; Shen YH, 2015, TUMOR BIOL, V36, P4525, DOI 10.1007/s13277-015-3097-8; Shibayama Y, 2015, ONCOL REP, V33, P2176, DOI 10.3892/or.2015.3839; Shrivastava S, 2013, HEPATOLOGY, V58, P863, DOI 10.1002/hep.26296; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Skendros P, 2013, REV SCI TECH OIE, V32, P137; Skendros P, 2007, J INFECTION, V54, P192, DOI 10.1016/j.jinf.2006.04.001; Solera J, 2010, INT J ANTIMICROB AG, V36, pS18, DOI 10.1016/j.ijantimicag.2010.06.015; Song CJ, 2015, PROSTATE, V75, P500, DOI 10.1002/pros.22936; Takahashi K, 2014, DRUG METAB PHARMACOK, V29, P333, DOI 10.2133/dmpk.DMPK-13-RG-114; Tan YW, 2015, CLIN CHIM ACTA, V451, P232, DOI 10.1016/j.cca.2015.10.002; Thirion M, 2013, VIRUSES-BASEL, V5, P2690, DOI 10.3390/v5112690; Ulu-Kilic Aysegul, 2013, Recent Pat Antiinfect Drug Discov, V8, P34; Veiga-Fernandes H, 2004, NAT IMMUNOL, V5, P31, DOI 10.1038/ni1015; Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981; Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang ZH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0577-9; Warnecke-Eberz U, 2015, TUMOR BIOL, V36, P4643, DOI 10.1007/s13277-015-3112-0; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu ZP, 2014, BIOCHEM BIOPH RES CO, V443, P944, DOI 10.1016/j.bbrc.2013.12.075; Xavier MN, 2009, J COMP PATHOL, V140, P149, DOI 10.1016/j.jcpa.2008.10.004; Xia ZY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/624037; Xu C, 2016, ONCOL REP, V35, P497, DOI 10.3892/or.2015.4392; Xun M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0288-2; Yabushita S, 2012, PANCREAS, V41, P1013, DOI 10.1097/MPA.0b013e31824ac3a5; Yamaguchi T, 1996, J BIOCHEM-TOKYO, V120, P494; Young EJ., 2005, PRINCIPLES PRACTICE, V6; Yu CR, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/359674; Yu T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-64; Yuan ZL, 2004, MOL CELL BIOL, V24, P9390, DOI 10.1128/MCB.24.21.9390-9400.2004; Yuce A, 2006, KLIMIK J, V19, P87; Zhang YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17942; Zheng GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083025; Zheng HY, 2016, ONCOTARGET, V7, P4647, DOI 10.18632/oncotarget.6615; Zheng K, 2012, INT J BIOL SCI, V8, P1013, DOI 10.7150/ijbs.3836; Zheng ZH, 2013, J VIROL, V87, P5645, DOI 10.1128/JVI.02655-12; Zhou W, 2014, BONE, V66, P267, DOI 10.1016/j.bone.2014.06.021	90	12	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165138	10.1371/journal.pone.0165138	http://dx.doi.org/10.1371/journal.pone.0165138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824867	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200014
J	Lo, WC; Arsenescu, V; Arsenescu, RI; Friedman, A				Lo, Wing-Cheong; Arsenescu, Violeta; Arsenescu, Razvan I.; Friedman, Avner			Inflammatory Bowel Disease: How Effective Is TNF-alpha Suppression?	PLOS ONE			English	Article							REGULATORY T-CELLS; INTERFERON-GAMMA-PRODUCTION; BLOOD MONONUCLEAR-CELLS; CYTOKINE PRODUCTION; MATHEMATICAL-MODEL; TH1; EXPRESSION; IL-2; SARCOIDOSIS; TOLERANCE	Crohn's Disease (CD) results from inappropriate response toward commensal flora. Earlier studies described CD as a Th1 mediated disease. Current models view both phenotypes as a continuum of various permutations between Th1, Th2 and Th17 pathways compounded by a range of Treg disfunctions. In the present paper, we develop a mathematical model, by a system of differential equations, which describe the dynamic relations among these T cells and their cytokines. The model identities four groups of CD patients according to up/down regulation of Th1 and Th2. The model simulations show that immunosuppression by TNF-alpha blockage benefits the group with Th1(High)/Th2(Low) while, by contrast, the group with Th1(Low)/Th2(High) will benefit from immune activation.	[Lo, Wing-Cheong] City Univ Hong Kong, Dept Math, Hong Kong, Hong Kong, Peoples R China; [Arsenescu, Violeta] Armedica LLC, Dublin, OH USA; [Arsenescu, Razvan I.] Morristown Med Ctr, Ctr Inflammatory Bowel Dis, Digest Hlth Inst, Morristown, NJ USA; [Friedman, Avner] Ohio State Univ, Dept Math, Math Biosci Inst, 231 W 18th Ave, Columbus, OH 43210 USA	City University of Hong Kong; Atlantic Health System; University System of Ohio; Ohio State University	Lo, WC (corresponding author), City Univ Hong Kong, Dept Math, Hong Kong, Hong Kong, Peoples R China.	wingclo@cityu.edu.hk			Mathematical Biosciences Institute; National Science Foundation [DMS 0931642]; CityU StUp Grant [7200437]	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF)); CityU StUp Grant	This research has been supported by the Mathematical Biosciences Institute and the National Science Foundation under Grant DMS 0931642. WCL was partially supported by a grant from a CityU StUp Grant (No. 7200437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research has been supported by the Mathematical Biosciences Institute and the National Science Foundation under Grant DMS 0931642. WCL was partially supported by a grant from a CityU StUp Grant (No. 7200437).	Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bhatia S, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-2; Brooks DG, 2010, P NATL ACAD SCI USA, V107, P3018, DOI 10.1073/pnas.0914500107; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Conlon P J, 1989, Biotechnol Ther, V1, P31; Coquet JM, 2008, J IMMUNOL, V180, P7097, DOI 10.4049/jimmunol.180.11.7097; Crouser ED, 2009, AM J RESP CRIT CARE, V179, P929, DOI 10.1164/rccm.200803-490OC; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Grassegger A, 2004, CLIN EXP DERMATOL, V29, P584, DOI 10.1111/j.1365-2230.2004.01652.x; Hao WR, 2014, P NATL ACAD SCI USA, V111, P16065, DOI 10.1073/pnas.1417789111; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Hong T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002122; HuLi J, 1997, P NATL ACAD SCI USA, V94, P3189, DOI 10.1073/pnas.94.7.3189; Hwang ES, 2005, J EXP MED, V202, P1289, DOI 10.1084/jem.20051044; Kaminska B, 2005, ACTA BIOCHIM POL, V52, P329; Le T, 1997, BLOOD, V89, P4112, DOI 10.1182/blood.V89.11.4112; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liu C, 2013, CLIN EXP IMMUNOL, V173, P102, DOI 10.1111/cei.12084; Lo WC, 2013, B MATH BIOL, V75, P1417, DOI 10.1007/s11538-013-9853-2; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Marino A, 2008, NEPHROL DIAL TRANSPL, V23, P1460, DOI 10.1093/ndt/gfm856; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Matinez FO, 2014, F1000PRIME REP, V6, P6; Mizoguchi A, 2010, CURR OPIN PHARMACOL, V10, P578, DOI 10.1016/j.coph.2010.05.007; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; OLIVER JC, 1993, LYMPHOKINE CYTOK RES, V12, P115; Osugi Y, 1997, BLOOD, V89, P4100, DOI 10.1182/blood.V89.11.4100; PUERINGER RJ, 1993, CHEST, V103, P832, DOI 10.1378/chest.103.3.832; Rao BM, 2004, MOL PHARMACOL, V66, P864, DOI 10.1124/mol.66.4.864; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Shim JO, 2013, PEDIATR GASTROENTERO, V16, P17, DOI 10.5223/pghn.2013.16.1.17; Stummvoll GH, 2008, J IMMUNOL, V181, P1908, DOI 10.4049/jimmunol.181.3.1908; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Targan SR, 2009, CURR GASTROENTEROL R, V11, P473; Toossi Z, 1996, J IMMUNOL, V156, P3461; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Viallard JF, 1999, CLIN EXP IMMUNOL, V115, P189; WALLACE WAH, 1992, THORAX, V47, P437, DOI 10.1136/thx.47.6.437; Wang YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S21; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Zenewicz LA, 2009, TRENDS MOL MED, V15, P199, DOI 10.1016/j.molmed.2009.03.002; Zhang JD, 2014, HYPERTENSION, V64, P1275, DOI 10.1161/HYPERTENSIONAHA.114.03863	44	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165782	10.1371/journal.pone.0165782	http://dx.doi.org/10.1371/journal.pone.0165782			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824890	Green Submitted, Green Published, gold			2022-12-27	WOS:000387615200033
J	Wang, YH; Vlasova, A; Velasquez, DE; Saif, LJ; Kandasamy, S; Kochba, E; Levin, Y; Jiang, BM				Wang, Yuhuan; Vlasova, Anastasia; Velasquez, Daniel E.; Saif, Linda J.; Kandasamy, Sukumar; Kochba, Efrat; Levin, Yotam; Jiang, Baoming			Skin Vaccination against Rotavirus Using Microneedles: Proof of Concept in Gnotobiotic Piglets	PLOS ONE			English	Article							ADULTS 18-64 YEARS; IMMUNE-RESPONSES; INTRADERMAL VACCINATION; REASSORTANT ROTAVIRUS; PROTECTIVE IMMUNITY; INFLUENZA VACCINES; RANDOMIZED-TRIAL; INDIAN INFANTS; IMMUNOGENICITY; INFECTION	Live-attenuated oral rotavirus (RV) vaccines have lower efficacy in low income countries, and additionally are associated with a rare but severe adverse event, intussusception. We have been pursuing the development of an inactivated rotavirus vaccine (IRV) using the human rotavirus strain CDC-9 (G1P[8]) through parenteral immunization and previously demonstrated dose sparing and enhanced immunogenicity of intradermal (ID) unadjuvanted IRV using a coated microneedle patch in comparison with intramuscular (IM) administration in mice. The aim of this study was to evaluate the immune response and protection against RV infection and diarrhea conferred by the administration of the ID unadjuvanted IRV using the microneedle device MicronJet600 (R) in neonatal gnotobiotic (Gn) piglets challenged with virulent Wa G1P[8] human RV. Three doses of 5 mu g IRV when administered intradermally and 5 mu g IRV formulated with aluminum hydroxide [Al(OH)(3)] when administered intramuscularly induced comparable rotavirus-specific antibody titers of IgA, IgG, IgG avidity index and neutralizing activity in sera of neonatal piglets. Both IRV vaccination regimens protected against RV antigen shedding in stools, and reduced the cumulative diarrhea scores in the piglets. This study demonstrated that the ID and IM administrations of IRV are immunogenic and protective against RV-induced diarrhea in neonatal piglets. Our findings highlight the potential value of an adjuvant sparing effect of the IRV ID delivery route.	[Wang, Yuhuan; Velasquez, Daniel E.; Jiang, Baoming] Ctr Dis Control & Prevent, Div Viral Dis, Gastroenteritis & Resp Viruses Lab Branch, Atlanta, GA USA; [Vlasova, Anastasia; Saif, Linda J.; Kandasamy, Sukumar] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Kochba, Efrat; Levin, Yotam] NanoPass Technol Ltd, Ness Ziona, Israel	Centers for Disease Control & Prevention - USA; University System of Ohio; Ohio State University	Jiang, BM (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Gastroenteritis & Resp Viruses Lab Branch, Atlanta, GA USA.	bxj4@cdc.gov			NanoPass Technologies Limited	NanoPass Technologies Limited	NanoPass Technologies Limited provided support in the form of salaries for authors [YL and EK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali SA, 2014, J INFECT DIS, V210, P1772, DOI 10.1093/infdis/jiu335; Angel J, 1999, J INTERF CYTOK RES, V19, P655, DOI 10.1089/107999099313802; Angel J, 2014, HUM VACC IMMUNOTHER, V10, P3659, DOI 10.4161/hv.34361; Angel J, 2012, CURR OPIN VIROL, V2, P419, DOI 10.1016/j.coviro.2012.05.003; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Boom JA, 2012, J INFECT DIS, V206, P1275, DOI 10.1093/infdis/jis490; Bowen MD, 2012, EXPERT REV VACCINES, V11, P1311, DOI [10.1586/erv.12.114, 10.1586/ERV.12.114]; CONNER ME, 1993, J VIROL, V67, P6633, DOI 10.1128/JVI.67.11.6633-6641.1993; Conner ME, 1996, ARCH VIROL, P199; DEBOISSIEU D, 1993, J PEDIATR GASTR NUTR, V16, P29; Della Cioppa G, 2014, HUM VACC IMMUNOTHER, V10, P1701, DOI 10.4161/hv.28618; Esona MD, 2010, HUMAN VACCINES, V6; Feng N, 2008, J VIROL, V82, P7578, DOI 10.1128/JVI.00391-08; FLYNN PM, 1994, CHEST, V106, P1463, DOI 10.1378/chest.106.5.1463; Gonzalez AM, 2010, IMMUNOLOGY, V131, P242, DOI 10.1111/j.1365-2567.2010.03298.x; Gorse GJ, 2013, VACCINE, V31, P6034, DOI 10.1016/j.vaccine.2013.09.012; Gorse GJ, 2013, VACCINE, V31, P2358, DOI 10.1016/j.vaccine.2013.03.008; Greenberg HB, 2011, NEW ENGL J MED, V364, P2354, DOI 10.1056/NEJMe1105302; Groome MJ, 2014, B WORLD HEALTH ORGAN, V92, P238, DOI 10.2471/BLT.13.128066; Hemming M, 2014, PEDIATR INFECT DIS J, V33, P655, DOI 10.1097/INF.0000000000000221; Hung IFN, 2012, VACCINE, V30, P6427, DOI 10.1016/j.vaccine.2012.08.014; Jiang BM, 2008, HUM VACCINES, V4, P143, DOI 10.4161/hv.4.2.5263; Jiang BM, 2013, HUM VACC IMMUNOTHER, V9, P1634, DOI 10.4161/hv.24958; Jiang BM, 1999, VACCINE, V17, P1005, DOI 10.1016/S0264-410X(98)00317-X; Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278; Kompithra RZ, 2014, VACCINE, V32, pA129, DOI 10.1016/j.vaccine.2014.03.002; LECCE J G, 1990, Molecular Biotherapy, V2, P211; Levin Y, 2015, HUM VACC IMMUNOTHER, V11, P991, DOI 10.1080/21645515.2015.1010871; Levin Y, 2014, VACCINE, V32, P4249, DOI 10.1016/j.vaccine.2014.03.024; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Madhusudana SN, 2014, EXPERT REV VACCINES, V13, P641, DOI 10.1586/14760584.2014.901893; Mankeshwar R, 2014, Nepal Med Coll J, V16, P68; Moon S, 2013, VACCINE, V31, P3396, DOI 10.1016/j.vaccine.2012.11.027; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Premkumar P, 2014, VACCINE, V32, pA55, DOI 10.1016/j.vaccine.2014.04.077; Rongsen-Chandola T, 2014, VACCINE, V32, pA134, DOI 10.1016/j.vaccine.2014.04.078; Rose TL, 2013, EMERG INFECT DIS, V19, P1843, DOI 10.3201/eid1911.121407; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; Saif L, 1997, ADV EXP MED BIOL, V412, P397; Saif LJ, 1996, ARCH VIROL, P153; SCHWERS A, 1985, ANN RECH VET, V16, P213; Su F., 2016, HUM VACC IMMUNOTHER, P1, DOI DOI 10.1080/21645515.2015.1114195; Tarnow K, 2004, APPL NURS RES, V17, P275, DOI 10.1016/S0897-1897(04)00079-5; Troy SB, 2015, J INFECT DIS, V211, P1969, DOI 10.1093/infdis/jiu841; Velasquez DE, 2015, HUM VACC IMMUNOTHER, V11, P531, DOI 10.4161/21645515.2014.988553; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wang YH, 2010, VACCINE, V28, P5432, DOI 10.1016/j.vaccine.2010.06.006; Yuan LJ, 2002, VET IMMUNOL IMMUNOP, V87, P147, DOI 10.1016/S0165-2427(02)00046-6; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	49	24	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166038	10.1371/journal.pone.0166038	http://dx.doi.org/10.1371/journal.pone.0166038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824918	Green Submitted, Green Published, gold			2022-12-27	WOS:000387615200057
J	Reisig, G; Kreinest, M; Richter, W; Wagner-Ecker, M; Dinter, D; Attenberger, U; Schneider-Wald, B; Fickert, S; Schwarz, ML				Reisig, Gregor; Kreinest, Michael; Richter, Wiltrud; Wagner-Ecker, Mechthild; Dinter, Dietmar; Attenberger, Ulrike; Schneider-Wald, Barbara; Fickert, Stefan; Schwarz, Markus L.			Osteoarthritis in the Knee Joints of Gottingen Minipigs after Resection of the Anterior Cruciate Ligament? Missing Correlation of MRI, Gene and Protein Expression with Histological Scoring	PLOS ONE			English	Article							OSTEOCHONDRAL DEFECT REPAIR; ARTICULAR-CARTILAGE; IN-VIVO; ANIMAL-MODELS; COLLAGEN DEGRADATION; GUINEA-PIG; POND-NUKI; HYALINE CARTILAGE; PROFILING REVEALS; ACL TRANSECTION	Introduction The Gottingen Minipig (GM) is used as large animal model in articular cartilage research. The aim of the study was to introduce osteoarthritis (OA) in the GM by resecting the anterior cruciate ligament (ACLR) according to Pond and Nuki, verified by histological and magnetic resonance imaging (MRI) scoring as well as analysis of gene and protein expression. Materials and Methods The eight included skeletally mature female GM were assessed after ACLR in the left and a sham operation in the right knee, which served as control. 26 weeks after surgery the knee joints were scanned using a 3-Tesla high-field MR tomography unit with a 3 TCP Large Flex Coil. Standard proton-density weighted fat saturated sequences in coronal and sagittal direction with a slice thickness of 3 mm were used. The MRI scans were assessed by two radiologists according to a modified WORMS-score, the X-rays of the knee joints by two evaluators. Osteochondral plugs with a diameter of 4mm were taken for histological examination from either the main loading zone or the macroscopic most degenerated parts of the tibia plateau or condyle respectively. The histological sections were blinded and scored by three experts according to Little et al. Gene expression analysis was performed from surrounding cartilage. Expression of adamts4, adamts5, acan, col1A1, col2, il-beta, mmp1, mmp3, mmp13, vegf was determined by qRT-PCR. Immunohistochemical staining (IH) of Col I and II was performed. IH was scored using a 4 point grading (0-no staining; 3-intense staining). Results and Discussion Similar signs of OA were evident both in ACLR and sham operated knee joints with the histological scoring result of the ACLR joints with 6.48 +/- 5.67 points and the sham joints with 6.86 +/- 5.84 points (p = 0.7953) The MRI scoring yielded 0.34 +/- 0.89 points for the ACLR and 0.03 +/- 0.17 for the sham knee joints. There was no correlation between the histological and MRI scores (r = 0.10021). The gene expression profiles as well as the immunohistochemical findings showed no significant differences between ACLR and sham knee joints. In conclusion, both knee joints showed histological signs of OA after 26 weeks irrespective of whether the ACL was resected or not. As MRI results did not match the histological findings, MRI was obviously unsuitable to diagnose the OA in GM. The analysis of the expression patterns of the 10 genes could not shed light on the question, whether sham operation also induced cartilage erosion or if the degeneration was spontaneous. The modified Pond-Nuki model may be used with reservation in the adult minipig to induce an isolated osteoarthritis.	[Reisig, Gregor; Kreinest, Michael; Schneider-Wald, Barbara; Fickert, Stefan; Schwarz, Markus L.] Heidelberg Univ, Med Fac Mannheim, Dept Expt Orthopaed & Trauma Surg, Orthopaed & Trauma Surg Ctr OUZ, Mannheim, Germany; [Richter, Wiltrud; Wagner-Ecker, Mechthild] Orthopaed Univ Hosp Heidelberg, Res Ctr Expt Orthopaed, Heidelberg, Germany; [Dinter, Dietmar; Attenberger, Ulrike] Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, Mannheim, Germany; [Kreinest, Michael] BG Trauma Ctr Ludwigshafen, Dept Trauma Surg & Orthopaed Surg, Ludwigshafen, Germany; [Fickert, Stefan] Sporthopaedicum, Straubing, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Schwarz, ML (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Expt Orthopaed & Trauma Surg, Orthopaed & Trauma Surg Ctr OUZ, Mannheim, Germany.	Markus.Schwarz@medma.uni-heidelberg.de	Kreinest, Michael/ABI-7282-2020; Richter, Wiltrud/V-3217-2017; Attenberger, Ulrike/ABD-8541-2020; Attenberger, Ulrike/HDN-2286-2022	Richter, Wiltrud/0000-0003-4694-2768; Attenberger, Ulrike/0000-0002-8123-5447; Attenberger, Ulrike/0000-0002-8123-5447	Medical Faculty Mannheim, Heidelberg University, Germany; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg, Germany	Medical Faculty Mannheim, Heidelberg University, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg, Germany	This study was supported by the Medical Faculty Mannheim, Heidelberg University, Germany and the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg, Germany within the funding programme Open Access Publishing.	Ahern BJ, 2009, OSTEOARTHR CARTILAGE, V17, P705, DOI 10.1016/j.joca.2008.11.008; Aigner T, 2004, REJUV RES, V7, P134, DOI 10.1089/1549168041552964; Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-H; Aigner T, 2006, ARTHRITIS RHEUM-US, V54, P3533, DOI 10.1002/art.22174; ALTMAN RD, 1989, SEMIN ARTHRITIS RHEU, V18, P1, DOI 10.1016/0049-0172(89)90007-3; Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Attia E, 2010, AM J SPORT MED, V38, P348, DOI 10.1177/0363546509348052; Bachmann G, 1997, ROFO-FORTSCHR RONTG, V166, P429, DOI 10.1055/s-2007-1015453; Barley RDC, 2010, VIRCHOWS ARCH, V456, P561, DOI 10.1007/s00428-010-0890-z; Batiste DL, 2004, OSTEOARTHR CARTILAGE, V12, P986, DOI 10.1016/j.joca.2004.08.010; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Bernstein P, 2009, J BIOMED MATER RES A, V91A, P910, DOI 10.1002/jbm.a.32308; Bittersohl B, 2009, EUR J RADIOL, V70, P561, DOI 10.1016/j.ejrad.2008.02.031; Bittersohl B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006895; Blackman AJ, 2013, AM J SPORT MED, V41, P1426, DOI 10.1177/0363546513485931; Boulocher C, 2007, OSTEOARTHR CARTILAGE, V15, P1378, DOI 10.1016/j.joca.2007.04.012; Bowers ME, 2008, OSTEOARTHR CARTILAGE, V16, P1167, DOI 10.1016/j.joca.2008.03.005; Calvo E, 2004, OSTEOARTHR CARTILAGE, V12, P878, DOI 10.1016/j.joca.2004.07.007; Carlson CS, 1996, J BONE MINER RES, V11, P1209; Casula V, 2014, KNEE SURG SPORTS TRA; Chaganti RK, 2011, CURR REV MUSCULOSKE, V4, P99, DOI 10.1007/s12178-011-9088-5; Chen BL, 2013, BIO-MED MATER ENG, V23, P263, DOI 10.3233/BME-130750; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]; Cook JL, 2010, OSTEOARTHR CARTILAGE, V18, pS66, DOI 10.1016/j.joca.2010.04.017; Costa-Paz M, 2012, CLIN ORTHOP RELAT R, V470, P979, DOI 10.1007/s11999-011-1933-8; Cruz R, 2015, PATHOL RES PRACT, V211, P829, DOI 10.1016/j.prp.2015.07.012; Curzer HJ, 2016, SCI ENG ETHICS, V22, P549, DOI 10.1007/s11948-015-9659-8; Eckstein F, 2006, ANN RHEUM DIS, V65, P433, DOI 10.1136/ard.2005.039370; Eckstein F, 2006, NMR BIOMED, V19, P822, DOI 10.1002/nbm.1063; Elsaid KA, 2012, OSTEOARTHR CARTILAGE, V20, P940, DOI 10.1016/j.joca.2012.04.021; Eltawil NM, 2009, OSTEOARTHR CARTILAGE, V17, P695, DOI 10.1016/j.joca.2008.11.003; Evangelopoulos DS, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140542; Fan ZY, 2005, ARTHRITIS RHEUM-US, V52, P136, DOI 10.1002/art.20725; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fischbach F, 2005, ACTA RADIOL, V46, P67, DOI 10.1080/02841850510012625; Flannery CR, 2009, ARTHRITIS RHEUM-US, V60, P840, DOI 10.1002/art.24304; Fleming Braden C, 2005, Curr Opin Orthop, V16, P354, DOI 10.1097/01.bco.0000176423.07865.d2; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Frost-Christensen LN, 2008, OSTEOARTHR CARTILAGE, V16, P1327, DOI 10.1016/j.joca.2008.03.013; Fukui N, 2008, ARTHRITIS RHEUM, V58, P3843, DOI 10.1002/art.24036; Gavenis K, 2014, J BIOMATER APPL, V28, P1008, DOI 10.1177/0885328213491440; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goranov NV, 2007, VET CLIN PATH, V36, P192, DOI 10.1111/j.1939-165X.2007.tb00208.x; Gotterbarm T, 2008, LAB ANIM-UK, V42, P71, DOI 10.1258/la.2007.06029e; Gray P, 1954, BLAKISTON, V43, P403; Grcevic D, 2010, J RHEUMATOL, V37, P246, DOI 10.3899/jrheum.090167; Gredes T, 2007, THESIS; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Hanashi Daisuke, 2002, J Orthop Sci, V7, P672, DOI 10.1007/s007760200119; Haslauer CM, 2013, OSTEOARTHR CARTILAGE, V21, P1950, DOI 10.1016/j.joca.2013.09.003; Haywood J, 2016, OSTEOARTHR CARTILAGE, V24, P942, DOI 10.1016/j.joca.2015.11.020; Heijink A, 2012, KNEE SURG SPORT TR A, V20, P423, DOI 10.1007/s00167-011-1818-0; Herzog W, 1993, Osteoarthritis Cartilage, V1, P243, DOI 10.1016/S1063-4584(05)80330-9; Hissnauer TN, 2010, OSTEOARTHR CARTILAGE, V18, P1630, DOI 10.1016/j.joca.2010.10.002; Huang CY, 2011, RHEUMATOLOGY, V50, P1379, DOI 10.1093/rheumatology/ker134; Huebner JL, 2009, OSTEOARTHR CARTILAGE, V17, P1056, DOI 10.1016/j.joca.2009.02.015; Huebner JL, 2002, OSTEOARTHR CARTILAGE, V10, P758, DOI 10.1053/joca.2002.0821; Hulmes DJS, 2004, OSTEOARTHR CARTILAGE, V12, P232, DOI 10.1016/j.joca.2003.11.007; Inoue K, 2005, RHEUMATOL INT, V26, P93, DOI 10.1007/s00296-004-0513-6; JACKSON DW, 1992, AM J SPORT MED, V20, P644, DOI 10.1177/036354659202000605; Jacquet R, 2005, ANAL BIOCHEM, V337, P22, DOI 10.1016/j.ab.2004.09.033; Jay GD, 2010, ARTHRITIS RHEUM-US, V62, P2382, DOI 10.1002/art.27550; Jefferies D, 2002, VET RES, V33, P383, DOI 10.1051/vetres:2002024; Jimenez PA, 1997, LAB ANIM SCI, V47, P598; Jung M, 2009, CELL TRANSPLANT, V18, P923, DOI 10.3727/096368909X471297; Kaab MJ, 1998, J ANAT, V193, P23, DOI 10.1046/j.1469-7580.1998.19310023.x; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kraus VB, 2010, OSTEOARTHR CARTILAGE, V18, pS35, DOI 10.1016/j.joca.2010.04.015; Kreinest M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159331; Kuyinu EL, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0346-5; LAFEBER FPJG, 1992, AM J PATHOL, V140, P1421; Lasch P, 2001, J BIOL CHEM, V276, P9492, DOI 10.1074/jbc.M008528200; Laverty S, 2010, OSTEOARTHR CARTILAGE, V18, pS53, DOI 10.1016/j.joca.2010.05.029; Le Graverand MPH, 2002, J ORTHOP RES, V20, P535, DOI 10.1016/S0736-0266(01)00126-7; Libicher M, 2005, EUR RADIOL, V15, P390, DOI 10.1007/s00330-004-2486-y; Little CB, 2010, OSTEOARTHR CARTILAGE, V18, pS80, DOI 10.1016/j.joca.2010.04.016; Liu WH, 2003, J ORTHOP RES, V21, P730, DOI 10.1016/S0736-0266(03)00002-0; Lorenz H, 2005, ARTHRITIS RES THER, V7, pR156, DOI 10.1186/ar1471; Lukas VA, 2015, J ORTHOP RES, V33, P640, DOI 10.1002/jor.22810; Makela JTA, 2014, OSTEOARTHR CARTILAGE, V22, P869, DOI 10.1016/j.joca.2014.04.010; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; MATYAS JR, 1995, ARTHRITIS RHEUM, V38, P420, DOI 10.1002/art.1780380320; McCoy AM, 2015, VET PATHOL, V52, P803, DOI 10.1177/0300985815588611; MCDEVITT C, 1977, J BONE JOINT SURG BR, V59, P24, DOI 10.1302/0301-620X.59B1.576611; McIlwraith CW, 2010, OSTEOARTHR CARTILAGE, V18, pS93, DOI 10.1016/j.joca.2010.05.031; McNulty AL, 2011, CONNECT TISSUE RES, V52, P523, DOI 10.3109/03008207.2011.597902; Miyatake K, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1094-8; Moriyama H, 2012, BIOGERONTOLOGY, V13, P369, DOI 10.1007/s10522-012-9381-8; Murray MM, 2007, J ORTHOP RES, V25, P81, DOI 10.1002/jor.20282; Nebelung W, 2005, ARTHROSCOPY, V21, P696, DOI 10.1016/j.arthro.2005.03.010; Nielsen RH, 2008, BIOMARKERS, V13, P79, DOI 10.1080/13547500701615108; Niemietz T, 2014, CELL TISSUE RES, V358, P749, DOI 10.1007/s00441-014-1982-x; O'Brien EJO, 2013, J ORTHOP RES, V31, P35, DOI 10.1002/jor.22187; Oppermann A, 2016, COMMUNICATION; Orth P, 2015, PROG HISTOCHEM CYTO, V50, P19, DOI 10.1016/j.proghi.2015.10.001; Palmer AJR, 2013, BONE JOINT J, V95B, P738, DOI 10.1302/0301-620X.95B6.31414; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Pond M J, 1973, Ann Rheum Dis, V32, P387, DOI 10.1136/ard.32.4.387; Prieto-Alhambra D, 2014, ANN RHEUM DIS, V73, P1659, DOI 10.1136/annrheumdis-2013-203355; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Rehnitz C, 2014, OSTEOARTHR CARTILAGE, V22, P1732, DOI 10.1016/j.joca.2014.04.020; ROSENTHAL AK, 1994, MECH AGEING DEV, V75, P35, DOI 10.1016/0047-6374(94)90026-4; Ruehe B, 2009, ORAL SURG ORAL MED O, V108, P699, DOI 10.1016/j.tripleo.2009.06.037; Saadat E, 2008, EUR RADIOL, V18, P2292, DOI 10.1007/s00330-008-0989-7; SAKAKIBARA Y, 1994, CLIN ORTHOP RELAT R, P282; Salzmann GM, 2014, AM J SPORT MED, V42, P1832, DOI 10.1177/0363546514536682; Schwarz ML, 2010, SCAND J LAB ANIM SCI, V37, P13; Sharma L, 1999, ARTHRITIS RHEUM, V42, P861, DOI 10.1002/1529-0131(199905)42:5<861::AID-ANR4>3.0.CO;2-N; Steck E, 2012, J MOL MED, V90, P1185, DOI 10.1007/s00109-012-0895-y; Steck E, 2009, STEM CELLS DEV, V18, P969, DOI 10.1089/scd.2008.0213; Stoker Aaron M, 2006, J Orthop Surg Res, V1, P8, DOI 10.1186/1749-799X-1-8; Stoop R, 2001, OSTEOARTHR CARTILAGE, V9, P308, DOI 10.1053/joca.2000.0390; Streitparth F, 2009, ACTA RADIOL, V50, P765, DOI 10.1080/02841850902980272; Tayade C, 2006, J IMMUNOL, V176, P148, DOI 10.4049/jimmunol.176.1.148; Tiraloche G, 2005, ARTHRITIS RHEUM-US, V52, P1118, DOI 10.1002/art.20951; Tsai PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076658; van Meer BL, 2015, BR J SPORTS MED; Vasara AI, 2006, OSTEOARTHR CARTILAGE, V14, P1066, DOI 10.1016/j.joca.2006.04.003; Verzijl N, 2002, ARTHRITIS RHEUM, V46, P114, DOI 10.1002/1529-0131(200201)46:1<114::AID-ART10025>3.0.CO;2-P; VILENSKY JA, 1994, J ELECTROMYOGR KINES, V4, P181, DOI 10.1016/1050-6411(94)90019-1; Visco DM, 1996, OSTEOARTHR CARTILAGE, V4, P9, DOI 10.1016/S1063-4584(96)80003-3; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; von Engelhardt LV, 2007, ARTHROSCOPY, V23, P496, DOI 10.1016/j.arthro.2006.12.027; Wachsmuth L, 2003, OSTEOARTHR CARTILAGE, V11, P891, DOI 10.1016/j.joca.2003.08.008; Wei B, 2015, J MAGN RESON IMAGING; Wei L, 2010, J ORTHOP RES, V28, P900, DOI 10.1002/jor.21093; Wenz W, 1998, Z ORTHOP GRENZGEB, V136, P298, DOI 10.1055/s-2008-1053741; Yin J, 2011, CHINESE MED J-PEKING, V124, P4245, DOI 10.3760/cma.j.issn.0366-6999.2011.24.022; Zayed N, 2008, ARTHRITIS RHEUM-US, V58, P3530, DOI 10.1002/art.23958; Zeni P, 2007, AM J PHYSIOL-CELL PH, V293, pC855, DOI 10.1152/ajpcell.00470.2006; Zhou QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-337; Zou LJ, 2008, J ORTHOP RES, V26, P56, DOI 10.1002/jor.20467	136	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165897	10.1371/journal.pone.0165897	http://dx.doi.org/10.1371/journal.pone.0165897			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820852	Green Published, Green Submitted, gold			2022-12-27	WOS:000387614800025
J	Rogal, SS; Mankaney, G; Udawatta, V; Chinman, M; Good, CB; Zickmund, S; Bielefeldt, K; Chidi, A; Jonassaint, N; Jazwinski, A; Shaikh, O; Hughes, C; Fontes, P; Humar, A; DiMartini, A				Rogal, Shari S.; Mankaney, Gautham; Udawatta, Viyan; Chinman, Matthew; Good, Chester B.; Zickmund, Susan; Bielefeldt, Klaus; Chidi, Alexis; Jonassaint, Naudia; Jazwinski, Alison; Shaikh, Obaid; Hughes, Christopher; Fontes, Paulo; Humar, Abhinav; DiMartini, Andrea			Pre-Transplant Depression Is Associated with Length of Hospitalization, Discharge Disposition, and Survival after Liver Transplantation	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; LONG-TERM SURVIVAL; HEART-FAILURE; ANTIDEPRESSANT USE; ELDERLY-PATIENTS; HEPATITIS-C; MORTALITY; SYMPTOMS; OUTCOMES; COMORBIDITY	Depression after liver transplantation has been associated with decreased survival, but the effects of pre-transplant depression on early and late post-transplant outcomes remain incompletely evaluated. We assessed all patients who had undergone single-organ liver transplantation at a single center over the prior 10 years. A diagnosis of pre-transplant depression, covariates, and the outcomes of interest were extracted from the electronic medical record. Potential covariates included demographics, etiology and severity of liver disease, comorbidities, donor age, graft type, immunosuppression, and ischemic times. In multivariable models adjusting for these factors, we evaluated the effect of pre-transplant depression on transplant length of stay (LOS), discharge disposition (home vs. facility) and long-term survival. Among 1115 transplant recipients with a median follow-up time of 5 years, the average age was 56 +/- 11 and MELD was 12 +/- 9. Nineteen percent of the study population had a history of pre-transplant depression. Pre-transplant depression was associated with longer LOS (median = 19 vs. 14 days, IRR = 1.25, CI = 1.13,1.39), discharge to a facility (36% vs. 25%, OR 1.70, CI = 1.18,2.45), and decreased survival (HR = 1.54, CI = 1.14,2.08) in this cohort, accounting for other potential confounders. In conclusion, pre-transplant depression was significantly associated with longer transplant length of stay, discharge to a facility, and mortality in this cohort.	[Rogal, Shari S.; Chinman, Matthew; Good, Chester B.; Zickmund, Susan; Chidi, Alexis] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15261 USA; [Rogal, Shari S.; Shaikh, Obaid; Hughes, Christopher; Fontes, Paulo; Humar, Abhinav] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA; [Rogal, Shari S.; Bielefeldt, Klaus; Jonassaint, Naudia; Jazwinski, Alison; Shaikh, Obaid] Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15260 USA; [Mankaney, Gautham; Udawatta, Viyan; Good, Chester B.; Zickmund, Susan; Chidi, Alexis] Univ Pittsburgh, Div Gen Internal Med, Pittsburgh, PA USA; [Chinman, Matthew] RAND Corp, Pittsburgh, PA USA; [DiMartini, Andrea] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; RAND Corporation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rogal, SS (corresponding author), VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15261 USA.; Rogal, SS (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA.; Rogal, SS (corresponding author), Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15260 USA.	rogalss@upmc.edu	Good, Chester B/K-2818-2019; , Matthew/AAO-9856-2020; Shaikh, Obaid/AAL-5339-2021	Good, Chester B/0000-0003-4388-4558; , Matthew/0000-0001-5390-8723; Shaikh, Obaid/0000-0002-4955-9222	Rand Corporation	Rand Corporation	The authors received no specific funding for this work. MC is employed by Rand Corporation. Rand Corporation provided support in the form of salaries for author MC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Albrecht JS, 2016, ANN AM THORAC SOC, V13, P1497, DOI 10.1513/AnnalsATS.201602-136OC; Albrecht JS, 2016, INT J GERIATR PSYCH, V31, P441, DOI 10.1002/gps.4348; Ayerbe L, 2014, NEUROLOGY, V83, P2007, DOI 10.1212/WNL.0000000000001029; Banankhah SK, 2015, WORLD J CARDIOL, V7, P215, DOI 10.4330/wjc.v7.i4.215; Barboza KC, 2016, METAB BRAIN DIS, V31, P869, DOI 10.1007/s11011-016-9817-y; Bhattacharya R, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0964-9; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Diamond G, 2005, J AM ACAD CHILD PSY, V44, P872, DOI 10.1097/01.chi.0000169010.96783.4e; Fan HJ, 2014, PREV MED, V63, P36, DOI 10.1016/j.ypmed.2014.03.007; Fiest KM, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0289-5; Hendrie HC, 2013, AM J GERIAT PSYCHIAT, V21, P1267, DOI 10.1016/j.jagp.2013.01.056; Jain A, 2000, ANN SURG, V232, P490, DOI 10.1097/00000658-200010000-00004; Lacson E, 2012, NEPHROL DIAL TRANSPL, V27, P2921, DOI 10.1093/ndt/gfr778; Leonard BE, 2001, PROG NEURO-PSYCHOPH, V25, P767, DOI 10.1016/S0278-5846(01)00155-5; Miller LR, 2013, LIVER TRANSPLANT, V19, P1272, DOI 10.1002/lt.23728; Moraska AR, 2013, CIRC-HEART FAIL, V6, P387, DOI 10.1161/CIRCHEARTFAILURE.112.000118; Mullish BH, 2014, ALIMENT PHARM THER, V40, P880, DOI 10.1111/apt.12925; Murad K, 2015, JACC-HEART FAIL, V3, P542, DOI 10.1016/j.jchf.2015.03.004; Nelligan JA, 2008, J CLIN PSYCHIAT, V69, P810, DOI 10.4088/JCP.v69n0514; Nemeroff CB, 2012, NAT REV CARDIOL, V9, P526, DOI 10.1038/nrcardio.2012.91; Neufeld KJ, 2013, ANESTH ANALG, V117, P471, DOI 10.1213/ANE.0b013e3182973650; Rogal SS, 2013, AM J TRANSPLANT, V13, P928, DOI 10.1111/ajt.12164; Rogal SS, 2015, CLIN GASTROENTEROL H, V13, P1009, DOI 10.1016/j.cgh.2014.10.029; Rogal SS, 2011, LIVER TRANSPLANT, V17, P251, DOI 10.1002/lt.22231; Saint Onge JM, 2014, J GERONTOL B-PSYCHOL, V69, P622, DOI 10.1093/geronb/gbu009; van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058; Vin-Raviv N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129169; Weitz ES, 2015, JAMA PSYCHIAT, V72, P1102, DOI 10.1001/jamapsychiatry.2015.1516	28	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165517	10.1371/journal.pone.0165517	http://dx.doi.org/10.1371/journal.pone.0165517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BB	27820828	gold, Green Submitted, Green Published			2022-12-27	WOS:000387614800010
J	Brachs, S; Winkel, AF; Polack, J; Tang, H; Brachs, M; Margerie, D; Brunner, B; Jahn-Hofmann, K; Ruetten, H; Spranger, J; Schmoll, D				Brachs, Sebastian; Winkel, Angelika F.; Polack, James; Tang, Hui; Brachs, Maria; Margerie, Daniel; Brunner, Bodo; Jahn-Hofmann, Kerstin; Ruetten, Hartmut; Spranger, Joachim; Schmoll, Dieter			Chronic Activation of Hepatic Nrf2 Has No Major Effect on Fatty Acid and Glucose Metabolism in Adult Mice	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; KEAP1/NRF2 PATHWAY; INSULIN-RESISTANCE; LIPID-METABOLISM; GENE-EXPRESSION; IN-VIVO; DELETION; STEATOSIS; DIET; LIVER	The transcription factor NF-E2-related factor 2 (Nrf2) induces cytoprotective genes, but has also been linked to the regulation of hepatic energy metabolism. In order to assess the pharmacological potential of hepatic Nrf2 activation in metabolic disease, Nrf2 was activated over 7 weeks in mice on Western diet using two different siRNAs against kelch-like ECH-associated protein 1 (Keap1), the inhibitory protein of Nrf2. Whole genome expression analysis followed by pathway analysis demonstrated successful knock-down of Keap1 expression and induction of Nrf2-dependent genes involved in anti-oxidative stress defense and biotransformation, proving the activation of Nrf2 by the siRNAs against Keap1. Neither the expression of fatty acid-nor carbohydrate-handling proteins was regulated by Keap1 knock-down. Metabolic profiling of the animals did also not show effects on plasma and hepatic lipids, energy expenditure or glucose tolerance. The data indicate that hepatic Keap1/Nrf2 is not a major regulator of glucose or lipid metabolism in mice.	[Brachs, Sebastian; Polack, James; Tang, Hui; Brachs, Maria; Spranger, Joachim] Charite, Sch Med, Ctr Cardiovasc Res, Dept Endocrinol Diabet & Nutr, Berlin, Germany; [Brachs, Sebastian; Polack, James; Tang, Hui; Brachs, Maria; Spranger, Joachim] German Ctr Cardiovasc Res, DZHK Partner Site Berlin, Berlin, Germany; [Winkel, Angelika F.; Margerie, Daniel; Brunner, Bodo; Jahn-Hofmann, Kerstin; Ruetten, Hartmut; Schmoll, Dieter] Sanofi Aventis Deutschland GmbH, Ind Pk Hoechst, Frankfurt, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Sanofi-Aventis	Spranger, J (corresponding author), Charite, Sch Med, Ctr Cardiovasc Res, Dept Endocrinol Diabet & Nutr, Berlin, Germany.; Spranger, J (corresponding author), German Ctr Cardiovasc Res, DZHK Partner Site Berlin, Berlin, Germany.	joachim.spranger@charite.de		Brachs, Sebastian/0000-0002-6336-3939; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Charite Deutschland GmbH; Sanofi-Aventis Deutschland GmbH; DZHK (BMBF); DZHK	Charite Deutschland GmbH; Sanofi-Aventis Deutschland GmbH(Sanofi-Aventis); DZHK (BMBF); DZHK	This work was supported by a collaboration between Charite and Sanofi-Aventis Deutschland GmbH and SB, JP, HT, MB and JS were supported by the DZHK (BMBF). Sanofi-Aventis Deutschland GmbH provided support in the form of salaries for authors [AFW, DM, BB, KJ-H, HR, and DS] and a research grant to SB and JS. DS was involved in study design and experiments were partially carried out in the labs of Sanofi-Aventis Deutschland GmbH. The specific roles of the authors are articulated in the 'author contributions' section. However Sanofi-Aventis Deutschland GmbH as funding organization did not have any further role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder did not directly benefit from the study and the study did not involve a product the funder sells. JS is PI of the German Center for Cardiovascular Research (DZHK) and this study was supported by resources of the DZHK. The DZHK provided salaries for authors [HT, MB], but the DZHK did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaucage SL, 2008, CURR OPIN DRUG DISC, V11, P203; Broering R, 2014, INT IMMUNOL, V26, P35, DOI 10.1093/intimm/dxt040; Camer D, 2015, MOL CELL ENDOCRINOL, V412, P36, DOI 10.1016/j.mce.2015.05.018; Chartoumpekis DV, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/340731; Chartoumpekis DV, 2013, CURR DIABETES REV, V9, P137, DOI 10.2174/1573399811309020005; Gao B, 2014, CLIN PHARMACOL-ADV A, V6, P19, DOI 10.2147/CPAA.S35078; Glien M, 2011, HORM METAB RES, V43, P601, DOI 10.1055/s-0031-1283138; Gonzalez-Rodriguez A, 2014, DIS MODEL MECH, V7, P1093, DOI 10.1242/dmm.015537; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Herling AW, 1999, EUR J PHARMACOL, V386, P75, DOI 10.1016/S0014-2999(99)00748-7; Kitteringham NR, 2010, J PROTEOMICS, V73, P1612, DOI 10.1016/j.jprot.2010.03.018; Kulkarni SR, 2013, PHARM RES-DORDR, V30, P2221, DOI 10.1007/s11095-013-1138-9; Meakin PJ, 2014, MOL CELL BIOL, V34, P3305, DOI [10.1128/MCB.00677-14, 10.1128/MCB.00677-1]; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; More VR, 2013, FREE RADICAL BIO MED, V61, P85, DOI 10.1016/j.freeradbiomed.2013.03.007; Muller S, 2004, CURR ORG SYNTH, V1, P293, DOI 10.2174/1570179043366675; Okada K, 2008, AM J PHYSIOL-GASTR L, V295, pG735, DOI 10.1152/ajpgi.90321.2008; Okada K, 2013, J GASTROENTEROL, V48, P620, DOI 10.1007/s00535-012-0659-z; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Ramadori P, 2016, FREE RADICAL BIO MED, V91, P114, DOI 10.1016/j.freeradbiomed.2015.12.014; Richter M, 2014, J TOXICOL SCI, V39, P353, DOI 10.2131/jts.39.353; Saha PK, 2010, J BIOL CHEM, V285, P40581, DOI 10.1074/jbc.M110.176545; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Slocum SL, 2016, ARCH BIOCHEM BIOPHYS, V591, P57, DOI 10.1016/j.abb.2015.11.040; Sugimoto H, 2010, AM J PHYSIOL-GASTR L, V298, pG283, DOI 10.1152/ajpgi.00296.2009; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Tanaka Y, 2012, J GASTROEN HEPATOL, V27, P1711, DOI 10.1111/j.1440-1746.2012.07180.x; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Uruno A, 2015, ARCH BIOCHEM BIOPHYS, V566, P76, DOI 10.1016/j.abb.2014.12.012; Wang CH, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-165; Weerachayaphorn J, 2014, J HEPATOL, V60, P160, DOI 10.1016/j.jhep.2013.08.015; Winkel AF, 2015, J BIOL CHEM, V290, P28446, DOI 10.1074/jbc.M115.678136; Xu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079841; Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716; Yu Z, 2011, DIABETOLOGIA, V54, P922, DOI 10.1007/s00125-010-2001-8; Zhang DD, 2013, ANTIOXID REDOX SIGN, V19, P517, DOI 10.1089/ars.2012.5118; Zhang P., 2012, BIO-PROTOCOL, V2, pe186	38	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166110	10.1371/journal.pone.0166110	http://dx.doi.org/10.1371/journal.pone.0166110			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814396	gold, Green Published, Green Submitted			2022-12-27	WOS:000386911100033
J	Diaz-Gutierrez, J; Martinez-Gonzalez, MA; Izquierdo, JJ; Gonzalez-Muniesa, P; Martinez, J; Bes-Rastrollo, M				Diaz-Gutierrez, Jesus; Martinez-Gonzalez, Miguel Angel; Pons Izquierdo, Juan Jose; Gonzalez-Muniesa, Pedro; Alfredo Martinez, J.; Bes-Rastrollo, Maira			Living at Higher Altitude and Incidence of Overweight/Obesity: Prospective Analysis of the SUN Cohort	PLOS ONE			English	Article							NORMOBARIC SHAM HYPOXIA; SERUM LEPTIN LEVELS; UNITED-STATES; SOCIOECONOMIC DIFFERENCES; INTERMITTENT HYPOXIA; OBESE SUBJECTS; BODY-WEIGHT; ASSOCIATION; EXERCISE; EXPOSURE	Background Residence at high altitude has been associated with lower obesity rates probably due to hypoxia conditions. However, there is no evidence of this association in a free-living population. Objectives We assessed the association between the altitude where each participant of a Spanish cohort (the SUN Project) was living and the incidence of overweight/obesity. Methods The SUN Project is a dynamic, prospective, multipurpose cohort of Spanish university graduates with a retention rate of 89%. We included in the analysis 9 365 participants free of overweight/obesity at baseline. At the baseline questionnaire, participants reported their postal code and the time they had been living in their city/village. We imputed the altitude of each postal code according to the data of the Spanish National Cartographic Institute and categorized participants in tertiles. We used Cox regression models to adjust for potential confounding variables. Results During a median follow-up of 10 years, we identified 2 156 incident cases of overweight/obesity. After adjusting for sex, age, time of residence at current city, baseline body mass index, physical activity, sedentarism and years of education (<= 3 years, >= 4 years, Master/PhD), those participants in the third tertile (> 456 m) exhibited a statistically significant 14% reduction in the risk of developing overweight/obesity in comparison to those in the first tertile (< 124 m) (adjusted HR = 0.86; 95% CI: 0.77, 0.96). Conclusions Living in cities of higher altitude was inversely associated with the risk of developing overweight/ obesity in a cohort of Spanish university graduates.	[Diaz-Gutierrez, Jesus; Martinez-Gonzalez, Miguel Angel; Bes-Rastrollo, Maira] Univ Navarra, Sch Med, Dept Prevent Med & Publ Hlth, Pamplona, Spain; [Martinez-Gonzalez, Miguel Angel; Gonzalez-Muniesa, Pedro; Alfredo Martinez, J.; Bes-Rastrollo, Maira] IDISNA Navarras Hlth Res Inst, Pamplona, Spain; [Martinez-Gonzalez, Miguel Angel; Gonzalez-Muniesa, Pedro; Alfredo Martinez, J.; Bes-Rastrollo, Maira] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain; [Martinez-Gonzalez, Miguel Angel] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Pons Izquierdo, Juan Jose] Univ Navarra, Sch Humanities & Social Sci, Dept Hist Art Hist & Geog, Pamplona, Spain; [Gonzalez-Muniesa, Pedro; Alfredo Martinez, J.] Univ Navarra, Sch Pharm, Dept Nutr & Food Sci & Physiol, Pamplona, Spain	University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Harvard University; Harvard T.H. Chan School of Public Health; University of Navarra; University of Navarra	Bes-Rastrollo, M (corresponding author), Univ Navarra, Sch Med, Dept Prevent Med & Publ Hlth, Pamplona, Spain.; Bes-Rastrollo, M (corresponding author), IDISNA Navarras Hlth Res Inst, Pamplona, Spain.; Bes-Rastrollo, M (corresponding author), Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain.	mbes@unav.es	Izquierdo, Juan José Pons/AAB-2991-2019; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Díaz-Gutiérrez, Jesús/O-2525-2016; González-Muniesa, Pedro/H-2158-2015; San-Miguel, Jesús F./V-8977-2018; Bes-Rastrollo, Maira/A-1329-2009	Izquierdo, Juan José Pons/0000-0002-5623-1591; Díaz-Gutiérrez, Jesús/0000-0003-0351-4018; González-Muniesa, Pedro/0000-0002-3130-2496; San-Miguel, Jesús F./0000-0002-9183-4857; Bes-Rastrollo, Maira/0000-0002-9139-4206; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808	Spanish Ministry of Health; European Regional Development Fund (FEDER) [PI10/02993, PI10/02658, PI13/00615, PI14/01668, PI14/01798, PI14/1764, RD06/0045, G03/140]; Navarra Regional Government [45/2011, 122/2014]; University of Navarra	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); European Regional Development Fund (FEDER)(European Commission); Navarra Regional Government; University of Navarra	The Seguimiento Universidad de Navarra (SUN) study has received funding from the Spanish Ministry of Health and European Regional Development Fund (FEDER) (Grants PI10/02993, PI10/02658, PI13/00615, PI14/01668, PI14/01798, PI14/1764, RD06/0045, G03/140), the Navarra Regional Government (45/2011, 122/2014), and the University of Navarra. Funding sources had no role in study design, data collection, analysis, interpretation of results, and in the writing of the manuscript. All authors were and are independent from funders.	Bailey D M, 2000, High Alt Med Biol, V1, P9, DOI 10.1089/152702900320649; Bes-Rastrollo M., 2005, REV ESP OBES, V3, P352; Cruickshank S., 2004, CONTIN ED ANAESTH CR, V4, P24, DOI [10.1093/bjaceaccp/mkh008, DOI 10.1093/BJACEACCP/MKH008]; De Irala-Estevez J, 2000, EUR J CLIN NUTR, V54, P706, DOI 10.1038/sj.ejcn.1601080; Donat-Vargas C, 2014, J EPIDEMIOL COMMUN H, V68, P834, DOI 10.1136/jech-2013-203752; Gatterer H, 2015, OBESITY FACTS, V8, P200, DOI 10.1159/000431157; Gonzalez-Muniesa P, 2015, J PHYSIOL BIOCHEM, V71, P589, DOI 10.1007/s13105-015-0410-3; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA62, DOI 10.1289/ehp.120-a62; Kayser B, 2013, OBES REV, V14, P579, DOI 10.1111/obr.12034; KAYSER B, 1994, SPORTS MED, V17, P309, DOI 10.2165/00007256-199417050-00004; Kong ZW, 2014, SLEEP BREATH, V18, P591, DOI 10.1007/s11325-013-0922-4; Lippl FJ, 2010, OBESITY, V18, P675, DOI 10.1038/oby.2009.509; Little BB, 2013, AM J PHYS ANTHROPOL, V152, P1, DOI 10.1002/ajpa.22326; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, p920e7; National Institute of Statistics, 2012, ENC NAC SAL ESP 2011; Netzer N, 2013, J TRAVEL MED, V20, P247, DOI 10.1111/jtm.12017; Netzer NC, 2008, SLEEP BREATH, V12, P129, DOI 10.1007/s11325-007-0149-3; Nielsen HB, 2003, SCAND J MED SCI SPOR, V13, P339, DOI 10.1046/j.1600-0838.2003.00325.x; Quintero P, 2010, MED HYPOTHESES, V74, P901, DOI 10.1016/j.mehy.2009.10.022; Raff H, 2008, J APPL PHYSIOL, V105, P1686, DOI 10.1152/japplphysiol.zdg-8233-vpcomm.2008; Roos E, 1996, EUR J CLIN NUTR, V50, P753; Rose G., 2008, ROSES STRATEGY PREVE; Segui-Gomez M, 2006, INT J EPIDEMIOL, V35, P1417, DOI 10.1093/ije/dyl223; Sherpa LY, 2010, INT J ENV RES PUB HE, V7, P1670, DOI 10.3390/ijerph7041670; Shukla V, 2005, NUTR NEUROSCI, V8, P161, DOI 10.1080/10284150500132823; Sierra-Johnson J, 2008, J APPL PHYSIOL, V105, P1684, DOI 10.1152/japplphysiol.01284.2007; Singh SN, 2001, NUTR NEUROSCI, V4, P323, DOI 10.1080/1028415X.2001.11747372; Trayhurn P, 2014, ANNU REV NUTR, V34, P207, DOI 10.1146/annurev-nutr-071812-161156; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Vafeiadi M, 2015, ENVIRON HEALTH PERSP, V123, P1015, DOI 10.1289/ehp.1409062; Vats P, 2013, HIGH ALT MED BIOL, V14, P45, DOI 10.1089/ham.2012.1071; Voss JD, 2013, INT J OBESITY, V37, P1407, DOI 10.1038/ijo.2013.5; Voss JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093493; Wasse LK, 2012, J APPL PHYSIOL, V112, P552, DOI 10.1152/japplphysiol.00090.2011; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Woolcott OO, 2002, HIGH ALT MED BIOL, V3, P245, DOI 10.1089/15270290260131975; Woolcott OO, 2014, OBESITY, V22, P2080, DOI 10.1002/oby.20800; Zaccaria M, 2004, EUR J APPL PHYSIOL, V92, P249, DOI 10.1007/s00421-004-1070-0; Zheutlin AR, 2014, ENVIRON INT, V73, P111, DOI 10.1016/j.envint.2014.07.012	40	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164483	10.1371/journal.pone.0164483	http://dx.doi.org/10.1371/journal.pone.0164483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812092	Green Submitted, gold, Green Published			2022-12-27	WOS:000386910000008
J	Larsson, M; Pettersson, KO; Kashiha, J; Ross, MW; Agardh, A				Larsson, Markus; Pettersson, Karen Odberg; Kashiha, John; Ross, Michael W.; Agardh, Anette			Stretching the Boundaries: Tanzanian Pharmacy Workers' Views and Experiences of Providing STI Services for Men Who Have Sex with Men	PLOS ONE			English	Article							DAR-ES-SALAAM; PRIVATE PHARMACIES; MALARIA TREATMENT; CARE; URETHRITIS; HIV/AIDS; BEHAVIOR; ISSUES; HANOI	Objective To explore the views and experiences of providing assistance and treatment of sexually transmitted infections to same-sex practicing male clients among service providers at pharmacies and drugstores in Dar es Salaam, Tanzania. Previous research suggests that sexually transmitted infections are an increasing concern for this population. Due to stigma and discrimination, men who have sex with men face limited access to treatment, which might contribute to increased self-medication. However, limited research has been conducted on the role of the pharmaceutical service provider with regards to this population in sub-Saharan Africa. Method In January 2016, 16 service providers at private pharmacies and drugstores with previous experience of providing services to this population were purposively selected for open-ended face-to-face interviews. The analysis was guided by the grounded theory approach. Results The process that emerged was labelled "Stretching Boundaries for Pharmaceutical Responsibilities". This reflected informants' perceptions of themselves as being involved in a transition from having limited engagement in the care of same-sex practicing male clients to becoming regular service-providers to this group. Findings further revealed that the emotional commitment they developed for clients through this process led to a transgression of provider-client boundaries, which undermined objective decision-making when clients lacked prescription. Financial interests also emerged as an underlying motivation for providing incomplete or inaccurate drug dosages. Conclusions Further studies are required to better address incentives related to unregulated sale of drugs. Inter-professional networks between pharmacy and healthcare workers could support the development of targeted treatment for men who have sex with men and other key populations.	[Larsson, Markus; Pettersson, Karen Odberg; Agardh, Anette] Lund Univ, Dept Clin Sci Malmo, Div Social Med & Global Hlth, Malmo, Sweden; [Kashiha, John] Community Hlth Educ Serv & Advocacy CHESA, Dar Es Salaam, Tanzania; [Ross, Michael W.] Univ Minnesota, Sch Med, Dept Family Med & Community Hlth, Programme Human Sexual, Minneapolis, MN 55455 USA	Lund University; University of Minnesota System; University of Minnesota Twin Cities	Larsson, M (corresponding author), Lund Univ, Dept Clin Sci Malmo, Div Social Med & Global Hlth, Malmo, Sweden.	markus.larsson@med.lu.se		Ross, Michael/0000-0002-5718-9989	Swedish Research Council [2014-2649]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by grants from the Swedish Research Council (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html), project grant number 2014-2649 (AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2007, CULT HEALTH SEX, V9, P153, DOI 10.1080/13691050601040480; Allport G. W., 1954, NATURE PREJUDICE; Anderson AM, 2015, AIDS CARE, V27, P63, DOI 10.1080/09540121.2014.951597; [Anonymous], 2012, 2012 FIP GLOB PHARM; [Anonymous], ACCR DRUG DISP OUTL; BENNER P, 1982, AM J NURS, V82, P402, DOI 10.2307/3462928; Benner P., 1984, NOVICE EXPERT EXCELL; Chalker JC, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0075-2; Chuc NTK, 1999, EUR J CLIN PHARMACOL, V55, P325, DOI 10.1007/s002280050636; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Crabbe F, 1996, GENITOURIN MED, V72, P220; Enhancing Nigeria's HIV/AIDS Response (ENR) Programme, 2010, PREV SEX TRANSM INF; Fonck K, 2001, SEX TRANSM DIS, V28, P367, DOI 10.1097/00007435-200107000-00002; GABBARD GO, 1995, JAMA-J AM MED ASSOC, V273, P1445, DOI 10.1001/jama.273.18.1445; Goel P, 1996, SOC SCI MED, V42, P1155, DOI 10.1016/0277-9536(95)00388-6; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Hart CA, 1998, BRIT MED J, V317, P647, DOI 10.1136/bmj.317.7159.647; Hawthorne N, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-48; Herek GM, 1998, AIDS PUBLIC POLICY J, V13, P36; Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-157; Kagashe Godeliver A B, 2011, Int J Pharm Pract, V19, P30, DOI 10.1111/j.2042-7174.2010.00075.x; King R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082937; King RC, 2010, INT J HEALTH PLAN M, V25, P30, DOI 10.1002/hpm.982; KITCHENER KS, 1988, J COUNS DEV, V67, P217, DOI 10.1002/j.1556-6676.1988.tb02586.x; Kvale S., 2009, INTERVIEWS LEARNING; Kwena Z A, 2008, East Afr Med J, V85, P419; Larsson M, 2016, INT J SEX HEALTH, V28, P163, DOI 10.1080/19317611.2016.1158763; Leshabari M, 2013, PREVALENCE HUMAN IMM; Lincoln Y.S., 1985, NATURALISTIC INQUIRY, DOI DOI 10.1016/0147-1767(85)90062-8; Magesa Daniel J, 2014, Tanzan J Health Res, V16, P118; Mhamba R, 2010, DRUGS IND ACCESS ESS; Ministry of Health and Social Welfare National AIDS Control Programme, 2012, NAT GUID MAN HIV AID; Mshana SE, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-28; Mugo PM, 2013, SEX TRANSM INFECT, V89, P583, DOI 10.1136/sextrans-2012-050979; Nadelson C, 2002, THEOR MED BIOETH, V23, P191, DOI 10.1023/A:1020899425668; National Bureau of Statistics Ministry of Finance Dar es Saaam Office of Chief Government Statistician President's Office Finance Economy and Development Planning Zanzibar, 2013, POP DISTR SEX AG; Niang CI, 2003, CULT HEALTH SEX, V5, P499, DOI 10.1080/1369105031000152715; Nyanzi S, 2013, CULT HEALTH SEX, V15, P952, DOI 10.1080/13691058.2013.798684; Nyoni J, 2012, SEX TRANSM INFECT, V88, P483, DOI 10.1136/sextrans-2012-050661; Okanlawon K, 2013, CULT HEALTH SEX, V15, P22, DOI 10.1080/13691058.2012.754053; Olsson E, 2002, J CLIN PHARM THER, V27, P273, DOI 10.1046/j.1365-2710.2002.00421.x; Paswa B, 1992, Int Q Community Health Educ, V13, P317, DOI 10.2190/7P6M-C4A4-4Y62-HW8B; Reamer FG, 2003, SOC WORK, V48, P121, DOI 10.1093/sw/48.1.121; Ross MW, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2014-006175, 10.1136/bmjopen-2012-001928]; Ross MW., 2014, RES SOCIAL SCI STUDY, V25, P160, DOI [DOI 10.1163/9789004272385_, 10.1163/9789004272385_010, DOI 10.1163/9789004272385_010]; Rutta Edmund, 2015, J Pharm Policy Pract, V8, P23, DOI 10.1186/s40545-015-0044-4; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Tanzania Food and Drugs Authority, 2010, TRAIN MAN ACCR DRUG; Torn A, 1998, J ADV NURS, V27, P1202, DOI 10.1046/j.1365-2648.1998.00648.x; VANDERGEEST S, 1987, SOC SCI MED, V25, P293, DOI 10.1016/0277-9536(87)90232-2; Ventola C Lee, 2015, P T, V40, P277; Viberg N, 2009, SEX TRANSM INFECT, V85, P300, DOI 10.1136/sti.2008.032888; Zahn R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147156	54	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166019	10.1371/journal.pone.0166019	http://dx.doi.org/10.1371/journal.pone.0166019			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812206	gold, Green Published, Green Submitted			2022-12-27	WOS:000386910000093
J	Mas-y-Mas, S; Barbon, M; Teyssier, C; Demene, H; Carvalho, JE; Bird, LE; Lebedev, A; Fattori, J; Schubert, M; Dumas, C; Bourguet, W; le Maire, A				Mas-y-Mas, Sarah; Barbon, Marta; Teyssier, Catherine; Demene, Helene; Carvalho, Joao E.; Bird, Louise E.; Lebedev, Andrey; Fattori, Juliana; Schubert, Michael; Dumas, Christian; Bourguet, William; le Maire, Albane			The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; H3K4 METHYLATION; HISTONE H3; EXPRESSION; HOMOLOG; COMPLEX; BINDING; FAMILY; SERVER	Mixed Lineage Leukemia 5 (MLL5) plays a key role in hematopoiesis, spermatogenesis and cell cycle progression. Chromatin binding is ensured by its plant homeodomain (PHD) through a direct interaction with the N-terminus of histone H3 (H3). In addition, MLL5 contains a Su(var) 3-9, Enhancer of zeste, Trithorax (SET) domain, a protein module that usually displays histone lysine methyltransferase activity. We report here the crystal structure of the unliganded SET domain of human MLL5 at 2.1 resolution. Although it shows most of the canonical features of other SET domains, both the lack of key residues and the presence in the SET-I subdomain of an unusually large loop preclude the interaction of MLL5 SET with its cofactor and substrate. Accordingly, we show that MLL5 is devoid of any in vitro methyltransferase activity on full-length histones and histone H3 peptides. Hence, the three dimensional structure of MLL5 SET domain unveils the structural basis for its lack of methyltransferase activity and suggests a new regulatory mechanism.	[Mas-y-Mas, Sarah; Barbon, Marta; Demene, Helene; Dumas, Christian; Bourguet, William; le Maire, Albane] INSERM, U1054, Ctr Biochim Struct, Montpellier, France; [Mas-y-Mas, Sarah; Barbon, Marta; Demene, Helene; Dumas, Christian; Bourguet, William; le Maire, Albane] CNRS, UMR5048, Ctr Biochim Struct, Montpellier, France; [Mas-y-Mas, Sarah; Barbon, Marta; Teyssier, Catherine; Demene, Helene; Dumas, Christian; Bourguet, William; le Maire, Albane] Univ Montpellier, Montpellier, France; [Teyssier, Catherine] IRCM, Montpellier, France; [Carvalho, Joao E.; Schubert, Michael] UPMC Univ Paris 06, Sorbonne Univ, CNRS, Lab Biol Dev Villefranche Sur Mer,Observ Oceanol, Villefranche Sur Mer, France; [Bird, Louise E.] Rutherford Appleton Lab, Res Complex Harwell, OPPF UK, Didcot OX11 0FA, Oxon, England; [Lebedev, Andrey] Rutherford Appleton Lab, Res Complex Harwell, CCP4, Didcot OX11 0FA, Oxon, England; [Fattori, Juliana; le Maire, Albane] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Campinas, SP, Brazil; [Barbon, Marta] Imperial Coll, Inst Clin Sci, DNA Replicat Grp, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Imperial College London	le Maire, A (corresponding author), INSERM, U1054, Ctr Biochim Struct, Montpellier, France.; le Maire, A (corresponding author), CNRS, UMR5048, Ctr Biochim Struct, Montpellier, France.; le Maire, A (corresponding author), Univ Montpellier, Montpellier, France.; le Maire, A (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Campinas, SP, Brazil.	albane.lemaire@cbs.cnrs.fr	Bourguet, William/I-5569-2013; Fattori, Juliana/M-4021-2019; Déméné, Hélène/AAZ-1691-2021; Bourguet, William/Y-6600-2019; Schubert, Michael/C-1875-2008; Teyssier, Catherine/AAC-2395-2020; Carvalho, João E/AAQ-1456-2020	Bourguet, William/0000-0002-0643-7719; Fattori, Juliana/0000-0002-5865-0183; Déméné, Hélène/0000-0002-7531-4309; Bourguet, William/0000-0002-0643-7719; Schubert, Michael/0000-0002-2341-712X; Teyssier, Catherine/0000-0003-4937-6503; Carvalho, João E/0000-0002-7770-4351; le Maire, Albane/0000-0003-3336-2158; Barbon, Marta/0000-0003-0891-5507; Bird, Louise/0000-0002-9846-5716	Association pour la Recherche sur le Cancer (ARC); FCT [SFRH/BD/86878/2012]; Medical Research Council [MR/K018779/1] Funding Source: researchfish; MRC [MR/K018779/1] Funding Source: UKRI	Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a research grant from the Association pour la Recherche sur le Cancer (ARC) (to A.I.M). J.E.C. is a FCT doctoral fellow (SFRH/BD/86878/2012).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ali M, 2013, P NATL ACAD SCI USA, V110, P11296, DOI 10.1073/pnas.1310156110; Antonysamy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084147; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deng LW, 2004, P NATL ACAD SCI USA, V101, P757, DOI 10.1073/pnas.2036345100; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horowitz S, 2011, J BIOL CHEM, V286, P18658, DOI 10.1074/jbc.M111.232876; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Justin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11316; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lemak A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077020; Li YJ, 2016, NATURE, V530, P447, DOI 10.1038/nature16952; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pons JL, 1996, J BIOMOL NMR, V8, P445, DOI 10.1007/BF00228146; Rincon-Arano H, 2012, CELL, V151, P1214, DOI 10.1016/j.cell.2012.11.009; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sali A., 2008, STRUCTURE, P779; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Tiwari SP, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0427-6; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083737; Wu J, 2012, J BIOMOL SCREEN, V17, P237, DOI 10.1177/1087057111414903; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Yap DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027127; Zhang P, 2012, NUCLEIC ACIDS RES, V40, P4237, DOI 10.1093/nar/gkr1235; Zhang Y, 2009, BLOOD, V113, P1455, DOI 10.1182/blood-2008-05-159905; Zheng WH, 2012, J AM CHEM SOC, V134, P18004, DOI 10.1021/ja307060p; Zhou PP, 2013, J BIOL CHEM, V288, P17532, DOI 10.1074/jbc.M112.439729	56	21	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165139	10.1371/journal.pone.0165139	http://dx.doi.org/10.1371/journal.pone.0165139			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812132	gold, Green Published, Green Submitted			2022-12-27	WOS:000386910000022
J	Mayo, C; Shelley, C; MacLachlan, NJ; Gardner, I; Hartley, D; Barker, C				Mayo, Christie; Shelley, Courtney; MacLachlan, N. James; Gardner, Ian; Hartley, David; Barker, Christopher			A Deterministic Model to Quantify Risk and Guide Mitigation Strategies to Reduce Bluetongue Virus Transmission in California Dairy Cattle	PLOS ONE			English	Article							CULICOIDES-VARIIPENNIS DIPTERA; SONORENSIS DIPTERA; RECENT EMERGENCE; CERATOPOGONIDAE; INFECTION; ABUNDANCE; SEROTYPE; VECTORS; CLIMATE; DISEASE	The global distribution of bluetongue virus (BTV) has been changing recently, perhaps as a result of climate change. To evaluate the risk of BTV infection and transmission in a BTV-endemic region of California, sentinel dairy cows were evaluated for BTV infection, and populations of Culicoides vectors were collected at different sites using carbon dioxide. A deterministic model was developed to quantify risk and guide future mitigation strategies to reduce BTV infection in California dairy cattle. The greatest risk of BTV transmission was predicted within the warm Central Valley of California that contains the highest density of dairy cattle in the United States. Temperature and parameters associated with Culicoides vectors (transmission probabilities, carrying capacity, and survivorship) had the greatest effect on BTV's basic reproduction number, R-0. Based on these analyses, optimal control strategies for reducing BTV infection risk in dairy cattle will be highly reliant upon early efforts to reduce vector abundance during the months prior to peak transmission.	[Mayo, Christie] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Shelley, Courtney; MacLachlan, N. James; Barker, Christopher] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Gardner, Ian] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE, Canada; [Hartley, David] Cincinnati Childrens Hosp Med Ctr, James M Anderson Ctr Hlth Syst Excellence, Cincinnati, OH 45229 USA	Colorado State University; University of California System; University of California Davis; University of Prince Edward Island; Cincinnati Children's Hospital Medical Center	Mayo, C (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Christie.Mayo@colostate.edu	Shelley, Courtney/AAD-6527-2021	Hartley, David/0000-0003-2589-2538	Agriculture and Food Research Initiative from U.S. Department of Agriculture-National Institute of Food and Agriculture [2012-67015-19527]; Center for Food Animal Health at University of California Davis; US Department of Agriculture; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health	Agriculture and Food Research Initiative from U.S. Department of Agriculture-National Institute of Food and Agriculture; Center for Food Animal Health at University of California Davis; US Department of Agriculture(United States Department of Agriculture (USDA)); Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	These studies were supported by funds provided by the Agriculture and Food Research Initiative competitive grant 2012-67015-19527 from the U.S. Department of Agriculture-National Institute of Food and Agriculture, and the Center for Food Animal Health at University of California Davis, the US Department of Agriculture under the Animal Health Act, 1977, Public Law 95-113. Additional support was received from the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security and Fogarty International Center, National Institutes of Health.	Baylis M, 2009, VET J, V182, P140, DOI 10.1016/j.tvjl.2009.08.014; Bonneau KR, 2001, J VIROL, V75, P8298, DOI 10.1128/JVI.75.17.8298-8305.2001; Boyer TC, 2007, AM J VET RES, V68, P1212, DOI 10.2460/ajvr.68.11.1212; Brenner J, 2010, EMERG INFECT DIS, V16, P2003, DOI 10.3201/eid1612.100239; BRENNER RJ, 1984, MOSQ NEWS, V44, P343; Burgin LE, 2013, TRANSBOUND EMERG DIS, V60, P263, DOI 10.1111/j.1865-1682.2012.01345.x; Calistri P, 2004, VETER ITAL SER, V40, P243; Cameron A R, 2004, Vet Ital, V40, P693; Carpenter S, 2011, VET REC, V168, P238, DOI 10.1136/vr.d1385; CHANEY RW, 1949, P NATL ACAD SCI USA, V35, P356, DOI 10.1073/pnas.35.7.356; Charron MVP, 2011, J THEOR BIOL, V291, P1, DOI 10.1016/j.jtbi.2011.08.041; Cheng Xu, 2002, Yingyong Shengtai Xuebao, V13, P1503; Eagles D, 2013, PREV VET MED, V110, P312, DOI 10.1016/j.prevetmed.2013.02.022; Eagles D, 2012, MED VET ENTOMOL, V26, P334, DOI 10.1111/j.1365-2915.2011.01005.x; Gerry AC, 2000, J MED ENTOMOL, V37, P675, DOI 10.1603/0022-2585-37.5.675; Gerry AC, 2001, J MED ENTOMOL, V38, P197, DOI 10.1603/0022-2585-38.2.197; Gerry AC, 2009, J MED ENTOMOL, V46, P615, DOI 10.1603/033.046.0329; GIBBS EPJ, 1983, AM J VET RES, V44, P2226; GIBBS EPJ, 1994, COMP IMMUNOL MICROB, V17, P207, DOI 10.1016/0147-9571(94)90044-2; Giovannini A, 2004, VETER ITAL SER, V40, P369; Gloster J, 2007, VET REC, V160, P54, DOI 10.1136/vr.160.2.54; Green AL, 2005, AM J VET RES, V66, P853, DOI 10.2460/ajvr.2005.66.853; Gubbins S, 2012, PREV VET MED, V105, P297, DOI 10.1016/j.prevetmed.2012.02.016; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; Holbrook F.R., 1985, Progress in Clinical and Biological Research, V178, P607; HOLBROOK FR, 1995, J MED ENTOMOL, V32, P413, DOI 10.1093/jmedent/32.4.413; Hoyle A, 2007, MATH BIOSCI, V210, P1, DOI 10.1016/j.mbs.2007.06.001; Kirkland PD, 2004, VETER ITAL SER, V40, P47; Maclachlan NJ, 2015, REV SCI TECH OIE, V34, P329, DOI 10.20506/rst.34.2.2360; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; Maclachlan NJ, 2013, ANTIVIR RES, V99, P79, DOI 10.1016/j.antiviral.2013.04.021; Maclachlan NJ, 2013, EMERG INFECT DIS, V19, P665, DOI 10.3201/eid1904.120347; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; Maclachlan NJ, 2010, VET CLIN N AM-FOOD A, V26, P163, DOI 10.1016/j.cvfa.2009.10.012; MacLachlan NJ, 2006, JAVMA-J AM VET MED A, V228, P1346, DOI 10.2460/javma.228.9.1346; MACLACHLAN NJ, 1994, ARCH VIROL, V136, P1, DOI 10.1007/BF01538812; Mayo CE, 2010, TRANSBOUND EMERG DIS, V57, P277, DOI 10.1111/j.1865-1682.2010.01149.x; Mayo CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106975; Mayo CE, 2012, VET PARASITOL, V187, P295, DOI 10.1016/j.vetpar.2012.01.004; Mayo CE, 2012, VET MICROBIOL, V155, P158, DOI 10.1016/j.vetmic.2011.08.029; McDermott EG, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1062-4; Mellor PS, 2008, PREV VET MED, V87, P4, DOI 10.1016/j.prevetmed.2008.06.002; Monteiro DMS, 2012, PREV VET MED, V105, P17, DOI 10.1016/j.prevetmed.2012.01.011; MULLENS BA, 1991, J AM MOSQUITO CONTR, V7, P588; Mullens BA, 1998, J MED ENTOMOL, V35, P245, DOI 10.1093/jmedent/35.3.245; Mullens BA, 2004, VETER ITAL SER, V40, P160; MULLENS BA, 1989, J MED ENTOMOL, V26, P566, DOI 10.1093/jmedent/26.6.566; Napp S, 2013, MED VET ENTOMOL, V27, P19, DOI 10.1111/j.1365-2915.2012.01016.x; Nunamaker RA, 1997, J MED ENTOMOL, V34, P18, DOI 10.1093/jmedent/34.1.18; O'Connell L., 2002, THESIS U BRISTOL, P176; OROURKE MJ, 1983, MOSQ NEWS, V43, P147; Ortega J, 2010, J VET DIAGN INVEST, V22, P134, DOI 10.1177/104063871002200129; Osborne CJ, 2015, J MED ENTOMOL, V52, P274, DOI 10.1093/jme/tju063; OSBURN BI, 1981, AM J VET RES, V42, P884; PRISM Climate Group. Oregon State University, 2004, STATE; Purse BV, 2006, MED VET ENTOMOL, V20, P335, DOI 10.1111/j.1365-2915.2006.00636.x; Purse BV, 2012, MED VET ENTOMOL, V26, P168, DOI 10.1111/j.1365-2915.2011.00991.x; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Roug A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050600; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Schmidtmann ET, 2000, J MED ENTOMOL, V37, P58, DOI 10.1603/0022-2585-37.1.58; Singer RS, 2001, J VET DIAGN INVEST, V13, P43, DOI 10.1177/104063870101300109; Spreull J, 1905, J COMP PATHOL, V18, P321, DOI DOI 10.1016/S0368-1742(05)80073-6; STALLKNECHT DE, 1991, J WILDLIFE DIS, V27, P668, DOI 10.7589/0090-3558-27.4.668; STOTT J L, 1985, P571; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Turner J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00319; Tuya F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020190; UHAA IJ, 1990, VET RES COMMUN, V14, P99; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Velthuis AGJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019612; Verwoerd D. W., 2004, Infectious diseases of livestock. Volume Two, P1201; Walton TE, 2004, VETER ITAL SER, V40, P31; Ward MP, 1997, PREV VET MED, V29, P299, DOI 10.1016/S0167-5877(96)01081-1; Zuliani A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130294	76	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165806	10.1371/journal.pone.0165806	http://dx.doi.org/10.1371/journal.pone.0165806			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812161	gold, Green Published, Green Submitted			2022-12-27	WOS:000386910000062
J	Rand, MK; Rentsch, S				Rand, Miya K.; Rentsch, Sebastian			Eye-Hand Coordination during Visuomotor Adaptation with Different Rotation Angles: Effects of Terminal Visual Feedback	PLOS ONE			English	Article							REAL SLIDING LEVERS; SENSORIMOTOR ADAPTATION; MOTOR TRANSFORMATIONS; EXPLICIT STRATEGY; MOVEMENTS; TARGET; GAZE; TASK; IMPLICIT; ERROR	This study examined adaptive changes of eye-hand coordination during a visuomotor rotation task under the use of terminal visual feedback. Young adults made reaching movements to targets on a digitizer while looking at targets on a monitor where the rotated feedback (a cursor) of hand movements appeared after each movement. Three rotation angles (30 degrees, 75 degrees and 150 degrees) were examined in three groups in order to vary the task difficulty. The results showed that the 30 degrees group gradually reduced direction errors of reaching with practice and adapted well to the visuomotor rotation. The 75 degrees group made large direction errors of reaching, and the 150 degrees group applied a 180 degrees reversal shift from early practice. The 75 degrees and 150 degrees groups, however, overcompensated the respective rotations at the end of practice. Despite these group differences in adaptive changes of reaching, all groups gradually adapted gaze directions prior to reaching from the target area to the areas related to the final positions of reaching during the course of practice. The adaptive changes of both hand and eye movements in all groups mainly reflected adjustments of movement directions based on explicit knowledge of the applied rotation acquired through practice. Only the 30 degrees group showed small implicit adaptation in both effectors. The results suggest that by adapting gaze directions from the target to the final position of reaching based on explicit knowledge of the visuomotor rotation, the oculomotor system supports the limb-motor system to make precise preplanned adjustments of reaching directions during learning of visuomotor rotation under terminal visual feedback.	[Rand, Miya K.; Rentsch, Sebastian] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Rand, MK (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	rand@ifado.de			German Research Foundation (DFG) [Ra 2183/1-3]	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by grant Ra 2183/1-3 of the German Research Foundation (DFG) to MKR, http://www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeele S, 2001, EXP BRAIN RES, V140, P407, DOI 10.1007/s002210100846; ABRAMS RA, 1990, J EXP PSYCHOL HUMAN, V16, P248, DOI 10.1037/0096-1523.16.2.248; Adam JJ, 2012, J EXP PSYCHOL HUMAN, V38, P891, DOI 10.1037/a0027592; Benson BL, 2011, J NEUROPHYSIOL, V105, P2843, DOI 10.1152/jn.00002.2011; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bernier PM, 2005, EXP BRAIN RES, V167, P292, DOI 10.1007/s00221-005-0063-5; Bowman M, 2009, EXP BRAIN RES, V195, P273, DOI 10.1007/s00221-009-1781-x; Crawford JD, 2004, J NEUROPHYSIOL, V92, P10, DOI 10.1152/jn.00117.2004; CUNNINGHAM HA, 1989, J EXP PSYCHOL HUMAN, V15, P493, DOI 10.1037/0096-1523.15.3.493; de Boor C, 1978, A PRACTICAL GUIDE TO; ELLIOTT D, 1988, CAN J PSYCHOL, V42, P57, DOI 10.1037/h0084172; Ferrel C, 2001, EXP BRAIN RES, V138, P313, DOI 10.1007/s002210100697; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Gaveau V, 2008, NEUROPSYCHOLOGIA, V46, P475, DOI 10.1016/j.neuropsychologia.2007.08.028; Gaveau V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00880; GEORGOPOULOS AP, 1987, EXP BRAIN RES, V65, P361; Ghez C, 2007, J NEUROPHYSIOL, V98, P3614, DOI 10.1152/jn.00652.2007; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; Granek JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0086138; Granek JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046619; Hayhoe MM, 2003, J VISION, V3, P49, DOI 10.1167/3.1.6; Hegele M, 2010, CONSCIOUS COGN, V19, P906, DOI 10.1016/j.concog.2010.05.005; Heuer H., 2013, AGE DIFFERENTIATED W, P369, DOI DOI 10.1007/978-3-642-35057-3_16; Heuer H, 2008, J MOTOR BEHAV, V40, P368, DOI 10.3200/JMBR.40.5.368-379; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; Heuer H, 2008, EXP BRAIN RES, V185, P101, DOI 10.1007/s00221-007-1135-5; Heuer H, 2012, HUM MOVEMENT SCI, V31, P1056, DOI 10.1016/j.humov.2012.01.004; Hinder MR, 2008, EXP BRAIN RES, V191, P143, DOI 10.1007/s00221-008-1513-7; Hinder MR, 2010, EXP BRAIN RES, V201, P191, DOI 10.1007/s00221-009-2025-9; IMAMIZU H, 1995, J EXP PSYCHOL HUMAN, V21, P719, DOI 10.1037/0096-1523.21.4.719; Ishihara S, 2005, ISHIHARA TESTS FOR C; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Lunenburger L, 2000, EUR J NEUROSCI, V12, P4107, DOI 10.1046/j.1460-9568.2000.00298.x; Martin TA, 1996, BRAIN, V119, P1199, DOI 10.1093/brain/119.4.1199; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Paillard J., 1982, ANAL VISUAL BEHAV, P367; Peled A, 2012, J MOTOR BEHAV, V44, P185, DOI 10.1080/00222895.2012.672349; Pisella L, 2009, NEUROPSYCHOLOGIA, V47, P3033, DOI 10.1016/j.neuropsychologia.2009.06.020; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; Rand MK, 2015, J NEUROPHYSIOL, V113, P88, DOI 10.1152/jn.00044.2014; Rand MK, 2014, EXP BRAIN RES, V232, P2753, DOI 10.1007/s00221-014-3951-8; Rand MK, 2010, EXP BRAIN RES, V207, P197, DOI 10.1007/s00221-010-2456-3; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Rentsch S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109819; Sailer U, 2005, J NEUROSCI, V25, P8833, DOI 10.1523/JNEUROSCI.2658-05.2005; Saunders JA, 2004, J NEUROSCI, V24, P3223, DOI 10.1523/JNEUROSCI.4319-03.2004; Scheidt RA, 2007, J NEUROPHYSIOL, V98, P3600, DOI 10.1152/jn.00121.2007; Shabbott BA, 2010, EXP BRAIN RES, V203, P75, DOI 10.1007/s00221-010-2209-3; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Sulzenbruck S, 2012, EXP BRAIN RES, V218, P283, DOI 10.1007/s00221-012-3011-1; Sulzenbruck S, 2012, Z PSYCHOL, V220, P3, DOI 10.1027/2151-2604/a000084; Sulzenbruck S, 2011, ERGONOMICS, V54, P34, DOI 10.1080/00140139.2010.535023; Sulzenbruck S, 2010, EXP BRAIN RES, V201, P549, DOI 10.1007/s00221-009-2071-3; Sulzenbruck S, 2009, EXP BRAIN RES, V195, P153, DOI 10.1007/s00221-009-1764-y; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; Taylor JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001096; TEASDALE N, 1993, J MOTOR BEHAV, V25, P97, DOI 10.1080/00222895.1993.9941644; Walsh CM, 2009, ACAD MED, V84, pS54, DOI 10.1097/ACM.0b013e3181b38daf; Werner S, 2007, EXP BRAIN RES, V178, P554, DOI 10.1007/s00221-007-0925-0; Winer BJ., 1971, STAT PRINCIPLES EXPT, V2nd ed	64	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0164602	10.1371/journal.pone.0164602	http://dx.doi.org/10.1371/journal.pone.0164602			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812093	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000010
J	Sekine, Y; Zyryanova, A; Crespillo-Casado, A; Amin-Wetzel, N; Harding, HP; Ron, D				Sekine, Yusuke; Zyryanova, Alisa; Crespillo-Casado, Ana; Amin-Wetzel, Niko; Harding, Heather P.; Ron, David			Paradoxical Sensitivity to an Integrated Stress Response Blocking Mutation in Vanishing White Matter Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; TRANSLATIONAL CONTROL; EIF2B; PHOSPHORYLATION; REPRESSION; DISORDERS; DISEASE; TARGET; GENES; GCN4	The eukaryotic translation initiation factor eIF2B promotes mRNA translation as a guanine nucleotide exchange factor (GEF) for translation initiation factor 2 (eIF2). Endoplasmic reticulum (ER) stress-mediated activation of the kinase PERK and the resultant phosphorylation of eIF2's alpha subunit (eIF2 alpha) attenuates eIF2B GEF activity thereby inducing an integrated stress response (ISR) that defends against protein misfolding in the ER. Mutations in all five subunits of human eIF2B cause an inherited leukoencephalopathy with vanishing white matter (VWM), but the role of the ISR in its pathogenesis remains unclear. Using CRISPR-Cas9 genome editing we introduced the most severe known VWM mutation, EIF2B4 A391D, into CHO cells. Compared to isogenic wildtype cells, GEF activity of cells with the VWM mutation was impaired and the mutant cells experienced modest enhancement of the ISR. However, despite their enhanced ISR, imposed by the intrinsic defect in eIF2B, disrupting the inhibitory effect of phosphorylated eIF2 alpha on GEF by a contravening EIF2S1/eIF2 alpha(S51A) mutation that functions upstream of eIF2B, selectively enfeebled both EIF2B4(A391D) and the related severe VWM EIF2B4(R483W) cells. The basis for paradoxical dependence of cells with the VWM mutations on an intact eIF2 alpha genotype remains unclear, as both translation rates and survival from stressors that normally activate the ISR were not reproducibly affected by the VWM mutations. Nonetheless, our findings support an additional layer of complexity in the development of VWM, beyond a hyperactive ISR.	[Sekine, Yusuke; Zyryanova, Alisa; Crespillo-Casado, Ana; Amin-Wetzel, Niko; Harding, Heather P.; Ron, David] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Sekine, Yusuke] NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA	University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sekine, Y; Ron, D (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge, England.; Sekine, Y (corresponding author), NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA.	yusuke.sekine@nih.gov; dr360@medschl.cam.ac.uk	Sekine, Yusuke/AHI-8340-2022	Harding, Heather P/0000-0002-7359-7974; Amin-Wetzel, Niko/0000-0002-4640-3724; Sekine, Yusuke/0000-0003-0345-1416; Ron, David/0000-0002-3014-5636	Wellcome Trust [200848/Z/16/Z, 100140]; European Commission (EU FP7 Beta-Bat) [277713]; Medical Research Council; Medical Research Council [1358405] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); European Commission (EU FP7 Beta-Bat); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the Wellcome Trust (Wellcome 200848/Z/16/Z) and the European Commission (EU FP7 Beta-Bat No: 277713) and, a Wellcome Trust Strategic Award for core facilities to the Cambridge Institute for Medical Research (Wellcome 100140). YS is a Japanese Society for the Promotion of Science Postdoctoral Fellow for Research Abroad. NAW is a Medical Research Council supported PhD student. DR is a Wellcome Trust Principal Research Fellow. Wellcome Trust URL; http://www.wellcome.ac.uk, JSPS URL; https://www.jsps.go.jp, MRC URL; http://www.mrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Fogli A, 2006, BIOCHEM SOC T, V34, P22, DOI 10.1042/BST0340022; Fogli A, 2003, AM J HUM GENET, V72, P1544, DOI 10.1086/375404; HARASHIMA S, 1986, MOL CELL BIOL, V6, P3990, DOI 10.1128/MCB.6.11.3990; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Kantor L, 2005, HUM GENET, V118, P99, DOI 10.1007/s00439-005-0024-x; Li W, 2004, MOL CELL BIOL, V24, P3295, DOI 10.1128/MCB.24.8.3295-3306.2004; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; Liu R, 2011, HUM MUTAT, V32, P1036, DOI 10.1002/humu.21535; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Maletkovic J, 2008, J CHILD NEUROL, V23, P205, DOI 10.1177/0883073807308705; Mohammad-Qureshi SS, 2008, BIOCHEM SOC T, V36, P658, DOI 10.1042/BST0360658; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pavitt GD, 2009, BIOCHEM SOC T, V37, P1298, DOI 10.1042/BST0371298; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Ronda C, 2014, BIOTECHNOL BIOENG, V111, P1604, DOI 10.1002/bit.25233; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; SCORSONE KA, 1987, J BIOL CHEM, V262, P14538; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; van der Knaap MS, 2003, AM J HUM GENET, V73, P1199, DOI 10.1086/379524; van der Knapp MS, 2006, LANCET NEUROL, V5, P413, DOI 10.1016/S1474-4422(06)70440-9; van Kollenburg B, 2006, NEUROBIOL DIS, V21, P496, DOI 10.1016/j.nbd.2005.08.009	28	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166278	10.1371/journal.pone.0166278	http://dx.doi.org/10.1371/journal.pone.0166278			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812215	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000107
J	Wang, JC; Shi, GF; Baptiste, S; Yarotska, M; Sindhu, H; Wong, C; Kalavar, M; Gotlieb, V; Bandarchuk, A; Chen, H				Wang, Jen C.; Shi, Guanfang; Baptiste, Stacey; Yarotska, Maryna; Sindhu, Hemant; Wong, Ching; Kalavar, Madhumati; Gotlieb, Vladimir; Bandarchuk, Andrei; Chen, Hui			Quantification of IGF-1 Receptor May Be Useful in Diagnosing Polycythemia Vera-Suggestion to Be Added to Be One of the Minor Criterionle	PLOS ONE			English	Article							CIRCULATING ERYTHROID PROGENITORS; BONE-MARROW; ESSENTIAL THROMBOCYTHEMIA; MYELOPROLIFERATIVE NEOPLASMS; HISTOLOGICAL CRITERIA; MONONUCLEAR-CELLS; COLONY FORMATION; IN-VITRO; ERYTHROPOIETIN; MYELOFIBROSIS	Endogenous erythroid colony (EEC) formation is one of the minor criteria for diagnosing polycythemia vera (PV) according to 2008 WHO diagnostic criteria. But EEC requires bone marrow aspiration and sophisticated laboratory procedures; therefore, practically it is rarely used to diagnose PV. Insulin-like growth factor 1 receptor (IGF-1R) was found to be constitutively phosphorylated and was responsible for the EEC formation in PV; therefore, we measured IGF-1R levels in the peripheral blood of 26 PV patients and compared them with those of 33 patients with secondary polycythemia and 29 normal controls. Among the PV patients, 16 were treated with only phlebotomy, 9 received hydroxyurea, and 1 was treated with ruxolinitinib. We found that PV patients treated with only phlebotomy had significantly higher IGF-1R levels than did those PV patients treated with hydroxyurea or ruxolinitinib. None of the secondary PV patients or normal controls had elevated IGR-1R levels, while 14 of 16 (87%) PV patients had significantly elevated IGF-1R levels. The new 2016 WHO has eliminated EEC as a minor criterion for diagnosing PV, but there are still some cases that cannot be definitively diagnosed by the current criteria. Therefore, we suggest that quantifying the IGF-1R level in peripheral blood by flow cytometry to replace EEC as the minor criterion for diagnosing PV.	[Wang, Jen C.; Shi, Guanfang; Baptiste, Stacey; Yarotska, Maryna; Sindhu, Hemant; Wong, Ching; Kalavar, Madhumati; Gotlieb, Vladimir; Bandarchuk, Andrei; Chen, Hui] Brookdale Univ Hosp Med Ctr, Div Hematol Oncol, Brooklyn, NY 11212 USA		Wang, JC (corresponding author), Brookdale Univ Hosp Med Ctr, Div Hematol Oncol, Brooklyn, NY 11212 USA.	jcwang0005@Gmail.com			Celgen Corp.	Celgen Corp.	JCW received grants from Celgen Corp. The other authors declare no competing financial interests. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Larran A, 2014, BRIT J HAEMATOL, V166, P911, DOI 10.1111/bjh.12990; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Barbui T, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.64; Barbui T, 2014, AM J HEMATOL, V89, P52, DOI 10.1002/ajh.23585; CORREA PN, 1994, BLOOD, V83, P99; EAVES CJ, 1978, BLOOD, V52, P1196; ELLIS JT, 1986, SEMIN HEMATOL, V23, P144; Gianelli U, 2008, AM J CLIN PATHOL, V130, P336, DOI 10.1309/6BQ5K8LHVYAKUAF4; Gianelli U, 2014, MODERN PATHOL, V27, P814, DOI 10.1038/modpathol.2013.196; Kim HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052518; Kvasnicka HM, 2010, AM J HEMATOL, V85, P62, DOI 10.1002/ajh.21543; LACOMBE C, 1980, BRIT J HAEMATOL, V44, P189, DOI 10.1111/j.1365-2141.1980.tb01201.x; LUTTON JD, 1979, ACTA HAEMATOL-BASEL, V62, P94, DOI 10.1159/000207547; MIRZA AM, 1995, BLOOD, V86, P877; Mossuz P, 2004, HAEMATOLOGICA, V89, P1194; Pardanani A, 2007, LEUKEMIA, V21, P1960, DOI 10.1038/sj.leu.2404810; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Silver RT, 2013, BLOOD, V122, P1881, DOI 10.1182/blood-2013-06-508416; Spivak JL, 2002, BLOOD, V100, P4272, DOI 10.1182/blood-2001-12-0349; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Tefferi A, 2007, BLOOD, V110, P1092, DOI 10.1182/blood-2007-04-083501; Thiele J, 2005, ACTA HAEMATOL-BASEL, V113, P213, DOI 10.1159/000084673; Thiele J, 2005, ANN HEMATOL, V84, P362, DOI 10.1007/s00277-005-1030-8; Thiele J, 2005, HISTOL HISTOPATHOL, V20, P317, DOI 10.14670/HH-20.317; Vannucchi AM, 2008, LEUKEMIA, V22, pCP5, DOI 10.1038/leu.2008.113; WEINBERG RS, 1989, LEUKEMIA RES, V13, P331, DOI 10.1016/0145-2126(89)90070-2; Wilkins BS, 2008, BLOOD, V111, P60, DOI 10.1182/blood-2007-05-091850; ZANJANI ED, 1977, J CLIN INVEST, V59, P841, DOI 10.1172/JCI108706	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165299	10.1371/journal.pone.0165299	http://dx.doi.org/10.1371/journal.pone.0165299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812134	gold, Green Submitted, Green Published			2022-12-27	WOS:000386910000027
J	Lang, K; Roberts, M; Harrison, A; Lopez, C; Goddard, E; Khondoker, M; Treasure, J; Tchanturia, K				Lang, Katie; Roberts, Marion; Harrison, Amy; Lopez, Carolina; Goddard, Elizabeth; Khondoker, Mizan; Treasure, Janet; Tchanturia, Kate			Central Coherence in Eating Disorders: A Synthesis of Studies Using the Rey Osterrieth Complex Figure Test	PLOS ONE			English	Article							COGNITIVE REMEDIATION THERAPY; ANOREXIA-NERVOSA PATIENTS; SHIFTING ABILITY; SCHIZOPHRENIA; ADOLESCENTS; DEPRESSION; RELATIVES; ANXIETY	Background Large variability in tests and differences in scoring systems used to study central coherence in eating disorders may lead to different interpretations, inconsistent findings and between study discrepancies. This study aimed to address inconsistencies by collating data from several studies from the same research group that used the Rey Osterrieth Complex Figure Test (Rey Figure) in order to produce norms to provide benchmark data for future studies. Method Data was collated from 984 participants in total. Anorexia Nervosa, Bulimia Nervosa, recovered Anorexia Nervosa, unaffected family members and healthy controls were compared using the Rey Figure. Results Poor global processing was observed across all current eating disorder sub-groups and in unaffected relatives. There was no difference in performance between recovered AN and HC groups. Conclusions This is the largest dataset reported in the literature and supports previous studies implicating poor global processing across eating disorders using the Rey Figure. It provides robust normative data useful for future studies.	[Lang, Katie; Roberts, Marion; Lopez, Carolina; Goddard, Elizabeth; Khondoker, Mizan; Treasure, Janet; Tchanturia, Kate] KCL, Psychol Med, Inst Psychiat Psychol & Neurosci, London, England; [Harrison, Amy] Regents Univ, Fac Humanities Arts & Social Sci, Regents Sch Psychotherapy & Psychol, London, England; [Lopez, Carolina] Univ Chile, Fac Med, Dept Pediat & Child Surg East, Santiago, Chile; [Tchanturia, Kate] Illia State Univ, Dept Psychol, Tbilisi, Georgia	University of London; King's College London; Universidad de Chile	Tchanturia, K (corresponding author), KCL, Psychol Med, Inst Psychiat Psychol & Neurosci, London, England.; Tchanturia, K (corresponding author), Illia State Univ, Dept Psychol, Tbilisi, Georgia.	kate.tchanturia@kcl.ac.uk	Khondoker, Mizanur/A-9860-2011; Khondoker, Mizanur/O-2656-2019; Tchanturia, Kate/H-1474-2011	Khondoker, Mizanur/0000-0002-1801-1635; Khondoker, Mizanur/0000-0002-1801-1635; Tchanturia, Kate/0000-0001-8988-3265; Harrison, Amy/0000-0002-3771-9735; Treasure, Janet/0000-0003-0871-4596; Roberts, Marion/0000-0001-6824-4413	National Institute for Health Research (NIHR) [Mental Health Biomedical Research Centre and/or Dementia Biomedical Research Unit] at South London & Maudsley NHS Foundation Trust	National Institute for Health Research (NIHR) [Mental Health Biomedical Research Centre and/or Dementia Biomedical Research Unit] at South London & Maudsley NHS Foundation Trust	The authors would like to thank the National Institute for Health Research (NIHR) [Mental Health Biomedical Research Centre and/or Dementia Biomedical Research Unit] at South London & Maudsley NHS Foundation Trust for financial support. The views expressed are those of the authors and not necessarily those of the NHS the NIHR or the Department of Health. Kate Tchanturia would also like to thank the Swiss Anorexia Foundation (34-16).	Aloi M, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0395-z; Anderluh M, 2009, PSYCHOL MED, V39, P105, DOI 10.1017/S0033291708003292; Booth R. D. L., 2006, LOCAL GLOBAL PROCESS; Cavedini P, 2010, BIOL PSYCHIAT, V67, P1178, DOI 10.1016/j.biopsych.2010.02.012; Darcy AM, 2015, INT J EAT DISORDER, V48, P487, DOI 10.1002/eat.22340; Dingemans AE, 2014, PSYCHOTHER PSYCHOSOM, V83, P29, DOI 10.1159/000355240; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; First MB, 1995, STRUCTURED CLIN INTE, P722; Galimberti E, 2013, PSYCHIAT RES, V208, P238, DOI 10.1016/j.psychres.2012.10.001; Goddard E, 2014, WORLD J BIOL PSYCHIA, V15, P317, DOI 10.3109/15622975.2012.750014; Harrison A, 2012, BRIT J CLIN PSYCHOL, V51, P261, DOI 10.1111/j.2044-8260.2011.02026.x; Harrison A, 2011, WORLD J BIOL PSYCHIA, V12, P462, DOI 10.3109/15622975.2010.551666; HEAD D, 1989, BIOL PSYCHIAT, V25, P929, DOI 10.1016/0006-3223(89)90272-2; Hill EL, 2004, TRENDS COGN SCI, V8, P26, DOI 10.1016/j.tics.2003.11.003; Hutchison S, 2015, COGNITIVE REMEDIATION THERAPY (CRT) FOR EATING AND WEIGHT DISORDERS, P147; Lang K., 2015, WORLD J BIOL PSYCHIA, P1; Lang K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131724; Lang K, 2015, PSYCHIAT RES, V225, P387, DOI 10.1016/j.psychres.2014.12.008; Lang K, 2014, WORLD J BIOL PSYCHIA, V15, P586, DOI 10.3109/15622975.2014.909606; Lindner SE, 2012, INT J EAT DISORDER, V45, P866, DOI 10.1002/eat.22025; Lopez C, 2008, PSYCHOL MED, V38, P1393, DOI 10.1017/S0033291708003486; Lopez C, 2009, J CLIN EXP NEUROPSYC, V31, P117, DOI 10.1080/13803390802036092; Lopez CA, 2008, INT J EAT DISORDER, V41, P340, DOI 10.1002/eat.20511; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Osterrieth PA., 1944, ARCH PSYCHOL-GENEVE, V30, P286; Pantelis C, 1999, SCHIZOPHR RES, V37, P251, DOI 10.1016/S0920-9964(98)00156-X; Roberts ME, 2013, WORLD J BIOL PSYCHIA, V14, P452, DOI 10.3109/15622975.2011.639804; Roberts ME, 2010, J PSYCHIATR RES, V44, P964, DOI 10.1016/j.jpsychires.2010.03.001; Snitz BE, 2006, SCHIZOPHRENIA BULL, V32, P179, DOI 10.1093/schbul/sbi048; Stedal K, 2012, ARCH CLIN NEUROPSYCH, V27, P329, DOI 10.1093/arclin/acs032; Tchanturia K, 2014, EUR EAT DISORD REV, V22, P454, DOI 10.1002/erv.2326; Tchanturia K, 2013, INT J EAT DISORDER, V46, P492, DOI 10.1002/eat.22106; Tchanturia K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028331; Tchanturia K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020462; Tenconi E, 2010, WORLD J BIOL PSYCHIA, V11, P813, DOI 10.3109/15622975.2010.483250; Treasure J, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-13; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	39	61	62	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165467	10.1371/journal.pone.0165467	http://dx.doi.org/10.1371/journal.pone.0165467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806073	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500031
J	Miguel-Hurtado, O; Guest, R; Stevenage, SV; Neil, GJ; Black, S				Miguel-Hurtado, Oscar; Guest, Richard; Stevenage, Sarah V.; Neil, Greg J.; Black, Sue			Comparing Machine Learning Classifiers and Linear/Logistic Regression to Explore the Relationship between Hand Dimensions and Demographic Characteristics	PLOS ONE			English	Article							SEX DETERMINATION; FINGER LENGTHS; STATURE; BIOMETRICS	Understanding the relationship between physiological measurements from human subjects and their demographic data is important within both the biometric and forensic domains. In this paper we explore the relationship between measurements of the human hand and a range of demographic features. We assess the ability of linear regression and machine learning classifiers to predict demographics from hand features, thereby providing evidence on both the strength of relationship and the key features underpinning this relationship. Our results show that we are able to predict sex, height, weight and foot size accurately within various data-range bin sizes, with machine learning classification algorithms out-performing linear regression in most situations. In addition, we identify the features used to provide these relationships applicable across multiple applications.	[Miguel-Hurtado, Oscar; Guest, Richard] Univ Kent, Sch Engn & Digital Arts, Canterbury, Kent, England; [Stevenage, Sarah V.; Neil, Greg J.] Univ Southampton, Dept Psychol, Southampton, Hants, England; [Black, Sue] Univ Dundee, Ctr Anat & Human Identificat, Dundee, Scotland	University of Kent; University of Southampton; University of Dundee	Miguel-Hurtado, O (corresponding author), Univ Kent, Sch Engn & Digital Arts, Canterbury, Kent, England.	O.Miguel-Hurtado-98@kent.ac.uk		Neil, Greg/0000-0003-1360-5490; Miguel-Hurtado, Oscar/0000-0002-3257-5170	UK Engineering and Physical Sciences Research Council, SID: An Exploration of Super-Identity project (EPSRC) [EP/J004995/1]; EPSRC [EP/J004995/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J004995/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council, SID: An Exploration of Super-Identity project (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is supported by the UK Engineering and Physical Sciences Research Council as part of the SID: An Exploration of Super-Identity project (EPSRC EP/J004995/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri Arun Kumar, 2008, J Forensic Leg Med, V15, P479, DOI 10.1016/j.jflm.2008.03.002; Ailisto H, 2006, PATTERN RECOGN LETT, V27, P325, DOI 10.1016/j.patrec.2005.08.018; Amayeh G., 2008, IEEE COMP SOC C COMP, P1; Black SM, 2012, SUPERIDENTITY FUSION; Case DT, 2007, J FORENSIC SCI, V52, P264, DOI 10.1111/j.1556-4029.2006.00365.x; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Collins RT, 2002, FIFTH IEEE INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION, PROCEEDINGS, P366, DOI 10.1109/AFGR.2002.1004181; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cuntoor N, 2003, AC SPEECH SIGN PROC, V3, pIII; Dash M., 1997, Intelligent Data Analysis, V1; Erman J., 2006, IEEE GLOBECOM 2006, P1, DOI DOI 10.1109/GLOCOM.2006.443; FALSETTI AB, 1995, J FORENSIC SCI, V40, P774; Garg T, 2014, RECENT ADV INNOVATIO, P1, DOI DOI 10.1109/ICRAIE.2014.6909184; Guest R, 2014, IEEE INT CARN C SEC, P152; Habib SR, 2010, J FORENSIC LEG MED, V17, P156, DOI 10.1016/j.jflm.2009.12.004; Hall M., 2009, ACM SIGKDD EXPLOR NE, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hunt DR, 2005, AM J PHYS ANTHROPOL, V127, P406, DOI 10.1002/ajpa.20135; Jain A, 2004, SIXTH IEEE INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION, PROCEEDINGS, P159, DOI 10.1109/AFGR.2004.1301524; Jain AK, 2004, LECT NOTES COMPUT SC, V3072, P731; Jain Anil K., 2007, HDB BIOMETRICS, DOI [10.1007/978-0-387-71041-9, DOI 10.1007/978-0-387-71041-9]; Jee SC, 2015, FORENSIC SCI INT, V257, DOI 10.1016/j.forsciint.2015.10.014; Jee SC, 2015, J FORENSIC LEG MED, V35, P9, DOI 10.1016/j.jflm.2015.06.014; Kanchan T, 2010, FORENSIC SCI INT, V199, DOI 10.1016/j.forsciint.2010.03.002; Kanchan T, 2009, J FORENSIC SCI, V54, P546, DOI 10.1111/j.1556-4029.2009.01018.x; Karki R, 2014, J UNIVERSAL COLL MED, V2, P12, DOI [10.3126/jucms.v2i1.10484, DOI 10.3126/JUCMS.V2I1.10484]; Khanpetch P, 2012, FORENSIC SCI INT, V217, DOI 10.1016/j.forsciint.2011.10.044; Lagree S., 2011, 2011 IEEE International Conference on Technologies for Homeland Security (HST 2011), P440, DOI 10.1109/THS.2011.6107909; Lemeshow S., 2004, APPLIED LOGISTIC REG; Lewis D. D., 1998, LECT NOTES COMPUTER, P4, DOI DOI 10.1007/BFB0026666; Lippa RA, 2006, BIOL PSYCHOL, V71, P116, DOI 10.1016/j.biopsycho.2005.02.004; Loehlin JC, 2009, ARCH SEX BEHAV, V38, P298, DOI 10.1007/s10508-007-9303-z; MALINA RM, 1983, HUM BIOL, V55, P867; Miguel-Hurtado O., 2016, HAND IMAGES LENGTHS; MUSGRAVE JH, 1978, AM J PHYS ANTHROPOL, V48, P113, DOI 10.1002/ajpa.1330480117; Patil BM, 2009, 2009 IEEE INTERNATIONAL ADVANCE COMPUTING CONFERENCE, VOLS 1-3, P1353, DOI 10.1109/IADCC.2009.4809213; Salzberg S.L., 1994, MACH LEARN, V16, P235, DOI [10.1007/bf00993309, DOI 10.1007/BF00993309, 10.1007/BF00993309]; Sanchez-Reillo R, 2000, IEEE T PATTERN ANAL, V22, P1168, DOI 10.1109/34.879796; Sanli SG, 2005, CLIN ANAT, V18, P589, DOI 10.1002/ca.20146; Siegel Jay A., 2012, ENCY FORENSIC SCI; Stevenage SV, 2015, PSYCHOL RES-PSYCH FO, V79, P989, DOI 10.1007/s00426-014-0625-x; Zhang DS, 2003, MULTIMEDIA SYST, V9, P15, DOI 10.1007/s00530-002-0075-y; Ziolko B, 2008, 2008 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOLS 1-4, P1297, DOI 10.1109/ICME.2008.4607680	42	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165521	10.1371/journal.pone.0165521	http://dx.doi.org/10.1371/journal.pone.0165521			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806075	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000386715500035
J	Qi, XQ; Zhang, K; Xu, T; Yamaki, VN; Wei, ZS; Huang, MF; Rose, GM; Cai, X				Qi, Xiaoqiang; Zhang, Ke; Xu, Ting; Yamaki, Vitor Nagai; Wei, Zhisheng; Huang, Mingfa; Rose, Gregory M.; Cai, Xiang			Sex Differences in Long-Term Potentiation at Temporoammonic-CA1 Synapses: Potential Implications for Memory Consolidation	PLOS ONE			English	Article							ENHANCED SYNAPTIC PLASTICITY; WATER MAZE PERFORMANCE; RAT ESTROUS-CYCLE; SPATIAL NAVIGATION; WORKING-MEMORY; POSTERIOR HIPPOCAMPUS; RETROGRADE-AMNESIA; GENDER-DIFFERENCES; PYRAMIDAL CELLS; RODENT MODELS	Sex differences in spatial memory have long been observed in humans, non-human primates and rodents, but the underlying cellular and molecular mechanisms responsible for these differences remain obscure. In the present study we found that adolescent male rats outperformed female rats in 7 d and 28 d retention probes, but not in learning trials and immediate probes, in the Morris water maze task. Male rats also had larger long-term potentiation (LTP) at hippocampal temproammonic-CA1 (TA-CA1) synapses, which have been implicated to play a key role in place field and memory consolidation, when protocols designed to elicit late-stage LTP (LLTP) were used. Interestingly, the ratio of evoked AMPA/NMDA currents was found to be smaller at TA-CA1 synapses in male rats compared to female rats. Protein biotinylation experiments showed that male rats expressed more surface GluN1 receptors in hippocampal CA1 stratum lacunosum-moleculare (SLM) than female rats, although GluA1 expression was also slightly higher in male rats. Taken together, our results suggest that differences in the expression of AMPA and NMDA receptors may affect LTP expression at TA-CA1 synapses in adolescent male and female rats, and thus possibly contribute to the observed sex difference in spatial memory.	[Qi, Xiaoqiang; Zhang, Ke; Yamaki, Vitor Nagai; Cai, Xiang] Southern Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; [Xu, Ting; Wei, Zhisheng; Huang, Mingfa; Cai, Xiang] Guangzhou Med Univ, Affiliated Hosp 2, Inst Neurosci, Key Lab Neurogenet & Channelopathies Guangdong Pr, Guangzhou, Guangdong, Peoples R China; [Xu, Ting; Wei, Zhisheng; Huang, Mingfa; Cai, Xiang] Guangzhou Med Univ, Affiliated Hosp 2, Minist Educ China, Guangzhou, Guangdong, Peoples R China; [Rose, Gregory M.] Southern Illinois Univ, Sch Med, Dept Anat, Carbondale, IL USA; [Rose, Gregory M.; Cai, Xiang] Southern Illinois Univ, Sch Med, Neurosci Res Ctr, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; Guangzhou Medical University; Guangzhou Medical University; Ministry of Education, China; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Cai, X (corresponding author), Southern Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.; Cai, X (corresponding author), Guangzhou Med Univ, Affiliated Hosp 2, Inst Neurosci, Key Lab Neurogenet & Channelopathies Guangdong Pr, Guangzhou, Guangdong, Peoples R China.; Cai, X (corresponding author), Guangzhou Med Univ, Affiliated Hosp 2, Minist Educ China, Guangzhou, Guangdong, Peoples R China.; Cai, X (corresponding author), Southern Illinois Univ, Sch Med, Neurosci Res Ctr, Carbondale, IL 62901 USA.	cai001@siu.edu	Cai, Xiang/AAD-8012-2021	cai, xiang/0000-0003-0222-553X	NIMH [R01 (NIHMH086828)]; SIU School of Medicine startup funds; NARSAD Young Investigator Awards	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); SIU School of Medicine startup funds; NARSAD Young Investigator Awards(NARSAD)	This study was supported by NIMH R01 (NIHMH086828) (ST and XC); SIU School of Medicine startup funds (XC); NARSAD Young Investigator Awards (XC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astur RS, 1998, BEHAV BRAIN RES, V93, P185, DOI 10.1016/S0166-4328(98)00019-9; Blokland A, 2006, BEHAV BRAIN RES, V171, P216, DOI 10.1016/j.bbr.2006.03.033; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Cai X, 2013, NAT NEUROSCI, V16, P464, DOI 10.1038/nn.3355; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Clark RE, 2002, J NEUROSCI, V22, P4663, DOI 10.1523/JNEUROSCI.22-11-04663.2002; Cooke BM, 2003, HORM BEHAV, V43, P336, DOI 10.1016/S0018-506X(02)00047-8; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Daniel JM, 1999, PHYSIOL BEHAV, V66, P11, DOI 10.1016/S0031-9384(98)00272-8; Duff SJ, 2001, BRAIN COGNITION, V47, P470, DOI 10.1006/brcg.2001.1326; Foy MR, 1999, J NEUROPHYSIOL, V81, P925, DOI 10.1152/jn.1999.81.2.925; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Giedd JN, 1996, J COMP NEUROL, V366, P223, DOI 10.1002/(SICI)1096-9861(19960304)366:2<223::AID-CNE3>3.0.CO;2-7; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; Gupta RR, 2001, BRAIN RES, V888, P356, DOI 10.1016/S0006-8993(00)03116-4; Harte-Hargrove LC, 2015, J NEUROSCI, V35, P1723, DOI 10.1523/JNEUROSCI.0820-14.2015; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; JEFFERY KJ, 1993, HIPPOCAMPUS, V3, P133, DOI 10.1002/hipo.450030205; Jonasson Z, 2005, NEUROSCI BIOBEHAV R, V28, P811, DOI 10.1016/j.neubiorev.2004.10.006; KEATING MB, 1986, CHILD DEV, V57, P115, DOI 10.2307/1130643; Kosaki Y, 2014, HIPPOCAMPUS, V24, P1633, DOI 10.1002/hipo.22343; Leon I, 2014, NEUROPSYCHOLOGY, V28, P485, DOI 10.1037/neu0000054; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MAREN S, 1994, BRAIN RES, V661, P25, DOI 10.1016/0006-8993(94)91176-2; MAREN S, 1995, NEUROSCI LETT, V196, P177, DOI 10.1016/0304-3940(95)11869-X; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Mendez-Lopez M, 2009, NEUROSCI RES, V65, P28, DOI 10.1016/j.neures.2009.05.001; Monfort P, 2015, ACS CHEM NEUROSCI, V6, P1420, DOI 10.1021/acschemneuro.5b00096; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Murphy DGM, 1996, ARCH GEN PSYCHIAT, V53, P585; Newhouse P, 2007, BEHAV BRAIN RES, V183, P1, DOI 10.1016/j.bbr.2007.05.011; Otmakhova NA, 2002, J NEUROSCI, V22, P1199, DOI 10.1523/JNEUROSCI.22-04-01199.2002; Persson J, 2014, NEUROIMAGE, V99, P215, DOI 10.1016/j.neuroimage.2014.05.038; Pruessner JC, 2001, J NEUROSCI, V21, P194, DOI 10.1523/JNEUROSCI.21-01-00194.2001; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Rizk-Jackson AM, 2006, BEHAV BRAIN RES, V173, P181, DOI 10.1016/j.bbr.2006.06.029; Russell NA, 2003, J NEUROSCI, V23, P6490; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Saucier DM, 2008, ANIM COGN, V11, P129, DOI 10.1007/s10071-007-0096-1; Saucier DM, 2002, BEHAV NEUROSCI, V116, P403, DOI 10.1037//0735-7044.116.3.403; Scharfman HE, 2003, J NEUROSCI, V23, P11641; Schmidt B, 2009, HORM BEHAV, V56, P199, DOI 10.1016/j.yhbeh.2009.04.004; Shah DS, 2013, BEHAV BRAIN RES, V257, P90, DOI 10.1016/j.bbr.2013.09.027; Sherry DF, 1997, TRENDS COGN SCI, V1, P50, DOI 10.1016/S1364-6613(97)01015-2; Smith CC, 2005, J NEUROSCI, V25, P7780, DOI 10.1523/JNEUROSCI.0762-05.2005; Smith CC, 2015, HIPPOCAMPUS; Sneider JT, 2015, BEHAV PROCESS, V111, P42, DOI 10.1016/j.beproc.2014.11.015; Speed HE, 2009, HIPPOCAMPUS, V19, P187, DOI 10.1002/hipo.20496; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Stavnezer AJ, 2000, BEHAV BRAIN RES, V112, P135, DOI 10.1016/S0166-4328(00)00174-1; Sutherland RJ, 2010, NEUROPSYCHOLOGIA, V48, P2357, DOI 10.1016/j.neuropsychologia.2010.04.015; Tan A, 2016, NEUROIMAGE, V124, P350, DOI 10.1016/j.neuroimage.2015.08.050; Taniike N, 2008, ACTA MED OKAYAMA, V62, P21; Tropp J, 2005, HIPPOCAMPUS, V15, P154, DOI 10.1002/hipo.20042; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Warren SG, 1997, BEHAV NEUROSCI, V111, P259, DOI 10.1037/0735-7044.111.2.259; Warren SG, 1995, BRAIN RES, V703, P26, DOI 10.1016/0006-8993(95)01059-9; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WILLIAMS CL, 1991, PSYCHONEUROENDOCRINO, V16, P155, DOI 10.1016/0306-4530(91)90076-6; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Woolley DG, 2010, BEHAV BRAIN RES, V208, P408, DOI 10.1016/j.bbr.2009.12.019; Yang DW, 2004, LIFE SCI, V75, P119, DOI 10.1016/j.lfs.2003.12.004; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627	69	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165891	10.1371/journal.pone.0165891	http://dx.doi.org/10.1371/journal.pone.0165891			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806108	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500070
J	Torbeyns, T; de Geus, B; Bailey, S; De Pauw, K; Decroix, L; Van Cutsem, J; Meeusen, R				Torbeyns, Tine; de Geus, Bas; Bailey, Stephen; De Pauw, Kevin; Decroix, Lieselot; Van Cutsem, Jeroen; Meeusen, Romain			Cycling on a Bike Desk Positively Influences Cognitive Performance	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; TASK-PERFORMANCE; WORKSTATIONS; EXERCISE; WALKING; RELIABILITY; INTENSITY; CONFLICT; ERP	Purpose Cycling desks as a means to reduce sedentary time in the office has gained interest as excessive sitting has been associated with several health risks. However, the question rises if people will still be as efficient in performing their desk-based office work when combining this with stationary cycling. Therefore, the effect of cycling at 30% Wmax on typing, cognitive performance and brain activity was investigated. Methods After two familiarisation sessions, 23 participants performed a test battery [typing test, Rey auditory verbal learning test (RAVLT), Stroop test and Rosvold continuous performance test (RCPT)] with electroencephalography recording while cycling and sitting on a conventional chair. Results Typing performance, performance on the RAVLT and accuracy on the Stroop test and the RCPT did not differ between conditions. Reaction times on the Stroop test and the RCPT were shorter while cycling relative to sitting (p < 0.05). N200, P300, N450 and conflict SP latency and amplitude on the Stroop test and N200 and P300 on the RCPT did not differ between conditions. Conclusions This study showed that typing performance and short-term memory are not deteriorated when people cycle at 30% Wmax. Furthermore, cycling had a positive effect on response speed across tasks requiring variable amounts of attention and inhibition.	[Torbeyns, Tine; de Geus, Bas; De Pauw, Kevin; Decroix, Lieselot; Van Cutsem, Jeroen; Meeusen, Romain] Vrije Univ Brussel, Human Physiol Res Grp, Brussels, Belgium; [Bailey, Stephen] Elon Univ, Dept Phys Therapy Educ, Elon, NC USA; [Meeusen, Romain] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld, Australia	Vrije Universiteit Brussel; Elon University; James Cook University	Meeusen, R (corresponding author), Vrije Univ Brussel, Human Physiol Res Grp, Brussels, Belgium.; Meeusen, R (corresponding author), James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld, Australia.	rmeeusen@vub.ac.be	Van Cutsem, Jeroen/AAZ-6281-2021; De Pauw, Kevin/E-8937-2018; de Geus, Bas/F-5335-2011; Van Cutsem, Jeroen/AAZ-7325-2021	de Geus, Bas/0000-0001-7447-0230; De Pauw, Kevin/0000-0002-6901-7199; Van Cutsem, Jeroen/0000-0001-6122-7629				Alderman BL, 2014, J PHYS ACT HEALTH, V11, P752, DOI 10.1123/jpah.2012-0097; Audiffren M, 2008, ACTA PSYCHOL, V129, P410, DOI 10.1016/j.actpsy.2008.09.006; Chen AT, 2011, INT J PSYCHOPHYSIOL, V80, P129, DOI 10.1016/j.ijpsycho.2011.02.012; Commissaris DACM, 2014, APPL ERGON, V45, P1570, DOI 10.1016/j.apergo.2014.05.003; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Dunstan DW, 2012, DIABETES RES CLIN PR, V97, P368, DOI 10.1016/j.diabres.2012.05.020; Elmer SJ, 2014, APPL ERGON, V45, P1240, DOI 10.1016/j.apergo.2014.03.001; Erickson KI, 2012, ARCH MED RES, V43, P615, DOI 10.1016/j.arcmed.2012.09.008; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Funk RE, 2012, PERCEPT MOTOR SKILL, V115, P309, DOI 10.2466/06.23.26.PMS.115.4.309-318; Gajewski PD, 2015, BRAIN COGNITION, V98, P87, DOI 10.1016/j.bandc.2015.06.004; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hruby T, 2003, ACTA NEUROBIOL EXP, V63, P55; JASPER HH, 1958, ELECTROENCEPHALOGRAP, V10, P370, DOI DOI 10.1016/0013-4694(58)90053-1; John D, 2009, J PHYS ACT HEALTH, V6, P617, DOI 10.1123/jpah.6.5.617; Kamijo K, 2007, INT J PSYCHOPHYSIOL, V65, P114, DOI 10.1016/j.ijpsycho.2007.04.001; Koren K, 2016, APPL ERGON, V54, P83, DOI 10.1016/j.apergo.2015.11.013; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Larson MJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00723; Larson MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121309; Larson MJ, 2014, INT J PSYCHOPHYSIOL, V93, P283, DOI 10.1016/j.ijpsycho.2014.06.007; Ma JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095198; Ohlinger CM, 2011, J PHYS ACT HEALTH, V8, P119, DOI 10.1123/jpah.8.1.119; Patel Salil H, 2005, Int J Med Sci, V2, P147; Pedersen SJ, 2014, WORK, V49, P289, DOI 10.3233/WOR-131644; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pontifex MB, 2007, CLIN NEUROPHYSIOL, V118, P570, DOI 10.1016/j.clinph.2006.09.029; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Sedentary Behaviour Research Network, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/h2012-024, DOI 10.1139/H2012-024]; Straker LM, 2009, HUM FACTORS, V51, P831, DOI 10.1177/0018720810362079; Strauss E., 2006, A COMPENDIUM OF NEUR; Torbeyns T, 2014, SPORTS MED, V44, P1261, DOI 10.1007/s40279-014-0202-x; World Health Organization, 2014, HEALTH TOPICS PHYSIC; World Health Organization, 2010, GLOBAL RECOMMENDATIO; World Health Organization, 2006, PHYSICAL ACTIVITY AN; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; Yuan JJ, 2011, BIOL PSYCHOL, V87, P17, DOI 10.1016/j.biopsycho.2011.01.004	39	25	25	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165510	10.1371/journal.pone.0165510	http://dx.doi.org/10.1371/journal.pone.0165510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA6DJ	27806079	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000386715500033
J	Liu, X; Ye, YK; Mi, Q; Huang, W; He, T; Huang, P; Xu, NN; Wu, QY; Wang, AL; Li, Y; Yuan, H				Liu, Xing; Ye, Yongkai; Mi, Qi; Huang, Wei; He, Ting; Huang, Pin; Xu, Nana; Wu, Qiaoyu; Wang, Anli; Li, Ying; Yuan, Hong			A Predictive Model for Assessing Surgery-Related Acute Kidney Injury Risk in Hypertensive Patients: A Retrospective Cohort Study	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE-RENAL-FAILURE; CARDIAC-SURGERY; URINARY INTERLEUKIN-18; METAANALYSIS; SOCIETY; DISEASE; BYPASS; SCORE; ALBUMINURIA	Background Acute kidney injury (AKI) is a serious post-surgery complication; however, few preoperative risk models for AKI have been developed for hypertensive patients undergoing general surgery. Thus, in this study involving a large Chinese cohort, we developed and validated a risk model for surgery-related AKI using preoperative risk factors. Methods and Findings This retrospective cohort study included 24,451 hypertensive patients aged >= 18 years who underwent general surgery between 2007 and 2015. The endpoints for AKI classification utilized by the KDIGO (Kidney Disease: Improving Global Outcomes) system were assessed. The most discriminative predictor was selected using Fisher scores and was subsequently used to construct a stepwise multivariate logistic regression model, whose performance was evaluated via comparisons with models used in other published works using the net reclassification index (NRI) and integrated discrimination improvement (IDI) index. Results Surgery-related AKI developed in 1994 hospitalized patients (8.2%). The predictors identified by our Xiang-ya Model were age, gender, eGFR, NLR, pulmonary infection, prothrombin time, thrombin time, hemoglobin, uric acid, serum potassium, serum albumin, total cholesterol, and aspartate amino transferase. The area under the receiver-operating characteristic curve (AUC) for the validation set and cross validation set were 0.87 (95% CI 0.86-0.89) and (0.89; 95% CI 0.88-0.90), respectively, and was therefore similar to the AUC for the training set (0.89; 95% CI 0.88-0.90). The optimal cutoff value was 0.09. Our model outperformed that developed by Kate et al., which exhibited an NRI of 31.38% (95% CI 25.7%-37.1%) and an IDI of 8% (95% CI 5.52%-10.50%) for patients who underwent cardiac surgery (n = 2101). Conclusions/Significance We developed an AKI risk model based on preoperative risk factors and biomarkers that demonstrated good performance when predicting events in a large cohort of hypertensive patients who underwent general surgery.	[Liu, Xing; Huang, Wei; He, Ting; Huang, Pin; Wu, Qiaoyu; Li, Ying; Yuan, Hong] Cent S Univ, Xiangya Hosp 3, Dept Cardiol, Changsha 410013, Hunan, Peoples R China; [Ye, Yongkai] Natl Univ Def Technol, Sch Comp, Changsha 410073, Hunan, Peoples R China; [Mi, Qi] Univ Pittsburgh, Dept Sports Med & Nutr, Pittsburgh, PA 15260 USA; [Xu, Nana; Li, Ying; Yuan, Hong] Cent S Univ, Xiangya Hosp 3, Ctr Clin Pharmacol, Changsha 410013, Hunan, Peoples R China; [Wang, Anli] Cent S Univ, Xiangya Hosp 3, Dept Informat, Changsha 410013, Hunan, Peoples R China	Central South University; National University of Defense Technology - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Central South University	Li, Y; Yuan, H (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Cardiol, Changsha 410013, Hunan, Peoples R China.; Li, Y; Yuan, H (corresponding author), Cent S Univ, Xiangya Hosp 3, Ctr Clin Pharmacol, Changsha 410013, Hunan, Peoples R China.	37618190@qq.com; yuanhongxy3@163.com			Fundamental Research Funds of Central South University [2015zzts122]; National Science Foundation of China [81273594, 81503071]; National Key Technology RD Program [2012BAI37B05]; National Science and Technology Major Project [2012ZX09303014001]; Mittal Innovation Funds of Central South University [15MX49]	Fundamental Research Funds of Central South University; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); National Science and Technology Major Project; Mittal Innovation Funds of Central South University	This study was supported by the Fundamental Research Funds of Central South University (no. 2015zzts122), the National Science Foundation of China (no. 81273594, 81503071), the National Key Technology R&D Program (no. 2012BAI37B05), the National Science and Technology Major Project (no. 2012ZX09303014001), and the Mittal Innovation Funds of Central South University (15MX49).	Aguado-Fraile E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127175; Akrawinthawong K, 2013, CARDIORENAL MED, V3, P7, DOI 10.1159/000346815; Ali FN, 2013, PEDIATR NEPHROL, V28, P959, DOI 10.1007/s00467-012-2395-2; Bedford M., 2016, DEV RISK MODELS PRED; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Berg KS, 2013, EUR J ANAESTH, V30, P704, DOI 10.1097/EJA.0b013e328365ae64; Birnie K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0606-x; Boos CJ, 2006, CURR PHARM DESIGN, V12, P1623, DOI 10.2174/138161206776843313; Buelow MW, 2012, CONGENIT HEART DIS, V7, P441, DOI 10.1111/j.1747-0803.2012.00662.x; Cardoso B, 2016, REV PORT CARDIOL, V35, P99, DOI 10.1016/j.repc.2015.06.006; Chang CH, 2016, INT J MED SCI, V13, P19, DOI 10.7150/ijms.13253; Chang CH, 2015, ANN THORAC SURG, V99, P123, DOI 10.1016/j.athoracsur.2014.07.072; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Cullen MR, 2014, ANN CLIN BIOCHEM, V51, P392, DOI 10.1177/0004563213507438; Demirjian S, 2012, AM J KIDNEY DIS, V59, P382, DOI 10.1053/j.ajkd.2011.10.046; Englberger L, 2010, AM J KIDNEY DIS, V56, P623, DOI 10.1053/j.ajkd.2010.04.017; Evans RG, 2013, CLIN EXP PHARMACOL P, V40, P106, DOI 10.1111/1440-1681.12031; Ferenbach David A, 2016, Nephrol Ther, V12 Suppl 1, pS41, DOI 10.1016/j.nephro.2016.02.005; Gammelager H, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0492-2; Hansell P, 2013, CLIN EXP PHARMACOL P, V40, P123, DOI 10.1111/1440-1681.12034; HUANG W, 2015, MEDICINE, V94, DOI DOI 10.1097/MD; Huen SC, 2012, ANN THORAC SURG, V93, P337, DOI 10.1016/j.athoracsur.2011.09.010; James MT, 2015, AM J KIDNEY DIS, V66, P602, DOI 10.1053/j.ajkd.2015.02.338; Jiang Jun, 2014, Zhonghua Nei Ke Za Zhi, V53, P947; Kandler K, 2014, J CARDIOTHOR VASC AN, V28, P1448, DOI 10.1053/j.jvca.2014.04.019; Kane-Gill SL, 2015, AM J KIDNEY DIS, V65, P860, DOI 10.1053/j.ajkd.2014.10.018; Kaushal GP, 2014, J AM SOC NEPHROL, V25, P877, DOI 10.1681/ASN.2013070780; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P505, DOI 10.1097/ALN.0b013e3181979440; Kiers HD, 2013, NEPHROL DIAL TRANSPL, V28, P345, DOI 10.1093/ndt/gfs518; Kim WH, 2013, J CARDIOTHOR VASC AN, V27, P1158, DOI 10.1053/j.jvca.2013.04.007; Kribben A, 2003, DEUT MED WOCHENSCHR, V128, P1231; Lin X, 2015, J TRAD CHIN MED MANA, V13, P79; Liu YW, 2013, AM J KIDNEY DIS, V62, P1058, DOI 10.1053/j.ajkd.2013.05.014; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Najjar M, 2015, EXPERT REV CARDIOVAS, V13, P301, DOI 10.1586/14779072.2015.1002467; Ng SY, 2014, J THORAC CARDIOV SUR, V147, P1875, DOI 10.1016/j.jtcvs.2013.06.049; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Palevsky PM, 2013, AM J KIDNEY DIS, V61, P649, DOI 10.1053/j.ajkd.2013.02.349; Palit S, 2015, CLIN J AM SOC NEPHRO, V10, P934, DOI 10.2215/CJN.08620814; Patschan Daniel, 2015, J Inj Violence Res, V7, P19, DOI 10.5249/jivr.v7i1.604; Pickering JW, 2015, AM J KIDNEY DIS, V65, P283, DOI 10.1053/j.ajkd.2014.09.008; Pietri P, 2015, CURR MED CHEM, V22, P2754, DOI 10.2174/0929867322666150420104727; Rewa O, 2014, NAT REV NEPHROL, V10, P193, DOI 10.1038/nrneph.2013.282; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Slankamenac K, 2009, ANN SURG, V250, P720, DOI 10.1097/SLA.0b013e3181bdd840; Wong Brian, 2015, Can J Kidney Health Dis, V2, P3, DOI 10.1186/s40697-015-0037-x; Wu VC, 2014, J AM SOC NEPHROL, V25, P595, DOI 10.1681/ASN.2013060610; Zhang W, 2015, CARDIORENAL MED, V5, P40, DOI 10.1159/000369834; Zhang ZH, 2015, HEART LUNG VESSEL, V7, P64; 高秀林, 2007, [北京医学, Beijing Medical Journal], V29, P559	50	6	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165280	10.1371/journal.pone.0165280	http://dx.doi.org/10.1371/journal.pone.0165280			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802302	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200021
J	Ayu, AP; Dijkstra, B; Golbach, M; De Jong, C; Schellekens, A				Ayu, Astri Parawita; Dijkstra, Boukje; Golbach, Milou; De Jong, Cor; Schellekens, Arnt			Good Psychometric Properties of the Addiction Version of the Revised Illness Perception Questionnaire for Health Care Professionals	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; MENTAL-HEALTH; PICTORIAL REPRESENTATION; SELF MEASURE; CONSEQUENCES; PREDICTORS; ATTITUDES; UTILITY; PEOPLE; STIGMA	Background Addiction, or substance dependence, is nowadays considered a chronic relapsing condition. However, perceptions of addiction vary widely, also among healthcare professionals. Perceptions of addiction are thought to contribute to attitude and stigma towards patients with addiction. However, studies into perceptions of addiction among healthcare professionals are limited and instruments for reliable assessment of their perceptions are lacking. The Illness Perception Questionnaire (IPQ) is widely used to evaluate perceptions of illness. The aim of this study was to evaluate the psychometric properties of the IPQ: factor structure, internal consistency, and discriminant validity, when applied to evaluate healthcare professionals' perceptions of addiction. Methods Participants were 1072 healthcare professionals in training and master students from the Netherlands and Indonesia, recruited from various addiction-training programs. The revised version of the IPQ was adapted to measure perceptions of addiction (IPQ-A). Maximum likelihood method was used to explore the best-fit IPQ factor structure. Internal consistency was evaluated for the final factors. The final factor structure was used to assess discriminant validity of the IPQ, by comparing illness perceptions of addiction between 1) medical students from the Netherlands and Indonesia, 2) medical students psychology students and educational science students from the Netherlands, and 3) participants with different training levels: medical students versus medical doctors. Results Factor analysis revealed an eight-factor structure for the perception subscale (demoralization, timeline chronic, consequences, personal control, treatment control, illness coherence, timeline cyclical emotional representations) and a four-factor structure for the attribution subscale (psychological attributions, risk factors, smoking/alcohol, overwork). Internal reliability was acceptable to good. The IPQ-A was able to detect differences in perceptions between healthcare professionals from different cultural and educational background and level of training. Conclusions The IPQ-A is a valid and reliable instrument to assess healthcare professionals' perceptions of addiction.	[Ayu, Astri Parawita] Atma Jaya Catholic Univ Indonesia, Sch Med, Dept Psychiat, Jakarta, Indonesia; [Ayu, Astri Parawita; Dijkstra, Boukje; De Jong, Cor; Schellekens, Arnt] Radboud Univ Nijmegen, Nijmegen Inst Scientist Pracititoners Addict, Nijmegen, Netherlands; [Golbach, Milou] Praktikon, Nijmegen, Netherlands; [Schellekens, Arnt] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, Nijmegen, Netherlands	University Katolik Indonesia Atma Jaya; Radboud University Nijmegen; Praktikon; Radboud University Nijmegen	Ayu, AP (corresponding author), Atma Jaya Catholic Univ Indonesia, Sch Med, Dept Psychiat, Jakarta, Indonesia.; Ayu, AP (corresponding author), Radboud Univ Nijmegen, Nijmegen Inst Scientist Pracititoners Addict, Nijmegen, Netherlands.	a.ayu@psych.ru.nl	Dijkstra, Boukje/AAC-7139-2020; DeJong, Cornelis A.J./G-3957-2012; Schellekens, Arnt F.A./G-5611-2013; Ayu, Astri Parawita/ABE-4934-2020	Dijkstra, Boukje/0000-0003-1467-7808; Schellekens, Arnt F.A./0000-0002-7715-5209; Ayu, Astri Parawita/0000-0003-0979-1593	Indonesian Directorate General of Resources for Research, Technology and Higher Education Ministry of Research, Technology, and Higher Education [94.19/E4.4/2014]	Indonesian Directorate General of Resources for Research, Technology and Higher Education Ministry of Research, Technology, and Higher Education	APA received a grant from the Indonesian Directorate General of Resources for Research, Technology and Higher Education Ministry of Research, Technology, and Higher Education, no: 94.19/E4.4/2014, (http://studi.dikti.go.id/web/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BK, 2012, SUBSTANCE USE MISUSE, V47; Baines T, 2013, MIDWIFERY, V29, P779, DOI 10.1016/j.midw.2012.06.020; Basu D, 2013, J DUAL DIAGN, V9, P23, DOI 10.1080/15504263.2012.749557; Brener L, 2010, DRUG ALCOHOL REV, V29, P491, DOI 10.1111/j.1465-3362.2010.00173.x; Brener L, 2010, SUBST USE MISUSE, V45, P1007, DOI 10.3109/10826081003659543; Buchi S, 2002, PSYCHOTHER PSYCHOSOM, V71, P333, DOI 10.1159/000065994; Calveti M, 2012, PSYCHOPATHOLOGY, V45, P259, DOI [10.1159/000330262, DOI 10.1159/000330262]; Coutu MF, 2008, J OCCUP REHABIL, V18, P347, DOI 10.1007/s10926-008-9148-x; Degenhardt L, 2010, DRUG ALCOHOL DEPEN, V108, P84, DOI 10.1016/j.drugalcdep.2009.12.001; Dempster M, 2012, PSYCHO-ONCOLOGY, V21, P524, DOI 10.1002/pon.1927; Dinos S, 2004, BRIT J PSYCHIAT, V184, P176, DOI 10.1192/bjp.184.2.176; Evers AWM, 2001, J CONSULT CLIN PSYCH, V69, P1026, DOI 10.1037//0022-006X.69.6.1026; Fleming MP, 2009, J EVAL CLIN PRACT, V15, P826, DOI 10.1111/j.1365-2753.2008.01103.x; Franz M, 2014, ACTA PSYCHIAT SCAND, V129, P143, DOI 10.1111/acps.12134; Gilchrist G, 2011, ADDICTION, V106, P1114, DOI 10.1111/j.1360-0443.2011.03407.x; Henden E, 2013, FRONTIERS PSYCHIAT, V4; Hopman P, 2015, PSYCHO-ONCOLOGY, V24, P11, DOI 10.1002/pon.3591; Husak DN, 2009, SUBST USE MISUSE, V39, P399; Iliceto P, 2010, J ADDICTIVE DIS, V29; Khalsa JH, 2008, SUBST ABUS, V29, P5, DOI 10.1080/08897070802218661; Kimmel PL, 1998, KIDNEY INT, V54, P245, DOI 10.1046/j.1523-1755.1998.00989.x; Lam WWT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142620; Leshner AI, 1997, SCIENCE, V278, P45, DOI 10.1126/science.278.5335.45; Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425; Lobban F, 2005, BRIT J CLIN PSYCHOL, V44, P163, DOI 10.1348/014466504X19785; Maas M, 2009, ANN RHEUM DIS, V68, P305, DOI 10.1136/ard.2008.089888; May EM, 2015, COMMUNITY MENT HLT J, V51, P695, DOI 10.1007/s10597-015-9888-y; Mo PKH, 2015, DRUG ALCOHOL DEPEN, V148, P195, DOI 10.1016/j.drugalcdep.2015.01.008; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Oliva EM, 2011, CURR PSYCHIAT REP, V13, P374, DOI 10.1007/s11920-011-0222-2; Petrie KJ, 2006, CLIN MED, V6, P536, DOI 10.7861/clinmedicine.6-6-536; Robinson S, 2016, AM J HOSP PALLIAT ME, V33, P93, DOI 10.1177/1049909114553461; Russell C, 2011, J SUBST ABUSE TREAT, V40, P150, DOI 10.1016/j.jsat.2010.09.006; Shallcross AJ, 2015, EPILEPSIA, V56, pe186, DOI 10.1111/epi.13194; Smith DE, 2012, J PSYCHOACTIVE DRUGS, V44, P1, DOI 10.1080/02791072.2012.662105; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Suchankova P, 2016, ADDICT BIOL, V21, P481, DOI 10.1111/adb.12277; TURK DC, 1986, J BEHAV MED, V9, P453, DOI 10.1007/BF00845133; United Nations Office on Drugs and Crime (UNODC), 2013, WORLD DRUG REP; van Boekel LC, 2016, HEALTH SOC CARE COMM, V24, pE23, DOI 10.1111/hsc.12279; van Boekel LC, 2015, INT J SOC PSYCHIATR, V61, P539, DOI 10.1177/0020764014562051; van Boekel LC, 2013, DRUG ALCOHOL DEPEN, V131, P23, DOI 10.1016/j.drugalcdep.2013.02.018; van der Have M, 2015, INFLAMM BOWEL DIS, V21, P369, DOI 10.1097/MIB.0000000000000278; van der Pol P, 2013, DRUG ALCOHOL DEPEN, V133, P776, DOI 10.1016/j.drugalcdep.2013.08.011; Volkow ND, 2016, NEW ENGLAND J MED, V374; Volkow ND, 2015, CELL, V162, P712, DOI 10.1016/j.cell.2015.07.046; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; WEIR R, 1994, PAIN, V58, P377, DOI 10.1016/0304-3959(94)90132-5; West R, 2001, ADDICTION, V96, P3, DOI 10.1046/j.1360-0443.2001.96131.x; Witteman C, 2011, J MENT HEALTH, V20, P115, DOI 10.3109/09638237.2010.507685; Wouters EJM, 2008, BEHAV MED, V34, P65, DOI 10.3200/BMED.34.2.65-78	51	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164262	10.1371/journal.pone.0164262	http://dx.doi.org/10.1371/journal.pone.0164262			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB8BE	27824872	Green Published, Green Submitted, gold			2022-12-27	WOS:000387615200003
J	El-Ansary, A; Hassan, WM; Qasem, H; Das, UN				El-Ansary, Afaf; Hassan, Wail M.; Qasem, Hanan; Das, Undurti N.			Identification of Biomarkers of Impaired Sensory Profiles among Autistic Patients	PLOS ONE			English	Article							DIAGNOSTIC INTERVIEW; CHILDREN; PERFORMANCE; DISORDER; RELEASE; BRAIN	Background Autism is a neurodevelopmental disorder that displays significant heterogeneity. Comparison of subgroups within autism, and analyses of selected biomarkers as measure of the variation of the severity of autistic features such as cognitive dysfunction, social interaction impairment, and sensory abnormalities might help in understanding the pathophysiology of autism. Methods and Participants In this study, two sets of biomarkers were selected. The first included 7, while the second included 6 biomarkers. For set 1, data were collected from 35 autistic and 38 healthy control participants, while for set 2, data were collected from 29 out of the same 35 autistic and 16 additional healthy subjects. These markers were subjected to a principal components analysis using either covariance or correlation matrices. Moreover, libraries composed of participants categorized into units were constructed. The biomarkers used include, PE (phosphatidyl ethanolamine), PS (phosphatidyl serine), PC (phosphatidyl choline), MAP2K1 (Dual specificity mitogen-activated protein kinase kinase 1), IL-10 (interleukin-10), IL-12, NF-kappa B (nuclear factor-kappa appa B); PGE2 (prostaglandin E2), PGE2-EP2, mPGES-1 (microsomal prostaglandin synthase E-1), cPLA2 (cytosolic phospholipase A2), 8-isoprostane, and COX-2 (cyclo-oxygenase-2). Results While none of the studied markers correlated with CARS and SRS as measure of cognitive and social impairments, six markers significantly correlated with sensory profiles of autistic patients. Multiple regression analysis identifies a combination of PGES, mPGES-1, and PE as best predictors of the degree of sensory profile impairment. Library identification resulted in 100% correct assignments of both autistic and control participants based on either set 1 or 2 biomarkers together with a satisfactory rate of assignments in case of sensory profile impairment using different sets of biomarkers. Conclusion The two selected sets of biomarkers were effective to separate autistic from healthy control subjects, demonstarting the possibility to accurately predict the severity of autism using the selected biomarkers. The effectiveness of the identified libraries lied in the fact that they were helpful in correctly assigning the study population as control or autistic patients and in classifying autistic patients with different degree of sensory profile impairment.	[El-Ansary, Afaf] King Saud Univ, Ctr Female Sci & Med Coll, Cent Lab, Riyadh, Saudi Arabia; [Qasem, Hanan] King Saud Univ, Coll Sci, Dept Biochem, Riyadh, Saudi Arabia; [El-Ansary, Afaf] Natl Res Ctr, Therapuet Chem Dept, Cairo, Egypt; [Hassan, Wail M.] Univ Wisconsin, Coll Hlth Sci, Dept Biomed Sci, Milwaukee, WI 53201 USA; [Das, Undurti N.] UND Life Sci, 2020 S 360th St,K-202,Fed Way, Washington, DC 98003 USA; [Das, Undurti N.] BioSci Res Ctr, GVP Coll Engn Campus, Visakhapatnam 530048, Andhra Pradesh, India	King Saud University; King Saud University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University of Wisconsin System; University of Wisconsin Milwaukee	Das, UN (corresponding author), UND Life Sci, 2020 S 360th St,K-202,Fed Way, Washington, DC 98003 USA.; Das, UN (corresponding author), BioSci Res Ctr, GVP Coll Engn Campus, Visakhapatnam 530048, Andhra Pradesh, India.	undurti@hotmail.com	Hassan, Wail/R-5045-2019	Hassan, Wail/0000-0002-2960-3927	Center for Female Scientific and Medical Collegesat King Saud University [2015-G3]	Center for Female Scientific and Medical Collegesat King Saud University	This research project was supported by a grant from the research center of the Center for Female Scientific and Medical Colleges at King Saud University. UND is employed by UND Life Sciences but UND Life Sciences did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This research project was supported by a grant from the research center of the Center for Female Scientific and Medical Colleges at King Saud University. Competing Interests: This does not alter our adherence to PLOS ONE policies on sharing data and materials. Financial Disclosure: This research project was supported by a grant from the research center of the Center for Female Scientific and Medical Colleges at King Saud University. Funding Information: Funder Name: The research center of the Center for Female Scientific and Medical Colleges at King Saud University Grant Number: 2015-G3 Grant Recipient: Afaf El-Ansary UND is employed by UND Life Sciences but UND Life Sciences did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Ahmad SF, 2016, MOL NEUROBIOLOGY; Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; Baranek GT, 2002, J AUTISM DEV DISORD, V32, P397, DOI 10.1023/A:1020541906063; Bell JG, 2004, PROSTAG LEUKOTR ESS, V71, P201, DOI 10.1016/j.plefa.2004.03.008; Bezzi P, 2001, CURR OPIN NEUROBIOL, V11, P387, DOI 10.1016/S0959-4388(00)00223-3; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Breece E, 2013, BRAIN BEHAV IMMUN, V31, P69, DOI 10.1016/j.bbi.2012.10.006; Connolly AM, 1999, J PEDIATR-US, V134, P607, DOI 10.1016/S0022-3476(99)70248-9; Constantino J. N., 2007, SOCIAL RESPONSIVENES; Das UN, 2013, NUTRITION, V29, P1175, DOI 10.1016/j.nut.2013.01.012; Das UN, 2013, NUTRITION, V29, P1066, DOI 10.1016/j.nut.2012.11.013; Dubois A, 2010, PAIN RES MANAG, V15, P245, DOI 10.1155/2010/749275; Dunn W, 1997, AM J OCCUP THER, V51, P25, DOI 10.5014/ajot.51.1.25; Dunn W, 2001, AM J OCCUP THER, V55, P608, DOI 10.5014/ajot.55.6.608; Dunn W., 1999, SENSORY PROFILE EXAM; Filipek PA, 2000, NEUROLOGY, V55, P468, DOI 10.1212/WNL.55.4.468; Gadad Bharathi S, 2013, Autism Res Treat, V2013, P731935, DOI 10.1155/2013/731935; Ganz M, 2006, UNDERSTANDING AUTISM; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Gillberg C, 2000, BIOL AUTISTIC SYNDRO, V3rd; Gorrindo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068444; Gorrindo P, 2012, AUTISM RES, V5, P101, DOI 10.1002/aur.237; Hu VW, 2009, AUTISM RES, V2, P67, DOI 10.1002/aur.72; Kientz MA, 1997, AM J OCCUP THER, V51, P530, DOI 10.5014/ajot.51.7.530; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Lawrence G. D., 2010, FATS LIFE ESSENTIAL; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; Mandell D, 2011, AUTISM, V15, P259, DOI 10.1177/1362361311410808; Mostafa GA, 2010, J NEUROIMMUNOL, V219, P114, DOI 10.1016/j.jneuroim.2009.12.003; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Perry A, 2005, J AUTISM DEV DISORD, V35, P625, DOI 10.1007/s10803-005-0006-9; Qasem H, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0298-0; Silver WG, 2012, PEDIATR CLIN N AM, V59, P45, DOI 10.1016/j.pcl.2011.10.010; Subramanian M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.2015.00313, 10.3339/fnins.2015.00373]; Szatmari P, 2011, BMJ, V342; Tomchek SD, 2007, AM J OCCUP THER, V61, P190, DOI 10.5014/ajot.61.2.190; Tostes MHFS, 2012, PHARMACOPSYCHIATRY, V45, P241, DOI 10.1055/s-0032-1301914; Wallace JL, 2001, GASTROENTEROL CLIN N, V30, P971, DOI 10.1016/S0889-8553(05)70223-5; Watling RL, 2001, AM J OCCUP THER, V55, P416, DOI 10.5014/ajot.55.4.416; Yao YM, 2006, ARCH NEUROL-CHICAGO, V63, P1161, DOI 10.1001/archneur.63.8.1161; Zonta M, 2003, J PHYSIOL-LONDON, V553, P407, DOI 10.1113/jphysiol.2003.046706	43	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0164153	10.1371/journal.pone.0164153	http://dx.doi.org/10.1371/journal.pone.0164153			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824861	gold, Green Published, Green Submitted			2022-12-27	WOS:000387615200001
J	Fontes, J; Semmens, B; Caselle, JE; Santos, RS; Prakya, R				Fontes, Jorge; Semmens, Brice; Caselle, Jennifer E.; Santos, Ricardo S.; Prakya, R.			Ocean Productivity May Predict Recruitment of the Rainbow Wrasse (Coris julis)	PLOS ONE			English	Article							TROPICAL REEF FISH; TEMPERATURE; VARIABILITY; PLANKTON; GROWTH; LARVAE; SIZE; INFORMATION; SETTLEMENT; CLIMATE	Predicting recruitment fluctuations of fish populations remains the Holy Grail of fisheries science. While previous work has linked recruitment of reef fish to environmental variables including temperature, the demonstration of a robust relationship with productivity remains elusive. Despite decades of research, empirical evidence to support this critical link remains limited. Here we identify a consistent and strong relationship between recruitment of a temperate wrasse Coris julis, from temperate reefs in the mid-Atlantic region, with Chlorophyll, over contrasting scales, across multiple years. Additionally, we find that the correlation between Chlorophyll and recruitment is not simply masking a temperature-recruitment relationship. Understanding the potential mechanisms underlying recruitment variability, particularly as it relates to changing climate and ocean regimes, is a critical first step towards characterizing species' vulnerability to mismatches between pulsed planktonic production and early pelagic life stages.	[Fontes, Jorge; Santos, Ricardo S.; Prakya, R.] Univ Azores IMAR UAz, Marine & Environm Sci Ctr MARE, Dept Oceanog & Fisheries, P-9901862 Horta, Portugal; [Fontes, Jorge; Santos, Ricardo S.; Prakya, R.] Univ Azores IMAR UAz, Inst Marine Res, Dept Oceanog & Fisheries, P-9901862 Horta, Portugal; [Semmens, Brice] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92023 USA; [Caselle, Jennifer E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	Universidade dos Acores; Universidade dos Acores; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California Santa Barbara	Fontes, J (corresponding author), Univ Azores IMAR UAz, Marine & Environm Sci Ctr MARE, Dept Oceanog & Fisheries, P-9901862 Horta, Portugal.; Fontes, J (corresponding author), Univ Azores IMAR UAz, Inst Marine Res, Dept Oceanog & Fisheries, P-9901862 Horta, Portugal.	fontes@uac.pt	Santos, Ricardo/B-3960-2008	Santos, Ricardo/0000-0002-2536-1369; Fontes, Jorge/0000-0002-8451-5532	Fundacao para a Ciencia e Tecnologia [SFRH/BD/12788/2003]; FCT [FCT- OCTI/BSE/41207/2001]; MARMACII [INTERREG/ 05/MAC/4.2/A4]; Programmatic and Pluriannual programs; UI&D through the Programmatic and Pluriannual programs of FCT/MCTES [531]; Azorean DRCT, FEDER	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); MARMACII; Programmatic and Pluriannual programs; UI&D through the Programmatic and Pluriannual programs of FCT/MCTES; Azorean DRCT, FEDER	This study was supported by the Fundacao para a Ciencia e Tecnologia funded JF (SFRH/BD/12788/2003), and FCT supported the project through MAREFISH (FCT- OCTI/BSE/41207/2001), MARMACII (INTERREG/ 05/MAC/4.2/A4) and Programmatic and Pluriannual programs. IMAR-DOP is UI&D #531 funded through the Programmatic and Pluriannual programs of FCT/MCTES and Azorean DRCT, part FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors would like to acknowledge the effort of Bernardo Broitman, Pedro Afonso, Robert Warner, Norberto Serpa, the crews of R.V. Arquipelago and R.V. Aguas vivas. FCT/MCTES (SFRH/BD/12788/2003 and FLAD. IMAR-DOP is UI&D #531 funded through the Programmatic and Pluriannual programs of FCT/MCTES and Azorean DRCT, part FEDER. This paper is a contribution to MAREFISH (FCT- OCTI/BSE/41207/2001) and MARMACII (INTERREG/05/MAC/4.2/A4).	Agnew DJ, 2000, CAN J FISH AQUAT SCI, V57, P2479, DOI 10.1139/cjfas-57-12-2479; AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; ANDERSON J T, 1988, Journal of Northwest Atlantic Fishery Science, V8, P55; Bashmatchnikov I, 2004, SST STATIONARY ANOMA, P148; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2010, CLIM RES, V41, P15, DOI 10.3354/cr00838; Beaugrand G, 2010, GLOBAL CHANGE BIOL, V16, P1268, DOI 10.1111/j.1365-2486.2009.02063.x; Biktashev VN, 2003, J PLANKTON RES, V25, P21, DOI 10.1093/plankt/25.1.21; Brodeur RD, 2008, MAR ECOL PROG SER, V366, P187, DOI 10.3354/meps07539; Caselle JE, 2010, B MAR SCI, V86, P355; Castonguay M, 2008, CAN J FISH AQUAT SCI, V65, P1528, DOI 10.1139/F08-126; Chambers R.C., 1997, EARLY LIFE HIST RECR; Conover WJ, 1999, PRACTICAL NONPARAMET; CUSHING D H, 1975, P278; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Findlay AM, 2002, MAR ECOL PROG SER, V238, P237, DOI 10.3354/meps238237; Fontes J, 2009, J FISH BIOL, V75, P1271, DOI 10.1111/j.1095-8649.2009.02363.x; Fontes J, 2011, J SEA RES, V65, P1, DOI 10.1016/j.seares.2010.05.001; Fontes J, 2010, SCI MAR, V74, P721, DOI 10.3989/scimar.2010.74n4721; Fox HE, 2012, MAR ECOL PROG SER, V463, P259, DOI 10.3354/meps09838; FREEDMAN DA, 1983, AM STAT, V37, P152, DOI 10.2307/2685877; Green BS, 2004, J EXP MAR BIOL ECOL, V299, P115, DOI 10.1016/j.jembe.2003.09.001; HEMING TA, 1982, CAN J FISH AQUAT SCI, V39, P184, DOI 10.1139/f82-021; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; HOUDE ED, 1989, FISH B-NOAA, V87, P471; Kristiansen T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017456; Laidig TE, 2007, FISH B-NOAA, V105, P39; MCCORMICK MI, 1995, MAR ECOL PROG SER, V118, P59, DOI 10.3354/meps118059; Meekan MG, 2003, MAR ECOL PROG SER, V256, P193, DOI 10.3354/meps256193; Minto C, 2008, NATURE, V452, P344, DOI 10.1038/nature06605; Murphy HM, 2014, OECOLOGIA, V175, P1201, DOI 10.1007/s00442-014-2968-9; Planque B, 2008, MAR ECOL PROG SER, V357, P213, DOI 10.3354/meps07274; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Porteiro Felipe Mora, 1996, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V14A, P23; Sampey A, 2007, MAR ECOL PROG SER, V339, P243, DOI 10.3354/meps339243; Schmiing M, 2013, MAR ECOL PROG SER, V474, P201, DOI 10.3354/meps10099; Sponaugle S, 2006, MAR ECOL PROG SER, V308, P1, DOI 10.3354/meps308001; Stige LC, 2015, PROG OCEANOGR, V134, P138, DOI 10.1016/j.pocean.2015.01.009; THRESHER RE, 1989, NATURE, V341, P641, DOI 10.1038/341641a0; Vaida F, 2005, BIOMETRIKA, V92, P351, DOI 10.1093/biomet/92.2.351; Wilson JR, 2008, ESTUAR COAST SHELF S, V79, P483, DOI 10.1016/j.ecss.2008.05.001; WOODS JD, 1995, ICES J MAR SCI, V52, P723, DOI 10.1016/1054-3139(95)80085-9	45	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165648	10.1371/journal.pone.0165648	http://dx.doi.org/10.1371/journal.pone.0165648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824889	Green Submitted, Green Published, gold			2022-12-27	WOS:000387615200025
J	Mahmoud, AM; Al-Alem, U; Dabbous, F; Ali, MM; Batai, K; Shah, E; Kittles, RA				Mahmoud, Abeer M.; Al-Alem, Umaima; Dabbous, Firas; Ali, Mohamed M.; Batai, Ken; Shah, Ebony; Kittles, Rick A.			Zinc Intake and Risk of Prostate Cancer: Case-Control Study and Meta-Analysis	PLOS ONE			English	Article							SUPPLEMENT USE; PREVENTION TRIAL; VITAMIN-E; DIETARY-INTAKE; SERUM ZINC; QUESTIONNAIRE; TRANSPORTERS; AMERICANS; ASSOCIATION; NUTRITION	Zinc is an essential dietary element that has been implicated in the pathogenesis of prostate cancer, a cancer that disproportionately affects men of African descent. Studies assessing the association of zinc intake and prostate cancer have yielded inconsistent results. Furthermore, very little is known about the relationship between zinc intake and prostate cancer among African Americans. We examined the association between self-reported zinc intake and prostate cancer in a hospital-based case-control study of African Americans. We then compared our results with previous studies by performing a meta-analysis to summarize the evidence regarding the association between zinc and prostate cancer. Newly diagnosed African American men with histologically confirmed prostate cancer (n = 127) and controls (n = 81) were recruited from an urban academic urology clinic in Washington, DC. Controls had higher zinc intake, with a mean of 14 mg/day versus 11 mg/day for cases. We observed a non-significant, non-linear increase in prostate cancer when comparing tertiles of zinc intake (OR (<6.5 vs 6.5-12.5mg/day) 1.8, 95% CI: 0.6,5.6; OR (<6.5 vs >12.5mg/day) 1.3, 95% CI: 0.2,6.5). The pooled estimate from 17 studies (including 3 cohorts, 2 nested case-control, 11 case-control studies, and 1 randomized clinical trial, with a total of 111,199 participants and 11,689 cases of prostate cancer) was 1.07 (hi vs lo) 95% CI: 0.98-1.16. Using a dose-response meta-analysis, we observed a non-linear trend in the relationship between zinc intake and prostate cancer (p for nonlinearity = 0.0022). This is the first study to examine the relationship between zinc intake in black men and risk of prostate cancer and systematically evaluate available epidemiologic evidence about the magnitude of the relationship between zinc intake and prostate cancer. Despite of the lower intake of zinc by prostate cancer patients, our meta-analysis indicated that there is no evidence for an association between zinc intake and prostate cancer.	[Mahmoud, Abeer M.; Ali, Mohamed M.] Univ Illinois, Sch Appl Hlth Sci, Dept Kinesiol & Nutr, Chicago, IL 60607 USA; [Mahmoud, Abeer M.; Ali, Mohamed M.] Univ Illinois, Sch Appl Hlth Sci, Dept Phys Therapy, Chicago, IL 60607 USA; [Mahmoud, Abeer M.] Assiut Univ, South Egypt Canc Inst, Dept Pathol, Assiut, Egypt; [Al-Alem, Umaima] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; [Dabbous, Firas] Advocate Lutheran Gen Hosp, James R & Helen D Russell Inst Res & Innovat, Park Ridge, IL USA; [Batai, Ken; Shah, Ebony; Kittles, Rick A.] Univ Arizona, Coll Med, Dept Surg, Tucson, AZ USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Egyptian Knowledge Bank (EKB); Assiut University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arizona	Mahmoud, AM (corresponding author), Univ Illinois, Sch Appl Hlth Sci, Dept Kinesiol & Nutr, Chicago, IL 60607 USA.; Mahmoud, AM (corresponding author), Univ Illinois, Sch Appl Hlth Sci, Dept Phys Therapy, Chicago, IL 60607 USA.; Mahmoud, AM (corresponding author), Assiut Univ, South Egypt Canc Inst, Dept Pathol, Assiut, Egypt.	amahmo4@uic.edu	Al-alem, Umaima/AHD-0666-2022; Batai, Ken/AAG-5277-2019; Batai, Ken/HHS-1700-2022; Al-alem, Umaima/AAW-2584-2021	Batai, Ken/0000-0002-0317-1118; Batai, Ken/0000-0002-0317-1118; Al-alem, Umaima/0000-0003-2984-076X; Ali, Mohamed/0000-0001-8085-7132	National Institutes of Health [5U54CA91431-01]; Egyptian Ministry of Higher Education [GM842]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF))	This research was supported by the following funding sources: National Institutes of Health (5U54CA91431-01) (RAK) and Egyptian Ministry of Higher Education GM842 (AM M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2016, CANC FACTS FIGURES 2; Andersson SO, 1996, INT J CANCER, V68, P716; Bekkering GE, 2008, AM J EPIDEMIOL, V167, P1017, DOI 10.1093/aje/kwn005; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B; Bonilla C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016044; Briefel RR, 2000, J NUTR, V130, p1367S, DOI 10.1093/jn/130.5.1367S; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; COATES RJ, 1991, AM J EPIDEMIOL, V134, P658, DOI 10.1093/oxfordjournals.aje.a116138; Cortesi M, 2008, PROSTATE, V68, P994, DOI 10.1002/pros.20766; Costello LC, 2005, CANCER CAUSE CONTROL, V16, P901, DOI 10.1007/s10552-005-2367-y; Costello LC, 2004, PROSTATE CANCER P D, V7, P111, DOI 10.1038/sj.pcan.4500712; Costello LC, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-17; Desouki MM, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-37; Epstein MM, 2011, AM J CLIN NUTR, V93, P586, DOI 10.3945/ajcn.110.004804; Franklin RB, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-32; Fulgoni VL, 2011, J NUTR, V141, P1847, DOI 10.3945/jn.111.142257; Gallus S, 2007, EUR UROL, V52, P1052, DOI 10.1016/j.eururo.2007.01.094; Gonzalez A, 2009, NUTR CANCER, V61, P206, DOI 10.1080/01635580802419749; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Greenlee H, 2004, J ALTERN COMPLEM MED, V10, P660, DOI 10.1089/acm.2004.10.660; Hambidge KM, 2010, AM J CLIN NUTR, V91, p1478S, DOI 10.3945/ajcn.2010.28674I; Hernandez W, 2007, CARCINOGENESIS, V28, P2154, DOI 10.1093/carcin/bgm190; HESHMAT MY, 1985, PROSTATE, V6, P7, DOI 10.1002/pros.2990060103; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ho E, 2009, CURR OPIN CLIN NUTR, V12, P640, DOI 10.1097/MCO.0b013e32833106ee; Johnson LA, 2010, METHODS, V52, P316, DOI 10.1016/j.ymeth.2010.08.004; Karimi G, 2012, ASIAN PAC J CANCER P, V13, P4249, DOI 10.7314/APJCP.2012.13.9.4249; Key TJA, 1997, BRIT J CANCER, V76, P678, DOI 10.1038/bjc.1997.445; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Kolenko V, 2013, NAT REV UROL, V10, P219, DOI 10.1038/nrurol.2013.43; KOLONEL LN, 1988, AM J EPIDEMIOL, V127, P999, DOI 10.1093/oxfordjournals.aje.a114903; Krebs NF, 2000, J NUTR, V130, p1374S, DOI 10.1093/jn/130.5.1374S; Kristal AR, 2008, AM J EPIDEMIOL, V167, P925, DOI 10.1093/aje/kwm389; Kristal AR, 2014, CANCER EPIDEM BIOMAR, V23, P1494, DOI 10.1158/1055-9965.EPI-14-0115; Kristal AR, 2010, AM J EPIDEMIOL, V172, P566, DOI 10.1093/aje/kwq148; Kristal AR, 1999, CANCER EPIDEM BIOMAR, V8, P887; Lawson KA, 2007, J NATL CANCER I, V99, P754, DOI 10.1093/jnci/djk177; Lee MM, 1998, CANCER CAUSE CONTROL, V9, P545, DOI 10.1023/A:1008840105531; Leitzmann MF, 2003, J NATL CANCER I, V95, P1004, DOI 10.1093/jnci/95.13.1004; Leonard T, 2002, STAT MED, V21, P2295, DOI 10.1002/sim.1048; Li XM, 2005, ASIAN J ANDROL, V7, P323, DOI 10.1111/j.1745-7262.2005.00044.x; Lin YS, 2013, J TOXICOL ENV HEAL A, V76, P1, DOI 10.1080/15287394.2012.722185; Marshall JR, 2012, WORLD J UROL, V30, P157, DOI 10.1007/s00345-011-0810-0; Meyer F, 2005, INT J CANCER, V116, P182, DOI 10.1002/ijc.21058; Neuhouser ML, 2001, NUTR CANCER, V39, P12, DOI 10.1207/S15327914nc391_2; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; Otten J.J., 2006, DIETARY REFERENCE IN, DOI DOI 10.17226/11537; Park SY, 2013, PROSTATE, V73, P261, DOI 10.1002/pros.22565; Platz EA, 2002, PROSTATE, V52, P288, DOI 10.1002/pros.10115; Rishi I, 2003, APPL IMMUNOHISTO M M, V11, P253; Robbins CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019494; TEMPANY CM, 1994, RADIOLOGY, V192, P47, DOI 10.1148/radiology.192.1.8208963; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; Vlajinac HD, 1997, EUR J CANCER, V33, P101, DOI 10.1016/S0959-8049(96)00373-5; Wagner SE, 2009, CANCER CAUSE CONTROL, V20, P345, DOI 10.1007/s10552-008-9248-0; WEST DW, 1991, CANCER CAUSE CONTROL, V2, P85, DOI 10.1007/BF00053126; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Zhang YQ, 2009, CANCER CAUSE CONTROL, V20, P691, DOI 10.1007/s10552-008-9282-y	59	12	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165956	10.1371/journal.pone.0165956	http://dx.doi.org/10.1371/journal.pone.0165956			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824905	Green Submitted, Green Published, gold			2022-12-27	WOS:000387615200049
J	Alzeidan, R; Rabiee, F; Mandil, A; Hersi, A; Fayed, A				Alzeidan, Rasmieh; Rabiee, Fatemeh; Mandil, Ahmed; Hersi, Ahmad; Fayed, Amel			Non-Communicable Disease Risk Factors among Employees and Their Families of a Saudi University: An Epidemiological Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; ARABIA; PREDICTION; KINGDOM; HYPERCHOLESTEROLEMIA; PREVALENCE; OBESITY	Objectives To assess the prevalence of noncommunicable disease (NCD) risk factors among Saudi university employees and their families; to estimate the cardiovascular risk (CVR) amongst the study population in the following 10years. Methods The NCD risk factors prevalence was estimated using a cross-sectional approach for a sample of employees and their families aged >= 18 years old, in a Saudi university (Riyadh in Kingdom of Saudi Arabia; KSA). WHO STEPwise standardized tools were used to estimate NCD risk factors and the Framingham Coronary Heart Risk Score calculator was used to calculate the CVR. Results Five thousand and two hundred subjects were invited, of whom 4,500 participated in the study, providing a response rate of 87%. The mean age of participants was 39.3 +/- 13.4 years. The majority of participants reported low fruit/vegetables consumption (88%), and physically inactive (77%). More than two thirds of the cohort was found to be either overweight or obese (72%), where 36% were obese, and 59% had abdominal obesity. Of the total cohort, 22 - 37% were found to suffer from dyslipidaemia, 22% either diabetes or hypertension, with rather low reported current tobacco use (12%). One quarter of participants was estimated to have > 10% risk to develop cardiovascular disease within the following 10-years. Conclusion The prevalence of NCD risk factors was found to be substantially high among the university employees and their families in this study.	[Alzeidan, Rasmieh; Hersi, Ahmad] King Saud Univ, Coll Med, Cardiac Sci Dept, Riyadh, Saudi Arabia; [Rabiee, Fatemeh] Birmingham City Univ, Sch Hlth Sci, Fac Hlth Educ & Life Sci, Birmingham, W Midlands, England; [Mandil, Ahmed] King Saud Univ, Coll Med, Family & Community Med Dept, Riyadh, Saudi Arabia; [Fayed, Amel] Princess Nourah Bint Abdulrahman Univ, Coll Med, Riyadh, Saudi Arabia; [Fayed, Amel] Univ Alexandria, High Inst Publ Hlth, Dept Biostat, Alexandria, Egypt; [Mandil, Ahmed] Univ Alexandria, High Inst Publ Hlth, Dept Epidemiol, Alexandria, Egypt	King Saud University; Birmingham City University; King Saud University; Princess Nourah bint Abdulrahman University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University	Alzeidan, R (corresponding author), King Saud Univ, Coll Med, Cardiac Sci Dept, Riyadh, Saudi Arabia.	ras_zeidan@hotmail.com	Fayed, Amel/H-8588-2016; Hersi, Ahmad/ABC-9266-2020	Fayed, Amel/0000-0003-3395-0486; Mandil, Ahmed/0000-0002-0903-3277	King Abdulaziz City for Science and Technology (KACST) [MS-34-5]	King Abdulaziz City for Science and Technology (KACST)	We are grateful and appreciative of the King Abdulaziz City for Science and Technology (KACST) (http://gdrg.kacst.edu.sa/Site/ar/Default.aspx) for supporting this work through the research grant number (MS-34-5) to AH. The funder had no role in study design, data collection, data analysis, decision or writing-up the manuscript.	Aaronson PI, 2013, CARDIOVASCULAR GLANC, V4, P76; Abalkhail BA, 2000, PREV MED, V31, P390, DOI 10.1006/pmed.2000.0713; Al Alwan I, 2013, INT J HEALTH SCI-IJH, V7, P3, DOI 10.12816/0006015; Al-Daghri NM, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-76; Al-Hazzaa HM, 2014, J PHYS ACT HEALTH, V11, P1202, DOI 10.1123/jpah.2012-0427; Al-Nakeeb Y, 2012, INT J ENV RES PUB HE, V9, P1490, DOI 10.3390/ijerph9041490; Al-Nooh AA, 2014, CARDIOLRESPRACT, V2014; Al-Rubeaan K, 2015, J DIABETES, V7, P622, DOI 10.1111/1753-0407.12224; Al-Zalabani AH, 2015, J TAIBAH UNIV MED SC, V10, P208, DOI 10.1016/j.jtumed.2014.11.001; Alhyas Layla, 2011, JRSM Short Rep, V2, P55, DOI 10.1258/shorts.2011.011019; Alsheikh-Ali AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102830; Amin TT, 2014, ASIAN PAC J CANCER P, V15, P7897, DOI 10.7314/APJCP.2014.15.18.7897; ANOKUTE CC, 1990, J ROY SOC HEALTH, V110, P201, DOI 10.1177/146642409011000604; Aswin K, 2014, J Family Med Prim Care, V3, P255, DOI 10.4103/2249-4863.141624; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Basulaiman M, 2015, NUTR DIETARY S, V7, P9; Basulaiman M, 2014, ANN EPIDEMIOL, V24, P801, DOI 10.1016/j.annepidem.2014.08.001; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Carnethon M, 2009, CIRCULATION, V120, P1725, DOI 10.1161/CIRCULATIONAHA.109.192653; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; El Bcheraoui C, 2014, INT J HYPERTENS, V2014, DOI 10.1155/2014/564679; El Bcheraoui C, 2014, INT J PUBLIC HEALTH, V59, P1011, DOI 10.1007/s00038-014-0612-4; Elkum N, 2014, DIABETIC MED, V31, P531, DOI 10.1111/dme.12386; Eriksen M, 2012, TOBACCO ATLAS; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guptha Soneil, 2014, Indian Heart J, V66, P280, DOI 10.1016/j.ihj.2014.03.005; Hajat C, 2010, PROG CARDIOVASC DIS, V53, P28, DOI 10.1016/j.pcad.2010.05.002; Kaukua J, 2001, DIABETES OBES METAB, V3, P17, DOI 10.1046/j.1463-1326.2001.00093.x; Lee HM, 2010, EUR RESPIR J, V36, P1002, DOI 10.1183/09031936.00042410; Mahfouz AA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/960292; Mattei J, 2013, J NUTR, V143, P1753, DOI 10.3945/jn.113.180141; Memish ZA, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140236; Mitwalli AH, 2013, J SAUDI HEART ASSOC, V25, P19, DOI 10.1016/j.jsha.2012.10.002; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Musaiger AO, 2012, INT J GEN MED, V5, P199, DOI 10.2147/IJGM.S29663; Patel JV, 2006, ATHEROSCLEROSIS, V185, P297, DOI 10.1016/j.atherosclerosis.2005.06.005; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sharma Divya, 2012, Indian Heart J, V64, P356, DOI 10.1016/j.ihj.2012.06.001; Soofi MA, 2015, J SAUDI HEART ASSOC, V27, P152, DOI 10.1016/j.jsha.2015.03.003; STEPwise, 2009, STEPWISE APPR NONC D; Tool-WHO S, 2009, TOOL WHO S WHO STEPS; WHO S, 2008, COND SURV DAT ENTR 4; WHO-EMRO, 2014, NONC DIS EMRO; WHO-HBA1C, 2011, WHO HBA1C USE GLYCAT; WHO-NCD-Profile, 2014, WHO NCD PROFILE NONC; WHO-NCD-status, 2014, GLOBAL STATUS REPORT; WHO-Obesity-EMRO, 2013, WHO OBESITY EMRO OBE; WHO-Workplace-Diet-PA, 2008, WHO WORKPLACE DIET P; World Health Organization, 2008, WAIST CIRCUMFERENCE	50	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0165036	10.1371/journal.pone.0165036	http://dx.doi.org/10.1371/journal.pone.0165036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814369	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000386911100006
J	Hannan, JP; Laskowski, J; Thurman, JM; Hageman, GS; Holers, VM				Hannan, Jonathan P.; Laskowski, Jennifer; Thurman, Joshua M.; Hageman, Gregory S.; Holers, V. Michael			Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; HEPARIN-BINDING DOMAIN; MACULAR DEGENERATION; RECEPTOR 2; REGULATORY DOMAINS; CRYSTAL-STRUCTURE; SELF-ASSOCIATION; IDENTIFICATION; C3D; SITE	Complement factor H-related protein 1 (CFHR1) is a complement regulator which has been reported to regulate complement by blocking C5 convertase activity and interfering with C5b surface association. CFHR1 also competes with complement factor H (CFH) for binding to C3b, and may act as an antagonist of CFH-directed regulation on cell surfaces. We have employed site-directed mutagenesis in conjunction with ELISA-based and functional assays to isolate the binding interaction that CFHR1 undertakes with complement components C3b and C3d to a single shared interface. The C3b/C3d: CFHR1 interface is identical to that which occurs between the two C-terminal domains (SCR19-20) of CFH and C3b. Moreover, we have been able to corroborate that dimerization of CFHR1 is necessary for this molecule to bind effectively to C3b and C3d, or compete with CFH. Finally, we have established that CFHR1 competes with complement factor H-like protein 1 (CFHL-1) for binding to C3b. CFHL-1 is a CFH gene splice variant, which is almost identical to the N-terminal 7 domains of CFH (SCR1-7). CFHR1, therefore, not only competes with the C-terminus of CFH for binding to C3b, but also sterically blocks the interaction that the N-terminus of CFH undertakes with C3b, and which is required for CFH-regulation.	[Hannan, Jonathan P.; Laskowski, Jennifer; Thurman, Joshua M.; Holers, V. Michael] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA; [Hageman, Gregory S.] Univ Utah, Sharon Eccles Ctr Translat Med, John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Utah System of Higher Education; University of Utah	Hannan, JP (corresponding author), Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA.	Jonathan.Hannan@ucdenver.edu		Hannan, Jonathan/0000-0003-3318-2341; Thurman, Joshua Michael/0000-0002-3476-9956	Moran Center for Translational Medicine at the University of Utah; Department of Medicine at the University of Colorado Denver; Beckman Initiative for Macular Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051749] Funding Source: NIH RePORTER	Moran Center for Translational Medicine at the University of Utah; Department of Medicine at the University of Colorado Denver; Beckman Initiative for Macular Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The generation of constructs for wild type recombinant CFH and CFHR1 was made possible in part by funding to JPH provided by a services agreement between the Moran Center for Translational Medicine at the University of Utah and the Department of Medicine at the University of Colorado Denver. Additional funding for this research was provided by a research grant from the Beckman Initiative for Macular Research to VMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorlo M, 2015, FEBS J, V282, P3883, DOI 10.1111/febs.13399; Bhattacharjee A, 2015, J BIOL CHEM, V290, P9500, DOI 10.1074/jbc.M114.630871; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Blaum BS, 2015, NAT CHEM BIOL, V11, P77, DOI [10.1038/NCHEMBIO.1696, 10.1038/nchembio.1696]; Buhlmann D, 2016, J IMMUNOL, V197, P620, DOI 10.4049/jimmunol.1600053; Clark SJ, 2014, J IMMUNOL, V193, P4962, DOI 10.4049/jimmunol.1401613; Clemenza L, 2000, J IMMUNOL, V165, P3839, DOI 10.4049/jimmunol.165.7.3839; de Jorge EG, 2013, P NATL ACAD SCI USA, V110, P4685, DOI 10.1073/pnas.1219260110; Eberhardt HU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078617; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; Fernando AN, 2007, J MOL BIOL, V368, P564, DOI 10.1016/j.jmb.2007.02.038; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Gale DP, 2010, LANCET, V376, P794, DOI 10.1016/S0140-6736(10)60670-8; GORDON DL, 1995, J IMMUNOL, V155, P348; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hakobyan S, 2010, KIDNEY INT, V78, P782, DOI 10.1038/ki.2010.275; Hannan JP, 2016, CURR PROTEIN PEPT SC, V17, P463, DOI 10.2174/1389203717666151201192124; Hebecker M, 2012, J BIOL CHEM, V287, P19528, DOI 10.1074/jbc.M112.364471; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Herbert AP, 2007, J BIOL CHEM, V282, P18960, DOI 10.1074/jbc.M609636200; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Isenman DE, 2010, J IMMUNOL, V184, P1946, DOI 10.4049/jimmunol.0902919; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jozsi M, 2015, TRENDS IMMUNOL, V36, P374, DOI 10.1016/j.it.2015.04.008; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; KLICKSTEIN LB, 1987, J EXP MED, V165, P1095, DOI 10.1084/jem.165.4.1095; Kuhn S, 1996, EUR J IMMUNOL, V26, P2383, DOI 10.1002/eji.1830261017; KUHN S, 1995, J IMMUNOL, V155, P5663; McRae JL, 2005, J IMMUNOL, V174, P6250, DOI 10.4049/jimmunol.174.10.6250; Morgan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032187; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Nan RD, 2008, J MOL BIOL, V375, P891, DOI 10.1016/j.jmb.2007.11.015; Okemefuna AI, 2008, J MOL BIOL, V375, P80, DOI 10.1016/j.jmb.2007.09.026; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Perkins SJ, 2012, IMMUNOBIOLOGY, V217, P281, DOI 10.1016/j.imbio.2011.10.003; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Sharma AK, 1996, P NATL ACAD SCI USA, V93, P10996, DOI 10.1073/pnas.93.20.10996; Shaw CD, 2010, J MOL BIOL, V404, P697, DOI 10.1016/j.jmb.2010.10.005; Thiel J, 2012, J ALLERGY CLIN IMMUN, V129, P801, DOI 10.1016/j.jaci.2011.09.027; Tortajada A, 2013, J CLIN INVEST, V123, P2434, DOI 10.1172/JCI68280; van den Elsen JMH, 2011, SCIENCE, V332, P608, DOI 10.1126/science.1201954; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Young KA, 2007, J BIOL CHEM, V282, P36614, DOI 10.1074/jbc.M706324200	49	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2016	11	11							e0166200	10.1371/journal.pone.0166200	http://dx.doi.org/10.1371/journal.pone.0166200			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8TH	27814381	Green Published, Green Submitted, gold			2022-12-27	WOS:000386911100036
J	Choi, DH; Ban, HY; Seo, BS; Lee, KJ; Lee, BW				Choi, Doug-Hwan; Ban, Ho-Young; Seo, Beom-Seok; Lee, Kyu-Jong; Lee, Byun-Woo			Phenology and Seed Yield Performance of Determinate Soybean Cultivars Grown at Elevated Temperatures in a Temperate Region	PLOS ONE			English	Article							BOUNDARY-LINE; GENOTYPES; DURATION; CLIMATE; STRESS; SIZE	Increased temperature means and fluctuations associated with climate change are predicted to exert profound effects on the seed yield of soybean. We conducted an experiment to evaluate the impacts of global warming on the phenology and yield of two determinate soybean cultivars in a temperate region (37.27 8 degrees N, 126.99 degrees E; Suwon, South Korea). These two soybean cultivars, Sinpaldalkong [maturity group (MG) IV] and Daewonkong (MG VI), were cultured on various sowing dates within a four-year period, under no water-stress conditions. Soybeans were kept in greenhouses controlled at the current ambient temperature (AT), AT+ 1.5 degrees C, AT+ 3.0 degrees C, and AT+ 5.0 degrees C throughout the growth periods. Growth periods (VE-R7) were significantly prolonged by the elevated temperatures, especially the R1-R5 period. Cultivars exhibited no significant differences in seed yield at the AT+ 1.5 degrees C and AT+ 3.0 degrees C treatments, compared to AT, while a significant yield reduction was observed at the AT+ 5.0 degrees C treatment. Yield reductions resulted from limited seed number, which was due to an overall low numbers of pods and seeds per pod. Heat stress conditions induced a decrease in pod number to a greater degree than in seed number per pod. Individual seed weight exhibited no significant variation among temperature elevation treatments; thus, seed weight likely had negligible impacts on overall seed yield. A boundary line analysis (using quantile regression) estimated optimum temperatures for seed number at 26.4 to 26.8 degrees C (VE-R5) for both cultivars; the optimum temperatures (R5-R7) for single seed weight were estimated at 25.2 degrees C for the Sinpaldalkong smaller-seeded cultivar, and at 22.3 degrees C for the Daewonkong larger-seeded cultivar. The optimum growing season (VE-R7) temperatures for seed yield, which were estimated by combining the two boundary lines for seed number and seed weight, were 26.4 and 25.0 inverted perpendicular C for the Sinpaldalkong and Daewonkong cultivars, respectively. Considering the current soybean growing season temperature, which ranges from 21.7 (in the north) to 24.6 degrees C (in the south) in South Korea, and the temperature response of potential soybean yields, further warming of less than approximately 1 degrees C would not become a critical limiting factor for soybean production in South Korea.	[Choi, Doug-Hwan; Ban, Ho-Young; Seo, Beom-Seok; Lee, Byun-Woo] Seoul Natl Univ, Coll Agr & Life Sci, Dept Plant Sci, Seoul, South Korea; [Lee, Kyu-Jong; Lee, Byun-Woo] Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, BW (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Plant Sci, Seoul, South Korea.; Lee, BW (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, Seoul, South Korea.	leebw@snu.ac.kr		, Byun-Woo/0000-0003-2284-1348	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea [PJ0101072016]	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This study was conducted with the support of the Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ0101072016), Rural Development Administration, Republic of Korea (www.rda.go.kr). DC, HB, BS, KL, and BL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaah G., 2012, PRINCIPLES PLANT GEN; BAKER JT, 1989, CROP SCI, V29, P98, DOI 10.2135/cropsci1989.0011183X002900010024x; Boote K. J., 1997, Advances in carbon dioxide effects research. Proceedings of a symposium, Cincinnati, Ohio, USA, 7-12 November 1993., P179; Boote K. J., 1998, Agricultural systems modeling and simulation., P651; Boote KJ, 2010, DECIS SUPPORT SYST, V4, P19; Brek Z., 1992, TECHNOLOGY PRODUCTIO; CREGAN PB, 1984, CROP SCI, V24, P659, DOI 10.2135/cropsci1984.0011183X002400040008x; Djanaguiraman M, 2011, ENVIRON EXP BOT, V71, P215, DOI 10.1016/j.envexpbot.2010.12.006; DORNBOS DL, 1991, CAN J PLANT SCI, V71, P373, DOI 10.4141/cjps91-052; EGLI DB, 1980, AGRON J, V72, P560, DOI 10.2134/agronj1980.00021962007200030036x; ELLIOTT JA, 1993, SOIL SCI SOC AM J, V57, P82, DOI 10.2136/sssaj1993.03615995005700010016x; EPHRATH J E, 1991, Biotronics, V20, P1; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Gibson LR, 1996, CROP SCI, V36, P98, DOI 10.2135/cropsci1996.0011183X003600060034x; GRIMM SS, 1994, AGRON J, V86, P31, DOI 10.2134/agronj1994.00021962008600010007x; Ha TJ, 2009, KOREAN J CROP SCI, V4, P104; Hartman GL, 2011, FOOD SECUR, V3, P5, DOI 10.1007/s12571-010-0108-x; Hatfield JL, 2011, AGRON J, V103, P351, DOI 10.2134/agronj2010.0303; Hatfield J.L., 2014, ENCY AGR FOOD SYSTEM, P256, DOI [10.1016/b978-0-444-52512-3.00003-6, DOI 10.1016/B978-0-444-52512-3.00003-6]; Hatfield J. L., 2008, EFFECTS CLIMATE CHAN, P362; HESKETH JD, 1973, CROP SCI, V13, P250, DOI 10.2135/cropsci1973.0011183X001300020030x; Jones JW, 2010, DECIS SUPPORT SYST, V4, P123; Kim ChangKug, 2001, Korean Journal of Crop Science, V46, P241; Korea Meteorological Administration, 2014, KOR CLIM CHANG ASS R; Kumagai E, 2014, AGR FOREST METEOROL, V198, P265, DOI 10.1016/j.agrformet.2014.08.016; LAWN RJ, 1985, CROP SCI, V25, P137, DOI 10.2135/cropsci1985.0011183X002500010034x; Lecoeur J, 1996, CROP SCI, V36, P331, DOI 10.2135/cropsci1996.0011183X003600020020x; Pachauri R.K., 2014, CLIM CHANG 2013 PHYS, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, 10.1017/cbo9781107415324]; PANDEY JP, 1973, CROP SCI, V13, P505, DOI 10.2135/cropsci1973.0011183X001300050004x; Purcell LC, 2014, ARKANSAS SOYBEAN HDB; Puteh A. B., 2013, Australian Journal of Crop Science, V7, P1472; Qiu LJ, 2010, SOYBEAN: BOTANY, PRODUCTION AND USES, P1, DOI 10.1079/9781845936440.0001; Ruiz-Vera UM, 2013, PLANT PHYSIOL, V162, P410, DOI 10.1104/pp.112.211938; Sadras VO, 2008, CROP SCI, V48, P408, DOI 10.2135/cropsci2007.05.0292; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Salem MA, 2007, CROP SCI, V47, P219, DOI 10.2135/cropsci2006.07.0443; Setiyono TD, 2007, FIELD CROP RES, V100, P257, DOI 10.1016/j.fcr.2006.07.011; SEXTON PJ, 1994, CROP SCI, V34, P84, DOI 10.2135/cropsci1994.0011183X003400010015x; Shatar TM, 2004, J AGR SCI-CAMBRIDGE, V142, P553, DOI 10.1017/S0021859604004642; Siebers MH, 2015, GLOBAL CHANGE BIOL, V21, P3114, DOI 10.1111/gcb.12935; Summerfield RJ, 1980, ADV LEGUME SCI, P17; SWANK JC, 1987, CROP SCI, V27, P85, DOI 10.2135/cropsci1987.0011183X002700010022x; Tacarindua CRP, 2013, FIELD CROP RES, V154, P74, DOI 10.1016/j.fcr.2013.07.021; Tischner T, 2003, CROP SCI, V43, P464, DOI 10.2135/cropsci2003.0464; Tubiello FN, 2007, EUR J AGRON, V26, P215, DOI 10.1016/j.eja.2006.10.002; Vachani S., 2014, ADAPTATION CLIMATE C, P1, DOI DOI 10.4337/9781781954737.00006; Wang J, 2006, CROP SCI, V46, P2171, DOI 10.2135/cropsci2006.02.0092; WEBB RA, 1972, J HORTIC SCI BIOTECH, V47, P309, DOI 10.1080/00221589.1972.11514472; Whigham D. K., 1983, Potential productivity of field crops under different environments., P205; Wiebold WJ, 2012, INTEGRATED PEST CROP, V22, P117; Woodworth CM, 2013, EARLY NAMED SOYBEAN, P635	51	28	28	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165977	10.1371/journal.pone.0165977	http://dx.doi.org/10.1371/journal.pone.0165977			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812185	gold, Green Published, Green Submitted			2022-12-27	WOS:000386910000087
J	Graczyk, MB; Queiros, SMD				Graczyk, Michelle B.; Duarte Queiros, Silvio M.			Intraday Seasonalities and Nonstationarity of Trading Volume in Financial Markets: Individual and Cross-Sectional Features	PLOS ONE			English	Article							STATISTICAL PROPERTIES; TRADED VOLUME; PRICES; INFORMATION; MODEL	We study the intraday behaviour of the statistical moments of the trading volume of the blue chip equities that composed the Dow Jones Industrial Average index between 2003 and 2014. By splitting that time interval into semesters, we provide a quantitative account of the nonstationary nature of the intraday statistical properties as well. Explicitly, we prove the well-known boolean OR-shape exhibited by the average trading volume-as well as the volatility of the price fluctuations-experienced a significant change from 2008 (the year of the-subprime" financial crisis) onwards. That has resulted in a faster relaxation after the market opening and relates to a consistent decrease in the convexity of the average trading volume intraday profile. Simultaneously, the last part of the session has become steeper as well, a modification that is likely to have been triggered by the new short-selling rules that were introduced in 2007 by the Securities and Exchange Commission. The combination of both results reveals that the [has been turning into a coproduct. Additionally, the analysis of higher-order cumulants-namely the skewness and the kurtosis-shows that the morning and the afternoon parts of the trading session are each clearly associated with different statistical features and hence dynamical rules. Concretely, we claim that the large initial trading volume is due to wayward stocks whereas the large volume during the last part of the session hinges on a cohesive increase of the trading volume. That dissimilarity between the two parts of the trading session is stressed in periods of higher uproar in the market.	[Graczyk, Michelle B.; Duarte Queiros, Silvio M.] Ctr Brasileiro Pesquisas Fis, Rio De Janeiro, RJ, Brazil; [Duarte Queiros, Silvio M.] Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, RJ, Brazil	Centro Brasileiro de Pesquisas Fisicas	Queiros, SMD (corresponding author), Ctr Brasileiro Pesquisas Fis, Rio De Janeiro, RJ, Brazil.; Queiros, SMD (corresponding author), Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, RJ, Brazil.	sdqueiro@google.com	Queirós, Sílvio M. Duarte/L-1170-2016	Queirós, Sílvio M. Duarte/0000-0001-6915-1892	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Dr Silvio M. Duarte Queiros) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Ms. Michelle Bau Graczyk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admati AR, 1988, REV FINANC STUD, V1, P3, DOI 10.1093/rfs/1.1.3; Alfi V, 2009, CENT EUR J PHYS, V7, P483, DOI [10.2478/S11534-009-0059-z, 10.2478/s11534-009-0059-z]; Allez R, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025010; Andersen T. G., 1997, J EMPIR FINANC, V2-3, P115, DOI DOI 10.1016/S0927-5398(97)00004-2; [Anonymous], 2013, NAT PHYS, V9, P119; Anteneodo C, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/10/P10023; Bak P., 1997, NATURE WORKS SCI SEL; Borland L, 2016, CHAOS SOLITON FRACT, V88, P59, DOI 10.1016/j.chaos.2016.03.014; Bouchaud JP, 2009, HANDB FINANC, P57, DOI 10.1016/B978-012374258-2.50006-3; Bouchaud JP, 2000, INTRO ECONOPHYSICS C; Camargo S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046702; Camargo S, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-30974-9; CLARK PK, 1973, ECONOMETRICA, V41, P135, DOI 10.2307/1913889; COPELAND TE, 1976, J FINANC, V31, P1149, DOI 10.2307/2326280; Cortines AAG, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/30003; de Souza J, 2006, EUR PHYS J B, V50, P165, DOI 10.1140/epjb/e2006-00130-1; Queiros SMD, 2008, BRAZ J PHYS, V38, P203, DOI 10.1590/S0103-97332008000200001; Queiros SMD, 2016, CHAOS SOLITON FRACT, V88, P1, DOI 10.1016/j.chaos.2016.03.022; Queiros SMD, 2016, CHAOS SOLITON FRACT, V88, P24, DOI 10.1016/j.chaos.2015.12.024; Eisler Z, 2006, EUR PHYS J B, V51, P145, DOI 10.1140/epjb/e2006-00189-6; GARMAN MB, 1976, J FINANC ECON, V3, P257, DOI 10.1016/0304-405X(76)90006-4; Good PI, 1999, RESAMPLING METHODS P, DOI [10.1007/0-8176-4444-X, DOI 10.1007/0-8176-4444-X]; Gopikrishnan P, 2000, PHYS REV E, V62, pR4493, DOI 10.1103/PhysRevE.62.R4493; Graczyk MB, 2016, INTRADAY SEASONALITI; Graczyk MB, 2016, NONSTATIONARITY INTR; JAIN PC, 1988, J FINANC QUANT ANAL, V23, P269, DOI 10.2307/2331067; Jensen HJ, 1988, SELF ORG CRITICALITY; KARPOFF JM, 1987, J FINANC QUANT ANAL, V22, P109, DOI 10.2307/2330874; Lee KE, 2007, PHYSICA A, V383, P65, DOI 10.1016/j.physa.2007.04.112; Lillo F, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.016119; Mantegna RN, 1999, INTRO ECONOPHYSICS C; Mu GH, 2009, EUR PHYS J B, V68, P145, DOI 10.1140/epjb/e2009-00059-9; Newman MEJ, 1996, P ROY SOC B-BIOL SCI, V263, P1605, DOI 10.1098/rspb.1996.0235; Osorio R., 2004, NONEXTENSIVE ENTROPY; Queiros SMD, 2007, PHYSICA A, V383, P10, DOI 10.1016/j.physa.2007.04.082; Queiros SMD, 2005, EUROPHYS LETT, V71, P339, DOI 10.1209/epl/i2005-10109-0; Rocha P, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.052122; Sornette D, 2003, RISK MAG, V16, P67; Varian HR, 2000, VARIANTS EC THEORY S	39	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165057	10.1371/journal.pone.0165057	http://dx.doi.org/10.1371/journal.pone.0165057			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8SX	27812141	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000021
J	He, PY; Yang, JG; Xu, HY; Gao, XJ; Xian, Y; Wu, Y; Li, W; Wang, Y; Tang, XR; Yan, RH; Jin, C; Song, L; Zhang, X; Fu, R; Ye, YQ; Dong, QT; Sun, H; Yan, XX; Gao, RL; Yang, YJ				He Peiyuan; Yang Jingang; Xu Haiyan; Gao Xiaojin; Xian Ying; Wu Yuan; Li Wei; Wang Yang; Tang Xinran; Yan Ruohua; Jin Chen; Song Lei; Zhang Xuan; Fu Rui; Ye Yunqing; Dong Qiuting; Sun Hui; Yan Xinxin; Gao Runlin; Yang Yuejin		CAMI Registry Study Grp	The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients >= 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTIONS; PRIMARY ANGIOPLASTY; THROMBOLYTIC THERAPY; MORTALITY; AGE; ABCIXIMAB; BENEFIT; IMPACT; WOMEN; TRIAL	Background Only a few randomized trials have analyzed the clinical outcomes of elderly ST-segment elevation myocardial infarction (STEMI) patients (>= 75 years old). Therefore, the best reperfusion strategy has not been well established. An observational study focused on clinical outcomes was performed in this population. Methods Based on the national registry on STEMI patients, the in-hospital outcomes of elderly patients with different reperfusion strategies were compared. The primary endpoint was defined as death. Secondary endpoints included recurrent myocardial infarction, ischemia driven revascularization, myocardial infarction related complications, and major bleeding. Multivariable regression analysis was performed to adjust for the baseline disparities between the groups. Results Patients who had primary percutaneous coronary intervention (PCI) or fibrinolysis were relatively younger. They came to hospital earlier, and had lower risk of death compared with patients who had no reperfusion. The guideline recommended medications were more frequently used in patients with primary PCI during the hospitalization and at discharge. The rates of death were 7.7%, 15.0%, and 19.9% respectively, with primary PCI, fibrinolysis, and no reperfusion (P < 0.001). Patients having primary PCI also had lower rates of heart failure, mechanical complications, and cardiac arrest compared with fibrinolysis and no reperfusion (P < 0.05). The rates of hemorrhage stroke (0.3%, 0.6%, and 0.1%) and other major bleeding (3.0%, 5.0%, and 3.1%) were similar in the primary PCI, fibrinolysis, and no reperfusion group (P > 0.05). In the multivariable regression analysis, primary PCI outweighs no reperfusion in predicting the in-hospital death in patients >= 75 years old. However, fibrinolysis does not. Conclusions Early reperfusion, especially primary PCI was safe and effective with absolute reduction of mortality compared with no reperfusion. However, certain randomized trials were encouraged to support the conclusion.	[He Peiyuan; Yang Jingang; Xu Haiyan; Gao Xiaojin; Wu Yuan; Song Lei; Zhang Xuan; Fu Rui; Ye Yunqing; Dong Qiuting; Sun Hui; Yan Xinxin; Gao Runlin; Yang Yuejin] Chinese Acad Med Sci, Dept Cardiol, Cardiovasc Inst, Beijing 100037, Peoples R China; [He Peiyuan; Yang Jingang; Xu Haiyan; Gao Xiaojin; Wu Yuan; Li Wei; Wang Yang; Tang Xinran; Yan Ruohua; Jin Chen; Song Lei; Zhang Xuan; Fu Rui; Ye Yunqing; Dong Qiuting; Sun Hui; Yan Xinxin; Gao Runlin; Yang Yuejin] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China; [He Peiyuan; Yang Jingang; Xu Haiyan; Gao Xiaojin; Wu Yuan; Li Wei; Wang Yang; Tang Xinran; Yan Ruohua; Jin Chen; Song Lei; Zhang Xuan; Fu Rui; Ye Yunqing; Dong Qiuting; Sun Hui; Yan Xinxin; Gao Runlin; Yang Yuejin] Peking Union Med Coll, Beijing 100037, Peoples R China; [Xian Ying] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Li Wei; Wang Yang; Tang Xinran; Yan Ruohua; Jin Chen] Chinese Acad Med Sci, Med Res & Biometr Ctr, Cardiovasc Inst, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Duke University; Chinese Academy of Medical Sciences - Peking Union Medical College	Yang, YJ (corresponding author), Chinese Acad Med Sci, Dept Cardiol, Cardiovasc Inst, Beijing 100037, Peoples R China.; Yang, YJ (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China.; Yang, YJ (corresponding author), Peking Union Med Coll, Beijing 100037, Peoples R China.	yangyuejin_fuwai@126.com	Dong, Qiuting/AAS-7540-2020; Xian, Ying/O-1956-2019; Yan, Ruohua/HGE-2321-2022; Song, Lei/AAD-8993-2020	Dong, Qiuting/0000-0001-5204-4978; Song, Lei/0000-0002-6657-9516; Xian, Ying/0000-0002-1237-1162	special fund for scientific research in the public interest by National Health and Family Planning Commision of the People's Republic of China [201402001]; "Twelfth Five-Year" Planning Project of the Scientific and Technological Department of China [2011BA111600]	special fund for scientific research in the public interest by National Health and Family Planning Commision of the People's Republic of China; "Twelfth Five-Year" Planning Project of the Scientific and Technological Department of China	This work was supported by the 2014 special fund for scientific research in the public interest by National Health and Family Planning Commision of the People's Republic of China (no. 201402001). This work was also supported by the "Twelfth Five-Year" Planning Project of the Scientific and Technological Department of China (no. 2011BA111600).	Abraham NS, 2013, CIRCULATION, V128, P1869, DOI 10.1161/CIRCULATIONAHA.113.004747; Antonsen L, 2013, CATHETER CARDIO INTE, V81, P912, DOI 10.1002/ccd.24591; Bazzino O, 1998, NEW ENGL J MED, V338, P1498; Berger AK, 2000, J AM COLL CARDIOL, V36, P366, DOI 10.1016/S0735-1097(00)00723-3; Bueno H, 2011, EUR HEART J, V32, P51, DOI 10.1093/eurheartj/ehq375; Claessen BEPM, 2010, HEART, V96, P843, DOI 10.1136/hrt.2009.185678; Dangas G, 2005, AM J CARDIOL, V95, P13, DOI 10.1016/j.amjcard.2004.08.056; De Luca G, 2005, EUR HEART J, V26, P662, DOI 10.1093/eurheartj/ehi110; Fosbol EL, 2008, AM HEART J, V156, P391, DOI 10.1016/j.ahj.2008.04.005; Goch A, 2009, CLIN CARDIOL, V32, pE46, DOI DOI 10.1002/CLC.20354; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Grines C., 2005, SENIOR PAMI PROSPECT; Guagliumi G, 2004, CIRCULATION, V110, P1598, DOI 10.1161/01.CIR.0000142862.98817.1F; Hasdai D, 2000, AM HEART J, V139, P858, DOI 10.1016/S0002-8703(00)90018-8; Kent DM, 2007, AM J CARDIOL, V99, P1384, DOI 10.1016/j.amjcard.2006.12.068; Le May MR, 2001, J AM COLL CARDIOL, V37, P985, DOI 10.1016/S0735-1097(00)01213-4; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Lemesle G, 2009, CATHETER CARDIO INTE, V74, P428, DOI 10.1002/ccd.22007; Levine GN, 2016, CATHETER CARDIO INTE, V87, P1001, DOI 10.1002/ccd.26325; Mehta RH, 2012, AM J CARDIOL, V109, P320, DOI 10.1016/j.amjcard.2011.09.012; Nakamura M, 2010, J CARDIOL, V55, P69, DOI 10.1016/j.jjcc.2009.08.007; Ndrepepa G, 2006, CIRCULATION, V114, P2040, DOI 10.1161/CIRCULATIONAHA.106.642306; Oduncu V, 2013, TURK KARDIYOL DERN A, V41, P319, DOI 10.5543/tkda.2013.76059; Ruparelia N, 2015, EXPERT REV CARDIOVAS, V13, P585, DOI 10.1586/14779072.2015.1046435; Shelton RJ, 2010, AM HEART J, V159, P956, DOI 10.1016/j.ahj.2010.02.026; Steg PG, 2003, CIRCULATION, V108, P2851, DOI 10.1161/01.CIR.0000103122.10021.F2; Teplitsky I, 2007, CATHETER CARDIO INTE, V70, P937, DOI 10.1002/ccd.21263; Thiemann DR, 2000, CIRCULATION, V101, P2239, DOI 10.1161/01.CIR.101.19.2239; Xu HY, 2016, AM HEART J, V175, P193, DOI 10.1016/j.ahj.2015.04.014	29	9	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165672	10.1371/journal.pone.0165672	http://dx.doi.org/10.1371/journal.pone.0165672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812152	Green Published, gold, Green Submitted			2022-12-27	WOS:000386910000046
J	Ishida, T; Takechi, S				Ishida, Takumi; Takechi, Shinji			Nrf2-ARE-Dependent Alterations in Zinc Transporter mRNA Expression in HepG2 Cells	PLOS ONE			English	Article							TERT-BUTYLHYDROQUINONE; OXIDATIVE STRESS; SUBUNIT GENE; ACRODERMATITIS-ENTEROPATHICA; INDUCIBLE EXPRESSION; RESPONSIVE ELEMENT; MAMMALIAN ZINC; BRAIN ZINC; ANTIOXIDANT; MOUSE	Zinc transporters are solute carrier family members. To date, 10 zinc transporters (ZnTs) and 14 Zrt-, Irt-like proteins (ZIPs) have been identified. ZnTs control intracellular zinc levels by effluxing zinc from the cytoplasm into the extracellular fluid, intracellular vesicles, and organelles; ZIPs also contribute to control intracellular zinc levels with influxing zinc into the cytoplasm. Recently, changes in zinc transporter expression have been observed in some stress-induced diseases, such as Alzheimer's disease and diabetes mellitus. However, little is known regarding the mechanisms that regulate zinc transporter expression. To address this, we have investigated the effect of a well-established stress response pathway, the nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant responsive element (ARE) pathway, on zinc transporter mRNA levels. Exposure to 10(-4) M tert-butylhydroquinone (t-BHQ), which activates Nrf2-ARE signaling, for 6 h significantly increases ZnT-1, ZnT-3, and ZnT-6 mRNAs levels, and significantly decreases ZnT-10 and ZIP-3 mRNA levels. These changes are not observed with 10(-6) M t-BHQ, which does not activate Nrf2-ARE signaling. Furthermore, t-BHQ exposure does not affect metal responsive element transcription, a cis element that is activated in response to intracellular free zinc accumulation. From these results, we believe that the transcription of ZnT-1, ZnT-3, ZnT-6, ZnT-10, and ZIP-3 is influenced by the Nrf2-ARE signal transduction pathway.	[Ishida, Takumi; Takechi, Shinji] Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, 4-22-1 Ikeda, Kumamoto 8600082, Japan	Sojo University	Ishida, T (corresponding author), Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, 4-22-1 Ikeda, Kumamoto 8600082, Japan.	ishida@ph.sojo-u.ac.jp		Takechi, Shinji/0000-0002-4397-9410				Bosomworth HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065475; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; Cauchi S, 2010, MOL GENET METAB, V100, P77, DOI 10.1016/j.ymgme.2010.01.001; Chowanadisai W, 2005, J NUTR, V135, P1002, DOI 10.1093/jn/135.5.1002; Desouki MM, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-37; FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Hudson FN, 2000, BBA-GENE STRUCT EXPR, V1492, P447, DOI 10.1016/S0167-4781(00)00128-7; JACKSON MJ, 1989, ZINC HUMAN BIOL, P1; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Lee JM, 2001, BIOCHEM BIOPH RES CO, V280, P286, DOI 10.1006/bbrc.2000.4106; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; LI Y, 1994, EUR J BIOCHEM, V226, P31, DOI 10.1111/j.1432-1033.1994.tb20023.x; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; Mulcahy RT, 1997, BIOL CHEM, V272, P7445; Nakamura Y, 2003, BIOCHEMISTRY-US, V42, P4300, DOI 10.1021/bi0340090; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Peters MMCG, 1996, CANCER RES, V56, P1006; PRESTERA T, 1995, MOL MED, V1, P827, DOI 10.1007/BF03401897; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Shibuya N, 2012, J VET MED SCI, V74, P583, DOI 10.1292/jvms.11-0412; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; TAKEDA A, 1995, BRAIN RES, V695, P53, DOI 10.1016/0006-8993(95)00916-E; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Wang YH, 2013, BIOL TRACE ELEM RES, V154, P418, DOI 10.1007/s12011-013-9737-1; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627	36	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0166100	10.1371/journal.pone.0166100	http://dx.doi.org/10.1371/journal.pone.0166100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812191	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000102
J	Won, YH; Lee, MY; Choi, YC; Ha, Y; Kim, H; Kim, DY; Kim, MS; Yu, JH; Seo, JH; Kim, M; Cho, SR; Kang, SW				Won, Yu Hui; Lee, Min-Young; Choi, Young-Chul; Ha, Yoon; Kim, Hyongbum; Kim, Do-Young; Kim, Myung-Sun; Yu, Ji Hea; Seo, Jung Hwa; Kim, MinGi; Cho, Sung-Rae; Kang, Seong-Woong			Elucidation of Relevant Neuroinflammation Mechanisms Using Gene Expression Profiling in Patients with Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							HEXANUCLEOTIDE REPEAT; SPINAL-CORD; RECEPTOR; CELLS; INFLAMMATION; CHEMOKINES; INDUCTION; PATHWAY; C9ORF72; TOLLIP	Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by damage of motor neurons. Recent reports indicate that inflammatory responses occurring within the central nervous system contribute to the pathogenesis of ALS. We aimed to investigate disease-specific gene expression associated with neuroinflammation by conducting transcriptome analysis on fibroblasts from three patients with sporadic ALS and three normal controls. Several pathways were found to be upregulated in patients with ALS, among which the toll-like receptor (TLR) and NOD-like receptor (NLR) signaling pathways are related to the immune response. Genes-toll-interacting protein (TOLLIP), mitogen-activated protein kinase 9 (MAPK9), interleukin-1 beta (IL-1 beta), interleukin-8 (IL-8), and chemokine (C-X-C motif) ligand 1 (CXCL1)-related to these two pathways were validated using western blotting. This study validated the genes that are associated with TLR and NLR signaling pathways from different types of patient-derived cells. Not only fibroblasts but also induced pluripotent stem cells (iPSCs) and neural rosettes from the same origins showed similar expression patterns. Furthermore, expression of TOLLIP, a regulator of TLR signaling pathway, decreased with cellular aging as judged by changes in its expression through multiple passages. TOLLIP expression was downregulated in ALS cells under conditions of inflammation induced by lipopolysaccharide. Our data suggest that the TLR and NLR signaling pathways are involved in pathological innate immunity and neuroinflammation associated with ALS and that TOLLIP, MAPK9, IL-1 beta, IL-8, and CXCL1 play a role in ALS-specific immune responses. Moreover, changes of TOLLIP expression might be associated with progression of ALS.	[Won, Yu Hui] Chonbuk Natl Univ, Dept Phys Med & Rehabil, Res Inst Clin Med, Biomed Res Inst,Chonbuk Natl Univ Hosp, Jeonju, South Korea; [Lee, Min-Young; Kim, Myung-Sun; Yu, Ji Hea; Seo, Jung Hwa; Kim, MinGi; Cho, Sung-Rae] Yonsei Univ, Dept & Res Inst Rehabil Med, Coll Med, Seoul, South Korea; [Choi, Young-Chul] Yonsei Univ, Gangnam Severance Hosp, Dept Neurol, Coll Med, Seoul, South Korea; [Ha, Yoon] Yonsei Univ, Spine & Spinal Cord Inst, Dept Neurosurg, Coll Med, Seoul, South Korea; [Kim, Hyongbum] Yonsei Univ, Dept Pharmacol, Coll Med, Seoul, South Korea; [Kim, Do-Young] Yonsei Univ, Cutaneous Biol Res Inst, Dept Dermatol, Coll Med, Seoul, South Korea; [Kim, Hyongbum; Yu, Ji Hea; Seo, Jung Hwa; Kim, MinGi; Cho, Sung-Rae] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea; [Kang, Seong-Woong] Yonsei Univ, Rehabil Inst Neuromuscular Dis, Gangnam Severance Hosp, Dept Rehabil Med,Coll Med, Seoul, South Korea; [Won, Yu Hui; Kang, Seong-Woong] Yonsei Univ, Dept Med, Grad Sch, Seoul, South Korea	Jeonbuk National University; Jeonbuk National University Hospital; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University	Cho, SR (corresponding author), Yonsei Univ, Dept & Res Inst Rehabil Med, Coll Med, Seoul, South Korea.; Cho, SR (corresponding author), Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea.; Kang, SW (corresponding author), Yonsei Univ, Rehabil Inst Neuromuscular Dis, Gangnam Severance Hosp, Dept Rehabil Med,Coll Med, Seoul, South Korea.; Kang, SW (corresponding author), Yonsei Univ, Dept Med, Grad Sch, Seoul, South Korea.	srcho918@yuhs.ac; kswoong@yuhs.ac	Kim, Hyongbum Henry/D-5804-2019	Kim, Hyongbum Henry/0000-0002-4693-738X; Choi, Young-Chul/0000-0001-5525-6861; Cho, Sung-Rae/0000-0003-1429-2684; Kang, Seong-Woong/0000-0002-7279-3893	National Research Foundation (SRC) [NRF-2014R1A2A1A11052042, 2015M3A9B4067068]; Ministry of Science and Technology, Republic of Korea; Korean Health Technology RD Project (YHW) [HI15C1529]; Ministry of Health & Welfare, Republic of Korea; "Dongwha" Faculty Research Assistance Program of Yonsei University College of Medicine (SRC) [6-2016-0126]	National Research Foundation (SRC); Ministry of Science and Technology, Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea); Korean Health Technology RD Project (YHW); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); "Dongwha" Faculty Research Assistance Program of Yonsei University College of Medicine (SRC)	This study was supported by grants from the National Research Foundation (SRC, NRF-2014R1A2A1A11052042; 2015M3A9B4067068), the Ministry of Science and Technology, Republic of Korea; the Korean Health Technology R&D Project (YHW, HI15C1529), Ministry of Health & Welfare, Republic of Korea; the "Dongwha" Faculty Research Assistance Program of Yonsei University College of Medicine (SRC, 6-2016-0126).	Ai B, 2015, MOL ECOL RESOUR, V15, P619, DOI 10.1111/1755-0998.12333; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Bendotti C, 2005, NEURODEGENER DIS, V2, P128, DOI 10.1159/000089617; Bowerman M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00214; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Byeon JS, 2010, INT J CANCER, V127, P2758, DOI 10.1002/ijc.25301; Casula M, 2011, NEUROSCIENCE, V179, P233, DOI 10.1016/j.neuroscience.2011.02.001; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Cruts M, 1993, GENEREVIEWS R; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Elliott JL, 2001, MOL BRAIN RES, V95, P172, DOI 10.1016/S0169-328X(01)00242-X; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Gillingwater TH, 2013, NEUROPATH APPL NEURO, V39, P320, DOI 10.1111/nan.12014; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim Woo Jin, 2013, International Journal of Industrial Entomology, V27, P271; Kirk K, 2014, ANN NEUROL, V76, P620, DOI 10.1002/ana.24244; Kuhle J, 2009, EUR J NEUROL, V16, P771, DOI 10.1111/j.1468-1331.2009.02560.x; Lee DR, 2015, STEM CELL REP, V4, P821, DOI 10.1016/j.stemcr.2015.04.002; Lee EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092447; Lee MY, 2013, NEUROREHAB NEURAL RE, V27, P561, DOI 10.1177/1545968313481277; Letiembre M, 2009, NEUROBIOL AGING, V30, P759, DOI 10.1016/j.neurobiolaging.2007.08.018; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li T, 2004, MOL IMMUNOL, V41, P85, DOI 10.1016/j.molimm.2004.03.009; Lin JQ, 2013, FUNGAL GENET BIOL, V56, P78, DOI 10.1016/j.fgb.2013.04.007; Liu Y, 2009, J BIOL CHEM, V284, P3691, DOI 10.1074/jbc.M804446200; Luan J, 1997, J LEUKOCYTE BIOL, V62, P588, DOI 10.1002/jlb.62.5.588; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Meissner F, 2010, P NATL ACAD SCI USA, V107, P13046, DOI 10.1073/pnas.1002396107; Omari KM, 2006, GLIA, V53, P24, DOI 10.1002/glia.20246; Park CY, 2014, P NATL ACAD SCI USA, V111, P9253, DOI 10.1073/pnas.1323941111; Piao YS, 2003, BRAIN PATHOLOGY ZURI, V13, P10, DOI DOI 10.1111/J.1750-3639.2003.TB00002.X; Raman R, 2015, NEUROPATH APPL NEURO, V41, P201, DOI 10.1111/nan.12147; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sabatelli M, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.02.009; Seo JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074405; Shaw PJ, 2010, EUR J IMMUNOL, V40, P624, DOI 10.1002/eji.200940211; Takeda Kiyoshi, 2007, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1412s77; Tateishi T, 2010, J NEUROIMMUNOL, V222, P76, DOI 10.1016/j.jneuroim.2010.03.004; van der Meer JWM, 2010, P NATL ACAD SCI USA, V107, P12741, DOI 10.1073/pnas.1007946107; Verbeke H, 2011, CYTOKINE GROWTH F R, V22, P345, DOI 10.1016/j.cytogfr.2011.09.002; Vlahopoulos S, 1999, BLOOD, V94, P1878, DOI 10.1182/blood.V94.6.1878; Xia Q, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.69; Xie T, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.014; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhang RZ, 2005, J NEUROIMMUNOL, V159, P215, DOI 10.1016/j.jneuroim.2004.10.009; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919	59	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165290	10.1371/journal.pone.0165290	http://dx.doi.org/10.1371/journal.pone.0165290			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812125	Green Submitted, Green Published, gold			2022-12-27	WOS:000386910000025
J	Czech-Kowalska, J; Czekuc-Kryskiewicz, E; Pludowski, P; Zaniuk, K; Jaworski, M; Luba, A; Grzybowska, K; Pilat, K; Dobrzanska, A				Czech-Kowalska, Justyna; Czekuc-Kryskiewicz, Edyta; Pludowski, Pawel; Zaniuk, Katarzyna; Jaworski, Maciej; Luba, Anna; Grzybowska, Karolina; Pilat, Krystyna; Dobrzanska, Anna			The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants	PLOS ONE			English	Article							SERUM ALKALINE-PHOSPHATASE; BIRTH-WEIGHT INFANTS; HIGH-TURNOVER OSTEOPENIA; X-RAY ABSORPTIOMETRY; CHRONIC LUNG-DISEASE; DEXAMETHASONE TREATMENT; PREMATURE-INFANTS; GESTATIONAL-AGE; METABOLISM; MINERALIZATION	Background Metabolic bone disease of prematurity still occurs in preterm infants, although a significant improvement in neonatal care has been observed in recent decades. Dual-energy X-ray absorptiometry (DXA) is the precise technique for assessing bone mineral content (BMC) in preterm infants, but is not widely available. Aim To investigate the clinical and biochemical parameters, including bone metabolism markers as potential predictors of BMC, in preterm infants up to 3 months corrected age (CA). Materials and Methods Ca-P homeostasis, iPTH, 25-hydroxyvitamin D, osteocalcin, N-terminal propeptide, crosslinked C-telopeptide and amino-terminal pro C-type natriuretic peptide and the DXA scans were prospectively performed in 184 preterm infants (<= 34 weeks' gestation) between term age and 3 mo CA. Lower bone mass was defined as BMC below or equal to respective median value for the whole study group, rounded to the nearest whole number. Results The appropriate quality DXA scans were available for 160 infants (87%) examined at term and for 130 (71%) tested at 3 mo CA. Higher iPTH level was the only independent predictor of lower BMC at term, whereas lower BMC at 3 mo CA was associated both with lower urinary phosphate excretion and higher serum osteocalcin level. ROC analysis showed that iPTH >43.6 pg/mL provided 40% sensitivity and 88% specificity in identification of preterm infants with lower BMC at term. In turn, urinary phosphate excretion (TRP>97% or UP/Cr <= 0.74 mg/mg) and serum osteocalcin >172 ng/mL provided 40% sensitivity and 93% specificity in identification of infants with decreased BMC at 3 mo CA. Conclusion Serum iPTH might to be a simple predictor of reduced BMC in preterm infants at term age, but urinary phosphate excretion and serum osteocalcin might predict reduced BMC at 3 mo CA. These results represent a promising diagnostic tool based on simple, widely available biochemical measurements for bone mass assessment in preterm infants.	[Czech-Kowalska, Justyna; Luba, Anna; Grzybowska, Karolina; Pilat, Krystyna; Dobrzanska, Anna] Childrens Mem Hlth Inst, Dept Neonatol & Neonatal Intens Care, Warsaw, Poland; [Czekuc-Kryskiewicz, Edyta; Pludowski, Pawel; Jaworski, Maciej] Childrens Mem Hlth Inst, Dept Biochem Radioimmunol & Expt Med, Warsaw, Poland; [Zaniuk, Katarzyna] Holy Family Hosp, Dept Neonatol, Warsaw, Poland	Children's Memorial Health Institute; Children's Memorial Health Institute	Czech-Kowalska, J (corresponding author), Childrens Mem Hlth Inst, Dept Neonatol & Neonatal Intens Care, Warsaw, Poland.	j.kowalska@ipczd.pl	Czech-Kowalska, Justyna/B-4306-2014; Płudowski, Paweł/P-2154-2018	Czech-Kowalska, Justyna/0000-0001-7563-3951; Płudowski, Paweł/0000-0001-8475-7112; Dobrzanska, Anna/0000-0003-2927-2344; Czekuc-Kryskiewicz, Edyta/0000-0002-3220-3780; Grzybowska, Karolina/0000-0002-2899-8170; Jaworski, Maciej/0000-0002-6758-371X	statutory grant of the Children's' Memorial Health Institute [173/2007]; statutory grant of the Children's Memorial Health [23/2004]	statutory grant of the Children's' Memorial Health Institute; statutory grant of the Children's Memorial Health	A statutory grant of the Children's' Memorial Health Institute No. 173/2007 (JCK).Prof Anna Dobrzanska is a recipient of a statutory grant of the Children's Memorial Health 23/2004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly Hany, 2004, J Perinatol, V24, P305, DOI 10.1038/sj.jp.7211083; Backstrom MC, 2000, ACTA PAEDIATR, V89, P867, DOI 10.1080/080352500750043792; Backstrom MC, 1999, ARCH DIS CHILD-FETAL, V80, pF161, DOI 10.1136/fn.80.3.F161; Baird J, 2011, OSTEOPOROSIS INT, V22, P1323, DOI 10.1007/s00198-010-1344-9; BEYERS N, 1994, BONE, V15, P5, DOI 10.1016/8756-3282(94)90884-2; Bowden SA, 2016, J PEDIAT ENDOCRINOL; Christmann V, 2014, J PEDIATR GASTR NUTR, V58, P398, DOI 10.1097/MPG.0000000000000251; Crofton PM, 2000, PEDIATR RES, V48, P155, DOI 10.1203/00006450-200008000-00007; Czech-Kowalska J, 2015, ANN NUTR METAB, V67, P33, DOI 10.1159/000437099; Faerk J, 2002, ARCH DIS CHILD-FETAL, V87, pF133, DOI 10.1136/fn.87.2.F133; Fenton TR, 2013, BMC PEDIATR, V13, P1, DOI DOI 10.1186/1471-2431-13-1; Figueras-Aloy J, 2014, J PEDIATR-US, V164, P499, DOI 10.1016/j.jpeds.2013.10.089; Gilsanz V, 1999, NUTR BONE DEV, V41, P147; Harrison CM, 2008, ACTA PAEDIATR, V97, P407, DOI 10.1111/j.1651-2227.2007.00721.x; Hung YL, 2011, J PAEDIATR CHILD H, V47, P134, DOI 10.1111/j.1440-1754.2010.01901.x; Kelly A, 2014, CLIN PEDIATR, V53, P1077, DOI 10.1177/0009922814535661; Lapillonne A, 2000, ACTA PAEDIATR, V89, P772, DOI 10.1080/080352500750043620; Lee SM, 2012, J KOREAN MED SCI, V27, P1552, DOI 10.3346/jkms.2012.27.12.1552; Litmanovitz I, 2004, J PERINAT MED, V32, P58, DOI 10.1515/JPM.2004.010; Lothe A, 2011, J PAEDIATR CHILD H, V47, P550, DOI 10.1111/j.1440-1754.2011.02019.x; Martinez-Mesa J, 2013, OSTEOPOROSIS INT, V24, P7, DOI 10.1007/s00198-012-2114-7; Mitchell SM, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-47; Moreira A, 2013, J PAEDIATR CHILD H, V49, pE12, DOI 10.1111/jpc.12052; Moyer-Mileur LJ, 2000, PEDIATRICS, V106, P1088, DOI 10.1542/peds.106.5.1088; Naylor KE, 1999, PEDIATR RES, V45, P363, DOI 10.1203/00006450-199903000-00012; Neve A, 2013, J CELL PHYSIOL, V228, P1149, DOI 10.1002/jcp.24278; Ng PC, 2002, ARCH DIS CHILD-FETAL, V86, pF49, DOI 10.1136/fn.86.1.F49; Picaud JC, 2002, ACTA PAEDIATR, V91, P1189, DOI 10.1080/080352502320777423; Pieltain C, 2013, WORLD REV NUTR DIET, V106, P181, DOI 10.1159/000342680; Prickett TCR, 2008, J CLIN ENDOCR METAB, V93, P225, DOI 10.1210/jc.2007-1815; Rigo J, 2000, CLIN PERINATOL, V27, P147, DOI 10.1016/S0095-5108(05)70011-7; Rigo J, 1998, J PEDIATR GASTR NUTR, V27, P184, DOI 10.1097/00005176-199808000-00011; Rigo J, 2007, ACTA PAEDIATR, V96, P969, DOI 10.1111/j.1651-2227.2007.00336.x; Routine administration of vitamin K to newborns, 1998, CAN FAM PHYS, V44, P1083; Staub E, 2014, J PEDIATR GASTR NUTR, V58, P404, DOI 10.1097/MPG.0000000000000244; Szulc P, 2000, OSTEOPOROSIS INT, V11, P281, DOI 10.1007/s001980070116; Tsukahara H, 1998, METABOLISM, V47, P333, DOI 10.1016/S0026-0495(98)90266-9; Tuchman S, 2008, J PEDIATR-US, V153, P484, DOI 10.1016/j.jpeds.2008.04.028; van de Lagemaat M, 2013, J NUTR, V143, P1439, DOI [10.3945/jn.113.178111, DOI 10.3945/JN.113.178111]; van de Lagemaat M, 2014, CLIN ENDOCRINOL OXF; van de Lagemaat M, 2013, EUR J NUTR, V52, P1781, DOI 10.1007/s00394-012-0481-7; van de Lagemaat M, 2012, BONE, V51, P441, DOI 10.1016/j.bone.2012.06.017; van der Sluis IM, 2002, HORM RES, V57, P170, DOI 10.1159/000058378; Vignochi CM, 2012, AM J PERINAT, V29, P573, DOI 10.1055/s-0032-1310520; Visser F, 2012, ACTA PAEDIATR, V101, P562, DOI 10.1111/j.1651-2227.2012.02626.x; Viswanathan S, 2014, JPEN-PARENTER ENTER, V38, P982, DOI 10.1177/0148607113499590; Yorifuji J, 2008, J CLIN ENDOCRINOLOGY, P1784; Zoch ML, 2016, BONE, V82, P42, DOI 10.1016/j.bone.2015.05.046	48	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165727	10.1371/journal.pone.0165727	http://dx.doi.org/10.1371/journal.pone.0165727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806112	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500052
J	Kinsey, CM; Hamlington, KL; O'Toole, J; Stapleton, R; Bates, JHT				Kinsey, C. Matthew; Hamlington, Katharine L.; O'Toole, Jacqueline; Stapleton, Renee; Bates, Jason H. T.			Predicting the Mortality Benefit of CT Screening for Second Lung Cancer in a High-Risk Population	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; ED AMERICAN-COLLEGE; STAGE-I; COMPUTED-TOMOGRAPHY; FOLLOW-UP; MANAGEMENT; SURVEILLANCE; DIAGNOSIS; RESECTION; TUMORS	Patients who survive an index lung cancer (ILC) after surgical resection continue to be at significant risk for a metachronous lung cancer (MLC). Indeed, this risk is much higher than the risk of developing an ILC in heavy smokers. There is currently little evidence upon which to base guidelines for screening at-risk patients for MLC, and the risk-reward tradeoffs for screening this patient population are unknown. The goal of this investigation was to estimate the maximum mortality benefit of CT screening for MLC. We developed a computational model to estimate the maximum rates of CT detection of MLC and surgical resection to be expected in a given population as a function of time after resection of an ILC. Applying the model to a hypothetical high-risk population suggests that screening for MLC within 5 years after resection of an ILC may identify only a very small number of treatable cancers. The risk of death from a potentially resectable MLC increases dramatically past this point, however, suggesting that screening after 5 years is imperative. The model also predicts a substantial detection gap for MLC that demonstrates the benefit to be gained as more sensitive screening methods are developed.	[Kinsey, C. Matthew; Hamlington, Katharine L.; Stapleton, Renee; Bates, Jason H. T.] Univ Vermont, Coll Med, Div Pulm & Crit Care, Burlington, VT 05405 USA; [O'Toole, Jacqueline] Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Kinsey, CM (corresponding author), Univ Vermont, Coll Med, Div Pulm & Crit Care, Burlington, VT 05405 USA.	Matt.Kinsey@uvmhealth.org		Hamlington, Katharine/0000-0002-5221-2123	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076122, K23HL133476] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL076122, K23 HL133476] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aberle DR, 2013, NEW ENGL J MED, V369, P920, DOI 10.1056/NEJMoa1208962; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Alberg AJ, 2008, SEMIN RESP CRIT CARE, V29, P223, DOI 10.1055/s-2008-1076742; Bae MK, 2011, ANN THORAC SURG, V92, P256, DOI 10.1016/j.athoracsur.2011.02.034; Battafarano RJ, 2004, J THORAC CARDIOV SUR, V127, P836, DOI 10.1016/j.jtcvs.2003.08.055; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Colt HG, 2013, CHEST, V143, pE437, DOI 10.1378/chest.12-2365; de Koning HJ, 2014, ANN INTERN MED, V160, P311, DOI 10.7326/M13-2316; Endo C, 2012, ANN THORAC SURG, V93, P1061, DOI 10.1016/j.athoracsur.2012.01.004; Friberg S, 1997, J SURG ONCOL, V65, P284, DOI 10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2; Howington JA, 2013, CHEST, V143, pE278, DOI 10.1378/chest.12-2359; Infante M, 2013, EUR RESPIR J, V42, P1706, DOI 10.1183/09031936.00186212; Johnson BE, 1998, JNCI-J NATL CANCER I, V90, P1335, DOI 10.1093/jnci/90.18.1335; Korst RJ, 2006, ANN THORAC SURG, V82, P1009, DOI 10.1016/j.athoracsur.2006.03.062; Lubin JH, 2007, AM J EPIDEMIOL, V166, P479, DOI 10.1093/aje/kwm089; MARTINI N, 1995, J THORAC CARDIOV SUR, V109, P120, DOI 10.1016/S0022-5223(95)70427-2; McMahon PM, 2012, RISK ANAL, V32, pS166, DOI 10.1111/j.1539-6924.2011.01714.x; Reich JM, 2015, LUNG CANCER, V87, P96, DOI 10.1016/j.lungcan.2014.12.002; Ripley RT, 2014, ANN THORAC SURG, V98, P968, DOI 10.1016/j.athoracsur.2014.04.098; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Wood DE, 2012, J NATL COMPR CANC NE, V10, P240, DOI 10.6004/jnccn.2012.0022	21	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165471	10.1371/journal.pone.0165471	http://dx.doi.org/10.1371/journal.pone.0165471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806080	Green Submitted, Green Published, gold			2022-12-27	WOS:000386715500032
J	Lin, MT; Yen, YH; Tsai, MC; Tseng, PL; Chang, KC; Wu, CK; Hu, TH				Lin, Ming-Tsung; Yen, Yi-Hao; Tsai, Ming-Chao; Tseng, Po-Lin; Chang, Kuo-Chin; Wu, Cheng-Kun; Hu, Tsung-Hui			Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice	PLOS ONE			English	Article							LONG-TERM ADEFOVIR; E-ANTIGEN; LIVER-TRANSPLANTATION; ANTIVIRAL THERAPY; NATURAL-HISTORY; RENAL-FUNCTION; DIPIVOXIL; RISK; COMBINATION; TENOFOVIR	Background and Aim Chronic hepatitis B infection remains a significant health issue worldwide. This study evaluated the efficacy and safety of combined therapy using lamivudine plus adefovir (LAM+ADV) versus telbivudine plus adefovir (LdT+ADV) and the corresponding renal function change and safety. Methods This study enrolled a total of 171 patients (110 patients received LAM+ADV and 60 patients received LdT+ADV). We analyzed the changes in renal function using the estimated glomerular filtration rate (eGFR). The DNA undetectable rate, hepatitis B e antigen (HBeAg) seroconversion rate, and alanine aminotransferase (ALT) normalization rate were analyzed. We checked the serum uric acid, phosphate and creatine kinase, and lactic acid levels to analyze safety. We observed these patients for 48 to 240 weeks and checked their serum profile every 6 months. Results There was no statistically significant difference between the two groups in anti-hepatitis B virus (HBV) efficacy in terms of DNA undetectable rate, ALT normalization rate, and HBeAg seroconversion rate. Both the LAM+ADV and LdT+ADV groups had stable or improved renal function. However, a higher eGFR was found in the LdT+ADV group with continuous serum fluctuation during 3 years of combined therapy as well as a higher serum creatine kinase level. Conclusions Long-term LdT+ADV combined therapy and LAM+ADV combined therapy were both associated with stable or improved renal function. The clinical efficacy was similar between the two groups, but the LdT group had a higher serum creatine kinase level. We need to monitor the data regularly in clinical practice.	[Hu, Tsung-Hui] Chang Gung Univ, Div Hepatogastroenterol, Dept Internal Med, Kaohsiung Chang Gung Mem Hosp, Taoyuan, Taiwan; Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Hu, TH (corresponding author), Chang Gung Univ, Div Hepatogastroenterol, Dept Internal Med, Kaohsiung Chang Gung Mem Hosp, Taoyuan, Taiwan.	dr.hu@msa.hinet.net	Tsai, Ming Chao/ABA-9806-2020	, Ming-Chao/0000-0002-3613-2051	 [CMRPG8D1451]		Partially supported by a grant (CMRPG8D1451) from Ming-Tsung Lin.; This study was partially supported by a grant (CMRPG8D1451) from Ming-Tsung Lin.	Adani GL, 2005, AM J TRANSPLANT, V5, P634, DOI 10.1111/j.1600-6143.2005.00691.x; Bayrakci US, 2008, PEDIATR TRANSPLANT, V12, P109, DOI 10.1111/j.1399-3046.2007.00839.x; Brancaccio P, 2010, CLIN CHEM LAB MED, V48, P757, DOI 10.1515/CCLM.2010.179; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen EQ, 2013, IRAN RED CRESCENT ME, V15, DOI 10.5812/ircmj.7788; DEJONGH FE, 1992, GASTROENTEROLOGY, V103, P1630, DOI 10.1016/0016-5085(92)91188-A; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; FATTOVICH G, 1991, GUT, V32, P294, DOI 10.1136/gut.32.3.294; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Fodale V, 2005, ANAESTHESIA, V60, P806, DOI 10.1111/j.1365-2044.2005.04208.x; Fontana RJ, 2009, HEPATOLOGY, V49, pS185, DOI 10.1002/hep.22885; Gaia S, 2004, ALIMENT PHARM THER, V20, P281, DOI 10.1111/j.1365-2036.2004.02073.x; Gane EJ, 2014, GASTROENTEROLOGY, V146, P138, DOI 10.1053/j.gastro.2013.09.031; Gara N, 2012, ALIMENT PHARM THER, V35, P1317, DOI 10.1111/j.1365-2036.2012.05093.x; Gish RG, 2012, CLIN GASTROENTEROL H, V10, P941, DOI 10.1016/j.cgh.2012.04.008; Hadziyannis SJ, 2005, NEW ENGL J MED, V352, P2673, DOI 10.1056/NEJMoa042957; Hadziyannis SJ, 2006, GASTROENTEROLOGY, V131, P1743, DOI 10.1053/j.gastro.2006.09.020; Hui CK, 2007, HEPATOLOGY, V46, P690, DOI 10.1002/hep.21758; Izzedine H, 2004, KIDNEY INT, V66, P1153, DOI 10.1111/j.1523-1755.2004.00866.x; Jiang L, 2009, WORLD J GASTROENTERO, V15, P2489, DOI 10.3748/wjg.15.2489; Kim YJ, 2012, J GASTROEN HEPATOL, V27, P306, DOI 10.1111/j.1440-1746.2011.06852.x; Lai CL, 2005, GASTROENTEROLOGY, V129, P528, DOI 10.1053/j.gastro.2005.05.053; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2010, DIGEST DIS SCI, V55, P2727, DOI 10.1007/s10620-010-1179-4; Liaw YF, 2009, GASTROENTEROLOGY, V136, P486, DOI 10.1053/j.gastro.2008.10.026; Lin CL, 2014, SCAND J GASTROENTERO, V49, P1456, DOI 10.3109/00365521.2014.962604; Lin MT, 2014, ARCH VIROL, V159, P29, DOI 10.1007/s00705-013-1786-4; Lo CM, 2003, TRANSPLANTATION, V75, pS41, DOI 10.1097/01.TP.0000047027.68167.07; Lok AS, 2007, HEPATOLOGY, V46, P254, DOI 10.1002/hep.21698; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Lok ASF, 2003, GASTROENTEROLOGY, V125, P1714, DOI 10.1053/j.gastro.2003.09.033; Marcellin P, 2008, HEPATOLOGY, V48, P750, DOI 10.1002/hep.22414; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Matthews SJ, 2007, CLIN THER, V29, P2635, DOI 10.1016/j.clinthera.2007.12.032; Mederacke I, 2012, J VIRAL HEPATITIS, V19, P387, DOI 10.1111/j.1365-2893.2011.01560.x; Perrella A, 2012, TRANSPL P, V44, P1986, DOI 10.1016/j.transproceed.2012.06.019; Peters MG, 2004, GASTROENTEROLOGY, V126, P91, DOI 10.1053/j.gastro.2003.10.051; Rapti I, 2007, HEPATOLOGY, V45, P307, DOI 10.1002/hep.21534; Ridruejo E, 2012, EXPERT OPIN DRUG SAF, V11, P357, DOI 10.1517/14740338.2012.672972; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Tsai MC, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.05.035; Tsai MC, 2014, CLIN MICROBIOL INFEC, V20, pO90, DOI 10.1111/1469-0691.12220; Wang Y, 2013, J VIRAL HEPATITIS, V20, pe37, DOI 10.1111/jvh.12025; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; Yao Na, 2015, Zhonghua Gan Zang Bing Za Zhi, V23, P250, DOI 10.3760/cma.j.issn.1007-3418.2015.04.004; Zhang XS, 2008, WORLD J GASTROENTERO, V14, P3549, DOI 10.3748/wjg.14.3549; Zhang Y, 2013, EUR J GASTROEN HEPAT, V25, P814, DOI 10.1097/MEG.0b013e32835ee516; Zhou XJ, 2007, ANTIMICROB AGENTS CH, V51, P4231, DOI 10.1128/AAC.00557-07	50	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165416	10.1371/journal.pone.0165416	http://dx.doi.org/10.1371/journal.pone.0165416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806120	gold, Green Published, Green Submitted			2022-12-27	WOS:000386715500028
J	Saryeddine, L; Zibara, K; Kassem, N; Badran, B; El-Zein, N				Saryeddine, Lilian; Zibara, Kazem; Kassem, Nouhad; Badran, Bassam; El-Zein, Nabil			EGF-Induced VEGF Exerts a PI3K-Dependent Positive Feedback on ERK and AKT through VEGFR2 in Hematological In Vitro Models	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ACTIVATED PROTEIN-KINASES; CELL-GROWTH; ANTIANGIOGENIC THERAPY; ANGIOGENESIS; PATHWAY	EGFR and VEGFR pathways play major roles in solid tumor growth and progression, however, little is known about these pathways in haematological tumors. This study investigated the crosstalk between EGFR and VEGFR2 signaling in two hematological in vitro models: THP1, a human monocytic leukemia, and Raji, a Burkitt's lymphoma, cell lines. Results showed that both cell lines express EGFR and VEGFR2 and responded to EGF stimulation by activating EGFR, triggering VEGF production and phosphorylating ERK, AKT, and p38 very early, with a peak of expression at 10-20min. Blocking EGFR using Tyrphostin resulted in inhibiting EGFR induced activation of ERK, AKT, and p38. In addition, EGF stimulation caused a significant and immediate increase, within 1min, in pVEGFR2 in both cell lines, which peaked at similar to 5-10 min after treatment. Selective inhibition of VEGFR2 by DMH4, anti-VEGFR2 antibody or siRNA diminished EGF-induced pAKT and pERK, indicating a positive feedback exerted by EGFR-induced VEGF. Similarly, the specific PI3K inhibitor LY294002, suppressed AKT and ERK phosphorylation showing that VEGF feedback is PI3K-dependent. On the other hand, phosphorylation of p38, initiated by EGFR and independent of VEGF feedback, was diminished using PLC inhibitor U73122. Moreover, measurement of intracellular [Ca2+] and ROS following VEGFR2 inhibition and EGF treatment proved that VEGFR2 is not implicated in EGF-induced Ca2+ release whereas it boosts EGF-induced ROS production. Furthermore, a significant decrease in pAKT, pERK and pp38 was shown following the addition of the ROS inhibitor NAC. These results contribute to the understanding of the crosstalk between EGFR and VEGFR in haematological malignancies and their possible combined blockade in therapy.	[Saryeddine, Lilian; Zibara, Kazem; Kassem, Nouhad; El-Zein, Nabil] Lebanese Univ, EDST, PRASE, ER045, Beirut, Lebanon; [Zibara, Kazem; El-Zein, Nabil] Lebanese Univ, Fac Sci 1, Dept Biol, Lab Cardiovasc Dis & Stem Cells, Beirut, Lebanon; [Badran, Bassam] Lebanese Univ, Fac Sci 1, Dept Biochem, Beirut, Lebanon	Lebanese University; Lebanese University; Lebanese University	El-Zein, N (corresponding author), Lebanese Univ, EDST, PRASE, ER045, Beirut, Lebanon.; El-Zein, N (corresponding author), Lebanese Univ, Fac Sci 1, Dept Biol, Lab Cardiovasc Dis & Stem Cells, Beirut, Lebanon.	nabilzein@hotmail.fr		Zibara, Kazem/0000-0002-9887-072X; el zein, nabil/0000-0002-8596-5359	Lebanese National Council for Scientific Research, Lebanese University grant [ER045]	Lebanese National Council for Scientific Research, Lebanese University grant	This work was supported by grants from Lebanese National Council for Scientific Research (KZ, NEZ), Lebanese University grant and ER045 (KZ).	Atmaca A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-524; Chatterjee S, 2013, J CLIN INVEST, V123, P1732, DOI 10.1172/JCI65385; Chen S, 2013, ONCOL REP, V29, P260, DOI 10.3892/or.2012.2097; Chien MH, 2009, CARCINOGENESIS, V30, P2005, DOI 10.1093/carcin/bgp244; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Demyanets S, 2011, BASIC RES CARDIOL, V106, P217, DOI 10.1007/s00395-010-0141-0; Dias S, 2000, J CLIN INVEST, V106, P511, DOI 10.1172/JCI8978; Dong XW, 2007, CRIT REV ONCOL HEMAT, V62, P105, DOI 10.1016/j.critrevonc.2006.11.006; El Zein N, 2006, CELL SIGNAL, V18, P162, DOI 10.1016/j.cellsig.2005.03.027; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Johnston JB, 2006, CURR MED CHEM, V13, P3483, DOI 10.2174/092986706779026174; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Larsen AK, 2011, PHARMACOL THERAPEUT, V131, P80, DOI 10.1016/j.pharmthera.2011.03.012; Lee SH, 2015, ANN SURG TREAT RES, V89, P1, DOI 10.4174/astr.2015.89.1.1; Mahtouk K, 2004, BLOOD, V103, P1829, DOI 10.1182/blood-2003-05-1510; Musumeci F, 2012, J MED CHEM, V55, P10797, DOI 10.1021/jm301085w; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Paniagua RT, 2011, J AM ACAD DERMATOL, V65, P389, DOI 10.1016/j.jaad.2010.04.026; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Ruan J, 2009, ANN ONCOL, V20, P413, DOI 10.1093/annonc/mdn666; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Sun JZ, 2012, HEMATOL ONCOL, V30, P89, DOI 10.1002/hon.1002; Tabernero J, 2007, MOL CANCER RES, V5, P203, DOI 10.1158/1541-7786.MCR-06-0404; Tan CS, 2016, LUNG CANCER, V93, P59, DOI 10.1016/j.lungcan.2016.01.003; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Witsch E, 2010, PHYSIOLOGY, V25, P85, DOI 10.1152/physiol.00045.2009; Yart A, 2001, J BIOL CHEM, V276, P8856, DOI 10.1074/jbc.M006966200	32	27	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165876	10.1371/journal.pone.0165876	http://dx.doi.org/10.1371/journal.pone.0165876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806094	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500067
J	Boattini, A; Sarno, S; Bini, C; Pesci, V; Barbieri, C; De Fanti, S; Quagliariello, A; Pagani, L; Ayub, Q; Ferri, G; Pettener, D; Luiselli, D; Pelotti, S				Boattini, Alessio; Sarno, Stefania; Bini, Carla; Pesci, Valeria; Barbieri, Chiara; De Fanti, Sara; Quagliariello, Andrea; Pagani, Luca; Ayub, Qasim; Ferri, Gianmarco; Pettener, Davide; Luiselli, Donata; Pelotti, Susi			Mutation Rates and Discriminating Power for 13 Rapidly-Mutating Y-STRs between Related and Unrelated Individuals	PLOS ONE			English	Article							SHORT TANDEM REPEATS; CHROMOSOME; POPULATION	Rapidly Mutating Y-STRs (RM Y-STRs) were recently introduced in forensics in order to increase the differentiation of Y-chromosomal profiles even in case of close relatives. We estimate RM Y-STRs mutation rates and their power to discriminate between related individuals by using samples extracted from a wide set of paternal pedigrees and by comparing RM Y-STRs results with those obtained from the Y-filer set. In addition, we tested the ability of RM Y-STRs to discriminate between unrelated individuals carrying the same Y-filer haplotype, using the haplogroup R-M269 (reportedly characterised by a strong resemblance in Y-STR profiles) as a case study. Our results, despite confirming the high mutability of RM Y-STRs, show significantly lower mutation rates than reference germline ones. Consequently, their power to discriminate between related individuals, despite being higher than the one of Y-filer, does not seem to improve significantly the performance of the latter. On the contrary, when considering R-M269 unrelated individuals, RM Y-STRs reveal significant discriminatory power and retain some phylogenetic signal, allowing the correct classification of individuals for some R-M269-derived sub-lineages. These results have important implications not only for forensics, but also for molecular anthropology, suggesting that RM Y-STRs are useful tools for exploring subtle genetic variability within Y-chromosomal haplogroups.	[Boattini, Alessio; Sarno, Stefania; Barbieri, Chiara; De Fanti, Sara; Quagliariello, Andrea; Pettener, Davide; Luiselli, Donata] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali BiGeA, Bologna, Italy; [Bini, Carla; Pesci, Valeria; Pelotti, Susi] Univ Bologna, Dipartimento Sci Med & Chirurg, Bologna, Italy; [Pagani, Luca] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England; [Ayub, Qasim] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Ferri, Gianmarco] Univ Modena & Reggio Emilia, Dipartimento Med Diagnost Clin & Sanita Pubbl, Modena, Italy	University of Bologna; University of Bologna; University of Cambridge; Wellcome Trust Sanger Institute; Universita di Modena e Reggio Emilia	Boattini, A; Sarno, S (corresponding author), Univ Bologna, Dipartimento Sci Biol Geol & Ambientali BiGeA, Bologna, Italy.	alessio.boattini2@unibo.it; stefania.sarno2@unibo.it	Pagani, Luca/G-8511-2017; Pettener, Davide/E-1576-2017; Quagliariello, Andrea/AAA-1710-2020; Quagliariello, Andrea/K-4955-2018	Pagani, Luca/0000-0002-6639-524X; Quagliariello, Andrea/0000-0002-3941-3684; Barbieri, Chiara/0000-0001-8827-5655	European Research Council [ERC-2011-AdG295733]	European Research Council(European Research Council (ERC)European Commission)	SS is supported by the European Research Council ERC-2011-AdG295733 grant (Langelin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantyne KN, 2014, HUM MUTAT, V35, P1021, DOI 10.1002/humu.22599; Ballantyne KN, 2012, FORENSIC SCI INT-GEN, V6, P208, DOI 10.1016/j.fsigen.2011.04.017; Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Behar DM, 2004, HUM GENET, V114, P354, DOI 10.1007/s00439-003-1073-7; Boattini A, 2015, HEREDITY, V114, P155, DOI 10.1038/hdy.2014.77; Boattini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065441; Bosch E, 1999, AM J HUM GENET, V65, P1623, DOI 10.1086/302676; Busby GBJ, 2012, P ROY SOC B-BIOL SCI, V279, P884, DOI 10.1098/rspb.2011.1044; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Jobling MA, 1997, INT J LEGAL MED, V110, P118, DOI 10.1007/s004140050050; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; King TE, 2009, MOL BIOL EVOL, V26, P1093, DOI 10.1093/molbev/msp022; Komsta L., 2011, OUTLIERS TESTS OUTLI; Larmuseau MHD, 2014, ANN HUM GENET, V78, P92, DOI 10.1111/ahg.12050; R Core Team, 2021, R LANGUAGE ENV STAT; Robino C, 2015, FORENSIC SCI INT-GEN, V15, P56, DOI 10.1016/j.fsigen.2014.10.008; Turrina S, 2016, TRANSFUSION, V56, P533, DOI 10.1111/trf.13368; Wei W, 2013, FORENSIC SCI INT-GEN, V7, P568, DOI 10.1016/j.fsigen.2013.03.014; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	21	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165678	10.1371/journal.pone.0165678	http://dx.doi.org/10.1371/journal.pone.0165678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802306	Green Published, Green Submitted, gold			2022-12-27	WOS:000386714200038
J	Lai, HTM; Koriyama, C; Tokudome, S; Tran, HH; Tran, LT; Nandakumar, A; Akiba, S; Le, NT				Hang Thi Minh Lai; Koriyama, Chihaya; Tokudome, Shinkan; Hoc Hieu Tran; Long Thanh Tran; Nandakumar, Athira; Akiba, Suminori; Ngoan Tran Le			Waterpipe Tobacco Smoking and Gastric Cancer Risk among Vietnamese Men	PLOS ONE			English	Article							STOMACH-CANCER; ALCOHOL-CONSUMPTION; CIGARETTE-SMOKING; LIFE-STYLE; HOOKAH; OPIUM	Background The association of waterpipe tobacco (WPT) smoking with gastric cancer (GC) risk was suggested. Methods A hospital-based case-control study was conducted to examine the association of WPT with GC risk among Vietnamese men, in Hanoi city, during the period of 2003-2011. Newly-diagnosed GC cases (n = 454) and control patients (n = 628) were matched by age (+/-5 years) and the year of hospitalization. Information on smoking and alcohol drinking habits and diet including salty food intake and fruits/vegetables consumption were obtained by the interview. Maximum likelihood estimates of odds ratios (ORs) and corresponding 95% confidence intervals (Cis) were obtained using conditional logistic regression models. Results The group with the highest consumption of citrus fruits showed a significantly low GC risk (OR = 0.6, 95% CI = 0.4-0.8, P for trend = 0.002). However, there was no association of raw vegetable consumption with GC risk. Referring to never smokers, GC risk was significantly higher in current WPT smokers (OR = 1.8, 95% CI = 1.3-2.4), and it was more evident in exclusively WPT smokers (OR = 2.7, 95% CI = 1.2-6.5). GC risk tended to be higher with daily frequency and longer duration of WPT smoking but these trends were not statistically significant (P for trend: 0.144 and 0.154, respectively). GC risk of those who started smoking WPT before the age of 25 was also significantly high (OR = 3.7, 95% CI = 1.2-11.3). Neither cigarette smoking nor alcohol drinking was related to GC risk. Conclusion The present findings revealed that WPT smoking was positively associated with GC risk in Vietnamese men.	[Hang Thi Minh Lai; Koriyama, Chihaya; Long Thanh Tran; Nandakumar, Athira; Akiba, Suminori] Kagoshima Univ, Dept Epidemiol & Prevent Med, Grad Sch Med & Dent Sci, Kagoshima, Japan; [Tokudome, Shinkan] Natl Inst Hlth & Nutr, Tokyo, Japan; [Hoc Hieu Tran] Hanoi Med Univ, Dept Surg, Hanoi, Vietnam; [Ngoan Tran Le] Hanoi Med Univ, Dept Occupat Hlth, Hanoi, Vietnam	Kagoshima University; National Institute of Health & Nutrition - Japan; Hanoi Medical University; Hanoi Medical University	Le, NT (corresponding author), Hanoi Med Univ, Dept Occupat Hlth, Hanoi, Vietnam.	letranngoan@yahoo.com		Nandakumar, Athira/0000-0001-5156-7304; TOKUDOME, SHINKAN/0000-0001-7311-2458; Akiba, Suminori/0000-0001-9004-3167; Le, Ngoan Tran/0000-0001-7862-492X	Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Science and Technology of Vietnam; UICC American Cancer Society Beginning Investigators Fellowship - American Cancer Society; UICC Yamagiwa-Yoshida Memorial International Cancer Study Grant; Kodama Memorial Fund for Medical Research	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Science and Technology of Vietnam; UICC American Cancer Society Beginning Investigators Fellowship - American Cancer Society; UICC Yamagiwa-Yoshida Memorial International Cancer Study Grant; Kodama Memorial Fund for Medical Research	The present study was supported by Grants-in-Aids for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology, Japan and Ministry of Science and Technology of Vietnam. This work has also been supported by a UICC American Cancer Society Beginning Investigators Fellowship funded by the American Cancer Society and by a UICC Yamagiwa-Yoshida Memorial International Cancer Study Grant to N T Le. This study was supported by the Kodama Memorial Fund for Medical Research.	Akl EA, 2010, INT J EPIDEMIOL, V39, P834, DOI 10.1093/ije/dyq002; Al Rashidi M, 2008, FOOD CHEM TOXICOL, V46, P3546, DOI 10.1016/j.fct.2008.09.007; Anh PM, 2013, PRACTICAL MED, V876, P112; Bae JM, 2008, GASTRIC CANCER, V11, P23, DOI 10.1007/s10120-007-0447-2; Chen MJ, 2000, AM J GASTROENTEROL, V95, P3242; Chow WH, 1999, INT J CANCER, V81, P871, DOI 10.1002/(SICI)1097-0215(19990611)81:6&lt;871::AID-IJC6&gt;3.0.CO;2-#; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Duell EJ, 2013, GENES NUTR, V8, P549, DOI 10.1007/s12263-013-0346-6; Eissenberg T, 2009, AM J PREV MED, V37, P518, DOI 10.1016/j.amepre.2009.07.014; Gajalakshmi CK, 1996, INT J EPIDEMIOL, V25, P1146, DOI 10.1093/ije/25.6.1146; Inoue M, 1999, INT J CANCER, V81, P39; International agency for research on cancer, 2003, INT TERR LEG CHALL R, V8, P66; International agency for research on cancer, 2004, IARC MON EV CARC RIS, V83, p[68, 557]; Jacob P, 2011, CANCER EPIDEM BIOMAR, V20, P2345, DOI 10.1158/1055-9965.EPI-11-0545; Jayalekshmi PA, 2015, WORLD J GASTROENTERO, V21, P12676, DOI 10.3748/wjg.v21.i44.12676; La Torre G, 2009, TUMORI, V95, P13; Le GM, 2002, INT J CANCER, V102, P412, DOI 10.1002/ijc.10725; Xuan LTT, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120100; Maziak W, 2013, CANCER EPIDEMIOL, V37, P1, DOI 10.1016/j.canep.2012.10.013; Ministry of Health of Vietnam Ha Noi Medical University General Statistics Office Centers for Disease Control and Prevention and World Health Organization, 2010, GLOB AD TOB SURV GAT; Monzer B, 2008, FOOD CHEM TOXICOL, V46, P2991, DOI 10.1016/j.fct.2008.05.031; Park B, 2011, CANCER CAUSE CONTROL, V22, P1497, DOI 10.1007/s10552-011-9823-7; Ray CS, 2009, CURR SCI INDIA, V96, P1319; Rock V. J., 2007, Morbidity and Mortality Weekly Report, V56, P1157; Sadjadi A, 2014, INT J CANCER, V134, P181, DOI 10.1002/ijc.28344; Sasazuki S, 2002, INT J CANCER, V101, P560, DOI 10.1002/ijc.10649; Sepetdjian E, 2008, FOOD CHEM TOXICOL, V46, P1582, DOI 10.1016/j.fct.2007.12.028; Sepetdjian E, 2013, NICOTINE TOB RES, V15, P1107, DOI 10.1093/ntr/nts255; Shakeri R, 2013, INT J CANCER, V133, P455, DOI 10.1002/ijc.28018; She J, 2014, CHEST, V146, P924, DOI 10.1378/chest.13-1499; Siman JH, 2001, SCAND J GASTROENTERO, V36, P208, DOI 10.1080/003655201750065988; Sung NY, 2007, BRIT J CANCER, V97, P700, DOI 10.1038/sj.bjc.6603893; Tredaniel J, 1997, INT J CANCER, V72, P565, DOI 10.1002/(SICI)1097-0215(19970807)72:4<565::AID-IJC3>3.0.CO;2-O; World Health Organization, 2015, WHO STUD GROUP TOB P; Zaridze D, 2000, CANCER CAUSE CONTROL, V11, P363, DOI 10.1023/A:1008907924938	35	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165587	10.1371/journal.pone.0165587	http://dx.doi.org/10.1371/journal.pone.0165587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802311	Green Submitted, Green Published, gold			2022-12-27	WOS:000386714200028
J	Tang, B; Wang, K; Jia, YP; Zhu, P; Fang, Y; Zhang, ZJ; Mao, XH; Li, Q; Zeng, DZ				Tang, Bin; Wang, Kun; Jia, Yin-ping; Zhu, Pan; Fang, Yao; Zhang, Zhu-jun; Mao, Xu-hu; Li, Qian; Zeng, Dong-zhu			Fusobacterium nucleatum-Induced Impairment of Autophagic Flux Enhances the Expression of Proinflammatory Cytokines via ROS in Caco-2 Cells	PLOS ONE			English	Article							EPITHELIAL-CELLS; VACUOLATING CYTOTOXIN; COLORECTAL-CANCER; INFLAMMATION; GENERATION; INFECTION; PATHWAY; DISEASE; MECHANISMS; MICROBIOTA	Fusobacterium nucleatum (F. nucleatum) plays a critical role in gastrointestinal inflammation. However, the exact mechanism by which F. nucleatum contributes to inflammation is unclear. In the present study, it was revealed that F. nucleatum could induce the production of proinflammatory cytokines (IL- 8, IL- 1 beta and TNF-alpha) and reactive oxygen species (ROS) in Caco-2 colorectal) adenocarcinoma cells. Furthermore, ROS scavengers (NAC or Tiron) could decrease the production of proinflammatory cytokines during F. nucleatum infection. In addition, we observed that autophagy is impaired in Caco-2 cells after F. nucleatum infection. The production of proinflammatory cytokines and ROS induced by F. nucleatum was enhanced with either autophagy pharmacologic inhibitors (3-methyladenine, bafilomycin A1) or RNA interference in essential autophagy genes (ATG5 or ATG12) in Caco-2 cells. Taken together, these results indicate that F. nucleatum-induced impairment of autophagic flux enhances the expression of proinflammatory cytokines via ROS in Caco-2 Cells.	[Tang, Bin; Wang, Kun; Jia, Yin-ping; Zhu, Pan; Fang, Yao; Zhang, Zhu-jun; Mao, Xu-hu; Li, Qian] Third Mil Med Univ, Southwest Hosp, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China; [Tang, Bin; Wang, Kun; Jia, Yin-ping; Zhu, Pan; Fang, Yao; Zhang, Zhu-jun; Mao, Xu-hu; Li, Qian] Third Mil Med Univ, Coll Med Lab Sci, Chongqing, Peoples R China; [Zeng, Dong-zhu] Third Mil Med Univ, Southwest Hosp, Dept Gen Surg, Chongqing, Peoples R China; [Zeng, Dong-zhu] Third Mil Med Univ, Southwest Hosp, Ctr Minimal Invas Gastrointestinal Surg, Chongqing, Peoples R China; [Tang, Bin] Emei Sanat PLA Rocket Force, Emeishan, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Li, Q (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China.; Li, Q (corresponding author), Third Mil Med Univ, Coll Med Lab Sci, Chongqing, Peoples R China.; Zeng, DZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Gen Surg, Chongqing, Peoples R China.; Zeng, DZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Ctr Minimal Invas Gastrointestinal Surg, Chongqing, Peoples R China.	liqianjane@163.com; zdz1140@163.com	bin, tang/AAK-9399-2020	bin, tang/0000-0002-1762-3883	National Natural Science Foundation of China (NSFC) [81301482, 81501796]; project of medical science and technology for training youth scholars of PLA [14QNP054]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); project of medical science and technology for training youth scholars of PLA	This work was supported by a grant from National Natural Science Foundation of China (NSFC, 81301482 and 81501796), and the project of medical science and technology for training youth scholars of PLA (14QNP054).; This work was supported by Grant Nos. 81301482 (for B.T.) and 81501796 (for Q.L.) from National Natural Science Foundation of China (NSFC,), and the project of medical science and technology for training youth scholars of PLA (14QNP054) (for B.T.).	Amano A, 2006, J BIOCHEM, V140, P161, DOI 10.1093/jb/mvj162; Bashir A, 2015, TUMOR BIOL, DOI [10.1007/a13277-015-4724-0, DOI 10.1007/A13277-015-4724-0]; Choudhury S, 2015, FREE RADICAL RES, V49, P1371, DOI 10.3109/10715762.2015.1075016; Cremer TJ, 2009, AUTOPHAGY, V5, P125, DOI 10.4161/auto.5.1.7305; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; FALKLER WA, 1982, J PERIODONTOL, V53, P762, DOI 10.1902/jop.1982.53.12.762; Flanagan L, 2014, EUR J CLIN MICROBIOL, V33, P1381, DOI 10.1007/s10096-014-2081-3; Fubini B, 2003, FREE RADICAL BIO MED, V34, P1507, DOI 10.1016/S0891-5849(03)00149-7; HSU CY, 1995, ACTA CYTOL, V39, P114; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Kayath CA, 2010, MICROBES INFECT, V12, P956, DOI 10.1016/j.micinf.2010.06.006; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Leavy O, 2014, NAT REV IMMUNOL, V14, P357, DOI 10.1038/nri3685; Leung A, 2015, EXPERT REV GASTROENT, V9, P651, DOI 10.1586/17474124.2015.1001745; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085280; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Marcato LG, 2008, ORAL MICROBIOL IMMUN, V23, P353, DOI 10.1111/j.1399-302X.2008.00432.x; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Pi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140935; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Raju D, 2012, GASTROENTEROLOGY, V142, P1160, DOI 10.1053/j.gastro.2012.01.043; Rasul A, 2013, MOLECULES, V18, P1418, DOI 10.3390/molecules18021418; Ray Katrina, 2011, Nat Rev Gastroenterol Hepatol, V8, P662, DOI 10.1038/nrgastro.2011.208; ROVIN BH, 1990, KIDNEY INT, V37, P1509, DOI 10.1038/ki.1990.142; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Tang B, 2015, AUTOPHAGY, V11, P344, DOI 10.1080/15548627.2015.1023682; Tang B, 2012, AUTOPHAGY, V8, P1045, DOI 10.4161/auto.20159; Terebiznik MR, 2009, AUTOPHAGY, V5, P370, DOI 10.4161/auto.5.3.7663; Underwood MA, 2014, PREV MED, V65, P133, DOI 10.1016/j.ypmed.2014.05.010	35	30	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165701	10.1371/journal.pone.0165701	http://dx.doi.org/10.1371/journal.pone.0165701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828984	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300055
J	Huang, JZ; Wang, XF; Chen, XH; Song, QY; Liu, W; Lu, LC				Huang, Jinzhu; Wang, Xiaofang; Chen, Xiaohong; Song, Qiuyue; Liu, Wen; Lu, Laichun			Perioperative Antibiotics to Prevent Acute Endophthalmitis after Ophthalmic Surgery: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CATARACT-SURGERY; POSTOPERATIVE ENDOPHTHALMITIS; INTRACAMERAL MOXIFLOXACIN; POVIDONE-IODINE; 4TH-GENERATION FLUOROQUINOLONES; TOPICAL MOXIFLOXACIN; 3-DAY APPLICATION; BACTERIAL-FLORA; PROPHYLAXIS; EFFICACY	Background Post-operative endophthalmitis is a rare and dreaded complication in ophthalmic operations because it often induces irreparable vision loss. Although many ophthalmological studies aimed at reducing the rate of endophthalmitis have been performed around the world, controversy continues to surround some issues, including the choice of antimicrobials and their route of administration, duration and timing. The aim of this study is to investigate some of these unresolved issues. Methods A systematic review and meta-analysis of randomized controlled trials and observational studies was performed. The PubMed, EMBASE, Cochrane Library and Clinical Trials data-bases were searched to identify studies published until Feb. 2016. The relative risk (RR) for each clinical outcome data is presented with 95% confidence intervals (CIs). Pooled estimates of effects were calculated using random-effect models. Results Thirty-four studies from twenty-four reports involving 1264797 eyes were included in this analysis. Endophthalmitis occurred, on average, in one out of 6177 eyes when intracameral vancomycin/moxifloxacin were used and in one out of 1517 eyes when intracameral vancomycin/moxifloxacin were not used. The relative risk (95% CI) of endophthalmitis was reduced to 0.20 (0.10, 0.42) when intracameral antibiotics were used (p<0.0001). The subconjunctival injection of antibiotics was not superior to other administration routes included in this study (RR = 1.67, 95% CI (0.55, 5.05), p = 0.36). A statistically significant difference was found in the rate of endophthalmitis between the use and lack of use of topical antibiotics (RR = 0.65, 95% CI (0.43, 0.99), p = 0.04). However, no statistically significant difference was found in microbial isolation rates between these groups (RR = 0.77, 95% CI (0.34, 1.75), p = 0.53). When long-term and short-term use of topical antibiotics before surgery were compared, a statistically significant difference was found in microbial isolation rates (RR = 0.57, 95% CI (0.44, 0.74), p<0.0001). Conclusions This meta-analysis concluded intracameral antibiotics are effective at preventing endophthalmitis in ocular surgery. A randomized controlled trial confirms the efficacy of cefuroxime but recent large cohort studies support the efficacy of vancomycin/moxifloxacin intracamerally. Intracameral antibitoics are superior to subconjunctival injections but that irrigation antibitoic data are not of enough quality to make a comparison. Different results were found in two clinical outcomes between the use or lack of use of topical antibiotic therapy, we did not find sufficient evidence to conclude that its use prevents endophthalmitis.	[Huang, Jinzhu; Liu, Wen] Third Mil Med Univ, Daping Hosp, Dept Pharm, Chongqing, Peoples R China; [Wang, Xiaofang] Chongqing Med Univ, Minist Educ, Key Lab Diagnost Med, Dept Lab Med, Chongqing, Peoples R China; [Chen, Xiaohong] Chongqing Hlth Ctr Women & Children, Dept Pharm, Chongqing, Peoples R China; [Song, Qiuyue] Third Mil Med Univ, Dept Hlth Stat, Chongqing, Peoples R China; [Lu, Laichun] Third Mil Med Univ, Coll Pharm, Chongqing, Peoples R China	Army Medical University; Chongqing Medical University; Army Medical University; Army Medical University	Lu, LC (corresponding author), Third Mil Med Univ, Coll Pharm, Chongqing, Peoples R China.	lulab2014@126.com		Huang, Jinzhu/0000-0001-5079-744X				Asencio MA, 2014, OPHTHAL EPIDEMIOL, V21, P45, DOI 10.3109/09286586.2013.867511; Anijeet DR, 2010, CLIN OPHTHALMOL, V4, P321; Barry P, 2007, J CATARACT REFR SURG, V33, P978, DOI 10.1016/j.jcrs.2007.02.032; Bratzler Dale W, 2013, Am J Health Syst Pharm, V70, P195, DOI 10.2146/ajhp120568; Bucci FA, 2008, EYE CONTACT LENS, V34, P39, DOI 10.1097/ICL.0b013e3180645d01; Cao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071731; Colleaux KM, 2000, CAN J OPHTHALMOL, V35, P373, DOI 10.1016/S0008-4182(00)80124-6; Coskun M, 2011, J OCUL PHARMACOL TH, V27, P589, DOI 10.1089/jop.2010.0192; Dave VP, 2014, CLIN OPHTHALMOL, V8, P2183, DOI 10.2147/OPTH.S71293; De Kaspar HM, 2008, AM J OPHTHALMOL, V145, P136, DOI 10.1016/j.ajo.2007.08.031; Friling E, 2013, J CATARACT REFR SURG, V39, P15, DOI 10.1016/j.jcrs.2012.10.037; Galvis V, 2014, OPHTHALMOL EYE DIS, V6, P1, DOI [10.4137/OED.S13102, 10.4137/OEd.s13102]; Garat M, 2009, J CATARACT REFR SURG, V35, P637, DOI 10.1016/j.jcrs.2008.12.023; Gordon-Bennett P, 2008, EYE, V22, P620, DOI 10.1038/sj.eye.6702675; Grzybowski A, 2016, CURR OPIN OPHTHALMOL, V27, P9, DOI 10.1097/ICU.0000000000000216; Halachimi-Eyal O, 2009, J CATARACT REFR SURG, V35, P2109, DOI 10.1016/j.jcrs.2009.06.038; Haripriya A, 2016, OPHTHALMOLOGY, V123, P302, DOI 10.1016/j.ophtha.2015.09.037; Hartling L, 2013, J CLIN EPIDEMIOL, V66, P982, DOI 10.1016/j.jclinepi.2013.03.003; He LM, 2009, J OCUL PHARMACOL TH, V25, P373, DOI 10.1089/jop.2008.0102; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Holland EJ, 2014, OPHTHALMOLOGY, V121, pS1, DOI 10.1016/j.ophtha.2014.06.049; Inoue Y, 2008, JPN J OPHTHALMOL, V52, P151, DOI 10.1007/s10384-008-0517-y; Jabbarvand M, 2016, OPHTHALMOLOGY, V123, P295, DOI 10.1016/j.ophtha.2015.08.023; Jensen MK, 2008, J CATARACT REFR SURG, V34, P1460, DOI 10.1016/j.jcrs.2008.05.045; Kessel L, 2015, ACTA OPHTHALMOL, V93, P303, DOI 10.1111/aos.12684; Li B, 2015, J CATARACT REFR SURG, V41, P724, DOI 10.1016/j.jcrs.2014.06.042; Matsuura K, 2013, J CATARACT REFR SURG, V39, P1702, DOI 10.1016/j.jcrs.2013.05.036; Moshirfar M, 2007, OPHTHALMOLOGY, V114, P686, DOI 10.1016/j.ophtha.2006.08.038; Moss JM, 2008, OPHTHALMOLOGY, V115, P2013, DOI 10.1016/j.ophtha.2008.06.024; Recchia FM, 2005, ARCH OPHTHALMOL-CHIC, V123, P341, DOI 10.1001/archopht.123.3.341; Rudnisky CJ, 2014, OPHTHALMOLOGY, V121, P835, DOI 10.1016/j.ophtha.2013.08.046; Rush SW, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/813697; Shorstein NH, 2013, J CATARACT REFR SURG, V39, P8, DOI 10.1016/j.jcrs.2012.07.031; Ta CN, 2007, EUR J OPHTHALMOL, V17, P689, DOI 10.1177/112067210701700501; Ta CN, 2008, J OCUL PHARMACOL TH, V24, P427, DOI 10.1089/jop.2008.0018; Ta CN, 2002, OPHTHALMOLOGY, V109, P2036, DOI 10.1016/S0161-6420(02)01236-8; Tan CSH, 2012, J CATARACT REFR SURG, V38, P425, DOI 10.1016/j.jcrs.2011.09.040; Vazirani J, 2013, CURR OPIN OPHTHALMOL, V24, P60, DOI 10.1097/ICU.0b013e32835a93be; Wu PC, 2006, J OCUL PHARMACOL TH, V22, P54, DOI 10.1089/jop.2006.22.54; Yu-Wai-Man P, 2008, J CATARACT REFR SURG, V34, P447, DOI 10.1016/j.jcrs.2007.10.041	40	27	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0166141	10.1371/journal.pone.0166141	http://dx.doi.org/10.1371/journal.pone.0166141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824933	Green Submitted, Green Published, gold			2022-12-27	WOS:000387615200064
J	Lian, XY; Zhang, ZH; Deng, ZQ; He, PF; Yao, DM; Xu, ZJ; Wen, XM; Yang, L; Lin, J; Qian, J				Lian, Xin-yue; Zhang, Zhi-hui; Deng, Zhao-qun; He, Pin-fang; Yao, Dong-ming; Xu, Zi-jun; Wen, Xiang-mei; Yang, Lei; Lin, Jiang; Qian, Jun			Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							TRANSFUSION-DEPENDENT PATIENTS; PROGNOSTIC SCORING SYSTEM; AML PROGRESSION; RISK; DEL(5Q); MDS; KARYOTYPES; MECHANISM; INCREASE; IMPACT	Background Lenalidomide could effectively induce red blood cell (RBC) transfusion independence (TI) in patients with lower-risk (Low/Intermediate-1) myelodysplastic syndrome (MDS) with or without 5q deletion. However whether lenalidomide ultimately improves the overall survival (OS) of lower-risk MDS patients and reduces the progression to AML remains controversial. Method A meta-analysis was conducted to examine the efficacy and safety of lenalidomide in the treatment of lower-risk MDS. Efficacy was assessed according to erythroid hematologic response (HI-E), cytogenetic response (CyR), OS and AML progression. Safety was evaluated based on the occurrence rates of grades 3-4 adverse events (AEs). Results Seventeen studies were included consisting of a total of 2160 patients. The analysis indicated that the overall rate of HI-E was 58% with 95% confidence interval (CI) of 43-74%. The pooled estimates for the rates of CyR, complete CyR, and partial CyR were 44% (95% CI 19-68%), 21% (95% CI 13-30%) and 23% (95% CI 15-32%), respectively. The patients with 5q deletion had significantly higher rate of HI-E and CyR than those without 5q deletion (P = 0.002 and 0.001, respectively). The incidences of grades 3-4 neutropenia, thrombocytopenia, leukopenia, anemia, deep vein thrombosis, diarrhea, fatigue and rash were 51% (95% CI 30-73%), 31% (95% CI 20-42%), 9% (95% CI 5-13%), 7% (95% CI 2-12%), 3% (95% CI 2-5%), 3% (95% CI 1-5%), 2% (95% CI 1-4%) and 2% (95% CI 1-3%), respectively. Lenalidomide significantly improved OS (HR: 0.62, 95% CI 0.47-0.83, P = 0.001) and lowered the risk of AML progression in del (5q) patients (RR: 0.61, 95% CI 0.41-0.91, P = 0.014). Conclusions In spite of the AEs, lenalidomide could be effectively and safely used for the treatment of lower-risk MDS patients with or without 5q deletion.	[Lian, Xin-yue; Zhang, Zhi-hui; Qian, Jun] Jiangsu Univ, Affiliated Peoples Hosp, Dept Hematol, Zhenjiang, Jiangsu, Peoples R China; [Deng, Zhao-qun; He, Pin-fang; Yao, Dong-ming; Xu, Zi-jun; Wen, Xiang-mei; Yang, Lei; Lin, Jiang] Jiangsu Univ, Affiliated Peoples Hosp, Lab Ctr, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Qian, J (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Hematol, Zhenjiang, Jiangsu, Peoples R China.; Lin, J (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Lab Ctr, Zhenjiang, Jiangsu, Peoples R China.	liniiangmail@sina.com; gianiun0007@hotmail.com			National Natural Science foundation of China [81270630]; Science and Technology Special Project in Clinical Medicine of Jiangsu Province [BL2012056]; Six talent peaks project in Jiangsu Province [2015-WSN-115]; Social Development Foundation of Zhenjiang [SH2015058]; Key Medical Talent Program of Zhenjiang City	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Special Project in Clinical Medicine of Jiangsu Province; Six talent peaks project in Jiangsu Province; Social Development Foundation of Zhenjiang; Key Medical Talent Program of Zhenjiang City	This work was supported by National Natural Science foundation of China (81270630), Science and Technology Special Project in Clinical Medicine of Jiangsu Province (BL2012056), Six talent peaks project in Jiangsu Province (2015-WSN-115), Social Development Foundation of Zhenjiang (SH2015058), and Key Medical Talent Program of Zhenjiang City.; This work was supported by National Natural Science foundation of China (81270630), Science and Technology Special Project in Clinical Medicine of Jiangsu Province (BL2012056), Six talent peaks project in Jiangsu Province (2015-WSN-115), Social Development Foundation of Zhenjiang (SH2015058), Key Medical Talent Program of Zhenjiang City.	Abouyahya I, 2013, LEUKEMIA LYMPHOMA, V54, P874, DOI 10.3109/10428194.2012.728702; Ades L, 2012, HAEMATOL-HEMATOL J, V97, P213, DOI 10.3324/haematol.2011.045914; Arcioni F, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.1693.1693; Arrizabalaga B, 2013, HAEMATOLOGICA, V98, P585; Butrym A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1444-1; Cazzola M, 2005, NEW ENGL J MED, V352, P536, DOI 10.1056/NEJMp048266; Chesnais V, 2016, BLOOD, V127, P749, DOI 10.1182/blood-2015-04-640128; Eisenmann KM, 2009, ONCOGENE, V28, P3429, DOI 10.1038/onc.2009.207; Fenaux P, 2011, BLOOD, V118, P3765, DOI 10.1182/blood-2011-01-330126; Gohring G, 2010, ANN HEMATOL, V89, P365, DOI 10.1007/s00277-009-0846-z; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Hellstrom-Lindberg E, 2008, BLOOD REV, V22, P75, DOI 10.1016/j.blre.2007.10.003; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hofmann WK, 2004, HEMATOL J, V5, P1, DOI 10.1038/sj.thj.6200335; Jansen AJG, 2003, BRIT J HAEMATOL, V121, P270, DOI 10.1046/j.1365-2141.2003.04272.x; Kantarjian H, 2008, CANCER-AM CANCER SOC, V113, P1351, DOI 10.1002/cncr.23697; Komrokji RS, 2012, BLOOD, V120, P3419, DOI 10.1182/blood-2012-03-415661; Kotla V, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-36; Kuendgen A, 2013, LEUKEMIA, V27, P1072, DOI 10.1038/leu.2012.369; Le Bras F, 2009, BLOOD, V114, P1080, DOI 10.1182/blood.V114.22.2764.2764; List AF, 2014, LEUKEMIA, V28, P1033, DOI 10.1038/leu.2013.305; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Malcovati L, 2011, HAEMATOL-HEMATOL J, V96, P1433, DOI 10.3324/haematol.2011.044602; Mallo M, 2013, BRIT J HAEMATOL, V162, P74, DOI 10.1111/bjh.12354; Oliva EN, 2013, LEUKEMIA LYMPHOMA, V54, P2458, DOI 10.3109/10428194.2013.778406; Pellagatti A, 2007, P NATL ACAD SCI USA, V104, P11406, DOI 10.1073/pnas.0610477104; Quach H, 2010, LEUKEMIA, V24, P22, DOI 10.1038/leu.2009.236; Raza A, 2008, BLOOD, V111, P86, DOI 10.1182/blood-2007-01-068833; Revicki DA, 2013, LEUKEMIA RES, V37, P259, DOI 10.1016/j.leukres.2012.11.017; Sanchez-Garcia J, 2014, BRIT J HAEMATOL, V166, P189, DOI 10.1111/bjh.12876; Santini V, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.409.409; Sibon D, 2012, BRIT J HAEMATOL, V156, P619, DOI 10.1111/j.1365-2141.2011.08979.x; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Toma A, 2016, LEUKEMIA, V30, P897, DOI 10.1038/leu.2015.296; Zeidan AM, 2015, CL LYMPH MYELOM LEUK, V15, P705, DOI 10.1016/j.clml.2015.08.083	36	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165948	10.1371/journal.pone.0165948	http://dx.doi.org/10.1371/journal.pone.0165948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824902	Green Submitted, Green Published, gold			2022-12-27	WOS:000387615200048
J	Liu, YQ; Yang, FQ; Pu, HT; Su, JP; Liu, ZJ; Dhiloo, KH; Wang, ZY				Liu, Yongqiang; Yang, Fuqian; Pu, Hongtie; Su, Junping; Liu, Zongjiang; Dhiloo, Khalid Hussain; Wang, Zhongyue			The Sublethal Effects of beta-Ecdysterone, a Highly Active Compound from Achyranthes bidentata Blume, on Grape Phylloxera, Daktulosphaira vitifoliae Fitch	PLOS ONE			English	Article							INSECT GROWTH-REGULATOR; LIFE-HISTORY; PLANT; COCCINELLIDAE; LEPIDOPTERA; HOMOPTERA; FECUNDITY; SUSCEPTIBILITY; PESTICIDES; MANAGEMENT	Grape phylloxera, Daktulosphaira vitifoliae (Fitch) (Hemiptera, Phylloxeridae), is a very destructive insect pest of grapevines. Intercropping of Achyranthes bidentata Blume (f. Amaranthaceae) and Vitis spp. grapevines can be useful to control this pest. In the present study, the toxicity of 22 compounds, known to be present in A. bidentata, to grape phylloxera was evaluated. All treatments were toxic towards grape phylloxera but the degree of toxicity differed between treatments. Among the 22 tested compounds, several of which proved toxic towards grape phylloxera. However beta-ecdysterone had higher toxic effects against grape phylloxera, with LC50 values of 175.73 mg a.i. liter(-1). In addition, we assessed the sublethal effects of LC10, LC20 and LC40 of beta- ecdysterone on grape phylloxera. The fourth instar and adult developmental periods and total life span were significantly prolonged by LC40 of beta- ecdysterone. Fecundity decreased when grape phylloxera were exposed to LC20 and LC40 of beta- ecdysterone. In addition, LC40 of beta- ecdysterone decreased the intrinsic rate of increase (r(m)) and the finite rate of increase (.) and prolonged the population doubling time (DT). The net reproductive rate (R-0) was significantly reduced by both the LC20 and LC40 beta-ecdysterone treatments. Our results demonstrated that beta- ecdysterone had higher toxic effects and significant sublethal effects on grape phylloxera, and showed potential control of grape phylloxera.	[Liu, Yongqiang; Su, Junping; Liu, Zongjiang; Dhiloo, Khalid Hussain; Wang, Zhongyue] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing, Peoples R China; [Yang, Fuqian; Pu, Hongtie] Plant Protect Stn Zhongfang Cty, Zhongfang, Hunan Province, Peoples R China; [Dhiloo, Khalid Hussain] Sindh Agr Univ, Dept Entomol, Fac Crop Protect, Tandojam, Pakistan	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Sindh Agricultural University	Wang, ZY (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing, Peoples R China.	wangzhy0301@sina.com			National Technology System project for Grape Industry [nycytx-30]	National Technology System project for Grape Industry	This study was financially supported by the National Technology System project for Grape Industry (nycytx-30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanassiou CG, 2005, J ECON ENTOMOL, V98, P1733, DOI 10.1603/0022-0493-98.5.1733; Ayyanath MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074532; BECHMANN RK, 1994, ENVIRON TOXICOL CHEM, V13, P1509, DOI 10.1897/1552-8618(1994)13[1509:UOLTAL]2.0.CO;2; Benheim D, 2012, ANN APPL BIOL, V161, P91, DOI 10.1111/j.1744-7348.2012.00561.x; Bickerton M. W, 2011, THESIS; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; CAMPS F, 1993, PHYTOCHEMISTRY, V32, P1361, DOI 10.1016/0031-9422(93)85139-I; CAMPS F, 1991, ECOLOGICAL CHEM BIOC, P331; Carey J. R., 1993, APPL DEMOGRAPHY BIOL; Chao ZM, 1999, CHIN PHARM J, V34, P587; Charleston DS, 2004, THESIS; CHAZEAU J, 1991, ENTOMOPHAGA, V36, P275, DOI 10.1007/BF02374563; Clouse SD, 1996, CURR BIOL, V6, P658, DOI 10.1016/S0960-9822(09)00442-4; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dixon AFG, 1987, APHIDS THEIR BIOL NA, VA, P269; Downie DA, 2001, EVOLUTION, V55, P1345, DOI 10.1111/j.0014-3820.2001.tb00657.x; Forbes VE, 1999, ENVIRON TOXICOL CHEM, V18, P1544, DOI 10.1002/etc.5620180729; Forneck A, 2009, ENTOMOL EXP APPL, V131, P1, DOI 10.1111/j.1570-7458.2008.00811.x; Francisco C, 1993, PHYTOCHEMISTRY, V32, P1361, DOI DOI 10.1016/0031-9422(93)85139-I; GALBRAITH MN, 1966, CHEM COMMUN, P905, DOI 10.1039/c19660000905; GRANETT J, 1985, J ECON ENTOMOL, V78, P1463, DOI 10.1093/jee/78.6.1463; Granett J, 2001, ANNU REV ENTOMOL, V46, P387, DOI 10.1146/annurev.ento.46.1.387; He YX, 2011, J ECON ENTOMOL, V104, P833, DOI 10.1603/EC10281; Herbert K, 2008, J ECON ENTOMOL, V101, P1934, DOI 10.1603/0022-0493-101.6.1934; Hoffmann M, 2016, AUST J GRAPE WINE R, V22, P271, DOI 10.1111/ajgw.12219; HU AM, 2004, JIANGSU PHARM CLIN R, V12, P18; Huang Z, 2008, PAK J BOT, V40, P1983; Hummel JD, 2009, THESIS; IZHEVSKY SS, 1988, ENTOMOPHAGA, V33, P101, DOI 10.1007/BF02372318; James DG, 2002, J ECON ENTOMOL, V95, P729, DOI 10.1603/0022-0493-95.4.729; Jeyabalan D, 2003, BIORESOURCE TECHNOL, V89, P185, DOI 10.1016/S0960-8524(03)00036-1; KAIRO MTK, 1995, J APPL ENTOMOL, V119, P487, DOI 10.1111/j.1439-0418.1995.tb01322.x; King PD, 1985, YITIS, V24, P32; Kovganko N, 1990, STEROIDS ECOLOGICAL; Kraiss H, 2008, PEST MANAG SCI, V64, P660, DOI 10.1002/ps.1541; [李娟 LI Juan], 2007, [中国药学杂志, Chinese Pharmaceutical Journal], V42, P178; Liu Xiaochun, 1998, Acta Phytophylacica Sinica, V25, P156; Liu YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128038; Meng D.L., 2004, THESIS; NAKANISHI K, 1966, J CHEM SOC CHEM COMM, V24, P915; Nicolov S, 1996, ACTA HORTIC, V426, P75; Pan HS, 2014, J PEST SCI, V87, P731, DOI 10.1007/s10340-014-0610-6; Powell KS, 2013, ADV INSECT PHYSIOL, V45, P159, DOI 10.1016/B978-0-12-417165-7.00004-0; Stark JD, 1997, ECOTOX ENVIRON SAFE, V37, P273, DOI 10.1006/eesa.1997.1552; Tapondjou LA, 2002, J STORED PROD RES, V38, P395, DOI 10.1016/S0022-474X(01)00044-3; TRUMAN JW, 1983, J INSECT PHYSIOL, V29, P895, DOI 10.1016/0022-1910(83)90052-5; Walthall WK, 1997, ECOTOX ENVIRON SAFE, V37, P45, DOI 10.1006/eesa.1997.1521; Wang AH, 2005, J ECON ENTOMOL, V98, P1144, DOI 10.1603/0022-0493-98.4.1144; WAPSHERE AJ, 1987, AM J ENOL VITICULT, V38, P216; Wei S, 1997, CHIN J CHIN MAT MED, V22, P293; WILLIAMS RN, 1988, ANN ENTOMOL SOC AM, V81, P1, DOI 10.1093/aesa/81.1.1; Xu D, 2011, BIOL CONTROL, V56, P239, DOI 10.1016/j.biocontrol.2010.11.011; Yu Jie, 2012, Acta Entomologica Sinica, V55, P386; Zhang HuaGe, 2009, Journal of Fruit Science, V26, P306; Zhong GH, 2001, J APPL ENTOMOL, V125, P563, DOI 10.1046/j.1439-0418.2001.00590.x; 赵素霞, 2011, [中药材, Journal of Chinese Medicinal Materials], V34, P690	56	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165860	10.1371/journal.pone.0165860	http://dx.doi.org/10.1371/journal.pone.0165860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824901	gold, Green Submitted, Green Published			2022-12-27	WOS:000387615200039
J	Ma, QP; Huang, C; Cui, QY; Yang, DJ; Sun, K; Chen, X; Li, XH				Ma, Qing-Ping; Huang, Chen; Cui, Qiao-Yun; Yang, Ding-Jun; Sun, Kang; Chen, Xuan; Li, Xing-Hui			Meta-Analysis of the Association between Tea Intake and the Risk of Cognitive Disorders	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CONSUMPTION; IMPAIRMENT; DEMENTIA; DECLINE; CATECHIN; CHINESE; POPULATION; COFFEE	Background Alzheimer's disease is a common neurodegenerative disorder in elderly. This study was aimed to systematically evaluate the association between tea intake and the risk of cognitive disorders by meta-analysis. Methods and Findings PubMed, Embase and Wanfang databases were systematically searched and a total of 26 observational studies were included in this study. Odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were calculated and pooled by using fixed or random effects models according to the degree of heterogeneity. Results The overall pooled analysis indicated that tea intake could significantly reduce the risk of cognitive disorders (OR = 0.65, 95%CI = 0.58-0.73). Subgroup analyses were conducted based on study design, population, frequency of tea drinking and type of cognitive disorders. The results showed that tea drinking was significantly associated with the reduced incidence of cognitive disorders in all of subgroups based on study design and frequency of tea drinking. In particular, tea drinking was inversely associated with the risk of cognitive impairment (CoI), mild cognitive impairment (MCI), cognitive decline and ungrouped cognitive disorders. Moreover, for population subgroups, the significant association was only found in Chinese people. Conclusion Our study suggests that daily tea drinking is associated with decreased risk of CoI, MCI and cognitive decline in the elderly. However, the association between tea intake and Alzheimer's disease remains elusive.	[Ma, Qing-Ping; Huang, Chen; Cui, Qiao-Yun; Yang, Ding-Jun; Sun, Kang; Chen, Xuan; Li, Xing-Hui] Nanjing Agr Univ, Tea Res Inst, Coll Hort, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Chen, X; Li, XH (corresponding author), Nanjing Agr Univ, Tea Res Inst, Coll Hort, Nanjing, Jiangsu, Peoples R China.	chenxuan@njau.edu.cn; LXH@njau.edu.cn		Sun, Kang/0000-0002-1417-1914	Earmarked Fund for Modern Agro-industry Technology Research System [CARS-23]; National Natural Science Foundation of China [31470690, 31570689]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Earmarked Fund for Modern Agro-industry Technology Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was supported by the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-23), the National Natural Science Foundation of China (31470690, 31570689) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendash GW, 2009, J ALZHEIMERS DIS, V17, P661, DOI 10.3233/JAD-2009-1087; Baluchnejadmojarad T, 2011, BEHAV BRAIN RES, V224, P305, DOI 10.1016/j.bbr.2011.06.007; Bishnoi RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117282; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; Chen X, 2012, J NUTR HEALTH AGING, V16, P549, DOI 10.1007/s12603-012-0023-2; Cheng J, 2014, J NINGXIA MED U, V36, P320; Crichton GE, 2013, PLANT FOOD HUM NUTR, V68, P279, DOI 10.1007/s11130-013-0370-0; Dai Q, 2006, AM J MED, V119, P751, DOI 10.1016/j.amjmed.2006.03.045; Di Marco LY, 2014, J ALZHEIMERS DIS, V42, P119, DOI 10.3233/JAD-132225; Ding D, 2012, POPULATION BASED PRE; Durga J, 2007, LANCET, V369, P208, DOI 10.1016/S0140-6736(07)60109-3; Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920; FORSTER DP, 1995, J EPIDEMIOL COMMUN H, V49, P253, DOI 10.1136/jech.49.3.253; Graham LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep21568; Henning SM, 2003, NUTR CANCER, V45, P226, DOI 10.1207/S15327914NC4502_13; Huang CQ, 2009, COGN BEHAV NEUROL, V22, P190, DOI 10.1097/WNN.0b013e3181b2790b; Huang CTL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32600; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Ide K, 2014, NUTRIENTS, V6, P4032, DOI 10.3390/nu6104032; Khokhar S, 2002, J AGR FOOD CHEM, V50, P565, DOI 10.1021/jf010153l; Kim YS, 2015, NEUROEPIDEMIOLOGY, V44, P51, DOI 10.1159/000371710; Kuriyama S, 2006, AM J CLIN NUTR, V83, P355; [连国民 Lian Guomin], 2013, [中国康复理论与实践, Chinese Journal of Rehabilitation Theory and Practice], V19, P465; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Luo X., 2015, CHIN J GERIATR HEART, V17, P227; Mandel S, 2004, J NEUROCHEM, V88, P1555, DOI 10.1046/j.1471-4159.2003.02291.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Ng TP, 2008, AM J CLIN NUTR, V88, P224, DOI 10.1093/ajcn/88.1.224; Noguchi-Shinohara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096013; Nurk E, 2009, J NUTR, V139, P120, DOI 10.3945/jn.108.095182; Pan CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep17301; Pan HY, 2012, NURSING J CHIN PEOPL, V29, P7; Panza F, 2015, J NUTR HEALTH AGING, V19, P313, DOI 10.1007/s12603-014-0563-8; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; Seeram NP, 2006, J AGR FOOD CHEM, V54, P1599, DOI 10.1021/jf052857r; Shen W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137781; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; [宋枫 SONG Feng], 2007, [第四军医大学学报, Journal of the Fourth Military Medical University], V28, P500; Sun H, 2012, PREVALENCE DEMANTIA; Wang G, 2014, J ALZHEIMERS DIS, V39, P891, DOI 10.3233/JAD-131514; Wang H-Y, 2012, CHIN J MULTI ORG DIS, V11, P256; Wells G., 2014, S SYST REV BAS; Wu MS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-22; XU X-H, 2012, STUDY PREVALENCE ASS; Yao YH, 2010, NEUROEPIDEMIOLOGY, V34, P245, DOI 10.1159/000297751; Yin LY., 2012, CLIN FOCUS, V27, P2032; 郭宗君, 2011, [中国老年学杂志, Chinese Journal of Gerontology], V31, P3228	47	26	28	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165861	10.1371/journal.pone.0165861	http://dx.doi.org/10.1371/journal.pone.0165861			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824892	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200040
J	Park, YB; Ha, CW; Kim, JA; Rhim, JH; Park, YG; Chung, JY; Lee, HJ				Park, Yong-Beom; Ha, Chul-Won; Kim, Jin-A; Rhim, Ji-Heon; Park, Yong-Geun; Chung, Jun Young; Lee, Han-Jun			Effect of Transplanting Various Concentrations of a Composite of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells and Hyaluronic Acid Hydrogel on Articular Cartilage Repair in a Rabbit Model	PLOS ONE			English	Article							HUMAN BONE-MARROW; CHONDROGENIC DIFFERENTIATION; STROMAL CELLS; CLINICAL-USE; IN-VITRO; DEFECTS; CHONDROCYTES; THERAPY; TISSUE; COCULTURE	Background Mesenchymal stem cells (MSCs) are known to have therapeutic potential for cartilage repair. However, the optimal concentration of MSCs for cartilage repair remains unclear. Therefore, we aimed to explore the feasibility of cartilage repair by human umbilical cord blood-derived MSCs (hUCB-MSCs) and to determine the optimal concentrations of the MSCs in a rabbit model. Methods Osteochondral defects were created in the trochlear groove of femur in 55 rabbits. Four experimental groups (11 rabbits/group) were treated by transplanting the composite of hUCB-MSCs and HA with various MSCs concentrations (0.1, 0.5, 1.0, and 1.5 x 10(7) cells/ ml). One control group was left untreated. At 4, 8, and 16 weeks post-transplantation, the degree of cartilage repair was evaluated grossly and histologically. Findings Overall, transplanting hUCB-MSCs and HA hydrogel resulted in cartilage repair tissue with better quality than the control without transplantation (P = 0.015 in 0.1, P = 0.004 in 0.5, P = 0.004 in 1.0, P = 0.132 in 1.5 x 10(7) cells/ml). Interestingly, high cell concentration of hUCB-MSCs (1.5x10(7) cells/ml) was inferior to low cell concentrations (0.1, 0.5, and 1.0 x 10(7) cells/ml) in cartilage repair (P = 0.394, P = 0.041, P = 0.699, respectively). The 0.5 x 10(7) cells/ml group showed the highest cartilage repair score at 4, 8 and 16 weeks post transplantation, and followed by 0.1x10(7) cells/ml group or 1.0 x 10(7) cell/ml group. Conclusions The results of this study suggest that transplantation of the composite of hUCB-MSCs and HA is beneficial for cartilage repair. In addition, this study shows that optimal MSC concentration needs to be determined for better cartilage repair.	[Park, Yong-Beom; Lee, Han-Jun] Chung Ang Univ, Coll Med, Chung Ang Univ Hosp, Dept Orthoped Surg, 102 Heukseok Ro, Seoul 06973, South Korea; [Ha, Chul-Won; Kim, Jin-A; Rhim, Ji-Heon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, 81 Irwon Ro, Seoul 06351, South Korea; [Ha, Chul-Won; Kim, Jin-A; Rhim, Ji-Heon] Samsung Med Ctr, Stem Cell & Regenerat Med Res Inst, 81 Irwon Ro, Seoul 06351, South Korea; [Ha, Chul-Won] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Park, Yong-Geun] Jeju Natl Univ, Sch Med, Jeju Natl Univ Hosp, Dept Orthoped Surg, 15 Aran 13 Gil, Jeju Si 63241, South Korea; [Chung, Jun Young] Ajou Univ, Sch Med, Ajou Univ Hosp, Dept Orthopaed Surg, 164 World Cup Ro, Suwon 16499, South Korea	Chung Ang University; Chung Ang University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Jeju National University; Ajou University; Ajou University Hospital	Ha, CW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, 81 Irwon Ro, Seoul 06351, South Korea.; Ha, CW (corresponding author), Samsung Med Ctr, Stem Cell & Regenerat Med Res Inst, 81 Irwon Ro, Seoul 06351, South Korea.; Ha, CW (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.	chulwon.ha@gmail.com	Ha, C/GZL-9046-2022	Park, Yong-Beom/0000-0002-3741-2311; CHUNG, JUN YOUNG/0000-0002-6944-5812	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C3484]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant (HI14C3484) of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea. The funding sources had no involvement in the study design, collection, data analysis, data interpretation, writing of the manuscript, or the decision to submit the manuscript for publication.	Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Choi YS, 2008, CYTOTHERAPY, V10, P165, DOI 10.1080/14653240701817002; Chung JY, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt427; De Bari C, 2003, J CELL BIOL, V160, P909, DOI 10.1083/jcb.200212064; Fischer J, 2010, ARTHRITIS RHEUM-US, V62, P2696, DOI 10.1002/art.27565; Fisher MB, 2015, TISSUE ENG PT A, V21, P850, DOI [10.1089/ten.tea.2014.0384, 10.1089/ten.TEA.2014.0384]; Flynn A, 2007, CYTOTHERAPY, V9, P717, DOI 10.1080/14653240701584578; Giovannini S, 2010, EUR CELLS MATER, V20, P245; GUERNE PA, 1995, ARTHRITIS RHEUM-US, V38, P960, DOI 10.1002/art.1780380712; Ha CW, 2015, STEM CELL TRANSL MED, V4, P1044, DOI 10.5966/sctm.2014-0264; Haleem AM, 2010, CARTILAGE, V1, P253, DOI 10.1177/1947603510366027; Ibrahim AM, 2015, MICROSC RES TECHNIQ, V78, P667, DOI 10.1002/jemt.22520; Isakova IA, 2007, STEM CELLS, V25, P3261, DOI 10.1634/stemcells.2007-0543; Jeong SY, 2013, STEM CELLS, V31, P2136, DOI 10.1002/stem.1471; Kao IT, 2008, CHINESE J PHYSIOL, V51, P252; Kim SM, 2008, CANCER RES, V68, P9614, DOI 10.1158/0008-5472.CAN-08-0451; Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5; Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311; Lee M, 2014, BIOCHEM BIOPH RES CO, V446, P983, DOI 10.1016/j.bbrc.2014.03.051; Li YY, 2014, ACTA BIOMATER, V10, P1919, DOI 10.1016/j.actbio.2014.01.002; Martin JA, 2003, J BONE JOINT SURG AM, V85A, P106, DOI 10.2106/00004623-200300002-00014; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; ODRISCOLL SW, 1986, J BONE JOINT SURG AM, V68A, P1017, DOI 10.2106/00004623-198668070-00008; Osiecka-Iwan A, 2003, CELL TRANSPLANT, V12, P389, DOI 10.3727/000000003108746939; Park YB, 2015, J ORTHOP RES, V33, P1580, DOI 10.1002/jor.22950; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Seo Seung-Suk, 2011, Knee Surg Relat Res, V23, P185, DOI 10.5792/ksrr.2011.23.4.185; Smith GD, 2005, ARTHROSCOPY, V21, P1462, DOI 10.1016/j.arthro.2005.09.007; Steck E, 2009, STEM CELLS DEV, V18, P969, DOI 10.1089/scd.2008.0213; Tipnis S, 2010, IMMUNOL CELL BIOL, V88, P795, DOI 10.1038/icb.2010.47; Veronesi F, 2013, STEM CELLS DEV, V22, P181, DOI 10.1089/scd.2012.0373; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504; Wakitani S, 2011, J TISSUE ENG REGEN M, V5, P146, DOI 10.1002/term.299; Wang M, 2009, IMMUNOLOGY, V126, P220, DOI 10.1111/j.1365-2567.2008.02891.x; Wong KL, 2013, ARTHROSCOPY, V29, P2020, DOI 10.1016/j.arthro.2013.09.074; Yang SE, 2004, CYTOTHERAPY, V6, P476, DOI 10.1080/14653240410005041; Yang SH, 2008, SPINE, V33, P1951, DOI 10.1097/BRS.0b013e31817e6974; Zhang X, 2011, J CELL BIOCHEM, V112, P1206, DOI 10.1002/jcb.23042; Zhao QJ, 2009, CYTOTHERAPY, V11, P414, DOI 10.1080/14653240902849754	43	24	25	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2016	11	11							e0165446	10.1371/journal.pone.0165446	http://dx.doi.org/10.1371/journal.pone.0165446			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BE	27824874	Green Published, gold, Green Submitted			2022-12-27	WOS:000387615200018
J	Chen, XG; Wang, YY; Nelson, D; Tian, S; Mulvey, E; Patel, B; Conti, I; Jaen, J; Rollins, BJ				Chen, Xuguang; Wang, Yunyue; Nelson, David; Tian, Sara; Mulvey, Erin; Patel, Bhumi; Conti, Ilaria; Jaen, Juan; Rollins, Barrett J.			CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHEMOKINE RECEPTOR 2; BREAST-CANCER; MACROPHAGE RECRUITMENT; INFLAMMATORY MONOCYTES; MCP-1; ANGIOGENESIS; EXPRESSION; CELLS	Chronic inflammation is a hallmark of cancer. Inflammatory chemokines, such as C-C chemokine ligand 2 (CCL2), are often present in tumors but their roles in cancer initiation and maintenance are not clear. Here we report that CCL2 promotes mammary carcinoma development in a clinically relevant murine model of breast cancer. Targeted disruption of Ccl2 slowed the growth of activated Her2/neu-driven mammary tumors and prolonged host survival. Disruption of Ccl2 was associated with a decrease in the development and mobilization of endothelial precursor cells (EPCs) which can contribute to tumor neovascularization. In contrast, disruption of Ccr2, which encodes CCL2's sole signaling receptor, accelerated tumor development, shortened host survival, and mobilized EPCs. However, pharmacological inhibition of CCR2 phenocopied Ccl2 disruption rather than Ccr2 disruption, suggesting that the Ccr2(-/-) phenotype is a consequence of unanticipated alterations not linked to intact CCL2/CCR2 signaling. Consistent with this explanation, Ccr2(-/-) monocytes are more divergent from wild type monocytes than Ccl2(-/-) monocytes in their expression of genes involved in key developmental and functional pathways. Taken together, our data suggest a tumor-promoting role for CCL2 acting through CCR2 on the tumor microenvironment and support the targeting of this chemokine/receptor pair in breast cancer.	[Chen, Xuguang; Wang, Yunyue; Nelson, David; Tian, Sara; Mulvey, Erin; Patel, Bhumi; Conti, Ilaria; Rollins, Barrett J.] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Chen, Xuguang; Wang, Yunyue; Nelson, David; Tian, Sara; Mulvey, Erin; Patel, Bhumi; Conti, Ilaria; Rollins, Barrett J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; [Chen, Xuguang; Wang, Yunyue; Rollins, Barrett J.] Harvard Med Sch, Boston, MA 02115 USA; [Jaen, Juan] ChemoCentryx Inc, Mountain View, CA 94043 USA; [Conti, Ilaria] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Jaen, Juan] Arcus Biosci Inc, Hayward, CA 94545 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Eli Lilly	Rollins, BJ (corresponding author), Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Rollins, BJ (corresponding author), Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA.; Rollins, BJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	Barrett_Rollins@dfci.harvard.edu						Allavena P, 2011, EXP CELL RES, V317, P664, DOI 10.1016/j.yexcr.2010.11.013; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Fang WB, 2012, J BIOL CHEM, V287, P36593, DOI 10.1074/jbc.M112.365999; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gazzaniga S, 2007, J INVEST DERMATOL, V127, P2031, DOI 10.1038/sj.jid.5700827; Goede V, 1999, INT J CANCER, V82, P765, DOI 10.1002/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Hong KH, 2005, BLOOD, V105, P1405, DOI 10.1182/blood-2004-08-3178; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; HUANG SY, 1994, CANCER IMMUNOL IMMUN, V39, P231, DOI 10.1007/BF01525986; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Li M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25474; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; NEGUS RPM, 1995, J CLIN INVEST, V95, P2391, DOI 10.1172/JCI117933; Owens Marilyn A, 2004, Clin Breast Cancer, V5, P63, DOI 10.3816/CBC.2004.n.011; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Spring H, 2005, P NATL ACAD SCI USA, V102, P18111, DOI 10.1073/pnas.0507158102; Svensson S, 2015, CLIN CANC RES; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takahashi M, 2009, CLIN EXP METASTAS, V26, P817, DOI 10.1007/s10585-009-9281-8; Takahashi M, 2009, J IMMUNOL, V183, P3463, DOI 10.4049/jimmunol.0802812; Ueno T, 2000, CLIN CANCER RES, V6, P3282; YOSHIMURA T, 1989, J EXP MED, V169, P1449, DOI 10.1084/jem.169.4.1449; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044	50	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165595	10.1371/journal.pone.0165595	http://dx.doi.org/10.1371/journal.pone.0165595			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820834	gold, Green Published			2022-12-27	WOS:000387614800013
J	Gaut, L; Robert, N; Delalande, A; Bonnin, MA; Pichon, C; Duprez, D				Gaut, Ludovic; Robert, Nicolas; Delalande, Antony; Bonnin, Marie-Ange; Pichon, Chantal; Duprez, Delphine			EGR1 Regulates Transcription Downstream of Mechanical Signals during Tendon Formation and Healing	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELLS; SCLERAXIS EXPRESSION; ACHILLES TENDONS; DIFFERENTIATION; RAT; TENOMODULIN; FIBROBLASTS; PROMOTES; MUSCLE	Background Tendon is a mechanical tissue that transmits forces generated by muscle to bone in order to allow body motion. The molecular pathways that sense mechanical forces during tendon formation, homeostasis and repair are not known. EGR1 is a mechanosensitive transcription factor involved in tendon formation, homeostasis and repair. We hypothesized that EGR1 senses mechanical signals to promote tendon gene expression. Methodology/ Principal findings Using in vitro and in vivo models, we show that the expression of Egr1 and tendon genes is downregulated in 3D-engineered tendons made of mesenchymal stem cells when tension is released as well as in tendon homeostasis and healing when mechanical signals are reduced. We further demonstrate that EGR1 overexpression prevents tendon gene down-regulation in 3D-engineered tendons when tension is released. Lastly, ultrasound and microbubbles mediated EGR1 overexpression prevents the downregulation of tendon gene expression during tendon healing in reduced load conditions. Conclusion/ Significance These results show that Egr1 expression is sensitive to mechanical signals in tendon cells. Moreover, EGR1 overexpression prevents the downregulation of tendon gene expression in the absence of mechanical signals in 3D-engineered tendons and tendon healing. These results show that EGR1 induces a transcriptional response downstream of mechanical signals in tendon cells and open new avenues to use EGR1 to promote tendon healing in reduced load conditions.	[Gaut, Ludovic; Robert, Nicolas; Bonnin, Marie-Ange; Duprez, Delphine] UPMC Univ Paris 06, Sorbonne Univ, IBPS Dev Biol Lab, CNRS,UMR7622,INSERM,U1156, F-75005 Paris, France; [Delalande, Antony; Pichon, Chantal] CNRS, UPR4301 CBM, 45071 Rue Charles Sadron, Orleans 2, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Duprez, D (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, IBPS Dev Biol Lab, CNRS,UMR7622,INSERM,U1156, F-75005 Paris, France.	delphine.duprez@upmc.fr	Duprez, Delphine/K-1856-2017	Duprez, Delphine/0000-0003-0248-7417; Bonnin, Marie-Ange/0000-0002-6521-3387; Delalande, Anthony/0000-0001-8280-4616; PICHON, Chantal/0000-0003-3161-3937	Fondation pour la Recherche Medicale [FRM DEQ20140329500]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Fondation pour la Recherche Medicale (FRM DEQ20140329500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberton P, 2015, STEM CELLS DEV, V24, P597, DOI 10.1089/scd.2014.0314; Aoki KR, 2001, TOXICON, V39, P1815, DOI 10.1016/S0041-0101(01)00101-5; Bagchi RA, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0243-8; Bayer ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086078; Bayer ML, 2010, BIOMATERIALS, V31, P4889, DOI 10.1016/j.biomaterials.2010.02.062; Berthet E, 2013, J ORTHOP RES, V31, P1475, DOI 10.1002/jor.22382; Bougault C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036964; Breidenbach AP, 2015, TISSUE ENG PT A, V21, P438, DOI [10.1089/ten.tea.2013.0768, 10.1089/ten.TEA.2013.0768]; Brown JP, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0043-z; Brown JP, 2014, J BIOMECH, V47, P214, DOI 10.1016/j.jbiomech.2013.09.018; Chan KM, 2008, WOUND REPAIR REGEN, V16, P399, DOI 10.1111/j.1524-475X.2008.00379.x; Delalande A, 2011, J CONTROL RELEASE, V156, P223, DOI 10.1016/j.jconrel.2011.08.020; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Eliasson P, 2013, J APPL PHYSIOL, V114, P1519, DOI 10.1152/japplphysiol.01500.2012; Eliasson P, 2009, J APPL PHYSIOL, V107, P399, DOI 10.1152/japplphysiol.91563.2008; Guerquin MJ, 2013, J CLIN INVEST, V123, P3564, DOI 10.1172/JCI67521; Hammerman M, 2014, J APPL PHYSIOL, V116, P54, DOI 10.1152/japplphysiol.00741.2013; Havis E, 2014, DEVELOPMENT, V141, P3683, DOI 10.1242/dev.108654; Heinemeier KM, 2011, J MUSCULOSKEL NEURON, V11, P115; Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999; Kapacce Z, 2008, MATRIX BIOL, V27, P371, DOI 10.1016/j.matbio.2007.11.006; Kapacee Z, 2010, MATRIX BIOL, V29, P668, DOI 10.1016/j.matbio.2010.08.005; Lavagnino M, 2015, J ORTHOP RES, V33, P813, DOI 10.1002/jor.22871; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; Liu HH, 2015, STEM CELLS, V33, P443, DOI 10.1002/stem.1866; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Mendias CL, 2012, J ORTHOP RES, V30, P606, DOI 10.1002/jor.21550; Morawietz H, 1999, CIRC RES, V84, P678, DOI 10.1161/01.RES.84.6.678; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Nourissat G, 2015, NAT REV RHEUMATOL, V11, P223, DOI 10.1038/nrrheum.2015.26; Pardo PS, 2011, J BIOL CHEM, V286, P2559, DOI 10.1074/jbc.M110.149153; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Scott A, 2011, J ORTHOP RES, V29, P289, DOI 10.1002/jor.21220; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Shwartz Y, 2013, DIFFERENTIATION, V86, P104, DOI 10.1016/j.diff.2013.07.003; Stula M, 2000, MOL CELL BIOCHEM, V210, P101, DOI 10.1023/A:1007126218740; Sugimoto Y, 2013, DEVELOPMENT, V140, P2280, DOI 10.1242/dev.096354; Tao X, 2015, CELL PHYSIOL BIOCHEM, V35, P699, DOI 10.1159/000369730; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Wang JHC, 2012, J HAND THER, V25, P133, DOI 10.1016/j.jht.2011.07.004; Wu XQ, 2010, ARTERIOSCL THROM VAS, V30, P471, DOI 10.1161/ATVBAHA.109.184259; Yeung CYC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13555	47	40	41	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0166237	10.1371/journal.pone.0166237	http://dx.doi.org/10.1371/journal.pone.0166237			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820865	Green Published, Green Submitted, gold			2022-12-27	WOS:000387614800043
J	Risnes, KR; Pape, K; Bjorngaard, JH; Moster, D; Bracken, MB; Romundstad, PR				Risnes, Kari R.; Pape, Kristine; Bjorngaard, Johan H.; Moster, Dag; Bracken, Michael B.; Romundstad, Pal R.			Premature Adult Death in Individuals Born Preterm: A Sibling Comparison in a Prospective Nationwide Follow-Up Study	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; LOW-BIRTH-WEIGHT; GESTATIONAL-AGE; YOUNG-ADULTS; RISK-FACTORS; MORTALITY; MORBIDITY; OUTCOMES; INFANTS; PERFORMANCE	Background Close to one in ten individuals worldwide is born preterm, and it is important to understand patterns of long-term health and mortality in this group. This study assesses the relationship between gestational age at birth and early adult mortality both in a nationwide population and within sibships. The study adds to existing knowledge by addressing selected causes of death and by assessing the role of genetic and environmental factors shared by siblings. Methods Study population was all Norwegian men and women born from 1967 to 1997 followed using nation-wide registry linkage for mortality through 2011 when they were between 15 and 45 years of age. Analyses were performed within maternal sibships to reduce variation in unobserved genetic and environmental factors shared by siblings. Specific outcomes were all-cause mortality and mortality from cardiovascular diseases, cancer and external causes including accidents, suicides and drug abuse/overdoses. Results Compared with a sibling born in week 37-41, preterm siblings born before 34 weeks gestation had 50% increased mortality from all causes (adjusted Hazard Ratio (aHR) 1.54, 95% confidence interval (CI) 1.17, 2.03). The corresponding estimate for the entire population was 1.27 (95% CI 1.09, 1.47). The majority of deaths (65%) were from external causes and the corresponding risk estimates for these deaths were 1.52 (95% CI 1.08, 2.14) in the sibships and 1.20 (95% CI 1.01, 1.43) in the population. Conclusion Preterm birth before week 34 was associated with increased mortality between 15 and 45 years of age. The results suggest that increased premature adult mortality in this group is related to external causes of death and that the increased risks are unlikely to be explained by factors shared by siblings.	[Risnes, Kari R.] Univ Hosp, St Olav Hosp, Dept Pediat, Trondheim, Norway; [Risnes, Kari R.; Pape, Kristine; Bjorngaard, Johan H.; Romundstad, Pal R.] Norwegian Univ Sci & Technol, NTNU, Inst Publ Hlth & Gen Practice, Trondheim, Norway; [Bjorngaard, Johan H.] Broset St Olavs Univ Hosp, Forens Dept, Trondheim, Norway; [Bjorngaard, Johan H.] Broset St Olavs Univ Hosp, Res Ctr, Trondheim, Norway; [Moster, Dag] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Moster, Dag] Haukeland Hosp, Dept Pediat, Bergen, Norway; [Moster, Dag] Norwegian Inst Publ Hlth, Oslo, Norway; [Bracken, Michael B.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Bracken, Michael B.] Yale Univ, Sch Med, New Haven, CT USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Bergen; University of Bergen; Haukeland University Hospital; Norwegian Institute of Public Health (NIPH); Yale University; Yale University	Risnes, KR (corresponding author), Univ Hosp, St Olav Hosp, Dept Pediat, Trondheim, Norway.; Risnes, KR (corresponding author), Norwegian Univ Sci & Technol, NTNU, Inst Publ Hlth & Gen Practice, Trondheim, Norway.	Kari.Risnes@ntnu.no		Risnes, Kari/0000-0001-6599-0146	Liaison Committee	Liaison Committee	KRR was financially supported by a grant from Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU). The funding source had no role in planning, analysis, writing or interpretation of results.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Ahlsson F, 2015, EPIDEMIOLOGY, V26, P106, DOI 10.1097/EDE.0000000000000171; Bergvall N, 2005, EPIDEMIOLOGY, V16, P635, DOI 10.1097/01.ede.0000172134.45742.49; Bjorngaard JH, 2013, AM J EPIDEMIOL, V177, P638, DOI 10.1093/aje/kwt014; Bonamy AKE, 2011, CIRCULATION, V124, P2839, DOI 10.1161/CIRCULATIONAHA.111.034884; Boyle MH, 2011, PSYCHOL MED, V41, P1763, DOI 10.1017/S0033291710002357; Class QA, 2014, AM J EPIDEMIOL, V179, P550, DOI 10.1093/aje/kwt304; Costeloe KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7976; Crump C, 2013, EPIDEMIOLOGY, V24, P270, DOI 10.1097/EDE.0b013e318280da0f; Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331; Crump C, 2010, INT J EPIDEMIOL, V39, P1522, DOI 10.1093/ije/dyq103; D'Onofrio BM, 2013, JAMA PSYCHIAT, V70, P1231, DOI 10.1001/jamapsychiatry.2013.2107; Eide MG, 2007, PEDIATR RES, V62, P636, DOI 10.1203/PDR.0b013e31815586e9; Ekbom A, 2000, J NATL CANCER I, V92, P840, DOI 10.1093/jnci/92.10.840; Ekeus C, 2010, PEDIATRICS, V125, pE67, DOI 10.1542/peds.2008-3329; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Hack M, 2009, J DEV BEHAV PEDIATR, V30, P460, DOI 10.1097/DBP.0b013e3181ba0fba; HORWOOD SP, 1982, PEDIATRICS, V69, P613; Kaijser M, 2008, CIRCULATION, V117, P405, DOI 10.1161/CIRCULATIONAHA.107.710715; Kajantie E, 2015, PAEDIATR PERINAT EP, V29, P515, DOI 10.1111/ppe.12219; Kajantie E, 2014, SEMIN FETAL NEONAT M, V19, P112, DOI 10.1016/j.siny.2013.11.006; Kallen B, 2010, PEDIATRICS, V126, pE270, DOI 10.1542/peds.2009-3225; Koupil I, 2005, J EPIDEMIOL COMMUN H, V59, P473, DOI 10.1136/jech.2004.026518; Lawlor DA, 2005, CIRCULATION, V112, P1414, DOI 10.1161/CIRCULATIONAHA.104.528356; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Lindstrom K, 2007, PEDIATRICS, V120, P70, DOI 10.1542/peds.2006-3260; Lindstrom K, 2011, PEDIATRICS, V127, P858, DOI 10.1542/peds.2010-1279; Lindstrom K, 2009, PEDIATRICS, V123, pE47, DOI 10.1542/peds.2008-1654; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lund LK, 2012, EARLY HUM DEV, V88, P623, DOI 10.1016/j.earlhumdev.2012.01.006; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Nosarti C, 2012, ARCH GEN PSYCHIAT, V69, P610, DOI 10.1001/archgenpsychiatry.2011.1374; Parkinson JRC, 2013, PEDIATRICS, V131, pE1240, DOI 10.1542/peds.2012-2177; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Saigal S, 2014, SEMIN FETAL NEONAT M, V19, P125, DOI 10.1016/j.siny.2013.11.001; Sipola-Leppanen M, 2015, AM J EPIDEMIOL, V181, P861, DOI 10.1093/aje/kwu443; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Swamy GK, 2008, JAMA-J AM MED ASSOC, V299, P1429, DOI 10.1001/jama.299.12.1429; Thompson JMD, 2006, PAEDIATR PERINAT EP, V20, P182, DOI 10.1111/j.1365-3016.2006.00711.x; Ueda P, 2014, EUR J EPIDEMIOL, V29, P253, DOI 10.1007/s10654-014-9892-5; Wennerstrom ECM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138594; Zoller B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007308	44	11	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2016	11	11							e0165051	10.1371/journal.pone.0165051	http://dx.doi.org/10.1371/journal.pone.0165051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB8BB	27820819	Green Published, gold, Green Submitted			2022-12-27	WOS:000387614800005
J	Aleksandrowicz, L; Green, R; Joy, EJM; Smith, P; Haines, A				Aleksandrowicz, Lukasz; Green, Rosemary; Joy, Edward J. M.; Smith, Pete; Haines, Andy			The Impacts of Dietary Change on Greenhouse Gas Emissions, Land Use, Water Use, and Health: A Systematic Review	PLOS ONE			English	Article							FOOD-CONSUMPTION; CLIMATE-CHANGE; ENVIRONMENTAL IMPACTS; SUSTAINABLE DIET; FOOTPRINT; RECOMMENDATIONS; MEAT; REQUIREMENTS; CONTRIBUTE; SCENARIOS	Food production is a major driver of greenhouse gas (GHG) emissions, water and land use, and dietary risk factors are contributors to non-communicable diseases. Shifts in dietary patterns can therefore potentially provide benefits for both the environment and health. However, there is uncertainty about the magnitude of these impacts, and the dietary changes necessary to achieve them. We systematically review the evidence on changes in GHG emissions, land use, and water use, from shifting current dietary intakes to environmentally sustainable dietary patterns. We find 14 common sustainable dietary patterns across reviewed studies, with reductions as high as 70-80% of GHG emissions and land use, and 50% of water use (with medians of about 20-30% for these indicators across all studies) possible by adopting sustainable dietary patterns. Reductions in environmental footprints were generally proportional to the magnitude of animal-based food restriction. Dietary shifts also yielded modest benefits in all-cause mortality risk. Our review reveals that environmental and health benefits are possible by shifting current Western diets to a variety of more sustainable dietary patterns.	[Aleksandrowicz, Lukasz; Green, Rosemary; Joy, Edward J. M.; Haines, Andy] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England; [Aleksandrowicz, Lukasz; Green, Rosemary; Joy, Edward J. M.] Leverhulme Ctr Integrat Res Agr & Hlth, London, England; [Smith, Pete] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Haines, Andy] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London, England	University of London; London School of Hygiene & Tropical Medicine; University of Aberdeen; University of London; London School of Hygiene & Tropical Medicine	Aleksandrowicz, L (corresponding author), London Sch Hyg & Trop Med, Dept Populat Hlth, London, England.; Aleksandrowicz, L (corresponding author), Leverhulme Ctr Integrat Res Agr & Hlth, London, England.	lukasz.aleksandrowicz@lshtm.ac.uk	Smith, Pete/G-1041-2010	Smith, Pete/0000-0002-3784-1124; Aleksandrowicz, Lukasz/0000-0002-3644-1372; Haines, Andy/0000-0002-8053-4605	Leverhulme Centre for Integrative Research on Agriculture and Health; Wellcome Trust [103932]	Leverhulme Centre for Integrative Research on Agriculture and Health; Wellcome Trust(Wellcome Trust)	This work was supported by Leverhulme Centre for Integrative Research on Agriculture and Health to LA (http://Icirah.ac.uk), Wellcome Trust Our Planet, Our Health, Grant 103932 to RG and EJ (http://www.wellcome.ac.uk/Funding/Strategic-funding/Our-planet-our-health/index.htm). This study is part of the Sustainable and Healthy Diets in India (SAHDI) project. The funders of this study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Abeliotis K., 2016, International Journal on Food System Dynamics, V7, P36; [Anonymous], 2015, UN FRAM CONV CLIM CH; [Anonymous], 2010, P INT SCI S BIOD SUS; Arnoult MH, 2010, LAND USE POLICY, V27, P1046, DOI 10.1016/j.landusepol.2010.02.001; Aston LM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001072; Audsley E, 2010, FOOD LAND GREEN HOUS; Audsley E., 2009, LOW CAN WE GO ASSESS; Berners-Lee M, 2012, ENERG POLICY, V43, P184, DOI 10.1016/j.enpol.2011.12.054; Biesbroek S, 2014, ENV HLTH, V13; Blauert E., 2010, BASIS NEW NORDIC DIE; Briggs ADM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003543; Bryngeisson D, 2016, FOOD POLICY, V59, P152, DOI 10.1016/j.foodpol.2015.12.012; Butler CD., 2014, CAB REV, V9; Capone R., 2013, J FOOD NUTR RES, V1, P59, DOI [DOI 10.12691/JFNR-1-4-5, 10.12691/jfnr-1-4-5]; Carbon Trust, 2016, EATW GUID MOR SUST D; Davis K, 2016, GLOBAL ENV CHANGE, V39; Del Gobbo LC, 2015, AM J CLIN NUTR, V101, P1038, DOI 10.3945/ajcn.114.087403; Donati M, 2016, APPETITE, V106, P48, DOI 10.1016/j.appet.2016.02.151; Edjabou LD, 2013, FOOD POLICY, V39, P84, DOI 10.1016/j.foodpol.2012.12.004; Fazeni K, 2011, ENERGY SUSTAIN SOC, V1, DOI 10.1186/2192-0567-1-6; Freyer B, 2008, 16 IFOAM ORG WORLD C; Germani A, 2014, INT J FOOD SCI NUTR, V65, P1008, DOI 10.3109/09637486.2014.945152; Gill M, 2010, ANIMAL, V4, P323, DOI 10.1017/S1751731109004662; Goldstein B, 2016, FOOD POLICY, V59, P139, DOI 10.1016/j.foodpol.2016.01.006; Grabs J, 2015, ECOL ECON, V116, P270, DOI 10.1016/j.ecolecon.2015.04.030; Green R, 2015, CLIMATIC CHANGE, V129, P253, DOI 10.1007/s10584-015-1329-y; Hallstrom E, 2015, J CLEAN PROD, V91, P1, DOI 10.1016/j.jclepro.2014.12.008; Heller MC, 2015, J IND ECOL, V19, P391, DOI 10.1111/jiec.12174; Heller MC, 2014, P 9 INT C LIF CYCL A; Hendrie GA, 2014, NUTRIENTS, V6, P289, DOI 10.3390/nu6010289; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20888, DOI 10.1073/pnas.1308149110; Hess T, 2015, FOOD POLICY, V50, P1, DOI 10.1016/j.foodpol.2014.10.013; Hoolohan C, 2013, ENERG POLICY, V63, P1065, DOI 10.1016/j.enpol.2013.09.046; Horgan GW, 2016, INT J BEHAV NUTR PHY, P13; Jalava M, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074016; Jalava M, 2016, EARTHS FUTURE, V4, P62, DOI 10.1002/2015EF000327; JOYCE A, 2014, ENERGY EMISS CONTROL, V2, P33, DOI DOI 10.2147/EECT.S58518; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Loladze I, 2014, ELIFE, V3, DOI 10.7554/eLife.02245; Macdiarmid JI, 2014, P NUTR SOC, V73, P368, DOI 10.1017/S0029665113003753; Macdiarmid JI, 2012, AM J CLIN NUTR, V96, P632, DOI 10.3945/ajcn.112.038729; Martin M., 2016, ENV IMPLICATIONS SWE; Masset G, 2014, AM J CLIN NUTR, V99, P1460, DOI 10.3945/ajcn.113.077958; Meier T, 2014, APPETITE, V74, P20, DOI 10.1016/j.appet.2013.11.006; Meier T, 2013, ENVIRON SCI TECHNOL, V47, P877, DOI 10.1021/es302152v; Mekonnen M. M., 2011, NATL WATER FOOTPRINT; Millward DJ, 2010, P NUTR SOC, V69, P103, DOI 10.1017/S0029665109991868; Milner J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007364; Ministry of Health of Brazil, 2014, DIET GUID BRAZ POP; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Niebylski ML, 2015, NUTRITION, V31, P787, DOI 10.1016/j.nut.2014.12.010; Noleppa S., 2012, CLIMATE CHANGE YOUR; Noleppa S, 2012, TONS FOR THE TRASH; Pairotti MB, 2015, J CLEAN PROD, V103, P507, DOI 10.1016/j.jclepro.2013.12.082; Payne CL, 2016, PUBLIC HEALTH NUTR, P1; Perignon M, 2016, PUBLIC HEALTH NUTR, V19, P2662, DOI 10.1017/S1368980016000653; Peters CJ, 2007, RENEW AGR FOOD SYST, V22, P145, DOI 10.1017/S1742170507001767; Pradhan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062228; Ranganathan J., 2016, SHIFTING DIETS SUSTA; Rao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004277; Renault D, 2000, AGR WATER MANAGE, V45, P275, DOI 10.1016/S0378-3774(99)00107-9; Risku-Norja Helmi, 2009, Progress in Industrial Ecology, V6, P340, DOI 10.1504/PIE.2009.032323; Roos E., 2015, FOOD CLIMATE RES NET; Roos E, 2015, ENVIRON SCI POLICY, V47, P157, DOI 10.1016/j.envsci.2014.12.001; Saez-Almendros S, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-118; Satiate J, 2015, ANN NUTR METAB, V67, P547; Saxe H, 2014, AM J CLIN NUTR, V99, P1117, DOI 10.3945/ajcn.113.066746; Saxe H, 2013, CLIMATIC CHANGE, V116, P249, DOI 10.1007/s10584-012-0495-4; Scarborough P, 2012, EUR J CLIN NUTR, V66, P710, DOI 10.1038/ejcn.2012.34; Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1; Silva V. de P. R. da, 2013, Ambiente & Agua, V8, P250; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; Soret S, 2014, AM J CLIN NUTR, V100, p490S, DOI 10.3945/ajcn.113.071589; Springmann M, 2016, P NATL ACAD SCI USA, V113, P4146, DOI 10.1073/pnas.1523119113; Stamm A, 2015, THESIS; Temme EHM, 2013, PUBLIC HEALTH NUTR, V16, P1900, DOI 10.1017/S1368980013000232; Thaler S, 2015, AGR SYST, V136, P14, DOI 10.1016/j.agsy.2015.01.006; Thompson S, 2013, BALANCE HLTH SUSTAIN; Thurstan RH, 2014, MAR POLLUT BULL, V89, P5, DOI 10.1016/j.marpolbul.2014.09.016; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Tom Michelle S., 2016, Environment Systems & Decisions, V36, P92, DOI 10.1007/s10669-015-9577-y; Trolle E, 2014, 9 INT C LIF CYCL ASS; Tukker A, 2011, ECOL ECON, V70, P1776, DOI 10.1016/j.ecolecon.2011.05.001; Tyszler M, 2014, 9 INT C LIF CYCL ASS; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; van Dooren C, 2014, FOOD POLICY, V44, P36, DOI 10.1016/j.foodpol.2013.11.002; van Dooren C, 2016, INT J LIFE CYCLE ASS, V21, P688, DOI 10.1007/s11367-015-1007-3; Vanham D, 2013, ECOL INDIC, V32, P1, DOI 10.1016/j.ecolind.2013.02.020; Vanham D, 2013, WATER SCI TECHNOL, V67, P824, DOI 10.2166/wst.2012.623; Vanham D, 2016, URBAN FOOD CONSUMPTI, V565, P239; Vieux F, 2012, ECOL ECON, V75, P91, DOI 10.1016/j.ecolecon.2012.01.003; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6; Weber CL, 2008, ENVIRON SCI TECHNOL, V42, P3508, DOI 10.1021/es702969f; Westhoek H, 2014, GLOBAL ENVIRON CHANG, V26, P196, DOI 10.1016/j.gloenvcha.2014.02.004; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; Wilson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059648; Wirsenius S, 2011, CLIMATIC CHANGE, V108, P159, DOI 10.1007/s10584-010-9971-x	99	395	398	31	289	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165797	10.1371/journal.pone.0165797	http://dx.doi.org/10.1371/journal.pone.0165797			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812156	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000386910000058
J	Hansen, ZR; Everts, KL; Fry, WE; Gevens, AJ; Grunwald, NJ; Gugino, BK; Johnson, DA; Johnson, SB; Judelson, HS; Knaus, BJ; McGrath, MT; Myers, KL; Ristaino, JB; Roberts, PD; Secor, GA; Smart, CD				Hansen, Zachariah R.; Everts, Kathryne L.; Fry, William E.; Gevens, Amanda J.; Gruenwald, Niklaus J.; Gugino, Beth K.; Johnson, Dennis A.; Johnson, Steven B.; Judelson, Howard S.; Knaus, Brian J.; McGrath, Margaret T.; Myers, Kevin L.; Ristaino, Jean B.; Roberts, Pamela D.; Secor, Gary A.; Smart, Christine D.			Genetic Variation within Clonal Lineages of Phytophthora infestans Revealed through Genotyping-By-Sequencing, and Implications for Late Blight Epidemiology	PLOS ONE			English	Article							IRISH POTATO FAMINE; NEIGHBOR-JOINING METHOD; EASTERN UNITED-STATES; SEXUAL REPRODUCTION; R-PACKAGE; POPULATIONS; TOMATO; DIVERSITY; MARKERS; AGGRESSIVENESS	Genotyping-by-sequencing (GBS) was performed on 257 Phytophthora infestans isolates belonging to four clonal lineages to study within-lineage diversity. The four lineages used in the study were US-8 (n = 28), US-11 (n = 27), US-23 (n = 166), and US-24 (n = 36), with isolates originating from 23 of the United States and Ontario, Canada. The majority of isolates were collected between 2010 and 2014 (94%), with the remaining isolates collected from 1994 to 2009, and 2015. Between 3,774 and 5,070 single-nucleotide polymorphisms (SNPs) were identified within each lineage and were used to investigate relationships among individuals. K-means hierarchical clustering revealed three clusters within lineage US-23, with US-23 isolates clustering more by collection year than by geographic origin. K-means hierarchical clustering did not reveal significant clustering within the smaller US-8, US-11, and US-24 data sets. Neighbor-joining (NJ) trees were also constructed for each lineage. All four NJ trees revealed evidence for pathogen dispersal and overwintering within regions, as well as long-distance pathogen transport across regions. In the US-23 NJ tree, grouping by year was more prominent than grouping by region, which indicates the importance of long-distance pathogen transport as a source of initial late blight inoculum. Our results support previous studies that found significant genetic diversity within clonal lineages of P. infestans and show that GBS offers sufficiently high resolution to detect sub-structuring within clonal populations.	[Hansen, Zachariah R.; Smart, Christine D.] Cornell Univ, Plant Pathol & Plant Microbe Biol Sect, Geneva, NY 14456 USA; [Everts, Kathryne L.] Univ Maryland, Dept Plant Sci & Landscape Architecture, Salisbury, MD USA; [Fry, William E.; Myers, Kevin L.] Cornell Univ, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY USA; [Gevens, Amanda J.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Gruenwald, Niklaus J.; Knaus, Brian J.] ARS, Hort Crops Res Lab, USDA, Corvallis, OR USA; [Gugino, Beth K.] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA; [Johnson, Dennis A.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Johnson, Steven B.] Univ Maine Cooperat Extens, Presque Isle, ME USA; [Judelson, Howard S.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [McGrath, Margaret T.] Cornell Univ, Plant Pathol & Plant Microbe Biol Sect, Riverhead, NY USA; [Ristaino, Jean B.] North Carolina State Univ, Dept Plant Pathol, Raleigh, NC USA; [Roberts, Pamela D.] Univ Florida, Dept Plant Pathol, Immokalee, FL USA; [Secor, Gary A.] North Dakota State Univ, Dept Plant Pathol, Fargo, ND USA	Cornell University; Cornell University; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Washington State University; University of Maine System; University of Maine Orono; University of California System; University of California Riverside; Cornell University; University of North Carolina; North Carolina State University; State University System of Florida; University of Florida; North Dakota State University Fargo	Smart, CD (corresponding author), Cornell Univ, Plant Pathol & Plant Microbe Biol Sect, Geneva, NY 14456 USA.	cds14@cornell.edu	Ristaino, Jean Beagle/N-3616-2018; Myers, Kevin/GZK-8865-2022	Ristaino, Jean Beagle/0000-0002-9458-0514; Hansen, Zachariah/0000-0001-8962-0094; Smart, Christine/0000-0003-4162-9502; Everts, Kathryne/0000-0002-5482-8466	United States Department of Agriculture, National Institute of Food and Agriculture [2011-68004-30154]; United States Department of Agriculture, National Institute of Food and Agriculture Pre-Doctoral Fellowship [2016-67011-25176]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016290] Funding Source: NIH RePORTER; ARS [ARS-0423109] Funding Source: Federal RePORTER	United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); United States Department of Agriculture, National Institute of Food and Agriculture Pre-Doctoral Fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding for this work was provided by the United States Department of Agriculture, National Institute of Food and Agriculture Grant no. 2011-68004-30154. Additional support for Z. R. Hansen was provided by the United States Department of Agriculture, National Institute of Food and Agriculture Pre-Doctoral Fellowship no. 2016-67011-25176.	Abu-El Samen FM, 2003, PLANT PATHOL, V52, P314, DOI 10.1046/j.1365-3059.2003.00858.x; Abu-El Samen FM, 2003, PHYTOPATHOLOGY, V93, P293, DOI 10.1094/PHYTO.2003.93.3.293; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Cooke DEL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002940; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Danies G, 2013, PLANT DIS, V97, P873, DOI 10.1094/PDIS-07-12-0682-RE; Danies G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116354; de Bary A., 1861, GEGENWARTIG HERRSCHE, P75; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Frost KE, 2016, PLANT DIS, V100, P180, DOI 10.1094/PDIS-04-15-0462-RE; Fry WE, 2015, PHYTOPATHOLOGY, V105, P966, DOI 10.1094/PHYTO-01-15-0005-FI; Fry WE, 2013, PLANT DIS, V97, P296, DOI 10.1094/PDIS-08-12-0791-FE; Fry WE, 1997, PLANT DIS, V81, P1349, DOI 10.1094/PDIS.1997.81.12.1349; Fu YB, 2014, GENET RESOUR CROP EV, V61, P579, DOI 10.1007/s10722-013-0058-1; Gavino PD, 2000, PLANT DIS, V84, P731, DOI 10.1094/PDIS.2000.84.7.731; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; GOODWIN SB, 1995, PLANT DIS, V79, P1181, DOI 10.1094/PD-79-1181; GOODWIN SB, 1995, PHYTOPATHOLOGY, V85, P669, DOI 10.1094/Phyto-85-669; Goodwin SB, 1998, PHYTOPATHOLOGY, V88, P939, DOI 10.1094/PHYTO.1998.88.9.939; Goodwin SB, 1997, PHYTOPATHOLOGY, V87, P462, DOI 10.1094/PHYTO.1997.87.4.462; GOODWIN SB, 1994, PHYTOPATHOLOGY, V84, P553, DOI 10.1094/Phyto-84-553; GOODWIN SB, 1994, P NATL ACAD SCI USA, V91, P11591, DOI 10.1073/pnas.91.24.11591; Griffith GW, 1998, APPL ENVIRON MICROB, V64, P4007; Grunwald NJ, 2003, PHYTOPATHOLOGY, V93, P738, DOI 10.1094/PHYTO.2003.93.6.738; Grunwald NJ, 2016, ANN REV PHY IN PRESS; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Haverkort AJ, 2008, POTATO RES, V51, P47, DOI 10.1007/s11540-008-9089-y; Hirst JM, 1960, ANN APPL BIOL, V48, P489, DOI 10.1111/j.1744-7348.1960.tb03554.x; Hu CH, 2012, PLANT DIS, V96, P1323, DOI 10.1094/PDIS-03-11-0156-RE; Jaime-Garcia R, 2000, PHYTOPATHOLOGY, V90, P1188, DOI 10.1094/PHYTO.2000.90.11.1188; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Knaus BJ, 2016, MOL ECOL RE IN PRESS; Lees AK, 2006, PLANT PATHOL, V55, P311, DOI 10.1111/j.1365-3059.2006.01359.x; LEGARD DE, 1995, PHYTOPATHOLOGY, V85, P1356, DOI 10.1094/Phyto-85-1356; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2012, G3-GENES GENOM GENET, V2, P1529, DOI 10.1534/g3.112.004150; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Martin MD, 2014, MOL BIOL EVOL, V31, P1414, DOI 10.1093/molbev/msu086; Milgroom MG., 2015, POPULATION BIOL PLAN; Milgroom MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106740; Miller JS, 1998, PHYTOPATHOLOGY, V88, P190, DOI 10.1094/PHYTO.1998.88.3.190; Mizubuti Eduardo S. G., 2006, P445, DOI 10.1007/1-4020-4581-6_17; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Peters RD, 2014, CAN J PLANT PATHOL, V36, P73, DOI 10.1080/07060661.2014.892900; PREVOSTI A, 1975, THEOR APPL GENET, V45, P231, DOI 10.1007/BF00831894; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saville A, 2015, PLANT DIS, V99, P659, DOI 10.1094/PDIS-05-14-0452-RE; Smart C. D., 2001, Biological Invasions, V3, P235, DOI 10.1023/A:1015200920772; Summers CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143665; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731; Zwankhuizen MJ, 1998, PHYTOPATHOLOGY, V88, P754, DOI 10.1094/PHYTO.1998.88.8.754	55	17	18	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2016	11	11							e0165690	10.1371/journal.pone.0165690	http://dx.doi.org/10.1371/journal.pone.0165690			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8SX	27812174	gold, Green Published, Green Submitted			2022-12-27	WOS:000386910000048
J	Chakraborty, N; Wang, M; Solocinski, J; Kim, W; Argento, A				Chakraborty, Nilay; Wang, Mian; Solocinski, Jason; Kim, Wonsuk; Argento, Alan			Imaging of Scleral Collagen Deformation Using Combined Confocal Raman Microspectroscopy and Polarized Light Microscopy Techniques	PLOS ONE			English	Article							SOFT-TISSUES; STRAIN; EYE; SPECTROSCOPY; GLAUCOMA; ELASTIN; BOVINE; TENDON; MODEL	This work presents an optospectroscopic characterization technique for soft tissue microstructure using site-matched confocal Raman microspectroscopy and polarized light microscopy. Using the technique, the microstructure of soft tissue samples is directly observed by polarized light microscopy during loading while spatially correlated spectroscopic information is extracted from the same plane, verifying the orientation and arrangement of the collagen fibers. Results show the response and orientation of the collagen fiber arrangement in its native state as well as during tensile and compressive loadings in a porcine sclera model. An example is also given showing how the data can be used with a finite element program to estimate the strain in individual collagen fibers. The measurements demonstrate features that indicate microstructural reorganization and damage of the sclera's collagen fiber arrangement under loading. The site-matched confocal Raman microspectroscopic characterization of the tissue provides a qualitative measure to relate the change in fibrillar arrangement with possible chemical damage to the collagen microstructure. Tests and analyses presented here can potentially be used to determine the stress-strain behavior, and fiber reorganization of the collagen microstructure in soft tissue during viscoelastic response.	[Chakraborty, Nilay; Wang, Mian; Solocinski, Jason; Kim, Wonsuk; Argento, Alan] Univ Michigan, Dept Mech Engn, Dearborn, MI 48128 USA	University of Michigan System; University of Michigan	Chakraborty, N (corresponding author), Univ Michigan, Dept Mech Engn, Dearborn, MI 48128 USA.	nilay@umich.edu	Chakraborty, Nilay/AAK-4812-2020	Chakraborty, Nilay/0000-0001-8138-3506; Kim, Wonsuk/0000-0002-4351-0321	National Science Foundation [CMMI 1130275]; University of Michigan's research seed fund UM [U038726, U046888]	National Science Foundation(National Science Foundation (NSF)); University of Michigan's research seed fund UM	This work was partly funded by the National Science Foundation under Grant CMMI 1130275 (AA) and by the University of Michigan's research seed fund UM project Nos. U038726 and U046888 (NC). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ammar DA, 2013, INVEST OPHTH VIS SCI, V54, P5258, DOI 10.1167/iovs.12-11513; Avetisov SE, 2013, J BIOMECH, V46, P1648, DOI 10.1016/j.jbiomech.2013.04.008; Beattie JR, 2011, INVEST OPHTH VIS SCI, V52, P1593, DOI 10.1167/iovs.10-6554; Billiar KL, 1997, J BIOMECH, V30, P753, DOI 10.1016/S0021-9290(97)00019-5; Camp CH, 2014, NAT PHOTONICS, V8, P627, DOI [10.1038/nphoton.2014.145, 10.1038/NPHOTON.2014.145]; Cheng VWT, 2007, J MATER SCI, V42, P8957, DOI 10.1007/s10853-007-1653-3; COLEMAN DJ, 1969, ARCH OPHTHALMOL-CHIC, V82, P637; Dehring KA, 2006, APPL SPECTROSC, V60, P366, DOI 10.1366/000370206776593582; Dieing T, 2008, VIB SPECTROSC, V48, P22, DOI 10.1016/j.vibspec.2008.03.004; Doehring TC, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3116155; Duma SM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1517, DOI 10.1001/archopht.120.11.1517; Gasior-Glogowska M, 2013, J MECH BEHAV BIOMED, V18, P240, DOI 10.1016/j.jmbbm.2012.11.023; Han M, 2005, OPT EXPRESS, V13, P5791, DOI 10.1364/OPEX.13.005791; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hill MR, 2012, J BIOMECH, V45, P762, DOI 10.1016/j.jbiomech.2011.11.016; HOELTZEL DA, 1992, J BIOMECH ENG-T ASME, V114, P202, DOI 10.1115/1.2891373; Hollman KW, 2002, CORNEA, V21, P68, DOI 10.1097/00003226-200201000-00015; Igra O., 2001, HANDBOOK OF SHOCK WA, V2, P1; Kim W, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006847; Kivell TL, 2009, ANAT SCI EDUC, V2, P173, DOI 10.1002/ase.95; Krause AC, 1932, ARCH OPHTHALMOL-CHIC, V7, P598; Liu R, 2015, SENSOR ACTUAT B-CHEM, V219, P283, DOI 10.1016/j.snb.2015.04.124; Matousek P, 2007, CHEM SOC REV, V36, P1292, DOI 10.1039/b614777c; Mattson MS, 2010, INVEST OPHTH VIS SCI, V51, P3120, DOI 10.1167/iovs.09-4001; McBrien NA, 2009, OPTOMETRY VISION SCI, V86, P23, DOI 10.1097/OPX.0b013e3181940669; Morris MD, 2001, BIOS 2001 THE INTERN; Myers KM, 2010, ACTA BIOMATER, V6, P4327, DOI 10.1016/j.actbio.2010.06.007; Nahas A, 2013, BIOMED OPT EXPRESS, V4, P2138, DOI 10.1364/BOE.4.002138; QUIGLEY HA, 1991, CURR EYE RES, V10, P877, DOI 10.3109/02713689109013884; Ruiz-Ederra J, 2005, EXP EYE RES, V81, P561, DOI 10.1016/j.exer.2005.03.014; Sander EA, 2009, P NATL ACAD SCI USA, V106, P17675, DOI 10.1073/pnas.0903716106; Scott R, 2011, PHILOS T R SOC B, V366, P251, DOI 10.1098/rstb.2010.0234; Screen HRC, 2004, P I MECH ENG H, V218, P109, DOI 10.1243/095441104322984004; Sherwood D, 2014, INVEST OPHTH VIS SCI, V55, P1124, DOI 10.1167/iovs.13-13295; Tower TT, 2002, ANN BIOMED ENG, V30, P1221, DOI 10.1114/1.1527047; Tseng Y, 2001, BIOPHYS J, V81, P1643, DOI 10.1016/S0006-3495(01)75818-3; Voytik-Harbin SL, 2003, MICROSC MICROANAL, V9, P74, DOI 10.1017/S1431927603030046; Wang YN, 2000, J BIOMECH, V33, P483, DOI 10.1016/S0021-9290(99)00194-3	39	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165520	10.1371/journal.pone.0165520	http://dx.doi.org/10.1371/journal.pone.0165520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806070	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500034
J	Gu, SY; Mu, YM; Zhai, SD; Zeng, YH; Zhen, XM; Dong, HJ				Gu, Shuyan; Mu, Yiming; Zhai, Suodi; Zeng, Yuhang; Zhen, Xuemei; Dong, Hengjin			Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China	PLOS ONE			English	Article							INADEQUATE GLYCEMIC CONTROL; CARDIOVASCULAR RISK-FACTORS; BIPHASIC INSULIN ASPART; DOUBLE-BLIND; ADD-ON; MELLITUS RATIONALE; JAPANESE PATIENTS; UTILITY ANALYSIS; HEALTH OUTCOMES; SGLT2 INHIBITOR	Objective To estimate the long-term cost-effectiveness of dapagliflozin versus acarbose as monotherapy in treatment-naive patients with type 2 diabetes mellitus (T2DM) in China. Methods The Cardiff Diabetes Model, an economic model designed to evaluate the cost-effectiveness of comparator therapies in diabetes was used to simulate disease progression and estimate the long-term effect of treatments on patients. Systematic literature reviews, hospital surveys, meta-analysis and indirect treatment comparison were conducted to obtain model-required patient profiles, clinical data and costs. Health insurance costs (2015 (sic)) were estimated over 40 years from a healthcare payer perspective. Univariate and probabilistic sensitivity analyses were performed. Results The model predicted that dapagliflozin had lower incidences of cardiovascular events, hypoglycemia and mortality events, was associated with a mean incremental benefit of 0.25 quality-adjusted life-years (QALYs) and with a lower cost of (sic)8,439 compared with acarbose. This resulted in a cost saving of (sic)33,786 per QALY gained with dapagliflozin. Sensitivity analyses determined that the results are robust. Conclusion Dapagliflozin is dominant compared with acarbose as monotherapy for Chinese T2DM patients, with a little QALY gain and lower costs. Dapagliflozin offers a well-tolerated and cost-effective alternative medication for treatment-naive patients in China, and may have a direct impact in reducing the disease burden of T2DM.	[Gu, Shuyan; Zeng, Yuhang; Zhen, Xuemei; Dong, Hengjin] Zhejiang Univ, Sch Med, Sch Publ Hlth, Ctr Hlth Policy Studies, Hangzhou, Zhejiang, Peoples R China; [Mu, Yiming] Chinese PLA Med Coll, Chinese PLA Gen Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China; [Zhai, Suodi] Peking Univ, Hosp 3, Dept Pharm, Beijing, Peoples R China	Zhejiang University; Chinese People's Liberation Army General Hospital; Peking University	Dong, HJ (corresponding author), Zhejiang Univ, Sch Med, Sch Publ Hlth, Ctr Hlth Policy Studies, Hangzhou, Zhejiang, Peoples R China.	donghj@zju.edu.cn			AstraZeneca	AstraZeneca(AstraZeneca)	This study was funded by AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad PE, 2015, ATEN PRIM, V47, P505, DOI [10.1016/aprim.2014/11.002, DOI 10.1016/J.APRIM.2014.11.002]; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amiel SA, 2008, DIABETIC MED, V25, P245, DOI 10.1111/j.1464-5491.2007.02341.x; [Anonymous], 2014, DIABETES RES CLIN PR, V104, P1, DOI 10.1016/j.diabres.2012.10.001; [Anonymous], BR J DIABETES VASC D, DOI DOI 10.1177/1474651410377832; Bailey CJ, 2015, DIABETIC MED, V32, P531, DOI 10.1111/dme.12624; Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Barry HC, 1997, J FAM PRACTICE, V44, P49; Bodegard J, 2013, DIABETES METAB, V39, P306, DOI 10.1016/j.diabet.2013.05.004; Bolin K, 2009, DIABETIC MED, V26, P928, DOI 10.1111/j.1464-5491.2009.02786.x; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; CARO JJ, 2007, J MED ECON, V10, P239, DOI DOI 10.3111/13696990701438629; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1066; Chan JCN, 1998, DIABETES CARE, V21, P1058, DOI 10.2337/diacare.21.7.1058; Charokopou M, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1139-y; Charokopou M, 2015, DIABETIC MED, V32, P890, DOI 10.1111/dme.12772; Chen GM, 2011, HYPERTENSION, V57, P891, DOI 10.1161/HYPERTENSIONAHA.110.162446; Chinese Diabetes Society, 2013, CHIN J DIABETES, V22, P2; Clarke P, 2002, MED DECIS MAKING, V22, P340, DOI 10.1177/027298902400448902; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Cochrane Collaboration, COCHRANE HDB SYSTEMA; Currie CJ, 2005, VALUE HEALTH, V8, P581, DOI 10.1111/j.1524-4733.2005.00046.x; Currie CJ, 2006, CURR MED RES OPIN, V22, P1523, DOI 10.1185/030079906X115757; Currie CJ, 2012, DIABETES CARE, V35, P1279, DOI 10.2337/dc11-1277; Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x; Ferrannini E, 2012, NAT REV ENDOCRINOL, V8, P495, DOI 10.1038/nrendo.2011.243; Ferrannini E, 2010, DIABETES CARE, V33, P2217, DOI 10.2337/dc10-0612; Fioretto P, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0297-x; Freeman JS, 2010, J AM OSTEOPATH ASSOC, V110, P528; Gao L, 2012, INT J TECHNOL ASSESS, V28, P436, DOI 10.1017/S0266462312000608; General Administration Of Sport Of China, 2014, NAT PHYS MON B; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Gu S, 2015, PLOS ONE, V10; Gu Shuyan, 2015, Value Health Reg Issues, V6, P84, DOI 10.1016/j.vhri.2015.03.012; Guisasola FA, 2008, DIABETES OBES METAB, V10, P25, DOI 10.1111/j.1463-1326.2008.00882.x; [郭慧 GUO Hui], 2007, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V22, P395; Henry RR, 2012, INT J CLIN PRACT, V66, P446, DOI 10.1111/j.1742-1241.2012.02911.x; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; HOTTA N, 1993, DIABETIC MED, V10, P134, DOI 10.1111/j.1464-5491.1993.tb00030.x; International Diabetes Federation, IDF DIABETES ATLAS, V10th; International Diabetes Federation, DIAB TYP DIAB; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Ji LN, 2015, J DIABETES, V7, P166, DOI 10.1111/1753-0407.12165; Ji LN, 2014, CLIN THER, V36, P84, DOI 10.1016/j.clinthera.2013.11.002; Ji LN, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.02.035; Kaku K, 2014, DIABETES OBES METAB, V16, P1102, DOI 10.1111/dom.12325; Kaku K, 2013, DIABETES OBES METAB, V15, P432, DOI 10.1111/dom.12047; Komoroski B, 2009, CLIN PHARMACOL THER, V85, P513, DOI 10.1038/clpt.2008.250; Lane S, 2014, CURR MED RES OPIN, V30, P1267, DOI 10.1185/03007995.2014.899207; Larkin AT, 2015, J DIABETES, V7, P864, DOI 10.1111/1753-0407.12264; Lee J, 2008, J HUM HYPERTENS, V22, P468, DOI 10.1038/jhh.2008.16; [李洪超 Li Hongchao], 2011, [中国新药杂志, Chinese Journal New Drugs], V20, P2163; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; List JF, 2009, DIABETES CARE, V32, P650, DOI 10.2337/dc08-1863; Lundkvist J, 2005, EUR J HEALTH ECON, P6; Marrett Elizabeth, 2011, BMC Res Notes, V4, P251, DOI 10.1186/1756-0500-4-251; Matza LS, 2007, QUAL LIFE RES, V16, P1251, DOI 10.1007/s11136-007-9226-0; McEwan P, 2006, CURR MED RES OPIN, V22, P121, DOI 10.1185/030079906X80350; McEwan P, 2010, DIABETES OBES METAB, V12, P623, DOI 10.1111/j.1463-1326.2010.01198.x; McEwan P, 2010, DIABETES OBES METAB, V12, P431, DOI 10.1111/j.1463-1326.2009.01184.x; McEwan P, 2010, PHARMACOECONOMICS, V28, P665, DOI 10.2165/11535350-000000000-00000; Meng H, 2009, J SHANDONG MIEICAL C, V31, P91; Miller BR, 2014, AM HEALTH DRUG BENEF, V7, P452; National Bureau of Statistics of China, GROSS DOM PROD GDP P; Oliva RV, 2014, J AM SOC HYPERTENS, V8, P330, DOI 10.1016/j.jash.2014.02.003; Organisation for Economic Co-operation and Development (OECD), EXCH RAT; Palmer JL, 2008, ADV THER, V25, P752, DOI 10.1007/s12325-008-0080-4; Parikh S, 2015, INT J CLIN PRACT, V69, P186, DOI 10.1111/ijcp.12531; Peters Anne L, 2009, Cleve Clin J Med, V76 Suppl 5, pS20, DOI 10.3949/ccjm.76.s5.04; Pi-Sunyer FX, 2009, POSTGRAD MED, V121, P94, DOI 10.3810/pgm.2009.09.2056; Price Bureau, OFF DRUG PRIC LIST; Ptaszynska A, 2014, DRUG SAFETY, V37, P815, DOI 10.1007/s40264-014-0213-4; Sabale U, 2015, PRIM CARE DIABETES, V9, P39, DOI 10.1016/j.pcd.2014.04.007; Shi J, 2015, CHINESE J CLIN PHARM, V31, P134; [石佳 Shi Jia], 2015, [中国临床药理学杂志, The Chinese Journal of Clinical Pharmacology], V31, P116; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Strojek K, 2011, DIABETES OBES METAB, V13, P928, DOI 10.1111/j.1463-1326.2011.01434.x; Tang L, 2003, CHINESE HLTH EC, V22, P21; Tunceli K, 2015, PATIENT PREFER ADHER, V9, P191, DOI 10.2147/PPA.S71346; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Van de Laar F, 2009, ALPHA GLUCOSIDASE IN, V1, P1; van Haalen HGM, 2014, CLIN DRUG INVEST, V34, P135, DOI 10.1007/s40261-013-0155-0; Vivian EM, 2015, AM J HEALTH-SYST PH, V72, P361, DOI 10.2146/ajhp140168; Wang WB, 2009, AM J MANAG CARE, V15, P593; Wells GA, 2009, INDIRECT EVIDENCE IN; White TJ, 2004, DIS MANAG HEALTH OUT, V12, P181, DOI 10.2165/00115677-200412030-00004; WHO, COMP QUANTIFICATION; Wilding JPH, 2009, DIABETES CARE, V32, P1656, DOI 10.2337/dc09-0517; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; World Health Organization, THE WORLD HEALTH REP; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2014, LANCET DIABETES ENDO, V2, P46, DOI 10.1016/S2213-8587(13)70021-4; Yu AP, 2007, CURR MED RES OPIN, V23, P2157, DOI 10.1185/0300799007X219544; ZHENG YM, 2012, CHINESE RURAL HLTH S, V32, P1195; Zhu QB, 2013, CLIN THER, V35, P880, DOI 10.1016/j.clinthera.2013.03.020; Zullig Leah L, 2015, Patient Prefer Adherence, V9, P139, DOI 10.2147/PPA.S69651	100	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165629	10.1371/journal.pone.0165629	http://dx.doi.org/10.1371/journal.pone.0165629			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806087	Green Published, gold, Green Submitted			2022-12-27	WOS:000386715500045
J	Jacob, AE; Turner, CE; Amack, JD				Jacob, Andrew E.; Turner, Christopher E.; Amack, Jeffrey D.			Evolution and Expression of Paxillin Genes in Teleost Fish	PLOS ONE			English	Article							FOCAL ADHESION LOCALIZATION; MESSENGER-RNA; TYROSINE PHOSPHORYLATION; MYOTENDINOUS JUNCTION; PROTEIN PAXILLIN; KUPFFERS VESICLE; CELL-ADHESION; ZEBRAFISH; INTEGRIN; HIC-5	Background Paxillin family proteins regulate intracellular signaling downstream of extracellular matrix adhesion. Tissue expression patterns and cellular functions of Paxillin proteins during embryo development remain poorly understood. Additionally, the evolution of this gene family has not been thoroughly investigated. Results This report characterizes the evolution and expression of a novel Paxillin gene, called Paxillin-b, in Teleosts. Alignments indicate that Teleost Paxillin-a and Paxillin-b proteins are highly homologous to each other and to human Paxillin. Phylogenetic and synteny analyses suggest that these genes originated from the duplication of an ancestral Paxillin gene that was in a common ancestor of Teleosts and Tetrapods. Analysis of the spatiotemporal expression profiles of Paxillin-a and Paxillin-b using zebrafish revealed both overlapping and distinct domains for Paxillin-a and Paxillin-b during embryo development. Localization of zebrafish Paxillin orthologs expressed in mammalian cells demonstrated that both proteins localize to focal adhesions, similar to mammalian Paxillin. This suggests these proteins regulate adhesion-dependent processes in their endogenous tissues. Conclusion Paxillin-a and Paxillin-b were generated by duplication in Teleosts. These genes likely play similar roles as Paxillin genes in other organisms. This work provides a framework for functional investigation of Paxillin family members during development using the zebrafish as an in vivo model system.	[Jacob, Andrew E.; Turner, Christopher E.; Amack, Jeffrey D.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Turner, CE; Amack, JD (corresponding author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA.	turnerce@upstate.edu; amackj@upstate.edu		Amack, Jeffrey/0000-0002-5465-9754	National Institute of Health [R01 GM47607, R01 HL095690]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047607] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health R01 GM47607 to CET (https://grants.nih.gov/grants/oer.htm); National Institute of Health R01 HL095690 to JDA (https://grants.nih.gov/grants/oer.htm).	Ablooglu AJ, 2007, DEV DYNAM, V236, P2268, DOI 10.1002/dvdy.21229; Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Bataille L, 2010, DEV CELL, V19, P317, DOI 10.1016/j.devcel.2010.07.008; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Bukahrova T, 2005, J CELL SCI, V118, P4295, DOI 10.1242/jcs.02557; Chen GC, 2005, MOL CELL BIOL, V25, P979, DOI 10.1128/MCB.25.3.979-987.2005; Chen PW, 2010, CELL ADHES MIGR, V4, P527, DOI 10.4161/cam.4.4.12399; Chicurel ME, 1998, NATURE, V392, P730, DOI 10.1038/33719; Compagnon J, 2014, DEV CELL, V31, P774, DOI 10.1016/j.devcel.2014.11.003; Cortesio CL, 2011, J BIOL CHEM, V286, P9998, DOI 10.1074/jbc.M110.187294; Costa ML, 2003, BRAZ J MED BIOL RES, V36, P1117, DOI 10.1590/S0100-879X2003000800019; Crawford BD, 2003, MOL BIOL CELL, V14, P3065, DOI 10.1091/mbc.E02-08-0537; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Deakin NO, 2014, J CELL BIOL, V206, P395, DOI 10.1083/jcb.201403039; Deakin Nicholas O, 2012, Genes Cancer, V3, P362, DOI 10.1177/1947601912458582; DIX DJ, 1990, J CELL BIOL, V111, P1885, DOI 10.1083/jcb.111.5.1885; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Furthauer M., 2001, R01RR15402 NIH; Gao CL, 2010, DEV DYNAM, V239, P2190, DOI 10.1002/dvdy.22355; Ghogomu SM, 2006, J BIOL CHEM, V281, P1755, DOI 10.1074/jbc.M505869200; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Goody MF, 2010, DEV BIOL, V344, P809, DOI 10.1016/j.ydbio.2010.05.513; Gros J, 2010, CURR BIOL, V20, P1993, DOI 10.1016/j.cub.2010.09.063; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Iioka H, 2007, NAT CELL BIOL, V9, P813, DOI 10.1038/ncb1607; Ishibe S, 2003, MOL CELL, V12, P1275, DOI 10.1016/S1097-2765(03)00406-4; Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017; Jin H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-19; Julich D, 2009, DEVELOPMENT, V136, P2913, DOI 10.1242/dev.038935; Kim-Kaneyama J, 2011, J MOL CELL CARDIOL, V50, P77, DOI 10.1016/j.yjmcc.2010.09.024; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Louis A, 2015, NUCLEIC ACIDS RES, V43, pD682, DOI 10.1093/nar/gku1112; Mackin NA, 2004, MOL BIOL CELL, V15, P1904, DOI 10.1091/mbc.E04-01-0004; Mardakheh FK, 2015, DEV CELL, V35, P344, DOI 10.1016/j.devcel.2015.10.005; Nishiya N, 1999, J BIOL CHEM, V274, P9847, DOI 10.1074/jbc.274.14.9847; Nishiya N, 2001, MOL CELL BIOL, V21, P5332, DOI 10.1128/MCB.21.16.5332-5345.2001; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Parsons MJ, 2002, DEVELOPMENT, V129, P3137; Pascoal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068021; Postel R, 2008, DEV BIOL, V318, P92, DOI 10.1016/j.ydbio.2008.03.024; Snow CJ, 2009, GENE EXPR PATTERNS, V9, P37, DOI 10.1016/j.gep.2008.08.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka T, 2010, CANCER SCI, V101, P363, DOI 10.1111/j.1349-7006.2009.01398.x; Tumbarello DA, 2005, J CELL SCI, V118, P4849, DOI 10.1242/jcs.02615; TURNER CE, 1991, EXP CELL RES, V192, P651, DOI 10.1016/0014-4827(91)90090-H; Warner A, 2011, MOL BIOL CELL, V22, P2551, DOI 10.1091/mbc.E10-12-0941; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Wheeler GN, 2001, GENE, V262, P291, DOI 10.1016/S0378-1119(00)00512-6; Yano T, 2012, DEVELOPMENT, V139, P2916, DOI 10.1242/dev.075572; Yuminamochi T, 2003, J HISTOCHEM CYTOCHEM, V51, P513, DOI 10.1177/002215540305100413	58	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165266	10.1371/journal.pone.0165266	http://dx.doi.org/10.1371/journal.pone.0165266			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806088	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500024
J	Ramirez-Lopez, MT; Arco, R; Decara, J; Vazquez, M; Blanco, RN; Alen, F; Suarez, J; de Heras, RG; de Fonseca, FR				Teresa Ramirez-Lopez, Maria; Arco, Raquel; Decara, Juan; Vazquez, Mariam; Noemi Blanco, Rosario; Alen, Francisco; Suarez, Juan; Gomez de Heras, Raquel; Rodriguez de Fonseca, Fernando			Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring	PLOS ONE			English	Article							HIGH-FAT DIET; MONOGLYCERIDE LIPASE DEFICIENCY; HYPOTHALAMIC GENE-EXPRESSION; CB1 RECEPTOR ANTAGONIST; JUNK FOOD DIET; ENDOCANNABINOID SYSTEM; BODY-WEIGHT; INDUCED OBESITY; DEVELOPMENTAL ORIGINS; MICE LEADS	Recent studies have linked gestational exposure to highly caloric diets with a disrupted endogenous cannabinoid system (ECS). In the present study, we have extended these studies by analyzing the impact of the exposure to a palatable diet during gestation and lactation on a) the adult expression of endocannabinoid-related behaviors, b) the metabolic profile of adult offspring and c) the mRNA expression of the signaling machinery of the ECS in the hypothalamus, the liver and the adipose tissue of adult offspring of both sexes. Exposure to a palatable diet resulted in a) sex-dimorphic and perinatal diet specific feeding behaviors, including the differential response to the inhibitory effects of the cannabinoid receptor inverse agonist AM251, b) features of metabolic syndrome including increased adiposity, hyperleptinemia, hypertriglyceridemia and hypercholesterolemia and c) tissue and sex-specific changes in the expression of both CB1 and CB2 receptors and in that of the endocannabinoid-degrading enzymes FAAH and MAGL, being the adipose tissue the most affected organ analyzed. Since the effects were observed in adult animals that were weaned while consuming a normal diet, the present results indicate that the ECS is one of the targets of maternal programming of the offspring energy expenditure. These results clearly indicate that the maternal diet has long-term effects on the development of pups through multiple alterations of signaling homeostatic pathways that include the ECS. The potential relevance of these alterations for the current obesity epidemic is discussed.	[Teresa Ramirez-Lopez, Maria; Noemi Blanco, Rosario; Gomez de Heras, Raquel] Univ Complutense Madrid, Dept Psicobiol, Fac Psicol, Campus Somosaguas S-N, Madrid 28223, Spain; [Arco, Raquel; Decara, Juan; Vazquez, Mariam; Alen, Francisco; Suarez, Juan; Rodriguez de Fonseca, Fernando] Univ Malaga, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Salud Mental, Hosp Reg Univ Malaga, Malaga 29010, Spain	Complutense University of Madrid; Universidad de Malaga	de Heras, RG (corresponding author), Univ Complutense Madrid, Dept Psicobiol, Fac Psicol, Campus Somosaguas S-N, Madrid 28223, Spain.; de Fonseca, FR (corresponding author), Univ Malaga, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Salud Mental, Hosp Reg Univ Malaga, Malaga 29010, Spain.	rgomezhe@psi.ucm.es; fernando.rodriguez@ibima.eu	de Heras, Raquel Gomez/F-3484-2016; Ramírez-López, María Teresa/AAB-5705-2021; Alen, Francisco/I-3890-2017; Suarez, Juan/I-5188-2015; Decara Del Olmo, Juan Manuel/I-1931-2015	de Heras, Raquel Gomez/0000-0002-5846-1059; Ramírez-López, María Teresa/0000-0002-3944-5264; Alen, Francisco/0000-0002-3847-3503; Suarez, Juan/0000-0001-5254-9802; RODRIGUEZ DE FONSECA, FERNANDO/0000-0002-4516-5795; Blanco Velilla, Rosario Noemi/0000-0003-0265-6655; Decara Del Olmo, Juan Manuel/0000-0002-9868-015X; Arco Gonzalez, Rocio/0000-0002-5618-5687	Instituto de Salud Carlos III UEDR-FEDER, Ministerio de Economia y Competitividad UE/ERDF [PI13/0226, CP12/03109, PSI-2012-35388]; Red de TrastornosAdictivos UE/ERDF [RD12/0028/0001]; CIBERobn, Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, UE/ERDF [PI45403, CTS-8221, CTS-433]; Consejeria de Salud, Junta de Andalucia [PI0232/2008, PI0029/2008, SAS111224]; FPU predoctoral fellowship of the Spanish Ministerio de Educacion, Cultura y Deporte [AP-2009-0225]; National System of Health, ISCIII [CP12/03109]; Instituto de Salud Carlos III, Ministerio de Economia y Competitividad [PI13/0226, CP12/03109, PSI-2012-35388, PI16/01374]; Red de Trastornos Adictivos [RD12/0028/0001]; Consejeria de Salud, Junta de Andalucia, UE/ERDF [SAS111224, SAF2010-20521]	Instituto de Salud Carlos III UEDR-FEDER, Ministerio de Economia y Competitividad UE/ERDF; Red de TrastornosAdictivos UE/ERDF; CIBERobn, Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, UE/ERDF; Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); FPU predoctoral fellowship of the Spanish Ministerio de Educacion, Cultura y Deporte; National System of Health, ISCIII; Instituto de Salud Carlos III, Ministerio de Economia y Competitividad; Red de Trastornos Adictivos(Instituto de Salud Carlos III); Consejeria de Salud, Junta de Andalucia, UE/ERDF	This work was supported by the Instituto de Salud Carlos III UEDR-FEDER, Ministerio de Economia y Competitividad UE/ERDF (PI13/0226 to F.R.F., CP12/03109 to J.S. and PSI-2012-35388 to R.G.H.), Red de TrastornosAdictivos UE/ERDF (RD12/0028/0001 to F.R.F.), CIBERobn, Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, UE/ERDF (PI45403, CTS-8221, CTS-433 to F.R.F.), Consejeria de Salud, Junta de Andalucia (PI0232/2008, PI0029/2008 and SAS111224 to J.S. and F.R.F. M.T. Ramirez-Lopez has been funded by a FPU predoctoral fellowship of the Spanish Ministerio de Educacion, Cultura y Deporte (AP-2009-0225); J.S. holds "Miguel Servet" research contract from the National System of Health, ISCIII (grant numbersCP12/03109).; This work was supported by the Instituto de Salud Carlos III, Ministerio de Economia y Competitividad con-founded by UE-ERDF program (CP12/03109 and PI16/01374 to J.S., PI13/0226 to FRF, and PSI-2012-35388 to R.G.H.), Red de Trastornos Adictivos (RD12/0028/0001 to F.R.F.), CIBERobn, Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, UE/ERDF (PI45403, CTS-8221, CTS-433 to F.R.F.), Consejeria de Salud, Junta de Andalucia, UE/ERDF (SAF2010-20521 and SAS111224 to F.R.F. M.T. Ramirez-Lopez has been funded by a FPU predoctoral fellowship of the Spanish Ministerio de Educacion, Cultura y Deporte (AP-2009-0225). JS holds a "Miguel Servet" research contract from the National System of Health, ISCIII (grant number CP12/03109).	Ahmadi SA, 2008, ARCH IRAN MED, V11, P318, DOI 08113/AIM.0014; Alen F, 2013, VITAM HORM, V92, P165, DOI 10.1016/B978-0-12-410473-0.00007-6; Alonso M, 2012, BRIT J PHARMACOL, V165, P2274, DOI 10.1111/j.1476-5381.2011.01698.x; Artmann A, 2008, BBA-MOL CELL BIOL L, V1781, P200, DOI 10.1016/j.bbalip.2008.01.006; Asarian L, 2006, PHILOS T R SOC B, V361, P1251, DOI 10.1098/rstb.2006.1860; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bayol SA, 2008, J PHYSIOL-LONDON, V586, P3219, DOI 10.1113/jphysiol.2008.153817; Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Bello NT, 2012, PHYSIOL BEHAV, V105, P720, DOI 10.1016/j.physbeh.2011.09.021; Berger A, 2001, P NATL ACAD SCI USA, V98, P6402, DOI 10.1073/pnas.101119098; Blasio A, 2014, BEHAV PHARMACOL, V25, P609, DOI 10.1097/FBP.0000000000000059; Brand T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031169; Brinton RD, 2012, ENDOCRINOLOGY, V153, P3571, DOI 10.1210/en.2012-1340; Brion MJA, 2010, AM J CLIN NUTR, V91, P748, DOI 10.3945/ajcn.2009.28623; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Catalano PM, 2009, AM J CLIN NUTR, V90, P1303, DOI 10.3945/ajcn.2008.27416; Cluny NL, 2013, AUTON NEUROSCI-BASIC, V179, P122, DOI 10.1016/j.autneu.2013.09.015; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cota D, 2007, ENDOCRINOLOGY, V148, P1574, DOI 10.1210/en.2005-1649; Cota D, 2006, BRAIN RES REV, V51, P85, DOI 10.1016/j.brainresrev.2005.10.004; Coupe B, 2009, AM J PHYSIOL-REG I, V297, pR813, DOI 10.1152/ajpregu.00201.2009; Cristino L, 2014, BIOFACTORS, V40, P389, DOI 10.1002/biof.1168; Dahlhoff M, 2014, BBA-MOL BASIS DIS, V1842, P304, DOI 10.1016/j.bbadis.2013.11.021; de Fonseca FR, 2000, METABOLISM, V49, P709, DOI 10.1053/meta.2000.6251; Dearden L, 2014, ENDOCRINOLOGY, V155, P2144, DOI 10.1210/en.2014-1131; DEFONSECA FR, 1994, LIFE SCI, V54, P159, DOI 10.1016/0024-3205(94)00585-0; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Deshmukh RR, 2012, PHARMACOL RES, V66, P276, DOI 10.1016/j.phrs.2012.06.004; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 2008, TRENDS PHARMACOL SCI, V29, P229, DOI 10.1016/j.tips.2008.03.001; Di Marzo V, 2008, DRUG DISCOV TODAY, V13, P1026, DOI 10.1016/j.drudis.2008.09.001; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; DiPatrizio NV, 2008, J NEUROSCI, V28, P9702, DOI 10.1523/JNEUROSCI.1171-08.2008; Droste SM, 2010, PHARMACOL BIOCHEM BE, V95, P443, DOI 10.1016/j.pbb.2010.03.005; El-Talatini MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004579; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fromentin G, 1997, BRIT J NUTR, V77, P299, DOI 10.1079/BJN19970031; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002; Gomez R, 2002, J NEUROSCI, V22, P9612; Haas MJ, 2012, OBESITY, V20, P721, DOI 10.1038/oby.2011.323; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Harrold JA, 2002, BRAIN RES, V952, P232, DOI 10.1016/S0006-8993(02)03245-6; Heyne A, 2009, ADDICT BIOL, V14, P373, DOI 10.1111/j.1369-1600.2009.00175.x; HOOK EB, 1980, INT J OBESITY, V4, P338; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Jimenez-Chillaron JC, 2006, DIABETOLOGIA, V49, P1974, DOI 10.1007/s00125-006-0311-7; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Keimpema E, 2013, BIOCHEM SOC T, V41, P1569, DOI 10.1042/BST20130117; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lage R, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv011; LUCAS A, 1991, CIBA F SYMP, V156, P38; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Decara JM, 2012, DIS MODEL MECH, V5, P660, DOI 10.1242/dmm.009233; Martin-Garcia E, 2010, J NEUROCHEM, V112, P1338, DOI 10.1111/j.1471-4159.2009.06549.x; Mathes CM, 2008, AM J PHYSIOL-REG I, V295, pR67, DOI 10.1152/ajpregu.00150.2008; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Mazier W, 2015, TRENDS ENDOCRIN MET, V26, P524, DOI 10.1016/j.tem.2015.07.007; MCCLINTOCK MK, 1984, PHYSIOL BEHAV, V32, P701, DOI 10.1016/0031-9384(84)90181-1; Mennella JA, 2004, PEDIATRICS, V113, P840, DOI 10.1542/peds.113.4.840; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Muhlhausler BS, 2006, FASEB J, V20, P1257, DOI 10.1096/fj.05-5241fje; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Ong ZY, 2011, FASEB J, V25, P2167, DOI 10.1096/fj.10-178392; Orloff NC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01076; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Paxinos G., RAT BRAIN STEREOTAXI, VSeventh; Polotsky HN, 2010, SEMIN REPROD MED, V28, P426, DOI 10.1055/s-0030-1262902; Primeaux SD, 2011, PEPTIDES, V32, P1270, DOI 10.1016/j.peptides.2011.03.022; Ragab SMM, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0087-1; Romero-Zerbo SY, 2012, J NEUROENDOCRINOL, V24, P1106, DOI 10.1111/j.1365-2826.2012.02325.x; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schank JC, 2001, PHYSIOL BEHAV, V72, P129, DOI 10.1016/S0031-9384(00)00395-4; Schank Jeffrey C, 2004, Nonlinear Dynamics Psychol Life Sci, V8, P147; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; Ramirez-Lopez MT, 2016, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00339; Tibirica E, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-5; Timofeeva E, 2009, J NEUROENDOCRINOL, V21, P982, DOI 10.1111/j.1365-2826.2009.01921.x; Tourino C, 2010, INT J OBESITY, V34, P557, DOI 10.1038/ijo.2009.262; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; Vahatalo LH, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.1; Verty ANA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140592; Vickers Mark H, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P17, DOI 10.1097/MED.0b013e328013da48; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vida M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090016; Vucetic Z, 2011, NEUROPSYCHOPHARMACOL, V36, P1199, DOI 10.1038/npp.2011.4; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; Vujic N, 2016, ATHEROSCLEROSIS, V244, P9, DOI 10.1016/j.atherosclerosis.2015.10.109; WARNICK GR, 1990, CLIN CHEM, V36, P15; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Yoshida R, 2010, P NATL ACAD SCI USA, V107, P935, DOI 10.1073/pnas.0912048107	95	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165432	10.1371/journal.pone.0165432	http://dx.doi.org/10.1371/journal.pone.0165432			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806128	Green Submitted, Green Published, gold			2022-12-27	WOS:000386715500029
J	Wolters, M; Pala, V; Russo, P; Rise, P; Moreno, LA; De Henauw, S; Mehlig, K; Veidebaum, T; Molnar, D; Tornaritis, M; Galli, C; Ahrens, W; Bornhorst, C				Wolters, Maike; Pala, Valeria; Russo, Paola; Rise, Patrizia; Moreno, Luis A.; De Henauw, Stefaan; Mehlig, Kirsten; Veidebaum, Toomas; Molnar, Denes; Tornaritis, Michael; Galli, Claudio; Ahrens, Wolfgang; Boernhorst, Claudia		IDEFICS I Family Consortia	Associations of Whole Blood n-3 and n-6 Polyunsaturated Fatty Acids with Blood Pressure in Children and Adolescents - Results from the IDEFICS/I.Family Cohort	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; LONG-CHAIN OMEGA-3-FATTY-ACIDS; EICOSAPENTAENOIC ACID; GENDER-DIFFERENCES; PHYSICAL-ACTIVITY; METABOLIC HEALTH; REFERENCE VALUES; SCHOOL-CHILDREN; OBESE CHILDREN; LIPID PROFILE	Background Polyunsaturated n-3 and n-6 polyunsaturated fatty acids (PUFA) are precursors of biologically active metabolites that affect blood pressure (BP) regulation. This study investigated the association of n-3 and n-6 PUFA and BP in children and adolescents. Methods In a subsample of 1267 children aged 2-9 years at baseline of the European IDEFICS (Identification and prevention of dietary-and lifestyle-induced health effects in children and infants) cohort whole blood fatty acids were measured by a validated gas chromatographic method. Systolic and diastolic BP was measured at baseline and after two and six years. Mixed-effects models were used to assess the associations between fatty acids at baseline and BP z-scores over time adjusting for relevant covariables. Models were further estimated stratified by sex and weight status. Results The baseline level of arachidonic acid was positively associated with subsequent systolic BP (beta = 0.08, P = 0.002) and diastolic BP (beta = 0.07, P< 0.001). In thin/normal weight children, baseline alpha-linolenic (beta = -1.13, P = 0.003) and eicosapentaenoic acid (beta = -0.85, P = 0.003) levels were inversely related to baseline and also to subsequent systolic BP and alpha-linolenic acid to subsequent diastolic BP. In overweight/obese children, baseline eicosapentaenoic acid level was positively associated with baseline diastolic BP (beta = 0.54, P = 0.005). Conclusions Low blood arachidonic acid levels in the whole sample and high n-3 PUFA levels in thin/normal weight children are associated with lower and therefore healthier BP. The beneficial effects of high n-3 PUFA on BP were not observed in overweight/obese children, suggesting that they may have been overlaid by the unfavorable effects of excess weight.	[Wolters, Maike; Ahrens, Wolfgang; Boernhorst, Claudia] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Pala, Valeria] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Epidemiol & Prevent Unit, Milan, Italy; [Russo, Paola] CNR, Inst Food Sci, Epidemiol & Populat Genet, Avellino, Italy; [Rise, Patrizia; Galli, Claudio] Univ Milan, Dept Pharmacol & Biomol Sci, DiSFeB, Milan, Italy; [Moreno, Luis A.] Univ Zaragoza, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, GENUD Growth Exercise Nutr & Dev Res Grp, IA2,IIS Aragon, Zaragoza, Spain; [De Henauw, Stefaan] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, Ghent, Belgium; [Mehlig, Kirsten] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Veidebaum, Toomas] Natl Inst Hlth Dev, Tallinn, Estonia; [Molnar, Denes] Univ Pecs, Natl Inst Hlth Promot, Pecs, Hungary; [Tornaritis, Michael] Res & Educ Inst Child Hlth, Nicosia, Cyprus; [Ahrens, Wolfgang] Univ Bremen, Fac Math & Comp Sci, Inst Stat, Bremen, Germany	Leibniz Institute for Prevention Research & Epidemiology (BIPS); Fondazione IRCCS Istituto Nazionale Tumori Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Milan; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Zaragoza; Ghent University; University of Gothenburg; National Institute for Health Development - Estonia; University of Pecs; Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen	Wolters, M (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany.	wolters@leibniz-bips.de	Mehlig, Kirsten/AAT-3468-2020; Russo, Paola/AAW-8308-2020; Molnár, Dénes/AAB-6820-2022; Moreno, Luis/S-1780-2019; Pala, Valeria/K-4738-2016; Ahrens, Wolfgang/A-2740-2012	Moreno, Luis/0000-0003-0454-653X; Pala, Valeria/0000-0001-5438-970X; Bornhorst, Claudia/0000-0001-9004-1540; Ahrens, Wolfgang/0000-0003-3777-570X; Wolters, Maike/0000-0002-4943-2141	European Commission within the Sixth RTD Framework Programme [016181]; European Commission within the Seventh RTD Framework Programme FP7 [266044 (KBBE 2010-4)]	European Commission within the Sixth RTD Framework Programme; European Commission within the Seventh RTD Framework Programme FP7	The baseline data collection and the first follow-up work as part of the I DEFICS Study (www.idefics.eu) were financially supported by the European Commission within the Sixth RTD Framework Programme Contract No. 016181 (FOOD). The most recent follow-up was conducted in the framework of the I.Family study (www.ifamilystudy.eu/) which was funded by the European Commission within the Seventh RTD Framework Programme Contract No. FP7 266044 (KBBE 2010-4).	Ahrens W, 2011, INT J OBESITY, V35, pS3, DOI 10.1038/ijo.2011.30; Ahrens W, 2016, INT J EPIDEMIOL ACCE; Alkerwi A, 2015, PUBLIC HEALTH NUTR, V18, P1831, DOI 10.1017/S1368980014002596; Alpert BS, 2007, BLOOD PRESS MONIT, V12, P345, DOI 10.1097/MBP.0b013e3282c9abf7; Barba G, 2014, INT J OBESITY, V38, pS48, DOI 10.1038/ijo.2014.135; Beaulieu-Jones BR, 2015, J NUTR, V145, P931, DOI 10.3945/jn.114.209619; Bonafini S, 2015, PROSTAG OTH LIPID M, V120, P72, DOI 10.1016/j.prostaglandins.2015.03.006; Burns Trudy L, 2009, J Pediatr, V155, DOI 10.1016/j.jpeds.2009.04.044; Cabo J, 2012, BRIT J NUTR, V107, pS195, DOI 10.1017/S0007114512001584; Childs CE, 2008, P NUTR SOC, V67, P19, DOI 10.1017/S0029665108005983; Chiolero A, 2007, J HYPERTENS, V25, P2209, DOI 10.1097/HJH.0b013e3282ef48b2; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Damsgaard CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109368; Damsgaard CT, 2013, BRIT J NUTR, V110, P1304, DOI 10.1017/S0007114513000585; Damsgaard CT, 2006, J NUTR, V136, P94, DOI 10.1093/jn/136.1.94; De Henauw S, 2011, INT J OBESITY, V35, pS16, DOI 10.1038/ijo.2011.31; Djousse L, 2005, HYPERTENSION, V45, P368, DOI 10.1161/01.HYP.0000154679.41568.e6; Ebbesson SOE, 2015, INT J CIRCUMPOL HEAL, V74, DOI 10.3402/ijch.v74.28055; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Falaschetti E, 2010, EUR HEART J, V31, P3063, DOI 10.1093/eurheartj/ehq355; Fan F, 2015, CURR OPIN NEPHROL HY, V24, P37, DOI 10.1097/MNH.0000000000000088; Farajian P, 2015, J HYPERTENS, V33, P1174, DOI 10.1097/HJH.0000000000000536; Fekete K, 2015, OBES REV, V16, P488, DOI 10.1111/obr.12280; de Moraes ACF, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000232; Fischer R, 2014, J LIPID RES, V55, P1150, DOI 10.1194/jlr.M047357; Friedemann C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4759; Geleijnse JM, 2002, J HYPERTENS, V20, P1493, DOI 10.1097/00004872-200208000-00010; Harika RK, 2011, BRIT J NUTR, V106, P307, DOI 10.1017/S0007114511001528; Hermanussen M, 2008, Georgian Med News, P84; Jackson LV, 2007, ARCH DIS CHILD, V92, P298, DOI 10.1136/adc.2005.081216; Julian-Almarcegui C, 2016, NUTR METAB CARDIOVAS, V26, P541, DOI 10.1016/j.numecd.2016.01.014; Kaikkonen JE, 2012, AM J CLIN NUTR, V95, P1422, DOI 10.3945/ajcn.111.030387; Kivimaki M, 2008, AM J CLIN NUTR, V87, P1876, DOI 10.1093/ajcn/87.6.1876; Knerr I, 2008, DIABETES CARE, V31, P726, DOI 10.2337/dc07-1392; Kollias A, 2012, EUR J PUBLIC HEALTH, V22, P389, DOI 10.1093/eurpub/ckr082; Lauritzen L, 2012, BRIT J NUTR, V107, P697, DOI 10.1017/S0007114511002418; Li SX, 2004, HYPERTENSION, V43, P541, DOI 10.1161/01.HYP.0000115922.98155.23; Liang YJ, 2011, BIOMED ENVIRON SCI, V24, P459, DOI 10.3967/0895-3988.2011.05.002; Lin Y, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-10; Lohner S, 2013, ANN NUTR METAB, V62, P98, DOI 10.1159/000345599; Marangoni F, 2004, ANAL BIOCHEM, V326, P267, DOI 10.1016/j.ab.2003.12.016; Marrero NM, 2014, HYPERTENSION, V63, P1026, DOI 10.1161/HYPERTENSIONAHA.113.02264; Martin L, 2015, INT J OBESITY, V39, P45, DOI 10.1038/ijo.2014.167; Miller PE, 2014, AM J HYPERTENS, V27, P885, DOI 10.1093/ajh/hpu024; Miyajima T, 2001, HYPERTENS RES, V24, P537, DOI 10.1291/hypres.24.537; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; National Institutes of Health, 2005, NIH PUBLICATION; Nyantika AN, 2015, J NUTR HEALTH AGING, V19, P498, DOI 10.1007/s12603-015-0463-6; Pedersen MH, 2010, J PEDIATR-US, V157, P395, DOI 10.1016/j.jpeds.2010.04.001; Ratnayake WMN, 2009, ANN NUTR METAB, V55, P8, DOI 10.1159/000228994; Reinehr T, 2015, J CLIN ENDOCR METAB, V100, P301, DOI 10.1210/jc.2014-2674; Rise P, 2007, PROSTAG LEUKOTR ESS, V76, P363, DOI 10.1016/j.plefa.2007.05.003; Rise P, 2013, PROSTAG LEUKOTR ESS, V89, P215, DOI 10.1016/j.plefa.2013.06.009; Sarkis A, 2004, CURR OPIN NEPHROL HY, V13, P205, DOI 10.1097/00041552-200403000-00009; Seven E, 2014, J HYPERTENS, V32, P1488, DOI 10.1097/HJH.0000000000000207; Skilton MR, 2013, HYPERTENSION, V61, P972, DOI 10.1161/HYPERTENSIONAHA.111.01030; Tomova A, 2015, J PEDIATR ENDOCR MET, V28, P859, DOI 10.1515/jpem-2014-0363; Totland TH, 2013, PUBLIC HEALTH NUTR, V16, P673, DOI 10.1017/S1368980012003060; Ulu A, 2013, J CARDIOVASC PHARM, V62, P285, DOI 10.1097/FJC.0b013e318298e460; United Nations, 1997, INTERNATIONAL STANDA; Virtanen JK, 2012, HYPERTENS RES, V35, P1000, DOI 10.1038/hr.2012.80; Williams ES, 2007, CLIN NUTR, V26, P474, DOI 10.1016/j.clnu.2007.03.004; Wolters M, 2014, INT J OBESITY, V38, pS86, DOI 10.1038/ijo.2014.139; Wolters M, 2015, J CLIN ENDOCR METAB, V100, P3760, DOI 10.1210/jc.2015-2693; Xi B, 2016, AM J HYPERTENS, V29, P217, DOI 10.1093/ajh/hpv091; Yang B, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0226-3; Yang B, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010058; Zeng FF, 2014, J NUTR, V144, P1240, DOI 10.3945/jn.114.192286; Zhai Y, 2015, BIOMED ENVIRON SCI, V28, P401, DOI 10.3967/bes2015.057; Zheng ZJ, 1999, AM J EPIDEMIOL, V150, P492, DOI 10.1093/oxfordjournals.aje.a010038	71	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2016	11	11							e0165981	10.1371/journal.pone.0165981	http://dx.doi.org/10.1371/journal.pone.0165981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6DJ	27806134	Green Published, Green Submitted, gold			2022-12-27	WOS:000386715500074
J	Lin, TY; Chen, YJ; Chen, WL; Peng, TC				Lin, Tzu-Yu; Chen, Ying-Jen; Chen, Wei-Liang; Peng, Tao-Chun			The Relationship between Nonalcoholic Fatty Liver Disease and Retinopathy in NHANES III	PLOS ONE			English	Article							RETINAL MICROVASCULAR ABNORMALITIES; DIABETIC-RETINOPATHY; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; PREVALENCE	Background Nonalcoholic fatty liver disease (NAFLD), an emerging multisystem disease, has the similar pathogenesis with diabetes and is prevalent in diabetes. This study investigated whether NAFLD is associated with retinopathy in individuals with diabetes and without diabetes. Methods The association between NAFLD and retinopathy was investigated in 5963 participants aged 40 years and older who participated in the NHANES III, a nationally representative, population-based and cross-sectional study. NAFLD was detected via ultrasonography, and fundus photographs were obtained to grade retinopathy patterns. We performed multi-variate logistic regression analysis to investigate the relationship between the presence of retinopathy and NAFLD and diabetes. Results After adjusting for multiple covariates, NAFLD population had no evidence of retinopathy increase in population without diabetes (odds ratio [OR]: 0.77; 95% confidence interval [CI]: 0.48 to 1.26). In addition, NAFLD in individuals with diabetes was not significantly associated with retinopathy (OR: 0.77; 95% CI: 0.47 to 1.26), independent of age, gender, ethnicity, waist circumference, serum high-density lipoprotein (HDL) cholesterol, serum triglycerides, systolic blood pressure, and glycated hemoglobin. Conclusions In the US general population, NAFLD is not a precipitating factor of retinopathy in population with or without diabetes.	[Lin, Tzu-Yu] Taipei Med Univ, Shuang Ho Hosp, Dept Ophthalmol, New Taipei, Taiwan; [Chen, Ying-Jen] Triserv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chen, Ying-Jen; Chen, Wei-Liang; Peng, Tao-Chun] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chen, Wei-Liang; Peng, Tao-Chun] Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan; [Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Chen, Wei-Liang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; National Defense Medical Center	Peng, TC (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Peng, TC (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.	koigojaff@gmail.com	Peng, Tao‑Chun/AAY-7035-2020					Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; [Anonymous], 1994, Vital Health Stat 1, P1; Cortez-Pinto H, 1999, CLIN NUTR, V18, P353, DOI 10.1016/S0261-5614(99)80015-6; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Gardner TW, 2011, ARCH OPHTHALMOL-CHIC, V129, P230, DOI 10.1001/archophthalmol.2010.362; Hanley AJG, 2005, DIABETES, V54, P3140, DOI 10.2337/diabetes.54.11.3140; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Keenan JD, 2009, AM J OPHTHALMOL, V147, P934, DOI 10.1016/j.ajo.2008.12.009; Kim BY, 2014, J DIABETES INVEST, V5, P170, DOI 10.1111/jdi.12139; KLEIN R, 1994, ARCH INTERN MED, V154, P2169, DOI 10.1001/archinte.154.19.2169; Leite NC, 2011, LIVER INT, V31, P700, DOI 10.1111/j.1478-3231.2011.02482.x; Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Liccardo D, 2014, J GASTROENTEROL, P1; Manchanayake J, 2011, J GASTROEN HEPATOL, V26, P510, DOI 10.1111/j.1440-1746.2010.06528.x; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Ortiz-Lopez C, 2012, DIABETES CARE, V35, P873, DOI 10.2337/dc11-1849; Sanyal Arun J, 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Smits MM, 2013, J GASTROEN HEPATOL, V28, P664, DOI 10.1111/jgh.12106; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Wong TY, 2004, INVEST OPHTH VIS SCI, V45, P2949, DOI 10.1167/iovs.04-0069; Wong TY, 2002, BRIT J OPHTHALMOL, V86, P1007, DOI 10.1136/bjo.86.9.1007; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X; Yan LH, 2016, J DIABETES INVEST, V7, P889, DOI 10.1111/jdi.12518; Yang W, 2015, HEPATOL INT, V9, P278, DOI 10.1007/s12072-015-9607-3	30	11	11	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165970	10.1371/journal.pone.0165970	http://dx.doi.org/10.1371/journal.pone.0165970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802330	Green Published, gold, Green Submitted			2022-12-27	WOS:000386714200072
J	Nakamori, M; Hosomi, N; Ishikawa, K; Imamura, E; Shishido, T; Ohshita, T; Yoshikawa, M; Tsuga, K; Wakabayashi, S; Maruyama, H; Matsumoto, M				Nakamori, Masahiro; Hosomi, Naohisa; Ishikawa, Kenichi; Imamura, Eiji; Shishido, Takeo; Ohshita, Tomohiko; Yoshikawa, Mineka; Tsuga, Kazuhiro; Wakabayashi, Shinichi; Maruyama, Hirofumi; Matsumoto, Masayasu			Prediction of Pneumonia in Acute Stroke Patients Using Tongue Pressure Measurements	PLOS ONE			English	Article							SWALLOWING ABILITY; ELDERLY PERSONS; MANN ASSESSMENT; DYSPHAGIA; PROBE	Swallowing dysfunction caused by stroke is a risk factor for aspiration pneumonia. Tongue pressure measurement is a simple and noninvasive method for evaluating swallowing dysfunction. We have hypothesized that low tongue pressure may be able to predict pneumonia occurrence in acute stroke patients. Tongue pressure was measured using balloon-type equipment in 220 acute stroke patients. The modified Mann Assessment of Swallowing Ability (MASA) score was evaluated independently on the same day. Tongue pressure was measured every week thereafter. An improvement in tongue pressure was observed within the first 2 weeks. Receiver operating curve analysis was performed to determine the ability of tongue pressure to predict modified MASA score < 95, which suggests swallowing dysfunction. The optimal cutoff for tongue pressure was 21.6 kPa (chi(2) = 45.82, p<0.001, sensitivity 95.9%, specificity 91.8%, area under the curve = 0.97). The tongue pressure was significantly lower in patients with pneumonia than in those without pneumonia. Using a Cox proportional hazard model for pneumonia onset with a cutoff tongue pressure value of 21.6 kPa and adjustment for age, sex, and National Institutes of Health Stroke Scale score at admission, the tongue pressure had additional predictive power for pneumonia onset (hazard ratio, 7.95; 95% confidence interval, 2.09 to 52.11; p = 0.0013). In the group with low tongue pressure, 27 of 95 patients showed improvement of tongue pressure within 2 weeks. Pneumonia occurred frequently in patients without improvement of tongue pressure, but not in patients with improvement (31/68 and 2/27, p<0.001). Tongue pressure is a sensitive indicator for predicting pneumonia occurrence in acute stroke patients.	[Nakamori, Masahiro; Hosomi, Naohisa; Shishido, Takeo; Maruyama, Hirofumi; Matsumoto, Masayasu] Hiroshima Univ, Dept Clin Neurosci & Therapeut, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Nakamori, Masahiro; Ishikawa, Kenichi; Imamura, Eiji; Ohshita, Tomohiko] Suiseikai Kajikawa Hosp, Dept Neurol, Hiroshima, Japan; [Yoshikawa, Mineka; Tsuga, Kazuhiro] Hiroshima Univ, Dept Adv Prosthodont, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Wakabayashi, Shinichi] Suiseikai Kajikawa Hosp, Dept Neurosurg, Hiroshima, Japan	Hiroshima University; Hiroshima University	Hosomi, N (corresponding author), Hiroshima Univ, Dept Clin Neurosci & Therapeut, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	nhosomi@hiroshima-u.ac.jp	Maruyama, Hirofumi/B-9333-2011; Tsuga, Kazuhiro/AAL-1592-2021; Hosomi, Naohisa/H-8660-2019	Maruyama, Hirofumi/0000-0001-7613-8717; 	Japan Society for the Promotion of Science (JSPS) KAKENHI [15K08615]; Smoking Research Foundation; Tsuchiya Foundation	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Smoking Research Foundation; Tsuchiya Foundation(Tsuchiya Foundation)	This study was supported in part by research grants from the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Number 15K08615), the Smoking Research Foundation, and the Tsuchiya Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Antonios N, 2010, J STROKE CEREBROVASC, V19, P49, DOI 10.1016/j.jstrokecerebrovasdis.2009.03.007; Carnaby-Mann G, 2008, PHYS MED REH CLIN N, V19, P747, DOI 10.1016/j.pmr.2008.05.008; Gonzalez-Fernandez M, 2011, AM J SPEECH-LANG PAT, V20, P331, DOI 10.1044/1058-0360(2011/10-0082); Harms H, 2012, J NEUROL NEUROSUR PS, V83, P1225, DOI 10.1136/jnnp-2012-302194; Hasan ZN, 2010, NEUROSCIENCES, V15, P90; Hayashi R, 2002, INT J PROSTHODONT, V15, P385; Hinchey JA, 2005, STROKE, V36, P1972, DOI 10.1161/01.STR.0000177529.86868.8d; Hinds NP, 1998, QJM-MON J ASSOC PHYS, V91, P829, DOI 10.1093/qjmed/91.12.829; Hirota N, 2010, STROKE, V41, P2982, DOI 10.1161/STROKEAHA.110.594960; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; Mano T, 2014, NEUROLOGY, V82, P255, DOI 10.1212/WNL.0000000000000041; Nakamori M, 2016, CLIN NEUROPHYSIOL, V127, P1669, DOI 10.1016/j.clinph.2015.07.032; Nilsson H, 1998, DYSPHAGIA, V13, P32, DOI 10.1007/PL00009547; Oh JC, 2015, OCCUP THER INT; Ono T, 2007, GERODONTOLOGY, V24, P143, DOI 10.1111/j.1741-2358.2007.00172.x; Robbins J, 2007, ARCH PHYS MED REHAB, V88, P150, DOI 10.1016/j.apmr.2006.11.002; Shaker R, 1988, Dysphagia, V3, P79, DOI 10.1007/BF02412424; Smithard DG, 1996, STROKE, V27, P1200, DOI 10.1161/01.STR.27.7.1200; Tsuga K, 2011, J ORAL REHABIL, V38, P680, DOI 10.1111/j.1365-2842.2011.02202.x; Tsuga K, 2012, GERODONTOLOGY, V29, pE1078, DOI 10.1111/j.1741-2358.2011.00615.x; Utanohara Y, 2008, DYSPHAGIA, V23, P286, DOI 10.1007/s00455-007-9142-z; Yoshida M, 2006, DYSPHAGIA, V21, P61, DOI 10.1007/s00455-005-9011-6; Yoshikawa M, 2005, J GERONTOL A-BIOL, V60, P506, DOI 10.1093/gerona/60.4.506; Yoshikawa M, 2011, DYSPHAGIA, V26, P232, DOI 10.1007/s00455-010-9291-3	25	33	35	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165837	10.1371/journal.pone.0165837	http://dx.doi.org/10.1371/journal.pone.0165837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802333	gold, Green Published, Green Submitted			2022-12-27	WOS:000386714200061
J	Shin, SJ; Chung, S; Kim, SJ; Lee, EM; Yoo, YH; Kim, JW; Ahn, YB; Kim, ES; Moon, SD; Kim, MJ; Ko, SH				Shin, Seok Joon; Chung, Sungjin; Kim, Soo Jung; Lee, Eun-Mi; Yoo, Young-Hye; Kim, Ji-Won; Ahn, Yu-Bae; Kim, Eun-Sook; Moon, Sung-Dae; Kim, Myung-Jun; Ko, Seung-Hyun			Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes	PLOS ONE			English	Article							PROXIMAL TUBULAR CELLS; ACTIVATED RECEPTOR-ALPHA; PANCREATIC-FUNCTION; HYPERTENSIVE-RATS; SGLT2 INHIBITORS; OXIDATIVE STRESS; GENE-EXPRESSION; DB/DB MICE; NEPHROPATHY; KIDNEY	Background Renal renin-angiotensin system (RAS) activation is one of the important pathogenic mechanisms in the development of diabetic nephropathy in type 2 diabetes. The aim of this study was to investigate the effects of a sodium-glucose co-transporter 2 (SGLT-2) inhibitor, dapagliflozin, on renal RAS in an animal model with type 2 diabetes. Methods Dapagliflozin (1.0 mg/kg, OL-DA) or voglibose (0.6 mg/kg, OL-VO, diabetic control) (n = 10 each) was administered to Otsuka Long-Evans Tokushima Fatty (OLETF) rats for 12 weeks. We used voglibose, an alpha-glucosidase inhibitor, as a comparable counterpart to SGLT2 inhibitor because of its postprandial glucose-lowering effect without proven renoprotective effects. Control Long-Evans Tokushima Otsuka (LT) and OLETF (OL-C) rats received saline (n = 10, each). Changes in blood glucose, urine albumin, creatinine clearance, and oxidative stress were measured. Inflammatory cell infiltration, mesangial widening, and interstitial fibrosis in the kidney were evaluated by histological analysis. The effects of dapagliflozin on renal expression of the RAS components were evaluated by quantitative RT-PCR in renal tissue. Results After treatment, hyperglycemia and urine microalbumin levels were attenuated in both OLDA and OL-VO rather than in the OL-C group (P < 0.05). The urine angiotensin II (Ang II) and angiotensinogen levels were significantly decreased following treatment with dapagliflozin or voglibose, but suppression of urine Ang II level was more prominent in the OL-DA than the OL-VO group (P < 0.05). The expressions of angiotensin type 1 receptor and tissue oxidative stress markers were markedly increased in OL-C rats, which were reversed by dapagliflozin or voglibose (P < 0.05, both). Inflammatory cell infiltration, mesangial widening, interstitial fibrosis, and total collagen content were significantly increased in OL-C rats, which were attenuated in OL-DA group (P < 0.05). Conclusion Dapagliflozin treatment showed beneficial effects on diabetic nephropathy, which might be via suppression of renal RAS component expression, oxidative stress and interstitial fibrosis in OLETF rats. We suggest that, in addition to control of hyperglycemia, partial suppression of renal RAS with an SGLT2 inhibitor would be a promising strategy for the prevention of treatment of diabetic nephropathy.	[Shin, Seok Joon; Chung, Sungjin; Kim, Soo Jung] Catholic Univ Korea, Div Nephrol, Dept Internal Med, Coll Med, Seoul, South Korea; [Lee, Eun-Mi; Yoo, Young-Hye; Kim, Ji-Won; Ahn, Yu-Bae; Kim, Eun-Sook; Moon, Sung-Dae; Ko, Seung-Hyun] Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Myung-Jun] Catholic Univ Korea, Dept Physiol, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Ko, SH (corresponding author), Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, Coll Med, Seoul, South Korea.	kosh@catholic.ac.kr			Korean Diabetes Association	Korean Diabetes Association	This work was supported by a grant from the Korean Diabetes Association (S.H.K 2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo S, 2015, J DIABETES METAB, V6, DOI 10.4172/2155-6156.1000547; ANDERSON S, 1993, AM J PHYSIOL, V265, pF477, DOI 10.1152/ajprenal.1993.265.4.F477; Barber MN, 1999, HYPERTENSION, V34, P1112, DOI 10.1161/01.HYP.34.5.1112; Barutta F, 2015, ENDOCRINE, V48, P730, DOI 10.1007/s12020-014-0437-1; Bouchie A, 2013, NAT BIOTECHNOL, V31, P469, DOI 10.1038/nbt0613-469; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; Chen L, 2012, CURR MOL MED, V12, P995, DOI 10.2174/156652412802480970; DeFronzo RA, 2013, DIABETES CARE, V36, P3169, DOI 10.2337/dc13-0387; Durvasula RV, 2008, AM J PHYSIOL-RENAL, V294, pF830, DOI 10.1152/ajprenal.00266.2007; Fan YY, 2013, HORM METAB RES, V45, P338, DOI 10.1055/s-0032-1331256; Feliers D, 2010, MOL CELL ENDOCRINOL, V314, P136, DOI 10.1016/j.mce.2009.09.009; Fujimori Y, 2008, J PHARMACOL EXP THER, V327, P268, DOI 10.1124/jpet.108.140210; GOTO Y, 1995, DIABETES RES CLIN PR, V28, P81, DOI 10.1016/0168-8227(95)01065-L; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Gurley SB, 2007, SEMIN NEPHROL, V27, P144, DOI 10.1016/j.semnephrol.2007.01.009; Hsieh TJ, 2003, ENDOCRINOLOGY, V144, P4338, DOI 10.1210/en.2003-0220; Jones ES, 2008, PHARMACOL THERAPEUT, V120, P292, DOI 10.1016/j.pharmthera.2008.08.009; Jung CH, 2014, DIABETES METAB J, V38, P261, DOI 10.4093/dmj.2014.38.4.261; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Kim J, 2006, J BIOL CHEM, V281, P20349, DOI 10.1074/jbc.M512740200; Komala MG, 2013, CURR OPIN NEPHROL HY, V22, P113, DOI 10.1097/MNH.0b013e32835a17ae; Kreisberg JI, 1996, KIDNEY INT, V50, P805, DOI 10.1038/ki.1996.379; Macdonald FR, 2010, DIABETES OBES METAB, V12, P1004, DOI 10.1111/j.1463-1326.2010.01291.x; Matsuo S, 2005, KIDNEY INT, V67, P2221, DOI 10.1111/j.1523-1755.2005.00327.x; Moon JY, 2011, AM J PHYSIOL-RENAL, V300, pF1271, DOI 10.1152/ajprenal.00065.2010; Mori Y, 2004, ENDOCRINE, V23, P39, DOI 10.1385/ENDO:23:1:39; Nagata T, 2013, BRIT J PHARMACOL, V170, P519, DOI 10.1111/bph.12269; Nozako M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143979; Paisley AJ, 2013, EXPERT OPIN INV DRUG, V22, P131, DOI 10.1517/13543784.2013.740009; Park CW, 2014, DIABETES METAB J, V38, P252, DOI 10.4093/dmj.2014.38.4.252; Park CW, 2006, DIABETES, V55, P885, DOI 10.2337/diabetes.55.04.06.db05-1329; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Plosker GL, 2012, DRUGS, V72, P2289, DOI 10.2165/11209910-000000000-00000; Raskin P, 2013, DIABETES-METAB RES, V29, P347, DOI 10.1002/dmrr.2403; Satirapoj B, 2014, KIDNEY RES CLIN PRAC, V33, P121, DOI 10.1016/j.krcp.2014.08.001; Shah NK, 2012, PHARMACOTHERAPY, V32, P80, DOI 10.1002/PHAR.1010; Shin SJ, 2009, HYPERTENS RES, V32, P835, DOI 10.1038/hr.2009.107; Singh R, 1999, DIABETES, V48, P2066, DOI 10.2337/diabetes.48.10.2066; Tahara A, 2013, EUR J PHARMACOL, V715, P246, DOI 10.1016/j.ejphar.2013.05.014; Terami N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100777; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Velez JCQ, 2009, NAT CLIN PRACT NEPHR, V5, P89, DOI 10.1038/ncpneph1015; Visavadiya NP, 2011, NEPHRON EXP NEPHROL, V117, pE62, DOI [10.1159/000320593, 10.1159/000320594]; Weibel ER., 1979, STEREOLOGICAL METHOD, P44; Wolf G, 1999, NEPHROL DIAL TRANSPL, V14, P42, DOI 10.1093/ndt/14.suppl_1.42; Wu J, 1998, BIOCHEM J, V329, P623, DOI 10.1042/bj3290623; Zaccardi F, 2016, DIABETES OBES METAB; Zhang SL, 2000, ENDOCRINOLOGY, V141, P4637, DOI 10.1210/endo.141.12.7844; Zhao FY, 2015, INT J CLIN EXP MED, V8, P22084	49	116	126	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2016	11	11							e0165703	10.1371/journal.pone.0165703	http://dx.doi.org/10.1371/journal.pone.0165703			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA6CX	27802313	Green Published, Green Submitted, gold			2022-12-27	WOS:000386714200040
